PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Krenciute, G; Liu, SF; Yucer, N; Shi, Y; Ortiz, P; Liu, QM; Kim, BJ; Odejimi, AO; Leng, M; Qin, J; Wang, Y				Krenciute, Giedre; Liu, Shangfeng; Yucer, Nur; Shi, Yi; Ortiz, Priscilla; Liu, Qiongming; Kim, Beom-Jun; Odejimi, Abiola Ore; Leng, Mei; Qin, Jun; Wang, Yi			Nuclear BAG6-UBL4A-GET4 Complex Mediates DNA Damage Signaling and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCYTHE; UBIQUITIN; PROTEINS; REGULATOR; APOPTOSIS; CHROMATIN; PROMOTES; CYCLE; GET3	BCL2-associated athanogene 6 (BAG6) is a member of the BAG protein family, which is implicated in diverse cellular processes including apoptosis, co-chaperone, and DNA damage response (DDR). Recently, it has been shown that BAG6 forms a stable complex with UBL4A and GET4 and functions in membrane protein targeting and protein quality control. The BAG6 sequence contains a canonical nuclear localization signal and is localized predominantly in the nucleus. However, GET4 and UBL4A are found mainly in cytoplasm. Whether GET4 and UBL4A are also involved in DDR in the context of the BAG6 complex remains unknown. Here, we provide evidence that nuclear BAG6-UBL4A-GET4 complex mediates DDR signaling and damage-induced cell death. BAG6 appears to be the central component for the process, as depletion of BAG6 leads to the loss of both UBL4A and GET4 proteins and resistance to cell killing by DNA-damaging agents. In addition, nuclear localization of BAG6 and phosphorylation of BAG6 by ATM/ATR are also required for cell killing. UBL4A and GET4 translocate to the nucleus upon DNA damage and appear to play redundant roles in cell killing, as depletion of either one has no effect but co-depletion leads to resistance. All three components of the BAG6 complex are required for optimal DDR signaling, as BAG6, and to a lesser extent, GET4 and UBL4A, regulate the recruitment of BRCA1 to sites of DNA damage. Together our results suggest that the nuclear BAG6 complex is an effector in DNA damage response pathway and its phosphorylation and nuclear localization are important determinants for its function.	[Krenciute, Giedre; Liu, Shangfeng; Yucer, Nur; Shi, Yi; Ortiz, Priscilla; Kim, Beom-Jun; Odejimi, Abiola Ore; Qin, Jun; Wang, Yi] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leng, Mei; Qin, Jun; Wang, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Qiongming] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Academy of Military Medical Sciences - China	Wang, Y (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	yiw@bcm.edu	Krenciute, Giedre/N-8094-2018; Shi, Yi/P-7972-2018	Krenciute, Giedre/0000-0003-4335-0644; Shi, Yi/0000-0002-2761-8324	National Institutes of Health [GM080703, AI036211, CA125123, RR024574]; Chinese Natural Science Foundation [31270822]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080703 and Chinese Natural Science Foundation Grant 31270822. This work was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health Grants AI036211, CA125123, and RR024574.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yong ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038085; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	23	23	26	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20547	20557		10.1074/jbc.M112.443416	http://dx.doi.org/10.1074/jbc.M112.443416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723067	Green Published, hybrid			2022-12-25	WOS:000321715100041
J	Fransolet, D; Roberty, S; Herman, AC; Tonk, L; Hoegh-Guldberg, O; Plumier, JC				Fransolet, David; Roberty, Stephane; Herman, Anne-Catherine; Tonk, Linda; Hoegh-Guldberg, Ove; Plumier, Jean-Christophe			Increased Cell Proliferation and Mucocyte Density in the Sea Anemone Aiptasia pallida Recovering from Bleaching	PLOS ONE			English	Article							SYMBIOTIC ALGAE; ULTRAVIOLET-RADIATION; SEAWATER TEMPERATURE; MONTASTREA-ANNULARIS; ENVIRONMENTAL-STRESS; ADAPTIVE RESPONSE; CLIMATE-CHANGE; REEF CORALS; MECHANISMS; MORTALITY	Recovery of coral after bleaching episodes is a critical period for the health of the reef ecosystem. While events such as symbiont (genus Symbiodinium) shifting/shuffling or tissue apoptosis have been demonstrated to occur following bleaching, little is known concerning tissue recovery or cell proliferation. Here, we studied the sea anemone Aiptasia pallida exposed to a transient elevation of water temperature combined with high illumination (33 degrees C and 1900 mmolphotons. m(-2).s(-1) for 30h). Following such treatment bleached anemones showed a significant reduction of their Symbiodinium density. Cell proliferation in the ectodermis and gastrodermis was determined by assessing the densities of cells labeled with a thymidine analogue (EdU). Cell proliferation significantly increased during the first day following stress in both tissue types. This increased cell proliferation returned to pre-stress values after one week. Although cell proliferation was higher in the ectodermis in absence of stress, it was relatively more pronounced in the gastrodermis of stressed anemones. In addition, the ratio of ectodermal mucocytes significantly increased three weeks after induced stress. These results suggest that thermal/photic stress coupled with the loss of the symbionts is able to enhance cell proliferation in both gastrodermis and ectodermis of cnidarians. While new cells formed in the gastrodermis are likely to host new Symbiodinium, the fate of new cells in the ectodermis was only partially revealed. Some new ectodermal cells may, in part, contribute to the increased number of mucocytes which could eventually help strengthen the heterotrophic state until restoration of the symbiosis.	[Fransolet, David; Herman, Anne-Catherine; Plumier, Jean-Christophe] Univ Liege, Liege, Belgium; [Roberty, Stephane] Univ Liege, Lab Ecol Anim & Ecotoxicol, Liege, Belgium; [Tonk, Linda; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Tonk, Linda; Hoegh-Guldberg, Ove] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Liege; University of Liege; University of Queensland; University of Queensland; University of Queensland	Plumier, JC (corresponding author), Univ Liege, Liege, Belgium.	jc.plumier@ulg.ac.be	Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Roberty, Stephane/0000-0001-6188-1970	F.R.I.A PhD Studentship; Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies; F.R.S.-F.N.R.S [FRFC 2.4.631.09]; University of Liege	F.R.I.A PhD Studentship(Fonds de la Recherche Scientifique - FNRS); Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); F.R.S.-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege)	DF is a recipient of a F.R.I.A PhD Studentship, SR is a research fellow of the F.R.S-F.N.R.S. LT and OHG were supported by funding from the Great Barrier Reef Foundation, the Queensland Smart State Fellowship Award (to OHG) and the ARC Centre of Excellence for Coral Reef Studies. JCP was supported by funding from the F.R.S.-F.N.R.S. (FRFC 2.4.631.09) and from the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bhagooli R, 2004, MAR BIOL, V145, P329, DOI 10.1007/s00227-004-1309-7; Bode HR, 1996, J CELL SCI, V109, P1155; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Brown BE, 1996, CORAL REEFS, V15, P151, DOI 10.1007/BF01145885; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Cook CB, 2001, HYDROBIOLOGIA, V461, P71, DOI 10.1023/A:1012785725378; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; Ferrier-Pages C, 2000, AQUAT MICROB ECOL, V21, P203, DOI 10.3354/ame021203; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Fransolet D, 2012, J EXP MAR BIOL ECOL, V420, P1, DOI 10.1016/j.jembe.2012.03.015; Galliot B, 2010, MOL REPROD DEV, V77, P837, DOI 10.1002/mrd.21206; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; GLYNN PW, 1985, DIS AQUAT ORGAN, V1, P29, DOI 10.3354/dao001029; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goldberg WM, 2002, TISSUE CELL, V34, P232, DOI 10.1016/S0040-8166(02)00009-5; GOREAU TJ, 1994, AMBIO, V23, P176; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; HAYES RL, 1990, CORAL REEFS, V8, P203, DOI 10.1007/BF00265012; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2008, MAR BIOL, V154, P65, DOI 10.1007/s00227-007-0900-0; KramarskyWinter E, 1996, MAR ECOL PROG SER, V134, P179, DOI 10.3354/meps134179; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; LASKER HR, 1984, CORAL REEFS, V3, P183, DOI 10.1007/BF00288253; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; LESSER MP, 1989, CYTOMETRY, V10, P653, DOI 10.1002/cyto.990100522; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; LeTissier MDA, 1996, MAR ECOL PROG SER, V136, P235, DOI 10.3354/meps136235; Lewis J. B., 1977, Proceedings int Coral Reef Symp, V3, P405; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Muscatine L., 1990, P75; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Niggl W, 2008, P 11 INT COR REEF S; Passamaneck YJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-34; Perez SF, 2001, J EXP MAR BIOL ECOL, V256, P1, DOI 10.1016/S0022-0981(00)00282-3; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Piggot AM, 2009, MAR BIOL, V156, P2379, DOI 10.1007/s00227-009-1267-1; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; Schlichter D, 1998, FACIES, V39, P227, DOI 10.1007/BF02537018; Siebert S, 2008, DEV BIOL, V313, P13, DOI 10.1016/j.ydbio.2007.09.007; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310	72	10	10	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65015	10.1371/journal.pone.0065015	http://dx.doi.org/10.1371/journal.pone.0065015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724115	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000112
J	Diaz-Chavez, J; Fonseca-Sanchez, MA; Arechaga-Ocampo, E; Flores-Perez, A; Palacios-Rodriguez, Y; Dominguez-Gomez, G; Marchat, LA; Fuentes-Mera, L; Mendoza-Hernandez, G; Gariglio, P; Lopez-Camarillo, C				Diaz-Chavez, Jose; Fonseca-Sanchez, Miguel A.; Arechaga-Ocampo, Elena; Flores-Perez, Ali; Palacios-Rodriguez, Yadira; Dominguez-Gomez, Guadalupe; Marchat, Laurence A.; Fuentes-Mera, Lizeth; Mendoza-Hernandez, Guillermo; Gariglio, Patricio; Lopez-Camarillo, Cesar			Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GROWTH-INHIBITION; INDUCED APOPTOSIS; PROSTATE-CANCER; CYCLE ARREST; ANDROGEN ABLATION; DRUG-RESISTANCE; DOWN-REGULATION; TUMOR-GROWTH; MCF-7	The use of chemopreventive natural compounds represents a promising strategy in the search for novel therapeutic agents in cancer. Resveratrol (3,4',5-trans-trihydroxystilbilene) is a dietary polyphenol found in fruits, vegetables and medicinal plants that exhibits chemopreventive and antitumor effects. In this study, we searched for modulated proteins with preventive or therapeutic potential in MCF-7 breast cancer cells exposed to resveratrol. Using two-dimensional electrophoresis we found significant changes (FC>2.0; p <= 0.05) in the expression of 16 proteins in resveratrol-treated MCF-7 cells. Six down-regulated proteins were identified by tandem mass spectrometry (ESI-MS/MS) as heat shock protein 27 (HSP27), translationally-controlled tumor protein, peroxiredoxin-6, stress-induced-phosphoprotein-1, pyridoxine-5'-phosphate oxidase-1 and hypoxanthine-guanine phosphoribosyl transferase; whereas one up-regulated protein was identified as triosephosphate isomerase. Particularly, HSP27 overexpression has been associated to apoptosis inhibition and resistance of human cancer cells to therapy. Consistently, we demonstrated that resveratrol induces apoptosis in MCF-7 cells. Apoptosis was associated with a significant increase in mitochondrial permeability transition, cytochrome c release in cytoplasm, and caspases -3 and -9 independent cell death. Then, we evaluated the chemosensitization effect of increasing concentrations of resveratrol in combination with doxorubicin anti-neoplastic agent in vitro. We found that resveratrol effectively sensitize MCF-7 cells to cytotoxic therapy. Next, we evaluated the relevance of HSP27 targeted inhibition in therapy effectiveness. Results evidenced that HSP27 inhibition using RNA interference enhances the cytotoxicity of doxorubicin. In conclusion, our data indicate that resveratrol may improve the therapeutic effects of doxorubicin in part by cell death induction. We propose that potential modulation of HSP27 levels using natural alternative agents, as resveratrol, may be an effective adjuvant in breast cancer therapy.	[Diaz-Chavez, Jose; Dominguez-Gomez, Guadalupe] Natl Inst Cancerol, Carcinogenesis Lab, Mexico City, DF, Mexico; [Fonseca-Sanchez, Miguel A.; Flores-Perez, Ali; Palacios-Rodriguez, Yadira; Lopez-Camarillo, Cesar] Autonomous Univ Mexico City, Oncogen & Canc Prote Lab, Genom Sci Program, Mexico City, DF, Mexico; [Arechaga-Ocampo, Elena] Natl Inst Cancerol, Virus & Canc Lab, Mexico City, DF, Mexico; [Marchat, Laurence A.] Natl Polytech Inst, Natl Sch Med & Homeopathy, Mol Biomed Program, Mexico City, DF, Mexico; [Marchat, Laurence A.] Natl Polytech Inst, Natl Sch Med & Homeopathy, Biotechnol Network, Mexico City, DF, Mexico; [Fuentes-Mera, Lizeth] Gen Dr Manuel Gea Gonzalez Hosp, Mol Biol & Histocompatibil Lab, Mexico City, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Gariglio, Patricio] Ctr Res & Adv Studies, Genet & Mol Biol Dept, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Lopez-Camarillo, C (corresponding author), Autonomous Univ Mexico City, Oncogen & Canc Prote Lab, Genom Sci Program, Mexico City, DF, Mexico.	genomicas@yahoo.com.mx	Lopez-Camarillo, Cesar/I-1946-2019; Marchat, Laurence A./S-8418-2018; Arechaga-Ocampo, Elena/AAG-8756-2021; Díaz-Chávez, José/HGU-7481-2022; Palacios, Yadira/G-8808-2019	Lopez-Camarillo, Cesar/0000-0002-9417-2609; Marchat, Laurence A./0000-0003-1615-8614; Arechaga-Ocampo, Elena/0000-0002-0787-5593; Dominguez-Gomez, Guadalupe/0000-0003-3906-4493; Fuentes-Mera, Lizeth/0000-0002-2649-5369; Palacios, Yadira/0000-0003-0712-4439; Ali, Flores-Perez/0000-0001-9141-9234; Diaz-Chavez, Jose/0000-0001-9583-3790; Fonseca-Sanchez, Miguel Angel/0000-0002-7901-221X	FONSEC SALUD [2009-01-112454]; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico (ICYT-DF)	FONSEC SALUD; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico (ICYT-DF)	This work was supported by FONSEC SALUD 2009-01-112454 grant. Miguel A. Fonseca-Sanchez and Yadira Palacios-Rodriguez were supported by Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico (ICYT-DF). (http://www.conacyt.gob.mx/Paginas/InicioNueva.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf M, 2007, EUR J CANCER PREV, V16, P334, DOI 10.1097/01.cej.0000228413.06471.4c; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Baylot V, 2012, MOL THER, V20, P2244, DOI 10.1038/mt.2012.155; Benitez DA, 2009, PROSTATE, V69, P1045, DOI 10.1002/pros.20953; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Brito PM, 2008, APOPTOSIS, V13, P1043, DOI 10.1007/s10495-008-0235-4; CAMICI M, 1990, CANCER BIOCHEM BIOPH, V11, P201; Chan THM, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/369384; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Chow AW, 2005, EUR J CANCER PREV, V14, P351, DOI 10.1097/00008469-200508000-00007; Dann JM, 2009, GYNECOL ONCOL, V113, P374, DOI 10.1016/j.ygyno.2009.02.014; Dintinjana RD, 2008, COLLEGIUM ANTROPOL, V32, P737; ElAttar TMA, 1999, ANTICANCER RES, V19, P5407; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Goncalves K, 2012, CANCER INVEST, V30, P38, DOI 10.3109/07357907.2011.629382; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kim LS, 2011, J BREAST CANCER, V14, P167, DOI 10.4048/jbc.2011.14.3.167; Kim MY, 2009, ANTICANCER RES, V29, P3733; Kurokawa H, 1999, ONCOL REP, V6, P33; Lee SK, 2008, J AGR FOOD CHEM, V56, P7572, DOI 10.1021/jf801014p; Leon-Galicia I, 2013, EUR J CANCER PREV, V22, P11, DOI 10.1097/CEJ.0b013e328353edcb; Lin HY, 2008, J CELL BIOCHEM, V104, P2131, DOI 10.1002/jcb.21772; Liu MM, 2012, ANTI-CANCER AGENT ME, V12, P1306; Ly D, 2013, INT J CANCER, V132, P1918, DOI 10.1002/ijc.27841; Malhotra A, 2011, EUR J CANCER PREV, V20, P411, DOI 10.1097/CEJ.0b013e3283481d71; Mathers C, 2012, LANCET, VS0140-6736, P60919; Montgomerie JZ, 1997, CLIN BIOCHEM, V30, P613, DOI 10.1016/S0009-9120(97)00115-X; Morii T, 2010, ANTICANCER RES, V30, P3565; Musayev FN, 2009, J BIOL CHEM, V284, P30949, DOI 10.1074/jbc.M109.038372; OESTERREICH S, 1993, CANCER RES, V53, P4443; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Park JW, 2001, CARCINOGENESIS, V22, P1633, DOI 10.1093/carcin/22.10.1633; Pietrocola F, 2012, CELL CYCLE, V11, P3851, DOI 10.4161/cc.22027; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Raj MHG, 2008, GYNECOL ONCOL, V110, P432, DOI 10.1016/j.ygyno.2008.05.001; Ralser M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-38; Robsahm TE, 1999, EUR J CANCER PREV, V8, P105, DOI 10.1097/00008469-199904000-00004; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Roy P, 2009, PHARM RES-DORDR, V26, P211, DOI 10.1007/s11095-008-9723-z; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Scalbert A, 2012, BR J NUTR, V14, P1; Schultz CR, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-20; Sinha P, 2003, ELECTROPHORESIS, V24, P2386, DOI 10.1002/elps.200305456; Sobolev VS, 1999, J AGR FOOD CHEM, V47, P1435, DOI 10.1021/jf9809885; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Stervbo U, 2006, CELL PROLIFERAT, V39, P479, DOI 10.1111/j.1365-2184.2006.00406.x; Torres RJ, 2012, GENE, V511, P306, DOI 10.1016/j.gene.2012.09.121; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Wolter F, 2002, J NUTR, V132, P2082, DOI 10.1093/jn/132.7.2082; Wolter F, 2001, J NUTR, V131, P2197, DOI 10.1093/jn/131.8.2197; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	65	57	61	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64378	10.1371/journal.pone.0064378	http://dx.doi.org/10.1371/journal.pone.0064378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724044	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100025
J	Dimon, MT; Wood, HM; Rabbitts, PH; Arron, ST				Dimon, Michelle T.; Wood, Henry M.; Rabbitts, Pamela H.; Arron, Sarah T.			IMSA: Integrated Metagenomic Sequence Analysis for Identification of Exogenous Reads in a Host Genomic Background	PLOS ONE			English	Article							MICROBES; VIRUSES	Metagenomics, the study of microbial genomes within diverse environments, is a rapidly developing field. The identification of microbial sequences within a host organism enables the study of human intestinal, respiratory, and skin microbiota, and has allowed the identification of novel viruses in diseases such as Merkel cell carcinoma. There are few publicly available tools for metagenomic high throughput sequence analysis. We present Integrated Metagenomic Sequence Analysis (IMSA), a flexible, fast, and robust computational analysis pipeline that is available for public use. IMSA takes input sequence from high throughput datasets and uses a user-defined host database to filter out host sequence. IMSA then aligns the filtered reads to a user-defined universal database to characterize exogenous reads within the host background. IMSA assigns a score to each node of the taxonomy based on read frequency, and can output this as a taxonomy report suitable for cluster analysis or as a taxonomy map (TaxMap). IMSA also outputs the specific sequence reads assigned to a taxon of interest for downstream analysis. We demonstrate the use of IMSA to detect pathogens and normal flora within sequence data from a primary human cervical cancer carrying HPV16, a primary human cutaneous squamous cell carcinoma carrying HPV 16, the CaSki cell line carrying HPV16, and the HeLa cell line carrying HPV18.	[Dimon, Michelle T.; Arron, Sarah T.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wood, Henry M.; Rabbitts, Pamela H.] St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of California System; University of California San Francisco; Saint James's University Hospital; University of Leeds	Arron, ST (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	arrons@derm.ucsf.edu		Wood, Henry/0000-0003-3009-5904; Arron, Sarah/0000-0001-5669-0627	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant [KL2 TR000143]; Yorkshire Cancer Research [L341PG]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant; Yorkshire Cancer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	S.T.A. was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number KL2 TR000143. H. M. W. and P. H. R. were supported by the Yorkshire Cancer Research grant L341PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arron ST, 2011, J INVEST DERMATOL; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Borewicz K, 2012, FEMS MICROBIOL LETT; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Conway C, 2012, J MOL DIAGN, V14, P104, DOI 10.1016/j.jmoldx.2011.10.003; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin Z, 2012, J VIROL, V86, P2970, DOI 10.1128/JVI.06717-11; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Zakrzewski M, 2012, J BIOTECHNOL; Zhu Z, 2012, BIOINFORMATICS	24	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64546	10.1371/journal.pone.0064546	http://dx.doi.org/10.1371/journal.pone.0064546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717627	Green Published, gold			2022-12-25	WOS:000319435600068
J	Farias, L; Faundez, J; Fernandez, C; Cornejo, M; Sanhueza, S; Carrasco, C				Farias, Laura; Faundez, Juan; Fernandez, Camila; Cornejo, Marcela; Sanhueza, Sandra; Carrasco, Cristina			Biological N2O Fixation in the Eastern South Pacific Ocean and Marine Cyanobacterial Cultures	PLOS ONE			English	Article							NITROUS-OXIDE DISTRIBUTION; OXYGEN-DEFICIENT WATERS; NORTH PACIFIC; DINITROGEN-FIXATION; NIFH GENES; DENITRIFICATION; DIVERSITY; SUBSTRATE; MECHANISM; SEA	Despite the importance of nitrous oxide (N2O) in the global radiative balance and atmospheric ozone chemistry, its sources and sinks within the Earth's system are still poorly understood. In the ocean, N2O is produced by microbiological processes such as nitrification and partial denitrification, which account for about a third of global emissions. Conversely, complete denitrification (the dissimilative reduction of N2O to N-2) under suboxic/anoxic conditions is the only known pathway accountable for N2O consumption in the ocean. In this work, it is demonstrated that the biological assimilation of N2O could be a significant pathway capable of directly transforming this gas into particulate organic nitrogen (PON). N2O is shown to be biologically fixed within the subtropical and tropical waters of the eastern South Pacific Ocean, under a wide range of oceanographic conditions and at rates ranging from 2 pmol N L-1 d(-) to 14.8 nmol N L-1 d(-1) (mean +/- SE of 0.522 +/- 1.06 nmol N L-1 d(-1), n = 93). Additional assays revealed that cultured cyanobacterial strains of Trichodesmium (H-9 and IMS 101), and Crocosphaera (W-8501) have the capacity to directly fix N2O under laboratory conditions; suggesting that marine photoautotrophic diazotrophs could be using N2O as a substrate. This metabolic capacity however was absent in Synechococcus (RCC 1029). The findings presented here indicate that assimilative N2O fixation takes place under extreme environmental conditions (i.e., light, nutrient, oxygen) where both autotrophic (including cyanobacteria) and heterotrophic microbes appear to be involved. This process could provide a globally significant sink for atmospheric N2O which in turn affects the oceanic N2O inventory and may also represent a yet unexplored global oceanic source of fixed N.	[Farias, Laura; Cornejo, Marcela] Univ Concepcion, Lab Oceanog & Climate Proc PROFC, Dept Oceanog, Concepcion, Chile; [Farias, Laura; Cornejo, Marcela] Ctr Climate Change & Resilience Res CR2, Concepcion, Chile; [Faundez, Juan; Sanhueza, Sandra; Carrasco, Cristina] Univ Concepcion, Grad Program Oceanog, Dept Oceanog, Concepcion, Chile; [Fernandez, Camila] Univ Paris 06, Banyuls S Mer, France; [Fernandez, Camila] Observ Oceanol, LOMIC, UMR 7621, CNRS, Banyuls S Mer, France	Universidad de Concepcion; Universidad de Concepcion; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Farias, L (corresponding author), Univ Concepcion, Lab Oceanog & Climate Proc PROFC, Dept Oceanog, Concepcion, Chile.	lfarias@profc.udec.cl	Cornejo-D'Ottone, Marcela/AAG-2744-2020	Farias, Laura/0000-0002-9479-1557; Cornejo-D'Ottone, Marcela/0000-0003-1016-4423	Chilean National Commission for Scientific and Technological Research (CONICYT) through the FONDECYT program [1050743, 3110158]; Chilean National Commission for Scientific and Technological Research (CONICYT) through FONDAP program [1501007]; Betty and Gordon Moore Foundation (MILOCO grant)	Chilean National Commission for Scientific and Technological Research (CONICYT) through the FONDECYT program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean National Commission for Scientific and Technological Research (CONICYT) through FONDAP program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Betty and Gordon Moore Foundation (MILOCO grant)	This work has been supported by the Chilean National Commission for Scientific and Technological Research (CONICYT) through the FONDECYT (grant 1050743 and 3110158) and FONDAP (grant 1501007) programs, as well as by the Betty and Gordon Moore Foundation (MILOCO grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bange HW, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P51, DOI 10.1016/B978-0-12-372522-6.00002-5; Bergman B., 2012, FEMS MICROBIOLOGY RE, V37, P1; Blain S, 2008, BIOGEOSCIENCES, V5, P269, DOI 10.5194/bg-5-269-2008; Bohlke JK, 2005, J PHYS CHEM REF DATA, V34, P57, DOI 10.1063/1.1836764; Bonnet S, 2008, BIOGEOSCIENCES, V5, P215, DOI 10.5194/bg-5-215-2008; Bruland KW, 2005, MAR CHEM, V93, P81, DOI 10.1016/j.marchem.2004.06.011; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Charpentier J, 2007, BIOGEOSCIENCES, V4, P729, DOI 10.5194/bg-4-729-2007; Charpentier J, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003388; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Christiansen J, 2000, J BIOL CHEM, V275, P36104, DOI 10.1074/jbc.M004889200; CICERONE RJ, 1989, J GEOPHYS RES-ATMOS, V94, P18265, DOI 10.1029/JD094iD15p18265; Claustre H, 2008, BIOGEOSCIENCES, V5, P679, DOI 10.5194/bg-5-679-2008; CLINE JD, 1987, DEEP-SEA RES, V34, P857, DOI 10.1016/0198-0149(87)90041-0; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; Cornejo M, 2007, PROG OCEANOGR, V75, P383, DOI 10.1016/j.pocean.2007.08.018; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Development Core Team, 2011, R LANG ENV STAT COMP; ELKINS JW, 1978, NATURE, V275, P602, DOI 10.1038/275602a0; Farias L, 2009, LIMNOL OCEANOGR, V54, P132, DOI 10.4319/lo.2009.54.1.0132; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Frame CH, 2010, BIOGEOSCIENCES, V7, P2695, DOI 10.5194/bg-7-2695-2010; Grasshoff K., 1983, VERLAG CHEMIE FRG, P419, DOI DOI 10.1002/IROH.19850700232; Grob C, 2007, BIOGEOSCIENCES, V4, P837, DOI 10.5194/bg-4-837-2007; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; HERZBERG G, 1966, ELECT SPECTRA ELECT, P778; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Jayakumar A, 2012, FEMS MICROBIOL ECOL, V82, P597, DOI 10.1111/j.1574-6941.2012.01430.x; JENSEN BB, 1986, BIOCHEMISTRY-US, V25, P1083, DOI 10.1021/bi00353a021; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Marie D., 2000, SPRING LAB MAN, P421, DOI 10.1007/978-3-642-57049-0_34; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; NEVISON CD, 1995, J GEOPHYS RES-OCEANS, V100, P15809, DOI 10.1029/95JC00684; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Popp BN, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001806; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; RIVERAORTIZ JM, 1975, J BACTERIOL, V123, P537, DOI 10.1128/JB.123.2.537-545.1975; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Sarmiento J.L., 2006, OCEAN BIOGEOCHEMICAL, DOI [10.1017/S0016756807003755, DOI 10.1017/S0016756807003755]; Shestakov AF, 2001, RUSS CHEM B+, V50, P2054, DOI 10.1023/A:1015028713288; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Suntharalingam P, 2000, GLOBAL BIOGEOCHEM CY, V14, P429, DOI 10.1029/1999GB900032; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Toyoda S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014311; VAUGHN SA, 1989, BIOCHEMISTRY-US, V28, P419, DOI 10.1021/bi00428a002; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Yamagishi H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021458; Yoshida N, 2000, NATURE, V405, P330, DOI 10.1038/35012558; YOSHINARI T, 1976, Marine Chemistry, V4, P189, DOI 10.1016/0304-4203(76)90007-4; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	68	21	21	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63956	10.1371/journal.pone.0063956	http://dx.doi.org/10.1371/journal.pone.0063956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717516	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600038
J	Lv, XB; Lian, GY; Wang, HR; Song, EW; Yao, HR; Wang, MH				Lv, Xiao-Bin; Lian, Gui-Yong; Wang, Hao-Ran; Song, Erwei; Yao, Herui; Wang, Ming-Hui			Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival	PLOS ONE			English	Article							CANCER	Background: It is currently unclear whether the expression of HOX transcript antisense RNA (HOTAIR) correlates with the progression of esophageal cancer. The aim of this study was to examine HOTAIR expression in patients with esophageal squamous cell cancer (ESCC) and explore its clinical significance. Methods: Differences in the expression of HOTAIR were examined via in situ hybridization (ISH) and quantitative reverse transcriptase PCR (qRT-PCR). The prognostic significance was evaluated using Kaplan-Meier and Cox regression analyses. Proliferation, colony formation and migration assays were performed in ESCC cell lines to determine the function of HOTAIR in the progression of ESCC in vitro. Results: A notably higher level of HOTAIR expression was found in ESCC tissues. High expression levels of HOTAIR in ESCC patients correlated positively with clinical stage, TNM classification, histological differentiation and vital status. HOTAIR expression was found to be an independent prognostic factor in ESCC patients. ESCC patients who expressed high levels of HOTAIR had substantially lower overall 5-year survival rates than HOTAIR-negative patients. In vitro assays of ESCC cell lines demonstrated that HOTAIR mediated the proliferation, colony formation and migratory capacity of ESCC cells. Conclusion: HOTAIR is a potential biomarker for ESCC prognosis, and the dysregulation of HOTAIR may play an important role in ESCC progression.	[Lian, Gui-Yong; Wang, Hao-Ran; Wang, Ming-Hui] Sun Yat Sen Univ, Dept Thoracic Cardiac Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Song, Erwei; Yao, Herui] Sun Yat Sen Univ, Breast Tumor Ctr, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Lv, Xiao-Bin] Sun Yat Sen Univ, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yao, HR (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China.	yaoherui@163.com; Wangminghui01@yahoo.com.cn	Lv, Xiao-Bin/T-7607-2019	Yao, Herui/0000-0001-5520-6469	National Natural Science Foundation of China [81102023, 30973505]; Foundation of Ministry of Education of the People's Republic of China [20120171110075]; Guangdong Natural Science Foundation [S2011040004481, 7001618]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1, 2008B030301135]; Sun Yat-Sen University [12ykpy32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of the People's Republic of China(Ministry of Education, China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation of Guangzhou Science and Technology Bureau; Sun Yat-Sen University	This study was supported by the National Natural Science Foundation of China (81102023 and 30973505) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Foundation of Ministry of Education of the People's Republic of China (20120171110075), the Guangdong Natural Science Foundation (S2011040004481 and 7001618), the Foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1 and 2008B030301135) and the Sun Yat-Sen University Training Project (12ykpy32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim K, 2013, ONCOGENE; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qi YJ, 2012, J PROTEOMICS, V75, P3129, DOI 10.1016/j.jprot.2012.04.025; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	26	155	167	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63516	10.1371/journal.pone.0063516	http://dx.doi.org/10.1371/journal.pone.0063516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717443	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600021
J	Zoerner, F; Wiklund, L; Miclescu, A; Martijn, C				Zoerner, Frank; Wiklund, Lars; Miclescu, Adriana; Martijn, Cecile			Therapeutic Hypothermia Activates the Endothelin and Nitric Oxide Systems after Cardiac Arrest in a Pig Model of Cardiopulmonary Resuscitation	PLOS ONE			English	Article							INTERNATIONAL LIAISON COMMITTEE; METHYLENE-BLUE; FREE-RADICALS; REPERFUSION; CARDIOMYOCYTES; DYSFUNCTION; EXPRESSION; STATEMENT; SURVIVAL; SYNTHASE	Post-cardiac arrest myocardial dysfunction is a major cause of mortality in patients receiving successful cardiopulmonary resuscitation (CPR). Mild therapeutic hypothermia (MTH) is the recommended treatment after resuscitation from cardiac arrest (CA) and is known to exert neuroprotective effects and improve short-term survival. Yet its cytoprotective mechanisms are not fully understood. In this study, our aim was to determine the possible effect of MTH on vasoactive mediators belonging to the endothelin/ nitric oxide axis in our porcine model of CA and CPR. Pigs underwent either untreated CA or CA with subsequent CPR. After state-of-the-art resuscitation, the animals were either left untreated, cooled between 32-34 degrees C after ROSC or treated with a bolus injection of S-PBN (sodium 4-[(tert-butylimino) methyl]benzene-3-sulfonate N-oxide) until 180 min after ROSC, respectively. The expression of endothelin 1 (ET-1), endothelin converting enzyme 1 (ECE-1), and endothelin A and B receptors (ETAR and ETBR) transcripts were measured using quantitative real-time PCR while protein levels for the ETAR, ETBR and nitric oxide synthases (NOS) were assessed using immunohistochemistry and Western Blot. Our results indicated that the endothelin system was not upregulated at 30, 60 and 180 min after ROSC in untreated postcardiac arrest syndrome. Post-resuscitative 3 hour-long treatments either with MTH or S-PBN stimulated ET-1, ECE-1, ETAR and ETBR as well as neuronal NOS and endothelial NOS in left ventricular cardiomyocytes. Our data suggests that the endothelin and nitric oxide pathways are activated by MTH in the heart.	[Zoerner, Frank; Wiklund, Lars; Miclescu, Adriana; Martijn, Cecile] Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden; [Zoerner, Frank] Hallands Hosp Halmstad, Dept Operat & Intens Care Med, Halmstad, Sweden; [Martijn, Cecile] Sci Life Lab, Uppsala, Sweden; [Martijn, Cecile] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Uppsala University; Uppsala University	Martijn, C (corresponding author), Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden.	cecile.martijn@surgsci.uu.se		Zoerner, Frank/0000-0001-9610-1225	Laerdal Foundation for Acute Medicine	Laerdal Foundation for Acute Medicine	Financial support was provided by the Laerdal Foundation for Acute Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiser DG, 2011, RESUSCITATION, V82, P115, DOI 10.1016/j.resuscitation.2010.08.038; Burkard N, 2010, CIRCULATION, V122, P1588, DOI 10.1161/CIRCULATIONAHA.109.933630; Chalkias A, 2012, HEART FAIL REV, V17, P117, DOI 10.1007/s10741-011-9255-1; Forni M, 2005, REGUL PEPTIDES, V131, P89, DOI 10.1016/j.regpep.2005.07.001; HAYNES WG, 1994, RESUSCITATION, V27, P117, DOI 10.1016/0300-9572(94)90003-5; HEARSE DJ, 1987, CIRC RES, V60, P375, DOI 10.1161/01.RES.60.3.375; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kolettis TM, 2011, HYPERTENS RES, V34, P170, DOI 10.1038/hr.2010.215; Lindner KH, 1996, HEART, V75, P145, DOI 10.1136/hrt.75.2.145; Liu XL, 2003, ACTA ANAESTH SCAND, V47, P958, DOI 10.1034/j.1399-6576.2003.00189.x; Massion PB, 2003, J PHYSIOL-LONDON, V546, P63, DOI 10.1113/jphysiol.2002.025973; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Miclescu A, 2007, RESUSCITATION, V75, P88, DOI 10.1016/j.resuscitation.2007.03.014; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; MOLENAAR P, 1993, CIRC RES, V72, P526, DOI 10.1161/01.RES.72.3.526; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Oikonomidis DL, 2010, J INTERV CARD ELECTR, V28, P157, DOI 10.1007/s10840-010-9493-5; Rapoport RM, 2011, J PHARM PHARMACOL, V63, P1373, DOI 10.1111/j.2042-7158.2011.01334.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Seddon M, 2007, CARDIOVASC RES, V75, P315, DOI 10.1016/j.cardiores.2007.04.031; SHARMA HS, 1990, ACT NEUR S, V51, P383; Tawa M, 2011, J CARDIOVASC PHARM, V57, P575, DOI 10.1097/FJC.0b013e31821325ad; TONNESSEN T, 1995, CIRC RES, V76, P767; Vrbjar N, 1998, MOL CELL BIOCHEM, V186, P107, DOI 10.1023/A:1006875515357; Wainwright Cherry L., 2005, Current Vascular Pharmacology, V3, P333, DOI 10.2174/157016105774329417; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wiklund L, 2005, ANN NY ACAD SCI, V1053, P205, DOI 10.1196/annals.1344.019; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yamamoto S, 2005, CIRCULATION, V111, P302, DOI 10.1161/01.CIR.0000153351.86708.F7; Zhao XS, 2006, CIRCULATION, V114, P830, DOI 10.1161/CIRCULATIONAHA.105.577288	31	10	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64792	10.1371/journal.pone.0064792	http://dx.doi.org/10.1371/journal.pone.0064792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717659	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600076
J	Cui, ZB; Cao, W; Li, J; Song, XM; Mao, L; Chen, WT				Cui, Zhibin; Cao, Wei; Li, Jiang; Song, Xiaomeng; Mao, Li; Chen, Wantao			TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes	PLOS ONE			English	Article							NUCLEAR RECEPTORS; BREAST-CANCER; GENE; TRANSCRIPTION; EXPRESSION; ALPHA; P53; COFACTORS; PROTEIN; TUMOR	Tripartite motif-containing 24 (TRIM24), a member of the transcriptional intermediary factor 1 family, functions as a coregulator that positively or negatively modulates the transcriptional activities of several nuclear receptors. The aim of this study was to investigate TRIM24 expression and its clinical significance in head and neck squamous cell carcinoma. The expression levels of TRIM24 variants were examined in head and neck squamous cell carcinoma (HNSCC) samples and cell lines by real-time PCR and WB. The expression levels of TRIM24 measured in 91 locally advanced HNSCC tumors were measured by immunohistochemistry and correlated with clinical and pathological parameters. The functional role of TRIM24 in HNSCC was further investigated by silencing its expression in HNSCC cell lines. TRIM24 variants were up-regulated in 56 HNSCC samples (P<.001) and 9 HNSCC cell lines (P<.05). TRIM24 protein was overexpressed in 6 of 8 HNSCC cell lines and in 2 of 3 HNSCC samples. Furthermore, 54.95% (50/91) of HNSCC samples exhibited remarkably elevated expression of TRIM24 by immunohistochemistry. Univariate analysis revealed that high TRIM24 expression was associated with worse overall survival (P=.020). In multivariate analysis, TRIM24 expression was identified as an independent predictor of overall survival (P=.030), after adjusting for other clinicopathological parameters. Upon TRIM24 silencing, the proliferation of HNSCC cells was notably inhibited due to the induction of apoptosis. These results suggest that aberrant TRIM24 expression may play an important role in the development of HNSCC and is a promising prognostic indicator for patients with locally advanced HNSCC.	[Cui, Zhibin; Cao, Wei; Li, Jiang; Song, Xiaomeng; Mao, Li; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China; [Cui, Zhibin; Cao, Wei; Song, Xiaomeng; Chen, Wantao] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Li, Jiang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral Pathol, Shanghai 200030, Peoples R China; [Mao, Li] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore	Mao, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China.	lmao@umaryland.edu; chenwantao2002@hotmail.com	Cao, Wei/ABE-1035-2021; Mao, Li/C-7570-2011	Cao, Wei/0000-0003-2184-9380; Mao, Li/0000-0001-7263-3358	National Natural Science Foundation of China [81072171, 30973343, 91229103]; Projects of the Shanghai Science and Technology Committee [08JC1414400, 10DZ1951300, 11DZ2291800, 10XD1402500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of the Shanghai Science and Technology Committee	This study was supported by the National Natural Science Foundation of China (81072171, 30973343 and 91229103), Projects of the Shanghai Science and Technology Committee (08JC1414400, 10DZ1951300, 11DZ2291800 and 10XD1402500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Ammerpoht Ole, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P511; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Cabanillas R, 2007, CANCER-AM CANCER SOC, V109, P1791, DOI 10.1002/cncr.22646; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Cao W, 2011, CANCER PREV RES, V4, P1816, DOI 10.1158/1940-6207.CAPR-11-0130; Cao W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-296; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Gandini D, 2002, LEUKEMIA, V16, P886, DOI 10.1038/sj.leu.2402452; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Martone T, 2007, CLIN CANCER RES, V13, P5089, DOI 10.1158/1078-0432.CCR-07-0119; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Matsubara N, 2012, DIS COLON RECTUM, V55, P96, DOI 10.1097/DCR.0b013e318233a1ef; ODA D, 1990, IN VITRO CELL DEV B, V26, P589; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Popanda O, 2000, INT J CANCER, V86, P318, DOI 10.1002/(SICI)1097-0215(20000501)86:3<318::AID-IJC3>3.0.CO;2-B; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	29	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63887	10.1371/journal.pone.0063887	http://dx.doi.org/10.1371/journal.pone.0063887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717505	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700077
J	Gillette, M; Bray, K; Blumenthaler, A; Vargo-Gogola, T				Gillette, Melissa; Bray, Kristi; Blumenthaler, Alisa; Vargo-Gogola, Tracy			P190B RhoGAP Overexpression in the Developing Mammary Epithelium Induces TGF beta-dependent Fibroblast Activation	PLOS ONE			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; LATENT TGF-BETA-1; EXPRESSION; FAMILY; GLAND; MORPHOGENESIS; PHENOTYPE; PATHWAYS; GTPASES	Rho GTPases mediate stromal-epithelial interactions that are important for mammary epithelial cell (MEC) morphogenesis. Increased extracellular matrix (ECM) deposition and reorganization affect MEC morphogenesis in a Rho GTPase-dependent manner. Although the effects of altered ECM on MEC morphogenesis have been described, how MECs regulate stromal deposition is not well understood. Previously, we showed that p190B RhoGAP overexpression disrupts mammary gland morphogenesis by inducing hyperbranching in association with stromal alterations. We therefore hypothesized that MEC overexpression of p190B regulates paracrine interactions to impact fibroblast activation. Using a combination of in vivo morphometric and immunohistochemical analyses and primary cell culture assays, we found that p190B overexpression in MECs activates fibroblasts leading to increased collagen, fibronectin, and laminin production and elevated expression of the collagen crosslinking enzyme lysyl oxidase. Phosphorylation of the TGF-beta effector SMAD2 and expression of the TGF-beta target gene alpha Sma were increased in p190B-associated fibroblasts, suggesting that elevated TGF-beta signaling promoted fibroblast activation. Mechanical tension and TGF-beta cooperate to activate fibroblasts. Interestingly, active TGF-beta was elevated in conditioned medium from p190B overexpressing MECs compared to control MECs, and p190B overexpressing MECs exhibited increased contractility in a collagen gel contraction assay. These data suggest that paracrine signaling from the p190B overexpressing MECs may activate TGF-beta signaling in adjacent fibroblasts. In support of this, transfer of conditioned medium from p190B overexpressing MECs onto wildtype fibroblasts or co-culture of p190B overexpressing MECs with wildtype fibroblasts increased SMAD2 phosphorylation and mRNA expression of ECM genes in the fibroblasts when compared to fibroblasts treated with control CM or co-cultured with control MECs. The increased ECM gene expression and SMAD2 phosphorylation were blocked by treatment with a TGF-beta receptor inhibitor. Taken together, these data suggest that p190B overexpression in the mammary epithelium induces fibroblast activation via elevated TGF-beta paracrine signaling.	[Gillette, Melissa; Bray, Kristi; Blumenthaler, Alisa; Vargo-Gogola, Tracy] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Gillette, Melissa; Bray, Kristi; Blumenthaler, Alisa; Vargo-Gogola, Tracy] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Gillette, Melissa; Bray, Kristi; Blumenthaler, Alisa; Vargo-Gogola, Tracy] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN USA; [Gillette, Melissa; Bray, Kristi; Blumenthaler, Alisa; Vargo-Gogola, Tracy] Simon Canc Ctr, South Bend, IN USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Vargo-Gogola, T (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	vargo-gogola.1@nd.edu		Blumenthaler, Alisa/0000-0001-8830-8509	National Cancer Institute [R00CA127361]; NATIONAL CANCER INSTITUTE [R00CA127361] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by a National Cancer Institute grant R00CA127361 awarded to Tracy Vargo-Gogola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Heckman BM, 2007, DEV BIOL, V309, P137, DOI 10.1016/j.ydbio.2007.07.002; Heckman-Stoddard BM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2352; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Hu YB, 2006, LUNG, V184, P33, DOI 10.1007/s00408-005-2560-5; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; McHenry PR, 2010, CURR DRUG TARGETS, V11, P1043, DOI 10.2174/138945010792006852; McHenry PR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2643; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; SAKAI N, 2013, BIOCH BIOPHYS ACTA, V925; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Vargo-Gogola T, 2006, MOL ENDOCRINOL, V20, P1391, DOI 10.1210/me.2005-0426; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010	44	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e65105	10.1371/journal.pone.0065105	http://dx.doi.org/10.1371/journal.pone.0065105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717689	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700190
J	Herzog, SK; Hamel-Leigue, AC; Larsen, TH; Mann, DJ; Soria-Auza, RW; Gill, BD; Edmonds, WD; Spector, S				Herzog, Sebastian K.; Hamel-Leigue, A. Caroli; Larsen, Trond H.; Mann, Darren J.; Soria-Auza, Rodrigo W.; Gill, Bruce D.; Edmonds, W. D.; Spector, Sacha			Elevational Distribution and Conservation Biogeography of Phanaeine Dung Beetles (Coleoptera: Scarabaeinae) in Bolivia	PLOS ONE			English	Article							SPECIES RICHNESS PATTERNS; BODY-SIZE; ALTITUDINAL GRADIENTS; DIVERSITY PATTERNS; GEOMETRID MOTHS; GLOBAL ANALYSIS; BERGMANNS RULE; PLANT GROUPS; RANGE; AREA	Insect macroecology and conservation biogeography studies are disproportionately scarce, especially in the Neotropics. Dung beetles are an ideal focal taxon for biodiversity research and conservation. Using distribution and body size data on the ecologically important Phanaeini, the best-known Neotropical dung beetle tribe, we determined elevational patterns of species richness, endemism, body size, and elevational range in Bolivia, specifically testing Bergmann's and Rapoport's rule. Richness of all 39 species and of 15 ecoregional endemics showed a hump-shaped pattern peaking at 400 m, but overall declined strongly with elevation up to 4000 m. The relationship between endemic and total species richness appeared to be curvilinear, providing only partial support for the null hypothesis that species-rich areas are more likely to be centers of endemism by chance alone. An elevational increase in the proportion of ecoregional endemics suggests that deterministic factors also appear to influence endemism in the Andes. When controlling for the effect of area using different species-area relationships, the statistically significant richness peak became more pronounced and shifted upslope to 750 m. Larger species did not have higher elevational mid-points, and mean body size decreased significantly with elevation, contradicting Bergmann's rule. Rapoport's rule was supported: species with higher elevational mid-points had broader elevational ranges, and mean elevational range increased significantly with elevation. The elevational decrease of phanaeine richness is in accordance with studies that demonstrated the combined influence of temperature and water availability on species diversity, but also is consistent with niche conservatism. For invertebrates, confirmation of Rapoport's and refutation of Bergmann's rule appear to be scale-invariant general patterns. Analyses of biogeographic patterns across elevational gradients can provide important insights for identifying conservation priorities. Phanaeines with narrow elevational ranges on isolated low-elevation mountains in eastern Bolivia are at greatest climate-change related extinction risk from range-shift gaps and mountaintop extinctions.	[Herzog, Sebastian K.; Soria-Auza, Rodrigo W.] Asociac Armonia, Santa Cruz, Bolivia; [Herzog, Sebastian K.; Hamel-Leigue, A. Caroli; Soria-Auza, Rodrigo W.] Museo Hist Nat Alcide Orbigny, Cochabamba, Bolivia; [Larsen, Trond H.] Conservat Int, Betty & Gordon Moore Ctr Ecosyst Sci & Econ, Arlington, VA USA; [Mann, Darren J.] Univ Oxford, Museum Nat Hist, Oxford, England; [Gill, Bruce D.] Canadian Food Inspect Agcy, Entomol Unit, Ottawa Plant Lab, Ottawa, ON, Canada; [Spector, Sacha] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA	Conservation International; University of Oxford; Canadian Food Inspection Agency; American Museum of Natural History (AMNH)	Herzog, SK (corresponding author), Asociac Armonia, Santa Cruz, Bolivia.	skherzog@armonia-bo.org	Mann, Darren/AAC-1049-2020	Mann, Darren/0000-0002-6732-6940				Almeida-Neto M, 2006, J BIOGEOGR, V33, P361, DOI 10.1111/j.1365-2699.2005.01389.x; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Arnaud P, 2002, COLEOPTERES MONDE 28; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; Blut H., 1939, Archiv fuer Naturgeschichte Leipzig NF, V8, P263; Brehm G, 2004, GLOBAL ECOL BIOGEOGR, V13, P7, DOI 10.1111/j.1466-882X.2004.00069.x; Brehm G, 2003, ECOGRAPHY, V26, P456, DOI 10.1034/j.1600-0587.2003.03498.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Chatzaki M, 2005, J BIOGEOGR, V32, P813, DOI 10.1111/j.1365-2699.2004.01189.x; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027004; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Edmonds WD, 2008, ZOOTAXA, P42; Edmonds W.D., 2004, Folia Heyrovskyana Supplementum, V11, P1; Edmonds W.D., 2000, Folia Heyrovskyana Supplementum, V6, P1; Edmonds W.D., 2010, Insecta Mundi, V0129, P1; Edmonds W.D., 1994, Contributions in Science (Los Angeles), V443, P1; Emmons LH, 2009, BIOTROPICA, V41, P493, DOI 10.1111/j.1744-7429.2009.00500.x; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P172, DOI 10.1111/j.1752-4598.2010.00091.x; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes J., 2007, ENCY BIODIVERSITY, P1, DOI [DOI 10.1038/NCLIMATE1347, DOI 10.1016/B978-012226865-6/00503-1]; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; HALFFTER G, 1974, Quaestiones Entomologicae, V10, P223; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Halffter Gonzalo, 1991, Folia Entomologica Mexicana, V0, P195; Hamel-Leigue AC, 2013, INSECT CONSERV DIVER, V6, P276, DOI 10.1111/j.1752-4598.2012.00211.x; Hamel-Leigue A. Caroli, 2009, Kempffiana, V5, P43; Hamel-Leigue A. Caroli, 2006, Revista Boliviana de Ecologia y Conservacion Ambiental, V20, P1; Hausdorf B, 2003, GLOBAL ECOL BIOGEOGR, V12, P389, DOI 10.1046/j.1466-822X.2003.00050.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 1996, ACTA OECOL, V17, P185; Herzog S.K., 2011, CLIMATE CHANGE BIODI; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Ibisch PL., 2003, BIODIVERSIDAD RIQUEZ, P47; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2001, BIODIVERS CONSERV, V10, P1897, DOI 10.1023/A:1013130902993; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Killeen Timothy J., 1998, RAP Working Papers, V10, P1; Krajcik Milan, 2006, animma.x Supplement, V3, P1; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; Kubota U, 2007, GLOBAL ECOL BIOGEOGR, V16, P632, DOI 10.1111/j.1466-8238.2007.00319.x; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2012, BIOTROPICA, V44, P82, DOI 10.1111/j.1744-7429.2011.00768.x; Lobo JM, 2000, ANN ENTOMOL SOC AM, V93, P115, DOI 10.1603/0013-8746(2000)093[0115:BAEFAT]2.0.CO;2; Lowenberg-Neto P, 2009, J BIOGEOGR, V36, P1750, DOI 10.1111/j.1365-2699.2009.02112.x; Martinez A, 1960, REV SOC ENTOMOLOGICA, V22, P77; Martinez NJ, 2009, NEOTROP ENTOMOL, V38, P708, DOI 10.1590/S1519-566X2009000600002; Martinez R, 2011, CLIMATE CHANGE BIODI, P260; Martinez R., 2011, CLIMATE CHANGE BIODI, P228; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McCain CM, 2010, ECOLOGY, V91, P601, DOI 10.1890/09-0704.1; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meiri S, 2011, GLOBAL ECOL BIOGEOGR, V20, P203, DOI 10.1111/j.1466-8238.2010.00577.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olsoufieff G, 1924, REV ILLUSTREE ENTOMO, V13, P4; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; PAYNTER RA, 1992, ORNITHOLOGICAL GAZET; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Philips TK, 2004, INSECT SYST EVOL, V35, P43, DOI 10.1163/187631204788964664; Radtke MG, 2005, ANN ENTOMOL SOC AM, V98, P548, DOI 10.1603/0013-8746(2005)098[0548:VALMAP]2.0.CO;2; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2000, P ROY SOC B-BIOL SCI, V267, P2259, DOI 10.1098/rspb.2000.1277; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TFLVB, 2005, ECOGRAPHY, V28, P253, DOI 10.1111/j.0906-7590.2005.04038.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Rivera Chavez L, 2004, PERU MEGANTONI, P185; Romdal TS, 2005, ECOLOGY, V86, P235, DOI 10.1890/04-0096; Rosenzweig Michael L., 1993, P52; Sanchez-Rodriguez J. F., 1995, Journal of the Lepidopterists' Society, V49, P192; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Sokal R. R., 2012, BIOMETRY; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; StatSoft Inc, 2004, STATISTICA DAT AN SO; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Verdu JR, 2006, J INSECT PHYSIOL, V52, P854, DOI 10.1016/j.jinsphys.2006.05.005; Wallace R. B., 2010, DISTRIBUCION ECOLOGI; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	103	34	34	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64963	10.1371/journal.pone.0064963	http://dx.doi.org/10.1371/journal.pone.0064963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717678	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700184
J	Yebra, G; de Mulder, M; Holguin, A				Yebra, Gonzalo; de Mulder, Miguel; Holguin, Africa			Description of HIV-1 Group M Molecular Epidemiology and Drug Resistance Prevalence in Equatorial Guinea from Migrants in Spain	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT; INFECTED IMMIGRANTS; NAIVE INDIVIDUALS; GENETIC DIVERSITY; TYPE-1 SUBTYPES; MUTATIONS; CAMEROON; CRF02-AG; THERAPY	Background: The HIV epidemic is increasing in Equatorial Guinea (GQ), West Central Africa, but few studies have reported its HIV molecular epidemiology. We aimed to describe the HIV-1 group M (HIV-1M) variants and drug-resistance mutations in GQ using sequences sampled in this country and in Spain, a frequent destination of Equatoguinean migrants. Methods: We collected 195 HIV-1M pol sequences from Equatoguinean subjects attending Spanish clinics during 19972011, and 83 additional sequences sampled in GQ in 1997 and 2008 from GenBank. All (n = 278) were re-classified using phylogeny and tested for drug-resistance mutations. To evaluate the origin of CRF02_AG in GQ, we analyzed 2,562 CRF02_AG sequences and applied Bayesian MCMC inference (BEAST program). Results: Most Equatoguinean patients recruited in Spain were women (61.1%) or heterosexuals (87.7%). In the 278 sequences, the variants found were CRF02_AG (47.8%), A (13.7%), B (7.2%), C (5.8%), G (5.4%) and others (20.1%). We found 6 CRF02_AG clusters emerged from 1983.9 to 2002.5 with origin in GQ (5.5 sequences/cluster). Transmitted drug-resistance (TDR) rate among naive patients attended in Spain (n = 144) was 4.7%: 3.4% for PI (all with M46IL), 1.8% for NRTI (all with M184V) and 0.9% for NNRTI (Y188L). Among pre-treated patients, 9/31 (29%) presented any resistance, mainly affecting NNRTI (27.8%). Conclusions: We report a low (< 5%) TDR rate among naive, with PI as the most affected class. Pre-treated patients also showed a low drug-resistance prevalence (29%) maybe related to the insufficient treatment coverage in GQ. CRF02_AG was the prevalent HIV-1M variant and entered GQ through independent introductions at least since the early 1980s.	[Holguin, Africa] Hosp Ramon y Cajal IRYCIS, Dept Microbiol, Mol Epidemiol Lab HIV 1, Madrid, Spain; CIBERESP, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Holguin, A (corresponding author), Hosp Ramon y Cajal IRYCIS, Dept Microbiol, Mol Epidemiol Lab HIV 1, Madrid, Spain.	africa.holguin@salud.madrid.org	de Mulder Rougvie, Miguel/AAG-6224-2020; Holguín, Africa/AAF-9001-2021	de Mulder Rougvie, Miguel/0000-0002-8026-7076; Holguín, Africa/0000-0002-1330-8050; Yebra, Gonzalo/0000-0002-3472-3667	Fondo de Investigaciones Sanitarias [FIS 09/00284]; Agencia Lain Entralgo	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia Lain Entralgo	This work was supported by grants from the Fondo de Investigaciones Sanitarias (FIS 09/00284). AH is supported by FIS and Agencia Lain Entralgo. This study is included in the Subprograma de Inmigracion y Salud, CIBERESP (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; Ceccarelli L, 2012, J MED VIROL, V84, P721, DOI 10.1002/jmv.23244; Veras NMC, 2011, AIDS RES HUM RETROV, V27, P1173, DOI [10.1089/aid.2010.0333, 10.1089/AID.2010.0333]; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2005, AIDS RES HUM RETROV, V21, P886, DOI 10.1089/aid.2005.21.886; Holguin A, 2002, AIDS, V16, P1163, DOI 10.1097/00002030-200205240-00010; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Mintsa-Ndong A, 2009, AIDS RES HUM RETROV, V25, P411, DOI 10.1089/aid.2008.0223; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Ortiz M, 2001, AIDS RES HUM RETROV, V17, P851, DOI 10.1089/088922201750252043; Perez-Molina JA, 2010, CURR HIV RES, V8, P521, DOI 10.2174/157016210793499178; Toro C, 2006, J MED VIROL, V78, P1599, DOI 10.1002/jmv.20744; UNAIDS, 2012, EQ GUIN NAT PROGR RE; UNAIDS, 2011, 2010 REP GLOB AIDS E; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; WHO, 2012, WHO HIV DRUG RES REP; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64293	10.1371/journal.pone.0064293	http://dx.doi.org/10.1371/journal.pone.0064293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717585	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700130
J	Zhao, N; Dong, Q; Du, LL; Fu, XX; Du, YM; Liao, YH				Zhao, Ning; Dong, Qian; Du, Li-Li; Fu, Xiao-Xing; Du, Yi-Mei; Liao, Yu-Hua			Potent Suppression of Kv1.3 Potassium Channel and IL-2 Secretion by Diphenyl Phosphine Oxide-1 in Human T Cells	PLOS ONE			English	Article							I-KUR BLOCKER; CA2+-ACTIVATED K+ CHANNELS; DIPHENYLPHOSPHINE OXIDE; THERAPEUTIC TARGET; ION CHANNELS; LYMPHOCYTES; ACTIVATION; MECHANISM; IKCA1; RAT	Diphenyl phosphine oxide-1 (DPO-1) is a potent Kv1.5 channel inhibitor that has therapeutic potential for the treatment of atrial fibrillation. Many other Kv1.5 channel blockers also potently inhibit the Kv1.3 channel, but whether DPO-1 blocks Kv1.3 channels has not been investigated. The Kv1.3 channel is highly expressed in activated T cells, which is considered a favorable target for immunomodulation. Accordingly, we hypothesized that DPO-1 may exert immunosuppressive and anti-inflammatory effects by inhibiting Kv1.3 channel activity. In this study, DPO-1 blocked Kv1.3 current in a voltage-dependent and concentration-dependent manner, with IC50 values of 2.58 mu M in Jurkat cells and 3.11 mu M in human peripheral blood T cells. DPO-1 also accelerated the inactivation rate and negatively shifted steady-state inactivation. Moreover, DPO-1 at 3 mM had no apparent effect on the Ca2+ activated potassium channel (K-Ca) current in both Jurkat cells and human peripheral blood T cells. In Jurkat cells, pre-treatment with DPO-1 for 24 h decreased Kv1.3 current density, and protein expression by 48 +/- 6% and 60 +/- 9%, at 3 and 10 mu M, respectively (both p < 0.05). In addition, Ca2+ influx to Ca2+-depleted cells was blunted and IL-2 production was also reduced in activated Jurkat cells. IL-2 secretion was also inhibited by the Kv1.3 inhibitors margatoxin and charybdotoxin. Our results demonstrate for the first time that that DPO-1, at clinically relevant concentrations, blocks Kv1.3 channels, decreases Kv1.3 channel expression and suppresses IL-2 secretion. Therefore, DPO-1 may be a useful treatment strategy for immunologic disorders.	[Zhao, Ning; Dong, Qian; Du, Li-Li; Fu, Xiao-Xing; Du, Yi-Mei; Liao, Yu-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Cardiovasc Dis, Union Hosp,Res Ctr Ion Channelopathy, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Du, YM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Cardiovasc Dis, Union Hosp,Res Ctr Ion Channelopathy, Wuhan 430074, Peoples R China.	yimeidu@mail.hust.edu.cn; liaoyh27@163.com	Du, Yi-mei/E-1581-2012; Du, Yimei/K-3232-2019	Du, Yi-mei/0000-0003-1125-0294; Du, Yimei/0000-0003-1125-0294	National Basic Research Program of China (973 Program) [2007CB512000, 2007CB512005]; National Natural Science Foundation of China [30971243, 81170164]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program: 2007CB512000; 2007CB512005, http://www.most.gov.cn/) to Dr. Liao, and the National Natural Science Foundation of China (http://www.nsfc.gov.cn) to Dr. Du (No 30971243 and No 81170164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2007, AM J PHYSIOL-CELL PH, V292, pC1714, DOI 10.1152/ajpcell.00258.2006; Ahn HS, 2007, N-S ARCH PHARMACOL, V374, P305, DOI 10.1007/s00210-006-0118-6; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Choi JS, 1999, J PHARMACOL EXP THER, V291, P1; Choi JS, 1999, N-S ARCH PHARMACOL, V359, P256, DOI 10.1007/PL00005350; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Du YM, 2010, J MOL CELL CARDIOL, V48, P1111, DOI 10.1016/j.yjmcc.2010.02.010; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fasth AER, 2004, SCAND J IMMUNOL, V60, P199, DOI 10.1111/j.0300-9475.2004.01464.x; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Liu HL, 2004, PROTEINS, V55, P558, DOI 10.1002/prot.20065; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; Pandit SV, 2011, CARDIOVASC RES, V89, P843, DOI 10.1093/cvr/cvq359; Pang B, 2010, BIOCHEM BIOPH RES CO, V391, P909, DOI 10.1016/j.bbrc.2009.11.162; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Regan CP, 2007, J CARDIOVASC PHARM, V49, P236, DOI 10.1097/FJC.0b013e3180325b2a; Regan CP, 2006, J PHARMACOL EXP THER, V316, P727, DOI 10.1124/jpet.105.094839; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Robe RJ, 2000, BRIT J PHARMACOL, V131, P1275, DOI 10.1038/sj.bjp.0703723; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; VERHEUGEN JAH, 1995, J GEN PHYSIOL, V105, P765, DOI 10.1085/jgp.105.6.765; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Wang XP, 2007, PHARMACOL RES, V56, P148, DOI 10.1016/j.phrs.2007.05.002; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921	40	13	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64629	10.1371/journal.pone.0064629	http://dx.doi.org/10.1371/journal.pone.0064629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717641	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700161
J	Rafidi, H; Mercado, F; Astudillo, M; Fry, WHD; Saldana, M; Carraway, KL; Sweeney, C				Rafidi, Hanine; Mercado, Francisco, III; Astudillo, Michael; Fry, William H. D.; Saldana, Matthew; Carraway, Kermit L., III; Sweeney, Colleen			Leucine-rich Repeat and Immunoglobulin Domain-containing Protein-1 (Lrigl) Negative Regulatory Action toward ErbB Receptor Tyrosine Kinases Is Opposed by Leucine-rich Repeat and Immunoglobulin Domain-containing Protein 3 (Lrig3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Protein Degradation; Receptor Tyrosine Kinase; Signal Transduction; Tumor Suppressor Gene; Lrig1; Lrig3; Growth Factor	GROWTH-FACTOR RECEPTOR; CANCER; STEM; EXPRESSION; LIGAND; UBIQUITYLATION; SUPPRESSION; ENDOCYTOSIS; REVEALS; CELLS	Lrig1 is the founding member of the Lrig family of transmembrane leucine-rich repeat proteins, which also includes Lrig2 and Lrig3. Lrig1 is a negative regulator of oncogenic receptor tyrosine kinases, including ErbB and Met receptors, and promotes receptor degradation. Lrig1 has recently emerged as both a tumor suppressor and a key regulator of epidermal and epithelial stem cell quiescence. Despite this, little is known of the mechanisms by which Lrig1 is regulated. Lrig3 was recently reported to increase ErbB receptor expression suggesting that it may function in a manner opposite to Lrig1. In this study, we explore the interaction between Lrig1 and Lrig3 and demonstrate that Lrig1 and Lrig3 functionally oppose one another. Lrig3 opposes Lrig1 negative regulatory activity and stabilizes ErbB receptors. Conversely, Lrig1 destabilizes Lrig3, limiting Lrig3's positive effects on receptors and identifying Lrig3 as a new target of Lrig1. These studies provide new insight into the regulation of Lrig1 and uncover a complex cross-talk between Lrig1 and Lrig3.	[Rafidi, Hanine; Mercado, Francisco, III; Astudillo, Michael; Fry, William H. D.; Saldana, Matthew; Carraway, Kermit L., III; Sweeney, Colleen] Univ Calif Davis, Ctr Comprehens Canc, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Sweeney, C (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Res Bldg 3,Rm 1100A,4645 2nd Ave, Sacramento, CA 95817 USA.	casweeney@ucdavis.edu			National Institutes of Health [CAI 18384, CA1 23541]; NATIONAL CANCER INSTITUTE [R01CA123541, R01CA118384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CAI 18384 (to C. S.) and CA1 23541 (to K. L. C. III).	Abraira VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008981; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee J. M., 2012, ONCOGENE, DOI 10.1038/onc.2012.551; Lill NL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003341; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Ljuslinder I, 2007, ACTA ONCOL, V46, P1118, DOI 10.1080/02841860701426823; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rouam S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-150; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sheu J. J., 2013, ONCOGENE IN PRESS; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Thomasson M, 2011, INT J CANCER, V128, P2843, DOI 10.1002/ijc.25820; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	35	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21593	21605		10.1074/jbc.M113.486050	http://dx.doi.org/10.1074/jbc.M113.486050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23723069	hybrid, Green Published			2022-12-25	WOS:000328841900012
J	Hildebrand, D; Merkel, P; Eggers, LF; Schluter, H				Hildebrand, Diana; Merkel, Philipp; Eggers, Lars Florian; Schlueter, Hartmut			Proteolytic Processing of Angiotensin-I in Human Blood Plasma	PLOS ONE			English	Article							AMINOPEPTIDASE-N; CONVERTING-ENZYME; VASCULAR BED; BRAIN; SYSTEM; IDENTIFICATION; RESPONSES; PEPTIDES; PURIFICATION; VASOPRESSIN	In mammalian species, except humans, N-terminal processing of the precursor peptide angiotensin I (ANG-1-10) into ANG-2-10 or ANG-3-10 was reported. Here we hypothesize that aminopeptidase-generated angiotensins bearing the same Cterminus as ANG-1-10 are also present in humans. We demonstrate the time dependent generation of ANG-2-10, ANG-3-10, ANG-4-10, ANG-5-10 and ANG-6-10 from the precursor ANG-1-10 by human plasma proteins. The endogenous presence of ANG-4-10, ANG-5-10 and ANG-6-10 in human plasma was confirmed by an immuno-fluorescence assay. Generation of ANG-2-10, ANG-3-10 and ANG-4-10 from ANG-1-10 by immobilized human plasma proteins was sensitive to the cysteine/serine protease inhibitor antipain. The metal ion chelator EDTA inhibited Ang-6-10-generation. Incubation of the substrates ANG3-10, ANG-4-10 and ANG-5-10 with recombinant aminopeptidase N (APN) resulted in a successive N-terminal processing, finally releasing ANG-6-10 as a stable end product, demonstrating a high similarity concerning the processing pattern of the angiotensin peptides compared to the angiotensin generating activity in plasma. Recombinant ACE-1 hydrolyzed the peptides ANG-2-10, ANG-3-10, ANG-4-10 and ANG-5-10 into ANG-2-8, ANG-3-8, ANG-4-8 and ANG-5-8. Since ANG-2-10 was processed into ANG-2-8, ANG-4-8 and ANG-5-8 by plasma proteases the angiotensin peptides bearing the same C-terminus as ANG-1-10 likely have a precursor function in human plasma. Our results confirm the hypothesis of aminopeptidase mediated processing of ANG-1-10 in humans. We show the existence of an aminopeptidase mediated pathway in humans that bypasses the known ANG-1-8-carboxypeptidase pathway. This expands the knowledge about the known human renin angiotensin system, showing how efficiently the precursor ANG-1-10 is used by nature.	[Hildebrand, Diana; Merkel, Philipp; Eggers, Lars Florian; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schluter, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany.	hschluet@uke.de	Schluter, Hartmut/D-1371-2015	Schluter, Hartmut/0000-0002-9358-7036	BMBF (Bundesministerium fur Bildung und Forschung) [0315341B]; LEXI (Landesexzellentinitiative, Hamburg)	BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); LEXI (Landesexzellentinitiative, Hamburg)	This work was funded by the BMBF (Bundesministerium fur Bildung und Forschung, Grant: 0315341B) and by LEXI (Landesexzellentinitiative, Hamburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; Bluher M, 2001, DIABETES CARE, V24, P328, DOI 10.2337/diacare.24.2.328; Brena B.M., 2006, METHODS BIOTECHNOLOG; CAMPBELLBOSWELL M, 1981, EXP MOL PATHOL, V35, P265, DOI 10.1016/0014-4800(81)90066-6; Capettini LSA, 2012, CURR PHARM DESIGN, V18, P963; Champion HC, 1996, EUR J PHARMACOL, V309, P251, DOI 10.1016/0014-2999(96)00355-X; CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518; COLE KR, 1991, BIOCHEMISTRY-US, V30, P648, DOI 10.1021/bi00217a009; DELRIO CG, 1981, ENDOCRINOLOGY, V108, P406; Dupont AG, 2010, J HYPERTENS, V28, P1599, DOI 10.1097/HJH.0b013e32833af3b2; FAVALORO E, 1993, EXP HEMATOL, V21, P1695; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gard PR, 2012, EUR J PHARMACOL, V683, P155, DOI 10.1016/j.ejphar.2012.02.048; Garrison EA, 1996, AM J PHYSIOL-HEART C, V270, pH1172, DOI 10.1152/ajpheart.1996.270.4.H1172; Heeb MJ, 1998, BLOOD CELL MOL DIS, V24, P411; INOUE T, 1994, J CLIN ENDOCR METAB, V79, P171, DOI 10.1210/jc.79.1.171; Jackman HL, 2002, HYPERTENSION, V39, P976, DOI 10.1161/01.HYP.0000017283.67962.02; Jalil JE, 2003, AM J CARDIOL, V92, P749, DOI 10.1016/S0002-9149(03)00847-6; KAPPELGAARD AM, 1976, CLIN CHIM ACTA, V67, P299; Kaye A D, 1998, Am J Ther, V5, P295, DOI 10.1097/00045391-199809000-00004; Kranzhofer R, 1999, BIOCHEM BIOPH RES CO, V257, P826, DOI 10.1006/bbrc.1999.0543; LALU K, 1984, BIOCHIM BIOPHYS ACTA, V789, P324, DOI 10.1016/0167-4838(84)90188-2; Lew RA, 2008, EXP PHYSIOL, V93, P685, DOI 10.1113/expphysiol.2007.040352; Li Q, 1997, J CARDIOVASC PHARM, V29, P451, DOI 10.1097/00005344-199704000-00004; NEVES LAA, 1995, BIOCHEM PHARMACOL, V50, P1451, DOI 10.1016/0006-2952(95)02049-7; Padia SH, 2007, HYPERTENSION, V49, P625, DOI 10.1161/01.HYP.0000254833.85106.4d; Palmieri F E, 1989, Adv Exp Med Biol, V247A, P305; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Reyes-Engel A, 2006, J RENIN-ANGIO-ALDO S, V7, P92, DOI 10.3317/jraas.2006.015; SCHERBERICH JE, 1990, J CHROMATOGR, V521, P279, DOI 10.1016/0021-9673(90)85052-W; Schluter H, 2003, ANAL BIOANAL CHEM, V377, P1102, DOI 10.1007/s00216-003-2211-8; Sim M K, 1994, Blood Press, V3, P260, DOI 10.3109/08037059409102267; Takai S, 2001, CLIN CHIM ACTA, V305, P191, DOI 10.1016/S0009-8981(01)00379-5; TOKIOKATERAO M, 1984, ENZYME, V32, P65, DOI 10.1159/000469453; Trusch M, 2010, J CHROMATOGR B, V878, P309, DOI 10.1016/j.jchromb.2009.11.035; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5; Velez JCQ, 2012, AM J PHYSIOL-RENAL, V302, pF1583, DOI 10.1152/ajprenal.00087.2012; Velez JCQ, 2009, HYPERTENSION, V53, P790, DOI 10.1161/HYPERTENSIONAHA.109.128819; Velloso EP, 2007, BRAZ J MED BIOL RES, V40, P583, DOI 10.1590/S0100-879X2007000400018; von Bohlen und Halbach O, 2003, CELL TISSUE RES, V311, P1, DOI 10.1007/s00441-002-0655-3; WARD PE, 1990, BIOCHEM PHARMACOL, V40, P1725, DOI 10.1016/0006-2952(90)90348-O; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	46	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64027	10.1371/journal.pone.0064027	http://dx.doi.org/10.1371/journal.pone.0064027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724017	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000035
J	Park, JM; Huang, SB; Tougeron, D; Sinicrope, FA				Park, Jae Myung; Huang, Shengbing; Tougeron, David; Sinicrope, Frank A.			MSH3 Mismatch Repair Protein Regulates Sensitivity to Cytotoxic Drugs and a Histone Deacetylase Inhibitor in Human Colon Carcinoma Cells	PLOS ONE			English	Article							MICROSATELLITE MUTATOR PHENOTYPE; HUMAN COLORECTAL CANCERS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; SOMATIC MUTATIONS; MOLECULAR CHARACTERIZATION; ADJUVANT THERAPY; CROSS-LINKS; P53 STATUS	Background: MSH3 is a DNA mismatch repair (MMR) gene that undergoes frequent somatic mutation in colorectal cancers (CRCs) with MMR deficiency. MSH3, together with MSH2, forms the MutS beta heteroduplex that interacts with interstrand cross-links induced by drugs such as cisplatin. To date, the impact of MSH3 on chemosensitivity is unknown. Methods: We utilized isogenic HCT116 (MLH1-/MSH3-) cells where MLH1 is restored by transfer of chromosome 3 (HCT116+ch3) and also MSH3 by chromosome 5 (HCT116+3+5). We generated HCT116+3+5, SW480 (MLH1+/MSH3+) and SW48 (MLH1-/MSH3+) cells with shRNA knockdown of MSH3. Cells were treated with 5-fluorouracil (5-FU), SN-38, oxaliplatin, or the histone deacetylase (HDAC) inhibitor PCI-24781 and cell viability, clonogenic survival, DNA damage and apoptosis were analyzed. Results: MSH3-deficient vs proficient CRC cells showed increased sensitivity to the irinotecan metabolite SN-38 and to oxaliplatin, but not 5-FU, as shown in assays for apoptosis and clonogenic survival. In contrast, suppression of MLH1 attenuated the cytotoxic effect of 5-FU, but did not alter sensitivity to SN-38 or oxaliplatin. The impact of MSH3 knockdown on chemosensitivity to SN-38 and oxaliplatin was maintained independent of MLH1 status. In MSH3-deficient vs proficient cells, SN-38 and oxaliplatin induced higher levels of phosphorylated histone H2AX and Chk2, and similar results were found in MLH1-proficient SW480 cells. MSH3-deficient vs proficient cells showed increased 53BP1 nuclear foci after irradiation, suggesting that MSH3 can regulate DNA double strand break (DSB) repair. We then utilized PCI-24781 that interferes with homologous recombination (HR) indicated by a reduction in Rad51 expression. The addition of PCI-24781 to oxaliplatin enhanced cytotoxicity to a greater extent compared to either drug alone. Conclusion: MSH3 status can regulate the DNA damage response and extent of apoptosis induced by chemotherapy. The ability of MSH3 to regulate chemosensitivity was independent of MLH1 status. PCI-24781-mediated impairment of HR enhanced oxaliplatin sensitivity, suggesting that reduced DSB repair capacity may be contributory.	[Park, Jae Myung; Huang, Shengbing; Tougeron, David; Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55905 USA; [Park, Jae Myung; Huang, Shengbing; Tougeron, David; Sinicrope, Frank A.] Mayo Canc Ctr, Rochester, MN USA; [Tougeron, David] Dept Gastroenterol, Poitiers, France	Mayo Clinic; Mayo Clinic; Universite de Poitiers	Sinicrope, FA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu	tougeron, david/ABF-3217-2020	tougeron, david/0000-0002-8065-9635	National Cancer Institute [K05CA-142885]; National Institutes of Health Silvio O. Conte Digestive Diseases Research Core Centers [P30DK084567]; NATIONAL CANCER INSTITUTE [K05CA142885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Silvio O. Conte Digestive Diseases Research Core Centers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by grants from the National Cancer Institute (K05CA-142885; Senior Scientist Award to FAS) and the National Institutes of Health Silvio O. Conte Digestive Diseases Research Core Centers (P30DK084567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Arnold CN, 2003, INT J CANCER, V106, P66, DOI 10.1002/ijc.11176; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bras-Goncalves RA, 2000, BRIT J CANCER, V82, P913, DOI 10.1054/bjoc.1999.1019; Campregher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050541; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Edelmann W, 2000, CANCER RES, V60, P803; Fink D, 1996, CANCER RES, V56, P4881; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Iwaizumi M, 2011, CANCER BIOL THER, V12, P756, DOI 10.4161/cbt.12.8.17169; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; KOI M, 1994, CANCER RES, V54, P4308; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Laghi L, 2012, CLIN CANCER RES, V18, P3142, DOI 10.1158/1078-0432.CCR-12-0175; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Liu A, 2008, J CELL BIOCHEM, V105, P245, DOI 10.1002/jcb.21824; Magrini R, 2002, INT J CANCER, V101, P23, DOI 10.1002/ijc.10565; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; Meyers M, 2005, J BIOL CHEM, V280, P5516, DOI 10.1074/jbc.M412105200; Meyers M, 2001, CANCER RES, V61, P5193; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Ohmiya N, 2001, GENE, V272, P301, DOI 10.1016/S0378-1119(01)00517-0; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Pocard M, 2000, ANTICANCER RES, V20, P85; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Tajima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028117; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tejpar S, 2009, J CLIN ONCOL S, V27; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; van Waardenburg RCA, 2004, MOL CANCER THER, V3, P393; Vilar E, 2008, BRIT J CANCER, V99, P1607, DOI 10.1038/sj.bjc.6604691; Watanabe A, 1996, GENOMICS, V31, P311, DOI 10.1006/geno.1996.0053; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yamamoto H, 1997, CANCER RES, V57, P4420; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	55	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65369	10.1371/journal.pone.0065369	http://dx.doi.org/10.1371/journal.pone.0065369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724141	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000131
J	Zhou, R; Gong, AY; Chen, DQ; Miller, RE; Eischeid, AN; Chen, XM				Zhou, Rui; Gong, Ai-Yu; Chen, Dongqing; Miller, Ryan E.; Eischeid, Alex N.; Chen, Xian-Ming			Histone Deacetylases and NF-kappa B Signaling Coordinate Expression of CX3CL1 in Epithelial Cells in Response to Microbial Challenge by Suppressing miR-424 and miR-503	PLOS ONE			English	Article							CRYPTOSPORIDIUM-PARVUM INFECTION; CHROMATIN-STRUCTURE; IMMUNE-RESPONSES; GENE-EXPRESSION; INNATE IMMUNITY; TRANSCRIPTION; CHEMOKINES; MICE; RNA; ACETYLATION	The NF-kappa B pathway is key to epithelial immune defense and has been implicated in secretion of antimicrobial peptides, release of cytokines/ chemokines to mobilize immune effector cells, and activation of adaptive immunity. The expression of many inflammatory genes following infection involves the remodeling of the chromatin structure. We reported here that histone deacetylases (HDACs) and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells following Cryptosporidium parvum infection. Upregulation of CX3CL1 was detected in cultured human biliary epithelial cells following infection. Expression of miR-424 and miR-503 was downregulated, and was involved in the induction of CX3CL1 in infected cells. C. parvum infection suppressed transcription of the mir-424-503 gene in a NF-kappa B-and HDAC-dependent manner. Increased promoter recruitment of NF-kappa B p50 and HDACs, and decreased promoter H3 acetylation associated with the mir-424- 503 gene were observed in infected cells. Upregulation of CX3CL1 in biliary epithelial cells and increased infiltration of CX3CR1+ cells were detected during C. parvum infection in vivo. Induction of CX3CL1 and downregulation of miR-424 and miR-503 were also detected in epithelial cells in response to LPS stimulation. The above results indicate that HDACs and NF-kappa B signaling coordinate epithelial expression of CX3CL1 to promote mucosal antimicrobial defense through suppression of the mir-424-503 gene.	[Zhou, Rui; Gong, Ai-Yu; Chen, Dongqing; Miller, Ryan E.; Eischeid, Alex N.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Creighton University	Chen, XM (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	xianmingchen@creighton.edu			National Institutes of Health [R01 AI071321, U01 AI095532]; Nebraska Tobacco Settlement Biomedical Research Program [LB692, LB595]; National Center for Research Resources [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI071321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Institutes of Health Grant R01 AI071321, U01 AI095532 and the Nebraska Tobacco Settlement Biomedical Research Program (LB692 and LB595). The project was also supported by Grant Number G20RR024001 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bode KA, 2011, BLOOD, V117, P1102, DOI 10.1182/blood-2010-11-315820; Chakravorty SJ, 2002, CLIN EXP IMMUNOL, V129, P150, DOI 10.1046/j.1365-2249.2002.01906.x; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Deng MQ, 2004, ADV DRUG DELIVER REV, V56, P869, DOI 10.1016/j.addr.2003.10.034; Gong AY, 2011, INT J PARASITOL, V41, P397, DOI 10.1016/j.ijpara.2010.11.011; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hong SH, 2001, J BIOL CHEM, V276, P28098, DOI 10.1074/jbc.M010912200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Laurent F, 1998, INFECT IMMUN, V66, P1787, DOI 10.1128/IAI.66.4.1787-1790.1998; Laurent F, 1997, INFECT IMMUN, V65, P5067, DOI 10.1128/IAI.65.12.5067-5073.1997; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; O'Hara SP, 2011, J PARASITOL, V97, P813, DOI 10.1645/GE-2703.1; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Petry F, 2010, EXP PARASITOL, V126, P304, DOI 10.1016/j.exppara.2010.05.022; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Rogers KA, 2006, INFECT IMMUN, V74, P549, DOI 10.1128/IAI.74.1.549-556.2006; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Seydel KB, 1998, INFECT IMMUN, V66, P2379, DOI 10.1128/IAI.66.5.2379-2382.1998; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stievano L, 2004, CRIT REV IMMUNOL, V24, P205, DOI 10.1615/CritRevImmunol.v24.i3.40; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tzipori S, 2002, MICROBES INFECT, V4, P1045, DOI 10.1016/S1286-4579(02)01628-3; Verdon R, 1998, J MED MICROBIOL, V47, P71, DOI 10.1099/00222615-47-1-71; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	42	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65153	10.1371/journal.pone.0065153	http://dx.doi.org/10.1371/journal.pone.0065153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724129	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000122
J	Huang, H; Tong, Y; Zhang, QJ; Gao, LZ				Huang, Hui; Tong, Yan; Zhang, Qun-Jie; Gao, Li-Zhi			Genome Size Variation among and within Camellia Species by Using Flow Cytometric Analysis	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; INTRASPECIFIC VARIATION; ISOLATION BUFFERS; EVOLUTION; GENUS; DYNAMICS; ANGIOSPERMS; MECHANISMS; CAFFEINE; SORGHUM	Background: The genus Camellia, belonging to the family Theaceae, is economically important group in flowering plants. Frequent interspecific hybridization together with polyploidization has made them become taxonomically "difficult taxa". The DNA content is often used to measure genome size variation and has largely advanced our understanding of plant evolution and genome variation. The goals of this study were to investigate patterns of interspecific and intraspecific variation of DNA contents and further explore genome size evolution in a phylogenetic context of the genus. Methodology/Principal Findings: The DNA amount in the genus was determined by using propidium iodide flow cytometry analysis for a total of 139 individual plants representing almost all sections of the two subgenera, Camellia and Thea. An improved WPB buffer was proven to be suitable for the Camellia species, which was able to counteract the negative effects of secondary metabolite and generated high-quality results with low coefficient of variation values (CV) <5%. Our results showed trivial effects on different tissues of flowers, leaves and buds as well as cytosolic compounds on the estimation of DNA amount. The DNA content of C. sinensis var. assamica was estimated to be 1C = 3.01 pg by flow cytometric analysis, which is equal to a genome size of about 2940 Mb. Conclusion: Intraspecific and interspecific variations were observed in the genus Camellia, and as expected, the latter was larger than the former. Our study suggests a directional trend of increasing genome size in the genus Camellia probably owing to the frequent polyploidization events.	[Huang, Hui] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Huang, Hui; Tong, Yan; Zhang, Qun-Jie; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Tong, Yan; Zhang, Qun-Jie] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Plant Germplasm & Genom Ctr, Kunming, Peoples R China.	lgao@mail.kib.ac.cn			National Science Foundation of China [U0936603, 31200515]; Top Talents Program of Yunnan Province [20080A 009]; Hundreds of Oversea Talents Program of Yunnan Province; Natural Science Foundation of Yunnan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Talents Program of Yunnan Province; Hundreds of Oversea Talents Program of Yunnan Province; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported by National Science Foundation of China (U0936603), Top Talents Program of Yunnan Province (20080A 009), and Hundreds of Oversea Talents Program of Yunnan Province to L.Z. Gao, and grants from National Science Foundation of China (31200515) and Natural Science Foundation of Yunnan Province to H. Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack EJ, 2004, AM J BOT, V91, P1783, DOI 10.3732/ajb.91.11.1783; Barakat A, 1997, P NATL ACAD SCI USA, V94, P6857, DOI 10.1073/pnas.94.13.6857; BARANYI M, 1995, PLANT SYST EVOL, V194, P231, DOI 10.1007/BF00982857; Beaulieu JM, 2007, NEW PHYTOL, V173, P422, DOI 10.1111/j.1469-8137.2006.01919.x; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Bennett MD, 2000, ANN BOT-LONDON, V85, P351, DOI 10.1006/anbo.1999.1071; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Chang HD, 1981, SYSTEMIC RES CAMELLI, P52; CHANG HD, 1998, TOMUS, V49, P1; Chase MW, 2005, ANN BOT-LONDON, V95, P191, DOI 10.1093/aob/mci012; Chen Liang, 2002, Journal of Tea Science, V22, P19; Cullis CA, 2005, ANN BOT-LONDON, V95, P201, DOI 10.1093/aob/mci013; d'Ennequin ML, 1998, J HERED, V89, P556; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DOLEZEL J, 1995, CYTOMETRY, V19, P103, DOI 10.1002/cyto.990190203; Dolezel J, 2010, CYTOM PART A, V77A, P635, DOI 10.1002/cyto.a.20915; Ellul P, 2002, ANN BOT-LONDON, V90, P345, DOI 10.1093/aob/mcf194; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; GREILHUBER J, 1986, CAN J GENET CYTOL, V28, P409, DOI 10.1139/g86-060; Greilhuber J, 1998, ANN BOT-LONDON, V82, P27, DOI 10.1006/anbo.1998.0725; Greilhuber J, 2005, ANN BOT-LONDON, V95, P91, DOI 10.1093/aob/mci004; GREILHUBER J, 1988, PLANT SYST EVOL, V158, P87; Grover C. E., 2010, Journal of Botany, V2010, P382732, DOI 10.1155/2010/382732; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Gu ZhiJian, 1997, Acta Botanica Yunnanica, V19, P159; Hall SE, 2000, ANN BOT-LONDON, V86, P1081, DOI 10.1006/anbo.2000.1272; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Kamemoto H., 1987, The breeding of horticultural crops. Proceedings of an international symposium held at National Chung Hsing University, Taiwan, December, 1986., P182; Krahulcova Anna, 2000, Fragmenta Floristica et Geobotanica, V45, P239; LAURIE DA, 1985, HEREDITY, V55, P307, DOI 10.1038/hdy.1985.112; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leong-Skornickova J, 2007, ANN BOT-LONDON, V100, P505, DOI 10.1093/aob/mcm144; LI GT, 1990, GUIHAIA, V10, P127; Li GT, 2001, CHIN WILD PLANT RESO, V20, P9; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; Loureiro J, 2006, ANN BOT-LONDON, V98, P515, DOI 10.1093/aob/mcl140; Lysak MA, 2000, ANN BOT-LONDON, V86, P399, DOI 10.1006/anbo.2000.1200; Moscone EA, 2003, ANN BOT-LONDON, V92, P21, DOI 10.1093/aob/mcg105; Noirot M, 2003, ANN BOT-LONDON, V92, P709, DOI 10.1093/aob/mcg183; Noirot M, 2003, ANN BOT-LONDON, V92, P259, DOI 10.1093/aob/mcg139; OHRI D, 1986, PLANT SYST EVOL, V153, P119, DOI 10.1007/BF00989421; Otto F.J., 1992, FLOW CYTOMETRY CELL, P65, DOI [10.1007/978-3-662-02785-1_8, DOI 10.1007/978-3-662-02785-1_8]; PFOSSER M, 1995, CYTOMETRY, V21, P387, DOI 10.1002/cyto.990210412; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Price HJ, 2000, ANN BOT-LONDON, V86, P929, DOI 10.1006/anbo.2000.1255; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; PRICE HJ, 1976, BOT REV, V42, P27, DOI 10.1007/BF02860861; PRICE HJ, 1988, EVOL TREND PLANT, V2, P53; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shepherd SA, 1989, BIOL SEAGRASSES, P112; Smarda P, 2006, ANN BOT-LONDON, V98, P665, DOI 10.1093/aob/mcl150; Smarda P, 2010, PRESLIA, V82, P41; Soltis DE, 2003, AM J BOT, V90, P1596, DOI 10.3732/ajb.90.11.1596; Suda J, 2010, CYTOM PART A, V77A, P717, DOI 10.1002/cyto.a.20907; Suda J, 2007, ANN BOT-LONDON, V100, P1323, DOI 10.1093/aob/mcm218; Suda J, 2006, TAXON, V55, P447, DOI 10.2307/25065591; Tanaka J., 2006, J REMOTE SENS SOC JP, V2006, P1, DOI [10.5979/cha.2006.1, DOI 10.5979/CHA.2006.1]; Tian Min, 2008, Acta Horticulturae Sinica, V35, P1685; TRAGANOS F, 1991, CANCER RES, V51, P3682; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Zhang ML, 2007, J TEA BUS, V1, P25; Zhang XC, 2010, FLORA CHINA, P366	67	37	39	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64981	10.1371/journal.pone.0064981	http://dx.doi.org/10.1371/journal.pone.0064981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724111	Green Submitted, gold, Green Published			2022-12-25	WOS:000319738100037
J	Lin, YM; Pajak, A; Marsolais, F; McCourt, P; Riggs, CD				Lin, Yimei; Pajak, Agnieszka; Marsolais, Frederic; McCourt, Peter; Riggs, C. Daniel			Characterization of a Cruciferin Deficient Mutant of Arabidopsis and Its Utility for Overexpression of Foreign Proteins in Plants	PLOS ONE			English	Article							SEED STORAGE PROTEIN; TRANSGENE EXPRESSION; REGULATORY ELEMENTS; GENE; ACCUMULATION; THALIANA; SULFUR; PHYTOHEMAGGLUTININ; PRODUCTS	Plant seeds naturally accumulate storage reserves (proteins, carbohydrates, lipids) that are mobilized during germination to provide energy and raw materials to support early seedling growth. Seeds have been exploited as bioreactors for the production to foreign materials, but stable, high level expression has been elusive, in part due to the intrinsic bias for producing the natural reserves in their typical proportions. To identify mutants governing seed filling, we screened a population of mutagenized Arabidopsis plants for a mutant that failed to fill its seeds. Here we report the identification of ssp1, a recessive, viable mutant that accumulates approximately 15% less protein than wildtype seeds. Molecular analyses revealed that ssp1 is due to the introduction of a premature stop codon in CRU3, one of the major cruciferin genes. Unlike many other reserve mutants or transgenic lines in which seed storage protein levels are reduced by antisense/RNAi technologies, ssp1 exhibits low level compensation by other reserves, and represents a mutant background that might prove useful for high level expression of foreign proteins. To test this hypothesis, we used a bean phytohemagglutinin (PHA) gene as a reporter and compared PHA expression levels in single copy insertion lines in ssp1 vs. wildtype. These near isogenic lines allow reporter protein levels to be compared without the confounding and sometimes unknown influences of transgene copy number and position effects on gene expression. The ssp1 lines consistently accumulated more PHA than the backcrossed counterparts, with increases ranging from 12% to 126%. This proof of principle study suggests that similar strategies in crop plants may improve the yield of foreign proteins of agronomic and economic interest.	[Lin, Yimei; McCourt, Peter; Riggs, C. Daniel] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Pajak, Agnieszka; Marsolais, Frederic] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada; [Marsolais, Frederic] Univ Western Ontario, Dept Biol, London, ON, Canada	University of Toronto; Agriculture & Agri Food Canada; Western University (University of Western Ontario)	Riggs, CD (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	riggs@utsc.utoronto.ca	Riggs, Dan/I-1718-2012	Riggs, Dan/0000-0002-3751-6129; Marsolais, Frederic/0000-0003-3914-141X	Ontario Ministry of Economic Development and Innovation [ORF-RE04-043]; Natural Sciences and Engineering Research Council of Canada (NSERC) [90057]; NSERC [STR0167294]	Ontario Ministry of Economic Development and Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by: Ontario Research Fund, Research Excellence Programme of the Ontario Ministry of Economic Development and Innovation (Grant # ORF-RE04-043) to FM; Natural Sciences and Engineering Research Council of Canada (NSERC) (Discovery Grant # 90057) to CDR; and NSERC Strategic Grant (Grant # STR0167294) to PM and CDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2012, BIOTECHNOL ADV, V30, P524, DOI 10.1016/j.biotechadv.2011.09.006; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; DICKINSON CD, 1989, PLANT CELL, V1, P459, DOI 10.1105/tpc.1.4.459; Dietz-Pfeilstetter A, 2010, PLANT SCI, V179, P164, DOI 10.1016/j.plantsci.2010.04.015; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Frizzi A, 2010, PLANT MOL BIOL, V73, P569, DOI 10.1007/s11103-010-9644-1; Goossens A, 1999, FEBS LETT, V456, P160, DOI 10.1016/S0014-5793(99)00943-6; Hagan ND, 2003, PLANT J, V34, P1, DOI 10.1046/j.1365-313X.2003.01699.x; Higashi Y, 2006, PLANT J, V48, P557, DOI 10.1111/j.1365-313X.2006.02900.x; Huang SS, 2005, PLANT BIOTECHNOL J, V3, P555, DOI 10.1111/j.1467-7652.2005.00146.x; Kawakatsu T, 2010, PLANT PHYSIOL, V154, P1842, DOI 10.1104/pp.110.164343; Lange M, 2007, J AGR FOOD CHEM, V55, P6074, DOI 10.1021/jf0709505; Lau OS, 2010, PLANT BIOTECHNOL J, V8, P994, DOI 10.1111/j.1467-7652.2010.00526.x; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Marsolais F, 2010, J PROTEOMICS, V73, P1587, DOI 10.1016/j.jprot.2010.03.013; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Mooney BP, 2004, PHYTOCHEMISTRY, V65, P1733, DOI 10.1016/j.phytochem.2004.04.011; Naqvi S, 2011, BIOTECHNOL ADV, V29, P40, DOI 10.1016/j.biotechadv.2010.08.009; Newell-McGloughlin M, 2008, PLANT PHYSIOL, V147, P939, DOI 10.1104/pp.108.121947; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; PANG PP, 1988, PLANT MOL BIOL, V11, P805, DOI 10.1007/BF00019521; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Petersen K, 2002, PLANT MOL BIOL, V49, P45, DOI 10.1023/A:1014464127973; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Rai M, 2007, PLANT CELL REP, V26, P1221, DOI 10.1007/s00299-007-0333-8; RIGGS CD, 1989, PLANT CELL, V1, P609, DOI 10.1105/tpc.1.6.609; Schmidt MA, 2008, PLANT BIOTECHNOL J, V6, P832, DOI 10.1111/j.1467-7652.2008.00364.x; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Scossa F, 2008, PROTEOMICS, V8, P2948, DOI 10.1002/pmic.200700861; Segal G, 2003, GENETICS, V165, P387; Shigemitsu T, 2012, PLANT CELL REP, V31, P539, DOI 10.1007/s00299-011-1191-y; Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; STURM A, 1988, PLANTA, V175, P170, DOI 10.1007/BF00392425; Tada Y, 2003, PLANT BIOTECHNOL J, V1, P411, DOI 10.1046/j.1467-7652.2003.00038.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; VOELKER T, 1987, EMBO J, V6, P3571, DOI 10.1002/j.1460-2075.1987.tb02687.x; Wan LL, 2007, BIOCHEM J, V404, P247, DOI 10.1042/BJ20061569; Werner S, 2011, P NATL ACAD SCI USA, V108, P14061, DOI 10.1073/pnas.1102928108; Zhang J, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x	46	14	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64980	10.1371/journal.pone.0064980	http://dx.doi.org/10.1371/journal.pone.0064980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724110	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100036
J	Schedin-Weiss, S; Inoue, M; Teranishi, Y; Yamamoto, NG; Karlstrom, H; Winblad, B; Tjernberg, LO				Schedin-Weiss, Sophia; Inoue, Mitsuhiro; Teranishi, Yasuhiro; Yamamoto, Natsuko Goto; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.			Visualizing Active Enzyme Complexes Using a Photoreactive Inhibitor for Proximity Ligation - Application on gamma-Secretase	PLOS ONE			English	Article							RAT-BRAIN; TRANSMEMBRANE ASPARTATES; ALZHEIMERS-DISEASE; IN-SITU; PROTEIN; PRESENILIN-1; NICASTRIN; INTERMEDIATE; LOCALIZATION; MEMBRANES	Here, we present a highly sensitive method to study protein-protein interactions and subcellular location selectively for active multicomponent enzymes. We apply the method on gamma-secretase, the enzyme complex that catalyzes the cleavage of the amyloid precursor protein (APP) to generate amyloid beta-peptide (A beta), the major causative agent in Alzheimer disease (AD). The novel assay is based on proximity ligation, which can be used to study protein interactions in situ with very high sensitivity. In traditional proximity ligation assay (PLA), primary antibody recognition is typically accompanied by oligonucleotide-conjugated secondary antibodies as detection probes. Here, we first performed PLA experiments using antibodies against the gamma-secretase components presenilin 1 (PS1), containing the catalytic site residues, and nicastrin, suggested to be involved in substrate recognition. To selectively study the interactions of active gamma-secretase, we replaced one of the primary antibodies with a photoreactive gamma-secretase inhibitor containing a PEG linker and a biotin group (GTB), and used oligonucleotide-conjugated streptavidin as a probe. Interestingly, significantly fewer interactions were detected with the latter, novel, assay, which is a reasonable finding considering that a substantial portion of PS1 is inactive. In addition, the PLA signals were located more peripherally when GTB was used instead of a PS1 antibody, suggesting that gamma-secretase matures distal from the perinuclear ER region. This novel technique thus enables highly sensitive protein interaction studies, determines the subcellular location of the interactions, and differentiates between active and inactive gamma-secretase in intact cells. We suggest that similar PLA assays using enzyme inhibitors could be useful also for other enzyme interaction studies.	[Schedin-Weiss, Sophia; Inoue, Mitsuhiro; Teranishi, Yasuhiro; Yamamoto, Natsuko Goto; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, KI ADRC, Stockholm, Sweden	Karolinska Institutet	Schedin-Weiss, S (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, KI ADRC, Novum Level 5, Stockholm, Sweden.	sophia.schedin.weiss@ki.se		Schedin Weiss, Sophia/0000-0003-2143-7052; Karlstrom, Helena/0000-0002-0498-2473	Dainippon Sumitomo Pharma Co., Ltd.; Stiftelsen gamla tjanarinnor; Gun and Bertil Stohnes stiftelse	Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Stiftelsen gamla tjanarinnor; Gun and Bertil Stohnes stiftelse	This work was supported by Dainippon Sumitomo Pharma Co., Ltd., Stiftelsen gamla tjanarinnor and Gun and Bertil Stohnes stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; Frykman S, 2012, NEUROCHEM INT, V61, P108, DOI 10.1016/j.neuint.2012.03.016; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Jeong SJ, 2000, FASEB J, V14, P2171, DOI 10.1096/fj.99-1068com; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Laudon H, 2007, PHYSIOL BEHAV, V92, P115, DOI 10.1016/j.physbeh.2007.05.037; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li T, 2003, J NEUROSCI, V23, P3272; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Nadin A, 2001, TETRAHEDRON, V57, P1861, DOI 10.1016/S0040-4020(00)01167-4; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pamren A, 2011, J BIOL CHEM, V286, P31153, DOI 10.1074/jbc.C111.235267; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Schon EA, 2010, J ALZHEIMERS DIS, V20, pS281, DOI 10.3233/JAD-2010-100495; Selkoe D.J., 2011, COLD SPRING HARB PER, V3; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	30	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63962	10.1371/journal.pone.0063962	http://dx.doi.org/10.1371/journal.pone.0063962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717518	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300030
J	Tadesse, T; Demissie, M; Berhane, Y; Kebede, Y; Abebe, M				Tadesse, Takele; Demissie, Meaza; Berhane, Yemane; Kebede, Yigzaw; Abebe, Markos			The Clustering of Smear-Positive Tuberculosis in Dabat, Ethiopia: A Population Based Cross Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; PATTERNS	Background: In Ethiopia where tuberculosis epidemic remains high, studies that describe hotspots of the disease are unavailable. This study tried to detect the spatial distribution and clustering of smear-positive tuberculosis cases in Dabat, Ethiopia. Methods and Findings: A population-based cross sectional study conducted in the Dabat Health and Demographic Surveillance System site from October 2010 to September 2011 identified smear-positive tuberculosis cases. Trained field workers collected demographic and location data from each study participant through house-to-house visits. A spatial scan statistic was used to identify purely spatial and space-time clusters of tuberculosis among permanent residents. Two significant (p<0.001) spatial and space-time clusters were identified in the study district. Conclusion: Tuberculosis is concentrated in certain geographic locations in Dabat, Ethiopia. This kind of clustering can be common in the country, so the National Tuberculosis Control Program can be more effective by identifying such clusters and targeting interventions.	[Tadesse, Takele; Kebede, Yigzaw] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Demissie, Meaza; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health	Tadesse, T (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	takele_tadesse@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar; AHRI (Armeaur Hansen Research Institute); TB Care I; Addis Continental Institute of Public Health	University of Gondar; AHRI (Armeaur Hansen Research Institute); TB Care I; Addis Continental Institute of Public Health	The authors wish to thank the University of Gondar, the AHRI (Armeaur Hansen Research Institute) and TB Care I for funding this study, and the Addis Continental Institute of Public Health for sponsoring the principal investigator doctoral training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian B, 2012, SCI WORLD J, V7; Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; John G, 2011, BMC PUBLIC HEALTH, V11, P515; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1403; Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395; Moonan Patrick K, 2004, Int J Health Geogr, V3, P23, DOI 10.1186/1476-072X-3-23; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Pronyk PM, 2007, SCAND J PUBLIC HEALT, V35, P45, DOI 10.1080/14034950701355767; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Tadesse T, 2013, INT J TUBERC LUNG D, V17, P630, DOI 10.5588/ijtld.12.0449; Tadesse T, 2011, ETHIOP J HLTH BIOMED, V4, P1; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Thomas N, 2005, MALAWI MED J, V17, P33; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; World Health Organization, 2012, WHOHTMTB20117	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e65022	10.1371/journal.pone.0065022	http://dx.doi.org/10.1371/journal.pone.0065022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717686	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600081
J	Wittkopp, S; Staimer, N; Tjoa, T; Gillen, D; Daher, N; Shafer, M; Schauer, JJ; Sioutas, C; Delfino, RJ				Wittkopp, Sharine; Staimer, Norbert; Tjoa, Thomas; Gillen, Daniel; Daher, Nancy; Shafer, Martin; Schauer, James J.; Sioutas, Constantinos; Delfino, Ralph J.			Mitochondrial Genetic Background Modifies the Relationship between Traffic-Related Air Pollution Exposure and Systemic Biomarkers of Inflammation	PLOS ONE			English	Article							AIRBORNE PARTICULATE MATTER; OXIDATIVE STRESS; ULTRAFINE PARTICLES; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SOURCE APPORTIONMENT; DNA HAPLOGROUPS; HEART-DISEASE; RISK	Background: Mitochondria are the main source of reactive oxygen species (ROS). Human mitochondrial haplogroups are linked to differences in ROS production and oxidative-stress induced inflammation that may influence disease pathogenesis, including coronary artery disease (CAD). We previously showed that traffic-related air pollutants were associated with biomarkers of systemic inflammation in a cohort panel of subjects with CAD in the Los Angeles air basin. Objective: We tested whether air pollutant exposure-associated inflammation was stronger in mitochondrial haplogroup H than U (high versus low ROS production) in this panel (38 subjects and 417 observations). Methods: Inflammation biomarkers were measured weekly in each subject (<= 12 weeks), including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), C-reactive protein, interleukin-6 soluble receptor and tumor necrosis factor-soluble receptor II. We determined haplogroup by restriction fragment length polymorphism analysis. Air pollutants included nitrogen oxides (NOx), carbon monoxide (CO), organic carbon, elemental and black carbon (EC, BC); and particulate matter mass, three size fractions (, 0.25 mu m, 0.25-2.5 mu m, and 2.5-10 mu m in aerodynamic diameter). Particulate matter extracts were analyzed for organic compounds, including polycyclic aromatic hydrocarbons (PAH), and in vitro oxidative potential of aqueous extracts. Associations between exposures and biomarkers, stratified by haplogroup, were analyzed by mixed-effects models. Results: IL-6 and TNF-alpha were associated with traffic-related air pollutants (BC, CO, NOx and PAH), and with mass and oxidative potential of quasi-ultrafine particles,0.25 mu m. These associations were stronger for haplogroup H than haplogroup U. Conclusions: Results suggest that mitochondrial haplogroup U is a novel protective factor for air pollution-related systemic inflammation in this small group of subjects.	[Wittkopp, Sharine] Univ Calif Irvine, Sch Med, Dept Med, Occupat & Environm Med Div, Irvine, CA 92717 USA; [Staimer, Norbert; Tjoa, Thomas; Delfino, Ralph J.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Gillen, Daniel] Univ Calif Irvine, Sch Informat & Comp Sci, Dept Stat, Irvine, CA USA; [Daher, Nancy; Sioutas, Constantinos] Univ So Calif, Dept Civil & Environm Engn, Viterbi Sch Engn, Los Angeles, CA USA; [Shafer, Martin; Schauer, James J.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Delfino, RJ (corresponding author), Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA.	rdelfino@uci.edu	Sioutas, Constantinos/R-1968-2019	Sioutas, Constantinos/0000-0001-5146-0857; Schauer, James/0000-0002-5405-1511	U.S. National Institutes of Health from the National Institute of Environmental Health Sciences [R01 ES12243, R21 ES016420, F30 ES021107-01A1]; National Center for Research Resources [MO1 RR00827]; California Air Resources Board [03-329, 09-341]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES021107, R21ES016420, R01ES012243] Funding Source: NIH RePORTER	U.S. National Institutes of Health from the National Institute of Environmental Health Sciences; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California Air Resources Board; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present project was supported by U.S. National Institutes of Health grant numbers R01 ES12243, R21 ES016420, and F30 ES021107-01A1 from the National Institute of Environmental Health Sciences, MO1 RR00827 from the National Center for Research Resources and California Air Resources Board contracts 03-329 and 09-341. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Arhami M, 2010, INDOOR AIR, V20, P17, DOI 10.1111/j.1600-0668.2009.00620.x; Ayres JG, 2008, INHAL TOXICOL, V20, P75, DOI [10.1080/08958370701665517, 10.1080/08958370701665517 ]; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Canter JA, 2010, J INFECT DIS, V201, P1703, DOI 10.1086/652419; De Luca A, 2012, JAIDS-J ACQ IMM DEF, V59, P113, DOI [10.1097/QAI.0b013e31823daff3, 10.1097/QAI.0b013e31823daff3.]; Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c; Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269; Docherty KS, 2008, ENVIRON SCI TECHNOL, V42, P7655, DOI 10.1021/es8008166; Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Landreman AP, 2008, AEROSOL SCI TECH, V42, P946, DOI 10.1080/02786820802363819; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mo YQ, 2012, TOXICOL IN VITRO, V26, P295, DOI 10.1016/j.tiv.2011.12.001; Morita M, 2012, J DIABETES COMPLICAT; Morita M, 2011, THER APHER DIAL, V15, P147, DOI 10.1111/j.1744-9987.2010.00887.x; Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Raman K, 2013, CAN J CARDIOL, V29, P67, DOI 10.1016/j.cjca.2012.06.025; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sannigrahi P, 2006, ENVIRON SCI TECHNOL, V40, P666, DOI 10.1021/es051150i; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Sioutas C, 2005, ENVIRON HEALTH PERSP, V113, P947, DOI 10.1289/ehp.7939; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Stone EA, 2008, ATMOS CHEM PHYS, V8, P1249, DOI 10.5194/acp-8-1249-2008; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Weber RJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008408; Woods JA, 2009, IMMUNOL ALLERGY CLIN, V29, P381, DOI 10.1016/j.iac.2009.02.011	48	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64444	10.1371/journal.pone.0064444	http://dx.doi.org/10.1371/journal.pone.0064444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717615	gold, Green Published			2022-12-25	WOS:000319435600066
J	Ford, ES; Capewell, S				Ford, Earl S.; Capewell, Simon			Trends in Total and Low-Density Lipoprotein Cholesterol among US Adults: Contributions of Changes in Dietary Fat Intake and Use of Cholesterol-Lowering Medications	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SERUM-CHOLESTEROL; STATIN THERAPY; UNITED-STATES; PLASMA; LIPIDS; METAANALYSIS; ADHERENCE; OBESITY; DRUGS	Objective: Our aim was to examine the relative contributions of changes in dietary fat intake and use of cholesterol-lowering medications to changes in concentrations of total cholesterol among adults in the United States from 1988-1994 to 2007-2008. Method: We used data from adults aged 20-74 years who participated in National Health and Nutrition Examination Surveys from 1988-1994 to 2007-2008. The effect of change in dietary fat intake on concentrations of total cholesterol was estimated by the use of equations developed by Keys, Hegsted, and successors. Results: Age-adjusted mean concentrations of total cholesterol were 5.60 mmol/L (216 mg/dl) during 1988-1994 falling to 5.09 mmol/L (197 mg/dl) in 2007-2008 (P<0.001). No significant changes in the intake of total fat, saturated fat, polyunsaturated fat, and dietary cholesterol were observed from 1988-1994 to 2007-2008. However, the age-adjusted use of cholesterol-lowering medications increased from 1.6% to 12.5% (P<0.001). The various equations suggested that changes in dietary fat made minimal contributions to the observed trend in mean concentrations of total cholesterol. The increased use of cholesterol-lowering medications was estimated to account for approximately 46% of the change. Discussion: Mean concentrations of total cholesterol among adults in the United States have declined by similar to 4% since 1988-1994. The increased use of cholesterol-lowering medications has apparently accounted for about half of this small fall. Further substantial decreases in cholesterol might be potentially achievable by implementing effective and feasible public health interventions to promote the consumption of a more healthful diet by US adults. Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	[Ford, Earl S.] Natl Ctr Chron Dis Prevent & Hlth Promot, Div Populat Hlth, Ctr Dis Control & Prevent, Atlanta, GA USA; [Capewell, Simon] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England	Centers for Disease Control & Prevention - USA; University of Liverpool	Ford, ES (corresponding author), Natl Ctr Chron Dis Prevent & Hlth Promot, Div Populat Hlth, Ctr Dis Control & Prevent, Atlanta, GA USA.	eford@cdc.gov						Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Caspard H, 2005, CLIN THER, V27, P1639, DOI 10.1016/j.clinthera.2005.10.005; *CDCP, 1994, VIT HLTH STAT, V1; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grant RW, 2004, ARCH INTERN MED, V164, P2343, DOI 10.1001/archinte.164.21.2343; Graves K L, 1993, Ann Epidemiol, V3, P605, DOI 10.1016/1047-2797(93)90083-G; HEGSTED DM, 1986, AM J CLIN NUTR, V44, P299, DOI 10.1093/ajcn/44.2.299; HEGSTED DM, 1993, AM J CLIN NUTR, V57, P875, DOI 10.1093/ajcn/57.6.875; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; KAHN HA, 1970, AM J CLIN NUTR, V23, P879; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Poluzzi E, 2008, EUR J CLIN PHARMACOL, V64, P425, DOI 10.1007/s00228-007-0428-8; Puska P, 2009, ANN NUTR METAB, V54, P33, DOI 10.1159/000220825; Rosengren A, 2009, J INTERN MED, V266, P268, DOI 10.1111/j.1365-2796.2009.02116.x; *US DEP HHS, 2011, HEART DIS STROK; *US DEP HHS, 1981, VIT HLTH STAT, V1; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; *US DHEW, 1977, VIT HLTH STAT, V1; *US DHEW, 1978, VIT HLTH STAT, V1; *US DHEW, 1973, VIT HLTH STAT, V1; Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x; Wright Jacqueline D, 2010, NCHS Data Brief, P1	37	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e65228	10.1371/journal.pone.0065228	http://dx.doi.org/10.1371/journal.pone.0065228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717695	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700192
J	Lee, JE; Lee, S; Lee, H; Song, YM; Lee, K; Han, MJ; Sung, J; Ko, G				Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Song, Yun-Mi; Lee, Kayoung; Han, Min Ji; Sung, Joohon; Ko, GwangPyo			Association of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin Cohort	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; PCR DETECTION; HEALTHY TWIN; WOMEN; RISK; DIVERSITY; HPV; HIV; INFLAMMATION; LACTOBACILLI	Human papillomavirus (HPV) is the most important causative agent of cervical cancers worldwide. However, our understanding of how the vaginal microbiota might be associated with HPV infection is limited. In addition, the influence of human genetic and physiological factors on the vaginal microbiota is unclear. Studies on twins and their families provide the ideal settings to investigate the complicated nature of human microbiota. This study investigated the vaginal microbiota of 68 HPV-infected or uninfected female twins and their families using 454-pyrosequencing analysis targeting the variable region (V2-V3) of the bacterial 16S rRNA gene. Analysis of the vaginal microbiota from both premenopausal women and HPV-discordant twins indicated that HPV-positive women had significantly higher microbial diversity with a lower proportion of Lactobacillus spp. than HPV-negative women. Fusobacteria, including Sneathia spp., were identified as a possible microbiological marker associated with HPV infection. The vaginal microbiotas of twin pairs were significantly more similar to each other than to those from unrelated individuals. In addition, there were marked significant differences from those of their mother, possibly due to differences in menopausal status. Postmenopausal women had a lower proportion of Lactobacillus spp. and a significantly higher microbiota diversity. This study indicated that HPV infection was associated with the composition of the vaginal microbiota, which is influenced by multiple host factors such as genetics and menopause. The potential biological markers identified in this study could provide insight into HPV pathogenesis and may represent biological targets for diagnostics.	[Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Ko, GwangPyo] Seoul Natl Univ, Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea; [Lee, Jung Eun; Lee, Sunghee; Lee, Heetae; Ko, GwangPyo] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul, South Korea; [Song, Yun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Kayoung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Family Med, Busan, South Korea; [Han, Min Ji; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Seoul National University (SNU)	Ko, G (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea.	gko@snu.ac.kr	LEE, Sunghee/HCH-4510-2022; Lee, Kayoung/AAV-1254-2020; lee, kayoung/AAU-8352-2020	lee, kayoung/0000-0002-2816-554X	National Research Foundation of Korea (NRF) [2012-0008692]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF; No. 2012-0008692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2008, SEX TRANSM DIS, V35, P791, DOI 10.1097/OLQ.0b013e3181788301; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Bachrach G, 2005, FEMS MICROBIOL LETT, V248, P235, DOI 10.1016/j.femsle.2005.05.055; BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro Therezita M Peixoto Patury Galvao, 2009, Braz J Otorhinolaryngol, V75, P167; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis-Devine S, 2005, AM J CLIN PATHOL, V124, P24, DOI [10.1309/BFVVU29HCC5RCKY5, 10.1309/BFWU29HCC5RCKY5]; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; DOLS JAM, 2012, ISRN OBESTET GYNECOL, V2012, P5; Dols JAM, 2012, DIAGN CYTOPATHOL, V40, P472, DOI 10.1002/dc.21786; FREEDMAN M, 2008, MENOPAUSE MANAG, V17, P9; Garcea G, 2005, PANCREATOLOGY, V5, P514, DOI 10.1159/000087493; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Haakensen M, 2008, INT J FOOD MICROBIOL, V125, P236, DOI 10.1016/j.ijfoodmicro.2008.04.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hillier SL, 1997, CLIN INFECT DIS, V25, pS123, DOI 10.1086/516221; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Keller MJ, 2012, JAMA-J AM MED ASSOC, V308, P362, DOI 10.1001/jama.2012.5664; KOSTIC AD, 2011, GENOME, DOI DOI 10.1101/GR.126573.126111; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lippman SA, 2010, INT J STD AIDS, V21, P105, DOI 10.1258/ijsa.2009.008436; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marks MA, 2012, J CLIN MICROBIOL, V50, P300, DOI 10.1128/JCM.05979-11; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Pabich WL, 2003, J INFECT DIS, V188, P1054, DOI 10.1086/378203; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott M, 1999, CLIN DIAGN LAB IMMUN, V6, P751, DOI 10.1128/CDLI.6.5.751-755.1999; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Song YM, 2010, TWIN RES HUM GENET, V13, P223, DOI 10.1375/twin.13.3.223; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Sung J, 2006, TWIN RES HUM GENET, V9, P844, DOI 10.1375/183242706779462822; TACHEZY R, 1994, BIOCHEM BIOPH RES CO, V204, P820, DOI 10.1006/bbrc.1994.2533; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uitto VJ, 2005, INFECT IMMUN, V73, P1171, DOI 10.1128/IAI.73.2.1171-1179.2005; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WILSON M, 2008, BACTERIOLOGY HUMANS, P171; Woodworth CD, 2002, FRONT BIOSCI-LANDMRK, V7, pD2058, DOI 10.2741/woodworth; Yamamoto T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/j.jpag.2008.01.073; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555	61	158	191	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63514	10.1371/journal.pone.0063514	http://dx.doi.org/10.1371/journal.pone.0063514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717441	Green Published, gold			2022-12-25	WOS:000320362700031
J	Santos, AJ; Ferreira, RL; Buzatto, BA				Santos, Adalberto J.; Ferreira, Rodrigo Lopes; Buzatto, Bruno A.			Two New Cave-Dwelling Species of the Short-Tailed Whipscorpion Genus Rowlandius (Arachnida: Schizomida: Hubbardiidae) from Northeastern Brazil, with Comments on Male Dimorphism	PLOS ONE			English	Article							ALLOMETRY; THRESHOLD; TACTICS; TRAITS	Two new species of the arachnid order Schizomida, Rowlandius ubajara sp. nov. and Rowlandius potiguar sp. nov., are described based on both male and female specimens collected in caves from northeastern Brazil. Rowlandius ubajara is known only from the Ubajara Cave, in the state of Ceara; R. potiguar is recorded from 20 caves of the Apodi Limestone Group, in the state of Rio Grande do Norte. A remarkable dimorphism in male pedipalp length is described and analyzed in R. potiguar. The distribution of male pedipalp length is clearly bimodal in the species, but the two male morphs (homeomorphic and heteromorphic) present some overlap in the sizes of this structure. Moreover, males show a steeper allometry in pedipalp length than females, indicating that this trait is under a different selective regime in males and in females.	[Santos, Adalberto J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil; [Ferreira, Rodrigo Lopes] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Buzatto, Bruno A.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Perth, WA 6009, Australia	Universidade Federal de Minas Gerais; Universidade Federal de Lavras; University of Western Australia	Santos, AJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil.	oxyopes@yahoo.com	Buzatto, Bruno Alves/B-6583-2011; Hymenoptera, Inct/I-2210-2013; Ferreira, RL/L-8419-2014; Santos, Adalberto J/H-8349-2012	Buzatto, Bruno Alves/0000-0002-2711-0336; Ferreira, RL/0000-0003-3288-4405; Santos, Adalberto J/0000-0002-0010-346X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPQ) [Procs. 300498/2009-8]; FAPEMIG [PPM-00553-11]; Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira [procs. 477712/2006-1]; University of Western Australia	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira; University of Western Australia	This study was financially supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPQ) (www.cnpq.br; Procs. 300498/2009-8) FAPEMIG (PPM-00553-11) and Instituto Nacional de Ciencia e Tecnologia dos Hymenoptera Parasitoides da Regiao Sudeste Brasileira (http://www.hympar.ufscar.br/) to AJS and CNPq (www.cnpq.br; procs. 477712/2006-1) to RLF. BAB was supported by the University of Western Australia through an International Postgraduate Research Scholarship (http://www.scholarships.uwa.edu.au/search?sc_view = 1&id = 454&page = 1&q = IPRS&s = 1&old_key = 0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Padilla F, 2007, J ARACHNOL, V35, P538, DOI 10.1636/Sh06-55.1; Armas L. F., 2010, B SOC ENTOMOLOGICA A, V47, P55; Armas LF, 2009, B SEA, V45, P253; Armas LF, 2004, REV IBERICA ARACNOLO, V2, P3263; Auler A., 2001, GRANDES CAVERNAS BRA; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Brockmann HJ, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P177, DOI 10.1017/CBO9780511542602.009; Buzatto BA, 2011, EVOL ECOL, V25, P331, DOI 10.1007/s10682-010-9431-0; COKENDOLPHER J C, 1988, Acta Arachnologica, V36, P79, DOI 10.2476/asjaa.36.79; Cokendolpher James C., 1992, Texas Memorial Museum Speleological Monograph, V3, P31; Cokendolpher JC, 2000, AMAZONIANA, V16, P187; de Armas L.F., 1989, Poeyana, P1; de Armas L.F., 2010, B SOC ENTOMOL ARAGON, V46, P203; de Armas Luis F., 2002, Revista Iberica de Aracnologia, V6, P149; Armas Luis F. de, 2009, Pap. Avulsos Zool., V49, P361; Drummond GM, 2009, BIOTA MINAS DIAGNOST, P160; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HARVEY M S, 1992, Invertebrate Taxonomy, V6, P77, DOI 10.1071/IT9920077; Harvey MS, 2003, CATALOUE SMALLER ARC; Harvey MS, 2007, INTEGRATED TAXONOMIC; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Knell RJ, 2009, ECOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-2311.2008.01022.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; LAWRENCE RF, 1969, T ROY SOC S AFR, V38, P123, DOI 10.1080/00359196909519080; Legendre P., 2011, LMODEL2 MODEL 2 REGR; MITTERMEIER R.A., 2003, WILDERNESS EARTHS LA; Packard GC, 2012, BIOL J LINN SOC, V107, P764, DOI 10.1111/j.1095-8312.2012.01995.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Radwan J, 2000, EXP APPL ACAROL, V24, P115, DOI 10.1023/A:1006492903270; Reddell James R., 1995, Texas Memorial Museum Speleological Monograph, V4, P1; ROWLAND JM, 1978, J ARACHNOL, V6, P161; Rowland JM, 2005, EVOL ECOL RES, V7, P421; Santos AJ, 2008, ZOOTAXA, P53; Santos AJ, 2009, J ARACHNOL, V37, P39, DOI 10.1636/H07-80.1; Shuster SM, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P224, DOI 10.1017/CBO9780511542602.010; SISSOM WD, 1980, J ARACHNOL, V8, P187; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; STURM H, 1958, NATURWISSENSCHAFTEN, V45, P142, DOI 10.1007/BF00641015; STURM H, 1973, Zeitschrift fuer Tierpsychologie, V33, P113; Teruel Rolando, 2007, Boletin de la SEA, V40, P39; Teruel Rolando, 2003, Revista Iberica de Aracnologia, V7, P39; Tomkins JL, 2009, EVOLUTION, V63, P459, DOI 10.1111/j.1558-5646.2008.00563.x; Tourinho Ana Lucia M., 1999, Boletim do Museu Nacional Rio de Janeiro Zoologia, V405, P1; Vanacker D, 2003, J ARACHNOL, V31, P309, DOI 10.1636/s02-06; Zatz C, 2011, BEHAV ECOL SOCIOBIOL, V65, P995, DOI 10.1007/s00265-010-1103-0; Zeh JA, 2013, BIOL J LINN SOC, V108, P509, DOI 10.1111/bij.12011	46	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63616	10.1371/journal.pone.0063616	http://dx.doi.org/10.1371/journal.pone.0063616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23723989	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700039
J	Taren, AA; Creswell, JD; Gianaros, PJ				Taren, Adrienne A.; Creswell, J. David; Gianaros, Peter J.			Dispositional Mindfulness Co-Varies with Smaller Amygdala and Caudate Volumes in Community Adults	PLOS ONE			English	Article							LONG-TERM MEDITATION; STRESS REDUCTION; INDIVIDUAL-DIFFERENCES; RHEUMATOID-ARTHRITIS; PREFRONTAL CORTEX; BRAIN STRUCTURE; PERSONALITY; DEPRESSION; RESPONSES; ATTENTION	Mindfulness, a psychological process reflecting attention and awareness to what is happening in the present moment, has been associated with increased well-being and decreased depression and anxiety in both healthy and patient populations. However, little research has explored underlying neural pathways. Recent work suggests that mindfulness (and mindfulness training interventions) may foster neuroplastic changes in cortico-limbic circuits responsible for stress and emotion regulation. Building on this work, we hypothesized that higher levels of dispositional mindfulness would be associated with decreased grey matter volume in the amgydala. In the present study, a self-report measure of dispositional mindfulness and structural MRI images were obtained from 155 healthy community adults. Volumetric analyses showed that higher dispositional mindfulness is associated with decreased grey matter volume in the right amygdala, and exploratory analyses revealed that higher dispositional mindfulness is also associated with decreased grey matter volume in the left caudate. Moreover, secondary analyses indicate that these amygdala and caudate volume associations persist after controlling for relevant demographic and individual difference factors (i.e., age, total grey matter volume, neuroticism, depression). Such volumetric differences may help explain why mindful individuals have reduced stress reactivity, and suggest new candidate structural neurobiological pathways linking mindfulness with mental and physical health outcomes.	[Taren, Adrienne A.; Gianaros, Peter J.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Creswell, J. David] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Gianaros, Peter J.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Creswell, JD (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	creswell@cmu.edu			Pittsburgh Life Sciences Greenhouse Opportunity Fund; National Institute of Health [R01 HL089850]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089850] Funding Source: NIH RePORTER	Pittsburgh Life Sciences Greenhouse Opportunity Fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institute of Health under Grant #R01 HL089850, and the Pittsburgh Life Sciences Greenhouse Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Astin JA, 2003, J RHEUMATOL, V30, P2257; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Barnes S, 2007, J MARITAL FAM THER, V33, P482, DOI 10.1111/j.1752-0606.2007.00033.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Brown KW, 2012, PSYCHONEUROENDOCRINO, V37, P2037, DOI 10.1016/j.psyneuen.2012.04.003; Brown KW, 2011, PSYCHOL ASSESSMENT, V23, P1023, DOI 10.1037/a0021338; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Creswell JD, 2009, BRAIN BEHAV IMMUN, V23, P184, DOI 10.1016/j.bbi.2008.07.004; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Farb NAS, 2010, EMOTION, V10, P25, DOI 10.1037/a0017151; Frewen PA, 2010, PERS INDIV DIFFER, V49, P479, DOI 10.1016/j.paid.2010.05.008; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Gianaros PJ, 2009, BIOL PSYCHIAT, V65, P943, DOI 10.1016/j.biopsych.2008.10.007; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501; Grossman P, 2011, PSYCHOL ASSESSMENT, V23, P1034, DOI 10.1037/a0022713; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jackson J, 2011, NEUROBIOL AGING, V32, P2162, DOI 10.1016/j.neurobiolaging.2009.12.009; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; KAPLAN KH, 1993, GEN HOSP PSYCHIAT, V15, P284, DOI 10.1016/0163-8343(93)90020-O; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Kilpatrick LA, 2011, NEUROIMAGE, V56, P290, DOI 10.1016/j.neuroimage.2011.02.034; Knutson B, 2001, BIOL PSYCHIAT, V50, P685, DOI 10.1016/S0006-3223(01)01220-3; Lanteaume L, 2007, CEREB CORTEX, V17, P1307, DOI 10.1093/cercor/bhl041; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lee TMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040054; Levita L, 2009, NEUROIMAGE, V44, P1178, DOI 10.1016/j.neuroimage.2008.09.039; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Modinos G, 2010, SOC COGN AFFECT NEUR, V5, P369, DOI 10.1093/scan/nsq006; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Morone NE, 2008, PAIN, V134, P310, DOI 10.1016/j.pain.2007.04.038; Nyklicek I, 2013, HEALTH PSYCHOL, V32, P1110, DOI 10.1037/a0032200; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Pradhan EK, 2007, ARTHRIT RHEUM-ARTHR, V57, P1134, DOI 10.1002/art.23010; Roiser JP, 2008, NEUROPSYCHOPHARMACOL, V33, P1992, DOI 10.1038/sj.npp.1301581; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Shekhar A, 2003, ANN NY ACAD SCI, V985, P308; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Siegle GJ, 2004, COGNITIVE THER RES, V28, P645, DOI 10.1023/B:COTR.0000045570.62733.9f; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Taren AA, 2013, HDB MINDFUL IN PRESS; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wager TD, 2008, HDB EMOTIONS; Wang DJJ, 2011, PSYCHIAT RES-NEUROIM, V191, P60, DOI 10.1016/j.pscychresns.2010.09.011; Way BM, 2010, EMOTION, V10, P12, DOI 10.1037/a0018312; Weniger G, 2006, J AFFECT DISORDERS, V94, P219, DOI 10.1016/j.jad.2006.04.017; Zangi HA, 2012, ANN RHEUM DIS, V71, P911, DOI 10.1136/annrheumdis-2011-200351; Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408	80	65	66	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64574	10.1371/journal.pone.0064574	http://dx.doi.org/10.1371/journal.pone.0064574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717632	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700155
J	Taulli, R; Foglizzo, V; Morena, D; Coda, DM; Ala, U; Bersani, F; Maestro, N; Ponzetto, C				Taulli, R.; Foglizzo, V.; Morena, D.; Coda, D. M.; Ala, U.; Bersani, F.; Maestro, N.; Ponzetto, C.			Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma	ONCOGENE			English	Article						BAF53a; chromatin remodeling; miR-206; rhabdomyosarcoma; differentiation therapy	TERMINAL DIFFERENTIATION; EXPRESSION; MIR-206; GENE; MYOD; PROLIFERATION; GROWTH; TRANSCRIPTION; INHIBITION; INDUCTION	Rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children and young adults, is characterized by a partially differentiated myogenic phenotype. We have previously shown that the blocking of tumor growth and resumption of differentiation can be achieved by re-expression of miR-206, a muscle-enriched microRNA missing in RMS. In this work, we focused on BAF53a, one of the genes downregulated in miR-206-expressing RMS cells, which codes for a subunit of the SWI/SNF chromatin remodeling complex. Here we show that the BAF53a transcript is significantly higher in primary RMS tumors than in normal muscle, and is a direct target of miR-206. Sustained expression of BAF53a interferes with differentiation in myogenic cells, whereas its silencing in RMS cells increases expression of myogenic markers and inhibits proliferation and anchorage-independent growth. Accordingly, BAF53a silencing also impairs embryonal RMS and alveolar RMS tumor growth, inducing their morphological and biochemical differentiation. These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.	[Taulli, R.; Foglizzo, V.; Morena, D.; Coda, D. M.; Bersani, F.; Maestro, N.; Ponzetto, C.] Univ Turin, Sch Med, Dept Oncol, I-10126 Turin, Italy; [Taulli, R.; Foglizzo, V.; Morena, D.; Coda, D. M.; Bersani, F.; Maestro, N.; Ponzetto, C.] Ctr Expt Res & Med Studies, CERMS, Turin, Italy; [Ala, U.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of Turin; University of Turin	Ponzetto, C (corresponding author), Univ Turin, Dept Oncol, Corso Massimo dAzeglio 52, I-10126 Turin, Italy.	carola.ponzetto@unito.it	Maestro, Nicola/AAA-6097-2020; Ala, Ugo/K-2029-2016; TAULLI, Riccardo/J-7347-2018	Maestro, Nicola/0000-0001-7909-3737; Ala, Ugo/0000-0001-5408-6397; TAULLI, Riccardo/0000-0003-1277-6263; Bersani, Francesca/0000-0002-0343-7078; Foglizzo, Valentina/0000-0001-5059-3279	Regione Piemonte (IMMONC Project); Italian Association for Cancer Research (AIRC); International Foundation of Research in Experimental Medicine (FIRMS)	Regione Piemonte (IMMONC Project)(Regione Piemonte); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); International Foundation of Research in Experimental Medicine (FIRMS)	We are grateful to Janet Shipley and Zoe Walters of the Molecular Cytogenetics Team (The Institute of Cancer Research, Sutton, Surrey, UK), for indicating the appropriate RMS databanks, to PL Puri (Sanford-Burnham, San Diego) for providing reagents and feedback, to Elisa DeLuca for technical help with the confocal microscope and to Rosella Rota and Giorgia Bracaglia for providing the human myoblasts samples and for helpful suggestions. This work was supported by funding from the Regione Piemonte (IMMONC Project) and the Italian Association for Cancer Research (AIRC). The support of the International Foundation of Research in Experimental Medicine (FIRMS) is gratefully acknowledged.	Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Belyea Brian, 2012, Sarcoma, V2012, P406239, DOI 10.1155/2012/406239; BOUCHE M, 1993, EXP CELL RES, V208, P209, DOI 10.1006/excr.1993.1239; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Coutinho P, 2012, SOC MUSCLE BIOL FRON; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; MacQuarrie KL, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-7; Mallappa C, 2010, MOL CELL BIOL, V30, P3176, DOI 10.1128/MCB.00214-10; McDowell HP, 2003, ARCH DIS CHILD, V88, P354, DOI 10.1136/adc.88.4.354; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001; Missiaglia E, 2010, BRIT J CANCER, V102, P1769, DOI 10.1038/sj.bjc.6605684; Ohfuchi E, 2002, BIOSCI BIOTECH BIOCH, V66, P1740, DOI 10.1271/bbb.66.1740; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Puri PL, 2000, GENE DEV, V14, P574; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Raney R B, 2001, Sarcoma, V5, P9, DOI 10.1080/13577140120048890; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Ricaud S, 2003, ONCOGENE, V22, P8221, DOI 10.1038/sj.onc.1207177; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Roma J, 2011, CLIN CANCER RES, V17, P505, DOI 10.1158/1078-0432.CCR-10-0166; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Taulli R, 2010, CELL CYCLE, V9, P918, DOI 10.4161/cc.9.5.10864; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Walters ZS, 2013, ONCOGENE, V1, P10; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Xia SJ, 2005, EUR J CANCER, V41, P2513, DOI 10.1016/j.ejca.2005.08.003; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023; Zhou J, 2013, BIOCHEM BIOPH RES CO, V13, P364	49	37	38	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2354	2362		10.1038/onc.2013.188	http://dx.doi.org/10.1038/onc.2013.188			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23728344				2022-12-25	WOS:000335451800008
J	Liu, HX; Stone, SL				Liu, Hongxia; Stone, Sophia L.			Cytoplasmic Degradation of the Arabidopsis Transcription Factor ABSCISIC ACID INSENSITIVE 5 Is Mediated by the RING-type E3 Ligase KEEP ON GOING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABI5; PROTEINS; GROWTH; GENE; UBIQUITINATION; LOCALIZATION; EXPRESSION; DIVERSITY; SIGNALS; BINDING	To mitigate the effects of environmental stress the abscisic acid (ABA)-responsive transcription factor ABI5 is required to delay growth of germinated seedlings. In the absence of stress, KEEP ON GOING(KEG) E3 is required to maintain low levels of ABI5. However, the mechanism underlying KEG-dependent turnover of ABI5 is not known. In addition, localization studies place KEG at the trans-Golgi network, whereas ABI5 is nuclear. Here we show that KEG interacts directly with ABI5 via its conserved C3 region. Interactions between KEG and ABI5 were observed in the cytoplasm and trans-Golgi network only when the RING domain of KEG was inactivated or when ABI5 was stabilized via mutations. Deletion of the C-terminal region of ABI5 or substituting lysine 344 for alanine (K344A) prohibited protein turnover. Furthermore, ABI5 is observed in the cytoplasm of Arabidopsis thaliana root cells when the K344A mutation is combined with the deletion of a nuclear localization signal. Other lysine mutations (K353A, K364A, and K376A) in conjunction with the nuclear localization signal deletion did not result in cytoplasmic accumulation of ABI5. Loss of lysine 344 did not affect the ability of ABI5 to promote ABA responses, which demonstrates that the mutant transcription factor is still functional. Based on the results, a model is suggested where KEG targets ABI5 for degradation in the cytoplasm, thus reducing nuclear accumulation of the transcription factor in the absence of ABA.	[Liu, Hongxia; Stone, Sophia L.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University	Stone, SL (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada.	sophia.stone@dal.ca		Stone, Sophia/0000-0003-2140-6037	Natural Science and Engineering Research Council of Canada; Human Frontier Science Program Center Developmental Award	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program Center Developmental Award	This work was supported in part by a Natural Science and Engineering Research Council of Canada grant and Human Frontier Science Program Center Developmental Award (to S.L.S.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Brocard IM, 2002, PLANT PHYSIOL, V129, P1533, DOI 10.1104/pp.005793; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Kircher S, 1999, J CELL BIOL, V144, P201, DOI 10.1083/jcb.144.2.201; Lee J, 2010, ASIAN NURS RES, V4, P1, DOI 10.1016/S1976-1317(10)60001-1; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Strieter ER, 2012, ACS CHEM BIOL, V7, P52, DOI 10.1021/cb2004059; Suo Y, 2004, PROTOPLASMA, V224, P79, DOI 10.1007/s00709-004-0050-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang F, 2009, PLANT CELL, V21, P2378, DOI 10.1105/tpc.108.065433	32	80	82	2	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20267	20279		10.1074/jbc.M113.465369	http://dx.doi.org/10.1074/jbc.M113.465369			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720747	hybrid, Green Published			2022-12-25	WOS:000321715100016
J	Alcaide, ML; Parmigiani, A; Pallikkuth, S; Roach, M; Freguja, R; Della Negra, M; Bolivar, H; Fischl, MA; Pahwa, S				Alcaide, Maria L.; Parmigiani, Anita; Pallikkuth, Suresh; Roach, Margaret; Freguja, Riccardo; Della Negra, Marina; Bolivar, Hector; Fischl, Margaret A.; Pahwa, Savita			Immune Activation in HIV-Infected Aging Women on Antiretrovirals-Implications for Age-Associated Comorbidities: A Cross-Sectional Pilot Study	PLOS ONE			English	Article							T-CELL-ACTIVATION; MICROBIAL TRANSLOCATION; CARDIOVASCULAR-DISEASE; FLOW-CYTOMETRY; SOLUBLE CD163; PLASMA-LEVELS; THERAPY; AIDS; DYSREGULATION; PROGRESSION	Background: Persistent immune activation and microbial translocation associated with HIV infection likely place HIV-infected aging women at high risk of developing chronic age-related diseases. We investigated immune activation and microbial translocation in HIV-infected aging women in the post-menopausal ages. Methods: Twenty-seven post-menopausal women with HIV infection receiving antiretroviral treatment with documented viral suppression and 15 HIV-negative age-matched controls were enrolled. Levels of immune activation markers (T cell immune phenotype, sCD25, sCD14, sCD163), microbial translocation (LPS) and biomarkers of cardiovascular disease and impaired cognitive function (sVCAM-1, sICAM-1 and CXCL10) were evaluated. Results: T cell activation and exhaustion, monocyte/macrophage activation, and microbial translocation were significantly higher in HIV-infected women when compared to uninfected controls. Microbial translocation correlated with T cell and monocyte/macrophage activation. Biomarkers of cardiovascular disease and impaired cognition were elevated in women with HIV infection and correlated with immune activation. Conclusions: HIV-infected antiretroviral-treated aging women who achieved viral suppression are in a generalized status of immune activation and therefore are at an increased risk of age-associated end-organ diseases compared to uninfected age-matched controls.	[Alcaide, Maria L.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Parmigiani, Anita; Pallikkuth, Suresh; Roach, Margaret; Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Freguja, Riccardo] Univ Padua, Sect Oncol & Immunol, Dept Surg Oncol & Gastroenterol, Unit Viral Oncol, I-35100 Padua, Italy; [Freguja, Riccardo] Univ Padua, AIDS Reference Ctr, I-35100 Padua, Italy; [Della Negra, Marina] Inst Infectol Emilio Ribas, Sao Paulo, Brazil; [Bolivar, Hector; Fischl, Margaret A.] Univ Miami, Miller Sch Med, AIDS Clin Res Unit, Div Infect Dis, Miami, FL 33136 USA	University of Miami; University of Miami; University of Padua; University of Padua; University of Miami	Pahwa, S (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	Spahwa@med.miami.edu	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Alcaide, Maria/0000-0003-4648-0145	University of Miami CFAR (United States National Institutes of Health) [P30 AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	University of Miami CFAR (United States National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded through a developmental award from the University of Miami CFAR (United States National Institutes of Health P30 AI073961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Burdo T. H., 2013, AIDS; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Dhillon NK, 2008, FRONT BIOSCI, V13, P3913, DOI 10.2741/2979; Douek Daniel, 2007, Top HIV Med, V15, P114; Engelmann F, 2011, AGE, V33, P275, DOI 10.1007/s11357-010-9178-0; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Hatano H, 2012, J INFECT DIS; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaplan RC, 2012, JAIDS-J ACQ IMM DEF, V60, P359, DOI 10.1097/QAI.0b013e31825b03be; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kiazyk SAK, 2008, TRENDS MICROBIOL, V16, P567, DOI 10.1016/j.tim.2008.08.011; Kolb SA, 1999, J NEUROIMMUNOL, V93, P172, DOI 10.1016/S0165-5728(98)00223-9; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Lyons JL, 2011, JAIDS-J ACQ IMM DEF, V57, P371, DOI 10.1097/QAI.0b013e3182237e54; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; Moore RD, 2012, CLIN INFECT DIS, V55, P1242, DOI 10.1093/cid/cis654; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; RHOADS GG, 1983, LANCET, V1, P492; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; Triant VA, 2011, J INFECT DIS, V203, P439, DOI 10.1093/infdis/jiq084; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9	50	55	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63804	10.1371/journal.pone.0063804	http://dx.doi.org/10.1371/journal.pone.0063804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724003	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000026
J	Ginger, KWK; Vera, CBS; Dineshram, R; Dennis, CKS; Adela, LJ; Yu, ZN; Thiyagarajan, V				Ginger, Ko W. K.; Vera, Chan B. S.; Dineshram, R.; Dennis, Choi K. S.; Adela, Li J.; Yu, Ziniu; Thiyagarajan, Vengatesen			Larval and Post-Larval Stages of Pacific Oyster (Crassostrea gigas) Are Resistant to Elevated CO2	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; MARINE INVERTEBRATE EMBRYOS; NEAR-FUTURE LEVELS; OCEAN ACIDIFICATION; SEAWATER ACIDIFICATION; SACCOSTREA-GLOMERATA; METABOLIC DEPRESSION; GROWTH; SHELL; TEMPERATURE	The average pH of surface oceans has decreased by 0.1 unit since industrialization and is expected to decrease by another 0.3-0.7 units before the year 2300 due to the absorption of anthropogenic CO2. This human-caused pH change is posing serious threats and challenges to the Pacific oyster (Crassostrea gigas), especially to their larval stages. Our knowledge of the effect of reduced pH on C. gigas larvae presently relies presumptively on four short-term (<4 days) survival and growth studies. Using multiple physiological measurements and life stages, the effects of long-term (40 days) exposure to pH 8.1, 7.7 and 7.4 on larval shell growth, metamorphosis, respiration and filtration rates at the time of metamorphosis, along with the juvenile shell growth and structure of the C. gigas, were examined in this study. The mean survival and growth rates were not affected by pH. The metabolic, feeding and metamorphosis rates of pediveliger larvae were similar, between pH 8.1 and 7.7. The pediveligers at pH 7.4 showed reduced weight-specific metabolic and filtration rates, yet were able to sustain a more rapid post-settlement growth rate. However, no evidence suggested that low pH treatments resulted in alterations to the shell ultrastructures (SEM images) or elemental compositions (i.e., Mg/Ca and Sr/Ca ratios). Thus, larval and post-larval forms of the C. gigas in the Yellow Sea are probably resistant to elevated CO2 and decreased near-future pH scenarios. The pre-adapted ability to resist a wide range of decreased pH may provide C. gigas with the necessary tolerance to withstand rapid pH changes over the coming century.	[Ginger, Ko W. K.; Vera, Chan B. S.; Dineshram, R.; Dennis, Choi K. S.; Adela, Li J.; Thiyagarajan, Vengatesen] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Ginger, Ko W. K.; Vera, Chan B. S.; Dineshram, R.; Dennis, Choi K. S.; Adela, Li J.; Thiyagarajan, Vengatesen] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Ziniu] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Thiyagarajan, V (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China.	rajan@hku.hk	Ram, Dinesh/GLQ-7529-2022; Li, Adela Jing/J-9573-2019	Ram, Dinesh/0000-0002-6723-4587; Li, Adela Jing/0000-0001-5737-8432; Thiyagarajan, Vengatesen/0000-0002-2062-4799; Chan, Bin San/0000-0003-3935-2700	Research Grants Council, Hong Kong [778309M, 780510M, 705511P]; University of Hong Kong [201011159105]	Research Grants Council, Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This study was supported by a three General Reserach Fund from the Research Grants Council, Hong Kong (grant numbers 778309M, 780510M and 705511P) and partially from the University of Hong Kong, grant number 201011159105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Albright R, 2011, POPULATION, V12, P15; Andreasen DH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001124; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Breese W. P., 1975, HATCHERY MANUAL PACI; Brown M, 2002, AQUACULTURE, V207, P289, DOI 10.1016/S0044-8486(01)00742-6; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Cao ZM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001596; Carriker M.R., 1979, PROCEEDINGS NATIONAL SHELLFISHERIES ASSOCIATION, V69, P103; Chan VBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042718; Christensen AB, 2011, J EXP MAR BIOL ECOL, V403, P31, DOI 10.1016/j.jembe.2011.04.002; Christo SW, 2010, BRAZ J BIOL, V70, P645, DOI 10.1590/S1519-69842010000300023; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Crean AJ, 2011, EVOLUTION, V65, P3079, DOI 10.1111/j.1558-5646.2011.01372.x; De Wit P, 2012, MOL ECOL IN PRESS; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dineshram R, 2013, MAR BIOL IN PRESS; Dineshram R, 2012, MAR POLLUT IN PRESS; Diz P, 2012, MAR MICROPALEONTOL, V92-93, P16, DOI 10.1016/j.marmicro.2012.04.006; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2012, MAR BIOL IN PRESS; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Forstner H., 1983, POLAROGRAPHIC OXYGEN, P321; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; GERDES D, 1983, AQUACULTURE, V31, P195, DOI 10.1016/0044-8486(83)90313-7; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hettinger A, 2012, ECOLOGY; Hilmi N, 2012, MAR BIOL IN PRESS; HOEGHGULDBERG O, 1995, J EXP BIOL, V198, P19; Hofmann EE, 2004, ICES J MAR SCI, V61, P596, DOI 10.1016/j.icesjms.2004.03.029; Kisakurek B, 2008, EARTH PLANET SC LETT, V273, P260, DOI 10.1016/j.epsl.2008.06.026; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kudo M, 2010, J STRUCT BIOL, V169, P1, DOI 10.1016/j.jsb.2009.07.014; Kuffner IB, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004128; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Laing I, 1998, AQUAC RES, V29, P19, DOI 10.1046/j.1365-2109.1998.00931.x; Lane AC, 2012, MAR BIOL IN PRESS; Langenbuch M, 2006, COMP BIOCHEM PHYS A, V144, P479, DOI 10.1016/j.cbpa.2006.04.017; Lee SW, 2008, MAT SCI ENG C-BIO S, V28, P258, DOI 10.1016/j.msec.2007.01.001; Li W, 2012, MAR POLLUT IN PRESS; MacDonald J, 2010, MAR BIOL, V157, P2087, DOI 10.1007/s00227-010-1476-7; Marsh AG, 1999, MAR ECOL PROG SER, V184, P1, DOI 10.3354/meps184001; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Medakovic D, 1997, MAR BIOL, V129, P615, DOI 10.1007/s002270050204; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Narita D, 2012, CLIMATIC CHANGE, P1; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2010, STUDIES METABOLIC RA; Reipschlager A, 1996, J EXP BIOL, V199, P1801; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Rico-Villa B, 2006, AQUACULTURE, V256, P377, DOI 10.1016/j.aquaculture.2006.02.015; Rico-Villa B, 2010, AQUACULTURE, V305, P84, DOI 10.1016/j.aquaculture.2010.04.018; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sokolova I, 2012, COMP BIOCHEM PHYS A, V163, pS9, DOI 10.1016/j.cbpa.2012.05.031; Somero G.N., 1985, P454; STENZEL HB, 1964, SCIENCE, V145, P155, DOI 10.1126/science.145.3628.155; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; Thiyagarajan V, 2012, AQUACULTURE, V370, P90, DOI 10.1016/j.aquaculture.2012.09.025; Timmins-Schiffman E, 2012, MAR BIOL IN PRESS; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Wallace D, 2006, MS EXCEL PROGRAM DEV; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Welladsen HM, 2010, MOLLUSCAN RES, V30, P125; WIDDOWS J, 1988, MAR ECOL PROG SER, V46, P113, DOI 10.3354/meps046113; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; [杨金鹏 Yang Jinpeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P1703; Yuan XC, 2011, BIOGEOSCIENCES, V8, P289, DOI 10.5194/bg-8-289-2011; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhai W., 2013, BIOGEOSCIENCES, V10, P3079	100	42	42	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64147	10.1371/journal.pone.0064147	http://dx.doi.org/10.1371/journal.pone.0064147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724027	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000043
J	Kriangkum, J; Motz, SN; Marun, CSD; Lafarge, ST; Gibson, SB; Venner, CP; Johnston, JB; Belch, AR; Pilarski, LM				Kriangkum, Jitra; Motz, Sarah N.; Marun, Carina S. Debes; Lafarge, Sandrine T.; Gibson, Spencer B.; Venner, Christopher P.; Johnston, James B.; Belch, Andrew R.; Pilarski, Linda M.			Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; INTRACLONAL HETEROGENEITY; PLASMA-CELLS; EVOLUTION; DOMINANCE; LYMPHOMA; ANTIBODY; DISTINCT; GENES; REARRANGEMENTS	Clonal diversity in multiple myeloma (MM) includes both MM-related and MM-unrelated clonal expansions which are subject to dominance exerted by the MM clone. Here we show evidence for the existence of minor but highly expanded unrelated B-cell clones in patients with MM defined by their complementary determining region 3 (CDR3) peak. We further characterize these clones over the disease and subsequent treatment. Second clones were identified by their specific IgH-VDJ sequences that are distinct from those of dominant MM clones. Clonal frequencies were determined through semi-quantitative PCR, quantitative PCR and single-cell polymerase chain reaction of the clone-specific sequence. In 13/74 MM patients, more than one dominant CDR3 peak was identified with 12 patients (16%) being truly biclonal. Second clones had different frequencies, were found in different locations and were found in different cell types from the dominant MM clone. Where analysis was possible, they were shown to have chromosomal characteristic distinct from those of the MM clone. The frequency of the second clone also changed over the course of the disease and often persisted despite treatment. Molecularly-defined second clones are infrequent in monoclonal gammopathy of undetermined significance (MGUS, 1/43 individuals or 2%), suggesting that they may arise at relatively late stages of myelomagenesis. In further support of our findings, biclonal gammopathy and concomitant MM and CLL (chronic lymphocytic leukemia) were confirmed to originate from two unrelated clones. Our data supports the idea that the clone giving rise to symptomatic myeloma exerts clonal dominance to prevent expansion of other clones. MM and second clones may arise from an underlying niche permissive of clonal expansion. The clinical significance of these highly expanded but unrelated clones remains to be confirmed. Overall, our findings add new dimensions to evaluating related and unrelated clonal expansions in MM and the impact of disease evolution and treatment on clonal diversity.	[Kriangkum, Jitra; Motz, Sarah N.; Marun, Carina S. Debes; Venner, Christopher P.; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Lafarge, Sandrine T.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Gibson, Spencer B.; Johnston, James B.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Alberta; University of Manitoba	Pilarski, LM (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada.	lpilarsk@ualberta.ca		Gibson, Spencer/0000-0003-0119-732X	Canadian Institutes of Health Research; Alberta Cancer Foundation; Myeloma Alberta Support Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Myeloma Alberta Support Society	This work was funded by the Canadian Institutes of Health Research and by the Alberta Cancer Foundation. The authors are grateful for fund-raising by the Myeloma Alberta Support Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKONAS BA, 1976, IMMUNOLOGY, V31, P541; ASKONAS BA, 1972, NATURE, V238, P339, DOI 10.1038/238339a0; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Bahlis NJ, 2012, BLOOD, V120, P927, DOI 10.1182/blood-2012-06-430645; BAKKUS MHC, 1992, BLOOD, V80, P2326; Chapman CJ, 1996, BLOOD, V88, P3562, DOI 10.1182/blood.V88.9.3562.bloodjournal8893562; Debes Marun CS, 2012, AM J HEMATOLOGY; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Ho PJ, 2002, CLIN LAB HAEMATOL, V24, P259; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; Kriangkum J, 2007, CLIN CANCER RES, V13, P2005, DOI 10.1158/1078-0432.CCR-06-2788; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; KYLE RA, 1981, AM J MED, V71, P999, DOI 10.1016/0002-9343(81)90326-0; Landgren O, 2011, CLIN CANCER RES, V17, P1243, DOI 10.1158/1078-0432.CCR-10-1822; Leleu X, 2010, BLOOD, V116, P375; Magrangeas F, 2013, LEUKEMIA, V27, P473, DOI 10.1038/leu.2012.226; McCarthy PL, 2010, BLOOD, V116, P21; Ottensmeier CH, 1998, BLOOD, V91, P4292, DOI 10.1182/blood.V91.11.4292.411a02_4292_4299; Palumbo AP, 2011, J CLIN ONCOL S, V29; Pantic M, 2010, LEUKEMIA, V24, P885, DOI 10.1038/leu.2009.294; Patriarca F, 2000, HAEMATOLOGICA, V85, P982; Pilarski LM, 2002, EXP HEMATOL, V30, P221, DOI 10.1016/S0301-472X(01)00788-3; Potter KN, 2003, BLOOD, V101, P3082, DOI 10.1182/blood-2002-08-2432; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Reece DE, 2010, BLOOD, V116, P1877; REFF ME, 1994, BLOOD, V83, P435; Reiman T, 2001, BLOOD, V98, P2791, DOI 10.1182/blood.V98.9.2791; Sam MR, 2008, INTERVIROLOGY, V51, P87, DOI 10.1159/000131666; Shokrgozar MA, 2001, IMMUNOLOGY, V104, P75, DOI 10.1046/j.1365-2567.2001.01273.x; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Taylor BJ, 2002, CLIN CANCER RES, V8, P502; Taylor Brian J., 2005, V113, P121, DOI 10.1385/1-59259-916-8:121; Taylor BJ, 2008, BLOOD, V112, P1894, DOI 10.1182/blood-2008-01-129221; Thulien KJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-78; Wadhera RK, 2011, BLOOD, V118, P2985, DOI 10.1182/blood-2011-04-349175; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; WILLIAMSON AR, 1972, NATURE, V238, P337, DOI 10.1038/238337a0	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64927	10.1371/journal.pone.0064927	http://dx.doi.org/10.1371/journal.pone.0064927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724106	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000105
J	Conejo, NM; Cimadevilla, JM; Gonzalez-Pardo, H; Mendez-Couz, M; Arias, JL				Maria Conejo, Nelida; Manuel Cimadevilla, Jose; Gonzalez-Pardo, Hector; Mendez-Couz, Marta; Luis Arias, Jorge			Hippocampal Inactivation with TTX Impairs Long-Term Spatial Memory Retrieval and Modifies Brain Metabolic Activity	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; DORSAL HIPPOCAMPUS; PERIRHINAL CORTEX; OXIDATIVE-METABOLISM; RETROGRADE-AMNESIA; RATS; CONSOLIDATION; AVOIDANCE; SYSTEM; INVOLVEMENT	Functional inactivation techniques enable studying the hippocampal involvement in each phase of spatial memory formation in the rat. In this study, we applied tetrodotoxin unilaterally or bilaterally into the dorsal hippocampus to evaluate the role of this brain structure in retrieval of memories acquired 28 days before in the Morris water maze. We combined hippocampal inactivation with the assessment of brain metabolism using cytochrome oxidase histochemistry. Several brain regions were considered, including the hippocampus and other related structures. Results showed that both unilateral and bilateral hippocampal inactivation impaired spatial memory retrieval. Hence, whereas subjects with bilateral hippocampal inactivation showed a circular swim pattern at the side walls of the pool, unilateral inactivation favoured swimming in the quadrants adjacent to the target one. Analysis of cytochrome oxidase activity disclosed regional differences according to the degree of hippocampal functional blockade. In comparison to control group, animals with bilateral inactivation showed increased CO activity in CA1 and CA3 areas of the hippocampus during retrieval, while the activity of the dentate gyrus substantially decreased. However, unilateral inactivated animals showed decreased CO activity in Ammon's horn and the dentate gyrus. This study demonstrated that retrieval recruits differentially the hippocampal subregions and the balance between them is altered with hippocampal functional lesions.	[Maria Conejo, Nelida; Gonzalez-Pardo, Hector; Mendez-Couz, Marta; Luis Arias, Jorge] Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain; [Manuel Cimadevilla, Jose] Univ Almeria, Dept Neurosci, Almeria, Spain	University of Oviedo; Universidad de Almeria	Conejo, NM (corresponding author), Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain.	conejonelida@uniovi.es	Redondo, José Manuel Cimadevilla/K-3249-2014; Mendez-couz, Marta/ABA-4744-2020; González-Pardo, Héctor/N-4053-2014	Redondo, José Manuel Cimadevilla/0000-0002-0557-5546; Mendez-couz, Marta/0000-0002-8931-019X; González-Pardo, Héctor/0000-0002-4374-6860; CONEJO, NELIDA MARIA/0000-0003-4749-5453; /0000-0003-0983-8654	Ministry of Science and Innovation (Spain) [PSI2008-02106, PSI2010-19348, PSI2011-26985]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministry of Science and Innovation (Spain) (PSI2008-02106; PSI2010-19348; PSI2011-26985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2009, BEHAV BRAIN RES, V197, P388, DOI 10.1016/j.bbr.2008.10.012; Albasser MM, 2011, LEARN MEMORY, V18, P435, DOI 10.1101/lm.2132911; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Broadbent NJ, 2010, HIPPOCAMPUS, V20, P1366, DOI 10.1002/hipo.20722; Canovas R, 2011, EPILEPSY BEHAV, V22, P364, DOI 10.1016/j.yebeh.2011.07.021; Churchwell JC, 2011, BEHAV BRAIN RES, V225, P389, DOI 10.1016/j.bbr.2011.07.045; Churchwell JC, 2010, NEUROBIOL LEARN MEM, V93, P415, DOI 10.1016/j.nlm.2009.12.008; Cimadevilla JM, 2007, J NEUROSCI RES, V85, P1138, DOI 10.1002/jnr.21222; Cimadevilla JM, 2011, HIPPOCAMPUS, V21, P48, DOI 10.1002/hipo.20720; Cimadevilla JM, 2005, COGNITIVE BRAIN RES, V25, P741, DOI 10.1016/j.cogbrainres.2005.09.001; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Cimadevilla JM, 2008, INT J NEUROSCI, V118, P619, DOI 10.1080/00207450701242818; Conejo NM, 2007, NEUROSCIENCE, V145, P403, DOI 10.1016/j.neuroscience.2006.11.057; Conejo NM, 2010, NEUROBIOL LEARN MEM, V93, P362, DOI 10.1016/j.nlm.2009.12.002; Conejo NM, 2004, BRAIN RES, V1011, P107, DOI 10.1016/j.brainres.2004.03.025; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Fidalgo C, 2011, BRAIN RES, V1368, P143, DOI 10.1016/j.brainres.2010.10.066; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Golob EJ, 1997, P NATL ACAD SCI USA, V94, P7645, DOI 10.1073/pnas.94.14.7645; GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HAYAKAWA T, 1989, J COMP NEUROL, V284, P1, DOI 10.1002/cne.902840102; Hopkins ME, 2010, NEUROBIOL LEARN MEM, V94, P278, DOI 10.1016/j.nlm.2010.06.006; Hunsaker MR, 2013, NEUROSCI BIOBEHAV R, V37, P36, DOI 10.1016/j.neubiorev.2012.09.014; Jerman T, 2006, LEARN MEMORY, V13, P458, DOI 10.1101/lm.246906; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Lopez Joelle, 2012, Hippocampus, V22, P827, DOI 10.1002/hipo.20943; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Maaswinkel H, 1999, BEHAV BRAIN RES, V99, P143, DOI 10.1016/S0166-4328(98)00100-4; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Matrov D, 2007, NEUROSCI LETT, V413, P154, DOI 10.1016/j.neulet.2006.11.076; Mendez-Lopez M, 2011, ACTA HISTOCHEM, V113, P465, DOI 10.1016/j.acthis.2010.04.004; Mendez-Lopez M, 2009, NEUROSCI RES, V65, P28, DOI 10.1016/j.neures.2009.05.001; Micheau J, 2004, BEHAV NEUROSCI, V118, P1022, DOI 10.1037/0735-7044.118.5.1022; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser MB, 1998, J NEUROSCI, V18, P7535; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Ramos JMJ, 2008, LEARN MEMORY, V15, P587, DOI 10.1101/lm.1036308; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Ros J, 2006, J CEREBR BLOOD F MET, V26, P468, DOI 10.1038/sj.jcbfm.9600208; Rowe JB, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00144; Sakata JT, 2005, BRAIN RES REV, V48, P1, DOI 10.1016/j.brainresrev.2004.07.017; Shao J., 1995, JACKKNIFE BOOTSTRAP; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; van Praag H, 1998, BRAIN RES, V795, P170, DOI 10.1016/S0006-8993(98)00287-X; Vann SD, 2011, BEHAV BRAIN RES, V224, P201, DOI 10.1016/j.bbr.2011.05.033; vanPraag H, 1997, BRAIN RES, V768, P233, DOI 10.1016/S0006-8993(97)00647-1; Wang GW, 2008, NEUROBIOL LEARN MEM, V90, P365, DOI 10.1016/j.nlm.2008.05.009; Whishaw IQ, 2001, BEHAV BRAIN RES, V118, P67, DOI 10.1016/S0166-4328(00)00312-0; Winter SS, 2011, EUR J NEUROSCI, V33, P371, DOI 10.1111/j.1460-9568.2010.07504.x; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; ZHURAVIN IA, 1991, EXP BRAIN RES, V83, P687	64	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64749	10.1371/journal.pone.0064749	http://dx.doi.org/10.1371/journal.pone.0064749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724089	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000090
J	Vazquez, P; Garrido, JM; Juste, RA				Vazquez, Patricia; Garrido, Joseba M.; Juste, Ramon A.			Specific Antibody and Interferon-Gamma Responses Associated with Immunopathological Forms of Bovine Paratuberculosis in Slaughtered Friesian Cattle	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; LINKED-IMMUNOSORBENT-ASSAY; CELLULAR IMMUNE-RESPONSES; FECAL CULTURE; MYCOBACTERIUM-PARATUBERCULOSIS; JOHNES-DISEASE; DIAGNOSIS; TUBERCULOSIS; INFECTION; COWS	Mycobacterium avium subsp. paratuberculosis (MAP) infection causes a chronic granulomatous inflammatory regional enteritis in ruminants. Cell-mediated immune responses are assumed to be protective and therefore, to be associated with its more delimited lesion types, while humoral responses are mainly associated with diffuse histopathological lesions. However, this duality of immune responses has been recently questioned. The aim of this study was to assess the relationship between both types of immunological responses and the type and extension of intestinal lesions and the presence of MAP in bovine tissues. Standard histopathological examinations, two microbiological procedures (culture and real time PCR (rtPCR)), as well as MAP specific antibody and interferon gamma (IFN-gamma) release assays (IGRA) were performed on tissues and blood of 333 slaughtered Holstein-Friesian animals. Paratuberculous lesions were observed in 176 (52.9%) of the animals and overall MAP detection rates were estimated at 13.5% and 28.5% for tissue culture and rtPCR, respectively. Unlike the relatively constant non-specific IFN-gamma release, both the antibody levels and the specific IFN-gamma release significantly increased with tissue damage. Delimited immunopathological forms, which accounted for 93.2% of all forms, were mostly related to positive testing in the IGRA (38.4%) whereas diffuse ones (6.8%) were associated with antibody seropositivity (91.7%). However, since the frequency of positive immune responses in both tests increased as the lesions severity increased, polarization of Th1/Th2 responses was less prominent than expected. MAP was detected in the majority of ELISA-positive animals (culture+: 90%, rtPCR+: 85%) but the bacteria was only confirmed in the 36.1% of IGRA-positive animals by any of the two microbiological tests. In terms of diagnosis, the antibody test was a good indicator of advanced tissue damage (diffuse forms), but the IGRA did not associate well with more delimited forms or with MAP detection.	[Vazquez, Patricia; Garrido, Joseba M.; Juste, Ramon A.] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain		Juste, RA (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain.	rjuste@neiker.net	Juste, Ramon A./C-3570-2008; GARRIDO, JOSEBA M/L-3202-2014	Juste, Ramon A./0000-0001-6037-5873; Joseba M., Garrido/0000-0002-7559-0653; Vazquez, Patricia/0000-0002-4582-202X	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2006-14315-CO2]; MINECO (Spain) [BES-2007-17170]	Spanish Ministry of Economy and Competitiveness (MINECO); MINECO (Spain)	This study was supported by a grant (AGL2006-14315-CO2) from the Spanish Ministry of Economy and Competitiveness (MINECO). Patricia Vazquez was held a FPI doctoral fellowship (BES-2007-17170) from the MINECO (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; Alvarez J, 2009, VET MICROBIOL, V135, P389, DOI 10.1016/j.vetmic.2008.09.060; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Bezos J, 2012, RES VET SCI, V93, P636, DOI 10.1016/j.rvsc.2011.10.009; Brady C, 2008, VET REC, V162, P147, DOI 10.1136/vr.162.5.147; Briscoe KA, 2011, J COMP PATHOL, V145, P187, DOI 10.1016/j.jcpa.2010.12.011; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Burrells C, 1999, VET IMMUNOL IMMUNOP, V68, P139, DOI 10.1016/S0165-2427(99)00022-7; CHIODINI RJ, 1984, CORNELL VET, V74, P218; Chiodini RJ, 1996, VET CLIN N AM-FOOD A, V12, P313, DOI 10.1016/S0749-0720(15)30409-6; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; Corpa JM, 2000, J COMP PATHOL, V122, P255, DOI 10.1053/jcpa.1999.0368; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Dargatz DA, 2001, J AM VET MED ASSOC, V218, P1163, DOI 10.2460/javma.2001.218.1163; Gatfield J, 2003, ADV IMMUNOL, V81, P45, DOI 10.1016/S0065-2776(03)81002-7; Golan L, 2009, J INFECT DIS, V199, P350, DOI 10.1086/596033; Gonzalez J, 2005, J COMP PATHOL, V133, P184, DOI 10.1016/j.jcpa.2005.04.007; Huda A, 2003, VET IMMUNOL IMMUNOP, V94, P95, DOI 10.1016/S0165-2427(03)00063-1; Huda A, 2003, J COMP PATHOL, V129, P259, DOI 10.1016/S0021-9975(03)00042-2; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; JUSTE RA, 1991, VET MICROBIOL, V28, P385, DOI 10.1016/0378-1135(91)90073-O; Juste RA, 2009, INT J INFECT DIS, V13, P247, DOI 10.1016/j.ijid.2008.06.034; Kalis CHJ, 2002, J VET DIAGN INVEST, V14, P219, DOI 10.1177/104063870201400305; Kirkpatrick BW, 2011, VET CLIN N AM-FOOD A, V27, P559, DOI 10.1016/j.cvfa.2011.07.003; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Kohler H, 2001, J VET MED B, V48, P185, DOI 10.1046/j.1439-0450.2001.00443.x; Koo HC, 2004, INFECT IMMUN, V72, P6870, DOI 10.1128/IAI.72.12.6870-6883.2004; Kurade NP, 2004, VET PATHOL, V41, P378, DOI 10.1354/vp.41-4-378; Minozzi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032578; MOSS MT, 1992, GUT, V33, P1209, DOI 10.1136/gut.33.9.1209; Munoz M, 2009, COMP IMMUNOL MICROB, V32, P239, DOI 10.1016/j.cimid.2007.11.009; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Perez V, 1999, AM J VET RES, V60, P123; Pierik M, 2005, GUT, V54, P223, DOI 10.1136/gut.2004.042572; Shu DR, 2011, CLIN VACCINE IMMUNOL, V18, P1467, DOI 10.1128/CVI.05201-11; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Stabel JR, 2000, AM J VET RES, V61, P754, DOI 10.2460/ajvr.2000.61.754; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; SWEENEY RW, 1995, J VET DIAGN INVEST, V7, P488, DOI 10.1177/104063879500700411; Sweeney RW, 1998, AM J VET RES, V59, P842; Thomsen VT, 2012, VET IMMUNOL IMMUNOP, V145, P316, DOI 10.1016/j.vetimm.2011.11.021; Van der Heyden S, 2011, J COMP PATHOL, V145, P199, DOI 10.1016/j.jcpa.2011.01.003; Vazquez P, 2012, SPAN J AGRIC RES, V10, P662, DOI 10.5424/sjar/2012103-2728; Vazquez P., 2012, Proceedings of the 11th International Colloquium on Paratuberculosis, Sydney, Australia, 5-10 February 2012, P136; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Weber MF, 2009, PREV VET MED, V92, P256, DOI 10.1016/j.prevetmed.2009.08.017; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; YOKOMIZO Y, 1985, JPN J VET SCI, V47, P111, DOI 10.1292/jvms1939.47.111	51	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64568	10.1371/journal.pone.0064568	http://dx.doi.org/10.1371/journal.pone.0064568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724062	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000067
J	Xu, J; Li, YB; Xiang, Y; Chen, X				Xu, Jun; Li, Yibing; Xiang, Yong; Chen, Xi			A Super Energy Mitigation Nanostructure at High Impact Speed Based on Buckyball System	PLOS ONE			English	Article							BALLISTIC IMPACT; DYNAMICS; DISSIPATION; SURFACE	The energy mitigation properties of buck balls are investigated using molecular dynamics (MD) simulations. A one dimensional buckyball long chain is employed as a unit cell of granular fullerene particles. Two types of buckyballs i.e. C-60 and C-720 with recoverable and non-recoverable behaviors are chosen respectively. For C-60 whose deformation is relatively small, a dissipative contact model is proposed. Over 90% of the total impact energy is proven to be mitigated through interfacial reflection of wave propagation, the van der Waals interaction, covalent potential energy and atomistic kinetic energy evidenced by the decent force attenuation and elongation of transmitted impact. Further, the C-720 system is found to outperform its C-60 counterpart and is able to mitigate over 99% of the total kinetic energy by using a much shorter chain thanks to its non-recoverable deformation which enhances the four energy dissipation terms. Systematic studies are carried out to elucidate the effects of impactor speed and mass, as well as buckyball size and number on the system energy mitigation performance. This one dimensional buckyball system is especially helpful to deal with the impactor of high impact speed but small mass. The results may shed some lights on the research of high-efficiency energy mitigation material selections and structure designs.	[Xu, Jun; Chen, Xi] Columbia Univ, Columbia Nanomech Res Ctr, Dept Earth & Environm Engn, New York, NY USA; [Li, Yibing] Tsinghua Univ, Dept Automot Engn, State Key Lab Automot Safety & Energy, Beijing 100084, Peoples R China; [Xiang, Yong] Univ Elect Sci & Technol China, Sch Energy Sci & Engn, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Sichuan, Peoples R China; [Chen, Xi] Hanyang Univ, Dept Civil & Environm Engn, Seoul 133791, South Korea; [Chen, Xi] Xi An Jiao Tong Univ, Int Ctr Appl Mech, SV Lab, Xian, Peoples R China	Columbia University; Tsinghua University; University of Electronic Science & Technology of China; Hanyang University; Xi'an Jiaotong University	Xiang, Y (corresponding author), Univ Elect Sci & Technol China, Sch Energy Sci & Engn, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Sichuan, Peoples R China.	xiang@uestc.edu.cn; xichen@columbia.edu	Chen, Xi/B-1539-2008; Xu, Jun/B-2260-2016; Xu, Jun/D-2096-2009	Chen, Xi/0000-0002-1263-1024; Xu, Jun/0000-0002-8619-8737; chen, xi/0000-0002-8911-4172	National Natural Science Foundation of China [11172231, 11102099]; DARPA [W91CRB-11-C-0112]; National Science Foundation [CMMI-0643726]; Tsinghua University [20121080050]; State Key Laboratory of Automotive Safety & Energy, Tsinghua University [ZZ2011-112]; Ministry of Education of China; National Research Foundation of Korea [R32-2008-000-20042-0]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Tsinghua University; State Key Laboratory of Automotive Safety & Energy, Tsinghua University; Ministry of Education of China(Ministry of Education, China); National Research Foundation of Korea(National Research Foundation of Korea)	The work is supported by National Natural Science Foundation of China (11172231 and 11102099), DARPA (W91CRB-11-C-0112), National Science Foundation (CMMI-0643726), International joint research project sponsored by Tsinghua University (20121080050), Individual-research founding State Key Laboratory of Automotive Safety & Energy, Tsinghua University (ZZ2011-112), Changjiang Scholar Program from Ministry of Education of China, and World Class University program through the National Research Foundation of Korea (R32-2008-000-20042-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antypov D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021303; Carretero-Gonzalez R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.024102; Chandraseker K, 2007, COMP MATER SCI, V40, P147, DOI 10.1016/j.commatsci.2006.11.014; Cowper G.R., 1957, STRAIN HARDENING STR; Cuong HM, 2011, COMP MATER SCI, V50, P2172, DOI 10.1016/j.commatsci.2011.02.029; Daraio C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058002; Deshpande VS, 2000, INT J IMPACT ENG, V24, P277, DOI 10.1016/S0734-743X(99)00153-0; Fraternali F, 2011, J MECH PHYS SOLIDS, V59, P89, DOI 10.1016/j.jmps.2010.09.004; Girifalco LA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125404; Grujicic M, 2012, J MATER ENG PERFORM, V21, P167, DOI 10.1007/s11665-011-9954-8; Gui XC, 2010, ADV MATER, V22, P617, DOI 10.1002/adma.200902986; Ha-Minh C, 2011, ENG FAIL ANAL, V18, P2179, DOI 10.1016/j.engfailanal.2011.07.011; Herbold EB, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2751592; Hou YQ, 2011, TEXT RES J, V81, P1287, DOI 10.1177/0040517511399966; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Jones N, 2010, INT J IMPACT ENG, V37, P754, DOI 10.1016/j.ijimpeng.2009.01.008; Kruyt NP, 2010, J MECH PHYS SOLIDS, V58, P1286, DOI 10.1016/j.jmps.2010.06.003; Lopatnikov SL, 2004, INT J IMPACT ENG, V30, P421, DOI 10.1016/S0734-743X(03)00066-6; Lopatnikov SL, 2003, COMPOS STRUCT, V61, P61, DOI 10.1016/S0263-8223(03)00039-4; Lu G.X., 2003, ENERGY ABSORPTION ST; Lu WY, 2011, INT J MATER RES, V102, P587, DOI 10.3139/146.110377; Mahfuz H, 2000, INT J IMPACT ENG, V24, P203, DOI 10.1016/S0734-743X(99)00047-0; MAN ZY, 1995, PHYS LETT A, V209, P53, DOI 10.1016/0375-9601(95)00768-7; Manjunath M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031308; Mueggenburg NW, 2002, PHYS REV E, V66; Mylvaganam K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356325; Nesterenko V.F., 2001, HIGH PR SH; Nilakantan G, 2012, COMPOS STRUCT, V94, P3624, DOI 10.1016/j.compstruct.2012.05.030; Pan H, 2011, ACS CATAL, V1, P99, DOI 10.1021/cs100045u; Pan ZY, 1998, J APPL PHYS, V83, P4963, DOI 10.1063/1.367298; Park J, 2009, EXP MECH, V49, P697, DOI 10.1007/s11340-008-9181-x; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Qin QH, 2011, COMPOS STRUCT, V93, P1526, DOI 10.1016/j.compstruct.2010.11.018; Reid SR, 1997, INT J IMPACT ENG, V19, P531, DOI 10.1016/S0734-743X(97)00016-X; Sen S, 2008, PHYS REP, V462, P21, DOI 10.1016/j.physrep.2007.10.007; Spannuth MJ, 2004, GRANUL MATTER, V6, P215, DOI 10.1007/s10035-004-0181-y; Tan CY, 2012, COMPOS PART B-ENG, V43, P1433, DOI 10.1016/j.compositesb.2011.08.036; Vaidya UK, 2006, MAT SCI ENG A-STRUCT, V428, P59, DOI 10.1016/j.msea.2006.04.114; Wang CM, 2010, APPL MECH REV, V63, DOI 10.1115/1.4001690; Xia F, 2010, J SANDW STRUCT MATER, V12, P47, DOI 10.1177/1099636209106256; Xu BX, 2011, J COMPUT THEOR NANOS, V8, P881, DOI 10.1166/jctn.2011.1768; Xu J, 2011, INT J AUTO TECH-KOR, V12, P687, DOI 10.1007/s12239-011-0080-2; Xu J, 2013, MECH RES COMMUN, V49, P8, DOI 10.1016/j.mechrescom.2013.01.003; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yang X., 2012, APPL PHYS LETT, V101; Yang XD, 2011, NANO RES, V4, P1191, DOI 10.1007/s12274-011-0169-y	47	7	8	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64697	10.1371/journal.pone.0064697	http://dx.doi.org/10.1371/journal.pone.0064697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724082	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000083
J	Benitez, M; Hejatko, J				Benitez, Mariana; Hejatko, Jan			Dynamics of Cell-Fate Determination and Patterning in the Vascular Bundles of Arabidopsis thaliana	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; TRACHEARY ELEMENTS; HOMEOBOX GENES; PHYTOCHROME-B; DIFFERENTIATION; STEM; ZIP; MESOPHYLL; SYSTEM; TRANSDIFFERENTIATION	Plant vascular meristems are sets of pluripotent cells that enable radial growth by giving rise to vascular tissues and are therefore crucial to plant development. However, the overall dynamics of cellular determination and patterning in and around vascular meristems is still unexplored. We study this process in the shoot vascular tissue of Arabidopsis thaliana, which is organized in vascular bundles that contain three basic cell types (procambium, xylem and phloem). A set of molecules involved in this process has now been identified and partially characterized, but it is not yet clear how the regulatory interactions among them, in conjunction with cellular communication processes, give rise to the steady patterns that accompany cell-fate determination and arrangement within vascular bundles. We put forward a dynamic model factoring in the interactions between molecules (genes, peptides, mRNA and hormones) that have been reported to be central in this process, as well as the relevant communication mechanisms. When a few proposed interactions (unverified, but based on related data) are postulated, the model reproduces the hormonal and molecular patterns expected for the three regions within vascular bundles. In order to test the model, we simulated mutant and hormone-depleted systems and compared the results with experimentally reported phenotypes. The proposed model provides a formal framework integrating a set of growing experimental data and renders a dynamic account of how the collective action of hormones, genes, and other molecules may result in the specification of the three main cell types within shoot vascular bundles. It also offers a tool to test the necessity and sufficiency of particular interactions and conditions for vascular patterning and yields novel predictions that may be experimentally tested. Finally, this model provides a reference for further studies comparing the overall dynamics of tissue organization and formation by meristems in other plant organs and species.	[Benitez, Mariana; Hejatko, Jan] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Benitez, Mariana] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico; [Benitez, Mariana] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Mexico City 04510, DF, Mexico	Masaryk University Brno; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hejatko, J (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	jan.hejatko@ceitec.muni.cz	Hejatko, Jan/H-4296-2014; Hejatko, Jan/AAN-1182-2021; Benítez, Mariana/E-2997-2012	Hejatko, Jan/0000-0002-2622-6046; 	Ministry of Education, Youth and Sports of the Czech Republic [LC06034]; Czech Science Foundation [P501/11/1150]; CEITEC (Central European Institute of Technology); European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); CEITEC (Central European Institute of Technology); European Regional Development Fund(European Commission)	The work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LC06034), the Czech Science Foundation (P501/11/1150), and the CEITEC (Central European Institute of Technology) project (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura MM, 2001, NEW PHYTOL, V151, P381, DOI 10.1046/j.0028-646x.2001.00188.x; Argueso CT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002448; Azpeitia E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-134; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Cano-Delgado A, 2010, ANNU REV CELL DEV BI, V26, P605, DOI 10.1146/annurev-cellbio-100109-104107; Carlsbecker A, 2005, CURR OPIN PLANT BIOL, V8, P512, DOI 10.1016/j.pbi.2005.07.001; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Elo A, 2009, SEMIN CELL DEV BIOL, V20, P1097, DOI 10.1016/j.semcdb.2009.09.009; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Esau K., 1977, ANATOMY SEED PLANTS; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Finet C, 2012, DEV BIOL, V369, P19, DOI 10.1016/j.ydbio.2012.05.039; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Fujita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018243; FUKUDA H, 1980, PLANT PHYSIOL, V65, P61, DOI 10.1104/pp.65.1.61; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gardiner J, 2011, DEV DYNAM, V240, P261, DOI 10.1002/dvdy.22516; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hernandez-Hernandez V, 2012, INT J DEV BIOL, V56, P661, DOI 10.1387/ijdb.120027mb; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horak J, 2011, CURR PROTEIN PEPT SC, V12, P126, DOI 10.2174/138920311795684940; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ibanes M, 2009, P NATL ACAD SCI USA, V106, P13630, DOI 10.1073/pnas.0906416106; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Ji JB, 2010, PLANT SIGNAL BEHAV, V5, P916, DOI [10.4161/psb.5.7.12104, 10.1104/pp.109.149641]; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kushwah S, 2011, PLANT PHYSIOL, V156, P1851, DOI 10.1104/pp.111.175794; La Rota C, 2011, PLANT CELL, V23, P4318, DOI 10.1105/tpc.111.092619; Lehesranta SJ, 2010, CURR OPIN PLANT BIOL, V13, P59, DOI 10.1016/j.pbi.2009.09.004; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mahonen AP, 2006, CURR BIOL, V16, P1116, DOI 10.1016/j.cub.2006.04.030; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Mattsson J, 1999, DEVELOPMENT, V126, P2979; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Nakata M, 2012, PLANT CELL, V24, P519, DOI 10.1105/tpc.111.092858; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Ohashi-Ito K, 2010, CURR OPIN PLANT BIOL, V13, P670, DOI 10.1016/j.pbi.2010.08.011; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sankar M, 2011, BIOINFORMATICS, V27, P1404, DOI 10.1093/bioinformatics/btr158; Sawa S, 2005, PLANT PHYSIOL, V137, P141, DOI 10.1104/pp.104.055145; Sieburth LE, 2003, AM SOC PLANT BIOL, V2, pe0073; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; TURNER S, 2003, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0073; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yoshida S, 2005, PLANT CELL PHYSIOL, V46, P2019, DOI 10.1093/pcp/pci217; Yoshida S, 2011, GENE DEV, V25, P1439, DOI 10.1101/gad.631211; Yoshida S, 2009, PLANT MOL BIOL, V70, P457, DOI 10.1007/s11103-009-9485-y	66	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63108	10.1371/journal.pone.0063108	http://dx.doi.org/10.1371/journal.pone.0063108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723973	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100005
J	Burguillos, MA; Magnusson, C; Nordin, M; Lenshof, A; Augustsson, P; Hansson, MJ; Elmer, E; Lilja, H; Brundin, P; Laurell, T; Deierborg, T				Burguillos, Miguel A.; Magnusson, Cecilia; Nordin, Maria; Lenshof, Andreas; Augustsson, Per; Hansson, Magnus J.; Elmer, Eskil; Lilja, Hans; Brundin, Patrik; Laurell, Thomas; Deierborg, Tomas			Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells	PLOS ONE			English	Article							ULTRASONIC STANDING-WAVE; MAMMALIAN-CELLS; VIABILITY; SEPARATION; PARTICLE; CHIP; PROLIFERATION; ACTIVATION; RETENTION; PERFUSION	Background: The use of acoustic forces to manipulate particles or cells at the microfluidic scale (i.e. acoustophoresis), enables non-contact, label-free separation based on intrinsic cell properties such as size, density and compressibility. Acoustophoresis holds great promise as a cell separation technique in several research and clinical areas. However, it has been suggested that the force acting upon cells undergoing acoustophoresis may impact cell viability, proliferation or cell function via subtle phenotypic changes. If this were the case, it would suggest that the acoustophoresis method would be a less useful tool for many cell analysis applications as well as for cell therapy. Methods: We investigate, for the first time, several key aspects of cellular changes following acoustophoretic processing. We used two settings of ultrasonic actuation, one that is used for cell sorting (10 V-pp operating voltage) and one that is close to the maximum of what the system can generate (20 V-pp). We used microglial cells and assessed cell viability and proliferation, as well as the inflammatory response that is indicative of more subtle changes in cellular phenotype. Furthermore, we adapted a similar methodology to monitor the response of human prostate cancer cells to acoustophoretic processing. Lastly, we analyzed the respiratory properties of human leukocytes and thrombocytes to explore if acoustophoretic processing has adverse effects. Results: BV2 microglia were unaltered after acoustophoretic processing as measured by apoptosis and cell turnover assays as well as inflammatory cytokine response up to 48 h following acoustophoresis. Similarly, we found that acoustophoretic processing neither affected the cell viability of prostate cancer cells nor altered their prostate-specific antigen secretion following androgen receptor activation. Finally, human thrombocytes and leukocytes displayed unaltered mitochondrial respiratory function and integrity after acoustophoretic processing. Conclusion: We conclude that microchannel acoustophoresis can be used for effective continuous flow-based cell separation without affecting cell viability, proliferation, mitochondrial respiration or inflammatory status.	[Burguillos, Miguel A.; Brundin, Patrik] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Nordin, Maria; Lenshof, Andreas; Augustsson, Per; Laurell, Thomas] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden; [Deierborg, Tomas] Lund Univ, Expt Neuroinflammat Lab, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Laurell, Thomas] Dongguk Univ, Dept Biomed Engn, Seoul, South Korea; [Burguillos, Miguel A.] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Magnusson, Cecilia; Lilja, Hans] Lund Univ, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden; [Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Pathophysiol Unit, Lund, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Urol Surg, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10021 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Lilja, Hans] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	Lund University; Lund University; Lund University; Dongguk University; Karolinska Institutet; Lund University; Skane University Hospital; Lund University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Tampere University	Deierborg, T (corresponding author), Lund Univ, Expt Neuroinflammat Lab, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	tomas.deierborg@med.lu.se	Burguillos, Miguel/N-4806-2019; Augustsson, Per/B-2064-2012; Lenshof, Andreas/D-8566-2013; Lilja, Hans/S-9703-2019; Antfolk, Maria/A-8144-2013; Elmér, Eskil/F-9341-2014; Laurell, Thomas/B-5524-2013; Augustsson, Per/AAY-9422-2020; Hansson, Magnus/G-4486-2014; Deierborg, Tomas/P-6345-2015	Burguillos, Miguel/0000-0002-3165-9997; Augustsson, Per/0000-0001-8542-7924; Lenshof, Andreas/0000-0003-2887-6365; Lilja, Hans/0000-0001-5871-7846; Antfolk, Maria/0000-0003-0129-5640; Elmér, Eskil/0000-0001-7901-1826; Laurell, Thomas/0000-0002-2486-3607; Hansson, Magnus/0000-0002-0201-0638; Deierborg, Tomas/0000-0002-3651-3444	Swedish governmental agency for innovation systems; VINNOVA; CellCARE; Swedish Research Council [2012-2229, 2010-4389]; Gyllenstiernska Krapperup; Royal Physiographic Society, Crafoord; A.E. Berger foundation; Wiberg foundation; Bergvall foundation; G&J Kock foundation; SSF Strategic Research Centre (Create Health); Swedish Cancer Society [11-0624]; Finnish Funding Agency for Technology and Innovation (TEKES); National Cancer Institute [R33 CA127768-03, R01CA160816, P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers, and David H. Koch through the Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program;  [2009-00236]; NATIONAL CANCER INSTITUTE [R01CA160816, P50CA092629, R33CA127768] Funding Source: NIH RePORTER	Swedish governmental agency for innovation systems(Vinnova); VINNOVA(Vinnova); CellCARE; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gyllenstiernska Krapperup; Royal Physiographic Society, Crafoord; A.E. Berger foundation; Wiberg foundation; Bergvall foundation; G&J Kock foundation; SSF Strategic Research Centre (Create Health); Swedish Cancer Society(Swedish Cancer Society); Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Center for Prostate and Urologic Cancers, and David H. Koch through the Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program(National Institute for Health Research (NIHR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Swedish governmental agency for innovation systems, VINNOVA, CellCARE, grant No. 2009-00236, the Swedish Research Council grant no. 2012-2229 and 2010-4389, by the Gyllenstiernska Krapperup, The Royal Physiographic Society, Crafoord, A.E. Berger, Wiberg, Bergvall, G&J Kock, Carl Trygger foundations, the SSF Strategic Research Centre (Create Health), Swedish Cancer Society [11-0624], Finnish Funding Agency for Technology and Innovation (TEKES), National Cancer Institute [R33 CA127768-03, R01CA160816 and P50-CA92629], Sidney Kimmel Center for Prostate and Urologic Cancers, and David H. Koch through the Prostate Cancer Foundation, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; Augustsson P, 2011, LAB CHIP, V11, P4152, DOI [10.1039/c1lc20637k, 10.1039/C1lc20637k]; Augustsson P, 2009, MICROCHIM ACTA, V164, P269, DOI 10.1007/s00604-008-0084-4; Barnkob R, 2010, LAB CHIP, V10, P563, DOI 10.1039/b920376a; Bazou D, 2008, TOXICOL IN VITRO, V22, P1321, DOI 10.1016/j.tiv.2008.03.014; Bazou D, 2011, ULTRASOUND MED BIOL, V37, P321, DOI 10.1016/j.ultrasmedbio.2010.10.019; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carugo D, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3660352; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Dykes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023074; Evander M, 2007, ANAL CHEM, V79, P2984, DOI 10.1021/ac061576v; Franke T, 2010, LAB CHIP, V10, P789, DOI 10.1039/b915522h; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Hawkes JJ, 2004, LAB CHIP, V4, P446, DOI 10.1039/b408045a; Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Javidan J, 2005, CANCER INVEST, V23, P520, DOI 10.1080/07357900500202721; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Johansson L, 2009, ANAL CHEM, V81, P5188, DOI 10.1021/ac802681r; Jonsson H, 2004, ANN THORAC SURG, V78, P1572, DOI 10.1016/j.athoracsur.2004.04.071; Kato Y, 2011, NEUROCRIT CARE; Khanna S, 2006, ULTRASOUND MED BIOL, V32, P289, DOI 10.1016/j.ultrasmedbio.2005.11.002; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Laurell T, 2012, LAB CHIP; Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k; Lenshof A, 2011, JALA-J LAB AUTOM, V16, P443, DOI 10.1016/j.jala.2011.07.004; Lenshof A, 2009, ANAL CHEM, V81, P6030, DOI 10.1021/ac9013572; MITRUNEN K, 1995, CLIN CHEM, V41, P1115; Nilsson A, 2004, LAB CHIP, V4, P131, DOI 10.1039/b313493h; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petersson F, 2005, LAB CHIP, V5, P20, DOI 10.1039/b405748c; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Radel S, 2000, ULTRASONICS, V38, P633, DOI 10.1016/S0041-624X(99)00211-5; Ryll T, 2000, BIOTECHNOL BIOENG, V69, P440, DOI 10.1002/1097-0290(20000820)69:4<440::AID-BIT10>3.0.CO;2-0; Shi JJ, 2008, LAB CHIP, V8, P221, DOI 10.1039/b716321e; Sjovall F, 2012, CRIT CARE MED, V40, P357, DOI 10.1097/CCM.0b013e318232949c; Thevoz P, 2010, ANAL CHEM, V82, P3094, DOI 10.1021/ac100357u; Vanherberghen B, 2010, LAB CHIP, V10, P2727, DOI 10.1039/c004707d; Wallace DC, 2011, COLD SPRING HARB S Q; Wang Y, 2011, TOXICOL LETT, V205, P26, DOI 10.1016/j.toxlet.2011.05.001; Wang ZW, 2004, BIOTECHNOL PROGR, V20, P384, DOI 10.1021/bp034105s; Wiklund M, 2012, LAB CHIP, V12, P2018, DOI 10.1039/c2lc40201g; Yasuda K, 1997, J ACOUST SOC AM, V102, P642, DOI 10.1121/1.421009	45	91	92	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64233	10.1371/journal.pone.0064233	http://dx.doi.org/10.1371/journal.pone.0064233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724038	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100022
J	Pinto, AYD; Valente, VD; Coura, JR; Valente, SAD; Junqueira, ACV; Santos, LC; Ferreira, AG; de Macedo, RC				das Neves Pinto, Ana Yece; Valente, Vera da Costa; Coura, Jose Rodrigues; da Silva Valente, Sebastiao Aldo; Verissimo Junqueira, Angela Cristina; Santos, Laura Cristina; Ferreira, Alberto Gomes, Jr.; de Macedo, Roberto Cavalleiro			Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; BLOOD-SAMPLES; EFFICACY; OUTBREAK; TOOL	A total of 179 individuals with acute Chagas disease mainly transmitted by oral source, from Para and Amapa State, Amazonian, Brazil were included during the period from 1988 to 2005. Blood samples were used to survey peripheral blood for T. cruzi hemoparasites by quantitative buffy coat (QBC), indirect xenodiagnosis, blood culture and serology to detection of total IgM and anti-T. cruzi IgG antibodies by indirect immunofluorescence assay (IFA) and indirect hemagglutination assay (HA). All assays were performed pre-treatment (0 days) and repeated 35 (+/- 7) and 68 (+/- 6) days after the initiation of treatment with benznidazol and every 6 months while remained seropositive. The endpoint of collection was performed in 2005. Total medium period of follow-up per person was 5.6 years. Also, a blood sample was collected from 72 randomly chosen treated patients to perform polimerase chain reaction (PCR) method. Proportions of subjects with negative or positive serology according to the number of years after treatment were compared. In the endpoint of follow-up we found 47 patients (26.7%) serologically negative, therefore considered cured and 5 (2.7%) exhibited mild cardiac Chagas disease. Other 132 patients had persistent positive serologic tests. The PCR carried out in 72 individuals was positive in 9.8%. Added, there was evidence of therapeutic failure immediately following treatment, as demonstrated by xenodiagnosis and blood culture methods in 2.3% and 3.5% of cases, respectively. There was a strong evidence of antibody clearing in the fourth year after treatment and continuous decrease of antibody titers. Authors suggest that control programs should apply operational researches with new drug interventions four years after the acute phase for those treated patients with persistently positive serology.	[das Neves Pinto, Ana Yece] Brazil Minist Hlth SVS MS, Secretaria Vigilancia Saude, Clin Epidemiol Dept Evandro Chagas Inst SOAMU IEC, Belem, Para, Brazil; [Valente, Vera da Costa; da Silva Valente, Sebastiao Aldo] Parasitol Dept IEC SVS MS, Belem, Para, Brazil; [Coura, Jose Rodrigues; Verissimo Junqueira, Angela Cristina; Santos, Laura Cristina] Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil; [Ferreira, Alberto Gomes, Jr.] Luis DEcourt Fdn, Belem, Para, Brazil; [de Macedo, Roberto Cavalleiro] Santa Casa Hosp, Belem, Para, Brazil	Instituto Evandro Chagas; Fundacao Oswaldo Cruz	Pinto, AYD (corresponding author), Brazil Minist Hlth SVS MS, Secretaria Vigilancia Saude, Clin Epidemiol Dept Evandro Chagas Inst SOAMU IEC, Belem, Para, Brazil.	ayece@iec.pa.gov.br	Oliveira, Claudia DL/G-8618-2011		Evandro Chagas Institute-SVS/Ministry Health from Brazil; UNESCO (United Nations, Educational, Scientific and Cultural Organization); OPAS-Brazil (Pan American Health Organization)	Evandro Chagas Institute-SVS/Ministry Health from Brazil; UNESCO (United Nations, Educational, Scientific and Cultural Organization); OPAS-Brazil (Pan American Health Organization)	This study was supported by Evandro Chagas Institute-SVS/Ministry Health from Brazil. UNESCO (United Nations, Educational, Scientific and Cultural Organization) and OPAS-Brazil (Pan American Health Organization) provided the funding to maintain the principal investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOORREGO L, 1980, MEDICINA-BUENOS AIRE, V40, P56; Albajar PV, 2003, ESTADO AMAZONAS REV, V6, P401; [Anonymous], [No title captured]; Brener Z, 2000, TRYPANOSOMA CRUZI DO, P389; BRITTO C, 1995, PARASITOLOGY, V110, P241, DOI 10.1017/S0031182000080823; Castro C, 2001, Rev Soc Bras Med Trop, V34, P309, DOI 10.1590/S0037-86822001000400001; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Coura JR, 1985, MEM I O CRUZ, V80; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Pinto AYD, 2009, REV PANAM SALUD PUBL, V25, P77, DOI 10.1590/S1020-49892009000100012; Altschuller MBCD, 2007, REV SOC BRAS MED TRO, V40, P665, DOI 10.1590/S0037-86822007000600014; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Dias JCP, 1982, THESIS U FEDERAL RIO; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Galvao LMC, 2003, J CLIN MICROBIOL, V41, P5066, DOI 10.1128/JCM.41.11.5066-5070.2003; Luquetti AO, 1997, CLIN TERAPEUTICA DOE, P99; Ministerio da Saude, 2005, REV SOC BRAS MED S3, V38, P30; Ostermayer A, 1995, REV SOC BRAS MED S3, V28, P99; Pinto A Y, 2001, Rev Soc Bras Med Trop, V34, P413; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Salomone OA, 2003, EMERG INFECT DIS, V9, P1558, DOI 10.3201/eid0912.030008; *SOC BRAS CARD, 2003, ARQ BRAS CARDIOL S1, V80, P1, DOI DOI 10.1590/S0066-782X2003000700001; Valente S. A. S., 2006, INFORM CONSULTA TECN, P21; Valente S.A.S., 2010, REV PAN AMAZONICA SA, V1, P67, DOI [10.5123/S217662232010000200008, DOI 10.5123/S217662232010000200008]; Valente SAS, 2009, SIIC SALUD BUENOS AI, V97205, P1; WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771; Xavier SS, 2006, REV SOC BRAS MED TRO, V39, P211, DOI 10.1590/S0037-86822006000200015	28	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64450	10.1371/journal.pone.0064450	http://dx.doi.org/10.1371/journal.pone.0064450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724050	Green Submitted, gold, Green Published			2022-12-25	WOS:000319738100027
J	Gao, S; Hsieh, CL; Bhansali, M; Kannan, A; Shemshedini, L				Gao, Shuai; Hsieh, Chen-Lin; Bhansali, Meenakshi; Kannan, Archana; Shemshedini, Lirim			A Peptide against Soluble Guanylyl Cyclase alpha 1: A New Approach to Treating Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CELL-PROLIFERATION; OXIDATIVE STRESS; ANTIANDROGEN; PROGRESSION; ACTIVATION; MUTATION; THERAPY; DOMAINS	Among the many identified androgen-regulated genes, sGC alpha 1 (soluble guanylyl cyclase alpha 1) appears to play a pivotal role in mediating the pro-cancer effects of androgens and androgen receptor. The classical role for sGC alpha 1 is to heterodimerize with the sGC beta 1 subunit, forming sGC, the enzyme that mediates nitric oxide signaling by catalyzing the synthesis of cyclic guanosine monophosphate. Our published data show that sGC alpha 1 can drive prostate cancer cell proliferation independent of hormone and provide cancer cells a pro-survival function, via a novel mechanism for p53 inhibition, both of which are independent of sGC beta 1, NO, and cGMP. All of these properties make sGC alpha 1 an important novel target for prostate cancer therapy. Thus, peptides were designed targeting sGC alpha 1 with the aim of disrupting this protein's pro-cancer activities. One peptide (A-8R) was determined to be strongly cytotoxic to prostate cancer cells, rapidly inducing apoptosis. Cytotoxicity was observed in both hormone-dependent and, significantly, hormone-refractory prostate cancer cells, opening the possibility that this peptide can be used to treat the usually lethal castration-resistant prostate cancer. In mouse xenograft studies, Peptide A-8R was able to stop tumor growth of not only hormone-dependent cells, but most importantly from hormone-independent cells. In addition, the mechanism of Peptide A cytotoxicity is generation of reactive oxygen species, which recently have been recognized as a major mode of action of important cancer drugs. Thus, this paper provides strong evidence that targeting an important AR-regulated gene is a new paradigm for effective prostate cancer therapy.	[Gao, Shuai; Hsieh, Chen-Lin; Bhansali, Meenakshi; Kannan, Archana; Shemshedini, Lirim] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Shemshedini, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	lshemsh@utnet.utoledo.edu		Gao, Shuai/0000-0002-7304-8801	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; Attar RM, 2009, CANCER RES, V69, P6522, DOI 10.1158/0008-5472.CAN-09-1111; Bartholomeusz C, 2012, EXPERT OPIN THER TAR, V16, P121, DOI 10.1517/14728222.2011.644788; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Downs I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038051; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; ISAACS JT, 1994, VITAM HORM, V49, P433; Itoh T, 2011, FREE RADICAL RES, V45, P1033, DOI 10.3109/10715762.2011.591391; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kotsinas A, 2012, CANCER LETT, V327, P97, DOI 10.1016/j.canlet.2011.12.009; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Rathkopf D, 2011, CLIN CANCER RES, V17, P880, DOI 10.1158/1078-0432.CCR-10-2955; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Schroder F, 2012, BJU INT, V109, P1, DOI 10.1111/j.1464-410X.2012.11215.x; Shemshedini L, 2005, MOL CANCER RES, V5, P725; Sinnaeve P, 2001, CIRC RES, V88, P103, DOI 10.1161/01.RES.88.1.103; Tepper CG, 2002, CANCER RES, V62, P6606; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d	31	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64189	10.1371/journal.pone.0064189	http://dx.doi.org/10.1371/journal.pone.0064189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724033	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100021
J	Lei, L; Dong, XH; Li, ZY; Zhong, GM				Lei, Lei; Dong, Xiaohua; Li, Zhongyu; Zhong, Guangming			Identification of a Novel Nuclear Localization Signal Sequence in Chlamydia trachomatis-Secreted Hypothetical Protein CT311	PLOS ONE			English	Article							HOST-CELL CYTOPLASM; INFECTED CELLS; APOPTOSIS; INHIBITION; SYSTEM	We previously reported that Chlamydia trachomatis hypothetical protein CT311 was secreted out of chlamydial inclusion and into host cell cytosol. We now found that CT311 further entered host cell nucleus at the late stage of infection and continued to accumulate in the nucleus of C. trachomatis-infected cells. When CT311 was expressed via a transgene in mammalian cells, CT311 protein was exclusively detected in the nucleus, suggesting that CT311 by itself is sufficient for nuclear targeting. However, preexisting nuclear CT311 did not affect subsequent chlamydial infection. Using deletion constructs, we mapped a nuclear localization signal sequence of CT311 to residues 21 to 63 ((21)AVEGKPLSRAAQL-RERRKDLHVSGKPSPRYALKKRALEAKKNK(63)). This sequence was sufficient for targeting a heterologous protein into mammalian cell nucleus and it contains two independent clusters of basic residues ((RERRK38)-R-34 and (53)KKRALEAKKNK(63) respectively). Deletion or alanine substitution of the basic residues in either cluster led to loss of nuclear targeting activity, suggesting that both clusters are critical for the nuclear targeting function. These observations have demonstrated that the hypothetical protein CT311 possesses a novel nuclear localization signal sequence with dual modules of basic residues for targeting host cell nucleus during Chlamydia trachomatis infection.	[Lei, Lei; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Dong, Xiaohua] Hebei Northern Univ, Sch Pharm, Dept Pharmacol, Zhangjiakou, Hebei, Peoples R China; [Li, Zhongyu] Univ South China, Dept Microbiol, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of South China	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.EDU	Lei, Lei/I-3002-2013		National Institutes of Health [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01AI064537 & R01AI047997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Gong SQ, 2011, MICROBIOL-SGM, V157, P1134, DOI 10.1099/mic.0.047746-0; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Guo H, 2009, VIRUS RES, V145, P312, DOI 10.1016/j.virusres.2009.07.024; Guo ZJ, 2010, ARCH VIROL, V155, P1943, DOI 10.1007/s00705-010-0782-1; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; Izaurralde E, 1998, RNA, V4, P351; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Moon DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038974; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Stephenson J, 2003, SEX TRANSM INFECT, V79, P352, DOI 10.1136/sti.79.4.352-a; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	30	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64529	10.1371/journal.pone.0064529	http://dx.doi.org/10.1371/journal.pone.0064529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717625	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600067
J	Chawla, T; Chan, KR; Zhang, SL; Tan, HC; Lim, APC; Hanson, BJ; Ooi, EE				Chawla, Tanu; Chan, Kuan Rong; Zhang, Summer L.; Tan, Hwee Cheng; Lim, Angeline P. C.; Hanson, Brendon J.; Ooi, Eng Eong			Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; HIGH-AFFINITY IGG; MEDIATED NEUTRALIZATION; MONONUCLEAR PHAGOCYTES; HEMORRHAGIC-FEVER; INFECTION; RI; MONOCYTES; CD64; PATHOGENESIS	Activating Fc gamma receptors (Fc gamma Rs) in hematopoietic cells serve to remove antibody-opsonized antigens, including dengue virus (DENV), from systemic circulation. While neutralizing antibody concentrations provide humoral immunity, cross-reactive or sub-neutralizing levels of antibody can result in antibody-dependent enhancement of DENV infection that increases overall viral burden. Recently, it has been suggested that the antibody levels needed for DENV neutralization differs when different Fc gamma R is engaged. If this is true, the threshold titer used to infer immunity should be influenced by Fc gamma R usage. Here, using cells that express both activating and inhibitory Fc gamma Rs, we show that the type of Fc gamma R engaged during phagocytosis can influence the antibody concentration requirement for DENV neutralization. We demonstrate that phagocytosis through Fc gamma RI requires significantly less antibody for complete DENV neutralization compared to Fc gamma RIIA. Furthermore, when DENV is opsonized with sub-neutralizing levels of antibody, Fc gamma RI-mediated phagocytosis resulted in significantly reduced DENV titers compared to Fc gamma RIIA. However, while Fc gamma RI may remove antibody-opsonized DENV more efficiently, this receptor is only preferentially engaged by clustering when neutralizing, but not sub-neutralizing antibody concentrations, were used. Collectively, our study demonstrates that activating Fc gamma R usage may influence antibody titers needed for DENV neutralization.	[Chawla, Tanu; Chan, Kuan Rong; Tan, Hwee Cheng; Ooi, Eng Eong] Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Zhang, Summer L.; Lim, Angeline P. C.; Hanson, Brendon J.; Ooi, Eng Eong] Def Sci Org, Natl Labs, Singapore 117548, Singapore		Ooi, EE (corresponding author), Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	engeong.ooi@duke-nus.edu.sg		Chan, Kuan Rong/0000-0002-2427-671X; Ooi, Eng Eong/0000-0002-0520-1544; Zhang, Summer Lixin/0000-0002-9762-4711	Singapore National Research Foundation	Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported by the Singapore National Research Foundation under its Clinician Scientist Award administered by the National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes N, 2002, IMMUNITY, V16, P379, DOI 10.1016/S1074-7613(02)00287-X; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; JAYARAM Y, 1989, CLIN EXP IMMUNOL, V75, P414; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; LITTAUA R, 1990, J IMMUNOL, V144, P3183; MADY BJ, 1991, J IMMUNOL, V147, P3139; Moi ML, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001536; Moi ML, 2010, CLIN VACCINE IMMUNOL, V17, P402, DOI 10.1128/CVI.00396-09; MOXEYMIMS MM, 1993, CLIN IMMUNOL IMMUNOP, V69, P117, DOI 10.1006/clin.1993.1158; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; PAYNE NR, 1993, PEDIATR RES, V33, P452, DOI 10.1203/00006450-199305000-00007; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; SABCHAREON A, 2012, LANCET; Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170; SITTISOMBUT N, 1995, J MED VIROL, V45, P43, DOI 10.1002/jmv.1890450109; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WU RS, 2012, ANTIVIRAL RES; Zhang SLX, 2010, J VIROL METHODS, V167, P172, DOI 10.1016/j.jviromet.2010.04.001	40	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e65231	10.1371/journal.pone.0065231	http://dx.doi.org/10.1371/journal.pone.0065231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717696	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700193
J	Lai, LY; Qian, J; Yang, YJ; Xie, QH; You, HZ; Zhou, Y; Ma, S; Hao, CM; Gu, Y; Ding, F				Lai, Lingyun; Qian, Jing; Yang, Yanjiao; Xie, Qionghong; You, Huaizhou; Zhou, Ying; Ma, Shuai; Hao, Chuanming; Gu, Yong; Ding, Feng			Is the Serum Vitamin D Level at the Time of Hospital-Acquired Acute Kidney Injury Diagnosis Associated with Prognosis?	PLOS ONE			English	Article							D DEFICIENCY; 25-HYDROXYVITAMIN-D; MORTALITY	Background: Low circulating vitamin D levels have been suggested to potentially contribute to acute complications in critically ill patients. However, in patients with acute kidney injury (AKI), whether vitamin D deficiency occurs and is a potential contributor to worse early outcomes at the time of AKI diagnosis remains unclear. Methodology/Principal Findings: Two hundred patients with AKI were enrolled in our study. Healthy subjects and critically ill patients without AKI served as controls. Serum vitamin D concentrations were measured in the three groups. The patients with AKI were followed up for 90 days and grouped according to median serum vitamin D concentrations. In addition, vitamin D receptor polymorphisms (BsmI and FokI) were measured in these patients; they were also followed up for 90 days and grouped according to vitamin D receptor gene mutations. Low serum 1,25-dihydroxyvitamin D levels (59.56 +/- 53.00 pmol/L) were detected in patients with AKI and decreased with increasing severity of AKI. There were no significant findings with respect to 25-hydroxyvitamin D. The 90-day survival curves of individuals with high vitamin D concentrations showed no significant differences compared with the curves of individuals with low concentrations. The survival curves of patients with BB/Bb or FF/Ff genotypes also showed no significant differences compared with patients with bb or ff genotypes. In Cox regression analysis, the vitamin D status in patients with AKI was not an independent prognostic factor as adjusted by age, sex, Sequential Organ Failure Assessment score, or vitamin D receptor polymorphisms. Conclusions/Significance: Patients with AKI manifested a marked decrease in the 1,25-dihydroxyvitamin D level at the time of AKI diagnosis, and the degree of 1,25-dihydroxyvitamin D deficiency increased with the severity of AKI. No association between the serum vitamin D level at the time of AKI diagnosis and 90-day all-cause mortality was found in patients with AKI.	[Lai, Lingyun; Qian, Jing; Yang, Yanjiao; Xie, Qionghong; You, Huaizhou; Zhou, Ying; Ma, Shuai; Hao, Chuanming; Gu, Yong; Ding, Feng] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University	Ding, F (corresponding author), Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China.	dingfeng@fudan.edu.cn			National Natural Science Foundation of China [81070609, 30800526]; Science and Technology Commission of Shanghai Municipality [09411961500]; Shanghai Pujiang Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study was funded in part by grants from National Natural Science Foundation of China (No: 81070609), the Science and Technology Commission of Shanghai Municipality (No: 09411961500), Shanghai Pujiang Program (to FD) and National Natural Science Foundation of China (No. 30800526) (to HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; COBURN JW, 1974, WESTERN J MED, V121, P22; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996; Li M, 2011, SHANGHAI MED J, V34; Lucidarme O, 2010, INTENS CARE MED, V36, P1609, DOI 10.1007/s00134-010-1875-8; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; World Health Organization International Agency for Research on Cancer, 2008, IARC WORK GROUP REP; Zittermann A, 2009, CURR OPIN CLIN NUTR, V12, P634, DOI 10.1097/MCO.0b013e3283310767	22	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64964	10.1371/journal.pone.0064964	http://dx.doi.org/10.1371/journal.pone.0064964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717679	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700185
J	Robertson, S; Rohwer, JM; Hapgood, JP; Louw, A				Robertson, Steven; Rohwer, Johann M.; Hapgood, Janet P.; Louw, Ann			Impact of Glucocorticoid Receptor Density on Ligand-Independent Dimerization, Cooperative Ligand-Binding and Basal Priming of Transactivation: A Cell Culture Model	PLOS ONE			English	Article							RESPONSE ELEMENT-BINDING; DNA-BINDING; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; INDUCTION PROPERTIES; HORMONE RECEPTORS; STEROID-RECEPTORS; GENE-EXPRESSION; GROWTH-HORMONE; BETA ISOFORMS; LIVING CELLS	Glucocorticoid receptor (GR) levels vary between tissues and individuals and are altered by physiological and pharmacological effectors. However, the effects and implications of differences in GR concentration have not been fully elucidated. Using three statistically different GR concentrations in transiently transfected COS-1 cells, we demonstrate, using co-immunoprecipitation (CoIP) and fluorescent resonance energy transfer (FRET), that high levels of wild type GR (wtGR), but not of dimerization deficient GR (GRdim), display ligand-independent dimerization. Whole-cell saturation ligand-binding experiments furthermore establish that positive cooperative ligand-binding, with a concomitant increased ligand-binding affinity, is facilitated by ligand-independent dimerization at high concentrations of wtGR, but not GRdim. The down-stream consequences of ligand-independent dimerization at high concentrations of wtGR, but not GRdim, are shown to include basal priming of the system as witnessed by ligand-independent transactivation of both a GRE-containing promoter-reporter and the endogenous glucocorticoid (GC)-responsive gene, GILZ, as well as ligand-independent loading of GR onto the GILZ promoter. Pursuant to the basal priming of the system, addition of ligand results in a significantly greater modulation of transactivation potency than would be expected solely from the increase in ligand-binding affinity. Thus ligand-independent dimerization of the GR at high concentrations primes the system, through ligand-independent DNA loading and transactivation, which together with positive cooperative ligand-binding increases the potency of GR agonists and shifts the bio-character of partial GR agonists. Clearly GR-levels are a major factor in determining the sensitivity to GCs and a critical factor regulating transcriptional programs.	[Robertson, Steven; Rohwer, Johann M.; Louw, Ann] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa; [Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa	Stellenbosch University; University of Cape Town	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	al@sun.ac.za	Rohwer, Johann/A-2027-2008; Louw, Ann/A-7620-2012; Hapgood, Janet P/P-2549-2018	Rohwer, Johann/0000-0001-6288-8904; Louw, Ann/0000-0002-1021-6732; Hapgood, Janet P/0000-0002-4414-4861	National Research Foundation (NRF), South Africa [78987]	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa)	The National Research Foundation (NRF), South Africa (http://www.nrf.ac.za/), is acknowledged for funding (Grant 78987 to AL and PhD bursary to SER). Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and therefore the NRF do not accept any liability in regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; ALMOSLIH MI, 1973, J GEN VIROL, V18, P189, DOI 10.1099/0022-1317-18-2-189; Avenant C, 2010, MOL CELL ENDOCRINOL, V327, P72, DOI 10.1016/j.mce.2010.06.007; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Beck IM, 2011, TRENDS ENDOCRIN MET, V22, P295, DOI 10.1016/j.tem.2011.03.009; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caamano CA, 1998, J BIOL CHEM, V273, P20473, DOI 10.1074/jbc.273.32.20473; Charmandari E, 2001, J CLIN ENDOCR METAB, V86, P3393, DOI 10.1210/jc.86.7.3393; Chen SY, 2000, J BIOL CHEM, V275, P30106, DOI 10.1074/jbc.M005418200; CHIKANZA IC, 1992, ARTHRITIS RHEUM, V35, P1281, DOI 10.1002/art.1780351107; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chriguer RS, 2005, J CLIN ENDOCR METAB, V90, P5978, DOI 10.1210/jc.2005-0067; CHROUSOS GP, 1982, J CLIN INVEST, V69, P1261, DOI 10.1172/JCI110565; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAVIDSON KA, 1983, CANCER RES, V43, P3847; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dong DD, 2006, J STEROID BIOCHEM, V101, P106, DOI 10.1016/j.jsbmb.2006.06.010; Driver PM, 2001, MOL HUM REPROD, V7, P357, DOI 10.1093/molehr/7.4.357; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; Duma D, 2006, J STEROID BIOCHEM, V102, P11, DOI 10.1016/j.jsbmb.2006.09.009; Dutta D, 2004, BIOGERONTOLOGY, V5, P177, DOI 10.1023/B:BGEN.0000031155.60748.0a; Ebrecht M, 2000, J CLIN ENDOCR METAB, V85, P3733, DOI 10.1210/jc.85.10.3733; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Elakovic I, 2007, CELL BIOCHEM FUNCT, V25, P427, DOI 10.1002/cbf.1323; Franco R, 2006, MOL PHARMACOL, V69, P1905, DOI 10.1124/mol.105.020685; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Gougat C, 2002, J MOL MED-JMM, V80, P309, DOI 10.1007/s00109-001-0302-6; Grasso G, 1997, LIFE SCI, V61, P301, DOI 10.1016/S0024-3205(97)00386-X; Guo WX, 1996, AM J PATHOL, V148, P1999; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; HO AD, 1983, KLIN WOCHENSCHR, V61, P455, DOI 10.1007/BF02664333; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; KAM JC, 1993, J IMMUNOL, V151, P3460; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Little HJ, 2008, NEUROSCIENCE, V156, P1017, DOI 10.1016/j.neuroscience.2008.08.029; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Lu YS, 2005, WORLD J GASTROENTERO, V11, P6373, DOI 10.3748/wjg.v11.i40.6373; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Matthews L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022289; Meijer OC, 2003, J ENDOCRINOL, V178, P13, DOI 10.1677/joe.0.1780013; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nimmagadda SR, 1997, AM J RESP CRIT CARE, V155, P87, DOI 10.1164/ajrccm.155.1.9001294; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; NOTIDES AC, 1981, P NATL ACAD SCI-BIOL, V78, P4926, DOI 10.1073/pnas.78.8.4926; ODONNELL D, 1995, BRAIN RES, V687, P133, DOI 10.1016/0006-8993(95)00479-A; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; PAOLETTI P, 1990, J NEUROSURG, V73, P736, DOI 10.3171/jns.1990.73.5.0736; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Pusch L, 2009, CELL MOL NEUROBIOL, V29, P583, DOI 10.1007/s10571-009-9350-1; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ritter HD, 2012, MOL CANCER RES, V10, P558, DOI 10.1158/1541-7786.MCR-11-0423-T; Robblee JP, 2012, BIOCHEMISTRY-US, V51, P4463, DOI 10.1021/bi3003956; Robertson S, 2013, STEROIDS, V78, P182, DOI 10.1016/j.steroids.2012.10.016; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Sarabdjitsingh RA, 2010, ENDOCRINOLOGY, V151, P1177, DOI 10.1210/en.2009-1119; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; SCHLAGHECKE R, 1992, ARTHRITIS RHEUM-US, V35, P740, DOI 10.1002/art.1780350704; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SegardMaurel I, 1996, BIOCHEMISTRY-US, V35, P1634, DOI 10.1021/bi951369h; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Smith C, 2007, AM J PHYSIOL-REG I, V292, pR1439, DOI 10.1152/ajpregu.00602.2006; Sola S, 2004, BIOCHEMISTRY-US, V43, P8429, DOI 10.1021/bi049781x; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Sui XM, 1999, J BIOL CHEM, V274, P9449, DOI 10.1074/jbc.274.14.9449; Sun XY, 2002, AM J PHYSIOL-REG I, V282, pR509, DOI 10.1152/ajpregu.00509.2001; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Szapary D, 1996, J BIOL CHEM, V271, P30576, DOI 10.1074/jbc.271.48.30576; Szapary D, 1999, MOL ENDOCRINOL, V13, P2108, DOI 10.1210/me.13.12.2108; TANAKA H, 1992, J RHEUMATOL, V19, P878; Tazawa H, 2003, MOL CELL BIOL, V23, P4187, DOI 10.1128/MCB.23.12.4187-4198.2003; van der Laan S, 2008, ENDOCRINOLOGY, V149, P725, DOI 10.1210/en.2007-1234; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Visser K, 2010, ENDOCRINOLOGY, V151, P5279, DOI 10.1210/en.2010-0368; Voutsas IF, 2007, J IMMUNOL METHODS, V324, P110, DOI 10.1016/j.jim.2007.05.007; Vujcic MT, 2007, COMP BIOCHEM PHYS B, V148, P463, DOI 10.1016/j.cbpb.2007.07.090; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Webster JC, 1997, J BIOL CHEM, V272, P9287; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Whorwood CB, 2001, J CLIN ENDOCR METAB, V86, P2296, DOI 10.1210/jc.86.5.2296; WILKINSON JRW, 1989, J CLIN INVEST, V84, P1930, DOI 10.1172/JCI114381; WRANGE O, 1989, J BIOL CHEM, V264, P5253; Yoshikawa N, 2002, J BIOL CHEM, V277, P5529, DOI 10.1074/jbc.M107946200; Zhang JH, 2009, J BIOL CHEM, V284, P6249, DOI 10.1074/jbc.M807997200; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012; Zhao QH, 2003, INT IMMUNOPHARMACOL, V3, P1803, DOI 10.1016/j.intimp.2003.08.005	107	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64831	10.1371/journal.pone.0064831	http://dx.doi.org/10.1371/journal.pone.0064831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717665	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700175
J	Yang, WH; Yang, C; Xue, YQ; Lu, T; Reiser, J; Zhao, LR; Duan, WM				Yang, Wei-Hua; Yang, Chun; Xue, Yue-Qiang; Lu, Tao; Reiser, Jakob; Zhao, Li-Ru; Duan, Wei-Ming			Regulated Expression of Lentivirus-Mediated GDNF in Human Bone Marrow-Derived Mesenchymal Stem Cells and Its Neuroprotection on Dopaminergic Cells In Vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GDNF; VIVO GENE DELIVERY; PARKINSONS-DISEASE; TRANSGENE EXPRESSION; TYROSINE-HYDROXYLASE; PROVIDES NEUROPROTECTION; MESENCEPHALIC NEURONS; FACTOR PROMOTES; DOWN-REGULATION; GROWTH-FACTOR	Gene regulation remains one of the major challenges for gene therapy in clinical trials. In the present study, we first generated a binary tetracycline-on (Tet-On) system based on two lentivirus vectors, one expressing both human glial cell line-derived neurotrophic factor (hGDNF) and humanized recombinant green fluorescent protein (hrGFP) genes under second-generation tetracycline response element (TRE), and the other expressing the advanced reverse tetracycline-controlled transactivator - rtTA2S-M2 under a human minimal cytomegalovirus immediate early (CMV-IE) promoter. This system allows simultaneous expression of hGDNF and hrGFP genes in the presence of doxycycline (Dox). Human bone marrow-derived mesenchymal stem cells (hMSCs) were transduced with the binary Tet-On lentivirus vectors and characterized in vitro in the presence (On) or absence (Off) of Dox. The expression of hGDNF and hrGFP transgenes in transduced hMSCs was tightly regulated as determined by flow cytometry (FCM), GDNF enzyme-linked immunosorbent assay (ELISA) and quantitative real time-polymerase chain reaction (qRT-PCR). There was a dose-dependent regulation for hrGFP transgene expression. The levels of hGDNF protein in culture medium were correlated with the mean fluorescence intensity (MFI) units of hrGFP. The levels of transgene background expression were very low in the absence of Dox. The treatment of the conditioned medium from cultures of transduced hMSCs in the presence of Dox protected SH-SY5Y cells against 6-hydroxydopamine (6-OHDA) toxicity as determined by cell viability using 3, [4,5-dimethylthiazol-2-yl]-diphenyltetrazolium bromide (MTT) assay. The treatment of the conditioned medium was also found to improve the survival of dopaminergic (DA) neurons of ventral mesencephalic (VM) tissue in serum-free culture conditions as assessed by cell body area, the number of neurites and dendrite branching points, and proportion of tyrosine hydroxylase (TH)-immunoreactive (IR) cells. Our inducible lentivirus-mediated hGDNF gene delivery system may provide useful tools for basic research on gene therapy for chronic neurological disorders such as Parkinson's disease (PD).	[Yang, Wei-Hua; Yang, Chun; Lu, Tao; Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Xue, Yue-Qiang] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Reiser, Jakob] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, New Orleans, LA USA; [Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA	Capital Medical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duan, WM (corresponding author), Capital Med Univ, Dept Anat, Beijing, Peoples R China.	duanwm08@yahoo.com			Chinese Ministry of Science and Technology [2011CB504100]; Beijing Natural Science Foundation [11120087, 7112011]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB504100, WMD) and Beijing Natural Science Foundation (11120087, WMD; 7112011, WMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; Bohn MC, 1999, BIOCHEM PHARMACOL, V57, P135, DOI 10.1016/S0006-2952(98)00280-9; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Cunningham LA, 2002, EXP NEUROL, V174, P230, DOI 10.1006/exnr.2002.7877; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ericson C, 2005, EUR J NEUROSCI, V22, P2755, DOI 10.1111/j.1460-9568.2005.04503.x; Eslamboli A, 2005, J NEUROSCI, V25, P769, DOI 10.1523/JNEUROSCI.4421-04.2005; Fitzsimons HL, 2001, GENE THER, V8, P1675, DOI 10.1038/sj.gt.3301582; FRODL EM, 1994, NEUROREPORT, V5, P2393, DOI 10.1097/00001756-199411000-00045; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Georgievska B, 2004, HUM GENE THER, V15, P934, DOI 10.1089/hum.2004.15.934; Georgievska B, 2004, J NEUROSCI, V24, P6437, DOI 10.1523/JNEUROSCI.1122-04.2004; Georgievska B, 2002, NEUROREPORT, V13, P75, DOI 10.1097/00001756-200201210-00019; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Glavaski-Joksimovic A, 2010, J NEUROSCI RES, V88, P2669, DOI 10.1002/jnr.22435; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kramer BC, 1999, BRAIN RES, V851, P221, DOI 10.1016/S0006-8993(99)02191-5; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mandel RJ, 1997, P NATL ACAD SCI USA, V94, P14083, DOI 10.1073/pnas.94.25.14083; Meyer M, 1999, CELL TRANSPLANT, V8, P25, DOI 10.1177/096368979900800112; Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Ostenfeld T, 2002, J NEUROSCI RES, V69, P955, DOI 10.1002/jnr.10396; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Reiser J, 2000, J VIROL, V74, P10589, DOI 10.1128/JVI.74.22.10589-10599.2000; Rosenblad C, 2003, EUR J NEUROSCI, V17, P260, DOI 10.1046/j.1460-9568.2003.02456.x; Rosenblad C, 2000, MOL CELL NEUROSCI, V15, P199, DOI 10.1006/mcne.1999.0817; Sawada H, 2000, J NEUROCHEM, V74, P1175; Schaller B, 2005, BRAIN RES, V1036, P163, DOI 10.1016/j.brainres.2004.12.054; Steinwaerder DS, 2000, GENE THER, V7, P556, DOI 10.1038/sj.gt.3301139; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tian XB, 2009, HUM GENE THER, V20, P113, DOI 10.1089/hum.2008.018; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Vogel R, 2004, HUM GENE THER, V15, P157, DOI 10.1089/104303404772679968; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Widmer HR, 2000, EXP NEUROL, V164, P71, DOI 10.1006/exnr.2000.7418; Winkler C, 2006, NEUROSCIENCE, V141, P521, DOI 10.1016/j.neuroscience.2006.03.068; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	56	19	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64389	10.1371/journal.pone.0064389	http://dx.doi.org/10.1371/journal.pone.0064389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717608	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700145
J	Zhao, HJ; Sun, N; Young, SR; Nolley, R; Santos, J; Wu, JC; Peehl, DM				Zhao, Hongjuan; Sun, Ning; Young, Sarah R.; Nolley, Rosalie; Santos, Jennifer; Wu, Joseph C.; Peehl, Donna M.			Induced Pluripotency of Human Prostatic Epithelial Cells	PLOS ONE			English	Article							STEM-CELLS; IPS CELLS; SOMATIC-CELLS; EPIGENETIC MEMORY; CANCER INITIATION; DEFINED FACTORS; IN-VITRO; DIFFERENTIATION; BASAL; INDUCTION	Induced pluripotent stem (iPS) cells are a valuable resource for discovery of epigenetic changes critical to cell type-specific differentiation. Although iPS cells have been generated from other terminally differentiated cells, the reprogramming of normal adult human basal prostatic epithelial (E-PZ) cells to a pluripotent state has not been reported. Here, we attempted to reprogram E-PZ cells by forced expression of Oct4, Sox2, c-Myc, and Klf4 using lentiviral vectors and obtained embryonic stem cell (ESC)-like colonies at a frequency of 0.01%. These E-PZ-iPS-like cells with normal karyotype gained expression of pluripotent genes typical of iPS cells (Tra-1-81, SSEA-3, Nanog, Sox2, and Oct4) and lost gene expression characteristic of basal prostatic epithelial cells (CK5, CK14, and p63). E-PZ-iPS-like cells demonstrated pluripotency by differentiating into ectodermal, mesodermal, and endodermal cells in vitro, although lack of teratoma formation in vivo and incomplete demethylation of pluripotency genes suggested only partial reprogramming. Importantly, E-PZ-iPS-like cells re-expressed basal epithelial cell markers (CD44, p63, MAO-A) in response to prostate-specific medium in spheroid culture. Androgen induced expression of androgen receptor (AR), and co-culture with rat urogenital sinus further induced expression of prostate-specific antigen (PSA), a hallmark of secretory cells, suggesting that E-PZ-iPS-like cells have the capacity to differentiate into prostatic basal and secretory epithelial cells. Finally, when injected into mice, E-PZ-iPS-like cells expressed basal epithelial cell markers including CD44 and p63. When co-injected with rat urogenital mesenchyme, E-PZ-iPS-like cells expressed AR and expression of p63 and CD44 was repressed. DNA methylation profiling identified epigenetic changes in key pathways and genes involved in prostatic differentiation as E-PZ-iPS-like cells converted to differentiated AR- and PSA-expressing cells. Our results suggest that iPS-like cells derived from prostatic epithelial cells are pluripotent and capable of prostatic differentiation; therefore, provide a novel model for investigating epigenetic changes involved in prostate cell lineage specification.	[Zhao, Hongjuan; Young, Sarah R.; Nolley, Rosalie; Santos, Jennifer; Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Sun, Ning; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Peehl, DM (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	dpeehl@stanford.edu	Santos, Jennifer Maiara dos/HGD-0723-2022; Wu, Joseph/H-1067-2013	Sun, Ning/0000-0002-7861-3646; Wu, Joseph/0000-0002-6068-8041	Department of Defense [W81XWH1010240]; Prostate Cancer Foundation Challenge Award	Department of Defense(United States Department of Defense); Prostate Cancer Foundation Challenge Award	This study was supported by Department of Defense (grant number W81XWH1010240) and a Prostate Cancer Foundation Challenge Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Aoki T, 2010, TISSUE ENG PT A, V16, P2197, DOI 10.1089/ten.TEA.2009.0747; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cox JL, 2010, EXP BIOL MED, V235, P148, DOI 10.1258/ebm.2009.009267; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gekas C, 2010, J EXP MED, V207, P2781, DOI 10.1084/jem.20102428; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Guo Changyong, 2012, Methods Mol Biol, V879, P315, DOI 10.1007/978-1-61779-815-3_18; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HAYASHI N, 1993, EPITHELIAL CELL BIOL, V2, P66; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Hibi K, 2012, HEPATO-GASTROENTEROL, V59, P2661, DOI 10.5754/hge09664; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huang LW, 2009, DEV BIOL, V328, P188, DOI 10.1016/j.ydbio.2009.01.003; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kim H, 2011, HUM MOL GENET, V20, P401, DOI 10.1093/hmg/ddq476; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Li JS, 2010, CANCER BIOL THER, V10, P617, DOI 10.4161/cbt.10.6.12609; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park JH, 2011, ENDOCRINOLOGY, V152, P1080, DOI 10.1210/en.2010-1072; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Peehl DM, 2002, CULTURE EPITHELIAL C, P171; Pietronave S, 2012, CAN J PHYSIOL PHARM, V90, P317, DOI [10.1139/Y11-125, 10.1139/y11-125]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Sobel RE, 2005, J UROLOGY, V173, P360, DOI 10.1097/01.ju.0000149989.01263.dc; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Sugawara T, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt99; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vencio EF, 2012, PROSTATE, V72, P1453, DOI 10.1002/pros.22497; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2001, CANCER RES, V61, P6064; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wesemann DR, 2012, P NATL ACAD SCI USA, V109, P13745, DOI 10.1073/pnas.1210286109; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhao H, 2008, DIFFERENTIATION, V76, P820, DOI 10.1111/j.1432-0436.2007.00263.x; Zhao HJ, 2010, AM J PATHOL, V177, P229, DOI 10.2353/ajpath.2010.090821	62	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64503	10.1371/journal.pone.0064503	http://dx.doi.org/10.1371/journal.pone.0064503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717621	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700152
J	Bae, HJ; Noh, JH; Kim, JK; Eun, JW; Jung, KH; Kim, MG; Chang, YG; Shen, Q; Kim, SJ; Park, WS; Lee, JY; Nam, SW				Bae, H. J.; Noh, J. H.; Kim, J. K.; Eun, J. W.; Jung, K. H.; Kim, M. G.; Chang, Y. G.; Shen, Q.; Kim, S-J; Park, W. S.; Lee, J. Y.; Nam, S. W.			MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma	ONCOGENE			English	Article						SIRT1; miR-29c; hepatocellular carcinoma; cell cycle; tumor suppressor	EXPRESSION; DEACETYLASE; CANCER; FAMILY; TUMORIGENESIS; INHIBITOR; PROGNOSIS; GENOMICS; MOUSE	Mammalian sirtuin 1 (SIRT1) has connected to an ever widening circle of activities that encompass cellular stress resistance, energy metabolism and tumorigenesis. However, underlying mechanisms leading to oncogenic SIRT1 overexpression are less understood. In this study, we identified SIRT1 regulatory microRNA (miRNA) and its function in hepatocellular carcinoma (HCC). Aberrant SIRT1 overexpression was demonstrated in a subset of human HCCs. SIRT1 knockdown suppressed HCC cell growth by transcriptional deregulation of cell cycle proteins. This led to hypophosphorylation of pRb, which inactivated E2F/DP1 target gene transcription, and thereby caused significant increase of HCC cells to remain in the G1/S phase. A comprehensive miRNA profiling analysis indentified five putative endogenous miRNAs that are significantly downregulated in HCC. Ectopic expression of miRNA mimics evidenced miR-29c to suppress SIRT1 in HCC cells. Notably, ectopic miR-29c expression repressed cancer cell growth and proliferation, and it recapitulated SIRT1 knockdown effects in HCC cells. In addition, miR-29c expression was downregulated in a large cohort of HCC patients, and low expression of miR-29c was significantly associated with poor prognosis of HCC patients. Taken together, we demonstrated that miR-29c suppresses oncogenic SIRT1 by way of binding to 30-untranslated region of SIRT1 mRNA causing translational inhibition in liver cancer cells. The loss or suppression of miR-29c may cause aberrant SIRT1 overexpression and promotes liver tumorigenesis. Overall, we suggest that miR-29c functions as a tumor suppressor by regulating abnormal SIRT1 activity in liver.	[Bae, H. J.; Noh, J. H.; Kim, J. K.; Eun, J. W.; Jung, K. H.; Kim, M. G.; Chang, Y. G.; Shen, Q.; Kim, S-J; Park, W. S.; Lee, J. Y.; Nam, S. W.] Catholic Univ Korea, Coll Med, Dept Pathol, Lab Oncogen, Seoul 137701, South Korea; [Bae, H. J.; Noh, J. H.; Kim, J. K.; Eun, J. W.; Jung, K. H.; Kim, M. G.; Chang, Y. G.; Shen, Q.; Kim, S-J; Park, W. S.; Lee, J. Y.; Nam, S. W.] Catholic Univ Korea, Funct RNom Res Ctr, Seoul 137701, South Korea; [Nam, S. W.] Catholic Univ Korea, Canc Evolut Res Ctr, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Nam, SW (corresponding author), Catholic Univ Korea, Funct RNom Res Ctr, Coll Med, Dept Pathol, Seoul 137701, South Korea.	swnam@catholic.ac.kr	Eun, Jung Woo/ABB-5127-2020	Eun, Jung Woo/0000-0002-2461-6702	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2011-0010705, 2012M3A9D1054476]; Korean Science and Engineering Foundation via the 'Cancer Evolution Research Center' at the Catholic University of Korea	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korean Science and Engineering Foundation via the 'Cancer Evolution Research Center' at the Catholic University of Korea(Korea Science and Engineering Foundation)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST; Grant No. 2011-0010705 and No. 2012M3A9D1054476), and by the Korean Science and Engineering Foundation via the 'Cancer Evolution Research Center' at the Catholic University of Korea.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xie HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034265; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380	25	121	128	2	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2557	2567		10.1038/onc.2013.216	http://dx.doi.org/10.1038/onc.2013.216			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23728341				2022-12-25	WOS:000336502700002
J	Feng, H; Hu, B; Vuori, K; Sarkaria, JN; Furnari, FB; Cavenee, WK; Cheng, SY				Feng, H.; Hu, B.; Vuori, K.; Sarkaria, J. N.; Furnari, F. B.; Cavenee, W. K.; Cheng, S-Y			EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180	ONCOGENE			English	Article						glioblastomas; EGFRvIII; Dock180; phosphorylation; PKA	PROTEIN-KINASE-A; CELL-MIGRATION; LIVING CELLS; RAC; GLIOBLASTOMA; ACTIVATION; GEF; TUMORIGENESIS; PATHWAY; COMPLEX	Glioblastomas (GBMs), the most common and malignant brain tumors, are highly resistant to current therapies. The failure of targeted therapies against aberrantly activated oncogenic signaling, such as that of the EGFR-PI3K/Akt pathway, underscores the urgent need to understand alternative downstream pathways and to identify new molecular targets for the development of more effective treatments for gliomas. Here, we report that EGFRvIII (Delta EGFR/de2-7EGFR), a constitutively active EGFR mutant that is frequently co-overexpressed with EGFR in clinical GBM tumors, promotes glioma growth and invasion through protein kinase A (PKA)-dependent phosphorylation of Dock180, a bipartite guanine nucleotide exchange factor (GEF) for Rac1. We demonstrate that EGFRvIII induces serine phosphorylation of Dock180, stimulates Rac1 activation and glioma cell migration. Treatments of glioma cells using the PKA inhibitors H-89 and KT5720, overexpression of a PKA inhibitor (PKI), and in vitro PKA kinase assays show that EGFRvIII induction of serine phosphorylation of Dock180 is PKA-dependent. Significantly, PKA induces phosphorylation of Dock180 at amino acid residue S1250 that resides within its Rac1-activating DHR-2 domain. Expression of the Dock180(S1250L) mutant, but not wild type Dock180(WT), protein in EGFRvIII-expressing glioma cells inhibited receptor-stimulated cell proliferation, survival, migration in vitro and glioma tumor growth and invasion in vivo. Together, our findings describe a novel mechanism by which EGFRvIII drives glioma tumorigenesis and invasion through PKA-dependent phosphorylation of Dock180, thereby suggesting that targeting EGFRvIII-PKA-Dock180-Rac1 signaling axis could provide a novel pathway to develop potential therapeutic strategies for malignant gliomas.	[Feng, H.; Hu, B.; Cheng, S-Y] Northwestern Univ, Feinberg Sch Med, Northwestern Brain Tumor Inst, Dept Neurol, Chicago, IL 60611 USA; [Feng, H.; Hu, B.; Cheng, S-Y] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Feng, H.; Hu, B.; Cheng, S-Y] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Feng, H.] Shanghai Jiao Tong Univ, Renji Hosp, Stem Cell Res Ctr, Sch Med, Shanghai 200030, Peoples R China; [Vuori, K.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Sarkaria, J. N.; Cavenee, W. K.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Furnari, F. B.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Shanghai Jiao Tong University; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Hu, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Northwestern Brain Tumor Inst, Dept Neurol, Chicago, IL 60611 USA.	bo.hu@northwestern.edu; shiyuan.cheng@northwestern.edu	Feng, Haizhong/E-5795-2017	Feng, Haizhong/0000-0003-3552-6865; Furnari, Frank/0000-0003-1909-4361	University of Pittsburgh Cancer Institute; NIH [CA130966, CA158911]; Northwestern Brain Tumor Institute; Department of Neurology at Northwestern University Feinberg School of Medicine; Zell Scholar Award from the Zell Family Foundation; Brain Cancer Research; Pennsylvania Department of Health; Innovative Research Scholar Awards of the Hillman Foundation; NATIONAL CANCER INSTITUTE [R01CA159811, R01CA130966, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939] Funding Source: NIH RePORTER	University of Pittsburgh Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern Brain Tumor Institute; Department of Neurology at Northwestern University Feinberg School of Medicine; Zell Scholar Award from the Zell Family Foundation; Brain Cancer Research; Pennsylvania Department of Health; Innovative Research Scholar Awards of the Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Most of the studies (and all the animal studies) were performed at the University of Pittsburgh in accordance with a protocol approved by the IACUC of the University of Pittsburgh. We acknowledge the support of University of Pittsburgh Cancer Institute and various core facilities. We also thank M Matsuda, R Tsien, E van Meir and Y Zhou for providing reagents, and Angel Alvarez for proofreading of this manuscript. WK Cavenee is a Fellow of the National Foundation for Cancer Research. This work was supported in part by a NIH grant CA130966, CA158911 to S-Y Cheng, a Zell Scholar Award from the Zell Family Foundation and funds from Northwestern Brain Tumor Institute and Department of Neurology at Northwestern University Feinberg School of Medicine to S-Y Cheng; Brain Cancer Research Awards from the James S McDonnell Foundation to B Hu and F Furnari; a grant with the Pennsylvania Department of Health, and Innovative Research Scholar Awards of the Hillman Foundation to S-Y Cheng and B Hu.	Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cai XM, 2005, INT J CANCER, V117, P905, DOI 10.1002/ijc.21251; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; de Farias CB, 2008, ONCOLOGY-BASEL, V75, P27, DOI 10.1159/000151616; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5; Liu KW, 2011, J CLIN INVEST, V121, P905, DOI 10.1172/JCI43690; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Payner T, 2006, MOL CANCER THER, V5, P1817, DOI 10.1158/1535-7163.MCT-05-0548; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Yang BC, 2003, J IMMUNOL, V171, P3947, DOI 10.4049/jimmunol.171.8.3947; Yiin JJ, 2010, MOL CANCER THER, V9, P929, DOI 10.1158/1535-7163.MCT-09-0953	33	54	56	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2504	2512		10.1038/onc.2013.198	http://dx.doi.org/10.1038/onc.2013.198			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23728337	Green Accepted			2022-12-25	WOS:000336033600010
J	Rimessi, A; Marchi, S; Patergnani, S; Pinton, P				Rimessi, A.; Marchi, S.; Patergnani, S.; Pinton, P.			H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling	ONCOGENE			English	Article						calcium signaling; caveolin-1; mitochondria; apoptosis; oncogenic H-Ras	MITOCHONDRIA-ASSOCIATED MEMBRANES; OXIDATIVE STRESS; CANCER-CELLS; ONCOGENIC TRANSFORMATION; MURINE FIBROBLASTS; PLASMA-MEMBRANE; GENE-EXPRESSION; DOWN-REGULATION; CAVEOLAE; METABOLISM	A growing body of research has highlighted the complex range of tumoral traits acquired during H-Ras-driven transformation and maintenance, which include proliferative signaling, growth suppressor evasion and resistance to cell death. Clear molecular information about these processes is not yet available, but recent evidence has provided solid support for the importance of mitochondria. Here, we show that the induction of oncogenic H-Ras leads to changes in intracellular calcium (Ca2+), evaluate the temporal relationship between oncogene expression and mitochondrial physiology, and demonstrate that Ca2+ homeostasis is altered by caveolin-1, a protein that has a key role in tumor maintenance. Our results indicate that tumor-suppressor caveolin-1 is a core component of the Ca2+-dependent apoptotic pathway and participates in the regulation of critical mitochondrial functions during tumor development. The compromised caveolin-1/Ca2+ axis contributes to failure in both mitochondrial metabolism and apoptosis, thereby sustaining the neoplastic phenotype. These results illustrate a direct link between Ca2+ regulation and mitochondrial biology in cancer.	[Rimessi, A.; Marchi, S.; Patergnani, S.; Pinton, P.] Univ Ferrar, Lab Technol Adv Therapies LTTA, Dept Morphol Surg & Expt Med, Sect Gen Pathol,Interdisciplinary Ctr Study Infla, I-44121 Ferrara, Italy		Pinton, P (corresponding author), Univ Ferrar, Lab Technol Adv Therapies LTTA, Dept Morphol Surg & Expt Med, Sect Gen Pathol,Interdisciplinary Ctr Study Infla, Via Borsari 46, I-44121 Ferrara, Italy.	pnp@unife.it	Marchi, Saverio/AAK-3308-2021; Rimessi, Alessandro/K-5420-2016; rimessi, alessandro/O-3335-2019; Marchi, Saverio/K-5997-2016; Pinton, Paolo/J-8025-2012; Patergnani, Simone/AAK-2929-2021; Patergnani, Simone/AAC-3969-2021	Marchi, Saverio/0000-0003-2708-1843; Rimessi, Alessandro/0000-0001-7091-5765; rimessi, alessandro/0000-0001-7091-5765; Marchi, Saverio/0000-0003-2708-1843; Pinton, Paolo/0000-0001-7108-6508; Patergnani, Simone/0000-0001-7951-9267; 	Italian Ministry of Health; FISM (Fondazione Italiana Sclerosi Multipla) research fellowship [2012/B/11]; FIRC (Fondazione Italiana Ricerca sul Cancro) fellowship; Italian Association for Cancer Research (AIRC), Telethon [GGP09128, GGP11139B]; local funds from the University of Ferrara; Italian Ministry of Education, University and Research (COFIN, FIRB and Futuro in Ricerca); Italian Cystic Fibrosis Research Foundation	Italian Ministry of Health(Ministry of Health, Italy); FISM (Fondazione Italiana Sclerosi Multipla) research fellowship; FIRC (Fondazione Italiana Ricerca sul Cancro) fellowship(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (AIRC), Telethon(Fondazione AIRC per la ricerca sul cancroFondazione Telethon); local funds from the University of Ferrara; Italian Ministry of Education, University and Research (COFIN, FIRB and Futuro in Ricerca)(Ministry of Education, Universities and Research (MIUR)); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This research was supported by: the Italian Ministry of Health to AR. SP is supported by a FISM (Fondazione Italiana Sclerosi Multipla) research fellowship (2012/B/11), whereas SM by FIRC (Fondazione Italiana Ricerca sul Cancro) fellowship. PP is financed by Italian Association for Cancer Research (AIRC), Telethon (GGP09128 and GGP11139B), local funds from the University of Ferrara, the Italian Ministry of Education, University and Research (COFIN, FIRB and Futuro in Ricerca), the Italian Cystic Fibrosis Research Foundation and Italian Ministry of Health.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Bender F, 2002, BIOL RES, V35, P151, DOI 10.4067/S0716-97602002000200006; Berridge MV, 2010, REJUV RES, V13, P139, DOI 10.1089/rej.2009.0948; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ferdek PE, 2012, CURR BIOL, V22, P1241, DOI 10.1016/j.cub.2012.05.002; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; GALLIMORE PH, 1986, ANTICANCER RES, V6, P499; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Hulit J, 2000, J BIOL CHEM, V275, P21203, DOI 10.1074/jbc.M000321200; Isshiki M, 2002, J CELL SCI, V115, P475; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Park DS, 2001, BIOCHEMISTRY-US, V40, P3354, DOI 10.1021/bi002787b; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Razani B, 2000, J CELL SCI, V113, P2103; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899	60	53	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2329	2340		10.1038/onc.2013.192	http://dx.doi.org/10.1038/onc.2013.192			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23728347				2022-12-25	WOS:000335451800006
J	Cooper, RS; Altenberg, GA				Cooper, Rebecca S.; Altenberg, Guillermo A.			Association/Dissociation of the Nucleotide-binding Domains of the ATP-binding Cassette Protein MsbA Measured during Continuous Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-ELECTRON RESONANCE; ABC TRANSPORTER MSBA; ENERGY-TRANSFER; P-GLYCOPROTEIN; ALTERNATING ACCESS; CATALYTIC CYCLE; MOVEMENT; SITES; DIMER	In ATP-binding cassette proteins, the two nucleotide-binding domains (NBDs) work as dimers to bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is controversial. It is still unresolved whether hydrolysis leads to dissociation of the ATP-induced dimers or partial opening of the dimers such that the NBDs remain in contact during the hydrolysis cycle. We studied the bacterial lipid flippase MsbA by luminescence resonance energy transfer (LRET). The LRET signal between optical probes reacted with single-cysteine mutants was employed to follow NBD association/dissociation in real time. The intermonomer distances calculated from LRET data indicate that the NBDs separate completely following ATP hydrolysis, even in the presence of mM MgATP, and that the dissociation occurs following each hydrolysis cycle. The results support association/dissociation, as opposed to constant contact models, for the mode of operation of ATP-binding cassette proteins.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention & Research Institute of Texas Grant [RP101073]; American Heart Association Predoctoral Fellowship [11PRE7360046]; Lubbock Chapter of the Achievement Rewards for College Scientists Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas Grant; American Heart Association Predoctoral Fellowship(American Heart Association); Lubbock Chapter of the Achievement Rewards for College Scientists Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by Cancer Prevention & Research Institute of Texas Grant RP101073 (to G. A. A.), American Heart Association Predoctoral Fellowship 11PRE7360046 (to R. S. C.), and a scholarship from the Lubbock Chapter of the Achievement Rewards for College Scientists Foundation (to R. S. C.).	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Bai J., 2011, PLOS ONE, V6; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HUANG C, 1973, J AM CHEM SOC, V95, P234, DOI 10.1021/ja00782a042; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Knauf PA, 2004, BLOOD CELL MOL DIS, V32, P360, DOI 10.1016/j.bcmd.2004.01.007; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Xiao M, 2001, J AM CHEM SOC, V123, P7067, DOI 10.1021/ja0031669; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	41	34	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20785	20796		10.1074/jbc.M113.477976	http://dx.doi.org/10.1074/jbc.M113.477976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23723071	Green Published, hybrid			2022-12-25	WOS:000322014400003
J	Cunningham, CL; Martinez-Cerdeno, V; Noctor, SC				Cunningham, Christopher L.; Martinez-Cerdeno, Veronica; Noctor, Stephen C.			Diversity of Neural Precursor Cell Types in the Prenatal Macaque Cerebral Cortex Exists Largely within the Astroglial Cell Lineage	PLOS ONE			English	Article							RADIAL GLIAL-CELLS; FIBRILLARY ACIDIC PROTEIN; SUBVENTRICULAR ZONE PROGENITORS; CORTICAL-NEURONS; VENTRICULAR ZONE; STEM-CELLS; ASYMMETRIC INHERITANCE; DEVELOPING NEOCORTEX; PROLIFERATIVE ZONES; GABAERGIC NEURONS	The germinal zones of the embryonic macaque neocortex comprise the ventricular zone (VZ) and the subventricular zone (SVZ). The mammalian SVZ is subdivided into an inner SVZ and an outer SVZ, with the outer SVZ being particularly large in primates. The existence of distinct precursor cell types in the neocortical proliferative zones was inferred over 100 years ago and recent evidence supports this concept. Precursor cells exhibiting diverse morphologies, patterns of transcription factor expression, and fate potential have been identified in the neocortical proliferative zones. Neurogenic precursor cells are thought to exhibit characteristics of glial cells, but the existence of neurogenic precursor cells that do not share glial specific properties has also been proposed. Therefore, one question that remains is whether neural precursor cells in the prenatal neocortex belong within the astroglial cell class, as they do in neurogenic regions of the adult neocortex, or instead include a diverse collection of precursor cells belonging to distinct cell classes. We examined the expression of astroglial markers by mitotic precursor cells in the telencephalon of prenatal macaque and human. We show that in the dorsal neocortex all mitotic cells at the surface of the ventricle, and all Pax6+ and Tbr2+ mitotic cells in the proliferative zones, express the astroglial marker GFAP. The majority of mitotic cells undergoing division away from the ventricle express GFAP, and many of the GFAP-negative mitoses express markers of cells derived from the ventral telencephalon or extracortical sites. In contrast, a markedly lower proportion of precursor cells express GFAP in the ganglionic eminence. In conclusion, we propose that the heterogeneity of neural precursor cells in the dorsal cerebral cortex develops within the GFAP+ astroglial cell class.	[Cunningham, Christopher L.; Martinez-Cerdeno, Veronica; Noctor, Stephen C.] Univ Calif Davis, Grad Program Neurosci, Davis, CA 95616 USA; [Martinez-Cerdeno, Veronica] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA; [Martinez-Cerdeno, Veronica] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Martinez-Cerdeno, Veronica; Noctor, Stephen C.] Univ Calif Davis, Sch Med, MIND Inst, Sacramento, CA 95817 USA; [Noctor, Stephen C.] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Noctor, SC (corresponding author), Univ Calif Davis, Grad Program Neurosci, Davis, CA 95616 USA.	scnoctor@ucdavis.edu		Cunningham, Christopher/0000-0002-9619-4190	UC Davis MIND Institute; National Institutes of Health; Shriners Hospitals for Children; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094681, R01MH101188] Funding Source: NIH RePORTER	UC Davis MIND Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	UC Davis MIND Institute, National Institutes of Health, Shriners Hospitals for Children, National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bayer S.A., 1991, NEOCORTICAL DEV; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Casarosa S, 1999, DEVELOPMENT, V126, P525; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; DAHL D, 1973, BRAIN RES, V61, P279, DOI 10.1016/0006-8993(73)90533-7; DAHL D, 1985, J COMP NEUROL, V239, P75, DOI 10.1002/cne.902390107; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; HIS W, 1889, ABH KGL SACHS GES WI, V15, P311; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kelava I, 2011, CEREB CORTEX; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Mione MC, 1997, J NEUROSCI, V17, P2018; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ono K, 2001, DEV BIOL, V231, P77, DOI 10.1006/dbio.2000.0137; Ono K, 2008, DEV BIOL, V320, P456, DOI 10.1016/j.ydbio.2008.06.001; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tyler WA, 2013, J NEUROSCI, V33, P5106, DOI 10.1523/JNEUROSCI.5380-12.2013; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011	75	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63848	10.1371/journal.pone.0063848	http://dx.doi.org/10.1371/journal.pone.0063848			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724007	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000030
J	Saad, R; Chen, Z; Zhu, SM; Jia, PL; Zhao, ZM; Washington, MK; Belkhiri, A; El-Rifai, W				Saad, Rama; Chen, Zheng; Zhu, Shoumin; Jia, Peilin; Zhao, Zhongming; Washington, M. Kay; Belkhiri, Abbes; El-Rifai, Wael			Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma	PLOS ONE			English	Article							CANCER; EXPRESSION; BARRETTS; SURVIVAL; CARCINOGENESIS; TARGETS; MIR-375; CARDIA; TISSUE	Background and Methods: Esophageal adenocarcinoma (EAC) is characterized by a steep rise in incidence rates in the Western population. The unique miRNA signature that distinguishes EAC from other upper gastrointestinal cancers remains unclear. Herein, we performed a comprehensive microarray profiling for the specific miRNA signature associated with EAC. We validated this signature by qRT-PCR. Results: Microarray analysis showed that 21 miRNAs were consistently deregulated in EAC. miR-194, miR-192, miR-200a, miR-21, miR-203, miR-205, miR-133b, and miR-31 were selected for validation using 46 normal squamous (NS), 23 Barrett's esophagus (BE), 17 Barrett's high grade dysplasia (HGD), 34 EAC, 33 gastric adenocarcinoma ( GC), and 45 normal gastric (NG) tissues. The qRT-PCR analysis indicated that 2 miRNAs (miR-21 and miR-133b) were deregulated in both EAC and GC, and 6 miRNAs (up-regulated: miR-194, miR-31, miR-192, and miR-200a; down-regulated: miR-203 and miR-205) in EAC, as compared to BE but not in GC, indicating their potential unique role in EAC. Our data showed that miR-194, miR-192, miR-21, and miR-31 were up-regulated in BE adjacent to HGD lesions relative to isolated BE samples. Analysis of clinicopathological features indicated that down-regulation of miR-203 is significantly associated with progression and tumor stages in EAC. Interestingly, the overexpression levels of miR-194, miR-200a, and miR-192 were significantly higher in early EAC stages, suggesting that these miRNAs may be involved in EAC tumor development rather than progression. Conclusion: Our findings demonstrate the presence of a unique miRNA signature for EAC. This may provide some clues for the distinct molecular features of EAC to be considered in future studies of the role of miRNAs in EAC and their utility as disease biomarkers.	[Saad, Rama; Chen, Zheng; Zhu, Shoumin; Belkhiri, Abbes; El-Rifai, Wael] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37235 USA; [Saad, Rama] Amer Univ Cairo, Biotechnol Grad Program, Cairo, Egypt; [Chen, Zheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA; [El-Rifai, Wael] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [El-Rifai, Wael] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA	Vanderbilt University; Egyptian Knowledge Bank (EKB); American University Cairo; Nanjing Medical University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	El-Rifai, W (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37235 USA.	wael.el-rifai@vanderbilt.edu		Ali, Rama/0000-0002-7001-3750	National Institutes of Health [R01CA106176]; Department of Veterans Affairs, Vanderbilt SPORE in Gastrointestinal Cancer [P50 CA95103]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [R01CA106176, P30CA068485, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Vanderbilt SPORE in Gastrointestinal Cancer; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health; R01CA106176, Department of Veterans Affairs, Vanderbilt SPORE in Gastrointestinal Cancer (P50 CA95103), Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute, Department of Veterans Affairs, or Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOT WJ, 1993, JAMA-J AM MED ASSOC, V270, P1320, DOI 10.1001/jama.270.11.1320; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; el-Rifai Wa'el, 2002, Surg Oncol Clin N Am, V11, P273, DOI 10.1016/S1055-3207(02)00004-2; Fassan M, 2011, INT J CANCER, V129, P1661, DOI 10.1002/ijc.25823; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Feber A, 2011, ANN THORAC SURG, V91, P1523, DOI 10.1016/j.athoracsur.2011.01.056; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; HESKETH PJ, 1989, CANCER, V64, P526, DOI 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B; Ilson DH, 2002, J CLIN ONCOL, V20, P1962, DOI 10.1200/JCO.2002.20.8.1962; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kumar S, 2006, BIOMARKERS, V11, P385, DOI 10.1080/13547500600775011; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Liu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005436; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patron JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035345; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Shah MA, 2010, HEMATOL ONCOL CLIN N, V24, P815, DOI 10.1016/j.hoc.2010.06.007; van Dekken H, 1999, CANCER RES, V59, P748; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743	29	43	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64463	10.1371/journal.pone.0064463	http://dx.doi.org/10.1371/journal.pone.0064463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724052	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000059
J	Yu, QH; Zhu, LQ; Lin, J; Zhang, Q; Tian, Q; Hu, WW; Yang, Q				Yu, Qinghua; Zhu, Liqi; Lin, Jian; Zhang, Qiang; Tian, Qi; Hu, Weiwei; Yang, Qian			Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells	PLOS ONE			English	Article							DIABETES-MELLITUS MODEL; FACILITATED HEXOSE; LACTATING RAT; EXPRESSION; TRANSPORTERS; LOCALIZATION; PROTEIN; TRANSLOCATION; INFECTION; MEMBRANE	Glucose transport, mediated by glucose transporters, is necessary for mammary gland development and lactation. GLUT1 and GLUT12 could both be expressed in the pregnant and lactating mammary gland to participate in the glucose uptake process. In this study, the goat GLUT1 and GLUT12 genes were cloned from Saanen dairy goats and transfected into goat mammary gland epithelial cells to assess their biological functions and distributions. The results showed that both goat GLUT1 and GLUT12 had 12 predicted membrane- spanning helices. Goat GLUT1 and GLUT12 each influenced the mRNA expression of the other transporter and increased the glucose consumption and lactose yield in GLUT1- and GLUT12-transfected goat mammary gland epithelial cells, respectively. The overexpression of GLUT1 or GLUT12 also increased the expression of amino acid transporters SLC1A5, SLC3A2 and SLC7A5 and affected genes expressions in GMGE cells. Using immunofluorescence staining, GLUT1 was detected throughout the cytoplasm and localized to the Golgi apparatus around the nuclear membrane, whereas GLUT12 was mainly distributed in the perinuclear region and cytoplasm. This study contributes to the understanding of how GLUT1 and GLUT12 cooperate in the incorporation of nutrient uptake into mammary gland epithelial cells and the promotion of milk synthesis in the goat mammary gland during lactation.	[Yu, Qinghua; Zhu, Liqi; Lin, Jian; Zhang, Qiang; Tian, Qi; Hu, Weiwei; Yang, Qian] Nanjing Agr Univ, Vet Coll, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Vet Coll, Nanjing, Jiangsu, Peoples R China.	iamspringyqh@yahoo.com.cn	Yu, Qinghua/T-3261-2019; yu, qing/HGC-4611-2022		National Animal Transgenic Breeding Grand Project [2011ZX08008-004, 2013ZX08008-004]; National Basic Research Program of China (973 program) [2013CB127300]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Animal Transgenic Breeding Grand Project; National Basic Research Program of China (973 program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Animal Transgenic Breeding Grand Project (2011ZX08008-004 and 2013ZX08008-004), National Basic Research Program of China (973 program 2013CB127300), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNISON EF, 1964, J PHYSIOL-LONDON, V175, P372, DOI 10.1113/jphysiol.1964.sp007522; BELL GI, 1991, INT J OBESITY, V15, P127; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; Carvalho KC, 2011, CLINICS, V66, P965, DOI 10.1590/S1807-59322011000600008; Chandler JD, 2003, CANCER-AM CANCER SOC, V97, P2035, DOI 10.1002/cncr.11293; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Flessner LB, 2009, TRAFFIC, V10, P324, DOI 10.1111/j.1600-0854.2008.00866.x; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ghez D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-99; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Ilinskaya A, 2010, FUTURE MED CHEM, V2, P1651, DOI [10.4155/fmc.10.255, 10.4155/FMC.10.255]; Jin QW, 2010, VIROLOGY, V396, P203, DOI 10.1016/j.virol.2009.10.015; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Keenan TW, 1998, HISTOCHEM CELL BIOL, V109, P505, DOI 10.1007/s004180050251; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; MADON RJ, 1990, J ENDOCRINOL, V125, P81, DOI 10.1677/joe.0.1250081; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; Miller PJ, 2005, MAMM GENOME, V16, P873, DOI 10.1007/s00335-005-0080-5; Ohno H, 2011, AM J PHYSIOL-CELL PH, V300, pC1047, DOI 10.1152/ajpcell.00416.2010; Riskin A, 2008, PEDIATR RES, V63, P56, DOI 10.1203/PDR.0b013e31815b440b; Rogers S, 2003, BIOCHEM BIOPH RES CO, V308, P422, DOI 10.1016/S0006-291X(03)01417-7; Rogers S, 2003, CANCER LETT, V193, P225, DOI 10.1016/S0304-3835(03)00010-7; Rogers S, 2002, AM J PHYSIOL-ENDOC M, V282, pE733, DOI 10.1152/ajpendo.2002.282.3.E733; Saigusa S, 2011, SURG TODAY; SASAKI S, 1990, HORM METAB RES, V22, P457, DOI 10.1055/s-2007-1004947; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; Sokolovska J, 2011, CELL BIOCHEM FUNCT, V29, P55, DOI 10.1002/cbf.1719; Sokolovska Jelizaveta, 2010, Archives of Physiology and Biochemistry, V116, P137, DOI 10.3109/13813455.2010.494672; Stuart CA, 2009, J CLIN ENDOCR METAB, V94, P3535, DOI 10.1210/jc.2009-0162; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tian Mohan, 2009, Zhongguo Fei Ai Za Zhi, V12, P770, DOI 10.3779/j.issn.1009-3419.2009.07.005; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Yang J, 2000, J ANIM SCI, V78, P3126; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS290, DOI 10.1016/j.legalmed.2009.01.094; Zhao FQ, 2007, J DAIRY SCI, V90, pE76, DOI 10.3168/jds.2006-470; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; ZHAO FQ, 1993, INT J BIOCHEM, V25, P1897, DOI 10.1016/0020-711X(88)90322-9; Zhao FQ, 1999, J ANIM SCI, V77, P2517	43	10	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65013	10.1371/journal.pone.0065013	http://dx.doi.org/10.1371/journal.pone.0065013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724114	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000111
J	Gustafsson, C; Bostrom, C				Gustafsson, Camilla; Bostrom, Christoffer			Influence of Neighboring Plants on Shading Stress Resistance and Recovery of Eelgrass, Zostera marina L	PLOS ONE			English	Article							POTAMOGETON-PERFOLIATUS; POSITIVE INTERACTIONS; LIGHT AVAILABILITY; SULFIDE INVASION; BIODIVERSITY; ECOSYSTEM; DIVERSITY; CARBON; PRODUCTIVITY; SEDIMENTS	Stressful environments may enhance the occurrence of facilitative interspecific interactions between plants. In several regions, Zostera marina occurs in mixed assemblages. However, the potential effects of plant diversity on stress responses and stability properties of Z. marina are poorly understood. We investigated the resistance and recovery of Z. marina subjected to shading (1 mo) in a field experiment lasting 2.5 mo. We shaded Z. marina planted in mono-and polycultures (Potamogeton perfoliatus, P. pectinatus, P. filiformis) in a factorial design (Shading x Richness) at 2 m depth. We estimated the resistance and recovery of Z. marina by measuring four response variables. Polyculture Z. marina lost proportionally less biomass than monocultures, thus having a greater resistance to shading. In contrast, after a 1 mo recovery period, monocultures exhibited higher biomass gain, and a faster recovery than polycultures. Our results suggest that plant species richness enhances the resistance of Z. marina through facilitative mechanisms, while the faster recovery in monocultures is possibly due to interspecific competition. Our results highlight the need of a much better understanding of the effects of interspecific interactions on ecosystem processes in mixed seagrass meadows, and the preservation of diverse plant assemblages to maintain ecosystem functioning.	[Gustafsson, Camilla; Bostrom, Christoffer] Abo Akad Univ, Dept Biosci, Turku, Finland	Abo Akademi University	Gustafsson, C (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	camilla.gustafsson@abo.fi	Gustafsson, Camilla/ABC-4849-2021; Bostrom, Christoffer/U-6679-2017	Gustafsson, Camilla/0000-0001-7308-3802; Bostrom, Christoffer/0000-0003-2845-8331	Maj and Tor Nessling Foundation [2008216]; Maa- ja Vesitekniikan Tuki ry; Juridiska Personen Abo Akademi; Stiftelsens for Abo Akademi Forskningsinstitut; Oskar Oflunds Stiftelse; Suomen Luonnonsuojelun saatio; Nordenskioldsam-fundet; Waldemar von Frenckells stiftelse	Maj and Tor Nessling Foundation; Maa- ja Vesitekniikan Tuki ry; Juridiska Personen Abo Akademi; Stiftelsens for Abo Akademi Forskningsinstitut; Oskar Oflunds Stiftelse; Suomen Luonnonsuojelun saatio; Nordenskioldsam-fundet; Waldemar von Frenckells stiftelse	This study was conducted as a part of the project "Biodiversity and ecosystem functioning under environmental stress: role of biological insurance in aquatic plant communities'' (Maj and Tor Nessling Foundation (project 2008216) to CB). CG received additional funding from Maa- ja Vesitekniikan Tuki ry., Juridiska Personen Abo Akademi, Stiftelsens for Abo Akademi Forskningsinstitut, Oskar Oflunds Stiftelse, Suomen Luonnonsuojelun saatio, Nordenskioldsam-fundet and Waldemar von Frenckells stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; [Anonymous], 2006, SAS MIXED MODELS; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Biber PD, 2009, J EXP MAR BIOL ECOL, V369, P110, DOI 10.1016/j.jembe.2008.10.031; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAFFREY JM, 1990, MAR ECOL PROG SER, V66, P147, DOI 10.3354/meps066147; CAFFREY JM, 1991, AQUAT BOT, V40, P109, DOI 10.1016/0304-3770(91)90090-R; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Duarte CM, 2005, COAST ESTUAR STUD, V60, P31; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Duarte CM, 2000, J EXP MAR BIOL ECOL, V250, P117, DOI 10.1016/S0022-0981(00)00194-5; Engelhardt KAM, 2002, ECOLOGY, V83, P2911; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P2308, DOI 10.4319/lo.2006.51.5.2308; Grace JB., 2015, STRUCTURAL EQUATION; Griffin John n., 2009, P78; Gustafsson C, 2011, OIKOS, V120, P1037, DOI 10.1111/j.1600-0706.2010.19008.x; Hardin JW., 2012, GEN LINEAR MODELS EX; Harper J. L, 1977, POPULATION BIOL PLAN; HELCOM, 2009, BALT SEA ENV PROC; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hemminga MA, 1998, J SEA RES, V39, P183, DOI 10.1016/S1385-1101(98)00004-5; Holmer M, 2002, J EXP MAR BIOL ECOL, V270, P25, DOI 10.1016/S0022-0981(02)00015-1; Holmer M, 2007, J EXP MAR BIOL ECOL, V353, P245, DOI 10.1016/j.jembe.2007.09.010; Holmer M, 2009, AQUAT BOT, V91, P303, DOI 10.1016/j.aquabot.2009.08.004; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; HUBER SC, 1982, PLANT PHYSIOL, V69, P691, DOI 10.1104/pp.69.3.691; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; KAUTSKY L, 1988, OIKOS, V53, P126, DOI 10.2307/3565672; Krause-Jensen D, 2008, ECOL INDIC, V8, P515, DOI 10.1016/j.ecolind.2007.06.004; KRISTENSEN E, 1987, J EXP MAR BIOL ECOL, V109, P15, DOI 10.1016/0022-0981(87)90182-1; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Longstaff BJ, 1999, J EXP MAR BIOL ECOL, V234, P1, DOI 10.1016/S0022-0981(98)00137-3; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Moore KA, 2000, J EXP MAR BIOL ECOL, V244, P1, DOI 10.1016/S0022-0981(99)00135-5; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; OLESEN B, 1993, MAR ECOL PROG SER, V94, P91, DOI 10.3354/meps094091; OLESEN B, 1994, MAR ECOL PROG SER, V109, P283, DOI 10.3354/meps109283; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PEDERSEN MF, 1992, MAR ECOL PROG SER, V80, P65, DOI 10.3354/meps080065; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Salo T, 2009, MAR ECOL PROG SER, V396, P261, DOI 10.3354/meps08325; SANDJENSEN K, 1982, OIKOS, V38, P349, DOI 10.2307/3544675; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zimmerman RC, 1996, MAR ECOL PROG SER, V136, P305, DOI 10.3354/meps136305	57	18	18	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64064	10.1371/journal.pone.0064064	http://dx.doi.org/10.1371/journal.pone.0064064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717532	gold, Green Submitted, Green Published			2022-12-25	WOS:000319385300028
J	Sevini, F; Yao, DY; Lomartire, L; Barbieri, A; Vianello, D; Ferri, G; Moretti, E; Dasso, MC; Garagnani, P; Pettener, D; Franceschi, C; Luiselli, D; Franceschi, ZA				Sevini, Federica; Yao, Daniele Yang; Lomartire, Laura; Barbieri, Annalaura; Vianello, Dario; Ferri, Gianmarco; Moretti, Edgardo; Cristina Dasso, Maria; Garagnani, Paolo; Pettener, Davide; Franceschi, Claudio; Luiselli, Donata; Franceschi, Zelda Alice			Analysis of Population Substructure in Two Sympatric Populations of Gran Chaco, Argentina	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; GENETIC-STRUCTURE; PATTERNS; NUMBER	Sub-population structure and intricate kinship dynamics might introduce biases in molecular anthropology studies and could invalidate the efforts to understand diseases in highly admixed populations. In order to clarify the previously observed distribution pattern and morbidity of Chagas disease in Gran Chaco, Argentina, we studied two populations (Wichi and Criollos) recruited following an innovative bio-cultural model considering their complex cultural interactions. By reconstructing the genetic background and the structure of these two culturally different populations, the pattern of admixture, the correspondence between genealogical and genetic relationships, this integrated perspective had the power to validate data and to link the gap usually relying on a singular discipline. Although Wichi and Criollos share the same area, these sympatric populations are differentiated from the genetic point of view as revealed by Non Recombinant Y Chromosome genotyping resulting in significantly high Fst values and in a lower genetic variability in the Wichi population. Surprisingly, the Amerindian and the European components emerged with comparable amounts (20%) among Criollos and Wichi respectively. The detailed analysis of mitochondrial DNA showed that the two populations have as much as 87% of private haplotypes. Moreover, from the maternal perspective, despite a common Amerindian origin, an Andean and an Amazonian component emerged in Criollos and in Wichi respectively. Our approach allowed us to highlight that quite frequently there is a discrepancy between self-reported and genetic kinship. Indeed, if self-reported identity and kinship are usually utilized in population genetics as a reliable proxy for genetic identity and parental relationship, in our model populations appear to be the result not only and not simply of the genetic background but also of complex cultural determinants. This integrated approach paves the way to a rigorous reconstruction of demographic and cultural history as well as of bioancestry and propensity to diseases of Wichi and Criollos.	[Sevini, Federica; Lomartire, Laura; Barbieri, Annalaura; Vianello, Dario; Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy; [Sevini, Federica; Lomartire, Laura; Barbieri, Annalaura; Vianello, Dario; Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Ctr Interdipartimentale Luigi Galvani CIG, Bologna, Italy; [Yao, Daniele Yang; Pettener, Davide; Luiselli, Donata] Univ Bologna, Sez Biol, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy; [Ferri, Gianmarco] Univ Modena, Dipartimento Attivita Integrata Lab Anat Patol Me, Azienda Osped, Modena, Italy; [Moretti, Edgardo] Coordinac Nacl Control Vectores, Cordoba, Spain; [Cristina Dasso, Maria] Ctr Invest Antropol Filosof & Cultural CIAFIC, Buenos Aires, DF, Argentina; [Cristina Dasso, Maria] Ctr Univ Interdisciplinario Enfermedad Chagas CUN, Buenos Aires, DF, Argentina; [Franceschi, Zelda Alice] Univ Bologna, Dipartimento Storia Culture Civilta DiSCi, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; Universita di Modena e Reggio Emilia; University of Bologna	Luiselli, D (corresponding author), Univ Bologna, Sez Biol, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy.	donata.luiselli@unibo.it	Pettener, Davide/E-1576-2017; Franceschi, Claudio/L-4484-2017	Franceschi, Claudio/0000-0001-9841-6386; Garagnani, Paolo/0000-0002-4161-3626; Vianello, Dario/0000-0003-1350-7284	CUIA - Consorzio Interuniversitario Italiano per l'Argentina; University of Bologna	CUIA - Consorzio Interuniversitario Italiano per l'Argentina; University of Bologna	This study was supported by research grants: CUIA - Consorzio Interuniversitario Italiano per l'Argentina and RFO 2009 and 2010 from the University of Bologna to C.F. and D.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bisso-Machado R, 2012, GENET MOL BIOL, V35, P365, DOI 10.1590/S1415-47572012005000027; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; Crossetti SG, 2008, AM J HUM BIOL, V20, P704, DOI 10.1002/ajhb.20798; Decker AE, 2008, FORENSIC SCI INT-GEN, V2, pE31, DOI 10.1016/j.fsigen.2007.08.016; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FRANCESCHI ZA, 2010, ETNO GRAFIAS ESCRITU; Hernandez I., 1992, INDIOS ARGENTINA; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; METRAUX A, 1943, AM INDIGENA, P198; Moretti E, 2010, MEM I OSWALDO CRUZ, V105, P621, DOI 10.1590/S0074-02762010000500004; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pritchard JK, 2000, GENETICS, V155, P945; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SCHNEIDER A, 1998, CAH INT SOCIOL, V105, P341; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037	34	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64054	10.1371/journal.pone.0064054	http://dx.doi.org/10.1371/journal.pone.0064054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717528	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700093
J	Chandra, A; Lan, SH; Zhu, J; Siclari, VA; Qin, L				Chandra, Abhishek; Lan, Shenghui; Zhu, Ji; Siclari, Valerie A.; Qin, Ling			Epidermal Growth Factor Receptor (EGFR) Signaling Promotes Proliferation and Survival in Osteoprogenitors by Increasing Early Growth Response 2 (EGR2) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FINGER TRANSCRIPTION FACTOR; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; REGULATORY FACTORS; BONE-FORMATION; IN-VITRO; T-CELLS; APOPTOSIS; PATHWAY	Maintaining bone architecture requires continuous generation of osteoblasts from osteoprogenitor pools. Our previous study of mice with epidermal growth factor receptor (EGFR) specifically inactivated in osteoblast lineage cells revealed that EGFR stimulates bone formation by expanding the population of mesenchymal progenitors. EGFR ligands are potent regulators for the osteoprogenitor pool, but the underlying mechanisms are largely unknown. Here we demonstrate that activation of EGFR increases the number of osteoprogenitors by promoting cell proliferation and suppressing either serum depletion-induced or TNF alpha-induced apoptosis mainly through the MAPK/ERK pathway. Mouse calvarial organ culture revealed that EGF elevated the number of proliferative cells and decreased the number of apoptotic cells, which led to increased osteoblasts. Microarray analysis of MC3T3 cells, an osteoprogenitor cell line, revealed that EGFR signaling stimulates the expression of MCL1, an antiapoptotic protein, and a family of EGR transcription factors (EGR1, -2, and -3). The up-regulation of MCL1 and EGR2 by EGF was further confirmed in osteoprogenitors close to the calvarial bone surface. Overexpression of NAB2, a co-repressor for EGRs, attenuated the EGF-induced increase in osteoprogenitor number. Interestingly, knocking down the expression of EGR2, but not EGR1 or -3, resulted in a similar effect. Using inhibitor, adenovirus overexpression, and siRNA approaches, we demonstrate that EGFR signaling activates the MAPK/ERK pathway to stimulate the expression of EGR2, which in turn leads to cell growth and MCL1-mediated cell survival. Taken together, our data clearly demonstrate that EGFR-induced EGR2 expression is critical for osteoprogenitor maintenance and new bone formation.	[Chandra, Abhishek; Lan, Shenghui; Zhu, Ji; Siclari, Valerie A.; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Lan, Shenghui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Hunan, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Huazhong University of Science & Technology	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th St, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669	National Institutes of Health [K01 DK071988]; Penn Center for Musculoskeletal Disorders [P30AR050950]; New Jersey Stem Cell Research Grant; Penn Institute on Aging pilot grant;  [NCI R25 CA101871-07]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095803, K01DK071988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Musculoskeletal Disorders; New Jersey Stem Cell Research Grant; Penn Institute on Aging pilot grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK071988 (to L. Q.), Penn Center for Musculoskeletal Disorders Grant P30AR050950 (NIAMS/National Institutes of Health), and Grant NCI R25 CA101871-07 (to V. S.). This work was also supported by a New Jersey Stem Cell Research Grant (to L. Q.) and a Penn Institute on Aging pilot grant (to L. Q.).	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Bertrand-Duchesne MP, 2010, J PERIODONTAL RES, V45, P87, DOI 10.1111/j.1600-0765.2009.01205.x; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kirsch KH, 1996, ONCOGENE, V12, P963; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Levi G, 1996, DEVELOPMENT, V122, P113; Li SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018498; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; NG KW, 1983, CALCIFIED TISSUE INT, V35, P624, DOI 10.1007/BF02405105; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Parfitt AM, 1997, J BONE MINER RES, V12, P1864, DOI 10.1359/jbmr.1997.12.11.1864; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; RANGNEKAR VM, 1990, NUCLEIC ACIDS RES, V18, P2749, DOI 10.1093/nar/18.9.2749; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Soulez M, 2010, STEM CELLS, V28, P810, DOI 10.1002/stem.403; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010; Zhu HY, 2010, CELLS TISSUES ORGANS, V192, P211, DOI 10.1159/000313417; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050099; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	46	76	80	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20488	20498		10.1074/jbc.M112.447250	http://dx.doi.org/10.1074/jbc.M112.447250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720781	hybrid, Green Published			2022-12-25	WOS:000321715100036
J	Spera, JM; Herrmann, CK; Roset, MS; Comerci, DJ; Ugalde, JE				Spera, Juan M.; Herrmann, Claudia K.; Roset, Mara S.; Comerci, Diego J.; Ugalde, Juan E.			A Brucella Virulence Factor Targets Macrophages to Trigger B-cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI INFECTION; PROLINE RACEMASE; MYOSIN-IIA; BACTERIAL PATHOGENS; HOST-CELLS; PROTEIN; IDENTIFICATION; SYSTEM; ACTIN; TRANSLOCATION	Brucella spp. and Trypanosoma cruzi are two intracellular pathogens that have no evolutionary common origins but share a similar lifestyle as they establish chronic infections for which they have to circumvent the host immune response. Both pathogens have a virulence factor (prpA in Brucella and tcPrac in T. cruzi) that induces B-cell proliferation and promotes the establishment of the chronic phase of the infectious process. We show here that, even though PrpA promotes B-cell proliferation, it targets macrophages in vitro and is translocated to the cytoplasm during the intracellular replication phase. We observed that PrpA-treated macrophages induce the secretion of a soluble factor responsible for B-cell proliferation and identified nonmuscular myosin IIA (NMM-IIA) as a receptor required for binding and function of this virulence factor. Finally, we show that the Trypanosoma cruzi homologue of PrpA also targets macrophages to induce B-cell proliferation through the same receptor, indicating that this virulence strategy is conserved between a bacterial and a protozoan pathogen.	[Spera, Juan M.; Herrmann, Claudia K.; Roset, Mara S.; Comerci, Diego J.; Ugalde, Juan E.] Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugalde, IIB INTECH, Natl Res Council Argentina CONICET, RA-1650 Buenos Aires, DF, Argentina; [Comerci, Diego J.] CNEA, Grp Pecuario, RA-1429 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Spera, JM (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugalde, IIB INTECH, UNSAM, Ave 25 Mayo Francia,Campus Miguelete, RA-1650 Buenos Aires, DF, Argentina.	jugalde@iibintech.com.ar		Comerci, Diego J./0000-0003-1949-4226; Roset, Mara/0000-0003-0487-199X	National Institutes of Health from the NIAID [AI078891]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-PRH08-230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078891] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI078891 from the NIAID (to J.E.U.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-PRH08-230 (to J.E.U.).	Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; ELBOUHDIDI A, 1994, PARASITE IMMUNOL, V16, P69, DOI 10.1111/j.1365-3024.1994.tb00325.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; MAUPIN P, 1994, J CELL SCI, V107, P3077; MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P661, DOI 10.1111/j.1365-3083.1986.tb02185.x; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rey M, 2002, J IMMUNOL, V169, P5410, DOI 10.4049/jimmunol.169.10.5410; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanborn KB, 2009, J IMMUNOL, V182, P6969, DOI 10.4049/jimmunol.0804337; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Young EJ, 2008, INFECTION, V36, P578, DOI 10.1007/s15010-008-8090-3	32	15	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20208	20216		10.1074/jbc.M113.453282	http://dx.doi.org/10.1074/jbc.M113.453282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720774	Green Published, hybrid			2022-12-25	WOS:000321715100010
J	Li, YR; Cai, WL; Wang, C; Yao, CF; Bao, XM; Deng, H; Girton, J; Johansen, J; Johansen, KM				Li, Yeran; Cai, Weili; Wang, Chao; Yao, Changfu; Bao, Xiaomin; Deng, Huai; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.			Domain Requirements of the JIL-1 Tandem Kinase for Histone H3 Serine 10 Phosphorylation and Chromatin Remodeling in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; H3S10 PHOSPHORYLATION; DOSAGE COMPENSATION; STATISTICAL-MODEL; MAP KINASE; DROSOPHILA; MSK1; PROTEINS; MEMBER	The JIL-1 kinase localizes to Drosophila polytene chromosome interbands and phosphorylates histone H3 at interphase, counteracting histone H3 lysine 9 dimethylation and gene silencing. JIL-1 can be divided into four main domains, including an NH2-terminal domain, two separate kinase domains, and a COOH-terminal domain. In this study, we characterize the domain requirements of the JIL-1 kinase for histone H3 serine 10 (H3S10) phosphorylation and chromatin remodeling in vivo. We show that a JIL-1 construct without the NH2-terminal domain is without H3S10 phosphorylation activity despite the fact that it localizes properly to polytene interband regions and that it contains both kinase domains. JIL-1 is a double kinase, and we demonstrate that both kinase domains of JIL-1 are required to be catalytically active for H3S10 phosphorylation to occur. Furthermore, we provide evidence that JIL-1 is phosphorylated at serine 424 and that this phosphorylation is necessary for JIL-1 H3S10 phosphorylation activity. Thus, these data are compatible with a model where the NH2-terminal domain of JIL-1 is required for chromatin complex interactions that position the kinase domain(s) for catalytic activity in the context of the state of higher order nucleosome packaging and chromatin structure and where catalytic H3S10 phosphorylation activity mediated by the first kinase domain is dependent on autophosphorylation of serine 424 by the second kinase domain. Furthermore, using a lacO repeat tethering system to target mutated JIL-1 constructs with or without catalytic activity, we show that the epigenetic H3S10 phosphorylation mark itself functions as a causative regulator of chromatin structure independently of any structural contributions from the JIL-1 protein.	[Li, Yeran; Cai, Weili; Wang, Chao; Yao, Changfu; Bao, Xiaomin; Deng, Huai; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, J (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Mol Biol Bldg, Ames, IA 50011 USA.	jorgen@iastate.edu; kristen@iastate.edu	Cai, Weili/B-7691-2013	Bao, Xiaomin/0000-0002-8845-5012	National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62916 (to K. M. J. and J. J.).	Bao XM, 2008, J BIOL CHEM, V283, P32741, DOI 10.1074/jbc.M806227200; Cai Weili, 2010, J Vis Exp, DOI 10.3791/1748; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Deng HA, 2010, GENETICS, V185, P1183, DOI 10.1534/genetics.110.117150; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Ji Y, 2005, J NEUROBIOL, V64, P157, DOI 10.1002/neu.20131; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 1999, CRIT REV EUKAR GENE, V9, P267, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.110; Johansen KM, 2009, METHODS, V48, P387, DOI 10.1016/j.ymeth.2009.02.019; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lerach S, 2005, GENESIS, V43, P213, DOI 10.1002/gene.20172; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sambrook J, 2001, MOL CLONING LAB MANU; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062484; Wang C, 2012, FLY, V6, P93, DOI 10.4161/fly.20029; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; Wang C, 2011, GENETICS, V188, P745, DOI 10.1534/genetics.111.129353; Wang CI, 2013, NAT STRUCT MOL BIOL, V20, P202, DOI 10.1038/nsmb.2477; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341	33	7	7	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19441	19449		10.1074/jbc.M113.464271	http://dx.doi.org/10.1074/jbc.M113.464271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23723094	Green Published, hybrid			2022-12-25	WOS:000321515800012
J	Anund, A; Fors, C; Hallvig, D; Akerstedt, T; Kecklund, G				Anund, Anna; Fors, Carina; Hallvig, David; Akerstedt, Torbjorn; Kecklund, Goran			Observer Rated Sleepiness and Real Road Driving: An Explorative Study	PLOS ONE			English	Article							FATIGUE	The aim of the present study was to explore if observer rated sleepiness (ORS) is a feasible method for quantification of driver sleepiness in field studies. Two measures of ORS were used: (1) one for behavioural signs based on facial expression, body gestures and body movements labelled B-ORS, and (2) one based on driving performance e. g. if swerving and other indicators of impaired driving occurs, labelled D-ORS. A limited number of observers sitting in the back of an experimental vehicle on a motorway about 2 hours repeatedly 3 times per day (before lunch, after lunch, at night) observed 24 participant's sleepiness level with help of the two observer scales. At the same time the participant reported subjective sleepiness (KSS), EOG was recorded (for calculation of blink duration) and several driving measure were taken and synchronized with the reporting. Based on mixed model Anova and correlation analysis the result showed that observer ratings of sleepiness based on drivers' impaired performance and behavioural signs are sensitive to extend the general pattern of time awake, circadian phase and time of driving. The detailed analysis of the subjective sleepiness and ORS showed weak correspondence on an individual level. Only 16% of the changes in KSS were predicted by the observer. The correlation between the observer ratings based on performance (D-ORS) and behavioural signs (B-ORS) are high (r = .588), and the B-ORS shows a moderately strong association (r = .360) with blink duration. Both ORS measures show an association (r>0.45) with KSS, whereas the association with driving performance is weak. The results show that the ORS-method detects the expected general variations in sleepy driving in field studies, however, sudden changes in driver sleepiness on a detailed level as 5 minutes is usually not detected; this holds true both when taking into account driving behaviour or driver behavioural signs.	[Anund, Anna; Fors, Carina; Hallvig, David] Swedish Rd & Transport Res Inst, Linkoping, Sweden; [Akerstedt, Torbjorn; Kecklund, Goran] Stress Res Inst, Stockholm, Sweden		Anund, A (corresponding author), Swedish Rd & Transport Res Inst, Linkoping, Sweden.	anna.anund@vti.se		Akerstedt, Torbjorn/0000-0001-8049-8504; Anund, Anna/0000-0002-4790-7094	VINNOVA, the Swedish Governmental Agency for Innovation Systems	VINNOVA, the Swedish Governmental Agency for Innovation Systems(Vinnova)	This work was supported by VINNOVA, the Swedish Governmental Agency for Innovation Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom C, 2013, TRANSPORT RES C-EMER, V26, P20, DOI 10.1016/j.trc.2012.07.008; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T., 2009, J SLEEP RES; Anund A, 2009, IND HLTH, V47, P1; Axelsson J, 2010, BMJ, V341; Campagne A, 2005, BIOL PSYCHOL, V68, P353, DOI 10.1016/j.biopsycho.2004.05.003; Dingus T. A., 2006, 810593 NHTSA DOT HS; Hallvig D, 2013, ACCIDENT ANAL PREV, V50, P44, DOI 10.1016/j.aap.2012.09.033; Hanowski RJ, 2003, ACCIDENT ANAL PREV, V35, P153, DOI 10.1016/S0001-4575(01)00098-7; Horne JA, 2004, PSYCHOPHYSIOLOGY, V41, P161, DOI 10.1046/j.1469-8986.2003.00130.x; Ingre M, 2006, J SLEEP RES, V15, P1; James B, 2008, SOMNOLOGIE, V12, P227; Klauer SG, 2006, 810594 NHTSA DOT HS; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Liu CC, 2009, J SAFETY RES, V40, P239, DOI 10.1016/j.jsr.2009.04.005; Mallis M, 2000, DTNH2293D07007; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Roge J, 2001, ACCIDENT ANAL PREV, V33, P181, DOI 10.1016/S0001-4575(00)00029-4; Sandberg D, 2011, INT TRANSP SYST ITSC; WIERWILLE WW, 1994, ACCIDENT ANAL PREV, V26, P571, DOI 10.1016/0001-4575(94)90019-1	21	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64782	10.1371/journal.pone.0064782	http://dx.doi.org/10.1371/journal.pone.0064782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155FM	23724094	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000095
J	Chirwa, T; Nyasulu, P; Chirwa, E; Ketlogetswe, A; Bello, G; Dambe, I; Ndalama, D; Joshua, M				Chirwa, Tobias; Nyasulu, Peter; Chirwa, Esnat; Ketlogetswe, Akeem; Bello, George; Dambe, Isiah; Ndalama, Dennis; Joshua, Martias			Levels of Tuberculosis Treatment Adherence among Sputum Smear Positive Pulmonary Tuberculosis Patients Attending Care at Zomba Central Hospital, Southern Malawi, 2007-2008	PLOS ONE			English	Article							TB TREATMENT; HIV; DETERMINANTS; PATTERNS; AFRICA	Background: Despite great efforts to control Tuberculosis (TB), progress is compromised by low adherence to medication, leading to prolonged duration of infectiousness and continued transmission. Investigating low adherence is of high importance from TB programmatic perspective. Though data on actual days of missed treatment exist, the effect of such on TB cure rates has not been investigated. Methods: TB operational research data were extracted for smear-positive pulmonary TB patients registered at Zomba Central hospital, Malawi from January 2007 to December 2008. Results: Of the 524 patients, 302 (57.6%) were males and 340 (64.9%) fully adhered to treatment. Excluding 5 individuals with missing data on cure, four hundred and eighty-one (92.7%) were cured of TB, and of these 162 (33.7%) missed at least one day of treatment. Respectively, 49/64 (76.6%) and 71/76 (93.4%) of those who missed treatment in the intensive and continuation phases were cured of TB (p = 0.005). The adjusted logistic regression analysis showed that those who missed 15-29 days of treatment (OR = 0.04, 95% CI: 0.01, 0.14) were less likely to be cured of TB compared with those who fully adhered. Conclusion: Treatment non-adherence was high and was observed even within the first 2 months of treatment. Thus, even at an earlier critical stage of treatment, simple algorithms need to be developed to identify and monitor patients at higher risk of non-adherence. Efforts on treatment compliance counselling should focus on enhanced counselling to improve adherence during the intensive treatment phase.	[Chirwa, Tobias; Nyasulu, Peter; Ketlogetswe, Akeem] Univ Witwatersrand Wits, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Chirwa, Esnat] Univ Malawi, Chancellor Coll, Dept Math Sci, Zomba, Malawi; [Bello, George; Dambe, Isiah] Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi; [Bello, George] Res Equity & Community Hlth REACH Trust, Lilongwe, Malawi; [Ndalama, Dennis; Joshua, Martias] Minist Hlth, Zomba Cent Hosp, Zomba, Malawi	University of Witwatersrand; University of Malawi	Chirwa, T (corresponding author), Univ Witwatersrand Wits, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa.	tobias.chirwa@wits.ac.za	Chirwa, Tobias/AAI-9087-2021	Chirwa, Esnat/0000-0003-0471-4978	University of the Witwatersrand Faculty of Health Sciences Individual Research Grant	University of the Witwatersrand Faculty of Health Sciences Individual Research Grant	The funding for this study was covered by the University of the Witwatersrand Faculty of Health Sciences Individual Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB TUB CONTR WHO R; Awofeso Niyi, 2008, Bull World Health Organ, V86, pB; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; CHIRWA T, 2005, SAJDEM, V10, P1, DOI DOI 10.1080/03768350500044065; Chirwa TF, 2009, J BIOPHARM STAT, V19, P190, DOI 10.1080/10543400802536248; Chirwa TF., 2006, SAJDEM, V9, P1; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; Cramm JM, 2010, PATIENT, V3, P159, DOI 10.2165/11531900-000000000-00000; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Frieden T, 2004, WHAT IS INTERMITTENT; Garner P, 2007, B WORLD HEALTH ORGAN, V85, P404, DOI 10.2471/BLT.06.035568; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Harries AD, 2001, B WORLD HEALTH ORGAN, V79, P329; Harries AD, 2011, HLTH CARE MANAG SCI; Harries AD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-593; Johansson E, 1999, INT J TUBERC LUNG D, V3, P862; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Kwanjana JH, 2001, MALAWI MED J, P13; Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838; Murray J, 2002, SIMHEALTH 808 TECHNO; Nyirenda M, 2006, INT J TUBERC LUNG D, V10, P585; Nyirenda Thomas, 2006, Malawi Med J, V18, P147; Population MoHa, 2002, NTP MANUAL; Population MoHa, 2008, NTP MANUAL; Rocha M, 2003, EUR RESPIR J, V21, P785, DOI 10.1183/09031936.03.00077302; Roy E, 2007, CURR MOL MED, V7, P373, DOI 10.2174/156652407780831557; Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; USAID, 2012, HLTH INF DIS TUB COU; World Health organization, 2010, MAN TUB TRAIN HLTH F; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63050	10.1371/journal.pone.0063050	http://dx.doi.org/10.1371/journal.pone.0063050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723972	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000005
J	Hilbert, T; Bongartz, J; Weisheit, C; Knufermann, P; Baumgarten, G; Hoeft, A; Poth, JM				Hilbert, Tobias; Bongartz, Josef; Weisheit, Christina; Knuefermann, Pascal; Baumgarten, Georg; Hoeft, Andreas; Poth, Jens M.			Beta(2)-Adrenoceptor Stimulation Suppresses TLR9-Dependent IFNA1 Secretion in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NATURAL-KILLER-CELLS; VIRAL-INFECTION; HUMAN MONOCYTES; BACTERIAL-DNA; CATECHOLAMINES; ACTIVATION; INDUCTION; TOLL-LIKE-RECEPTOR-9; BETA-ARRESTIN-2	Introduction: IFNA1 (interferon alpha) is a key cytokine regulating the activity of numerous immune cells. Plasmacytoid dendritic cells (pDCs) as natural interferon-producing cells play critical roles as sensors of pathogens and link innate to adaptive immunity. CpG motifs within DNA sequences activating toll-like receptor 9 (TLR9) are the main stimuli eliciting IFNA1 secretion from pDCs. Adrenergic substances are capable of differentially modulating the response from various immune cells. Hence, the aim of this study was to examine how adrenoceptor stimulation influences TLR9-induced IFNA1 secretion from human pDCs. Methods: PBMCs generated from human whole blood and pDCs enriched from buffy coats were stimulated with LPS and CpG-ODN 2336 in the presence or absence of epinephrine and different adrenoceptor antagonists. Secretion of TNF and IFNA1 was measured by ELISA. Flow cytometry was used to determine efficacy of pDC enrichment and adrenoceptor expression of PBMC subsets. The influence of modified IFNA1 secretion on NK cell activity was evaluated using a colorimetric tumor cell lysis assay. Results: TLR9-induced IFNA1 secretion as well as TLR4-induced TNF secretion from PBMCs was dose-dependently attenuated by coincubation with epinephrine. Combination with different specific adrenoceptor antagonists revealed that this effect was mediated by the adrenoceptor b2 (ADRB2). Since flow cytometric analysis could exclude the presence of ADRB2 on pDCs, highly enriched pDCs lacked any visible impact of adrenoceptor stimulation on TLR9-induced IFNA1 release. Combination of pDCs with PBMCs restored the effect, even when they were separated by a permeable membrane. Suppression of TLR9-mediated IFNA1 secretion from PBMCs by adrenoceptor stimulation reduced the lytic activity of NK cells on K562 tumor cells. Conclusion: We provide insights into the underlying mechanisms of the interrelation between immune responses and pharmacological agents widely used in clinical practice. Our results have implications for the future treatment of human patients, in which the endogenous immune response plays a pivotal role, such as during viral infections, inflammatory diseases and cancers.	[Hilbert, Tobias; Bongartz, Josef; Weisheit, Christina; Knuefermann, Pascal; Baumgarten, Georg; Hoeft, Andreas; Poth, Jens M.] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany	University of Bonn	Poth, JM (corresponding author), Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany.	thilbert@uni-bonn.de	Weisheit, Christina/V-2507-2018	Weisheit, Christina/0000-0002-7647-1613; Poth, Jens/0000-0003-2534-5382				Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Berggren O, 2012, ARTHRITIS RHEUM-US, V64, P3409, DOI 10.1002/art.34599; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Coch C, 2009, J LEUKOCYTE BIOL, V86, P663, DOI 10.1189/jlb.0509314; Collado-Hidalgo A, 2006, BRAIN BEHAV IMMUN, V20, P552, DOI 10.1016/j.bbi.2006.01.005; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Farid SG, 2010, ANN SURG, V251, P91, DOI 10.1097/SLA.0b013e3181bfda3c; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flierl MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004414; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; HELLSTRAND K, 1985, J IMMUNOL, V134, P4095; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Janke M, 2009, J ALLERGY CLIN IMMUN, V123, P1026, DOI 10.1016/j.jaci.2009.02.015; Kizaki T, 2008, IMMUNOLOGY, V124, P348, DOI 10.1111/j.1365-2567.2007.02781.x; Kizaki T, 2009, MOL IMMUNOL, V46, P1195, DOI 10.1016/j.molimm.2008.11.005; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Laurent C, 2006, J AM COLL SURGEONS, V203, P684, DOI 10.1016/j.jamcollsurg.2006.07.021; Li CY, 2003, ANESTH ANALG, V96, P518, DOI 10.1097/00000539-200302000-00040; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Martinet J, 2012, GASTROENTEROLOGY, V143, P1586, DOI 10.1053/j.gastro.2012.08.046; Pinto A, 2012, ONCOIMMUNOLOGY, V1, P726, DOI 10.4161/onci.20171; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Poth JM, 2010, J IMMUNOL, V185, P7367, DOI 10.4049/jimmunol.1001798; PROSS HF, 1981, J CLIN IMMUNOL, V1, P51, DOI 10.1007/BF00915477; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Takahashi HK, 2004, J NEUROIMMUNOL, V151, P137, DOI 10.1016/j.jneuroim.2004.03.001; Takeuchi H, 2010, WORLD J SURG, V34, P277, DOI 10.1007/s00268-009-0331-9; Tan HJ, 2012, J UROLOGY, V187, P60, DOI 10.1016/j.juro.2011.09.031; Tsujimoto H, 2009, ANN SURG ONCOL, V16, P311, DOI 10.1245/s10434-008-0249-8; Wahle M, 2005, J INTERF CYTOK RES, V25, P384, DOI 10.1089/jir.2005.25.384; Wang W, 2009, ACTA PHARMACOL SIN, V30, P1522, DOI 10.1038/aps.2009.153; WEST WH, 1977, J IMMUNOL, V118, P355	39	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65024	10.1371/journal.pone.0065024	http://dx.doi.org/10.1371/journal.pone.0065024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724117	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000114
J	Kishikawa, J; Ibuki, T; Nakamura, S; Nakanishi, A; Minamino, T; Miyata, T; Namba, K; Konno, H; Ueno, H; Imada, K; Yokoyama, K				Kishikawa, Jun-ichi; Ibuki, Tatsuya; Nakamura, Shuichi; Nakanishi, Astuko; Minamino, Tohru; Miyata, Tomoko; Namba, Keiichi; Konno, Hiroki; Ueno, Hiroshi; Imada, Katsumi; Yokoyama, Ken			Common Evolutionary Origin for the Rotor Domain of Rotary Atpases and Flagellar Protein Export Apparatus	PLOS ONE			English	Article							V-ATPASE; THERMUS-THERMOPHILUS; CENTRAL STALK; CRYSTAL-STRUCTURE; SUBUNIT; ROTATION; HYDROLYSIS; MECHANISM; COMPLEX	The V-1-and F-1-rotary ATPases contain a rotor that rotates against a catalytic A(3)B(3) or alpha(3)beta(3) stator. The rotor F-1-gamma or V-1-DF is composed of both anti-parallel coiled coil and globular-loop parts. The bacterial flagellar type III export apparatus contains a V-1/F-1-like ATPase ring structure composed of FliI6 homo-hexamer and FliJ which adopts an anti-parallel coiled coil structure without the globular-loop part. Here we report that FliJ of Salmonella enterica serovar Typhimurium shows a rotor like function in Thermus thermophilus A(3)B(3) based on both biochemical and structural analysis. Single molecular analysis indicates that an anti-parallel coiled-coil structure protein (FliJ structure protein) functions as a rotor in A(3)B(3). A rotary ATPase possessing an F-1-gamma-like protein generated by fusion of the D and F subunits of V-1 rotates, suggesting F-1-gamma could be the result of a fusion of the genes encoding two separate rotor subunits. Together with sequence comparison among the globular part proteins, the data strongly suggest that the rotor domains of the rotary ATPases and the flagellar export apparatus share a common evolutionary origin.	[Kishikawa, Jun-ichi; Nakanishi, Astuko; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 603, Japan; [Ibuki, Tatsuya; Nakamura, Shuichi; Minamino, Tohru; Miyata, Tomoko; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Nakamura, Shuichi] Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Namba, Keiichi] Riken Quantitat Biol Ctr, Osaka, Japan; [Konno, Hiroki] Kanazawa Univ, BioAFM Frontier Res Ctr, Imaging Res Div, Kanazawa, Ishikawa, Japan; [Ueno, Hiroshi] Chuo Univ, Dept Phys, Fac Sci & Engn, Bunkyo Ku, Tokyo 112, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 560, Japan	Kyoto Sangyo University; Osaka University; Tohoku University; Japan Science & Technology Agency (JST); RIKEN; Kanazawa University; Chuo University; Osaka University	Imada, K (corresponding author), Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 560, Japan.	kimada@chem.sci.osaka-u.ac.jp; yokoken@cc.kyoto-su.ac.jp	Yokoyama, Ken/AAJ-3582-2020; Namba, Keiichi/A-9406-2016	Yokoyama, Ken/0000-0002-6813-1096; Nakamura, Shuichi/0000-0003-3972-7779; Imada, Katsumi/0000-0003-1342-8885; Kishikawa, Jun-ichi/0000-0003-3913-7330	Ministry of Education, Science, Sports and Culture of Japan [21370042, 24370059, 18074006]; Targeted Proteins Research Program (TPRP) [B-37, FBA1]; Grants-in-Aid for Scientific Research [24570131] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 21370042 and 24370059 to KY, and 18074006 to KI), Targeted Proteins Research Program (TPRP) (B-37, to KY and FBA1 to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2006, J BIOL CHEM, V281, P38582, DOI 10.1074/jbc.M608253200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lorenzini E, 2010, J BACTERIOL, V192, P2746, DOI 10.1128/JB.01479-09; Ludtke SJ, 2003, J STRUCT BIOL, V144, P73, DOI 10.1016/j.jsb.2003.10.012; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	26	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64695	10.1371/journal.pone.0064695	http://dx.doi.org/10.1371/journal.pone.0064695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724081	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000082
J	Kohler, S				Kohler, Stefan			More Fair Play in an Ultimatum Game after Resettlement in Zimbabwe: A Field Experiment and a Structural Model	PLOS ONE			English	Article							SOCIAL DISTANCE; LAND-REFORM; DICTATOR; ANONYMITY; ALTRUISM; BEHAVIOR; AVERSION; EQUITY; AREAS	Zimbabwean villagers of distinct background have resettled in government-organized land reforms for more than three decades. Against this backdrop, I assess the level of social cohesion in some of the newly established communities by estimating the average preferences for fairness in a structural model of bounded rationality. The estimations are based on behavioral data from an ultimatum game field experiment played by 234 randomly selected households in 6 traditional and 14 resettled villages almost two decades after resettlement. Equal or higher degrees of fairness are estimated in all resettlement schemes. In one, or arguably two, out of three distinct resettlement schemes studied, the resettled villagers exhibit significantly higher degrees of fairness (p <= 0.11) and rationality (p <= 0.04) than those who live in traditional villages. Overall, villagers appear similarly rational, but the attitude toward fairness is significantly stronger in resettled communities (p <= 0.01). These findings are consistent with the idea of an increased need for cooperation required in recommencement.	Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kohler, S (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	stefan.kohler@charite.de	Kohler, Stefan/GPT-0877-2022	Kohler, Stefan/0000-0003-1365-7506	European University Institute; German Academic Exchange Service	European University Institute; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	SK gratefully acknowledges the financial support provided by the European University Institute and the German Academic Exchange Service at an early stage of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SP, 1998, J PUBLIC ECON, V70, P297, DOI 10.1016/S0047-2727(98)00035-8; Barr A, 2004, WORLD DEV, V32, P1753, DOI 10.1016/j.worlddev.2004.06.007; Barr A, 2003, ECON J, V113, P614, DOI 10.1111/1468-0297.t01-1-00150; Barr A, 2009, U OXFORD EC SERIES W, V422; Barr A., 2004, FDN HUMAN SOCIALITY, P305, DOI [10.1093/0199262055.003.0010, DOI 10.1093/0199262055.003.0010]; Bellemare C, 2008, ECONOMETRICA, V76, P815, DOI 10.1111/j.1468-0262.2008.00860.x; Bezu S, 2013, 113 CLTS NORW U LIF; Bohnet I, 1999, AM ECON REV, V89, P335, DOI 10.1257/aer.89.1.335; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Burnham TC, 2003, J ECON BEHAV ORGAN, V50, P133, DOI 10.1016/S0167-2681(02)00044-6; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; De Bruyn A, 2008, MANAGE SCI, V54, P1774, DOI 10.1287/mnsc.1080.0887; Deininger K, 2004, WORLD DEV, V32, P1697, DOI 10.1016/j.worlddev.2004.06.006; Dekker M, 2004, WORLD DEV, V32, P1735, DOI 10.1016/j.worlddev.2004.06.002; Dekker M, 2004, THESIS TINBERGEN I A; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Goeree JK, 2000, EUR ECON REV, V44, P1079, DOI 10.1016/S0014-2921(99)00048-3; Gunning JW, 2000, J DEV STUD, V36, P131, DOI 10.1080/00220380008422657; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hoogeveen JGM, 2001, J S AFR STUD, V27, P127, DOI 10.1080/03057070120029536; Kinsey B, 1998, WORLD DEV, V26, P89, DOI 10.1016/S0305-750X(97)00124-1; Kinsey BH, 1999, J S AFR STUD, V25, P173, DOI 10.1080/030570799108650; Kinsey BH, 2004, WORLD DEV, V32, P1669, DOI 10.1016/j.worlddev.2004.06.005; Kinsey BH, 1999, DETERMINANTS RURAL H; Kohler S., 2008, GAMES RATIONALITY BE, P63; Kohler S, 2011, J ECON BEHAV ORGAN, V80, P101, DOI 10.1016/j.jebo.2011.02.014; Lind E. A., 1988, SOCIAL PSYCHOL PROCE; Mandel DR, 2006, J CONFLICT RESOLUT, V50, P584, DOI 10.1177/0022002706290432; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Offerman T. A. S., 1998, EUROPEAN J POLITICAL, V14, P89, DOI [10.1016/S0176-2680(97)00044-X, DOI 10.1016/S0176-2680(97)00044-X]; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Parks JM, 1996, ORGAN BEHAV HUM DEC, V67, P181, DOI 10.1006/obhd.1996.0073; Scoones I., 2010, ZIMBABWES LAND REFOR; Singer MS, 1998, BRIT J PSYCHOL, V89, P663, DOI 10.1111/j.2044-8295.1998.tb02709.x; Voice of America, 2009, VOANEWS; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009; Yi KO, 2005, GAME ECON BEHAV, V51, P324, DOI 10.1016/S0899-8256(03)00051-4	40	0	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64791	10.1371/journal.pone.0064791	http://dx.doi.org/10.1371/journal.pone.0064791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155FM	23724095	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000096
J	Korecka, JA; van Kesteren, RE; Blaas, E; Spitzer, SO; Kamstra, JH; Smit, AB; Swaab, DF; Verhaagen, J; Bossers, K				Korecka, Joanna A.; van Kesteren, Ronald E.; Blaas, Eva; Spitzer, Sonia O.; Kamstra, Jorke H.; Smit, August B.; Swaab, Dick F.; Verhaagen, Joost; Bossers, Koen			Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; NIGRA PARS COMPACTA; MIDBRAIN DOPAMINERGIC-NEURONS; SPORADIC PARKINSONS-DISEASE; GENE-EXPRESSION; SUBSTANTIA-NIGRA; RECEPTOR SUBUNITS; UBIQUITIN-PROTEASOME; SYMPATHETIC NEURONS; OXIDATIVE STRESS	Multiple genetic and environmental factors play a role in the development and progression of Parkinson's disease (PD). The main neuropathological hallmark of PD is the degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta. To study genetic and molecular contributors to the disease process, there is a great need for readily accessible cells with prominent DAergic features that can be used for reproducible in vitro cellular screening. Here, we investigated the molecular phenotype of retinoic acid (RA) differentiated SH-SY5Y cells using genome wide transcriptional profiling combined with gene ontology, transcription factor and molecular pathway analysis. We demonstrated that RA induces a general neuronal differentiation program in SH-SY5Y cells and that these cells develop a predominantly mature DAergic-like neurotransmitter phenotype. This phenotype is characterized by increased dopamine levels together with a substantial suppression of other neurotransmitter phenotypes, such as those for noradrenaline, acetylcholine, glutamate, serotonin and histamine. In addition, we show that RA differentiated SH-SY5Y cells express the dopamine and noradrenalin neurotransmitter transporters that are responsible for uptake of MPP(+), a well known DAergic cell toxicant. MPP(+) treatment alters mitochondrial activity according to its proposed cytotoxic effect in DAergic neurons. Taken together, RA differentiated SH-SY5Y cells have a DAergic-like phenotype, and provide a good cellular screening tool to find novel genes or compounds that affect cytotoxic processes that are associated with PD.	[Korecka, Joanna A.; Spitzer, Sonia O.; Verhaagen, Joost; Bossers, Koen] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroregenerat, Amsterdam, Netherlands; [van Kesteren, Ronald E.; Blaas, Eva; Smit, August B.; Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Kamstra, Jorke H.] Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands; [Swaab, Dick F.] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuropsychiat Disorders, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Korecka, JA (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroregenerat, Amsterdam, Netherlands.	j.korecka@nin.knaw.nl	Bossers, Koen/I-4002-2013; van Kesteren, Ronald E/E-2505-2014; Verhaagen, Joost/G-4773-2012; Kamstra, Jorke/K-9533-2013	van Kesteren, Ronald/0000-0002-9592-3777; Swaab, Dick/0000-0002-9665-7845; Bossers, Koen/0000-0002-0272-4518; Kamstra, Jorke/0000-0001-7984-0229	Top Institute Pharma [T5-207]; Leiden, The Netherlands; Stichting Internationaal Parkinson Fonds, The Netherlands	Top Institute Pharma; Leiden, The Netherlands; Stichting Internationaal Parkinson Fonds, The Netherlands	The authors wish to thank Top Institute Pharma (grant number T5-207), Leiden, The Netherlands (www.tipharma.com) and Stichting Internationaal Parkinson Fonds, The Netherlands (www.parkinsonfonds.nl) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 1999, NEUROSCIENCE, V89, P209, DOI 10.1016/S0306-4522(98)00328-5; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonifati V, 2007, PARKINSONISM RELAT D, V13, pS233, DOI 10.1016/S1353-8020(08)70008-7; Bossers K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-112; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brill LB, 2003, EXP NEUROL, V181, P25, DOI 10.1016/S0014-4886(02)00045-6; Bustos G, 2004, BRAIN RES REV, V47, P126, DOI 10.1016/j.brainresrev.2004.05.002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Conn KJ, 2003, NEUROCHEM RES, V28, P1873, DOI 10.1023/A:1026179926780; Cuende J, 2008, ONCOGENE, V27, P3339, DOI 10.1038/sj.onc.1210987; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Ding QX, 2004, FREE RADICAL BIO MED, V36, P445, DOI 10.1016/j.freeradbiomed.2003.10.025; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ernsberger U, 2000, EUR J BIOCHEM, V267, P6976, DOI 10.1046/j.1432-1327.2000.01827.x; GEFFARD M, 1984, BRAIN RES, V294, P161, DOI 10.1016/0006-8993(84)91323-4; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kito K, 1997, GENE, V184, P73, DOI 10.1016/S0378-1119(96)00577-X; Kurimoto K, 2010, CURR OPIN GENET DEV, V20, P470, DOI 10.1016/j.gde.2010.06.003; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; Mena-Segovia J, 2008, BRAIN RES REV, V58, P265, DOI 10.1016/j.brainresrev.2008.02.003; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miloso M, 2004, J NEUROSCI RES, V75, P241, DOI 10.1002/jnr.10848; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nakamura K, 2000, MOL PHARMACOL, V58, P271, DOI 10.1124/mol.58.2.271; Nicotra A, 2002, NEUROTOXICOL TERATOL, V24, P599, DOI 10.1016/S0892-0362(02)00213-1; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; Okada H, 2004, J NEUROCHEM, V89, P7, DOI 10.1111/j.1471-4159.2004.02271.x; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Paquet M, 1997, J NEUROSCI, V17, P1377; Pifl C, 1996, J PHARMACOL EXP THER, V277, P1437; ROSSINO P, 1991, CELL REGUL, V2, P1021, DOI 10.1091/mbc.2.12.1021; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schoffelmeer ANM, 2011, J NEUROSCI, V31, P1284, DOI 10.1523/JNEUROSCI.3779-10.2011; Schwarzer C, 2001, J COMP NEUROL, V433, P526, DOI 10.1002/cne.1158; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Truckenmiller ME, 2001, RESTOR NEUROL NEUROS, V18, P67; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verney C, 2003, J CHEM NEUROANAT, V26, P283, DOI 10.1016/j.jchemneu.2003.08.002; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Winther M, 2012, INT J BIOCHEM CELL B, V44, P441, DOI 10.1016/j.biocel.2011.11.020; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x	68	149	150	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63862	10.1371/journal.pone.0063862	http://dx.doi.org/10.1371/journal.pone.0063862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724009	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000031
J	Kuhlhorn, F; Rath, M; Schmoeckel, K; Cziupka, K; Nguyen, HH; Hildebrandt, P; Hunig, T; Sparwasser, T; Huehn, J; Potschke, C; Broker, BM				Kuehlhorn, Franziska; Rath, Matthias; Schmoeckel, Katrin; Cziupka, Katharina; Huu Hung Nguyen; Hildebrandt, Petra; Huenig, Thomas; Sparwasser, Tim; Huehn, Jochen; Poetschke, Christian; Broeker, Barbara M.			Foxp3(+) Regulatory T Cells Are Required for Recovery from Severe Sepsis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TGF-BETA; MEDIATED SUPPRESSION; POLYMICROBIAL SEPSIS; IMPROVES SURVIVAL; ADOPTIVE TRANSFER; INFECTED MICE; IN-VIVO; CD4(+)CD25(+); CD4(+)	The role of regulatory T cells (Tregs) in bacterial sepsis remains controversial because antibody-mediated depletion experiments gave conflicting results. We employed DEREG mice (DEpletion of REGulatory T cells) and a caecal ligation and puncture model to elucidate the role of CD4(+) Foxp3(+) Tregs in sepsis. In DEREG mice natural Tregs can be visualized easily and selectively depleted by diphtheria toxin because the animals express the diphtheria toxin receptor and enhanced green fluorescent protein as a fusion protein under the control of the foxp3 locus. We confirmed rapid Treg-activation and an increased ratio of Tregs to Teffs in sepsis. Nevertheless, 24 h after sepsis induction, Treg-depleted and control mice showed equally strong inflammation, immune cell immigration into the peritoneum and bacterial dissemination. During the first 36 h of disease survival was not influenced by Treg-depletion. Later, however, only Treg-competent animals recovered from the insult. We conclude that the suppressive capacity of Tregs is not sufficient to control overwhelming inflammation and early mortality, but is a prerequisite for the recovery from severe sepsis.	[Kuehlhorn, Franziska; Rath, Matthias; Schmoeckel, Katrin; Huu Hung Nguyen; Poetschke, Christian; Broeker, Barbara M.] Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Cziupka, Katharina] Univ Med Greifswald, Dept Surg, Greifswald, Germany; [Hildebrandt, Petra] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Braunschweig, Germany	Greifswald Medical School; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Broker, BM (corresponding author), Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany.	broeker@uni-greifswald.de	Sparwasser, Tim D/AAA-4306-2022; Bröker, Barbara M/O-4850-2015; Nguyen, Huu-Hung/GYJ-6241-2022; Sparwasser, Tim/AAF-7085-2019	Bröker, Barbara M/0000-0002-5020-8542; Sparwasser, Tim/0000-0001-5645-902X	Deutsche Forschungsgemeinschaft [GRK 840]; Gerhard Domagk Scholarship from the University Medicine, Greifswald; Ministry of Education on Training, Vietnam; TheraMab LLC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gerhard Domagk Scholarship from the University Medicine, Greifswald; Ministry of Education on Training, Vietnam; TheraMab LLC	This work was financially supported by the Deutsche Forschungsgemeinschaft (GRK 840). Franziska Kuhlhorn and Matthias Rath received a Gerhard Domagk Scholarship from the University Medicine, Greifswald. Huu Hung Nguyen received funding by the Ministry of Education on Training, Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Thomas Hunig was paid for consultancies and holds stock options from TheraMab LLC. All other authors declare no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Beres AJ, 2012, J IMMUNOL, V189, P464, DOI 10.4049/jimmunol.1200886; Busse M, 2008, GUT, V57, P188, DOI 10.1136/gut.2007.121616; Cavassani KA, 2010, BLOOD, V115, P4403, DOI 10.1182/blood-2009-09-241083; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Dai J, 2009, INT IMMUNOPHARMACOL, V9, P528, DOI 10.1016/j.intimp.2009.01.027; Demengeot J, 2006, SPRINGER SEMIN IMMUN, V28, P41, DOI 10.1007/s00281-006-0024-5; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; Hahn BH, 2005, J IMMUNOL, V175, P7728, DOI 10.4049/jimmunol.175.11.7728; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Leithauser F, 2006, AM J PATHOL, V168, P1898, DOI 10.2353/ajpath.2006.050228; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marshall JC, 2004, MICROBES INFECT, V6, P1015, DOI 10.1016/j.micinf.2004.05.017; Martignoni A, 2008, SHOCK, V29, P591, DOI 10.1097/SHK.0b013e318157f427; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Nakagawa T, 2010, INT IMMUNOL, V22, P129, DOI 10.1093/intimm/dxp119; Nicolson KS, 2006, J IMMUNOL, V176, P5329, DOI 10.4049/jimmunol.176.9.5329; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Put S, 2012, BLOOD, V119, P1316, DOI 10.1182/blood-2011-11-391755; Reim D, 2009, SHOCK, V31, P245, DOI 10.1097/SHK.0b013e31817fd02c; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Saito K, 2008, TOHOKU J EXP MED, V216, P61, DOI 10.1620/tjem.216.61; Sawamukai N, 2012, BLOOD, V119, P5575, DOI 10.1182/blood-2011-07-367987; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh KP, 2005, IMMUNOLOGY, V114, P410, DOI 10.1111/j.1365-2567.2004.02083.x; Slade E, 2003, CRIT CARE, V7, P1, DOI 10.1186/cc1876; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Suvas S, 2006, CURR OPIN IMMUNOL, V18, P344, DOI 10.1016/j.coi.2006.03.005; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; van Maren WWC, 2008, IMMUNOLOGY, V124, P445, DOI 10.1111/j.1365-2567.2008.02871.x; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wraith DC, 2004, CURR OPIN IMMUNOL, V16, P695, DOI 10.1016/j.coi.2004.09.015; Xia CQ, 2007, DIABETES, V56, P2116, DOI 10.2337/db06-0825; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998; Zeng MH, 2009, TRANSPL IMMUNOL, V22, P82, DOI 10.1016/j.trim.2009.07.004; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	79	35	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65109	10.1371/journal.pone.0065109	http://dx.doi.org/10.1371/journal.pone.0065109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724126	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000119
J	Lachance, C; Segura, M; Gerber, PP; Xu, JG; Gottschalk, M				Lachance, Claude; Segura, Mariela; Gerber, Pehuen Pereyra; Xu, Jianguo; Gottschalk, Marcelo			Toll-Like Receptor 2-Independent Host Innate Immune Response against an Epidemic Strain of Streptococcus suis That Causes a Toxic Shock-Like Syndrome in Humans	PLOS ONE			English	Article							LIPOTEICHOIC ACID LTA; SEQUENCE TYPE-7; ZOONOTIC AGENT; INFLAMMATORY RESPONSE; MOUSE MODEL; PATHOGEN; RECOGNITION; SEROTYPE-2; VIRULENCE; LIPOPROTEINS	Streptococcus suis is an emerging zoonotic agent causing meningitis and septicemia. Outbreaks in humans in China with atypical cases of streptococcal toxic shock-like syndrome have been described to be caused by a clonal epidemic S. suis strain characterized as sequence type (ST) 7 by multilocus sequence typing, different from the classical ST1 usually isolated in Europe. Previous in vitro studies showed that Toll-like receptor (TLR) 2 plays a major role in S. suis ST1 interactions with host cells. In the present study, the in vivo role of TLR2 in systemic infections caused by S. suis ST1 or ST7 strains using TLR2 deficient (TLR2(-/-)) mice was evaluated. TLR2-mediated recognition significantly contributes to the acute disease caused by the highly virulent S. suis ST1 strain, since the TLR2(-/-) mice remained unaffected when compared to wild type (WT) mice. The lack of mortality could not be associated with a lower bacterial burden; however, a significant decrease in the induction of pro-inflammatory mediators, as evaluated by microarray, real-time PCR and protein assays, was observed. On the other hand, TLR2(-/-) mice infected with the epidemic ST7 strain presented no significant differences regarding survival and expression of pro-inflammatory mediators when compared to the WT mice. Together, these results show a TLR2-independent host innate immune response to S. suis that depends on the strain.	[Lachance, Claude; Segura, Mariela; Gerber, Pehuen Pereyra; Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, St Hyacinthe, PQ J2S 7C6, Canada; [Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Universite de Montreal; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gottschalk, M (corresponding author), Univ Montreal, Fac Vet Med, St Hyacinthe, PQ J2S 7C6, Canada.	marcelo.gottschalk@umontreal.ca	Segura, Mariela/AAG-5708-2020; Lachance, Claude/A-4214-2012; Gottschalk, Marcelo/I-8116-2012	Lachance, Claude/0000-0002-1974-1787; 	Natural Sciences and Engineering Research Council of Canada [154280, 380299]; Canadian Institutes of Health Research; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This work was supported by Natural Sciences and Engineering Research Council of Canada (grant # 154280 and DAS # 380299) and Canadian Institutes of Health Research (to MG). CL is the recipient of a Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) postdoctoral fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Echchannaoui H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-25; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Gottschalk M., 2012, DIS SWINE, VIn Straw B; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Lachance C, 2013, INFECT IMMUN; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Segura M, 2012, CAN J MICROBIOL, V58, P249, DOI [10.1139/w2012-003, 10.1139/W2012-003]; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Zheng H, 2008, CLIN EXP IMMUNOL, V153, P385, DOI 10.1111/j.1365-2249.2008.03722.x; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014; Zheng H, 2011, J NEUROIMMUNOL, V234, P71, DOI 10.1016/j.jneuroim.2011.02.005	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65031	10.1371/journal.pone.0065031	http://dx.doi.org/10.1371/journal.pone.0065031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724118	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000115
J	Bao, LQ; Huy, NT; Kikuchi, M; Yanagi, T; Senba, M; Shuaibu, MN; Honma, K; Yui, K; Hirayama, K				Lam Quoc Bao; Nguyen Tien Huy; Kikuchi, Mihoko; Yanagi, Tetsuo; Senba, Masachika; Shuaibu, Mohammed Nasir; Honma, Kiri; Yui, Katsuyuki; Hirayama, Kenji			CD19(+) B Cells Confer Protection against Experimental Cerebral Malaria in Semi-Immune Rodent Model	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLASMODIUM-BERGHEI-ANKA; CD4(+) T-CELLS; IFN-GAMMA; INTERFERON-GAMMA; IL-10 PRODUCTION; PARASITE BURDEN; NKT CELLS; DISEASE; RESPONSES	In African endemic area, adults are less vulnerable to cerebral malaria than children probably because of acquired partial immunity or semi-immune status. Here, we developed an experimental cerebral malaria (ECM) model for semi-immune mice. C57BL/6 (B6) mice underwent one, two and three cycles of infection and radical treatment (1-cure, 2-cure and 3-cure, respectively) before being finally challenged with 10(4) Plasmodium berghei ANKA without treatment. Our results showed that 100% of naive (0-cure), 67% of 1-cure, 37% of 2-cure and none of 3-cure mice succumbed to ECM within 10 days post challenge infection. In the protected 3-cure mice, significantly higher levels of plasma IL-10 and lower levels of IFN-gamma than the others on day 7 post challenge infection were observed. Major increased lymphocyte subset of IL-10 positive cells in 3-cure mice was CD5(-)CD19(+) B cells. Passive transfer of splenic CD19(+) cells from 3-cure mice protected naive mice from ECM. Additionally, aged 3-cure mice were also protected from ECM 12 and 20 months after the last challenge infection. In conclusion, mice became completely resistant to ECM after three exposures to malaria. CD19(+) B cells are determinants in protective mechanism of semi-immune mice against ECM possibly via modulatory IL-10 for pathogenic IFN-gamma production.	[Lam Quoc Bao; Nguyen Tien Huy; Shuaibu, Mohammed Nasir; Hirayama, Kenji] Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki 852, Japan; [Kikuchi, Mihoko] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki 852, Japan; [Yanagi, Tetsuo] Nagasaki Univ, Inst Trop Med, Anim Res Ctr Trop Infect, Nagasaki 852, Japan; [Senba, Masachika] Nagasaki Univ, Dept Pathol, Inst Trop Med, Nagasaki 852, Japan; [Honma, Kiri; Yui, Katsuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Lam Quoc Bao; Shuaibu, Mohammed Nasir; Yui, Katsuyuki; Hirayama, Kenji] Nagasaki Univ, Global Ctr Excellence GCOE, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Huy, NT (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki 852, Japan.	tienhuy@nagasaki-u.ac.jp; hiraken@nagasaki-u.ac.jp	Huy, Nguyen Tien/B-2573-2010; Hirayama, Kenji/AAN-7065-2021	Huy, Nguyen Tien/0000-0002-9543-9440; Shuaibu, Mohammed Nasir/0000-0002-1442-140X; Lam, Bao/0000-0003-1252-009X; Hirayama, Kenji/0000-0001-9467-1777	Global COE Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [17301870]	Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	LQB is a recipient of Ph.D. scholarship from the Global COE Program (2009-2013). This work was supported in part by a "Grand-in-Aid for Young Scientists" (17301870, 2008-2009 for NTH) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by Global COE Program for KH (2008-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 1998, INFECT IMMUN, V66, P4093; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; [Anonymous], 11 NIH FOG INT CTR; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bouabe H, 2011, J IMMUNOL, V187, P3165, DOI 10.4049/jimmunol.1101477; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; ERUNKULU OA, 1992, CLIN EXP IMMUNOL, V89, P296, DOI 10.1111/j.1365-2249.1992.tb06948.x; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; GORDEUK V, 1992, NEW ENGL J MED, V327, P1473, DOI 10.1056/NEJM199211193272101; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; Groux H, 1997, CD4 T CELL SUBSET IN; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hansen DS, 2005, INFECT IMMUN, V73, P2288, DOI 10.1128/IAI.73.4.2288-2297.2005; Hanum S, 2003, INT IMMUNOL, V15, P633, DOI 10.1093/intimm/dxg065; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Helegbe GK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-91; Herfarth H, 2002, GUT, V50, P146, DOI 10.1136/gut.50.2.146; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Ikome Lois E, 2002, Afr J Health Sci, V9, P61; Jeong YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046553; Knodler A, 2009, LEUKEMIA, V23, P535, DOI 10.1038/leu.2008.301; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lackner P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-36; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Manrique SZ, 2011, J EXP MED, V208, P1485, DOI 10.1084/jem.20100730; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Matsushita T, 2006, AM J PATHOL, V168, P812, DOI 10.2353/ajpath.2006.050923; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; MILOSEVITS J, 1995, SCAND J IMMUNOL, V42, P493, DOI 10.1111/j.1365-3083.1995.tb03685.x; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Noh Joonyong, 2010, Immune Netw, V10, P247, DOI 10.4110/in.2010.10.6.247; Nunes JK, 2009, INFECT IMMUN, V77, P414, DOI 10.1128/IAI.00982-08; Oh SJ, 2011, J IMMUNOL, V186, P6815, DOI 10.4049/jimmunol.1003916; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Plebanski M, 1999, IMMUNITY, V10, P651, DOI 10.1016/S1074-7613(00)80064-3; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarfo BY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-69; Scapini P, 2011, P NATL ACAD SCI USA, V108, pE823, DOI 10.1073/pnas.1107913108; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Shibui A, 2009, PARASITOL RES, V105, P281, DOI 10.1007/s00436-009-1435-8; Sindhava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011445; Specht S, 2010, MICROBES INFECT, V12, P635, DOI 10.1016/j.micinf.2010.04.006; Srivastava K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010413; Thuma PE, 2011, J INFECT DIS, V203, P211, DOI 10.1093/infdis/jiq041; Tung JW, 2001, BMC MOL BIOL, V2; Turner GDH, 1998, AM J PATHOL, V152, P1477; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Watanabe R, 2007, AM J PATHOL, V171, P560, DOI 10.2353/ajpath.2007.061279; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	95	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64836	10.1371/journal.pone.0064836	http://dx.doi.org/10.1371/journal.pone.0064836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724100	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000100
J	Robertson, OJ; McAlpine, C; House, A; Maron, M				Robertson, Oliver J.; McAlpine, Clive; House, Alan; Maron, Martine			Influence of Interspecific Competition and Landscape Structure on Spatial Homogenization of Avian Assemblages	PLOS ONE			English	Article							GAP-CROSSING DECISIONS; BIOTIC HOMOGENIZATION; BIRD COMMUNITIES; LAND-USE; FUNCTIONAL HOMOGENIZATION; BRIGALOW BELT; AUSTRALIA; FOREST; CONSERVATION; DISTURBANCE	Human-induced biotic homogenization resulting from landscape change and increased competition from widespread generalists or ` winners', is widely recognized as a global threat to biodiversity. However, it remains unclear what aspects of landscape structure influence homogenization. This paper tests the importance of interspecific competition and landscape structure, for the spatial homogeneity of avian assemblages within a fragmented agricultural landscape of eastern Australia. We used field observations of the density of 128 diurnal bird species to calculate taxonomic and functional similarity among assemblages. We then examined whether taxonomic and functional similarity varied with patch type, the extent of woodland habitat, land-use intensity, habitat subdivision, and the presence of Manorina colonies (a competitive genus of honeyeaters). We found the presence of a Manorina colony was the most significant factor positively influencing both taxonomic and functional similarity of bird assemblages. Competition from members of this widespread genus of native honeyeater, rather than landscape structure, was the main cause of both taxonomic and functional homogenization. These species have not recently expanded their range, but rather have increased in density in response to agricultural landscape change. The negative impacts of Manorina honeyeaters on assemblage similarity were most pronounced in landscapes of moderate land-use intensity. We conclude that in these human-modified landscapes, increased competition from dominant native species, or 'winners', can result in homogeneous avian assemblages and the loss of specialist species. These interacting processes make biotic homogenization resulting from land-use change a global threat to biodiversity in modified agro-ecosystems.	[Robertson, Oliver J.; McAlpine, Clive; Maron, Martine] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [House, Alan] Ecosure, W Burleigh, Qld, Australia	University of Queensland; El Colegio de la Frontera Sur (ECOSUR)	Robertson, OJ (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia.	o.robertson@uq.edu.au	Maron, Martine/D-9699-2011	Maron, Martine/0000-0002-5563-5789; McAlpine, Clive/0000-0003-0457-8144	Cotton Communities and Catchments CRC; Birdlife Australia	Cotton Communities and Catchments CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Birdlife Australia	Funding provided by the Cotton Communities and Catchments CRC and Birdlife Australia (formerly Birds Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Anderson M.J., 2009, PRIMER 6 PERMANOVA 6; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blair R, 2004, ECOL SOC, V9; Chu GX, 2010, PEDOBIOLOGIA, V53, P353, DOI 10.1016/j.pedobi.2010.04.002; Clark KL, 2009, PRIMER V6 USER MANUA; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Debus S. J. S., 2008, Pacific Conservation Biology, V14, P185; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; DOW D D, 1977, Emu, V77, P115; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Eyre TJ, 2009, AUSTRAL ECOL, V34, P705, DOI 10.1111/j.1442-9993.2009.01979.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Fulton Graham R., 2008, Corella, V32, P30; Gioria M, 2009, J VEG SCI, V20, P547, DOI 10.1111/j.1654-1103.2009.01054.x; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; Grey Merilyn J., 1998, Pacific Conservation Biology, V4, P55; Hajkova P, 2011, J VEG SCI, V22, P891, DOI 10.1111/j.1654-1103.2011.01297.x; Hannah D, 2007, AUSTRAL ECOL, V32, P261, DOI 10.1111/j.1442-9993.2007.01683.x; Harrison S., 1993, BIOTIC INTERACTIONS; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Higgins P. J., 1996, HDB AUSTR NZ ANTARCT, V3; Higgins P.J., 2006, VOLUME 7 BOATBILL ST; Higgins P.J., 1999, HDB AUSTR NZ ANTARCT, V4; Higgins PJ, 2001, HDB AUTRALIAN NZ ANT, V5; Hinsch M, 2010, J THEOR BIOL, V266, P606, DOI 10.1016/j.jtbi.2010.07.033; Hobbs RJ, 1998, CONSERV BIOL, V12, P271, DOI 10.1046/j.1523-1739.1998.96233.x; Howes A, IN PRESS; Howes AL, 2009, WILDLIFE RES, V36, P617, DOI 10.1071/WR09054; Kath J, 2009, LANDSCAPE URBAN PLAN, V92, P72, DOI 10.1016/j.landurbplan.2009.02.007; Kunstler, 1993, GEOGRAPHY NOWHERE RI; La Sorte FA, 2007, J BIOGEOGR, V34, P2159, DOI 10.1111/j.1365-2699.2007.01761.x; Lindenmayer David, 2010, Ecological Management & Restoration, V11, P201, DOI 10.1111/j.1442-8903.2010.00550.x; Lockwood JL, 2000, ANIM CONSERV, V3, P27, DOI 10.1111/j.1469-1795.2000.tb00084.x; Mac Nally R, 2012, ECOLOGY, V93, P668, DOI 10.1890/10-2340.1; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; Maron M, 2011, EMU, V111, P40, DOI 10.1071/MU09108; Maron M, 2012, GLOBAL ECOLOGY BIOGE; Maron M, 2007, FOREST ECOL MANAG, V240, P24, DOI 10.1016/j.foreco.2006.11.017; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI [10.1111/j.1466-822X.2006.00214.x, 10.1111/j.1466-822x.2006.00214.x]; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Pakeman RJ, 2000, COMMUNITY ECOL, V1, P171, DOI 10.1556/ComEc.1.2000.2.7; Petraitis PS, 2006, J EXP MAR BIOL ECOL, V338, P222, DOI 10.1016/j.jembe.2006.06.022; Piper SD, 2003, OIKOS, V101, P602, DOI 10.1034/j.1600-0706.2003.12292.x; Pizzey G., 2010, FIELD GUIDE BIRDS AU; QMDC, 2007, SAT IM; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; Rooney TP, 2007, BIOL CONSERV, V134, P447, DOI 10.1016/j.biocon.2006.07.008; Seabrook L, 2006, LANDSCAPE URBAN PLAN, V78, P373, DOI 10.1016/j.landurbplan.2005.11.007; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; Tlig-Zouari S, 2011, J SEA RES, V65, P161, DOI 10.1016/j.seares.2010.09.004; van Rensburg BJ, 2009, LANDSCAPE URBAN PLAN, V92, P233, DOI 10.1016/j.landurbplan.2009.05.002; Wilkinson DM, 1999, OIKOS, V84, P145, DOI 10.2307/3546874; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4	66	34	35	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65299	10.1371/journal.pone.0065299	http://dx.doi.org/10.1371/journal.pone.0065299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724136	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000128
J	Pereira, FTV; Oliveira, LJ; Barreto, RDN; Mess, A; Perecin, F; Bressan, FF; Mesquita, LG; Miglino, MA; Pimentel, JR; Neto, PF; Meirelles, FV				Verechia Pereira, Flavia Thomaz; Oliveira, Lilian J.; Nunes Barreto, Rodrigo da Silva; Mess, Andrea; Perecin, Felipe; Bressan, Fabiana Fernandes; Mesquita, Ligia Garcia; Miglino, Maria Angelica; Pimentel, Jose RodrigoValim; Neto, Paulo Fantinato; Meirelles, Flavio Vieira			Fetal-Maternal Interactions in the Synepitheliochorial Placenta Using the eGFP Cloned Cattle Model	PLOS ONE			English	Article							UNCONVENTIONAL PROTEIN SECRETION; TRANSFER PREGNANCIES; NUCLEAR TRANSFER; CELLS; DNA; MICROCHIMERISM; APOPTOSIS; PLASMA; TRAFFICKING; ACTIVATION	Background: To investigate mechanisms of fetal-maternal cell interactions in the bovine placenta, we developed a model of transgenic enhanced Green Fluorescent Protein (t-eGFP) expressing bovine embryos produced by nuclear transfer (NT) to assess the distribution of fetal-derived products in the bovine placenta. In addition, we searched for male specific DNA in the blood of females carrying in vitro produced male embryos. Our hypothesis is that the bovine placenta is more permeable to fetal-derived products than described elsewhere. Methodology/Principal Findings: Samples of placentomes, chorion, endometrium, maternal peripheral blood leukocytes and blood plasma were collected during early gestation and processed for nested-PCR for eGFP and testis-specific Y-encoded protein (TSPY), western blotting and immunohistochemistry for eGFP detection, as well as transmission electron microscopy to verify the level of interaction between maternal and fetal cells. TSPY and eGFP DNA were present in the blood of cows carrying male pregnancies at day 60 of pregnancy. Protein and mRNA of eGFP were observed in the trophoblast and uterine tissues. In the placentomes, the protein expression was weak in the syncytial regions, but intense in neighboring cells on both sides of the fetal-maternal interface. Ultrastructurally, our samples from t-eGFP expressing NT pregnancies showed to be normal, such as the presence of interdigitating structures between fetal and maternal cells. In addition, channels-like structures were present in the trophoblast cells. Conclusions/Significance: Data suggested that there is a delivery of fetal contents to the maternal system on both systemic and local levels that involved nuclear acids and proteins. It not clear the mechanisms involved in the transfer of fetal-derived molecules to the maternal system. This delivery may occur through nonclassical protein secretion; throughout transtrophoblastic-like channels and/or by apoptotic processes previously described. In conclusion, the bovine synepitheliochorial placenta displays an intimate fetal-maternal interaction, similar to other placental types for instance human and mouse.	[Verechia Pereira, Flavia Thomaz] Univ Estadual Paulista, Dracena, Brazil; [Oliveira, Lilian J.; Perecin, Felipe; Bressan, Fabiana Fernandes; Pimentel, Jose RodrigoValim; Meirelles, Flavio Vieira] Univ Sao Paulo, Coll Anim Sci & Food Engn, Dept Vet Med, Pirassununga, Brazil; [Nunes Barreto, Rodrigo da Silva; Mess, Andrea; Miglino, Maria Angelica; Neto, Paulo Fantinato] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Surg, Butanta, Brazil; [Mesquita, Ligia Garcia] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Anim Nutr & Prod, Butanta, Brazil; [Meirelles, Flavio Vieira] Univ Sao Paulo, Coll Med Ribeirao Preto, Ctr Cell Based The, BR-14049 Ribeirao Preto, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Oliveira, LJ (corresponding author), Univ Sao Paulo, Coll Anim Sci & Food Engn, Dept Vet Med, Pirassununga, Brazil.	lijoli@usp.br	Mesquita, Ligia/C-4935-2012; Meirelles, Flavio V/B-5048-2010; Bressan, Fabiana F./C-6679-2012; Barreto, Rodrigo/E-4634-2015; J., Oliveira L./V-9028-2017; Miglino, Maria Angelica/B-9519-2012; Perecin, Felipe/C-7268-2012; Fantinato-Neto, P./D-7235-2012; CTC USP, CEPID 13 18/J-8951-2014	Meirelles, Flavio V/0000-0003-0372-4920; Bressan, Fabiana F./0000-0001-9862-5874; Barreto, Rodrigo/0000-0001-5240-6959; J., Oliveira L./0000-0003-1402-8373; Miglino, Maria Angelica/0000-0003-4979-115X; Perecin, Felipe/0000-0003-2009-5863; Fantinato-Neto, P./0000-0002-3243-8248; Garcia Mesquita, Ligia/0000-0001-9938-4275; CTC USP, CEPID 13 18/0000-0002-7123-9524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/52676-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Project was supported by grants supplied by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant n. 05/52676-1. The FAPESP/CAPES had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2011, J REPROD IMMUNOL, V88, P112, DOI 10.1016/j.jri.2010.12.003; Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x; Baruselli P. S., 2003, Brazilian Journal of Veterinary Research and Animal Science, V40, P96; Bebington C, 2000, Early Pregnancy, V4, P240; Bianchi DW, 2001, ANN NY ACAD SCI, V945, P119; Bressan FF, 2011, CELL REPROGRAM, V13, P29, DOI 10.1089/cell.2010.0022; Capellini I, 2012, PLACENTA, V33, P763, DOI 10.1016/j.placenta.2012.07.004; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Cazerta SMM, 2007, PESQUI VET BRASIL, V27, P229, DOI 10.1590/S0100-736X2007000600002; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chen Q, 2012, PLACENTA, V33, P548, DOI 10.1016/j.placenta.2012.03.007; Chua CEL, 2012, J CELL PHYSIOL, V227, P3722, DOI 10.1002/jcp.24082; Cornelis G, 2013, P NATL ACAD SCI USA, V110, pE828, DOI 10.1073/pnas.1215787110; Dantzer V, 1982, Bibl Anat, P144; Davies CJ, 2000, PLACENTA, V21, P194, DOI 10.1053/plac.1999.0475; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Facciotti PR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-25; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Giuliani F, 2011, CURR OPIN CELL BIOL, V23, P498, DOI 10.1016/j.ceb.2011.04.005; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hiendleder S, 2004, CLONING STEM CELLS, V6, P150, DOI 10.1089/1536230041372391; Jockusch H, 2003, J HISTOCHEM CYTOCHEM, V51, P401, DOI 10.1177/002215540305100315; Jousan FD, 2008, MOL REPROD DEV, V75, P681, DOI 10.1002/mrd.20830; Kamemori Y, 2011, PLACENTA, V32, P20, DOI 10.1016/j.placenta.2010.10.016; Kertschanska S, 1997, PLACENTA, V18, P219, DOI 10.1016/S0143-4004(97)90096-5; Kertschanska S, 2000, PLACENTA, V21, P670, DOI 10.1053/plac.2000.0558; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kumpel BM, 2012, VOX SANG, V102, P2, DOI 10.1111/j.1423-0410.2011.01533.x; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275; Lemos DC, 2011, PLACENTA, V32, P912, DOI 10.1016/j.placenta.2011.07.088; Lemos DC, 2005, GENET MOL BIOL, V28, P117, DOI 10.1590/S1415-47572005000100020; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mess A, 2007, COMP BIOCHEM PHYS A, V148, P769, DOI 10.1016/j.cbpa.2007.01.029; Miglino MA, 2007, THERIOGENOLOGY, V68, P604, DOI 10.1016/j.theriogenology.2007.04.060; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mulla MJ, 2011, AM J REPROD IMMUNOL, V65, P542, DOI 10.1111/j.1600-0897.2010.00960.x; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Oliveira LJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013213, DOI 10.1371/J0URNAL.P0NE.0013213]; Ostrup E, 2011, REPROD FERT DEVELOP, V23, P964, DOI 10.1071/RD11140; Pereira FTV, 2010, REPROD DOMEST ANIM, V45, P907, DOI 10.1111/j.1439-0531.2009.01462.x; Pfarrer C, 2001, J ANAT, V198, P591, DOI 10.1046/j.1469-7580.2001.19850591.x; Rici REG, 2009, ANIM REPROD SCI, V115, P29, DOI 10.1016/j.anireprosci.2008.11.015; Sangalli JR, 2012, CELL REPROGRAM, V14, P235, DOI 10.1089/cell.2011.0079; Sayres LC, 2011, OBSTET GYNECOL SURV, V66, P431, DOI 10.1097/OGX.0b013e31822dfbe2; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Smith Lawrence C, 2009, Methods Mol Biol, V550, P267, DOI 10.1007/978-1-60327-009-0_17; STULC J, 1989, PLACENTA, V10, P113, DOI 10.1016/0143-4004(89)90012-X; Stulc J, 1996, PLACENTA, V17, P377, DOI 10.1016/S0143-4004(96)90064-8; Tanudji M, 2002, J CELL SCI, V115, P3849, DOI 10.1242/jcs.00047; Turin L, 2007, VET RES COMMUN, V31, P205, DOI 10.1007/s11259-007-0095-3; Turin Lauretta, 2007, Biotechnology Journal, V2, P486, DOI 10.1002/biot.200600218; von Rango U, 2003, PLACENTA, V24, P929, DOI 10.1016/S0143-4004(03)00168-1; Wang GL, 2010, J REPROD DEVELOP, V56, P639, DOI 10.1262/jrd.10-010T; Wooding FBP, 2010, PLACENTA, V31, P675, DOI 10.1016/j.placenta.2010.04.001; Wooding FBP, 1996, PLACENTA, V17, P75, DOI 10.1016/S0143-4004(05)80646-0; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Xi J, 2006, J SHIHEZI U NAT SCI, V24, P446	62	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64399	10.1371/journal.pone.0064399	http://dx.doi.org/10.1371/journal.pone.0064399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724045	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000054
J	Xu, XF; Efremov, AK; Li, A; Lai, LP; Dao, M; Lim, CT; Cao, JS				Xu, Xiaofeng; Efremov, Artem K.; Li, Ang; Lai, Lipeng; Dao, Ming; Lim, Chwee Teck; Cao, Jianshu			Probing the Cytoadherence of Malaria Infected Red Blood Cells under Flow	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ADHESION; DEFORMATION; FORCE; MODEL	Malaria is one of the most widespread and deadly human parasitic diseases caused by the Plasmodium (P.) species with the P. falciparum being the most deadly. The parasites are capable of invading red blood cells (RBCs) during infection. At the late stage of parasites' development, the parasites export proteins to the infected RBCs (iRBC) membrane and bind to receptors of surface proteins on the endothelial cells that line microvasculature walls. Resulting adhesion of iRBCs to microvasculature is one of the main sources of most complications during malaria infection. Therefore, it is important to develop a versatile and simple experimental method to quantitatively investigate iRBCs cytoadhesion and binding kinetics. Here, we developed an advanced flow based adhesion assay to demonstrate that iRBC's adhesion to endothelial CD36 receptor protein coated channels is a bistable process possessing a hysteresis loop. This finding confirms a recently developed model of cell adhesion which we used to fit our experimental data. We measured the contact area of iRBC under shear flow at different stages of infection using Total Internal Reflection Fluorescence (TIRF), and also adhesion receptor and ligand binding kinetics using Atomic Force Microscopy (AFM). With these parameters, we reproduced in our model the experimentally observed changes in adhesion properties of iRBCs accompanying parasite maturation and investigated the main mechanisms responsible for these changes, which are the contact area during the shear flow as well as the rupture area size.	[Xu, Xiaofeng; Efremov, Artem K.; Li, Ang; Dao, Ming; Lim, Chwee Teck; Cao, Jianshu] Singapore MIT Alliance Res & Technol SMART, Singapore, Singapore; [Xu, Xiaofeng; Lim, Chwee Teck] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Lai, Lipeng; Cao, Jianshu] MIT, Dept Chem, Cambridge, MA 02139 USA; [Lai, Lipeng] MIT, MIT SUTD Collaborat, Cambridge, MA 02139 USA; [Dao, Ming] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Lim, Chwee Teck] Natl Univ Singapore, Nano Biomech Lab, Dept Bioengn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National University of Singapore; National University of Singapore; National University of Singapore	Lim, CT (corresponding author), Singapore MIT Alliance Res & Technol SMART, Singapore, Singapore.	ctlim@nus.edu.sg; jianshu@mit.edu	Lim, chwee Teck/B-3307-2011; Dao, Ming/B-1602-2008	Lim, chwee Teck/0000-0003-4019-9782; Dao, Ming/0000-0001-5372-385X; Efremov, Artem/0000-0002-1603-610X	Singapore-MIT alliance for Research and Technology (SMART) Center; Global Enterprise for Micro-Mechanics and Molecular Medicine (GEM4) fund; SMART fellowship; DOD-ARO [W 911 NF-09-0480]; NSF [1112825]	Singapore-MIT alliance for Research and Technology (SMART) Center; Global Enterprise for Micro-Mechanics and Molecular Medicine (GEM4) fund; SMART fellowship; DOD-ARO(United States Department of Defense); NSF(National Science Foundation (NSF))	This work was supported by Singapore-MIT alliance for Research and Technology (SMART) Center and the Global Enterprise for Micro-Mechanics and Molecular Medicine (GEM4) fund. X. Xu was supported by SMART fellowship J. Cao is also supported by DOD-ARO (W 911 NF-09-0480) and NSF (Grant No.1112825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Efremov A, 2011, BIOPHYS J, V101, P1032, DOI 10.1016/j.bpj.2011.07.026; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Li A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016929; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WHO, 2011, WORLD MALARIA REPORT 2011, P1	16	25	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64763	10.1371/journal.pone.0064763	http://dx.doi.org/10.1371/journal.pone.0064763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724092	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000093
J	Zhou, LQ; Zhang, XJ; Li, ZQ; Zhou, CC; Li, M; Tang, XH; Lu, C; Li, HL; Yuan, QP; Yang, M				Zhou, Liqing; Zhang, Xiaojiao; Li, Ziqiang; Zhou, Changchun; Li, Meng; Tang, Xiaohu; Lu, Chao; Li, Helou; Yuan, Qipeng; Yang, Ming			Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER RISK; SUSCEPTIBILITY LOCI; MISSING HERITABILITY; CHINESE POPULATIONS; P53; POLYMORPHISMS; PROTEIN; VARIANTS; PLCE1	As an oncoprotein, MDM4 plays a key part in P53 tumor suppressor pathway through negatively regulating P53 function. It has been reported that an rs4245739 A>C polymorphism locating in the MDM4 3'-untranslated region creates a miR-191 target site and results in decreased MDM4 expression. Therefore, we investigated the association between this polymorphism and esophageal squamous cell carcinoma (ESCC) risk as well as its biological function in vivo. Genotypes were determined in two independent case-control sets consisted of 1128 ESCC cases and 1150 controls from two regions of China. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. The impact of the polymorphism on MDM4 expression was examined with esophagus tissues. Our results demonstrated that the MDM4 rs4245739 AC and CC genotypes were significantly associated with decreased ESCC risk compared with the AA genotype in both case-control sets (Jinan set: OR = 0.54, 95% Cl = 0.35-0.82, P = 0.004; Huaian set: OR = 0.68, 95% Cl = 0.45-0.99, P = 0.049). Stratified analyses revealed that a multiplicative interaction between rs4245739 and smoking or drinking was evident (Gene-smoking: P-interactioin = 0.022; gene-drinking: P-interactioin = 0.032). After detecting In vivo MDM4 mRNA expression, we found that the rs4245739 AC and CC genotype carriers had significantly decreased MDM4 expression in normal esophagus tissues compared with AA genotype carriers, indicating a consistent genotype-phenotype correlation. Our results elucidate that the MDM4 rs4245739 polymorphism contributes to susceptibility of ESCC and support the hypothesis that genetic variants, interrupting miRNA-mediated gene regulation, may modify cancer risk.	[Zhou, Liqing] Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China; [Zhang, Xiaojiao; Li, Meng; Tang, Xiaohu; Lu, Chao; Yuan, Qipeng; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Li, Ziqiang] Shandong Univ, Qianfoshan Hosp, Hepatobiliary Surg Dept, Jinan 250100, Shandong, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Li, Helou] Taishan Med Univ, Affiliated Hosp, Clin Lab, Tai An, Shandong, Peoples R China	Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.	yangm@mail.buct.edu.cn	, CC. Zhou/AGI-1229-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487	National Natural Science Foundation of China [31271382, 81201586]; Beijing Nova Program [2010B013]; Beijing Natural Science Foundation [5122020]; Beijing City Talent Training Project [2012D009016000002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing City Talent Training Project	This work was supported by National Natural Science Foundation of China (no. 31271382 and no. 81201586), Beijing Nova Program (no. 2010B013), Beijing Natural Science Foundation (no. 5122020) and Beijing City Talent Training Project (no. 2012D009016000002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Landers JE, 1997, CANCER RES, V57, P3562; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Ma J, 2012, J HUM GENET, V57, P261, DOI 10.1038/jhg.2012.15; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Shi J, INT J CANC IN PRESS; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Zhang L, 2010, INT J RADIAT ONCOL, V77, P1360, DOI 10.1016/j.ijrobp.2009.07.1675	34	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64331	10.1371/journal.pone.0064331	http://dx.doi.org/10.1371/journal.pone.0064331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724042	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000053
J	Gassling, V; Hampe, J; Acil, Y; Braesen, JH; Wiltfang, J; Hasler, R				Gassling, Volker; Hampe, Jochen; Acil, Yahya; Braesen, Jan Hinrich; Wiltfang, Joerg; Haesler, Robert			Disease-Associated miRNA-mRNA Networks in Oral Lichen Planus	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PREMALIGNANT LESIONS; MICRORNA TARGETS; EXPRESSION; HEAD; NECK; PROGRESSION; CANCER; GENES; SIGNATURES	Background: A large number of pathophysiological mechanisms are regulated by microRNAs (miRNAs), which represent a new class of posttranscriptional regulators of gene expression. To date, little is known about their role in oral lichen planus (OLP), a chronic inflammatory mucocutaneous disease of unknown etiology which is being discussed as a potentially premalignant condition of oropharyngeal cancer. The aim of the present investigation was to assess the pathophysiological impact of miRNAs and to determine regulatory miRNA networks which are directly linked to potentially disease-associated target transcripts in OLP. Methods: Native tissue samples were collected from the oral mucosa of seven patients with OLP. The control group was composed of native tissue from elective oral surgery. The mRNA profiling was performed using the Affymetrix Human Gene 1.0 ST Array while miRNA profiling was performed using the microRNA Galaxy Array. Subsequent validation of initial results was carried out using TaqMan real time PCR. Results: We identified 24 differentially regulated miRNA and 2,694 regulated transcripts. Linking the miRNAs to their potential targets we found 11 potential miRNA-mRNA pairs, of which several are functionally related to premalignant as well as to inflammatory events. Conclusions: Our data shows miRNA associated with transcripts which are regulated when comparing OLP patients with healthy control individuals. This suggests that miRNAs may potentially regulate disease-relevant transcripts, proposing the concept of therapeutic interventions based on miRNAs.	[Gassling, Volker; Acil, Yahya; Wiltfang, Joerg] Univ Hosp Schleswig Holstein, Dept Oral & Maxillofacial Surg, Kiel, Germany; [Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Hampe, Jochen; Haesler, Robert] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Braesen, Jan Hinrich] Univ Hosp Schleswig Holstein, Dept Pathol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Hasler, R (corresponding author), Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel, Kiel, Germany.	r.haesler@mucosa.de	Häsler, Robert/A-4908-2009; Hampe, Jochen/A-2555-2010; Cruz e Silva, Odete/AAH-5595-2020; Gassling, Volker/E-4671-2016	Häsler, Robert/0000-0003-4174-8229; Hampe, Jochen/0000-0002-2421-6127; Gassling, Volker/0000-0002-0096-6142	National German Genome Network; Clusters of Excellence Inflammation at Interfaces; Cross-Campus Research Funding Medical Board Schleswig-Holstein	National German Genome Network; Clusters of Excellence Inflammation at Interfaces; Cross-Campus Research Funding Medical Board Schleswig-Holstein	This study was supported by the National German Genome Network, the Clusters of Excellence Inflammation at Interfaces, and by the Cross-Campus Research Funding Medical Board Schleswig-Holstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Baras N, 2008, CANC GERMANY 2007 20; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Eisenberg E, 2000, J ORAL MAXIL SURG, V58, P1278, DOI 10.1053/joms.2000.16629; Enarsson K, 2006, CLIN IMMUNOL, V118, P24, DOI 10.1016/j.clim.2005.08.001; Gorsky Meir, 2004, Tob Induc Dis, V2, P103, DOI 10.1186/1617-9625-2-2-103; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Ha PK, 2003, CLIN CANCER RES, V9, P3058; Ha PK, 2002, INT J CANCER, V102, P615, DOI 10.1002/ijc.10748; Hasler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031151; Hasler R, 2011, EUR J CELL BIOL, V90, P603, DOI 10.1016/j.ejcb.2010.11.010; Hasler R, 2009, PHYSIOL GENOMICS, V38, P73, DOI 10.1152/physiolgenomics.00010.2009; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Ismail Sumairi B, 2007, J Oral Sci, V49, P89; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reichart PA, 2005, ORAL ONCOL, V41, P551, DOI 10.1016/j.oraloncology.2004.12.003; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Silverman S, 2000, J ORAL MAXIL SURG, V58, P1286, DOI 10.1053/joms.2000.16630; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van der Meij EH, 2003, ORAL SURG ORAL MED O, V96, P164, DOI 10.1016/S1079-2104(03)00305-6; van der Waal I, 1997, HISTOLOGICAL TYPING, p[21, 29]; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhang LW, 1997, AM J PATHOL, V151, P323; Zhang Qi, 2010, Zhongguo Fei Ai Za Zhi, V13, P612, DOI 10.3779/j.issn.1009-3419.2010.06.009	52	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63015	10.1371/journal.pone.0063015	http://dx.doi.org/10.1371/journal.pone.0063015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723971	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100004
J	Peters, L; Mocroft, A; Soriano, V; Rockstroh, J; Rauch, A; Karlsson, A; Knysz, B; Pradier, C; Zilmer, K; Lundgren, JD				Peters, Lars; Mocroft, Amanda; Soriano, Vincent; Rockstroh, Juergen; Rauch, Andri; Karlsson, Anders; Knysz, Brygida; Pradier, Christian; Zilmer, Kai; Lundgren, Jens D.		EuroSIDA EuroCoord	Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SERUM FIBROSIS MARKERS; C VIRUS; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; NONINVASIVE MARKERS; INFECTED PATIENTS; PROGNOSTIC VALUE; HIV-INFECTION; AIDS	Background: Whereas it is well established that various soluble biomarkers can predict level of liver fibrosis, their ability to predict liver-related clinical outcomes is less clearly established, in particular among HIV/viral hepatitis co-infected persons. We investigated plasma hyaluronic acid's (HA) ability to predict risk of liver-related events (LRE; hepatic coma or liver-related death) in the EuroSIDA study. Methods: Patients included were positive for anti-HCV and/or HBsAg with at least one available plasma sample. The earliest collected plasma sample was tested for HA (normal range 0-75 ng/mL) and levels were associated with risk of LRE. Change in HA per year of follow-up was estimated after measuring HA levels in latest sample before the LRE for those experiencing this outcome (cases) and in a random selection of one sixth of the remaining patients (controls). Results: During a median of 8.2 years of follow-up, 84/1252 (6.7%) patients developed a LRE. Baseline median (IQR) HA in those without and with a LRE was 31.8 (17.2-62.6) and 221.6 ng/mL (74.9-611.3), respectively (p<0.0001). After adjustment, HA levels predicted risk of contracting a LRE; incidence rate ratios for HA levels 75-250 or >= 250 vs. <75 ng/mL were 5.22 (95% CI 2.86-9.26, p<0.0007) and 28.22 (95% CI 14.95-46.00, p<0.0001), respectively. Median HA levels increased substantially prior to developing a LRE (107.6 ng/mL, IQR 0.8 to 251.1), but remained stable for controls (1.0 ng/mL, IQR -5.1 to 8.2), (p<0.0001 comparing cases and controls), and greater increases predicted risk of a LRE in adjusted models (p<0.001). Conclusions: An elevated level of plasma HA, particularly if the level further increases over time, substantially increases the risk of contracting LRE over the next five years. HA is an inexpensive, standardized and non-invasive supplement to other methods aimed at identifying HIV/viral hepatitis co-infected patients at risk of hepatic complications.	[Peters, Lars; Lundgren, Jens D.] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Peters, Lars; Lundgren, Jens D.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Mocroft, Amanda] Univ Coll Med Sch, London, England; [Soriano, Vincent] Hosp Carlos III, Madrid, Spain; [Rockstroh, Juergen] Univ Bonn, Bonn, Germany; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Karlsson, Anders] Soder Sjukhuset, Venhalsan, S-10064 Stockholm, Sweden; [Knysz, Brygida] Wroclaw Med Univ, Dept Infect Dis, Wroclaw, Poland; [Pradier, Christian] CHU Nice Hop lArchet 1, Nice, France; [Zilmer, Kai] West Tallin Cent Hosp, Tallinn, Estonia	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of London; University College London; Hospital Carlos III; University of Bonn; University of Bern; University Hospital of Bern; University of Bern; Sodersjukhuset Hospital; Wroclaw Medical University; CHU Nice	Peters, L (corresponding author), Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark.	lpe@cphiv.dk	Castagna, Antonella/K-3280-2018; Pradier, Christian/AAE-9669-2022; Mitsura, Viktar/G-2457-2017; Pradier, Christian/AFE-8255-2022; Parczewski, Milosz/AAV-4280-2021; Lundgren, Jens/AAE-6876-2019; Soriano, Vicente/O-5730-2018; Begovac, Josip/AAI-5672-2021; Rauch, Andri/E-9948-2017; GALLI, MASSIMO/L-7282-2017; Flisiak, Robert/S-5356-2018; LAZZARIN, Adriano/K-3607-2018; Grzeszczuk, Anna/R-7844-2018; Sedlacek, Dalibor/K-3035-2017	Castagna, Antonella/0000-0002-8338-9714; Mitsura, Viktar/0000-0002-0449-5026; Parczewski, Milosz/0000-0003-1869-1084; Soriano, Vicente/0000-0002-4624-5199; Begovac, Josip/0000-0003-2641-4327; Rauch, Andri/0000-0001-5297-6062; Anna, Vassilenko/0000-0003-1907-2322; GALLI, MASSIMO/0000-0001-8887-6215; Antunes, Francisco/0000-0001-7932-1154; Flisiak, Robert/0000-0003-3394-1635; Benfield, Thomas/0000-0003-0698-9385; Jevtovic, Dorde/0000-0003-1127-6072; LAZZARIN, Adriano/0000-0003-2551-7754; Knysz, Brygida/0000-0003-2605-1079; Ostergaard, Lars/0000-0003-2459-0511; Grzeszczuk, Anna/0000-0002-6420-5545; Leen, Clifford/0000-0001-8439-7719; Sedlacek, Dalibor/0000-0003-4711-6679; Lundgren, Jens/0000-0001-8901-7850; Gianotti, Nicola/0000-0002-7182-5080	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Gilead; Pfizer; Merck and Co.; Swiss National Science Foundation [108787]; Copenhagen HIV Programme	European Commission(European CommissionEuropean Commission Joint Research Centre); Gilead(Gilead Sciences); Pfizer(Pfizer); Merck and Co.(Merck & Company); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Copenhagen HIV Programme	Primary support for EuroSIDA is provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no 260694) programmes. Current support also includes unrestricted grants by Gilead, Pfizer, and Merck and Co. The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). Copenhagen HIV Programme sponsored the HA measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2011, 18 C RETR OPP INF; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Butt AA, 2009, HIV CLIN TRIALS, V10, P25, DOI [10.1310/hct1001-025, 10.1310/hct1001-25]; Cacoub P, 2006, J VIRAL HEPATITIS, V13, P678, DOI 10.1111/j.1365-2893.2006.00740.x; ENGSTROMLAURENT A, 1987, ARTHRITIS RHEUM, V30, P1333, DOI 10.1002/art.1780301203; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontana RJ, 2010, GUT, V59, P1401, DOI 10.1136/gut.2010.207423; Guechot J, 2000, J HEPATOL, V32, P447, DOI 10.1016/S0168-8278(00)80396-7; Guha I, 2008, CLIN LIVER DIS, V12, P883, DOI 10.1016/j.cld.2008.07.010; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Idobe Y, 1998, INTERNAL MED, V37, P568, DOI 10.2169/internalmedicine.37.568; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961; Nunes D, 2005, JAIDS-J ACQ IMM DEF, V40, P538, DOI 10.1097/01.qai.0000184856.31695.bf; Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Parkes J, 2010, GUT, V59, P1245, DOI 10.1136/gut.2009.203166; Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Resino S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-244; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sanvisens A, 2009, J VIRAL HEPATITIS, V16, P513, DOI 10.1111/j.1365-2893.2009.01103.x; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Vogel M, 2009, CURR OPIN HIV AIDS, V4, P171, DOI 10.1097/COH.0b013e328329c602; Wong CSM, 1998, J GASTROEN HEPATOL, V13, P1218, DOI 10.1111/j.1440-1746.1998.tb00608.x; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x; Zetterberg E, 2013, AIDS, V27, P59, DOI 10.1097/QAD.0b013e32835a104d	40	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64283	10.1371/journal.pone.0064283	http://dx.doi.org/10.1371/journal.pone.0064283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724041	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100023
J	Sichova, J; Nguyen, P; Dalikova, M; Marec, F				Sichova, Jindra; Petr Nguyen; Dalikova, Martina; Marec, Frantisek			Chromosomal Evolution in Tortricid Moths: Conserved Karyotypes with Diverged Features	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; SEX-CHROMOSOMES; CODLING MOTH; MOLECULAR DIFFERENTIATION; CYDIA-POMONELLA; W-CHROMOSOME; RDNA GENES; LEPIDOPTERA; CHROMATIN	Moths of the family Tortricidae constitute one of the major microlepidopteran groups in terms of species richness and economic importance. Yet, despite their overall significance, our knowledge of their genome organization is very limited. In order to understand karyotype evolution in the family Tortricidae, we performed detailed cytogenetic analysis of Grapholita molesta, G. funebrana, Lobesia botrana, and Eupoecilia ambiguella, representatives of two main tortricid subfamilies, Olethreutinae and Tortricinae. Besides standard cytogenetic methods, we used fluorescence in situ hybridization for mapping of major rRNA and histone gene clusters and comparative genomic hybridization to determine the level of molecular differentiation of the W and Z sex chromosomes. Our results in combination with available data in the codling moth, Cydia pomonella, and other tortricids allow us a comprehensive reconstruction of chromosomal evolution across the family Tortricidae. The emerging picture is that the karyotype of a common ancestor of Tortricinae and Olethreutinae differentiated from the ancestral lepidopteran chromosome print of n = 31 by a sex chromosome-autosome fusion. This rearrangement resulted in a large neo-sex chromosome pair and a karyotype with n = 30 conserved in most Tortricinae species, which was further reduced to n = 28 observed in Olethreutinae. Comparison of the tortricid neo-W chromosomes showed differences in their structure and composition presumably reflecting stochasticity of molecular degeneration of the autosomal part of the neo-W chromosome. Our analysis also revealed conservative pattern of the histone distribution, which is in contrast with high rDNA mobility. Despite the dynamic evolution of rDNA, we can infer a single NOR-chromosome pair as an ancestral state not only in tortricids but probably in all Lepidoptera. The results greatly expand our knowledge of the genome architecture in tortricids, but also contribute to the understanding of chromosomal evolution in Lepidoptera in general.	[Sichova, Jindra; Petr Nguyen; Dalikova, Martina; Marec, Frantisek] Biol Ctr ASCR, Inst Entomol, Ceske Budejovice, Czech Republic; [Sichova, Jindra; Petr Nguyen; Dalikova, Martina; Marec, Frantisek] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Marec, F (corresponding author), Biol Ctr ASCR, Inst Entomol, Ceske Budejovice, Czech Republic.	marec@entu.cas.cz	Nguyen, Petr/AAI-5203-2020; Yakovlev, Roman/J-7243-2013; Šíchová, Jindra/O-8602-2017; Marec, Frantisek/G-7943-2014; Nguyen, Petr/G-5826-2010; Dalikova, Martina/J-5722-2015	Nguyen, Petr/0000-0003-1395-4287; Marec, Frantisek/0000-0002-6745-5603; Nguyen, Petr/0000-0003-1395-4287; Dalikova, Martina/0000-0002-0266-8894	Coordinated Research Project of the IAEA, Vienna [15838];  [GACR 523/09/2106];  [GAAV IAA600960925];  [GAJU 137/2010/P];  [059/2010/P]	Coordinated Research Project of the IAEA, Vienna; ; ; ; 	This research was part of a Coordinated Research Project of the IAEA, Vienna (Research Agreement No. 15838). Experiments were funded by GACR 523/09/2106 and GAAV IAA600960925 grants. Additional support was provided from GAJU 137/2010/P and 059/2010/P grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MM, 1991, TORTRICID PESTS THEI, P313; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Brianti MT, 2009, CYTOGENET GENOME RES, V125, P149, DOI 10.1159/000227840; Brown JW, 2010, TORTRICID LIT LIB VE; Brown KS, 2007, HEREDITAS, V144, P137; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; De Prins Jurate, 2003, Handbuch der Zoologie (Berlin), V4, P449; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Emelianov I, 2004, P ROY SOC B-BIOL SCI, V271, P97, DOI 10.1098/rspb.2003.2574; ENNIS TJ, 1976, CAN J GENET CYTOL, V18, P119, DOI 10.1139/g76-017; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Fukova I, 2007, CHROMOSOMA, V116, P135, DOI 10.1007/s00412-006-0086-0; Galian J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-158; Gilligan T.M., 2012, T RTS ONLINE WORLD C; Harvey GT, 1997, CAN ENTOMOL, V129, P519, DOI 10.4039/Ent129519-3; Horak M, 1998, HDB ZOOLOGY 35, VIV, P199; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; LUKHTANOV V A, 1989, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V68, P12; Lukhtanov VA, 2000, J ZOOL SYST EVOL RES, V38, P73, DOI 10.1046/j.1439-0469.2000.382130.x; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; MARCHI A, 1994, HEREDITY, V72, P599, DOI 10.1038/hdy.1994.83; Marec F, 2005, J ECON ENTOMOL, V98, P248, DOI 10.1603/0022-0493-98.2.248; MAREC F, 1994, GENOME, V37, P426, DOI 10.1139/g94-060; Marec F, 2010, MOL BIOL GENETICS LE, P49; Mediouni J, 2004, CARYOLOGIA, V57, P184, DOI 10.1080/00087114.2004.10589391; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Notter-Hausmann C, 2010, ENVIRON ENTOMOL, V39, P561, DOI 10.1603/EN09231; ORTIZ E, 1976, EOS-Revista Espanola de Entomologia, V51, P77; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Rafael MS, 2006, HEREDITAS, V143, P62; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072678, 10.1371/journal.pone.0058568]; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Robinson R, 1971, LEPIDOPTERA GENETICS; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; SAITOH K, 1966, JPN J GENET, V41, P275, DOI 10.1266/jjg.41.275; SAITOH K, 1968, Kontyu, V36, P403; SUOMALAINEN E, 1971, HEREDITAS-GENETISK A, V68, P313; SUOMALAINEN E, 1969, CHROMOSOMA, V28, P298; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; Traut W, 1996, Q REV BIOL, V71, P239, DOI 10.1086/419371; TRAUT W, 1986, GENETICA, V70, P69, DOI 10.1007/BF00123216; van der Geest L. P., 1991, TORTRICID PESTS THEI; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Van't Hof AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003882; Vitkova M, 2007, CHROMOSOME RES, V15, P917, DOI 10.1007/s10577-007-1173-7; Vreysen MJB, 2010, J APPL ENTOMOL, V134, P165, DOI 10.1111/j.1439-0418.2009.01430.x; Warchalowska-Sliwa E, 2011, EUR J ENTOMOL, V108, P183, DOI 10.14411/eje.2011.025; Wolf KW, 1996, INT J INSECT MORPHOL, V25, P37, DOI 10.1016/0020-7322(95)00021-6; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465; Yoshido A, 2005, CHROMOSOMA, V114, P193, DOI 10.1007/s00412-005-0013-9; ZHANG B-C., 1994, INDEX EC IMPORTANT L; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	61	41	42	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64520	10.1371/journal.pone.0064520	http://dx.doi.org/10.1371/journal.pone.0064520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717623	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300019
J	Aguirre, C; ten Brink, T; Walker, O; Guilliere, F; Davesne, D; Krimm, I				Aguirre, Clementine; ten Brink, Tim; Walker, Olivier; Guilliere, Florence; Davesne, Dany; Krimm, Isabelle			BcL-xL Conformational Changes upon Fragment Binding Revealed by NMR	PLOS ONE			English	Article							COMPLEXATION-INDUCED CHANGES; CHEMICAL-SHIFTS; DIPOLAR COUPLINGS; LIGAND EFFICIENCY; SMALL MOLECULES; DISCOVERY; INHIBITOR; PROTEINS; BCL-X(L); POTENT	Protein-protein interactions represent difficult but increasingly important targets for the design of therapeutic compounds able to interfere with biological processes. Recently, fragment-based strategies have been proposed as attractive approaches for the elaboration of protein-protein surface inhibitors from fragment-like molecules. One major challenge in targeting protein-protein interactions is related to the structural adaptation of the protein surface upon molecular recognition. Methods capable of identifying subtle conformational changes of proteins upon fragment binding are therefore required at the early steps of the drug design process. In this report we present a fast NMR method able to probe subtle conformational changes upon fragment binding. The approach relies on the comparison of experimental fragment-induced Chemical Shift Perturbation (CSP) of amine protons to CSP simulated for a set of docked fragment poses, considering the ring-current effect from fragment binding. We illustrate the method by the retrospective analysis of the complex between the anti-apoptotic Bcl-xL protein and the fragment 4'-fluoro-[1,1'-biphenyl]-4-carboxylic acid that was previously shown to bind one of the Bcl-xL hot spots. The CSP-based approach shows that the protein undergoes a subtle conformational rearrangement upon interaction, for residues located in helices alpha 2, alpha 3 and the very beginning of alpha 5. Our observations are corroborated by residual dipolar coupling measurements performed on the free and fragment-bound forms of the Bcl-xL protein. These NMR-based results are in total agreement with previous molecular dynamic calculations that evidenced a high flexibility of Bcl-xL around the binding site. Here we show that CSP of protein amine protons are useful and reliable structural probes. Therefore, we propose to use CSP simulation to assess protein conformational changes upon ligand binding in the fragment-based drug design approach.	[Aguirre, Clementine; ten Brink, Tim; Walker, Olivier; Guilliere, Florence; Krimm, Isabelle] Univ Lyon 1, Inst Sci Analyt, UMR5280, F-69622 Villeurbanne, France; [Davesne, Dany] IN2P3, UMR5822, F-69622 Lyon, France; [Davesne, Dany] Univ Lyon, IPNL, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3)	Krimm, I (corresponding author), Univ Lyon 1, Inst Sci Analyt, UMR5280, F-69622 Villeurbanne, France.	isabelle.krimm@univ-lyon1.fr	Krimm, Isabelle/O-4972-2014; WALKER, Olivier/B-2580-2016	Krimm, Isabelle/0000-0002-5981-109X; WALKER, Olivier/0000-0001-7284-2555; GUILLIERE, Florence/0000-0002-4025-2988	Agence National de la Recherche [ANR-11-JS07-0008]	Agence National de la Recherche(French National Research Agency (ANR))	The work presented here was supported by the Agence National de la Recherche, project ANR-11-JS07-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Babaoglu K, 2006, NAT CHEM BIOL, V2, P720, DOI 10.1038/nchembio831; Barelier S, 2010, J MED CHEM, V53, P2577, DOI 10.1021/jm100009z; Bembenek SD, 2009, DRUG DISCOV TODAY, V14, P278, DOI 10.1016/j.drudis.2008.11.007; Bower JF, 2012, CURR PHARM DESIGN, V18, P4685; Braisted AC, 2003, J AM CHEM SOC, V125, P3714, DOI 10.1021/ja034247i; Braun P, 2012, PROTEOMICS, V12, P1478, DOI 10.1002/pmic.201100563; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; Carra JH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-72; Christensen AS, 2011, J CHEM THEORY COMPUT, V7, P2078, DOI 10.1021/ct2002607; Cioffi M, 2008, J MED CHEM, V51, P2512, DOI 10.1021/jm701194r; Cioffi M, 2009, J BIOMOL NMR, V43, P11, DOI 10.1007/s10858-008-9286-7; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Constantine KL, 2006, J AM CHEM SOC, V128, P7252, DOI 10.1021/ja060356w; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Goddard T.D., 2004, SPARKY 3, P3; Gonzalez-Ruiz D, 2009, J CHEM INF MODEL, V49, P2260, DOI 10.1021/ci900188r; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; HAIGH CW, 1979, PROG NUCL MAG RES SP, V13, P303, DOI 10.1016/0079-6565(79)80010-2; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hu WD, 2006, ANNU REP NMR SPECTRO, V58, P231, DOI 10.1016/S0066-4103(05)58005-0; Hunter CA, 1999, CHEM-EUR J, V5, P1891, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1891::AID-CHEM1891>3.0.CO;2-G; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuo LC, 2011, METHOD ENZYMOL, V493, P159, DOI 10.1016/B978-0-12-381274-2.00007-8; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Manion MK, 2004, J BIOL CHEM, V279, P2159, DOI 10.1074/jbc.M306021200; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; McCoy MA, 2002, J AM CHEM SOC, V124, P11758, DOI 10.1021/ja026166c; McCoy MA, 2000, J BIOMOL NMR, V18, P189, DOI 10.1023/A:1026508025631; Metzler W.J., 2008, FRAGMENT BASED DRUG, P99, DOI [10.1002/9780470721551.ch5, DOI 10.1002/9780470721551.CH5]; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murray CW, 2012, TRENDS PHARMACOL SCI, V33, P224, DOI 10.1016/j.tips.2012.02.006; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Novak W, 2009, J COMPUT AID MOL DES, V23, P49, DOI 10.1007/s10822-008-9237-0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Parker LL, 2006, J AM CHEM SOC, V128, P9863, DOI 10.1021/ja0617901; Perryman AL, 2010, CHEM BIOL DRUG DES, V75, P257, DOI 10.1111/j.1747-0285.2009.00943.x; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2010, BIOORG MED CHEM LETT, V20, P6587, DOI 10.1016/j.bmcl.2010.09.033; Rega MF, 2011, J MED CHEM, V54, P6000, DOI 10.1021/jm200826s; Sahakyan AB, 2011, J BIOMOL NMR, V50, P331, DOI 10.1007/s10858-011-9524-2; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; Tian F, 2001, J AM CHEM SOC, V123, P485, DOI 10.1021/ja002900l; Tolman JR, 2001, CURR OPIN STRUC BIOL, V11, P532, DOI 10.1016/S0959-440X(00)00245-1; Tsao DHH, 2006, BIOORGAN MED CHEM, V14, P7953, DOI 10.1016/j.bmc.2006.07.050; Umemoto K, 2003, BIOCHEMISTRY-US, V42, P3688, DOI 10.1021/bi026671m; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang YS, 2010, J MED CHEM, V53, P942, DOI 10.1021/jm901472u; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Wyss DF, 2004, J MED CHEM, V47, P2486, DOI 10.1021/jm0305117; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Yang CY, 2012, ACS MED CHEM LETT, V3, P308, DOI 10.1021/ml200301w; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	76	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64400	10.1371/journal.pone.0064400	http://dx.doi.org/10.1371/journal.pone.0064400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717610	Green Published, gold			2022-12-25	WOS:000319435600065
J	Engelbrecht, B; Stratmann, B; Hess, C; Tschoepe, D; Gawlowski, T				Engelbrecht, Britta; Stratmann, Bernd; Hess, Cornelius; Tschoepe, Diethelm; Gawlowski, Thomas			Impact of GLO1 Knock Down on GLUT4 Trafficking and Glucose Uptake in L6 Myoblasts	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROTEIN-KINASE-B; OXIDATIVE STRESS; INSULIN-RESISTANCE; GLYOXALASE SYSTEM; DIABETES-MELLITUS; METHYLGLYOXAL; ACTIVATION; GLUCOSE-TRANSPORTER-4; TRANSLOCATION	Methylglyoxal (MG), a highly reactive alpha-dicarbonyl metabolite of glucose degradation pathways, protein and fatty acid metabolism, plays an important role in the pathogenesis of diabetic complications. Hyperglycemia triggers enhanced production of MG and increased generation of advanced glycation endproducts (AGEs). In non-enzymatic reactions, MG reacts with arginine residues of proteins to form the AGEs argpyrimidine and hydroimidazolone. Glyoxalase 1 (GLO1), in combination with glyoxalase 2 and the co-factor glutathione constitute the glyoxalase system, which is responsible for the detoxification of MG. A GLO1 specific knock down results in accumulation of MG in targeted cells. The aim of this study was to investigate the effect of intracellularly accumulated MG on insulin signaling and on the translocation of the glucose transporter 4 (GLUT4). Therefore, L6 cells stably expressing a myc-tagged GLUT4 were examined. For the intracellular accumulation of MG, GLO1, the first enzyme of the glyoxalase pathway, was down regulated by siRNA knock down and cells were cultivated under hyperglycemic conditions (25 mM glucose) for 48 h. Here we show that GLO1 knock down augmented GLUT4 level on the cell surface of L6 myoblasts at least in part through reduction of GLUT4 internalization, resulting in increased glucose uptake. However, intracellular accumulation of MG had no effect on GLUT4 concentration or modification. The antioxidant and MG scavenger NAC prevented the MG-induced GLUT4 translocation. Tiron, which is also a well-known antioxidant, had no impact on MG-induced GLUT4 translocation.	[Engelbrecht, Britta; Stratmann, Bernd; Tschoepe, Diethelm; Gawlowski, Thomas] Ruhr Univ Bochum, Ctr Diabet, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Hess, Cornelius] Univ Bonn, Inst Forens Med, Bonn, Germany	Ruhr University Bochum; University of Bonn	Gawlowski, T (corresponding author), Ruhr Univ Bochum, Ctr Diabet, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany.	thgawlowski@gmail.de			Deutsche Diabetes Gesellschaft	Deutsche Diabetes Gesellschaft	This work was supported by a grant from the Deutsche Diabetes Gesellschaft to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Alzaid AA, 1996, ACTA DIABETOL, V33, P87; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Cooper ME, 2004, AM J HYPERTENS, V17, p31S, DOI 10.1016/j.amjhyper.2004.08.021; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Dhar A, 2010, BRIT J PHARMACOL, V161, P1843, DOI 10.1111/j.1476-5381.2010.01017.x; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Gawlowski T, 2009, HORM METAB RES, V41, P594, DOI 10.1055/s-0029-1216374; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Guo Q, 2009, J HYPERTENS, V27, P1664, DOI 10.1097/HJH.0b013e32832c419a; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hess C, 2013, INT J LEGAL MED, V127, P385, DOI 10.1007/s00414-012-0740-4; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Lee JJ, 2012, MOL VIS, V18, P838; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; Liu BF, 2003, KIDNEY INT, V63, P947, DOI 10.1046/j.1523-1755.2003.00829.x; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mazlan M, 2010, SAINS MALAYS, V39, P315; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Mostafa AA, 2007, MOL CELL BIOCHEM, V302, P35, DOI 10.1007/s11010-007-9422-9; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ogawa S, 2010, HYPERTENSION, V56, P471, DOI 10.1161/HYPERTENSIONAHA.110.156786; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Randell E. W., 2005, Journal of Pharmacological and Toxicological Methods, V51, P153, DOI 10.1016/j.vascn.2004.08.005; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Santarius T, 2010, GENE CHROMOSOME CANC, V49, P711, DOI 10.1002/gcc.20784; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Stratmann B, 2010, HERZ, V35, P161, DOI 10.1007/s00059-010-3336-0; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yoshida A, 2012, J BIOL CHEM; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	57	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e65195	10.1371/journal.pone.0065195	http://dx.doi.org/10.1371/journal.pone.0065195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717693	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600083
J	Jiang, JL; Barnwell, JW; Meyer, EVS; Galinski, MR				Jiang, Jianlin; Barnwell, John W.; Meyer, Esmeralda V. S.; Galinski, Mary R.			Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; NATURALLY ACQUIRED ANTIBODIES; BINDING-LIKE PROTEINS; ERYTHROCYTE INVASION; GENETIC DIVERSITY; FALCIPARUM MEROZOITES; VACCINE; IDENTIFICATION; KNOWLESI; AMAZON	Background: Three members of the Plasmodium vivax merozoite surface protein-3 (PvMSP3) family (PvMSP3-alpha, PvMSP3-beta and PvMSP3-gamma) were initially characterized and later shown to be part of a larger highly diverse family, encoded by a cluster of genes arranged head-to-tail in chromosome 10. PvMSP3-alpha and PvMSP3-beta have become genetic markers in epidemiological studies, and are being evaluated as vaccine candidates. This research investigates the gene and protein expression of the entire family and pertinent implications. Methodology/Principal Findings: A 60 kb multigene locus from chromosome 10 in P. vivax (Salvador 1 strain) was studied to classify the number of pvmsp3 genes present, and compare their transcription, translation and protein localization patterns during blood-stage development. Eleven pvmsp3 paralogs encode an N-terminal NLRNG signature motif, a central domain containing repeated variable heptad sequences, and conserved hydrophilic C-terminal features. One additional ORF in the locus lacks these features and was excluded as a member of the family. Transcripts representing all eleven pvmsp3 genes were detected in trophozoite- and schizont-stage RNA. Quantitative immunoblots using schizont-stage extracts and antibodies specific for each PvMSP3 protein demonstrated that all but PvMSP3.11 could be detected. Homologs were also detected by immunoblot in the closely related simian species, P. cynomolgi and P. knowlesi. Immunofluorescence assays confirmed that eight of the PvMSP3s are present in mature schizonts. Uniquely, PvMSP3.7 was expressed exclusively at the apical end of merozoites. Conclusion/Significance: Specific proteins were detected representing the expression of 10 out of 11 genes confirmed as members of the pvmsp3 family. Eight PvMSP3s were visualized surrounding merozoites. In contrast, PvMSP3.7 was detected at the apical end of the merozoites. Pvmsp3.11 transcripts were present, though no corresponding protein was detected. PvMSP3 functions remain unknown. The ten expressed PvMSP3s are predicted to have unique and complementary functions in merozoite biology.	[Jiang, Jianlin; Meyer, Esmeralda V. S.; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA USA; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA	Emory University; Centers for Disease Control & Prevention - USA; Emory University	Galinski, MR (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA.	mary.galinski@emory.edu			National Institutes of Health, National Institute for Allergy and Infectious Diseases [1R01AI24710, R21AI094449]; National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs/OD [P51OD011132]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094449, R01AI024710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health, National Institute for Allergy and Infectious Diseases to MRG (1R01AI24710 and R21AI094449). The Yerkes National Primate Research Center received support from the National Center for Research Resources P51RR000165, and it is currently supported by the Office of Research Infrastructure Programs/OD P51OD011132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Balu B, 2009, EXP PARASITOL, V121, P110, DOI 10.1016/j.exppara.2008.10.003; Bang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028165; Bannister LH, 2009, PARASITOLOGY, V136, P1435, DOI 10.1017/S0031182009990734; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bruce MC, 1999, POLYMORPHISM MEROZOI, P518; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CAMPBELL CC, 1983, J PARASITOL, V69, P598, DOI 10.2307/3281376; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; DAVID PH, 1985, J IMMUNOL, V134, P4146; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2005, MOLECULAR APPROACHES TO MALARIA, P113; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gunalan K, 2012, CELLULAR MICROBIOLOG; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Ji YE, 1996, MOL BIOCHEM PARASIT, V81, P211, DOI 10.1016/0166-6851(96)02712-0; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627; Li J, 2012, BIOCHEM BIOPH RES CO, V426, P1, DOI 10.1016/j.bbrc.2012.08.055; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Manamperi A, 2008, TROP BIOMED, V25, P100; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; MULHERN TD, 1995, BIOCHEMISTRY-US, V34, P3479, DOI 10.1021/bi00011a001; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OEUVRAY C, 1994, BLOOD, V84, P1594; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Prajapati SK, 2010, J VECTOR DIS, V47, P85; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SAUL A, 1990, MOL BIOCHEM PARASIT, V42, P55, DOI 10.1016/0166-6851(90)90112-Y; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Veron V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-40; WATERS AP, 1993, MOL BIOL EVOL, V10, P914; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Zakeri S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-53	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63888	10.1371/journal.pone.0063888	http://dx.doi.org/10.1371/journal.pone.0063888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717506	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600035
J	Ringel-Kulka, T; Cheng, J; Ringel, Y; Salojarvi, J; Carroll, I; Palva, A; de Vos, WM; Satokari, R				Ringel-Kulka, Tamar; Cheng, Jing; Ringel, Yehuda; Salojarvi, Jarkko; Carroll, Ian; Palva, Airi; de Vos, Willem M.; Satokari, Reetta			Intestinal Microbiota in Healthy US Young Children and Adults-A High Throughput Microarray Analysis	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; REAL-TIME PCR; HUMAN GASTROINTESTINAL-TRACT; FECAL MICROBIOTA; GUT MICROBIOTA; REDUCED DIVERSITY; ALLERGIC DISEASE; INCREASED RISK; ANTIBIOTIC USE; DIARRHEA	It is generally believed that the infant's microbiota is established during the first 1-2 years of life. However, there is scarce data on its characterization and its comparison to the adult-like microbiota in consecutive years. Aim: To characterize and compare the intestinal microbiota in healthy young children (1-4 years) and healthy adults from the North Carolina region in the U. S. using high-throughput bacterial phylogenetic microarray analysis. Methods: Detailed characterization and comparison of the intestinal microbiota of healthy children aged 1-4 years old (n = 28) and healthy adults of 21-60 years (n = 23) was carried out using the Human Intestinal Tract Chip (HITChip) phylogenetic microarray targeting the V1 and V6 regions of 16S rRNA and quantitative PCR. Results: The HITChip microarray data indicate that Actinobacteria, Bacilli, Clostridium cluster IV and Bacteroidetes are the predominant phylum-like groups that exhibit differences between young children and adults. The phylum-like group Clostridium cluster XIVa was equally predominant in young children and adults and is thus considered to be established at an early age. The genus-like level show significant 3.6 fold (higher or lower) differences in the abundance of 26 genera between young children and adults. Young U. S. children have a significantly 3.5-fold higher abundance of Bifidobacterium species than the adults from the same location. However, the microbiota of young children is less diverse than that of adults. Conclusions: We show that the establishment of an adult-like intestinal microbiota occurs at a later age than previously reported. Characterizing the microbiota and its development in the early years of life may help identify 'windows of opportunity' for interventional strategies that may promote health and prevent or mitigate disease processes.	[Ringel-Kulka, Tamar] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Cheng, Jing; Salojarvi, Jarkko; Palva, Airi; de Vos, Willem M.; Satokari, Reetta] Univ Helsinki, Dept Vet Biosci, Div Microbiol & Epidemiol, Helsinki, Finland; [Ringel, Yehuda; Carroll, Ian] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [de Vos, Willem M.] Univ Helsinki, Haartman Inst, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Wageningen University & Research	Ringel-Kulka, T (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	ringelta@email.unc.edu	Satokari, Reetta/C-4782-2011; Salojärvi, Jarkko/E-9103-2016	Salojärvi, Jarkko/0000-0002-4096-6278; Satokari, Reetta/0000-0002-4258-3414	Academy of Finland [1138902]; National Institutes of Health [DK075621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075621] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This grant was supported in part by the Academy of Finland (grant 1138902 - JC, JS, AP, WDV, RS) and National Institutes of Health (grant DK075621 - YR, IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Becker RA., 1988, NEW S LANGUAGE PROGR; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bjorkstrom MV, 2009, ACTA PAEDIATR, V98, P1762, DOI 10.1111/j.1651-2227.2009.01471.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Carroll IM, 2011, AM J PHYSIOL-GASTR L, V301, pG799, DOI 10.1152/ajpgi.00154.2011; Carroll IM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-19; CT RD, 2010, R LANG ENV STAT COMP; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Floch MH, 2012, NUTR CLIN PRACT, V27, P193, DOI 10.1177/0884533612439708; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gaboriau-Routhiau V, 2011, CURR OPIN GASTROEN, V27, P502, DOI 10.1097/MOG.0b013e32834bb82b; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Han J, 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kallus SJ, 2012, J CLIN GASTROENTEROL, V46, P16, DOI 10.1097/MCG.0b013e31823711fd; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ringel Yehuda, 2009, Gastrointest Endosc Clin N Am, V19, P141, DOI 10.1016/j.giec.2008.12.004; Ringel-Kulka T, 2012, NUTR CLIN PRACT, V27, P226, DOI 10.1177/0884533612439895; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Simpson E.H., 1949, NATURE, P163, DOI DOI 10.1038/163688A0; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Venable W.B., 2002, MODERN APPL STAT S, V4th; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Westfall PH, 1999, MULTIPLE COMP MULTIP; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	64	118	121	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64315	10.1371/journal.pone.0064315	http://dx.doi.org/10.1371/journal.pone.0064315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717595	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600059
J	Chen, NX; Kiattisunthorn, K; O'Neill, KD; Chen, XM; Moorthi, RN; Gattone, VH; Allen, MR; Moe, SM				Chen, Neal X.; Kiattisunthorn, Kraiwiporn; O'Neill, Kalisha D.; Chen, Xianming; Moorthi, Ranjani N.; Gattone, Vincent H., II; Allen, Matthew R.; Moe, Sharon M.			Decreased MicroRNA Is Involved in the Vascular Remodeling Abnormalities in Chronic Kidney Disease (CKD)	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TYPE-1 RECEPTOR EXPRESSION; DOWN-REGULATION; CIRCULATING MICRORNAS; THERAPEUTIC TARGETS; MORTALITY RISK; DIFFERENTIATION; CALCIFICATION; FIBROBLASTS; PROLIFERATION	Patients with CKD have abnormal vascular remodeling that is a risk factor for cardiovascular disease. MicroRNAs (miRNAs) control mRNA expression intracellularly and are secreted into the circulation; three miRNAs (miR-125b, miR-145 and miR-155) are known to alter vascular smooth muscle cell (VSMC) proliferation and differentiation. We measured these vascular miRNAs in blood from 90 patients with CKD and found decreased circulating levels with progressive loss of eGFR by multivariate analyses. Expression of these vascular miRNAs miR-125b, miR-145, and miR-155 was decreased in the thoracic aorta in CKD rats compared to normal rats, with concordant changes in target genes of RUNX2, angiotensin II type I receptor (AT1R), and myocardin. Furthermore, the expression of miR-155 was negatively correlated with the quantity of calcification in the aorta, a process known to be preceded by vascular de-differentiation in these animals. We then examined the mechanisms of miRNA regulation in primary VSMC and found decreased expression of miR-125b, 145, and 155 in VSMC from rats with CKD compared to normal littermates but no alteration in DROSHA or DICER, indicating that the low levels of expression is not due to altered intracellular processing. Finally, overexpression of miR-155 in VSMC from CKD rats inhibited AT1R expression and decreased cellular proliferation supporting a direct effect of miR-155 on VSMC. In conclusion, we have found ex vivo and in vitro evidence for decreased expression of these vascular miRNA in CKD, suggesting that alterations in miRNAs may lead to the synthetic state of VSMC found in CKD. The decreased levels in the circulation may reflect decreased vascular release but more studies are needed to confirm this relationship.	[Chen, Neal X.; O'Neill, Kalisha D.; Chen, Xianming; Moorthi, Ranjani N.; Moe, Sharon M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Kiattisunthorn, Kraiwiporn] Mahidol Univ, Fac Siriraj Med Sch, Bangkok 10700, Thailand; [Gattone, Vincent H., II; Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Moe, Sharon M.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Mahidol University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Moe, SM (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.	smoe@iupui.edu	Allen, Matthew/A-8799-2015	Allen, Matthew/0000-0002-1174-9004	VA Merit Award; NIH [5R01AR058005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058005] Funding Source: NIH RePORTER	VA Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a VA Merit Award and NIH R01 (5R01AR058005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanco RR, 2012, J CARD FAIL, V18, P717, DOI 10.1016/j.cardfail.2012.06.531; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Chen NX, 2011, AM J NEPHROL, V34, P211, DOI 10.1159/000330175; Chen NX, 2002, KIDNEY INT, V62, P1724, DOI 10.1046/j.1523-1755.2002.00625.x; Chen X, 2009, NEPHROL DIAL TRANSPL; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; COWLEY BD, 1993, KIDNEY INT, V43, P522, DOI 10.1038/ki.1993.79; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Emilian C, 2012, CLIN J AM SOC NEPHRO, V7, P619, DOI 10.2215/CJN.10471011; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; K/DOQI, 2004, AM J KIDNEY DIS S, P1; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; Neal CS, 2011, NEPHROL DIAL TRANSPL, V26, P3794, DOI 10.1093/ndt/gfr485; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pecoits R, 2005, PEDIATR NEPHROL, V20, P714, DOI 10.1007/s00467-005-1891-z; Pisetkul Chotima, 2010, J Med Assoc Thai, V93 Suppl 1, pS147; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Suga T, 2011, J ATHEROSCLER THROMB, V18, P670, DOI 10.5551/jat.7120; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2012, CIRC RES, V110, P481, DOI 10.1161/CIRCRESAHA.111.257311; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wenzel UO, 2010, J RENIN-ANGIO-ALDO S, V11, P37, DOI 10.1177/1470320309347787; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu Chan-Chan, 2008, Shengli Xuebao, V60, P553; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zheng LA, 2010, BIOCHEM BIOPH RES CO, V400, P483, DOI 10.1016/j.bbrc.2010.08.067	50	94	98	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64558	10.1371/journal.pone.0064558	http://dx.doi.org/10.1371/journal.pone.0064558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717629	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700154
J	Eisinger, BE; Zhao, CJ; Driessen, TM; Saul, MC; Gammie, SC				Eisinger, Brian E.; Zhao, Changjiu; Driessen, Terri M.; Saul, Michael C.; Gammie, Stephen C.			Large Scale Expression Changes of Genes Related to Neuronal Signaling and Developmental Processes Found in Lateral Septum of Postpartum Outbred Mice	PLOS ONE			English	Article							MESSENGER-RNA; BEHAVIORAL-RESPONSES; MATERNAL AGGRESSION; KNOCKOUT MICE; BRAIN; ACTIVATION; INHIBITION; PLASTICITY; RECEPTORS; CHANNELS	Coordinated gene expression changes across the CNS are required to produce the mammalian maternal phenotype. Lateral septum (LS) is a brain region critically involved with aspects of maternal care, and we recently examined gene expression of whole septum (LS and medial septum) in selectively bred maternal mice. Here, we expand on the prior study by 1) conducting microarray analysis solely on LS in virgin and postpartum mice, 2) using outbred mice, and 3) evaluating the role of sensory input on gene expression changes. Large scale changes in genes related to neuronal signaling were identified, including four GABA(A) receptor subunits. Subunits alpha 4 and delta were downregulated in maternal LS, likely reflecting a reduction in the extrasynaptic, neurosteroid-sensitive alpha 4/delta containing receptor subtype. Conversely, subunits epsilon and theta were increased in maternal LS. Fifteen K+ channel related genes showed altered expression, as did dopamine receptors Drd1a and Drd2 (both downregulated), hypocretin receptor 1 (Hcrtr1), kappa opioid receptor 1 (Oprk1), and transient receptor potential channel 4 (Trpc4). Expression of a large number of genes linked to developmental processes or cell differentiation were also altered in postpartum LS, including chemokine (C-X-C) motif ligand 12 (Cxcl12), fatty acid binding protein 7 (Fabp7), plasma membrane proteolipid (Pllp), and suppressor of cytokine signaling 2 (Socs2). Additional genes that are linked to anxiety, such as glutathione reductase (Gsr), exhibited altered expression. Pathway analysis also identified changes in genes related to cyclic nucleotide metabolism, chromatin structure, and the Ras gene family. The sensory presence of pups was found to contribute to the altered expression of a subset of genes across all categories. This study suggests that both large changes in neuronal signaling and the possible terminal differentiation of neuronal and/or glial cells play important roles in producing the maternal state.	[Eisinger, Brian E.; Zhao, Changjiu; Driessen, Terri M.; Saul, Michael C.; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Eisinger, BE (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	beeisinger@wisc.edu	Zhao, Changjiu/M-8263-2014; Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	United States National Institutes of Health [R01 MH 085642]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085642] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by United States National Institutes of Health Grant R01 MH 085642 to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Banisadr G, 2003, EUR J NEUROSCI, V18, P1593, DOI 10.1046/j.1460-9568.2003.02893.x; Bradley J, 1997, J NEUROSCI, V17, P1993; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Childs E, 2008, NEUROPSYCHOPHARMACOL, V33, P2791, DOI 10.1038/npp.2008.17; COCHARY EF, 1990, J NEUROCHEM, V55, P602, DOI 10.1111/j.1471-4159.1990.tb04176.x; D'Anna KL, 2006, J NEUROENDOCRINOL, V18, P553, DOI 10.1111/j.1365-2826.2006.01448.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espana RA, 2004, PEPTIDES, V25, P1927, DOI 10.1016/j.peptides.2004.06.006; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; FISCHER I, 1991, J NEUROSCI RES, V28, P81, DOI 10.1002/jnr.490280108; Gammie SC, 2005, MOL BRAIN RES, V139, P201, DOI 10.1016/j.molbrainres.2005.05.011; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; Levy F, 2011, J NEUROENDOCRINOL, V23, P984, DOI 10.1111/j.1365-2826.2011.02203.x; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; LISK RD, 1971, ANIM BEHAV, V19, P606, DOI 10.1016/S0003-3472(71)80118-5; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; MANN PE, 1992, BRAIN RES, V580, P241, DOI 10.1016/0006-8993(92)90950-E; MANN PE, 1989, PHARMACOL BIOCHEM BE, V34, P83, DOI 10.1016/0091-3057(89)90357-2; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; MONTAGNESE CM, 1987, J ENDOCRINOL, V115, P97, DOI 10.1677/joe.0.1150097; Nephew BC, 2009, BEHAV NEUROSCI, V123, P949, DOI 10.1037/a0016734; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; Ransome MI, 2004, EUR J NEUROSCI, V19, P2069, DOI 10.1111/j.0953-816X.2004.03308.x; RASMUS K, 2011, NATURE PRECEDINGS; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; ROMANO GJ, 1988, MOL ENDOCRINOL, V2, P1320, DOI 10.1210/mend-2-12-1320; Sakurai T, 1998, Cell, V92, P696; SAPIRSTEIN VS, 1988, J NEUROCHEM, V51, P925, DOI 10.1111/j.1471-4159.1988.tb01829.x; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; SHEA TB, 1986, J NEUROCHEM, V47, P697; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Simmons ML, 1996, MOL PHARMACOL, V50, P80; Sinkkonen ST, 2004, EUR J NEUROSCI, V20, P2168, DOI 10.1111/j.1460-9568.2004.03684.x; SITTMAN DB, 1983, P NATL ACAD SCI-BIOL, V80, P1849, DOI 10.1073/pnas.80.7.1849; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; SLOTNICK BM, 1975, J COMP PHYSIOL PSYCH, V88, P118, DOI 10.1037/h0076200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turnley AM, 2005, TRENDS ENDOCRIN MET, V16, P53, DOI 10.1016/j.tem.2005.01.006; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; VANDERSCHUREN LJMJ, 1995, EUR J PHARMACOL, V276, P257, DOI 10.1016/0014-2999(95)00040-R; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Wang JP, 2002, J NEUROSCI RES, V67, P423, DOI 10.1002/jnr.10145; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; Zhao CJ, 2012, BRAIN RES, V1470, P35, DOI 10.1016/j.brainres.2012.06.002; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Zufall F, 1997, CURR OPIN NEUROBIOL, V7, P404, DOI 10.1016/S0959-4388(97)80070-0	74	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63824	10.1371/journal.pone.0063824	http://dx.doi.org/10.1371/journal.pone.0063824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717492	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700067
J	Eissmann, M; Schwamb, B; Melzer, IM; Moser, J; Siele, D; Kohl, U; Rieker, RJ; Wachter, DL; Agaimy, A; Herpel, E; Baumgarten, P; Mittelbronn, M; Rakel, S; Kogel, D; Bohm, S; Gutschner, T; Diederichs, S; Zornig, M				Eissmann, Moritz; Schwamb, Bettina; Melzer, Inga Maria; Moser, Julia; Siele, Dagmar; Koehl, Ulrike; Rieker, Ralf Joachim; Wachter, David Lukas; Agaimy, Abbas; Herpel, Esther; Baumgarten, Peter; Mittelbronn, Michel; Rakel, Stefanie; Koegel, Donat; Boehm, Stefanie; Gutschner, Tony; Diederichs, Sven; Zoernig, Martin			A Functional Yeast Survival Screen of Tumor-Derived cDNA Libraries Designed to Identify Anti-Apoptotic Mammalian Oncogenes	PLOS ONE			English	Article							CANCER STEM-CELLS; NONCODING RNA; LUNG-CANCER; SCHIZOSACCHAROMYCES-POMBE; DEATH PATHWAY; BREAST-CANCER; FISSION YEAST; EXPRESSION; TARGET; GENE	Yeast cells can be killed upon expression of pro-apoptotic mammalian proteins. We have established a functional yeast survival screen that was used to isolate novel human anti-apoptotic genes overexpressed in treatment-resistant tumors. The screening of three different cDNA libraries prepared from metastatic melanoma, glioblastomas and leukemic blasts allowed for the identification of many yeast cell death-repressing cDNAs, including 28% of genes that are already known to inhibit apoptosis, 35% of genes upregulated in at least one tumor entity and 16% of genes described as both anti-apoptotic in function and upregulated in tumors. These results confirm the great potential of this screening tool to identify novel antiapoptotic and tumor-relevant molecules. Three of the isolated candidate genes were further analyzed regarding their antiapoptotic function in cell culture and their potential as a therapeutic target for molecular therapy. PAICS, an enzyme required for de novo purine biosynthesis, the long non-coding RNA MALAT1 and the MAST2 kinase are overexpressed in certain tumor entities and capable of suppressing apoptosis in human cells. Using a subcutaneous xenograft mouse model, we also demonstrated that glioblastoma tumor growth requires MAST2 expression. An additional advantage of the yeast survival screen is its universal applicability. By using various inducible pro-apoptotic killer proteins and screening the appropriate cDNA library prepared from normal or pathologic tissue of interest, the survival screen can be used to identify apoptosis inhibitors in many different systems.	[Eissmann, Moritz; Schwamb, Bettina; Melzer, Inga Maria; Moser, Julia; Siele, Dagmar; Boehm, Stefanie; Zoernig, Martin] Chemotherapeut Forschungsinst Georg Speyer Ha, Frankfurt, Germany; [Koehl, Ulrike] IFB Tx, Hannover Med Sch, Inst Cellular Therapeut, Hannover, Germany; [Rieker, Ralf Joachim; Wachter, David Lukas; Agaimy, Abbas] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Herpel, Esther] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Baumgarten, Peter; Mittelbronn, Michel] Edinger Inst, Inst Neurol, Frankfurt, Germany; [Rakel, Stefanie; Koegel, Donat] Goethe Univ Hosp Frankfurt, Ctr Neurol & Neurosurg, Frankfurt, Germany; [Gutschner, Tony; Diederichs, Sven] Helmholtz Univ, Grp Mol RNA Biol & Canc, German Canc Res Ctr DKFZ, Heidelberg, Germany	Hannover Medical School; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Zornig, M (corresponding author), Chemotherapeut Forschungsinst Georg Speyer Ha, Frankfurt, Germany.	zoernig@em.uni-frankfurt.de	Baumgarten, Peter/AAS-6061-2020; Gutschner, Tony/I-3944-2019; Baumgarten, Peter/AAE-1140-2021; Diederichs, Sven/J-6237-2012	Baumgarten, Peter/0000-0002-2563-2691; Gutschner, Tony/0000-0002-1722-3134; Baumgarten, Peter/0000-0002-2563-2691; Diederichs, Sven/0000-0001-7901-4752; Koehl, Ulrike/0000-0002-8159-9160; Mittelbronn, Michel/0000-0002-2998-052X; Kogel, Donat/0000-0003-1209-0210	Graduiertenkolleg [1172]; Deutsche Krebshilfe [108795]; Georg-Speyer-Haus; Wilhelm Sander-Stiftung [2008.091.1]; LOEWE Center for Cell and Gene Therapy Frankfurt [L 4-518/17.004 (2010)]; LOEWE initiative Oncogenic Signaling Frankfurt; German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK)	Graduiertenkolleg(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Georg-Speyer-Haus; Wilhelm Sander-Stiftung; LOEWE Center for Cell and Gene Therapy Frankfurt; LOEWE initiative Oncogenic Signaling Frankfurt; German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK)	This work was supported by the Graduiertenkolleg 1172 (to M.E. and M.Z.), the Deutsche Krebshilfe (grant no. 108795 to D.K.) and institutional funds of the Georg-Speyer-Haus. M.Z. is thankful for the support by the Wilhelm Sander-Stiftung (grant no. 2008.091.1), the LOEWE Center for Cell and Gene Therapy Frankfurt (HMWK III L 4-518/17.004 (2010)) and the LOEWE initiative Oncogenic Signaling Frankfurt (funded by the Hessian Ministry of Higher Education, Research and the Arts; funding reference number III L 4-518/55.004 (2009)). The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES PM, 2006, CANC IMMUNOL; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Bohl SR, 2011, ONKOLOGIE, V34, P269, DOI 10.1159/000327815; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chen G, 1997, ONCOGENE, V15, P1643, DOI 10.1038/sj.onc.1201347; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787; Garland P, 2008, BRAIN RES, V1195, P12, DOI 10.1016/j.brainres.2007.12.027; Gasparic MB, 2010, ANAL BIOANAL CHEM, V396, P2023, DOI 10.1007/s00216-009-3418-0; Gorelik E, 2010, ANTI-CANCER AGENT ME, V10, P164, DOI 10.2174/187152010790909308; Greenhalf W, 1999, YEAST, V15, P1307, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1307::AID-YEA455>3.3.CO;2-V; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; GUTSCHNER T, 2012, RNA BIOL IN PRESS, V9; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; HAAR CP, 2012, NEUROCHEM RES; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Ink B, 1997, MOL CELL BIOL, V17, P2468, DOI 10.1128/MCB.17.5.2468; Ito R, 2011, J BIOCHEM, V149, P731, DOI 10.1093/jb/mvr028; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Johnston NIF, 2008, FRONT BIOSCI-LANDMRK, V13, P4361, DOI 10.2741/3009; Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; Lai MC, 2011, MED ONCOL; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; LONG JS, 2012, ONCOGENE; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Maia CJB, 2008, ENDOCRINE, V34, P108, DOI 10.1007/s12020-008-9113-7; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Melzer IM, 2012, CELL DEATH DIFFER, V19, P1435, DOI 10.1038/cdd.2012.17; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nonn L, 2003, MOL CANCER RES, V1, P682; Pourkarimi E, 2012, CELL DEATH DIFFER, V19, P406, DOI 10.1038/cdd.2011.104; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Sodir NM, 2011, ONCOTARGET, V2, P1307; Soler DC, 2009, BIOL REPROD, V81, P343, DOI 10.1095/biolreprod.109.076398; Speirs CK, 2011, AM J CANCER RES, V1, P43; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tischner D, 2010, Cell Death Dis, V1, pe48, DOI 10.1038/cddis.2010.27; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulukaya E, 2011, CELL BIOCHEM FUNCT, V29, P468, DOI 10.1002/cbf.1774; Unterkircher T, 2011, CLIN CANCER RES, V17, P4019, DOI 10.1158/1078-0432.CCR-11-0075; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Wellenreuther R, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-36; Westhouse RA, 2010, TOXICOL PATHOL, V38, P165, DOI 10.1177/0192623309354341; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xiong HB, 2004, J BIOL CHEM, V279, P43675, DOI 10.1074/jbc.M404328200; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yamada K, 2006, CANCER SCI, V97, P106, DOI 10.1111/j.1349-7006.2006.00147.x; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; YAUCH RL, 2012, CURR OPIN GENET DEV; Yu Yang, 2012, Front Biosci (Elite Ed), V4, P1528; Zakeri Z, 2002, J IMMUNOL METHODS, V265, P3, DOI 10.1016/S0022-1759(02)00067-4; ZHANG LQ, 2011, MOL CELL BIOCH; Zhou H, 2004, J IMMUNOL, V172, P2559, DOI 10.4049/jimmunol.172.4.2559; Zornig M, 2001, BBA-REV CANCER, V1551, pF1, DOI 10.1016/S0304-419X(01)00031-2; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	75	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64873	10.1371/journal.pone.0064873	http://dx.doi.org/10.1371/journal.pone.0064873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717670	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700179
J	Filchakova, O; McIntosh, JM				Filchakova, Olena; McIntosh, J. Michael			Functional Expression of Human alpha 9*Nicotinic Acetylcholine Receptors in X. laevis Oocytes Is Dependent on the alpha 9 Subunit 5 ' UTR	PLOS ONE			English	Article							OPEN READING FRAMES; NICOTINIC CHOLINERGIC-RECEPTOR; CELL-SURFACE EXPRESSION; MOSAIC-VIRUS RNA; MESSENGER-RNA; PHARMACOLOGICAL-PROPERTIES; IN-VITRO; UNTRANSLATED REGION; MOLECULAR-CLONING; K+ CHANNEL	Nicotinic acetylcholine receptors (nAChRs) containing the alpha 9 subunit are expressed in a wide variety of non-neuronal tissues ranging from immune cells to breast carcinomas. The alpha 9 subunit is able to assemble into a functional homomeric nAChR and also co-assemble with the alpha 10 subunit into functional heteromeric nAChRs. Despite the increasing awareness of the important roles of this subunit in vertebrates, the study of human alpha 9-containing nAChRs has been severely limited by difficulties in its expression in heterologous systems. In Xenopus laevis oocytes, functional expression of human alpha 9 alpha 10 nAChRs is very low compared to that of rat alpha 9 alpha 10 nAChRs. When oocytes were co-injected with cRNA of alpha 9 and alpha 10 subunits of human versus those of rat, oocytes with the rat alpha 9 human alpha 10 combination had an similar to-fold higher level of acetylcholine-gated currents (IACh) than those with the human alpha 9 rat alpha 10 combination, suggesting difficulties with human alpha 9 expression. When the ratio of injected human alpha 9 cRNA to human alpha 10 cRNA was increased from 1:1 to 5:1, I-ACh increased 36-fold (from 142 +/- 23 nA to 5171 +/- 748 nA). Functional expression of human alpha 9-containing receptors in oocytes was markedly improved by appending the 5'-untranslated region of alfalfa mosaic virus RNA4 to the 5'-leader sequence of the alpha 9 subunit cRNA. This increased the functional expression of homomeric human alpha 9 receptors by 70-fold (from 7 +/- 1 nA to 475 +/- 158 nA) and of human alpha 9 alpha 10 heteromeric receptors by 80-fold (from 113 +/- 62 nA to 9192 +/- 1137 nA). These findings indicate the importance of the composition of the 5' untranslated leader sequence for expression of alpha 9-containing nAChRs.	[Filchakova, Olena; McIntosh, J. Michael] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Filchakova, O (corresponding author), Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA.	filchako@yahoo.com		Filchakova, Olena/0000-0002-4120-7206	National Institute of Health [GM48677, GM103801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institute of Health Grants GM48677 and GM103801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2010, J MOL NEUROSCI, V40, P12, DOI 10.1007/s12031-009-9246-z; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; BARNARD EA, 1982, PROC R SOC SER B-BIO, V215, P241, DOI 10.1098/rspb.1982.0040; BREDERODE FT, 1980, NUCLEIC ACIDS RES, V8, P2213, DOI 10.1093/nar/8.10.2213; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cheng AX, 2005, J BIOL CHEM, V280, P22502, DOI 10.1074/jbc.M414341200; Colomer C, 2010, J NEUROSCI, V30, P6732, DOI 10.1523/JNEUROSCI.4997-09.2010; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; Dani John A, 2011, J Addict Res Ther, VS1; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; Fan QL, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-22; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Fucile S, 2006, CELL CALCIUM, V39, P349, DOI 10.1016/j.ceca.2005.12.002; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; GALLIE DR, 1992, NUCLEIC ACIDS RES, V20, P4631, DOI 10.1093/nar/20.17.4631; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; GEHRKE L, 1983, BIOCHEMISTRY-US, V22, P5157, DOI 10.1021/bi00291a015; Gopalakrishnan M, 1996, J PHARMACOL EXP THER, V276, P289; GOTTI C, 1994, EUR J NEUROSCI, V6, P1281, DOI 10.1111/j.1460-9568.1994.tb00318.x; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Holtman JR, 2011, EUR J PHARMACOL, V670, P500, DOI 10.1016/j.ejphar.2011.08.053; Hudder A, 2000, J BIOL CHEM, V275, P34586, DOI 10.1074/jbc.M005199200; HUEZ G, 1974, P NATL ACAD SCI USA, V71, P3143, DOI 10.1073/pnas.71.8.3143; Jacobs E, 2012, J GENET GENOMICS, V39, P535, DOI 10.1016/j.jgg.2012.08.002; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; KUFFLER SW, 1975, J PHYSIOL-LONDON, V244, P703, DOI 10.1113/jphysiol.1975.sp010821; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lee CH, 2010, JNCI-J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Levin ED, 2012, CURR DRUG TARGETS, V13, P602, DOI 10.2174/138945012800398937; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lips KS, 2005, PLACENTA, V26, P735, DOI 10.1016/j.placenta.2004.10.009; Lips KS, 2002, NEUROSCIENCE, V115, P1, DOI 10.1016/S0306-4522(02)00274-9; Lustig LR, 2001, GENOMICS, V73, P272, DOI 10.1006/geno.2000.6503; Maison SF, 2002, J NEUROSCI, V22, P10838; Marchi M, 2010, PROG NEUROBIOL, V92, P105, DOI 10.1016/j.pneurobio.2010.06.004; McIntosh JM, 2009, BIOCHEM PHARMACOL, V78, P693, DOI 10.1016/j.bcp.2009.05.020; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morel N, 2000, J BIOL CHEM, V275, P7304, DOI 10.1074/jbc.275.10.7304; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nie LP, 2004, J NEUROPHYSIOL, V91, P1536, DOI 10.1152/jn.00630.2003; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Nishizaki T, 2003, MOL BRAIN RES, V114, P172, DOI 10.1016/S0169-328X(03)00171-2; Nomura M, 1984, Nucleic Acids Symp Ser, P173; Osman AA, 2008, MOL CELL NEUROSCI, V38, P153, DOI 10.1016/j.mcn.2008.02.008; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pascale A, 2012, CELL MOL LIFE SCI, V69, P501, DOI 10.1007/s00018-011-0810-7; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Skok VI, 2002, AUTON NEUROSCI-BASIC, V97, P1, DOI 10.1016/S1566-0702(01)00386-1; SLEAT DE, 1987, GENE, V60, P217, DOI 10.1016/0378-1119(87)90230-7; SOREQ H, 1974, J MOL BIOL, V88, P233, DOI 10.1016/0022-2836(74)90307-6; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; SUMIKAWA K, 1981, NATURE, V292, P862, DOI 10.1038/292862a0; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Valles AS, 2012, BBA-BIOMEMBRANES, V1818, P718, DOI 10.1016/j.bbamem.2011.10.012; Valles AS, 2009, ACTA PHARMACOL SIN, V30, P818, DOI 10.1038/aps.2009.54; van Kleef RGDM, 2008, TOXICOL IN VITRO, V22, P1568, DOI 10.1016/j.tiv.2008.06.007; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Vincler M, 2005, EXPERT OPIN INV DRUG, V14, P1191, DOI 10.1517/13543784.14.10.1191; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wala EP, 2012, ANESTH ANALG, V115, P713, DOI 10.1213/ANE.0b013e31825a3c72; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang NS, 2002, PROG NEUROBIOL, V68, P341, DOI 10.1016/S0301-0082(02)00106-5; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200	102	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64655	10.1371/journal.pone.0064655	http://dx.doi.org/10.1371/journal.pone.0064655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717646	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700164
J	Merz, WM; Kubler, K; Fimmers, R; Willruth, A; Stoffel-Wagner, B; Gembruch, U				Merz, Waltraut M.; Kuebler, Kirsten; Fimmers, Rolf; Willruth, Arne; Stoffel-Wagner, Birgit; Gembruch, Ulrich			Cardiorenal Syndrome is Present in Human Fetuses with Severe, Isolated Urinary Tract Malformations	PLOS ONE			English	Article							NATRIURETIC PEPTIDE CONCENTRATIONS; CHRONIC HEART-FAILURE; CARDIOVASCULAR-DISEASE; FETAL ANEMIA; CORD BLOOD; DIAGNOSIS; BETA(2)-MICROGLOBULIN; CIRCULATION; UPDATE; CKD	Objective: We analyzed the association between renal and cardiovascular parameters in fetuses with isolated severe urinary tract malformations. Methods: 39 fetuses at a mean gestational age of 23.6 weeks with nephropathies or urinary tract malformations and markedly impaired or absent renal function were prospectively examined. Fetal echocardiography was performed, and thicknesses of the interventricular septum, and left and right ventricular wall were measured. Blood flow velocity waveforms of the umbilical artery, middle cerebral artery, and ductus venosus were obtained by color Doppler ultrasound. Concentrations of circulating n-terminal pro-B-type natriuretic peptide (nt-proBNP), cystatin C, beta(2)-microglobulin, and hemoglobin were determined from fetal blood samples. Results: Malformations included 21 cases of obstructive uropathy, 10 fetuses with bilateral nephropathy, and 8 cases of bilateral renal agenesis. Marked biventricular myocardial hypertrophy was present in all cases. The ratio between measured and gestational age-adjusted normal values was 2.01 (interventricular septum), 1.85, and 1.78 (right and left ventricular wall, respectively). Compared to controls, levels of circulating nt-proBNP were significantly increased (median (IQR) 5035 ng/L (5936 ng/L) vs. 1874 ng/L (1092 ng/L); p<0.001). Cystatin C and beta(2)-microglobulin concentrations were elevated as follows (mean +/- SD) 1.85 +/- 0.391 mg/L and 8.44 +/- 2.423 mg/L, respectively (normal range 1.66 +/- 0.202 mg/L and 4.25 +/- 0.734 mg/L, respectively). No correlation was detected between cardiovascular parameters and urinary tract morphology and function. Despite increased levels of nt-proBNP cardiovascular function was preserved, with normal fetal Doppler indices in 90.2% of cases. Conclusion: Urinary tract malformations resulting in severe renal impairment are associated with biventricular myocardial hypertrophy and elevated concentrations of circulating nt-proBNP during fetal life. Cardiovascular findings do not correlate with kidney function or morphology.	[Merz, Waltraut M.; Kuebler, Kirsten; Willruth, Arne; Gembruch, Ulrich] Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Sch Med, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Sch Med, Inst Clin Chem & Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Merz, WM (corresponding author), Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany.	waltraut.merz@ukb.uni-bonn.de	Gembruch, Ulrich/Q-8228-2017	Gembruch, Ulrich/0000-0001-8284-4669; Kubler, Kirsten/0000-0002-0342-5579				BERRY SM, 1995, LANCET, V345, P1277, DOI 10.1016/S0140-6736(95)90928-1; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Bokenkamp A, 2001, AM J OBSTET GYNECOL, V185, P468, DOI 10.1067/mob.2001.115283; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Copelovitch L, 2011, CLIN J AM SOC NEPHRO, V6, P2047, DOI 10.2215/CJN.10751210; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; deFilippi CR, 2009, CLIN CHEM, V55, P1271, DOI 10.1373/clinchem.2009.128157; DeVore GR, 2005, ULTRASOUND OBST GYN, V26, P596, DOI 10.1002/uog.2605; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Firpo C, 2001, AM J CARDIOL, V87, P594, DOI 10.1016/S0002-9149(00)01437-5; Gibson KJ, 1999, CLIN EXP PHARMACOL P, V26, P765, DOI 10.1046/j.1440-1681.1999.03127.x; Girsen A, 2007, ULTRASOUND OBST GYN, V29, P296, DOI 10.1002/uog.3934; Hammerer-Lercher A, 2005, CLIN CHEM, V51, P913, DOI 10.1373/clinchem.2004.046557; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; Kocylowski RD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.009; Lechner E, 2009, PEDIATR RES, V66, P466, DOI 10.1203/PDR.0b013e3181b3aee4; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; McGrath MF, 2005, PEPTIDES, V26, P933, DOI 10.1016/j.peptides.2004.12.022; Merz WM, 2012, PEDIATR RES, V72, P174, DOI 10.1038/pr.2012.53; Merz WM, 2012, CLIN RES CARDIOL, V101, P73, DOI 10.1007/s00392-011-0366-4; Merz WM, 2010, CLIN BIOCHEM, V43, P519, DOI 10.1016/j.clinbiochem.2009.11.012; Nybo M, 2007, CLIN CHEM, V53, P1921, DOI 10.1373/clinchem.2007.089391; Ordonez-Llanos J, 2008, AM J CARDIOL, V101, p9A, DOI 10.1016/j.amjcard.2007.11.013; Patel HP, 2010, RENAL FAILURE, V32, P1, DOI 10.3109/08860220903288534; Pedra SRFF, 2002, CIRCULATION, V106, P585, DOI 10.1161/01.CIR.0000023900.58293.FE; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Rinat C, 2012, PEDIATR NEPHROL, V27, P617, DOI 10.1007/s00467-011-2025-4; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Rychik J, 2010, ULTRASOUND OBST GYN, V36, P682, DOI 10.1002/uog.7664; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Sanjuan R, 2011, CARDIORENAL MED, V1, P147, DOI 10.1159/000329337; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Sivasankaran S, 2005, CARDIOL YOUNG, V15, P409, DOI 10.1017/S1047951105000855; Veniant M, 1996, J CLIN INVEST, V98, P1966, DOI 10.1172/JCI119000; Wilson AC, 2009, AM J KIDNEY DIS, V54, P345, DOI 10.1053/j.ajkd.2009.04.027; Yamashita T, 2010, J CARDIOL, V55, P377, DOI 10.1016/j.jjcc.2010.01.008	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63664	10.1371/journal.pone.0063664	http://dx.doi.org/10.1371/journal.pone.0063664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717461	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700046
J	Moyle, PB; Kiernan, JD; Crain, PK; Quinones, RM				Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.			Climate Change Vulnerability of Native and Alien Freshwater Fishes of California: A Systematic Assessment Approach	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; BIODIVERSITY; IMPACTS; DECLINE; THREATS	Freshwater fishes are highly vulnerable to human-caused climate change. Because quantitative data on status and trends are unavailable for most fish species, a systematic assessment approach that incorporates expert knowledge was developed to determine status and future vulnerability to climate change of freshwater fishes in California, USA. The method uses expert knowledge, supported by literature reviews of status and biology of the fishes, to score ten metrics for both (1) current status of each species (baseline vulnerability to extinction) and (2) likely future impacts of climate change (vulnerability to extinction). Baseline and climate change vulnerability scores were derived for 121 native and 43 alien fish species. The two scores were highly correlated and were concordant among different scorers. Native species had both greater baseline and greater climate change vulnerability than did alien species. Fifty percent of California's native fish fauna was assessed as having critical or high baseline vulnerability to extinction whereas all alien species were classified as being less or least vulnerable. For vulnerability to climate change, 82% of native species were classified as highly vulnerable, compared with only 19% for aliens. Predicted climate change effects on freshwater environments will dramatically change the fish fauna of California. Most native fishes will suffer population declines and become more restricted in their distributions; some will likely be driven to extinction. Fishes requiring cold water (<22 degrees C) are particularly likely to go extinct. In contrast, most alien fishes will thrive, with some species increasing in abundance and range. However, a few alien species will likewise be negatively affected through loss of aquatic habitats during severe droughts and physiologically stressful conditions present in most waterways during summer. Our method has high utility for predicting vulnerability to climate change of diverse fish species. It should be useful for setting conservation priorities in many different regions.	[Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Moyle, Peter B.; Kiernan, Joseph D.; Crain, Patrick K.; Quinones, Rebecca M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Kiernan, Joseph D.] NOAA, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Crain, Patrick K.] ICF Int, Sacramento, CA USA; [Quinones, Rebecca M.] Tech Univ Munich, Lehrstuhl Aquat Systembiol, Freising Weihenstephan, Germany	University of California System; University of California Davis; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA; Technical University of Munich	Moyle, PB (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	pbmoyle@ucdavis.edu	Kiernan, Joseph/S-3613-2019		California Energy Commission	California Energy Commission	Funding for this work was provided by the California Energy Commission. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. An earlier version of the manuscript is available as a report (CEC-500-2012-028) at http://www.energy.ca.gov/publications.	[Anonymous], CONSERVATION BIOL TH; Aparicio E, 2000, ENVIRON BIOL FISH, V59, P11, DOI 10.1023/A:1007618517557; Aparicio E, 2011, AQUAT CONSERV, V21, P324, DOI 10.1002/aqc.1197; Arthington A. H., 2012, ENV FLOWS SAVING RIV; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Donley EE, 2012, GLOBAL CHANGE BIOL, V18, P3071, DOI 10.1111/j.1365-2486.2012.02773.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Galbraith H, 2009, EPA600R09011 NAT CTR; Galbraith H, 2011, SCANNING CONSERVATIO, P90; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002; Hanak E., 2011, MANAGING CALIFORNIAS; Helfman G. S., 2007, FISH CONSERVATION; Katz JVE, 2012, ENV BIOL FISHES; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Kiernan JD, 2012, ECOL APPL, V22, P1472; Kiernan JD, 2012, ECOL APPL, V22, P1146, DOI 10.1890/11-1047.1; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Leidy RA, 2011, AQUAT CONSERV, V21, P472, DOI 10.1002/aqc.1208; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; Moyle P, 2008, SALMON STEELHEAD TRO; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 1995, FISH SPECIES SPECIAL; Moyle PB, 2012, CALIFORNIA ENERGY CO, VCEC-500-2012-028; Moyle PB, 2013, FISH SPECIE IN PRESS; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Null S, 2012, CLIMATIC CHANGE, P1; Quinones RM, 2013, LINKING SCI MANAGEME; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wenger SJ, 2011, P NATL ACAD SCI	30	100	102	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63883	10.1371/journal.pone.0063883	http://dx.doi.org/10.1371/journal.pone.0063883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717503	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700075
J	Weng, LM; Piotrowski, A; Morrison, DA				Weng, Liming; Piotrowski, Andrew; Morrison, Donald A.			Exit from Competence for Genetic Transformation in Streptococcus pneumoniae Is Regulated at Multiple Levels	PLOS ONE			English	Article							ALTERNATIVE SIGMA-FACTOR; FACTOR COMX; DNA; IDENTIFICATION; PHEROMONE; REGULONS; STRESS; CONSTRUCTION; MUTAGENESIS; EXPRESSION	Development of natural competence in S. pneumoniae entails coordinated expression of two sets of genes. Early gene expression depends on ComE, a response regulator activated by the pheromone CSP (Competence-Stimulating-Peptide). Subsequently, an early gene product (the alternative sigma factor ComX) activates expression of late genes, establishing the competent state. Expression of both sets of genes is transient, rapidly shut off by a mechanism that depends on the late gene, dprA. It has been thought that the rapid shutoff of late gene expression is the combined result of auto-inhibition of ComE and the instability of ComX. However, this explanation seems incomplete, because of evidence for ComX-dependent repressor(s) that might also be important for shutting off the response to CSP and identifying dprA as such a gene. We screened individual late gene mutants to investigate further the roles of ComX-dependent genes in competence termination. A Delta dprA mutant displayed a prolonged late gene expression pattern, whereas mutants lacking cbpD, cibABC, cglEFG, coiA, ssbB, celAB, cclA, cglABCD, cflAB, or radA, exhibited a wild-type temporal expression pattern. Thus, no other gene than dprA was found to be involved in shutoff. DprA limits the amounts of ComX and another early gene product, ComW, by restriction of early gene expression rather than by promoting proteolysis. To ask if DprA also affects late gene expression, we decoupled late gene expression from early gene regulation. Because DprA did not limit ComX activity under these conditions, we also conclude that ComX activity is limited by another mechanism not involving DprA.	[Weng, Liming; Piotrowski, Andrew; Morrison, Donald A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Morrison, DA (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	DAMorris@uic.edu	Weng, Liming/E-7791-2015		National Science Foundation Division of Molecular and Cellular Biosciences Genetic Mechanisms Program [MCB1020863]	National Science Foundation Division of Molecular and Cellular Biosciences Genetic Mechanisms Program	This material is based upon work supported in part by the National Science Foundation Division of Molecular and Cellular Biosciences Genetic Mechanisms Program under Grant No. MCB1020863. No additional external funding received for this study. The NSF web site is at: https://www.fastlane.nsf.gov/fastlane.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bai C, 1997, ADV MOLEC BIOL, P11; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; Berge M, 2002, COMPETENCE TRANSFORM; CATO A, 1968, J MOL BIOL, V37, P157, DOI 10.1016/0022-2836(68)90080-6; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2002, FRONT BIOSCI-LANDMRK, V7, pD1798, DOI 10.2741/claverys; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Desai BV, 2006, J BACTERIOL, V188, P5177, DOI 10.1128/JB.00103-06; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Granadel C, 2007, 8 EUR M MOL BIOL PNE, P90; James P, 1996, GENETICS, V144, P1425; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Lee MS, 1999, APPL ENVIRON MICROB, V65, P1883; Luo P, 2004, MOL MICROBIOL, V54, P172, DOI 10.1111/j.1365-2958.2004.04254.x; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; Luo P, 2003, THESIS; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Mirouze N, 2013, P NATL ACAD SCI USA, V110, P352, DOI 10.1073/pnas.1219868110; MORRISON DA, 1984, J BACTERIOL, V159, P870, DOI 10.1128/JB.159.3.870-876.1984; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; OGGIONI MR, 2008, CHEM COMMUNICATION B, P345, DOI DOI 10.1128/9781555815578.CH22; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Piotrowski A, 2009, J BACTERIOL, V191, P3359, DOI 10.1128/JB.01750-08; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; Sambrook J., 2001, MOL CLONING LAB MANU; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tokarev AA, 2009, TRAFFIC, V10, P1831, DOI 10.1111/j.1600-0854.2009.00988.x; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; Ween O, 1999, MOL MICROBIOL, V33, P817, DOI 10.1046/j.1365-2958.1999.01528.x	38	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64197	10.1371/journal.pone.0064197	http://dx.doi.org/10.1371/journal.pone.0064197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717566	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700116
J	Yang, W; Dietz, T; Liu, W; Luo, JY; Liu, JG				Yang, Wu; Dietz, Thomas; Liu, Wei; Luo, Junyan; Liu, Jianguo			Going Beyond the Millennium Ecosystem Assessment: An Index System of Human Dependence on Ecosystem Services	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; BIODIVERSITY CONSERVATION; BENEFIT TRANSFER; VALUATION; ECOTOURISM; SCIENCE; AREAS	The Millennium Ecosystem Assessment (MA) estimated that two thirds of ecosystem services on the earth have degraded or are in decline due to the unprecedented scale of human activities during recent decades. These changes will have tremendous consequences for human well-being, and offer both risks and opportunities for a wide range of stakeholders. Yet these risks and opportunities have not been well managed due in part to the lack of quantitative understanding of human dependence on ecosystem services. Here, we propose an index of dependence on ecosystem services (IDES) system to quantify human dependence on ecosystem services. We demonstrate the construction of the IDES system using household survey data. We show that the overall index and sub-indices can reflect the general pattern of households' dependences on ecosystem services, and their variations across time, space, and different forms of capital (i.e., natural, human, financial, manufactured, and social capitals). We support the proposition that the poor are more dependent on ecosystem services and further generalize this proposition by arguing that those disadvantaged groups who possess low levels of any form of capital except for natural capital are more dependent on ecosystem services than those with greater control of capital. The higher value of the overall IDES or sub-index represents the higher dependence on the corresponding ecosystem services, and thus the higher vulnerability to the degradation or decline of corresponding ecosystem services. The IDES system improves our understanding of human dependence on ecosystem services. It also provides insights into strategies for alleviating poverty, for targeting priority groups of conservation programs, and for managing risks and opportunities due to changes of ecosystem services at multiple scales.	[Yang, Wu; Dietz, Thomas; Liu, Wei; Luo, Junyan; Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Dietz, Thomas] Michigan State Univ, Dept Sociol, Environm Sci & Policy Program, E Lansing, MI 48824 USA; [Dietz, Thomas] Michigan State Univ, Anim Studies Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Yang, W (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	yangwu1201@gmail.com	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Yang, Wu/0000-0002-1682-3349; Dietz, Thomas/0000-0001-9399-0784	National Science Foundation (NSF) [0709717, OISE-0729709]; National Aeronautics and Space Administration (NASA) [NNX08AL04G]; Michigan State University AgBioResearch; Michigan State University's Environmental Science and Policy Program; Michigan State University's Graduate Office	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Michigan State University AgBioResearch; Michigan State University's Environmental Science and Policy Program; Michigan State University's Graduate Office	We gratefully acknowledge financial support from the National Science Foundation (NSF Award Numbers 0709717 and OISE-0729709), the National Aeronautics and Space Administration (NASA Award Number NNX08AL04G), Michigan State University AgBioResearch (http://agbioresearch.msu.edu/), and fellowships from Michigan State University's Environmental Science and Policy Program (http://www.espp.msu.edu/) and Graduate Office (http://grad.msu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah S, 2008, ECOL ECON, V65, P35, DOI 10.1016/j.ecolecon.2007.11.009; Alberti M., 2011, B ECOL SOC AM, V92, P218, DOI [10.1890/0012-9623-92.2.218, DOI 10.1890/0012-9623-92.2.218]; An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; Barbier EB, 2011, ANNU REV RESOUR ECON, V3, P337, DOI 10.1146/annurev-resource-083110-120115; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Boardman A, 2006, COST BENEFIT ANAL CO; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; CAMPBELL A, 1976, AM PSYCHOL, V31, P117, DOI 10.1037/0003-066X.31.2.117; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carson RT, 2001, ENVIRON RESOUR ECON, V19, P173, DOI 10.1023/A:1011128332243; Chang J, 2011, ECOL ECON, V70, P740, DOI 10.1016/j.ecolecon.2010.11.011; Chee YE, 2004, BIOL CONSERV, V120, P549, DOI 10.1016/j.biocon.2004.03.028; Chen XD, 2012, ORGAN ENVIRON, V25, P3, DOI 10.1177/1086026611436216; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; DeRus G, 2010, INTRODUCTION TO COST-BENEFIT ANALYSIS: LOOKING FOR REASONABLE SHORTCUTS, P1; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Farber SC, 2002, ECOL ECON, V41, P375, DOI 10.1016/S0921-8009(02)00088-5; Grant S, 2009, PSYCHOL REP, V105, P205, DOI 10.2466/PR0.105.1.205-231; Grigg A, 2008, DEPENDENCY IMPACT EC; Hanley N, 1998, J AGR ECON, V49, P1, DOI 10.1111/j.1477-9552.1998.tb01248.x; Hanley N., 2001, INTRO ENV EC; He GM, 2008, ENVIRON MANAGE, V42, P1017, DOI 10.1007/s00267-008-9214-3; He GM, 2009, LANDSCAPE URBAN PLAN, V92, P1, DOI 10.1016/j.landurbplan.2009.01.010; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Lai B, 2005, DEV HIST WOLONG NATU; Liu J., 2013, ENCY BIODIVERSITY, P372, DOI DOI 10.1016/B978-0-12-384719-5.00335-X; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2012, SCIENCE, V337, P649, DOI 10.1126/science.1219471; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035420; Millennium Ecosystem Assessment, 2005, EC HUM WELL BRING SY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; National Bureau of Statistics of China, 2011, RUR HOUS SURV INSTR; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Ready R, 2006, ECOL ECON, V60, P429, DOI 10.1016/j.ecolecon.2006.05.008; Rosa EA., 2010, HUMAN FOOTPRINTS GLO; Scott MJ, 1998, ENVIRON MANAGE, V22, P49, DOI 10.1007/s002679900083; Shackleton C., 2008, LINKS ECOSYSTEM SERV; Shrestha R, 2007, ECON NON-MARK GOOD, V9, P161, DOI 10.1007/1-4020-5405-X_9; Turner BL, 2008, P NATL ACAD SCI USA, V105, P2751, DOI 10.1073/pnas.0800052105; Wallace K, 2008, BIOL CONSERV, V141, P353, DOI 10.1016/j.biocon.2007.12.014; Wallace KJ, 2007, BIOL CONSERV, V139, P235, DOI 10.1016/j.biocon.2007.07.015; Wilson MA, 2006, ECOL ECON, V60, P335, DOI 10.1016/j.ecolecon.2006.08.015; Yang W, 2013, J ENV MANAG IN PRESS, DOI [10.1016/j.jenvman.2013.1004.1019, DOI 10.1016/J.JENVMAN.2013.1004.1019]; Yang W, 2008, ECOL ECON, V68, P116, DOI 10.1016/j.ecolecon.2008.02.008; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064582; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	55	88	98	7	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64581	10.1371/journal.pone.0064581	http://dx.doi.org/10.1371/journal.pone.0064581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717634	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700157
J	Comito, G; Giannoni, E; Segura, CP; Barcellos-de-Souza, P; Raspollini, MR; Baroni, G; Lanciotti, M; Serni, S; Chiarugi, P				Comito, G.; Giannoni, E.; Segura, C. P.; Barcellos-de-Souza, P.; Raspollini, M. R.; Baroni, G.; Lanciotti, M.; Serni, S.; Chiarugi, P.			Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression	ONCOGENE			English	Article						prostate carcinoma progression; cancer-associated fibroblasts; cancer-associated macrophages; M1/M2 macrophage polarization; IL-6; SDF-1	ENDOTHELIAL PROGENITOR CELLS; TUMOR PROGRESSION; OXIDATIVE STRESS; GROWTH; MICROENVIRONMENT; DIFFERENTIATION; ANGIOGENESIS; ACTIVATION; TRANSITION; MONOCYTES	Inflammation is now acknowledged as an hallmark of cancer. Cancer-associated fibroblasts (CAFs) force a malignant cross talk with cancer cells, culminating in their epithelial-mesenchymal transition and achievement of stemness traits. Herein, we demonstrate that stromal tumor-associated cells cooperate to favor malignancy of prostate carcinoma (PCa). Indeed, prostate CAFs are active factors of monocyte recruitment toward tumor cells, mainly acting through stromal-derived growth factor-1 delivery and promote their trans-differentiation toward the M2 macrophage phenotype. The relationship between M2 macrophages and CAFs is reciprocal, as M2 macrophages are able to affect mesenchymal-mesenchymal transition of fibroblasts, leading to their enhanced reactivity. On the other side, PCa cells themselves participate in this cross talk through secretion of monocyte chemotactic protein-1, facilitating monocyte recruitment and again macrophage differentiation and M2 polarization. Finally, this complex interplay among cancer cells, CAFs and M2 macrophages, cooperates in increasing tumor cell motility, ultimately fostering cancer cells escaping from primary tumor and metastatic spread, as well as in activation of endothelial cells and their bone marrow-derived precursors to drive de novo angiogenesis. In keeping with our data obtained in vitro, the analysis of patients affected by prostate cancers at different clinical stages revealed a clear increase in the M2/M1 ratio in correlation with clinical values. These data, coupled with the role of CAFs in carcinoma malignancy to elicit expression of stem-like traits, should focus great interest for innovative strategies aimed at the co-targeting of inflammatory cells and fibroblasts to improve therapeutic efficacy.	[Comito, G.; Giannoni, E.; Segura, C. P.; Barcellos-de-Souza, P.; Chiarugi, P.] Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy; [Raspollini, M. R.; Baroni, G.] Univ Florence, Histol & Mol Diagnost Univ, Careggi Hosp, I-50134 Florence, Italy; [Lanciotti, M.; Serni, S.] Univ Florence, Careggi Hosp, Dept Urol, I-50134 Florence, Italy; [Chiarugi, P.] Ctr Res Transfer & High Educ DenoTHE, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Chiarugi, P (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy.	paola.chiarugi@unifi.it	Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022; de Souza, Pedro Barcellos/E-4957-2017	de Souza, Pedro Barcellos/0000-0003-1903-5089; Lanciotti, Michele/0000-0002-3368-8652; Comito, Giuseppina/0000-0002-4614-067X; Chiarugi, Paola/0000-0001-7655-2969; Giannoni, Elisa/0000-0001-7136-1098	Associazione Italiana Ricerca sul Cancro (AIRC); Istituto Toscano Tumori; MIUR (PRIN); Capes (Ministerio da Educacao, Brazil)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori; MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Capes (Ministerio da Educacao, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC), by Istituto Toscano Tumori, and by MIUR (PRIN 2008). Pedro Barcellos-de-Souza was supported by postdoctoral fellowship from Capes (Ministerio da Educacao, Brazil).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Cat B, 2006, J CELL SCI, V119, P2727, DOI 10.1242/jcs.03011; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Comito G, 2012, CANCER LETT, V324, P31, DOI 10.1016/j.canlet.2012.04.025; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Geldhof Anja B, 2003, Clin Dev Immunol, V10, P71, DOI 10.1080/10446670310001626580; Giannoni E, 2013, J MOL MED, V91, P103, DOI 10.1007/s00109-012-0941-9; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Guido C, 2012, CELL CYCLE, V11, P3019, DOI 10.4161/cc.21384; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hembruff SL, 2010, NEOPLASIA, V12, P425, DOI 10.1593/neo.10200; Inoue H, 2005, CANCER LETT, V223, P121, DOI 10.1016/j.canlet.2004.09.053; Jinushi M, 2012, AM J CANCER RES, V2, P529; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Ksiazkiewicz M, 2010, IMMUNOBIOLOGY, V215, P737, DOI 10.1016/j.imbio.2010.05.019; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Margheri F, 2011, BLOOD, V118, P3743, DOI 10.1182/blood-2011-02-338681; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, CANCER MICROENVIRON, V5, P133, DOI 10.1007/s12307-011-0091-6; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yoder MC, 2007, CELL STEM CELL, V1, P603, DOI 10.1016/j.stem.2007.11.005; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	45	280	292	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2423	2431		10.1038/onc.2013.191	http://dx.doi.org/10.1038/onc.2013.191			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23728338				2022-12-25	WOS:000336033600002
J	Frazier, SJ; Cohen, BN; Lester, HA				Frazier, Shawnalea J.; Cohen, Bruce N.; Lester, Henry A.			An Engineered Glutamate-gated Chloride (GluCl) Channel for Sensitive, Consistent Neuronal Silencing by Ivermectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; ACETYLCHOLINE-RECEPTOR; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; GABA(B) RECEPTOR; M2 DOMAIN; ACTIVATION; PROTEINS; IDENTIFICATION; MUTATION	A modified invertebrate glutamate-gated Cl- channel (GluCl alpha beta) was previously employed to allow pharmacologically induced silencing of electrical activity in CNS neurons upon exposure to the anthelmintic drug ivermectin (IVM). Usefulness of the previous receptor was limited by 1) the high concentration of IVM necessary to elicit a consistent silencing phenotype, raising concern about potential side effects, and 2) the variable extent of neuronal spike suppression, due to variations in the co-expression levels of the fluorescent protein-tagged alpha and beta subunits. To address these issues, mutant receptors generated via rational protein engineering strategies were examined for improvement. Introduction of a gain-of-function mutation (L9'F) in the second transmembrane domain of the alpha subunit appears to facilitate beta subunit incorporation and substantially increase heteromeric GluCl alpha beta sensitivity to IVM. Removal of an arginine-based endoplasmic reticulum retention motif (RSR mutated to AAA) from the intracellular loop of the beta subunit further promotes heteromeric expression at the plasma membrane possibly by preventing endoplasmic reticulum-associated degradation of the beta subunit rather than simply reducing endoplasmic reticulum retention. A monomeric XFP (mXFP) mutation that prevents fluorescent protein dimerization complements the mutant channel effects. Expression of the newly engineered GluCl opt alpha-mXFP L9'F + opt beta-mXFP Y182F RSR_ AAA receptor in dissociated neuronal cultures markedly increases conductance and reduces variability in spike suppression at 1 nM IVM. This receptor, named "GluClv2.0," is an improved tool for IVM-induced silencing.	[Frazier, Shawnalea J.] CALTECH, Pasadena, CA 91125 USA; [Frazier, Shawnalea J.; Cohen, Bruce N.; Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lester, HA (corresponding author), CALTECH, Div Biol, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	lester@caltech.edu			National Institutes of Health [NS034407, EY018502, MH088550]; McKnight Foundation; NATIONAL EYE INSTITUTE [R21EY018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS034407, EY018502, and MH088550. This work was also supported by the McKnight Foundation.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; Bianchi MT, 2001, NEUROPHARMACOLOGY, V41, P737, DOI 10.1016/S0028-3908(01)00132-0; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; Bonifacino J. S., 1991, CURR OPIN CELL BIOL, V3, P592; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Burdett EC, 1997, CONTEMP TOP LAB ANIM, V36, P73; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kearney PC, 1996, NEURON, V17, P1221, DOI 10.1016/S0896-6273(00)80252-4; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Kosolapov AV, 2000, J MEMBRANE BIOL, V174, P191, DOI 10.1007/s002320001043; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Li YX, 1998, J NEUROSCI, V18, P10231; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Pan ZH, 1997, P NATL ACAD SCI USA, V94, P6490, DOI 10.1073/pnas.94.12.6490; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thompson SA, 1999, BRIT J PHARMACOL, V127, P1349, DOI 10.1038/sj.bjp.0702687; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zacharias David A, 2002, Sci STKE, V2002, ppe23, DOI 10.1126/stke.2002.131.pe23; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhou Y, 2003, J NEUROSCI, V23, P9004	67	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21029	21042		10.1074/jbc.M112.423921	http://dx.doi.org/10.1074/jbc.M112.423921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720773	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000322014400024
J	Jelk, J; Gao, NG; Serricchio, M; Signorell, A; Schmidt, RS; Bangs, JD; Acosta-Serrano, A; Lehrman, MA; Butikofer, P; Menon, AK				Jelk, Jennifer; Gao, Ningguo; Serricchio, Mauro; Signorell, Aita; Schmidt, Remo S.; Bangs, James D.; Acosta-Serrano, Alvaro; Lehrman, Mark A.; Buetikofer, Peter; Menon, Anant K.			Glycoprotein Biosynthesis in a Eukaryote Lacking the Membrane Protein Rft1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; LIPID-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; TRYPANOSOMA-BRUCEI; N-GLYCOSYLATION; QUALITY-CONTROL; GENE; TRANSLOCATION; EXPRESSION; MOVEMENT	Mature dolichol-linked oligosaccharides (mDLOs) needed for eukaryotic protein N-glycosylation are synthesized by a multistep pathway in which the biosynthetic lipid intermediate Man(5)GlcNAc(2)-PP-dolichol (M5-DLO) flips from the cytoplasmic to the luminal face of the endoplasmic reticulum. The endoplasmic reticulum membrane protein Rft1 is intimately involved in mDLO biosynthesis. Yeast genetic analyses implicated Rft1 as the M5-DLO flippase, but because biochemical tests challenged this assignment, the function of Rft1 remains obscure. To understand the role of Rft1, we sought to analyze mDLO biosynthesis in vivo in the complete absence of the protein. Rft1 is essential for yeast viability, and no Rft1-null organisms are currently available. Here, we exploited Trypanosoma brucei (Tb), an early diverging eukaryote whose Rft1 homologue functions in yeast. We report that TbRft1-null procyclic trypanosomes grow nearly normally. They have normal steady-state levels of mDLO and significant N-glycosylation, indicating robust M5-DLO flippase activity. Remarkably, the mutant cells have 30-100-fold greater steady-state levels of M5-DLO than wild-type cells. All N-glycans in the TbRft1-null cells originate from mDLO indicating that the M5-DLO excess is not available for glycosylation. These results suggest that rather than facilitating M5-DLO flipping, Rft1 facilitates conversion of M5-DLO to mDLO by another mechanism, possibly by acting as an M5-DLO chaperone.	[Signorell, Aita; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Jelk, Jennifer; Serricchio, Mauro; Schmidt, Remo S.; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Acosta-Serrano, Alvaro] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Cornell University; University of Bern; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine	Lehrman, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Mark.Lehrman@UTSouthwestern.edu; peter.buetikofer@ibmm.unibe.ch; akm2003@med.cornell.edu	Acosta-Serrano, Alvaro/L-5503-2015; Menon, Anant/AAN-8663-2021	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Menon, Anant/0000-0001-6924-2698; Schmidt, Remo S./0000-0002-6599-9201; Serricchio, Mauro/0000-0002-7094-9807	National Institutes of Health [AI35739, GM38545, GM71041]; Swiss National Science Foundation [31003A-130815]; Wellcome Trust [093691MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035739, R01AI035739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R01GM071041, R56GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35739 (to J. D. B.), GM38545 (to M. A. L.), and GM71041 (to A. K. M.). This work was also supported by Swiss National Science Foundation Grant 31003A-130815 (to P. B.) and Wellcome Trust Grant 093691MA (to A. A. S.).	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Alexander DL, 2002, J CELL SCI, V115, P3253; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Gao XD, 2004, GLYCOBIOLOGY, V14, P559, DOI 10.1093/glycob/cwh072; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Hwa KY, 2000, MOL BIOCHEM PARASIT, V111, P173, DOI 10.1016/S0166-6851(00)00310-8; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; LENNARZ WJ, 1987, BIOCHEMISTRY-US, V26, P7205, DOI 10.1021/bi00397a001; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Noffz C, 2009, GLYCOBIOLOGY, V19, P472, DOI 10.1093/glycob/cwp001; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schenk B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; WASSLER M, 1993, J CELL BIOL, V123, P285, DOI 10.1083/jcb.123.2.285; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	36	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20616	20623		10.1074/jbc.M113.479642	http://dx.doi.org/10.1074/jbc.M113.479642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720757	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000321715100047
J	Vytla, VS; Ochs, RS				Vytla, Veeravenkata S.; Ochs, Raymond S.			Metformin Increases Mitochondrial Energy Formation in L6 Muscle Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; GLUCOSE-TRANSPORT; RESPIRATORY-CHAIN; CANCER CELLS; COMPLEX I; AMP; RAT; PHOSPHORYLATION	A popular hypothesis for the action of metformin, the widely used anti-diabetes drug, is the inhibition of mitochondrial respiration, specifically at complex I. This is consistent with metformin stimulation of glucose uptake by muscle and inhibition of gluconeogenesis by liver. Yet, mitochondrial inhibition is inconsistent with metformin stimulation of fatty acid oxidation in both tissues. In this study, we measured mitochondrial energy production in intact cells adapting an in vivo technique of phosphocreatine (PCr) formation following energy interruption ("PCr recovery") to cell cultures. Metformin increased PCr recovery from either dinitrophenol (DNP) or azide in L6 cells. We found that metformin alone had no effect on cell viability as measured by total ATP concentration, trypan blue exclusion, or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction. However, treatments with low concentrations of DNP or azide reversibly decreased ATP concentration. Metformin increased 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction during recovery from either agent. Viability measured by trypan blue exclusion indicated that cells were intact under these conditions. We also found that metformin increased free AMP and, to a smaller extent, free ADP concentrations in cells, an action that was duplicated by a structurally unrelated AMP deaminase inhibitor. We conclude that, in intact cells, metformin can lead to a stimulation of energy formation, rather than an inhibition.	[Vytla, Veeravenkata S.; Ochs, Raymond S.] St Johns Univ, Sch Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA	Saint John's University	Vytla, VS (corresponding author), St Johns Univ, Sch Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA.	vsatyavylta@gmail.com; ochsr@stjohns.edu	Nili, Mona/P-5570-2016					BAILEY CJ, 1992, DIABETES CARE, V15, P755, DOI 10.2337/diacare.15.6.755; Barreto-Torres GA, 2013, FASEB J, V27; BAUR H, 1975, H-S Z PHYSIOL CHEM, V356, P827, DOI 10.1515/bchm2.1975.356.s1.827; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673; BRIDGER WA, 1983, CELL ATP; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Calabro AR, 2008, TOXICOL IN VITRO, V22, P1273, DOI 10.1016/j.tiv.2008.02.023; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Cornell N. W., 1983, ISOLATION CHARACTERI, P11; Silva FMD, 2010, MOL CELL BIOCHEM, V340, P283, DOI 10.1007/s11010-010-0429-2; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoek JB, 2006, GASTROENTEROLOGY, V131, P974, DOI 10.1053/j.gastro.2006.07.033; Hoek JB, 2006, GASTROENTEROLOGY, V130, P2234, DOI 10.1053/j.gastro.2006.05.009; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Morioka K, 2005, INT J MOL MED, V15, P449; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; OCHS RS, 1978, ARCH BIOCHEM BIOPHYS, V190, P193, DOI 10.1016/0003-9861(78)90267-9; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; PRESSMAN BC, 1963, J BIOL CHEM, V238, P401; Ronner P, 1999, ANAL BIOCHEM, V275, P208, DOI 10.1006/abio.1999.4317; SCHAFER G, 1972, EUR J BIOCHEM, V27, P364, DOI 10.1111/j.1432-1033.1972.tb01846.x; Simmons A, 2013, FASEB J, V27; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; WARBURG O, 1956, SCIENCE, V124, P269; WISEMAN RW, 1995, J BIOL CHEM, V270, P12428, DOI 10.1074/jbc.270.21.12428; Yuan L, 2002, CHINESE MED J-PEKING, V115, P1843; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	59	30	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20369	20377		10.1074/jbc.M113.482646	http://dx.doi.org/10.1074/jbc.M113.482646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720772	Green Published, hybrid			2022-12-25	WOS:000321715100025
J	Diaz, M; Moller, AP; Flensted-Jensen, E; Grim, T; Ibanez-Alamo, JD; Jokimaki, J; Marko, G; Tryjanowski, P				Diaz, Mario; Moller, Anders Pape; Flensted-Jensen, Einar; Grim, Tomas; Diego Ibanez-Alamo, Juan; Jokimaki, Jukka; Marko, Gabor; Tryjanowski, Piotr			The Geography of Fear: A Latitudinal Gradient in Anti-Predator Escape Distances of Birds across Europe	PLOS ONE			English	Article							FLIGHT DISTANCE; PREDATION RISK; HYPOTHESIS; DIVERSITY; DEFENSES; ECOLOGY; NUMBER; LIFE; TREE	All animals flee from potential predators, and the distance at which this happens is optimized so the benefits from staying are balanced against the costs of flight. Because predator diversity and abundance decreases with increasing latitude, and differs between rural and urban areas, we should expect escape distance when a predator approached the individual to decrease with latitude and depend on urbanization. We measured the distance at which individual birds fled (flight initiation distance, FID, which represents a reliable and previously validated surrogate measure of response to predation risk) following a standardized protocol in nine pairs of rural and urban sites along a ca. 3000 km gradient from Southern Spain to Northern Finland during the breeding seasons 2009-2010. Raptor abundance was estimated by means of standard point counts at the same sites where FID information was recorded. Data on body mass and phylogenetic relationships among bird species sampled were extracted from the literature. An analysis of 12,495 flight distances of 714 populations of 159 species showed that mean FID decreased with increasing latitude after accounting for body size and phylogenetic effects. This decrease was paralleled by a similar cline in an index of the abundance of raptors. Urban populations had consistently shorter FIDs, supporting previous findings. The difference between rural and urban habitats decreased with increasing latitude, also paralleling raptor abundance trends. Overall, the latitudinal gradient in bird fear was explained by raptor abundance gradients, with additional small effects of latitude and intermediate effects of habitat. This study provides the first empirical documentation of a latitudinal trend in anti-predator behavior, which correlated positively with a similar trend in the abundance of predators.	[Diaz, Mario] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Global Change BGC, E-28006 Madrid, Spain; [Moller, Anders Pape] Univ Paris 11, CNRS UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France; [Grim, Tomas] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Grim, Tomas] Ornithol Lab, Olomouc, Czech Republic; [Diego Ibanez-Alamo, Juan] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Jokimaki, Jukka] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Jokimaki, Jukka] Rovaniemi Univ Appl Sci, Rovaniemi, Finland; [Marko, Gabor] Eotvos Lorand Univ, Behav Ecol Grp, Dept Systemat Zool & Ecol, Budapest, Hungary; [Marko, Gabor] Corvinus Univ Budapest, Dept Plant Pathol, Budapest, Hungary; [Tryjanowski, Piotr] Poznan Univ Life Sci, Inst Zool, Poznan, Poland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Palacky University Olomouc; University of Granada; University of Lapland; Eotvos Lorand University; Corvinus University Budapest; Poznan University of Life Sciences	Diaz, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Global Change BGC, E-28006 Madrid, Spain.	Mario.Diaz@ccma.csic.es	Diaz, Mario/C-3052-2017; Marko, Gabor/AAX-1166-2020; Jokimäki, Jukka/L-4434-2013; Ibáñez-Álamo, Juan Diego/H-7624-2019; Moller, Anders/O-6665-2016; Grim, Tomas/A-2852-2008	Diaz, Mario/0000-0002-6384-6674; Marko, Gabor/0000-0003-1351-4070; Jokimäki, Jukka/0000-0002-7903-4128; Moller, Anders/0000-0003-3739-4675; Grim, Tomas/0000-0002-5775-6269; Ibanez Alamo, Juan Diego/0000-0002-2136-1767; Tryjanowski, Piotr/0000-0002-8358-0797	Human Frontier Science Program [RGY69/07, MSM6198959212]; EU Regional Development Foundation [A31026]; RISKDISP of the Spanish Ministerio de Ciencia e Innovacion [CGL2009-08430];  [TAMOP-4.2.1./B-09/1-KMR-2010-0005];  [TAMOP-4.2.2./B-10/1-2010-0023]	Human Frontier Science Program(Human Frontier Science Program); EU Regional Development Foundation; RISKDISP of the Spanish Ministerio de Ciencia e Innovacion; ; 	TG was supported by the Human Frontier Science Program (RGY69/07) and MSM6198959212. JJ was supported by the EU Regional Development Foundation for the project (A31026). MD was funded by the project RISKDISP (CGL2009-08430) of the Spanish Ministerio de Ciencia e Innovacion. GM was supported by TAMOP-4.2.1./B-09/1-KMR-2010-0005 and TAMOP-4.2.2./B-10/1-2010-0023 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W. A., 1984, Manual of quantitative genetics.; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Caro Tim, 2005, pXIII; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; CONNELL J H, 1971, P298; COOKE AS, 1980, BIOL CONSERV, V18, P85, DOI 10.1016/0006-3207(80)90072-5; Cramp S, 1977, P1; Donnelly, 2001, AVIAN ECOLOGY CONSER, P20, DOI DOI 10.1007/978-1-4615-1531-9; Dyer Lee A., 2002, P67, DOI 10.1017/CBO9780511542190.004; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; GLIWICZ J, 1994, MEM ZOOLOGI, V49, P237; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Guegan JF, 2001, EVOLUTION, V55, P1308; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jerzak Leszek, 2001, P403; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Jokimaki J, 2005, ECOGRAPHY, V28, P59, DOI 10.1111/j.0906-7590.2005.04001.x; Klausnitzer B., 1989, VERSTADTERUNG TIEREN; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; Lipsey MW, 2001, PRACTICAL METAANALYS, DOI DOI 10.1016/J.AUTNEU.2007.06.087; MacArthur R.H., 1972, pvii; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2012, ANIM BEHAV, V84, P341, DOI 10.1016/j.anbehav.2012.04.030; Moller AP, 2011, ETHOLOGY, V117, P529, DOI 10.1111/j.1439-0310.2011.01899.x; Moller AP, 2008, BEHAV ECOL, V19, P1305, DOI 10.1093/beheco/arn074; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2013, BEHAV ECOL, V24, P267, DOI 10.1093/beheco/ars163; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Moller AP, 2012, BEHAV ECOL, V23, P1030, DOI 10.1093/beheco/ars067; Moller Anders Pape, 2010, Chinese Birds, V1, P97; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Rohde K, 1998, OIKOS, V82, P184, DOI 10.2307/3546928; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Soler JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010509; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Stephan B, 1990, AMSEL; TATNER P, 1986, AUK, V103, P169; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vorisek P, 2010, BEST PRACTICE GUIDE; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	50	117	120	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64634	10.1371/journal.pone.0064634	http://dx.doi.org/10.1371/journal.pone.0064634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724070	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000070
J	Fessenden, JD; Mahalingam, M				Fessenden, James D.; Mahalingam, Mohana			Site-Specific Labeling of the Type 1 Ryanodine Receptor Using Biarsenical Fluorophores Targeted to Engineered Tetracysteine Motifs	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; TAGGED PROTEINS; SKELETAL-MUSCLE; RELEASE CHANNEL; INTACT-CELLS; BINDING; FLUORESCENCE; IDENTIFICATION; FLASH-EDT2; AFFINITY	The type 1 ryanodine receptor (RyR1) is an intracellular Ca2+ release channel that mediates skeletal muscle excitation contraction coupling. While the overall shape of RyR1 has been elucidated using cryo electron microscopic reconstructions, fine structural details remain elusive. To better understand the structure of RyR1, we have previously used a cell-based fluorescence resonance energy transfer (FRET) method using a fused green fluorescent protein (GFP) donor and a fluorescent acceptor, Cy3NTA that binds specifically to short poly-histidine 'tags' engineered into RyR1. However, the need to permeabilize cells to allow Cy3NTA entry as well as the noncovalent binding of Cy3NTA to the His tag limits future applications of this technique for studying conformational changes of the RyR. To overcome these problems, we used a dodecapeptide sequence containing a tetracysteine (Tc) motif to target the biarsenical fluorophores, FIAsH and ReAsH to RyR1. These compounds freely cross intact cell membranes where they then bind covalently to the tetracysteine motif. First, we used this system to conduct FRET measurements in intact cells by fusing a yellow fluorescent protein (YFP) FRET donor to the N-terminus of RyR1 and then targeting the FRET acceptor, ReAsH to an adjacent Tc tag. Moderate energy transfer (similar to 33%) was observed whereas ReAsH incubation of a YFPRyR1 fusion protein lacking the Tc tag resulted in no detectable FRET. We also developed a FRET-based system that did not require RyR fluorescent protein fusions by labeling N-terminal Tc-tagged RyR1 with FIAsH, a FRET donor and then targeting the FRET acceptor Cy3NTA to an adjacent decahistidine (His(10)) tag. A high degree of energy transfer (similar to 66%) indicated proper binding of both compounds to these unique recognition sequences in RyR1. Thus, these two systems should provide unprecedented flexibility in future FRET-based structural determinations of RyR1.	[Fessenden, James D.; Mahalingam, Mohana] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Fessenden, JD (corresponding author), Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	jfessenden@partners.org			NIH from NIAMS [R01AR059124]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059124] Funding Source: NIH RePORTER	NIH from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant R01AR059124 from NIAMS (http://www.niams.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2002, FORBES, V169, P124; Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Bhunia AK, 2007, CHEMBIOCHEM, V8, P1642, DOI 10.1002/cbic.200700192; Cao HS, 2007, J AM CHEM SOC, V129, P8672, DOI 10.1021/ja070003c; Chen BW, 2007, BIOCONJUGATE CHEM, V18, P1259, DOI 10.1021/bc0603900; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Madani F, 2009, J AM CHEM SOC, V131, P4613, DOI 10.1021/ja809315x; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Raina SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038594; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Zurn A, 2010, BIOCONJUGATE CHEM, V21, P853, DOI 10.1021/bc900394j	26	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64686	10.1371/journal.pone.0064686	http://dx.doi.org/10.1371/journal.pone.0064686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724080	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000081
J	Steckbeck, JD; Sun, CQ; Sturgeon, TJ; Montelaro, RC				Steckbeck, Jonathan D.; Sun, Chengqun; Sturgeon, Timothy J.; Montelaro, Ronald C.			Detailed Topology Mapping Reveals Substantial Exposure of the "Cytoplasmic" C-Terminal Tail (CTT) Sequences in HIV-1 Env Proteins at the Cell Surface	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; MEMBRANE-SPANNING DOMAIN; GP41 TRANSMEMBRANE PROTEIN; AMINO-ACID SUBSTITUTIONS; MURINE LEUKEMIA-VIRUS; NEUTRALIZING ANTIBODIES; CALMODULIN-BINDING; SYNTHETIC PEPTIDES; FUSION	Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). While few studies have been designed to directly address the topology of the CTT, results from envelope (Env) protein trafficking studies suggest that the CTT sequence is cytoplasmically localized, as interactions with intracellular binding partners are required for proper Env targeting. However, previous studies from our lab demonstrate the exposure of a short CTT sequence, the Kennedy epitope, at the plasma membrane of intact Env-expressing cells, the exposure of which is not observed on viral particles. To address the topology of the entire CTT sequence, we serially replaced CTT sequences with a VSV-G epitope tag sequence and examined reactivity of cell-and virion-surface Env to an anti-VSV-G monoclonal antibody. Our results demonstrate that the majority of the CTT sequence is accessible to antibody binding on the surface of Env expressing cells, and that the CTT-exposed Env constitutes 20-50% of the cell-surface Env. Cell surface CTT exposure was also apparent in virus-infected cells. Passive transfer of Env through cell culture media to Env negative (non-transfected) cells was not responsible for the apparent cell surface CTT exposure. In contrast to the cell surface results, CTT-exposed Env was not detected on infectious pseudoviral particles containing VSV-G-substituted Env. Finally, a monoclonal antibody directed to the Kennedy epitope neutralized virus in a temperature-dependent manner in a post-attachment neutralization assay. Collectively, these results suggest that the membrane topology of the HIV gp41 CTT is more complex than the widely accepted intracytoplasmic model.	[Steckbeck, Jonathan D.; Sun, Chengqun; Sturgeon, Timothy J.; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Steckbeck, Jonathan D.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	rmont@pitt.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R01 AI087533, 5T32 AI065380]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533, T32AI065380] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants 1R01 AI087533 (RCM) and 5T32 AI065380 (JDS) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, BIOCHEM BIOPH RES CO, V276, P157, DOI 10.1006/bbrc.2000.3457; Blot G, 2006, J MOL BIOL, V364, P1034, DOI 10.1016/j.jmb.2006.09.080; Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655; Brass V, 2007, J VIROL, V81, P2745, DOI 10.1128/JVI.01279-06; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; CHAKRABARTI L, 1989, J VIROL, V63, P4395, DOI 10.1128/JVI.63.10.4395-4403.1989; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cheung L, 2005, J GEN VIROL, V86, P131, DOI 10.1099/vir.0.80439-0; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FUJII G, 1992, PROTEIN SCI, V1, P1454, DOI 10.1002/pro.5560011107; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Griffith DA, 2003, FEBS LETT, V553, P45, DOI 10.1016/S0014-5793(03)00952-9; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; Heap CJ, 2005, J GEN VIROL, V86, P1499, DOI 10.1099/vir.0.80414-0; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; HO DD, 1987, J VIROL, V61, P2024, DOI 10.1128/JVI.61.6.2024-2028.1987; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Liu SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-100; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; Luciw P. A., 2002, FIELDS VIROLOGY; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuhaus EM, 1998, J STRUCT BIOL, V121, P326, DOI 10.1006/jsbi.1998.3971; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Postler TS, 2012, CELL HOST MICROBE, V11, P181, DOI 10.1016/j.chom.2011.12.005; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Reading SA, 2003, VIROLOGY, V315, P362, DOI 10.1016/S0042-6822(03)00533-6; Sanderson CM, 2008, GENOME RES, V18, P517, DOI 10.1101/gr.074583.107; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Shang LA, 2010, VIROLOGY, V404, P158, DOI 10.1016/j.virol.2010.03.016; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; TENCZA SB, 1995, J VIROL, V69, P5199, DOI 10.1128/JVI.69.8.5199-5202.1995; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09	73	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e65220	10.1371/journal.pone.0065220	http://dx.doi.org/10.1371/journal.pone.0065220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724133	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100041
J	Wang, XL; Zhao, QY; Huang, H; Tang, YH; Xiao, JP; Dai, ZX; Yu, SB; Huang, CX				Wang, Xule; Zhao, Qingyan; Huang, He; Tang, Yanhong; Xiao, Jinping; Dai, Zixuan; Yu, Shengbo; Huang, Congxin			Effect of Renal Sympathetic Denervation on Atrial Substrate Remodeling in Ambulatory Canines with Prolonged Atrial Pacing	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; MYOCYTE APOPTOSIS; FIBRILLATION; PREVENTION; FIBROSIS; HEART; MODEL; EXPRESSION; INHIBITOR; ABLATION	We have previously demonstrated that catheter-based renal sympathetic denervation (RSD) could suppress atrial fibrillation (AF) in canines with short-time rapid right atrial pacing (RAP). However, the role of renal denervation on atrial remodeling is unclear. The aim of the present study was to explore the long-term effect of RSD on the atrial remodeling during prolonged RAP. Twenty mongrel dogs were implanted with a high-frequency cardiac pacemaker with a transvenous lead inserted into the right atrial appendage. The dogs were divided into three groups: a sham-operated group (n = 6), the chronic RAP (CRAP) group (n = 7), and the CRAP+RSD group (n = 7). In the CRAP+RSD group, a pacemaker was implanted 6 weeks after RSD was performed bilaterally for recovery. RAP was maintained for 5 weeks in CRAP group and CRAP+RSD group. The plasma levels of Angiotensin II and aldosterone were significantly increased in CRAP group compared with sham-operated group, but the increasing trend was inhibited in CRAP+RSD group compared with CRAP group (P<0.05). Similarly, RSD suppressed the increasing trend that prolonged RAP produced in the left atrial levels of ANP, TNF-alpha and IL-6. Compared with the sham-operated group, the CRAP group had significantly increased levels of caspase-3, bax and Cx40 whereas the level of Bcl-2 decreased (P<0.05). RSD markedly reduced the upregulation of caspase-3, bax and Cx40 and the downregulation of Bcl-2 expression compared with the CRAP group (P<0.05). Picric acid-sirius red staining study suggested that RSD could markedly alleviate the lesion degree of cardic fibrosis induced by CRAP (P<0.05). Immunohistochemistry results showed that the densities of TH- and GAP43-positive nerves were significantly elevated in the CRAP group compared with the sham-operated group, while RSD operation signicantly inhibited the these changes produced by CRAP. These findings suggest that renal denervation could suppress the atrial remodeling after prolonged RAP in ambulatory canines.	[Wang, Xule; Zhao, Qingyan; Huang, He; Tang, Yanhong; Xiao, Jinping; Dai, Zixuan; Yu, Shengbo; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Wang, Xule; Zhao, Qingyan; Huang, He; Tang, Yanhong; Xiao, Jinping; Dai, Zixuan; Yu, Shengbo; Huang, Congxin] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhao, QY (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	ruyan1971@yahoo.com.cn; huangcongxin@yahoo.com.cn			National Science and Technology Pillar Program of China [2011BAI11B12]; Fundamental Research Funds for the Central Universities [2012302020210]; National Natural Science Foundation of China [81070144]	National Science and Technology Pillar Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science and Technology Pillar Program of China (2011BAI11B12), the Fundamental Research Funds for the Central Universities (2012302020210) and the National Natural Science Foundation of China (81070144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; Ausma J, 2003, CIRCULATION, V107, P2051, DOI 10.1161/01.CIR.0000062689.04037.3F; Belluzzi F, 2009, J AM COLL CARDIOL, V53, P24, DOI 10.1016/j.jacc.2008.08.071; Boldt A, 2003, J AM COLL CARDIOL, V42, P1785, DOI 10.1016/j.jacc.2003.07.014; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Cao HL, 2010, PEPTIDES, V31, P1531, DOI 10.1016/j.peptides.2010.04.019; Chang CM, 2001, CIRCULATION, V103, P22; Chanson M, 2001, AM J PATHOL, V158, P1775, DOI 10.1016/S0002-9440(10)64133-8; Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019; Duffy HS, 2008, J MOL CELL CARDIOL, V44, P4, DOI 10.1016/j.yjmcc.2007.08.016; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Fukuda Y, 2011, EUR J ECHOCARDIOGR, V12, P278, DOI 10.1093/ejechocard/jeq193; Harada E, 2001, CIRCULATION, V104, P137, DOI 10.1161/01.CIR.104.2.137; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Iravanian S, 2008, HEART RHYTHM, V5, pS12, DOI 10.1016/j.hrthm.2008.02.025; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Kiryu M, 2012, EUROPACE, V14, P1206, DOI 10.1093/europace/eus052; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; Patlolla V, 2006, PACE, V29, P1006, DOI 10.1111/j.1540-8159.2006.00477.x; Pokushalov E, 2012, J AM COLL CARDIOL, V60, P1163, DOI 10.1016/j.jacc.2012.05.036; Polontchouk L, 2001, J AM COLL CARDIOL, V38, P883, DOI 10.1016/S0735-1097(01)01443-7; Sarkissian SD, 2003, CARDIOVASC RES, V57, P775, DOI 10.1016/S0008-6363(02)00789-7; Schiffrin EL, 2012, INT J HYPERTENS, V2012; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Stambler BS, 2005, J CARDIOVASC ELECTR, V16, P1341, DOI 10.1111/j.1540-8167.2005.00259.x; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; van der Velden HMW, 2000, CARDIOVASC RES, V46, P476, DOI 10.1016/S0008-6363(00)00026-2; Rueda JOV, 2012, J APPL PHYSIOL, V112, P2110, DOI 10.1152/japplphysiol.01383.2011; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zhang YH, 2005, CIRCULATION, V112, P2904, DOI 10.1161/CIRCULATIONAHA.105.568832; Zhao J, 2010, BRIT J PHARMACOL, V159, P1584, DOI 10.1111/j.1476-5381.2009.00551.x; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y; Zhou Q, 2012, PLOS ONE, V7	45	40	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64611	10.1371/journal.pone.0064611	http://dx.doi.org/10.1371/journal.pone.0064611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724069	gold, Green Published, Green Submitted			2022-12-25	WOS:000319738100034
J	Arrighi, JF; Cartieaux, F; Chaintreuil, C; Brown, S; Boursot, M; Giraud, E				Arrighi, Jean-Francois; Cartieaux, Fabienne; Chaintreuil, Clemence; Brown, Spencer; Boursot, Marc; Giraud, Eric			Genotype Delimitation in the Nod-Independent Model Legume Aeschynomene evenia	PLOS ONE			English	Article							STEM NODULATION; DIVERSITY; INFECTION; SYMBIOSIS; GENETICS; PLANT	Research on the nitrogen-fixing symbiosis has been so far focused on two model legumes, Medicago truncatula and Lotus japonicus, which use a sophisticated infection process involving infection thread formation. However, in 25% of the legumes, the bacterial entry occurs more simply in an intercellular fashion. Among them, some semi-aquatic Aeschynomene species present the distinctive feature to form nitrogen-fixing nodules on both roots and stems following elicitation by photosynthetic bradyrhizobia that do not produce Nod factors. This interaction is believed to represent a living testimony of the ancestral state of the rhizobium-legume symbiosis. To decipher the molecular mechanisms of this unique Nod-independent nitrogen-fixing symbiosis, we previously identified A. evenia C. Wright as an appropriate model legume, because it displays all the requisites for molecular and genetic approaches. To advance the use of this new model legume species, here we characterized the intraspecific diversity found in A. evenia. For this, the accessions available in germplasm banks were collected and subjected to morphological investigations, genotyping with RAPD and SSR markers, molecular phylogenies using ITS and single nuclear gene sequences, and cross-compatibility tests. These combined analyses revealed an important intraspecific differentiation that led us to propose a new taxonomic classification for A. evenia comprising two subspecies and four varieties. The A. evenia ssp. evenia contains var. evenia and var. pauciciliata whereas A. evenia ssp. serrulata comprises var. serrulata and var. major. This study provides information to exploit efficiently the diversity encountered in A. evenia and proposes subsp. evenia as the most appropriate subspecies for future projects aimed at identifying plant determinants of the Nod-independent symbiotic process.	[Arrighi, Jean-Francois; Cartieaux, Fabienne; Chaintreuil, Clemence; Boursot, Marc; Giraud, Eric] UMR IRD SupAgro INRA UM2 CIRAD, Lab Symbioses Trop & Mediterraneennes, IRD, Montpellier, France; [Brown, Spencer] CNRS, IBiSA Imagerie Gif & Imagif BioCell, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Arrighi, JF (corresponding author), UMR IRD SupAgro INRA UM2 CIRAD, Lab Symbioses Trop & Mediterraneennes, IRD, Campus Int Baillarguet, Montpellier, France.	jean-francois.arrighi@ird.fr	ARRIGHI, Jean-Francois JF/B-1130-2012; BROWN, Spencer/B-6878-2014; Cartieaux, Fabienne/GNH-3617-2022	ARRIGHI, Jean-Francois/0000-0001-6184-2066; Cartieaux, Fabienne/0000-0002-8992-0131	French National Research Agency [ANR-SESAM-2010-BLAN-170801, ANR-10-LABX-0001-01, 1202-009]; Agropolis Fondation [ANR-10-LABX-0001-01, 1202-009]	French National Research Agency(French National Research Agency (ANR)); Agropolis Fondation	This work was supported by grants from the French National Research Agency (ANR-SESAM-2010-BLAN-170801) and conjointly from the Agropolis Fondation and the French National Research Agency (program "Investissements d'avenir" ANR-10-LABX-0001-01, Project "Aeschynomene mapping" id: 1202-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAZARD D, 1987, PLANT SOIL, V101, P141, DOI 10.1007/BF02371043; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arrighi JF, 2012, MOL PLANT MICROBE IN, V25, P851, DOI 10.1094/MPMI-02-12-0045-TA; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Bishop H. G., 1997, P 18 INT GRASSL C; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; Boivin C, 1997, CRIT REV PLANT SCI, V16, P1, DOI 10.1080/713608143; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; CHANDLER MR, 1982, J EXP BOT, V33, P47, DOI 10.1093/jxb/33.1.47; CHANDLER MR, 1978, J EXP BOT, V29, P749, DOI 10.1093/jxb/29.3.749; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Ellwood SR, 2006, THEOR APPL GENET, V112, P977, DOI 10.1007/s00122-005-0202-1; EVANS WR, 1990, APPL ENVIRON MICROB, V56, P3445, DOI 10.1128/AEM.56.11.3445-3449.1990; Ferguson ME, 2004, CROP SCI, V44, P1847, DOI 10.2135/cropsci2004.1847; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; KRETSCHMER AE, 1994, SOIL CROP SCI SOC FL, V53, P52; Kretschmer AE, 1997, CROP SCI, P37; Macedo Selma E, 2012, BMC Res Notes, V5, P86, DOI 10.1186/1756-0500-5-86; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Nicholas KB., 1997, GENEDOC TOOL EDITING; RUDD VELVA E., 1955, CONTR U S NATL HERBARIUM, V32, P1; Sprent JI, 2008, NEW PHYTOL, V179, P3, DOI 10.1111/j.1469-8137.2008.02494.x; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vendramini J, 2010, FLORIDA FORAGE HDB; Xu P, 2010, MOL BREEDING, V25, P675, DOI 10.1007/s11032-009-9364-x	32	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63836	10.1371/journal.pone.0063836	http://dx.doi.org/10.1371/journal.pone.0063836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717496	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600034
J	Njuguna, C; Orrell, C; Kaplan, R; Bekker, LG; Wood, R; Lawn, SD				Njuguna, Christine; Orrell, Catherine; Kaplan, Richard; Bekker, Linda-Gail; Wood, Robin; Lawn, Stephen D.			Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir	PLOS ONE			English	Article							PROGRAMMATIC OUTCOMES; THERAPY; SAFETY; ADULTS; COMBINATION; TOXICITY; EFFICACY; DF	Introduction: Antiretroviral changes (single drug substitutions and regimen switches) limit treatment options and introduce challenges such as increased cost, monitoring and adherence difficulties. Patterns of drug substitutions and regimen switches from stavudine (d4T) and zidovudine (AZT) regimens have been well described but data on tenofovir (TDF) are more limited. This study describes the patterns and risk factors for drug changes of these antiretroviral drugs in adults. Method: This retrospective cohort study included HIV positive, antiretroviral treatment (ART) naive adults aged >= 18 years who started ART with two nucleoside reverse transcriptase inhibitors (NRTIs) and a non-nucleoside reverse transcriptase inhibitor. Follow-up was censored at first drug change and analysis focused on NRTI changes only. Results: Between September 2002 and April 2011, 5095 adults initiated ART in Gugulethu. This comprised 948 subjects on TDF, 3438 on d4T and 709 subjects on AZT. Virological suppression rates at 1 year, regimen switching due to virological failure and overall losses to the programme were similar across the three groups. TDF had the lowest incidence rate of drug substitutions (2.6 per 100 P/Ys) compared to 17.9 for d4T and 8.5 per 100 P/Ys for AZT. Adverse drug reactions (ADRs) accounted for the majority of drug substitutions of d4T. Multivariate analysis showed that increasing age, female sex and d4T exposure were associated with increased hazard of drug substitution due to ADRs. Conversely, TDF exposure was associated with a substantially lower risk of substitution (adjusted hazards ratio 0.38; 95% CI 0.20-0.72). Conclusion: Regimen switches and virological suppression were similar for patients exposed to TDF, d4T and AZT, suggesting all regimens were equally effective. However, TDF was better tolerated with a substantially lower rate of drug substitutions due to ADRs.	[Njuguna, Christine; Orrell, Catherine; Kaplan, Richard; Bekker, Linda-Gail; Wood, Robin; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Njuguna, C (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	christine_njuguna@yahoo.co.uk	Orrell, Catherine/AAF-3405-2019; Bekker, Linda-Gail/AAZ-8929-2020	Orrell, Catherine/0000-0003-1134-7475; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Kaplan, Richard/0000-0003-1565-4704	Fogarty International Grant [5D43TW007115-06]; Wellcome Trust; FOGARTY INTERNATIONAL CENTER [D43TW007115] Funding Source: NIH RePORTER	Fogarty International Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by Fogarty International Grant, grant number 5D43TW007115-06. Dr. Stephen D. Lawn is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Boulle A, 2007, ANTIVIR THER, V12, P753; BOYLE A, 2012, 11 INT C DRUG THER H; BRENNAN A, 2013, CROI C ATL; BRENNAN A, 2012, IMPACT CHANGE STAVUD; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Davidson I, 2010, ANTIVIR RES, V86, P227, DOI 10.1016/j.antiviral.2010.03.001; *DESM TUT HIV FDN, 2011, ANN REV 2010 2011 DE; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; National Department of Health, 2004, NAT ANT TREATM GUID; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Orrell C, 2007, ANTIVIR THER, V12, P83; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; South African National Department of Health, 2010, S AFR ANT TREATM GUI; Statistics South Africa, 2010, MID POP EST; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; TAKUVA S, 2012, J ANTIVIR ANTIRETROV, V4; WHO, 2010, ANT THER HIV INF AD	26	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63596	10.1371/journal.pone.0063596	http://dx.doi.org/10.1371/journal.pone.0063596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717451	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000320362700037
J	Gang, EJ; Hsieh, YT; Pham, J; Zhao, Y; Nguyen, C; Huantes, S; Park, E; Naing, K; Klemm, L; Swaminathan, S; Conway, EM; Pelus, LM; Crispino, J; Mullighan, CG; McMillan, M; Muschen, M; Kahn, M; Kim, YM				Gang, E. J.; Hsieh, Y-T; Pham, J.; Zhao, Y.; Nguyen, C.; Huantes, S.; Park, E.; Naing, K.; Klemm, L.; Swaminathan, S.; Conway, E. M.; Pelus, L. M.; Crispino, J.; Mullighan, C. G.; McMillan, M.; Mueschen, M.; Kahn, M.; Kim, Y-M			Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia	ONCOGENE			English	Article						acute lymphoblastic leukemia; drug resistance; small-molecule inhibitor; CBP; p300; ICG-001	TRANSCRIPTIONAL COACTIVATOR CBP; CREB-BINDING PROTEIN; RUBINSTEIN-TAYBI-SYNDROME; WNT/BETA-CATENIN PATHWAY; HEMATOPOIETIC STEM-CELLS; BETA-CATENIN; SELF-RENEWAL; PRE-B; HISTONE ACETYLATION; DIFFERENTIAL ROLES	Drug resistance in acute lymphoblastic leukemia (ALL) remains a major problem warranting new treatment strategies. Wnt/catenin signaling is critical for the self-renewal of normal hematopoietic progenitor cells. Deregulated Wnt signaling is evident in chronic and acute myeloid leukemia; however, little is known about ALL. Differential interaction of catenin with either the Kat3 coactivator CREBBP (CREB-binding protein (CBP)) or the highly homologous EP300 (p300) is critical to determine divergent cellular responses and provides a rationale for the regulation of both proliferation and differentiation by the Wnt signaling pathway. Usage of the coactivator CBP by catenin leads to transcriptional activation of cassettes of genes that are involved in maintenance of progenitor cell self-renewal. However, the use of the coactivator p300 leads to activation of genes involved in the initiation of differentiation. ICG-001 is a novel small-molecule modulator of Wnt/catenin signaling, which specifically binds to the N-terminus of CBP and not p300, within amino acids 1-110, thereby disrupting the interaction between CBP and catenin. Here, we report that selective disruption of the CBP/beta-and gamma-catenin interactions using ICG-001 leads to differentiation of pre-B ALL cells and loss of self-renewal capacity. Survivin, an inhibitor-of-apoptosis protein, was also downregulated in primary ALL after treatment with ICG-001. Using chromatin immunoprecipitation assay, we demonstrate occupancy of the survivin promoter by CBP that is decreased by ICG-001 in primary ALL. CBP mutations have been recently identified in a significant percentage of ALL patients, however, almost all of the identified mutations reported occur C-terminal to the binding site for ICG-001. Importantly, ICG-001, regardless of CBP mutational status and chromosomal aberration, leads to eradication of drug-resistant primary leukemia in combination with conventional therapy in vitro and significantly prolongs the survival of NOD/SCID mice engrafted with primary ALL. Therefore, specifically inhibiting CBP/catenin transcription represents a novel approach to overcome relapse in ALL.	[Gang, E. J.; Hsieh, Y-T; Pham, J.; Huantes, S.; Park, E.; Naing, K.; Kim, Y-M] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Hematol & Oncol,Dept Pediat, Los Angeles, CA 90033 USA; [Zhao, Y.; Nguyen, C.; McMillan, M.; Kahn, M.] Univ So Calif, Ctr Mol Pathways & Drug Discovery, Dept Mol Pharmacol & Toxicol, Norris Comprehens Canc Ctr,Dept Biochem & Mol Bio, Los Angeles, CA 90033 USA; [Klemm, L.; Swaminathan, S.; Mueschen, M.] Univ Calif San Francisco, Dept Lab Med, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Conway, E. M.] Univ British Columbia, Fac Med, Div Hematol, Ctr Blood Res, Vancouver, BC, Canada; [Pelus, L. M.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Crispino, J.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Mullighan, C. G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of British Columbia; Indiana University System; Indiana University Bloomington; Northwestern University; St Jude Children's Research Hospital	Kahn, M (corresponding author), Univ So Calif, Ctr Mol Pathways & Drug Discovery, Dept Mol Pharmacol & Toxicol, Norris Comprehens Canc Ctr,Dept Biochem & Mol Bio, 1450 Biggy St,NRT 4501, Los Angeles, CA 90033 USA.	kahnm@usc.edu	Mullighan, Charles/H-3253-2011; kim, y/AAR-6095-2020	Mullighan, Charles/0000-0002-1871-1850; Kim, Yong-Mi/0000-0003-3793-6438; Crispino, John/0000-0002-8182-8306; Conway, Edward/0000-0003-0081-0305	William Lawrence and Blanche Hughes Foundation; Concern Foundation; American Cancer Society [R01CA172896]; USC Norris Comprehensive Cancer Center [P30 CA014089, R01CA137060, R01CA139032, R01CA157644]; Canadian Institutes for Health Research (CIHR); Nautica Triathlon; NATIONAL CANCER INSTITUTE [R01CA169458, P30CA021765, R01CA166161, R01CA172558, R01CA139032, R01CA157644, P30CA014089, R01CA172896, R01CA137060] Funding Source: NIH RePORTER; Cancer Research UK [18131] Funding Source: researchfish	William Lawrence and Blanche Hughes Foundation; Concern Foundation; American Cancer Society(American Cancer Society); USC Norris Comprehensive Cancer Center; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nautica Triathlon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported by Grants from: William Lawrence and Blanche Hughes Foundation, Concern Foundation, Nautica Triathlon and the American Cancer Society and R01CA172896 (YMK); and USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (MK); R01CA137060, R01CA139032, R01CA157644 (MM). EMC is supported by a CSL Behring Research Chair and a Canada Research Chair in Endothelial Cell Biology and by grants from the Canadian Institutes for Health Research (CIHR).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Blough RI, 2000, AM J MED GENET, V90, P29, DOI 10.1002/(SICI)1096-8628(20000103)90:1<29::AID-AJMG6>3.0.CO;2-Z; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gastaldi T, 2006, CARCINOGENESIS, V27, P1758, DOI 10.1093/carcin/bgl008; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kawasaki H., 1999, NUCL ACIDS S SER, V42, P263; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Kim YM, 2011, CURR CANCER DRUG TAR, V11, P213, DOI 10.2174/156800911794328420; Klein F, 2005, J IMMUNOL, V174, P367, DOI 10.4049/jimmunol.174.1.367; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; Morrison DJ, 2012, LEUKEMIA, V26, P271, DOI 10.1038/leu.2011.199; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Tyner JW, 2012, LEUKEMIA, V26, P623, DOI 10.1038/leu.2011.249; Verkaar F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019185; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zheng XM, 2004, BLOOD, V103, P3535, DOI 10.1182/blood-2003-09-3335	50	120	127	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2169	2178		10.1038/onc.2013.169	http://dx.doi.org/10.1038/onc.2013.169			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23728349	Green Submitted, Green Accepted			2022-12-25	WOS:000334996000003
J	Kang, MS; Baek, SH; Chun, YS; Moore, AZ; Landman, N; Berman, D; Yang, HO; Morishima-Kawashima, M; Osawa, S; Funamoto, S; Ihara, Y; Di Paolo, G; Park, JH; Chung, S; Kim, TW				Kang, Min Suk; Baek, Seung-Hoon; Chun, Yoon Sun; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Yang, Hyun Ok; Morishima-Kawashima, Maho; Osawa, Satoko; Funamoto, Satoru; Ihara, Yasuo; Di Paolo, Gilbert; Park, Jeong Hill; Chung, Sungkwon; Kim, Tae-Wan			Modulation of Lipid Kinase PI4KII alpha Activity and Lipid Raft Association of Presenilin 1 Underlies gamma-Secretase Inhibition by Ginsenoside (20S)-Rg3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRAMEMBRANE PROTEOLYSIS; BETA-PEPTIDE; COGNITIVE PERFORMANCE; NATURAL-PRODUCTS; CHOLESTEROL; HYPOTHESIS; REVEALS	Amyloid beta-peptide (A beta) pathology is an invariant feature of Alzheimer disease, preceding any detectable clinical symptoms by more than a decade. To this end, we seek to identify agents that can reduce A beta levels in the brain via novel mechanisms. We found that (20S)-Rg3, a triterpene natural compound known as ginsenoside, reduced A beta levels in cultured primary neurons and in the brains of a mouse model of Alzheimer disease. The (20S)-Rg3 treatment induced a decrease in the association of presenilin 1 (PS1) fragments with lipid rafts where catalytic components of the gamma-secretase complex are enriched. The A beta-lowering activity of (20S)-Rg3 directly correlated with increased activity of phosphatidylinositol 4-kinase II alpha (PI4KII alpha), a lipid kinase that mediates the rate-limiting step in phosphatidylinositol 4,5-bisphosphate synthesis. PI4KII alpha overexpression recapitulated the effects of (20S)-Rg3, whereas reduced expression of PI4KII alpha abolished the A beta-reducing activity of (20S)-Rg3 in neurons. Our results substantiate an important role for PI4KII alpha and phosphoinositide modulation in gamma-secretase activity and A beta biogenesis.	[Kang, Min Suk; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Di Paolo, Gilbert; Kim, Tae-Wan] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kang, Min Suk; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Di Paolo, Gilbert; Kim, Tae-Wan] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Baek, Seung-Hoon] Ajou Univ, Coll Pharm, Suwon 443749, South Korea; [Chun, Yoon Sun; Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon 440746, South Korea; [Yang, Hyun Ok] Korea Inst Sci & Technol, Gangneung Inst, Nat Prod Res Ctr, Kangnung 210340, Gangwon Do, South Korea; [Morishima-Kawashima, Maho] Hokkaido Univ, Fac Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600808, Japan; [Osawa, Satoko] Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; [Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 6100394, Japan; [Park, Jeong Hill] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea	Columbia University; Columbia University; Ajou University; Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Hokkaido University; University of Tokyo; Doshisha University; Seoul National University (SNU)	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	twk16@columbia.edu	CHUNG, SUNGKWON/ABF-8293-2021		National Institutes of Health [R01 NS074536, R01 NS056049]; Korea Society of Ginseng; National Research Foundation of Korea [2009-0072220]; Ministry of Education, Science and Technology; Samsung Biomedical Research Institute [B-A8-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049, R01NS074536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Society of Ginseng; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute(Samsung); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS074536 (to T.-W. K.) and R01 NS056049 (to G. D. P.). This work was also supported by a grant from the Korea Society of Ginseng (to T.-W. K.).; Supported by Basic Science Research Program Grant 2009-0072220 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and by Samsung Biomedical Research Institute Grant B-A8-003.	Baek SH, 2012, J GINSENG RES, V36, P119, DOI 10.5142/jgr.2012.36.2.119; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heo JH, 2008, EUR J NEUROL, V15, P865, DOI 10.1111/j.1468-1331.2008.02157.x; Heo JH, 2011, J GINSENG RES, V35, P457, DOI 10.5142/jgr.2011.35.4.457; Hien TT, 2010, TOXICOL APPL PHARM, V246, P171, DOI 10.1016/j.taap.2010.05.008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kang M. S., 2006, ALZHEIMERS DEMENT, V2, pS490; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Kim YC, 1998, J NEUROSCI RES, V53, P426, DOI 10.1002/(SICI)1097-4547(19980815)53:4<426::AID-JNR4>3.3.CO;2-K; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Kwon SW, 2001, J CHROMATOGR A, V921, P335, DOI 10.1016/S0021-9673(01)00869-X; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lee ST, 2008, ALZ DIS ASSOC DIS, V22, P222, DOI 10.1097/WAD.0b013e31816c92e6; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Park IH, 2002, ARCH PHARM RES, V25, P837, DOI 10.1007/BF02977001; Park IH, 2002, ARCH PHARM RES, V25, P428, DOI 10.1007/BF02976595; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Reay JL, 2005, J PSYCHOPHARMACOL, V19, P357, DOI 10.1177/0269881105053286; Schmidt Stephen D., 2004, V299, P279; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shibata S, 2001, J KOREAN MED SCI, V16, pS28, DOI 10.3346/jkms.2001.16.S.S28; Simons JP, 2009, P NATL ACAD SCI USA, V106, P11535, DOI 10.1073/pnas.0903011106; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wesnes KA, 2000, PSYCHOPHARMACOLOGY, V152, P353, DOI 10.1007/s002130000533; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200	81	29	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20868	20882		10.1074/jbc.M112.445734	http://dx.doi.org/10.1074/jbc.M112.445734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23723072	hybrid, Green Published			2022-12-25	WOS:000322014400011
J	Sheikh, IA; Koley, H; Chakrabarti, MK; Hoque, KM				Sheikh, Irshad Ali; Koley, Hemanta; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			The Epac1 Signaling Pathway Regulates Cl- Secretion via Modulation of Apical KCNN4c Channels in Diarrhea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; INTERMEDIATE-CONDUCTANCE; CHLORIDE SECRETION; K+ CHANNELS; ANION SECRETION; ION-TRANSPORT; ELECTROLYTE TRANSPORT; BASAL ACTIVITY; RABBIT COLON; CYCLIC-AMP	The apical membrane of intestinal epithelia expresses intermediate conductance K+ channel (KCNN4), which provides the driving force for Cl- secretion. However, its role in diarrhea and regulation by Epac1 is unknown. Previously we have established that Epac1 upon binding of cAMP activates a PKA-independent mechanism of Cl- secretion via stimulation of Rap2-phospholipase C epsilon-[Ca2+](i) signaling. Here we report that Epac1 regulates surface expression of KCNN4c channel through its downstream Rap1A-RhoA-Rho-associated kinase (ROCK) signaling pathway for sustained Cl- secretion. Depletion of Epac1 protein and apical addition of TRAM-34, a specific KCNN4 inhibitor, significantly abolished cAMP-stimulated Cl- secretion and apical K+ conductance (I-K(ap)) in T84WT cells. The current-voltage relationship of basolaterally permeabilized monolayers treated with Epac1 agonist 8-(4-chlorophenylthio)-2'-O- methyladenosine 3',5'-cyclic monophosphate showed the presence of an inwardly rectifying and TRAM-34-sensitive K+ channel in T84WT cells that was absent in Epac1KDT84 cells. Reconstructed confocal images in Epac1KDT84 cells revealed redistribution of KCNN4c proteins into subapical intracellular compartment, and a biotinylation assay showed similar to 83% lower surface expression of KCNN4c proteins compared with T84WT cells. Further investigation revealed that an Epac1 agonist activates Rap1 to facilitate I-K(ap). Both RhoA inhibitor (GGTI298) and ROCK inhibitor (H1152) significantly reduced cAMP agonist-stimulated I-K(ap), whereas the latter additionally reduced colocalization of KCNN4c with the apical membrane marker wheat germ agglutinin in T84WT cells. In vivo mouse ileal loop experiments showed reduced fluid accumulation by TRAM-34, GGTI298, or H1152 when injected together with cholera toxin into the loop. We conclude that Rap1A-dependent signaling of Epac1 involving RhoA-ROCK is an important regulator of intestinal fluid transport via modulation of apical KCNN4c channels, a finding with potential therapeutic value in diarrheal diseases.	[Sheikh, Irshad Ali; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, Kolkata 700010, India; [Koley, Hemanta] Natl Inst Cholera & Enter Dis, Div Microbiol, Kolkata 700010, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Hoque, KM (corresponding author), Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, P-33 CIT Rd, Kolkata 700010, India.	kmh_niced@yahoo.co.in	Kazi, Mirajul Hoque/AAR-5291-2021		Government of India, Ministry of Science and Technology, Department of Biotechnology [BT/HRD/35/02/07/2009]	Government of India, Ministry of Science and Technology, Department of Biotechnology	This work was supported in part by Government of India, Ministry of Science and Technology, Department of Biotechnology Grant BT/HRD/35/02/07/2009 (to K. M. H.).	Almassy J, 2012, J GEN PHYSIOL, V139, P121, DOI 10.1085/jgp.201110718; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Barrett KE, 2008, ADV PHYSIOL EDUC, V32, P25, DOI 10.1152/advan.00092.2007; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chan HC, 1996, AM J PHYSIOL-CELL PH, V271, pC469, DOI 10.1152/ajpcell.1996.271.2.C469; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Duffey ME, 2012, FASEB J, V26; Eid AH, 2008, AM J PHYSIOL-HEART C, V295, pH266, DOI 10.1152/ajpheart.00084.2008; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Geibel JP, 2005, ANNU REV PHYSIOL, V67, P471, DOI 10.1146/annurev.physiol.67.031103.153530; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Greger R, 1997, COMP BIOCHEM PHYS A, V118, P271, DOI 10.1016/S0300-9629(96)00304-0; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Jeyaraj SC, 2012, AM J PHYSIOL-CELL PH, V303, pC499, DOI 10.1152/ajpcell.00461.2011; Keely SJ, 2000, ANN NY ACAD SCI, V915, P67; Kiela PR, 2009, CURR OPIN GASTROEN, V25, P87, DOI 10.1097/MOG.0b013e3283260900; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Matos JE, 2007, ACTA PHYSIOL, V189, P251, DOI 10.1111/j.1748-1716.2006.01646.x; Mun EC, 1998, GASTROENTEROLOGY, V114, P1257, DOI 10.1016/S0016-5085(98)70432-9; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Palmer ML, 2008, J PHYSIOL-LONDON, V586, P717, DOI 10.1113/jphysiol.2007.142877; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Turnheim K, 2002, BBA-BIOMEMBRANES, V1560, P51, DOI 10.1016/S0005-2736(01)00456-4; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Warth R, 2003, J MEMBRANE BIOL, V193, P67, DOI 10.1007/s00232-002-2001-9; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186	49	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20404	20415		10.1074/jbc.M113.467860	http://dx.doi.org/10.1074/jbc.M113.467860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720748	hybrid, Green Published			2022-12-25	WOS:000321715100028
J	Huang, HY; Hu, XX; Eno, CO; Zhao, GP; Li, C; White, C				Huang, Huiya; Hu, Xiangxin; Eno, Colins O.; Zhao, Guoping; Li, Chi; White, Carl			An Interaction between Bcl-x(L) and the Voltage-dependent Anion Channel (VDAC) Promotes Mitochondrial Ca2+ Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; BCL-XL; ENDOPLASMIC-RETICULUM; APOPTOSIS REGULATION; OUTER-MEMBRANE; INNER MEMBRANE; CYTOCHROME-C; CALCIUM; PROTEIN; MODULATION	The role of the antiapoptotic protein Bcl-x(L) in regulating mitochondrial Ca2+ ([Ca2+](mito)) handling was examined in wild-type (WT) and Bcl-x(L) knock-out (Bcl-x(L)-KO) mouse embryonic fibroblast cells. Inositol 1,4,5-trisphosphate-generating agonist evoked cytosolic Ca2+ transients that produced a larger [Ca2+] mito uptake in WT cells compared with Bcl-x(L)-KO. In permeabilized cells, stepping external [Ca2+] from 0 to 3+ M also produced a larger [Ca2+](mito) uptake in WT; moreover, the [Ca2+](mito) uptake capacity of Bcl-x(L)-KO cells was restored by re-expression of mitochondrially targeted Bcl-x(L). Bcl-x(L) enhancement of [Ca2+](mito) uptake persisted after dissipation of the mitochondrial membrane potential but was absent in mitoplasts lacking an outer mitochondrial membrane. The outer membrane-localized voltage-dependent anion channel (VDAC) is a known Ca2+ permeability pathway that directly interacts with Bcl-x(L). Bcl-x(L) interacted with VDAC1 and -3 isoforms, and peptides based on the VDAC sequence disrupted Bcl-x(L) binding. Peptides reduced [Ca2+](mito) uptake in WT but were without effect in Bcl-xL-KO cells. In addition, peptides reduced [Ca2+](mito) uptake in VDAC1 and VDAC3 knock-out but not VDAC1 and -3 double knock-out mouse embryonic fibroblast cells, confirming that Bcl-x(L) interacts functionally with VDAC1 and -3 but not VDAC2. Thus, an interaction between Bcl-x(L) and VDAC promotes matrix Ca2+ accumulation by increasing Ca2+ transfer across the outer mitochondrial membrane.	[Huang, Huiya; Hu, Xiangxin; White, Carl] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Pharmacol, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Toxicol, Louisville, KY 40202 USA	Rosalind Franklin University Medical & Science; University of Louisville; University of Louisville; University of Louisville; University of Louisville	White, C (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	carl.white@rosalindfranklin.edu		White, Carl/0000-0002-0535-6968	National Institutes of Health [CA106599, RR018733]; American Heart Association scientist development grant; Rosalind Franklin University; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [K01CA106599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association scientist development grant(American Heart Association); Rosalind Franklin University; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106599 and RR018733 (to C. L.). This work was also supported by an American Heart Association scientist development grant and Rosalind Franklin University (to C. W.) and funding from the Kentucky Lung Cancer Research Program (to C. L.).	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Csordas G, 2002, EMBO J, V21, P2198, DOI 10.1093/emboj/21.9.2198; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Decaudin D, 1997, CANCER RES, V57, P62; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kowaltowski AJ, 2000, AM J PHYSIOL-CELL PH, V279, pC852, DOI 10.1152/ajpcell.2000.279.3.C852; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Pavlov E, 2005, BBA-BIOENERGETICS, V1710, P96, DOI 10.1016/j.bbabio.2005.09.006; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szanda G, 2010, CELL CALCIUM, V48, P168, DOI 10.1016/j.ceca.2010.08.005; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Vander Heiden MG, 1999, MOL CELL, V3, P159; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	54	100	100	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19870	19881		10.1074/jbc.M112.448290	http://dx.doi.org/10.1074/jbc.M112.448290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720737	hybrid, Green Published			2022-12-25	WOS:000321515800054
J	Chen, LM; Nergard, JC; Ni, LQ; Rosser, CJ; Chai, KX				Chen, Li-Mei; Nergard, Jennifer C.; Ni, Liqiang; Rosser, Charles J.; Chai, Karl X.			Long-Term Exposure to Cigarette Smoke Extract Induces Hypomethylation at the RUNX3 and IGF2-H19 Loci in Immortalized Human Urothelial Cells	PLOS ONE			English	Article							DOWN-REGULATES RUNX3; BLADDER-CANCER; EPITHELIAL-CELLS; GENE-EXPRESSION; DIHYDROFOLATE-REDUCTASE; CARCINOGEN EXPOSURE; DNA METHYLATION; IN-VITRO; PROMOTER; HYPERMETHYLATION	Cigarette smoking is the single most important epidemiological risk factor for bladder cancer but it is not known whether exposure of urothelial cells to the systemic soluble contents of cigarette smoke is directly causative to bladder cancer and the associated epigenetic changes such as tumor suppressor gene hypermethylation. We undertook this study to investigate if long-term treatment of human urothelial cells with cigarette smoke extract (CSE) results in tumor suppressor gene hypermethylation, a phenotype that was previously associated with long-term constant CSE treatment of airway epithelial cells. We chronically treated an immortalized human urothelial cell line UROtsa with CSE using a cyclic daily regimen but the cells were cultured in CSE-free medium between daily treatments. Bisulfite sequencing and real-time PCR array-based methylation profiling were employed to evaluate methylation changes at tumor suppressor gene loci in the chronically CSE-treated cells versus the passage-matched untreated control cells. The RUNX3 tumor suppressor gene promoter was hypomethylated with a significant increase in proportion of the completely unmethylated haplotype after the long-term CSE treatment; whereas RUNX3 promoter hypermethylation was previously reported for bladder cancers of smokers. Hypomethylation induced by the long-term CSE treatment was also observed for the IGF2-H19 locus. The methylation status at the PRSS8/prostasin and 16 additional loci however, was unaffected by the chronic CSE treatment. Transient CSE treatment over 1 daily regimen resulted in transcriptional down-regulation of RUNX3 and H19, but only the H19 transcription was down-regulated in the chronically CSE-treated urothelial cells. Transcription of a key enzyme in one-carbon metabolism, dihydrofolate reductase (DHFR) was greatly reduced by the long-term CSE treatment, potentially serving as a mechanism for the hypomethylation phenotype via a reduced supply of methyl donor. In conclusion, chronic cyclic CSE treatment of urothelial cells induced hypomethylation rather than hypermethylation at specific loci.	[Chen, Li-Mei; Nergard, Jennifer C.; Chai, Karl X.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Ni, Liqiang] Univ Cent Florida, Dept Stat, Coll Sci, Orlando, FL 32816 USA; [Rosser, Charles J.] MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL USA; [Rosser, Charles J.] MD Anderson Canc Ctr Orlando, Sect Urol Oncol, Orlando, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chai, KX (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kxchai@mail.ucf.edu			Florida Department of Health James & Esther King Biomedical Research Program [06NIR-03, 10KT-1]	Florida Department of Health James & Esther King Biomedical Research Program	This work was supported by the Florida Department of Health James & Esther King Biomedical Research Program Grants 06NIR-03 to LMC and 10KT-1 (Project 5) to KXC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2006, INT J ONCOL, V28, P1491; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen LM, 2009, PROSTATE, V69, P1790, DOI 10.1002/pros.21030; Chen LM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-377; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen LM, 2002, INT J CANCER, V97, P323, DOI 10.1002/ijc.1601; Chen MQ, 2006, PROSTATE, V66, P911, DOI 10.1002/pros.20325; Chen WC, 2010, J GASTROEN HEPATOL, V25, P823, DOI 10.1111/j.1440-1746.2009.06191.x; Cui HM, 2002, CANCER RES, V62, P6442; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Friedrich MG, 2005, EUR J CANCER, V41, P2769, DOI 10.1016/j.ejca.2005.07.019; Fu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043042; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; Hao Jianyu, 2009, INHAL TOXICOL, V21, P1007; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liu LM, 2005, INT J ONCOL, V26, P275; Marsit CJ, 2006, ANN NY ACAD SCI, V1076, P810, DOI 10.1196/annals.1371.031; Marsit CJ, 2006, CARCINOGENESIS, V27, P112, DOI 10.1093/carcin/bgi172; Milara J, 2010, EUR J PHARM SCI, V39, P363, DOI 10.1016/j.ejps.2010.01.005; OKAMOTO M, 1995, CANCER RES, V55, P4581; Serra M, 2004, ANN ONCOL, V15, P151, DOI 10.1093/annonc/mdh004; Somji S, 2008, ENVIRON HEALTH PERSP, V116, P434, DOI 10.1289/ehp.10279; Sontag Ryan L, 2012, BMC Res Notes, V5, P217, DOI 10.1186/1756-0500-5-217; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Wolff EM, 2005, NAT CLIN PRACT UROL, V2, P502, DOI 10.1038/ncpuro0318; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wyatt TA, 2000, P SOC EXP BIOL MED, V225, P91, DOI 10.1046/j.1525-1373.2000.22511.x; Yan F, 2005, J ENVIRON MONITOR, V7, P681, DOI 10.1039/b502061a	34	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65513	10.1371/journal.pone.0065513	http://dx.doi.org/10.1371/journal.pone.0065513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724145	gold, Green Published			2022-12-25	WOS:000319733000134
J	Kim, YB; Kim, JK; Uddin, MR; Xu, H; Park, WT; Tuan, PA; Li, X; Chung, E; Lee, JH; Park, SU				Kim, Yeon Bok; Kim, Jae Kwang; Uddin, Md Romij; Xu, Hui; Park, Woo Tae; Pham Anh Tuan; Li, Xiaohua; Chung, Eunsook; Lee, Jai-Heon; Park, Sang Un			Metabolomics Analysis and Biosynthesis of Rosmarinic Acid in Agastache rugosa Kuntze Treated with Methyl Jasmonate	PLOS ONE			English	Article							PHENYLALANINE-AMMONIA-LYASE; CELL-SUSPENSION CULTURES; LITHOSPERMUM-ERYTHRORHIZON; EXPRESSION; GENE; ACCUMULATION; CLONING; 4-HYDROXYLASE; ELICITORS; CATECHINS	This study investigated the effect of methyl jasmonate (MeJA) on metabolic profiles and rosmarinic acid (RA) biosynthesis in cell cultures of Agastache rugosa Kuntze. Transcript levels of phenylpropanoid biosynthetic genes, i.e., ArPAL, Ar4CL, and ArC4H, maximally increased 4.5-fold, 3.4-fold, and 3.5-fold, respectively, compared with the untreated controls, and the culture contained relatively high amounts of RA after exposure of cells to 50 mu M MeJA. RA levels were 2.1-, 4.7-, and 3.9-fold higher after exposure to 10, 50, and 100 mu M MeJA, respectively, than those in untreated controls. In addition, the transcript levels of genes attained maximum levels at different time points after the initial exposure. The transcript levels of ArC4H and Ar4CL were transiently induced by MeJA, and reached a maximum of up to 8-fold at 3 hr and 6 hr, respectively. The relationships between primary metabolites and phenolic acids in cell cultures of A. rugosa treated with MeJA were analyzed by gas chromatography coupled with time-of-flight mass spectrometry. In total, 45 metabolites, including 41 primary metabolites and 4 phenolic acids, were identified from A. rugosa. Metabolite profiles were subjected to partial least square-discriminate analysis to evaluate the effects of MeJA. The results indicate that both phenolic acids and precursors for the phenylpropanoid biosynthetic pathway, such as aromatic amino acids and shikimate, were induced as a response to MeJA treatment. Therefore, MeJA appears to have an important impact on RA accumulation, and the increased RA accumulation in the treated cells might be due to activation of the phenylpropanoid genes ArPAL, ArC4H, and Ar4CL.	[Kim, Yeon Bok; Uddin, Md Romij; Park, Woo Tae; Pham Anh Tuan; Li, Xiaohua; Park, Sang Un] Chungnam Natl Univ, Dept Crop Sci, Taejon, South Korea; [Kim, Jae Kwang] Natl Acad Agr Sci, Rural Dev Adm, Suwon, South Korea; [Xu, Hui] Inner Mongolia Univ Nationalities, Coll Life Sci, Inner Mongolia, Peoples R China; [Chung, Eunsook; Lee, Jai-Heon] Dong A Univ, Dept Genet Engn, Pusan, South Korea	Chungnam National University; Rural Development Administration (RDA); Inner Mongolia University for Nationalities; Dong A University	Park, SU (corresponding author), Chungnam Natl Univ, Dept Crop Sci, Taejon, South Korea.	supark@cnu.ac.kr		Uddin, Md. Romij/0000-0003-2188-7619	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20110010231]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009520]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This study was supported by a grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110010231) and also partially from the Next-Generation BioGreen 21 Program (SSAC, PJ009520), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonfill M, 2011, PLANT CELL TISS ORG, V104, P61, DOI 10.1007/s11240-010-9804-7; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Coste A, 2011, PLANT CELL TISS ORG, V106, P279, DOI 10.1007/s11240-011-9919-5; Creelman Robert A, 2002, Arabidopsis Book, V1, pe0012, DOI 10.1199/tab.0012; Hanik N, 2010, J CHEM ECOL, V36, P1058, DOI 10.1007/s10886-010-9835-x; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Hong JJ, 2001, FEBS LETT, V495, P142, DOI 10.1016/S0014-5793(01)02379-1; Jeong GA, 2007, APPL BIOCHEM BIOTECH, V130, P436; Ketchum REB, 1999, BIOTECHNOL BIOENG, V62, P97, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;97::AID-BIT11&gt;3.0.CO;2-C; Kim HK, 2001, BIOTECHNOL LETT, V23, P55, DOI 10.1023/A:1026738409671; Kim JK, 2013, PLANT BIOTECHNOL REP, V7, P121, DOI 10.1007/s11816-012-0231-6; Kim OT, 2009, PLANT CELL TISS ORG, V98, P25, DOI 10.1007/s11240-009-9535-9; Kok EJ, 2008, REGUL TOXICOL PHARM, V50, P98, DOI 10.1016/j.yrtph.2007.09.007; Korsangruang S, 2010, PLANT CELL TISS ORG, V103, P333, DOI 10.1007/s11240-010-9785-6; Krzyzanowska J, 2012, PLANT CELL TISS ORG, V108, P73, DOI 10.1007/s11240-011-0014-8; Liang YS, 2006, PHYTOCHEMISTRY, V67, P2503, DOI 10.1016/j.phytochem.2006.08.018; Lukmanul Hakkim F, 2011, INT J BIOL MED RES, V2, P1070; Lystvan K, 2010, PLANT CELL TISS ORG, V101, P99, DOI 10.1007/s11240-009-9657-0; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; MIZUKAMI H, 1992, PLANT CELL REP, V11, P480, DOI 10.1007/BF00232695; MIZUKAMI H, 1993, PLANT CELL REP, V12, P706, DOI 10.1007/BF00233424; Oh HM, 2005, ARCH PHARM RES, V28, P305, DOI 10.1007/BF02977797; Park JH, 2010, J NAT PROD, V73, P1394, DOI 10.1021/np1003356; PARNHAM M J, 1985, Drugs of the Future, V10, P756; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Petersen M, 1997, PHYTOCHEMISTRY, V45, P1165, DOI 10.1016/S0031-9422(97)00135-0; Tuan PA, 2012, J AGR FOOD CHEM, V60, P5945, DOI 10.1021/jf300833m; Rani A, 2009, FUNCT INTEGR GENOMIC, V9, P271, DOI 10.1007/s10142-008-0098-3; RAZZAQUE A, 1977, PLANTA, V137, P287, DOI 10.1007/BF00388164; Rhee HS, 2010, PLANT CELL TISS ORG, V101, P295, DOI 10.1007/s11240-010-9688-6; Scarpati ML., 1958, RIC SCI, V28, P2329, DOI DOI 10.1038/APS.2012.126; Shin S, 2003, LETT APPL MICROBIOL, V36, P111, DOI 10.1046/j.1472-765X.2003.01271.x; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Smetanska I, 2008, ADV BIOCHEM ENG BIOT, V111, P187, DOI 10.1007/10_2008_103; Tassoni A, 2005, NEW PHYTOL, V166, P895, DOI 10.1111/j.1469-8137.2005.01383.x; Tsuruga A., 2006, PLANT BIOTECHNOL, V23, P297; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Weitzel C, 2010, PLANTA, V232, P731, DOI 10.1007/s00425-010-1206-x; Xu F, 2008, AFR J BIOTECHNOL, V7, P721; Yamamura Y, 2001, PLANT CELL REP, V20, P655, DOI 10.1007/s002990100373; ZENK MH, 1977, NATURWISSENSCHAFTEN, V64, P585, DOI 10.1007/BF00450645	44	61	62	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64199	10.1371/journal.pone.0064199	http://dx.doi.org/10.1371/journal.pone.0064199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724034	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000047
J	Steinestel, J; Cronauer, MV; Muller, J; Al Ghazal, A; Skowronek, P; Arndt, A; Kraft, K; Schrader, M; Schrader, AJ; Steinestel, K				Steinestel, Julie; Cronauer, Marcus V.; Mueller, Johannes; Al Ghazal, Andreas; Skowronek, Peter; Arndt, Annette; Kraft, Klaus; Schrader, Mark; Schrader, Andres J.; Steinestel, Konrad			Overexpression of p16(INK4a) in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection	PLOS ONE			English	Article							EAU INTERNATIONAL CONSULTATION; BLADDER-CANCER; INVERTED PAPILLOMA; CERVICAL NEOPLASIA; URINARY-BLADDER; CELL CARCINOMA; GROWTH-FACTOR; P16; EXPRESSION; GENE	Background: The role of human papillomavirus (HPV) in bladder carcinogenesis remains controversial. Overexpression of p16(INK4a), a surrogate marker for infection with oncogenic HPV in other tumours, has been described for urothelial carcinoma in situ (UCIS). Our goal was therefore to evaluate whether overexpression of p16(INK4a) is associated with HPV infection and to identify mechanisms of p16(INK4a) upregulation in UCIS. Materials and Methods: In 60 tissue specimens from a total of 45 patients (UCIS and controls), we performedp16(INK4a) immunohistochemistry followed by detection and subclassification of HPV DNA. In a subset of samples, we tested for gene amplification of p16 INK4a applying fluorescence in situ hybridization (FISH). RAS/MAPK signalling and epithelial-mesenchymal transition (EMT) was assessed using immunohistochemistry. Finally, we transfected urothelial carcinoma cells with KRAS and examined the expression of p16(INK4a) as well as markers of EMT. Results: We found overexpression of p16(INK4a) in 92.6% of UCIS and in all cervical intraepithelial neoplasia (CIN) controls. In contrast, we detected high-risk HPV DNA in 80% of CIN, but none in UCIS. There was no gene amplification of p16(INK4a). High levels of phosphorylated kinases and urokinase plasminogen activator (uPA) and loss of membraneous E-cadherin were detected in UCIS. KRAS transfection of urothelial carcinoma cells led to upregulation of p16(INK4a) and uPA accompanied by loss of E-cadherin that could be inhibited by application of the kinase-inhibitor Sorafenib. Conclusions: Our results show that overexpression of p16(INK4a) in UCIS is neither associated with HPV infection nor p16(INK4a) gene amplification but is a consequence of enhanced RAS/MAPK signalling that promotes EMT, possibly due to Sorafenib-sensitive paracrine secretion of the EMT activator uPA. These findings might open a novel therapeutic option for localized but aggressive urothelial cancer.	[Steinestel, Julie; Cronauer, Marcus V.; Mueller, Johannes; Al Ghazal, Andreas; Schrader, Mark; Schrader, Andres J.] Univ Ulm, Dept Urol, D-89069 Ulm, Germany; [Skowronek, Peter] Gemeinschaftspraxis Pathol Augsburg, Augsburg, Germany; [Arndt, Annette; Kraft, Klaus] Bundeswehrkrankenhaus Ulm, Inst Pathol & Mol Pathol, Ulm, Germany; [Steinestel, Konrad] Bundeswehr Inst Radiobiol, Munich, Germany; [Steinestel, Konrad] Univ Ulm, Inst Pathol, D-89069 Ulm, Germany	Ulm University; Ulm University; Military Hospital Ulm; Ulm University	Steinestel, K (corresponding author), Bundeswehr Inst Radiobiol, Munich, Germany.	konrad@steinestel.com	Cronauer, Marcus/AAG-7457-2021	Steinestel, Konrad/0000-0002-6549-9848				Aggarwal S, 2009, DIAGN CYTOPATHOL, V37, P174, DOI 10.1002/dc.20978; Alexander RE, 2012, MODERN PATHOL, V25, P1526, DOI 10.1038/modpathol.2012.103; Amin MB, 2013, EUR UROL, V63, P16, DOI 10.1016/j.eururo.2012.09.063; Ben Selma W, 2010, PATHOL RES PRACT, V206, P740, DOI 10.1016/j.prp.2010.06.005; Beothe T, 2012, ANTICANCER RES, V32, P523; Blanco S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-122; Burger M, 2012, EUR UROL; Burger M, 2013, EUR UROL, V63, P36, DOI 10.1016/j.eururo.2012.08.061; Chan KW, 1997, J CLIN PATHOL, V50, P1018, DOI 10.1136/jcp.50.12.1018; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; Cheng LA, 2010, EXPERT REV ANTICANC, V10, P865, DOI 10.1586/era.10.73; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Davies M, 2012, INT J EXP PATHOL, V93, P148, DOI 10.1111/j.1365-2613.2011.00806.x; Doeberitz MV, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, 10.1586/EPR.12.13]; Edgecombe A, 2012, APPL IMMUNOHISTO M M, V20, P264, DOI 10.1097/PAI.0b013e3182351ed3; Genua M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040148; Gould VE, 2010, CANCER LETT, V292, P171, DOI 10.1016/j.canlet.2009.11.022; Hepburn AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050690; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hodges KB, 2010, HUM PATHOL, V41, P155, DOI 10.1016/j.humpath.2009.07.002; Kamat AM, 2013, EUR UROL, V63, P4, DOI 10.1016/j.eururo.2012.09.057; Keating JT, 2001, AM J SURG PATHOL, V25, P884, DOI 10.1097/00000478-200107000-00006; Kenney PA, 2011, BJU INT, V107, P656, DOI 10.1111/j.1464-410X.2010.09489.x; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; McKenney JK, 2001, AM J SURG PATHOL, V25, P356, DOI 10.1097/00000478-200103000-00010; Monticone M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-92; Nasioutziki M, 2011, INT J GYNECOL CANCER, V21, P79, DOI 10.1097/IGC.0b013e3182009eea; Ogawa T, 2010, J UROLOGY, V183, P1206, DOI 10.1016/j.juro.2009.11.007; Encina JO, 2012, EUR UROL, V61, P847, DOI 10.1016/j.eururo.2012.01.033; Polesel J, 2012, BRIT J CANCER, V106, P222, DOI 10.1038/bjc.2011.519; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Reuschenbach M, 2008, INT J CANCER, V123, P2626, DOI 10.1002/ijc.23837; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Roperto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033569; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Shaker OG, 2012, BIOMED PHARMACOTHER; Shigehara K, 2011, J MED VIROL, V83, P277, DOI 10.1002/jmv.21966; Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Shuto M, 2012, ACTA HISTOCHEM CYTOC, V45, P25, DOI 10.1267/ahc.11048; Steinestel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040671; Volgareva GM, 2010, B EXP BIOL MED+, V149, P242, DOI 10.1007/s10517-010-0917-0; Volgareva G. M., 2004, Arkhiv Patologii, V66, P3; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yavuzer D, 2011, MED ONCOL, V28, P919, DOI 10.1007/s12032-010-9540-1; Yin M, 2008, HUM PATHOL, V39, P527, DOI 10.1016/j.humpath.2007.08.005; Yoo HJ, 2012, CELL SIGNAL, V24, P1471, DOI 10.1016/j.cellsig.2012.03.010	48	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65189	10.1371/journal.pone.0065189	http://dx.doi.org/10.1371/journal.pone.0065189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724131	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000124
J	Van Wynsberge, S; Andrefouet, S; Gilbert, A; Stein, A; Remoissenet, G				Van Wynsberge, Simon; Andrefouet, Serge; Gilbert, Antoine; Stein, Arsene; Remoissenet, Georges			Best Management Strategies for Sustainable Giant Clam Fishery in French Polynesia Islands: Answers from a Spatial Modeling Approach	PLOS ONE			English	Article							MARINE PROTECTED AREAS; ATOLL EASTERN TUAMOTU; TRIDACNA-MAXIMA; FISHING EFFORT; POPULATION-DYNAMICS; CORAL-REEFS; ARCHIPELAGO; CROCEA; SIZE; MORTALITY	The giant clam Tridacna maxima has been largely overexploited in many tropical regions over the past decades, and was therefore listed in appendix II of the Convention of International Trade in Endangered Species (CITES) in 1985. In French Polynesia, several atolls and islands harbor the world's highest stocks of giant clams in very shallow and accessible areas, which are therefore highly vulnerable to fishing pressure. The local fishery authority (i.e., Direction des Resources Marines or "DRM") implemented several management schemes in 2002 to control and regulate fishing pressure. However, for further decisions DRM was missing a sensitivity analysis on the effectiveness of the possible management actions. Here, we report on the use of a deterministic Viable Population Analysis (VPA) and spatially-explicit age-based population model that simulated the 30-year trajectory of a Tridacna maxima stock under different management approaches. Specifically, given various scenarios of intra-island larval dispersal, we tested which of No-take-Areas (NTAs), rotational closures, size limits, quotas, and restocking schemes would lead to the highest future stocks in Tubuai and Raivavae, two exploited islands of the Austral archipelago. For both islands, stock abundances were estimated in 2004/2010 and 2005/2010 respectively, and natural mortalities were assessed previously only in Tubuai. When compared to field data, the model successfully predicted the 2010 stocks for Tubuai, but proved to be less reliable for Raivavae, where natural mortality rates may well be different from those on Tubuai. For Tubuai, the spatial model suggested that reducing fishing effort (through fixed quotas) and banning fishing below the 12 cm size limit (as currently implemented) were the most effective management actions to sustain T. maxima populations into the future. Implementing NTAs was of poor effectiveness. NTAs increased giant clam stock inside the protected area, but also increased overfishing in the neighboring areas, and were ineffective overall.	[Van Wynsberge, Simon; Andrefouet, Serge] Inst Rech Dev, UR CoReUs, Noumea, New Caledonia; [Gilbert, Antoine] Ginger Soproner, Noumea, New Caledonia; [Stein, Arsene; Remoissenet, Georges] Direct Ressources Marines, Papeete, Fare Ute, France	Institut de Recherche pour le Developpement (IRD)	Van Wynsberge, S (corresponding author), Inst Rech Dev, UR CoReUs, Noumea, New Caledonia.	simon.vanwynsberge@gmail.com			Direction des Ressources Marines of French Polynesia	Direction des Ressources Marines of French Polynesia	Self-funding for modeling and analysis, and field work funded to IRD by the Direction des Ressources Marines of French Polynesia.	Addessi L, 2001, CORAL REEFS, V19, P220, DOI 10.1007/PL00006957; Adessi L, 1999, THESIS; Adjeroud M, 2001, CORAL REEFS, V19, P287, DOI 10.1007/PL00006962; Andrefouet S, 2005, ICES J MAR SCI, V62, P1037, DOI 10.1016/j.icesjms.2005.04.006; Andrefouet S, 2013, BIOL CONSERV, V160, P190, DOI 10.1016/j.biocon.2013.01.017; Andrefouet S, 2009, ICES J MAR SCI, V66, P1825, DOI 10.1093/icesjms/fsp148; Apte Deepak, 2010, Marine Biodiversity Records, V3, pe78; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; bin Othman AS, 2010, RAFFLES B ZOOL, V58, P103; Black R, 2011, MAR FRESHWATER RES, V62, P1318, DOI 10.1071/MF11093; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Chinain M, 2010, TOXICON, V56, P674, DOI 10.1016/j.toxicon.2009.05.032; Cinner JE, 2011, PNAS, V109, P5219; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; COLVIN M A, 1991, North American Journal of Fisheries Management, V11, P585, DOI 10.1577/1548-8675(1991)011<0585:EOMSLA>2.3.CO;2; Danielsson B, 1954, ATOLL RES B, V32, P92; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Eckman JE, 1996, J EXP MAR BIOL ECOL, V200, P207, DOI 10.1016/S0022-0981(96)02644-5; FAO Fisheries and Aquaculture Department, 2010, STAT WORLD FISH AQ; Foster SJ, 2005, CONSERV BIOL, V19, P1044, DOI 10.1111/j.1523-1739.2005.00192.x; Gilbert, 2005, RAPPORT FINAL ARUE; Gilbert A, 2005, CORAL REEFS, V24, P495, DOI 10.1007/s00338-005-0494-2; Gilbert A, 2007, 60080 I RECH DEV; Gilbert A, 2006, ICES J MAR SCI, V63, P1573, DOI 10.1016/j.icesjms.2006.07.001; Govan H., 1988, ACIAR Monograph Series, P54; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; Hadfield MG, 2000, SEMIN CELL DEV BIOL, V11, P437, DOI 10.1006/scdb.2000.0197; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hamel MA, 2010, MAR POLLUT BULL, V60, P1397, DOI 10.1016/j.marpolbul.2010.07.002; HAMNER WM, 1978, OECOLOGIA, V34, P267, DOI 10.1007/BF00344906; Hart AM, 1998, AQUACULTURE, V165, P203, DOI 10.1016/S0044-8486(98)00255-5; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Hean RL, 2003, ECOL MODEL, V163, P87, DOI 10.1016/S0304-3800(02)00400-3; JAMESON SC, 1976, PAC SCI, V30, P219; Jouve JM, 2010, EXPLOITATION BENITIE; Kaplan DM, 2009, MAR ECOL PROG SER, V377, P213, DOI 10.3354/meps07825; LABARBERA M, 1975, Malacologia, V15, P69; Langi V., 1988, ACIAR Monograph Series, P58; Laurent V, 2002, BIOL J LINN SOC, V77, P221, DOI 10.1046/j.1095-8312.2002.00106.x; Leopold M., 2013, ENV CONSERV IN PRESS; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lucas John S., 1994, Reviews in Fisheries Science, V2, P181; MacCall AD, 1975, PURSE SEINE FISHERY, VXVIII, p[138, 146]; Maceina Michael J., 1998, North American Journal of Fisheries Management, V18, P66, DOI 10.1577/1548-8675(1998)018<0066:AOTSFW>2.0.CO;2; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McKoy J. L., 1979, LETT INFORM COMMISSI, V19, P1; Melville-Smith R., 2011, FACTORS POTENTIALLY; MERGNER H, 1974, HELGOLAND WISS MEER, V26, P238, DOI 10.1007/BF01627619; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; MORRIS WF, 2002, THEORY PRACTICE POPU; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; OSMAN RW, 1995, J EXP MAR BIOL ECOL, V190, P199, DOI 10.1016/0022-0981(95)00036-Q; Pelletier D, 2005, FISH FISH, V6, P307, DOI 10.1111/j.1467-2979.2005.00199.x; Planes S, 1993, ATOLL RES B, V385; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Remoissenet G., 2009, REG MAN SUST FISH GI; Richard G., 1982, THESIS; RICHARDS LJ, 1986, CAN J FISH AQUAT SCI, V43, P1214, DOI 10.1139/f86-151; Roa-Quiaoit H., 2005, ECOLOGY CULTURE GIAN; Rogers-Bennett L, 2006, ECOL APPL, V16, P213, DOI 10.1890/04-1688; Romimohtarto K, 1988, ACIAR MONOGRAPH, V9, P258; SAINSBURY KJ, 1982, NEW ZEAL J MAR FRESH, V16, P163, DOI 10.1080/00288330.1982.9515959; Salvat B., 1972, CAHIERS PACIFIQUE, V16, P30; SCHTICKZELLE M, 1981, POPULATION, V36, P541, DOI 10.2307/1532620; Schumway SE, 2006, SCALLOPS BIOL ECOLOG; Stephenson A., 1934, Scientific Reports Great Barrier Reef Expedition 1928-29 London, V3, P247; Teitelbaum A, 2008, AUSTR AQ C BRISB QUE; Thomas Y, 2012, MAR POLLUT BULL, V65, P441, DOI 10.1016/j.marpolbul.2011.12.027; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; VILLANOY CL, 1988, CORAL REEFS, V7, P1, DOI 10.1007/BF00301974; Walters C, 2000, B MAR SCI, V66, P745; Wijnstekers W, 2000, EVOLUTION CITES PREC; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yau AJY, 2011, THESIS	81	18	19	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64641	10.1371/journal.pone.0064641	http://dx.doi.org/10.1371/journal.pone.0064641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724072	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000072
J	Xu, Y; Ma, HX; Yu, HP; Liu, ZS; Wang, LE; Tan, DF; Muddasani, R; Lu, V; Ajani, JA; Wang, YN; Wei, QY				Xu, Yu; Ma, Hongxia; Yu, Hongping; Liu, Zhensheng; Wang, Li-E; Tan, Dongfeng; Muddasani, Ramya; Lu, Victoria; Ajani, Jaffer A.; Wang, Yanong; Wei, Qingyi			The miR-184 Binding-Site rs8126 T > C Polymorphism in TNFAIP2 Is Associated with Risk of Gastric Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PRIMARY RESPONSE GENE; NECROSIS-FACTOR-ALPHA; OXIDATIVE DNA-DAMAGE; HELICOBACTER-PYLORI; TARGET GENE; MICRORNAS; SUSCEPTIBILITY; VARIANT; HEAD	Background: TNFAIP2 is a crucial gene involved in apoptosis. Single nucleotide polymorphisms (SNPs) in its miRNA binding sites could modulate functions of the miRNA-target genes and thus risk of cancers. In this study, we investigated associations between potentially functional SNPs in the miRNA binding sites of the 3'UTR of TNFAIP2 and gastric cancer risk in a US population. Methods: We conducted a case-control study of 301 gastric cancer patients and 313 cancer-free controls frequency-matched by age, sex and ethnicity. We genotyped four selected TNFAIP2 SNPs (rs8126 T>C, rs710100 G>A, rs1052912 G>A and rs1052823 G>T) and used the logistic regression analysis to assess associations of these SNPs with cancer risk. Results: The rs8126 CC genotype was associated with a significantly elevated risk of gastric cancer (adjusted OR = 2.00, 95% CI = 1.09-3.64 and P = 0.024), compared with the combined rs8126 TT+TC genotypes, particularly in current drinkers. However, none of other TNFAIP2 SNPs was associated with risk of gastric cancer. Conclusions: Our data suggested that the TNFAIP2 miRNA binding site rs8126 T>C SNP may be a marker for susceptibility to gastric cancer, and this finding requires further validation by larger studies.	[Xu, Yu; Ma, Hongxia; Yu, Hongping; Liu, Zhensheng; Wang, Li-E; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Tan, Dongfeng; Muddasani, Ramya; Lu, Victoria] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA; [Xu, Yu; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcomas Surg, Shanghai 200433, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fudan University	Xu, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xuyudaniel@gmail.com; qwei@mdanderson.org		Muddasani, Ramya/0000-0002-2651-8276	National Institute of Health [R01 CA131274, R01 ES011740, P30 CA016672]; NATIONAL CANCER INSTITUTE [R01CA131274, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants R01 CA131274 and R01 ES011740 (Q. Wei), and P30 CA016672 (The University of Texas M.D. Anderson Cancer Center). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Baik SC, 1996, CANCER RES, V56, P1279; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Choi JY, 2003, INT IMMUNOPHARMACOL, V3, P553, DOI 10.1016/S1567-5769(03)00046-8; CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Farinati F, 1998, GUT, V42, P351, DOI 10.1136/gut.42.3.351; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Guan XX, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-77; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; KIM K, 2011, EPIGENETICS, V6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu ZS, 2008, CANCER LETT, V268, P158, DOI 10.1016/j.canlet.2008.03.034; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Rusiniak ME, 2000, CANCER RES, V60, P1824; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SARMA V, 1992, J IMMUNOL, V148, P3302; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Tivnan A, 2010, ANTICANCER RES, V30, P4391; WOLF FW, 1994, J BIOL CHEM, V269, P3633; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	32	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64973	10.1371/journal.pone.0064973	http://dx.doi.org/10.1371/journal.pone.0064973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724109	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000108
J	Anema, A; Chan, K; Chen, YL; Weiser, S; Montaner, JSG; Hogg, RS				Anema, Aranka; Chan, Keith; Chen, Yalin; Weiser, Sheri; Montaner, Julio S. G.; Hogg, Robert S.			Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BODY-MASS INDEX; CD4 CELL COUNT; NUTRITIONAL-STATUS; INFECTED INDIVIDUALS; DEPRESSIVE SYMPTOMS; MEDICATION ADHERENCE; RISK-FACTORS; VIRAL LOAD; SURVIVAL	Objectives: Little is known about the potential impact of food insecurity on mortality among people living with HIV/AIDS. We examined the potential relationship between food insecurity and all-cause mortality among HIV-positive injection drug users (IDU) initiating antiretroviral therapy (ART) across British Columbia (BC). Methods: Cross-sectional measurement of food security status was taken at participant ART initiation. Participants were prospectively followed from June 1998 to September 2011 within the fully subsidized ART program. Cox proportional hazard models were used to ascertain the association between food insecurity and mortality, controlling for potential confounders. Results: Among 254 IDU, 181 (71.3%) were food insecure and 108 (42.5%) were hungry. After 13.3 years of median follow-up, 105 (41.3%) participants died. In multivariate analyses, food insecurity remained significantly associated with mortality (adjusted hazard ratio [AHR] = 1.95, 95% CI: 1.07-3.53), after adjusting for potential confounders. Conclusions: HIV-positive IDU reporting food insecurity were almost twice as likely to die, compared to food secure IDU. Further research is required to understand how and why food insecurity is associated with excess mortality in this population. Public health organizations should evaluate the possible role of food supplementation and socio-structural supports for IDU within harm reduction and HIV treatment programs.	[Anema, Aranka; Montaner, Julio S. G.; Hogg, Robert S.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Anema, Aranka; Chan, Keith; Chen, Yalin; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; [Weiser, Sheri] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Weiser, Sheri] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Hogg, Robert S.] Univ British Columbia, Fac Hlth Sci, Burnaby, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia	Anema, A (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	aanema@cfenet.ubc.ca		Hogg, Robert/0000-0003-3463-5488	Canadian Institutes of Health Research (CIHR); National Institutes of Health (NIH) [R01 MH095683-01]; Burke Family Foundation; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the NIH [1DP1DA026182]; CIHR; International AIDS Society; United Nations AIDS Program; World Health Organization; NIH Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; Abbott; Biolytical; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; ViiV Healthcare; NIH; Health Canada; Social Sciences and Humanities Research Council of Canada (SSHRC); Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc; GlaxoSmithKline; Abbott Laboratories; Agouron Pharmaceuticals Inc.; Borean Pharma AS; DuPont Pharma; Hoffmann-La Roche; Immune Response Corporation; Incyte; Janssen-Ortho Inc.; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada Inc.; Sanofi Pasteur; Shire Biochem Inc.; Tibotec Pharmaceuticals Ltd.; Trimeris Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Family Foundation; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the NIH; CIHR(Canadian Institutes of Health Research (CIHR)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); NIH Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; Abbott(Abbott Laboratories); Biolytical; Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Canada; Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Abbott Laboratories(Abbott Laboratories); Agouron Pharmaceuticals Inc.; Borean Pharma AS; DuPont Pharma; Hoffmann-La Roche(Hoffmann-La Roche); Immune Response Corporation; Incyte; Janssen-Ortho Inc.; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada Inc.; Sanofi Pasteur; Shire Biochem Inc.; Tibotec Pharmaceuticals Ltd.; Trimeris Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Aranka Anema is supported by the Canadian Institutes of Health Research (CIHR) Vanier Award for doctoral research. Dr. Sheri D. Weiser is supported by a National Institutes of Health (NIH) grant (R01 MH095683-01) and the Burke Family Foundation. Dr. Julio Montaner is supported by the British Columbia Ministry of Health; through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse (NIDA), at the NIH; and through a KT Award from CIHR. He has also received financial support from the International AIDS Society, United Nations AIDS Program, World Health Organization, NIH Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), UNICEF, the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health Authority. He has received grants from Abbott, Biolytical, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. Dr. Robert S. Hogg has held grant funding in the last five years from the NIH, CIHR, Health Canada, Merck, and Social Sciences and Humanities Research Council of Canada (SSHRC). He has also received funding from Agouron Pharmaceuticals Inc, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb, GlaxoSmithKline, and Merck Frosst Laboratories for participating in continued medical education programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Julio S. G. Montaner has received educational grants from, served as an ad hoc adviser to or spoken at various events sponsored by Abbott Laboratories, Agouron Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc., Borean Pharma AS, Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immune Response Corporation, Incyte, Janssen-Ortho Inc., Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pfizer Canada Inc., Sanofi Pasteur, Shire Biochem Inc., Tibotec Pharmaceuticals Ltd. and Trimeris Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andrews G, 2010, DEPRESS ANXIETY, V27, P134, DOI 10.1002/da.20658; Anema A, 2011, AIDS CARE, V23, P221, DOI 10.1080/09540121.2010.498908; Anema A, 2011, FOOD INS CONT HIV HA; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Au-Yeung CG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-642; Baum MK, 2000, J ACQ IMMUN DEF SYND, V25, pS49, DOI 10.1097/00126334-200010001-00008; Bickel D, 2000, US DEP AGR USDA GUID; British Columbia Centre for Excellence in HIVAIDS (BC-CfE), 2011, THER GUID ANT TREATM; Campa A, 2005, CLIN INFECT DIS, V41, P1179, DOI 10.1086/444499; Cohen MH, 2002, AM J MED, V113, P91, DOI 10.1016/S0002-9343(02)01169-5; Cunningham WE, 2005, J HEALTH CARE POOR U, V16, P655; Forrester JE, 2005, PUBLIC HEALTH NUTR, V8, P61, DOI [10.1079/PHN2005667, 10.1079/PHN2004667]; Frongillo EA, 1999, J NUTR, V129, p506S, DOI 10.1093/jn/129.2.506S; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Himmelgreen DA, 1998, AM J PHYS ANTHROPOL, V107, P351, DOI 10.1002/(SICI)1096-8644(199811)107:3<351::AID-AJPA10>3.3.CO;2-Z; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; Islam SKN, 2002, BRIT J NUTR, V88, P507, DOI 10.1079/BJN2002702; Kadiyala S, 2012, J ACQ IMMUN DEF SYND, V62, P246; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; KENDALL A, 1995, J NUTR, V125, P2793; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Koethe JR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-19; Koethe JR, 2010, AIDS, V24, P2117, DOI 10.1097/QAD.0b013e32833b784a; Leserman J, 2007, AM J PSYCHIAT, V164, P1707, DOI 10.1176/appi.ajp.2007.06111775; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Lima VD, 2010, CAN J PUBLIC HEALTH, V101, P415, DOI 10.1007/BF03404864; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mayne TJ, 1996, ARCH INTERN MED, V156, P2233, DOI 10.1001/archinte.156.19.2233; McMahon J, 2011, AIDS BEHAV, V15, P1503, DOI 10.1007/s10461-010-9759-z; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Niyongabo T, 1999, NUTRITION, V15, P740, DOI 10.1016/S0899-9007(99)00146-X; Nolan S, 2011, AIDS CARE, V23, P980, DOI 10.1080/09540121.2010.543882; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Nurutdinova D, 2012, AIDS, V26, P229, DOI 10.1097/QAD.0b013e32834e1404; Office of Policy Support of the Food and Nutrition Service of the USDA, 2015, ASSESSMENT CONTRIBUT; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; Quach LA, 2008, DRUG ALCOHOL DEPEN, V95, P30, DOI 10.1016/j.drugalcdep.2007.12.004; Radimer KL, 2002, PUBLIC HEALTH NUTR, V5, P859, DOI 10.1079/PHN2002385; RADIMER KL, 1990, J NUTR, V120, P1544, DOI 10.1093/jn/120.suppl_11.1544; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Romero-Daza Nancy, 1999, MED ANTHROPOL, V18, P281; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sahni S, 2007, J AM DIET ASSOC, V107, P968, DOI 10.1016/j.jada.2007.04.003; SANTOLARIAFERNANDEZ FJ, 1995, DRUG ALCOHOL DEPEN, V38, P11, DOI 10.1016/0376-8716(94)01088-3; SEMBA RD, 1993, ARCH INTERN MED, V153, P2149, DOI 10.1001/archinte.153.18.2149; Smit E, 2000, J ACQ IMMUN DEF SYND, V25, pS62, DOI 10.1097/00126334-200010001-00010; Statistics Canada Canadian Community Health Survey (CCHS), CYCL 2 2 NUTR INC RE; Statistics Canada Income Statistics Division, 2011, LOW INC LIN 2009 201, V002; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Tang AM, 1997, J NUTR, V127, P345, DOI 10.1093/jn/127.2.345; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; United States Department of Agriculture (USDA) Household Food Security Survey Module (HFSSM), HOUS FOOD SEC SURV M; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; Wood E, 2003, CAN MED ASSOC J, V169, P656; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; World Health Organisation (WHO), 2012, BMI CLASS TABL 1 INT; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	77	63	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e61277	10.1371/journal.pone.0061277	http://dx.doi.org/10.1371/journal.pone.0061277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HH	23723968	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100002
J	Mahendram, S; Kelly, KF; Paez-Parent, S; Mahmood, S; Polena, E; Cooney, AJ; Doble, BW				Mahendram, Sujeivan; Kelly, Kevin F.; Paez-Parent, Sabrina; Mahmood, Sharmeen; Polena, Enio; Cooney, Austin J.; Doble, Bradley W.			Ectopic gamma-catenin Expression Partially Mimics the Effects of Stabilized beta-catenin on Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							SELF-RENEWAL; E-CADHERIN; OVARIAN CARCINOMAS; TUMOR-SUPPRESSOR; GROUND-STATE; PLAKOGLOBIN; PLURIPOTENCY; DISTINCT; PROTEIN; COMPLEX	beta-catenin, an adherens junction component and key Wnt pathway effector, regulates numerous developmental processes and supports embryonic stem cell (ESC) pluripotency in specific contexts. The beta-catenin homologue gamma-catenin (also known as Plakoglobin) is a constituent of desmosomes and adherens junctions and may participate in Wnt signaling in certain situations. Here, we use beta-catenin((+/+)) and beta-catenin((-/-)) mouse embryonic stem cells (mESCs) to investigate the role of gamma-catenin in Wnt signaling and mESC differentiation. Although gamma-catenin protein is markedly stabilized upon inhibition or ablation of GSK-3 in wild-type (WT) mESCs, efficient silencing of its expression in these cells does not affect beta-catenin/TCF target gene activation after Wnt pathway stimulation. Nonetheless, knocking down gamma-catenin expression in WT mESCs appears to promote their exit from pluripotency in short-term differentiation assays. In beta-catenin((-/-)) mESCs, GSK-3 inhibition does not detectably alter cytosolic gamma-catenin levels and does not activate TCF target genes. Intriguingly, beta-catenin/TCF target genes are induced in beta-catenin((-/-)) mESCs overexpressing stabilized gamma-catenin and the ability of these genes to be activated upon GSK-3 inhibition is partially restored when wild-type gamma-catenin is overexpressed in these cells. This suggests that a critical threshold level of total catenin expression must be attained before there is sufficient signaling-competent gamma-catenin available to respond to GSK-3 inhibition and to regulate target genes as a consequence. WT mESCs stably overexpressing gamma-catenin exhibit robust Wnt pathway activation and display a block in tri-lineage differentiation that largely mimics that observed upon overexpression of beta-catenin. However, beta-catenin overexpression appears to be more effective than gamma-catenin overexpression in sustaining the retention of markers of naive pluripotency in cells that have been subjected to differentiation-inducing conditions. Collectively, our study reveals a function for gamma-catenin in the regulation of mESC differentiation and has implications for human cancers in which gamma-catenin is mutated and/or aberrantly expressed.	[Kelly, Kevin F.; Polena, Enio; Doble, Bradley W.] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Mahendram, Sujeivan; Paez-Parent, Sabrina; Mahmood, Sharmeen; Doble, Bradley W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	McMaster University; McMaster University; Baylor College of Medicine	Doble, BW (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada.	dobleb@mcmaster.ca	Doble, Brad/L-7551-2016; Doble, Bradley/V-7848-2019	Doble, Brad/0000-0002-0260-2983; Doble, Bradley/0000-0002-0260-2983	CIHR [MOP-102490]	CIHR(Canadian Institutes of Health Research (CIHR))	BWD was supported by grant MOP-102490 from CIHR, and KFK was supported by a CIHR postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1991, International Journal of Developmental Biology, V35, P389; Basler K, 2012, EMBO J; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; KARNOVSKY A, 1995, P NATL ACAD SCI USA, V92, P4522, DOI 10.1073/pnas.92.10.4522; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim YM, 2011, CURR CANCER DRUG TAR, V11, P213, DOI 10.2174/156800911794328420; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; Kodama S, 1999, J BIOL CHEM, V274, P27682, DOI 10.1074/jbc.274.39.27682; Kolligs FT, 2000, GENE DEV, V14, P1319; Li LJ, 2007, MOL CARCINOGEN, V46, P824, DOI 10.1002/mc.20310; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Morgan RG, 2013, LEUKEMIA, V27, P336, DOI 10.1038/leu.2012.221; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Sarrio D, 2006, HUM PATHOL, V37, P1042, DOI 10.1016/j.humpath.2006.03.003; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SHIBATA T, 1994, BIOCHEM BIOPH RES CO, V203, P519, DOI 10.1006/bbrc.1994.2213; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	59	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e65320	10.1371/journal.pone.0065320	http://dx.doi.org/10.1371/journal.pone.0065320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724138	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100042
J	Bodammer, P; Kerkhoff, C; Maletzki, C; Lamprecht, G				Bodammer, Peggy; Kerkhoff, Claus; Maletzki, Claudia; Lamprecht, Georg			Bovine Colostrum Increases Pore-Forming Claudin-2 Protein Expression but Paradoxically Not Ion Permeability Possibly by a Change of the Intestinal Cytokine Milieu	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD MONONUCLEAR-CELLS; TIGHT JUNCTION PERMEABILITY; HEALTH FOOD SUPPLEMENT; IMMUNE-SYSTEM; ULCERATIVE-COLITIS; CROHNS-DISEASE; HUMAN-MILK; EPITHELIAL-CELLS; MURINE COLITIS	An impaired intestinal barrier function is involved in the pathogenesis of inflammatory bowel disease (IBD). Several nutritional factors are supposed to be effective in IBD treatment but scientific data about the effects on the intestinal integrity remain scarce. Bovine colostrum was shown to exert beneficial effects in DSS-induced murine colitis, and the present study was undertaken to explore the underlying molecular mechanisms. Western blot revealed increased claudin-2 expression in the distal ileum of healthy mice after feeding with colostrum for 14 days, whereas other tight junction proteins (claudin-3, 4, 10, 15) remained unchanged. The colostrum-induced claudin-2 induction was confirmed in differentiated Caco-2 cells after culture with colostrum for 48 h. Paradoxically, the elevation of claudin-2, which forms a cation-selective pore, was neither accompanied by increased ion permeability nor impaired barrier function. In an in situ perfusion model, 1 h exposure of the colonic mucosa to colostrum induced significantly increased mRNA levels of barrier-strengthening cytokine transforming growth factor-beta, while interleukine-2, interleukine-6, interleukine-10, interleukine-13, and tumor-necrosis factor-alpha remained unchanged. Thus, modulation of the intestinal transforming growth factor-beta expression might have compensated the claudin-2 increase and contributed to the observed barrier strengthening effects of colostrum in vivo and in vitro.	[Bodammer, Peggy; Kerkhoff, Claus] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Project Grp Extracorporal Immunomodulat, Rostock, Germany; [Bodammer, Peggy; Lamprecht, Georg] Univ Rostock, Dept Med 2, Div Gastroenterol, D-18055 Rostock, Germany; [Maletzki, Claudia] Univ Rostock, Dept Gen Vasc Thorac & Transplantat Surg, Sect Mol Oncol & Immunotherapy, D-18055 Rostock, Germany	Fraunhofer Gesellschaft; University of Rostock; University of Rostock	Bodammer, P (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Project Grp Extracorporal Immunomodulat, Rostock, Germany.	peggy.bodammer@uni-rostock.de			"Deutsche Crohn und Colitis Vereinigung'', DCCV e.V.	"Deutsche Crohn und Colitis Vereinigung'', DCCV e.V.	This study was financially supported by the research grant for complementary medicine in IBD of the "Deutsche Crohn und Colitis Vereinigung'', DCCV e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Amasheh M, 2009, ANN NY ACAD SCI, V1165, P267, DOI 10.1111/j.1749-6632.2009.04063.x; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Arnott IDR, 2002, ALIMENT PHARM THER, V16, P857, DOI 10.1046/j.1365-2036.2002.01242.x; Biswas P, 2007, NEW MICROBIOL, V30, P447; Bodammer P, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-10; Bodammer P, 2011, J NUTR, V141, P1056, DOI 10.3945/jn.110.128702; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Cabre E, 2012, WORLD J GASTROENTERO, V18, P3814, DOI 10.3748/wjg.v18.i29.3814; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Feagins LA, 2010, DIGEST DIS SCI, V55, P226, DOI 10.1007/s10620-009-1042-7; Filipp D, 2001, P NATL ACAD SCI USA, V98, P603, DOI 10.1073/pnas.98.2.603; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gruber L, 2012, J CLIN GASTROENTEROL, V46, P735, DOI 10.1097/MCG.0b013e31825ca21a; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Jenny M, 2010, NEW MICROBIOL, V33, P129; Jorgensen ALW, 2010, J PEPT SCI, V16, P21, DOI 10.1002/psc.1190; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Krug SM, 2012, ANN NY ACAD SCI, V1257, P20, DOI 10.1111/j.1749-6632.2012.06555.x; Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807; Langmead L, 2006, ALIMENT PHARM THER, V23, P341, DOI 10.1111/j.1365-2036.2006.02761.x; Magrone T, 2013, CURR PHARM DESIGN, V19, P1329; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Playford RJ, 2001, CLIN SCI, V100, P627, DOI 10.1042/CS20010015; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Schmitz H, 1999, J CELL SCI, V112, P137; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shing CM, 2009, J INTERF CYTOK RES, V29, P37, DOI 10.1089/jir.2008.0015; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Solomons NW, 2002, EUR J CLIN NUTR, V56, pS24, DOI 10.1038/sj.ejcn.1601480; Suzuki T, 2012, CELL MOL LIFE SCI; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	43	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64210	10.1371/journal.pone.0064210	http://dx.doi.org/10.1371/journal.pone.0064210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717570	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600052
J	Shi, Y; Yan, X; Zhao, PS; Yin, HX; Zhao, X; Xiao, HL; Li, XR; Chen, GX; Ma, XF				Shi, Yong; Yan, Xia; Zhao, Pengshan; Yin, Hengxia; Zhao, Xin; Xiao, Honglang; Li, Xinrong; Chen, Guoxiong; Ma, Xiao-Fei			Transcriptomic Analysis of a Tertiary Relict Plant, Extreme Xerophyte Reaumuria soongorica to Identify Genes Related to Drought Adaptation	PLOS ONE			English	Article							FLOWERING TIME; RNA-SEQ; REVERSE-TRANSCRIPTASE; ROOT TRANSCRIPTOME; DESERT SHRUB; ARABIDOPSIS; EVOLUTION; STRESS; TOOL; TOLERANCE	Background: Reaumuria soongorica is an extreme xerophyte shrub widely distributed in the desert regions including sand dune, Gobi and marginal loess of central Asia which plays a crucial role to sustain and restore fragile desert ecosystems. However, due to the lacking of the genomic sequences, studies on R. soongorica had mainly limited in physiological responses to drought stress. Here, a deep transcriptomic sequencing of R. soongorica will facilitate molecular functional studies and pave the path to understand drought adaptation for a desert plant. Methodology/Principal Findings: A total of 53,193,660 clean paired-end reads was generated from the Illumina HiSeq (TM) 2000 platform. By assembly with Trinity, we got 173,700 contigs and 77,647 unigenes with mean length of 677 bp and N50 of 1109 bp. Over 55% (43,054) unigenes were successfully annotated based on sequence similarity against public databases as well as Rfam and Pfam database. Local BLAST and Kyoto Encyclopedia of Genes and Genomes (KEGG) maps were used to further exhausting seek for candidate genes related to drought adaptation and a set of 123 putative candidate genes were identified. Moreover, all the C-4 photosynthesis genes existed and were active in R. soongorica, which has been regarded as a typical C-3 plant. Conclusion/Significance: The assembled unigenes in present work provide abundant genomic information for the functional assignments in an extreme xerophyte R. soongorica, and will help us exploit the genetic basis of how desert plants adapt to drought environment in the near future.	[Shi, Yong; Zhao, Pengshan; Yin, Hengxia; Zhao, Xin; Li, Xinrong; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Dept Ecol & Agr Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Yan, Xia; Xiao, Honglang] Chinese Acad Sci, Key Lab Ecohydrol & Inland River Basin, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Li, Xinrong] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Ma, XF (corresponding author), Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Dept Ecol & Agr Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China.	maxiaofei@lzb.ac.cn	Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program) [2013CB4229906]; Chinese Academy of Sciences [29Y127E71]; National Natural Science Foundation of China [91125025]	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project of Chinese National Programs for Fundamental Research and Development (973 Program, 2013CB4229906), by Grant 29Y127E71 from the "One Hundred Talents" Project of the Chinese Academy of Sciences, and by National Natural Science Foundation of China (No. 91125025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai J, 2008, PHOTOSYNTHETICA, V46, P232, DOI 10.1007/s11099-008-0037-5; Bai Juan, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P2444; Bai J, 2009, J PLANT BIOL, V52, P417, DOI 10.1007/s12374-009-9053-7; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Bruex A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002446; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; CHENG SH, 1989, PLANT PHYSIOL, V89, P1129, DOI 10.1104/pp.89.4.1129; Chong PeiFang, 2011, Acta Prataculturae Sinica, V20, P26; [种培芳 CHONG Peifang], 2010, [生态学报, Acta Ecologica Sinica], V30, P914; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; FLAVELL AJ, 1995, COMP BIOCHEM PHYS B, V110, P3, DOI 10.1016/0305-0491(94)00122-B; FOX GA, 1990, AM J BOT, V77, P1508, DOI 10.2307/2444763; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Gorai M, 2007, ANN APPL BIOL, V151, P53, DOI 10.1111/j.1744-7348.2007.00151.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Kim SY, 2006, PHYSIOL PLANTARUM, V126, P519, DOI 10.1111/j.1399-3054.2005.00601.x; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li XR, 2012, CATENA, V97, P119, DOI 10.1016/j.catena.2012.05.009; [李秀玲 LI Xiuling], 2008, [中国沙漠, Journal of Desert Research], V28, P468; Li ZH, 2012, J SYST EVOL, V50, P351, DOI 10.1111/j.1759-6831.2012.00201.x; Liu JL, 2012, BIODIVERS CONSERV, V21, P2601, DOI 10.1007/s10531-012-0320-4; Liu JQ, 1982, ACTA BOT SIN, V24, P485; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu YB, 2007, SCI CHINA SER C, V50, P15, DOI 10.1007/s11427-007-0002-8; [吕美婷 Lv Meiting], 2010, [中国草地学报, Chinese Journal of Grassland], V32, P58; Ma JY, 2005, J INTEGR PLANT BIOL, V47, P1065, DOI 10.1111/j.1744-7909.2005.00129.x; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Qian ZQ, 2008, BIOCHEM SYST ECOL, V36, P593, DOI 10.1016/j.bse.2008.01.008; RAGHAVENDRA AS, 1978, NATURE, V273, P143, DOI 10.1038/273143a0; Ramadan T, 1998, NEW PHYTOL, V139, P273, DOI 10.1046/j.1469-8137.1998.00159.x; Raven P.H., 1992, BIOL PLANTS; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Schnittger A, 1998, DEVELOPMENT, V125, P2283; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Slemnev N. N., 1994, Rastitel'nye Resursy, V30, P1; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; TAIZ L, 1991, PLANT PHYSL; Tominaga-Wada R, 2011, INT REV CEL MOL BIO, V286, P67, DOI 10.1016/B978-0-12-385859-7.00002-1; Ueno O, 1998, PLANT CELL, V10, P571; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams BP, 2012, TRENDS PLANT SCI, V17, P213, DOI 10.1016/j.tplants.2012.01.008; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu DH, 2010, PLANT GROWTH REGUL, V60, P183, DOI 10.1007/s10725-009-9440-6; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu L, 2003, ACTA BOT SIN, V45, P787; [徐莉 Xu Li], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P742; [严巧娣 Yan Qiaodi], 2012, [中国沙漠, Journal of Desert Research], V32, P364; Yang J, 2011, PLANT PHYSIOL BIOCH, V49, P1448, DOI 10.1016/j.plaphy.2011.09.006; Yang XP, 2011, QUATERNARY SCI REV, V30, P3219, DOI 10.1016/j.quascirev.2011.08.009; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; [曾彦军 Zeng Yanjun], 2004, [生态学报, Acta Ecologica Sinica], V24, P1629; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042927; Zhu Z.D., 1980, OUTLINE CHINESE DESE	88	45	52	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63993	10.1371/journal.pone.0063993	http://dx.doi.org/10.1371/journal.pone.0063993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717523	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600039
J	Wei, CY; Henderson, H; Spradley, C; Li, L; Kim, IK; Kumar, S; Hong, N; Arroliga, AC; Gupta, S				Wei, Chuanyu; Henderson, Heather; Spradley, Christopher; Li, Li; Kim, Il-Kwon; Kumar, Sandeep; Hong, Nayeon; Arroliga, Alejandro C.; Gupta, Sudhiranjan			Circulating miRNAs as Potential Marker for Pulmonary Hypertension	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MICRORNAS; PLASMA; EXPRESSION; BIOMARKERS; MECHANISM; GENOMICS; IMPACT	MircoRNAs (miRNAs) are small non-coding RNAs that govern the gene expression and, play significant role in the pathogenesis of heart failure. The detection of miRNAs in circulation of pulmonary hypertensive (PH) human subjects remains elusive. In the current study, we determined the pattern of miRNAs of mild-to-severe human PH subjects and, compared them with the control subjects by miRNA array. Blood was obtained using fluoroscopic and waveform guided catheterization from the distal (pulmonary artery) port of the catheter. A total 40 human subjects were included in the study and, the degree of PH was determined by mean pulmonary arterial pressure. Among several miRNAs in the array, we validated 14 miRNAs and, the data were consistent with the array profile. We identified several novel downregulated miRNAs (miR-451, miR-1246) and upregulated miRNAs (miR-23b, miR-130a and miR-191) in the circulation of PH subjects. Our study showed novel set of miRNAs which are dysregulated in PH and, are directly proportional to the degree of PH. These miRNAs may be considered as potential biomarker for early detection of PH.	[Wei, Chuanyu; Li, Li; Kim, Il-Kwon; Kumar, Sandeep; Hong, Nayeon; Gupta, Sudhiranjan] Cent Texas Vet Hlth Care Syst, Scott & White, Texas A&M Hlth Sci Ctr, Div Mol Cardiol,Dept Med,Coll Med, Temple, TX USA; [Henderson, Heather; Spradley, Christopher; Arroliga, Alejandro C.] Scott & White Mem Hosp & Clin, Temple, TX 76508 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center	Gupta, S (corresponding author), Cent Texas Vet Hlth Care Syst, Scott & White, Texas A&M Hlth Sci Ctr, Div Mol Cardiol,Dept Med,Coll Med, Temple, TX USA.	sgupta@medicine.tamhsc.edu	Arroliga, Alejandro/AAX-3933-2021; wei, chuanyu/H-3150-2016		Texas A & M Health Science Center, College of Medicine; American Heart Association National Scientist Development Grant [0835227N]	Texas A & M Health Science Center, College of Medicine; American Heart Association National Scientist Development Grant(American Heart Association)	This study was partly supported by start-up funds from the Texas A & M Health Science Center, College of Medicine, by an American Heart Association National Scientist Development Grant (0835227N) to S. Gupta (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chida A, 2012, CIRC J; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Di Stefano V, 2011, VASC PHARMACOL, V55, P111, DOI 10.1016/j.vph.2011.08.001; Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kumar S, 2012, AM J PHYSIOL-HEART C, V302, pH1655, DOI 10.1152/ajpheart.00756.2011; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Li Wei, 2010, Proc Am Thorac Soc, V7, P395, DOI 10.1513/pats.201002-024AW; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Safdar Z, 2011, RESP MED, V105, P818, DOI 10.1016/j.rmed.2010.12.018; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Simon MA, 2010, CURR OPIN CRIT CARE, V16, P237, DOI 10.1097/MCC.0b013e3283382e58; Stamm Jason A, 2011, Pulm Circ, V1, P138, DOI 10.4103/2045-8932.83444; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	41	103	110	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64396	10.1371/journal.pone.0064396	http://dx.doi.org/10.1371/journal.pone.0064396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717609	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600064
J	Xie, C; Wu, JH; Yun, JP; Lai, JM; Yuan, YF; Gao, ZL; Li, MF; Li, J; Song, LB				Xie, Chan; Wu, Jueheng; Yun, Jingping; Lai, Jiaming; Yuan, Yunfei; Gao, Zhiliang; Li, Mengfeng; Li, Jun; Song, Libing			MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma	PLOS ONE			English	Article							MARKER	Background: The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC). Methods: mRNA and protein levels of MACC1 expression in one normal liver epithelial cells THLE3 and 15 HCC cell lines were examined using reverse transcription-PCR and Western blot. MACC1 expression was also comparatively studied in 6 paired HCC lesions and the adjacent non-cancerous tissue samples. Immunohistochemistry was employed to analyze MACC1 expression in 308 clinicopathologically characterized HCC cases. Statistical analyses were applied to derive association between MACC1 expression scores and clinical staging as well as patient survival. Results: Levels of MACC1 mRNA and protein were higher in HCC cell lines and HCC lesions than in normal liver epithelial cells and the paired adjacent noncancerous tissues. Significant difference in MACC1 expression was found in patients of different TNM stages (P<0.001). Overall survival analysis showed that high MACC1 expression level correlated with lower survival rate (P = 0.001). Importantly, an inverse correlation between MACC1 level and patient survival remained significant in subjects with early-stage HCC or with normal serum AFP level. Conclusions: MACC1 protein may represent a promising biomarker for predicting the prognosis of HCC, including in early-stage and AFP-normal patients.	[Xie, Chan; Gao, Zhiliang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Chan; Song, Libing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Jiaming] Sun Yat Sen Univ, First Affiliated 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Yunfei] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Song, LB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	lb.song1@gmail.com	Song, LB/AAL-1968-2020; meng, li/GVT-2063-2022	Yuan, Yunfei/0000-0003-2467-3683	National Program on Key Basic Research Project (973 Program) [2012CB519003]; National Science and Technique Major Project [201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030]; Key Science and Technique Research Project of Guangdong Province [2010B030600003, 2009010058]; Natural Science Foundation of China [81071780, 81272198, U1201121, 30900569, 81101864]; Science and Technology Department of Guangdong Province [S2011020002757]; Ministry of Education of China [20100171110080]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Science and Technique Major Project; Key Science and Technique Research Project of Guangdong Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guangdong Province; Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Program on Key Basic Research Project (973 Program, No. 2012CB519003); The National Science and Technique Major Project (201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030); The Key Science and Technique Research Project of Guangdong Province (2010B030600003, 2009010058); Natural Science Foundation of China (No. 81071780, 81272198, U1201121, 30900569, 81101864); The Science and Technology Department of Guangdong Province (No. S2011020002757); and Ministry of Education of China (20100171110080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gu CD, 2011, ANTICANCER RES, V31, P1141; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kokoszynska K, 2009, ACTA BIOCHIM POL, V56, P317; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Nagasue N, 1998, J Hepatobiliary Pancreat Surg, V5, P7, DOI 10.1007/PL00009954; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PATERON D, 1994, J HEPATOL, V20, P65, DOI 10.1016/S0168-8278(05)80468-4; Qiu JL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-166; Shirahata A, 2011, ANTICANCER RES, V31, P777; Shirahata A, 2010, ANTICANCER RES, V30, P3441; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Wong GLH, 2008, LIVER INT, V28, P79, DOI 10.1111/j.1478-3231.2007.01576.x; Xie C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040607	20	32	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64235	10.1371/journal.pone.0064235	http://dx.doi.org/10.1371/journal.pone.0064235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717574	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600053
J	Burch, TC; Watson, MT; Nyalwidhe, JO				Burch, Tanya C.; Watson, Megan T.; Nyalwidhe, Julius O.			Variable Metastatic Potentials Correlate with Differential Plectin and Vimentin Expression in Syngeneic Androgen Independent Prostate Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; MAP KINASES; PROTEIN; ACTIVATION; EPHA2; OVEREXPRESSION; RECEPTOR; MARKER; IDENTIFICATION	Prostate cancer is a clinically heterogeneous disease, ranging from indolent asymptomatic disease to very aggressive metastatic and life threatening forms of the disease. Distant metastasis represents the major lethal cause of prostate cancer. The most critical clinical challenge in the management of the patients is identifying those individuals at risk of developing metastatic disease. To understand the molecular mechanisms of prostate cancer metastasis and identify markers with metastatic potential, we have analyzed protein expression in two syngeneic prostate cancer cells lines PC3-N2 and PC3-ML2 using isobaric tags for relative and absolute quantitation labeling and multi-dimensional protein identification technology liquid chromatography matrix assisted laser desorption ionization tandem mass spectrometry. PC3-N2 is lowly metastatic while PC3-ML2 highly metastatic. A total of 1,756 proteins were identified in the analyses with 130 proteins showing different expression levels (p<0.01) in the two cell lines. Out of these, 68 proteins were found to be significantly upregulated while 62 are significantly down-regulated in PC3-ML2 cells compared with PC3-N2 cells. The upregulation of plectin and vimentin which were the most significantly differentially expressed were validated by Western blot and their functional relevance with respect to invasion and migration was determined by siRNA gene silencing. To our knowledge, this study is the first to demonstrate that up-regulation of vimentin and plectin expression positively correlates with the invasion and metastasis of androgen-independent PCA.	[Burch, Tanya C.; Watson, Megan T.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Burch, Tanya C.; Watson, Megan T.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Nyalwidhe, JO (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	nyalwijo@evms.edu			Eastern Virginia Medical School (EVMS)	Eastern Virginia Medical School (EVMS)	This work was supported by start-up funds from the Eastern Virginia Medical School (EVMS) to Dr. Julius O. Nyalwidhe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren MAE, 2004, MOL CANCER RES, V2, P387; Bartholow TL, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-1; Bausch D, 2011, CLIN CANCER RES, V17, P302, DOI 10.1158/1078-0432.CCR-10-0999; Bausch D, 2009, J GASTROINTEST SURG, V13, P1948, DOI 10.1007/s11605-009-1001-9; Beck Florian, 2012, Methods Mol Biol, V893, P101, DOI 10.1007/978-1-61779-885-6_8; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Bunting PS, 2002, CLIN CHIM ACTA, V315, P71, DOI 10.1016/S0009-8981(01)00717-3; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Cangul H, 2002, ENVIRON HEALTH PERSP, V110, P783, DOI 10.1289/ehp.02110s5783; Carpenter B, 2004, MOL CELL BIOL, V24, P537, DOI 10.1128/MCB.24.2.537-549.2004; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chao C, 1996, CANCER RES, V56, P4811; Chen BS, 2012, MOL CANCER RES, V10, P305, DOI 10.1158/1541-7786.MCR-11-0300; Dahl E, 2005, J PATHOL, V205, P21, DOI 10.1002/path.1687; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Dolloff NG, 2007, CANCER RES, V67, P555, DOI 10.1158/0008-5472.CAN-06-2593; Dolloff NG, 2005, ONCOGENE, V24, P6848, DOI 10.1038/sj.onc.1208815; Dudderidge TJ, 2010, BRIT J CANCER, V103, P701, DOI 10.1038/sj.bjc.6605785; Dutsch-Wicherek M, 2011, CANCER MICROENVIRON, V4, P105, DOI 10.1007/s12307-010-0058-z; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Glen A, 2010, PROSTATE, V70, P1313, DOI 10.1002/pros.21167; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hengstschlager M, 1998, ADV EXP MED BIOL, V431, P455; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Karashima T, 2012, J DERMATOL SCI, V66, P44, DOI 10.1016/j.jdermsci.2012.01.008; Katada K, 2012, J PROTEOMICS, V75, P1803, DOI 10.1016/j.jprot.2011.12.018; Koochekpour S, 2012, PROSTATE, V72, P253, DOI 10.1002/pros.21427; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lal A, 1999, CANCER RES, V59, P5403; LaSpina M, 2008, CAN J UROL, V15, P3; Lee EK, 2011, BIOCHEM BIOPH RES CO, V412, P279, DOI 10.1016/j.bbrc.2011.07.083; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li M, 2008, J STRUCT BIOL, V162, P229, DOI 10.1016/j.jsb.2008.01.005; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Loilome W, 2012, PARASITOL INT, V61, P136, DOI 10.1016/j.parint.2011.07.003; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Malecz N, 1996, J BIOL CHEM, V271, P8203, DOI 10.1074/jbc.271.14.8203; McInroy L, 2011, EXP CELL RES, V317, P2468, DOI 10.1016/j.yexcr.2011.07.013; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Meng MV, 2001, CLIN CANCER RES, V7, P2712; Miao H, 2003, J CELL BIOL, V162, P1281, DOI 10.1083/jcb.200304018; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mikulits W, 1996, J BIOL CHEM, V271, P853, DOI 10.1074/jbc.271.2.853; Moyer VA., 2012, ANN INTERN MED; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; ONODA K, 1993, CELL MOTIL CYTOSKEL, V26, P227, DOI 10.1002/cm.970260306; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Renz M, 2008, INT J CANCER, V122, P1476, DOI 10.1002/ijc.23215; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Sakamoto H, 2001, CLIN CANCER RES, V7, P2513; Santarius T, 2010, GENE CHROMOSOME CANC, V49, P711, DOI 10.1002/gcc.20784; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Srinivas PR, 2002, CLIN CHEM, V48, P1160; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; van Gils MPMQ, 2005, EUR UROL, V48, P1031, DOI 10.1016/j.eururo.2005.06.009; Van Ginkel PR, 1998, BBA-MOL CELL RES, V1448, P290, DOI 10.1016/S0167-4889(98)00133-5; Vaudel Marc, 2012, Methods Mol Biol, V893, P501, DOI 10.1007/978-1-61779-885-6_30; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wehder L, 2009, CELL CYCLE, V8, P1552, DOI 10.4161/cc.8.10.8404; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Yang LF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007294; Yang ZM, 2007, MOL ENDOCRINOL, V21, P343, DOI 10.1210/me.2006-0104; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372; Zhu XY, 2011, INT J CANCER, V129, P2847, DOI 10.1002/ijc.25947	89	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e65005	10.1371/journal.pone.0065005	http://dx.doi.org/10.1371/journal.pone.0065005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717685	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700189
J	Ding, JR; An, DM; Liao, W; Li, JM; Wu, GR; Xu, Q; Long, ZL; Gong, QY; Zhou, D; Sporns, O; Chen, HF				Ding, Ju-Rong; An, Dongmei; Liao, Wei; Li, Jinmei; Wu, Guo-Rong; Xu, Qiang; Long, Zhiliang; Gong, Qiyong; Zhou, Dong; Sporns, Olaf; Chen, Huafu			Altered Functional and Structural Connectivity Networks in Psychogenic Non-Epileptic Seizures	PLOS ONE			English	Article							SMALL-WORLD; BRAIN NETWORKS; ORGANIZATION	Psychogenic non-epileptic seizures (PNES) are paroxysmal behaviors that resemble epileptic seizures but lack abnormal electrical activity. Recent studies suggest aberrant functional connectivity involving specific brain regions in PNES. Little is known, however, about alterations of topological organization of whole-brain functional and structural connectivity networks in PNES. We constructed functional connectivity networks from resting-state functional MRI signal correlations and structural connectivity networks from diffusion tensor imaging tractography in 17 PNES patients and 20 healthy controls. Graph theoretical analysis was employed to compute network properties. Moreover, we investigated the relationship between functional and structural connectivity networks. We found that PNES patients exhibited altered small-worldness in both functional and structural networks and shifted towards a more regular (lattice-like) organization, which could serve as a potential imaging biomarker for PNES. In addition, many regional characteristics were altered in structural connectivity network, involving attention, sensorimotor, subcortical and default-mode networks. These regions with altered nodal characteristics likely reflect disease-specific pathophysiology in PNES. Importantly, the coupling strength of functional-structural connectivity was decreased and exhibited high sensitivity and specificity to differentiate PNES patients from healthy controls, suggesting that the decoupling strength of functional-structural connectivity might be an important characteristic reflecting the mechanisms of PNES. This is the first study to explore the altered topological organization in PNES combining functional and structural connectivity networks, providing a new way to understand the pathophysiological mechanisms of PNES.	[Ding, Ju-Rong; Wu, Guo-Rong; Xu, Qiang; Long, Zhiliang; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat Minist Educ, Chengdu 610054, Peoples R China; [Ding, Ju-Rong; Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Ding, Ju-Rong; Sporns, Olaf] Indiana Univ, Program Cognit Sci, Bloomington, IN USA; [Ding, Ju-Rong] Third Mil Med Univ, Dept Med Informat & Med Image, Coll Biomed Engn & Med Imaging, Chongqing, Peoples R China; [An, Dongmei; Li, Jinmei; Zhou, Dong] West China Hosp Sichuan Univ, Dept Neurol, Chengdu, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Wu, Guo-Rong] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium; [Gong, Qiyong] West China Hosp Sichuan Univ, Dept Radiol, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Army Medical University; Sichuan University; Hangzhou Normal University; Hangzhou Normal University; Ghent University; Sichuan University	Zhou, D (corresponding author), West China Hosp Sichuan Univ, Dept Neurol, Chengdu, Peoples R China.	zhoudong66@yahoo.de; chenhf@uestc.edu.cn	Gong, Qiyong/W-3052-2019; Sporns, Olaf/A-1667-2010	Gong, Qiyong/0000-0002-5912-4871; Sporns, Olaf/0000-0001-7265-4036; Xu, Qiang/0000-0002-7739-7515	973 Project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304]; Academic new artist Ministry of Education doctoral post graduate [A03003023901004]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]	973 Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic new artist Ministry of Education doctoral post graduate; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the 973 Project [2012CB517901]; the Natural Science Foundation of China [61035006, 61125304]; the Academic new artist Ministry of Education doctoral post graduate [A03003023901004]; and the Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baslet G, 2011, SEIZURE-EUR J EPILEP, V20, P1, DOI 10.1016/j.seizure.2010.10.032; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benbadis SR, 2000, SEIZURE-EUR J EPILEP, V9, P280, DOI 10.1053/seiz.2000.0409; Benbadis SR, 2004, NEUROLOGY, V63, P1728, DOI 10.1212/01.WNL.0000143273.18099.50; Brown RJ, 2011, EPILEPSY BEHAV, V22, P85, DOI 10.1016/j.yebeh.2011.02.016; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Devinsky O, 2011, NAT REV NEUROL, V7, P210, DOI 10.1038/nrneurol.2011.24; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Feil D, 1999, Curr Psychiatry Rep, V1, P69, DOI 10.1007/s11920-999-0012-2; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Knyazeva MG, 2011, J NEUROL NEUROSUR PS, V82, P505, DOI 10.1136/jnnp.2010.224873; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LEIS AA, 1992, NEUROLOGY, V42, P95, DOI 10.1212/WNL.42.1.95; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Reuber M, 2004, NEUROLOGY, V62, P834, DOI 10.1212/01.WNL.0000113755.11398.90; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	42	135	139	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63850	10.1371/journal.pone.0063850	http://dx.doi.org/10.1371/journal.pone.0063850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717498	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700071
J	He, LS; Zhang, G; Qian, PY				He, Li-Sheng; Zhang, Gen; Qian, Pei-Yuan			Characterization of Two 20kDa-Cement Protein (cp20k) Homologues in Amphibalanus amphitrite	PLOS ONE			English	Article							BARNACLE CEMENT; REATTACHMENT; GENERATION; APPARATUS; LARVA	The barnacle, Amphibalanus amphitrite, is a common marine fouling organism. Understanding the mechanism of barnacle adhesion will be helpful in resolving the fouling problem. Barnacle cement is thought to play a key role in barnacle attachment. Although several adult barnacle cement proteins have been identified in Megabalanus rosa, little is known about their function in barnacle settlement. In this study, two homologous 20k-cement proteins (cp20k) in Amphibalanus amphitrite, named Bamcp20k-1 and Bamcp20k-2, were characterized. The two homologues share primary sequence structure with proteins from other species including Megabalanus rosa and Fistulobalanus albicostatus. The conserved structure included repeated Cys domains and abundant charged amino acids, such as histidine. In this study we demonstrated that Bamcp20k-1 localized at the alpha secretory cells in the cyprid cement gland, while Bamcp20k-2 localized to the beta secretory cells. The differential localizations suggest differential regulation for secretion from the secretory cells. Both Bamcp20k-1 and Bamcp20k-2 from cyprids dissolved in PBS. However, adult Bamcp20k-2, which was dominant in the basal shell of adult barnacles, was largely insoluble in PBS. Solubility increased in the presence of the reducing reagent Dithiothreitol (DTT), suggesting that the formation of disulfide bonds plays a role in Bamcp20k-2 function. In comparison, Bamcp20k-1, which was enriched in soft tissue, could not be easily detected in the shell and base by Western blot and easily dissolved in PBS. These differential solubilities and localizations indicate that Bamcp20k-1 and Bamcp20k-2 have distinct functions in barnacle cementing.	[He, Li-Sheng; Zhang, Gen; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Zhang/L-6428-2017	Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); China Ocean Mineral Resources Research and Development Association	The authors' research grant from China Ocean Mineral Resources Research and Development Association (DY125-15-T-02), and King Abdullah University of Science and Technology (SA-C0040/UK-C0016) to P.Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; DOUGHERTY WJ, 1990, J CRUSTACEAN BIOL, V10, P469, DOI 10.2307/1548336; Gunnar vH, 1986, NUCLEIC ACIDS RES, V14, P4683; He LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047195; Hoeg JT, 2009, ARTHROPOD SYSTEMATIC, V67, P179; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 2001, BIOCHEM J, V356, P503, DOI 10.1042/0264-6021:3560503; Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033; LACOMBE D, 1969, BIOL BULL, V137, P170, DOI 10.2307/1539940; LACOMBE D, 1970, BIOL BULL, V139, P164, DOI 10.2307/1540134; Manly R S, 1970, ADHESION BIOL SYSTEM, V9, P113; Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x; NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221; Odling K, 2006, J EXP BIOL, V209, P956, DOI 10.1242/jeb.02031; Power AM, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P153, DOI 10.1007/978-3-7091-0286-2_9; SAROYAN JR, 1970, BIOL BULL, V139, P333, DOI 10.2307/1540088; SAROYAN JR, 1970, IND ENG CHEM PROD RD, V9, P122, DOI 10.1021/i360034a002; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; WALKER G, 1972, J MAR BIOL ASSOC UK, V52, P429, DOI 10.1017/S0025315400018786; WALKER G, 1971, MAR BIOL, V9, P205, DOI 10.1007/BF00351380; Wang H, 2010, J EXP ZOOL PART B, V314B, P390, DOI 10.1002/jez.b.21344	22	30	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64130	10.1371/journal.pone.0064130	http://dx.doi.org/10.1371/journal.pone.0064130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717550	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700106
J	Talbott, EO; Rager, JR; Brink, LL; Benson, SM; Bilonick, RA; Wu, WC; Han, YY				Talbott, Evelyn O.; Rager, Judith R.; Brink, LuAnn L.; Benson, Stacey M.; Bilonick, Richard A.; Wu, Wen Chi; Han, Yueh-Ying			Trends in Acute Myocardial Infarction Hospitalization Rates for US States in the CDC Tracking Network	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; MINNESOTA; MORTALITY; OUTCOMES	Objective: We examined temporal trends, spatial variation, and gender differences in rates of hospitalization due to acute myocardial infarction. Methods: We used data from the Centers for Disease Control National Environmental Public Health Tracking Network to evaluate temporal trends, geographic variation, and gender differences in 20 Environmental Public Health Tracking Network states from 2000 to 2008. A longitudinal linear mixed effects model was fitted to the acute myocardial infarction hospitalization rates for the states and counties within each state to examine the overall temporal trend. Results: There was a significant overall decrease in age-adjusted acute myocardial infarction hospitalization rates between 2000 and 2008, with most states showing over a 20% decline during the period. The ratio of male/female rates for acute myocardial infarction hospitalization rates remained relatively consistent over time, approximately two-fold higher in men compared to women. A large geographic variability was found for age-adjusted acute myocardial infarction hospitalization rates, with the highest rates found in the Northeastern states. Results of two ecological analyses revealed that the NE region remained significantly associated with increased AMI hospitalization rates after adjustment for socio-demographic factors. Conclusions: This investigation is one of the first to explore geographic differences in AMI age adjusted hospital rates in individuals 35+ years of age for 2000-2008. We showed a decreasing trend in AMI hospitalization rates in men and women. A large geographic variability in rates was found with particularly higher rates in the New England/Mid-Atlantic region of the US and lower rates in the mountain and Pacific states of the tracking network. It appeared that over time this disparity in rates became less notable.	[Talbott, Evelyn O.; Rager, Judith R.; Brink, LuAnn L.; Benson, Stacey M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Bilonick, Richard A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Wu, Wen Chi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Han, Yueh-Ying] Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Div Pediat Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Talbott, EO (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15213 USA.	eot1@pitt.edu		Talbott, Evelyn/0000-0002-5198-7939	Centers for Disease Control and Prevention [BAA2010-N-11993]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention contract number BAA2010-N-11993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Centers for Disease Control and Prevention, 1999, COMPR MORT 1999 2007; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Conolly DC, 1981, MAYO CLIN P, V56, P661; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 2 ESRI; Fang J, 2002, AM J MED, V113, P208, DOI 10.1016/S0002-9343(02)01172-5; Fang J, 2010, AM J MED, V123, P259, DOI 10.1016/j.amjmed.2009.08.018; GILLUM RF, 1983, NEW ENGL J MED, V309, P1353, DOI 10.1056/NEJM198312013092203; Goff David C. Jr., 1993, Ethnicity and Disease, V3, P64; Goff DC, 1997, CIRCULATION, V95, P1433; KEIL JE, 1989, AM HEART J, V117, P1022, DOI 10.1016/0002-8703(89)90857-0; KEYFITZ N, 1966, HUM BIOL, V38, P309; MCGOVERN PG, 1992, CIRCULATION, V85, P172, DOI 10.1161/01.CIR.85.1.172; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; R Development Core Team, 2005, R LANG ENV STAT COMP; Wang OJ, 2012, AM J CARDIOL, V109, P1589, DOI 10.1016/j.amjcard.2012.01.381; Yeh RW, 2012, CIRC-CARDIOVASC QUAL, V5, P197, DOI 10.1161/CIRCOUTCOMES.111.962456; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	20	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64457	10.1371/journal.pone.0064457	http://dx.doi.org/10.1371/journal.pone.0064457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717617	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700150
J	Wiegand, S; Hammann, C				Wiegand, Stephan; Hammann, Christian			The 5 ' Spreading of Small RNAs in Dictyostelium discoideum Depends on the RNA- Dependent RNA Polymerase RrpC and on the Dicer-Related Nuclease DrnB	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENE-EXPRESSION; MESSENGER-RNA; INTERFERENCE; DNA; AMPLIFICATION; ARABIDOPSIS; BIOGENESIS; ARGONAUTE2; MICRORNAS	RNA interference (RNAi) is a gene-regulatory mechanism in eukarya that is based on the presence of double stranded RNA and that can act on both, the transcription or post-transcriptional level. In many species, RNA-dependent RNA polymerases (RdRPs) are required for RNAi. To study the function of the three RdRPs in the amoeba Dictyostelium discoideum, we have deleted the encoding genes rrpA, rrpB and rrpC in all possible combinations. In these strains, expression of either antisense or hairpin RNA constructs against the transgene lacZ resulted in a 50% reduced b-Galactosidase activity. Northern blots surprisingly revealed unchanged lacZ mRNA levels, indicative of post-transcriptional regulation. Only in rrpC knock out strains, low levels of b-gal small interfering RNAs (siRNAs) could be detected in antisense RNA expressing strains. In contrast to this, and at considerably higher levels, all hairpin RNA expressing strains featured b-gal siRNAs. Spreading of the silencing signal to mRNA sequences 5' of the original hairpin trigger was observed in all strains, except when the rrpC gene or that of the dicer-related nuclease DrnB was deleted. Thus, our data indicate that transitivity of an RNA silencing signal exists in D. discoideum and that it requires the two enzymes RrpC and DrnB.	[Wiegand, Stephan; Hammann, Christian] Jacobs Univ Bremen, MOLIFE Res Ctr, Sch Sci & Engn, Ribogenet Biochem Lab, Bremen, Germany	Jacobs University	Hammann, C (corresponding author), Jacobs Univ Bremen, MOLIFE Res Ctr, Sch Sci & Engn, Ribogenet Biochem Lab, Bremen, Germany.	c.hammann@jacobs-university.de	Hammann, Christian/AAE-7325-2020		Deutsche Forschungsgemeinschaft [HA 3459/5, HA3459/7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft with a personal fellowship in the Heisenberg Program to CH (HA 3459/5) and with grant HA3459/7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVESSON L, 2012, RNA IN PRESS; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; DINGERMANN T, 1990, DEV GENET, V11, P410, DOI 10.1002/dvg.1020110514; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; Dubin M, 2010, GENE, V465, P1, DOI 10.1016/j.gene.2010.06.010; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Hinas A, 2007, CURR GENET, V51, P141, DOI 10.1007/s00294-006-0112-z; HUGHES JE, 1988, NUCLEIC ACIDS RES, V16, P2338, DOI 10.1093/nar/16.5.2338; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mount R C, 1996, Methods Mol Biol, V53, P239; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Thivierge C, 2012, NAT STRUCT MOL BIOL, V19, P90, DOI 10.1038/nsmb.2186; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wiegand S, 2011, GENOMICS, V97, P321, DOI 10.1016/j.ygeno.2011.02.001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang C, 2012, RNA BIOL, V9, P1045, DOI 10.4161/rna.21246; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64804	10.1371/journal.pone.0064804	http://dx.doi.org/10.1371/journal.pone.0064804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23724097	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400065
J	Cousin, M; Silva-Zacarin, E; Kretzschmar, A; El Maataoui, M; Brunet, JL; Belzunces, LP				Cousin, Marianne; Silva-Zacarin, Elaine; Kretzschmar, Andre; El Maataoui, Mohamed; Brunet, Jean-Luc; Belzunces, Luc P.			Size Changes in Honey Bee Larvae Oenocytes Induced by Exposure to Paraquat at Very Low Concentrations	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; N-ACETYLCYSTEINE; PESTICIDE-RESIDUES; OXIDATIVE STRESS; BRAIN; EXPRESSION; DIQUAT; REPRODUCTION; MORTALITY; STRIATUM	The effects of the herbicide Paraquat were investigated in honey bee larvae with attention focused on oenocytes. Honey bee larvae were exposed to Paraquat at different concentrations in the food: 0, 0.001, 0.01, 0.1 and 1 mu g/kg. In controls, between 24 h and 48 h, oenocytes grew from 630.1 to 1643.8 mu m(2) while nuclei changed in size from 124.9 to 245.6 mu m(2). At 24 h, Paraquat induced a slight decrease in the size of oenocytes and nuclei. N-acetylcysteine (NAC), an antioxidant substance, slightly lowered the effects of Paraquat. At 48 h, Paraquat elicited a strong concentration-dependent decrease in the size of oenocytes, even at the lowest concentration. NAC reversed the effect of Paraquat at a concentration of >= 0.01 mu g/kg. This reversion suggested different modes of action of Paraquat, with an oxidant action prevalent at concentrations >= 0.01 mu g/kg. This study is the first which reports an effect of a pesticide at the very low concentration of 1 ng/kg, a concentration below the detection limits of the most efficient analytic methods. It shows that chemicals, including pesticides, are likely to have a potential impact at such exposure levels. We also suggest that Paraquat could be used as a suitable tool for investigating the functions of oenocytes.	[Cousin, Marianne; Brunet, Jean-Luc; Belzunces, Luc P.] INRA, UR Abeilles & Environm 406, Lab Toxicol Environm, Avignon, France; [Silva-Zacarin, Elaine] Univ Fed Sao Carlos, Lab Struct & Funct Biol, Sorocaba, SP, Brazil; [Kretzschmar, Andre] INRA, UR Biostat & Proc Spatiaux, Avignon, France; [El Maataoui, Mohamed] Univ Avignon, Avignon, France	INRAE; Universidade Federal de Sao Carlos; INRAE; Avignon Universite	Belzunces, LP (corresponding author), INRA, UR Abeilles & Environm 406, Lab Toxicol Environm, Avignon, France.	luc.belzunces@avignon.inra.fr	BRUNET, Jean-Luc/ABE-9178-2021; , Belzunces/P-7061-2019	BRUNET, Jean-Luc/0000-0002-3827-1135; , Belzunces/0000-0003-1798-9962	INRA; Avignon University	INRA; Avignon University	This work was funded by INRA and Avignon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRESSAMI M, 1973, Zeitschrift fuer Angewandte Zoologie, V60, P321; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Bacchetta R, 2002, J MOLLUS STUD, V68, P181, DOI 10.1093/mollus/68.2.181; BAUER CA, 1985, J WILDLIFE MANAGE, V49, P1066, DOI 10.2307/3801397; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen Q, 2010, NEUROTOXICOLOGY, V31, P310, DOI 10.1016/j.neuro.2010.02.006; Choi WI, 2008, ECOTOX ENVIRON SAFE, V69, P227, DOI 10.1016/j.ecoenv.2007.01.008; Cocenza DS, 2012, WATER AIR SOIL POLL, V223, P3093, DOI 10.1007/s11270-012-1092-x; Cousin M, 1998, SCI HORTIC-AMSTERDAM, V72, P287, DOI 10.1016/S0304-4238(97)00138-6; de Olliveira Vagner Tadeu Paes, 2003, Biociencias (Porto Alegre), V11, P195; DENNEULIN JC, 1977, ANN ENDOCRINOL-PARIS, V38, P405; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DIAL CAB, 1987, ARCH ENVIRON CON TOX, V16, P759, DOI 10.1007/BF01055427; EISLER R, 1990, 85122 USFAW SERV, P1; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; FAO, 2003, FAO SPEC EV AGR PEST; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Hendriksma HP, 2011, METHODS ECOL EVOL, V2, P509, DOI 10.1111/j.2041-210X.2011.00099.x; HEPBURN HR, 1991, APIDOLOGIE, V22, P21, DOI 10.1051/apido:19910104; Hoffer E, 1997, FREE RADICAL BIO MED, V22, P567, DOI 10.1016/S0891-5849(96)00385-1; JOHNSON MB, 1985, J MORPHOL, V184, P51, DOI 10.1002/jmor.1051840106; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kolberg DIS, 2012, ANAL BIOANAL CHEM, V404, P2465, DOI 10.1007/s00216-012-6340-9; Lacoume S, 2009, BIOL CONTROL, V49, P214, DOI 10.1016/j.biocontrol.2009.02.002; LANDIM CD, 1985, RIV BIOL-BIOL FORUM, V78, P107; LINDQUIST NG, 1988, NEUROSCI LETT, V93, P1, DOI 10.1016/0304-3940(88)90002-X; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Malaspina Osmar, 2006, Brazilian Journal of Morphological Sciences, V23, P303; MARONDE U, 1991, J COMP NEUROL, V309, P328, DOI 10.1002/cne.903090304; Martins GF, 2012, ISJ-INVERT SURVIV J, V9, P139; Miller A., 1950, BIOL DROSOPHILA, P420; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Patel S, 2006, BRAIN RES, V1081, P9, DOI 10.1016/j.brainres.2006.01.060; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Restek, 2006, 580006 REST CORP; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Salama AK, 2001, TOXICOLOGY, V164, P193; Silva-Zacarin ECM, 2007, J BIOSCIENCES, V32, P309, DOI 10.1007/s12038-007-0031-2; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; THAKAR JH, 1988, LIFE SCI, V43, P143, DOI 10.1016/0024-3205(88)90291-3; US-EPA, 1997, 738F96018 USEPA; VANDENBERG JD, 1986, ENVIRON ENTOMOL, V15, P166, DOI 10.1093/ee/15.1.166; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; Wang AiYue, 2010, Journal of Environment and Health, V27, P261; WIGGLESWORTH V B, 1970, Tissue and Cell, V2, P155, DOI 10.1016/S0040-8166(70)80013-1; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Yeh STY, 2006, TOXICOLOGY, V223, P181, DOI 10.1016/j.tox.2006.03.019; Zhi QM, 2011, INT IMMUNOPHARMACOL, V11, P96, DOI 10.1016/j.intimp.2010.10.012	61	35	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65693	10.1371/journal.pone.0065693	http://dx.doi.org/10.1371/journal.pone.0065693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724149	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000138
J	Li, W; Reeb, AN; Sewell, WA; Elhomsy, G; Lin, RY				Li, Wen; Reeb, Ashley N.; Sewell, William A.; Elhomsy, George; Lin, Reigh-Yi			Phenotypic Characterization of Metastatic Anaplastic Thyroid Cancer Stem Cells	PLOS ONE			English	Article							PROSPECTIVE IDENTIFICATION; SIDE POPULATION; LINES; CARCINOMA; CD133(+); TUMORS; ASSAY; ACID	Emerging evidence suggests cancer stem cells (CSCs) may initiate new tumors in anaplastic thyroid carcinoma (ATC), one of the most aggressive solid tumors in humans. However, the involvement of CSCs in human tumorigenesis has not been previously studied in authenticated ATC cell lines. Here we demonstrate a functional role of CSCs in four new validated human ATC cell lines (THJ-11T, THJ-16T, THJ-21T and THJ-29T). We identified and enriched CSCs using a spheroid-forming assay. About 3 to 9% of cells from four ATC cell lines formed thyrospheres. The thyrospheres expressed the stem cell markers NANOG and Oct4 and possessed the ability to self-renew. Injection of these thyrospheres into the thyroids of NOD/SCID Il2rg(-/-)mice resulted in the formation of metastatic tumors that recapitulated the clinical features of human ATC. To our knowledge, this is the first in vivo characterization of thyroid CSCs using validated human ATC cell lines. The availability of disease-specific thyrospheres and our orthotopic tumor models will enable the elucidation of disease mechanisms and the environmental niche of CSCs. They may also be useful for preclinical therapeutic screening and for monitoring the effects of biological therapies on ATC.	[Li, Wen; Reeb, Ashley N.; Sewell, William A.; Elhomsy, George; Lin, Reigh-Yi] St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol, St Louis, MO 63103 USA; [Lin, Reigh-Yi] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Lin, RY (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol, St Louis, MO 63103 USA.	rlin7@slu.edu			National Institutes of Health [R01 DK068057]; President's Research Fund of Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Research Fund of Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grant R01 DK068057 and President's Research Fund of Saint Louis University (RYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Boldarine VT, 2010, J CLIN ENDOCR METAB, V95, P1726, DOI 10.1210/jc.2009-1354; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Friedman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005395; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Lin RY, 2011, NAT REV ENDOCRINOL, V7, P609, DOI 10.1038/nrendo.2011.127; Marlow LA, 2010, J CLIN ENDOCR METAB, V95, P5338, DOI 10.1210/jc.2010-1421; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Presta I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-80; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Thomas D, 2008, ENDOCR-RELAT CANCER, V15, P51, DOI 10.1677/ERC-07-0210; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yu CY, 2011, IN VIVO, V25, P69; Zhang P, 2006, PATHOL INT, V56, P485, DOI 10.1111/j.1440-1827.2006.01995.x; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	25	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65095	10.1371/journal.pone.0065095	http://dx.doi.org/10.1371/journal.pone.0065095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724124	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000118
J	Wei, WJ; Bai, LJ; Wang, J; Dai, RW; Tong, RKY; Zhang, YM; Song, Z; Jiang, W; Shi, CY; Li, MY; Ai, L; Tian, J				Wei, Wenjuan; Bai, Lijun; Wang, Jun; Dai, Ruwei; Tong, Raymond Kai-yu; Zhang, Yumei; Song, Zheng; Jiang, Wen; Shi, Chuanying; Li, Mengyuan; Ai, Lin; Tian, Jie			A Longitudinal Study of Hand Motor Recovery after Sub-Acute Stroke: A Study Combined fMRI with Diffusion Tensor Imaging	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL TRACT INTEGRITY; SUBCORTICAL STROKE; FRONTAL-LOBE; FUNCTIONAL-PROPERTIES; CONTROLLED TRIAL; ASSESSMENT SCALE; ISCHEMIC-STROKE; PYRAMIDAL TRACT; PREMOTOR CORTEX	Previous studies have shown that motor recovery of stroke can be assessed by the cortical activity and the structural integrity of the corticospinal tract (CST), but little is known about the relation between the cortical activity and the structural integrity during motor recovery. In the present study, we investigated the changes in brain activities evoked by twenty days functional electrical stimulation (FES) training in twelve sub-acute stroke patients with unilateral upper-limb disability. We compared cortex activity evoked by wrist movement of eleven stroke patients to that of eleven age-matched healthy subjects to figure out how cortex activity changed after stroke. We also measured the structural integrity represented by the fractional anisotropy (FA) asymmetry of the posterior limb of the internal capsule (PLIC) to find the relationship between the brain activity and the structure integrity. In our study, we found that patients with sub-acute stroke have shown greater activity in the contralesional primary motor cortex (M1) during the affected hands movement compared with healthy group, while the activity in ipsilesional M1 was decreased after the therapy compared to that before therapy, and the contralesional non-primary motor cortex showed greater activity after therapy. At the baseline we found that the positive correlation between the FA asymmetry of PLIC and the contralesional non-primary motor cortex activity showed that the greater damaged CST, the greater contralesional non-primary motor cortex recruited. While the negative correlation between them after the FES training indicates that after recovery the non-primary motor cortex plays different role in different stroke phases. Our study demonstrates that functional organization of a residual distributed motor system is related to the degree of disruption to the CST, and the non-primary motor areas plays an important role in motor recovery.	[Wei, Wenjuan; Bai, Lijun; Dai, Ruwei; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China; [Wang, Jun; Song, Zheng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Jiang, Wen; Shi, Chuanying; Li, Mengyuan; Ai, Lin] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China; [Tong, Raymond Kai-yu] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Beijing, Peoples R China; [Zhang, Yumei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Beijing Normal University; Capital Medical University; Hong Kong Polytechnic University; Capital Medical University	Ai, L (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China.	ailin136@yahoo.com.cn; tian@ieee.org	Tian, Jie/H-1190-2011; Tong, Raymond Kai-yu/C-3546-2009; Bai, Lijun/C-5119-2015; tian, jie/M-6336-2013	Tian, Jie/0000-0003-0498-0432; Tong, Raymond Kai-yu/0000-0003-4375-653X; Bai, Lijun/0000-0001-8790-5424; 	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217]; Fundamental Research Funds for the Central Universities [2011JBM226]; NIH [R01HD046526, R01HD060595]; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]; Fellowship for Young International Scientists of the Chinese Academy of Sciences [2010Y2GA03]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1G0036, 2010T2G36, 2012T1G0039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060595, R01HD046526] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fellowship for Young International Scientists of the Chinese Academy of Sciences; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This paper is supported by the National Basic Research Program of China (973 Program) under Grant 2011CB707700, the National Natural Science Foundation of China under Grant No. 81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217, the Fundamental Research Funds for the Central Universities (2011JBM226) and NIH (R01HD046526 & R01HD060595), the Beijing Nova program (grant number Z111101054511116), and Beijing Natural Science Foundation (grant number 4122082), the Fellowship for Young International Scientists of the Chinese Academy of Sciences under Grant No. 2010Y2GA03, and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under Grant No. 2012T1G0036, 2010T2G36, 2012T1G0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon G, 2007, NEUROREHAB NEURAL RE, V21, P207, DOI 10.1177/1545968306297871; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Conforto AB, 2002, ANN NEUROL, V51, P122, DOI 10.1002/ana.10070; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Floel A, 2004, ANN NEUROL, V56, P206, DOI 10.1002/ana.20170; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Glauche V, 2010, SPM NORMALIZATION TO, P1648; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; HE SQ, 1995, J NEUROSCI, V15, P3284; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Lannin N, 2004, DISABIL REHABIL, V26, P109, DOI 10.1080/0963828032000157970; Leemans A, 2009, EXPLOREDTI GRAPHICAL; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lotze M, 2011, NEUROREHABILITATION; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Moller M, 2007, J NEUROL NEUROSUR PS, V78, P587, DOI 10.1136/jnnp.2006.100248; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Popovic MB, 2002, ARTIF ORGANS, V26, P271, DOI 10.1046/j.1525-1594.2002.06950.x; Puig J, 2011, AM J NEURORADIOL, V32, P857, DOI 10.3174/ajnr.A2400; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Takeuchi N, 2010, J REHABIL MED, V42, P962, DOI 10.2340/16501977-0628; Tang PF, 2010, AM J NEURORADIOL, V31, P1023, DOI 10.3174/ajnr.A1981; Teitti S, 2008, NEUROIMAGE, V40, P1243, DOI 10.1016/j.neuroimage.2007.12.065; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Thrasher TA, 2008, NEUROREHAB NEURAL RE, V22, P706, DOI 10.1177/1545968308317436; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	53	22	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64154	10.1371/journal.pone.0064154	http://dx.doi.org/10.1371/journal.pone.0064154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724030	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000045
J	Frings, V; van der Veldt, AAM; Boellaard, R; Herder, GJM; Giovannetti, E; Honeywell, R; Peters, GJ; Thunnissen, E; Hoekstra, OS; Smit, EF				Frings, Virginie; van der Veldt, Astrid A. M.; Boellaard, Ronald; Herder, Gerarda J. M.; Giovannetti, Elisa; Honeywell, Richard; Peters, Godefridus J.; Thunnissen, Erik; Hoekstra, Otto S.; Smit, Egbert F.			Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3 '-Deoxy-3 '-[F-18]fluorothymidine Positron Emission Tomography	PLOS ONE			English	Article							MULTITARGETED ANTIFOLATE; PHASE-II; 5-FLUOROURACIL; CHEMOTHERAPY; TUMORS; PET; PROLIFERATION; POLYMORPHISMS; PHARMACOLOGY; VALIDATION	Objectives: Pemetrexed is a thymidylate synthase (TS) inhibitor and is effective in non-small cell lung cancer (NSCLC). 3'-deoxy-3'-[F-18] fluorothymidine (F-18-FLT), a proliferation marker, could potentially identify tumor specific TS-inhibition. The aim of this study was to investigate the effect of pemetrexed-induced TS-inhibition on F-18-FLT uptake 4 hours after pemetrexed administration in metastatic NSCLC patients. Methods: Fourteen NSCLC patients underwent dynamic F-18-FLT positron emission tomography (PET) scans at baseline and 4 hours after the first dose of pemetrexed. Volumes of interest were defined with a 41%, 50% and 70% threshold of the maximum pixel. Kinetic analysis and simplified measures were performed. At one, two, four and six hours after pemetrexed, plasma deoxyuridine was measured as systemic indicator of TS-inhibition. Tumor response measured with response evaluation criteria in solid tumors (RECIST), time to progression (TTP) and overall survival (OS) were determined. Results: Eleven patients had evaluable F-18-FLT PET scans at baseline and 4 hours after pemetrexed. Two patients had increased F-18-FLT uptake of 35% and 31% after pemetrexed, whereas two other patients had decreased uptake of 31%. In the remaining seven patients F-18-FLT uptake did not change beyond test-retest borders. In all patients deoxyuridine levels raised after administration of pemetrexed, implicating pemetrexed-induced TS-inhibition. F-18-FLT uptake in bone marrow was significantly increased 4 hours after pemetrexed administration. Six weeks after the start of treatment 5 patients had partial response, 4 stable disease and 2 progressive disease. Median TTP was 4.2 months (range 3.0-7.4 months); median OS was 13.0 months (range 5.1-30.8 months). Changes in F-18-FLT uptake were not predictive for tumor response, TTP or OS. Conclusions: Measuring TS-inhibition in a clinical setting 4 hours after pemetrexed revealed a non-systematic change in F-18-FLT uptake within the tumor. No significant association with tumor response, TTP or OS was observed.	[Frings, Virginie; van der Veldt, Astrid A. M.; Boellaard, Ronald; Hoekstra, Otto S.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Herder, Gerarda J. M.] St Antonius Hosp, Dept Pulm Dis, Nieuwegein, Netherlands; [Giovannetti, Elisa; Honeywell, Richard; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Thunnissen, Erik] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Smit, Egbert F.] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Frings, V (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	v.frings@vumc.nl	giovannetti, elisa/F-4261-2011; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Smit, Egbert/0000-0002-7329-6995; Thunnissen, Erik/0000-0001-5355-8508; Hoekstra, Otto S/0000-0003-0767-2734; Boellaard, Ronald/0000-0002-0313-5686; Peters, Godefridus J/0000-0002-5447-2877	Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI)	Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI)	The authors acknowledge the Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy project (QuIC-ConCePT project) from the Innovative Medicines Initiative (IMI) for partly funding the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bijnsdorp IV, 2011, INVEST NEW DRUG, V29, P248, DOI 10.1007/s10637-009-9353-2; Brix G, 1997, J NUCL MED, V38, P1614; Clarke SJ, 2002, ANN ONCOL, V13, P737, DOI 10.1093/annonc/mdf115; Contractor KB, 2011, CLIN CANCER RES, V17, P7664, DOI 10.1158/1078-0432.CCR-11-0783; de Langen AJ, 2009, EUR J NUCL MED MOL I, V36, P389, DOI 10.1007/s00259-008-0960-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ford HER, 2002, CLIN CANCER RES, V8, P103; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Galvani E, 2011, EXPERT OPIN INV DRUG, V20, P1343, DOI 10.1517/13543784.2011.617742; Giovannetti E, 2008, LEUKEMIA RES, V32, P19, DOI 10.1016/j.leukres.2007.02.011; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hammad H, 2012, ONCOL REP, V27, P246, DOI 10.3892/or.2011.1469; Honeywell R, 2007, J CHROMATOGR B, V847, P142, DOI 10.1016/j.jchromb.2006.09.045; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Joerger M, 2010, CURR DRUG TARGETS, V11, P37, DOI 10.2174/138945010790030974; Kenny LM, 2009, CLIN CANCER RES, V15, P6649, DOI 10.1158/1078-0432.CCR-09-1213; Muzi M, 2005, J NUCL MED, V46, P274; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perumal M, 2006, CANCER RES, V66, P8558, DOI 10.1158/0008-5472.CAN-06-0898; Peters GJ, 2009, PTERIDINES, V20, P115; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Pillai RG, 2008, CANCER RES, V68, P3827, DOI 10.1158/0008-5472.CAN-08-0135; Rollins KD, 2005, CLIN THER, V27, P1343, DOI 10.1016/j.clinthera.2005.09.010; Rusthoven JJ, 1999, J CLIN ONCOL, V17, P1194, DOI 10.1200/JCO.1999.17.4.1194; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Takehara A, 2005, ANTICANCER RES, V25, P4455; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; van der Wilt CL, 1997, J CANCER RES CLIN, V123, P595, DOI 10.1007/s004320050111; Van TB, 2000, J HISTOCHEM CYTOCHEM, V48, P755; VANDERWILT CL, 1995, EUR J CANCER, V31A, P754, DOI 10.1016/0959-8049(94)00477-M; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Visvikis D, 2004, EUR J NUCL MED MOL I, V31, P169, DOI 10.1007/s00259-003-1339-2; Wells P, 2003, JNCI-J NATL CANCER I, V95, P675, DOI 10.1093/jnci/95.9.675	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63705	10.1371/journal.pone.0063705	http://dx.doi.org/10.1371/journal.pone.0063705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717468	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300035
J	Zanini, C; Ercole, E; Mandili, G; Salaroli, R; Poli, A; Renna, C; Papa, V; Cenacchi, G; Forni, M				Zanini, Cristina; Ercole, Elisabetta; Mandili, Giorgia; Salaroli, Roberta; Poli, Alice; Renna, Cristiano; Papa, Valentina; Cenacchi, Giovanna; Forni, Marco			Medullospheres from DAOY, UW228 and ONS-76 Cells: Increased Stem Cell Population and Proteomic Modifications	PLOS ONE			English	Article							CANCER CELLS; MEDULLOBLASTOMA; EXPRESSION; PROFILES; FEATURES; IDENTIFICATION; INVASIVENESS; CYTOSCAPE; NETWORKS; LINES	Background: Medulloblastoma (MB) is an aggressive pediatric tumor of the Central Nervous System (CNS) usually treated according to a refined risk stratification. The study of cancer stem cells (CSC) in MB is a promising approach aimed at finding new treatment strategies. Methodology/Principal Findings: The CSC compartment was studied in three characterized MB cell lines (DAOY, UW228 and ONS-76) grown in standard adhesion as well as being grown as spheres, which enables expansion of the CSC population. MB cell lines, grown in adherence and as spheres, were subjected to morphologic analysis at the light and electron microscopic level, as well as cytofluorimetric determinations. Medullospheres (MBS) were shown to express increasingly immature features, along with the stem cells markers: CD133, Nestin and beta-catenin. Proteomic analysis highlighted the differences between MB cell lines, demonstrating a unique protein profile for each cell line, and minor differences when grown as spheres. In MBS, MALDI-TOF also identified some proteins, that have been linked to tumor progression and resistance, such as Nucleophosmin (NPM). In addition, immunocytochemistry detected Sox-2 as a stemness marker of MBS, as well as confirming high NPM expression. Conclusions/Significance: Culture conditioning based on low attachment flasks and specialized medium may provide new data on the staminal compartment of CNS tumors, although a proteomic profile of CSC is still elusive for MB.	[Zanini, Cristina; Ercole, Elisabetta; Forni, Marco] Univ Turin, MBC, EuroClone SpA Res Lab, Turin, Italy; [Mandili, Giorgia] Univ Turin, Dept Expt Med & Oncol CERMS, Turin, Italy; [Salaroli, Roberta; Renna, Cristiano; Papa, Valentina; Cenacchi, Giovanna] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Poli, Alice] BioDigitalValley Srl, Pont St Martin, AO, Italy	University of Turin; University of Turin; University of Bologna	Zanini, C (corresponding author), Univ Turin, MBC, EuroClone SpA Res Lab, Turin, Italy.	c.zanini@euroclone.it		Zanini, Cristina/0000-0002-6554-2113; Papa, Valentina/0000-0002-0718-2965; CENACCHI, GIOVANNA/0000-0001-5824-3118	Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM)	This work was supported by Ricerca Finanziata Regione Piemonte and Comitato Interministeriale per la programmazione Economica (CIPE); by Piattaforma Piemontese per la Ricerca sulle Cellule staminali (PISTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; BURT AD, 1986, J CLIN PATHOL, V39, P114, DOI 10.1136/jcp.39.1.114-d; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Knights MJ, 2012, BRAIN PATHOL, V22, P592, DOI 10.1111/j.1750-3639.2012.00573.x; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kuo MF, 2009, J NEUROSURG-PEDIATR, V4, P74, DOI 10.3171/2009.2.PEDS08287; Kyrgidis Athanassios, 2010, J Carcinog, V9, P3, DOI 10.4103/1477-3163.62141; Lee EK, 2011, BIOCHEM BIOPH RES CO, V412, P279, DOI 10.1016/j.bbrc.2011.07.083; Liu Y, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-53; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mandili G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018254; Manoranjan B, 2012, PEDIATR RES, V71, P516, DOI 10.1038/pr.2011.62; Natale M, 2010, BIOINFORMATICS, V26, P946, DOI 10.1093/bioinformatics/btq073; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Peyrl A, 2003, PROTEOMICS, V3, P1781, DOI 10.1002/pmic.200300460; Ranger A, 2010, J NEURO-ONCOL, V96, P181, DOI 10.1007/s11060-009-9962-9; Raso A, 2008, NEUROPATH APPL NEURO, V34, P306, DOI 10.1111/j.1365-2990.2007.00896.x; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Read TA, 2012, CANCER CELL, V21, P1, DOI 10.1016/j.ccr.2011.12.011; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Rodini CO, 2012, J NEURO-ONCOL, V106, P71, DOI 10.1007/s11060-011-0647-9; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zanini C, 2010, J CANC THERAPY, V1, P97, DOI DOI 10.4236/JCT.2010.12017; Zanini C, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-59; Zanini C, 2011, CHILD NERV SYST, V27, P2077, DOI 10.1007/s00381-011-1515-9	37	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63748	10.1371/journal.pone.0063748	http://dx.doi.org/10.1371/journal.pone.0063748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717474	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300034
J	Lombardo, F; Maggini, M; Gruden, G; Bruno, G				Lombardo, Flavia; Maggini, Marina; Gruden, Gabriella; Bruno, Graziella			Temporal Trend in Hospitalizations for Acute Diabetic Complications: A Nationwide Study, Italy, 2001-2010	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; TIME TRENDS; KETOACIDOSIS; MORTALITY; CHILDREN; HYPOGLYCEMIA; RISK; ASSOCIATION; ONTARIO; ACCORD	Background: We investigated temporal trends and geographic variations in both hospitalizations and in-hospital mortality rates for acute diabetic complications (ADC) in the Italian universal health care system. Methods and Findings: A retrospective review of the medical records of patients with either primary or secondary discharge diagnosis of hyperglycaemic acute complications (ICD-9-CM codes 250.1, 250.2, 250.3) or hypoglycemic coma (ICD-9-CM code 251.0) was performed in period 2001-2010. Standardized rates by age and gender on 2001 Italian population and by diabetic population were calculated. We identified 7,601.883 diabetes-related hospital discharges. Out of them, 266,374 (3.5%) were due to ADC, either ketoacidosis/hyperosmolarity (94.4%) or hypoglycemic coma (5.6%). The rate of discharge for ADC decreased by 51.1% from 2001 to 2010 (14.4 vs. 7.1 discharge rate/1,000 diabetic people; 5.7% decrease per year, test for trend, p<0.001) with a similar trend for both hyperglycemic and hypoglycemic complications. Diabetic people in the younger age groups (<= 19 and 20-44 years old) had a significantly greater rate of discharge for ADC than people aged 65 years and over (<= 19 10-fold increase; 20-44: 2-fold increase). In-hospital mortality rate was 7.6%, with 211 preventable deaths in younger diabetic people (<= 44 years old). There was a large variability among Italian Regions and the ratio between the highest and the lowest regional discharge rate reached 300% in 2010. Conclusions: Decreasing temporal trend in hospitalizations for preventable ADC suggests improving outpatient care. In younger diabetic patients, however, both hospitalization rates and in-hospital mortality are still a matter of concern.	[Lombardo, Flavia; Maggini, Marina] Natl Inst Hlth, Rome, Italy; [Gruden, Gabriella; Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy	Istituto Superiore di Sanita (ISS); University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it	Oliveira, Claudia DL/G-8618-2011; Lombardo, Flavia/AAA-9723-2021	BRUNO, Graziella/0000-0002-3011-8304; Lombardo, Flavia Lucia/0000-0001-6183-0735	Piedmont Region, Diabetes Prevention	Piedmont Region, Diabetes Prevention	This work was supported by the Piedmont Region, Diabetes Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdure D, 2013, PEDIATR DIABETES, V14, P18, DOI 10.1111/j.1399-5448.2012.00897.x; BILD D, 1988, J CLIN EPIDEMIOL, V41, P999, DOI 10.1016/0895-4356(88)90039-X; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Bruno G, 2012, NUTR METAB CARDIOVAS, V22, P684, DOI 10.1016/j.numecd.2011.04.007; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Chen HF, 2010, INTERNAL MED, V49, P729, DOI 10.2169/internalmedicine.49.2965; Curtis JR, 2002, DIABETES CARE, V25, P1591, DOI 10.2337/diacare.25.9.1591; Fadini GP, 2009, DIABETES RES CLIN PR, V84, P267, DOI 10.1016/j.diabres.2009.01.019; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Govan L, 2012, DIABETOLOGIA, V55, P2356, DOI 10.1007/s00125-012-2601-6; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Hirasing RA, 1996, DIABETES CARE, V19, P431, DOI 10.2337/diacare.19.5.431; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Jiang HJ, 2003, DIABETES CARE, V26, P1421, DOI 10.2337/diacare.26.5.1421; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Liu CC, 2010, J FORMOS MED ASSOC, V109, P725, DOI 10.1016/S0929-6646(10)60117-9; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Punthakee Z, 2012, DIABETES CARE, V35, P787, DOI 10.2337/dc11-1855; Randall L, 2011, DIABETES CARE, V34, P1891, DOI 10.2337/dc11-0701; Rosenbauer J, 2002, J PEDIATR ENDOCR MET, V15, P1137; Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996; Wang J, 2009, DIABETES CARE, V32, P1213, DOI 10.2337/dc08-2211	26	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63675	10.1371/journal.pone.0063675	http://dx.doi.org/10.1371/journal.pone.0063675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717464	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600028
J	Chang, HC; Yang, YR; Wang, PS; Kuo, CH; Wang, RY				Chang, Heng-Chih; Yang, Yea-Ru; Wang, Paulus S.; Kuo, Chia-Hua; Wang, Ray-Yau			The Neuroprotective Effects of Intramuscular Insulin-Like Growth Factor-I Treatment in Brain Ischemic Rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MUSCLE; IGF-1; EXPRESSION; STROKE; NERVE; INACTIVITY; TRANSPORT; EXERCISE	Brain ischemia leads to muscle inactivity-induced atrophy and may exacerbate motor function deficits. Intramuscular insulin-like growth factor I (IGF-I) injection has been shown to alleviate the brain ischemia-induced muscle atrophy and thus improve the motor function. Motor function is normally gauged by the integrity and coordination of the central nervous system and peripheral muscles. Whether brain ischemic regions are adaptively changed by the intramuscular IGF-I injection is not well understood. In this study, the effect of intramuscular IGF-I injection was examined on the central nervous system of brain ischemic rats. Rats were divided into 4 groups: sham control, brain ischemia control, brain ischemia with IGF-I treatment, and brain ischemia with IGF-I plus IGF-I receptor inhibitor treatment. Brain ischemia was induced by right middle cerebral artery occlusion. IGF-I and an IGF-I receptor inhibitor were injected into the affected calf and anterior tibialis muscles of the treated rats for 4 times. There was an interval of 2 days between each injection. Motor function was examined and measured at the 24 hours and 7 days following a brain ischemia. The affected hind-limb muscles, sciatic nerve, lumbar spinal cord, and motor cortex were collected for examination after euthanizing the rats. IGF-I expression in the central nervous system and affected muscles were significantly decreased after brain ischemia. Intramuscular IGF-I injection increased the IGF-I expression in the affected muscles, sciatic nerve, lumbar spinal cord, and motor cortex. It also increased the p-Akt expression in the affected motor cortex. Furthermore, intramuscular IGF-I injection decreased the neuronal apoptosis and improved the motor function. However, co-administration of the IGF-I receptor inhibitor eliminated these effects. Intramuscular IGF-I injection after brain ischemia attenuated or reversed the decrease of IGF-I in both central and peripheral tissues, and these effects could contribute to neuroprotection and improve motor function.	[Chang, Heng-Chih; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan; [Wang, Paulus S.] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Wang, Paulus S.] China Med Univ, Coll Med, PhD Program Aging, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wang, Paulus S.] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Kuo, Chia-Hua] Taipei Phys Educ Coll, Grad Inst Exercise Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; Asia University Taiwan; University of Taipei	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan.	rywang@ym.edu.tw		Kuo, Chia-Hua/0000-0002-1731-4984	National Science Council of the Republic of China [NSC95-2314-B-010-041-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This article was supported by grant NSC95-2314-B-010-041-MY3 from the National Science Council of the Republic of China. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Aperghis M, 2004, BRAIN RES, V1009, P213, DOI 10.1016/j.brainres.2004.02.049; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CARY GA, 2008, PHYS MED REH CLIN N, V19, pR8; Cary GA, 2008, PHYS MED REH CLIN N, V19, P479, DOI 10.1016/j.pmr.2008.03.002; CHANG HC, 2010, CHIN J PHYSL, V53, P1; Chang HC, 2011, MED SCI SPORT EXER, V43, P2274, DOI 10.1249/MSS.0b013e318223b5d9; Choe MA, 2004, NURS RES, V53, P283, DOI 10.1097/00006199-200409000-00001; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Grossman EJ, 1998, MUSCLE NERVE, V21, P375, DOI 10.1002/(SICI)1097-4598(199803)21:3<375::AID-MUS12>3.3.CO;2-Y; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; HANSSON HA, 1987, CELL TISSUE RES, V247, P241; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Lista I, 2010, CELL MOL NEUROBIOL, V30, P493, DOI 10.1007/s10571-009-9488-x; MCCOMAS AJ, 1994, MED SCI SPORT EXER, V26, P1498; McCusker RH, 2006, J NEUROIMMUNOL, V179, P186, DOI 10.1016/j.jneuroim.2006.06.014; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Musaro A, 2007, EXP GERONTOL, V42, P76, DOI 10.1016/j.exger.2006.05.004; Nindl BC, 2010, MED SCI SPORT EXER, V42, P35, DOI 10.1249/MSS.0b013e3181b07c39; Nunez A, 2003, J NEUROPHYSIOL, V89, P3008, DOI 10.1152/jn.00089.2003; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Pan WH, 2000, NEUROENDOCRINOLOGY, V72, P171, DOI 10.1159/000054584; PAXINOS G, 2007, RAT BRAIN STEREOTAXI, P11; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Yang YR, 2003, CAN J NEUROL SCI, V30, P252, DOI 10.1017/S0317167100002687	35	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64015	10.1371/journal.pone.0064015	http://dx.doi.org/10.1371/journal.pone.0064015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717526	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700091
J	Chen, HT; Liu, YS				Chen, Hao-tai; Liu, Yong-sheng			Immunity of Foot-and-Mouth Disease Serotype Asia 1 by Sublingual Vaccination	PLOS ONE			English	Article							PANDEMIC STRAIN; VIRUS; OUTBREAK; EFFICACY; CATTLE; COSTS; PIGS; FMDV	Foot-and-mouth disease virus (FMDV) causes vesicular disease of cloven-hoofed animals, with severe agricultural and economic losses. Here we present study using a sublingual (SL) route with the killed serotype Asia 1 FMDV vaccine. Guinea pigs were vaccinated using a commercially available vaccine formulation at the manufacturer's recommended full, 1/4, and 1/16 antigen doses. Animals were challenged with homologous FMDV Asia1 strain at various times following vaccination. All control guinea pigs exhibited clinical disease, including fever, viremia, and lesions, specifically vesicle formation in feet. Animals vaccinated with the 1/16 and 1/4 doses were protected after challenge at days 7, 28, and 35 post vaccination. These data suggest that effective protection against foot-and-mouth disease can be achieved with 1/16 of the recommended vaccine dose using SL vaccination, indicating that the sublingual route is an attractive alternative for the administration of the FMDV vaccine.	[Chen, Hao-tai; Liu, Yong-sheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab China, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Chen, HT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab China, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	haotaichen@163.com; liuyongshengvip@sina.com.cn			National Natural Science Foundation of China [31172335, 31072143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31172335 and No. 31072143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beignon AS, 2005, VET IMMUNOL IMMUNOP, V104, P273, DOI 10.1016/j.vetimm.2004.12.008; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Chen HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-489; Dory D, 2009, ANTIVIR RES, V83, P45, DOI 10.1016/j.antiviral.2009.03.004; Dory D, 2009, ANTIVIR RES, V81, P217, DOI 10.1016/j.antiviral.2008.11.005; Dunn CS, 1997, VET REC, V141, P174, DOI 10.1136/vr.141.7.174; Eble PL, 2009, VACCINE, V27, P1272, DOI 10.1016/j.vaccine.2008.12.011; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Golde WT, 2005, VACCINE, V23, P5775, DOI 10.1016/j.vaccine.2005.07.043; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Joo YS, 2002, CAN J VET RES, V66, P122; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Knowles NJ, 2001, VET REC, V148, P258; Niborski V, 2006, VACCINE, V24, P7204, DOI 10.1016/j.vaccine.2006.06.048; Nobiron I, 2005, VIRUS RES, V108, P225, DOI 10.1016/j.virusres.2004.08.023; Pacheco JM, 2010, J VET SCI, V11, P133, DOI 10.4142/jvs.2010.11.2.133; Parida S, 2005, VACCINE, V23, P5186, DOI 10.1016/j.vaccine.2005.06.012; Pasick John, 2004, Animal Health Research Reviews, V5, P257, DOI 10.1079/AHR200479; Remond M, 2009, VACCINE, V27, P93, DOI 10.1016/j.vaccine.2008.10.036; Sakamoto K, 2002, J VET MED SCI, V64, P91, DOI 10.1292/jvms.64.91; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731; Yoon SH, 2011, ARCH VIROL, V156, P817, DOI 10.1007/s00705-011-0921-3	26	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63839	10.1371/journal.pone.0063839	http://dx.doi.org/10.1371/journal.pone.0063839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717497	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700070
J	Meyer, F; Ehlers, E; Steadman, A; Waterbury, T; Cao, MX; Zhang, LW				Meyer, Florencia; Ehlers, Erica; Steadman, Andrew; Waterbury, Thomas; Cao, Mingxia; Zhang, Luwen			TLR-TRIF Pathway Enhances the Expression of KSHV Replication and Transcription Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; EPSTEIN-BARR-VIRUS; TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTOR-7; RTA PROMOTES DEGRADATION; HUMAN B-LYMPHOCYTES; KAPOSIS-SARCOMA; LYTIC REPLICATION; GENE-EXPRESSION; SELECTIVE EXPRESSION	Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gamma-herpesvirus. KSHV replication and transcription activator (RTA) is necessary and sufficient for KSHV reactivation from latency. Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns, act through adaptors, and initiate innate and adaptive immune responses against pathogens. Toll/interleukin-1-receptor domain containing adaptor protein inducing interferon-beta (TRIF) is an adaptor associated with TLR3 and TLR4 signaling, and is closely related to antiviral signaling to activate type I interferon (IFN) production. We previously found that KSHVRTA degrades TRIF indirectly and blocks TLR3 pathways. In this report, we find that TRIF, as well as TLR3 activation, enhances KSHVRTA protein expression. The C-terminal region of the RTA is involved in the responding TRIF-mediated enhancement. The degradation of TRIF and the enhancement of RTA expression are using two different pathways. The enhancement by TLR-TRIF is at least partially via promoting translational efficiency of RTA mRNA. Finally, the receptor-interacting protein 1 (RIP1) may be involved in TRIF-mediated enhancement of RTA expression, but not in the RTA-mediated degradation of TRIF. Therefore, the activation of TLR-TRIF pathway enhances KSHV RTA protein expression, and KSHV RTA in turn degrades TRIF to block innate immunity. The putative KSHV-TLR-adaptor-interacting loop may be a critical element to evade and usurp host innate immunity in KSHV life-cycle.	[Meyer, Florencia; Ehlers, Erica; Steadman, Andrew; Waterbury, Thomas; Cao, Mingxia; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhang, LW (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Morrison Ctr 238, 4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unl.edu	Meyer, Florencia/V-3406-2019		National Institutes of Health [CA138213, RR15635]; Department of Defense-Army Medical Research [W81XWH-12-1-0225]; NATIONAL CANCER INSTITUTE [R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense-Army Medical Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health Grants CA138213, RR15635, and Grant W81XWH-12-1-0225 (to L. Z.) from the Department of Defense-Army Medical Research.	Ahmad H, 2011, J BIOL CHEM, V286, P7865, DOI 10.1074/jbc.M110.191452; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Dong XN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001001; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzner N, 2008, CLIN VACCINE IMMUNOL, V15, P138, DOI 10.1128/CVI.00257-07; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gargano LM, 2008, J VIROL, V82, P3853, DOI 10.1128/JVI.02577-07; Gargano LM, 2009, J VIROL, V83, P1474, DOI 10.1128/JVI.01717-08; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Jiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moore P., 2001, VIROLOGY, P2803; Moore P S, 1998, J Natl Cancer Inst Monogr, P65; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Valente RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043317; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; West JA, 2011, J VIROL, V85, P895, DOI 10.1128/JVI.01007-10; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	63	19	20	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20435	20442		10.1074/jbc.M113.487421	http://dx.doi.org/10.1074/jbc.M113.487421			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723066	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000321715100031
J	Scott, SA; Xiang, Y; Mathews, TP; Cho, HP; Myers, DS; Armstrong, MD; Tallman, KA; O'Reilly, MC; Lindsley, CW; Brown, HA				Scott, Sarah A.; Xiang, Yun; Mathews, Thomas P.; Cho, Hyekyung P.; Myers, David S.; Armstrong, Michelle D.; Tallman, Keri A.; O'Reilly, Matthew C.; Lindsley, Craig W.; Brown, H. Alex			Regulation of Phospholipase D Activity and Phosphatidic Acid Production after Purinergic (P2Y(6)) Receptor Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ADP-RIBOSYLATION FACTOR; FUNCTIONAL EXPRESSION; KINETIC-ANALYSIS; ACTIVATION; CLONING; ISOFORM; DESIGN; ALPHA; IDENTIFICATION	Phosphatidic acid (PA) is a lipid second messenger located at the intersection of several lipid metabolism and cell signaling events including membrane trafficking, survival, and proliferation. Generation of signaling PA has long been primarily attributed to the activation of phospholipase D (PLD). PLD catalyzes the hydrolysis of phosphatidylcholine into PA. A variety of both receptor-tyrosine kinase and G-protein-coupled receptor stimulations have been shown to lead to PLD activation and PA generation. This study focuses on profiling the PA pool upon P2Y(6) receptor signaling manipulation to determine the major PA producing enzymes. Here we show that PLD, although highly active, is not responsible for the majority of stable PA being produced upon UDP stimulation of the P2Y(6) receptor and that PA levels are tightly regulated. By following PA flux in the cell we show that PLD is involved in an initial increase in PA upon receptor stimulation; however, when PLD is blocked, the cell compensates by increasing PA production from other sources. We further delineate the P2Y(6) signaling pathway showing that phospholipase C beta 3 (PLC beta 3), PLC delta 1, DGK zeta and PLD are all downstream of receptor activation. We also show that DGK zeta is a novel negative regulator of PLD activity in this system that occurs through an inhibitory mechanism with PKC alpha. These results further define the downstream events resulting in PA production in the P2Y(6) receptor signaling pathway.	[Scott, Sarah A.; Xiang, Yun; Mathews, Thomas P.; Cho, Hyekyung P.; Myers, David S.; Armstrong, Michelle D.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Cho, Hyekyung P.; O'Reilly, Matthew C.; Lindsley, Craig W.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Tallman, Keri A.; O'Reilly, Matthew C.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu			National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network [U54 MH084659, P01-ES013125, U54 069338, T32 MH093366]; McDonnell Foundation for Brain Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093366, U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation for Brain Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network U54 MH084659, Grants P01-ES013125 and U54 069338, and Grant T32 MH093366 (postdoctoral training in CNS Drug Discovery Research (to T. P. M.). This work also supported in part by The McDonnell Foundation for Brain Cancer Research.	Berg KA, 2003, J PHARMACOL EXP THER, V304, P200, DOI 10.1124/jpet.102.042564; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Callender HL, 2007, ANAL CHEM, V79, P263, DOI 10.1021/ac061083q; Chalifa-Caspi V, 1998, NEUROCHEM RES, V23, P589, DOI 10.1023/A:1022422418388; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Communi D, 1995, J BIOL CHEM, V270, P30849, DOI 10.1074/jbc.270.52.30849; DAWSON RMC, 1967, BIOCHEM J, V102, P205, DOI 10.1042/bj1020205; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; EXTON JH, 1990, J BIOL CHEM, V265, P1; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Foster DA, 2003, MOL CANCER RES, V1, P789; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Henage LG, 2006, J BIOL CHEM, V281, P3408, DOI 10.1074/jbc.M508800200; Hu TH, 2005, BIOCHEM BIOPH RES CO, V327, P1047, DOI 10.1016/j.bbrc.2004.12.117; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; King BF, 1998, TRENDS PHARMACOL SCI, V19, P506, DOI 10.1016/S0165-6147(98)01271-1; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Lindsley CW, 2012, NEUROPSYCHOPHARMACOL, V37, P301, DOI 10.1038/npp.2011.178; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Myers DS, 2011, BBA-MOL CELL BIOL L, V1811, P748, DOI 10.1016/j.bbalip.2011.05.015; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; PURKISS J, 1992, BIOCHEM PHARMACOL, V43, P1235, DOI 10.1016/0006-2952(92)90497-7; Ralevic V, 1998, PHARMACOL REV, V50, P413; RANDALL RW, 1990, FEBS LETT, V264, P87, DOI 10.1016/0014-5793(90)80772-B; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Seidler L, 1996, PHARMACOL TOXICOL, V78, P249, DOI 10.1111/j.1600-0773.1996.tb00213.x; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Steed P. M., 2001, Current Pharmaceutical Biotechnology, V2, P241, DOI 10.2174/1389201013378644; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tallman KA, 2013, J LIPID RES, V54, P859, DOI 10.1194/jlr.D033332; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Walker Stephanie J., 2003, V237, P89; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; YANG SF, 1967, J BIOL CHEM, V242, P477; Ye Q, 2013, J MOL BIOL, V425, P755, DOI 10.1016/j.jmb.2012.11.035	61	16	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20477	20487		10.1074/jbc.M113.451708	http://dx.doi.org/10.1074/jbc.M113.451708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723068	Green Published, hybrid			2022-12-25	WOS:000321715100035
J	Takeuchi, K; Morizane, Y; Kamami-Levy, C; Suzuki, J; Kayama, M; Cai, WY; Miller, JW; Vavvas, DG				Takeuchi, Kimio; Morizane, Yuki; Kamami-Levy, Cynthia; Suzuki, Jun; Kayama, Maki; Cai, Wenyi; Miller, Joan W.; Vavvas, Demetrios G.			AMP-dependent Kinase Inhibits Oxidative Stress-induced Caveolin-1 Phosphorylation and Endocytosis by Suppressing the Dissociation between c-Abl and Prdx1 Proteins in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXAMIDE RIBONUCLEOTIDE AICAR; PAG GENE-PRODUCT; TYROSINE KINASE; GLUCOKINASE TRANSLOCATION; PHYSIOLOGICAL INHIBITOR; SRC KINASE; ACTIVATION; MICE; PERMEABILITY; PATHWAY	Caveolin-1 is the primary structural component of endothelial caveolae that is essential for transcellular trafficking of albumin and is also a critical scaffolding protein that regulates the activity of signaling molecules in caveolae. Phosphorylation of caveolin-1 plays a fundamental role in the mechanism of oxidant-induced vascular hyper permeability. However, the regulatory mechanism of caveolin-1 phosphorylation remains unclear. Here we identify a previously unexpected role for AMPK in inhibition of caveolin-1 phosphorylation under oxidative stress. A pharmacological activator of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR), inhibited oxidative stress-induced phosphorylation of both caveolin-1 and c-Abl, which is the major kinase of caveolin-1, and endocytosis of albumin in human umbilical vein endothelial cell. These effects were abolished by treatment with two specific inhibitors of AICAR, dipyridamole, and 5-iodotubericidin. Consistently, knockdown of the catalytic AMPK alpha subunit by siRNA abolished the inhibitory effect of AICAR on oxidant-induced phosphorylation of both caveolin-1 and c-Abl. Pretreatment with specific c-Abl inhibitor, imatinib mesylate, and knock down of c-Abl significantly decreased the caveolin-1 phosphorylation after H2O2 exposure and abolished the inhibitory effect of AICAR on the caveolin-1 phosphorylation. Interestingly, knockdown of Prdx-1, an antioxidant enzyme associated with c-Abl, increased phosphorylation of both caveolin-1 and c-Abl and abolished the inhibitory effect of AICAR on the caveolin-1 phosphorylation. Furthermore, co-immunoprecipitation experiment showed that AICAR suppressed the oxidant-induced dissociation between c-Abl and Prdx1. Overall, our results suggest that activation of AMPK inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis, and this effect is mediated in part by stabilizing the interaction between c-Abl and Prdx-1.	[Takeuchi, Kimio; Morizane, Yuki; Kamami-Levy, Cynthia; Suzuki, Jun; Kayama, Maki; Cai, Wenyi; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02114 USA; [Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama 7008558, Japan	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Okayama University	Vavvas, DG (corresponding author), 243 Charles St, Boston, MA 02114 USA.	Demetrios_Vavvas@meei.harvard.edu		Vavvas, Demetrios/0000-0002-8622-6478; Kamami-Levy, Cynthia/0000-0002-5770-5269; Miller, Joan/0000-0003-2046-3996	National Institutes of Health [EY014104]; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Yeatts Family Fund; Bausch and Lomb Japan Vitreoretinal fellowship; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Yeatts Family Fund; Bausch and Lomb Japan Vitreoretinal fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014104 (NEI). This work was also supported by an unrestricted grant to Massachusetts Eye and Ear Infirmary from the Research to Prevent Blindness Foundation (to D. G. V. and J. W. M.), the Lions Eye Research Fund (to D. G. V. and J. W. M.), the Fight for Sight Grant in Aid (to D. G. V.), the Harvard Ophthalmology Department (to D. G. V.), Yeatts Family Fund (to D. G. V. and J. W. M.), and a Bausch and Lomb Japan Vitreoretinal fellowship (to K. T., Y. M., J. S., and M. K.).	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Deng G, 2010, INT J OBESITY, V34, P165, DOI 10.1038/ijo.2009.205; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gayard M, 2011, ARTERIOSCL THROM VAS, V31, P2634, DOI 10.1161/ATVBAHA.111.228304; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hagerkvist R, 2006, CELL BIOL INT, V30, P1013, DOI 10.1016/j.cellbi.2006.08.006; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Morell M, 2007, PROTEOMICS, V7, P1023, DOI 10.1002/pmic.200600966; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mueller BA, 2009, CURR PHARM DESIGN, V15, P120, DOI 10.2174/138161209787002933; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Razani B, 2001, J BIOL CHEM, V276, P38121; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sun SW, 2010, ACTA PHARMACOL SIN, V31, P1336, DOI 10.1038/aps.2010.87; Sun Y, 2011, METHODS MOL BIOL, V763, P303, DOI 10.1007/978-1-61779-191-8_21; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wang F, 2013, TOXICOLOGY, V305, P10, DOI 10.1016/j.tox.2012.12.004; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022	52	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20581	20591		10.1074/jbc.M113.460832	http://dx.doi.org/10.1074/jbc.M113.460832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723070	Green Published, hybrid			2022-12-25	WOS:000321715100044
J	Hordijk, J; Wagenaar, JA; Kant, A; van Essen-Zandbergen, A; Dierikx, C; Veldman, K; Wit, B; Mevius, D				Hordijk, Joost; Wagenaar, Jaap A.; Kant, Arie; van Essen-Zandbergen, Alieda; Dierikx, Cindy; Veldman, Kees; Wit, Ben; Mevius, Dik			Cross-Sectional Study on Prevalence and Molecular Characteristics of Plasmid Mediated ESBL/AmpC-Producing Escherichia coli Isolated from Veal Calves at Slaughter	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; EXTENDED-SPECTRUM; CTX-M; SALMONELLA-ENTERICA; FECAL CARRIAGE; ANTIMICROBIAL RESISTANCE; FOOD ANIMALS; HOST-RANGE; CATTLE; ENTEROBACTERIACEAE	Objectives: The presence of ESBL/AmpC-producing E. coli in cattle has been reported previously, however information on veal calves is limited. This study describes the prevalence and molecular characteristics of E. coli with non-wild type susceptibility to cefotaxime in veal calves at slaughter. Methods: Faecal samples from 100 herds, 10 individual animals per herd, were screened for E. coli with non-wild type susceptibility for cefotaxime. Molecular characterization of ESBL/AmpC genes and plasmids was performed on one isolate per herd by microarray, PCR and sequence analysis. Results: 66% of the herds were positive for E. coli with non-wild type susceptibility for cefotaxime. Within-herd prevalence varied from zero to 90%. 83% of E. coli producing ESBL/AmpC carried bla(CTX-M) genes, of which bla(CTX-M-1), bla(CTX-M-14) and bla(CTX-M-15) were most prevalent. The dominant plasmids were Incl1 and IncF-type plasmids. Conclusions: A relatively high prevalence of various bla(CTX-M) producing E. coli was found in veal calves at slaughter. The genes were mainly located on Incl1 and IncF plasmids.	[Hordijk, Joost; Wagenaar, Jaap A.; Mevius, Dik] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Hordijk, Joost; Wagenaar, Jaap A.; Kant, Arie; van Essen-Zandbergen, Alieda; Dierikx, Cindy; Veldman, Kees; Mevius, Dik] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Wit, Ben] Netherlands Food & Consumer Prod Safety Author, Utrecht, Netherlands	Utrecht University; Wageningen University & Research	Hordijk, J (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	J.Hordijk@uu.nl			Dutch Ministry of Economic Affairs, Agriculture and Innovation [3201949]; Product Boards for Livestock and Meat [08.30.002]	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Product Boards for Livestock and Meat	This study was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (project 3201949) and the Product Boards for Livestock and Meat (project 08.30.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Bortolaia V, 2011, APPL ENVIRON MICROB, V77, P5830, DOI 10.1128/AEM.02890-10; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Caroff N, 1999, FEMS MICROBIOL LETT, V173, P459, DOI 10.1016/S0378-1097(99)00111-1; Clinical and Laboratory Standards Institute (CLSI), 2010, PERF STAND ANT SUSC; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; Duan RS, 2006, MICROB DRUG RESIST, V12, P145, DOI 10.1089/mdr.2006.12.145; EFSA (European Food Safety Authority), 2007, EFSA J, V96, P1, DOI DOI 10.2903./j.efsa.2007.96r; Frye JG, 2008, MICROB DRUG RESIST, V14, P251, DOI 10.1089/mdr.2008.0844; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P2774, DOI 10.1093/jac/dks282; Hiroi M, 2012, J VET MED SCI, V74, P189, DOI 10.1292/jvms.11-0372; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P1970, DOI 10.1093/jac/dkt132; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liebana E, 2006, J CLIN MICROBIOL, V44, P1630, DOI 10.1128/JCM.44.5.1630-1634.2006; Madec JY, 2008, J CLIN MICROBIOL, V46, P1566, DOI 10.1128/JCM.02299-07; Madec JY, 2012, J ANTIMICROB CHEMOTH, V67, P578, DOI 10.1093/jac/dkr542; MARAN, 2012, MON ANT RES ANT US A; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Novais A, 2007, ANTIMICROB AGENTS CH, V51, P796, DOI 10.1128/AAC.01070-06; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; Shiraki Y, 2004, EMERG INFECT DIS, V10, P69, DOI 10.3201/eid1001.030219; Stokes MO, 2012, J ANTIMICROB CHEMOTH, V67, P1639, DOI 10.1093/jac/dks126; Teale CJ, 2005, VET REC, V156, P186; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wasyl D, 2012, MICROB DRUG RESIST, V18, P79, DOI 10.1089/mdr.2011.0033; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001	48	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65681	10.1371/journal.pone.0065681	http://dx.doi.org/10.1371/journal.pone.0065681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724148	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000137
J	Sharma, NK; Langberg, KA; Mondal, AK; Das, SK				Sharma, Neeraj K.; Langberg, Kurt A.; Mondal, Ashis K.; Das, Swapan K.			Phospholipid Biosynthesis Genes and Susceptibility to Obesity: Analysis of Expression and Polymorphisms	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; GLUCOSE-HOMEOSTASIS; DEFICIENT MICE; INDIVIDUALS; ASSOCIATION; METABOLISM; PATHWAY; TISSUES; INDEX	Recent studies have identified links between phospholipid composition and altered cellular functions in animal models of obesity, but the involvement of phospholipid biosynthesis genes in human obesity are not well understood. We analyzed the transcript of four phospholipid biosynthesis genes in adipose and muscle from 170 subjects. We examined publicly available genome-wide association data from the GIANT and MAGIC cohorts to investigate the association of SNPs in these genes with obesity and glucose homeostasis traits, respectively. Trait-associated SNPs were genotyped to evaluate their roles in regulating expression in adipose. In adipose tissue, expression of PEMT, PCYT1A, and PTDSS2 were positively correlated and PCYT2 was negatively correlated with percent fat mass and body mass index (BMI). Among the polymorphisms in these genes, SNP rs4646404 in PEMT showed the strongest association (p = 3.07E-06) with waist-to-hip ratio (WHR) adjusted for BMI. The WHR-associated intronic SNP rs4646343 in the PEMT gene showed the strongest association with its expression in adipose. Allele "C'' of this SNP was associated with higher WHR (p = 2.47E-05) and with higher expression (p = 4.10E-04). Our study shows that the expression of PEMT gene is high in obese insulin-resistant subjects. Intronic cis-regulatory polymorphisms may increase the genetic risk of obesity by modulating PEMT expression.	[Sharma, Neeraj K.; Langberg, Kurt A.; Mondal, Ashis K.; Das, Swapan K.] Wake Forest Sch Med, Dept Internal Med, Sect Endocrinol & Metab, Winston Salem, NC USA	Wake Forest University	Das, SK (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Endocrinol & Metab, Winston Salem, NC USA.	sdas@wakehealth.edu		Das, Swapan/0000-0002-2197-8855	National Institutes of Health/NIDDK [R01 DK039311]; General Clinical Research Center grant [M01RR14288]; National Center for Research Resources, National Institutes of Health to the University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR014288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039311] Funding Source: NIH RePORTER	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); General Clinical Research Center grant; National Center for Research Resources, National Institutes of Health to the University of Arkansas for Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant R01 DK039311 from the National Institutes of Health/NIDDK. Clinical studies were supported by the General Clinical Research Center grant M01RR14288 from National Center for Research Resources, National Institutes of Health to the University of Arkansas for Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Parikh H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-72; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sharma NK, 2011, J CLIN ENDOCR METAB, V96, pE394, DOI 10.1210/jc.2010-1754; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Singh RK, 2012, J LIPID RES, V53, P1811, DOI 10.1194/jlr.M021881; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	23	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65303	10.1371/journal.pone.0065303	http://dx.doi.org/10.1371/journal.pone.0065303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724137	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000129
J	Sun, XY; Chen, J; Shi, YH; Zeng, QQ; Wei, NF; Xie, RQ; Chang, C; Du, WJ				Sun, Xinying; Chen, Juan; Shi, Yuhui; Zeng, Qingqi; Wei, Nanfang; Xie, Ruiqian; Chang, Chun; Du, Weijing			Measuring Health Literacy Regarding Infectious Respiratory Diseases: A New Skills-Based Instrument	PLOS ONE			English	Article								Background: There is no special instrument to measure skills-based health literacy where it concerns infectious respiratory diseases. This study aimed to explore and evaluate a new skills-based instrument on health literacy regarding respiratory infectious diseases. Methods: This instrument was designed to measure not only an individual's reading and numeracy ability, but also their oral communication ability and their ability to use the internet to seek information. Sixteen stimuli materials were selected to enable measurement of the skills, which were sourced from the WHO, China CDC, and Chinese Center of Health Education. The information involved the distribution of epidemics, immunization programs, early symptoms, means of disease prevention, individual's preventative behavior, use of medications and thermometers, treatment plans and the location of hospitals. Multi-stage stratified cluster sampling was employed to collect participants. Psychometric properties were used to evaluate the reliability and validity of the instrument. Results: The overall degree of difficulty and discrimination of the instrument were 0.693 and 0.482 respectively. The instrument demonstrated good internal consistency reliability with a Cronbach's alpha of 0.864. As for validity, six factors were extracted from 30 items, which together explained 47.3% of the instrument's variance. And based on confirmatory factor analysis, the items were grouped into five subscales representing prose, document, quantitative, oral and internet based information seeking skills (chi(2) = 9.200, P>0.05, GFI = 0.998, TLI = 0.988, AGFI = 0.992, RMSEA = 0.028). Conclusion: The new instrument has good reliability and validity, and it could be used to assess the health literacy regarding respiratory infectious disease status of different groups.	[Sun, Xinying; Chen, Juan; Shi, Yuhui; Zeng, Qingqi; Chang, Chun] Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; [Wei, Nanfang; Xie, Ruiqian; Du, Weijing] Chinese Ctr Hlth Educ, Beijing, Peoples R China	Peking University	Chang, C (corresponding author), Peking Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China.	cchangbj2004@yahoo.com.cn; weijingdu03@163.com	Chang, Chun/AAL-9055-2020	Sun, Xinying/0000-0001-6638-1473	China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases [5U2GGHH000018-02]	China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases	This study was funded by China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases (5U2GGHH000018-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Barrera-Anderson T., 2007, TRAVEL MED INFECT DI, V5, P410; Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985; Davis TC, 2002, CA-CANCER J CLIN, V52, P134, DOI 10.3322/canjclin.52.3.134; Kutner M, 2006, 2006483 NCES; McCormack L, 2010, J HEALTH COMMUN, V15, P51, DOI 10.1080/10810730.2010.499987; Pappas G, 2007, J INFECTION, V54, P40, DOI 10.1016/j.jinf.2006.01.018; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; RATZAN SC, 2000, NATL LIB MED CURRENT; Wang P, 2010, CHINESE J HLTH ED, V26, P243, DOI DOI 10.16168/J.CNKI.ISSN.1002-9982.2010.04.021; Wu Shuang-sheng, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P301; Zheng Ying-dong, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P314	12	15	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64153	10.1371/journal.pone.0064153	http://dx.doi.org/10.1371/journal.pone.0064153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724029	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000044
J	Wulbrand, C; Seidl, C; Gaertner, FC; Bruchertseifer, F; Morgenstern, A; Essler, M; Senekowitsch-Schmidtke, R				Wulbrand, Christian; Seidl, Christof; Gaertner, Florian C.; Bruchertseifer, Frank; Morgenstern, Alfred; Essler, Markus; Senekowitsch-Schmidtke, Reingard			Alpha-Particle Emitting Bi-213-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation	PLOS ONE			English	Article							RADIATION-THERAPY; CANCER-THERAPY; IONIZING RADIATIONS; TISSUE-CULTURE; HYPOXIC CELLS; IRRADIATION; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; RADIOTHERAPY; HIF-1-ALPHA	Hypoxia is a central problem in tumor treatment because hypoxic cells are less sensitive to chemo- and radiotherapy than normoxic cells. Radioresistance of hypoxic tumor cells is due to reduced sensitivity towards low Linear Energy Transfer (LET) radiation. High LET alpha-emitters are thought to eradicate tumor cells independent of cellular oxygenation. Therefore, the aim of this study was to demonstrate that cell-bound alpha-particle emitting Bi-213 immunoconjugates kill hypoxic and normoxic CAL33 tumor cells with identical efficiency. For that purpose CAL33 cells were incubated with Bi-213-anti-EGFR-MAb or irradiated with photons with a nominal energy of 6 MeV both under hypoxic and normoxic conditions. Oxygenation of cells was checked via the hypoxia-associated marker HIF-1 alpha. Survival of cells was analysed using the clonogenic assay. Cell viability was monitored with the WST colorimetric assay. Results were evaluated statistically using a t-test and a Generalized Linear Mixed Model (GLMM). Survival and viability of CAL33 cells decreased both after incubation with increasing Bi-213-antiEGFR- MAb activity concentrations (9.25 kBq/ml-1.48 MBq/ml) and irradiation with increasing doses of photons (0.5-12 Gy). Following photon irradiation survival and viability of normoxic cells were significantly lower than those of hypoxic cells at all doses analysed. In contrast, cell death induced by Bi-213-anti-EGFR-MAb turned out to be independent of cellular oxygenation. These results demonstrate that alpha-particle emitting Bi-213-immunoconjugates eradicate hypoxic tumor cells as effective as normoxic cells. Therefore, Bi-213-radioimmunotherapy seems to be an appropriate strategy for treatment of hypoxic tumors.	[Wulbrand, Christian; Seidl, Christof; Gaertner, Florian C.; Essler, Markus; Senekowitsch-Schmidtke, Reingard] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Bruchertseifer, Frank; Morgenstern, Alfred] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany	Technical University of Munich; University of Munich; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU)	Seidl, C (corresponding author), Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany.	christof.seidl@lrz.tum.de		Multhoff, Gabriele/0000-0002-2616-3137				Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; BARENDSE.GW, 1966, INT J RADIAT BIOL RE, V10, P317, DOI 10.1080/09553006614550421; BARENDSEN GW, 1960, RADIAT RES, V13, P832, DOI 10.2307/3570858; Beerman TA, 2009, CANCER RES, V69, P593, DOI 10.1158/0008-5472.CAN-08-2753; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carlin S, 2012, J NUCL MED, V53, P1171, DOI 10.2967/jnumed.111.099770; Chaudary N, 2007, CLIN CANCER RES, V13, P1947, DOI 10.1158/1078-0432.CCR-06-2971; Cordier D, 2010, EUR J NUCL MED MOL I, V37, P1335, DOI 10.1007/s00259-010-1385-5; Harada H, 2011, J RADIAT RES, V52, P545, DOI 10.1269/jrr.11056; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Huber R, 2003, CLIN CANCER RES, V9, p3922S; JENNER TJ, 1993, INT J RADIAT BIOL, V64, P265, DOI 10.1080/09553009314551421; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y; Liu J, 2007, BRIT J CANCER, V96, P1871, DOI 10.1038/sj.bjc.6603812; Mirzadeh S, 1990, BIOCONJUGATE CHEM, V1, P59, DOI 10.1021/bc00001a007; Moeller B, 2006, BRIT J CANCER, V95, P1, DOI 10.1038/sj.bjc.6603201; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Morgenstern A, 2012, CURR RADIOPHARM, V5, P221, DOI 10.2174/1874471011205030221; NIKULA TK, 1995, NUCL MED BIOL, V22, P387, DOI 10.1016/0969-8051(94)00126-5; Oommen D, 2012, BIOCHEM BIOPH RES CO, V421, P538, DOI 10.1016/j.bbrc.2012.04.040; Pettersen EO, 1996, INT J RADIAT BIOL, V70, P319, DOI 10.1080/095530096145058; Pfost B, 2009, J NUCL MED, V50, DOI 10.2967/jnumed.109.065961; Raja C, 2007, CANCER BIOL THER, V6, P846, DOI 10.4161/cbt.6.6.4089; Reeves TD, 2011, OTOLARYNG HEAD NECK, V144, P676, DOI 10.1177/0194599811399559; Rischin D, 2005, J CLIN ONCOL, V23, P79, DOI 10.1200/JCO.2005.01.072; Rosenblat TL, 2010, CLIN CANCER RES, V16, P5303, DOI 10.1158/1078-0432.CCR-10-0382; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Tejani MA, 2010, BIOL-TARGETS THER, V4, P173; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; VERGROESEN AJ, 1963, INT J RADIAT BIOL RE, V6, P117, DOI 10.1080/09553006314550111; Weeks AJ, 2010, EUR J NUCL MED MOL I, V37, P330, DOI 10.1007/s00259-009-1305-8; Wenzl T, 2011, PHYS MED BIOL, V56, P3251, DOI 10.1088/0031-9155/56/11/006; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015; Zalutsky MR, 2008, J NUCL MED, V49, P30, DOI 10.2967/jnumed.107.046938	42	43	45	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64730	10.1371/journal.pone.0064730	http://dx.doi.org/10.1371/journal.pone.0064730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724085	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000086
J	Segura, V; Perez-Aso, M; Monto, F; Carceller, E; Noguera, MA; Pediani, J; Milligan, G; McGrath, IC; D'Ocon, P				Segura, Vanessa; Perez-Aso, Miguel; Monto, Fermi; Carceller, Elena; Antonia Noguera, Maria; Pediani, John; Milligan, Graeme; McGrath, Ian Christie; D'Ocon, Pilar			Differences in the Signaling Pathways of alpha(1A)- and alpha(1B)-Adrenoceptors Are Related to Different Endosomal Targeting	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; ADRENERGIC-RECEPTOR; ALPHA(1A)-ADRENERGIC RECEPTOR; ALPHA-1-ADRENERGIC RECEPTORS; INTERNALIZATION PROPERTIES; DESENSITIZATION; ENDOCYTOSIS; ACTIVATION; PHOSPHORYLATION	Aims: To compare the constitutive and agonist-dependent endosomal trafficking of alpha(1A)- and alpha(1B)-adrenoceptors (ARs) and to establish if the internalization pattern determines the signaling pathways of each subtype. Methods: Using CypHer5 technology and VSV-G epitope tagged alpha(1A)- and alpha(1B)-ARs stably and transiently expressed in HEK 293 cells, we analyzed by confocal microscopy the constitutive and agonist-induced internalization of each subtype, and the temporal relationship between agonist induced internalization and the increase in intracellular calcium (determined by FLUO-3 flouorescence), or the phosphorylation of ERK1/2 and p38 MAP kinases (determined by Western blot). Results and Conclusions: Constitutive as well as agonist-induced trafficking of alpha(1A) and alpha(1B) ARs maintain two different endosomal pools of receptors: one located close to the plasma membrane and the other deeper into the cytosol. Each subtype exhibited specific characteristics of internalization and distribution between these pools that determines their signaling pathways: alpha(1A)-ARs, when located in the plasma membrane, signal through calcium and ERK1/2 pathways but, when translocated to deeper endosomes, through a mechanism sensitive to beta-arrestin and concanavalin A, continue signaling through ERK1/2 and also activate the p38 pathway. alpha(1B)-ARs signal through calcium and ERK1/2 only when located in the membrane and the signals disappear after endocytosis and by disruption of the membrane lipid rafts by methyl-beta-cyclodextrin	[Segura, Vanessa; Perez-Aso, Miguel; Monto, Fermi; Carceller, Elena; Antonia Noguera, Maria; D'Ocon, Pilar] Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain; [Pediani, John; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Pediani, John; McGrath, Ian Christie] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Auton Physiol Unit, Glasgow, Lanark, Scotland	University of Valencia; University of Glasgow; University of Glasgow	D'Ocon, P (corresponding author), Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain.	doconp@uv.es	Pediani, John/F-2708-2019; Segura, Vanessa/I-2730-2015; Milligan, Graeme/F-9426-2011	Pediani, John/0000-0001-6615-537X; Milligan, Graeme/0000-0002-6946-3519; Carceller, Elena/0000-0001-9466-2491; D'Ocon, Pilar/0000-0001-8544-7124	Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias [FIS PI070509]; Generalitat Valenciana [GVACOMP2009/261]; Universitat de Valencia [UV-INV-AE11-42176]; Spanish Ministry of Education and Science	Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat de Valencia; Spanish Ministry of Education and Science(Spanish Government)	This study has been supported by research grants from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (FIS PI070509); Generalitat Valenciana (GVACOMP2009/261) and Universitat de Valencia (UV-INV-AE11-42176). Vanessa Segura and Miguel Perez-Aso received a fellowship from the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Cardaba CM, 2008, CELL SIGNAL, V20, P1687, DOI 10.1016/j.cellsig.2008.05.014; Chalothorn D, 2002, MOL PHARMACOL, V61, P1008, DOI 10.1124/mol.61.5.1008; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hirasawa A, 1997, MOL PHARMACOL, V52, P764, DOI 10.1124/mol.52.5.764; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Keffel S, 2000, BIOCHEM BIOPH RES CO, V272, P906, DOI 10.1006/bbrc.2000.2850; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; LATTION AL, 1994, J BIOL CHEM, V269, P22887; LEE MW, 1994, AM J PHYSIOL, V267, pC659, DOI 10.1152/ajpcell.1994.267.3.C659; Lei BL, 2009, CELL SIGNAL, V21, P1532, DOI 10.1016/j.cellsig.2009.06.001; Liu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021520; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oliver E, 2009, J PHARMACOL EXP THER, V328, P982, DOI 10.1124/jpet.108.146043; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pediani JD, 2000, J PHARMACOL EXP THER, V293, P887; PEREZ DM, 1993, MOL PHARMACOL, V44, P784; Price RR, 2002, J BIOL CHEM, V277, P9570, DOI 10.1074/jbc.M111762200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Theroux TL, 1996, MOL PHARMACOL, V50, P1376; Tsang MYC, 2009, CLIN EXP PHARMACOL P, V36, pe12, DOI 10.1111/j.1440-1681.2009.05193.x; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; WU DQ, 1992, J BIOL CHEM, V267, P25798	46	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64996	10.1371/journal.pone.0064996	http://dx.doi.org/10.1371/journal.pone.0064996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717684	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000319385300006
J	Huang, CM; Chen, QY; Lin, JX; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J				Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun			Short-Term Clinical Implications of the Accessory Left Hepatic Artery in Patients Undergoing Radical Gastrectomy for Gastric Cancer	PLOS ONE			English	Article							LIVER; ANATOMY; ANGIOGRAPHY; SURGERY	Background: To evaluate the prevalence of the accessory left hepatic artery (ALHA; defined as a vessel arising from the left gastric artery, which, together with a typical left hepatic artery, supplies blood to the left lobe of the liver) and its short-term clinical implications in patients undergoing radical gastrectomy for gastric cancer. Methods: Clinical data of 1173 patients with gastric cancer who underwent laparoscopy-assisted radical gastrectomy were retrospectively analyzed. Groups of patients with and without ALHA were compared to identify differences in intraoperative and postoperative variables and changes in liver function. Results: Of the 1173 patients, 135 (11.5%) had an ALHA and 1038 (88.5%) did not. There were no significant between-group differences in clinicopathological and intraoperative characteristics, postoperative recovery, and morbidity and mortality rates (P>0.05 each). None of the patients had postoperative symptoms associated with impaired liver function. Glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and total bilirubin (TBIL) concentrations were similar preoperatively. TBIL concentrations on postoperative days 1, 3, and 7 were similar (P>0.05), while GOT and GPT activities were higher in the ALHA than in the non-ALHA group on days 1 and 7 (P<0.05), with all three markers similar in the two groups on day 14. In patients without chronic liver disease (CLD), GOT, GPT and TBIL concentrations were similar in patients with and without ALHA; whereas, in patients with CLD, GOT and GPT concentrations on days 1 and 3 and GOT on day 7 were higher in patients with than without ALHA. Conclusion: ALHA is a common anomaly that was found in 11.5% of patients. It can be safely severed during radical gastrectomy in patients without CLD, but should be left intact in patients with CLD to prevent liver dysfunction. If severed in the latter, the patient should be monitored and liver-protecting therapy may be necessary.	[Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022	Zheng, Chao-hui/0000-0001-8680-3127; 				Abdullah SS, 2006, SURG RADIOL ANAT, V28, P468, DOI 10.1007/s00276-006-0121-0; Adachi B., 1928, ARTERIENSYSTEM JAPAN; ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395; Bell BP, 2008, AM J GASTROENTEROL, V103, P2727, DOI 10.1111/j.1572-0241.2008.02071.x; Carr JC, 2003, J VASC INTERV RADIOL, V14, P441, DOI 10.1097/01.RVI.0000064853.87207.42; Cavdar S, 1997, CLIN ANAT, V10, P231, DOI 10.1002/(SICI)1098-2353(1997)10:4<231::AID-CA2>3.0.CO;2-V; Chevrel JP, 1991, ANATOMIE CLIN; Covey AM, 2002, RADIOLOGY, V224, P542, DOI 10.1148/radiol.2242011283; FRIESEN S R, 1957, Am Surg, V23, P1103; GALL EA, 1960, AM J PATHOL, V36, P241; Gruttadauria S, 2001, CLIN TRANSPLANT, V15, P359, DOI 10.1034/j.1399-0012.2001.150510.x; HEMMING AW, 1992, ANN THORAC SURG, V54, P166, DOI 10.1016/0003-4975(92)91173-7; HIATT JR, 1994, ANN SURG, V220, P50, DOI 10.1097/00000658-199407000-00008; Hu Yan-feng, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P510; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; KOEHLER RE, 1975, RADIOLOGY, V117, P49, DOI 10.1148/117.1.49; LURIE AS, 1987, ARCH SURG-CHICAGO, V122, P725; MARUYAMA K, 1995, WORLD J SURG, V19, P532, DOI 10.1007/BF00294714; MAYS ET, 1974, NEW ENGL J MED, V290, P993, DOI 10.1056/NEJM197405022901804; MICHELS NA, 1966, AM J SURG, V112, P337, DOI 10.1016/0002-9610(66)90201-7; Munson JL, 2005, SURG CLIN N AM, V85, P1021, DOI 10.1016/j.suc.2005.05.008; Osawa T, 2004, CLIN ANAT, V17, P518, DOI 10.1002/ca.10234; Paprottka PM, 2012, CARDIOVASC INTER RAD, V35, P454, DOI 10.1007/s00270-011-0169-z; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; PLENGVAN.U, 1972, ANN SURG, V175, P105, DOI 10.1097/00000658-197201000-00016; Polguj M, 2010, SURG RADIOL ANAT, V32, P175, DOI 10.1007/s00276-009-0536-5; REIMANN B, 1983, LANGENBECK ARCH CHIR, V359, P81; Sano T, 1996, LANCET, V348, P195, DOI 10.1016/S0140-6736(05)66140-5; Sobin L, 2009, TNM CLASSIFICATION M; Weiglein A H, 1996, Clin Anat, V9, P143, DOI 10.1002/(SICI)1098-2353(1996)9:3<143::AID-CA1>3.0.CO;2-H; Williams P.L, 1995, GRAYS ANATOMY, V38th	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64300	10.1371/journal.pone.0064300	http://dx.doi.org/10.1371/journal.pone.0064300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717589	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600057
J	Shinzawa, N; Ishino, T; Tachibana, M; Tsuboi, T; Torii, M				Shinzawa, Naoaki; Ishino, Tomoko; Tachibana, Mayumi; Tsuboi, Takafumi; Torii, Motomi			Phenotypic Dissection of a Plasmodium-Refractory Strain of Malaria Vector Anopheles stephensi: The Reduced Susceptibility to P. berghei and P. yoelii	PLOS ONE			English	Article							OOKINETE DESTRUCTION; XANTHURENIC ACID; GENETIC-ANALYSIS; MOSQUITO; GAMBIAE; FALCIPARUM; MIDGUT; INFECTION; RESISTANCE; PROTEINS	Anopheline mosquitoes are the major vectors of human malaria. Parasite-mosquito interactions are a critical aspect of disease transmission and a potential target for malaria control. Current investigations into parasite-mosquito interactions frequently assume that genetically resistant and susceptible mosquitoes exist in nature. Therefore, comparisons between the Plasmodium susceptibility profiles of different mosquito species may contribute to a better understanding of vectorial capacity. Anopheles stephensi is an important malaria vector in central and southern Asia and is widely used as a laboratory model of parasite transmission due to its high susceptibility to Plasmodium infection. In the present study, we identified a rodent malaria-refractory strain of A. stephensi mysorensis (Ehime) by comparative study of infection susceptibility. A very low number of oocysts develop in Ehime mosquitoes infected with P. berghei and P. yoelii, as determined by evaluation of developed oocysts on the basal lamina. A stage-specific study revealed that this reduced susceptibility was due to the impaired formation of ookinetes of both Plasmodium species in the midgut lumen and incomplete crossing of the midgut epithelium. There were no apparent abnormalities in the exflagellation of male parasites in the ingested blood or the maturation of oocysts after the rounding up of the ookinetes. Overall, these results suggest that invasive-stage parasites are eliminated in both the midgut lumen and epithelium in Ehime mosquitoes by strain-specific factors that remain unknown. The refractory strain newly identified in this report would be an excellent study system for investigations into novel parasite-mosquito interactions in the mosquito midgut.	[Shinzawa, Naoaki; Ishino, Tomoko; Tachibana, Mayumi; Torii, Motomi] Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Shinzawa, N (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime, Japan.	shinzawa@m.ehime-u.ac.jp	Tsuboi, Takafumi/AAK-6145-2021	Tsuboi, Takafumi/0000-0002-7415-1325; Ishino, Tomoko/0000-0003-2466-711X	Japan Society for the Promotion of Science KAKENHI [22890128]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 22890128. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 2005, J PARASITOL, V91, P79, DOI 10.1645/GE-3514; Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Baton LA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-15; Baton LA, 2012, INT J PARASITOL, V42, P249, DOI 10.1016/j.ijpara.2011.12.005; Billingsley PF, 1997, PARASITOL TODAY, V13, P297, DOI 10.1016/S0169-4758(97)01094-6; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; FELDMANN AM, 1990, PARASITOLOGY, V101, P193, DOI 10.1017/S003118200006323X; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Feldmann AM, 1998, MED VET ENTOMOL, V12, P302, DOI 10.1046/j.1365-2915.1998.00122.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frischknecht F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-23; Gonzalez-Ceron L, 2001, EXP PARASITOL, V98, P152, DOI 10.1006/expr.2001.4626; Gorman MJ, 1997, GENETICS, V146, P965; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P279, DOI 10.2987/8756-971X(2005)21[279:CSOTSO]2.0.CO;2; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jacobs-Lorena VY, 2010, MOL BIOCHEM PARASIT, V171, P40, DOI 10.1016/j.molbiopara.2009.12.009; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; PORTER CH, 1991, AM J TROP MED HYG, V45, P271, DOI 10.4269/ajtmh.1991.45.271; Prevot GI, 1998, INSECT MOL BIOL, V7, P375, DOI 10.1046/j.1365-2583.1998.740375.x; Ramakrishnan C, 2011, INT J PARASITOL, V41, P1029, DOI 10.1016/j.ijpara.2011.05.007; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; SUBBARAO SK, 1987, MED VET ENTOMOL, V1, P265, DOI 10.1111/j.1365-2915.1987.tb00353.x; Tikar SN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8501; Tsuboi T, 1997, INFECT IMMUN, V65, P2260, DOI 10.1128/IAI.65.6.2260-2264.1997; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Vatandoost H, 2006, ACTA TROP, V97, P196, DOI 10.1016/j.actatropica.2005.11.002; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	48	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63753	10.1371/journal.pone.0063753	http://dx.doi.org/10.1371/journal.pone.0063753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717475	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600031
J	Jiang, YS; Zhang, RJ; Lv, HC; Li, J; Wang, M; Chang, YM; Lv, WH; Sheng, X; Zhang, JJ; Liu, PP; Zheng, JJ; Shi, M; Liu, GY				Jiang, Yongshuai; Zhang, Ruijie; Lv, Hongchao; Li, Jin; Wang, Miao; Chang, Yiman; Lv, Wenhua; Sheng, Xin; Zhang, Jingjing; Liu, Panpan; Zheng, Jiajia; Shi, Miao; Liu, Guiyou			HGPGD: The Human Gene Population Genetic Difference Database	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; KYOTO ENCYCLOPEDIA; PATHWAY ANALYSIS; HAPLOTYPE; ASSOCIATION; HISTORY; COMMON; KEGG; TRANSFERABILITY; SELECTION	Demographic events such as migration, and evolutionary events like mutation and recombination, have contributed to the genetic variations that are found in the human genome. During the evolution and differentiation of human populations, different functional genes and pathways (a group of genes that act together to perform specific biological tasks) would have displayed different degrees of genetic diversity or evolutionary conservatism. To query the genetic differences of functional genes or pathways in populations, we have developed the human gene population genetic difference (HGPGD) database. Currently, 11 common population genetic features, 18,158 single human genes, 220 KEGG (Kyoto Encyclopedia of Genes and Genomes) human pathways and 4,639 Gene Ontology (GO) categories (3,269 in biological process; 862 in molecular function; and 508 in cellular component) are available in the HGPGD database. The 11 population genetic features are related mainly to three aspects: allele frequency, linkage disequilibrium pattern, and transferability of tagSNPs. By entering a list of Gene IDs, KEGG pathway IDs or GO category IDs and selecting a population genetic feature, users can search the genetic differences between pairwise HapMap populations. We hope that, when the researchers carry out gene-based, KEGG pathway-based or GO category-based research, they can take full account of the genetic differences between populations. The HGPGD database (V1.0) is available at http://www.bioapp.org/hgpgd.	[Jiang, Yongshuai; Zhang, Ruijie; Lv, Hongchao; Li, Jin; Wang, Miao; Chang, Yiman; Lv, Wenhua; Liu, Panpan; Zheng, Jiajia; Shi, Miao] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Sheng, Xin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, Jingjing] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Changsha, Hunan, Peoples R China; [Liu, Guiyou] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Harbin Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central South University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Jiang, YS (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	jiangyongshuai@gmail.com; zhangruijie2009@yahoo.com.cn		Jiang, Yongshuai/0000-0002-7163-6554; Liu, Guiyou/0000-0002-1126-2888	National Natural Science Foundation of China [31200934, 81172842]; Natural Science Foundation of Heilongjiang Province, China [C201206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31200934, 81172842) and the Natural Science Foundation of Heilongjiang Province, China (Grant No. C201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balaresque PL, 2007, HUM MOL GENET, V16, pR134, DOI 10.1093/hmg/ddm242; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BLAKE JA, 2002, CURR PROTOC BIOINFOR; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gardner M, 2006, MOL PSYCHIATR, V11, P66, DOI 10.1038/sj.mp.4001749; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Liu P, 2007, BIOINFORMATICS, V23, P739, DOI 10.1093/bioinformatics/btl664; Lundmark PE, 2008, EUR J HUM GENET, V16, P1142, DOI 10.1038/ejhg.2008.77; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Marvelle AF, 2007, J HUM GENET, V52, P729, DOI 10.1007/s10038-007-0175-9; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Ribas G, 2006, HUM GENET, V118, P669, DOI 10.1007/s00439-005-0094-9; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64150	10.1371/journal.pone.0064150	http://dx.doi.org/10.1371/journal.pone.0064150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717556	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700111
J	Chen, TR; Xu, XQ; Wei, JJ; Chen, J; Miu, RC; Huang, LM; Zhou, XX; Fu, Y; Yan, R; Wang, Z; Liu, BY; He, F				Chen, Tingrui; Xu, Xuqing; Wei, Jinjiao; Chen, Jiang; Miu, Renchao; Huang, Liming; Zhou, Xiaoxiao; Fu, Yun; Yan, Rui; Wang, Zhen; Liu, Biyao; He, Fan			Food-Borne Disease Outbreak of Diarrhetic Shellfish Poisoning Due to Toxic Mussel Consumption: The First Recorded Outbreak in China	PLOS ONE			English	Article								Objectives: This investigation was undertaken in response to an outbreak of suspected shellfish poisoning in Zhejiang Province, China. The objectives of this project were to confirm the outbreak and to identify the aetiology, source and mode of transmission. Methods: A probable case was defined as an individual with diarrhea (>= 3 times/day) plus at least one of the following symptoms: fever (>= 37.5 degrees C), vomiting, or abdominal pain after consuming seafood between May 23rd and May 28th, 2011. Using a case-control study design, we compared exposures to suspected seafood items and cooking methods between 61 probable cases and 61 controls. Results: Over 220 suspected or probable cases of diarrhetic shellfish poisoning (DSP) were identified (incidence of 18 cases per 100,000). The case control study revealed that 100% of cases and 18% of controls had eaten mussels during the exposure period (OR = infinity, chi(2) = 84.72, P = 0.000). The number of mussels consumed was related to DSP risk (P = 0.004, chi(2) test for trend). Consumption of other seafood items was not associated with disease. The frequency of diarrhea and vomiting were positively correlated with the number of mussels consumed (r = 0.424 and r = 0.562, respectively). The frequency of vomiting and the incubation period were significantly correlated with the total time the mussels were boiled (r = 0.594 and r = -0.336, respectively). Mussels from 3 food markets and one family contained Okadaic acid (OA) and Dinophysistoxin-1 (DTX-1). Conclusions: This outbreak was attributed to the consumption of mussels contaminated by DSP-toxins (OA and DTX-1) which are produced by different species of dinoflagellates (toxic microalgae) from the genus Dinophysis or Prorocentrum. Suspension of mussel sales and early public announcements were highly effective in controlling the outbreak, although oversight of seafood quality should be a priority to prevent future contamination and outbreaks.	[Chen, Tingrui; Miu, Renchao; Yan, Rui; Wang, Zhen; Liu, Biyao; He, Fan] Cangnan Ctr Dis Control & Prevent, Cangnan, Peoples R China; [Xu, Xuqing; Chen, Jiang] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wei, Jinjiao] Wenzhou Ctr Dis Control & Prevent, Wenzhou, Peoples R China; [Huang, Liming] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhou, Xiaoxiao] Taizhou Ctr Dis Control & Prevent, Taizhou, Peoples R China; [Fu, Yun] Huzhou Ctr Dis Control & Prevent, Huzhou, Peoples R China		He, F (corresponding author), Cangnan Ctr Dis Control & Prevent, Cangnan, Peoples R China.	zjhefan@126.com			Zhejiang leading team of science and technology innovation [2011R50021]	Zhejiang leading team of science and technology innovation	This study was supported by the program for Zhejiang leading team of science and technology innovation (2011R50021)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1996, TOXICON, V34, P579, DOI 10.1016/0041-0101(95)00158-1; Chung P. H., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P120; Draisci R, 1996, TOXICON, V34, P923, DOI 10.1016/0041-0101(96)00030-X; Fleming L., DIARRHETIC SHELLFISH; Fux E, 2007, J CHROMATOGR A, V1157, P273, DOI 10.1016/j.chroma.2007.05.016; Li L. M., 2004, EPIDEMIOLOGY; Scoging AC, 1991, CDR, V1, P117; VIVIANI R, 1992, SCIENCE OF THE TOTAL ENVIRONMENT, SUPPLEMENT 1992, P631; Wang ZH, 2011, MAR ENVIRON RES, V72, P53, DOI 10.1016/j.marenvres.2011.04.007; Zhou MJ, 1999, MAR POLLUT BULL, V39, P331, DOI 10.1016/S0025-326X(99)00026-0	10	17	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65049	10.1371/journal.pone.0065049	http://dx.doi.org/10.1371/journal.pone.0065049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23724121	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200185
J	Cui, D; Li, L; Lou, H; Sun, H; Ngai, SM; Shao, G; Tang, J				Cui, D.; Li, L.; Lou, H.; Sun, H.; Ngai, S-M; Shao, G.; Tang, J.			The ribosomal protein S26 regulates p53 activity in response to DNA damage	ONCOGENE			English	Article						ribosomal proteins; RPS26; p53; DNA damage response; p53 acetylation	INDUCED PHOSPHORYLATION; MEDIATES STABILIZATION; ACTIVATES P53; MDM2; L11; INHIBITION; L5; DEGRADATION; UBIQUITINATION; ACETYLATION	Ribosomal proteins have emerged as novel regulators of the Mdm2-p53 feedback loop, especially in the context of ribosomal stress. RPS26 is a recently identified Diamond-Blackfan Anemia-related ribosomal protein and its role in p53 activation has not been previously explored. In this study we found knockdown of RPS26 induced p53 stabilization and activation via a RPL11-dependent mechanism, resulting in p53-dependent cell growth inhibition. Moreover, RPS26 has the ability to interact with Mdm2 and inhibits Mdm2-mediated p53 ubiquitination that leads to p53 stabilization upon overexpression. Importantly, we discovered that RPS26 knockdown impaired p53' s ability to transcriptionally activate its target genes in response to DNA damage, without affecting its stability. Accordingly, the cells lost the ability to induce G2/M cell cycle arrest. We further found that upon RPS26 knockdown, the DNA damage induced recruitment of p53 to the promoters of its target genes and p53 acetylation were both greatly reduced. In addition, RPS26 can interact with p53 independent of Mdm2 and coexist in a complex with p53 and p300. These data establish a role of RPS26 in DNA damage response by directly influencing p53 transcriptional activity, and suggest that RPS26 acts distinctively in different scenarios of p53 activation. Our finding also implicates p53 transcriptional activity control as an important mechanism of p53 regulation by ribosomal proteins.	[Cui, D.; Li, L.; Lou, H.; Sun, H.; Tang, J.] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Cui, D.; Li, L.; Sun, H.; Tang, J.] China Agr Univ, Coll Vet Med, Dept Basic Vet Med, Beijing 100193, Peoples R China; [Lou, H.] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China; [Ngai, S-M] Chinese Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Ngai, S-M] Chinese Univ Hong Kong, State China Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Shao, G.] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University	Tang, J (corresponding author), China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	jtang@cau.edu.cn	Lou, Huiqiang/B-6287-2012; Ngai, Sai Ming/S-4898-2018	Lou, Huiqiang/0000-0003-4465-6186; Ngai, Sai Ming/0000-0002-4484-2483	National Natural Science Foundation of China [31171331]; Program for New Century Excellent Talents in University of China [NCET-09-0737]; State Key Laboratory of Agrobiotechnology of China [2010SKLAB06-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Agrobiotechnology of China	We thank Dr Xiaolu Yang for generously providing constructs and reagents; Dr Weiguo Zhu for providing the Ha-p300 expression plasmid; Yongqiang Wang for technical assistance; Dr Julia Hill for critically reading the manuscript and Caroline Kitzmiller for proofreading the manuscript. This work was supported by the National Natural Science Foundation of China (31171331); the Program for New Century Excellent Talents in University of China (NCET-09-0737) and the research fund from the State Key Laboratory of Agrobiotechnology of China (2010SKLAB06-5).	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2012, HUM MUTAT, V33, P1037, DOI 10.1002/humu.22081; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Ivanov AV, 2005, BBA-GENE STRUCT EXPR, V1727, P134, DOI 10.1016/j.bbaexp.2004.12.011; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li LJ, 2012, DNA REPAIR, V11, P112, DOI 10.1016/j.dnarep.2011.10.010; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Zhang X, 2013, ONCOGENE, V32, P2782, DOI 10.1038/onc.2012.289; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	60	66	69	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2225	2235		10.1038/onc.2013.170	http://dx.doi.org/10.1038/onc.2013.170			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23728348				2022-12-25	WOS:000334996000008
J	Cianchetti, FA; Kim, DH; Dimiduk, S; Nishimura, N; Schaffer, CB				Cianchetti, Flor A.; Kim, Dong Hwan; Dimiduk, Sally; Nishimura, Nozomi; Schaffer, Chris B.			Stimulus-Evoked Calcium Transients in Somatosensory Cortex Are Temporarily Inhibited by a Nearby Microhemorrhage	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; CEREBRAL MICROBLEEDS; IN-VIVO; BRAIN-INJURY; COGNITIVE FUNCTION; DEMENTIA; MODELS; STROKE; MRI; PREVALENCE	Although microhemorrhages are common in the brain of the elderly, the direct impact of these lesions on neural function remains unclear. In this work, we used femtosecond laser irradiation to rupture the wall of single arterioles in the brain of anesthetized rodents, producing a hematoma of similar to 100-mu m diameter. Our objective was to study the impact of these microhemorrhages on cortical activity using cell-resolved two-photon imaging of bulk-loaded calcium-sensitive dye. We monitored peripheral sensory stimulus-induced calcium transients from individual neuronal cell bodies, regions of neuropil, and astrocytes at different distances from the microhemorrhage before and 0.5, 2, and 4 hours after the creation of the lesion. We found that immediately after the hemorrhage the average amplitude of the stimulus-induced calcium response was reduced to about half within 150 mu m from the hematoma. Beyond 300 mu m, there was little effect on cell response, with a smooth increase in response amplitude from 150 mu m to 300 mu m from the lesion. Cortical function gradually improved with time and by four hours after the lesion the response from neurons and astrocytes had recovered to baseline everywhere but within 150 mu m from the hematoma. To assess whether the cells closest to the microhemorrhage recovered over a longer timeframe, we developed a re-openable chronic cranial window preparation that allowed reinjection of calcium-sensitive fluorescent dye. We found that the response largely recovered by one day after the microhemorrhage even within 150 mu m from the hematoma. This work suggests that neuronal and astrocyte function is transiently lost near a microhemorrhage, but recovers within one day after the lesion.	[Cianchetti, Flor A.; Kim, Dong Hwan; Dimiduk, Sally; Nishimura, Nozomi; Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Schaffer, CB (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cs385@cornell.edu	Nishimura, Nozomi/P-8908-2015; Schaffer, Chris B./A-7409-2008; Nishimura, Nozomi/AAV-2425-2020	Nishimura, Nozomi/0000-0003-4342-9416; Schaffer, Chris B./0000-0002-7800-9596; Nishimura, Nozomi/0000-0003-4342-9416	National Institutes of Health [R01 EB002019, F32 AG031620]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG031620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health grant (R01 EB002019) and by a National Institutes of Health post-doctoral fellowship to NN (F32 AG031620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cordonnier Charlotte, 2010, Pract Neurol, V10, P94, DOI 10.1136/jnnp.2010.206086; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; De Reuck J, 2011, J NEUROL SCI, V300, P63, DOI 10.1016/j.jns.2010.09.031; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fiehler J, 2006, INT J STROKE, V1, P122, DOI 10.1111/j.1747-4949.2006.00042.x; Gold G, 2005, STROKE, V36, P1184, DOI 10.1161/01.STR.0000166052.89772.b5; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Keep RF, 2008, ACT NEUR S, V105, P73; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Kovari E, 2004, STROKE, V35, P410, DOI 10.1161/01.STR.0000110791.51378.4E; Liem MK, 2009, NEUROLOGY, V72, P143, DOI 10.1212/01.wnl.0000339038.65508.96; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pettersen JA, 2008, ARCH NEUROL-CHICAGO, V65, P790, DOI 10.1001/archneur.65.6.790; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rojas MJ, 2006, AM J PHYSIOL-REG I, V291, pR189, DOI 10.1152/ajpregu.00409.2005; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; TUOR UI, 1984, AM J PHYSIOL, V247, pH40, DOI 10.1152/ajpheart.1984.247.1.H40; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wagner KR, 2007, STROKE, V38, P753, DOI 10.1161/01.STR.0000255033.02904.db; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakisaka Y, 2010, J CEREBR BLOOD F MET, V30, P56, DOI 10.1038/jcbfm.2009.183; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Werring DJ, 2010, J NEUROL SCI, V299, P131, DOI 10.1016/j.jns.2010.08.034; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yakushiji Y, 2008, STROKE, V39, P3323, DOI 10.1161/STROKEAHA.108.516112; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65663	10.1371/journal.pone.0065663	http://dx.doi.org/10.1371/journal.pone.0065663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724147	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000136
J	Cruz, VMV; Kilian, A; Dierig, DA				Cruz, Von Mark V.; Kilian, Andrzej; Dierig, David A.			Development of DArT Marker Platforms and Genetic Diversity Assessment of the US Collection of the New Oilseed Crop Lesquerella and Related Species	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; DESERT MUSTARD; POPULATION-GENETICS; FENDLERI GERMPLASM; CLUSTER-ANALYSIS; SEED BANK; REGISTRATION; BRASSICACEAE; PLANT; SEQUENCES	The advantages of using molecular markers in modern genebanks are well documented. They are commonly used to understand the distribution of genetic diversity in populations and among species which is crucial for efficient management and effective utilization of germplasm collections. We describe the development of two types of DArT molecular marker platforms for the new oilseed crop lesquerella (Physaria spp.), a member of the Brassicaceae family, to characterize a collection in the National Plant Germplasm System (NPGS) with relatively little known in regards to the genetic diversity and traits. The two types of platforms were developed using a subset of the germplasm conserved ex situ consisting of 87 Physaria and 2 Paysonia accessions. The microarray DArT revealed a total of 2,833 polymorphic markers with an average genotype call rate of 98.4% and a scoring reproducibility of 99.7%. On the other hand, the DArTseq platform developed for SNP and DArT markers from short sequence reads showed a total of 27,748 high quality markers. Cluster analysis and principal coordinate analysis indicated that the different accessions were successfully classified by both systems based on species, by geographical source, and breeding status. In the germplasm set analyzed, which represented more than 80% of the P. fendleri collection, we observed that a substantial amount of variation exists in the species collection. These markers will be valuable in germplasm management studies and lesquerella breeding, and augment the microsatellite markers previously developed on the taxa.	[Cruz, Von Mark V.; Dierig, David A.] USDA ARS, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80522 USA; [Kilian, Andrzej] Div Arrays Technol Pty Ltd, Yarralumla, ACT, Australia; [Cruz, Von Mark V.] Colorado State Univ, Dept Bioagr Sci & Pest Mgt, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	Dierig, DA (corresponding author), USDA ARS, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80522 USA.	david.dierig@ars.usda.gov		Kilian, Andrzej/0000-0002-2730-7462; Cruz, Von Mark/0000-0001-8318-093X	U.S. Department of Agriculture (USDA) - Agricultural Research Service [5402-21000-007-00]; NPGS Plant Exploration/Exchange Program	U.S. Department of Agriculture (USDA) - Agricultural Research Service(United States Department of Agriculture (USDA)); NPGS Plant Exploration/Exchange Program	Funding for the study was provided by U.S. Department of Agriculture (USDA) - Agricultural Research Service Project No. 5402-21000-007-00. The acquisition of new germplasm in 2010 was supported by the NPGS Plant Exploration/Exchange Program. No additional external funding was received or used for this study. USDA determines the research priorities of all research that it funds. Publication of research is subject to review of USDA officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Al-Shehbaz IA, 2002, NOVON, V12, P319, DOI 10.2307/3393073; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], 1997, IPGRI TECHNICAL B IPGRI TECHNICAL B; AYLING S, 2012, TECHNICAL APPRAISAL; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; BORNER A, 2012, J STRESS PHYSL BIO S, V3, pS10; Cabin RJ, 1996, EVOLUTION, V50, P1830, DOI 10.1111/j.1558-5646.1996.tb03569.x; Cabin RJ, 1997, AM MIDL NAT, V138, P121, DOI 10.2307/2426660; Cabin RJ, 1998, AM J BOT, V85, P1098, DOI 10.2307/2446343; CRUZ VMV, 2010, P COL NAT PLANT SOC; Cruz VMV, 2007, EUPHYTICA, V153, P43, DOI 10.1007/s10681-006-9233-1; Cruz VMV, 2006, EUPHYTICA, V152, P339, DOI 10.1007/s10681-006-9221-5; Cruz VMV, 2012, IND CROP PROD, V37, P141, DOI 10.1016/j.indcrop.2011.11.029; Dalirsefat SB, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7101; *DART, 2012, PAP DART; Dierig DA, 2006, CROP SCI, V46, P1832, DOI 10.2135/cropsci2006.02-0103; Dierig DA, 2006, IND CROP PROD, V24, P17, DOI 10.1016/j.indcrop.2005.10.004; Dierig DA, 2000, CROP SCI, V40, P865; Dierig DA, 1998, CROP SCI, V38, P287, DOI 10.2135/cropsci1998.0011183X003800010066x; Dierig DA, 2001, CROP SCI, V41, P604, DOI 10.2135/cropsci2001.412604x; DIERIG DA, J PLANT REG UNPUB; Dierig D, 2009, HANDB PLANT BREED, V4, P507, DOI 10.1007/978-0-387-77594-4_18; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faltusova Z, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue3-fulltext-4; *FAO, 2010, 2 FAO UN, P69; FREELAND J, 2005, MOL ECOL, P109; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Hedrick PW, 2000, CONSERV BIOL SER, V4, P113; Howard EL, 2011, THEOR APPL GENET, V122, P1265, DOI 10.1007/s00122-011-1529-4; *ILL, 2013, AGR GEN DEC REACH CR; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jenderek MM, 2009, IND CROP PROD, V29, P154, DOI 10.1016/j.indcrop.2008.04.019; Jones N, 1997, NEW PHYTOL, V137, P165, DOI 10.1046/j.1469-8137.1997.00826.x; Kamel Ehab A., 2004, Cytologia (Tokyo), V69, P249, DOI 10.1508/cytologia.69.249; Kilian A, 2005, P INT C WAK DOUBL HE, P443; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; KISH S, 2008, LESQUERELLA NEXT SOU; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Mitchell RJ, 1998, AM J BOT, V85, P48, DOI 10.2307/2446553; Mondini L., 2009, Diversity, V1, P19; Moser BR, 2008, ENERG FUEL, V22, P1349, DOI 10.1021/ef700628r; O'Kane SL, 2003, ANN MO BOT GARD, V90, P603, DOI 10.2307/3298545; O'Kane SL, 2002, NOVON, V12, P379, DOI 10.2307/3393083; Payson E, 1921, ANN MO BOT GARD, V8, P103; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2010, CROP PASTURE SCI, V61, P222, DOI 10.1071/CP09093; Rauf S., 2010, INT J PLANT BREED, V4, P1, DOI DOI 10.3923/ijpbg.2010.1.12; Redden R, 2009, 16 AUSTR RES ASS BRA; Rohlf FJ, 2011, NTSYSPC NUMERICAL TA; Rollins R.C., 1973, GENUS LESQUERELLA CR; ROLLINS RC, 1988, SYST BOT, V13, P60, DOI 10.2307/2419241; ROLLINS RC, 1958, B SOC BOT MEX, V23, P42; Salywon A, 2006, MOL ECOL NOTES, V6, P382, DOI 10.1111/j.1471-8286.2006.01241.x; Salywon AM, 2005, AM J BOT, V92, P53, DOI 10.3732/ajb.92.1.53; Sesli M, 2010, GENET MOL RES, V9, P2248, DOI 10.4238/vol9-4gmr966; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Toledo J, 1998, ANN BOT-LONDON, V82, P523, DOI 10.1006/anbo.1998.0715; *USDA NCRS, 2012, PLANTS DAT; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; Wang G., 2010, LESQUERELLA WINTER O; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4	69	157	159	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64062	10.1371/journal.pone.0064062	http://dx.doi.org/10.1371/journal.pone.0064062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724020	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000038
J	Deng, C; Hsueh, AJW				Deng, Cheng; Hsueh, Aaron J. W.			Evolution of a Potential Hormone Antagonist following Gene Splicing during Primate Evolution	PLOS ONE			English	Article							HUMAN PANCREATIC-CANCER; STIMULATES FOOD-INTAKE; EWING TUMOR-GROWTH; NEW-WORLD MONKEYS; INTERNATIONAL UNION; PEPTIDE GENE; CELL-LINES; MALE RATS; CHOLECYSTOKININ; RECEPTORS	Alternative splicing of genes generates novel mRNAs, leading to the evolution of new functional proteins. Cholecystokinin (CCK) induces the release of pancreatic enzymes and the contraction of the gallbladder to promote the digestion of fat and proteins. CCK activates two G-protein-coupled receptors, CCKA and CCKB. Here, we showed that a CCKsv (splicing variant), originated de novo during Catarrhini evolution by including a portion of intronic sequence of the CCK gene, encodes novel C-terminal peptide sequence followed by a new poly-adenylation signal. CCKsv is expressed in many human tissues and likely a secreted peptide retaining the original signal peptide and the N-terminal proteolytic processing signal, together with novel C-terminal sequences. Although CCKsv cannot activate CCK receptors, it partially inhibits the CRE-or SRF-driven reporter activities stimulated by wide type CCK-8 mediated by both CCK receptors. Co-treatment with CCKsv also partially antagonizes Ewing tumor cell growth stimulated by CCK-8. Our study provides an example of new peptide hormone antagonist evolution in primates.	[Deng, Cheng; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA	Stanford University	Deng, C (corresponding author), Stanford Univ, Sch Med, Dept Obstet Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA.	cdeng@stanford.edu		deng, cheng/0000-0002-5296-8879				Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Boughton CK, 2010, BRIT J PHARMACOL, V161, P601, DOI 10.1111/j.1476-5381.2010.00893.x; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Carrillo J, 2009, ANTI-CANCER DRUG, V20, P527, DOI 10.1097/CAD.0b013e32832c3a4f; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Dembinski A, 1991, J Physiol Pharmacol, V42, P263; Dockray GJ, 2009, REGUL PEPTIDES, V155, P6, DOI 10.1016/j.regpep.2009.03.015; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; GUBLER U, 1984, P NATL ACAD SCI-BIOL, V81, P4307, DOI 10.1073/pnas.81.14.4307; HARADA ML, 1995, MOL PHYLOGENET EVOL, V4, P331, DOI 10.1006/mpev.1995.1029; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; JONAS V, 1985, P NATL ACAD SCI USA, V82, P1994, DOI 10.1073/pnas.82.7.1994; MARINO CR, 1993, FEBS LETT, V316, P48, DOI 10.1016/0014-5793(93)81734-H; Matters GL, 2011, INT J ONCOL, V38, P593, DOI 10.3892/ijo.2010.886; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003; Neverov AD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-266; Noble F, 1999, PHARMACOL REV, V51, P745; Ohlsson B, 1999, SCAND J GASTROENTERO, V34, P1224; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Santic R, 2007, P NATL ACAD SCI USA, V104, P10217, DOI 10.1073/pnas.0608585104; Santic R, 2006, J MOL NEUROSCI, V29, P145, DOI 10.1385/JMN:29:2:145; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; SMITH JP, 1991, REGUL PEPTIDES, V32, P341; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TALBOT RT, 1995, J MOL ENDOCRINOL, V15, P81, DOI 10.1677/jme.0.0150081; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THUMWOOD CM, 1991, EXP CELL RES, V192, P189, DOI 10.1016/0014-4827(91)90174-S; Van Der Kolk N, 2010, NEUROPEPTIDES, V44, P333, DOI 10.1016/j.npep.2010.04.001; Wang CJ, 2009, BIOSENS BIOELECTRON, V24, P2298, DOI 10.1016/j.bios.2008.11.023; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; YOU SK, 1995, ENDOCRINOLOGY, V136, P2602, DOI 10.1210/en.136.6.2602	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64610	10.1371/journal.pone.0064610	http://dx.doi.org/10.1371/journal.pone.0064610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724068	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000069
J	Xu, ZW; Huang, CR; Turner, LR; Su, H; Qiao, Z; Tong, SL				Xu, Zhiwei; Huang, Cunrui; Turner, Lyle R.; Su, Hong; Qiao, Zhen; Tong, Shilu			Is Diurnal Temperature Range a Risk Factor for Childhood Diarrhea?	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; HOSPITAL ADMISSIONS; ROTAVIRUS; CHILDREN; DISEASE; MORTALITY; IMPACT; BURDEN	Background: Previous studies have found that high and cold temperatures increase the risk of childhood diarrhea. However, little is known about whether the within-day variation of temperature has any effect on childhood diarrhea. Methods: A Poisson generalized linear regression model combined with a distributed lag non-linear model was used to examine the relationship between diurnal temperature range and emergency department admissions for diarrhea among children under five years in Brisbane, from 1st January 2003 to 31st December 2009. Results: There was a statistically significant relationship between diurnal temperature range and childhood diarrhea. The effect of diurnal temperature range on childhood diarrhea was the greatest at one day lag, with a 3% (95% confidence interval: 2%-5%) increase of emergency department admissions per 1 degrees C increment of diurnal temperature range. Conclusion: Within-day variation of temperature appeared to be a risk factor for childhood diarrhea. The incidence of childhood diarrhea may increase if climate variability increases as predicted.	[Xu, Zhiwei; Turner, Lyle R.; Qiao, Zhen; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Huang, Cunrui] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia; [Su, Hong] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China	Queensland University of Technology (QUT); Griffith University; Anhui Medical University	Tong, SL (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au	Huang, Cunrui/ABI-3312-2020; Qiao, Zhen/G-2588-2019; Turner, Lyle R/I-9929-2012	Qiao, Zhen/0000-0002-4401-774X; Turner, Lyle R/0000-0002-9696-9232; Xu, Zhiwei/0000-0001-7903-2141	China Scholarship Council Postgraduate Scholarship; Queensland University of Technology fee waiving scholarship; National Health and Medical Research Council [553043]	China Scholarship Council Postgraduate Scholarship(China Scholarship Council); Queensland University of Technology fee waiving scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	ZX was funded by a China Scholarship Council Postgraduate Scholarship and Queensland University of Technology fee waiving scholarship; ST was supported by a National Health and Medical Research Council Research Fellowship (# 553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BULL GM, 1980, LANCET, V1, P1405; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Chen GH, 2007, INT J CARDIOL, V116, P408, DOI 10.1016/j.ijcard.2006.03.067; Chu C, 2011, BIOMED ENVIRON SCI, V24, P518, DOI 10.3967/0895-3988.2011.05.010; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Desai R, 2012, PEDIATRICS, V129, pE907, DOI 10.1542/peds.2011-2537; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Ethelberg S, 2006, EPIDEMIOLOGY, V17, P24, DOI 10.1097/01.ede.0000187621.41373.0a; Feng BS, 2007, AM J PATHOL, V171, P537, DOI 10.2353/ajpath.2007.061274; FRASCAROLO P, 1990, J APPL PHYSIOL, V69, P2029, DOI 10.1152/jappl.1990.69.6.2029; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, ARMSTRONG B DISTRIBU; Gerba CP, 1996, INT J FOOD MICROBIOL, V30, P113, DOI 10.1016/0168-1605(96)00996-8; Graudenz GS, 2006, J ALLERGY CLIN IMMUN, V118, P1126, DOI 10.1016/j.jaci.2006.07.005; Grucza R, 1990, Acta Physiol Pol, V41, P123; Kan HD, 2007, ENVIRON RES, V103, P424, DOI 10.1016/j.envres.2006.11.009; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lim YH, 2012, SCI TOTAL ENVIRON, V417, P55, DOI 10.1016/j.scitotenv.2011.12.048; Lim YH, 2012, INT J BIOMETEOROL, V56, P33, DOI 10.1007/s00484-010-0395-0; Malek MA, 2006, PEDIATRICS, V117, P1887, DOI 10.1542/peds.2005-2351; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Qiao M, 2007, IMVS NEWSLETTER, V65; Ramsay David B, 2010, Gastroenterol Hepatol (N Y), V6, P772; Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; TOGIAS AG, 1985, J CLIN INVEST, V76, P1375, DOI 10.1172/JCI112113; Xu ZW, 2012, ENVIRON RES, V117, P120, DOI 10.1016/j.envres.2012.07.002; Zhao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043749	34	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64713	10.1371/journal.pone.0064713	http://dx.doi.org/10.1371/journal.pone.0064713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724083	Green Published, gold			2022-12-25	WOS:000319733000084
J	Youngstrom, DW; Barrett, JG; Jose, RR; Kaplan, DL				Youngstrom, Daniel W.; Barrett, Jennifer G.; Jose, Rod R.; Kaplan, David L.			Functional Characterization of Detergent-Decellularized Equine Tendon Extracellular Matrix for Tissue Engineering Applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DIGITAL FLEXOR TENDON; HEART-VALVES; EXTRACTION TECHNIQUES; STROMAL CELLS; IN-VIVO; SCAFFOLD; REPAIR; REGENERATION; SLICES	Natural extracellular matrix provides a number of distinct advantages for engineering replacement orthopedic tissue due to its intrinsic functional properties. The goal of this study was to optimize a biologically derived scaffold for tendon tissue engineering using equine flexor digitorum superficialis tendons. We investigated changes in scaffold composition and ultrastructure in response to several mechanical, detergent and enzymatic decellularization protocols using microscopic techniques and a panel of biochemical assays to evaluate total protein, collagen, glycosaminoglycan, and deoxyribonucleic acid content. Biocompatibility was also assessed with static mesenchymal stem cell (MSC) culture. Implementation of a combination of freeze/thaw cycles, incubation in 2% sodium dodecyl sulfate (SDS), trypsinization, treatment with DNase-I, and ethanol sterilization produced a non-cytotoxic biomaterial free of appreciable residual cellular debris with no significant modification of biomechanical properties. These decellularized tendon scaffolds (DTS) are suitable for complex tissue engineering applications, as they provide a clean slate for cell culture while maintaining native three-dimensional architecture.	[Youngstrom, Daniel W.] Virginia Tech, Dept Biomed & Vet Sci, Virginia Maryland Reg Coll Vet Med, Leesburg, VA USA; [Barrett, Jennifer G.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Marion duPont Scott Equine Med Ctr, Dept Large Anim Clin Sci, Leesburg, VA USA; [Jose, Rod R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Tissue Engn Resource Ctr, Medford, MA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Tufts University	Barrett, JG (corresponding author), Virginia Tech, Virginia Maryland Reg Coll Vet Med, Marion duPont Scott Equine Med Ctr, Dept Large Anim Clin Sci, Leesburg, VA USA.	jgbarrett@vt.edu	Barrett, Jennifer G/B-9476-2013	Barrett, Jennifer G/0000-0002-5550-4412; Youngstrom, Daniel/0000-0002-1193-8868	Virginia Tech Institute for Critical Technology and Applied Science (ICTAS); Morris Animal Foundation; Tissue Engineering Resource Center (TERC) at Tufts University [NIH P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Virginia Tech Institute for Critical Technology and Applied Science (ICTAS); Morris Animal Foundation; Tissue Engineering Resource Center (TERC) at Tufts University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge partial funding by the Virginia Tech Institute for Critical Technology and Applied Science (ICTAS), the Morris Animal Foundation, and the Tissue Engineering Resource Center (TERC) at Tufts University [NIH P41 EB002520]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON SO, 1989, SCAND J PLAST RECONS, V23, P191, DOI 10.3109/02844318909075117; Ahmad Z, 2012, ARTHROSCOPY, V28, P1018, DOI 10.1016/j.arthro.2011.12.009; Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084952102000940; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Birch HL, 2002, EQUINE VET J, V34, P288; Birch HL, 1997, J EXP BIOL, V200, P1703; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; Blevins FT, 1997, ORTHOP CLIN N AM, V28, P1, DOI 10.1016/S0030-5898(05)70260-1; Butcher MT, 2009, COMP BIOCHEM PHYS A, V152, P100, DOI 10.1016/j.cbpa.2008.09.007; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.0.CO;2-D; Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]; Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753; Dowling BA, 2005, VET J, V170, P184, DOI 10.1016/j.tvjl.2004.03.021; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; KRAUSHANSEN AE, 1992, EQUINE VET J, V24, P46, DOI 10.1111/j.2042-3306.1992.tb02778.x; LOPPNOW H, 1989, IMMUNOBIOLOGY, V179, P283, DOI 10.1016/S0171-2985(89)80023-3; Lui PPY, 2012, J CELL MOL MED, V20, P1; MCINTOSH JK, 1989, J IMMUNOL, V143, P162; Ning LJ, 2012, J BIOMED MATER RES A, V100A, P1448, DOI 10.1002/jbm.a.34083; Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park KM, 2012, TRANSPL P, V44, P1151, DOI 10.1016/j.transproceed.2012.03.017; Patterson-Kane JC, 2012, J COMP PATHOL, V147, P227, DOI 10.1016/j.jcpa.2012.05.010; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457; Qin TW, 2012, J BIOMED MATER RES B, V100B, P752, DOI 10.1002/jbm.b.32508; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Santiago JA, 2009, TISSUE ENG PT A, V15, P3911, DOI 10.1089/ten.tea.2008.0603; Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002; Schulze-Tanzil Gundula, 2012, Cells, V1, P1010, DOI 10.3390/cells1041010; Stewart AA, 2009, AM J VET RES, V70, P750, DOI 10.2460/ajvr.70.6.750; Thornton GM, 2011, J MUSCULOSKEL NEURON, V11, P94; Thorpe CT, 2010, EQUINE VET J, V42, P174, DOI 10.2746/042516409X480395; Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Weber B, 2011, SEMIN IMMUNOPATHOL, V33, P307, DOI 10.1007/s00281-011-0258-8; Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066; Xu Q, 2012, ADV HEALTHC MAT 1212; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088	57	72	78	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64151	10.1371/journal.pone.0064151	http://dx.doi.org/10.1371/journal.pone.0064151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724028	Green Published, gold			2022-12-25	WOS:000319738100019
J	McManus, SA; Li, YF				McManus, Simon A.; Li, Yingfu			Assessing the Amount of Quadruplex Structures Present within G(2)-Tract Synthetic Random-Sequence DNA Libraries	PLOS ONE			English	Article							IN-VITRO SELECTION; PROMOTER REGION; APTAMER; DEOXYRIBOZYME; STABILITY; TOPOLOGY; ION; MOLECULES; EVOLUTION; DESIGN	The process of in vitro selection has led to the discovery of many aptamers with potential to be developed into inhibitors and biosensors, but problems in isolating aptamers against certain targets with desired affinity and specificity still remain. One possible improvement is to use libraries enhanced for motifs repeatedly isolated in aptamer molecules. One such frequently observed motif is the two-tiered guanine quadruplex. In this study we investigated whether DNA libraries could be designed to contain a large fraction of molecules capable of folding into two-tiered guanine quadruplexes. Using comprehensive circular dichroism analysis, we found that DNA libraries could be designed to contain a large proportion of sequences that adopt guanine quadruplex structures. Analysis of individual sequences from a small library revealed a mixture of quadruplexes of different topologies providing the diversity desired for an in vitro selection. We also found that primer-binding sites are detrimental to quadruplex formation and devised a method for post-selection amplification of primer-less quadruplex libraries. With the development of guanine quadruplex enriched DNA libraries, it should be possible to improve the chances of isolating aptamers that utilize a quadruplex scaffold and enhance the success of in vitro selection experiments.	[McManus, Simon A.; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Li, Yingfu] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [McManus, Simon A.; Li, Yingfu] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	liying@mcmaster.ca			Natural Science and Engineering Research Council of Canada [227594-2009]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Science and Engineering Research Council of Canada, grant number 227594-2009, (http://www.nserc-crsng.gc.ca/index_eng.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Chinnapen DJF, 2004, P NATL ACAD SCI USA, V101, P65, DOI 10.1073/pnas.0305943101; Crnugelj M, 2003, J AM CHEM SOC, V125, P7866, DOI 10.1021/ja0348694; Cruz RPG, 2004, CHEM BIOL, V11, P57, DOI 10.1016/j.chembiol.2003.12.012; Silva MW, 2007, CHEM-EUR J, V13, P9738, DOI 10.1002/chem.200701255; da Silva MW, 2009, ANGEW CHEM INT EDIT, V48, P9167, DOI 10.1002/anie.200902454; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Davis JH, 2002, P NATL ACAD SCI USA, V99, P11616, DOI 10.1073/pnas.182095699; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Faulhammer D, 1996, ANGEW CHEM INT EDIT, V35, P2837, DOI 10.1002/anie.199628371; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gevertz J, 2005, RNA, V11, P853, DOI 10.1261/rna.7271405; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Lau PS, 2011, CURR ORG CHEM, V15, P557; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Li YF, 2000, BIOCHEMISTRY-US, V39, P3106, DOI 10.1021/bi992710r; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Luo XM, 2010, RNA, V16, P2252, DOI 10.1261/rna.2102210; Mazumder A, 1996, BIOCHEMISTRY-US, V35, P13762, DOI 10.1021/bi960541u; McManus SA, 2008, J MOL BIOL, V375, P960, DOI 10.1016/j.jmb.2007.10.080; McManus SA, 2007, BIOCHEMISTRY-US, V46, P2198, DOI 10.1021/bi061613c; Mergny J.-L., 2009, CURR PROTOC NUCL ACI, V37, P171; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Neidle S, 2006, QUADRUPLEX NUCL ACID, Vxiv; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P1061, DOI 10.1002/anie.200461848; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Rachwal PA, 2007, METHODS, V43, P291, DOI 10.1016/j.ymeth.2007.05.004; Rachwal PA, 2007, NUCLEIC ACIDS RES, V35, P4214, DOI 10.1093/nar/gkm316; Radi AE, 2006, CHEM COMMUN, P3432, DOI 10.1039/b606804a; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Risitano A, 2004, NUCLEIC ACIDS RES, V32, P2598, DOI 10.1093/nar/gkh598; Ruff KM, 2010, J AM CHEM SOC, V132, P9453, DOI 10.1021/ja103023m; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2004, BIOCHEMISTRY-US, V43, P9695, DOI 10.1021/bi049757j; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ueyama H, 2002, J AM CHEM SOC, V124, P14286, DOI 10.1021/ja026892f; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Xiao Y, 2005, ANGEW CHEM INT EDIT, V44, P5456, DOI 10.1002/anie.200500989; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	11	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64131	10.1371/journal.pone.0064131	http://dx.doi.org/10.1371/journal.pone.0064131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717551	gold, Green Published, Green Submitted			2022-12-25	WOS:000319385300025
J	Zhang, W; Pal, SK; Liu, XL; Yang, CM; Allahabadi, S; Bhanji, S; Figlin, RA; Yu, H; Reckamp, KL				Zhang, Wang; Pal, Sumanta K.; Liu, Xueli; Yang, Chunmei; Allahabadi, Sachin; Bhanji, Shaira; Figlin, Robert A.; Yu, Hua; Reckamp, Karen L.			Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MICROMETASTATIC TUMOR-CELLS; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODES; BONE-MARROW; SIGNAL TRANSDUCER; TRANSCRIPTION 3; STAT3; DIFFERENTIATION; RECRUITMENT; ACTIVATOR	Background: This study aimed to understand the role of myeloid cell clusters in uninvolved regional lymph nodes from early stage non-small cell lung cancer patients. Methods: Uninvolved regional lymph node sections from 67 patients with stage I-III resected non-small cell lung cancer were immunostained to detect myeloid clusters, STAT3 activity and occult metastasis. Anthracosis intensity, myeloid cluster infiltration associated with anthracosis and pSTAT3 level were scored and correlated with patient survival. Multivariate Cox regression analysis was performed with prognostic variables. Human macrophages were used for in vitro nicotine treatment. Results: CD68(+) myeloid clusters associated with anthracosis and with an immunosuppressive and metastasis-promoting phenotype and elevated overall STAT3 activity were observed in uninvolved lymph nodes. In patients with a smoking history, myeloid cluster score significantly correlated with anthracosis intensity and pSTAT3 level (P<0.01). Nicotine activated STAT3 in macrophages in long-term culture. CD68(+) myeloid clusters correlated and colocalized with occult metastasis. Myeloid cluster score was an independent prognostic factor (P = 0.049) and was associated with survival by Kaplan-Maier estimate in patients with a history of smoking (P = 0.055). The combination of myeloid cluster score with either lymph node stage or pSTAT3 level defined two populations with a significant difference in survival (P = 0.024 and P = 0.004, respectively). Conclusions: Myeloid clusters facilitate a pro-metastatic microenvironment in uninvolved regional lymph nodes and associate with occult metastasis in early stage non-small cell lung cancer. Myeloid cluster score is an independent prognostic factor for survival in patients with a history of smoking, and may present a novel method to inform therapy choices in the adjuvant setting. Further validation studies are warranted.	[Zhang, Wang; Yang, Chunmei; Yu, Hua] City Hope Comprehens Canc Ctr, Dept Canc Immunotherapy & Immunol, Duarte, CA USA; [Pal, Sumanta K.; Reckamp, Karen L.] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Liu, Xueli] City Hope Comprehens Canc Ctr, Dept Informat Sci, Duarte, CA USA; [Allahabadi, Sachin] Rice Univ, Dept Bioengn, Houston, TX USA; [Bhanji, Shaira] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Figlin, Robert A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	City of Hope; City of Hope; City of Hope; Rice University; Harvard University; Cedars Sinai Medical Center	Yu, H (corresponding author), City Hope Comprehens Canc Ctr, Dept Canc Immunotherapy & Immunol, Duarte, CA USA.	hyu@oh.org; kreckamp@coh.org	Allahabadi, Sachin/AAO-7625-2021	Allahabadi, Sachin/0000-0002-1185-3039; YU, Hua/0000-0003-0931-1000; Reckamp, Karen/0000-0002-9213-0325	National Cancer Institute of the National Institutes of Health [P30CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under grant number P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HLTH CONS SMOK REP S; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Dumitriu IE, 2009, J IMMUNOL, V182, P2795, DOI 10.4049/jimmunol.0712671; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gu CD, 2002, ANN SURG, V235, P133, DOI 10.1097/00000658-200201000-00017; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P302, DOI 10.1073/pnas.1016917108; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Hou M, 1998, JPN J CANCER RES, V89, P1251, DOI 10.1111/j.1349-7006.1998.tb00521.x; Ihara S, 2012, CANCER RES, V72, P2990, DOI 10.1158/0008-5472.CAN-11-4062; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER RES, V69, P2497, DOI 10.1158/0008-5472.CAN-08-3031; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Osaki T, 2002, J CLIN ONCOL, V20, P2930, DOI 10.1200/JCO.2002.11.011; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reckamp KL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-213; Rusch VW, 2011, J CLIN ONCOL, V29, P4313, DOI 10.1200/JCO.2011.35.2500; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang DY, 2011, EXP MOL PATHOL, V90, P131, DOI 10.1016/j.yexmp.2010.10.014; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	34	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e65121	10.1371/journal.pone.0065121	http://dx.doi.org/10.1371/journal.pone.0065121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717691	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300003
J	Yang, B; Lu, AR; Peng, Q; Ling, QZ; Ling, EJ				Yang, Bing; Lu, Anrui; Peng, Qin; Ling, Qing-Zhi; Ling, Erjun			Activity of Fusion Prophenoloxidase-GFP and Its Potential Applications for Innate Immunity Study	PLOS ONE			English	Article							MANDUCA-SEXTA; PHENOL OXIDASE; DROSOPHILA; MELANIZATION; PHENOLOXIDASE; ACTIVATION; RESPONSES; SILKWORM; INSECT; PURIFICATION	Insect prophenoloxidase (PPO) is essential for physiological functions such as melanization of invading pathogens, wound healing and cuticle sclerotization. The insect PPO activation pathway is well understood. However, it is not very clear how PPO is released from hemocytes and how PPO takes part in cellular immunity. To begin to assess this, three Drosophila melanogaster PPO genes were separately fused with GFP at the C-terminus (rPPO-GFP) and were over-expressed in S2 cells. The results of staining and morphological observation show that rPPO-GFP expressed in S2 cells has green fluorescence and enzyme activity if Cu2+ was added during transfection. Each rPPO-GFP has similar properties as the corresponding rPPO. However, cells with rPPO-GFP over-expressed are easier to trace without PO activation and staining. Further experiments show that rPPO1-GFP is cleaved and activated by Drosophila serine protease, and rPPO1-GFP binds to Micrococcus luteus and Beauveria bassiana spores as silkworm plasma PPO. The above research indicates that the GFP-tag has no influence on the fusion enzyme activation and PPO-involved innate immunity action in vitro. Thus, rPPO-GFP may be a convenient tool for innate immunity study in the future if it can be expressed in vivo.	[Yang, Bing; Lu, Anrui; Peng, Qin; Ling, Erjun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Ling, Qing-Zhi] Zhejiang Pharmaceut Coll, Dept Appl Biol, Ningbo, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ling, EJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.	erjunling@sippe.ac.cn		Ling, Qingzhi Ling/0000-0002-4451-1537	National Natural Science Foundation of China [31172151]; National Basic Research Program of China [2012CB114605]; Ministry of Agriculture of China [2011ZX08009-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Natural Science Foundation of China (31172151), the National Basic Research Program of China (2012CB114605) and the Ministry of Agriculture of China (2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASADA N, 1993, INSECT BIOCHEM MOLEC, V23, P515, DOI 10.1016/0965-1748(93)90060-6; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; ASHIDA M, 1971, ARCH BIOCHEM BIOPHYS, V144, P749, DOI 10.1016/0003-9861(71)90383-3; Ashida Masaaki, 1998, P135; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chen Y, 2012, DEV COMP IMMUNOL, V38, P88, DOI 10.1016/j.dci.2012.04.007; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Diao YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041416; Dittmer NT, 2012, J PROTEOME RES, V11, P269, DOI 10.1021/pr2009803; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Fairhead M, 2012, NEW BIOTECHNOL, V29, P183, DOI 10.1016/j.nbt.2011.05.007; FUJIMOTO K, 1993, J BIOCHEM-TOKYO, V113, P285, DOI 10.1093/oxfordjournals.jbchem.a124040; Hillyer JF, 2005, J HISTOCHEM CYTOCHEM, V53, P689, DOI 10.1369/jhc.4A6564.2005; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Lai SC, 2002, J MED ENTOMOL, V39, P266, DOI 10.1603/0022-2585-39.2.266; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Ling E, 2005, TISSUE CELL, V37, P101, DOI 10.1016/j.tice.2004.10.007; Ling EJ, 2005, INSECT BIOCHEM MOLEC, V35, P1356, DOI 10.1016/j.ibmb.2005.08.007; Liu F, 2012, DEV COMP IMMUNOL, V36, P619, DOI 10.1016/j.dci.2011.12.001; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Nam HJ, 2008, MOL CELLS, V26, P606; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Phonpala Y, 2009, J FOOD SCI, V74, pS240, DOI 10.1111/j.1750-3841.2009.01189.x; Ragan EJ, 2008, THESIS KANSAS STATE; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SEYBOLD WD, 1975, BIOCHEM GENET, V13, P85, DOI 10.1007/BF00486009; Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shrestha S, 2011, J INSECT PHYSIOL, V57, P1568, DOI 10.1016/j.jinsphys.2011.08.010; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Wang Y, 2009, EXP PARASITOL, V123, P6, DOI 10.1016/j.exppara.2009.05.017; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	50	11	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64106	10.1371/journal.pone.0064106	http://dx.doi.org/10.1371/journal.pone.0064106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717543	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600045
J	Chua, CLL; Brown, GV; Hamilton, JA; Molyneux, ME; Rogerson, SJ; Boeuf, P				Chua, Caroline Lin Lin; Brown, Graham V.; Hamilton, John A.; Molyneux, Malcolm E.; Rogerson, Stephen J.; Boeuf, Philippe			Soluble CD163, a Product of Monocyte/Macrophage Activation, Is Inversely Associated with Haemoglobin Levels in Placental Malaria	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; EXPRESSION; PREGNANCY; IDENTIFICATION; EPIDEMIOLOGY; CYTOKINES; SEVERITY; MARKER; ALPHA; GAMMA	In Plasmodium falciparum malaria, activation of monocytes and macrophages (monocytes/macrophages) can result in the production of various inflammatory mediators that contribute to immunopathology. Soluble CD163 (sCD163) is a specific marker of monocyte/macrophage activation typically found at increased levels during various inflammatory conditions and can be associated with poor clinical outcomes. To better understand the relationships between levels of sCD163 and clinical parameters in women with placental malaria, we measured plasma sCD163 levels in maternal peripheral and placental blood compartments at delivery and determined their correlations with birth weight and maternal haemoglobin concentrations. sCD163 levels were negatively correlated with birth weight only in the placental compartment (r = -0.145, p = 0.03) and were inversely correlated with maternal haemoglobin concentrations, both in peripheral blood (r = -0.238, p = 0.0004) and in placental blood (r = -0.259, p = 0.0001). These inverse relationships suggest a potential role for monocyte/macrophage activation in the pathogenesis of malaria in pregnancy, particularly in relation to malaria-associated anaemia.	[Chua, Caroline Lin Lin; Brown, Graham V.; Hamilton, John A.; Rogerson, Stephen J.; Boeuf, Philippe] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Brown, Graham V.] Univ Melbourne, Nossal Inst Global Hlth, Parkville, Vic 3052, Australia; [Molyneux, Malcolm E.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Rogerson, Stephen J.; Boeuf, Philippe] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; Royal Melbourne Hospital	Chua, CLL (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.	carolynn85@yahoo.com.sg		Boeuf, Philippe/0000-0002-5851-3373; Rogerson, Stephen/0000-0003-4287-1982; Hamilton, John A/0000-0002-9493-9224	Wellcome Trust Senior Overseas Fellowship [063215]; Nossal Institute for Global Health, Melbourne, Australia	Wellcome Trust Senior Overseas Fellowship(Wellcome Trust); Nossal Institute for Global Health, Melbourne, Australia	Sample collection was funded by a Wellcome Trust Senior Overseas Fellowship to SJR (ref 063215). CLLC was supported by a PhD scholarship from the Nossal Institute for Global Health, Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Avery JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031090; BOEUF P, 2012, PLOS PATH, P3153; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Conroy AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028540; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Fried M, 1998, J IMMUNOL, V160, P2523; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Luppi P, 2002, J LEUKOCYTE BIOL, V72, P874; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2007, J HEPATOL, V47, P671, DOI 10.1016/j.jhep.2007.05.014; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Okoko BJ, 2003, ACTA TROP, V87, P193, DOI 10.1016/S0001-706X(03)00097-4; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Paidas MJ, 2004, J THROMB HAEMOST, V2, P1009, DOI 10.1111/j.1538-7836.2004.00681.x; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64127	10.1371/journal.pone.0064127	http://dx.doi.org/10.1371/journal.pone.0064127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717548	Green Published, Green Accepted, gold			2022-12-25	WOS:000320362700104
J	Demmers, MWHJ; Baan, CC; van Beelen, E; IJzermans, JNM; Weimar, W; Rowshani, AT				Demmers, Martijn W. H. J.; Baan, Carla C.; van Beelen, Els; IJzermans, Jan N. M.; Weimar, Willem; Rowshani, Ajda T.			Differential Effects of Activated Human Renal Epithelial Cells on T-Cell Migration	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; IN-VITRO; TRANSPLANT REJECTION; KIDNEY-TRANSPLANTS; TH17 CELLS; CHEMOKINES; RECEPTOR; INTERLEUKIN-17; EXPRESSION; RECRUITMENT	Background: Renal tubular epithelial cells (TECs) are one of the main targets of inflammatory insults during interstitial nephritis and kidney transplant rejection. While Th1 cells are know to be essential in the pathogenesis of rejection, the role of Th17 is still under debate. We hypothesize that TECs modulate the outcome of rejection process by production of distinct chemokines and cytokines that determine the attraction of different T-cell subsets. Therefore, we studied differential effects of activated human renal epithelial cells on T-cell migration. Methods: Human primary TECs were stimulated by IFN-gamma and TNF-alpha in vitro. Chemokines and cytokines produced by activated TECs were measured using Luminex or ELISA. Chemotaxis assay was performed using activated peripheral blood mononuclear cells composed of CD4(+)CXCR3(+) and CD4(+)CCR6(+) T cells migrating towards stimulated and unstimulated TECs. Results: While activated TECs secreted abundant amounts of the pro-inflammatory cytokines IL-6 and IL-8, the T helper cell differentiation cytokines IL-1 beta, IL-12p70, IL-23 or TGF-beta 1 were not produced. The production of Th1 chemokines CXCL9, CXCL10 and CCL5 were significantly upregulated after TEC stimulation. In contrast, Th17 chemokine CCL20 could not be detected. Finally, activated TECs attracted significantly higher numbers of CD4(+)CXCR3(+) T cells as compared to unstimulated TECs. No migration of CD4(+)CCR6(+) T cells could be observed. Conclusion: Activated primary renal tubular epithelial cells do not attract Th17 cells nor produce cytokines promoting Th17 cell differentiation in our experimental system mimicking the proinflammatory microenvironment of rejection.	[Demmers, Martijn W. H. J.; Baan, Carla C.; Weimar, Willem; Rowshani, Ajda T.] Univ Med Ctr Rotterdam, Dept Internal Med, Div Nephrol & Transplantat, Erasmus MC, Rotterdam, Netherlands; [van Beelen, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [IJzermans, Jan N. M.] Univ Med Ctr Rotterdam, Dept Surg, Div Transplant Surg, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Demmers, MWHJ (corresponding author), Univ Med Ctr Rotterdam, Dept Internal Med, Div Nephrol & Transplantat, Erasmus MC, Rotterdam, Netherlands.	m.demmers@erasmusmc.nl; t.rowshani@erasmusmc.nl		Baan, Carla/0000-0003-2274-2788				Atalar K, 2009, CURR OPIN ORGAN TRAN, V14, P23, DOI 10.1097/MOT.0b013e32831b70c2; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Broen K, 2011, BIOL BLOOD MARROW TR, V17, P1443, DOI 10.1016/j.bbmt.2011.07.004; Chadha R, 2011, TRANSPLANTATION, V91, P939, DOI 10.1097/TP.0b013e3182126eeb; Cockwell P, 2002, NEPHROL DIAL TRANSPL, V17, P734, DOI 10.1093/ndt/17.5.734; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Deckers JGM, 1998, J AM SOC NEPHROL, V9, P1187; Florquin S, 2011, NEPHROL DIAL TRANSPL; Gerritsma JSJ, 1996, CLIN EXP IMMUNOL, V103, P289, DOI 10.1046/j.1365-2249.1996.d01-617.x; Halloran PF, 2010, AM J TRANSPLANT, V10, P1126, DOI 10.1111/j.1600-6143.2010.03053.x; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hoffmann SC, 2005, AM J TRANSPLANT, V5, P573, DOI 10.1111/j.1600-6143.2005.00719.x; Jackson JA, 2011, AM J TRANSPLANT, V11, P2228, DOI 10.1111/j.1600-6143.2011.03680.x; Lo DJ, 2011, TRANSPLANTATION, V91, P70, DOI 10.1097/TP.0b013e3181fe12fc; Loong CC, 2002, J PATHOL, V197, P322, DOI 10.1002/path.1117; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mueller TF, 2007, AM J TRANSPLANT, V7, P2712, DOI 10.1111/j.1600-6143.2007.02005.x; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Nguan Christopher Y C, 2009, Transplant Rev (Orlando), V23, P129, DOI 10.1016/j.trre.2009.02.003; OCONNELL PJ, 1993, J IMMUNOL, V150, P1093; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; Panzer U, 2004, TRANSPLANTATION, V78, P1341, DOI 10.1097/01.TP.0000140483.59664.64; Pelletier R, 2000, TRANSPLANTATION, V70, P674, DOI 10.1097/00007890-200008270-00023; Segerer S, 2000, KIDNEY INT, V58, P1546, DOI 10.1046/j.1523-1755.2000.00316.x; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; van Kooten C, 1999, KIDNEY INT, V56, P41, DOI 10.1046/j.1523-1755.1999.00514.x; van Kooten C, 2001, J NEPHROL, V14, P204; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Woltman AM, 2005, AM J TRANSPLANT, V5, P2114, DOI 10.1111/j.1600-6143.2005.00997.x; Yapici U, 2011, TRANSPL INT, V24, P1008, DOI 10.1111/j.1432-2277.2011.01302.x	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64916	10.1371/journal.pone.0064916	http://dx.doi.org/10.1371/journal.pone.0064916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717673	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700180
J	Scharmann, M; Thornham, DG; Grafe, TU; Federle, W				Scharmann, Mathias; Thornham, Daniel G.; Grafe, T. Ulmar; Federle, Walter			A Novel Type of Nutritional Ant-Plant Interaction: Ant Partners of Carnivorous Pitcher Plants Prevent Nutrient Export by Dipteran Pitcher Infauna	PLOS ONE			English	Article							ALTERNATIVE TRAPPING STRATEGIES; LEAF-LITTER UTILIZATION; NEPENTHES-BICALCARATA; NITROGEN; PREY; CAPTURE; EFFICIENCY; DIVERSITY; PREDATION; MUTUALISM	Many plants combat herbivore and pathogen attack indirectly by attracting predators of their herbivores. Here we describe a novel type of insect-plant interaction where a carnivorous plant uses such an indirect defence to prevent nutrient loss to kleptoparasites. The ant Camponotus schmitzi is an obligate inhabitant of the carnivorous pitcher plant Nepenthes bicalcarata in Borneo. It has recently been suggested that this ant-plant interaction is a nutritional mutualism, but the detailed mechanisms and the origin of the ant-derived nutrient supply have remained unexplained. We confirm that N. bicalcarata host plant leaves naturally have an elevated N-15/N-14 stable isotope abundance ratio (delta N-15) when colonised by C. schmitzi. This indicates that a higher proportion of the plants' nitrogen is insect-derived when C. schmitzi ants are present (ca. 100%, vs. 77% in uncolonised plants) and that more nitrogen is available to them. We demonstrated direct flux of nutrients from the ants to the host plant in a N-15 pulse-chase experiment. As C. schmitzi ants only feed on nectar and pitcher contents of their host, the elevated foliar delta N-15 cannot be explained by classic ant-feeding (myrmecotrophy) but must originate from a higher efficiency of the pitcher traps. We discovered that C. schmitzi ants not only increase the pitchers' capture efficiency by keeping the pitchers' trapping surfaces clean, but they also reduce nutrient loss from the pitchers by predating dipteran pitcher inhabitants (infauna). Consequently, nutrients the pitchers would have otherwise lost via emerging flies become available as ant colony waste. The plants' prey is therefore conserved by the ants. The interaction between C. schmitzi, N. bicalcarata and dipteran pitcher infauna represents a new type of mutualism where animals mitigate the damage by nutrient thieves to a plant.	[Scharmann, Mathias] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Scharmann, Mathias; Thornham, Daniel G.; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Thornham, Daniel G.] Univ Glamorgan, Div Biol, Pontypridd CF37 1DL, M Glam, Wales; [Grafe, T. Ulmar] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei	University of Wurzburg; University of Cambridge; University of South Wales; University Brunei Darussalam	Scharmann, M (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	mathias.scharmann@env.ethz.ch	Federle, Walter/K-8263-2014	Federle, Walter/0000-0002-6375-3005	Leverhulme Trust [F/09 364/G]; German Academic Exchange Service; BBSRC [BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from the Leverhulme Trust (F/09 364/G; http://www.leverhulme.ac.uk/) to WF, and a scholarship from the German Academic Exchange Service (http://www.daad.de) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Jumaat H., 1997, Pertanika Journal of Tropical Agricultural Science, V20, P121; Adlassnig W, 2011, ANN BOT-LONDON, V107, P181, DOI 10.1093/aob/mcq238; Anderson B, 2002, OECOLOGIA, V132, P369, DOI 10.1007/s00442-002-0998-1; [Anonymous], 2001, FLORA MALESIANA 1; Bauer U, 2012, J EVOLUTION BIOL, V25, P90, DOI 10.1111/j.1420-9101.2011.02406.x; Bauer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038951; Bauer U, 2011, J EXP BOT, V62, P3683, DOI 10.1093/jxb/err082; Bazile V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036179; BEATTIE A, 1989, TRENDS ECOL EVOL, V4, P172, DOI 10.1016/0169-5347(89)90122-5; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Beaver R.A., 1983, P129; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bohn HF, 2012, J COMP PHYSIOL A, V198, P465, DOI 10.1007/s00359-012-0723-4; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Burbidge FW, 1880, GARDENS SUN; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Clarke C., 1997, NEPENTHES OF BORNEO; Clarke CM, 2009, BIOL LETTERS, V5, P632, DOI 10.1098/rsbl.2009.0311; CLARKE CM, 1993, ECOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-2311.1993.tb01074.x; CLARKE CM, 1995, J TROP ECOL, V11, P589, DOI 10.1017/S0266467400009160; Clarke CM, 1992, THESIS U NEW ENGLAND; Cresswell JE, 2000, ECOL ENTOMOL, V25, P362, DOI 10.1046/j.1365-2311.2000.00267.x; Darwin C., 1875, INSECTIVOROUS PLANTS; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; GAY H, 1993, BIOL J LINN SOC, V50, P221, DOI 10.1111/j.1095-8312.1993.tb00928.x; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Karagatzides JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006164; Kato M., 1993, Tropical Zoology, V6, P11; KITCHING R, 1986, NEW SCI, V109, P48; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Merbach MA, 2002, NATURE, V415, P36, DOI 10.1038/415036a; Merbach MA, 2001, FLORA, V196, P153, DOI 10.1016/S0367-2530(17)30030-0; Merbach Marlis A., 2007, Ecotropica-Bonn, V13, P45; Merbach Marlis A., 1999, Ecotropica, V5, P45; MOGI M, 1992, OECOLOGIA, V90, P172, DOI 10.1007/BF00317174; Mogi M, 1996, RAFFLES B ZOOL, V44, P233; Moran JA, 2003, INT J PLANT SCI, V164, P635, DOI 10.1086/375422; Moran JA, 2001, ANN BOT-LONDON, V88, P307, DOI 10.1006/anbo.2001.1460; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474; Moran JA, 1998, INT J PLANT SCI, V159, P996; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oosterbroek P., 1998, FAMILIES DIPTERA MAL; Osunkoya OO, 2008, ANN BOT-LONDON, V102, P845, DOI 10.1093/aob/mcn162; Pavlovic A, 2010, PHOTOSYNTHETICA, V48, P227, DOI 10.1007/s11099-010-0028-1; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; Poppinga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045735; Rotheray Graham E., 2012, Entomologist's Monthly Magazine, V148, P15; SCHULZE ED, 1991, OECOLOGIA, V87, P240, DOI 10.1007/BF00325262; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Sota T, 1998, BIOTROPICA, V30, P82, DOI 10.1111/j.1744-7429.1998.tb00371.x; Starcke A., 1933, Natuurhistorisch Maandblad Maastricht, V22, P29; Starzomski BM, 2010, ECOL ENTOMOL, V35, P53, DOI 10.1111/j.1365-2311.2009.01155.x; Thornham DG, 2012, FUNCT ECOL, V26, P11, DOI 10.1111/j.1365-2435.2011.01937.x; Tofilski A, 2012, DRAWWING INSECTS IDE; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0; Watkins JE, 2008, NEW PHYTOL, V180, P5, DOI 10.1111/j.1469-8137.2008.02606.x; ZAMORA R, 1990, OIKOS, V59, P368, DOI 10.2307/3545148; Zamora R, 1996, J ANIM ECOL, V65, P154, DOI 10.2307/5718	69	21	21	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63556	10.1371/journal.pone.0063556	http://dx.doi.org/10.1371/journal.pone.0063556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717446	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700034
J	Zhang, H; Zhang, Y; Zhao, HS; Zhang, YF; Chen, Q; Peng, HY; Lei, L; Qiao, JQ; Shi, JC; Cao, ZH; Duan, EK; Jin, YP				Zhang, He; Zhang, Ying; Zhao, Huashan; Zhang, Yunfang; Chen, Qi; Peng, Hongying; Lei, Li; Qiao, Jingqiao; Shi, Junchao; Cao, Zhonghong; Duan, Enkui; Jin, Yaping			Hormonal Regulation of Ovarian Bursa Fluid in Mice and Involvement of Aquaporins	PLOS ONE			English	Article							LYMPHATIC STOMATA; GOLDEN-HAMSTER; WATER CHANNELS; REPRODUCTIVE-SYSTEMS; 8-DEFICIENT MICE; OVULATION; RAT; ESTROGEN; FEMALE; IDENTIFICATION	In rodent species, the ovary and the end of oviduct are encapsulated by a thin membrane called ovarian bursa. The biological functions of ovarian bursa remain unexplored despite its structural arrangement in facilitating oocytes transport into oviduct. In the present study, we observed a rapid fluid accumulation and reabsorption within the ovarian bursa after ovarian stimulation (PMSG-primed hCG injection), suggesting that the ovarian bursa might play an active role in regulating local fluid homeostasis around the timing of ovulation. We hypothesized that the aquaporin proteins, which are specialized channels for water transport, might be involved in this process. By screening the expression of aquaporin family members (Aqp1-9) in the ovarian tissue and isolated ovarian bursa (0, 1, 2 and 5 h after hCG injection), we found that AQP2 and AQP5 mRNA showed dynamic changes after hCG treatment, showing upregulation at 1-2 h followed by gradually decrease at 5 h, which is closely related with the intra-bursa fluid dynamics. Further immunofluorescence examinations of AQP2 and AQP5 in the ovarian bursa revealed that AQP2 is specifically localized in the outer layer (peritoneal side) while AQP5 localized in the inner layer (ovarian side) of the bursa, such cell type specific and spatial-temporal expressions of AQP2 and 5 support our hypothesis that they might be involved in efficient water transport through ovarian bursa under ovulation related hormonal regulation. The physiological significance of aquaporin-mediated water transport in the context of ovarian bursa still awaits further clarification.	[Zhang, He; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Zhang, Ying; Zhao, Huashan; Zhang, Yunfang; Chen, Qi; Peng, Hongying; Lei, Li; Qiao, Jingqiao; Shi, Junchao; Cao, Zhonghong; Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Zhao, Huashan; Lei, Li; Cao, Zhonghong] Univ Chinese Acad Sci, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, EK (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn; yapingjin@163.com	cao, zhonghong/AAQ-9968-2020; Shi, Junchao/J-4909-2019; Chen, Qi/K-4059-2019; Chen, Qi/W-1759-2019	Shi, Junchao/0000-0002-1548-5069; Chen, Qi/0000-0001-6353-9589; Zhang, Ying/0000-0003-4082-5026; Cao, Zhonghong/0000-0003-1138-0080	National Basic Research Program of China [2011CB944401, 2011CB710905]; National Natural Science Foundation of China [31200879]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB944401 and 2011CB710905) and National Natural Science Foundation of China (31200879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; GUERRE EF, 1991, FERTIL STERIL, V56, P126; Hausman GJ, 2012, BIOCHIMIE, V94, P2075, DOI 10.1016/j.biochi.2012.02.022; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; Li M, 2007, ANAT REC, V290, P1195, DOI 10.1002/ar.20583; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; McConnell NA, 2002, ENDOCRINOLOGY, V143, P2905, DOI 10.1210/en.143.8.2905; NAKATANI T, 1986, J ANAT, V148, P1; PARR EL, 1974, BIOL REPROD, V11, P504, DOI 10.1095/biolreprod11.5.504; PARR EL, 1974, BIOL REPROD, V11, P483, DOI 10.1095/biolreprod11.5.483; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Sha XY, 2011, ACTA PHARMACOL SIN, V32, P840, DOI 10.1038/aps.2011.45; SHINOHARA H, 1985, ANAT REC, V213, P44, DOI 10.1002/ar.1092130107; SHINOHARA H, 1987, AM J ANAT, V179, P385, DOI 10.1002/aja.1001790408; SHINOHARA H, 1986, J ANAT, V147, P45; Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Su WH, 2010, IUBMB LIFE, V62, P852, DOI 10.1002/iub.398; Sui M H, 2001, Shi Yan Sheng Wu Xue Bao, V34, P291; Sun XL, 2009, FERTIL STERIL, V92, P1736, DOI 10.1016/j.fertnstert.2008.07.1785; Thoroddsen A, 2011, J CLIN ENDOCR METAB, V96, P1021, DOI 10.1210/jc.2010-2545; Van der Hoek KH, 2000, BIOL REPROD, V62, P1059, DOI 10.1095/biolreprod62.4.1059; VANDERHYDEN BC, 1986, J REPROD FERTIL, V77, P393, DOI 10.1530/jrf.0.0770393; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wang ZB, 2010, ANAT REC, V293, P754, DOI 10.1002/ar.21101; Zhang D, 2012, MOL ASPECTS MED, V33, P676, DOI 10.1016/j.mam.2012.02.002; Zou LB, 2011, J CLIN ENDOCR METAB, V96, pE1399, DOI 10.1210/jc.2011-0426	34	14	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63823	10.1371/journal.pone.0063823	http://dx.doi.org/10.1371/journal.pone.0063823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717491	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700066
J	Xiao, YG; Peng, YH; Wan, J; Tang, GY; Chen, YW; Tang, J; Ye, WC; Ip, NY; Shi, L				Xiao, Yangui; Peng, Yinghui; Wan, Jun; Tang, Genyun; Chen, Yuewen; Tang, Jing; Ye, Wen-Cai; Ip, Nancy Y.; Shi, Lei			The Atypical Guanine Nucleotide Exchange Factor Dock4 Regulates Neurite Differentiation through Modulation of Rac1 GTPase and Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; HIPPOCAMPAL-NEURONS; AXONAL OUTGROWTH; RHO-GEFS; FAMILY; PROTEINS; INTERACTS; DISORDER; PHOSPHORYLATION; IDENTIFICATION	Precise regulation of neurite growth and differentiation determines accurate formation of synaptic connections, whose disruptions are frequently associated with neurological disorders. Dedicator of cytokinesis 4 (Dock4), an atypical guanine nucleotide exchange factor for Rac1, is found to be associated with neuropsychiatric diseases, including autism and schizophrenia. Nonetheless, the neuronal function of Dock4 is only beginning to be understood. Using mouse neuroblastoma (Neuro-2a) cells as a model, this study identifies that Dock4 is critical for neurite differentiation and extension. This regulation is through activation of Rac1 and modulation of the dynamics of actin-enriched protrusions on the neurites. In cultured hippocampal neurons, Dock4 regulates the establishment of the axon-dendrite polarity and the arborization of dendrites, two critical processes during neural differentiation. Importantly, a microdeletion Dock4 mutant linked to autism and dyslexia that lacks the GEF domain leads to defective neurite outgrowth and neuronal polarization. Further analysis reveals that the SH3 domain-mediated interaction of Dock4 is required for its activity toward neurite differentiation, whereas its proline-rich C terminus is not essential for this regulation. Together, our findings reveal an important role of Dock4 for neurite differentiation during early neuronal development.	[Xiao, Yangui; Peng, Yinghui; Tang, Genyun; Chen, Yuewen; Ye, Wen-Cai; Ip, Nancy Y.; Shi, Lei] Jinan Univ, Joint Lab Neurosci & Innovat Drug Res, JNU HKUST, Guangzhou 510632, Guangdong, Peoples R China; [Wan, Jun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen 518036, Guangdong, Peoples R China; [Wan, Jun; Chen, Yuewen; Tang, Jing; Ip, Nancy Y.; Shi, Lei] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Chen, Yuewen; Tang, Jing; Ip, Nancy Y.; Shi, Lei] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Clear Water Bay, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Jinan University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Shi, L (corresponding author), JNU HKUST Joint Lab Neurosci & Innovat Drug Res, Rm606,2nd Bldg Sci & Technol,601 Huang Pu Ave, Guangzhou 510632, Guangdong, Peoples R China.	shilei@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Shi, Lei/0000-0001-8695-3432	National Natural Science Foundation of China [81101015]; Research Fund for the Doctoral Program of Higher Education of China [20110001120103]; Fundamental Research Funds for the Central Universities of China [21612205]; Bureau of Science and Information Technology of Guangzhou Municipality [2011J2200048]; Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality [JC201005260217A]; Program of Introducing Talents of Discipline to Universities of China (111 Project) [B13038]; National Program on Key Basic Research Project (973 Program) [2013CB530900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Bureau of Science and Information Technology of Guangzhou Municipality; Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality; Program of Introducing Talents of Discipline to Universities of China (111 Project); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China for Young Scholars Grant 81101015; by Research Fund for the Doctoral Program of Higher Education of China Grant 20110001120103; by Fundamental Research Funds for the Central Universities of China Grant 21612205; by Bureau of Science and Information Technology of Guangzhou Municipality for Young Scholars Grant 2011J2200048; by Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality for Distinguished Young Scholars Grant JC201005260217A; by Program of Introducing Talents of Discipline to Universities of China (111 Project) Grant B13038; and by National Program on Key Basic Research Project (973 Program) Grant 2013CB530900.	Alkelai A, 2012, INT J NEUROPSYCHOPH, V15, P459, DOI 10.1017/S1461145711000903; Biersmith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016120; Chen Q, 2001, AM J PATHOL, V159, P1597, DOI 10.1016/S0002-9440(10)63005-2; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Detera-Wadleigh SD, 2007, PSYCHIAT GENET, V17, P274, DOI 10.1097/YPG.0b013e328133f352; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kanai A, 2008, IUBMB LIFE, V60, P467, DOI 10.1002/iub.67; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; SHEA TB, 1985, DEV BRAIN RES, V21, P307, DOI 10.1016/0165-3806(85)90220-2; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Ueda S, 2013, MOL BIOL CELL, V24, P1602, DOI 10.1091/mbc.E12-11-0782; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006	44	50	50	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20034	20045		10.1074/jbc.M113.458612	http://dx.doi.org/10.1074/jbc.M113.458612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720743	hybrid, Green Published			2022-12-25	WOS:000321515800066
J	Carneiro, J; Duarte-Pereira, S; Azevedo, L; Castro, LFC; Aguiar, P; Moreira, IS; Amorim, A; Silva, RM				Carneiro, Joao; Duarte-Pereira, Sara; Azevedo, Luisa; Castro, L. Filipe C.; Aguiar, Paulo; Moreira, Irina S.; Amorim, Antonio; Silva, Raquel M.			The Evolutionary Portrait of Metazoan NAD Salvage	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; LIFE-SPAN EXTENSION; NICOTINIC-ACID; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; NICOTINAMIDASE; INHIBITION; PHOSPHORIBOSYLTRANSFERASE; METABOLISM; MECHANISM	Nicotinamide Adenine Dinucleotide (NAD) levels are essential for cellular homeostasis and survival. Main sources of intracellular NAD are the salvage pathways from nicotinamide, where Nicotinamide phosphoribosyltransferases (NAMPTs) and Nicotinamidases (PNCs) have a key role. NAMPTs and PNCs are important in aging, infection and disease conditions such as diabetes and cancer. These enzymes have been considered redundant since either one or the other exists in each individual genome. The co-occurrence of NAMPT and PNC was only recently detected in invertebrates though no structural or functional characterization exists for them. Here, using expression and evolutionary analysis combined with homology modeling and protein-ligand docking, we show that both genes are expressed simultaneously in key species of major invertebrate branches and emphasize sequence and structural conservation patterns in metazoan NAMPT and PNC homologues. The results anticipate that NAMPTs and PNCs are simultaneously active, raising the possibility that NAD salvage pathways are not redundant as both are maintained to fulfill the requirement for NAD production in some species.	[Carneiro, Joao; Duarte-Pereira, Sara; Azevedo, Luisa; Amorim, Antonio; Silva, Raquel M.] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Carneiro, Joao; Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Castro, L. Filipe C.] Univ Porto, CIMAR Associate Lab, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal; [Aguiar, Paulo] CMUP, Oporto, Portugal; [Moreira, Irina S.] Univ Porto, Fac Sci, REQUIMTE Rede Quim & Tecnol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Silva, RM (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	raquelsilva@ua.pt	Moreira, Irina/AAU-6975-2021; Moreira, Irina S/K-4711-2012; Amorim, Antonio/A-7938-2008; Silva, Raquel M/B-8337-2008; Aguiar, Paulo/AAD-2462-2020; Azevedo, Luisa/J-4051-2013; Castro, Filipe/AAA-2197-2022; Aguiar, Paulo/J-4106-2013; Carneiro, Joao/A-6289-2009	Moreira, Irina/0000-0003-2970-5250; Moreira, Irina S/0000-0003-2970-5250; Amorim, Antonio/0000-0002-7518-6247; Silva, Raquel M/0000-0001-5926-8042; Aguiar, Paulo/0000-0003-4164-5713; Azevedo, Luisa/0000-0002-3157-7342; Castro, Filipe/0000-0001-7697-386X; Aguiar, Paulo/0000-0003-4164-5713; Carneiro, Joao/0000-0002-5153-2395	Portuguese Foundation for Science and Technology [PTDC/BIA-PRO/099888/2008]; FCT; FCT Ciencia (POPH); FCT Ciencia (QREN); FCT Ciencia (Typology) [4.2]; FCT Ciencia (Promoting Scientific Employment); FCT Ciencia (MES national funding); FCT Ciencia (European Social Fund)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT Ciencia (POPH); FCT Ciencia (QREN); FCT Ciencia (Typology); FCT Ciencia (Promoting Scientific Employment); FCT Ciencia (MES national funding); FCT Ciencia (European Social Fund)	This work was supported by the Portuguese Foundation for Science and Technology (PTDC/BIA-PRO/099888/2008). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science, and is partially supported by FCT. LA and RMS are supported by FCT Ciencia2007 (Hiring of PhDs for the SCTN - financed by POPH - QREN - Typology 4.2 - Promoting Scientific Employment, co-financed by MES national funding and The European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; [Anonymous], 2011, LIGPREP VERS 2 5; [Anonymous], 2009, PRIM VERS 2 1; [Anonymous], 2010, PYMOL MOL GRAPHICS S; Azevedo L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-266; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Burgos ES, 2009, P NATL ACAD SCI USA, V106, P13748, DOI 10.1073/pnas.0903898106; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Drummond AJ, 2011, GENEIOUS V5 5; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jewett MW, 2011, MICROBIOL-SGM, V157, P2831, DOI 10.1099/mic.0.051706-0; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Li YF, 2007, FEMS YEAST RES, V7, P657, DOI 10.1111/j.1567-1364.2007.00231.x; Lin HW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001105; Louis A, 2012, BRIEF FUNCT GENOMICS, V11, P89, DOI 10.1093/bfgp/els003; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Martin PR, 2001, J BACTERIOL, V183, P1168, DOI 10.1128/JB.183.4.1168-1174.2001; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Miller ES, 2003, J BACTERIOL, V185, P5220, DOI 10.1128/JB.185.17.5220-5233.2003; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ocean Genome Legacy, OC GEN RES DAT; Olesen UH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-677; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Seiner DR, 2010, BIOCHEMISTRY-US, V49, P9613, DOI 10.1021/bi1011157; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Silva RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005212; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Takahashi R, 2010, J BIOCHEM, V147, P95, DOI 10.1093/jb/mvp152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wang Z, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-2; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039546; Zhang LY, 2012, EUR J PHARMACOL, V674, P163, DOI 10.1016/j.ejphar.2011.11.017; ZUCKERKANDL EMILE, 1965, P97	66	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64674	10.1371/journal.pone.0064674	http://dx.doi.org/10.1371/journal.pone.0064674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724078	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000079
J	Coelho, HCC; Lopes, SCP; Pimentel, JPD; Nogueira, PA; Costa, FTM; Siqueira, AM; Melo, GC; Monteiro, WM; Malheiro, A; Lacerda, MVG				Coelho, Helena Cristina C.; Lopes, Stefanie C. P.; Pimentel, Joao Paulo D.; Nogueira, Paulo A.; Costa, Fabio T. M.; Siqueira, Andre M.; Melo, Gisely C.; Monteiro, Wuelton M.; Malheiro, Adriana; Lacerda, Marcus V. G.			Thrombocytopenia in Plasmodium vivax Malaria Is Related to Platelets Phagocytosis	PLOS ONE			English	Article							FALCIPARUM-MALARIA; INFECTION; TRANSMISSION; POPULATION; MECHANISMS; CHILDREN; LIMITS	Background: Although thrombocytopenia is a hematological disorder commonly reported in malarial patients, its mechanisms are still poorly understood, with only a few studies focusing on the role of platelets phagocytosis. Methods and Findings: Thirty-five malaria vivax patients and eight healthy volunteers (HV) were enrolled in the study. Among vivax malaria patients, thrombocytopenia (<150,000 platelets/mu L) was found in 62.9% (22/35). Mean platelet volume (MPV) was higher in thrombocytopenic patients as compared to non-thrombocytopenic patients (p = 0.017) and a negative correlation was found between platelet count and MPV (r = -0.483; p = 0.003). Platelets from HV or patients were labeled with 5-chloromethyl fluorescein diacetate (CMFDA), incubated with human monocytic cell line (THP-1) and platelet phagocytosis index was analyzed by flow cytometry. The phagocytosis index was higher in thrombocytopenic patients compared to non-thrombocytopenic patients (p = 0.042) and HV (p = 0.048). A negative correlation was observed between platelet count and phagocytosis index (r = -0.402; p = 0.016). Platelet activation was assessed measuring the expression of P-selectin (CD62-P) in platelets' surface by flow cytometry. No significant difference was found in the expression of P-selectin between thrombocytopenic patients and HV (p = 0.092). After evaluating the cytokine profile (IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma and IL-17) in the patients' sera, levels of IL-6, IL-10 and IFN-gamma were elevated in malaria patients compared to HV. Moreover, IL-6 and IL-10 values were higher in thrombocytopenic patients than non-thrombocytopenic ones (p = 0.044 and p = 0.017, respectively. In contrast, TNF-alpha levels were not different between the three groups, but a positive correlation was found between TNF-alpha and phagocytosis index (r = -0.305; p = 0.037). Conclusion/Significance: Collectively, our findings indicate that platelet phagocytosis may contribute to thrombocytopenia found in vivax malaria. Finally, we believe that this study opens new avenues to explore the mechanisms involved in platelet dysfunction, commonly found in vivax malaria patients.	[Coelho, Helena Cristina C.; Siqueira, Andre M.; Melo, Gisely C.; Lacerda, Marcus V. G.] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Coelho, Helena Cristina C.; Siqueira, Andre M.; Monteiro, Wuelton M.; Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Lopes, Stefanie C. P.; Costa, Fabio T. M.] Univ Estadual Campinas, Sao Paulo, Brazil; [Pimentel, Joao Paulo D.; Nogueira, Paulo A.] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Monteiro, Wuelton M.; Malheiro, Adriana] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Pimentel, Joao Paulo D.; Malheiro, Adriana] Fundacao Hematol & Hemoterapia Amazonas, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz; Universidade Federal de Amazonas	Lacerda, MVG (corresponding author), Univ Estado Amazonas, Manaus, Amazonas, Brazil.	marcuslacerda.br@gmail.com	Costa, Fabio/E-1181-2012; Nogueira, Paulo/AAK-8822-2020; Lopes, Stefanie/A-8314-2012; Siqueira, Andre M/G-1340-2010; melo, gisely/GZK-5350-2022	Costa, Fabio/0000-0001-9969-7300; Nogueira, Paulo/0000-0001-9677-7225; Siqueira, Andre M/0000-0003-2208-0294; Lopes, Stefanie/0000-0002-6981-2192	CAPES; FAPESP fellowship; CNPq; FAPEAM	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM	HCCC received a fellowship from CAPES and SCPL was sponsored by a FAPESP fellowship. MVGL and FTMC are CNPq fellows. FTMC is also a fellow from Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes Estaduais de Saude (PECTI/AM-Saude) from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM, Amazonas - Brazil). This work was supported by CNPq and FAPEAM grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alecrim MGC, 2000, CLIN ASPECTS RESISTA; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Andrade BB, 2011, MEM I OSWALDO CRUZ, V106, P70, DOI 10.1590/S0074-02762011000900009; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Armah Henry, 2005, Int J Environ Res Public Health, V2, P123, DOI 10.3390/ijerph2005010123; Badlou BA, 2006, TRANSFUSION, V46, P1432, DOI 10.1111/j.1537-2995.2006.00913.x; Casals-Pascual C, 2006, AM J TROP MED HYG, V75, P434, DOI 10.4269/ajtmh.2006.75.434; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; de Monbrison F, 2003, T ROY SOC TROP MED H, V97, P387, DOI 10.1016/S0035-9203(03)90065-4; Echeverri Marcela, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P29, DOI 10.1590/S0036-46652003000100006; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Gonzalez B, 2009, INVEST CLIN, V50, P187; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007; Honda S, 2009, AM J TROP MED HYG, V80, P841, DOI 10.4269/ajtmh.2009.80.841; JAFF MS, 1985, J CLIN PATHOL, V38, P1318, DOI 10.1136/jcp.38.11.1318; KELTON JG, 1983, J CLIN INVEST, V71, P832, DOI 10.1172/JCI110836; Klein E, 2012, BLOOD, V119, P910, DOI 10.1182/blood-2011-02-336420; Kochar DK, 2012, J VECTOR DIS, V49, P191; Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Lee SH, 1997, THROMB HAEMOSTASIS, V77, P289; LOOAREESUWAN S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P44; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Park JW, 2003, ANN TROP MED PARASIT, V97, P339, DOI 10.1179/000349803235002416; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; Rogier C, 2004, ARCH DIS CHILD, V89, P795, DOI 10.1136/adc.2003.045179; Saravu K, 2011, ANN TROP MED PARASIT, V105, P593, DOI 10.1179/2047773211Y.0000000013; SKUDOWITZ RB, 1973, BMJ-BRIT MED J, V2, P515, DOI 10.1136/bmj.2.5865.515; Sosman JA, 2000, BRIT J HAEMATOL, V111, P104, DOI 10.1046/j.1365-2141.2000.02314.x; Tacchini-Cottier F, 1998, J IMMUNOL, V160, P6182; Tanwar GS, 2012, PLATELETS, V23, P211, DOI 10.3109/09537104.2011.607520; TOUZE JE, 1990, PATHOL BIOL, V38, P678; Tyagi Padmawati, 1999, Indian Journal of Malariology, V36, P12; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Wroczynska A, 2005, INT MARIT HEALTH, V56, P103; Yamaguchi S, 1997, AM J HEMATOL, V56, P183, DOI 10.1002/(SICI)1096-8652(199711)56:3&lt;183::AID-AJH9&gt;3.0.CO;2-U; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	44	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63410	10.1371/journal.pone.0063410	http://dx.doi.org/10.1371/journal.pone.0063410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723981	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000009
J	Macias, M; Blazejczyk, M; Kazmierska, P; Caban, B; Skalecka, A; Tarkowski, B; Rodo, A; Konopacki, J; Jaworski, J				Macias, Matylda; Blazejczyk, Magdalena; Kazmierska, Paulina; Caban, Bartosz; Skalecka, Agnieszka; Tarkowski, Bartosz; Rodo, Anna; Konopacki, Jan; Jaworski, Jacek			Spatiotemporal Characterization of mTOR Kinase Activity Following Kainic Acid Induced Status Epilepticus and Analysis of Rat Brain Response to Chronic Rapamycin Treatment	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PROTEIN S6 PHOSPHORYLATION; MAMMALIAN TARGET; TUBEROUS-SCLEROSIS; IN-VIVO; MOUSE MODEL; HIPPOCAMPAL-NEURONS; INDUCED SEIZURES; GENE-EXPRESSION; NERVOUS-SYSTEM	Mammalian target of rapamycin (mTOR) is a protein kinase that senses nutrient availability, trophic factors support, cellular energy level, cellular stress, and neurotransmitters and adjusts cellular metabolism accordingly. Adequate mTOR activity is needed for development as well as proper physiology of mature neurons. Consequently, changes in mTOR activity are often observed in neuropathology. Recently, several groups reported that seizures increase mammalian target of rapamycin (mTOR) kinase activity, and such increased activity in genetic models can contribute to spontaneous seizures. However, the current knowledge about the spatiotemporal pattern of mTOR activation induced by proconvulsive agents is rather rudimentary. Also consequences of insufficient mTOR activity on a status epilepticus are poorly understood. Here, we systematically investigated these two issues. We showed that mTOR signaling was activated by kainic acid (KA)-induced status epilepticus through several brain areas, including the hippocampus and cortex as well as revealed two waves of mTOR activation: an early wave (2 h) that occurs in neurons and a late wave that predominantly occurs in astrocytes. Unexpectedly, we found that pretreatment with rapamycin, a potent mTOR inhibitor, gradually (i) sensitized animals to KA treatment and (ii) induced gross anatomical changes in the brain.	[Macias, Matylda; Blazejczyk, Magdalena; Skalecka, Agnieszka; Tarkowski, Bartosz; Jaworski, Jacek] Int Inst Mol & Cell Biol, Lab Mol & Cell Neurobiol, Warsaw, Poland; [Kazmierska, Paulina; Caban, Bartosz; Konopacki, Jan] Univ Lodz, Dept Neurobiol, PL-90131 Lodz, Poland; [Rodo, Anna] Warsaw Univ Life Sci SGGW, Dept Pathol & Vet Diagnost, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Lodz; Warsaw University of Life Sciences	Jaworski, J (corresponding author), Int Inst Mol & Cell Biol, Lab Mol & Cell Neurobiol, Warsaw, Poland.	jaworski@iimcb.gov.pl		Kazmierska-Grebowska, Paulina/0000-0002-3784-6718; Jaworski, Jacek/0000-0001-8760-7865; Tarkowski, Bartosz/0000-0001-8187-1307; Rodo, Anna/0000-0002-3591-3788; Caban, Bartosz/0000-0002-4651-8492; Macias, Matylda/0000-0002-0412-7151; Konopacki, Jan/0000-0003-2814-0550	Polish-Norwegian Research Fund [PNRF - 96 - A I - 1/07, ERA-NET-NEURON/03/2010]; National Centre for Research and Development; FP7-HealthProt [229676]; Polish National Science Center OPUS [2012/05/B/NZ3/00429]	Polish-Norwegian Research Fund; National Centre for Research and Development; FP7-HealthProt; Polish National Science Center OPUS	This work was supported by a Polish-Norwegian Research Fund grant (PNRF - 96 - A I - 1/07), ERA-NET-NEURON/03/2010 grant (co-financed by the National Centre for Research and Development), FP7-HealthProt grant (#229676) and Polish National Science Center OPUS grant (2012/05/B/NZ3/00429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENZYMES; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bostanci MO, 2007, NEUROPHARMACOLOGY, V52, P362, DOI 10.1016/j.neuropharm.2006.08.008; Buckmaster PS, 2011, EPILEPSIA, V52, P2057, DOI 10.1111/j.1528-1167.2011.03253.x; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Deli A, 2012, BEHAV BRAIN RES, V229, P320, DOI 10.1016/j.bbr.2012.01.017; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Gajda Z, 2005, EPILEPSIA, V46, P1581, DOI 10.1111/j.1528-1167.2005.00254.x; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garelick MG, 2011, EXP GERONTOL, V46, P155, DOI 10.1016/j.exger.2010.08.030; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jabs R, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01488.x; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwiatkowski DJ, 2003, CANCER BIOL THER, V2, P471, DOI 10.4161/cbt.2.5.446; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; Malik AR, 2012, BIOCH BIOPHYS ACTA; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Moore CEJ, 2009, J MOL BIOL, V389, P480, DOI 10.1016/j.jmb.2009.04.020; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Park IH, 2002, J BIOL CHEM, V277, P31423, DOI 10.1074/jbc.M204080200; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Paxinos G., 2004, RAT BRAIN STEREOTAXI; POPOVICI T, 1990, BRAIN RES, V536, P183, DOI 10.1016/0006-8993(90)90024-6; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruegg S, 2007, EPILEPSY RES, V77, P85, DOI 10.1016/j.eplepsyres.2007.09.009; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sha LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039152; Shacka JJ, 2007, NEUROSCI LETT, V414, P57, DOI 10.1016/j.neulet.2006.12.025; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sliwa A, 2011, NEUROSCI LETT; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Willoughby JO, 1997, NEUROSCIENCE, V77, P379, DOI 10.1016/S0306-4522(96)00462-9; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2010, CELL CYCLE, V9, P2281, DOI 10.4161/cc.9.12.11866; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zinzalla V, 2010, ENZYMES, V27, P1, DOI 10.1016/S1874-6047(10)27001-4	72	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64455	10.1371/journal.pone.0064455	http://dx.doi.org/10.1371/journal.pone.0064455			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724051	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000058
J	Yanai, G; Hayashi, T; Zhi, Q; Yang, KC; Shirouzu, Y; Shimabukuro, T; Hiura, A; Inoue, K; Sumi, S				Yanai, Goichi; Hayashi, Takashi; Zhi, Qi; Yang, Kai-Chiang; Shirouzu, Yasumasa; Shimabukuro, Takashi; Hiura, Akihito; Inoue, Kazutomo; Sumi, Shoichiro			Electrofusion of Mesenchymal Stem Cells and Islet Cells for Diabetes Therapy: A Rat Model	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; INSULIN-SECRETION; FOLLOW-UP; IN-VIVO; TRANSPLANTATION; FUSION; APOPTOSIS; HYBRIDIZATION; MIGRATION	Islet transplantation is a minimally invasive treatment for severe diabetes. However, it often requires multiple donors to accomplish insulin-independence and the long-term results are not yet satisfying. Therefore, novel ways to overcome these problems have been explored. Isolated islets are fragile and susceptible to pro-apoptotic factors and poorly proliferative. In contrast, mesenchymal stem cells (MSCs) are highly proliferative, anti-apoptotic and pluripotent to differentiate toward various cell types, promote angiogenesis and modulate inflammation, thereby studied as an enhancer of islet function and engraftment. Electrofusion is an efficient method of cell fusion and nuclear reprogramming occurs in hybrid cells between different cell types. Therefore, we hypothesized that electrofusion between MSC and islet cells may yield robust islet cells for diabetes therapy. We establish a method of electrofusion between dispersed islet cells and MSCs in rats. The fusion cells maintained glucose-responsive insulin release for 20 days in vitro. Renal subcapsular transplantation of fusion cells prepared from suboptimal islet mass (1,000 islets) that did not correct hyperglycemia even if co-transplanted with MSCs, caused slow but consistent lowering of blood glucose with significant weight gain within the observation period in streptozotocin-induced diabetic rats. In the fusion cells between rat islet cells and mouse MSCs, RT-PCR showed new expression of both rat MSC-related genes and mouse beta-cell-related genes, indicating bidirectional reprogramming of both beta-cell and MSCs nuclei. Moreover, decreased caspase3 expression and new expression of Ki-67 in the islet cell nuclei suggested alleviated apoptosis and gain of proliferative capability, respectively. These results show that electrofusion between MSCs and islet cells yield special cells with beta-cell function and robustness of MSCs and seems feasible for novel therapeutic strategy for diabetes mellitus.	[Yanai, Goichi; Shirouzu, Yasumasa; Hiura, Akihito; Sumi, Shoichiro] Kyoto Univ, Inst Frontier Med Sci, Dept Organ Reconstruct, Kyoto, Japan; [Hayashi, Takashi] Gakkentoshi Hosp, Kyoto, Japan; [Zhi, Qi] Nankai Univ, Sch Med, Dept Histol & Embryol, Tianjin 300071, Peoples R China; [Yang, Kai-Chiang] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan; [Shimabukuro, Takashi] Takeda Biohlth Res Ctr, Kyoto, Japan; [Inoue, Kazutomo] Inoue Clin Diabet Ctr, Kyoto, Japan	Kyoto University; Nankai University; Taipei Medical University	Sumi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Organ Reconstruct, Kyoto, Japan.	sumi@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science [18390364]; Japan Science and Technology Agency (Core Research for Evolutional Science and Technology) [100083300006]; Grants-in-Aid for Scientific Research [25461943] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (Core Research for Evolutional Science and Technology)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (B), No. 18390364) and Japan Science and Technology Agency (Core Research for Evolutional Science and Technology, No. 100083300006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Augello A, 2010, EUR CELLS MATER, V20, P121; Barrera-Escorcia E, 2005, BIOMED PHARMACOTHER, V59, P275, DOI 10.1016/j.biopha.2004.11.011; Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731; Bell GI, 2012, STEM CELLS DEV, V21, P97, DOI 10.1089/scd.2010.0583; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Berney T, 2001, TRANSPLANTATION, V71, P125, DOI 10.1097/00007890-200101150-00020; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dittmar T, 2006, CONTRIB MICROBIOL, V13, P156, DOI 10.1159/000092971; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; InternationalGas Union (IGU), 2011, GUID GAS INT GAS QUA, P23; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; Maltman DJ, 2011, NEUROCHEM INT, V59, P347, DOI 10.1016/j.neuint.2011.06.008; Merani S, 2006, CLIN SCI, V110, P611, DOI 10.1042/CS20050342; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mortaza B, 2003, PNAS, V100, P5840; OKADA Y, 1963, EXP CELL RES, V32, P417, DOI 10.1016/0014-4827(63)90182-4; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Qi Z, 2010, BIOMATERIALS, V31, P4026, DOI 10.1016/j.biomaterials.2010.01.088; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sally AB, 2012, STEM CELLS INT, V2012, P1; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Szegezdi E, 2009, J CELL MOL MED, V13, P4409, DOI 10.1111/j.1582-4934.2008.00522.x; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tanaka H, 2002, CELL IMMUNOL, V220, P1, DOI 10.1016/S0008-8749(03)00009-1; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; Vignery Agnes, 2008, V475, P149, DOI 10.1007/978-1-59745-250-2_9; ZIMMERMANN U, 1982, BIOCHIM BIOPHYS ACTA, V694, P227, DOI 10.1016/0304-4157(82)90007-7	41	24	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64499	10.1371/journal.pone.0064499	http://dx.doi.org/10.1371/journal.pone.0064499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724055	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000062
J	Li, JM; Darlak, KA; Southerland, L; Hossain, MS; Jaye, DL; Josephson, CD; Rosenthal, H; Waller, EK				Li, Jian-Ming; Darlak, Kasia A.; Southerland, Lauren; Hossain, Mohammad S.; Jaye, David L.; Josephson, Cassandra D.; Rosenthal, Hilary; Waller, Edmund K.			VIPhyb, an Antagonist of Vasoactive Intestinal Peptide Receptor, Enhances Cellular Antiviral Immunity in Murine Cytomegalovirus Infected Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; DENDRITIC CELLS; IN-VIVO; SIGNALING PATHWAYS; VIRAL-INFECTION	Vasoactive intestinal peptide (VIP) is a neuropeptide hormone that suppresses Th1-mediated cellular immunity. We previously reported that VIP-knockout (VIP-KO) mice have enhanced cellular immune responses and increased survival following murine cytomegalovirus (mCMV) infection in C57BL/6 mice. In this study, we tested whether treatment with a VIP receptor antagonistic peptide protects C57BL/6 and BALB/c mice from mCMV-infection. One week of daily subcutaneous injections of VIPhyb was non-toxic and did not alter frequencies of immune cell subsets in non-infected mice. VIPhyb administration to mCMV-infected C57BL/6 and BALB/c mice markedly enhanced survival, viral clearance, and reduced liver and lung pathology compared with saline-treated controls. The numbers of effector/memory CD8+ T-cells and mature NK cells were increased in VIPhyb-treated mice compared with PBS-treated groups. Pharmacological blockade of VIP-receptor binding or genetic blockade of VIP-signaling prevented the up-regulation of PD-L1 and PD-1 expression on DC and activated CD8(+) T-cells, respectively, in mCMV-infected mice, and enhanced CD80, CD86, and MHC-II expression on conventional and plasmacytoid DC. VIPhyb-treatment increased type-I IFN synthesis, numbers of IFN-gamma- and TNF-alpha-expressing NK cells and T-cells, and the numbers of mCMV-M45 epitope-peptide-MHC-I tetramer CD8(+) T-cells following mCMV infection. VIP-treatment lowered the percentage of Treg cells in spleens compared with PBS-treated WT mice following mCMV infection, while significantly decreasing levels of serum VEGF induced by mCMV-infection. The mice in all treated groups exhibited similar levels of anti-mCMV antibody titers. Short-term administration of a VIP-receptor antagonist represents a novel approach to enhance innate and adaptive cellular immunity in a murine model of CMV infection.	[Li, Jian-Ming; Darlak, Kasia A.; Hossain, Mohammad S.; Rosenthal, Hilary; Waller, Edmund K.] Emory Univ, Dept Hematol Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Southerland, Lauren] Duke Univ, Sch Med, Durham, NC USA; [Jaye, David L.] Emory Univ, Dept Pathol & Lab Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Josephson, Cassandra D.] Emory Univ, Dept Pathol & Pediat, Atlanta, GA 30322 USA	Emory University; Duke University; Emory University; Emory University	Waller, EK (corresponding author), Emory Univ, Dept Hematol Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	ewaller@emory.edu	Josephson, Cassandra/AFS-2243-2022; Waller, Edmund K/AAP-3055-2020	jaye, david/0000-0001-7977-6909; Southerland, Lauren/0000-0002-3561-8332	National Institutes of Health [R01 CA-74364-03]; When Everyone Survives Foundation; Emory University Research Council; NATIONAL CANCER INSTITUTE [R01CA074364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); When Everyone Survives Foundation; Emory University Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA-74364-03 (to E.K.W.). J.M.L. was supported by a research grant from the When Everyone Survives Foundation and the Emory University Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Allie SR, 2011, J IMMUNOL, V186, P6280, DOI 10.4049/jimmunol.1003870; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Chorny A, 2006, BLOOD, V107, P3787, DOI 10.1182/blood-2005-11-4495; Chorny A, 2006, REGUL PEPTIDES, V137, P67, DOI 10.1016/j.regpep.2006.04.021; Collado B, 2004, REGUL PEPTIDES, V119, P69, DOI 10.1016/j.regpep.2004.01.013; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Delgado M, 2005, J LEUKOCYTE BIOL, V78, P1327, DOI 10.1189/jlb.0605299; Delgado M, 2004, J LEUKOCYTE BIOL, V75, P1122, DOI 10.1189/jlb.1203626; Delgado M, 2001, J IMMUNOL, V166, P2907, DOI 10.4049/jimmunol.166.5.2907; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2000, EUR J IMMUNOL, V30, P3236, DOI 10.1002/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L; Delgado M, 2009, HUM IMMUNOL, V70, P300, DOI 10.1016/j.humimm.2009.01.020; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; DOWLING JN, 1976, J INFECT DIS, V133, P399, DOI 10.1093/infdis/133.4.399; Eddleston M, 1997, CLIN INFECT DIS, V24, P52, DOI 10.1093/clinids/24.1.52; El Zein N, 2008, J LEUKOCYTE BIOL, V83, P972, DOI 10.1189/jlb.0507327; ESKAY RL, 1992, ENDOCRINOLOGY, V130, P2252, DOI 10.1210/en.130.4.2252; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Farrell HE, 1999, IMMUNOL REV, V168, P187, DOI 10.1111/j.1600-065X.1999.tb01293.x; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Giver CR, 2003, BIOL BLOOD MARROW TR, V9, P616, DOI 10.1016/S1083-8791(03)00229-5; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; GOZES I, 1995, J PHARMACOL EXP THER, V273, P161; GOZES Y, 1991, BRAIN RES, V540, P319, DOI 10.1016/0006-8993(91)90528-4; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hossain MS, 2008, J IMMUNOL, V180, P6892, DOI 10.4049/jimmunol.180.10.6892; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; HUDSON JB, 1979, ARCH VIROL, V62, P1, DOI 10.1007/BF01314900; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; JORDAN MC, 1983, INFECT IMMUN, V41, P841, DOI 10.1128/IAI.41.2.841-843.1983; Langston A, 2007, BLOOD; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Li JM, 2013, BLOOD, V121, P2347, DOI 10.1182/blood-2012-06-437640; Li JM, 2011, J IMMUNOL, V187, P1057, DOI 10.4049/jimmunol.1100686; Li JM, 2009, J IMMUNOL, V183, P7799, DOI 10.4049/jimmunol.0900155; Liu ZX, 2000, J IMMUNOL, V164, P6480, DOI 10.4049/jimmunol.164.12.6480; McGregor Alistair, 2010, Inflammation & Allergy Drug Targets, V9, P286; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Moody TW, 2004, LIFE SCI, V74, P1345, DOI 10.1016/j.lfs.2003.07.043; ODORISIO MS, 1985, J IMMUNOL, V134, P4078; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Ozdemir E, 2002, BLOOD, V100, P3690, DOI 10.1182/blood-2002-05-1387; Rameshwar P, 2002, EXP HEMATOL, V30, P1001, DOI 10.1016/S0301-472X(02)00875-5; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; REYNOLDS RP, 1993, LAB ANIM SCI, V43, P291; Roback JD, 2003, J IMMUNOL, V171, P6023, DOI 10.4049/jimmunol.171.11.6023; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; SENA M, 1994, DNA SEQUENCE, V5, P25, DOI 10.3109/10425179409039701; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Streblow DN, 2003, TRENDS MICROBIOL, V11, P293, DOI 10.1016/S0966-842X(03)00149-5; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Suzuki H, 2010, EUR J IMMUNOL, V40, P197, DOI 10.1002/eji.200939887; Symes A, 1997, J BIOL CHEM, V272, P9648; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TURNER JT, 1986, PEPTIDES, V7, P849, DOI 10.1016/0196-9781(86)90105-1; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Varela N, 2007, EXPERT OPIN BIOL TH, V7, P461, DOI 10.1517/14712598.7.4.461; Vassiliou E, 2001, Arch Physiol Biochem, V109, P365, DOI 10.1076/apab.109.4.365.4245; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wada J, 2009, ANTICANCER RES, V29, P881; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; WEINER RS, 1986, ANN INTERN MED, V104, P168, DOI 10.7326/0003-4819-104-2-168; ZOMAS A, 1994, BONE MARROW TRANSPL, V14, P799	81	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63381	10.1371/journal.pone.0063381	http://dx.doi.org/10.1371/journal.pone.0063381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723978	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100007
J	Hurst, RE; Hauser, PJ; Kyker, KD; Heinlen, JE; Hodde, JP; Hiles, MC; Kosanke, SD; Dozmorov, M; Ihnat, MA				Hurst, Robert E.; Hauser, Paul J.; Kyker, Kimberly D.; Heinlen, Jonathan E.; Hodde, Jason P.; Hiles, Michael C.; Kosanke, Stanley D.; Dozmorov, Mikhail; Ihnat, Michael A.			Suppression and Activation of the Malignant Phenotype by Extracellular Matrix in Xenograft Models of Bladder Cancer: A Model for Tumor Cell "Dormancy"	PLOS ONE			English	Article							RESISTANCE; PROLIFERATION; EXPRESSION; CARCINOMA; BIOLOGY; GENES	A major problem in cancer research is the lack of a tractable model for delayed metastasis. Herein we show that cancer cells suppressed by SISgel, a gel-forming normal ECM material derived from Small Intestine Submucosa (SIS), in flank xenografts show properties of suppression and re-activation that are very similar to normal delayed metastasis and suggest these suppressed cells can serve as a novel model for developing therapeutics to target micrometastases or suppressed cancer cells. Co-injection with SISgel suppressed the malignant phenotype of highly invasive J82 bladder cancer cells and highly metastatic JB-V bladder cancer cells in nude mouse flank xenografts. Cells could remain viable up to 120 days without forming tumors and appeared much more highly differentiated and less atypical than tumors from cells co-injected with Matrigel. In 40% of SISgel xenografts, growth resumed in the malignant phenotype after a period of suppression or dormancy for at least 30 days and was more likely with implantation of 3 million or more cells. Ordinary Type I collagen did not suppress malignant growth, and tumors developed about as well with collagen as with Matrigel. A clear signal in gene expression over different cell lines was not seen by transcriptome microarray analysis, but in contrast, Reverse Phase Protein Analysis of 250 proteins across 4 cell lines identified Integrin Linked Kinase (ILK) signaling that was functionally confirmed by an ILK inhibitor. We suggest that cancer cells suppressed on SISgel could serve as a model for dormancy and re-awakening to allow for the identification of therapeutic targets for treating micrometastases.	[Hurst, Robert E.; Hauser, Paul J.; Kyker, Kimberly D.; Heinlen, Jonathan E.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Urol, Oklahoma City, OK 73190 USA; [Hurst, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Coll Med, Oklahoma City, OK 73190 USA; [Ihnat, Michael A.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Physiol, Oklahoma City, OK 73190 USA; [Hurst, Robert E.; Ihnat, Michael A.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA; [Kosanke, Stanley D.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Pathol, Oklahoma City, OK 73190 USA; [Ihnat, Michael A.] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Hodde, Jason P.; Hiles, Michael C.] Cook Biotech Inc, W Lafayette, IN USA; [Hurst, Robert E.; Hauser, Paul J.; Kyker, Kimberly D.; Ihnat, Michael A.] DormaTarg Inc, Oklahoma City, OK USA; [Dozmorov, Mikhail] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Hurst, RE (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Urol, Oklahoma City, OK 73190 USA.	Robert-hurst@ouhsc.edu	Dozmorov, Mikhail/B-1374-2009	Dozmorov, Mikhail/0000-0002-0086-8358; Hurst, Robert/0000-0003-0370-1817	Cook Biotech; Stephenson Cancer Center (REH);  [R01CA75322];  [R01DK69808];  [R01 CA136944];  [R43 CA135867];  [R43CA139804]; NATIONAL CANCER INSTITUTE [R01CA136944, R44CA135867, R43CA139804, R43CA135867, R01CA075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069808] Funding Source: NIH RePORTER	Cook Biotech; Stephenson Cancer Center (REH); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by research grants R01CA75322, R01DK69808, a grant from Cook Biotech and a grant from the Stephenson Cancer Center (REH); R01 CA136944 and R43 CA135867(MAI) and R43CA139804 (PJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling CL, 2001, CURR PROB CANCER, V25, P219; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dozmorov MG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-12; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hockel A, 2005, CANCER RES, V65, P2997; Hoffman RM, 2008, APMIS, V116, P716, DOI 10.1111/j.1600-0463.2008.01036.x; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hurst RE, 2005, CANCER LETT, V217, P171, DOI 10.1016/j.canlet.2004.07.043; Hurst RE, 2003, ANTICANCER RES, V23, P3119; Hurst RE, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-13; IOZZO RV, 1995, LAB INVEST, V73, P157; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knowlton N, 2006, IEE P SYST BIOL, V153, P4, DOI 10.1049/ip-syb:20050020; Leung CT, 2012, NATURE; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Muschler J, 1999, MOL BIOL CELL, V10, P2817, DOI 10.1091/mbc.10.9.2817; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Quesnel B, 2008, CANCER LETT, V267, P10, DOI 10.1016/j.canlet.2008.02.055; RAO JY, 1993, P NATL ACAD SCI USA, V90, P8287, DOI 10.1073/pnas.90.17.8287; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Saudemont A, 2005, BLOOD, V105, P2428, DOI 10.1182/blood-2004-09-3458; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Vessella RL, 2007, CANC BIOL THER, P6; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P561; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144	35	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64181	10.1371/journal.pone.0064181	http://dx.doi.org/10.1371/journal.pone.0064181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717563	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300024
J	Leeper, NJ; Bauer-Mehren, A; Iyer, SV; LePendu, P; Olson, C; Shah, NH				Leeper, Nicholas J.; Bauer-Mehren, Anna; Iyer, Srinivasan V.; LePendu, Paea; Olson, Cliff; Shah, Nigam H.			Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; INTERMITTENT CLAUDICATION; TRIAL; RISK; ATHEROTHROMBOSIS; MORTALITY; AWARENESS; SURVIVAL; PLACEBO; WOMEN	Background: Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mortality. To assess the validity of this black box warning, we employed a novel text-analytics pipeline to quantify the adverse events associated with Cilostazol use in a clinical setting, including patients with congestive heart failure (CHF). Methods and Results: We analyzed the electronic medical records of 1.8 million subjects from the Stanford clinical data warehouse spanning 18 years using a novel text-mining/statistical analytics pipeline. We identified 232 PAD patients taking Cilostazol and created a control group of 1,160 PAD patients not taking this drug using 1: 5 propensity-score matching. Over a mean follow up of 4.2 years, we observed no association between Cilostazol use and any major adverse cardiovascular event including stroke (OR = 1.13, CI [0.82, 1.55]), myocardial infarction (OR = 1.00, CI [0.71, 1.39]), or death (OR = 0.86, CI [0.63, 1.18]). Cilostazol was not associated with an increase in any arrhythmic complication. We also identified a subset of CHF patients who were prescribed Cilostazol despite its black box warning, and found that it did not increase mortality in this high-risk group of patients. Conclusions: This proof of principle study shows the potential of text-analytics to mine clinical data warehouses to uncover 'natural experiments' such as the use of Cilostazol in CHF patients. We envision this method will have broad applications for examining difficult to test clinical hypotheses and to aid in post-marketing drug safety surveillance. Moreover, our observations argue for a prospective study to examine the validity of a drug safety warning that may be unnecessarily limiting the use of an efficacious therapy.	[Leeper, Nicholas J.] Stanford Univ, Div Vasc Surg, Stanford, CA 94305 USA; [Leeper, Nicholas J.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Bauer-Mehren, Anna; Iyer, Srinivasan V.; LePendu, Paea; Shah, Nigam H.] Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Olson, Cliff] Palo Alto Med Fdn, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute	Bauer-Mehren, A (corresponding author), Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA.	anna.bauermehren@stanford.edu; nigam@stanford.edu		LePendu, Paea/0000-0001-7358-931X	National Institutes of Health (NIH) [U54 HG004028]; Department of Medicine of the Stanford University; NIH [K12 HL087746]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine of the Stanford University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	ABM, PLP and NHS acknowledge support from the National Institutes of Health (NIH) grant U54 HG004028 for the National Center for Biomedical Ontology, and the Department of Medicine of the Stanford University. NJL acknowledges support from the NIH grant K12 HL087746. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez Luis Javier, 2009, Med Clin (Barc), V132 Suppl 2, P25, DOI 10.1016/S0025-7753(09)71749-X; [Anonymous], 2007, WORKSH BIONLP 2007 B, P1; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chi YW, 2008, VASC HEALTH RISK MAN, V4, P1197, DOI 10.2147/VHRM.S3160; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Frankovich J, 2011, NEW ENGL J MED, V365, P1758, DOI 10.1056/NEJMp1108726; GAIL MH, 1981, BIOMETRIKA, V68, P703, DOI 10.1093/biomet/68.3.703; Hiatt WR, 2008, J VASC SURG, V47, P330, DOI 10.1016/j.jvs.2007.10.009; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; LePendu P, 2013, PHARMACOVIGILANCE US; Lependu Paea, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P63; Lependu Paea, 2012, J Biomed Semantics, V3 Suppl 1, pS5, DOI 10.1186/2041-1480-3-S1-S5; Liu Yi, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P47; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; Marshall MS, 2012, J WEB SEMANT, V14, P2, DOI 10.1016/j.websem.2012.02.003; McDermott MM, 2003, J GEN INTERN MED, V18, P461, DOI 10.1046/j.1525-1497.2003.20527.x; Mechtouff L, 2010, J INTERN MED, V267, P621, DOI 10.1111/j.1365-2796.2009.02198.x; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Pande RL, 2010, VASC MED, V15, P181, DOI 10.1177/1358863X10361545; Parai Gautam K, 2010, AMIA Annu Symp Proc, V2010, P587; Pratt CM, 2001, AM J CARDIOL, V87, p28D; Regensteiner JG, 2008, VASC MED, V13, P15, DOI 10.1177/1358863X07084911; Reilly MP, 2001, ANN PHARMACOTHER, V35, P48; Robless P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub3; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sekhon J, 2011, J STAT SOFTWARE, V42; Shah NH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S14; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Thernau T, 2012, PACKAGE SURVIVAL ANA; Thompson PD, 2002, AM J CARDIOL, V90, P1314, DOI 10.1016/S0002-9149(02)02869-2; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wilson AM, 2011, J VASC SURG, V54, P427, DOI 10.1016/j.jvs.2011.02.052; Wu ST, 2012, J AM MED INFORM ASS; Xu Rong, 2010, AMIA Annu Symp Proc, V2010, P907	38	49	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63499	10.1371/journal.pone.0063499	http://dx.doi.org/10.1371/journal.pone.0063499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717437	gold, Green Submitted, Green Published			2022-12-25	WOS:000319435600020
J	Shugart, JA; Bambina, S; Alice, AF; Montler, R; Bahjat, KS				Shugart, Jessica A.; Bambina, Shelly; Alice, Alejandro F.; Montler, Ryan; Bahjat, Keith S.			A Self-Help Program for Memory CD8+T Cells: Positive Feedback via CD40-CD40L Signaling as a Critical Determinant of Secondary Expansion	PLOS ONE			English	Article							CD8(+) T-CELLS; DENDRITIC CELLS; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; COSTIMULATION; POTENCY; ACTIVATION; INITIATION; VACCINES; REQUIRES	The ability of memory CD8+ T cells to rapidly proliferate and acquire cytolytic activity is critical for protective immunity against intracellular pathogens. The signals that control this recall response remain unclear. We show that CD40L production by memory CD8+ T cells themselves is an essential catalyst for secondary expansion when systemic inflammation is limited. Secondary immunization accompanied by high levels of systemic inflammation results in CD8+ T cell secondary expansion independent of CD4+ T cells and CD40-CD40L signaling. Conversely, when the inflammatory response is limited, memory CD8+ T cell secondary expansion requires CD40L-producing cells, and memory CD8+ T cells can provide this signal. These results demonstrate that vaccination regimens differ in their dependence on CD40L-expressing CD8+ T cells for secondary expansion, and propose that CD40L-expression by CD8+ T cells is a fail-safe mechanism that can promote memory CD8+ T cell secondary expansion when inflammation is limited.	[Shugart, Jessica A.; Bambina, Shelly; Alice, Alejandro F.; Montler, Ryan; Bahjat, Keith S.] Providence Canc Ctr, Robert W Franz Canc Res Ctr, Earle A Chiles Res Inst, Portland, OR USA		Bahjat, KS (corresponding author), Providence Canc Ctr, Robert W Franz Canc Res Ctr, Earle A Chiles Res Inst, Portland, OR USA.	keith.bahjat@providence.org			Providence Portland Medical Foundation	Providence Portland Medical Foundation	This work was funded by the Providence Portland Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi K, 2006, SCAND J IMMUNOL, V64, P83, DOI 10.1111/j.1365-3083.2006.01767.x; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Bahjat KS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000568; Bertram EM, 2004, J IMMUNOL, V172, P981, DOI 10.4049/jimmunol.172.2.981; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Dawicki W, 2004, J IMMUNOL, V173, P5944, DOI 10.4049/jimmunol.173.10.5944; Devriendt B, 2012, EUR J PHARM BIOPHARM; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Garidou L, 2009, J VIROL, V83, P8905, DOI 10.1128/JVI.00027-09; Hernandez MGH, 2007, J IMMUNOL, V178, P2844, DOI 10.4049/jimmunol.178.5.2844; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Le DT, 2011, CLIN CANC RES; Leong ML, 2009, INFECT IMMUN, V77, P3958, DOI 10.1128/IAI.01274-08; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Maciag PC, 2009, VACCINE, V27, P3975, DOI 10.1016/j.vaccine.2009.04.041; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Malarkannan S, 2000, METH MOL B, V156, P265; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Ryu SJ, 2009, BLOOD, V113, P4273, DOI 10.1182/blood-2008-09-181263; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; THOMPSON CH, 1992, J MED VIROL, V36, P54, DOI 10.1002/jmv.1890360111; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Whitmire JK, 1999, J IMMUNOL, V163, P3194; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Wong KL, 2009, J IMMUNOL, V183, P41, DOI 10.4049/jimmunol.0803473	39	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64878	10.1371/journal.pone.0064878	http://dx.doi.org/10.1371/journal.pone.0064878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717671	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600079
J	Lee, YY; Veerman, JL; Barendregt, JJ				Lee, Yong Yi; Veerman, J. Lennert; Barendregt, Jan J.			The Cost-Effectiveness of Laparoscopic Adjustable Gastric Banding in the Morbidly Obese Adult Population of Australia	PLOS ONE			English	Article							INDUCED WEIGHT-LOSS; BARIATRIC SURGERY; MANAGEMENT; OVERWEIGHT; BYPASS; IMPACT	Background: To examine the cost-effectiveness of providing laparoscopic adjustable gastric banding (LAGB) surgery to all morbidly obese adults in the 2003 Australian population. Methods and Findings: Analyzed costs and benefits associated with two intervention scenarios, one providing LAGB surgery to individuals with BMI>40 and another to individuals with BMI>35, with each compared relative to a 'do nothing' scenario. A multi-state, multiple cohort Markov model was used to determine the cost-effectiveness of LAGB surgery over the lifetime of each cohort. All costs and health outcomes were assessed from an Australian health sector perspective and were discounted using a 3% annual rate. Uncertainty and sensitivity analyzes were conducted to test the robustness of model outcomes. Incremental cost-effectiveness ratios (ICERs) were measured in 2003 Australian dollars per disability adjusted life year (DALY) averted. The ICER for the scenario providing LAGB surgery to all individuals with a BMI>40 was dominant [95% CI: dominant -$588] meaning that the intervention led to both improved health and cost savings. The ICER when providing surgery to those with a BMI>35 was $2 154/DALY averted [95% CI: dominant -$6 033]. Results were highly sensitive to changes in the likelihood of long-term complications. Conclusion: LAGB surgery is highly cost-effective when compared to the $50 000/DALY threshold for cost-effectiveness used in Australia. LAGB surgery also ranks highly in terms of cost-effectiveness when compared to other population-level interventions for weight loss in Australia. The results of this study are in line with other economic evaluations on LAGB surgery. This study recommends that the Australian federal government provide a full subsidy for LAGB surgery to morbidly obese Australians with a BMI>40.	[Lee, Yong Yi; Veerman, J. Lennert; Barendregt, Jan J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Queensland	Lee, YY (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	y.lee5@uq.edu.au	Veerman, Lennert/A-9973-2011; Barendregt, Jan J/F-6895-2010; Lee, Yong Yi/C-1373-2015	Veerman, Lennert/0000-0002-3206-8232; Lee, Yong Yi/0000-0003-2359-6823	National Health and Medical Research Council [351558]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The ACE Prevention study was funded by a National Health and Medical Research Council grant (no. 351558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2008, OV OB AD AUSTR 2004; Ackroyd R, 2006, OBES SURG, V16, P1488, DOI 10.1381/096089206778870067; AIHW, 2007, HLTH EXP AUSTR 2005; AIHW, 2001, DIS COSTS IMP STUD D; AIHW, 2005, HLTH EXP AUSTR 2003; Ananthapavan J, 2010, SURG OBES RELAT DIS, V6, P377, DOI 10.1016/j.soard.2010.02.040; Anselmino M, 2009, OBES SURG, V19, P1542, DOI 10.1007/s11695-009-9946-z; Barendregt J J, 1998, Math Popul Stud, V7, P29; Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274; Begg S., 2007, BURDEN DIS INJURY AU; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Campbell J, 2010, AM J MANAG CARE, V16, pE174; Carelli AM, 2010, SURG ENDOSC, V24, P1819, DOI 10.1007/s00464-009-0858-8; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Garb J, 2009, OBES SURG, V19, P1447, DOI 10.1007/s11695-009-9927-2; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Haby M., 2008, FUTURE PREVALENCE OV; Haby MM, 2011, FUTURE PREDICTIONS B; Hofmann B, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265161.2010.528509; Kaplan LM, 2010, GASTROENTEROL CLIN N, V39, P69, DOI 10.1016/j.gtc.2010.01.001; Keating CL, 2009, DIABETES CARE, V32, P580, DOI 10.2337/dc08-1748; Keating CL, 2009, DIABETES CARE, V32, P567, DOI 10.2337/dc08-1749; Lanthaler M, 2010, OBES SURG, V20, P1078, DOI 10.1007/s11695-010-0190-3; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Lopez AD, 2004, COMP QUANTIFICATION, P497; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P127; Millar JA, 2007, PHARMACOECONOMICS, V25, P429, DOI 10.2165/00019053-200725050-00006; Moodie M, 2008, ECON HUM BIOL, V6, P363, DOI 10.1016/j.ehb.2008.06.001; Morgenstern H, 1982, J Community Health, V7, P292, DOI 10.1007/BF01318961; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; NICE, 2006, OB PREV ID ASS MAN O; O'Brien PE, 2013, ANN SURG, V257, P87, DOI 10.1097/SLA.0b013e31827b6c02; O'Brien PE, 2005, MED J AUSTRALIA, V183, P310, DOI 10.5694/j.1326-5377.2005.tb07061.x; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Salem L, 2008, SURG OBES RELAT DIS, V4, P26, DOI 10.1016/j.soard.2007.09.009; Suter M, 2006, OBES SURG, V16, P829, DOI 10.1381/096089206777822359; van Mastrigt GAPG, 2006, OBES SURG, V16, P75, DOI 10.1381/096089206775222113; Veerman L., 2010, ASSESSING COST EFFEC	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64965	10.1371/journal.pone.0064965	http://dx.doi.org/10.1371/journal.pone.0064965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717680	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700186
J	Noh, JY; Song, JY; Cheong, HJ; Choi, WS; Lee, J; Lee, JS; Wie, SH; Jeong, HW; Kim, YK; Choi, SH; Han, SB; So, BH; Kim, H; Kim, WJ				Noh, Ji Yun; Song, Joon Young; Cheong, Hee Jin; Choi, Won Suk; Lee, Jacob; Lee, Jin-Soo; Wie, Seong-Heon; Jeong, Hye Won; Kim, Young Keun; Choi, Sung Hyuk; Han, Seung Baik; So, Byung-Hak; Kim, Hyun; Kim, Woo Joo			Laboratory Surveillance of Influenza-Like Illness in Seven Teaching Hospitals, South Korea: 2011-2012 Season	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SEVERE BRONCHIOLITIS; VIRAL-INFECTION; YOUNG-CHILDREN; INFANTS; EPIDEMIOLOGY	Background: A well-constructed and properly operating influenza surveillance scheme is essential for public health. This study was conducted to evaluate the distribution of respiratory viruses in patients with influenza-like illness (ILI) through the first teaching hospital-based surveillance scheme for ILI in South Korea. Methods: Respiratory specimens were obtained from adult patients (>= 18 years) who visited the emergency department (ED) with ILI from week 40, 2011 to week 22, 2012. Multiplex PCR was performed to detect respiratory viruses: influenza virus, adenovirus, coronavirus, respiratory syncytial virus, rhinovirus, human metapneumovirus, parainfluenza virus, bocavirus, and enterovirus. Results: Among 1,983 patients who visited the ED with ILI, 811 (40.9%) were male. The median age of patients was 43 years. Influenza vaccination rate was 21.7% (430/1,983) during the 2011-2012 season. At least one comorbidity was found in 18% of patients. The positive rate of respiratory viruses was 52.1% (1,033/1,983) and the total number of detected viruses was 1,100. Influenza A virus was the dominant agent (677, 61.5%) in all age groups. The prevalence of human metapneumovirus was higher in patients more than 50 years old, while adenovirus was detected only in younger adults. In 58 (5.6%) cases, two or more respiratory viruses were detected. The co-incidence case was identified more frequently in patients with hematologic malignancy or organ transplantation recipients, however it was not related to clinical outcomes. Conclusion: This study is valuable as the first extensive laboratory surveillance of the epidemiology of respiratory viruses in ILI patients through a teaching hospital-based influenza surveillance system in South Korea.	[Noh, Ji Yun] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Song, Joon Young; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul 136705, South Korea; [Noh, Ji Yun; Song, Joon Young; Cheong, Hee Jin; Choi, Won Suk; Kim, Woo Joo] Korea Univ, Coll Med, Asia Pacific Influenza Inst, Seoul 136705, South Korea; [Choi, Won Suk] Korea Univ, Coll Med, Ansan Hosp, Div Infect Dis,Dept Internal Med, Ansan, Gyeonggi Provin, South Korea; [Lee, Jacob] Hallym Univ, Sch Med, Kangnam Sacred Heart Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Lee, Jin-Soo] Inha Univ, Coll Med, Div Infect Dis, Dept Internal Med, Inchon, South Korea; [Wie, Seong-Heon] Catholic Univ Korea, Sch Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Suwon, Gyeonggi Provin, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, Chungcheongbuk, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Dept Infect Dis, Wonju, Gangwon Provinc, South Korea; [Choi, Sung Hyuk] Korea Univ, Coll Med, Guro Hosp, Dept Emergency Med, Seoul 136705, South Korea; [Han, Seung Baik] Inha Univ, Dept Emergency Med, Coll Med, Inchon, South Korea; [So, Byung-Hak] Catholic Univ Korea, Sch Med, St Vincents Hosp, Dept Emergency Med, Suwon, Gyeonggi Provin, South Korea; [Kim, Hyun] Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju, Gangwon Provinc, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hallym University; Inha University; Catholic University of Korea; Chungbuk National University; Yonsei University; Korea University; Korea University Medicine (KU Medicine); Inha University; Catholic University of Korea; Yonsei University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul 136705, South Korea.	wjkim@korea.ac.kr	Choi, Won Suk/V-2730-2017; Kim, Woo Joo/D-2733-2015	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; So, Byung Hak/0000-0003-0383-9197; Kim, Young Keun/0000-0002-2120-6265; Choi, Sung-Hyuk/0000-0002-6686-6937; Cheong, Hee Jin/0000-0002-2532-1463; Kim, Woo Joo/0000-0002-4546-3880	Seegene Inc. (Seoul, Korea); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A103001]	Seegene Inc. (Seoul, Korea); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001) and Seegene Inc. (Seoul, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Cho HJ, 2012, PEDIAT INT; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Comach G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044511; Douce RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022206; Gensheimer KF, 2003, EMERG INFECT DIS, V9, P1645, DOI 10.3201/eid0912.030289; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Karakitsos P, 2012, CLIN MICROBIOL INFEC; Khamis FA, 2012, J MED VIROL, V84, P1323, DOI 10.1002/jmv.23330; Kim Sun Hyung, 2006, Korean J Lab Med, V26, P351, DOI 10.3343/kjlm.2006.26.5.351; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Peci A, 2012, INFLUENZA OTHER RESP; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028786; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174	18	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64295	10.1371/journal.pone.0064295	http://dx.doi.org/10.1371/journal.pone.0064295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717587	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700131
J	Pintova, S; Cohen, HW; Billett, HH				Pintova, Sofya; Cohen, Hillel W.; Billett, Henny H.			Sickle Cell Trait: Is There an Increased VTE Risk in Pregnancy and the Postpartum?	PLOS ONE			English	Article							VENOUS THROMBOEMBOLIC DISEASE; PULMONARY-EMBOLISM; POPULATION; PREVALENCE; THROMBOSIS; BLACKS; PERIOD; TRENDS; CALIFORNIA; AMERICANS	Blacks are purported to have a higher venous thromboembolism (VTE) risk than whites. We hypothesized that this might be due, in part, to the greater presence of sickle cell trait (SCT) among blacks. We investigated whether the presence of SCT resulted in a higher VTE incidence in a population predisposed to VTE, the pregnant/postpartum women. Methods: Using a mirrored clinical database that prospectively gathered in- and out-patient information for the years 1998-2008, we collected demographic data, including hemoglobin electrophoreses, on all pregnant/postpartum non-Hispanic women who delivered at a large, diverse, urban hospital. We identified those women who developed VTE either while pregnant or postpartum during those 11 years. Charts initially identified as potential VTE cases were subjected to review to ensure accuracy of VTE coding. Results: Of 12,429 women, 679 non-Hispanic SCT black women, 5,465 non-Hispanic Hemoglobin AA (women with HbA as the only hemoglobin present on electrophoresis, with normal amounts of the minor hemoglobins) black women and 1,162 non-Hispanic HbAA white women were included in the analysis. SCT prevalence was high (11.1%) within this black population as compared to 8.3% in the general non-white population. Proportions with VTE were similar for black SCT and black HbAA groups: 0.44% for the SCT group, 0.49% for non-Hispanic black HbAA women. Black HbAA women had a non-significantly higher proportion of VTE than white HbAA women 0.49% vs 0.26% (RR 1.9, 95% CI: 0.6,6.3, p = 0.28). Women with VTE were older than those without VTE (32.2 vs. 27.6 years, p = 0.0002) and the majority of VTE occurred postpartum in all groups, and significantly in the HbAA groups. There was no increase in the incidence of pulmonary emboli in the SCT group. Conclusion: In the largest analysis to date, we could not detect a meaningful difference in peripartum VTE incidence between women with and without sickle cell trait.	[Pintova, Sofya] Mountt Sinai Med Ctr, Dept Med, New York, NY USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Billett, Henny H.] Montefiore Med Ctr, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Billett, HH (corresponding author), Montefiore Med Ctr, Dept Med, Bronx, NY USA.	henny.billett@einstein.yu.edu		Cohen, Hillel/0000-0002-4524-0898	CTSA [UL1 RR025750, KL2 RR025749]; National Center for Research Resources (NCRR), National Institutes of Health (NIH), and NIH roadmap for Medical Research [TL1 RR025748]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750, KL2RR025749, TL1RR025748] Funding Source: NIH RePORTER	CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR), National Institutes of Health (NIH), and NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported in part by the CTSA Grant UL1 RR025750, KL2 RR025749 and TL1 RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessary represent the official view of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin H, 2007, BLOOD, V110, P908, DOI 10.1182/blood-2006-11-057604; Austin H, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.038; CASTRO O, 1987, GENET EPIDEMIOL, V4, P307, DOI 10.1002/gepi.1370040409; Dilley A, 1998, J LAB CLIN MED, V132, P452, DOI 10.1016/S0022-2143(98)90121-4; Dowling NF, 2003, J THROMB HAEMOST, V1, P80, DOI 10.1046/j.1538-7836.2003.00031.x; Dresang LT, 2008, AM FAM PHYSICIAN, V77, P1709; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Heit JA, 2010, AM J HEMATOL, V85, P467, DOI 10.1002/ajh.21735; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; HICKS EJ, 1978, AM J PUBLIC HEALTH, V68, P1135, DOI 10.2105/AJPH.68.11.1135; Hooper WC, 2010, THROMB RES, V125, P12, DOI 10.1016/j.thromres.2009.04.019; Hooper WC, 1996, THROMB RES, V81, P577, DOI 10.1016/0049-3848(96)00032-1; James Andra H, 2009, Hematology Am Soc Hematol Educ Program, P277, DOI 10.1182/asheducation-2009.1.277; McAlpine DD, 2007, HEALTH SERV RES, V42, P2373, DOI 10.1111/j.1475-6773.2007.00771.x; MCGREW CJ, 1975, JAMA-J AM MED ASSOC, V232, P1329, DOI 10.1001/jama.1975.03250130013006; Morris JM, 2010, J THROMB HAEMOST, V8, P998, DOI 10.1111/j.1538-7836.2010.03794.x; Naik RP, 2013, J THROMB THROMBOLYS; O'Connor DJ, 2011, ANN VASC SURG, V25, P9, DOI 10.1016/j.avsg.2010.04.003; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stein PD, 2004, AM J MED, V117, P121, DOI 10.1016/j.amjmed.2004.02.021; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Westerman MP, 2002, AM J HEMATOL, V69, P89, DOI 10.1002/ajh.10021; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006; White RH, 2005, THROMB HAEMOSTASIS, V93, P298, DOI 10.1160/TH04-08-0506; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152; Zotz RB, 2003, SEMIN THROMB HEMOST, V29, P143, DOI 10.1055/s-2003-38829	29	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64141	10.1371/journal.pone.0064141	http://dx.doi.org/10.1371/journal.pone.0064141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717554	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700109
J	Raja, R; Kale, S; Thorat, D; Soundararajan, G; Lohite, K; Mane, A; Karnik, S; Kundu, GC				Raja, R.; Kale, S.; Thorat, D.; Soundararajan, G.; Lohite, K.; Mane, A.; Karnik, S.; Kundu, G. C.			Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1 alpha-mediated VEGF-dependent angiogenesis	ONCOGENE			English	Article						osteopontin; hypoxia; HIF1 alpha; angiogenesis	LINKED KINASE ILK; NF-KAPPA-B; INDUCIBLE FACTOR 1-ALPHA; CANCER-CELLS; PROSTATE-CANCER; GENE-EXPRESSION; MALIGNANT PROGRESSION; UP-REGULATION; ACTIVATION; HIF-1-ALPHA	Hypoxia is a salient feature of most solid tumors, and hypoxic adaptation of cancer cells has crucial implications in propagation of malignant clonal cell population. Osteopontin (OPN) has been identified as a hypoxia-responsive gene, but the mechanistic and regulatory role of OPN under hypoxia is less characterized. The present study identifies the existence of a positive inter-regulatory loop between hypoxia and OPN. We have shown that hypoxia induces OPN expression in breast cancer cells; however, the expression was found to be HIF1 alpha independent. OPN enabled transcriptional upregulation of HIF1 alpha expression both under normoxia and hypoxia, whereas stability of HIF1 alpha protein in breast cancer cells remained unaffected. Moreover, we have shown that OPN induces integrin-linked kinase (ILK)/Akt-mediated nuclear factor (NF)-kappa B p65 activation leading to HIF1 alpha-dependent vascular endothelial growth factor (VEGF) expression and angiogenesis in response to hypoxia. These in vitro data are biologically important as OPN expressing cells induce greater tumor growth and angiogenesis through enhanced expressions of proangiogenic molecules as compared with control. Immunohistochemical analysis of human breast cancer specimens revealed significant correlation between OPN and HIF1 alpha but not HIF2 alpha. Elevated expression of HIF1 alpha and OPN was observed in pre-neoplastic and early stage infiltrating ductal carcinoma implicating the role of these proteins in neoplastic progression of breast cancer. Together, our results substantiate the prime role of OPN in cellular adaptation through ILK and NF-kappa B-mediated HIF1 alpha-dependent VEGF expression in response to hypoxia that ultimately controls breast cancer progression and angiogenesis. Our study reinforces the fact that targeting OPN and its regulated signaling network hold important therapeutic implications.	[Raja, R.; Kale, S.; Thorat, D.; Soundararajan, G.; Kundu, G. C.] Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, Pune 411007, Maharashtra, India; [Lohite, K.; Mane, A.; Karnik, S.] Ruby Hall Clin, Grant Med Fdn, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Kundu, GC (corresponding author), Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, NCCS Complex, Pune 411007, Maharashtra, India.	kundu@nccs.res.in	Kundu, Gopal C./ABA-9897-2020; Raja, Remya/GXM-8598-2022	Raja, Remya/0000-0002-7576-6778	Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); CSIR; ICMR; NCCS, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR)); NCCS, Government of India	We thank Dr B. Ramanamurthy, In-charge, Experimental Animal Facility (EAF), NCCS, India for breeding and maintaining NOD-SCID and OPN KO mice. We also thank Dr S. Ghaskabdi, Department of Zoology, University of Pune, India for providing the facility for CAM assay. This work was supported by grants from Council of Scientific and Industrial Research (CSIR) (to GCK, SK and GS) and Indian Council of Medical Research (ICMR) (to RR). This project was funded by CSIR, ICMR and NCCS, Government of India.	Ahmed M, 2011, EXPERT OPIN THER TAR, V15, P1113, DOI 10.1517/14728222.2011.594438; Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Behera R, 2010, CARCINOGENESIS, V31, P192, DOI 10.1093/carcin/bgp289; Bendinelli P, 2009, MOL CANCER RES, V7, P1328, DOI 10.1158/1541-7786.MCR-08-0548; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brahimi Horn C, 2005, CELL SIGNAL, V17, P1; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Gu T, 2009, LUNG CANCER, V66, P176, DOI 10.1016/j.lungcan.2009.02.004; Hammond EM, 2006, CLIN CANCER RES, V12, P5007, DOI 10.1158/1078-0432.CCR-06-0613; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hockel M, 1996, CANCER RES, V56, P4509; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jain A, 2009, CLIN CANCER RES, V15, P5199, DOI 10.1158/1078-0432.CCR-09-0783; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Janji B, 2000, ONCOGENE, V19, P3069, DOI 10.1038/sj.onc.1203640; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Kuo HP, 2009, BIOCHEM BIOPH RES CO, V389, P640, DOI 10.1016/j.bbrc.2009.09.042; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Le QT, 2003, CLIN CANCER RES, V9, P59; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Machado-Linde F, 2012, REPROD SCI, V19, P1018, DOI 10.1177/1933719112446080; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mihai LG, 2012, FARMACIA, V60, P49; Miller RL, 1998, J LAB CLIN MED, V131, P45, DOI 10.1016/S0022-2143(98)90076-2; Mukundan H, 2004, J CARDIOVASC PHARM, V44, P93, DOI 10.1097/00005344-200407000-00013; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Said HM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-55; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Singhal H, 1997, CLIN CANCER RES, V3, P605; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Stasinopoulos I, 2009, CANCER BIOL THER, V8, P31, DOI 10.4161/cbt.8.1.7079; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2003, CANCER RES, V63, P7634; Vaupel P., 2010, Experimental Oncology, V32, P125; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Yang L, 2012, CHINESE MED J-PEKING, V125, P293, DOI 10.3760/cma.j.issn.0366-6999.2012.02.024; Zhong H, 1999, CANCER RES, V59, P5830; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	66	83	90	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2053	2064		10.1038/onc.2013.171	http://dx.doi.org/10.1038/onc.2013.171			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23728336				2022-12-25	WOS:000334599100005
J	Zhang, YQ; Davis, C; Sakellariou, GK; Shi, Y; Kayani, AC; Pulliam, D; Bhattacharya, A; Richardson, A; Jackson, MJ; McArdle, A; Brooks, SV; Van Remmen, H				Zhang, Yiqiang; Davis, Carol; Sakellariou, George K.; Shi, Yun; Kayani, Anna C.; Pulliam, Daniel; Bhattacharya, Arunabh; Richardson, Arlan; Jackson, Malcolm J.; McArdle, Anne; Brooks, Susan V.; Van Remmen, Holly			CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice	FASEB JOURNAL			English	Article						oxidative stress; regeneration; central nuclei	CU,ZN SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ADAPTIVE RESPONSES; FIBERS; AGE; DEFICIENCY; MOUSE; IDENTIFICATION; MECHANISMS; SARCOPENIA	We have previously shown that deletion of CuZnSOD in mice (Sod1(-/-) mice) leads to accelerated loss of muscle mass and contractile force during aging. To dissect the relative roles of skeletal muscle and motor neurons in this process, we used a Cre-Lox targeted approach to establish a skeletal muscle-specific Sod1-knockout (mKO) mouse to determine whether muscle-specific CuZnSOD deletion is sufficient to cause muscle atrophy. Surprisingly, mKO mice maintain muscle masses at or above those of wild-type control mice up to 18 mo of age. In contrast, maximum isometric specific force measured in gastrocnemius muscle is significantly reduced in the mKO mice. We found no detectable increases in global measures of oxidative stress or ROS production, no reduction in mitochondrial ATP production, and no induction of adaptive stress responses in muscle from mKO mice. However, Akt-mTOR signaling is elevated and the number of muscle fibers with centrally located nuclei is increased in skeletal muscle from mKO mice, which suggests elevated regenerative pathways. Our data demonstrate that lack of CuZnSOD restricted to skeletal muscle does not lead to muscle atrophy but does cause muscle weakness in adult mice and suggest loss of CuZnSOD may potentiate muscle regenerative pathways.Zhang, Y., Davis, C., Sakellariou, G.K., Shi, Y., Kayani, A.C., Pulliam, D., Bhattacharya, A., Richardson, A., Jackson, M.J., McArdle, A., Brooks, S.V., Van Remmen, H. CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice.	[Zhang, Yiqiang; Davis, Carol] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78249 USA; [Shi, Yun; Pulliam, Daniel; Bhattacharya, Arunabh; Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78249 USA; [Zhang, Yiqiang; Shi, Yun; Bhattacharya, Arunabh; Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78249 USA; [Richardson, Arlan; Van Remmen, Holly] South Texas Vet Hlth Syst, GRECC, San Antonio, TX USA; [Brooks, Susan V.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sakellariou, George K.; Kayani, Anna C.; Jackson, Malcolm J.; McArdle, Anne] Univ Liverpool, Dept Musculoskeletal Biol, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan; University of Liverpool	Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78249 USA.	svbrooks@umich.edu; vanremmen@uthscsa.edu	Zhang, Yiqiang/AAA-3143-2019	Brooks, Susan/0000-0003-1954-967X; Jackson, Malcolm/0000-0003-3683-8297	U.S. National Institute on Aging [AG-020591]; U.S. National Institute of Child Health and Human Development; NATIONAL INSTITUTE ON AGING [P01AG020591, P30AG013283] Funding Source: NIH RePORTER; Medical Research Council [MR/K006312/1, G0700919] Funding Source: researchfish; MRC [MR/K006312/1, G0700919] Funding Source: UKRI	U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Jose Gomez and Anne Erickson for technical assistance. The work was supported by U.S. National Institute on Aging grant AG-020591. The F1.652 antibody was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the U.S. National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology (Iowa City, IA, USA).	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Barker T, 2007, J PHYSIOL-LONDON, V583, P421, DOI 10.1113/jphysiol.2007.139378; Baroffio A, 1996, DIFFERENTIATION, V60, P47, DOI 10.1046/j.1432-0436.1996.6010047.x; CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174; Chan S, 2007, AM J PHYSIOL-CELL PH, V293, pC985, DOI 10.1152/ajpcell.00128.2007; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Geiger PC, 2001, J APPL PHYSIOL, V90, P380, DOI 10.1152/jappl.2001.90.1.380; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; JOHNSON BD, 1994, J APPL PHYSIOL, V77, P481, DOI 10.1152/jappl.1994.77.1.481; Larkin L. M., 2012, AGE DORDR, DOI 10.1007/s11357-012-9441-7; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Lowe DA, 2001, AM J PHYSIOL-CELL PH, V280, pC540, DOI 10.1152/ajpcell.2001.280.3.C540; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; McFadden SL, 1999, J COMP NEUROL, V413, P101; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Muller FL, 2008, MUSCLE NERVE, V38, P1173, DOI 10.1002/mus.21049; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Palomero J, 2008, ANTIOXID REDOX SIGN, V10, P1463, DOI 10.1089/ars.2007.2009; Plant DR, 2001, CLIN EXP PHARMACOL P, V28, P779, DOI 10.1046/j.1440-1681.2001.03521.x; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Vasilaki A, 2010, AGING CELL, V9, P979, DOI 10.1111/j.1474-9726.2010.00635.x; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wu RF, 2010, AUTOPHAGY, V6, P828, DOI 10.1128/MCB.01445-09; Zong YN, 2012, GENE DEV, V26, P247, DOI 10.1101/gad.180885.111	37	47	47	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3536	3548		10.1096/fj.13-228130	http://dx.doi.org/10.1096/fj.13-228130			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23729587	Green Published, Green Submitted			2022-12-25	WOS:000328840500014
J	Kononova, O; Litvinov, RI; Zhmurov, A; Alekseenko, A; Cheng, CH; Agarwal, S; Marx, KA; Weisel, JW; Barsegov, V				Kononova, Olga; Litvinov, Rustem I.; Zhmurov, Artem; Alekseenko, Andrey; Cheng, Chia Ho; Agarwal, Silvi; Marx, Kenneth A.; Weisel, John W.; Barsegov, Valeri			Molecular Mechanisms, Thermodynamics, and Dissociation Kinetics of Knob-Hole Interactions in Fibrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; FORMS CATCH BONDS; CRYSTAL-STRUCTURES; SYNTHETIC PEPTIDES; ESSENTIAL DYNAMICS; SLIP BONDS; FRAGMENT-D; POLYMERIZATION; BINDING; LIGANDS	Polymerization of fibrin, the primary structural protein of blood clots and thrombi, occurs through binding of knobs 'A' and 'B' in the central nodule of fibrin monomer to complementary holes 'a' and 'b' in the gamma- and beta-nodules, respectively, of another monomer. We characterized the A:a and B:b knob-hole interactions under varying solution conditions using molecular dynamics simulations of the structural models of fibrin(ogen) fragment D complexed with synthetic peptides GPRP (knob 'A' mimetic) and GHRP (knob 'B' mimetic). The strength of A:a and B:b knob-hole complexes was roughly equal, decreasing with pulling force; however, the dissociation kinetics were sensitive to variations in acidity (pH 5-7) and temperature (T = 25-37 degrees C). There were similar structural changes in holes 'a' and 'b' during forced dissociation of the knob-hole complexes: elongation of loop I, stretching of the interior region, and translocation of the moveable flap. The disruption of the knob-hole interactions was not an "all-or-none" transition as it occurred through distinct two-step or single step pathways with or without intermediate states. The knob-hole bonds were stronger, tighter, and more brittle at pH 7 than at pH 5. The B:b knob-hole bonds were weaker, looser, and more compliant than the A:a knob-hole bonds at pH 7 but stronger, tighter, and less compliant at pH 5. Surprisingly, the knob-hole bonds were stronger, not weaker, at elevated temperature (T = 37 degrees C) compared with T = 25 degrees C due to the helix-to-coil transition in loop I that helps stabilize the bonds. These results provide detailed qualitative and quantitative characteristics underlying the most significant non-covalent interactions involved in fibrin polymerization.	[Kononova, Olga; Zhmurov, Artem; Cheng, Chia Ho; Agarwal, Silvi; Marx, Kenneth A.; Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA; [Kononova, Olga; Zhmurov, Artem; Alekseenko, Andrey; Barsegov, Valeri] Moscow Inst Phys & Technol, Moscow 141700, Moscow Region, Russia; [Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Lowell; Moscow Institute of Physics & Technology; University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu; Valeri_Barsegov@uml.edu	Kononova, Olga/ABB-3741-2020; Alekseenko, Andrey/C-9812-2013; Kononova, Olga G/C-8698-2014; Barsegov, Valeri/A-6203-2014; Zhmurov, Artem A/F-4455-2012; Litvinov, Rustem/E-5291-2011	Kononova, Olga/0000-0001-9267-312X; Alekseenko, Andrey/0000-0003-4906-7241; Zhmurov, Artem A/0000-0002-4414-8352; Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917	National Institutes of Health [HL030954, HL090774]; American Heart Association [09SDG2460023]; Russian Ministry of Education and Science [14.A18.21.1239]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL090774, R01HL030954, R01HL090774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL030954 and HL090774 (to J. W. W.). This work was also supported by American Heart Association Grant 09SDG2460023 (to V. B.) and Russian Ministry of Education and Science Grant 14.A18.21.1239 (to V. B.).	Ajjan Ramzi A, 2005, Expert Rev Cardiovasc Ther, V3, P1047, DOI 10.1586/14779072.3.6.1047; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andrews RK, 2008, J CLIN INVEST, V118, P3009, DOI 10.1172/JCI36883; Averett LE, 2008, LANGMUIR, V24, P4979, DOI 10.1021/la703264x; Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Barsegov V, 2006, J PHYS CHEM B, V110, P26403, DOI 10.1021/jp0653306; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Buch I, 2011, J CHEM THEORY COMPUT, V7, P1765, DOI 10.1021/ct2000638; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767; Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129; Ferry J. D., 1988, BIOL SYNTHETIC POLYM, P41; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kostelansky MS, 2002, BIOCHEMISTRY-US, V41, P12124, DOI 10.1021/bi0261894; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; SHAINOFF JR, 1979, SCIENCE, V204, P200, DOI 10.1126/science.155308; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801; Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003; Watson JW, 2011, BIOCHEMISTRY-US, V50, P9923, DOI 10.1021/bi201406c; Weisel JW, 2008, SCIENCE, V320, P456, DOI 10.1126/science.1154210; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhmurov A, 2010, PROTEINS, V78, P2984, DOI 10.1002/prot.22824; Zhmurov A, 2011, STRUCTURE, V19, P1615, DOI 10.1016/j.str.2011.08.013; Zhmurov A, 2012, J AM CHEM SOC, V134, P20396, DOI 10.1021/ja3076428	53	24	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22681	22692		10.1074/jbc.M113.472365	http://dx.doi.org/10.1074/jbc.M113.472365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23720752	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000330596300047
J	Cao, ZP; Zhang, RW; Li, JX; Huang, HS; Zhang, DY; Zhang, JJ; Gao, JM; Chen, JY; Huang, CS				Cao, Zipeng; Zhang, Ruowen; Li, Jingxia; Huang, Haishan; Zhang, Dongyun; Zhang, Jingjie; Gao, Jimin; Chen, Jingyuan; Huang, Chuanshu			X-linked Inhibitor of Apoptosis Protein (XIAP) Regulation of Cyclin D1 Protein Expression and Cancer Cell Anchorage-independent Growth via Its E3 Ligase-mediated Protein Phosphatase 2A/c-Jun Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATOR PROTEIN-1; AP-1 ACTIVITY; UV-RADIATION; CL41 CELLS; C-JUN; INDUCTION; PATHWAY; TRANSFORMATION; IAPS	The X-linked inhibitor of apoptosis protein (XIAP) is a well known potent inhibitor of apoptosis; however, it is also involved in other cancer cell biological behavior. In the current study, we discovered that XIAP and its E3 ligase played a crucial role in regulation of cyclin D1 expression in cancer cells. We found that deficiency of XIAP expression resulted in a marked reduction in cyclin D1 expression. Consistently, cell cycle transition and anchorage-independent cell growth were also attenuated in XIAP-deficient cancer cells compared with those of the parental wild-type cells. Subsequent studies demonstrated that E3 ligase activity within the RING domain of XIAP is crucial for its ability to regulate cyclin D1 transcription, cell cycle transition, and anchorage-independent cell growth by up-regulating transactivation of c-Jun/AP-1. Moreover, we found that E3 ligase within RING domain was required for XIAP inhibition of phosphatase PP2A activity by up-regulation of PP2A phosphorylation at Tyr-307 in its catalytic subunit. Such PP2A phosphorylation and inactivation resulted in phosphorylation and activation of its downstream target c-Jun in turn leading to cyclin D1 expression. Collectively, our studies uncovered a novel function of E3 ligase activity of XIAP in the up-regulation of cyclin D1 expression, providing significant insight into the understanding of the biomedical significance of overexpressed XIAP in cancer development, further offering a new molecular basis for utilizing XIAP E3 ligase as a cancer therapeutic target.	[Cao, Zipeng; Zhang, Ruowen; Li, Jingxia; Huang, Haishan; Zhang, Dongyun; Zhang, Jingjie; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Cao, Zipeng; Chen, Jingyuan] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Shannxi, Peoples R China; [Huang, Haishan; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Air Force Military Medical University; Wenzhou Medical University	Gao, JM (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China.	jimingao@yahoo.com; jy_chen@fmmu.edu.cn; Chuanshu.huang@nyumc.org	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022	Huang, Chuanshu/0000-0003-4133-5096; Zhang, Ruowen/0000-0003-1403-2356	National Institute of Health from the NCI [CA112557]; National Institute of Health from the NIEHS [ES000260]; National Natural Science Foundation of China [NSFC81229002, NSFC9102970]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institute of Health from the NCI; National Institute of Health from the NIEHS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from the NCI and ES000260 from the NIEHS. This work was also supported by National Natural Science Foundation of China Grants NSFC81229002 and NSFC9102970.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Al-Murrani SWK, 1999, BIOCHEM J, V341, P293, DOI 10.1042/0264-6021:3410293; ALBERTS AS, 1993, MOL CELL BIOL, V13, P2104, DOI 10.1128/MCB.13.4.2104; Arber N, 1997, CANCER RES, V57, P1569; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Che YF, 2012, AM J PATHOL, V180, P1798, DOI 10.1016/j.ajpath.2012.01.016; CHEN J, 1994, J BIOL CHEM, V269, P7957; Cooper SJ, 2003, MOL CANCER RES, V1, P848; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Ma JJ, 2009, EUR J OBSTET GYN R B, V146, P222, DOI 10.1016/j.ejogrb.2009.06.011; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; O'Shaughnessy RFL, 2009, DEVELOPMENT, V136, P3423, DOI 10.1242/dev.037010; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Palmqvist R, 2000, AM J PATHOL, V157, P1947, DOI 10.1016/S0002-9440(10)64833-X; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang R, 2009, AURIS NASUS LARYNX, V36, P332, DOI 10.1016/j.anl.2008.08.006; Yang L, 2003, CANCER RES, V63, P6815; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2007, CARCINOGENESIS, V28, P883, DOI 10.1093/carcin/bgl186; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002; Zhang JJ, 2012, TOXICOL APPL PHARM, V263, P218, DOI 10.1016/j.taap.2012.06.012	55	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20238	20247		10.1074/jbc.M112.448365	http://dx.doi.org/10.1074/jbc.M112.448365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720779	Green Published, hybrid			2022-12-25	WOS:000321715100013
J	Tsukamoto, K; Wales, TE; Daniels, K; Pal, R; Sheng, R; Cho, W; Stafford, W; Engen, JR; Krieger, M; Kocher, O				Tsukamoto, Kosuke; Wales, Thomas E.; Daniels, Kathleen; Pal, Rinku; Sheng, Ren; Cho, Wonhwa; Stafford, Walter; Engen, John R.; Krieger, Monty; Kocher, Olivier			Noncanonical Role of the PDZ4 Domain of the Adaptor Protein PDZK1 in the Regulation of the Hepatic High Density Lipoprotein Receptor Scavenger Receptor Class B, Type I (SR-BI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; E-DEFICIENT MICE; APOLIPOPROTEIN-E; HYDROGEN-EXCHANGE; HOMOLOGOUS RECOMBINATION; SEDIMENTATION-VELOCITY; SURFACE LOCALIZATION; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; COMPLEX REVEALS	The four PDZ (PDZ1 to PDZ4) domain-containing adaptor protein PDZK1 controls the expression, localization, and function of the HDL receptor scavenger receptor class B, type I (SR-BI), in hepatocytes in vivo. This control depends on both the PDZ4 domain and the binding of SR-BI's cytoplasmic C terminus to the canonical peptide-binding sites of either the PDZ1 or PDZ3 domain (no binding to PDZ2 or PDZ4). Using transgenic mice expressing in the liver domain deletion (Delta PDZ2 or Delta PDZ3), domain replacement (PDZ2 -> 1), or target peptide binding-negative (PDZ4(G389P)) mutants of PDZK1, we found that neither PDZ2 nor PDZ3 nor the canonical target peptide binding activity of PDZ4 were necessary for hepatic SR-BI regulatory activity. Immunohistochemical studies established that the localization of PDZK1 on hepatocyte cell surface membranes in vivo is dependent on its PDZ4 domain and the presence of SR-BI. Analytical ultracentrifugation and hydrogen deuterium exchange mass spectrometry suggested that the requirement of PDZ4 for localization and SR-BI regulation is not due to PDZ4-mediated oligomerization or induction of conformational changes in the PDZ123 portion of PDZK1. However, surface plasmon resonance analysis showed that PDZ4, but not the other PDZ domains, can bind vesicles that mimic the plasma membrane. Thus, PDZ4 may potentiate PDZK1's regulation of SR-BI by promoting its lipid-mediated attachment to the cytoplasmic membrane. Our results show that not all of the PDZ domains of a multi-PDZ domain-containing adaptor protein are required for its biological activities and that both canonical target peptide binding and noncanonical (peptide binding-independent) capacities of PDZ domains may be employed by a single such adaptor for optimal in vivo activity.	[Tsukamoto, Kosuke; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Vasc Biol Res Ctr, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sheng, Ren; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Stafford, Walter] Boston Biomed Res Inst, Watertown, MA 02472 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Boston Biomedical Research Institute	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu; okocher@bidmc.harvard.edu	Stafford, Walter/ABC-6553-2020	Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689	National Institutes of Health [HL077780, HL52212, HL66105, GM68849, GM086507, GM101135]; Waters Corp.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105, R01HL052212, R01HL077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849, R01GM101135, R01GM086507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corp.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.), HL52212 and HL66105 (to M. K.), GM68849 (to W. C.), and GM086507 and GM101135 (to J. R. E.). This work was also supported by a research collaboration with the Waters Corp. (to J. R. E.).	Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iacob RE, 2012, J AM SOC MASS SPECTR, V23, P1003, DOI 10.1007/s13361-012-0377-z; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; MORRISON JR, 1994, J BIOL CHEM, V269, P13911; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Stafford W., 1994, METHODS ENZYMOLOGY B, P478; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	55	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19845	19860		10.1074/jbc.M113.460170	http://dx.doi.org/10.1074/jbc.M113.460170			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720744	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000321515800052
J	Gransee, HM; Zhan, WZ; Sieck, GC; Mantilla, CB				Gransee, Heather M.; Zhan, Wen-Zhi; Sieck, Gary C.; Mantilla, Carlos B.			Targeted Delivery of TrkB Receptor to Phrenic Motoneurons Enhances Functional Recovery of Rhythmic Phrenic Activity after Cervical Spinal Hemisection	PLOS ONE			English	Article							RESPIRATORY MOTOR OUTPUT; CORD-INJURY; ADULT-RATS; NEUROTROPHIC FACTORS; AXONAL REGENERATION; ADENOASSOCIATED-VIRUS; INTERMITTENT HYPOXIA; NEUROMUSCULAR-JUNCTIONS; SYNAPTIC-TRANSMISSION; SIGNAL-TRANSDUCTION	Progressive recovery of rhythmic phrenic activity occurs over time after a spinal cord hemisection involving unilateral transection of anterolateral funiculi at C-2 (SH). Brain-derived neurotrophic factor (BDNF) acting through its full-length tropomyosin related kinase receptor subtype B (TrkB.FL) contributes to neuroplasticity after spinal cord injury, but the specific cellular substrates remain unclear. We hypothesized that selectively targeting increased TrkB.FL expression to phrenic motoneurons would be sufficient to enhance recovery of rhythmic phrenic activity after SH. Several adeno-associated virus (AAV) serotypes expressing GFP were screened to determine specificity for phrenic motoneuron transduction via intrapleural injection in adult rats. GFP expression was present in the cervical spinal cord 3 weeks after treatment with AAV serotypes 7, 8, and 9, but not with AAV2, 6, or rhesus-10. Overall, AAV7 produced the most consistent GFP expression in phrenic motoneurons. SH was performed 3 weeks after intrapleural injection of AAV7 expressing human TrkB.FL-FLAG or saline. Delivery of TrkB.FL-FLAG to phrenic motoneurons was confirmed by FLAG protein expression in the phrenic motor nucleus and human TrkB.FL mRNA expression in microdissected phrenic motoneurons. In all SH rats, absence of ipsilateral diaphragm EMG activity was confirmed at 3 days post-SH, verifying complete interruption of ipsilateral descending drive to phrenic motoneurons. At 14 days post-SH, all AAV7-TrkB.FL treated rats (n = 11) displayed recovery of ipsilateral diaphragm EMG activity compared to 3 out of 8 untreated SH rats (p<0.01). During eupnea, AAV7-TrkB.FL treated rats exhibited 73 +/- 7% of pre-SH root mean squared EMG vs. only 31 +/- 11% in untreated SH rats displaying recovery (p<0.01). This study provides direct evidence that increased TrkB.FL expression in phrenic motoneurons is sufficient to enhance recovery of ipsilateral rhythmic phrenic activity after SH, indicating that selectively targeting gene expression in spared motoneurons below the level of spinal cord injury may promote functional recovery.	[Gransee, Heather M.; Zhan, Wen-Zhi; Sieck, Gary C.; Mantilla, Carlos B.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sieck, Gary C.; Mantilla, Carlos B.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Mantilla, CB (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	mantilla.carlos@mayo.edu	Mantilla, Carlos/AAQ-2133-2020; Mantilla, Carlos B/A-3562-2013	Mantilla, Carlos/0000-0001-5446-9208; sieck, gary/0000-0003-3040-9424; Gransee, Heather/0000-0001-5387-3583	NIH [R01-HL096750, T32-HL105355]; Paralyzed Veterans of America Research Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105355, R01HL096750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America Research Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01-HL096750 and T32-HL105355 (HMG), a grant from the Paralyzed Veterans of America Research Foundation, and the Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2008, EXP NEUROL, V212, P348, DOI 10.1016/j.expneurol.2008.04.017; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Baxter GT, 1997, J NEUROSCI, V17, P2683; Boulenguez P, 2007, BRAIN RES, V1148, P96, DOI 10.1016/j.brainres.2007.02.060; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Bregman BS, 2002, PROG BRAIN RES, V137, P257; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; De B, 2004, MOL THER, V10, P1003, DOI 10.1016/j.ymthe.2004.08.022; De BP, 2006, MOL THER, V13, P67, DOI 10.1016/j.ymthe.2005.09.003; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Dow DE, 2009, IEEE ENG MED BIO, P404, DOI 10.1109/IEMBS.2009.5334892; Dow Douglas E, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1204; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; Fuller DD, 2006, J APPL PHYSIOL, V100, P800, DOI 10.1152/japplphysiol.00960.2005; Fuller DD, 2005, J NEUROTRAUM, V22, P203, DOI 10.1089/neu.2005.22.203; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Golder FJ, 2003, J NEUROSCI, V23, P2494; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; GOSHGARIAN HG, 1991, EXP NEUROL, V111, P135, DOI 10.1016/0014-4886(91)90061-G; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iarikov DE, 2007, J NEUROTRAUM, V24, P690, DOI 10.1089/neu.2006.0172; Issa AN, 2010, J COMP NEUROL, V518, P4213, DOI 10.1002/cne.22449; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; King VR, 2000, EXP NEUROL, V165, P327, DOI 10.1006/exnr.2000.7480; Kinkead R, 1998, J NEUROSCI, V18, P8436; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; LESSMANN V, 1994, NEUROREPORT, V6, P21; LIU GS, 1990, J NEUROPHYSIOL, V64, P423, DOI 10.1152/jn.1990.64.2.423; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Lynskey JV, 2006, J NEUROTRAUM, V23, P617, DOI 10.1089/neu.2006.23.617; Mantilla CB, 2007, NEUROSCIENCE, V146, P178, DOI 10.1016/j.neuroscience.2007.01.048; Mantilla CB, 2013, J APPL PHYSIOL, V114, P380, DOI 10.1152/japplphysiol.01122.2012; Mantilla CB, 2012, EXP NEUROL, V234, P191, DOI 10.1016/j.expneurol.2011.12.036; Mantilla CB, 2012, MUSCLE NERVE, V45, P274, DOI 10.1002/mus.22295; Mantilla CB, 2011, RESP PHYSIOL NEUROBI, V177, P176, DOI 10.1016/j.resp.2011.03.011; Mantilla CB, 2010, RESP PHYSIOL NEUROBI, V173, P101, DOI 10.1016/j.resp.2010.07.001; Mantilla CB, 2009, J NEUROSCI METH, V182, P244, DOI 10.1016/j.jneumeth.2009.06.016; MCCRIMMON DR, 1989, J NEUROSCI, V9, P1910; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIYATA H, 1995, J APPL PHYSIOL, V79, P1640, DOI 10.1152/jappl.1995.79.5.1640; Nantwi KD, 1999, NEUROREHAB NEURAL RE, V13, P225, DOI 10.1177/154596839901300404; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; Novikova LN, 2000, J COMP NEUROL, V428, P671, DOI 10.1002/1096-9861(20001225)428:4<671::AID-CNE7>3.0.CO;2-H; Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381; Peel AL, 1997, GENE THER, V4, P16, DOI 10.1038/sj.gt.3300358; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Prakash YS, 1999, MUSCLE NERVE, V22, P307, DOI 10.1002/(SICI)1097-4598(199903)22:3<307::AID-MUS3>3.3.CO;2-D; Prakash YS, 2000, J APPL PHYSIOL, V89, P563, DOI 10.1152/jappl.2000.89.2.563; Qiu K, 2010, EXP NEUROL, V226, P254, DOI 10.1016/j.expneurol.2010.08.026; Qiu K, 2012, MOL THER, V20, P21, DOI 10.1038/mt.2011.214; Rankin SL, 2008, BRAIN RES, V1217, P10, DOI 10.1016/j.brainres.2008.03.076; Rankin SL, 2005, NEUROSCI LETT, V383, P305, DOI 10.1016/j.neulet.2005.04.043; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Satriotomo I, 2012, EXP NEUROL, V237, P103, DOI 10.1016/j.expneurol.2012.05.020; Sieck GC, 2009, RESP PHYSIOL NEUROBI, V169, P218, DOI 10.1016/j.resp.2009.08.008; Singh LP, 2012, EXP NEUROL, V238, P79, DOI 10.1016/j.expneurol.2012.08.009; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Tai Q, 1996, J COMP NEUROL, V372, P343, DOI 10.1002/(SICI)1096-9861(19960826)372:3<343::AID-CNE2>3.0.CO;2-2; Tai Q, 1997, J COMP NEUROL, V386, P613; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; TRELEASE RB, 1982, ELECTROEN CLIN NEURO, V53, P459, DOI 10.1016/0013-4694(82)90011-6; Vinit S, 2008, EUR J NEUROSCI, V27, P897, DOI 10.1111/j.1460-9568.2008.06072.x; Vinit S, 2006, J NEUROTRAUM, V23, P1137, DOI 10.1089/neu.2006.23.1137; Watanabe M, 2010, GENE THER, V17, P1042, DOI 10.1038/gt.2010.87; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Zhan WZ, 1997, J APPL PHYSIOL, V82, P1145, DOI 10.1152/jappl.1997.82.4.1145	76	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64755	10.1371/journal.pone.0064755	http://dx.doi.org/10.1371/journal.pone.0064755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724091	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000092
J	Ma, JW; Yang, J; Zhou, LS; Zhang, ZY; Ma, HB; Xie, XH; Zhang, F; Xiong, XW; Cui, LL; Yang, H; Liu, XX; Duan, YY; Xiao, SJ; Ai, HS; Ren, J; Huang, LS				Ma, Junwu; Yang, Jie; Zhou, Lisheng; Zhang, Zhiyan; Ma, Huanban; Xie, Xianhua; Zhang, Feng; Xiong, Xinwei; Cui, Leilei; Yang, Hui; Liu, Xianxian; Duan, Yanyu; Xiao, Shijun; Ai, Huashui; Ren, Jun; Huang, Lusheng			Genome-Wide Association Study of Meat Quality Traits in a White Duroc x Erhualian F2 Intercross and Chinese Sutai Pigs	PLOS ONE			English	Article							INTRAMUSCULAR FAT-CONTENT; CARCASS COMPOSITION; CANDIDATE GENES; PORK QUALITY; BACKFAT THICKNESS; BOAR TAINT; DRIP LOSS; LOCI; GROWTH; QTL	Thousands of QTLs for meat quality traits have been identified by linkage mapping studies, but most of them lack precise position or replication between populations, which hinder their application in pig breeding programs. To localize QTLs for meat quality traits to precise genomic regions, we performed a genome-wide association (GWA) study using the Illumina PorcineSNP60K Beadchip in two swine populations: 434 Sutai pigs and 933 F2 pigs from a White Duroc x Erhualian intercross. Meat quality traits, including pH, color, drip loss, moisture content, protein content and intramuscular fat content (IMF), marbling and firmness scores in the M. longissimus (LM) and M. semimembranosus (SM) muscles, were recorded on the two populations. In total, 127 chromosome-wide significant SNPs for these traits were identified. Among them, 11 SNPs reached genome-wise significance level, including 1 on SSC3 for pH, 1 on SSC3 and 3 on SSC15 for drip loss, 3 (unmapped) for color a*, and 2 for IMF each on SSC9 and SSCX. Except for 11 unmapped SNPs, 116 significant SNPs fell into 28 genomic regions of approximately 10 Mb or less. Most of these regions corresponded to previously reported QTL regions and spanned smaller intervals than before. The loci on SSC3 and SSC7 appeared to have pleiotropic effects on several related traits. Besides them, a few QTL signals were replicated between the two populations. Further, we identified thirteen new candidate genes for IMF, marbling and firmness, on the basis of their positions, functional annotations and reported expression patterns. The findings will contribute to further identification of the causal mutation underlying these QTLs and future marker-assisted selection in pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	Lushenghuang@hotmail.com	zhou, lisheng/AGY-5728-2022; Ren, Jun/H-9793-2019		National Natural Science Foundation of China [31230069, 31101697]; Development Programs for Basic Research of China (973 Programs) [2012CB722502, 2012CB124702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Programs for Basic Research of China (973 Programs)	Funding was provided by the Key Project of National Natural Science Foundation of China (No. 31230069), the National Natural Science Foundation of China (No. 31101697), and the Development Programs for Basic Research of China (973 Programs, No. 2012CB722502 and 2012CB124702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PORK COMPOSITION QUA; AOAC, 2000, OFFICIAL METHODS ANA; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen XH, 2010, INT J MOL MED, V25, P361, DOI 10.3892/ijmm_00000353; Cheng R, 2011, MOL MED REP, V4, P519, DOI 10.3892/mmr.2011.443; Cherel P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-76; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; de Koning DJ, 2003, J ANIM SCI, V81, P2155; de Koning DJ, 2001, J ANIM SCI, V79, P2812; de Vries AG, 2000, FOOD CHEM, V69, P397, DOI 10.1016/S0308-8146(00)00049-2; Duan Y, 2009, CHINESE J ANIMAL VET, V40, P6; Duan YY, 2009, J ANIM SCI, V87, P9, DOI 10.2527/jas.2008-1128; Edwards DB, 2008, J ANIM SCI, V86, P254, DOI 10.2527/jas.2006-626; Evans GJ, 2003, GENETICS, V164, P621; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Gao Y, 2007, MEAT SCI, V77, P36, DOI 10.1016/j.meatsci.2007.03.026; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Guo YM, 2008, ANIM GENET, V39, P486, DOI 10.1111/j.1365-2052.2008.01756.x; Harlizius B, 2000, MAMM GENOME, V11, P800, DOI 10.1007/s003350010147; Harmegnies N, 2006, ANIM GENET, V37, P543, DOI 10.1111/j.1365-2052.2006.01523.x; Hermesch S, 2000, LIVEST PROD SCI, V65, P239, DOI 10.1016/S0301-6226(00)00150-0; Heuven HCM, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-4; Honikel K. O., 1987, Fleischwirtschaft, V67, P1098; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Iiritano S, 2012, MOL ENDOCRINOL, V26, P1578, DOI 10.1210/me.2011-1379; Karol A, 2010, ANIM BIOTECHNOL, V21, P114, DOI 10.1080/10495390903534457; Kim KS, 2004, OBES RES, V12, P1981, DOI 10.1038/oby.2004.249; Li HD, 2010, J ANIM SCI, V88, P2904, DOI 10.2527/jas.2009-2590; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Lu X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-488; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Markljung E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-22; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Mercade A, 2005, MAMM GENOME, V16, P374, DOI 10.1007/s00335-004-2447-4; National Pork Producers Council (NPPC), 1991, PROC EV MARK HOGS, V3; Nii M, 2005, J ANIM SCI, V83, P308; Otto G, 2007, MEAT SCI, V75, P185, DOI 10.1016/j.meatsci.2006.03.022; Ovilo C, 2002, J ANIM SCI, V80, P2801; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUESENBERRY CP, 1980, J STAT COMPUT SIM, V11, P41, DOI 10.1080/00949658008810388; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Rasmussen AJ, 1996, INT C MEAT SCI TECHN, P286; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren J., 2006, P 8 WORLD C GEN APPL; Rohrer GA, 2006, ANIM GENET, V37, P17, DOI 10.1111/j.1365-2052.2005.01368.x; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; Rossi E, 2012, GENES NUTR, V7, P511, DOI 10.1007/s12263-012-0291-9; Sabino-Silva R, 2010, BRAZ J MED BIOL RES, V43, P1019, DOI 10.1590/S0100-879X2010001100002; Sato S, 2006, ANIM GENET, V37, P113, DOI 10.1111/j.1365-2052.2005.01397.x; Scheffler TL, 2007, MEAT SCI, V77, P7, DOI 10.1016/j.meatsci.2007.04.024; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Su Yu-Hong, 2004, Yi Chuan Xue Bao, V31, P132; Suzuki K, 2005, J ANIM SCI, V83, P2058; Thomsen H, 2004, J ANIM SCI, V82, P2213; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wimmers K, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-15; Xiong X, 2012, J BIOL CHEM; Yamaguchi M, 2007, INT J MOL MED, V20, P323; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhou LiHua, 2011, Scientia Agricultura Sinica, V44, P2131	73	144	149	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64047	10.1371/journal.pone.0064047	http://dx.doi.org/10.1371/journal.pone.0064047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724019	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000037
J	Mizushima, D; Nishijima, T; Gatanaga, H; Tsukada, K; Teruya, K; Kikuchi, Y; Oka, S				Mizushima, Daisuke; Nishijima, Takeshi; Gatanaga, Hiroyuki; Tsukada, Kunihisa; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi			Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naive Patients with Advanced HIV-1 Infection in the HAART Era	PLOS ONE			English	Article							CMV DNA LOAD; ORAL GANCICLOVIR; ANTIRETROVIRAL THERAPY; RISK-FACTORS; AIDS; VALGANCICLOVIR; SURVIVAL; EFFICACY; SAFETY; PROPHYLAXIS	Background: The efficacy of preemptive therapy against cytomegalovirus (CMV) infection remains unknown in treatment naive patients with advanced HIV-1 infection in the HAART era. Methods: The subjects of this single-center observation study were126 treatment-naive HIV-1 infected patients with positive CMV viremia between January 1, 2000 and December 31, 2006. Inclusion criteria were age more than 17 years, CD4 count less than 100/ml, plasma CMV DNA positive, never having received antiretroviral therapy (ART) and no CMV end-organ disease (EOD) at first visit. The incidence of CMV-EOD was compared in patients with and without preemptive therapy against CMV-EOD. The effects of the CMV preemptive therapy were estimated in uni-and multivariate Cox hazards models. Results: CMV-EOD was diagnosed in 30 of the 96 patients of the non-preemptive therapy group (31%, 230.3 per 1000 person-years), compared with 3 of the 30 patients of the preemptive therapy group (10%, 60.9 per 1000 person-years). Univariate (HR = 0.286; 95% CI, 0.087-0.939; p = 0.039) and multivariate (adjusted HR = 0.170; 95% CI, 0.049-0.602; p = 0.005) analyses confirmed that CMV-EOD is significantly prevented by CMV preemptive therapy. Multivariate analysis showed that plasma CMV DNA level correlated significantly with CMV-EOD (per log10/ml, adjusted HR = 1.941; 95% CI, 1.266-2.975; p = 0.002). Among the 30 patients on preemptive therapy, 7 (23.3%) developed grade 3-4 leukopenia. The mortality rate was not significantly different between the two groups (p = 0.193, Log-rank test). Conclusions: The results indicate that preemptive therapy lowers the incidence of CMV-EOD by almost 25%. Preemptive therapy for treatment-naive patients with CMV viremia is effective, although monitoring of potential treatment-related side effects is required.	[Mizushima, Daisuke; Nishijima, Takeshi; Gatanaga, Hiroyuki; Tsukada, Kunihisa; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Mizushima, Daisuke; Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	National Center for Global Health and Medicine [23-114]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by a Grant for National Center for Global Health and Medicine (23-114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Brosgart CL, 1998, AIDS, V12, P269, DOI 10.1097/00002030-199803000-00004; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Erice A, 2003, CLIN INFECT DIS, V37, P567, DOI 10.1086/375843; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hodge WG, 2005, CAN J OPHTHALMOL, V40, P701, DOI 10.1016/S0008-4182(05)80086-9; Humar A, 2005, AM J TRANSPLANT, V5, P1462, DOI 10.1111/j.1600-6143.2005.00866.x; Jabs DA, 2007, OPHTHALMOLOGY, V114, P780, DOI 10.1016/j.ophtha.2006.11.008; Kalil AC, 2005, ANN INTERN MED, V143, P870, DOI 10.7326/0003-4819-143-12-200512200-00005; Kalil AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005512; Kempen JH, 2003, OPHTHALMOLOGY, V110, P987, DOI 10.1016/S0161-6420(03)00089-7; Kute VB, 2012, TRANSPL P, V44, P706, DOI 10.1016/j.transproceed.2011.12.025; Micol R, 2009, JAIDS-J ACQ IMM DEF, V51, P486, DOI 10.1097/QAI.0b013e3181a254c2; Park JM, 2006, LIVER TRANSPLANT, V12, P112, DOI 10.1002/lt.20562; Pergam SA, 2012, BIOL BLOOD MARROW TR, V18, P1391, DOI 10.1016/j.bbmt.2012.02.008; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rose DN, 1997, AIDS, V11, P883, DOI 10.1097/00002030-199707000-00007; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; Spector SA, 1996, NEW ENGL J MED, V334, P1491, DOI 10.1056/NEJM199606063342302; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143; Yoshida A, 2001, CLIN INFECT DIS, V33, P1756, DOI 10.1086/323782	25	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65348	10.1371/journal.pone.0065348	http://dx.doi.org/10.1371/journal.pone.0065348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724140	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000130
J	Zhu, JJ; Arzt, J; Puckette, MC; Smoliga, GR; Pacheco, JM; Rodriguez, LL				Zhu, James J.; Arzt, Jonathan; Puckette, Michael C.; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.			Mechanisms of Foot-and-Mouth Disease Virus Tropism Inferred from Differential Tissue Gene Expression	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; NECROSIS-FACTOR-ALPHA; INTEGRIN ALPHA(V)BETA(3); EXTRACELLULAR-MATRIX; MESSENGER-RNA; EPITHELIAL-CELLS; WILD-TYPE; IN-VITRO; PATHOGENESIS; INFECTION	Foot-and-mouth disease virus (FMDV) targets specific tissues for primary infection, secondary high-titer replication (e. g. foot and mouth where it causes typical vesicular lesions) and long-term persistence at some primary replication sites. Although integrin alpha V beta 6 receptor has been identified as primary FMDV receptors in animals, their tissue distribution alone fails to explain these highly selective tropism-driven events. Thus, other molecular mechanisms must play roles in determining this tissue specificity. We hypothesized that differences in certain biological activities due to differential gene expression determine FMDV tropism and applied whole genome gene expression profiling to identify genes differentially expressed between FMDV-targeted and non-targeted tissues in terms of supporting primary infection, secondary replication including vesicular lesions, and persistence. Using statistical and bioinformatic tools to analyze the differential gene expression, we identified mechanisms that could explain FMDV tissue tropism based on its association with differential expression of integrin alpha V beta 6 heterodimeric receptor (FMDV receptor), fibronectin (ligand of the receptor), IL-1 cytokines, death receptors and the ligands, and multiple genes in the biological pathways involved in extracellular matrix turnover and interferon signaling found in this study. Our results together with reported findings indicate that differences in (1) FMDV receptor availability and accessibility, (2) type I interferon-inducible immune response, and (3) ability to clear virus infected cells via death receptor signaling play roles in determining FMDV tissue tropism and the additional increase of high extracellular matrix turnover induced by FMDV infection, likely via triggering the signaling of highly expressed IL-1 cytokines, play a key role in the pathogenesis of vesicular lesions.	[Zhu, James J.; Arzt, Jonathan; Puckette, Michael C.; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.] USDA, Plum Isl Anim Dis Res Ctr, Agr Res Unit, Foreign Anim Dis Res Unit, Orient Point, NY USA	United States Department of Agriculture (USDA)	Zhu, JJ (corresponding author), USDA, Plum Isl Anim Dis Res Ctr, Agr Res Unit, Foreign Anim Dis Res Unit, Orient Point, NY USA.	james.zhu@ars.usda.gov; luis.rodriguez@ars.usda.gov	Puckette, Michael/T-6715-2019	Arzt, Jonathan/0000-0002-7517-7893; Pacheco, Juan/0000-0001-5477-0201	USDA-ARS project [1940-32000-057-00D]	USDA-ARS project	This work was funded by USDA-ARS project 1940-32000-057-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Bechtel MJ, 1996, EXP CELL RES, V223, P395, DOI 10.1006/excr.1996.0094; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Bongiovanni L, 2011, EXP DERMATOL, V20, P457, DOI 10.1111/j.1600-0625.2011.01273.x; Brincks EL, 2011, J IMMUNOL, V187, P4581, DOI 10.4049/jimmunol.1002241; Brown CC, 1996, J VIROL, V70, P5638, DOI 10.1128/JVI.70.8.5638-5641.1996; Bryan L, 2008, MOL CANCER RES, V6, P1469, DOI 10.1158/1541-7786.MCR-08-0082; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Choi IK, 2010, GENE THER, V17, P190, DOI 10.1038/gt.2009.142; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de los Santos T, 2009, J VIROL, V83, P1800, DOI 10.1128/JVI.02112-08; DEVANEY MA, 1988, J VIROL, V62, P4407, DOI 10.1128/JVI.62.11.4407-4409.1988; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Evans DJ, 1998, TRENDS MICROBIOL, V6, P198, DOI 10.1016/S0966-842X(98)01263-3; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; Feliciani C, 2003, EXP DERMATOL, V12, P466, DOI 10.1034/j.1600-0625.2002.120415.x; Feliciani C, 2000, J INVEST DERMATOL, V114, P71, DOI 10.1046/j.1523-1747.2000.00835.x; Fracastorius H, 1546, HEIRS LA JUNTA BOOK, P36; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kolodkin-Gal D, 2008, J VIROL, V82, P999, DOI 10.1128/JVI.01769-07; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Neff S, 2001, J VIROL, V75, P527, DOI 10.1128/JVI.75.1.527-532.2001; Neff S, 2000, J VIROL, V74, P7298, DOI 10.1128/JVI.74.16.7298-7306.2000; O'Donnell V, 2009, J COMP PATHOL, V141, P98, DOI 10.1016/j.jcpa.2008.09.008; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; PROUD D, 1994, J INFECT DIS, V169, P1007, DOI 10.1093/infdis/169.5.1007; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schuurhof A, 2012, EUR RESPIR J, V39, P1475, DOI 10.1183/09031936.00012311; Schwab W, 2004, HISTOL HISTOPATHOL, V19, P105, DOI 10.14670/HH-19.105; Segundo FDS, 2010, J VIROL, V84, P2063, DOI 10.1128/JVI.01874-09; Shepard Brett D., 2009, Anti-Infective Agents in Medicinal Chemistry, V8, P87; Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Yaacov B, 2012, J GEN VIROL, V93, P1664, DOI 10.1099/vir.0.043281-0; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0; Zhang ZD, 2004, J GEN VIROL, V85, P415, DOI 10.1099/vir.0.19538-0; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431; Zhu J, 2010, VIROLOGY, V404, P32, DOI 10.1016/j.virol.2010.04.021	61	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64119	10.1371/journal.pone.0064119	http://dx.doi.org/10.1371/journal.pone.0064119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724025	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000041
J	Boieiro, M; Carvalho, JC; Cardoso, P; Aguiar, CAS; Rego, C; Silva, IDE; Amorim, IR; Pereira, F; Azevedo, EB; Borges, PAV; Serrano, ARM				Boieiro, Mario; Carvalho, Jose C.; Cardoso, Pedro; Aguiar, Carlos A. S.; Rego, Carla; de Faria e Silva, Israel; Amorim, Isabel R.; Pereira, Fernando; Azevedo, Eduardo B.; Borges, Paulo A. V.; Serrano, Artur R. M.			Spatial Factors Play a Major Role as Determinants of Endemic Ground Beetle Beta Diversity of Madeira Island Laurisilva	PLOS ONE			English	Article							SPECIES RICHNESS; DISTANCE DECAY; BIODIVERSITY HOTSPOTS; VEGETATION STRUCTURE; CARABID ASSEMBLAGES; BODY-SIZE; PATTERNS; COLEOPTERA; COMMUNITIES; LANDSCAPE	The development in recent years of new beta diversity analytical approaches highlighted valuable information on the different processes structuring ecological communities. A crucial development for the understanding of beta diversity patterns was also its differentiation in two components: species turnover and richness differences. In this study, we evaluate beta diversity patterns of ground beetles from 26 sites in Madeira Island distributed throughout Laurisilva - a relict forest restricted to the Macaronesian archipelagos. We assess how the two components of ground beetle beta diversity (beta(repl) - species turnover and beta(rich) - species richness differences) relate with differences in climate, geography, landscape composition matrix, woody plant species richness and soil characteristics and the relative importance of the effects of these variables at different spatial scales. We sampled 1025 specimens from 31 species, most of which are endemic to Madeira Island. A spatially explicit analysis was used to evaluate the contribution of pure environmental, pure spatial and environmental spatially structured effects on variation in ground beetle species richness and composition. Variation partitioning showed that 31.9% of species turnover (beta(repl)) and 40.7% of species richness variation (beta(rich)) could be explained by the environmental and spatial variables. However, different environmental variables controlled the two types of beta diversity: beta(repl) was influenced by climate, disturbance and soil organic matter content whilst beta(rich) was controlled by altitude and slope. Furthermore, spatial variables, represented through Moran's eigenvector maps, played a significant role in explaining both beta(repl) and beta(rich), suggesting that both dispersal ability and Madeira Island complex orography are crucial for the understanding of beta diversity patterns in this group of beetles.	[Boieiro, Mario; Aguiar, Carlos A. S.; de Faria e Silva, Israel; Serrano, Artur R. M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Boieiro, Mario; Aguiar, Carlos A. S.; de Faria e Silva, Israel; Serrano, Artur R. M.] Univ Lisbon, Fac Ciencias, Portuguese Platform Enhancing Ecol Res & Sustaina, Lisbon, Portugal; [Carvalho, Jose C.; Cardoso, Pedro; Rego, Carla; Amorim, Isabel R.; Pereira, Fernando; Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Azorean Biodivers Grp, Angra Do Heroismo, Acores, Portugal; [Carvalho, Jose C.; Cardoso, Pedro; Rego, Carla; Amorim, Isabel R.; Pereira, Fernando; Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Portuguese Platform Enhancing Ecol Res & Sustaina, Angra Do Heroismo, Acores, Portugal; [Cardoso, Pedro] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Azevedo, Eduardo B.] Univ Acores, Dept Ciencias Agr, Ctr Estudos Clima Meteorol & Mudancas Globais, Angra Do Heroismo, Acores, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade dos Acores; Universidade dos Acores; University of Helsinki; Universidade dos Acores	Boieiro, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	mboieiro@fc.ul.pt	Amorim do Rosario, Isabel/AAW-2610-2020; Rosário, Isabel M Amorim do/P-5140-2015; Rego, Carla/A-8344-2012; Borges, Paulo/H-5153-2019; Cardoso, Pedro/A-8820-2008; Rego, Carla/L-8027-2013; Azevedo, Eduardo B/M-4266-2013; Cardoso, Pedro/AAY-9650-2020; Borges, Paulo/B-2780-2008; Serrano, Artur Raposo Moniz/P-6425-2015; Boieiro, Mário/A-8366-2012; , CINTESIS/C-6631-2014	Amorim do Rosario, Isabel/0000-0001-6847-3320; Rosário, Isabel M Amorim do/0000-0001-6847-3320; Rego, Carla/0000-0001-8005-4508; Borges, Paulo/0000-0002-8448-7623; Cardoso, Pedro/0000-0001-8119-9960; Azevedo, Eduardo B/0000-0001-5172-7742; Cardoso, Pedro/0000-0001-8119-9960; Borges, Paulo/0000-0002-8448-7623; Boieiro, Mário/0000-0002-9087-091X; Serrano, Artur/0000-0003-4282-6073; , CINTESIS/0000-0001-7248-2086; Pereira, Fernando/0000-0002-2238-9681	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PDCT/BIA-BDE/59202/2004, PTDC/BIA-BEC/99138/2008]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology)	Financial support was provided by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through projects PDCT/BIA-BDE/59202/2004 and PTDC/BIA-BEC/99138/2008 (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andresen E, 2008, J INSECT CONSERV, V12, P639, DOI 10.1007/s10841-007-9100-y; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Aviron S, 2005, AGR ECOSYST ENVIRON, V108, P205, DOI 10.1016/j.agee.2005.02.004; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Azevedo E. B., 1999, AGR WATER MANAGE, V40, P393, DOI DOI 10.1016/S0378-3774(99)00012-8; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Baselga A, 2011, INSECT CONSERV DIVER, V5, P331; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2007, ECOL ENTOMOL, V32, P312, DOI 10.1111/j.1365-2311.2007.00880.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bates AJ, 2007, EUR J ENTOMOL, V104, P479, DOI 10.14411/eje.2007.068; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Boieiro M, 2010, TERRESTRIAL ARTHROPO, P115; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borcard D, 1994, ENVIRON ECOL STAT, V1, P37, DOI 10.1007/BF00714196; Borges P. A. V., 2008, Listagem dos fungos, flora e fauna terrestres dos arquipelagos de Madeira e Selvagens; Borges P. A. V., 2008, LIST TERRESTRIAL FUN, P157; Borges PAV, 2009, J BIOGEOGR, V36, P178, DOI 10.1111/j.1365-2699.2008.01980.x; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV, 2005, BIODIVERS CONSERV, V14, P2029, DOI 10.1007/s10531-004-4283-y; Britton-Davidian J, 2007, HEREDITY, V99, P432, DOI 10.1038/sj.hdy.6801021; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Cameron RAD, 2001, J MOLLUS STUD, V67, P257, DOI 10.1093/mollus/67.3.257; CAPELO J., 2004, QUERCETEA, V6, P3; Cardoso P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063294; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Cook LM, 2008, J BIOGEOGR, V35, P647, DOI 10.1111/j.1365-2699.2007.01801.x; da Silva PM, 2008, AGR ECOSYST ENVIRON, V124, P270, DOI 10.1016/j.agee.2007.10.007; Dray S, 2010, R PACKAGE VERSION 0; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fuller RJ, 2008, INSECT CONSERV DIVER, V1, P242, DOI 10.1111/j.1752-4598.2008.00032.x; Genner MJ, 2004, ECOGRAPHY, V27, P601, DOI 10.1111/j.0906-7590.2004.03824.x; IUCN IUCN, 1999, REPORT 23 ORDINARY S, P93; Jimenez-Valverde A, 2010, INSECT CONSERV DIVER, V3, P51, DOI 10.1111/j.1752-4598.2009.00067.x; Judas M, 2002, J BIOGEOGR, V29, P491, DOI 10.1046/j.1365-2699.2002.00697.x; Jukes MR, 2001, FOREST ECOL MANAG, V148, P271, DOI 10.1016/S0378-1127(00)00530-2; Kallimanis AS, 2010, BIODIVERS CONSERV, V19, P1225, DOI 10.1007/s10531-009-9748-6; Karst J, 2005, ECOLOGY, V86, P2473, DOI 10.1890/04-1420; Koivula M, 1999, ECOGRAPHY, V22, P424, DOI 10.1111/j.1600-0587.1999.tb00579.x; Koivula MJ, 2011, ZOOKEYS, P287, DOI 10.3897/zookeys.100.1533; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lindo Z, 2009, OECOLOGIA, V160, P817, DOI 10.1007/s00442-009-1348-3; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Magura T, 2000, BIOL CONSERV, V93, P95, DOI 10.1016/S0006-3207(99)00073-7; Marini L, 2013, GLOBAL ECOL BIOGEOGR, V22, P450, DOI 10.1111/geb.12006; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Neves H, 1996, LAURISSILVA MADEIRA; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Okuda T, 2010, ACTA OECOL, V36, P413, DOI 10.1016/j.actao.2010.04.002; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pestano J, 2003, MOL PHYLOGENET EVOL, V27, P422, DOI 10.1016/S1055-7903(03)00017-4; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Prada SN, 2000, BOCAGIANA, V200, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Schuldt A, 2009, ECOGRAPHY, V32, P705, DOI 10.1111/j.1600-0587.2009.05763.x; Serrano Artur R.M., 1998, Boletim do Museu Municipal do Funchal Suplemento, V5, P399; Serrano Artur R.M., 1997, Portugaliae Zoologica, V4, P9; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Spiesman BJ, 2008, LANDSCAPE ECOL, V23, P313, DOI 10.1007/s10980-007-9186-3; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Thiele H, 1977, CARABID BEETLES THEI; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Triantis KA, 2012, J BIOGEOGR, V39, P1179, DOI 10.1111/j.1365-2699.2011.02623.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Tyler G, 2008, FOREST ECOL MANAG, V256, P2154, DOI 10.1016/j.foreco.2008.08.006; Vasconcelos HL, 2010, J BIOGEOGR, V37, P432, DOI 10.1111/j.1365-2699.2009.02230.x; Vele A, 2011, EUR J SOIL BIOL, V47, P349, DOI 10.1016/j.ejsobi.2011.09.003; Wang ZH, 2012, ECOGRAPHY, V35, P1092, DOI 10.1111/j.1600-0587.2012.06988.x; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Williams PH, 1999, J BIOGEOGR, V26, P459, DOI 10.1046/j.1365-2699.1999.00294.x	96	27	28	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64591	10.1371/journal.pone.0064591	http://dx.doi.org/10.1371/journal.pone.0064591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724065	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100032
J	Scheven, L; Halbesma, N; de Jong, PE; de Zeeuw, D; Bakker, SJL; Gansevoort, RT				Scheven, Lieneke; Halbesma, Nynke; de Jong, Paul E.; de Zeeuw, Dick; Bakker, Stephan J. L.; Gansevoort, Ron T.			Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR MORTALITY; RENAL-DISEASE; ALL-CAUSE; MICROALBUMINURIA; RISK; EXCRETION; NEPHROPATHY	Background: Urinary albumin excretion is known to be independently associated with progression of renal and cardiovascular disease. The aim of this study was to identify predictors for progression in albuminuria in the general population. Methods: Data were used of the first 4 screening rounds of a community-based prospective cohort study (PREVEND). Included were 5,825 subjects that at baseline had no known renal disease or macroalbuminuria. Subjects were defined as having progressive albuminuria when they belonged to the quintile of subjects with highest absolute increase in urinary albumin excretion per year and a urinary albumin excretion during the last screening in which they participated of >= 150 mg/24 h. Change in urinary albumin excretion per year was calculated as last available urinary albumin excretion minus baseline UAE divided by follow-up time. Results: During 9.3 years follow-up 132 subjects had progressive albuminuria. These subjects were significantly older, more often of male gender and had a worse cardiovascular risk profile. In a multivariable model, testing baseline values, significant predictors of progressive albuminuria were male gender (OR 2.23; p < 0.001), age (OR 1.03; p < 0.001), BMI (OR 1.06; p = 0.02) and baseline albuminuria (OR 5.71; p < 0.001). Based on these findings a risk score was made to estimate a subject's risk for progressive albuminuria. Conclusion: A high baseline albuminuria is by far the most important predictor of progressive albuminuria. Thus, screening for baseline albuminuria will be more important than screening for cardiovascular risk factors in order to identify subjects at risk for progressive albuminuria.	[Scheven, Lieneke; de Jong, Paul E.; Bakker, Stephan J. L.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Halbesma, Nynke] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC)	Gansevoort, RT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	r.t.gansevoort@umcg.nl	de Zeeuw, Dick/E-9080-2014; Bakker, Stephan J. L./J-4023-2015	de Zeeuw, Dick/0000-0003-3434-7777; Bakker, Stephan J. L./0000-0003-3356-6791	Dutch Kidney Foundation	Dutch Kidney Foundation	The PREVEND Study was made possible by grants from the Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang HJ, 2009, NEPHROL DIAL TRANSPL, V24, P2452, DOI 10.1093/ndt/gfp124; Brantsma AH, 2005, DIABETES CARE, V28, P2525, DOI 10.2337/diacare.28.10.2525; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Brantsma AH, 2007, J AM SOC NEPHROL, V18, P637, DOI 10.1681/ASN.2006070738; Close CF, 1999, DIABETIC MED, V16, P918; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gavin JR, 1999, DIABETES CARE, V22, pS5; Halbesma N, 2011, CLIN J AM SOC NEPHRO, V6, P1731, DOI 10.2215/CJN.08590910; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; MOGENSEN CE, 1990, DIABETES, V39, P761, DOI 10.2337/diabetes.39.7.761; MYKKANEN L, 1994, DIABETES, V43, P552, DOI 10.2337/diabetes.43.4.552; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; O'Seaghdha CM, 2010, AM J KIDNEY DIS, V56, P852, DOI 10.1053/j.ajkd.2010.04.013; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; Schirm E, 2004, PHARMACOEPIDEM DR S, V13, P173, DOI 10.1002/pds.882; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Spoelstra-De Man AME, 2001, DIABETES CARE, V24, P2097, DOI 10.2337/diacare.24.12.2097; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wakai K, 2006, NEPHROL DIAL TRANSPL, V21, P2800, DOI 10.1093/ndt/gfl342; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; Warram JH, 2000, DIABETES, V49, P94, DOI 10.2337/diabetes.49.1.94; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; Yamada T, 2005, DIABETES CARE, V28, P2733, DOI 10.2337/diacare.28.11.2733	34	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e61119	10.1371/journal.pone.0061119	http://dx.doi.org/10.1371/journal.pone.0061119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723966	gold, Green Published, Green Submitted			2022-12-25	WOS:000319738100001
J	van Vliet, E; Eixarch, E; Illa, M; Arbat-Plana, A; Gonzalez-Tendero, A; Hogberg, HT; Zhao, L; Hartung, T; Gratacos, E				van Vliet, Erwin; Eixarch, Elisenda; Illa, Miriam; Arbat-Plana, Ariadna; Gonzalez-Tendero, Anna; Hogberg, Helena T.; Zhao, Liang; Hartung, Thomas; Gratacos, Eduard			Metabolomics Reveals Metabolic Alterations by Intrauterine Growth Restriction in the Fetal Rabbit Brain	PLOS ONE			English	Article							FATTY-ACIDS; GESTATIONAL-AGE; PRETERM INFANTS; NEUROBEHAVIORAL OUTCOMES; DEVELOPMENTAL-CHANGES; N-ACETYLASPARTATE; MODEL; NEWBORN; PREGNANCIES; MATURATION	Background: Intrauterine Growth Restriction (IUGR) due to placental insufficiency occurs in 5-10% of pregnancies and is a major risk factor for abnormal neurodevelopment. The perinatal diagnosis of IUGR related abnormal neurodevelopment represents a major challenge in fetal medicine. The development of clinical biomarkers is considered a promising approach, but requires the identification of biochemical/molecular alterations by IUGR in the fetal brain. This targeted metabolomics study in a rabbit IUGR model aimed to obtain mechanistic insight into the effects of IUGR on the fetal brain and identify metabolite candidates for biomarker development. Methodology/Principal Findings: At gestation day 25, IUGR was induced in two New Zealand rabbits by 40-50% uteroplacental vessel ligation in one horn and the contralateral horn was used as control. At day 30, fetuses were delivered by Cesarian section, weighed and brains collected for metabolomics analysis. Results showed that IUGR fetuses had a significantly lower birth and brain weight compared to controls. Metabolomics analysis using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and database matching identified 78 metabolites. Comparison of metabolite intensities using a t-test demonstrated that 18 metabolites were significantly different between control and IUGR brain tissue, including neurotransmitters/peptides, amino acids, fatty acids, energy metabolism intermediates and oxidative stress metabolites. Principle component and hierarchical cluster analysis showed cluster formations that clearly separated control from IUGR brain tissue samples, revealing the potential to develop predictive biomarkers. Moreover birth weight and metabolite intensity correlations indicated that the extent of alterations was dependent on the severity of IUGR. Conclusions: IUGR leads to metabolic alterations in the fetal rabbit brain, involving neuronal viability, energy metabolism, amino acid levels, fatty acid profiles and oxidative stress mechanisms. Overall findings identified aspargine, ornithine, N-acetylaspartylglutamic acid, N-acetylaspartate and palmitoleic acid as potential metabolite candidates to develop clinical biomarkers for the perinatal diagnosis of IUGR related abnormal neurodevelopment.	[van Vliet, Erwin; Eixarch, Elisenda; Illa, Miriam; Arbat-Plana, Ariadna; Gonzalez-Tendero, Anna; Gratacos, Eduard] Hosp Clin Barcelona, Dept Maternal Fetal Med, ICGON, Barcelona, Spain; [van Vliet, Erwin; Eixarch, Elisenda; Illa, Miriam; Arbat-Plana, Ariadna; Gonzalez-Tendero, Anna; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Hogberg, Helena T.; Zhao, Liang; Hartung, Thomas] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gratacos, E (corresponding author), Hosp Clin Barcelona, Dept Maternal Fetal Med, ICGON, Barcelona, Spain.	gratacos@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Zhao, Liang/I-4777-2015	Gratacos, Eduard/0000-0002-7405-7224; Zhao, Liang/0000-0002-2126-6778; Illa, Miriam/0000-0002-8366-830X; Hogberg, Helena/0000-0001-8034-6818; Eixarch, Elisenda/0000-0001-7379-9608; Arbat-Plana, Ariadna/0000-0003-0479-8323	Obra Social La Caixa (Barcelona, Spain)	Obra Social La Caixa (Barcelona, Spain)(La Caixa Foundation)	The presented research was supported by Obra Social La Caixa (Barcelona, Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Als H, 2011, J PERINATOL, V31, P130, DOI 10.1038/jp.2010.81; Alvino G, 2008, PEDIATR RES, V64, P615, DOI 10.1203/PDR.0b013e31818702a2; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Benavides-Serralde A, 2009, ULTRASOUND OBST GYN, V33, P530, DOI 10.1002/uog.6343; Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129; CETIN I, 1992, EARLY HUM DEV, V29, P183, DOI 10.1016/0378-3782(92)90136-5; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Cruz-Lemini M, 2012, FETAL DIAGN THER, V32, P116, DOI 10.1159/000333001; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; de Vrijer B, 2004, AM J PHYSIOL-ENDOC M, V287, pE1114, DOI 10.1152/ajpendo.00259.2004; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Esteban FJ, 2010, NEUROIMAGE, V53, P1225, DOI 10.1016/j.neuroimage.2010.07.019; Favretto D, 2012, ANAL BIOANAL CHEM, V402, P1109, DOI 10.1007/s00216-011-5540-z; Figueras F, 2011, ULTRASOUND OBST GYN, V38, P288, DOI 10.1002/uog.9041; Forster DM, 2012, NMR BIOMED, V25, P52, DOI 10.1002/nbm.1712; Georgieff MK, 2005, PEDIATR RES, V57, p99R, DOI 10.1203/01.PDR.0000160542.69840.0F; Geva R, 2008, J CHILD PSYCHOL PSYC, V49, P1321, DOI 10.1111/j.1469-7610.2008.01917.x; Green P, 1999, J LIPID RES, V40, P960; Horgan RP, 2009, BJOG-INT J OBSTET GY, V116, P173, DOI 10.1111/j.1471-0528.2008.01997.x; Ikeno M, 2009, EARLY HUM DEV, V85, P733, DOI 10.1016/j.earlhumdev.2009.09.006; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kuipers RS, 2012, PROSTAG LEUKOTR ESS, V86, P39, DOI 10.1016/j.plefa.2011.10.007; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nissen PM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/378268; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Ross JC, 1996, AM J PHYSIOL-ENDOC M, V270, pE491, DOI 10.1152/ajpendo.1996.270.3.E491; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	48	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64545	10.1371/journal.pone.0064545	http://dx.doi.org/10.1371/journal.pone.0064545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724060	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100029
J	Yelskaya, Z; Carrillo, V; Dubisz, E; Gulzar, H; Morgan, D; Mahajan, SS				Yelskaya, Zarina; Carrillo, Vangie; Dubisz, Ewa; Gulzar, Hira; Morgan, Devon; Mahajan, Shahana S.			Synergistic Inhibition of Survival, Proliferation, and Migration of U87 Cells with a Combination of LY341495 and Iressa	PLOS ONE			English	Article							PROTEIN-KINASE B; GROWTH-FACTOR RECEPTOR; HUMAN GLIOMA-CELLS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS; AMPA RECEPTORS; IN-VIVO; PHOSPHOINOSITIDE 3-KINASE; PHARMACOLOGICAL BLOCKADE; GLUTAMATE TRANSPORTERS	Glioblastomas exploit various molecular pathways to promote glutamate-dependent growth by activating the AMPA (2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid) receptor, the group II metabotropic glutamate receptor, mGluR, and the epidermal growth factor receptor, EGFR. We hypothesized that targeting more than one of these pathways would be more effective in inhibiting glutamate-dependent growth. Using a model of U87 cell line, we show that blocking glutamate release by Riluzole inhibits cell proliferation. Glutamate-dependent growth is effectively inhibited by a combination of Iressa, an inhibitor of EGFR activation and LY341495, a group II mGluR inhibitor. Treatment of U87 cells with a combination of Iressa and LY341495 inhibits proliferation as indicated by Ki-67 staining, induces apoptosis and inhibits migration of U87 cells more effectively than the treatment by Iressa or LY341495 alone. These results demonstrate that a combinatorial therapy with Iressa and LY341495 is more effective due to synergistic effects of these drugs in inhibiting the growth of glioblastoma.	[Yelskaya, Zarina; Carrillo, Vangie; Dubisz, Ewa; Gulzar, Hira; Morgan, Devon; Mahajan, Shahana S.] CUNY Hunter Coll, Dept Hlth Sci, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Mahajan, SS (corresponding author), CUNY Hunter Coll, Dept Hlth Sci, New York, NY 10021 USA.	smahajan@hunter.cuny.edu			Hunter College President's Fund for Faculty Enhancement; PSC-CUNY [TRADB 43-141]	Hunter College President's Fund for Faculty Enhancement; PSC-CUNY	This work is supported by Hunter College President's Fund for Faculty Enhancement and PSC-CUNY grant # TRADB 43-141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu K, 2009, ANTICANCER RES, V29, P2195; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arcella A, 2005, NEURO-ONCOLOGY, V7, P236, DOI 10.1215/S1152851704000961; Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; Beretta F, 2009, EUR J NEUROSCI, V30, P25, DOI 10.1111/j.1460-9568.2009.06804.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Choe G, 2003, CANCER RES, V63, P2742; Cuevas P, 2006, J CELL MOL MED, V10, P225, DOI 10.1111/j.1582-4934.2006.tb00303.x; D'Onofrio M, 2003, J NEUROCHEM, V84, P1288, DOI 10.1046/j.1471-4159.2003.01633.x; de Groot JF, 2005, CANCER RES, V65, P1934, DOI 10.1158/0008-5472.CAN-04-3626; Decraene D, 2004, J INVEST DERMATOL, V123, P207, DOI 10.1111/j.0022-202X.2004.22702.x; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; Fumagalli E, 2008, EUR J PHARMACOL, V578, P171, DOI 10.1016/j.ejphar.2007.10.023; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Gupta T, 2002, LANCET ONCOL, V3, P557, DOI 10.1016/S1470-2045(02)00853-7; Hatton JD, 1995, J NEUROSURG, V82, P841; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; LAERUM OD, 1984, CANCER METAST REV, V3, P223, DOI 10.1007/BF00048386; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahajan SS, 2007, MOL CELL NEUROSCI, V35, P470, DOI 10.1016/j.mcn.2007.04.006; Mahajan SS, 2011, NEUROSCIENCE, V189, P305, DOI 10.1016/j.neuroscience.2011.05.027; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mandell JW, 1998, AM J PATHOL, V153, P1411, DOI 10.1016/S0002-9440(10)65728-8; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; McLendon RE, 2007, ARCH PATHOL LAB MED, V131, P1585; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Nauc V, 2004, J ANDROL, V25, P573; Nieder C, 2008, AM J CLIN ONCOL-CANC, V31, P300, DOI 10.1097/COC.0b013e31815e3fdc; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Schunemann DP, 2010, PATHOL ONCOL RES, V16, P285, DOI 10.1007/s12253-009-9223-4; Shinojima N, 2003, CANCER RES, V63, P6962; Sonoda Y, 2001, CANCER RES, V61, P6674; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tsai KD, 2012, INT IMMUNOPHARMACOL, V12, P471, DOI 10.1016/j.intimp.2011.12.017; van Vuurden DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005953; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yoshida Y, 2006, PATHOL INT, V56, P262, DOI 10.1111/j.1440-1827.2006.01954.x	54	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64588	10.1371/journal.pone.0064588	http://dx.doi.org/10.1371/journal.pone.0064588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724064	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100031
J	Shah, S; Butler, NM; Hannapel, DJ; Rao, AG				Shah, Shweta; Butler, Nathaniel M.; Hannapel, David J.; Rao, A. Gururaj			Mapping and Characterization of the Interaction Interface between Two Polypyrimidine-Tract Binding Proteins and a Nova-Type Protein of Solanum tuberosum	PLOS ONE			English	Article							RNA RECOGNITION MOTIFS; PEPTIDE MOTIF; HOT-SPOTS; PTB; ARABIDOPSIS; POTATO; RAVER1; HOMOLOGS; DOMAINS	Polypyrimidine tract-binding (PTB) proteins are RNA-binding proteins that generally contain four RNA recognition motifs (RRMs). In potato, six cDNAs encoding full-length PTB proteins have been identified. In the present study Nova1-like protein, designated StNova1, was identified as a potential interacting partner of the StPTB proteins via yeast two-hybrid screening. Nova protein is a RNA-binding protein that contains three K-homology (KH) domains. In humans, these proteins are involved in regulation of neuronal RNA metabolism but the role of Nova-like proteins in plants is poorly understood. We have validated this interaction and mapped the protein binding region on StNova1 and StPTB1 and 26 using a novel domain interaction phage display (DIPP) technique. The interaction between the two RNA-binding proteins StPTB1/6 and StNova1 is mediated through linker regions that are distinctly separated from the RRMs. Furthermore, using a random 21-mer phage-peptide library, we have identified a number of peptides with the consensus sequence motif [S/G][V/I][L/V]G that recognize the StPTB proteins. One over-represented peptide that recognizes StPTB6 contains the GVLGPWP sequence that is similar to the GIGGRYP sequence in the glycine-rich linker region between the KH2 and KH3 domains of StNova1. We show, through site-specific mutations, the importance of glycine and proline residues in StNova1-StPTB interactions.	[Shah, Shweta; Rao, A. Gururaj] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Butler, Nathaniel M.; Hannapel, David J.] Iowa State Univ, Ames, IA USA	Iowa State University; Iowa State University	Rao, AG (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gururao@iastate.edu		Butler, Nathaniel/0000-0002-9235-7626	National Science Foundation Plant Genome Research Program [DBI-0820659]; National Research Initiative from the USDA National Institute of Food and Agriculture [2008-02806]	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Research Initiative from the USDA National Institute of Food and Agriculture	This research was supported by the National Science Foundation Plant Genome Research Program (Grant no. DBI-0820659) and National Research Initiative (Grant no. 2008-02806) from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler NM, 2012, PLANTA, V236, P1747, DOI 10.1007/s00425-012-1726-7; Chen H, 2003, PLANT PHYSIOL, V132, P1391, DOI 10.1104/pp.103.022434; Clerte C, 2009, BIOCHEMISTRY-US, V48, P2063, DOI 10.1021/bi8016872; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Fujisaki K, 2008, VIROLOGY, V380, P402, DOI 10.1016/j.virol.2008.07.033; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Henneberg B, 2010, EXP CELL RES, V316, P966, DOI 10.1016/j.yexcr.2009.11.023; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Joshi A, 2011, STRUCTURE, V19, P1816, DOI 10.1016/j.str.2011.09.020; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kleinhenz B, 2005, FEBS LETT, V579, P4254, DOI 10.1016/j.febslet.2005.07.001; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mahajan A, 2012, PLANT MOL BIOL, V79, P595, DOI 10.1007/s11103-012-9931-0; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Ruhl C, 2012, PLANT CELL, V24, P4360, DOI 10.1105/tpc.112.103622; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Stauffer E, 2010, PLANT J, V64, P243, DOI 10.1111/j.1365-313X.2010.04321.x; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Wachter A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00081; Wang SY, 2009, PLANT CELL PHYSIOL, V50, P179, DOI 10.1093/pcp/pcn207	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64783	10.1371/journal.pone.0064783	http://dx.doi.org/10.1371/journal.pone.0064783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717658	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300011
J	Mohamad, O; Drury-Stewart, D; Song, MK; Faulkner, B; Chen, DD; Yu, SP; Wei, L				Mohamad, Osama; Drury-Stewart, Danielle; Song, Mingke; Faulkner, Ben; Chen, Dongdong; Yu, Shan Ping; Wei, Ling			Vector-Free and Transgene-Free Human iPS Cells Differentiate into Functional Neurons and Enhance Functional Recovery after Ischemic Stroke in Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA; IN-VITRO; DIRECTED DIFFERENTIATION; NEURAL DIFFERENTIATION; HUMAN FIBROBLASTS; IMMUNE CELLS; TRANSPLANTATION; INDUCTION; GENERATION	Stroke is a leading cause of human death and disability in the adult population in the United States and around the world. While stroke treatment is limited, stem cell transplantation has emerged as a promising regenerative therapy to replace or repair damaged tissues and enhance functional recovery after stroke. Recently, the creation of induced pluripotent stem (iPS) cells through reprogramming of somatic cells has revolutionized cell therapy by providing an unlimited source of autologous cells for transplantation. In addition, the creation of vector-free and transgene-free human iPS (hiPS) cells provides a new generation of stem cells with a reduced risk of tumor formation that was associated with the random integration of viral vectors seen with previous techniques. However, the potential use of these cells in the treatment of ischemic stroke has not been explored. In the present investigation, we examined the neuronal differentiation of vector-free and transgene-free hiPS cells and the transplantation of hiPS cell-derived neural progenitor cells (hiPS-NPCs) in an ischemic stroke model in mice. Vector-free hiPS cells were maintained in feeder-free and serum-free conditions and differentiated into functional neurons in vitro using a newly developed differentiation protocol. Twenty eight days after transplantation in stroke mice, hiPS-NPCs showed mature neuronal markers in vivo. No tumor formation was seen up to 12 months after transplantation. Transplantation of hiPS-NPCs restored neurovascular coupling, increased trophic support and promoted behavioral recovery after stroke. These data suggest that using vector-free and transgene-free hiPS cells in stem cell therapy are safe and efficacious in enhancing recovery after focal ischemic stroke in mice.	[Mohamad, Osama; Song, Mingke; Faulkner, Ben; Chen, Dongdong; Yu, Shan Ping; Wei, Ling] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Drury-Stewart, Danielle] Georgia Tech Inst, Dept Biomed Engn, Atlanta, GA USA	Emory University	Wei, L (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA.	lwei7@emory.edu	Song, Mingke/N-5971-2014		National Institutes of Health (NIH) [NS 045810, NS062097, NS058710, NS057255]; American Heart Association [10PRE4430032]; NIH [NS055077]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045810, P30NS055077, R01NS062097, R01NS058710, R01NS057255] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) grants NS 045810, NS062097, NS058710, NS057255 and the American Heart Association Established Investigator Award. It was partly supported by American Heart Association pre-doctoral fellowship award (10PRE4430032). It was also supported by the NIH grant NS055077 to the ENNCF (Emory Neurology-NINDS Core Facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Wert G, 2003, HUM REPROD, V18, P672, DOI 10.1093/humrep/DEG143; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Drury-Stewart Danielle, 2011, J Stem Cells, V6, P1; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Green A. Richard, 2004, Critical Reviews in Neurobiology, V16, P91, DOI 10.1615/CritRevNeurobiol.v16.i12.100; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Ingvarsson S, 1990, Semin Cancer Biol, V1, P359; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jensen MB, 2011, J STROKE CEREBROVASC; Jiang M, 2011, MOL CELL BIOCHEM, V354, P67, DOI 10.1007/s11010-011-0806-5; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim DS, STEM CELL REV, V6, P270; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Manzerra P, 2001, P NATL ACAD SCI USA, V98, P11055, DOI 10.1073/pnas.191353598; Marcen R, 2009, DRUGS, V69, P2227, DOI 10.2165/11319260-000000000-00000; Marler JR, 2007, STROKE, V38, P3302, DOI 10.1161/STROKEAHA.107.485144; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mohamad O, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-51; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wei N, 2012, CELL TRANSPLANT; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamashita T, 2011, CELL TRANSPLANT, V20, P883, DOI 10.3727/096368910X539092; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	76	57	58	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64160	10.1371/journal.pone.0064160	http://dx.doi.org/10.1371/journal.pone.0064160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717557	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600047
J	Bear, A; Monteiro, A				Bear, Ashley; Monteiro, Antonia			Male Courtship Rate Plasticity in the Butterfly Bicyclus anynana Is Controlled by Temperature Experienced during the Pupal and Adult Stages	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; PATTERN-FORMATION; HORMONAL-CONTROL; CRITICAL PERIOD; POLYPHENISM; LEPIDOPTERA; EVOLUTION; RESPONSES	Environmental cues can act to initiate alternative developmental trajectories that result in different adult phenotypes, including behavioral phenotypes. The developmental period when an organism is sensitive to the cue is often described as a critical period. Here we investigated the critical period for temperature-sensitive courtship rate plasticity in the butterfly Bicyclus anynana. We performed a series of temperature-shift experiments in which larvae, pupae, or adults were shifted for blocks of time from one temperature to an alternative temperature, and then we quantified the courtship rate exhibited by adult males. We discovered that the critical period begins during pupal development and extends into adulthood, but temperature experienced during larval development does not affect male courtship rate. This finding allows us to develop hypotheses that address how developmental and physiological factors may have influenced the evolution of behavioral plasticity in this species.	[Bear, Ashley; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Bear, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	ashley.bear@yale.edu; antonia.monteiro@yale.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	Yale University; National Science Foundation Doctoral Dissertation Improvement Grants award [IOS-1110523]; Direct For Biological Sciences [1146933] Funding Source: National Science Foundation	Yale University; National Science Foundation Doctoral Dissertation Improvement Grants award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Yale University and National Science Foundation Doctoral Dissertation Improvement Grants award IOS-1110523 to AM and AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan TN, 2009, PHENOTYPIC PLASTICIT, P281; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Brakefield Paul M., 1997, EXS, V83, P65; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brown MR, 2009, ANNU REV ENTOMOL, V54, P105, DOI 10.1146/annurev.ento.53.103106.093334; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Dalton JE, 2009, CURR BIOL, V19, P1447, DOI 10.1016/j.cub.2009.06.063; Emlen DJ, 2001, J INSECT PHYSIOL, V47, P1045, DOI 10.1016/S0022-1910(01)00084-1; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Ganter GK, 2007, BEHAV GENET, V37, P507, DOI 10.1007/s10519-006-9140-1; HIROYOSHI S, 1992, APPL ENTOMOL ZOOL, V27, P155, DOI 10.1303/aez.27.155; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Noor MAF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003142; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P987, DOI 10.1016/0022-1910(95)00046-W; Schrempf A, 2006, EVOL DEV, V8, P266, DOI 10.1111/j.1525-142X.2006.00097.x; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	31	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64061	10.1371/journal.pone.0064061	http://dx.doi.org/10.1371/journal.pone.0064061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717531	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700095
J	Lin, MS; Hsu, KY; Chen, YJ; Chen, CR; Chen, CM; Chen, W				Lin, Ming-Shian; Hsu, Kun-Yen; Chen, Yi-Jen; Chen, Cheng-Ren; Chen, Chuan-Mu; Chen, Wei			Prevalence and Risk Factors of Asymptomatic Peripheral Arterial Disease in Patients with COPD in Taiwan	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANKLE-BRACHIAL INDEX; LUNG-FUNCTION; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; SYSTEMIC INFLAMMATION; BODY-MASS; OBESITY; DIAGNOSIS; BURDEN	Aim: Chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular morbidity and mortality. The aim of this study was to determine the prevalence of asymptomatic peripheral arterial disease (PAD) and the associated risk factors for patients with COPD. Methods: This prospective cross-sectional study enrolled 427 COPD patients (mean age: 70.0 years) without PAD symptoms consecutively. Demographic data, lung function and cardiovascular risk factors were recorded. The ankle-brachial index (ABI) was used to detect PAD (ABI < 0.90). Results: The overall prevalence of asymptomatic PAD in the COPD patients was 8% (2.5% in the younger participants (<65 years of age, n = 118) and 10% in the elderly participants (>= 65 years of age, n = 309). The COPD patients with asymptomatic PAD had a significantly higher rate of hyperlipidemia (47.1% vs. 10.4%) and hypertension (79.4% vs. 45.8%) than those without asymptomatic PAD (p < 0.05). There was no significant difference in lung function (forced vital capacity and forced expiratory volume in one second) between the two groups. In multivariate logistic regression, hyperlipidemia was the strongest independent factor for PAD (odds ratio (OR): 6.89, p < 0.005), followed by old age (OR: 4.80), hypertension (OR: 3.39) and smoking burden (pack-years, OR: 1.02). Conclusions: The prevalence of asymptomatic PAD among COPD patients in Taiwan is lower than in Western countries. Hyperlipidemia, old age, hypertension, and smoking burden were the associated cardiovascular risk factors. However, there was no association between lung function and PAD in the COPD patients.	[Lin, Ming-Shian; Hsu, Kun-Yen; Chen, Yi-Jen; Chen, Cheng-Ren; Chen, Wei] Chia Yi Christian Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Ming-Shian; Chen, Yi-Jen] Chang Gung Univ Sci & Technol, Dept Resp Care, Taichung, Taiwan; [Chen, Wei] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Chen, Chuan-Mu; Chen, Wei] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	China Medical University Taiwan; National Chung Hsing University	Chen, W (corresponding author), Chia Yi Christian Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan.	peteralfa2004@yahoo.com.tw	Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150				Arunachalam G, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-34; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Blum A, 2011, ISR MED ASSOC J, V13, P672; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Castagna O, 2008, EUR J CARDIOV PREV R, V15, P270, DOI 10.1097/HJR.0b013e3282f009a9; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; CHEN YJ, 2013, ANGIOLOGY; Daskalopoulou SS, 2008, CIRC J, V72, P441, DOI 10.1253/circj.72.441; Eagan TML, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-48; Engstrom G, 2000, J CARDIOVASC RISK, V7, P267; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; GILLUM RF, 1990, AM HEART J, V120, P1414, DOI 10.1016/0002-8703(90)90257-X; Giugliano G, 2010, INT J OBESITY, V34, P280, DOI 10.1038/ijo.2009.244; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Hunninghake Donald B, 2005, Proc Am Thorac Soc, V2, P44, DOI 10.1513/pats.200410-050SF; Ix JH, 2011, AM J EPIDEMIOL, V174, P1036, DOI 10.1093/aje/kwr228; Jakovljevic B, 2011, EUR J INTERN MED, V22, P84, DOI 10.1016/j.ejim.2010.07.019; Lee SY, 2010, KOREAN J ANESTHESIOL, V59, P196, DOI 10.4097/kjae.2010.59.3.196; Magnussen Helgo, 2009, Proc Am Thorac Soc, V6, P648, DOI 10.1513/pats.200906-053DP; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McDermott MM, 2006, J VASC SURG, V43, P1198, DOI 10.1016/j.jvs.2006.02.036; Pecci R, 2012, INT ANGIOL, V31, P444; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; REMELS AH, 2012, J APPL PHYSL; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schroeder EB, 2005, ATHEROSCLEROSIS, V180, P367, DOI 10.1016/j.atherosclerosis.2004.12.012; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; SORIANO JB, 2012, CHEST; Taneda Kenichiro, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS31, DOI 10.1111/j.1440-1681.2004.04116.x; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; Wohlfahrt P, 2011, EUR J CARDIOV PREV R, V18, P790, DOI 10.1177/1741826711398840; Wood-Baker R, 2010, INTERN MED J, V40, P94, DOI 10.1111/j.1445-5994.2009.02109.x; Yang Z, 2004, CIRCULATION, V110, P3715, DOI 10.1161/01.CIR.0000149747.82157.01; Zureik M, 2001, AM J RESP CRIT CARE, V164, P2181, DOI 10.1164/ajrccm.164.12.2107137	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64714	10.1371/journal.pone.0064714	http://dx.doi.org/10.1371/journal.pone.0064714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717654	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700169
J	Mahmoud, MF; Hassan, NA; El Bassossy, HM; Fahmy, A				Mahmoud, Mona F.; Hassan, Noura A.; El Bassossy, Hany M.; Fahmy, Ahmed			Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; FACTOR-ALPHA; CARDIOVASCULAR COMPLICATIONS; PROINFLAMMATORY CYTOKINES; VASCULAR REACTIVITY; OXIDATIVE STRESS; HIGH GLUCOSE	Vascular complications are the leading cause of morbidity and mortality in patients with diabetes. Quercetin is an important flavonoid with antioxidant and anti-inflammatory activity. Here, the effect of quercetin on diabetes-induced exaggerated vasoconstriction in insulin deficient and insulin resistant rat models was investigated. Insulin deficiency was induced by streptozotocin while, insulin resistance by fructose. Rats were left 8 weeks or 12 weeks after STZ or fructose administration respectively. Quercetin was daily administered in the last 6 weeks. Then, tail blood pressure (BP) was recorded in conscious animals; concentration-response curves for phenylephrine (PE) and KCl were studied in thoracic aorta rings. Non-fasting blood glucose level, serum insulin level, insulin resistance index, serum tumour necrosis factor-alpha (TNF-alpha) and serum Creactive protein (CRP) were determined. Nuclear transcription factor-kappa B (NF-kappa B) was assessed by immunofluorescence technique. Histopathological examination was also performed. The results showed that quercetin protected against diabetes-induced exaggerated vasoconstriction and reduced the elevated blood pressure. In addition, quercetin inhibited diabetes associated adventitial leukocyte infiltration, endothelial pyknosis and increased collagen deposition. These effects were accompanied with reduction in serum level of both TNF-alpha and CRP and inhibition of aortic NF-kappa B by quercetin in both models of diabetes. On the other hand, quercetin did not affect glucose level in any of the used diabetic models. This suggests that the protective effect of quercetin is mediated by its anti-inflammatory effect rather than its metabolic effects. In summary, quercetin is potential candidate to prevent diabetic vascular complications in both insulin deficiency and resistance via its inhibitory effect on inflammatory pathways especially NF-kappa B signaling.	[Mahmoud, Mona F.; Hassan, Noura A.; El Bassossy, Hany M.; Fahmy, Ahmed] Zagazig Univ, Fac Pharm, Dept Pharmacol & Toxicol, Zagazig, Egypt; [El Bassossy, Hany M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia	Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University	Mahmoud, MF (corresponding author), Zagazig Univ, Fac Pharm, Dept Pharmacol & Toxicol, Zagazig, Egypt.	mona_pharmacology@yahoo.com	Hassan, Noura/GXN-4621-2022; Mahmoud, Mona/Q-8851-2019; El-Bassossy, Hany M/I-1576-2012; El-Bassossy, Hany/O-2242-2019	Hassan, Noura/0000-0001-8941-3781; El-Bassossy, Hany M/0000-0002-6838-6945; El-Bassossy, Hany/0000-0002-6838-6945; Mahmoud, Mona/0000-0002-5312-2066	Science and Technology Development Fund, Egypt [ID1024]	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF))	The publication fees and the additional measurements were funded by a research grant ID1024 provided by the Science and Technology Development Fund, Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Ajay M, 2006, DIABETES RES CLIN PR, V73, P1, DOI 10.1016/j.diabres.2005.11.004; Alvarez A, 1999, J ETHNOPHARMACOL, V67, P333, DOI 10.1016/S0378-8741(99)00092-6; Ansarullah, 2010, EUR J INTEGR MED, V2, P79, DOI 10.1016/j.eujim.2010.03.005; Bhaskar S, 2013, NUTRITION, V29, P219, DOI 10.1016/j.nut.2012.01.019; Carlstrom J, 2007, J NUTR, V137, P628, DOI 10.1093/jn/137.3.628; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Cirico TL, 2006, FOOD CHEM TOXICOL, V44, P510, DOI 10.1016/j.fct.2005.08.025; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; DANIELSEN R, 1987, AM J CARDIOL, V60, P143, DOI 10.1016/0002-9149(87)91001-0; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El-Bassossy HM, 2012, VASC PHARMACOL, V57, P194, DOI 10.1016/j.vph.2012.01.001; El-Bassossy HM, 2011, FOOD CHEM TOXICOL, V49, P3007, DOI 10.1016/j.fct.2011.07.060; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; Ergul A, 2011, PHARMACOL RES, V63, P477, DOI 10.1016/j.phrs.2011.01.012; Fan X, 2003, ARCH BIOCHEM BIOPHYS, V409, P274, DOI 10.1016/S0003-9861(02)00599-4; Farhangkhoee H, 2006, PHARMACOL THERAPEUT, V111, P384, DOI 10.1016/j.pharmthera.2005.10.008; FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363; Fukui M, 2003, DIABETES RES CLIN PR, V59, P153, DOI 10.1016/S0168-8227(02)00204-8; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Ghanem FA, 2007, J AM SOC HYPERTENS, V1, P113, DOI 10.1016/j.jash.2007.01.004; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Hertog MGL, 1996, CANCER EPIDEM BIOMAR, V5, P673; Hill BJF, 2001, ATHEROSCLEROSIS, V159, P117, DOI 10.1016/S0021-9150(01)00501-9; Huang BF, 2009, PATHOL RES PRACT, V205, P515, DOI 10.1016/j.prp.2009.01.007; Iwasaki Y, 2007, J DIABETES COMPLICAT, V21, P56, DOI 10.1016/j.jdiacomp.2006.02.001; Jain SK, 2007, FREE RADICAL BIO MED, V43, P1124, DOI 10.1016/j.freeradbiomed.2007.05.019; Kawakami Y, 2012, FOOD CHEM, V131, P1069, DOI 10.1016/j.foodchem.2011.10.011; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Li Jian-Mei, 2008, Chinese Journal of Natural Medicines, V6, P466, DOI 10.3724/SP.J.1009.2008.00466; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu CM, 2010, ENVIRON TOXICOL PHAR, V30, P264, DOI 10.1016/j.etap.2010.07.002; Liu XL, 2012, FOOD CHEM, V131, P685, DOI 10.1016/j.foodchem.2011.09.063; Liu XP, 2010, EUR J PHARMACOL, V629, P153, DOI 10.1016/j.ejphar.2009.11.059; Mahmoud MF, 2012, ARCH PHARM RES, V35, P155, DOI 10.1007/s12272-012-0117-8; MANACH C, 1995, J NUTR, V125, P1911, DOI 10.1093/jn/125.7.1911; Mansour SM, 2011, PHYTOMEDICINE, V18, P641, DOI 10.1016/j.phymed.2011.01.014; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; MING WJ, 1987, J IMMUNOL, V138, P1469; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Mythili MD, 2004, MICROSC RES TECHNIQ, V63, P274, DOI 10.1002/jemt.20039; Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Punithavathi VR, 2009, CHEM-BIOL INTERACT, V181, P322, DOI 10.1016/j.cbi.2009.07.002; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rial NS, 2012, MED HYPOTHESES, V78, P29, DOI 10.1016/j.mehy.2011.09.034; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Romero M, 2010, EUR J PHARMACOL, V627, P242, DOI 10.1016/j.ejphar.2009.11.006; Shahid M, 2008, AM J PHYSIOL-RENAL, V295, pF1836, DOI 10.1152/ajprenal.90297.2008; Shiomi T, 2003, J AM COLL CARDIOL, V42, P165, DOI 10.1016/S0735-1097(03)00509-6; Shoskes DA, 2011, UROL CLIN N AM, V38, P279, DOI 10.1016/j.ucl.2011.05.003; Southerland JH, 2012, ATHEROSCLEROSIS, V222, P196, DOI 10.1016/j.atherosclerosis.2012.01.026; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Tan K., 2004, INT C SER, V1262, P511, DOI [10.1016/j.ics.2003.11.028, DOI 10.1016/J.ICS.2003.11.028]; Tribolo S, 2008, ATHEROSCLEROSIS, V197, P50, DOI 10.1016/j.atherosclerosis.2007.07.040; Tsimogiannis DI, 2006, INNOV FOOD SCI EMERG, V7, P140, DOI 10.1016/j.ifset.2005.09.001; Vasdev S, 1998, MOL CELL BIOCHEM, V181, P1, DOI 10.1023/A:1006844222963; Wang HR, 2005, CLIN CHIM ACTA, V353, P53, DOI 10.1016/j.cccn.2004.10.007; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wyllie AH, 1997, BRIT MED BULL, V53, P451	72	99	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63784	10.1371/journal.pone.0063784	http://dx.doi.org/10.1371/journal.pone.0063784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717483	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700060
J	Qi, HP; Cao, YG; Huang, W; Liu, Y; Wang, Y; Li, L; Liu, LJ; Ji, Z; Sun, HL				Qi, Hanping; Cao, Yonggang; Huang, Wei; Liu, Yang; Wang, Ye; Li, Lei; Liu, Lijuan; Ji, Zhong; Sun, Hongli			Crucial Role of Calcium-Sensing Receptor Activation in Cardiac Injury of Diabetic Rats	PLOS ONE			English	Article							INDUCED APOPTOSIS; CYCLOPHILIN-D; CELL-DEATH; IN-SITU; STRESS; IDENTIFICATION; KINASES	Cardiac injury is a common pathological change frequently accompanied by diabetes mellitus. Recently, some evidence indicated that calcium-sensing receptor (CaSR) expressed in the cardiac tissue. However, the functional role of CaSR in diabetic cardiac injury remains unclear. The present study was designed to investigate the relationship between CaSR activation and diabetes-induced cardiac injury. Diabetic model was successfully established by administration of streptozotocin (STZ) in vivo, and cardiomyocyte injury was simulated by 25.5 mM glucose in vitro. Apoptotic rate, intracellular calcium concentration ([Ca2+](i)) and the expression of Bcl-2, Bax, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 were examined. We demonstrated a significant increase in left ventricular end-diastolic pressure (LVEDP) as well as decrease in maximum rate of left ventricular pressure rise and fall (+/- dp/dtmax), and left ventricular systolic pressure (LVSP), apoptosis of cardiomyocytes was also observed by TUNEL staining. In vitro, 25.5 mM glucose-induced apoptosis was detected by flow cytometry in neonatal rat cardiomyocytes. Further results showed that 25.5 mM glucose significantly increased [Ca2+](i), up-regulated the expression of Bax, P-ERK and P-JNK, and suppressed Bcl-2 expression. However, the above deleterious changes were further confirmed when co-treatment with CaSR agonist GdCl3 (300 mM). But the effects of GdCl3 were attenuated by 10 mu M NPS-2390, a specific CaSR inhibitor. When CaSR was silence by siRNA transfection, the effects of high glucose were inhibited. These results suggest that CaSR activation could lead to the apoptosis of cardiomyocytes in diabetic cardiac injury through the induction of calcium overload, the activation of the mitochondrial, and mitogen-activated protein kinase pathway.	[Qi, Hanping; Cao, Yonggang; Huang, Wei; Wang, Ye; Sun, Hongli] Harbin Med Univ Daqing, Dept Pharmacol, Daqing, Heilongjiang, Peoples R China; [Liu, Yang] Harbin Med Univ Daqing, Dept Basic Nursing, Daqing, Heilongjiang, Peoples R China; [Li, Lei] Harbin Med Univ, Clin Coll 5, Dept Surg, Daqing, Heilongjiang, Peoples R China; [Liu, Lijuan] Harbin Med Univ Daqing, Dept Pathol, Daqing, Heilongjiang, Peoples R China; [Ji, Zhong] Harbin Med Univ Daqing, Dept Physiol, Daqing, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Sun, HL (corresponding author), Harbin Med Univ Daqing, Dept Pharmacol, Daqing, Heilongjiang, Peoples R China.	hlsun2002@yahoo.com.cn			National Natural Science Foundation of China [81072640]; Natural Science Foundation of Heilongjiang Province of China [D200960]; Postdoctoral Science Foundation of China [20080440902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by National Natural Science Foundation of China (81072640, http://www.nsfc.gov.cn/Portal0/default152.htm), Natural Science Foundation of Heilongjiang Province of China (D200960, http://jj.hljkj.cn/zr/), Postdoctoral Science Foundation of China (20080440902 www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bai SZ, 2012, DIABETES RES CLIN PR, V95, P378, DOI 10.1016/j.diabres.2011.11.007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BENSASSON SA, 1995, METHOD CELL BIOL, V46, P29; Bevilacqua M, 2005, J CLIN ENDOCR METAB, V90, P1489, DOI 10.1210/jc.2004-0045; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gottlieb RA, 2000, FEBS LETT, V482, P6, DOI 10.1016/S0014-5793(00)02010-X; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; McGehee DS, 1997, J PHYSIOL-LONDON, V502, P31, DOI 10.1111/j.1469-7793.1997.031bl.x; MOKUDA O, 1990, ANN NUTR METAB, V34, P259, DOI 10.1159/000177596; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang R, 2003, EUR J BIOCHEM, V270, P2680, DOI 10.1046/j.1432-1033.2003.03645.x; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Xing WJ, 2011, CLIN EXP PHARMACOL P, V38, P605, DOI 10.1111/j.1440-1681.2011.05559.x; Yong-Gang C, 2010, PHYTOTHER RES, V24, P1844, DOI 10.1002/ptr.3206; Zhang WH, 2006, BIOCHEM BIOPH RES CO, V347, P872, DOI 10.1016/j.bbrc.2006.06.176; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	32	27	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e65147	10.1371/journal.pone.0065147	http://dx.doi.org/10.1371/journal.pone.0065147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717692	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700191
J	Takasu, NN; Pendergast, JS; Olivas, CS; Yamazaki, S; Nakamura, W				Takasu, Nana N.; Pendergast, Julie S.; Olivas, Cathya S.; Yamazaki, Shin; Nakamura, Wataru			In Vivo Monitoring of Multi-Unit Neural Activity in the Suprachiasmatic Nucleus Reveals Robust Circadian Rhythms in Period1(-/-) Mice	PLOS ONE			English	Article							FREE-RUNNING PERIOD; MOTOR-ACTIVITY; SCN; MUTATION; PACEMAKERS; DECLINE	The master pacemaker in the suprachiasmatic nucleus (SCN) controls daily rhythms of behavior in mammals. C57BL/6J mice lacking Period1 (Per1(-/-)) are an anomaly because their SCN molecular rhythm is weak or absent in vitro even though their locomotor activity rhythm is robust. To resolve the contradiction between the in vitro and in vivo circadian phenotypes of Per1(-/-) mice, we measured the multi-unit activity (MUA) rhythm of the SCN neuronal population in freely-behaving mice. We found that in vivo Per1(-/-) SCN have high-amplitude MUA rhythms, demonstrating that the ensemble of neurons is driving robust locomotor activity in Per1(-/-) mice. Since the Per1(-/-) SCN electrical activity rhythm is indistinguishable from wild-types, in vivo physiological factors or coupling of the SCN to a known or unidentified circadian clock(s) may compensate for weak endogenous molecular rhythms in Per1(-/-) SCN. Consistent with the behavioral light responsiveness of Per1(-/-) mice, in vivo MUA rhythms in Per1(-/-) SCN exhibited large phase shifts in response to light. Since the acute response of the MUA rhythm to light in Per1(-/-) SCN is equivalent to wild-types, an unknown mechanism mediates enhanced light responsiveness of Per1(-/-) mice. Thus, Per1(-/-) mice are a unique model for investigating the component(s) of the in vivo environment that confers robust rhythmicity to the SCN as well as a novel mechanism of enhanced light responsiveness.	[Takasu, Nana N.; Nakamura, Wataru] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Suita, Osaka, Japan; [Pendergast, Julie S.; Olivas, Cathya S.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Nakamura, Wataru] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Osaka University; Vanderbilt University; Japan Science & Technology Agency (JST)	Nakamura, W (corresponding author), Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Suita, Osaka, Japan.	wataru@dent.osaka-u.ac.jp		Yamazaki, Shin/0000-0002-6691-1531	Japan Science and Technology Agency PRESTO program; Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science postdoctoral fellowship; Grants-in-Aid for Scientific Research [10J06634] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency PRESTO program and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to WN), and a Japan Society for Promotion of Science postdoctoral fellowship (to NNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nakamura W, 2008, CURR BIOL, V18, P381, DOI 10.1016/j.cub.2008.02.024; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Pendergast JS, 2012, P NATL ACAD SCI USA, V109, P14218, DOI 10.1073/pnas.1206213109; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAWAKI Y, 1984, Neuroscience Research, V1, P67, DOI 10.1016/0168-0102(84)90031-2; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SHIOIRI T, 1991, PHYSIOL BEHAV, V49, P779, DOI 10.1016/0031-9384(91)90318-I; SILVER R, 1990, BRAIN RES, V525, P45, DOI 10.1016/0006-8993(90)91319-C; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; TUREK FW, 1986, NATURE, V321, P167, DOI 10.1038/321167a0; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; VanderLeest HT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004976; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; YAMADA N, 1990, BRAIN RES BULL, V25, P115, DOI 10.1016/0361-9230(90)90261-W; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yang W, 2013, EUR J NEUROSCI; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003	36	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64333	10.1371/journal.pone.0064333	http://dx.doi.org/10.1371/journal.pone.0064333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717599	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700139
J	Asuthkar, S; Velpula, KK; Nalla, AK; Gogineni, VR; Gondi, CS; Rao, JS				Asuthkar, S.; Velpula, K. K.; Nalla, A. K.; Gogineni, V. R.; Gondi, C. S.; Rao, J. S.			Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells	ONCOGENE			English	Article						matrix metalloproteinase-9 (MMP-9); syndecan-1 (SDC1); microRNA-494 (miR-494); ionizing radiation (IR); 3 '-untranslated region (3 '-UTR); CpG methylation	PLASMINOGEN-ACTIVATOR RECEPTOR; HISTONE ACETYLTRANSFERASE; TUMOR-GROWTH; SOLUBLE SYNDECAN-1; DNA METHYLATION; DOWN-REGULATION; CANCER; EXPRESSION; INVASION; GENE	Matrix metalloproteinase-9 (MMP-9) represents one of the most prominent proteins associated with tumorigenesis and is a modulator of the tumor microenvironment during angiogenesis. Recently, syndecan-1 (SDC1), a transmembrane heparan sulfatebearing proteoglycan, was also speculated to have a critical role in contributing to angiogenesis when associated with MMP-9. However, the mechanism behind their synergistic regulation is not fully understood. In the current study, we report for the first time that ionizing radiation (IR)-induced MMP-9 enhances SDC1 shedding, corroborating to tube-inducing ability of medulloblastoma (MB) cells. Furthermore, we observed that the tumor angiogenesis is associated with higher MMP-9-SDC1 interactions on both the cell surface and extracellular medium. Our results also revealed the existence of a novel regulatory mechanism where MMP-9 drives the suppression of miR-494, resulting in enhanced SDC1 shedding and angiogenesis. From the in situ hybridization analysis, we found that MMP-9-specific shRNA (shMMP-9) treatment of mouse intracranial tumors resulted in elevated expression of miR-494. This negative correlation between MMP-9 and miR-494 levels was observed to be dependent on the methylation status of a miR-494 promoter-associated CpG island region (- 186 to - 20), which was confirmed by bisulfite-sequencing and methylation-specific PCR (MSP) analysis. Further, validation of MMP-9 and SDC1 3 '-untranslated region (3 '-UTR) targets with luciferase reporter assay provided a more favorable result for miR-494-mediated regulation of SDC1 but not of MMP-9, suggesting that the 3 '-UTR of SDC1 mRNA is a direct target of miR-494. Overall, our results indicate that angiogenesis induced by radiotherapy is associated with an MMP-9-miR-494-SDC1 regulatory loop and that MMP-9-SDC1 activity creates a negative feedback loop by regulating the expression of miR-494.	[Asuthkar, S.; Velpula, K. K.; Nalla, A. K.; Gogineni, V. R.; Gondi, C. S.; Rao, J. S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Rao, J. S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Asuthkar, S (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, One Illini Dr, Peoria, IL 61605 USA.	asuthkar@uic.edu		Gondi, Christopher/0000-0002-3036-9920	National Cancer Institute Grant [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Peggy Mankin and Noorjehan Ali for their technical assistance, Susan Renner and Debbie McCollum for manuscript preparation, and Diana Meister and Sushma Jasti for manuscript review. This research was supported by National Cancer Institute Grant CA138409 (to JSR).	ALIOSMAN F, 1990, CANCER RES, V50, P6976; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Asuthkar S, 2011, NEURO-ONCOLOGY, V13, P1059, DOI 10.1093/neuonc/nor109; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; BIGNER SH, 1990, CANCER RES, V50, P2347; Brieger J, 2004, ANN NY ACAD SCI, V1030, P37, DOI 10.1196/annals.1329.005; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Enright AJ, 2004, GENOME BIOL, V5; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Fandy TE, 2010, EPIGENOMICS-UK, V2, P221, DOI 10.2217/EPI.10.1; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Han L, 2007, CANCER BIOL THER, V6, P1284; Huang YC, 2011, TOXICOL LETT, V201, P62, DOI 10.1016/j.toxlet.2010.12.006; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Kishikawa Shotaro, 2002, Nucleic Acids Res Suppl, P209; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Li XH, 2011, ONCOL REP, V26, P1431, DOI 10.3892/or.2011.1437; Lindsey JC, 2007, BRIT J CANCER, V97, P267, DOI 10.1038/sj.bjc.6603852; Lindsey JC, 2004, CARCINOGENESIS, V25, P661, DOI 10.1093/carcin/bgh055; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Massimino M, 2012, J NEURO-ONCOL, V108, P163, DOI 10.1007/s11060-012-0822-7; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Oh JH, 2010, INT J GYNECOL CANCER, V20, P751, DOI 10.1111/IGC.0b013e3181e02faa; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Olaru AV, 2011, HEPATOLOGY, V54, P2089, DOI 10.1002/hep.24591; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Shan SQ, 2001, CLIN CANCER RES, V7, P2590; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Taillandier L, 2011, REV NEUROL-FRANCE, V167, P431, DOI 10.1016/j.neurol.2011.01.014; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yu Q, 2000, GENE DEV, V14, P163; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743; Zhao CH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-224	59	52	54	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2014	33	15					1922	1933		10.1038/onc.2013.151	http://dx.doi.org/10.1038/onc.2013.151			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RK	23728345				2022-12-25	WOS:000334346300005
J	Christianen, MJA; van Belzen, J; Herman, PMJ; van Katwijk, MM; Lamers, LPM; van Leent, PJM; Bouma, TJ				Christianen, Marjolijn J. A.; van Belzen, Jim; Herman, Peter M. J.; van Katwijk, Marieke M.; Lamers, Leon P. M.; van Leent, Peter J. M.; Bouma, Tjeerd J.			Low-Canopy Seagrass Beds Still Provide Important Coastal Protection Services	PLOS ONE			English	Article							WAVE ATTENUATION; SEDIMENT DEPOSITION; POSIDONIA-OCEANICA; CORAL-REEFS; SALT-MARSH; DYNAMICS; TRANSPORT; CAPACITY; MEADOWS; MUDFLAT	One of the most frequently quoted ecosystem services of seagrass meadows is their value for coastal protection. Many studies emphasize the role of above-ground shoots in attenuating waves, enhancing sedimentation and preventing erosion. This raises the question if short-leaved, low density (grazed) seagrass meadows with most of their biomass in belowground tissues can also stabilize sediments. We examined this by combining manipulative field experiments and wave measurements along a typical tropical reef flat where green turtles intensively graze upon the seagrass canopy. We experimentally manipulated wave energy and grazing intensity along a transect perpendicular to the beach, and compared sediment bed level change between vegetated and experimentally created bare plots at three distances from the beach. Our experiments showed that i) even the short-leaved, low-biomass and heavily-grazed seagrass vegetation reduced wave-induced sediment erosion up to threefold, and ii) that erosion was a function of location along the vegetated reef flat. Where other studies stress the importance of the seagrass canopy for shoreline protection, our study on open, low-biomass and heavily grazed seagrass beds strongly suggests that belowground biomass also has a major effect on the immobilization of sediment. These results imply that, compared to shallow unvegetated nearshore reef flats, the presence of a short, low-biomass seagrass meadow maintains a higher bed level, attenuating waves before reaching the beach and hence lowering beach erosion rates. We propose that the sole use of aboveground biomass as a proxy for valuing coastal protection services should be reconsidered.	[Christianen, Marjolijn J. A.; van Katwijk, Marieke M.; van Leent, Peter J. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [van Belzen, Jim; Herman, Peter M. J.; Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Spatial Ecol Dept, Yerseke, Netherlands; [Lamers, Leon P. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, Fac Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Radboud University Nijmegen	Christianen, MJA (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, Fac Sci, NL-6525 ED Nijmegen, Netherlands.	marjolijn.christianen@gmail.com	Christianen, Marjolijn J. A./AAD-3865-2021; Herman, Peter M.J./A-9018-2011; Christianen, Marjolijn/B-8847-2011; van Katwijk, Marieke M/B-1709-2012; Bouma, Tjeerd J/A-9841-2011; Lamers, Leon P.M./A-8718-2012	Christianen, Marjolijn J. A./0000-0001-5839-2981; Herman, Peter M.J./0000-0003-2188-6341; Christianen, Marjolijn/0000-0001-5839-2981; van Katwijk, Marieke M/0000-0002-4482-5835; Lamers, Leon P.M./0000-0003-3769-2154; Bouma, Tjeerd/0000-0001-7824-7546; van Belzen, Jim/0000-0003-2099-1545	Netherlands Organization for Scientific Research - Science for Global Development (NWO-WOTRO) [W84-645]; THESEUS project; European Union within FP7-THEME 6 - Environment [244104]	Netherlands Organization for Scientific Research - Science for Global Development (NWO-WOTRO); THESEUS project; European Union within FP7-THEME 6 - Environment	Research by MJAC is funded by the Netherlands Organization for Scientific Research - Science for Global Development (NWO-WOTRO), grant W84-645 (appointed to MJAC). The work of JvB and TJB is supported by the THESEUS project on innovative technologies for safer European coasts in a changing climate, which is funded by the European Union within FP7-THEME 6 - Environment, including climate (contract no. 244104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Araujo R, 2012, J EXP MAR BIOL ECOL, V422, P1, DOI 10.1016/j.jembe.2012.04.006; Austen I, 1999, ESTUAR COAST SHELF S, V49, P99, DOI 10.1006/ecss.1998.0491; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Borsje BW, 2011, ECOL ENG, V37, P113, DOI 10.1016/j.ecoleng.2010.11.027; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Bouma TJ, 2010, ECOLOGY, V91, P2696, DOI 10.1890/09-0690.1; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; BOUMANS RMJ, 1993, ESTUARIES, V16, P375, DOI 10.2307/1352509; Callaghan DP, 2010, ESTUAR COAST SHELF S, V89, P73, DOI 10.1016/j.ecss.2010.05.013; Christianen MJA, 2012, J ECOL, V100, P546, DOI 10.1111/j.1365-2745.2011.01900.x; Christianen MJA, 2013, SEAGRASS SYSTEMS NUT; De Falco G, 2000, GEO-MAR LETT, V20, P50, DOI 10.1007/s003670000030; Eklof JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023229; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Friedrichs CT, 1996, MIXING ESTUARIES COA, V50, P405, DOI DOI 10.1029/CE050P0405; Gacia E, 1999, ESTUAR COAST SHELF S, V48, P757, DOI 10.1006/ecss.1999.0477; Gacia E, 2003, ESTUAR COAST SHELF S, V56, P909, DOI 10.1016/S0272-7714(02)00286-X; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; GRIFFIS RB, 1991, MAR ECOL PROG SER, V79, P171, DOI 10.3354/meps079171; HARLIN MM, 1982, AQUAT BOT, V14, P127, DOI 10.1016/0304-3770(82)90092-4; Hemminga M. A., 2000, SEAGRASS ECOLOGY INT; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hendriks IE, 2010, MAR BIOL, V157, P473, DOI 10.1007/s00227-009-1333-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houser C, 2010, J COASTAL RES, V26, P403, DOI 10.2112/08-1117.1; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Kleinhans MG, 2006, COAST ENG, V53, P983, DOI 10.1016/j.coastaleng.2006.06.009; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Lal A, 2010, BIOL CONSERV, V143, P2730, DOI 10.1016/j.biocon.2010.07.020; Le Hir P, 2007, CONT SHELF RES, V27, P1116, DOI 10.1016/j.csr.2005.11.016; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; Luhar M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006345; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Mellors J, 2002, B MAR SCI, V71, P1215; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Moller I, 1999, ESTUAR COAST SHELF S, V49, P411, DOI 10.1006/ecss.1999.0509; Mork M, 1996, SARSIA, V80, P323, DOI 10.1080/00364827.1996.10413607; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paul M, 2012, MAR ECOL PROG SER, V444, P31, DOI 10.3354/meps09489; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; Quartel S, 2007, J ASIAN EARTH SCI, V29, P576, DOI 10.1016/j.jseaes.2006.05.008; Ramage DL, 1999, MAR ECOL PROG SER, V189, P275, DOI 10.3354/meps189275; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Storlazzi CD, 2011, CORAL REEFS, V30, P83, DOI 10.1007/s00338-011-0723-9; Tucker M.J., 2001, WAVES OCEAN ENG; Umar MJ, 1998, CORAL REEFS, V17, P169, DOI 10.1007/s003380050111; van der Heide T, 2010, ECOLOGY, V91, P362, DOI 10.1890/08-1567.1; van Katwijk MM, 2010, ESTUAR COAST SHELF S, V89, P175, DOI 10.1016/j.ecss.2010.06.008; VANRIJN LC, 1990, J HYDRAUL ENG-ASCE, V116, P1270, DOI 10.1061/(ASCE)0733-9429(1990)116:10(1270); Vermaat JE, 1997, AMBIO, V26, P499; Vonk JA, 2010, MAR BIOL RES, V6, P282, DOI 10.1080/17451000903233789; WARD LG, 1984, MAR GEOL, V59, P85, DOI 10.1016/0025-3227(84)90089-6	58	157	158	2	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e62413	10.1371/journal.pone.0062413	http://dx.doi.org/10.1371/journal.pone.0062413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723969	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000004
J	Loman, NJ; Gladstone, RA; Constantinidou, C; Tocheva, AS; Jefferies, JMC; Faust, SN; O'Connor, L; Chan, J; Pallen, MJ; Clarke, SC				Loman, Nicholas J.; Gladstone, Rebecca A.; Constantinidou, Chrystala; Tocheva, Anna S.; Jefferies, Johanna M. C.; Faust, Saul N.; O'Connor, Leigh; Chan, Jacqueline; Pallen, Mark J.; Clarke, Stuart C.			Clonal Expansion within Pneumococcal Serotype 6C after Use of Seven-Valent Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPE; CONJUGATE VACCINE; INVASIVE-DISEASE; UNITED-STATES; CARRIAGE; PROTEIN; EPIDEMIOLOGY; CHILDREN; GENOME; PREVALENCE	Streptococcus pneumoniae causes invasive infections, primarily at the extremes of life. A seven-valent conjugate vaccine (PCV7) is used to protect against invasive pneumococcal disease in children. Within three years of PCV7 introduction, we observed a fourfold increase in serotype 6C carriage, predominantly due to a single clone. We determined the whole-genome sequences of nineteen S. pneumoniae serotype 6C isolates, from both carriage (n = 15) and disease (n = 4) states, to investigate the emergence of serotype 6C in our population, focusing on a single multi-locus sequence type (MLST) clonal complex 395 (CC395). A phylogenetic network was constructed to identify different lineages, followed by analysis of variability in gene sets and sequences. Serotype 6C isolates from this single geographical site fell into four broad phylogenetically distinct lineages. Variation was seen in the 6C capsular locus and in sequences of genes encoding surface proteins. The largest clonal complex was characterised by the presence of lantibiotic synthesis locus. In our population, the 6C capsular locus has been introduced into multiple lineages by independent capsular switching events. However, rapid clonal expansion has occurred within a single MLST clonal complex. Worryingly, plasticity exists within current and potential vaccine-associated loci, a consideration for future vaccine use, target selection and design.	[Loman, Nicholas J.; O'Connor, Leigh] Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England; [Gladstone, Rebecca A.; Tocheva, Anna S.; Jefferies, Johanna M. C.; Faust, Saul N.; Clarke, Stuart C.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Mol Microbiol Grp,Sir Henry Wellcome Labs, Southampton SO9 5NH, Hants, England; [Constantinidou, Chrystala; Chan, Jacqueline; Pallen, Mark J.] Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England; [Faust, Saul N.] Univ Hosp Southampton Fdn NHS Trust, NIHR, Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Clarke, Stuart C.] Hlth Protect Agcy, Southampton, Hants, England; [Jefferies, Johanna M. C.; Faust, Saul N.; Clarke, Stuart C.] Univ Hosp Southampton Fdn NHS Trust, Resp Biomed Res Unit, Southampton NIHR, Southampton, Hants, England	University of Birmingham; University of Southampton; University of Warwick; University of Southampton; Health Protection Agency	Pallen, MJ (corresponding author), Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Loman, Nicholas/Z-1573-2019; Faust, Saul/J-9779-2014; Clarke, Stuart/M-2473-2013; Gladstone, Rebecca A/J-8821-2017	Faust, Saul/0000-0003-3410-7642; Gladstone, Rebecca A/0000-0002-7993-3051; Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Clarke, Stuart/0000-0002-7009-1548	Bupa Foundation; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E011179/1]; GlaxoSmithKline; vaccine manufacturers; BBSRC [BB/E011179/1] Funding Source: UKRI; MRC [MR/J014370/1, G0901717] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish; Medical Research Council [MR/J014370/1, G0901717] Funding Source: researchfish	Bupa Foundation; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); vaccine manufacturers; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded, in part, by an award to SCC by The Bupa Foundation. NJL is funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) BB/E011179/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SCC currently receives unrestricted research funding from Pfizer Vaccines (previously Wyeth Vaccines). JMJ and SCC have received consulting fees from GlaxoSmithKline. SNF acts as principal investigator for clinical trials conducted on behalf of Southampton University Hospitals NHS Trust/University of Southampton that are sponsored by vaccine manufacturers but receives no personal payments from them. SNF has participated in advisory boards for vaccine manufacturers but receives no personal payments for this work. SNF, SCC and JMJ have received financial assistance from vaccine manufacturers to attend conferences. All grants and honoraria are paid into accounts within the respective NHS Trusts or Universities, or to independent charities. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2000, GENETICS, V154, P1439; Gladstone RA, 2011, J MED MICROBIOL, V60, P1, DOI 10.1099/jmm.0.020016-0; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Green MC, 2011, J CLIN MICROBIOL, V49, P2097, DOI 10.1128/JCM.02207-10; Hanage WP, 2011, PEDIATR INFECT DIS J, V30, P302, DOI 10.1097/INF.0b013e318201a154; Hanna JN, 2010, COMMUN DIS INTELL, V34, P122; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Hermans PWM, 2008, VACCINE, V26, P449, DOI 10.1016/j.vaccine.2007.11.026; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hillman JD, 1998, INFECT IMMUN, V66, P2743, DOI 10.1128/IAI.66.6.2743-2749.1998; Ho PL, 2010, DIAGN MICR INFEC DIS, V68, P439, DOI 10.1016/j.diagmicrobio.2010.07.020; Hornsey M, 2011, J ANTIMICROB CHEMOTH, V66, P1499, DOI 10.1093/jac/dkr168; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Jefferies JMC, 2011, TRENDS MICROBIOL, V19, P377, DOI 10.1016/j.tim.2011.06.001; Kim KH, 2011, J KOREAN MED SCI, V26, P184, DOI 10.3346/jkms.2011.26.2.184; Leach AJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-121; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Porat N, 2010, J CLIN MICROBIOL, V48, P4649, DOI 10.1128/JCM.01600-10; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Vakevainen M, 2001, J INFECT DIS, V184, P789, DOI 10.1086/322984; Vickers I, 2011, EPIDEMIOL INFECT, V139, P783, DOI 10.1017/S0950268810001743; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yao KH, 2011, DIAGN MICR INFEC DIS, V70, P291, DOI 10.1016/j.diagmicrobio.2011.03.015	55	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64731	10.1371/journal.pone.0064731	http://dx.doi.org/10.1371/journal.pone.0064731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724086	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000319733000087
J	Loporto, M; Holmes, PS; Wright, DJ; McAllister, CJ				Loporto, Michela; Holmes, Paul S.; Wright, David J.; McAllister, Craig J.			Reflecting on Mirror Mechanisms: Motor Resonance Effects during Action Observation Only Present with Low-Intensity Transcranial Magnetic Stimulation	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; EXCITABILITY; FACILITATION; SYSTEM; BRAIN; MODULATION; IMITATION; MUSCLES; IMAGERY; PULSE	Transcranial magnetic stimulation (TMS) studies indicate that the observation of other people's actions influences the excitability of the observer's motor system. Motor evoked potential (MEP) amplitudes typically increase in muscles which would be active during the execution of the observed action. This 'motor resonance' effect is thought to result from activity in mirror neuron regions, which enhance the excitability of the primary motor cortex (M1) via cortico-cortical pathways. The importance of TMS intensity has not yet been recognised in this area of research. Low-intensity TMS predominately activates corticospinal neurons indirectly, whereas high-intensity TMS can directly activate corticospinal axons. This indicates that motor resonance effects should be more prominent when using low-intensity TMS. A related issue is that TMS is typically applied over a single optimal scalp position (OSP) to simultaneously elicit MEPs from several muscles. Whether this confounds results, due to differences in the manner that TMS activates spatially separate cortical representations, has not yet been explored. In the current study, MEP amplitudes, resulting from single-pulse TMS applied over M1, were recorded from the first dorsal interosseous (FDI) and abductor digiti minimi (ADM) muscles during the observation of simple finger abductions. We tested if the TMS intensity (110% vs. 130% resting motor threshold) or stimulating position (FDI-OSP vs. ADM-OSP) influenced the magnitude of the motor resonance effects. Results showed that the MEP facilitation recorded in the FDI muscle during the observation of index-finger abductions was only detected using low-intensity TMS. In contrast, changes in the OSP had a negligible effect on the presence of motor resonance effects in either the FDI or ADM muscles. These findings support the hypothesis that MN activity enhances M1 excitability via cortico-cortical pathways and highlight a methodological framework by which the neural underpinnings of action observation can be further explored.	[Loporto, Michela; Holmes, Paul S.] Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England; [Wright, David J.] Univ Roehampton, Dept Life Sci, London, England; [McAllister, Craig J.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Manchester Metropolitan University; Roehampton University; Aston University	Loporto, M (corresponding author), Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England.	p.s.holmes@mmu.ac.uk		McAllister, Craig/0000-0002-2972-039X; Wright, David/0000-0001-9568-0237; Holmes, Paul/0000-0003-0821-3580	Government of Malta	Government of Malta	This work was partly funded by the Government of Malta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Holmes P.S., 2007, BRIT J OCCUP THER, V70, P454, DOI [10.1177/030802260707001007, DOI 10.1177/030802260707001007]; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Labruna L, 2011, BRAIN STIMUL, V4, P152, DOI 10.1016/j.brs.2010.09.010; Loporto M, 2011, J MOTOR BEHAV, V43, P361, DOI 10.1080/00222895.2011.604655; Melgari JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003069; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Williams J, 2012, BEHAV BRAIN RES, V226, P369, DOI 10.1016/j.bbr.2011.09.014	39	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64911	10.1371/journal.pone.0064911	http://dx.doi.org/10.1371/journal.pone.0064911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724104	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000319733000103
J	Zhang, QX; Liu, HP; Chen, RY; Shen, KL; Wang, KJ				Zhang, Qiu-xia; Liu, Hai-peng; Chen, Rong-yuan; Shen, Kai-li; Wang, Ke-jian			Identification of a Serine Proteinase Homolog (Sp-SPH) Involved in Immune Defense in the Mud Crab Scylla paramamosain	PLOS ONE			English	Article							RECOGNITION PROTEIN; CELL-ADHESION; MANDUCA-SEXTA; ACTIVATION; SHRIMP; PHENOLOXIDASE; CRUSTACEAN; BACTERIA; CLONING; SYSTEM	Clip domain serine proteinase homologs are involved in many biological processes including immune response. To identify the immune function of a serine proteinase homolog (Sp-SPH), originally isolated from hemocytes of the mud crab, Scylla paramamosain, the Sp-SPH was expressed recombinantly and purified for further studies. It was found that the Sp-SPH protein could bind to a number of bacteria (including Aeromonas hydrophila, Escherichia coli, Staphylococcus aureus, Vibrio fluvialis, Vibrio harveyi and Vibrio parahemolyticus), bacterial cell wall components such as lipopolysaccharide or peptidoglycan (PGN), and beta-1, 3-glucan of fungus. But no direct antibacterial activity of Sp-SPH protein was shown by using minimum inhibitory concentration or minimum bactericidal concentration assays. Nevertheless, the Sp-SPH protein was found to significantly enhance the crab hemocyte adhesion activity (paired t-test, P<0.05), and increase phenoloxidase activity if triggered by PGN in vitro (paired t-test, P<0.05). Importantly, the Sp-SPH protein was demonstrated to promote the survival rate of the animals after challenge with A. hydrophila or V. parahemolyticus which were both recognized by Sp-SPH protein, if pre-incubated with Sp-SPH protein, respectively. Whereas, the crabs died much faster when challenged with Vibrio alginolyiicus, a pathogenic bacterium not recognized by Sp-SPH protein, compared to those of crabs challenged with A. hydrophila or V. parahemolyticus when pre-coated with Sp-SPH protein. Taken together, these data suggested that Sp-SPH molecule might play an important role in immune defense against bacterial infection in the mud crab S. paramamosain.	[Zhang, Qiu-xia; Liu, Hai-peng; Chen, Rong-yuan; Shen, Kai-li; Wang, Ke-jian] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University	Liu, HP (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	haipengliu@xmu.edu.cn	Wang, KJ/G-4609-2010; zhang, qiu/GXG-5600-2022		National Natural Science Foundation of China [41006077]; Research Fund for the Doctoral Program of Higher Education [20100121120028]; Science Foundation of the Fujian Province, China [2010NZ0002-3, JA10002]; Public Science and Technology Research Funds Projects of Ocean [201105027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Science Foundation of the Fujian Province, China(Natural Science Foundation of Fujian Province); Public Science and Technology Research Funds Projects of Ocean	This work was supported by The National Natural Science Foundation of China (41006077); The Research Fund for the Doctoral Program of Higher Education (20100121120028); Science Foundation of the Fujian Province, China (2010NZ0002-3, JA10002); and Public Science and Technology Research Funds Projects of Ocean (201105027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; BANK HL, 1987, DIABETOLOGIA, V30, P812; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Chen FY, 2010, FISH SHELLFISH IMMUN, V28, P167, DOI 10.1016/j.fsi.2009.10.017; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Cui L, 2000, INSECT MOL BIOL, V9, P127, DOI 10.1046/j.1365-2583.2000.00169.x; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gonzalez M, 2005, BIOCHEM BIOPH RES CO, V338, P1089, DOI 10.1016/j.bbrc.2005.10.075; Huang TS, 2000, J BIOL CHEM, V275, P9996, DOI 10.1074/jbc.275.14.9996; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Johansson MW, 1999, DEV COMP IMMUNOL, V23, P303, DOI 10.1016/S0145-305X(99)00013-0; Kawabata S, 1996, FEBS LETT, V398, P146, DOI 10.1016/S0014-5793(96)01224-0; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 2002, FISH SHELLFISH IMMUN, V12, P421, DOI 10.1006/fsim.2002.0420; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Lin CY, 2006, DEV COMP IMMUNOL, V30, P1132, DOI 10.1016/j.dci.2006.03.006; Liu HP, 2010, DEV COMP IMMUNOL, V34, P741, DOI 10.1016/j.dci.2010.02.005; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2011, DEV COMP IMMUNOL, V35, P51, DOI 10.1016/j.dci.2010.08.005; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Rieger AM, 2010, J IMMUNOL METHODS, V358, P81, DOI 10.1016/j.jim.2010.03.019; Romo-Figueroa MG, 2004, DEV COMP IMMUNOL, V28, P713, DOI 10.1016/j.dci.2003.11.008; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Sritunyalucksana K, 2002, DEV COMP IMMUNOL, V26, P237, DOI 10.1016/S0145-305X(01)00074-X; VargasAlbores F, 1996, DEV COMP IMMUNOL, V20, P299, DOI 10.1016/S0145-305X(96)00007-9; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009	38	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63787	10.1371/journal.pone.0063787	http://dx.doi.org/10.1371/journal.pone.0063787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724001	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000024
J	Agulleiro, MJ; Sanchez, E; Leal, E; Cortes, R; Fernandez-Duran, B; Guillot, R; Davis, P; Dores, RM; Gallo-Payet, N; Cerda-Reverter, JM				Josep Agulleiro, Maria; Sanchez, Elisa; Leal, Esther; Cortes, Raul; Fernandez-Duran, Begona; Guillot, Raul; Davis, Perry; Dores, Robert M.; Gallo-Payet, Nicole; Miguel Cerda-Reverter, Jose			Molecular Characterization and Functional Regulation of Melanocortin 2 Receptor (MC2R) in the Sea Bass. A Putative Role in the Adaptation to Stress	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; ACCESSORY PROTEIN; ACTH RECEPTOR; ADRENOCORTICOTROPIC HORMONE; DIFFERENTIAL REGULATION; DICENTRARCHUS-LABRAX; CORTISOL RELEASE; RAINBOW-TROUT; EXPRESSION; ALPHA	The activation of melanocortin 2 receptor (MC2R) by ACTH mediates the signaling cascade leading to steroid synthesis in the interrenal tissue (analogous to the adrenal cortex in mammals) of fish. However, little is known about the functional regulation of this receptor in fish. In this work described, we cloned sea bass MC2R from a liver cDNA. SbMC2R requires the melanocortin 2 receptor accessory protein (MRAP) for its functional expression. Dietary cortisol but not long-term stress protocols downregulated interrenal sbMC2R expression. Data suggest the existence of a negative feedback on interrenal sbMC2R expression imposed by local or systemic glucocorticoids. This feedback could be involved in long-term stress adaptation by regulating interrenal sensitivity to ACTH. ACTH-induced MC2R activation stimulates hepatic lipolysis, suggesting that ACTH may mediate stress-induced effects upstream of cortisol release.	[Josep Agulleiro, Maria; Sanchez, Elisa; Leal, Esther; Cortes, Raul; Fernandez-Duran, Begona; Guillot, Raul; Miguel Cerda-Reverter, Jose] IATS CSIC, Dept Fish Physiol & Biotechnol, Castellon de La Plana, Spain; [Davis, Perry; Dores, Robert M.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Gallo-Payet, Nicole] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Denver; University of Sherbrooke	Cerda-Reverter, JM (corresponding author), IATS CSIC, Dept Fish Physiol & Biotechnol, Castellon de La Plana, Spain.	cerdarev@iats.csic.es	Leal, Esther/ABA-6058-2021; Sánchez, Elisa/Z-3780-2019; Agulleiro, Maria Josep/K-4982-2014; Cerda-Reverter, Jose Miguel/K-4934-2014; Cortes, Raul/AAG-3048-2019; Guillot, Raúl/Z-1884-2019	Agulleiro, Maria Josep/0000-0003-3758-8867; Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Cortes, Raul/0000-0002-7807-681X; Guillot, Raul/0000-0001-9248-7263; Sanchez, Elisa/0000-0001-9302-9600; , Esther/0000-0003-2847-450X	Spanish Science and Innovation Ministry [AGL2010-22247-C03-01, CSD 2007-00002, 2010/006]; "Juan de la Cierva" research contract from the Spanish Science and Innovation Ministry; Generalitat Valenciana (GV)	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Juan de la Cierva" research contract from the Spanish Science and Innovation Ministry; Generalitat Valenciana (GV)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Spanish Science and Innovation Ministry Grants: Life Sciences and Agrofeeding Research Program (AGL2010-22247-C03-01) and Consolider Program (CSD 2007-00002) Generalitat Valenciana Grant: PROMETEO program (2010/006) to JMC-R. MJA is recipient of a "Juan de la Cierva" research contract (2009) from the Spanish Science and Innovation Ministry. EL was recipient of a Geronimo Forteza fellowship from the Generalitat Valenciana (GV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006463; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Aluru N, 2008, ENDOCRINOLOGY, V149, P4577, DOI 10.1210/en.2008-0435; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Castillo J, 2009, FISH SHELLFISH IMMUN, V27, P493, DOI 10.1016/j.fsi.2009.06.021; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Cooray SN, 2011, ENDOCRINOLOGY, V152, P495, DOI 10.1210/en.2010-1053; Domenice S, 2001, J CLIN ENDOCR METAB, V86, P4068, DOI 10.1210/jc.86.9.4068; Fridmanis D, 2010, MOL CELL ENDOCRINOL, V321, P175, DOI 10.1016/j.mce.2010.02.032; Galac S, 2010, DOMEST ANIM ENDOCRIN, V39, P259, DOI 10.1016/j.domaniend.2010.07.001; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Hinkle PM, 2011, EUR J PHARMACOL, V660, P94, DOI 10.1016/j.ejphar.2010.10.113; Jacobs K, 2002, ANIM GENET, V33, P415, DOI 10.1046/j.1365-2052.2002.00899.x; Agulleiro MJ, 2010, MOL CELL ENDOCRINOL, V320, P145, DOI 10.1016/j.mce.2010.01.032; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; Kobayashi Y, 2011, GEN COMP ENDOCR, V170, P558, DOI 10.1016/j.ygcen.2010.11.019; Krasnov A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-3; LAMERS AE, 1992, J ENDOCRINOL, V135, P285, DOI 10.1677/joe.0.1350285; Leal E, 2011, J COMP PHYSIOL B, V181, P1035, DOI 10.1007/s00360-011-0585-z; Liang L, 2011, GEN COMP ENDOCR, V174, P5, DOI 10.1016/j.ygcen.2011.07.005; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Metz JR, 2005, AM J PHYSIOL-REG I, V289, pR814, DOI 10.1152/ajpregu.00826.2004; Cerda-Reverter JM, 2011, EUR J PHARMACOL, V660, P53, DOI 10.1016/j.ejphar.2010.10.108; Mola L, 2005, GEN COMP ENDOCR, V143, P99, DOI 10.1016/j.ygcen.2005.02.021; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; Reinick CL, 2012, ENDOCRINOLOGY, V153, P4757, DOI 10.1210/en.2012-1482; Rotllant J, 2003, COMP BIOCHEM PHYS A, V136, P613, DOI 10.1016/S1095-6433(03)00211-3; Rotllant J, 2000, GEN COMP ENDOCR, V119, P152, DOI 10.1006/gcen.2000.7508; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Rubio VC, 2010, AQUACULTURE, V298, P332, DOI 10.1016/j.aquaculture.2009.10.031; Sanchez E, 2010, GEN COMP ENDOCR, V165, P163, DOI 10.1016/j.ygcen.2009.06.008; Sanchez E, 2009, J EXP BIOL, V212, P3901, DOI 10.1242/jeb.035121; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Takeuchi S, 1998, BBA-MOL CELL RES, V1403, P102, DOI 10.1016/S0167-4889(98)00022-6; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Verburg-Van Kemenade BML, 2011, GEN COMP ENDOCR, V172, P31, DOI 10.1016/j.ygcen.2011.01.004; Xia Y, 1996, CELL TISSUE RES, V286, P63, DOI 10.1007/s004410050675	45	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e65450	10.1371/journal.pone.0065450	http://dx.doi.org/10.1371/journal.pone.0065450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724142	gold, Green Published, Green Submitted			2022-12-25	WOS:000319738100044
J	Hedenius, M; Ullman, MT; Alm, P; Jennische, M; Persson, J				Hedenius, Martina; Ullman, Michael T.; Alm, Per; Jennische, Margareta; Persson, Jonas			Enhanced Recognition Memory after Incidental Encoding in Children with Developmental Dyslexia	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; IMPLICIT LEARNING-DEFICITS; LONG-TERM-MEMORY; WORKING-MEMORY; READING DISABILITIES; LANGUAGE IMPAIRMENT; EPISODIC MEMORY; DEFINITION; SYSTEMS; ADULTS	Developmental dyslexia (DD) has previously been associated with a number of cognitive deficits. Little attention has been directed to cognitive functions that remain intact in the disorder, though the investigation and identification of such strengths might be useful for developing new, and improving current, therapeutical interventions. In this study, an old/new recognition memory paradigm was used to examine previously untested aspects of declarative memory in children with DD and typically developing control children. The DD group was not only not impaired at the task, but actually showed superior recognition memory, as compared to the control children. These findings complement previous reports of enhanced cognition in other domains (e. g., visuo-spatial processing) in DD. Possible underlying mechanisms for the observed DD advantage in declarative memory, and the possibility of compensation by this system for reading deficits in dyslexia, are discussed.	[Hedenius, Martina; Alm, Per; Jennische, Margareta] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Ullman, Michael T.] Georgetown Univ, Brain & Language Lab, Dept Neurosci, Washington, DC USA; [Persson, Jonas] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Persson, Jonas] Stockholm Univ, S-10691 Stockholm, Sweden	Uppsala University; Georgetown University; Karolinska Institutet; Stockholm University	Persson, J (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	martina.hedenius@neuro.uu.se		Persson, Jonas/0000-0001-9143-3730; Alm, Per/0000-0003-1506-5897	Sven Jerring Foundation; Foundation Sunnerdahls Disability Fund; NIH [R01 HD049347]; Mable H. Flory Charitable Trust; Swedish Research Council [2007-1895]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049347] Funding Source: NIH RePORTER	Sven Jerring Foundation; Foundation Sunnerdahls Disability Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mable H. Flory Charitable Trust; Swedish Research Council(Swedish Research CouncilEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support for this study was provided by the Sven Jerring Foundation and the Foundation Sunnerdahls Disability Fund to MH, MJ and PA, by NIH R01 HD049347 (MTU) and the Mable H. Flory Charitable Trust to MTU, and by a Swedish Research Council grant 2007-1895 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MH, 2008, BRAIN COGNITION, V68, P134, DOI 10.1016/j.bandc.2008.03.008; Bishop D, 1982, TROG TEST RECEPTION; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Chang Q, 2003, BEHAV BRAIN RES, V144, P19, DOI 10.1016/S0166-4328(03)00063-9; Cornelissen K, 2004, BRAIN LANG, V89, P617, DOI 10.1016/j.bandl.2003.12.007; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Dunn L. M., 1997, BRIT PICTURE VOCABUL, V3rd; EALS M, 1994, ETHOL SOCIOBIOL, V15, P95, DOI 10.1016/0162-3095(94)90020-5; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ferrer E, 2010, PSYCHOL SCI, V21, P93, DOI 10.1177/0956797609354084; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Foerde K, 2011, NEUROBIOL LEARN MEM, V96, P624, DOI 10.1016/j.nlm.2011.08.006; Hensler BS, 2010, J DEV BEHAV PEDIATR, V31, P525, DOI 10.1097/DBP.0b013e3181ee4b70; Henson R, 2005, Q J EXP PSYCHOL-B, V58, P340, DOI 10.1080/02724990444000113; Holmberg E., 2002, TROG SVENSK MANUAL; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Jimenez-Fernandez G, 2011, ANN DYSLEXIA, V61, P85, DOI 10.1007/s11881-010-0048-3; Kamhi A., 2005, LANGUAGE READING DIS; Kaplan BJ, 1998, J CLIN EXP NEUROPSYC, V20, P518, DOI 10.1076/jcen.20.4.518.1477; Kibby MY, 2009, ARCH CLIN NEUROPSYCH, V24, P245, DOI 10.1093/arclin/acp028; Kibby M, 2008, CHILD NEUROPSYCHOL, V14, P525, DOI 10.1080/09297040701821752; Kim H, 2009, BRAIN RES, V1282, P103, DOI 10.1016/j.brainres.2009.05.080; Kramer JH, 2000, ARCH CLIN NEUROPSYCH, V15, P83, DOI 10.1016/S0887-6177(99)00022-0; Li H, 2009, J EXP CHILD PSYCHOL, V103, P135, DOI 10.1016/j.jecp.2009.02.001; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Lorusso Maria Luisa, 2005, Brain Cogn, V57, P135, DOI 10.1016/j.bandc.2004.08.057; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Lyytinen H, 2004, DYSLEXIA, V10, P146, DOI 10.1002/dys.274; Mayringer H, 2000, J EXP CHILD PSYCHOL, V75, P116, DOI 10.1006/jecp.1999.2525; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Menghini D, 2010, DYSLEXIA, V16, P213, DOI 10.1002/dys.410; Menghini D, 2008, ANN NY ACAD SCI, V1145, P212, DOI 10.1196/annals.1416.010; Messbauer VCS, 2003, J EXP CHILD PSYCHOL, V84, P77, DOI 10.1016/S0022-0965(02)00179-0; MITCHELL JA, 1988, Q J EXP PSYCHOL-B, V40, P243; Moody TD, 2004, BEHAV NEUROSCI, V118, P438, DOI 10.1037/0735-7044.118.2.438; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Olofsson A., 2003, DYSLEXIA CROSSLINGUI, P137; Olson R., 1994, FRAMES REFERENCE ASS, P243; Pavlidou EV, 2009, ANN DYSLEXIA, V59, P55, DOI 10.1007/s11881-009-0023-z; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Rauch SL, 2007, BIOL PSYCHIAT, V61, P330, DOI 10.1016/j.biopsych.2005.12.012; RAVEN J, 1998, STANDARD PROGR MATRI; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; RISPENS J, 1991, J LEARN DISABIL, V24, P434, DOI 10.1177/002221949102400709; Schneps MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035724; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; SIEGEL LS, 1995, PSYCHOL SCI, V6, P250, DOI 10.1111/j.1467-9280.1995.tb00601.x; Smith-Spark JH, 2007, MEMORY, V15, P34, DOI 10.1080/09658210601043384; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snowling MJ, 2003, CHILD DEV, V74, P358, DOI 10.1111/1467-8624.7402003; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stoodley CJ, 2006, NEUROPSYCHOLOGIA, V44, P795, DOI 10.1016/j.neuropsychologia.2005.07.009; Stuss D.T., 2002, PRINCIPLES FRONTAL L; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Ullman MT, 2005, CORTEX, V41, P399, DOI 10.1016/S0010-9452(08)70276-4; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; van der Leij A, 1999, J LEARN DIS, V32, P28177; VELLUTINO FR, 1985, J EXP CHILD PSYCHOL, V39, P363, DOI 10.1016/0022-0965(85)90046-3; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; VICARI S, 2005, J NEUROL NEUROSUR PS, P1; von Karolyi C, 2003, BRAIN LANG, V85, P427, DOI 10.1016/S0093-934X(03)00052-X; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wass M, 2008, SCAND J PSYCHOL, V49, P559, DOI 10.1111/j.1467-9450.2008.00680.x; Williams P, 1997, J EXP PSYCHOL LEARN, V23, P1344, DOI 10.1037/0278-7393.23.6.1344; Wimmer H, 2010, DYSLEXIA, V16, P283, DOI 10.1002/dys.411	80	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63998	10.1371/journal.pone.0063998	http://dx.doi.org/10.1371/journal.pone.0063998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717524	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600040
J	Hoepner, S; Loh, JMS; Riccadonna, C; Derouazi, M; Maroun, CY; Dietrich, PY; Walker, PR				Hoepner, Sabine; Loh, Jacelyn M. S.; Riccadonna, Cristina; Derouazi, Madiha; Maroun, Celine Yacoub; Dietrich, Pierre-Yves; Walker, Paul R.			Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIOBLASTOMA PATIENTS; CANCER-IMMUNOTHERAPY; INTRACRANIAL TUMORS; MALIGNANT GLIOMA; LATE ANTIGEN-4; RESPONSES; INFILTRATION; TRAFFICKING; EXPRESSION	The feasibility of cancer immunotherapy mediated by T lymphocytes is now a clinical reality. Indeed, many tumour associated antigens have been identified for cytotoxic CD8 T cells, which are believed to be key mediators of tumour rejection. However, for aggressive malignancies in specialised anatomic sites such as the brain, a limiting factor is suboptimal tumour infiltration by CD8 T cells. Here we take advantage of recent advances in T cell biology to differentially polarise CD4 T cells in order to explore their capacity to enhance immunotherapy. We used an adoptive cell therapy approach to work with clonal T cell populations of defined specificity. Th1 CD4 T cells preferentially homed to and accumulated within intracranial tumours compared with Th2 CD4 T cells. Moreover, tumour-antigen specific Th1 CD4 T cells enhanced CD8 T cell recruitment and function within the brain tumour bed. Survival of mice bearing intracranial tumours was significantly prolonged when CD4 and CD8 T cells were co-transferred. These results should encourage further definition of tumour antigens recognised by CD4 T cells, and exploitation of both CD4 and CD8 T cell subsets to optimise T cell therapy of cancer.	[Walker, Paul R.] Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland; Univ Geneva, Geneva, Switzerland	University of Geneva; University of Geneva	Walker, PR (corresponding author), Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland.	paul.walker@hcuge.ch	Derouazi, Madiha/GVK-8912-2022		Swiss National Science Foundation [31003A_120609]; Copley May Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Copley May Foundation	This work was supported by a Swiss National Science Foundation (www.snf.ch/E/) Grant (31003A_120609) to PRW and by the Copley May Foundation to PYD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Calzascia T, 2003, J IMMUNOL, V171, P2187, DOI 10.4049/jimmunol.171.5.2187; Dietrich PY, 2010, CURR OPIN ONCOL, V22, P604, DOI 10.1097/CCO.0b013e32833dead8; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Fujita M, 2009, CANCER RES, V69, P1587, DOI 10.1158/0008-5472.CAN-08-2915; Grauer OM, 2008, J IMMUNOL, V181, P6720, DOI 10.4049/jimmunol.181.10.6720; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Heimberger AB, 2011, NEURO-ONCOLOGY, V13, P3, DOI 10.1093/neuonc/noq169; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Jacobs JFM, 2009, NEURO-ONCOLOGY, V11, P394, DOI 10.1215/15228517-2008-104; Kallmann BA, 2000, BRAIN, V123, P687, DOI 10.1093/brain/123.4.687; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Lohr J, 2011, CLIN CANCER RES, V17, P4296, DOI 10.1158/1078-0432.CCR-10-2557; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Martorelli D, 2012, CLIN DEV IMMUNOL, V2012, P931; Masson F, 2007, J IMMUNOL, V179, P845, DOI 10.4049/jimmunol.179.2.845; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Plautz GE, 1997, INT J ONCOL, V11, P389; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Riccadonna C, 2012, TUMOR MICROENVIRONME, P173; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sampson JH, 2008, SEMIN IMMUNOL, V20, P267, DOI 10.1016/j.smim.2008.04.001; Sasaki K, 2007, CANCER RES, V67, P6451, DOI 10.1158/0008-5472.CAN-06-3280; Sasaki K, 2009, J IMMUNOTHER, V32, P793, DOI 10.1097/CJI.0b013e3181acec1e; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Thang NNT, 2010, CANCER RES, V70, P4829, DOI 10.1158/0008-5472.CAN-09-3074; Thomas DL, 2009, J IMMUNOL, V183, P1828, DOI 10.4049/jimmunol.0802322; Wang LX, 2007, BLOOD, V109, P4865, DOI 10.1182/blood-2006-09-045245; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Wright JL, 1997, ACTA NEUROPATHOL, V93, P78; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63933	10.1371/journal.pone.0063933	http://dx.doi.org/10.1371/journal.pone.0063933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717511	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600037
J	Patil, DN; Datta, M; Dev, A; Dhindwal, S; Singh, N; Dasauni, P; Kundu, S; Sharma, AK; Tomar, S; Kumar, P				Patil, Dipak N.; Datta, Manali; Dev, Aditya; Dhindwal, Sonali; Singh, Nirpendra; Dasauni, Pushpanjali; Kundu, Suman; Sharma, Ashwani K.; Tomar, Shailly; Kumar, Pravindra			Structural Investigation of a Novel N-Acetyl Glucosamine Binding Chi-Lectin Which Reveals Evolutionary Relationship with Class III Chitinases	PLOS ONE			English	Article							CRYSTAL-STRUCTURE DETERMINATION; CARBOHYDRATE-BINDING; PLANT-LECTINS; MAXIMUM-LIKELIHOOD; 4 COMPLEXES; XIP-I; PROTEIN; FAMILY; GLYCOPROTEIN; IDENTIFICATION	The glycosyl hydrolase 18 (GH18) family consists of active chitinases as well as chitinase like lectins/proteins (CLPs). The CLPs share significant sequence and structural similarities with active chitinases, however, do not display chitinase activity. Some of these proteins are reported to have specific functions and carbohydrate binding property. In the present study, we report a novel chitinase like lectin (TCLL) from Tamarindus indica. The crystal structures of native TCLL and its complex with N-acetyl glucosamine were determined. Similar to the other CLPs of the GH18 members, TCLL lacks chitinase activity due to mutations of key active site residues. Comparison of TCLL with chitinases and other chitin binding CLPs shows that TCLL has substitution of some chitin binding site residues and more open binding cleft due to major differences in the loop region. Interestingly, the biochemical studies suggest that TCLL is an N-acetyl glucosamine specific chi-lectin, which is further confirmed by the complex structure of TCLL with N-acetyl glucosamine complex. TCLL has two distinct N-acetyl glucosamine binding sites S1 and S2 that contain similar polar residues, although interaction pattern with N-acetyl glucosamine varies extensively among them. Moreover, TCLL structure depicts that how plants utilize existing structural scaffolds ingenuously to attain new functions. To date, this is the first structural investigation of a chi-lectin from plants that explore novel carbohydrate binding sites other than chitin binding groove observed in GH18 family members. Consequently, TCLL structure confers evidence for evolutionary link of lectins with chitinases.	[Patil, Dipak N.; Datta, Manali; Dev, Aditya; Dhindwal, Sonali; Sharma, Ashwani K.; Tomar, Shailly; Kumar, Pravindra] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Singh, Nirpendra; Dasauni, Pushpanjali; Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi, India; [Dasauni, Pushpanjali] Univ Delhi, Cent Instrumentat Facil, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of Delhi; University of Delhi	Kumar, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	pravshai@gmail.com	KUMAR, PRAVINDRA/AAF-2859-2020; Patil, Dipak N./X-9567-2019	KUMAR, PRAVINDRA/0000-0003-2128-7736; Patil, Dipak N./0000-0003-1112-5557; Dasauni, Pushpanjali/0000-0002-7556-7330; Datta, Manali/0000-0002-5335-3446	Department of Science and Technology (DST), New Delhi, India [SERB/F/5551/2012-13]; University of Delhi (RD Grant); UGC (SAP programme); DBT; MHRD; AICTE, Government of India	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); University of Delhi (RD Grant); UGC (SAP programme); DBT(Department of Biotechnology (DBT) India); MHRD; AICTE, Government of India(All India Council for Technical Education (AICTE))	Financial support has been provided for this work by Department of Science and Technology (DST ref no. SERB/F/5551/2012-13 dated 22/01/2012), New Delhi, India. DNP and MD thank MHRD and AICTE, Government of India for financial support, respectively. Financial support to SK from University of Delhi (R&D Grant), UGC (SAP programme) and DBT are duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bokma E, 2002, EUR J BIOCHEM, V269, P893, DOI 10.1046/j.0014-2956.2001.02721.x; Bovi M, 2011, GLYCOBIOLOGY, V21, P1000, DOI 10.1093/glycob/cwr012; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Carrizo ME, 2005, J BIOL CHEM, V280, P10614, DOI 10.1074/jbc.M411989200; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Chandra NR, 2006, GLYCOBIOLOGY, V16, P938, DOI 10.1093/glycob/cwl012; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; COULSON AFW, 1994, FEBS LETT, V354, P41, DOI 10.1016/0014-5793(94)01084-6; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harata K, 2000, J MOL BIOL, V297, P673, DOI 10.1006/jmbi.2000.3594; Hayashida M, 2003, J MOL BIOL, V334, P551, DOI 10.1016/j.jmb.2003.09.076; HENNIG M, 1992, FEBS LETT, V306, P80, DOI 10.1016/0014-5793(92)80842-5; HENNIG M, 1995, ACTA CRYSTALLOGR D, V51, P177, DOI 10.1107/S0907444994009807; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Itoh Y, 2006, APPL MICROBIOL BIOT, V72, P1176, DOI 10.1007/s00253-006-0405-7; Kaur N, 2006, PROTEIN PEPTIDE LETT, V13, P895; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kumar J, 2007, ACTA CRYSTALLOGR D, V63, P437, DOI 10.1107/S0907444907001631; Kumar J, 2006, ACTA CRYSTALLOGR D, V62, P953, DOI 10.1107/S0907444906020427; Kumar S, 2010, FEBS J, V277, P2868, DOI 10.1111/j.1742-4658.2010.07703.x; Kuo CJ, 2008, J AGR FOOD CHEM, V56, P11507, DOI 10.1021/jf8017589; Lee BS, 2005, RAPID COMMUN MASS SP, V19, P2629, DOI 10.1002/rcm.2096; Leonidas DD, 2007, J MOL BIOL, V368, P1145, DOI 10.1016/j.jmb.2007.02.092; Lienemann M, 2009, GLYCOBIOLOGY, V19, P1116, DOI 10.1093/glycob/cwp102; Loris R, 2000, J MOL BIOL, V301, P987, DOI 10.1006/jmbi.2000.4016; Manali Datta, 2010, International Journal of Life Sciences and Technology (IJLST), V3, P16; Meng G, 2010, J BIOL CHEM, V285, P39898, DOI 10.1074/jbc.M110.130781; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P175, DOI 10.1002/bmb.2002.494030030035; MORRISON BW, 1994, ONCOGENE, V9, P3417; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Patil DN, 2009, ACTA CRYSTALLOGR F, V65, P343, DOI 10.1107/S1744309109006472; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Payan F, 2003, BIOCHEM J, V372, P399, DOI 10.1042/BJ20021802; Rao DH, 2008, J AGR FOOD CHEM, V56, P2175, DOI 10.1021/jf073183i; Rudiger H, 2001, GLYCOCONJUGATE J, V18, P589, DOI 10.1023/A:1020687518999; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sinha S, 2007, CURR OPIN STRUC BIOL, V17, P498, DOI 10.1016/j.sbi.2007.06.007; Somashekar D, 1997, CARBOHYD POLYM, V34, P343, DOI 10.1016/S0144-8617(97)00052-0; Srivastava DB, 2007, J STRUCT BIOL, V158, P255, DOI 10.1016/j.jsb.2006.11.002; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Van Damme EJM, 2007, PLANT PHYSIOL, V144, P662, DOI 10.1104/pp.106.087981; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Varela PF, 2002, J BIOL CHEM, V277, P13229, DOI 10.1074/jbc.M110502200; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2001, FEBS LETT, V494, P74, DOI 10.1016/S0014-5793(01)02317-1; Ye XY, 2001, J PROTEIN CHEM, V20, P367, DOI 10.1023/A:1012276619686; Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899; Zhu KY, 1996, PLANT PHYSIOL, V110, P195, DOI 10.1104/pp.110.1.195; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2004, BIOINFORMATICS, V20, P161, DOI 10.1093/bioinformatics/bth020	78	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63779	10.1371/journal.pone.0063779	http://dx.doi.org/10.1371/journal.pone.0063779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717482	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600032
J	Kari, V; Karpiuk, O; Tieg, B; Kriegs, M; Dikomey, E; Krebber, H; Begus-Nahrmann, Y; Johnsen, SA				Kari, Vijayalakshmi; Karpiuk, Oleksandra; Tieg, Bettina; Kriegs, Malte; Dikomey, Ekkehard; Krebber, Heike; Begus-Nahrmann, Yvonne; Johnsen, Steven A.			A Subset of Histone H2B Genes Produces Polyadenylated mRNAs under a Variety of Cellular Conditions	PLOS ONE			English	Article							STEM-LOOP; EXPRESSION; MONOUBIQUITINATION; IDENTIFICATION; PATTERNS; PATHWAY; CDK9; LIFE; END; P53	Unlike other metazoan mRNAs, replication-dependent histone gene transcripts are not polyadenylated but instead have a conserved stem-loop structure at their 39 end. Our previous work has shown that under certain conditions replication-dependent histone genes can produce alternative transcripts that are polyadenylated at the 39 end and, in some cases, spliced. A number of microarray studies examining the expression of polyadenylated mRNAs identified changes in the levels of histone transcripts e. g. during differentiation and tumorigenesis. However, it remains unknown which histone genes produce polyadenylated transcripts and which conditions regulate this process. In the present study we examined the expression and polyadenylation of the human histone H2B gene complement in various cell lines. We demonstrate that H2B genes display a distinct expression pattern that is varies between different cell lines. Further we show that the fraction of polyadenylated HIST1H2BD and HIST1H2AC transcripts is increased during differentiation of human mesenchymal stem cells (hMSCs) and human fetal osteoblast (hFOB 1.19). Furthermore, we observed an increased fraction of polyadenylated transcripts produced from the histone genes in cells following ionizing radiation. Finally, we show that polyadenylated transcripts are transported to the cytoplasm and found on polyribosomes. Thus, we propose that the production of polyadenylated histone mRNAs from replication-dependent histone genes is a regulated process induced under specific cellular circumstances.	[Kari, Vijayalakshmi; Johnsen, Steven A.] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Kari, Vijayalakshmi; Karpiuk, Oleksandra; Begus-Nahrmann, Yvonne; Johnsen, Steven A.] Univ Med Ctr Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Oncol, Gottingen, Germany; [Tieg, Bettina; Krebber, Heike] Univ Med Ctr Gottingen, Inst Microbiol & Genet, Dept Mol Genet, Gottingen, Germany; [Kriegs, Malte; Dikomey, Ekkehard] Univ Med Ctr Hamburg Eppendorf, Dept Radiat Oncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Johnsen, SA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	sjohnsen@alumni.mayo.edu	Johnsen, Steven/AAX-2322-2020	Johnsen, Steven/0000-0003-1198-5805	Dorothea-Schlozer Program at the University of Gottingen; Deutsche Forschungsgemeinschaft [JO 815/1, GRK1034]; State of Lower Saxony, Hannover, Germany [VWZN2562]	Dorothea-Schlozer Program at the University of Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Lower Saxony, Hannover, Germany	This work was supported by a doctoral fellowship from the Dorothea-Schlozer Program at the University of Gottingen to O.K. and grants from the Deutsche Forschungsgemeinschaft (JO 815/1 and GRK1034) and the State of Lower Saxony, Hannover, Germany (VWZN2562) to S.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Kari V, 2011, CELL CYCLE, V10, P3495, DOI 10.4161/cc.10.20.17769; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; PANDEY NB, 1990, NUCLEIC ACIDS RES, V18, P3161, DOI 10.1093/nar/18.11.3161; PANDEY NB, 1994, MOL CELL BIOL, V14, P1709, DOI 10.1128/MCB.14.3.1709; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	29	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63745	10.1371/journal.pone.0063745	http://dx.doi.org/10.1371/journal.pone.0063745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717473	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700053
J	Li, X; Zhao, WC; Sun, XY; Huang, HY; Kong, LC; Niu, DD; Sui, XL; Zhang, ZX				Li, Xin; Zhao, Wenchao; Sun, Xiyan; Huang, Hongyu; Kong, Lingcui; Niu, Dandan; Sui, Xiaolei; Zhang, Zhenxian			Molecular Cloning and Characterization of Violaxanthin De-Epoxidase (CsVDE) in Cucumber	PLOS ONE			English	Article							XANTHOPHYLL-CYCLE; CHLOROPHYLL FLUORESCENCE; GENE-EXPRESSION; DEPENDENT PHOTOPROTECTION; LIGHT; ARABIDOPSIS; PHOTOSYNTHESIS; PHOTOINHIBITION; STRESS; OVEREXPRESSION	Violaxanthin de-epoxidase (VDE) plays an important role in protecting the photosynthetic apparatus from photo-damage by dissipating excessively absorbed light energy as heat, via the conversion of violaxanthin (V) to intermediate product antheraxanthin (A) and final product zeaxanthin (Z) under high light stress. We have cloned a violaxanthin de-epoxidase gene (CsVDE) from cucumber. The amino acid sequence of CsVDE has high homology with VDEs in other plants. RT-PCR analysis and histochemical staining show that CsVDE is expressed in all green tissues in cucumber and Arabidopsis. Using GFP fusion protein and immunogold labeling methods, we show that CsVDE is mainly localized in chloroplasts in cucumber. Under high light stress, relative expression of CsVDE and the de-epoxidation ratio (A+Z)/(V+A+Z) is increased rapidly, and abundance of the gold particles was also increased. Furthermore, CsVDE is quickly induced by cold and drought stress, reaching maximum levels at the 2nd hour and the 9th day, respectively. The ratio of (A+Z)/(V+A+Z) and non-photochemical quenching (NPQ) is reduced in transgenic Arabidopsis down-regulated by the antisense fragment of CsVDE, compared to wild type (WT) Arabidopsis under high light stress. This indicates decreased functionality of the xanthophyll cycle and increased sensitivity to photoinhibition of photosystem II (PSII) in transgenic Arabidopsis under high light stress.	[Li, Xin; Zhao, Wenchao; Sun, Xiyan; Huang, Hongyu; Kong, Lingcui; Sui, Xiaolei; Zhang, Zhenxian] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China; [Niu, Dandan] Ecotech Ecol Technol Ltd, Ecol Lab, Beijing, Peoples R China	China Agricultural University	Zhang, ZX (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	zhangzx@cau.edu.cn			Ministry of Agriculture of China for transgenic research [2011ZX08009-003]; China Agriculture Research System [CARS-25]	Ministry of Agriculture of China for transgenic research; China Agriculture Research System	This work was supported by projects (2011ZX08009-003) from the Ministry of Agriculture of China for transgenic research, and China Agriculture Research System (CARS-25). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Baroli I, 2000, PHILOS T R SOC B, V355, P1385, DOI 10.1098/rstb.2000.0700; Bertamini M, 2006, ENVIRON EXP BOT, V57, P25, DOI 10.1016/j.envexpbot.2005.04.002; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Emanuelsson A, 2003, PHYSIOL PLANTARUM, V119, P97, DOI 10.1034/j.1399-3054.2003.00151.x; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Fernandez-Marin B, 2010, PLANTA, V231, P1335, DOI 10.1007/s00425-010-1129-6; Frommolt R, 2001, PLANTA, V213, P446, DOI 10.1007/s004250100589; Gao S, 2010, J INTEGR PLANT BIOL, V52, P332, DOI 10.1111/j.1744-7909.2010.00891.x; Gilmore AM, 1997, PHYSIOL PLANTARUM, V99, P197, DOI 10.1034/j.1399-3054.1997.990127.x; Gisselsson A, 2004, PHYSIOL PLANTARUM, V122, P337, DOI 10.1111/j.1399-3054.2004.00415.x; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Han H, 2010, J PLANT PHYSIOL, V167, P176, DOI 10.1016/j.jplph.2009.08.009; Hartel H, 1996, PLANT PHYSIOL, V110, P471, DOI 10.1104/pp.110.2.471; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Huang HY, 2013, SCI HORTIC-AMSTERDAM, V150, P206, DOI 10.1016/j.scienta.2012.11.011; Huang JL, 2007, PLANT SCI, V172, P228, DOI 10.1016/j.plantsci.2006.08.013; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; North HM, 2005, PLANT SCI, V169, P115, DOI 10.1016/j.plantsci.2005.03.002; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Woitsch S, 2003, PLANT PHYSIOL, V132, P1508, DOI 10.1104/pp.102.019364; Zhang DP, 2001, PLANT CELL ENVIRON, V24, P691, DOI 10.1046/j.0016-8025.2001.00720.x; Zhao WC, 2012, PLANT CELL REP, V31, P1381, DOI 10.1007/s00299-012-1254-8	40	11	16	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64383	10.1371/journal.pone.0064383	http://dx.doi.org/10.1371/journal.pone.0064383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717606	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700144
J	Ringholm, S; Knudsen, JG; Leick, L; Lundgaard, A; Nielsen, MM; Pilegaard, H				Ringholm, Stine; Knudsen, Jakob Grunnet; Leick, Lotte; Lundgaard, Anders; Nielsen, Maja Munk; Pilegaard, Henriette			PGC-1 alpha Is Required for Exercise- and Exercise Training-Induced UCP1 Up-Regulation in Mouse White Adipose Tissue	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; BROWN; FAT; ADIPOCYTES; MICE; ANGIOGENESIS; ACTIVATION	Background: The aim of the present study was to test the hypotheses that 1) a single exercise bout increases UCP1 mRNA in both inguinal (i)WAT and epididymal (e)WAT, 2) UCP1 expression and responsiveness to exercise are different in iWAT and eWAT, 3) PGC-1 alpha determines the basal levels of UCP1 and PRDM16 in WAT and 4) exercise and exercise training regulate UCP1 and PRDM16 expression in WAT in a PGC-1 alpha-dependent manner. Methods: Whole body PGC-1 alpha knockout (KO) and wildtype (WT) littermate mice performed a single treadmill exercise bout at 14 m/min and 10% slope for 1 hour. Mice were sacrificed and iWAT, eWAT and quadriceps muscle were removed immediately after, 2, 6 and 10 hours after running, and from sedentary mice that served as controls. In addition, PGC-1 alpha KO mice and WT littermates were exercise trained for 5 weeks with sedentary mice as untrained controls. Thirty-six-37 hours after the last exercise bout iWAT was removed. Results: UCP1 mRNA content increased 19-fold in iWAT and 7.5-fold in eWAT peaking at 6 h and 0' of recovery, respectively, in WT but with no changes in PGC-1 alpha KO mice. UCP1 protein was undetectable in eWAT and very low in iWAT of untrained mice but increased with exercise training to 4.4 (AU) in iWAT from WT mice without significant effects in PGC-1 alpha KO mice. Conclusion: The present observations provide evidence that exercise training increases UCP1 protein in iWAT through PGC-1 alpha, likely as a cumulative effect of transient increases in UCP1 expression after each exercise bout. Moreover, the results suggest that iWAT is more responsive than eWAT in exercise-induced regulation of UCP1. In addition, as PRDM16 mRNA content decreased in recovery from acute exercise, the present findings suggest that acute exercise elicits regulation of several brown adipose tissue genes in mouse WAT.	[Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark; Univ Copenhagen, August Krogh Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pilegaard, H (corresponding author), Univ Copenhagen, Dept Biol, Ctr Inflammat & Metab, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Knudsen, Jakob G/Q-2227-2018; Pilegaard, Henriette/M-2315-2014	Knudsen, Jakob G/0000-0001-7237-8457; Pilegaard, Henriette/0000-0002-1071-0327	Lundbeck Foundation; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Lundbeck Foundation [R5-2006-225, R13-2007-1300] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Lundbeck Foundation. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; STALLKNECHT B, 1993, AM J PHYSIOL, V265, pE128, DOI 10.1152/ajpendo.1993.265.1.E128; STALLKNECHT B, 1991, AM J PHYSIOL, V261, pE410, DOI 10.1152/ajpendo.1991.261.3.E410; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; TERRY RB, 1991, METABOLISM, V40, P733, DOI 10.1016/0026-0495(91)90093-C; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; Williams RS, 1996, REGULATION GENE EXPR; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	27	51	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64123	10.1371/journal.pone.0064123	http://dx.doi.org/10.1371/journal.pone.0064123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717545	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700102
J	West, L; Lowman, DW; Mora-Montes, HM; Grubb, S; Murdoch, C; Thornhill, MH; Gow, NAR; Williams, D; Haynes, K				West, Lara; Lowman, Douglas W.; Mora-Montes, Hector M.; Grubb, Sarah; Murdoch, Craig; Thornhill, Martin H.; Gow, Neil A. R.; Williams, David; Haynes, Ken			Differential Virulence of Candida glabrata Glycosylation Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Cell Wall; Fungi; Host-Pathogen Interactions; Virulence Factors	CELL-WALL MANNAN; WILD-TYPE LEVELS; SACCHAROMYCES-CEREVISIAE; GENE FAMILY; PROTEIN GLYCOSYLATION; PATTERN-RECOGNITION; ENDOTHELIAL-CELLS; HYPERTONIC-STRESS; BETA-GLUCAN; SIDE-CHAIN	The fungus Candida glabrata is an important and increasingly common pathogen of humans, particularly in immunocompromised hosts. Despite this, little is known about the attributes that allow this organism to cause disease or its interaction with the host immune system. However, in common with other fungi, the cell wall of C. glabrata is the initial point of contact between the host and pathogen, and as such, it is likely to play an important role in mediating interactions and hence virulence. Here, we show both through genetic complementation and polysaccharide structural analyses that C. glabrata ANP1, MNN2, and MNN11 encode functional orthologues of the respective Saccharomyces cerevisiae mannosyltransferases. Furthermore, we show that deletion of the C. glabrata Anp1, Mnn2, and Mnn11 mannosyltransferases directly affects the structure of the fungal N-linked mannan, in line with their predicted functions, and this has implications for cell wall integrity and consequently virulence. C. glabrata anp1 and mnn2 mutants showed increased virulence, compared with wild-type (and mnn11) cells. This is in contrast to Candida albicans where inactivation of genes involved in mannan biosynthesis has usually been linked to an attenuation of virulence. In the long term, a better understanding of the attributes that allow C. glabrata to cause disease will provide insights that can be adopted for the development of novel therapeutic and diagnostic approaches.	[West, Lara; Haynes, Ken] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London SW7 2AZ, England; [Lowman, Douglas W.; Williams, David] E Tennessee State Univ, Dept Surg, Quillen Coll Med, Johnson City, TN 37614 USA; [Lowman, Douglas W.] AppRidge Int LLC, Jonesborough, TN 37659 USA; [Mora-Montes, Hector M.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Mora-Montes, Hector M.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato 36050, Gto, Mexico; [Grubb, Sarah; Murdoch, Craig; Thornhill, Martin H.] Univ Sheffield, Sch Clin Dent, Sheffield S102TA, S Yorkshire, England; [Haynes, Ken] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England	Imperial College London; East Tennessee State University; University of Aberdeen; Universidad de Guanajuato; University of Sheffield; University of Exeter	Haynes, K (corresponding author), 325 Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	k.haynes@exeter.ac.uk	GOW, Neil/AAS-5323-2021; Montes, Hector Manuel Mora/H-1729-2014	GOW, Neil/0000-0002-2776-5850; Montes, Hector Manuel Mora/0000-0001-6973-0595; Murdoch, Craig/0000-0001-9724-122X; Thornhill, Martin/0000-0003-0681-4083	National Institutes of Health from NIGMS [RO1 GM53522]; Biotechnology and Biological Sciences Research Council [BBF005210]; Wellcome Trust [072420 075174, 080088]; National Institutes of Health from NIAID [R21 A1065549-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F005210/2, BB/F005210/1, BBS/B/10331] Funding Source: researchfish; BBSRC [BB/F005210/2, BB/F005210/1] Funding Source: UKRI	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM53522 from NIGMS (to D. L. W.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BBF005210 (to the Haynes Laboratory), Wellcome Trust Grants 072420 075174, and Wellcome Trust Grant 080088 (to the Gow Laboratory).; Supported by National Institutes of Health Grant R21 A1065549-01A1 from NIAID (to M. H. T.).	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; BALLOU L, 1980, J BIOL CHEM, V255, P5986; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brachmann CB, 1998, YEAST, V14, P115; Calcagno AM, 2005, MED MYCOL, V43, P355, DOI 10.1080/13693780400006088; Calcagno AM, 2004, YEAST, V21, P557, DOI 10.1002/yea.1125; Calcagno AM, 2003, MOL MICROBIOL, V50, P1309, DOI 10.1046/j.1365-2958.2003.03755.x; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; CHAPMAN RE, 1994, EMBO J, V13, P4896, DOI 10.1002/j.1460-2075.1994.tb06817.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Findon H., 2006, THESIS IMPERIAL COLL; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glee PM, 2001, INFECT IMMUN, V69, P2815, DOI 10.1128/IAI.69.5.2815-2820.2001; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; HILL K, 1992, GENETICS, V130, P273; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jawhara S, 2012, J BIOL CHEM, V287, P11313, DOI 10.1074/jbc.M111.329300; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Jungmann J, 1999, J BIOL CHEM, V274, P6579, DOI 10.1074/jbc.274.10.6579; Kamran M, 2004, EUKARYOT CELL, V3, P546, DOI 10.1128/EC.3.2.546-552.2004; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kitada K, 1996, GENE, V175, P105, DOI 10.1016/0378-1119(96)00132-1; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; KNAUER R, 1994, FEBS LETT, V344, P83, DOI 10.1016/0014-5793(94)00356-4; Kobayashi H, 1998, ARCH MICROBIOL, V169, P188, DOI 10.1007/s002030050559; Kobayashi H, 2003, ARCH MICROBIOL, V180, P76, DOI 10.1007/s00203-003-0550-7; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lizicarova I, 2007, CARBOHYD POLYM, V70, P89, DOI 10.1016/j.carbpol.2007.03.007; Lussier M, 1997, YEAST, V13, P267, DOI 10.1002/(SICI)1097-0061(19970315)13:3<267::AID-YEA72>3.0.CO;2-K; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; MacCallum DM, 2006, INFECT IMMUN, V74, P5244, DOI 10.1128/IAI.00817-06; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Mora-Montes HM, 2009, FUTURE MICROBIOL, V4, P1167, DOI 10.2217/FMB.09.88; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; OGAWA T, 1981, CARBOHYD RES, V97, P205, DOI 10.1016/S0008-6215(00)80667-9; Okawa Y, 2006, BIOL PHARM BULL, V29, P187, DOI 10.1248/bpb.29.187; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romani Luigina, 2004, Nat Rev Immunol, V4, P1, DOI 10.1038/nri2939; Romero PA, 1997, BIOCHEM J, V321, P289, DOI 10.1042/bj3210289; Ruan SY, 2008, CLIN MICROBIOL INFEC, V14, P136, DOI 10.1111/j.1469-0691.2007.01892.x; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stead D, 2005, PROTEOMICS, V5, P1838, DOI 10.1002/pmic.200401064; Stead DA, 2010, PROTEOMICS, V10, P212, DOI 10.1002/pmic.200800706; Takahashi S, 2012, FEBS J, V279, P1844, DOI 10.1111/j.1742-4658.2012.08564.x; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	85	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22006	10.1074/jbc.M113.478743	http://dx.doi.org/10.1074/jbc.M113.478743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23720756	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000328841900047
J	Chapman, BB; Eriksen, A; Baktoft, H; Brodersen, J; Nilsson, PA; Hulthen, K; Bronmark, C; Hansson, LA; Gronkjaer, P; Skov, C				Chapman, Ben B.; Eriksen, Anders; Baktoft, Henrik; Brodersen, Jakob; Nilsson, P. Anders; Hulthen, Kaj; Broenmark, Christer; Hansson, Lars-Anders; Gronkjaer, Peter; Skov, Christian			A Foraging Cost of Migration for a Partially Migratory Cyprinid Fish	PLOS ONE			English	Article							SEASONAL MIGRATION; PREDATION RISK; SIZE; EVOLUTION; PATTERNS; GUIDE; DIEL	Migration has evolved as a strategy to maximise individual fitness in response to seasonally changing ecological and environmental conditions. However, migration can also incur costs, and quantifying these costs can provide important clues to the ultimate ecological forces that underpin migratory behaviour. A key emerging model to explain migration in many systems posits that migration is driven by seasonal changes to a predation/growth potential (p/g) trade-off that a wide range of animals face. In this study we assess a key assumption of this model for a common cyprinid partial migrant, the roach Rutilus rutilus, which migrates from shallow lakes to streams during winter. By sampling fish from stream and lake habitats in the autumn and spring and measuring their stomach fullness and diet composition, we tested if migrating roach pay a cost of reduced foraging when migrating. Resident fish had fuller stomachs containing more high quality prey items than migrant fish. Hence, we document a feeding cost to migration in roach, which adds additional support for the validity of the p/g model of migration in freshwater systems.	[Chapman, Ben B.; Nilsson, P. Anders; Hulthen, Kaj; Broenmark, Christer; Hansson, Lars-Anders] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden; [Eriksen, Anders; Baktoft, Henrik; Skov, Christian] Tech Univ Denmark DTU, Natl Inst Aquat Resources, Silkeborg, Denmark; [Brodersen, Jakob] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Eriksen, Anders; Gronkjaer, Peter] Aarhus Univ, Dept Biosci, Aarhus, Denmark	Lund University; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Aarhus University	Chapman, BB (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden.	ben.chapman@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Grønkjær, Peter/A-3697-2008; Nilsson, Anders/H-6836-2014; Baktoft, Henrik/E-6581-2011; Skov, Christian/X-6511-2019	Grønkjær, Peter/0000-0003-1337-4661; Nilsson, Anders/0000-0002-3541-9835; Baktoft, Henrik/0000-0002-3644-4960; Skov, Christian/0000-0002-8547-6520; Hansson, Lars-Anders/0000-0002-3035-1317	Danish National Fishing License Funds, Formas, Swedish Research Council; Marie Curie EU fellowship (FP7)	Danish National Fishing License Funds, Formas, Swedish Research Council; Marie Curie EU fellowship (FP7)	This work was funded by the Danish National Fishing License Funds, Formas, Swedish Research Council, and a Marie Curie EU fellowship (FP7) to BBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Bolger DT, 2008, ECOL LETT, V11, P63; Borcherding J, 2002, J FISH BIOL, V61, P1154, DOI 10.1006/jfbi.2002.2129; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2012, J FISH BIOL, V81, P479, DOI 10.1111/j.1095-8649.2012.03349.x; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Dingle Hugh, 1996, P1; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hansson LA, 2009, P R SOC B, V276, P331, DOI 10.1098/rspb.2008.1088; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Jepsen N, 2002, HYDROBIOLOGIA, V483, P167, DOI 10.1023/A:1021379528719; Jonsson B, 2011, FISH FISH SER, V33, P1, DOI 10.1007/978-94-007-1189-1; Jonsson N, 1997, J ANIM ECOL, V66, P425, DOI 10.2307/5987; Mehner T, 2012, FRESHWATER BIOL, V57, P1342, DOI 10.1111/j.1365-2427.2012.02811.x; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; PERSSON L, 1983, OIKOS, V41, P118, DOI 10.2307/3544353; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Sims DW, 2001, P ROY SOC B-BIOL SCI, V268, P2607, DOI 10.1098/rspb.2001.1847; Skov C, 2008, ECOL FRESHW FISH, V17, P406, DOI 10.1111/j.1600-0633.2008.00291.x; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Skov C, 2011, P ROY SOC B-BIOL SCI, V278, P1414, DOI 10.1098/rspb.2010.2035; Southwood A, 2010, J COMP PHYSIOL B, V180, P1, DOI 10.1007/s00360-009-0415-8; Stefanescu C., 2012, ECOGRAPHY; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487	33	17	17	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e61223	10.1371/journal.pone.0061223	http://dx.doi.org/10.1371/journal.pone.0061223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723967	Green Published, gold			2022-12-25	WOS:000319733000003
J	Liu, BR; Liou, JS; Huang, YW; Aronstam, RS; Lee, HJ				Liu, Betty R.; Liou, Ji-Sing; Huang, Yue-Wern; Aronstam, Robert S.; Lee, Han-Jung			Intracellular Delivery of Nanoparticles and DNAs by IR9 Cell-penetrating Peptides	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; QUANTUM DOTS; PROTEIN TRANSDUCTION; PLASMA-MEMBRANE; MOLECULAR-MECHANISM; UPTAKE KINETICS; DRUG-DELIVERY; GENE-TRANSFER; LIVING CELLS; TAT PROTEIN	Cell-penetrating peptides (CPPs) comprised of basic amino residues are able to cross cytoplasmic membranes and are able to deliver biologically active molecules inside cells. However, CPP/cargo entrapment in endosome limits biomedical utility as cargoes are destroyed in the acidic environment. In this study, we demonstrate protein transduction of a novel CPP comprised of an INF7 fusion peptide and nona-arginine (designated IR9). IR9 noncovalently interacts with quantum dots (QDs) and DNAs to form stable IR9/QD and IR9/DNA complexes which are capable of entering human A549 cells. Zeta-potentials were a better predictor of transduction efficiency than gel shift analysis, emphasizing the importance of electrostatic interactions of CPP/cargo complexes with plasma membranes. Mechanistic studies revealed that IR9, IR9/QD and IR9/DNA complexes may enter cells by endocytosis. Further, IR9, IR9/QD and IR9/DNA complexes were not cytotoxic at concentrations below 30, 5 and 20.1 mu M, respectively. Without labor intensive production of fusion proteins from prokaryotes, these results indicate that IR9 could be a safe carrier of genes and drugs in biomedical applications.	[Liu, Betty R.; Liou, Ji-Sing; Lee, Han-Jung] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Huang, Yue-Wern; Aronstam, Robert S.] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO USA	National Dong Hwa University; University of Missouri System; Missouri University of Science & Technology	Lee, HJ (corresponding author), Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan.	hjlee@mail.ndhu.edu.tw	Liu, Betty Revon/GLU-3300-2022	Aronstam, Robert/0000-0001-7188-8412; Liu, Betty Revon/0000-0002-5152-8687	National Science Council of Taiwan [NSC 101-2811-B-259-001, NSC 101-2320-B-259-002-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The financial support of this study was provided by the Postdoctoral Fellowship NSC 101-2811-B-259-001 (to Liu BR) and the Grant Number NSC 101-2320-B-259-002-MY3 from the National Science Council of Taiwan (to Lee HJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ADV STUD BIOL; Bharali DJ, 2005, J AM CHEM SOC, V127, P11364, DOI 10.1021/ja051455x; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Chan M. H., 2013, PHARM NANOTECHNOL, V1, P151; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chen CP, 2007, FEBS LETT, V581, P1891, DOI 10.1016/j.febslet.2007.03.076; Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q; Chen YJ, 2012, GENE, V493, P201, DOI 10.1016/j.gene.2011.11.060; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dai YH, 2011, GENE, V489, P89, DOI 10.1016/j.gene.2011.08.011; Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; EKIMOV AI, 1981, JETP LETT+, V34, P345; El-Sayed A, 2009, J CONTROL RELEASE, V138, P160, DOI 10.1016/j.jconrel.2009.05.018; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Floren A, 2011, METHODS MOL BIOL, V683, P117, DOI 10.1007/978-1-60761-919-2_9; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Hou YW, 2007, EXP DERMATOL, V16, P999, DOI 10.1111/j.1600-0625.2007.00622.x; Hu JW, 2009, PEPTIDES, V30, P1669, DOI 10.1016/j.peptides.2009.06.006; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kilk K, 2009, TOXICOLOGY, V265, P87, DOI 10.1016/j.tox.2009.09.016; Koshman YE, 2008, J MOL CELL CARDIOL, V45, P853, DOI 10.1016/j.yjmcc.2008.08.006; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Lee CY, 2011, BIOMATERIALS, V32, P6264, DOI 10.1016/j.biomaterials.2011.05.012; Li JF, 2010, ANTICANCER RES, V30, P2193; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Liou JS, 2012, PEPTIDES, V37, P273, DOI 10.1016/j.peptides.2012.07.019; Liu BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-57; Liu BR, 2011, BIOMATERIALS, V32, P3520, DOI 10.1016/j.biomaterials.2011.01.041; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P7897, DOI 10.1166/jnn.2010.3012; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P6534, DOI 10.1166/jnn.2010.2637; Liu BR, 2008, J MEMBRANE BIOL, V222, P1, DOI 10.1007/s00232-008-9096-6; Liu BR, 2012, GENE, V505, P37, DOI 10.1016/j.gene.2012.05.053; Liu K, 2007, J PLANT GROWTH REGUL, V26, P278, DOI 10.1007/s00344-007-9015-6; LIU MJ, 2013, ADV STUD BIOL, V5, P71; Lu SW, 2010, J AGR FOOD CHEM, V58, P2288, DOI 10.1021/jf903039j; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mager I, 2012, BBA-BIOMEMBRANES, V1818, P502, DOI 10.1016/j.bbamem.2011.11.020; Maiolo JR, 2005, BBA-BIOMEMBRANES, V1712, P161, DOI 10.1016/j.bbamem.2005.04.010; Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Nakase I, 2012, J CONTROL RELEASE, V159, P181, DOI 10.1016/j.jconrel.2012.01.016; Nakase I, 2010, BIOPOLYMERS, V94, P763, DOI 10.1002/bip.21487; Noguchi H, 2010, CELL TRANSPLANT, V19, P649, DOI 10.3727/096368910X508744; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; PLANK C, 1994, J BIOL CHEM, V269, P12918; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Rucevic M, 2011, ELECTROPHORESIS, V32, P1549, DOI 10.1002/elps.201100212; Schaeublin NM, 2011, NANOSCALE, V3, P410, DOI 10.1039/c0nr00478b; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Schrand AM, 2009, CRIT REV SOLID STATE, V34, P18, DOI 10.1080/10408430902831987; Shao LJ, 2011, SENSORS-BASEL, V11, P11736, DOI 10.3390/s111211736; Siennicka Joanna, 2003, Medycyna Doswiadczalna i Mikrobiologia, V55, P157; Sugita T, 2007, BIOCHEM BIOPH RES CO, V363, P1027, DOI 10.1016/j.bbrc.2007.09.077; Suhorutsenko J, 2011, BIOCONJUGATE CHEM, V22, P2255, DOI 10.1021/bc200293d; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wagstaff KM, 2006, CURR MED CHEM, V13, P1371, DOI 10.2174/092986706776872871; Wang YH, 2007, J BIOCHEM BIOPH METH, V70, P579, DOI 10.1016/j.jbbm.2007.01.010; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Wei YF, 2009, BIOCONJUGATE CHEM, V20, P1752, DOI 10.1021/bc8003777; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Xu Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948543; Xue FL, 2007, J FLUORESC, V17, P149, DOI 10.1007/s10895-006-0152-2; Yang S, 2009, J CONTROL RELEASE, V135, P159, DOI 10.1016/j.jconrel.2008.12.015; Ye SF, 2012, NANOMED-NANOTECHNOL, V8, P833, DOI 10.1016/j.nano.2011.10.003; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604	81	27	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64205	10.1371/journal.pone.0064205	http://dx.doi.org/10.1371/journal.pone.0064205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724035	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000048
J	Nolen, BM; Orlichenko, LS; Marrangoni, A; Velikokhatnaya, L; Prosser, D; Grizzle, WE; Ho, K; Jenkins, FJ; Bovbjerg, DH; Lokshin, AE				Nolen, Brian M.; Orlichenko, Lidiya S.; Marrangoni, Adele; Velikokhatnaya, Liudmila; Prosser, Denise; Grizzle, William E.; Ho, Kevin; Jenkins, Frank J.; Bovbjerg, Dana H.; Lokshin, Anna E.			An Extensive Targeted Proteomic Analysis of Disease-Related Protein Biomarkers in Urine from Healthy Donors	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; MASS-SPECTROMETRY; BLADDER-CANCER; ELECTROPHORETIC TRANSFER; GLOMERULAR CAPILLARIES; POLYACRYLAMIDE GELS; OVARIAN-CANCER; DISCOVERY; MARKER; KIDNEY	The analysis of protein biomarkers in urine is expected to lead to advances in a variety of clinical settings. Several characteristics of urine including a low-protein matrix, ease of testing and a demonstrated proteomic stability offer distinct advantages over current widely used biofluids, serum and plasma. Improvements in our understanding of the urine proteome and in methods used in its evaluation will facilitate the clinical development of urinary protein biomarkers. Multiplexed bead-based immunoassays were utilized to evaluate 211 proteins in urines from 103 healthy donors. An additional 25 healthy donors provided serial urine samples over the course of two days in order to assess temporal variation in selected biomarkers. Nearly one-third of the evaluated biomarkers were detected in urine at levels greater than 1ng/ml, representing a diverse panel of proteins with respect to structure, function and biological role. The presence of several biomarkers in urine was confirmed by western blot. Several methods of data normalization were employed to assess impact on biomarker variability. A complex pattern of correlations with urine creatinine, albumin and beta-2-microglobulin was observed indicating the presence of highly specific mechanisms of renal filtration. Further investigation of the urinary protein biomarkers identified in this preliminary study along with a consideration of the underlying proteomic trends suggested by these findings should lead to an improved capability to identify candidate biomarkers for clinical development.	[Nolen, Brian M.; Orlichenko, Lidiya S.; Marrangoni, Adele; Velikokhatnaya, Liudmila; Prosser, Denise; Jenkins, Frank J.; Bovbjerg, Dana H.; Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Ho, Kevin] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA; [Jenkins, Frank J.; Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Dept Psychol, Dietrich Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Ob Gyn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lokshin, AE (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA.	lokshina@pitt.edu			United States National Institutes of Health [U01CA117452, RO1 570 CA098642, R01 CA108990, P50 CA083639, P30CA047904, CA129557, CA086381, CA105009]; UPCI Hillman 571 Fellows Award; The Frieda G. and Saul F. Shapira BRCA Cancer Research 572 Program Award; NATIONAL CANCER INSTITUTE [R01CA098642, P50CA105009, P50CA101955, P30CA047904, R01CA129557, U01CA086381, R01CA108990, U01CA117452, P50CA083639] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPCI Hillman 571 Fellows Award; The Frieda G. and Saul F. Shapira BRCA Cancer Research 572 Program Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by United States National Institutes of Health grants: U01CA117452 (EDRN), RO1 570 CA098642, R01 CA108990, P50 CA083639, P30CA047904, CA129557, CA086381, CA105009, UPCI Hillman 571 Fellows Award, and The Frieda G. and Saul F. Shapira BRCA Cancer Research 572 Program Award (AEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Ammon A., 1995, International Journal of Biological Markers, V10, P17; [Anonymous], 2012, SEER CANC STAT REV 1; Basaran A, 2007, MED HYPOTHESES, V68, P197, DOI 10.1016/j.mehy.2006.04.076; Bautista DS, 1996, J CELL BIOCHEM, V61, P402, DOI 10.1002/(SICI)1097-4644(19960601)61:3<402::AID-JCB7>3.0.CO;2-X; Bigbee WL, 2012, J THORAC ONCOL, V7, P698, DOI 10.1097/JTO.0b013e31824ab6b0; Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Comte B, 2006, KIDNEY INT, V69, P1048, DOI 10.1038/sj.ki.5000133; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Dyer AR, 2004, AM J EPIDEMIOL, V160, P1122, DOI 10.1093/aje/kwh326; FOUNDATION NK, 2002, AM J KIDNEY DIS S, V39, pS1; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gollapalli K, 2012, PROTEOMICS; Gonzalez-Buitrago JM, 2007, CLIN CHIM ACTA, V375, P49, DOI 10.1016/j.cca.2006.07.027; Hazzaa SM, 2010, PATHOL ONCOL RES, V16, P101, DOI 10.1007/s12253-009-9196-3; Hellstrom I, 2010, CANCER LETT, V296, P43, DOI 10.1016/j.canlet.2010.03.013; Hjalmarsson C, 2004, MICROVASC RES, V67, P9, DOI 10.1016/j.mvr.2003.10.001; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; Kentsis A, 2009, PROTEOM CLIN APPL, V3, P1052, DOI 10.1002/prca.200900008; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Liu Liyun, 2009, Zhongguo Fei Ai Za Zhi, V12, P300, DOI 10.3779/j.issn.1009-3419.2009.04.08; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Navarro-Munoz M, 2012, KIDNEY BLOOD PRESS R, V35, P314, DOI 10.1159/000335383; Nolen BM, 2011, INT J BIOL MARKER, V26, P141, DOI 10.5301/JBM.2011.8613; Obeidat M, 2012, EXP CELL RES, V318, P964, DOI 10.1016/j.yexcr.2012.02.032; Pejcic M, 2010, RENAL FAILURE, V32, P259, DOI 10.3109/08860221003599759; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Polotsky Vsevolod Y, 2007, Proc Am Thorac Soc, V4, P121, DOI 10.1513/pats.200606-134JG; Riaz S, 2010, DIABETES TECHNOL THE, V12, P979, DOI 10.1089/dia.2010.0078; Rostgaard J, 2002, CELLS TISSUES ORGANS, V170, P132, DOI 10.1159/000046186; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Shio K, 2010, J RHEUMATOL, V37, P704, DOI 10.3899/jrheum.090582; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Steinhoff J, 1997, TRANSPLANT P, V29, P3098, DOI 10.1016/S0041-1345(97)00797-5; Takashi M, 1996, UROL INT, V56, P174, DOI 10.1159/000282835; Tantipaiboonwong P, 2005, PROTEOMICS, V5, P1140, DOI 10.1002/pmic.200401143; Tay S. K., 1994, Annals Academy of Medicine Singapore, V23, P311; TEISNER B, 1983, CLIN CHIM ACTA, V127, P413, DOI 10.1016/0009-8981(83)90170-5; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vinken P, 2012, TOXICOL PATHOL; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121; Ye B, 2006, CLIN CANCER RES, V12, P432, DOI 10.1158/1078-0432.CCR-05-0461; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484	51	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63368	10.1371/journal.pone.0063368	http://dx.doi.org/10.1371/journal.pone.0063368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723977	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000008
J	Piper, SC; Ferguson, J; Kay, L; Parker, LC; Sabroe, I; Sleeman, MA; Briend, E; Finch, DK				Piper, Sian C.; Ferguson, John; Kay, Linda; Parker, Lisa C.; Sabroe, Ian; Sleeman, Matthew A.; Briend, Emmanuel; Finch, Donna K.			The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BLOOD MONONUCLEAR-CELLS; IN-VITRO; IMMUNE-RESPONSE; INFECTION; EXACERBATION; AIRWAY; IL-18; ACTIVATION; EXPRESSION	Human Rhinovirus (HRV) is associated with acute exacerbations of chronic respiratory disease. In healthy individuals, innate viral recognition pathways trigger release of molecules with direct anti-viral activities and pro-inflammatory mediators which recruit immune cells to support viral clearance. Interleukin-1alpha (IL-1 alpha), interleukin-1beta (IL-1 beta) and interleukin-18 (IL-18) have critical roles in the establishment of neutrophilic inflammation, which is commonly seen in airways viral infection and thought to be detrimental in respiratory disease. We therefore investigated the roles of these molecules in HRV infection of primary human epithelial cells. We found that all three cytokines were released from infected epithelia. Release of these cytokines was not dependent on cell death, and only IL-1 beta and IL-18 release was dependent on caspase-1 catalytic activity. Blockade of IL-1 but not IL-18 signaling inhibited up-regulation of pro-inflammatory mediators and neutrophil chemoattractants but had no effect on virus induced production of interferons and interferon-inducible genes, measured at both mRNA and protein level. Similar level of virus mRNA was detected with and without IL-1RI blockade. Hence IL-1 signaling, potentially involving both IL-1 beta and IL-1 alpha, downstream of viral recognition plays a key role in induction of pro-inflammatory signals and potentially in recruitment and activation of immune cells in response to viral infection instigated by the epithelial cells, whilst not participating in direct anti-viral responses.	[Piper, Sian C.; Ferguson, John; Sleeman, Matthew A.; Briend, Emmanuel; Finch, Donna K.] MedImmune Ltd, Resp Inflammat & Autoimmun, Cambridge, England; [Kay, Linda; Parker, Lisa C.; Sabroe, Ian] Univ Sheffield, Fac Med, Dept Infect & Immun, Sheffield, S Yorkshire, England	AstraZeneca; Medimmune; University of Sheffield	Finch, DK (corresponding author), MedImmune Ltd, Resp Inflammat & Autoimmun, Cambridge, England.	finchd@medimmune.com	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013; Sleeman, Matthew A/E-6675-2016	Sabroe, Ian/0000-0001-9750-8975; Tripp, Ralph/0000-0002-2924-9956	MedImmune Ltd	MedImmune Ltd(AstraZenecaMedimmune)	The authors have the following interests: All work was funded by MedImmune Ltd, the employer of Sian C Piper, John Ferguson, Matthew A. Sleeman, Emmanuel Briend and Donna K. Finch who may receive AstraZeneca shares as part of their usual renumeration. MedImmune Ltd is currently evaluating antibodies to IL-1RI and IL-18 for use in COPD patients, and has filed associated patents. The HRV14 and HRV1b virus preparations used in this study were generated and purified by Laura Liggins and Melanie Snow within Discovery Enabling Capabilities and Science (DECS) at AstraZeneca R&D, Alderley Park, UK. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Elbim C, 2005, CLIN DIAGN LAB IMMUN, V12, P436, DOI 10.1128/CDLI.12.3.436-446.2005; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Greenberg SB, 2000, AM J RESP CRIT CARE, V162, P167, DOI 10.1164/ajrccm.162.1.9911019; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; Kim Jean, 2009, P267, DOI 10.1007/978-4-431-88315-9_17; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Mahy BWJ, 1996, VIROLOGY METHODS MAN; Mallia Patrick, 2005, Proc Am Thorac Soc, V2, P361, DOI 10.1513/pats.200504-025SR; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Manigold T, 2000, CYTOKINE, V12, P1788, DOI 10.1006/cyto.2000.0783; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Poeck H, 2012, EUR J CELL BIOL, V91, P59, DOI 10.1016/j.ejcb.2011.01.013; PROUD D, 1994, J INFECT DIS, V169, P1007, DOI 10.1093/infdis/169.5.1007; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Shi L, 2012, AM J RESP CELL MOL B; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Stokes CA, 2011, J VIROL, V85, P7912, DOI 10.1128/JVI.02649-10; Terajima M, 1997, AM J PHYSIOL-LUNG C, V273, pL749, DOI 10.1152/ajplung.1997.273.4.L749; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807; Wang XM, 2006, J IMMUNOL, V177, P6859, DOI 10.4049/jimmunol.177.10.6859; Wedzicha Jadwiga A, 2003, Respir Care, V48, P1204; Winther Birgit, 2011, Proc Am Thorac Soc, V8, P79, DOI 10.1513/pats.201006-039RN; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC	40	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63365	10.1371/journal.pone.0063365	http://dx.doi.org/10.1371/journal.pone.0063365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723976	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000319733000007
J	Savic, R; He, XX; Fiel, I; Schuchman, EH				Savic, Radoslav; He, Xingxuan; Fiel, Isabel; Schuchman, Edward H.			Recombinant Human Acid Sphingomyelinase as an Adjuvant to Sorafenib Treatment of Experimental Liver Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-ANALYSIS; TARGETED THERAPIES; ANTITUMOR-ACTIVITY; KUPFFER CELLS; RECEPTOR; INHIBITOR; CERAMIDE; DELIVERY; GENE	Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the third leading cause of cancer death worldwide. The only approved systemic treatment for unresectable HCC is the oral kinase inhibitor, sorafenib. Recombinant human acid sphingomyelinase (rhASM), which hydrolyzes sphingomyelin to ceramide, is an orphan drug under development for the treatment of Type B Niemann-Pick disease (NPD). Due to the hepatotropic nature of rhASM and its ability to generate pro-apoptotic ceramide, this study evaluated the use of rhASM as an adjuvant treatment with sorafenib in experimental models of HCC. Methodology/Principal Findings: In vitro, rhASM/sorafenib treatment reduced the viability of Huh7 liver cancer cells more than sorafenib. In vivo, using a subcutaneous Huh7 tumor model, mouse survival was increased and proliferation in the tumors decreased to a similar extent in both sorafenib and rhASM/sorafenib treatment groups. However, combined rhASM/ sorafenib treatment significantly lowered tumor volume, increased tumor necrosis, and decreased tumor blood vessel density compared to sorafenib. These results were obtained despite poor delivery of rhASM to the tumors. A second (orthotopic) model of Huh7 tumors also was established, but modest ASM activity was similarly detected in these tumors compared to healthy mouse livers. Importantly, no chronic liver toxicity or weight loss was observed from rhASM therapy in either model. Conclusions/Significance: The rhASM/sorafenib combination exhibited a synergistic effect on reducing the tumor volume and blood vessel density in Huh7 xenografts, despite modest activity of rhASM in these tumors. No significant increases in survival were observed from the rhASM/sorafenib treatment. The poor delivery of rhASM to Huh7 tumors may be due, at least in part, to low expression of mannose receptors. The safety and efficacy of this approach, together with the novel findings regarding enzyme targeting, merits further investigation.	[Savic, Radoslav; He, Xingxuan; Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Fiel, Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Schuchman, EH (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA.	Edward.Schuchman@mssm.edu			NIH [HD28607]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028607] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: NIH HD28607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Barth BM, 2011, ANTI-CANCER AGENT ME, V11, P911; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Braulke T, 1999, HORM METAB RES, V31, P242, DOI 10.1055/s-2007-978725; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Dhami R, 2004, J BIOL CHEM, V279, P1526, DOI 10.1074/jbc.M309465200; Draper JM, 2011, MOL CANCER THER, V10, P2052, DOI 10.1158/1535-7163.MCT-11-0365; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garnacho C, 2008, J PHARMACOL EXP THER, V325, P400, DOI 10.1124/jpet.107.133298; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Hakomori S, 1973, Adv Cancer Res, V18, P265, DOI 10.1016/S0065-230X(08)60755-1; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He XX, 1999, BBA-PROTEIN STRUCT M, V1432, P251, DOI 10.1016/S0167-4838(99)00069-2; He XX, 2005, ANAL BIOCHEM, V340, P113, DOI 10.1016/j.ab.2005.01.058; He XX, 2003, ANAL BIOCHEM, V314, P116, DOI 10.1016/S0003-2697(02)00629-2; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Liu K, 2003, WORLD J GASTROENTERO, V9, P1946, DOI 10.3748/wjg.v9.i9.1946; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Muro S, 2006, MOL THER, V13, P135, DOI 10.1016/j.ymthe.2005.07.687; Osawa Y, 2013, J CLIN INVEST; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Puxbaum V, 2012, J HEPATOL, V57, P337, DOI 10.1016/j.jhep.2012.03.026; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sato S, 2011, HISTOL HISTOPATHOL, V26, P497, DOI 10.14670/HH-26.497; Savic R, 2006, J DRUG TARGET, V14, P343, DOI 10.1080/10611860600874538; Savic R, 2013, ADV CANCER RES, V117, P91, DOI 10.1016/B978-0-12-394274-6.00004-2; Schuchman EH, 2009, INT J CLIN PHARM TH, V47, pS48; Smith E. L., 2008, ACID SPHINGOMYELINAS; Smith EL, 2008, MOL THER, V16, P1565, DOI 10.1038/mt.2008.145; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; TAGHIAN A, 1993, CANCER RES, V53, P5012; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; Tanaka M, 1996, HEPATOLOGY, V24, P807; Thomas MB, 2005, J CLIN ONCOL, V23, P8093, DOI 10.1200/JCO.2004.00.1537; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang J, 2000, ANTICANCER RES, V20, P1635; Zhang XS, 2011, J INHERIT METAB DIS, V34, P795, DOI 10.1007/s10545-011-9285-9; Zhu AX, 2010, EXPERT OPIN INV DRUG, V19, P663, DOI 10.1517/13543781003767426	55	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65620	10.1371/journal.pone.0065620	http://dx.doi.org/10.1371/journal.pone.0065620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724146	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000135
J	Singh, GG; Markel, RW; Martone, RG; Salomon, AK; Harley, CDG; Chan, KMA				Singh, Gerald G.; Markel, Russell W.; Martone, Rebecca G.; Salomon, Anne K.; Harley, Christopher D. G.; Chan, Kai M. A.			Sea Otters Homogenize Mussel Beds and Reduce Habitat Provisioning in a Rocky Intertidal Ecosystem	PLOS ONE			English	Article							FORAGING STRATEGIES; WAVE EXPOSURE; PHASE-SHIFTS; PATTERNS; COMMUNITIES; EQUILIBRIA; BOUNDARIES; PREDATION; ABALONES; LEADS	Sea otters (Enhydra lutris) are keystone predators that consume a variety of benthic invertebrates, including the intertidal mussel, Mytilus californianus. By virtue of their competitive dominance, large size, and longevity, M. californianus are ecosystem engineers that form structurally complex beds that provide habitat for diverse invertebrate communities. We investigated whether otters affect mussel bed characteristics (i.e. mussel length distributions, mussel bed depth, and biomass) and associated community structure (i.e. biomass, alpha and beta diversity) by comparing four regions that varied in their histories of sea otter occupancy on the west coast of British Columbia and northern Washington. Mussel bed depth and average mussel lengths were 1.5 times lower in regions occupied by otters for >20 years than those occupied for <5 yrs. Diversity of mussel bed associated communities did not differ between regions; however, the total biomass of species associated with mussel beds was more than three-times higher where sea otters were absent. We examined alternative explanations for differences in mussel bed community structure, including among-region variation in oceanographic conditions and abundance of the predatory sea star Pisaster ochraceus. We cannot discount multiple drivers shaping mussel beds, but our findings indicate the sea otters are an important one. We conclude that, similar to their effects on subtidal benthic invertebrates, sea otters reduce the size distributions of intertidal mussels and, thereby, habitat available to support associated communities. Our study indicates that by reducing populations of habitat-providing intertidal mussels, sea otters may have substantial indirect effects on associated communities.	[Singh, Gerald G.; Markel, Russell W.; Martone, Rebecca G.; Chan, Kai M. A.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Salomon, Anne K.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Harley, Christopher D. G.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Harley, Christopher D. G.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia	Singh, GG (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	gsingh@ires.ubc.ca	Harley, Christopher D. G./K-5593-2012; Chan, Kai M A/C-1682-2009	Harley, Christopher D. G./0000-0003-4099-943X; Chan, Kai M A/0000-0002-7804-3276	Natural Science and Engineering Council of Canada [08-1970]; Canadian Foundation for Innovation/BC Knowledge Development Fund [F07-0010]; Nature Conservancy [08-0687]	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation/BC Knowledge Development Fund(Canada Foundation for Innovation); Nature Conservancy	This project was funded by a Strategic Projects Grant from the Natural Science and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/; K. Chan, C. Harley, J. Shurin and E. Pakhomov as co-PIs, grant # 08-1970), a Leaders Opportunity Fund grant from the Canadian Foundation for Innovation/BC Knowledge Development Fund (http://www.innovation.ca/; K. Chan as PI, grant # F07-0010), and a grant from the The Nature Conservancy (http://www.nature.org/; KC as PI, grant # 08-0687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RG, 2008, ECOLOGY, V89, P2725, DOI 10.1890/07-1818.1; Barnes H, 1960, J ZOOL, V132, P569; Coe WR, 1944, BIOL BULL-US, V87, P59, DOI 10.2307/1538129; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Crawley M.J., 2007, R BOOK; Donahue MJ, 2011, AM NAT, V178, P612, DOI 10.1086/662177; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; EsTEs J. A., 1980, MAMMAL SPECIES, V133, P1, DOI [10.2307/3503844, DOI 10.2307/3503844]; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Everitt B. S., 2001, CLUSTER ANAL; Fanshawe S, 2003, CONSERV BIOL, V17, P273, DOI 10.1046/j.1523-1739.2003.00432.x; Feder HM, 1988, ENV STUDIES PORT VAL, P116; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gregr EJ, 2008, J WILDLIFE MANAGE, V72, P382, DOI 10.2193/2006-518; Guinez R, 1999, AM NAT, V154, P341, DOI 10.1086/303234; Hammond W, 2004, MAR BIOL, V144, P547, DOI 10.1007/s00227-003-1210-9; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; IRONS DB, 1986, ECOLOGY, V67, P1460, DOI 10.2307/1939077; James CS, 2007, PLANT ECOL, V190, P205, DOI 10.1007/s11258-006-9201-9; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kanter R, 1979, INTERTIDAL STUDY SO, VII; Kanter RG, 1977, STRUCTURE DIVERSITY; KVITEK RG, 1992, ECOLOGY, V73, P413, DOI 10.2307/1940749; Laidre KL, 2006, J MAMMAL, V87, P799, DOI 10.1644/05-MAMM-A-244R2.1; Lance M.M., 2004, WASHINGTON STATE REC; LOWRY LF, 1973, MAR BIOL, V23, P213, DOI 10.1007/BF00389487; MacArthur R. H., 1972, GEOGRAPHICAL ECOLOGY; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; MORRIS R, 1981, BIOL CONSERV, V20, P291, DOI 10.1016/0006-3207(81)90015-X; Morris R.H., 1980, INTERTIDAL INVERTEBR; Nicol LM, 2005, ASSESSMENT ABUNDANCE; Oksanen J., 2017, R PACKAGE VERSION 26; OSTFELD RS, 1982, OECOLOGIA, V53, P170, DOI 10.1007/BF00545660; Ozen O, 2009, J APPL ICHTHYOL, V25, P238, DOI 10.1111/j.1439-0426.2009.01235.x; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Pearse JS, 2010, ECHINODERMS: DURHAM, P633; PICKETT S T A, 1989, P110; Picquelle SJ, 2011, FISH RES, V107, P1, DOI 10.1016/j.fishres.2010.09.009; POWER ME, 1990, SCIENCE, V250, P811, DOI 10.1126/science.250.4982.811; Preisser EL, 2003, ECOLOGY, V84, P869, DOI 10.1890/0012-9658(2003)084[0869:FEFARC]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Reidman ML, 1990, 9014 US FISH WILDL S, V90; Robles CD, 2010, LANDSCAPE ECOL, V25, P745, DOI 10.1007/s10980-010-9450-9; Robles CD, 2009, ECOLOGY, V90, P985, DOI 10.1890/08-0919.1; Salomon AK, 2007, ECOL APPL, V17, P1752, DOI 10.1890/06-1369.1; SAWYER PJ, 1967, COPEIA, P55; Smith JR, 2009, J SEA RES, V61, P165, DOI 10.1016/j.seares.2008.10.009; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Suchanek T H, 1979, MYTILUS CALIFORNIANU; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; VanBlaricom G.R., 1988, Ecological Studies, V65, P48; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Watson J, 2011, ECOL MONOGR, V81, P215, DOI 10.1890/10-0262.1; Watson Jane, 2000, Canadian Special Publication of Fisheries and Aquatic Sciences, V130, P123	63	19	19	1	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e65435	10.1371/journal.pone.0065435	http://dx.doi.org/10.1371/journal.pone.0065435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717697	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300001
J	Goecks, J; Mortimer, NT; Mobley, JA; Bowersock, GJ; Taylor, J; Schlenke, TA				Goecks, Jeremy; Mortimer, Nathan T.; Mobley, James A.; Bowersock, Gregory J.; Taylor, James; Schlenke, Todd A.			Integrative Approach Reveals Composition of Endoparasitoid Wasp Venoms	PLOS ONE			English	Article							DROSOPHILA CELLULAR-IMMUNITY; RNA-SEQ DATA; LEPTOPILINA-BOULARDI; NASONIA-VITRIPENNIS; HEMOCYTE CHANGES; REFERENCE GENOME; MELANOGASTER; PARASITOIDS; PROTEIN; HYMENOPTERA	The fruit fly Drosophila melanogaster and its endoparasitoid wasps are a developing model system for interactions between host immune responses and parasite virulence mechanisms. In this system, wasps use diverse venom cocktails to suppress the conserved fly cellular encapsulation response. Although numerous genetic tools allow detailed characterization of fly immune genes, lack of wasp genomic information has hindered characterization of the parasite side of the interaction. Here, we use high-throughput nucleic acid and amino acid sequencing methods to describe the venoms of two related Drosophila endoparasitoids with distinct infection strategies, Leptopilina boulardi and L. heterotoma. Using RNA-seq, we assembled and quantified libraries of transcript sequences from female wasp abdomens. Next, we used mass spectrometry to sequence peptides derived from dissected venom gland lumens. We then mapped the peptide spectral data against the abdomen transcriptomes to identify a set of putative venom genes for each wasp species. Our approach captured the three venom genes previously characterized in L. boulardi by traditional cDNA cloning methods as well as numerous new venom genes that were subsequently validated by a combination of RT-PCR, blast comparisons, and secretion signal sequence search. Overall, 129 proteins were found to comprise L. boulardi venom and 176 proteins were found to comprise L. heterotoma venom. We found significant overlap in L. boulardi and L. heterotoma venom composition but also distinct differences that may underlie their unique infection strategies. Our joint transcriptomic-proteomic approach for endoparasitoid wasp venoms is generally applicable to identification of functional protein subsets from any non-genome sequenced organism.	[Goecks, Jeremy; Mortimer, Nathan T.; Taylor, James; Schlenke, Todd A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Goecks, Jeremy; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Mobley, James A.; Bowersock, Gregory J.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Mobley, James A.; Bowersock, Gregory J.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	Emory University; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Taylor, J (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	james@taylorlab.org; tschlen@emory.edu	Taylor, James/F-1026-2011	Taylor, James/0000-0001-5079-840X; Schlenke, Todd/0000-0003-3091-3057; Mortimer, Nathan/0000-0003-3787-9445	National Institutes of Health [R01 AI081879, R21 HG005133]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institutes of Health under awards R01 AI081879 to TAS and R21 HG005133 to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Asgari S, 2003, J GEN VIROL, V84, P1165, DOI 10.1099/vir.0.19026-0; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Carton Y, 1997, PARASITOL TODAY, V13, P218, DOI 10.1016/S0169-4758(97)01058-2; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chiu H, 2002, CELL DEATH DIFFER, V9, P1379, DOI 10.1038/sj.cdd.4401134; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2011, J BIOL CHEM, V286, P40110, DOI 10.1074/jbc.M111.288845; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Crawford AM, 2008, INSECT MOL BIOL, V17, P313, DOI 10.1111/j.1365-2583.2008.00802.x; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; DRIESSEN G, 1990, NETH J ZOOL, V40, P409, DOI 10.1163/156854290X00019; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Eslin P, 2009, ADV PARASIT, V70, P189, DOI 10.1016/S0065-308X(09)70007-7; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; JANSSEN A, 1988, NETH J ZOOL, V38, P61, DOI 10.1163/156854288X00049; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kraaijeveld AR, 2011, DEV COMP IMMUNOL, V35, P857, DOI 10.1016/j.dci.2011.03.019; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Labrosse C, 2003, J INSECT PHYSIOL, V49, P513, DOI 10.1016/S0022-1910(03)00054-4; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mabiala-Moundoungou ADN, 2010, J INSECT PHYSIOL, V56, P35, DOI 10.1016/j.jinsphys.2009.09.001; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Moreau SJM, 2004, INSECT BIOCHEM MOLEC, V34, P485, DOI 10.1016/j.ibmb.2004.03.001; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Nappi AJ, 1998, J PARASITOL, V84, P1150, DOI 10.2307/3284664; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richman A, 1996, CURR OPIN IMMUNOL, V8, P14, DOI 10.1016/S0952-7915(96)80099-9; RIVERS DB, 1994, J INSECT PHYSIOL, V40, P207, DOI 10.1016/0022-1910(94)90044-2; RIZKI TM, 1990, EXP PARASITOL, V70, P466, DOI 10.1016/0014-4894(90)90131-U; RIZKI TM, 1994, ANN NY ACAD SCI, V712, P178, DOI 10.1111/j.1749-6632.1994.tb33572.x; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Russo J, 2001, J INSECT PHYSIOL, V47, P167, DOI 10.1016/S0022-1910(00)00102-5; Salvador G, 2008, BIOL CONTROL, V45, P103, DOI 10.1016/j.biocontrol.2007.12.007; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Yamamoto T, 2007, INSECT BIOCHEM MOLEC, V37, P278, DOI 10.1016/j.ibmb.2006.12.001; Zhang GM, 2006, DEV COMP IMMUNOL, V30, P756, DOI 10.1016/j.dci.2005.11.001; Zhu JY, 2010, ARCH INSECT BIOCHEM, V75, P28, DOI 10.1002/arch.20380	58	59	62	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64125	10.1371/journal.pone.0064125	http://dx.doi.org/10.1371/journal.pone.0064125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717546	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600046
J	Romano, TG; Schmidtbauer, I; Silva, FMD; Pompilio, CE; D'Albuquerque, LAC; Macedo, E				Romano, Thiago Gomes; Schmidtbauer, Ivana; de Queiroz Silva, Fernanda Maria; Pompilio, Carlos Eduardo; Carneiro D'Albuquerque, Luiz Augusto; Macedo, Etienne			Role of MELD Score and Serum Creatinine as Prognostic Tools for the Development of Acute Kidney Injury after Liver Transplantation	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; RISK-FACTORS; CIRRHOTIC-PATIENTS; DISEASE SEVERITY; RIFLE CRITERIA; MODEL; IMPACT; PREDICTORS; ALLOCATION; EQUATIONS	Background: The role of the Model for End-Stage Liver Disease (MELD) score in predicting complications, such as Acute Kidney Injury (AKI), after orthotopic liver transplantation (OLT) has yet to be evaluated and serum creatinine may be too heavily weighted in the existing MELD formula, since it has many pitfalls in cirrhotic patients. Methods: Retrospective data of the perioperative period from consecutive adult OLTs performed from January to December 2009 were recorded. Univariate and multivariate analysis were performed to analyze the risk factors for AKI and mortality after OLT. Results: There were 114 OLTs performed in the study period, 22 (19,2%) were submitted to dialysis prior OLT and were excluded from the analysis for AKI. The median age was 52 years and 66% were male. Median creatinine value was 0.85mg/dL and MELD was 19. Fifty-two of the 92 patients (56,5%) developed AKI in the first 72 hours after OLT. The only independent risk factor for AKI was calculated MELD and when the components of the MELD score were analyzed, INR had a much stronger impact in predicting AKI then serum creatinine. Overall mortality rate was 32,5% and anesthesia duration was the only variable associated with higher mortality rate. Conclusions: Although MELD score seems to have a good performance in predicting AKI after OLT, serum creatinine had no impact on its prediction despite its importance on MELD calculation. Modifying the MELD score, which could include novel AKI biomarkers, may improve its prognostic accuracy and provide a better tool for public health planning.	[Romano, Thiago Gomes] ABC Med Sch, Dept Nephrol, Sao Bernardo, SP, Brazil; [Schmidtbauer, Ivana; de Queiroz Silva, Fernanda Maria; Pompilio, Carlos Eduardo] Univ Sao Paulo, Surg & Intens Care Unit, Sao Paulo, Brazil; [Carneiro D'Albuquerque, Luiz Augusto] Univ Sao Paulo, Dept Gastroenterol, Sao Paulo, Brazil; [Macedo, Etienne] Univ Sao Paulo, Dept Nephrol, Sao Paulo, Brazil; [Romano, Thiago Gomes; de Queiroz Silva, Fernanda Maria] Hosp Sirio Libanes, Intens Care Unit, Sao Paulo, Brazil	Faculdade de Medicina do ABC; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Sirio Libanes	Romano, TG (corresponding author), ABC Med Sch, Dept Nephrol, Sao Bernardo, SP, Brazil.	thromano25@hotmail.com	Pompilio, Carlos/C-6051-2014; D'Albuquerque, Luiz A Carneiro/I-4011-2012; Macedo, Etienne/D-4659-2012	Pompilio, Carlos/0000-0003-2559-8689; D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Macedo, Etienne/0000-0002-3669-6519				Ahmad J, 2007, LIVER TRANSPLANT, V13, P1564, DOI 10.1002/lt.21262; Alvares-da-Silva MR, 1999, TRANSPLANT P, V31, P3050, DOI 10.1016/S0041-1345(99)00666-1; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Bilbao I, 1998, CLIN TRANSPLANT, V12, P123; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; Cywinski JB, 2011, HEPATOL INT, V5, P841, DOI 10.1007/s12072-011-9257-z; Francoz C, 2010, LIVER TRANSPLANT, V16, P1169, DOI 10.1002/lt.22128; Freeman RB, 2004, LIVER TRANSPLANT, V10, P7, DOI 10.1002/lt.20024; Iglesias JI, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-30; Kanwal F, 2005, ALIMENT PHARM THER, V21, P169, DOI 10.1111/j.1365-2036.2005.02321.x; Kellum JA, 2012, KIDNEY INT S, V2, P4, DOI DOI 10.1038/KISUP2012.4; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kundakci A, 2010, TRANSPL P, V42, P4171, DOI 10.1016/j.transproceed.2010.09.137; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; O'Riordan A, 2007, AM J TRANSPLANT, V7, P168, DOI 10.1111/j.1600-6143.2006.01602.x; Palomba H, 2007, KIDNEY INT, V72, P624, DOI 10.1038/sj.ki.5002419; Paramesh AS, 2004, CLIN TRANSPLANT, V18, P94, DOI 10.1046/j.1399-0012.2003.00132.x; Paugam-Burtz C, 2009, LIVER TRANSPLANT, V15, P522, DOI 10.1002/lt.21730; Pirlich M, 2000, HEPATOLOGY, V32, P1208, DOI 10.1053/jhep.2000.20524; Rafael-Valdivia L, 2011, TRANSPL P, V43, P697, DOI 10.1016/j.transproceed.2011.01.091; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Sherman DS, 2003, AM J KIDNEY DIS, V41, P269, DOI 10.1053/ajkd.2003.50035; Wagner D, 2012, TRANSPL INT, V25, P527, DOI 10.1111/j.1432-2277.2012.01449.x; Wang VS, 2004, LIVER INT, V24, P1, DOI 10.1111/j.1478-3231.2004.00888.x; Weigand K, 2011, NEPHRON CLIN PRACT, V119, pC342, DOI 10.1159/000331072; Xu XA, 2010, HEPATOB PANCREAT DIS, V9, P259; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031256; Zhu M, 2010, TRANSPL P, V42, P3634, DOI 10.1016/j.transproceed.2010.08.059	32	47	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64089	10.1371/journal.pone.0064089	http://dx.doi.org/10.1371/journal.pone.0064089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717537	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600043
J	Chen, L; Zhou, JP; Kuang, DB; Tang, J; Li, YJ; Chen, XP				Chen, Lei; Zhou, Ji-Peng; Kuang, Da-Bin; Tang, Jie; Li, Yuan-Jian; Chen, Xiao-Ping			4-HNE Increases Intracellular ADMA Levels in Cultured HUVECs: Evidence for miR-21-Dependent Mechanisms	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; MEDIATED INHIBITION; MURINE MACROPHAGES; PATHWAY; DISEASE; CELLS; DIMETHYLAMINOHYDROLASE; CONTRIBUTES; TRANSPORTER; EXPRESSION	Objective: To investigate whether 4-hydroxynonenal (4-HNE) regulates asymmetric dimethylarginine (ADMA) metabolism through pathway independent of direct adduct formation with ADMA metabolizing enzyme and the involvement of microRNA (miRNA) miR-21 in human umbilical venous endothelial cells (HUVECs). Methods: Cultured HUVECs were treated with 4-HNE (at concentrations of 1, 5, and 10 mu M, respectively) or 1% DMSO (vehicle control) for 24 h. MiR-21 inhibitor (final concentration of 100 nM) was transfected at 1 h before 4-HNE treatment. HUVECs were also transfected with miR-21 (at concentrations of 50 nM and 100 nM) and cultured for 12, 24, and 48 h, respectively. DDAH mRNA and miR-21 expression in the HUVECs were determined by semi-quantitative real time PCR. DDAH1 and DDAH2 protein expression were analyzed by Western blot. ADMA in the cell medium and cell lysates were analyzed by ELISA. ADMA metabolizing activity of the cell lysates was also determined. Results: MiR-21 decreased DDAH1 and DDAH2 expression and ADMA metabolic activity significantly, while increased intracellular ADMA accumulation significantly in HUVECs. 10 mu M 4-HNE treatment for 24 h increased the expression of miR-21 and intracellular ADMA concentration, decreased the expression of DDAH1/2 mRNA and protein, decreased ADMA metabolizing activity of the cell lysates significantly. MiR-21 inhibitor reversed the inhibitory effects of 4-HNE on DDAH1 expression completely, and partially reversed the changes in ADMA metabolizing activity and intracellular ADMA accumulation challenged by 10 mu M 4-HNE. Conclusion: 4-HNE down-regulates DDAH1 expression and increases intracellular ADMA accumulation in HUVECs through a miR-21-dependent mechanism.	[Chen, Lei; Zhou, Ji-Peng; Kuang, Da-Bin; Li, Yuan-Jian; Chen, Xiao-Ping] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [Zhou, Ji-Peng; Kuang, Da-Bin; Tang, Jie; Chen, Xiao-Ping] Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, XP (corresponding author), Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China.	chenxp74@hotmail.com	Li, Yuan/GXV-1310-2022	Kuang, Dabin/0000-0002-6240-038X	Chinese National Science Foundation [30971584, 81000120, 81170091]; Excellent Youth Foundation of Hu'nan Natural Science Foundation [13JJ1010]; Funds for the Central Universities [2011JQ016]; Graduate degree thesis Innovation Foundation of Central South University [CX2010B108]; Hunan science and technology program [2020FJ3085]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Hu'nan Natural Science Foundation; Funds for the Central Universities; Graduate degree thesis Innovation Foundation of Central South University; Hunan science and technology program	Chinese National Science Foundation (No. 30971584, No. 81000120 and No. 81170091), Excellent Youth Foundation of Hu'nan Natural Science Foundation (No. 13JJ1010), Funds for the Central Universities (2011JQ016), the Graduate degree thesis Innovation Foundation of Central South University (CX2010B108) and Hunan science and technology program (No. 2020FJ3085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Chen JB, 2009, INVEST OPHTH VIS SCI, V50, P936, DOI 10.1167/iovs.08-2439; Closs EI, 2012, BIOCHEM BIOPH RES CO, V423, P218, DOI 10.1016/j.bbrc.2012.05.044; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Forbes SP, 2008, BIOCHEMISTRY-US, V47, P1819, DOI 10.1021/bi701659n; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Ishigaki Y, 2009, CURR OPIN LIPIDOL, V20, P363, DOI 10.1097/MOL.0b013e32832fa58d; Ishikado A, 2010, BIOCHEM BIOPH RES CO, V402, P99, DOI 10.1016/j.bbrc.2010.09.124; Kaida Y, 2012, LIFE SCI, V91, P301, DOI 10.1016/j.lfs.2012.06.015; Lee SJ, 2010, CARDIOVASC RES, V88, P352, DOI 10.1093/cvr/cvq194; Lee WC, 2012, BIOCHEM BIOPH RES CO, V425, P842, DOI 10.1016/j.bbrc.2012.08.002; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Ling M, 2012, FREE RADICAL BIO MED, V52, P1508, DOI 10.1016/j.freeradbiomed.2012.02.020; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Niebauer J, 2003, AM J PHYSIOL-HEART C, V285, pH535, DOI 10.1152/ajpheart.00360.2001; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P194, DOI 10.3389/fgene.2012.00194; Shearn CT, 2011, BIOCHEMISTRY-US, V50, P3984, DOI 10.1021/bi200029w; Shearn CT, 2012, FREE RADICAL BIO MED, V53, P1, DOI 10.1016/j.freeradbiomed.2012.04.021; Strobel J, 2012, J MOL CELL CARDIOL, V53, P392, DOI 10.1016/j.yjmcc.2012.06.002; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wang S, 2009, J NEUROSCI RES, V87, P1938, DOI 10.1002/jnr.21999; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wilson AM, 2010, VASC MED, V15, P267, DOI 10.1177/1358863X10364552; Yamakuchi M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/794898; Yun MR, 2008, FREE RADICAL BIO MED, V45, P177, DOI 10.1016/j.freeradbiomed.2008.04.014; Yun MR, 2010, FREE RADICAL RES, V44, P742, DOI 10.3109/10715761003758122; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639	35	21	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64148	10.1371/journal.pone.0064148	http://dx.doi.org/10.1371/journal.pone.0064148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717555	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700110
J	Chou, JP; Ramirez, CM; Wu, JE; Effros, RB				Chou, Jennifer P.; Ramirez, Christina M.; Wu, Jennifer E.; Effros, Rita B.			Accelerated Aging in HIV/AIDS: Novel Biomarkers of Senescent Human CD8+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; TELOMERASE ACTIVITY; ACTIVATION; EXPRESSION; DISEASE; LYMPHOCYTES; INFECTION; SYSTEM; CD26	Clinical evaluation of immune reconstitution and health status during HIV-1 infection and anti-retroviral therapy (ART) is largely based on CD4+ T cell counts and viral load, measures that fail to take into account the CD8+ T cell subset, known to show features of accelerated aging in HIV disease. Here, we compare adenosine deaminase (ADA), glucose uptake receptor 1 (GLUT1), and leucine-rich repeat neuronal 3 (LRRN3) to CD38 expression and telomerase activity, two strong predictors of HIV disease progression. Our analysis revealed that reduced ADA, telomerase activity and LRRN3 gene expression were significantly associated with high CD38 and HLA-DR in CD8+ T cells, with % ADA+ cells being the most robust predictor of CD8+ T cell activation. Our results suggest that ADA, LRRN3 and telomerase activity in CD8+ T cells may serve as novel, clinically relevant biomarkers of immune status in HIV-1 infection, specifically by demonstrating the degree to which CD8+ T cells have progressed to the end stage of replicative senescence. Since chronological aging itself leads to the accumulation of senescent CD8+ T cells, the prolonged survival and resultant increased age of the HIV+ population may synergize with the chronic immune activation to exacerbate both immune decline and age-associated pathologies. The identification and future validation of these new biomarkers may lead to fresh immune-based HIV treatments.	[Chou, Jennifer P.; Wu, Jennifer E.; Effros, Rita B.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Chou, Jennifer P.; Wu, Jennifer E.] Univ Calif Los Angeles, Lab Med, Los Angeles, CA USA; [Ramirez, Christina M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Effros, RB (corresponding author), Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA.	reffros@mednet.ucla.edu	Ramirez, Christina/AAT-5088-2021; Wu, Jennifer/GRX-1831-2022	Ramirez, Christina/0000-0002-8435-0416	Effros ARRA Supplement [U01AI035040-18S1]; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; National Institutes of Health awards [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI037613, U01AI035040, P30AI028697, U01AI035041, U01AI035042, U01AI035039, U01AI035043, U01AI037984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032422] Funding Source: NIH RePORTER	Effros ARRA Supplement; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by U01AI035040-18S1 (Effros ARRA Supplement to the UCLA MACS). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; AZUMA M, 1993, J IMMUNOL, V150, P1147; Bailer RT, 1999, J IMMUNOL, V162, P7534; Butler JJ, 2003, J CELL BIOCHEM, V89, P975, DOI 10.1002/jcb.10562; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Dagarag M, 2004, J IMMUNOL, V173, P6303, DOI 10.4049/jimmunol.173.10.6303; DOSREIS GA, 1986, CELL IMMUNOL, V101, P213, DOI 10.1016/0008-8749(86)90199-1; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; LEEANSYAH E, 2013, J INFECT DIS; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lichterfeld M, 2008, BLOOD, V112, P3679, DOI 10.1182/blood-2008-01-135442; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Mandapathil M, 2012, ONCOIMMUNOLOGY, V1, P659, DOI 10.4161/onci.20387; Nichols WS, 1999, SCAND J IMMUNOL, V49, P302, DOI 10.1046/j.1365-3083.1999.00505.x; Ohta A, 2009, J IMMUNOL, V183, P5487, DOI 10.4049/jimmunol.0901247; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; Parish ST, 2010, J IMMUNOL, V184, P2847, DOI 10.4049/jimmunol.0903647; PERILLO NL, 1989, EXP GERONTOL, V24, P177, DOI 10.1016/0531-5565(89)90009-0; Pupilli C, 1999, DIABETES, V48, P2309, DOI 10.2337/diabetes.48.12.2309; Saldanha SN, 2003, ANAL BIOCHEM, V315, P1, DOI 10.1016/S0003-2697(02)00663-2; Valenzuela A, 1997, J IMMUNOL, V158, P3721; Valenzuela A, 1997, ADV EXP MED BIOL, V421, P185; Yang OO, 1997, ADV IMMUNOL, V66, P273, DOI 10.1016/S0065-2776(08)60600-8	27	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64702	10.1371/journal.pone.0064702	http://dx.doi.org/10.1371/journal.pone.0064702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717651	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700167
J	Muths, D; Le Couls, S; Evano, H; Grewe, P; Bourjea, J				Muths, Delphine; Le Couls, Sarah; Evano, Hugues; Grewe, Peter; Bourjea, Jerome			Multi-Genetic Marker Approach and Spatio-Temporal Analysis Suggest There Is a Single Panmictic Population of Swordfish Xiphias gladius in the Indian Ocean	PLOS ONE			English	Article							SOUTH ATLANTIC POPULATIONS; TUNA THUNNUS-OBESUS; BIGEYE TUNA; STOCK STRUCTURE; INDO-PACIFIC; MIGRATION; PATTERNS; DIFFERENTIATION; PHYLOGEOGRAPHY; POLYMORPHISM	Genetic population structure of swordfish Xiphias gladius was examined based on 2231 individual samples, collected mainly between 2009 and 2010, among three major sampling areas within the Indian Ocean (IO; twelve distinct sites), Atlantic (two sites) and Pacific (one site) Oceans using analysis of nineteen microsatellite loci (n = 2146) and mitochondrial ND2 sequences (n = 2001) data. Sample collection was stratified in time and space in order to investigate the stability of the genetic structure observed with a special focus on the South West Indian Ocean. Significant AMOVA variance was observed for both markers indicating genetic population subdivision was present between oceans. Overall value of F-statistics for ND2 sequences confirmed that Atlantic and Indian Oceans swordfish represent two distinct genetic stocks. Indo-Pacific differentiation was also significant but lower than that observed between Atlantic and Indian Oceans. However, microsatellite F-statistics failed to reveal structure even at the inter-oceanic scale, indicating that resolving power of our microsatellite loci was insufficient for detecting population subdivision. At the scale of the Indian Ocean, results obtained from both markers are consistent with swordfish belonging to a single unique panmictic population. Analyses partitioned by sampling area, season, or sex also failed to identify any clear structure within this ocean. Such large spatial and temporal homogeneity of genetic structure, observed for such a large highly mobile pelagic species, suggests as satisfactory to consider swordfish as a single panmictic population in the Indian Ocean.	[Muths, Delphine; Le Couls, Sarah; Evano, Hugues; Bourjea, Jerome] IFREMER, Delegat Ocean Indien, Le Port, France; [Grewe, Peter] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Ifremer; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Muths, D (corresponding author), IFREMER, Delegat Ocean Indien, Le Port, France.	muthsdelphine@yahoo.fr	Grewe, Peter/AAJ-5227-2021; Grewe, Peter/P-1515-2015; Muths, Delphine/G-1693-2010	Grewe, Peter/0000-0001-7111-4150; Grewe, Peter/0000-0001-7111-4150; Muths, Delphine/0000-0002-5366-4834; Bourjea, Jerome/0000-0001-7149-3648	European Union: The FEP (DMSOI La Reunion) [31122/DRAM/2009]; European Union: French State (DMSOI La Reunion) [31122/DRAM/2009]; La Reunion Council (Region Reunion) [DAE4/20090164]; EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences); Ifremer	European Union: The FEP (DMSOI La Reunion); European Union: French State (DMSOI La Reunion); La Reunion Council (Region Reunion); EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences); Ifremer	This work was funded by the European Union: The FEP and the French State (DMSOI La Reunion; No31122/DRAM/2009), La Reunion Council (Region Reunion; NoDAE4/20090164), the EU 7th Funding Program: Capacities, Research Potential (project RUNSeaSciences) and Ifremer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IOTCWPB10; Appleton B, 2010, CONSERV GENET, V3, P263; Bakun Andrew, 1998, P103; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bradman H, 2011, FISH RES, V109, P95, DOI 10.1016/j.fishres.2011.01.022; Bremer JRA, 2005, J EXP MAR BIOL ECOL, V327, P167, DOI 10.1016/j.jembe.2005.06.022; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; CAREY FG, 1981, FISH B-NOAA, V79, P277; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cherel Y, 2012, DEEP SEA RES 2; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Chow S, 2000, MOL ECOL, V9, P221, DOI 10.1046/j.1365-294x.2000.00851.x; Chow S, 2000, J FISH BIOL, V56, P1087, DOI 10.1006/jfbi.2000.1229; Codispoti LA, 1991, US JGOFS ARABIAN SEA; Conway N, 2011, E AFRICA BILLFISH CO; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Fu YX, 1997, GENETICS, V147, P915; Garcia A, 2011, ICES J MAR SCI, V68, P175, DOI 10.1093/icesjms/fsq147; Garcia-Cortes B., 2003, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V55, P1476; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; Graves JE, 2006, B MAR SCI, V79, P469; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heileman S., 2009, UNEP LARGE MARINE EC; International Hydrographic Organization, 1953, LIM OC SEAS, V3rd; IOTC, 2011, IOTCSC14; IOTC, 2011, 9 SESS ITC WORK PART; Jean C, 2006, B MAR SCI, V79, P521; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KOTOULAS G, 1995, MOL ECOL, V4, P473, DOI 10.1111/j.1365-294X.1995.tb00241.x; Levy M, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004090; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lu CP, 2006, ZOOL STUD, V45, P269; Lukas R, 1996, J GEOPHYS RES-OCEANS, V101, P12209, DOI 10.1029/96JC01204; Luschi P, 2006, S AFR J SCI, V102, P51; Lutjeharms JRE, 2007, OCEAN SCI, V3, P129, DOI 10.5194/os-3-129-2007; Lutjeharms JRE, 2006, AGULHAS CURRENT; MCCARTHY C., 1997, CHROMAS VERSION 1 41; Mejuto J., 2006, OVERVIEW RES ACTIVIT; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Muths D, 2009, FISH RES, V97, P263, DOI 10.1016/j.fishres.2009.03.004; Nakamura I., 1985, FAO SPECIES CATALOGU, V5, P65; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nei M., 1987, MOL EVOLUTIONARY GEN; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nishikawa Y, 1985, S SERIES FAR SEAS FI, V12, P99; Palko B, 1981, 441 NOAA NMFS, V441, P2; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P45, DOI 10.1051/alr/2009007; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Reeb CA, 2003, MOL ECOL NOTES, V3, P147, DOI 10.1046/j.1471-8286.2003.00385.x; Reeb CA, 2000, MAR BIOL, V136, P1123, DOI 10.1007/s002270000291; Richardson PL, 2003, DEEP-SEA RES PT II, V50, P1, DOI 10.1016/S0967-0645(02)00376-4; Rousset F, 1997, TRENDS ECOL EVOL, V12, P313, DOI 10.1016/S0169-5347(97)01104-X; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Sedberry GR, 2001, MAR BIOL, V139, P355; Stanley C, 2006, DETERMINING NATURE E; Takahashi M, 2003, MAR FRESHWATER RES, V54, P527, DOI 10.1071/MF01245; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Watanabe H, 1959, REP NANKAI REG FISH, V10, P107; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright F, 1969, THEORY GENE FREQUENC, V2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	80	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63558	10.1371/journal.pone.0063558	http://dx.doi.org/10.1371/journal.pone.0063558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717447	Green Published, gold			2022-12-25	WOS:000320362700035
J	Sommerfeld, J; Kato, A; Ropert-Coudert, Y; Garthe, S; Hindell, MA				Sommerfeld, Julia; Kato, Akiko; Ropert-Coudert, Yan; Garthe, Stefan; Hindell, Mark A.			Foraging Parameters Influencing the Detection and Interpretation of Area-Restricted Search Behaviour in Marine Predators: A Case Study with the Masked Booby	PLOS ONE			English	Article							FINE-SCALE; 1ST-PASSAGE TIME; GPS TRACKING; FUR SEALS; MOVEMENT; BUOYANCY; ANIMALS; HABITAT; SUCCESS; DIVE	Identification of Area-restricted search (ARS) behaviour is used to better understand foraging movements and strategies of marine predators. Track-based descriptive analyses are commonly used to detect ARS behaviour, but they may be biased by factors such as foraging trip duration or non-foraging behaviours (i.e. resting on the water). Using first-passage time analysis we tested if (I) daylight resting at the sea surface positions falsely increase the detection of ARS behaviour and (II) short foraging trips are less likely to include ARS behaviour in Masked Boobies Sula dactylatra. We further analysed whether ARS behaviour may be used as a proxy to identify important feeding areas. Depth-acceleration and GPS-loggers were simultaneously deployed on chick-rearing adults to obtain (1) location data every 4 minutes and (2) detailed foraging activity such as diving rates, time spent sitting on the water surface and in flight. In 82% of 50 foraging trips, birds adopted ARS behaviour. In 19.3% of 57 detected ARS zones, birds spent more than 70% of total ARS duration resting on the water, suggesting that these ARS zones were falsely detected. Based on generalized linear mixed models, the probability of detecting false ARS zones was 80%. False ARS zones mostly occurred during short trips in close proximity to the colony, with low or no diving activity. This demonstrates the need to account for resting on the water surface positions in marine animals when determining ARS behaviour based on foraging locations. Dive rates were positively correlated with trip duration and the probability of ARS behaviour increased with increasing number of dives, suggesting that the adoption of ARS behaviour in Masked Boobies is linked to enhanced foraging activity. We conclude that ARS behaviour may be used as a proxy to identify important feeding areas in this species.	[Sommerfeld, Julia; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Sommerfeld, Julia; Garthe, Stefan] Univ Kiel, Res & Technol Ctr, Busum, Germany; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France	University of Tasmania; University of Kiel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sommerfeld, J (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Julia.Sommerfeld@utas.edu.au	Hindell, Mark A/K-1131-2013; Kato, Akiko/W-2447-2019	Hindell, Mark/0000-0002-7823-7185; Kato, Akiko/0000-0002-8947-3634	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society	This research was funded by the ANZ Trustees Foundation - Holsworth Wildlife Research Endowment, Birds Australia and the Australian Geographic Society. URL of funders' websites: http://www.anz.com/personal/, http://www.birdlife.org.au/, http://www.australiangeographic.com.au/society/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSONSPRECHER R, 1991, J AM STAT ASSOC, V86, P596, DOI 10.2307/2290387; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; BENHAMOU S, 1989, ANIM BEHAV, V38, P375, DOI 10.1016/S0003-3472(89)80030-2; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Bolker B, 2011, PACKAGE LME4 R SOFTW; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Calenge C., 2012, PACKAGE ADEHABITATLT; Capuska GEM, 2011, MAR ECOL PROG SER, V442, P255, DOI 10.3354/meps09458; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Crawley MJ., 2007, R BOOK; Dorward DF, 1962, IBIS, V103, P221; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dutson G, 2010, ACTION PLAN AUSTR BI; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Furlani D, 2006, ASSESSMENT CONSERVAT; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Harkonen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002006; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, 5339 I NAT RECH INF; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; MARSH LM, 1988, J THEOR BIOL, V133, P113, DOI 10.1016/S0022-5193(88)80028-6; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pittau MG, 2012, PACKAGE ARM R SOFTWA; Priddel David, 2010, Notornis, V57, P113; QUENOUILLE MH, 1949, J ROY STAT SOC B, V11, P68; R Development Core Team, 2012, R LANG ENV STAT COMP; Ripley B, 2011, PACKAGE TREE R SOFTW; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Tanaka H, 2001, J EXP BIOL, V204, P3895; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; TRILLMICH F, 1990, BEHAVIOUR, V114, P3, DOI 10.1163/156853990X00022; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	59	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63742	10.1371/journal.pone.0063742	http://dx.doi.org/10.1371/journal.pone.0063742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717471	Green Published, gold			2022-12-25	WOS:000320362700052
J	Villar, SR; Ronco, MT; Bussy, RF; Roggero, E; Lepletier, A; Manarin, R; Savino, W; Perez, AR; Bottasso, O				Villar, Silvina R.; Ronco, M. Teresa; Fernandez Bussy, Rodrigo; Roggero, Eduardo; Lepletier, Ailin; Manarin, Romina; Savino, Wilson; Rosa Perez, Ana; Bottasso, Oscar			Tumor Necrosis Factor-alpha Regulates Glucocorticoid Synthesis in the Adrenal Glands of Trypanosoma cruzi Acutely-Infected Mice. The Role of TNF-R1	PLOS ONE			English	Article							GENE-EXPRESSION; THYMUS ATROPHY; CYTOKINES; AXIS; STEROIDOGENESIS; RECEPTORS	Adrenal steroidogenesis is under a complex regulation involving extrinsic and intrinsic adrenal factors. TNF-alpha is an inflammatory cytokine produced in response to tissue injury and several other stimuli. We have previously demonstrated that TNF-R1 knockout (TNF-R1(-/-)) mice have a dysregulated synthesis of glucocorticoids (GCs) during Trypanosoma cruzi acute infection. Since TNF-alpha may influence GCs production, not only through the hypothalamus-pituitary axis, but also at the adrenal level, we now investigated the role of this cytokine on the adrenal GCs production. Wild type (WT) and TNF-R1(-/-) mice undergoing acute infection (Tc-WT and Tc-TNF-R1(-/-) groups), displayed adrenal hyperplasia together with increased GCs levels. Notably, systemic ACTH remained unchanged in Tc-WT and Tc-TNF-R1(-/-) compared with uninfected mice, suggesting some degree of ACTH-independence of GCs synthesis. TNF-alpha expression was increased within the adrenal gland from both infected mouse groups, with Tc-WT mice showing an augmented TNF-R1 expression. Tc-WT mice showed increased levels of P-p38 and P-ERK compared to uninfected WT animals, whereas Tc-TNF-R1(-/-) mice had increased p38 and JNK phosphorylation respect to Tc-WT mice. Strikingly, adrenal NF-kappa B and AP-1 activation during infection was blunted in Tc-TNF-R1(-/-) mice. The accumulation of mRNAs for steroidogenic acute regulatory protein and cytochrome P450 were significantly increased in both Tc-WT and Tc-TNF-R1(-/-) mice; being much more augmented in the latter group, which also had remarkably increased GCs levels. TNF-alpha emerges as a potent modulator of steroidogenesis in adrenocortical cells during T. cruzi infection in which MAPK pathways, NF-kappa B and AP-1 seem to play a role in the adrenal synthesis of pro-inflammatory cytokines and enzymes regulating GCs synthesis. These results suggest the existence of an intrinsic immune-adrenal interaction involved in the dysregulated synthesis of GCs during murine Chagas disease.	[Villar, Silvina R.; Fernandez Bussy, Rodrigo; Roggero, Eduardo; Manarin, Romina; Rosa Perez, Ana; Bottasso, Oscar] Univ Nacl Rosario, Fac Ciencias Med, Inst Inmunol, RA-2000 Rosario, Argentina; [Ronco, M. Teresa] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE CONICET, RA-2000 Rosario, Argentina; [Roggero, Eduardo] UAI, Fac Med, Dept Fisiol, Rosario, Argentina; [Lepletier, Ailin; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Fundacao Oswaldo Cruz	Villar, SR (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Inst Inmunol, RA-2000 Rosario, Argentina.	svillar@conicet.gov.ar		Ronco, Maria Teresa/0000-0003-0559-2095; Lepletier, Ailin/0000-0002-1371-7313	SCYT-UNR [1MED 372]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2008-0980]; AmSud-Pasteur Network; CNPq; Faperj (Brazil)	SCYT-UNR; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); AmSud-Pasteur Network; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	S.R.V., A.R.P., M.T.R. and O.A.B. are members of National Council Research (CONICET). Support for this study was provided by SCYT-UNR (1MED 372) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT 2008-0980), AmSud-Pasteur Network, as well as CNPq and Faperj (Brazil). The funders had no role in study design, data collection and analysis, decision to publish or preparation the manuscript.	Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Barney M, 2000, ENDOCRINE, V13, P369, DOI 10.1385/ENDO:13:3:369; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Bornstein SR, 1998, HORM METAB RES, V30, P292, DOI 10.1055/s-2007-978887; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015; Correa-De-Santana E, 2006, ANN NY ACAD SCI, V1088, P274, DOI 10.1196/annals.1366.005; DARLING G, 1989, SURGERY, V106, P1155; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Foster RH, 2004, J MOL ENDOCRINOL, V32, P893, DOI 10.1677/jme.0.0320893; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Judd AM, 2000, ANN NY ACAD SCI, V917, P628; Kanczkowski W, 2010, NEUROIMMUNOMODULAT, V17, P180, DOI 10.1159/000258718; Karin M, 2001, J ENDOCRINOL, V169, P447, DOI 10.1677/joe.0.1690447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marx C, 1998, HORM METAB RES, V30, P416, DOI 10.1055/s-2007-978907; MILKHAYLOVA IV, 2001, ENDOCRINOLOGY, V148, P386; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; Roggero E, 2006, J ENDOCRINOL, V190, P495, DOI 10.1677/joe.1.06642; Roggero E, 2009, ANN NY ACAD SCI, V1153, P264, DOI 10.1111/j.1749-6632.2008.03982.x; Perez AR, 2011, NEUROIMMUNOMODULAT, V18, P328, DOI 10.1159/000329494; Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1	34	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63814	10.1371/journal.pone.0063814	http://dx.doi.org/10.1371/journal.pone.0063814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717489	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700064
J	Wu, D; Li, CY; Yao, DZ				Wu, Dan; Li, Chaoyi; Yao, Dezhong			Scale-Free Brain Quartet: Artistic Filtering of Multi-Channel Brainwave Music	PLOS ONE			English	Article							EEG; SONIFICATION	To listen to the brain activities as a piece of music, we proposed the scale-free brainwave music (SFBM) technology, which translated scalp EEGs into music notes according to the power law of both EEG and music. In the present study, the methodology was extended for deriving a quartet from multi-channel EEGs with artistic beat and tonality filtering. EEG data from multiple electrodes were first translated into MIDI sequences by SFBM, respectively. Then, these sequences were processed by a beat filter which adjusted the duration of notes in terms of the characteristic frequency. And the sequences were further filtered from atonal to tonal according to a key defined by the analysis of the original music pieces. Resting EEGs with eyes closed and open of 40 subjects were utilized for music generation. The results revealed that the scale-free exponents of the music before and after filtering were different: the filtered music showed larger variety between the eyes-closed (EC) and eyes-open (EO) conditions, and the pitch scale exponents of the filtered music were closer to 1 and thus it was more approximate to the classical music. Furthermore, the tempo of the filtered music with eyes closed was significantly slower than that with eyes open. With the original materials obtained from multi-channel EEGs, and a little creative filtering following the composition process of a potential artist, the resulted brainwave quartet opened a new window to look into the brain in an audible musical way. In fact, as the artistic beat and tonal filters were derived from the brainwaves, the filtered music maintained the essential properties of the brain activities in a more musical style. It might harmonically distinguish the different states of the brain activities, and therefore it provided a method to analyze EEGs from a relaxed audio perspective.	[Wu, Dan; Li, Chaoyi; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Chaoyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Life Sci, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn		Yao, Dezhong/0000-0002-8042-879X	973 project [2011CB707803]; Natural Science Foundations of China [81201159, 91232725]; PCSIRT [IRT 0910]; Doctor Training Fund of the Ministry of Education [20100185110016]	973 project(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Doctor Training Fund of the Ministry of Education	This work was supported by the following: 973 project 2011CB707803; the Natural Science Foundations of China 81201159, 91232725; the PCSIRT (IRT 0910); and the Doctor Training Fund of the Ministry of Education 20100185110016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Baier G, 2007, CLIN NEUROPHYSIOL, V118, P1377, DOI 10.1016/j.clinph.2007.01.025; Fechner G.T., 1966, INTRO FECHNER; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Hinterberger T, 2005, IEEE MULTIMEDIA, V12, P70, DOI 10.1109/MMUL.2005.36; HSU KJ, 1990, P NATL ACAD SCI USA, V87, P938, DOI 10.1073/pnas.87.3.938; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049773; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; Miranda ER, 2010, INT J ARTS TECHNOL, V3, P154, DOI 10.1504/IJART.2010.032562; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Randel DonMichael., 2003, HARVARD DICT MUSIC, V4th ed.; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Rosenboom D., 1997, LEONARDO MONOGRAPH S, P1; Rosenboom D., 1976, BIOFEEDBACK ARTS RES; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Vialatte FB, 2006, LECT NOTES COMPUT SC, V4234, P92; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wu Dan, 2010, Comput Intell Neurosci, P267671, DOI 10.1155/2010/267671; Wu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005915; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	20	5	6	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64046	10.1371/journal.pone.0064046	http://dx.doi.org/10.1371/journal.pone.0064046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717527	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700092
J	Zhang, SS; Xu, LL; Zhao, XW; Chen, X; Fan, YL; Wan, ZP; Xu, YS; Liu, WL				Zhang, Shaosen; Xu, Liling; Zhao, Xingwang; Chen, Xin; Fan, Yilin; Wan, Zhengpeng; Xu, Yinsheng; Liu, Wanli			A New and Robust Method of Tethering IgG Surrogate Antigens on Lipid Bilayer Membranes to Facilitate the TIRFM Based Live Cell and Single Molecule Imaging Experiments	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-A; STAPHYLOCOCCUS-AUREUS; IMMUNOLOGICAL-SYNAPSE; T-CELLS; IMMUNE-SYNAPSE; ACTIVATION; RECEPTOR; BINDING; STIMULATION	Our understanding of cell-cell interactions has been significantly improved in the past years with the help of Total Internal Reflection Fluorescence Microscope (TIRFM) in combination with an antigen presenting system supported by planar lipid bilayer (PLB) membranes, which are used to mimic the extensive receptor and ligand interactions within cell-cell contact interface. In TIRFM experiments, it is a challenge to uniformly present ligand molecules in monomeric format on the surface of PLB membranes. Here, we introduce a new and robust method of tethering IgG surrogate antigen ligands on the surface of Ni2+-containing PLB membranes. In this method, we use a modified D domain from staphylococcal protein A molecule that is fused with an N-terminus polyhistidine tag (H12-D-domain) to tether IgG surrogate antigens on Ni2+-containing PLB membranes. We systematically assessed the specificity and capability of H12-D-domain construct to capture IgG molecules from different species through live cell and single molecule TIRFM imaging. We find that these IgG surrogate antigens tethered by H12-D-domain show better lateral mobility and are more uniformly distributed on PLB membranes than the ones tethered by streptavidin. Neither IgM molecules, nor Fab or F(ab')(2) fragments of IgG molecules can be tethered on PLB membranes by H12-D-domain construct. These tethered IgG surrogate antigens strongly induce the formation and accumulation of signaling active antigen receptor microclusters within the immunological synapse in B or T lymphocyte cells. Thus our method provides a new and robust method to tether IgG surrogate antigens or other molecules fused with IgG Fc portion on PLB membranes for TIRFM based molecule imaging experiments.	[Zhang, Shaosen; Xu, Liling; Zhao, Xingwang; Fan, Yilin; Wan, Zhengpeng; Xu, Yinsheng; Liu, Wanli] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Liu, Wanli] Collaborat Innovat Ctr Infect Dis, Beijing, Peoples R China; [Chen, Xin] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Liu, WL (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	liuwanli@biomed.tsinghua.edu.cn	Chen, Xin/GNH-1799-2022; Wan, Zhengpeng/AAZ-9783-2021; liu, wanli/H-5690-2011	Chen, Xin/0000-0001-6212-2335; Wan, Zhengpeng/0000-0001-5626-7722; liu, wanli/0000-0003-2624-6802; Liu, Wanli/0000-0003-0395-2800; Zhang, Shaosen/0000-0003-0010-1445; Fan, Yilin/0000-0001-7713-4152	National Science Foundation China [31270913]; Beijing Natural Science Foundation [5132016]; Ph.D. Programs Foundation of Ministry of Education of China [20120002120007]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0299]; Tsinghua University-Gates Foundation	National Science Foundation China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Tsinghua University-Gates Foundation	This work is supported by funds from National Science Foundation China (31270913), Beijing Natural Science Foundation (5132016), The Ph.D. Programs Foundation of Ministry of Education of China (20120002120007), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-12-0299) and Tsinghua University-Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Arva E, 1999, SCAND J IMMUNOL, V49, P237; Bajenoff M, 2007, EUR J IMMUNOL, V37, pS18, DOI 10.1002/eji.200737663; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BJORCK L, 1984, J IMMUNOL, V133, P969; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; De Meyer SF, 2009, BLOOD, V113, P5049, DOI 10.1182/blood-2008-10-165621; Dehmelt L, 2010, NAT REV MOL CELL BIO, V11, P440, DOI 10.1038/nrm2903; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Douglass AD, 2008, METHOD CELL BIOL, V85, P113, DOI 10.1016/S0091-679X(08)85006-6; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Dustin ML, 2009, J STRUCT BIOL, V168, P152, DOI 10.1016/j.jsb.2009.05.007; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fooksman DR, 2009, ANN REV IMMUNOL; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; HAFEMAN DG, 1981, P NATL ACAD SCI-BIOL, V78, P4552, DOI 10.1073/pnas.78.7.4552; Hartleib J, 2000, BLOOD, V96, P2149; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; Lund LN, 2011, J MOL RECOGNIT, V24, P945, DOI 10.1002/jmr.1140; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; REIS KJ, 1984, J IMMUNOL, V132, P3091; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Waldemarson S, 2012, J EXP MED; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660; WEIS RM, 1982, J BIOL CHEM, V257, P6440	54	3	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63735	10.1371/journal.pone.0063735	http://dx.doi.org/10.1371/journal.pone.0063735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717469	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700051
J	Ganguly, K; Rejmak, E; Mikosz, M; Nikolaev, E; Knapska, E; Kaczmarek, L				Ganguly, Krishnendu; Rejmak, Emilia; Mikosz, Marta; Nikolaev, Evgeni; Knapska, Ewelina; Kaczmarek, Leszek			Matrix Metalloproteinase (MMP) 9 Transcription in Mouse Brain Induced by Fear Learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IV COLLAGENASE GENE; MATRIX-METALLOPROTEINASE-9 GENE; SYNAPTIC PLASTICITY; MOLECULAR-BIOLOGY; C-FOS; EXPRESSION; DYSTROGLYCAN; AP-1; MECHANISM	Memory formation requires learning-based molecular and structural changes in neurons, whereas matrix metalloproteinase (MMP) 9 is involved in the synaptic plasticity by cleaving extracellular matrix proteins and, thus, is associated with learning processes in the mammalian brain. Because the mechanisms of MMP-9 transcription in the brain are poorly understood, this study aimed to elucidate regulation of MMP-9 gene expression in the mouse brain after fear learning. We show here that contextual fear conditioning markedly increases MMP-9 transcription, followed by enhanced enzymatic levels in the three major brain structures implicated in fear learning, i.e. the amygdala, hippocampus, and prefrontal cortex. To reveal the role of AP-1 transcription factor in MMP-9 gene expression, we have used reporter gene constructs with specifically mutated AP-1 gene promoter sites. The constructs were introduced into the medial prefrontal cortex of neonatal mouse pups by electroporation, and the regulation of MMP-9 transcription was studied after contextual fear conditioning in the adult animals. Specifically, -42/-50- and -478/-486-bp AP-1 binding motifs of the mouse MMP-9 promoter sequence have been found to play a major role in MMP-9 gene activation. Furthermore, increases in MMP-9 gene promoter binding by the AP-1 transcription factor proteins c-Fos and c-Jun have been demonstrated in all three brain structures under investigation. Hence, our results suggest that AP-1 acts as a positive regulator of MMP-9 transcription in the brain following fear learning.	[Ganguly, Krishnendu; Rejmak, Emilia; Nikolaev, Evgeni; Kaczmarek, Leszek] Nencki Inst, Neurobiol Lab, PL-02093 Warsaw, Poland; [Mikosz, Marta; Knapska, Ewelina] Nencki Inst, Lab Neurobiol Emot, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences	Ganguly, K (corresponding author), Nencki Inst, Lab Mol Neurobiol, Pasteur 3, PL-02093 Warsaw, Poland.	k.ganguly@nencki.gov.pl; l.kaczmarek@nencki.gov.pl	Knapska, Ewelina/A-9134-2009; Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008	Knapska, Ewelina/0000-0001-9319-2176; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; GANGULY, KRISHNENDU/0000-0002-9905-4724; Rejmak-Kozicka, Emilia/0000-0003-0522-5316	Foundation for Polish Science Programmes Homing; TEAM Programs	Foundation for Polish Science Programmes Homing; TEAM Programs	This work was supported by the Foundation for Polish Science Programmes Homing (to K.G.) and TEAM (to L.K.) Programs.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Crowe David L., 1999, Neoplasia (New York), V1, P368, DOI 10.1038/sj.neo.7900041; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Deschamps AM, 2006, CARDIOVASC RES, V69, P666, DOI 10.1016/j.cardiores.2005.10.004; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Ganguly K, 2012, BIOCHIMIE, V94, P2687, DOI 10.1016/j.biochi.2012.08.004; Gawlak M, 2009, NEUROSCIENCE, V158, P167, DOI 10.1016/j.neuroscience.2008.05.045; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Himelstein BP, 1998, CLIN EXP METASTAS, V16, P169; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kaminska B, 1996, J NEUROSCI, V16, P3968; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Magid R, 2003, J BIOL CHEM, V278, P32994, DOI 10.1074/jbc.M304799200; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Moon SK, 2004, ARCH BIOCHEM BIOPHYS, V421, P267, DOI 10.1016/j.abb.2003.11.007; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rylski M, 2009, MOL CELL NEUROSCI, V40, P98, DOI 10.1016/j.mcn.2008.09.005; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Taheri F, 2007, INVEST OPHTH VIS SCI, V48, P1931, DOI 10.1167/iovs.06-1008; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang JQ, 2001, FREE RADICAL BIO MED, V31, P520, DOI 10.1016/S0891-5849(01)00613-X; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004	49	60	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20978	20991		10.1074/jbc.M113.457903	http://dx.doi.org/10.1074/jbc.M113.457903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720741	hybrid, Green Published			2022-12-25	WOS:000322014400020
J	Malhi, H; Kropp, EM; Clavo, VF; Kobrossi, CR; Han, J; Mauer, AS; Yong, J; Kaufman, RJ				Malhi, Harmeet; Kropp, Erin M.; Clavo, Vinna F.; Kobrossi, Christina R.; Han, JaeSeok; Mauer, Amy S.; Yong, Jing; Kaufman, Randal J.			C/EBP Homologous Protein-induced Macrophage Apoptosis Protects Mice from Steatohepatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; NONALCOHOLIC STEATOHEPATITIS; OXIDATIVE STRESS; CELL-DEATH; CHOP; EXPRESSION; ROLES; BETA; LIPOAPOPTOSIS	Nonalcoholic fatty liver disease is a heterogeneous disorder characterized by liver steatosis; inflammation and fibrosis are features of the progressive form nonalcoholic steatohepatitis. The endoplasmic reticulum stress response is postulated to play a role in the pathogenesis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. In particular, C/EBP homologous protein (CHOP) is undetectable under normal conditions but is induced by cellular stress, including endoplasmic reticulum stress. Chop wild type (Chop(+/+)) and knock-out (Chop(-/-)) mice were used in these studies to elucidate the role of CHOP in the pathogenesis of fatty liver disease. Paradoxically, Chop(-/-) mice developed greater liver injury, inflammation, and fibrosis than Chop(+/+) mice, with greater macrophage activation. Primary, bone marrow-derived, and peritoneal macrophages from Chop(+/+) and Chop(-/-) were challenged with palmitic acid, an abundant saturated free fatty acid in plasma and liver lipids. Where palmitic acid treatment activated Chop(+/+) and Chop(-/-) macrophages, Chop(-/-) macrophages were resistant to its lipotoxicity. Chop(-/-) mice were sensitized to liver injury in a second model of dietary steatohepatitis using the methionine-cholinedeficient diet. Analysis of bone marrow chimeras between Chop(-/-) and Chop(+/+) mice demonstrated that Chop in macrophages protects from liver injury and inflammation when fed the methionine-choline-deficient diet. We conclude that Chop deletion has a proinflammatory effect in fatty liver injury apparently due to decreased cell death of activated macrophages, resulting in their net accumulation in the liver. Thus, macrophage CHOP plays a key role in protecting the liver from steatohepatitis likely by limiting macrophage survival during lipotoxicity.	[Malhi, Harmeet; Kropp, Erin M.; Clavo, Vinna F.; Kobrossi, Christina R.; Han, JaeSeok; Kaufman, Randal J.] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Han, JaeSeok; Yong, Jing; Kaufman, Randal J.] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Mauer, Amy S.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic	Kaufman, RJ (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rkaufman@sanfordburnham.org	Han, Jaeseok/AAE-6872-2020	Yong, Jing/0000-0001-8579-1558	National Institutes of Health [K08 DK097178, DK07198]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567, DK042394, DK088227, DK093074, HL052173, HL057346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, K08DK097178, R01DK088227, R37DK042394, P30DK084567, R24DK093074, T32DK007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK097178, DK07198, and a Pilot and Feasibility award from the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567) (to H. M.) and DK042394, DK088227, DK093074, HL052173, and HL057346 (to R. J. K.).	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Siyan S, 2012, INFLAMM BOWEL DIS, V18, P1735, DOI 10.1002/ibd.22878; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; VALENTE AJ, 1992, CIRCULATION, V86, P20; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Zhan YT, 2010, WORLD J GASTROENTERO, V16, P4652, DOI 10.3748/wjg.v16.i37.4652; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	37	60	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18624	18642		10.1074/jbc.M112.442954	http://dx.doi.org/10.1074/jbc.M112.442954			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720735	hybrid, Green Published			2022-12-25	WOS:000321335800001
J	Al Batran, R; Al-Bayaty, F; Al-Obaidi, MMJ; Abdualkader, AM; Hadi, HA; Ali, HM; Abdulla, MA				Al Batran, Rami; Al-Bayaty, Fouad; Al-Obaidi, Mazen M. Jamil; Abdualkader, Abdualrahman Mohammed; Hadi, Hamid A.; Ali, Hapipah Mohd; Abdulla, Mahmood Ameen			In Vivo Antioxidant and Antiulcer Activity of Parkia speciosa Ethanolic Leaf Extract against Ethanol-Induced Gastric Ulcer in Rats	PLOS ONE			English	Article							CYTOPROTECTION; INHIBITION; MUCUS	Background: The current study was carried out to examine the gastroprotective effects of Parkia speciosa against ethanol-induced gastric mucosa injury in rats. Methodology/Principal Findings: Sprague Dawley rats were separated into 7 groups. Groups 1-2 were orally challenged with carboxymethylcellulose (CMC); group 3 received 20 mg/kg omeprazole and groups 4-7 received 50, 100, 200 and 400 mg/kg of ethanolic leaf extract, respectively. After 1 h, CMC or absolute ethanol was given orally to groups 2-7. The rats were sacrificed after 1 h. Then, the injuries to the gastric mucosa were estimated through assessment of the gastric wall mucus, the gross appearance of ulcer areas, histology, immunohistochemistry and enzymatic assays. Group 2 exhibited significant mucosal injuries, with reduced gastric wall mucus and severe damage to the gastric mucosa, whereas reductions in mucosal injury were observed for groups 4-7. Groups 3-7 demonstrated a reversal in the decrease in Periodic acid-Schiff (PAS) staining induced by ethanol. No symptoms of toxicity or death were observed during the acute toxicity tests. Conclusion: Treatment with the extract led to the upregulation of heat-shock protein 70 (HSP70) and the downregulation of the pro-apoptotic protein BAX. Significant increases in the levels of the antioxidant defense enzymes glutathione (GSH) and superoxide dismutase (SOD) in the gastric mucosal homogenate were observed, whereas that of a lipid peroxidation marker (MDA) was significantly decreased. Significance was defined as p<0.05 compared to the ulcer control group (Group 2).	[Al Batran, Rami; Al-Bayaty, Fouad; Al-Obaidi, Mazen M. Jamil] Univ Technol MARA UiTM, Ctr Studies Periodontol, Fac Dent, Shah Alam, Selangor, Malaysia; [Abdualkader, Abdualrahman Mohammed] Int Islam Univ Malaysia, Fac Pharm, Dept Pharmaceut Chem, Kuantan, Pahang, Malaysia; [Hadi, Hamid A.; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; International Islamic University Malaysia; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	Abdualkader, Abdualrahman M./A-8120-2012; Al Batran, Rami/D-2177-2015; Al-Obaidi, Mazen/GQR-0358-2022	Abdualkader, Abdualrahman M./0000-0001-8081-9988; Al Batran, Rami/0000-0001-5412-3346; Al-Obaidi, Mazen/0000-0001-5950-4498; AL BAYATY, FOUAD/0000-0002-3117-595X	University of Malaya [F000009-21001]	University of Malaya(Universiti Malaya)	The authors express gratitude to the University of Malaya for the financial support of UM/MOHE High Impact Research Grant (HIR Grant No. F000009-21001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2011, EVID-BASED COMPL ALT, V2011, DOI [10.1155/2011/156765, 10.1093/ecam/neq010]; Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Bardi D. A. A., 2011, Scientific Research and Essays, V6, P3232; Behmer O.A., 1976, MANUAL TECNICAS HIST, V1st; BOLTON JP, 1978, AM J DIG DIS, V23, P359, DOI 10.1007/BF01072421; Chemicals D., 2005, OECD GUIDELINE TESTI; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Ching LS, 2001, J AGR FOOD CHEM, V49, P3101, DOI 10.1021/jf000891u; CLAMP JR, 1978, BRIT MED BULL, V34, P25, DOI 10.1093/oxfordjournals.bmb.a071455; DAVENPOR.HW, 1968, GASTROENTEROLOGY, V54, P175; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Gan CY, 2011, FOOD CHEM, V124, P1277, DOI 10.1016/j.foodchem.2010.07.074; Itatsu T, 2011, INTERNAL MED, V50, P713, DOI 10.2169/internalmedicine.50.4644; Jainu Mallika, 2006, Indian J Med Res, V123, P799; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; Kushima W, 2005, J ETHNOPHARMACOL, V101, P61, DOI 10.1016/j.jep.2005.03.014; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lanas A, 2009, AM J MED SCI, V338, P96, DOI 10.1097/MAJ.0b013e3181ad8cd3; LUKIE BE, 1972, BIOCHIM BIOPHYS ACTA, V273, P380, DOI 10.1016/0304-4165(72)90230-9; Mahmood AA, 2010, J MED PLANTS RES, V4, P685; Mahmood AA, 2011, J MED PLANTS RES, V5, P2562; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; MARHUENDA E, 1993, PHYTOTHER RES, V7, P13, DOI 10.1002/ptr.2650070105; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; PIPER DW, 1970, GASTROENTEROLOGY, V59, P534; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; Resources IoLA, 1996, GUIDE CARE USE LAB A; ROBERT A, 1984, GASTROENTEROLOGY, V86, P670; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Soberg Taran, 2010, Tidsskr Nor Laegeforen, V130, P1135, DOI 10.4045/tidsskr.08.0693; SUN Y, 1988, CLIN CHEM, V34, P497; Thirunavukkarasu P., 2010, World Applied Sciences Journal, V9, P55; Tytell M, 2001, Expert Opin Ther Targets, V5, P267, DOI 10.1517/14728222.5.2.267; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Yeomans ND, 2009, CURR MED RES OPIN, V25, P2785, DOI 10.1185/03007990903212682; Yuan L, 2010, CHINESE CHEM LETT, V21, P155, DOI 10.1016/j.cclet.2009.10.004	41	91	93	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64751	10.1371/journal.pone.0064751	http://dx.doi.org/10.1371/journal.pone.0064751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724090	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000091
J	Benosman, S; Ravanan, P; Correa, RG; Hou, YC; Yu, MJ; Gulen, MF; Li, XX; Thomas, J; Cuddy, M; Matsuzawa, Y; Sano, R; Diaz, P; Matsuzawa, S; Reed, JC				Benosman, Samir; Ravanan, Palaniyandi; Correa, Ricardo G.; Hou, Ying-Chen; Yu, Minjia; Gulen, Muhammet Fatih; Li, Xiaoxia; Thomas, James; Cuddy, Michael; Matsuzawa, Yasuko; Sano, Renata; Diaz, Paul; Matsuzawa, Shu-ichi; Reed, John C.			Interleukin-1 Receptor-Associated Kinase-2 (IRAK2) Is a Critical Mediator of Endoplasmic Reticulum (ER) Stress Signaling	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; CELL-DEATH; ACTIVATION; APOPTOSIS; CHOP; INHIBITION; PATHWAYS; FAMILY; IRE1	Endoplasmic reticulum (ER) stress occurs when unfolded proteins accumulate in the lumen of the organelle, triggering signal transduction events that contribute either to cellular adaptation and recovery or alternatively to cellular dysfunction and death. ER stress has been implicated in numerous diseases. To identify novel modulators of ER stress, we undertook a siRNA library screen of the kinome, revealing Interleukin-1 Receptor-Associated Kinase-2 (IRAK2) as a contributor to unfolded protein response (UPR) signaling and ER stress-induced cell death. Knocking down expression of IRAK2 (but not IRAK1) in cultured mammalian cells suppresses ER stress-induced expression of the pro-apoptotic transcription factor CHOP and activation of stress kinases. Similarly, RNAi-mediated silencing of the IRAK family member Tube (but not Pelle) suppresses activation of stress kinase signaling induced by ER stress in Drosophila cells. The action of IRAK2 maps to the IRE1 pathway, rather than the PERK or ATF6 components of the UPR. Interestingly, ER stress also induces IRAK2 gene expression in an IRE1/XBP1-dependent manner, suggesting a mutually supporting amplification loop involving IRAK2 and IRE1. In vivo, ER stress induces Irak2 expression in mice. Moreover, Irak2 gene knockout mice display defects in ER stress-induced CHOP expression and IRE1 pathway signaling. These findings demonstrate an unexpected linkage of the innate immunity machinery to UPR signaling, revealing IRAK2 as a novel amplifier of the IRE1 pathway.	[Benosman, Samir; Ravanan, Palaniyandi; Correa, Ricardo G.; Hou, Ying-Chen; Cuddy, Michael; Matsuzawa, Yasuko; Sano, Renata; Diaz, Paul; Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Yu, Minjia; Gulen, Muhammet Fatih; Li, Xiaoxia] Lerner Res Inst NB30, Cleveland Clin Fdn, Dept Immunol, Cleveland, OH USA; [Thomas, James] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75230 USA	Sanford Burnham Prebys Medical Discovery Institute; Cleveland Clinic Foundation; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Reed, JC (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	reedoffice@sanfordburnham.org	Correa, Ricardo G/G-7613-2012	Correa, Ricardo G/0000-0001-6940-7034; Gulen, Muhammet/0000-0002-7139-6781; Palaniyandi, Ravanan/0000-0003-0665-5801	National Institutes of Health (NIH) [AG-15393]; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the authors received generous support from National Institutes of Health (NIH) (AG-15393).	Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lapillonne H, 2003, CANCER RES, V63, P5926; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; McGuckin MA, 2011, BIOCHEM SOC T, V39, P1081, DOI 10.1042/BST0391081; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Milanesi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S20; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ravanan P, 2011, MOL CANCER THER, V10, P1635, DOI 10.1158/1535-7163.MCT-10-0887; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yin WG, 2011, J INTERF CYTOK RES, V31, P415, DOI 10.1089/jir.2010.0094; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	35	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64256	10.1371/journal.pone.0064256	http://dx.doi.org/10.1371/journal.pone.0064256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724040	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000052
J	Stevens, DC; Conway, KR; Pearce, N; Villegas-Penaranda, LR; Garza, AG; Boddy, CN				Stevens, David Cole; Conway, Kyle R.; Pearce, Nelson; Villegas-Penaranda, Luis Roberto; Garza, Anthony G.; Boddy, Christopher N.			Alternative Sigma Factor Over-Expression Enables Heterologous Expression of a Type II Polyketide Biosynthetic Pathway in Escherichia coli	PLOS ONE			English	Article							ENHANCER-BINDING PROTEINS; GENE-CLUSTER; ENGINEERED BIOSYNTHESIS; SECONDARY METABOLISM; NATURAL-PRODUCTS; PROMOTER; IDENTIFICATION; CLONING; TRANSLATION; EPOTHILONE	Background: Heterologous expression of bacterial biosynthetic gene clusters is currently an indispensable tool for characterizing biosynthetic pathways. Development of an effective, general heterologous expression system that can be applied to bioprospecting from metagenomic DNA will enable the discovery of a wealth of new natural products. Methodology: We have developed a new Escherichia coli-based heterologous expression system for polyketide biosynthetic gene clusters. We have demonstrated the over-expression of the alternative sigma factor sigma(54) directly and positively regulates heterologous expression of the oxytetracycline biosynthetic gene cluster in E. coli. Bioinformatics analysis indicates that sigma(54) promoters are present in nearly 70% of polyketide and non-ribosomal peptide biosynthetic pathways. Conclusions: We have demonstrated a new mechanism for heterologous expression of the oxytetracycline polyketide biosynthetic pathway, where high-level pleiotropic sigma factors from the heterologous host directly and positively regulate transcription of the non-native biosynthetic gene cluster. Our bioinformatics analysis is consistent with the hypothesis that heterologous expression mediated by the alternative sigma factor sigma(54) may be a viable method for the production of additional polyketide products.	[Stevens, David Cole; Conway, Kyle R.; Pearce, Nelson; Villegas-Penaranda, Luis Roberto; Boddy, Christopher N.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Garza, Anthony G.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Boddy, Christopher N.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa; Syracuse University; University of Ottawa	Boddy, CN (corresponding author), Univ Ottawa, Dept Chem, Ottawa, ON, Canada.	cboddy@uottawa.ca	Boddy, Christopher N./H-8084-2019	Stevens, David Cole/0000-0001-6668-9419; Boddy, Christopher/0000-0002-3259-3184; Villegas Penaranda, Luis Roberto/0000-0002-3748-9554	NSERC; Ontario Ministry of Research and Innovation; University of Ottawa	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); University of Ottawa	This work was supported by NSERC, Ontario Ministry of Research and Innovation, and the University of Ottawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andexer JN, 2011, P NATL ACAD SCI USA, V108, P4776, DOI 10.1073/pnas.1015773108; AOKI H, 1991, NUCLEIC ACIDS RES, V19, P6215, DOI 10.1093/nar/19.22.6215; Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108; Baltz RH, 2010, J IND MICROBIOL BIOT, V37, P759, DOI 10.1007/s10295-010-0730-9; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Binz TM, 2008, CHEMBIOCHEM, V9, P447, DOI 10.1002/cbic.200700549; Boddy CN, 2004, J AM CHEM SOC, V126, P7436, DOI 10.1021/ja048108s; Bode HB, 2006, J IND MICROBIOL BIOT, V33, P577, DOI 10.1007/s10295-006-0082-7; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Buntin K, 2010, CHEM BIOL, V17, P342, DOI 10.1016/j.chembiol.2010.02.013; BURROWS GE, 1993, J VET DIAGN INVEST, V5, P541, DOI 10.1177/104063879300500407; Carlson JC, 2010, CHEMBIOCHEM, V11, P564, DOI 10.1002/cbic.200900658; Chen GZ, 2003, CAN J MICROBIOL, V49, P733, DOI 10.1139/W03-096; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Dworkin J, 1997, J MOL BIOL, V273, P377, DOI 10.1006/jmbi.1997.1317; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Gao X, 2010, APPL MICROBIOL BIOT, V88, P1233, DOI 10.1007/s00253-010-2860-4; Giglio KM, 2010, J BACTERIOL, V192, P360, DOI 10.1128/JB.01019-09; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gordon JJ, 2006, BIOINFORMATICS, V22, P142, DOI 10.1093/bioinformatics/bti771; Gronewold TMA, 2007, J BACTERIOL, V189, P1836, DOI 10.1128/JB.01618-06; Hesketh A, 2001, MOL MICROBIOL, V150, P1485; Jakobsen JS, 2004, J BACTERIOL, V186, P4361, DOI 10.1128/JB.186.13.4361-4368.2004; Janaszak A, 2007, MICROBIOL-SGM, V153, P111, DOI 10.1099/mic.0.2006/000463-0; Jorgensen H, 2009, APPL ENVIRON MICROB, V75, P3296, DOI 10.1128/AEM.02730-08; KAO CM, 1994, SCIENCE, V265, P509, DOI 10.1126/science.8036492; Knauber T, 2008, MOL MICROBIOL, V69, P254, DOI 10.1111/j.1365-2958.2008.06285.x; Kumar R, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-3; Lackner G, 2007, J AM CHEM SOC, V129, P9306, DOI 10.1021/ja0718624; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lundgren BR, 2007, ORG BIOMOL CHEM, V5, P1903, DOI 10.1039/b703519e; McLeay RC, 2011, BIOINFORMATICS, V27, P2354, DOI 10.1093/bioinformatics/btr399; MULLIGAN ME, 1986, NUCLEIC ACIDS RES, V14, P109, DOI 10.1093/nar/14.1.109; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Ossa F, 2007, J BACTERIOL, V189, P8474, DOI 10.1128/JB.00894-07; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Pickens LB, 2010, J BIOL CHEM, V285, P27509, DOI 10.1074/jbc.R110.130419; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Qiu P, 2003, BIOCHEM BIOPH RES CO, V309, P495, DOI 10.1016/j.bbrc.2003.08.052; Rodriguez E, 2009, METHOD ENZYMOL, V459, P339, DOI 10.1016/S0076-6879(09)04615-1; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Stevens DC, 2010, APPL ENVIRON MICROB, V76, P2681, DOI 10.1128/AEM.02841-09; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Studholme DJ, 2000, MICROBIOL-SGM, V146, P3021, DOI 10.1099/00221287-146-12-3021; Tang L, 2000, SCIENCE, V287, P640, DOI 10.1126/science.287.5453.640; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Van Lanen SG, 2006, CURR OPIN MICROBIOL, V9, P252, DOI 10.1016/j.mib.2006.04.002; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Yurkovich ME, 2012, CHEMBIOCHEM, V13, P66, DOI 10.1002/cbic.201100590; Zaleta-Rivera K, 2010, J AM CHEM SOC, V132, P9122, DOI 10.1021/ja102519v; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P20683, DOI 10.1073/pnas.0809084105; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006; Zhoa K, 2010, NUCLEIC ACIDS RES, V38, P1273	62	37	37	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64858	10.1371/journal.pone.0064858	http://dx.doi.org/10.1371/journal.pone.0064858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724102	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000102
J	Stypula-Cyrus, Y; Damania, D; Kunte, DP; Dela Cruz, M; Subramanian, H; Roy, HK; Backman, V				Stypula-Cyrus, Yolanda; Damania, Dhwanil; Kunte, Dhananjay P.; Dela Cruz, Mart; Subramanian, Hariharan; Roy, Hemant K.; Backman, Vadim			HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; EARLY EVENT; CANCER; EXPRESSION; ACETYLATION; GENE; APOPTOSIS; APC; DIFFERENTIATION; EPIGENETICS	Normal cell function is dependent on the proper maintenance of chromatin structure. Regulation of chromatin structure is controlled by histone modifications that directly influence chromatin architecture and genome function. Specifically, the histone deacetylase (HDAC) family of proteins modulate chromatin compaction and are commonly dysregulated in many tumors, including colorectal cancer (CRC). However, the role of HDAC proteins in early colorectal carcinogenesis has not been previously reported. We found HDAC1, HDAC2, HDAC3, HDAC5, and HDAC7 all to be up-regulated in the field of human CRC. Furthermore, we observed that HDAC2 up-regulation is one of the earliest events in CRC carcinogenesis and observed this in human field carcinogenesis, the azoxymethane-treated rat model, and in more aggressive colon cancer cell lines. The universality of HDAC2 up-regulation suggests that HDAC2 up-regulation is a novel and important early event in CRC, which may serve as a biomarker. HDAC inhibitors (HDACIs) interfere with tumorigenic HDAC activity; however, the precise mechanisms involved in this process remain to be elucidated. We confirmed that HDAC inhibition by valproic acid (VPA) targeted the more aggressive cell line. Using nuclease digestion assays and transmission electron microscopy imaging, we observed that VPA treatment induced greater changes in chromatin structure in the more aggressive cell line. Furthermore, we used the novel imaging technique partial wave spectroscopy (PWS) to quantify nanoscale alterations in chromatin. We noted that the PWS results are consistent with the biological assays, indicating a greater effect of VPA treatment in the more aggressive cell type. Together, these results demonstrate the importance of HDAC activity in early carcinogenic events and the unique role of higher-order chromatin structure in determining cell tumorigenicity.	[Stypula-Cyrus, Yolanda; Damania, Dhwanil; Subramanian, Hariharan; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Kunte, Dhananjay P.] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Dela Cruz, Mart; Roy, Hemant K.] Boston Med Ctr, Dept Med, Boston, MA USA	Northwestern University; NorthShore University Health System; Boston Medical Center	Backman, V (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	v-backman@northwestern.edu	Backman, Vadim/B-6689-2009; Roy, Hemant/AAC-9096-2020		National Institutes of Health (NIH) [U54CA143869, R01CA128641]; National Science Foundation (NSF) [CBET-0937987]; NATIONAL CANCER INSTITUTE [R01CA128641, U54CA143869] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants U54CA143869 and R01CA128641 and by National Science Foundation (NSF) grant CBET-0937987. (http://www.nih.gov/, http://www.nsf.gov/#1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2007, CANCER EPIDEM BIOMAR, V16, P2704, DOI 10.1158/1055-9965.EPI-07-0595; Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7; Backman V, 2011, GASTROENTEROLOGY, V140, P35, DOI 10.1053/j.gastro.2010.11.023; Banerjee A, 1998, DIS COLON RECTUM, V41, P490, DOI 10.1007/BF02235764; BARER R, 1954, NATURE, V173, P821, DOI 10.1038/173821b0; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Damania D, 2010, BIOPHYS J, V99, P989, DOI 10.1016/j.bpj.2010.05.023; DAVIES HG, 1954, Q J MICROSC SCI, V95, P271; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang DC, 2002, WORLD J GASTROENTERO, V8, P787, DOI 10.3748/wjg.v8.i5.787; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Kawai H, 2003, INT J CANCER, V107, P353, DOI 10.1002/ijc.11403; Kim JS, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015004; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kunte DP, 2008, MOL CANCER THER, V7, P1797, DOI 10.1158/1535-7163.MCT-08-0022; Kunte DP, 2005, FEBS LETT, V579, P3497, DOI 10.1016/j.febslet.2005.05.030; Lao VV, 2011, NAT REV GASTROENTERO; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Michor F, 2011, NAT REV CANCER, V11, P657, DOI 10.1038/nrc3092; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Nakagawa M, 2007, ONCOL REP, V18, P769; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pradhan P, 2011, APPL PHYS LETT, V97; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Roy HK, 2010, CANCER RES, V70, P7748, DOI 10.1158/0008-5472.CAN-10-1686; Sawan C, 2010, ADV GENET, V70, P57, DOI [10.1016/S0065-2660(10)70003-1, 10.1016/B978-0-12-380866-0.60003-4]; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Subramanian H, 2009, OPT LETT, V34, P518, DOI 10.1364/OL.34.000518; Subramanian H, 2009, CANCER RES, V69, P5357, DOI 10.1158/0008-5472.CAN-08-3895; Subramanian H, 2008, P NATL ACAD SCI USA, V105, P20118, DOI 10.1073/pnas.0804723105; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; VanLint C, 1996, GENE EXPRESSION, V5, P245; Venkatachalam R, 2010, CANCER GENET CYTOGEN, V203, P1, DOI 10.1016/j.cancergencyto.2010.08.013; Wali RK, 2005, GUT, V54, P654, DOI 10.1136/gut.2004.056010; Zaret K, 2005, CURR PROTOC MOL BIOL; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	50	89	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64600	10.1371/journal.pone.0064600	http://dx.doi.org/10.1371/journal.pone.0064600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724067	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000068
J	van der Meijden, PEJ; Bouman, AC; Feijge, MAH; van Oerle, R; Spronk, HMH; Hamulyak, K; ten Cate-Hoek, AJ; ten Cate, H; Heemskerk, JWM				van der Meijden, Paola E. J.; Bouman, Annemieke C.; Feijge, Marion A. H.; van Oerle, Rene; Spronk, Henri M. H.; Hamulyak, Karly; ten Cate-Hoek, Arina J.; ten Cate, Hugo; Heemskerk, Johan W. M.			Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ORAL ANTICOAGULANT-THERAPY; ATRIAL-FIBRILLATION; HEMORRHAGIC COMPLICATIONS; MYOCARDIAL-INFARCTION; RISK; PLASMA; MORTALITY; ACTIVATION; GENERATION	Background: Recurrent bleeding can complicate the treatment of thrombosis patients with vitamin K antagonists (VKA), even at a well-regulated level of anticoagulation. In this proof-of-principle study, we investigated whether alterations in platelet function or von Willebrand factor (vWf) contribute to a bleeding phenotype in these patients. Methods: In this case-control study 33 well-regulated patients without bleeding events (controls) and 33 patients with recurrent bleeding (cases) were retrospectively included. Thrombin generation and vWf were determined in plasma. Platelet function was assessed by light transmission aggregometry and flow cytometry using a validated panel of agonists. Results: Thrombin generation was similarly reduced in controls and cases, in comparison to normal plasma. Plasma vWf level was above the normal range in 85% of controls and 67% of the cases. vWf activity was similarly increased in all patients in comparison to healthy volunteers. Platelet aggregation was in the normal range for almost all patients irrespective of the type of agonist. However, in response to a low collagen dose, platelets from 21% of controls and 27% of cases showed diminished responses. Agonist-induced secretion of alpha- and dense-granules or integrin aIIbb3 activation were affected in platelets from neither controls nor cases. Conclusion: Recurrent bleeding in well-controlled patients on VKA therapy is not explained by anti-hemostatic changes in platelet or vWf function.	[van der Meijden, Paola E. J.; Feijge, Marion A. H.; Heemskerk, Johan W. M.] Maastricht Univ Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [van der Meijden, Paola E. J.; Bouman, Annemieke C.; van Oerle, Rene; Spronk, Henri M. H.; ten Cate-Hoek, Arina J.; ten Cate, Hugo] Maastricht Univ Med Ctr, Dept Internal Med, Cardiovasc Res Inst Maastricht CARIM, Lab Clin Thrombosis & Haemostasis, Maastricht, Netherlands; [Hamulyak, Karly] Maastricht Univ Med Ctr, Dept Internal Med, Haemostasis Lab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	van der Meijden, PEJ (corresponding author), Maastricht Univ Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	p.vandermeijden@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021; Heemskerk, Johan/AAM-8323-2021	Heemskerk, Johan/0000-0002-2848-5121; van der Meijden, Paola/0000-0002-6532-2583; ten Cate, Hugo/0000-0001-7796-4463; Spronk, Henri/0000-0002-3858-334X	Cardiovascular Centre (HVC), Maastricht University Medical Center; Centre for Translational Molecular Medicine (CTMM), Innovative Coagulation Diagnostics	Cardiovascular Centre (HVC), Maastricht University Medical Center; Centre for Translational Molecular Medicine (CTMM), Innovative Coagulation Diagnostics	The authors would like to thank the Cardiovascular Centre (HVC), Maastricht University Medical Center and Centre for Translational Molecular Medicine (CTMM), Innovative Coagulation Diagnostics, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAANSEN HJ, 2010, SUMM MED YEAR REP 20; Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Christie DJ, 2008, PLATELET FUNCTION TE, V28, P1; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; DAWOOD BB, 2012, BLOOD, DOI DOI 10.1182/BL00D-2012-07-444281; Dentali F, 2007, ARCH INTERN MED, V167, P117, DOI 10.1001/archinte.167.2.117; *FED NED TROMB, 2009, IND RANG FNT; *FED NED TROMB, 2011, KUNST DOS; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; GUSTAFSSON C, 1990, STROKE, V21, P47, DOI 10.1161/01.STR.21.1.47; Hayward CPM, 2009, J THROMB HAEMOST, V7, P676, DOI 10.1111/j.1538-7836.2009.03273.x; Hayward CPM, 2008, TRANSFUS APHER SCI, V38, P65, DOI 10.1016/j.transci.2007.12.009; Hayward Catherine P M, 2005, Hematology Am Soc Hematol Educ Program, P423; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; James PD, 2011, GENET MED, V13, P365, DOI 10.1097/GIM.0b013e3182035931; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lind M, 2012, J INTERN MED, V271, P239, DOI 10.1111/j.1365-2796.2011.02418.x; LIP GYH, 1995, BRIT HEART J, V73, P527; Nurden P, 2008, THROMB HAEMOSTASIS, V99, P253, DOI 10.1160/TH07-09-0568; Palareti G, 2011, HAMOSTASEOLOGIE, V31, P237, DOI 10.5482/ha-1151; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864; REDWOOD M, 1991, AGE AGEING, V20, P217, DOI 10.1093/ageing/20.3.217; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; Rydz N, 2012, J THROMB HAEMOST, V10, P2223, DOI 10.1111/j.1538-7836.2012.04923.x; Schalekamp T, 2008, THROMB HAEMOSTASIS, V100, P1076, DOI 10.1160/TH08-05-0290; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; SHIMA M, 1995, VOX SANG, V68, P236, DOI 10.1111/j.1423-0410.1995.tb02579.x; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Snoep JD, 2010, J THROMB HAEMOST, V8, P2377, DOI 10.1111/j.1538-7836.2010.04018.x; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Spronk HMH, 2008, THROMB HAEMOSTASIS, V100, P362, DOI 10.1160/TH08-03-0141; Steffensen FH, 1997, J INTERN MED, V242, P497, DOI 10.1111/j.1365-2796.1997.tb00023.x; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Veeger NJGM, 2005, BRIT J HAEMATOL, V128, P513, DOI 10.1111/j.1365-2141.2004.05348.x; WICKRAMASINGHE LSP, 1988, AGE AGEING, V17, P388, DOI 10.1093/ageing/17.6.388	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64112	10.1371/journal.pone.0064112	http://dx.doi.org/10.1371/journal.pone.0064112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724024	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000040
J	Yang, Q; Yan, L; Luo, JL; Li, A; Zhang, Y; Tian, XH; Zhang, DX				Yang, Qun; Yan, Li; Luo, Junlong; Li, An; Zhang, Ye; Tian, Xuehong; Zhang, Dexuan			Temporal Dynamics of Disgust and Morality: An Event-Related Potential Study	PLOS ONE			English	Article							BAD TASTE; SENSITIVITY; JUDGMENT; SCALE	Disgust is argued to be an emotion that motivates the avoidance of disease-causing entities in the physical domain and unacceptable behaviors in the social-moral domain. Empirical work from behavioral, physiological and brain imaging studies suggests moral judgments are strongly modulated by disgust feelings. Yet, it remains unclear how they are related in the time course of neural processing. Examining the temporal order of disgust emotion and morality could help to clarify the role of disgust in moral judgments. In the present research, a Go/No-Go paradigm was employed to evoke lateralized readiness potentials (LRPs) to investigate the temporal order of physical disgust and moral information processing. Participants were asked to give a "yes'' or "no'' response regarding the physical disgust and moral wrongness of a social act. The results showed that the evaluation of moral information was processed prior to that of physical disgust information. This suggests that moral information is available earlier than physical disgust, and provides more data on the biological heterogeneity between disgust and morality in terms of the time course of neural activity. The findings implicate that physical disgust emotion may not be necessary for people to make moral judgments. They also suggest that some of our moral experience may be more fundamental (than physical disgust experience) to our survival and development, as humans spend a considerable amount of time engaging in social interaction.	[Yang, Qun; Yan, Li; Tian, Xuehong; Zhang, Dexuan] Hangzhou Normal Univ, Coll Educ Sci, Hangzhou, Zhejiang, Peoples R China; [Luo, Junlong] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China; [Li, An] Hangzhou Normal Univ, Sch Law, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ye] Hangzhou Normal Univ, Ctr Cognit & Brain Disorder, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Shanghai Normal University; Hangzhou Normal University; Hangzhou Normal University	Tian, XH (corresponding author), Hangzhou Normal Univ, Coll Educ Sci, Hangzhou, Zhejiang, Peoples R China.	tianxh66@163.com; zhang.dexuan@gmail.com		Zhang, Ye/0000-0002-8549-8420	Philosophical and Social Science Foundation of Zhejiang Province [12JCJY19YB]; National Natural Science Foundation of China [31070909, 30870861, 31200768, 30970893]	Philosophical and Social Science Foundation of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Philosophical and Social Science Foundation of Zhejiang Province (Grant No. 12JCJY19YB); and National Natural Science Foundation of China (31070909, 30870861, 31200768, 30970893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair J., 2006, PHILOS EXPLOR, V9, P13, DOI DOI 10.1080/13869790500492359; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Chapman HA, 2012, ANN NY ACAD SCI, V1251, P62, DOI 10.1111/j.1749-6632.2011.06369.x; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Darwin C., 1965, EXPRESSION EMOTIONS; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J, 2001, J APPL SOC PSYCHOL, V31, P191, DOI 10.1111/j.1559-1816.2001.tb02489.x; Haidt J., 1997, PSYCHOL DEV SOC, V9, P107, DOI [10.1177%2F097133369700900105, DOI 10.1177/097133369700900105, 10.1177/097133369700900105]; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hayes CJ, 2007, NEUROPSYCHOLOGIA, V45, P1135, DOI 10.1016/j.neuropsychologia.2006.10.015; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Huebner B, 2009, TRENDS COGN SCI, V13, P1, DOI 10.1016/j.tics.2008.09.006; KUTAS M, 1980, BRAIN RES, V202, P95, DOI 10.1016/0006-8993(80)90646-0; Luck S.J., 2005, INTRO EVENT RELATED; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Nikolaev AR, 2008, BIOL PSYCHOL, V78, P53, DOI 10.1016/j.biopsycho.2007.12.010; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281; Pizarro DA, 2003, PSYCHOL REV, V110, P193, DOI 10.1037/0033-295X.110.1.193; Pizarro D, 2011, EMOT REV, V3, P267, DOI 10.1177/1754073911402394; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Rozin P., 2000, HDB EMOTIONS, P637; Sarlo M, 2012, J COGNITIVE NEUROSCI, V24, P1018, DOI 10.1162/jocn_a_00146; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Shweder R.A., 1987, EMERGENCE MORALITY Y, P1, DOI DOI 10.1017/CBO9781139173728.005; Simpson J, 2006, MOTIV EMOTION, V30, P31, DOI 10.1007/s11031-006-9005-1; Sloman S., 2005, CAUSAL MODELS PEOPLE; Stevenson RJ, 2010, DEV PSYCHOL, V46, P165, DOI 10.1037/a0016692; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	44	11	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65094	10.1371/journal.pone.0065094	http://dx.doi.org/10.1371/journal.pone.0065094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155FM	23724123	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000117
J	Hecker, N; Stephan, C; Mollenkopf, HJ; Jung, K; Preissner, R; Meyer, HA				Hecker, Nikolai; Stephan, Carsten; Mollenkopf, Hans-Joachim; Jung, Klaus; Preissner, Robert; Meyer, Hellmuth-A			A New Algorithm for Integrated Analysis of miRNA-mRNA Interactions Based on Individual Classification Reveals Insights into Bladder Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MICRORNA TARGETS; URINARY-BLADDER; WEB TOOL; DATABASE; MECHANISMS; CARCINOMA; PATTERNS; BINDING	Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression. It has been proposed that miRNAs play an important role in cancer development and progression. Their ability to affect multiple gene pathways by targeting various mRNAs makes them an interesting class of regulators. Methodology/Principal Findings: We have developed an algorithm, Classification based Analysis of Paired Expression data of RNA (CAPE RNA), which is capable of identifying altered miRNA-mRNA regulation between tissues samples that assigns interaction states to each sample without preexisting stratification of groups. The distribution of the assigned interaction states compared to given experimental groups is used to assess the quality of a predicted interaction. We demonstrate the applicability of our approach by analyzing urothelial carcinoma and normal bladder tissue samples derived from 24 patients. Using our approach, normal and tumor tissue samples as well as different stages of tumor progression were successfully stratified. Also, our results suggest interesting differentially regulated miRNA-mRNA interactions associated with bladder tumor progression. Conclusions/Significance: The need for tools that allow an integrative analysis of microRNA and mRNA expression data has been addressed. With this study, we provide an algorithm that emphasizes on the distribution of samples to rank differentially regulated miRNA-mRNA interactions. This is a new point of view compared to current approaches. From bootstrapping analysis, our ranking yields features that build strong classifiers. Further analysis reveals genes identified as differentially regulated by miRNAs to be enriched in cancer pathways, thus suggesting biologically interesting interactions.	[Hecker, Nikolai] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Hecker, Nikolai; Preissner, Robert; Meyer, Hellmuth-A] Charite, Inst Physiol, D-13353 Berlin, Germany; [Stephan, Carsten; Jung, Klaus; Meyer, Hellmuth-A] Charite, Dept Urol, D-13353 Berlin, Germany; [Stephan, Carsten; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Genom Microarray, Berlin, Germany	University of Hamburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Meyer, HA (corresponding author), Charite, Inst Physiol, D-13353 Berlin, Germany.	hellmuth.meyer@charite.de	Mollenkopf, Hans-Joachim/AAH-2500-2019; Jung, Klaus/Z-2122-2018; Hecker, Nikolai/O-6824-2019	Jung, Klaus/0000-0001-9797-5362; Hecker, Nikolai/0000-0003-1693-4257; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; preissner, robert/0000-0002-2407-1087; Stephan, Carsten/0000-0002-3270-258X	BMBF (MedSys) [0315450]; Deutsche Forschungsgemeinschaft (DFG) [GRK 1772]	BMBF (MedSys)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by BMBF (MedSys, grant No. 0315450) http://www.bmbf.de/and Deutsche Forschungsgemeinschaft (DFG) GRK 1772 "Computational Systems Biology" http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cho S, 2011, NUCLEIC ACIDS RES, V39, pD158, DOI 10.1093/nar/gkq1094; Christoph F, 2007, J CANCER RES CLIN, V133, P343, DOI 10.1007/s00432-006-0174-9; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Enright AJ, 2004, GENOME BIOL, V5; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hernandez S, 2009, MODERN PATHOL, V22, P848, DOI 10.1038/modpathol.2009.46; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GT, 2011, NUCLEIC ACIDS RES, V39, pW416, DOI 10.1093/nar/gkr276; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laczny C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-36; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Langzam L, 2001, AM J CLIN PATHOL, V116, P377, DOI 10.1309/1VKK-HWH7-YVJN-7UF7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; Liang Z, 2011, NUCLEIC ACIDS RES, V39, pW139, DOI 10.1093/nar/gkr351; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markina MS, 2007, ZH VOPR NEIROKHIR IM, V36-39, P39; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Mengual L, 2010, CLIN CANCER RES, V16, P2624, DOI 10.1158/1078-0432.CCR-09-3373; Messing EM, 2002, CAMPBELLS UROLOGY, P2732; MIYAO N, 1993, CANCER RES, V53, P4066; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobin, 2009, UICC TNM CLASSIFICAT; Sobti RC, 2010, BIOMARKERS, V15, P167, DOI 10.3109/13547500903395124; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Struyf A, 1997, COMPUT STAT DATA AN, V26, P17, DOI 10.1016/S0167-9473(97)00020-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Witkos TM, 2011, CURR MOL MED, V11, P93; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	75	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64543	10.1371/journal.pone.0064543	http://dx.doi.org/10.1371/journal.pone.0064543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717626	Green Submitted, gold, Green Published			2022-12-25	WOS:000319385300017
J	Coleman, MA				Coleman, Melinda A.			Connectivity of the Habitat-Forming Kelp, Ecklonia radiata within and among Estuaries and Open Coast	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION SUBDIVISION; MARINE; DISPERSAL; DIFFERENTIATION; PATTERNS; DISTANCE; FLOW; BIOGEOGRAPHY; AUSTRALIA	With marine protected areas being established worldwide there is a pressing need to understand how the physical setting in which these areas are placed influences patterns of dispersal and connectivity of important marine organisms. This is particularly critical for dynamic and complex nearshore marine environments where patterns of genetic structure of organisms are often chaotic and uncoupled from broad scale physical processes. This study determines the influence of habitat heterogeneity (presence of estuaries) on patterns of genetic structure and connectivity of the common kelp, Ecklonia radiata. There was no genetic differentiation of kelp between estuaries and the open coast and the presence of estuaries did not increase genetic differentiation among open coast populations. Similarly, there were no differences in level of inbreeding or genetic diversity between estuarine and open coast populations. The presence of large estuaries along rocky coastlines does not appear to influence genetic structure of this kelp and factors other than physical heterogeneity of habitat are likely more important determinants of regional connectivity. Marine reserves are currently lacking in this bioregion and may be designated in the future. Knowledge of the factors that influence important habitat forming organisms such as kelp contribute to informed and effective marine protected area design and conservation initiatives to maintain resilience of important marine habitats.	[Coleman, Melinda A.] Univ New S Wales, Ctr Marine BioInnovat, Sydney, NSW, Australia; [Coleman, Melinda A.] New South Wales Fisheries, Dept Primary Ind, Coffs Harbour, NSW, Australia; [Coleman, Melinda A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	University of New South Wales Sydney; NSW Department of Primary Industries; Southern Cross University	Coleman, MA (corresponding author), Univ New S Wales, Ctr Marine BioInnovat, Sydney, NSW, Australia.	melinda.coleman@gmail.com	Coleman, Melinda A/R-5563-2016	Coleman, Melinda A/0000-0003-2623-633X	Australian Research Council [DP0663550]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Discovery Grant (DP0663550, www.arc.gov.au) awarded to Coleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, ECOLOGY, V91, P49, DOI 10.1890/09-0050.1; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; AYVAZIAN SG, 1994, MAR BIOL, V118, P25, DOI 10.1007/BF00699216; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Belkhir K, 2000, GENETIX WINDOWSTM BA; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; Bishop MJ, 2010, OECOLOGIA, V163, P517, DOI 10.1007/s00442-009-1555-y; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Coleman MA, 2009, MAR FRESHWATER RES, V60, P802, DOI 10.1071/MF08268; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Coleman MA, 2007, MAR FRESHWATER RES, V58, P589, DOI 10.1071/MF06216; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cornuet JM, 1999, GENETICS, V153, P1989; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; Dolman G, 2009, CONSERV GENET, V10, P657, DOI 10.1007/s10592-008-9603-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faugeron S, 2001, J PHYCOL, V37, P705, DOI 10.1046/j.1529-8817.2001.01072.x; FISH JD, 1972, J MAR BIOL ASSOC UK, V52, P1011, DOI 10.1017/S0025315400040728; GAINES SD, 1992, NATURE, V360, P579, DOI 10.1038/360579a0; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hurwood DA, 2005, MAR FRESHWATER RES, V56, P1099, DOI 10.1071/MF04261; Irving AD, 2004, MAR BIOL, V144, P361, DOI 10.1007/s00227-003-1202-9; JENNINGS R, 1967, Journal of the Royal Society of Western Australia, V50, P93; Kirkman H, 1997, J APPL PHYCOL, V9, P311, DOI 10.1023/A:1007965506873; KIRKMAN H, 1981, J EXP MAR BIOL ECOL, V55, P243, DOI 10.1016/0022-0981(81)90115-5; Muniz-Salazar R, 2006, MAR ECOL PROG SER, V309, P107, DOI 10.3354/meps309107; Nicastro KR, 2008, MAR ECOL PROG SER, V368, P189, DOI 10.3354/meps07607; Palumbi SR, 2003, ECOL APPL, V13, pS146; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Raimondi PT, 2004, ECOLOGY, V85, P3267, DOI 10.1890/03-0559; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts DG, 2010, MAR ECOL PROG SER, V412, P223, DOI 10.3354/meps08676; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waters JM, 2013, TRENDS ECOL EVOL, V28, P190, DOI 10.1016/j.tree.2013.01.008; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214	48	20	21	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64667	10.1371/journal.pone.0064667	http://dx.doi.org/10.1371/journal.pone.0064667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717648	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600073
J	Duval, BD; Dijkstra, P; Drake, BG; Johnson, DW; Ketterer, ME; Megonigal, JP; Hungate, BA				Duval, Benjamin D.; Dijkstra, Paul; Drake, Bert G.; Johnson, Dale W.; Ketterer, Michael E.; Megonigal, J. Patrick; Hungate, Bruce A.			Element Pool Changes within a Scrub-Oak Ecosystem after 11 Years of Exposure to Elevated CO2	PLOS ONE			English	Article							PROGRESSIVE NITROGEN LIMITATION; ATMOSPHERIC CO2; SOIL CARBON; PHOSPHORUS-AVAILABILITY; ABOVEGROUND BIOMASS; N-FERTILIZATION; PLANT; ENRICHMENT; RESPONSES; FIRE	The effects of elevated CO2 on ecosystem element stocks are equivocal, in part because cumulative effects of CO2 on element pools are difficult to detect. We conducted a complete above and belowground inventory of non-nitrogen macro- and micronutrient stocks in a subtropical woodland exposed to twice-ambient CO2 concentrations for 11 years. We analyzed a suite of nutrient elements and metals important for nutrient cycling in soils to a depth of similar to 2 m, in leaves and stems of the dominant oaks, in fine and coarse roots, and in litter. In conjunction with large biomass stimulation, elevated CO2 increased oak stem stocks of Na, Mg, P, K, V, Zn and Mo, and the aboveground pool of K and S. Elevated CO2 increased root pools of most elements, except Zn. CO2-stimulation of plant Ca was larger than the decline in the extractable Ca pool in soils, whereas for other elements, increased plant uptake matched the decline in the extractable pool in soil. We conclude that elevated CO2 caused a net transfer of a subset of nutrients from soil to plants, suggesting that ecosystems with a positive plant growth response under high CO2 will likely cause mobilization of elements from soil pools to plant biomass.	[Duval, Benjamin D.; Dijkstra, Paul; Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Duval, Benjamin D.; Dijkstra, Paul; Hungate, Bruce A.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Drake, Bert G.; Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Johnson, Dale W.] Univ Nevada, Dept Nat Resources, Reno, NV 89557 USA; [Ketterer, Michael E.] No Arizona Univ, Dept Chem & Biochem, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University; Smithsonian Institution; Smithsonian Environmental Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Northern Arizona University	Duval, BD (corresponding author), USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA.	Benjamin.Duval@ars.usda.gov		Megonigal, Patrick/0000-0002-2018-7883	NSF [DEB-0092642, DEB-0543218]	NSF(National Science Foundation (NSF))	Research was funded by NSF grants DEB-0092642 and DEB-0543218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; BOERNER REJ, 1982, BIOSCIENCE, V32, P187, DOI 10.2307/1308941; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Cheng L, 2010, ECOL LETT, V13, P284, DOI 10.1111/j.1461-0248.2009.01421.x; Cotrufo MF, 2005, GLOBAL CHANGE BIOL, V11, P971, DOI 10.1111/j.1365-2486.2005.00958.x; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Crawley MJ., 2007, R BOOK; Dijkstra P, 2002, GLOBAL CHANGE BIOL, V8, P90, DOI 10.1046/j.1354-1013.2001.00458.x; Duval BD, 2012, PLANT ECOL, V213, P505, DOI 10.1007/s11258-011-9998-8; Duval BD, 2011, ENVIRON SCI TECHNOL, V45, P2570, DOI 10.1021/es102250u; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Hungate BA, 2006, ECOLOGY, V87, P26, DOI 10.1890/04-1732; Johnson DW, 2006, ECOLOGY, V87, P64, DOI 10.1890/04-1781; Johnson DW, 2004, BIOGEOCHEMISTRY, V69, P379, DOI 10.1023/B:BIOG.0000031054.19158.7c; Johnson DW, 2003, ECOL APPL, V13, P1388, DOI 10.1890/02-5139; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Kawano M, 1996, CLAY CLAY MINER, V44, P672, DOI 10.1346/CCMN.1996.0440510; Khan FN, 2008, SOIL BIOL BIOCHEM, V40, P1716, DOI 10.1016/j.soilbio.2008.02.008; Lagomarsino A, 2008, PLANT SOIL, V308, P131, DOI 10.1007/s11104-008-9614-4; Langley JA, 2009, SOIL BIOL BIOCHEM, V41, P54, DOI 10.1016/j.soilbio.2008.09.016; Liu D, 1996, COMMUN SOIL SCI PLAN, V27, P2511, DOI 10.1080/00103629609369720; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Marinari S, 2007, ENVIRON POLLUT, V147, P507, DOI 10.1016/j.envpol.2006.08.041; Natali SM, 2009, ECOSYSTEMS, V12, P715, DOI 10.1007/s10021-009-9251-7; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Oh NH, 2004, GLOBAL CHANGE BIOL, V10, P1936, DOI 10.1111/j.1365-2486.2004.00864.x; Penuelas J, 2001, GLOBAL CHANGE BIOL, V7, P291, DOI 10.1046/j.1365-2486.2001.00409.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Schroeder RE, 2011, THESIS OLD DOMINION; Seiler TJ, 2009, GLOBAL CHANGE BIOL, V15, P356, DOI 10.1111/j.1365-2486.2008.01740.x; Sillen WMA, 2012, BIOGEOSCIENCES, V9, P2247, DOI 10.5194/bg-9-2247-2012; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stover DB, 2007, ECOLOGY, V88, P1328, DOI 10.1890/06-0989; Tang JJ, 2006, ECOL RES, V21, P664, DOI 10.1007/s11284-006-0161-2; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475	41	6	6	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64386	10.1371/journal.pone.0064386	http://dx.doi.org/10.1371/journal.pone.0064386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717607	gold, Green Submitted, Green Published			2022-12-25	WOS:000319435600063
J	Nystrom, A; Buttgereit, J; Bader, M; Shmidt, T; Ozcelik, C; Hausser, I; Bruckner-Tuderman, L; Kern, JS				Nystroem, Alexander; Buttgereit, Jens; Bader, Michael; Shmidt, Tatiana; Oezcelik, Cemil; Hausser, Ingrid; Bruckner-Tuderman, Leena; Kern, Johannes S.			Rat Model for Dominant Dystrophic Epidermolysis Bullosa: Glycine Substitution Reduces Collagen VII Stability and Shows Gene-Dosage Effect	PLOS ONE			English	Article							DISEASE SEVERITY; MMP1 PROMOTER; ANIMAL-MODEL; COL7A1; MUTATIONS; PHENOTYPE; DATABASE; EXON	Dystrophic epidermolysis bullosa, a severely disabling hereditary skin fragility disorder, is caused by mutations in the gene coding for collagen VII, a specialized adhesion component of the dermal-epidermal junction zone. Both recessive and dominant forms are known; the latter account for about 40% of cases. Patients with dominant dystrophic epidermolysis bullosa exhibit a spectrum of symptoms ranging from mild localized to generalized skin manifestations. Individuals with the same mutation can display substantial phenotypic variance, emphasizing the role of modifying genes in this disorder. The etiology of dystrophic epidermolysis bullosa has been known for around two decades; however, important pathogenetic questions such as involvement of modifier genes remain unanswered and a causative therapy has yet to be developed. Much of the failure to make progress in these areas is due to the lack of suitable animal models that capture all aspects of this complex monogenetic disorder. Here, we report the first rat model of dominant dystrophic epidermolysis bullosa. Affected rats carry a spontaneous glycine to aspartic acid substitution, p.G1867D, within the main structural domain of collagen VII. This confers dominant-negative interference of protein folding and decreases the stability of mutant collagen VII molecules and their polymers, the anchoring fibrils. The phenotype comprises fragile and blister-prone skin, scarring and nail dystrophy. The model recapitulates all signs of the human disease with complete penetrance. Homozygous carriers of the mutation are more severely affected than heterozygous ones, demonstrating for the first time a gene-dosage effect of mutated alleles in dystrophic epidermolysis bullosa. This novel viable and workable animal model for dominant dystrophic epidermolysis bullosa will be valuable for addressing molecular disease mechanisms, effects of modifying genes, and development of novel molecular therapies for patients with dominantly transmitted skin disease.	[Nystroem, Alexander; Bruckner-Tuderman, Leena; Kern, Johannes S.] Univ Freiburg, Dept Dermatol, Med Ctr, Freiburg, Germany; [Buttgereit, Jens; Bader, Michael; Shmidt, Tatiana; Oezcelik, Cemil] Max Delbuck Ctr Mol Med MDC, Berlin, Germany; [Buttgereit, Jens; Shmidt, Tatiana; Oezcelik, Cemil] ECRC, Berlin, Germany; [Hausser, Ingrid] Heidelberg Univ, Dept Dermatol, Heidelberg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Freiburg Inst Adv Studies, Sch Life Sci, LifeNet, D-79106 Freiburg, Germany	University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; University of Freiburg	Bruckner-Tuderman, L (corresponding author), Univ Freiburg, Dept Dermatol, Med Ctr, Hauptstr 7, Freiburg, Germany.	bruckner-tuderman@uniklinik-freiburg.de	Bader, Michael/K-2124-2013	Kern, Johannes S/0000-0001-6372-8048; Bader, Michael/0000-0003-4780-4164; Nystrom, Alexander/0000-0002-4666-2240	Excellence Initiative of the German Federal and State Governments (Freiburg Institute for Advanced Studies, FRIAS, School of Life Sciences); German Research Foundation (DFG) [BR 1475/12-1]; Debra International; Federal Ministry for Education and Research [BMBF 01GN0970]; BMBF	Excellence Initiative of the German Federal and State Governments (Freiburg Institute for Advanced Studies, FRIAS, School of Life Sciences); German Research Foundation (DFG)(German Research Foundation (DFG)); Debra International; Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Excellence Initiative of the German Federal and State Governments (Freiburg Institute for Advanced Studies, FRIAS, School of Life Sciences), by grant Nr. BR 1475/12-1 from the German Research Foundation (DFG), by grants from Debra International, and by the stem cell therapy for inherited skin fragility disorders grant from the Federal Ministry for Education and Research (BMBF 01GN0970). AN was supported by a grant from BMBF, under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Bruckner-Tuderman L, 2012, J INVEST DERMATOL, V132, pE2, DOI [10.1038/skinbio.2012.2, DOI 10.1038/SKINBIO.2012.2]; Bruckner-Tuderman Leena, 2010, J Invest Dermatol, V130, P1485, DOI 10.1038/jid.2010.75; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P452, DOI 10.1111/1523-1747.ep12470130; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fine JD, 2010, CURR OPIN PEDIATR, V22, P453, DOI 10.1097/MOP.0b013e32833bb74f; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Fritsch A, 2009, J BIOL CHEM, V284, P30248, DOI 10.1074/jbc.M109.045294; Goto M, 2006, J INVEST DERMATOL, V126, P2614, DOI 10.1038/sj.jid.5700435; Hammami-Hauasli N, 1998, J INVEST DERMATOL, V111, P1214, DOI 10.1046/j.1523-1747.1998.00394.x; Heinonen S, 1999, J CELL SCI, V112, P3641; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Kern JS, 2006, J INVEST DERMATOL, V126, P1006, DOI 10.1038/sj.jid.5700219; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; McGrath JA, 2012, AM J HUM GENET, V91, P1115, DOI 10.1016/j.ajhg.2012.10.012; Medeiros GX, 2013, J COMP PATHOL, V148, P354, DOI 10.1016/j.jcpa.2012.09.002; Menoud A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038823; Nagata M, 1995, BRIT J DERMATOL, V133, P1000, DOI 10.1111/j.1365-2133.1995.tb06942.x; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Oldak M, 2011, J DERMATOL SCI, V61, P64, DOI 10.1016/j.jdermsci.2010.11.002; Olivry T, 1999, VET PATHOL, V36, P616, DOI 10.1354/vp.36-6-616; Palazzi X, 2000, J INVEST DERMATOL, V115, P135, DOI 10.1046/j.1523-1747.2000.00031-5.x; Perez V, 2011, J COMP PATHOL, V145, P226, DOI 10.1016/j.jcpa.2010.12.002; Qin W, 2012, AM PHARM REV, V15; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Titeux M, 2008, HUM MUTAT, V29, P267, DOI 10.1002/humu.20647; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; van den Akker PC, 2011, HUM MUTAT, V32, P1100, DOI 10.1002/humu.21551; Varki R, 2007, J MED GENET, V44, P181, DOI 10.1136/jmg.2006.045302; White S. D., 1993, Veterinary Dermatology, V4, P91, DOI 10.1111/j.1365-3164.1993.tb00197.x	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64243	10.1371/journal.pone.0064243	http://dx.doi.org/10.1371/journal.pone.0064243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717576	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319435600054
J	Hanifi, A; McCarthy, H; Roberts, S; Pleshko, N				Hanifi, Arash; McCarthy, Helen; Roberts, Sally; Pleshko, Nancy			Fourier Transform Infrared Imaging and Infrared Fiber Optic Probe Spectroscopy Identify Collagen Type in Connective Tissues	PLOS ONE			English	Article							CARTILAGE REPAIR TISSUE; ARTICULAR-CARTILAGE; CHONDROCYTE IMPLANTATION; DEGENERATIVE CARTILAGE; BASIC SCIENCE; RABBIT MODEL; TYPES I; PROTEOGLYCAN; SPECIFICITY; DEGRADATION	Hyaline cartilage and mechanically inferior fibrocartilage consisting of mixed collagen types are frequently found together in repairing articular cartilage. The present study seeks to develop methodology to identify collagen type and other tissue components using Fourier transform infrared (FTIR) spectral evaluation of matrix composition in combination with multivariate analyses. FTIR spectra of the primary molecular components of repair cartilage, types I and II collagen, and aggrecan, were used to develop multivariate spectral models for discrimination of the matrix components of the tissues of interest. Infrared imaging data were collected from bovine bone, tendon, normal cartilage, meniscus and human repair cartilage tissues, and composition predicted using partial least squares analyses. Histology and immunohistochemistry results were used as standards for validation. Infrared fiber optic probe spectral data were also obtained from meniscus (a tissue with mixed collagen types) to evaluate the potential of this method for identification of collagen type in a minimally-invasive clinical application. Concentration profiles of the tissue components obtained from multivariate analysis were in excellent agreement with histology and immunohistochemistry results. Bone and tendon showed a uniform distribution of predominantly type I collagen through the tissue. Normal cartilage showed a distribution of type II collagen and proteoglycan similar to the known composition, while in repair cartilage, the spectral distribution of both types I and II collagen were similar to that observed via immunohistochemistry. Using the probe, the outer and inner regions of the meniscus were shown to be primarily composed of type I and II collagen, respectively, in accordance with immunohistochemistry data. In summary, multivariate analysis of infrared spectra can indeed be used to differentiate collagen type I and type II, even in the presence of proteoglycan, in connective tissues, using both imaging and fiber optic methodology. This has great potential for clinical in situ applications for monitoring tissue repair.	[Hanifi, Arash; Pleshko, Nancy] Temple Univ, Dept Bioengn, Tissue Imaging & Spect Lab, Philadelphia, PA 19122 USA; [McCarthy, Helen; Roberts, Sally] Keele Univ, Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry, Shrops, England; [McCarthy, Helen; Roberts, Sally] Keele Univ, ISTM, Oswestry, Shrops, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Keele University; Keele University	Hanifi, A (corresponding author), Temple Univ, Dept Bioengn, Tissue Imaging & Spect Lab, Philadelphia, PA 19122 USA.	a.hanifi@gmail.com; npleshko@temple.edu		roberts, sally/0000-0003-1835-327X; McCarthy, Helen/0000-0001-9534-7565	National Institutes of Health (NIH) [EB000744, AR056145]; Arthritis Research UK [18480, 19429]; Versus Arthritis [18480] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000744] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by National Institutes of Health (NIH) grants EB000744 and AR056145 and by the Arthritis Research UK (grant numbers 18480 and 19429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1995, CHEMOMETRICS ANAL SP; Aptula AO, 2005, QSAR COMB SCI, V24, P385, DOI 10.1002/qsar.200430909; Athanasiou KA, 2001, CLIN SPORT MED, V20, P223, DOI 10.1016/S0278-5919(05)70304-5; Baykal D, 2010, APPL SPECTROSC, V64, P1160, DOI 10.1366/000370210792973604; Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y; Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008; Bi XH, 2007, ANAL BIOANAL CHEM, V387, P1601, DOI 10.1007/s00216-006-0910-7; Bi XH, 2006, BBA-BIOMEMBRANES, V1758, P934, DOI 10.1016/j.bbamem.2006.05.014; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Coleman MD, 2009, VIB SPECTROSC, V51, P177, DOI 10.1016/j.vibspec.2009.04.005; David-Vaudey E, 2005, Eur Cell Mater, V10, P51; DODGE GR, 1989, J CLIN INVEST, V83, P647, DOI 10.1172/JCI113929; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Flatten A, 2005, MEAT SCI, V69, P433, DOI 10.1016/j.meatsci.2004.10.002; Gao JZ, 2000, KNEE SURG SPORT TR A, V8, P61, DOI 10.1007/s001670050013; GELADI P, 1989, CHEMOMETR INTELL LAB, V5, P209, DOI 10.1016/0169-7439(89)80049-8; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; HANIFI A, 2012, OSTEOARTHRI IN PRESS; Hanifi A, 2012, AM J SPORT MED, V40, P2853, DOI 10.1177/0363546512462009; Hassani S, 2010, CHEMOMETR INTELL LAB, V104, P140, DOI 10.1016/j.chemolab.2010.08.008; Hoemann CD, 2004, METH MOLEC MED, V101, P127; Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787; Hollander Anthony P, 2003, Novartis Found Symp, V249, P218; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; Jensen HE, 1997, J PATHOL, V181, P100, DOI 10.1002/(SICI)1096-9896(199701)181:1&lt;100::AID-PATH100&gt;3.0.CO;2-O; Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009; Jiang EY, 2006, J MOL STRUCT, V799, P196, DOI 10.1016/j.molstruc.2006.03.069; Kim M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922329; Kim MY, 2011, J CLIN GASTROENTEROL, V45, P330, DOI 10.1097/MCG.0b013e318206474e; Kim M, 2010, TISSUE ENG PART C-ME, V16, P355, DOI [10.1089/ten.tec.2009.0020, 10.1089/ten.TEC.2009.0020]; Kobrina Y, 2012, OSTEOARTHR CARTILAGE, V20, P460, DOI 10.1016/j.joca.2012.01.014; KRAFFT C, 2012, VIBRATIONAL SPECTROS; Le Graverand MPH, 2001, OSTEOARTHR CARTILAGE, V9, P65, DOI 10.1053/joca.2000.0351; Li GY, 2005, APPL SPECTROSC, V59, P1527, DOI 10.1366/000370205775142593; MATOS LL, BIOMARK INSIGHTS, V5, P9; Nakamura N, 2009, ARTHROSCOPY, V25, P531, DOI 10.1016/j.arthro.2009.02.007; Pataridis S, 2008, J SEP SCI, V31, P3483, DOI 10.1002/jssc.200800351; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO;2-E; Rieppo J, 2009, OSTEOARTHR CARTILAGE, V17, P448, DOI 10.1016/j.joca.2008.09.004; RIEPPO JRL, 2007, T ORTHOP RES SOC, V32, P666; Rieppo L, 2012, OSTEOARTHR CARTILAGE, V20, P451, DOI 10.1016/j.joca.2012.01.010; Rieppo L, 2010, MICROSC RES TECHNIQ, V73, P503, DOI 10.1002/jemt.20789; Rieppo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032344; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Roberts S, 2001, ARTHRITIS RHEUM-US, V44, P2586, DOI 10.1002/1529-0131(200111)44:11<2586::AID-ART439>3.0.CO;2-I; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095; West PA, 2004, APPL SPECTROSC, V58, P376, DOI 10.1366/000370204773580194; Westad F, 2002, MULTIVARIATE DATA AN; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yin JH, 2012, SPECTROCHIM ACTA A, V88, P90, DOI 10.1016/j.saa.2011.12.002	55	43	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64822	10.1371/journal.pone.0064822	http://dx.doi.org/10.1371/journal.pone.0064822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717662	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000320362700173
J	Lin, CY; Chen, TC; Lu, PL; Lai, CC; Yang, YH; Lin, WR; Huang, PM; Chen, YH				Lin, Chun-Yu; Chen, Tun-Chieh; Lu, Po-Liang; Lai, Chung-Chih; Yang, Yi-Hsin; Lin, Wei-Ru; Huang, Pei-Ming; Chen, Yen-Hsu			Effects of Gender and Age on Development of Concurrent Extrapulmonary Tuberculosis in Patients with Pulmonary Tuberculosis: A Population Based Study	PLOS ONE			English	Article							SEX-DIFFERENCES; MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY	Most cases of adult-onset tuberculosis (TB) result from reactivation of a pre-existing Mycobacterium tuberculosis infection. Mycobacterium tuberculosis usually invades the respiratory tract and most patients develop intrapulmonary TB; however, some patients develop concurrent pulmonary and extra-pulmonary TB. The purpose of the present study was to identify the demographic and clinical factors associated with an increased risk of concurrent extra-pulmonary diseases in patients with pulmonary TB. We compared patients who had isolated pulmonary TB with patients who had concurrent pulmonary and extra-pulmonary TB. We initially analyzed one-million randomly selected subjects from the population-based Taiwan National Health Insurance database. Based on analysis of 5414 pulmonary TB patients in this database, women were more likely than men to have concurrent extra-pulmonary TB (OR: 1.30, p = 0.013). A separate analysis of the Kaohsiung Medical University Hospital database, which relied on sputum culture-proven pulmonary TB, indicated that women were more likely than men to have concurrent extra-pulmonary TB (OR: 1.62, p = 0.039). There was no significant gender difference in extra-pulmonary TB for patients younger than 45 years in either database. However, for patients 45 years and older, women were more likely than men to have concurrent extra-pulmonary TB (insurance database: 9.0% vs. 6.8%, p = 0.016, OR: 1.36; hospital database: 27.3% vs. 16.0%, p = 0.008, OR = 1.98). Our results indicate that among patients who have pulmonary TB, older females have an increased risk for concurrent extra-pulmonary TB.	[Lin, Chun-Yu; Chen, Tun-Chieh; Lu, Po-Liang; Lai, Chung-Chih; Lin, Wei-Ru; Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lin, Chun-Yu; Chen, Tun-Chieh; Lu, Po-Liang; Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Coll Med, Trop Med Res Ctr, Grad Inst Med, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ Hosp, Dept Med Res, Div Stat Anal, Kaohsiung, Taiwan; [Huang, Pei-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Chest Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, YH (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.	d810070@cc.kmu.edu.tw	Lai, Chung-chih/L-5775-2013; Chen, Tun-Chieh/J-2877-2013; Lu, Po-Liang/D-4499-2009; Yang, Yi-Hsin/D-6471-2012	Lai, Chung-chih/0000-0003-4422-1596; Chen, Tun-Chieh/0000-0002-9258-0692; Lu, Po-Liang/0000-0002-7423-6783; Yang, Yi-Hsin/0000-0002-9581-2778; Chen, Yen-hsu/0000-0002-8667-4844	Kaohsiung Medical University Hospital [KMUH100-7G17]	Kaohsiung Medical University Hospital	This study was supported by a grant from the Kaohsiung Medical University Hospital (KMUH100-7G17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V. K., 2006, Indian Journal of Tuberculosis, V53, P77; Bureau of Health Promotion, 2010, TAIW TOB CONTR ANN R; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Centers for Disease Control Department of Health, 2012, TAIW HIV AIDS STAT M; Centers for Disease Control Department of Health, 2009, TAIW TUB CONTR REP 2; Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P11; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; du Plessis DG, 2001, TUBERCULOSIS EDINB, V81, P211; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Kaufmann SHE, 2008, NATURE, V453, P295, DOI 10.1038/453295a; Kipp Aaron M, 2008, BMC Public Health, V8, P107, DOI 10.1186/1471-2458-8-107; Kok HS, 2005, HUM REPROD UPDATE, V11, P483, DOI 10.1093/humupd/dmi024; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Lee CH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0037978; Lin CY, 2010, J FORMOS MED ASSOC, V109, P269, DOI 10.1016/S0929-6646(10)60052-6; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Lourenco MCS, 2000, TROP MED INT HEALTH, V5, P488, DOI 10.1046/j.1365-3156.2000.00583.x; Martinez AN, 2000, INT J TUBERC LUNG D, V4, P26; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Razanamparany VR, 2002, J CLIN MICROBIOL, V40, P3964, DOI 10.1128/JCM.40.11.3964-3969.2002; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; Rock RB, 2006, EMERG INFECT DIS, V12, P1434, DOI 10.3201/eid1209.050295; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Taiwan Centers for Disease Control, 2022, TAIWAN GUIDELINES TB, V7th; Torgersen J, 2006, CLIN INFECT DIS, V42, P1375, DOI 10.1086/503421; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang XY, 2011, AM J TROP MED HYG, V85, P285, DOI 10.4269/ajtmh.2011.10-0630	35	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63936	10.1371/journal.pone.0063936	http://dx.doi.org/10.1371/journal.pone.0063936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717513	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700082
J	Kennedy, CL; Najdovska, M; Tye, H; McLeod, L; Yu, L; Jarnicki, A; Bhathal, PS; Putoczki, T; Ernst, M; Jenkins, BJ				Kennedy, C. L.; Najdovska, M.; Tye, H.; McLeod, L.; Yu, L.; Jarnicki, A.; Bhathal, P. S.; Putoczki, T.; Ernst, M.; Jenkins, B. J.			Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis	ONCOGENE			English	Article						gastric cancer; TLR2; MyD88; Mal/TIRAP	INNATE IMMUNITY; HELICOBACTER-PYLORI; MUTANT MICE; INFLAMMATION; CANCER; STAT3; TLR2; ACTIVATION; SUSCEPTIBILITY; POLYMORPHISM	Signalling by the toll-like receptor (TLR) family of pathogen recognition receptors has emerged as a key molecular component in the pathogenesis of an increasing number of inflammatory-related cancers, among which gastric cancer rates as the second most lethal cancer world-wide. The myeloid differentiation factor 88 (MyD88) adapter molecule has a critical role in mediating innate immune signalling by members of the TLR and interleukin (IL)-1 families, and has been associated with either pro-or antitumourigenic responses in various cancer models. However, little is known about the in vivo role of MyD88 adapter-like (Mal)/TIR-domain containing adapter protein (TIRAP), which is restricted to facilitating TLR4 and TLR2 signalling. To interrogate the role of these innate immune signalling components in gastric tumourigenesis, here we have employed the spontaneous gastric cancer gp130(F/F) mouse model, in which TLR2 promotes the growth of gastric tumours. Genetic ablation of Myd88 in gp130(F/F) mice suppressed tumourigenesis and was associated with increased apoptosis and reduced proliferation in the gastric tumour epithelium, comparable to that observed previously upon deletion of Tlr2 in gp130(F/F) mice. By contrast, the tumour burden in gp130(F/F):Mal(-/-) mice was equivalent to their gp130F/F littermates. At the molecular level, suppressed tumourigenesis in gp130(F/F):Myd88(-/-) mice correlated with reduced expression and activation of TLR2-regulated protumourigenic genes and signalling pathways, respectively. Consistent with the previously defined non-essential role for TLR2 in gastric tumour inflammation, the extent of inflammatory cell infiltrates in gastric tumours from gp130(F/F):Mal(-/-) and gp130(F/F):Myd88(-/-) mice remained unaltered compared with gp130(F/F) mice. Collectively, our data reveal a differential, but inflammation-independent, requirement for Mal and MyD88 during TLR2-promoted gastric tumourigenesis.	[Kennedy, C. L.; Najdovska, M.; Tye, H.; McLeod, L.; Yu, L.; Jenkins, B. J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Jarnicki, A.; Putoczki, T.; Ernst, M.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Bhathal, P. S.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Monash University; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne	Jenkins, BJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	Brendan.Jenkins@monash.edu	Ernst, Matthias/D-5111-2012	Ernst, Matthias/0000-0002-6399-1177; Kennedy, Catherine/0000-0001-6359-6161; Jenkins, Brendan/0000-0002-7552-4656	Association for International Cancer Research (UK); Cancer Council of Victoria (Australia); National Health and Medical Research Council (Australia); Victorian Government of Australia; Sylvia and Charles Viertel Foundation	Association for International Cancer Research (UK); Cancer Council of Victoria (Australia)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government of Australia; Sylvia and Charles Viertel Foundation	This study was supported by research grants from the Association for International Cancer Research (UK), the Cancer Council of Victoria (Australia) and the National Health and Medical Research Council (Australia), as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. BJ Jenkins is supported by a Senior Medical Research Fellowship awarded by the Sylvia and Charles Viertel Foundation.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hoebe K, 2006, ADV IMMUNOL, V91, P175, DOI 10.1016/S0065-2776(06)91005-0; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hutchinson E, 2012, NAT REV IMMUNOL, V12, P681, DOI 10.1038/nri3304; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kennedy CL, 2011, J PATHOL, V225, P255, DOI 10.1002/path.2933; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schiechl G, 2011, J CLIN INVEST, V121, P1692, DOI 10.1172/JCI42540; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	29	31	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2540	2546		10.1038/onc.2013.205	http://dx.doi.org/10.1038/onc.2013.205			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23728346				2022-12-25	WOS:000336033600014
J	Tashiro, E; Zako, T; Muto, H; Itoo, Y; Sorgjerd, K; Terada, N; Abe, A; Miyazawa, M; Kitamura, A; Kitaura, H; Kubota, H; Maeda, M; Momoi, T; Iguchi-Ariga, SMM; Kinjo, M; Ariga, H				Tashiro, Erika; Zako, Tamotsu; Muto, Hideki; Itoo, Yoshinori; Soergjerd, Karin; Terada, Naofumi; Abe, Akira; Miyazawa, Makoto; Kitamura, Akira; Kitaura, Hirotake; Kubota, Hiroshi; Maeda, Mizuo; Momoi, Takashi; Iguchi-Ariga, Sanae M. M.; Kinjo, Masataka; Ariga, Hiroyoshi			Prefoldin Protects Neuronal Cells from Polyglutamine Toxicity by Preventing Aggregation Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; MYC-BINDING PROTEIN; INTRANUCLEAR INCLUSIONS; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; C-MYC; HUNTINGTONS-DISEASE; EXPANSION PROTEINS; MUTANT HUNTINGTIN; UNFOLDED PROTEINS	Huntington disease is caused by cell death after the expansion of polyglutamine (polyQ) tracts longer than similar to 40 repeats encoded by exon 1 of the huntingtin (HTT) gene. Prefoldin is a molecular chaperone composed of six subunits, PFD1-6, and prevents misfolding of newly synthesized nascent polypeptides. In this study, we found that knockdown of PFD2 and PFD5 disrupted prefoldin formation in HTT-expressing cells, resulting in accumulation of aggregates of a pathogenic form of HTT and in induction of cell death. Dead cells, however, did not contain inclusions of HTT, and analysis by a fluorescence correlation spectroscopy indicated that knockdown of PFD2 and PFD5 also increased the size of soluble oligomers of pathogenic HTT in cells. In vitro single molecule observation demonstrated that prefoldin suppressed HTT aggregation at the small oligomer (dimer to tetramer) stage. These results indicate that prefoldin inhibits elongation of large oligomers of pathogenic Htt, thereby inhibiting subsequent inclusion formation, and suggest that soluble oligomers of polyQ-expanded HTT are more toxic than are inclusion to cells.	[Tashiro, Erika; Abe, Akira; Miyazawa, Makoto; Kitaura, Hirotake; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Tashiro, Erika; Abe, Akira; Miyazawa, Makoto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Zako, Tamotsu; Itoo, Yoshinori; Soergjerd, Karin; Maeda, Mizuo] Riken Inst Phys & Chem Res, Bioengn Lab, Wako, Saitama 3510198, Japan; [Muto, Hideki; Terada, Naofumi; Kitamura, Akira; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido 0010021, Japan; [Itoo, Yoshinori] Univ Tokyo, Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kubota, Hiroshi] Akita Univ, Grad Sch, Akita 0108502, Japan; [Kubota, Hiroshi] Akita Univ, Fac Engn & Resource Sci, Akita 0108502, Japan; [Momoi, Takashi] Int Univ Hlth & Welf, Med Res Ctr, Otawara, Tochigi 3240011, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; RIKEN; Hokkaido University; University of Tokyo; Akita University; Akita University; International University of Health & Welfare; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maeda, Mizuo/I-3498-2014; Zako, Tamotsu/C-3004-2012; Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369	Ministry of Education, Culture, Sports, Science and Technology; New Energy and Industrial Technology Development Organization; RIKEN; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [24570143] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); RIKEN; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, New Energy and Industrial Technology Development Organization, RIKEN, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dong GF, 2012, J BIOL CHEM, V287, P1279, DOI 10.1074/jbc.M111.294280; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; GELL C, 2006, HDB SINGLE MOL FLUOR; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lee Y, 2011, J BIOL CHEM, V286, P726, DOI 10.1074/jbc.M110.177352; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tang B, 2011, NEUROBIOL DIS, V42, P459, DOI 10.1016/j.nbd.2011.02.008; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zako T, 2005, FEBS LETT, V579, P3718, DOI 10.1016/j.febslet.2005.05.061; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	56	36	38	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19958	19972		10.1074/jbc.M113.477984	http://dx.doi.org/10.1074/jbc.M113.477984			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720755	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000321515800061
J	Bissonette, GB; Burton, AC; Gentry, RN; Goldstein, BL; Hearn, TN; Barnett, BR; Kashtelyan, V; Roesch, MR				Bissonette, Gregory B.; Burton, Amanda C.; Gentry, Ronny N.; Goldstein, Brandon L.; Hearn, Taylor N.; Barnett, Brian R.; Kashtelyan, Vadim; Roesch, Matthew R.			Separate Populations of Neurons in Ventral Striatum Encode Value and Motivation	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; NUCLEUS-ACCUMBENS CORE; ANTERIOR CINGULATE CORTEX; DECISION-MAKING; PREDICTION ERRORS; BASOLATERAL AMYGDALA; REWARD PREDICTION; PREFRONTAL CORTEX; PRIMATE STRIATUM; PREMOTOR CORTEX	Neurons in the ventral striatum (VS) fire to cues that predict differently valued rewards. It is unclear whether this activity represents the value associated with the expected reward or the level of motivation induced by reward anticipation. To distinguish between the two, we trained rats on a task in which we varied value independently from motivation by manipulating the size of the reward expected on correct trials and the threat of punishment expected upon errors. We found that separate populations of neurons in VS encode expected value and motivation.	[Bissonette, Gregory B.; Burton, Amanda C.; Gentry, Ronny N.; Goldstein, Brandon L.; Hearn, Taylor N.; Barnett, Brian R.; Kashtelyan, Vadim; Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Burton, Amanda C.; Gentry, Ronny N.; Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Bissonette, GB (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	bissonette@gmail.com; mroesch@umd.edu	Goldstein, Brandon/AAA-5649-2020	Bissonette, Gregory/0000-0003-4478-652X	National Institute on Drug Abuse [R01DA031695]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031695] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (R01DA031695, MRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Barto A. G., 1995, ADAPTIVE CRITICS BAS; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Blokland A, 1998, NEUROSCI BIOBEHAV R, V22, P847, DOI 10.1016/S0149-7634(98)00013-X; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bryden DW, 2011, J NEUROSCI, V31, P18266, DOI 10.1523/JNEUROSCI.4715-11.2011; Bryden DW, 2011, EUR J NEUROSCI, V33, P2308, DOI 10.1111/j.1460-9568.2011.07705.x; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardinal RN, 2002, BEHAV NEUROSCI, V116, P553, DOI 10.1037/0735-7044.116.4.553; CARELLI RM, 1994, J NEUROSCI, V14, P7735; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Day JJ, 2011, EUR J NEUROSCI, V33, P308, DOI 10.1111/j.1460-9568.2010.07531.x; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Ghods-Sharifi S, 2010, BEHAV NEUROSCI, V124, P179, DOI 10.1037/a0018932; Giertler C, 2003, EUR J NEUROSCI, V18, P1993, DOI 10.1046/j.1460-9568.2003.02904.x; Goldstein BL, 2012, J NEUROSCI, V32, P2027, DOI 10.1523/JNEUROSCI.5349-11.2012; Gruber AJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00050; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Houk J. C., 1995, MODEL BASAL GANGLIA; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Janak PH, 2004, BEHAV BRAIN RES, V154, P125, DOI 10.1016/j.bbr.2004.02.003; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Kalenscher T, 2010, J NEUROPHYSIOL, V103, P1658, DOI 10.1152/jn.00432.2009; Kashtelyan V, 2012, EUR J NEUROSCI, V35, P952, DOI 10.1111/j.1460-9568.2012.08022.x; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kimchi EY, 2009, J NEUROSCI, V29, P14891, DOI 10.1523/JNEUROSCI.4060-09.2009; Lansink CS, 2010, EUR J NEUROSCI, V32, P494, DOI 10.1111/j.1460-9568.2010.07293.x; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nakamura K, 2012, J NEUROSCI, V32, P15963, DOI 10.1523/JNEUROSCI.1518-12.2012; Nicola SM, 2004, J NEUROPHYSIOL, V91, P1840, DOI 10.1152/jn.00657.2003; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pessoa L, 2010, FRONT NEUROSCI, V4, P17; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robinson DL, 2008, EUR J NEUROSCI, V28, P1887, DOI 10.1111/j.1460-9568.2008.06464.x; Roesch MR, 2007, ANN NY ACAD SCI, V1121, P431, DOI 10.1196/annals.1401.004; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Roesch MR, 2010, J NEUROPHYSIOL, V104, P587, DOI 10.1152/jn.00173.2010; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Roesch MR, 2009, J NEUROSCI, V29, P13365, DOI 10.1523/JNEUROSCI.2572-09.2009; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Shidara M, 2004, NEUROSCI RES, V49, P307, DOI 10.1016/j.neures.2004.03.008; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stopper CM, 2011, COGN AFFECT BEHAV NE, V11, P97, DOI 10.3758/s13415-010-0015-9; Sutton RaB AG, 1998, REINFORCEMENT LEARNI; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; TAIRA M, 1993, NEUROSCI RES, V17, P39, DOI 10.1016/0168-0102(93)90027-N; Takahashi Y, 2008, FRONT NEUROSCI-SWITZ, V2, P86, DOI 10.3389/neuro.01.014.2008; Tye KM, 2010, J NEUROSCI, V30, P116, DOI 10.1523/JNEUROSCI.4240-09.2010; van der Meer MAA, 2011, CURR OPIN NEUROBIOL, V21, P387, DOI 10.1016/j.conb.2011.02.011; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; WADENBERG ML, 1990, BIOL PSYCHIAT, V28, P297, DOI 10.1016/0006-3223(90)90657-N; Wakabayashi KT, 2004, BEHAV BRAIN RES, V154, P19, DOI 10.1016/j.bbr.2004.01.013; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	87	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64673	10.1371/journal.pone.0064673	http://dx.doi.org/10.1371/journal.pone.0064673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724077	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000078
J	Li, YJ; Li, ZM; Xia, Y; Huang, JJ; Huang, HQ; Xia, ZJ; Lin, TY; Li, S; Cai, XY; Wu-Xiao, ZJ; Jiang, WQ				Li, Ya-Jun; Li, Zhi-Ming; Xia, Yi; Huang, Jia-Jia; Huang, Hui-Qiang; Xia, Zhong-Jun; Lin, Tong-Yu; Li, Su; Cai, Xiu-Yu; Wu-Xiao, Zhi-Jun; Jiang, Wen-Qi			Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type	PLOS ONE			English	Article							PERIPHERAL T-CELL; INFLAMMATION; INTERLEUKIN-6; SURVIVAL; LEVEL; RECEPTORS; MORTALITY; INDICATOR; ELEVATION; MARKER	Background: C-reactive protein (CRP) is a biomarker of the inflammatory response, and it shows significant prognostic value for several types of solid tumors. The prognostic significance of CRP for lymphoma has not been fully examined. We evaluated the prognostic role of baseline serum CRP levels in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL). Methods: We retrospectively analyzed 185 patients with newly diagnosed ENKTL. The prognostic value of the serum CRP level was evaluated for the low-CRP group (CRP <= 10 mg/L) versus the high-CRP group (CRP>10 mg/L). The prognostic value of the International Prognostic Index (IPI) and the Korean Prognostic Index (KPI) were evaluated and compared with the newly developed prognostic model. Results: Patients in the high-CRP group tended to display increased adverse clinical characteristics, lower rates of complete remission (P<0.001), inferior progression-free survival (PFS, P = 0.001), and inferior overall survival (OS, P<0.001). Multivariate analysis demonstrated that elevated serum CRP levels, age >60 years, hypoalbuminemia, and elevated lactate dehydrogenase levels were independent adverse predictors of OS. Based on these four independent predictors, we constructed a new prognostic model that identified 4 groups with varying OS: group 1, no adverse factors; group 2, 1 factor; group 3, 2 factors; and group 4, 3 or 4 factors (P<0.001). The novel prognostic model was found to be superior to both the IPI in discriminating patients with different outcomes in the IPI low-risk group and the KPI in distinguishing between the low-and intermediate-low-risk groups, the intermediate-low- and high-intermediate-risk groups, and the high-intermediate-and high-risk groups. Conclusions: Our results suggest that pretreatment serum CRP levels represent an independent predictor of clinical outcome for patients with ENKTL. The prognostic value of the new prognostic model is superior to both IPI and KPI.	[Li, Ya-Jun; Li, Zhi-Ming; Xia, Yi; Huang, Jia-Jia; Huang, Hui-Qiang; Xia, Zhong-Jun; Lin, Tong-Yu; Li, Su; Cai, Xiu-Yu; Wu-Xiao, Zhi-Jun; Jiang, Wen-Qi] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Li, Ya-Jun; Li, Zhi-Ming; Xia, Yi; Huang, Jia-Jia; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Su; Cai, Xiu-Yu; Wu-Xiao, Zhi-Jun; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Zhong-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Jiang, WQ (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	wqjiang@yahoo.com	jiang, wen/GYI-9662-2022		National Natural Scientific Research Fund of China [30400589, 81071950]; Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period of China [2008ZX09312-002]; National University Outstanding Young Teacher Supporting Program in Sun Yat-Sen University; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen University Cancer Center	National Natural Scientific Research Fund of China; Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period of China; National University Outstanding Young Teacher Supporting Program in Sun Yat-Sen University; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen University Cancer Center	This work was supported by National Natural Scientific Research Fund of China (30400589 and 81071950), Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period of China (2008ZX09312-002), National University Outstanding Young Teacher Supporting Program in Sun Yat-Sen University, and the Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen University Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003251; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Chim CS, 2004, BLOOD, V103, P216, DOI 10.1182/blood-2003-05-1401; Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Delongui F, 2013, J CLIN LAB ANAL; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Groblewska M, 2012, CLIN CHIM ACTA, V413, P1583, DOI 10.1016/j.cca.2012.05.009; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Herishanu Y, 2007, EUR J HAEMATOL, V79, P150, DOI 10.1111/j.1600-0609.2007.00894.x; Huang HH, 2012, EXP THER MED, V4, P473, DOI 10.3892/etm.2012.607; Huang JJ, 2011, ANN ONCOL, V22, P149, DOI 10.1093/annonc/mdq314; Ito K, 2006, INT J UROL, V13, P1365, DOI 10.1111/j.1442-2042.2006.01563.x; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kim SJ, 2007, ANN ONCOL, V18, P1382, DOI 10.1093/annonc/mdm183; Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Lee J, 2005, EUR J CANCER, V41, P1402, DOI 10.1016/j.ejca.2005.03.010; Legouffe E, 1998, LEUKEMIA LYMPHOMA, V31, P351, DOI 10.3109/10428199809059228; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-5; O'Dowd C, 2010, J THORAC ONCOL, V5, P988, DOI 10.1097/JTO.0b013e3181da78f9; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Pieroni L, 2003, DIABETES METAB, V29, P133, DOI 10.1016/S1262-3636(07)70019-8; Pitsavos C, 2003, AM J CARDIOL, V91, P368, DOI 10.1016/S0002-9149(02)03175-2; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Swerdlow E., 2008, WHO CLASSIFICATION T; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wieland A, 2003, MED PEDIATR ONCOL, V41, P21, DOI 10.1002/mpo.10286; Yang J, 2007, CANCER CELL, V12, P252, DOI 10.1016/j.ccr.2007.08.008; You JY, 2004, ANN ONCOL, V15, P618, DOI 10.1093/annonc/mdh143; Zacho J, 2010, EUR HEART J, V31, P1624, DOI 10.1093/eurheartj/ehq103	39	13	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64158	10.1371/journal.pone.0064158	http://dx.doi.org/10.1371/journal.pone.0064158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724031	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000046
J	Pavan, FR; Poelhsitz, GV; da Cunha, LVP; Barbosa, MIF; Leite, SRA; Batista, AA; Cho, SH; Franzblau, SG; de Camargo, MS; Resende, FA; Varanda, EA; Leite, CQF				Pavan, Fernando R.; Poelhsitz, Gustavo V.; da Cunha, Lucas V. P.; Barbosa, Marilia I. F.; Leite, Sergio R. A.; Batista, Alzir A.; Cho, Sang H.; Franzblau, Scott G.; de Camargo, Mariana S.; Resende, Flavia A.; Varanda, Eliana A.; Leite, Clarice Q. F.			In Vitro and In Vivo Activities of Ruthenium(II) Phosphine/Diimine/Picolinate Complexes (SCAR) against Mycobacterium tuberculosis	PLOS ONE			English	Article							DRUG-RESISTANCE; ASSAY; LIGAND; MODEL	Rifampicin, discovered more than 50 years ago, represents the last novel class of antibiotics introduced for the first-line treatment of tuberculosis. Drugs in this class form part of a 6-month regimen that is ineffective against MDR and XDR TB, and incompatible with many antiretroviral drugs. Investments in R&D strategies have increased substantially in the last decades. However, the number of new drugs approved by drug regulatory agencies worldwide does not increase correspondingly. Ruthenium complexes (SCAR) have been tested in our laboratory and showed promising activity against Mycobacterium tuberculosis. These complexes showed up to 150 times higher activity against MTB than its organic molecule without the metal (free ligand), with low cytotoxicity and high selectivity. In this study, promising results inspired us to seek a better understanding of the biological activity of these complexes. The in vitro biological results obtained with the SCAR compounds were extremely promising, comparable to or better than those for first-line drugs and drugs in development. Moreover, SCAR 1 and 4, which presented low acute toxicity, were assessed by Ames test, and results demonstrated absence of mutagenicity.	[Pavan, Fernando R.; de Camargo, Mariana S.; Resende, Flavia A.; Varanda, Eliana A.; Leite, Clarice Q. F.] Univ Estadual Paulista, Coll Pharm, Dept Biol Sci, Araraquara, SP, Brazil; [Poelhsitz, Gustavo V.] Univ Fed Uberlandia, Inst Chem, BR-38400 Uberlandia, MG, Brazil; [da Cunha, Lucas V. P.; Barbosa, Marilia I. F.; Batista, Alzir A.; Cho, Sang H.] Univ Fed Sao Carlos, Dept Chem, BR-13560 Sao Carlos, SP, Brazil; [Leite, Sergio R. A.] Univ Estadual Paulista, Inst Chem, Araraquara, SP, Brazil; [Franzblau, Scott G.] Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL USA	Universidade Estadual Paulista; Universidade Federal de Uberlandia; Universidade Federal de Sao Carlos; Universidade Estadual Paulista; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Pavan, FR (corresponding author), Univ Estadual Paulista, Coll Pharm, Dept Biol Sci, Araraquara, SP, Brazil.	fernandopavan@fcfar.unesp.br	Camargo, Mariana/A-9928-2015; Fernandes, Guilherme/HHT-1055-2022; Barbosa, Marília/G-7816-2018; Batista, Alzir A./C-3492-2012; Resende, Flávia/P-1580-2019; Barbosa, Marília/AAA-2862-2020; Resende, Flávia Aparecida/J-4686-2012; Von Poelhsitz, Gustavo/A-3668-2013; Pavan, Fernando Rogério/F-6046-2010	Camargo, Mariana/0000-0002-3791-4725; Barbosa, Marília/0000-0001-9875-545X; Resende, Flávia/0000-0002-9432-5919; Barbosa, Marília/0000-0001-9875-545X; Resende, Flávia Aparecida/0000-0002-9432-5919; Von Poelhsitz, Gustavo/0000-0003-1329-2260; Pavan, Fernando Rogério/0000-0002-6969-3963; Franzblau, Scott/0000-0002-8698-0243; CHO, SANG HYUN/0000-0003-0926-6246	CNPq; PROEX; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11593-7, 2009/06499-1]; CYTED-RIIDFCM	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEX; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CYTED-RIIDFCM	This study was supported by CNPq, PROEX and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) ref. Process: 2011/11593-7 and 2009/06499-1 and CYTED-RIIDFCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TUBERCULOSIS, V88, P85; BERNERSPRICE SJ, 1987, J INORG BIOCHEM, V31, P197, DOI 10.1016/0162-0134(87)80005-3; BERNSTEIN L, 1982, MUTAT RES, V97, P267, DOI 10.1016/0165-1161(82)90026-7; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; do Nascimento FB, 2008, J INORG BIOCHEM, V102, P1783, DOI 10.1016/j.jinorgbio.2008.05.009; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Hunter JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002237; Isenberg H.D., 1992, AM SOC MICROBIOL, V1, P5; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Luna-Herrera J, 2007, J ANTIMICROB CHEMOTH, V59, P548, DOI 10.1093/jac/dkl523; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Miyata M, 2011, BIOMED PHARMACOTHER, V65, P456, DOI 10.1016/j.biopha.2011.04.021; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pavan FR, 2011, EUR J MED CHEM, V46, P5099, DOI 10.1016/j.ejmech.2011.08.023; Pavan FR, 2010, EUR J MED CHEM, V45, P598, DOI 10.1016/j.ejmech.2009.10.049; Pavan FR, 2011, MYCOBACTERIUM TUBERC; Queiroz SL, 1998, INORG CHIM ACTA, V267, P209, DOI 10.1016/S0020-1693(97)05615-6; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sala C, 2010, ANTIMICROB AGENTS CH, V54, P4150, DOI 10.1128/AAC.00821-10; Santos FV, 2006, FOOD CHEM TOXICOL, V44, P1585, DOI 10.1016/j.fct.2006.03.012; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446	34	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64242	10.1371/journal.pone.0064242	http://dx.doi.org/10.1371/journal.pone.0064242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724039	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000051
J	He, Y; Peterson, BW; Jongsma, MA; Ren, YJ; Sharma, PK; Busscher, HJ; van der Mei, HC				He, Yan; Peterson, Brandon W.; Jongsma, Marije A.; Ren, Yijin; Sharma, Prashant K.; Busscher, Henk J.; van der Mei, Henny C.			Stress Relaxation Analysis Facilitates a Quantitative Approach towards Antimicrobial Penetration into Biofilms	PLOS ONE			English	Article							BACTERIAL BIOFILMS; PSEUDOMONAS-AERUGINOSA; VIABILITY; CHLORHEXIDINE; HYDRODYNAMICS; ADHESION; VITALITY; MODEL	Biofilm-related infections can develop everywhere in the human body and are rarely cleared by the host immune system. Moreover, biofilms are often tolerant to antimicrobials, due to a combination of inherent properties of bacteria in their adhering, biofilm mode of growth and poor physical penetration of antimicrobials through biofilms. Current understanding of biofilm recalcitrance toward antimicrobial penetration is based on qualitative descriptions of biofilms. Here we hypothesize that stress relaxation of biofilms will relate with antimicrobial penetration. Stress relaxation analysis of single-species oral biofilms grown in vitro identified a fast, intermediate and slow response to an induced deformation, corresponding with outflow of water and extracellular polymeric substances, and bacterial re-arrangement, respectively. Penetration of chlorhexidine into these biofilms increased with increasing relative importance of the slow and decreasing importance of the fast relaxation element. Involvement of slow relaxation elements suggests that biofilm structures allowing extensive bacterial re-arrangement after deformation are more open, allowing better antimicrobial penetration. Involvement of fast relaxation elements suggests that water dilutes the antimicrobial upon penetration to an ineffective concentration in deeper layers of the biofilm. Next, we collected biofilms formed in intra-oral collection devices bonded to the buccal surfaces of the maxillary first molars of human volunteers. Ex situ chlorhexidine penetration into two weeks old in vivo formed biofilms followed a similar dependence on the importance of the fast and slow relaxation elements as observed for in vitro formed biofilms. This study demonstrates that biofilm properties can be derived that quantitatively explain antimicrobial penetration into a biofilm.	[He, Yan; Peterson, Brandon W.; Sharma, Prashant K.; Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [He, Yan; Peterson, Brandon W.; Sharma, Prashant K.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Groningen, Netherlands; [Jongsma, Marije A.; Ren, Yijin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Mei, HC (corresponding author), Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020; Peterson, Brandon/I-5380-2019; He, Helen/AAM-7420-2021; He, Helen/Y-5734-2018	Busscher, Henk/0000-0002-3644-5533; Peterson, Brandon/0000-0002-8969-3696; He, Helen/0000-0002-0949-8525; He, Helen/0000-0002-0949-8525; Sharma, Prashant/0000-0002-8342-8939; Ren, Yijin/0000-0002-2374-1771	China Scholarship Council; W.J. Kolff Institute, University Medical Center Groningen	China Scholarship Council(China Scholarship Council); W.J. Kolff Institute, University Medical Center Groningen	The China Scholarship Council and W.J. Kolff Institute, University Medical Center Groningen are gratefully acknowledged for scholarships, enabling this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Busscher HJ, 2010, EUR J ORAL SCI, V118, P177, DOI 10.1111/j.1600-0722.2010.00723.x; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11; Davis Stephen C, 2006, Curr Diab Rep, V6, P439, DOI 10.1007/s11892-006-0076-x; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Guelon T, 2011, SPRINGER SER BIOFILM, V5, P111, DOI 10.1007/978-3-642-19940-0_6; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hope CK, 2006, J MICROBIOL METH, V66, P390, DOI 10.1016/j.mimet.2006.01.003; Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; MASSOLDEYA AA, 1995, APPL ENVIRON MICROB, V61, P769; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Peterson Brandon W, 2012, Biofouling, V28, P913, DOI 10.1080/08927014.2012.721515; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Sambunjak D., 2011, COCHRANE DB SYST REV, V12; Sjollema J, 2011, APPL ENVIRON MICROB, V77, P5027, DOI 10.1128/AEM.00178-11; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Takenaka S, 2008, APPL ENVIRON MICROB, V74, P1869, DOI 10.1128/AEM.02218-07; Tiirola M, 2009, J IND MICROBIOL BIOT, V36, P929, DOI 10.1007/s10295-009-0571-6; van der Mei HC, 2006, J CLIN PERIODONTOL, V33, P14, DOI 10.1111/j.1600-051X.2005.00859.x; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001	30	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63750	10.1371/journal.pone.0063750	http://dx.doi.org/10.1371/journal.pone.0063750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723995	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100012
J	Puligheddu, M; Pillolla, G; Melis, M; Lecca, S; Marrosu, F; De Montis, MG; Scheggi, S; Carta, G; Murru, E; Aroni, S; Muntoni, AL; Pistis, M				Puligheddu, Monica; Pillolla, Giuliano; Melis, Miriam; Lecca, Salvatore; Marrosu, Francesco; De Montis, Maria Graziella; Scheggi, Simona; Carta, Gianfranca; Murru, Elisabetta; Aroni, Sonia; Muntoni, Anna Lisa; Pistis, Marco			PPAR-Alpha Agonists as Novel Antiepileptic Drugs: Preclinical Findings	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; FRONTAL-LOBE EPILEPSY; PROLIFERATOR-ACTIVATED RECEPTORS; PREFRONTAL CORTEX; INDUCED SEIZURES; NUCLEAR RECEPTORS; MICE; EXPRESSION; FAMILY; INTERNEURONS	Nicotinic acetylcholine receptors (nAChRs) are involved in seizure mechanisms. Hence, nocturnal frontal lobe epilepsy was the first idiopathic epilepsy linked with specific mutations in alpha 4 or beta 2 nAChR subunit genes. These mutations confer gain of function to nAChRs by increasing sensitivity toward acetylcholine. Consistently, nicotine elicits seizures through nAChRs and mimics the excessive nAChR activation observed in animal models of the disease. Treatments aimed at reducing nicotinic inputs are sought as therapies for epilepsies where these receptors contribute to neuronal excitation and synchronization. Previous studies demonstrated that peroxisome proliferator-activated receptors-alpha (PPAR alpha), nuclear receptor transcription factors, suppress nicotine-induced behavioral and electrophysiological effects by modulating nAChRs containing b2 subunits. On these bases, we tested whether PPAR alpha agonists were protective against nicotine-induced seizures. To this aim we utilized behavioral and electroencephalographic (EEG) experiments in C57BL/J6 mice and in vitro patch clamp recordings from mice and rats. Convulsive doses of nicotine evoked severe seizures and bursts of spike-waves discharges in similar to 100% of mice. A single dose of the synthetic PPAR alpha agonist WY14643 (WY, 80 mg/kg, i.p.) or chronic administration of fenofibrate, clinically available for lipid metabolism disorders, in the diet (0.2%) for 14 days significantly reduced or abolished behavioral and EEG expressions of nicotine-induced seizures. Acute WY effects were reverted by the PPAR alpha antagonist MK886 (3 mg/kg, i.p.). Since neocortical networks are crucial in the generation of ictal activity and synchrony, we performed patch clamp recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) from frontal cortex layer II/III pyramidal neurons. We found that both acute and chronic treatment with PPAR alpha agonists abolished nicotine-induced sIPSC increases. PPAR alpha within the CNS are key regulators of neuronal activity through modulation of nAChRs. These effects might be therapeutically exploited for idiopathic or genetically determined forms of epilepsy where nAChRs play a major role.	[Puligheddu, Monica; Pillolla, Giuliano; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Melis, Miriam; Lecca, Salvatore; Carta, Gianfranca; Murru, Elisabetta; Aroni, Sonia; Pistis, Marco] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [De Montis, Maria Graziella; Scheggi, Simona] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Melis, Miriam; Muntoni, Anna Lisa; Pistis, Marco] CNR Neurosci Inst, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Siena; Consiglio Nazionale delle Ricerche (CNR)	Pistis, M (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	mpistis@unica.it	Puligheddu, Monica/AAB-8503-2019; Pistis, Marco/A-3773-2013; Carta, Gianfranca/AAB-8947-2022; Melis, Miriam/AAF-3235-2020; Puligheddu, Monica/AGD-8274-2022; Murru, Elisabetta/AAW-4909-2021	Pistis, Marco/0000-0002-4622-3205; Carta, Gianfranca/0000-0002-3527-4197; Melis, Miriam/0000-0001-9631-8651; Scheggi, Simona/0000-0002-0229-6090; Pillolla, Giuliano/0000-0002-6797-4905; ARONI, SONIA/0000-0001-6864-8784; DE MONTIS, Maria Graziella/0000-0001-5835-1880; Lecca, Salvatore/0000-0001-5411-5485; Murru, Maria Elisabetta/0000-0002-7394-5780	Italian Ministry of University (MIUR) [200928EEX4, 2009HST9YF]; FIRE-AICE; Fondazione Banco di Sardegna	Italian Ministry of University (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRE-AICE; Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This research was supported by the Italian Ministry of University (MIUR) to Marco Pistis (grant PRIN 2009: 200928EEX4) and to Francesco Marrosu and Anna Lisa Muntoni (grant PRIN 2009: 2009HST9YF) by the FIRE-AICE 2011 grant and Fondazione Banco di Sardegna grant 2012 to Marco Pistis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Aracri P, 2010, CEREB CORTEX, V20, P1539, DOI 10.1093/cercor/bhp214; Banni S, 2013, CNS NEUROL DISORD DR; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bertrand D, 2005, NEUROBIOL DIS, V20, P799, DOI 10.1016/j.nbd.2005.05.013; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Cho CH, 2005, J NEUROSCI, V25, P3712, DOI 10.1523/JNEUROSCI.5389-03.2005; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Cimini A, 2005, NEUROSCIENCE, V130, P325, DOI 10.1016/j.neuroscience.2004.09.043; COHEN SL, 1981, PROG NEURO-PSYCHOPHA, V5, P383, DOI 10.1016/0364-7722(81)90089-8; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; De Fusco M, 2000, NAT GENET, V26, P275; Di Marzo V, 2001, BIOCHEM J, V358, P249, DOI 10.1042/0264-6021:3580249; Di Resta C, 2010, EUR J PHARMACOL, V643, P13, DOI 10.1016/j.ejphar.2010.05.063; Dobelis P, 2003, J PHARMACOL EXP THER, V306, P1159, DOI 10.1124/jpet.103.053066; Franceschini D, 2002, MOL BRAIN RES, V98, P29, DOI 10.1016/S0169-328X(01)00309-6; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Lecca S, 2013, J NEUROSCIE IN PRESS; Mascia P, 2011, BIOL PSYCHIAT, V69, P633, DOI 10.1016/j.biopsych.2010.07.009; McLellan A, 2003, EPILEPSIA, V44, P613, DOI 10.1046/j.1528-1157.2003.20102.x; Melis M, 2010, BIOL PSYCHIAT, V68, P256, DOI 10.1016/j.biopsych.2010.04.016; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Oldani A, 1998, BRAIN, V121, P205, DOI 10.1093/brain/121.2.205; Panlilio LV, 2012, NEUROPSYCHOPHARMACOL, V37, P1838, DOI 10.1038/npp.2012.31; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Poorthuis R. B., 2012, CEREBRAL CORTEX; Porta N, 2009, EPILEPSIA, V50, P943, DOI 10.1111/j.1528-1167.2008.01901.x; Porter JT, 1999, J NEUROSCI, V19, P5228; Raggenbass M, 2002, J NEUROBIOL, V53, P580, DOI 10.1002/neu.10152; Salas R, 2004, NEUROPHARMACOLOGY, V47, P401, DOI 10.1016/j.neuropharm.2004.05.002; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Stitzel JA, 2000, BEHAV BRAIN RES, V113, P57, DOI 10.1016/S0166-4328(00)00200-X; Sutor B, 2001, PFLUG ARCH EUR J PHY, V442, P642, DOI 10.1007/s004240100614; Zheng C, 2010, J PHARMACOL EXP THER, V335, P401, DOI 10.1124/jpet.110.171108; Zolles G, 2009, CEREB CORTEX, V19, P1079, DOI 10.1093/cercor/bhn158	46	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64541	10.1371/journal.pone.0064541	http://dx.doi.org/10.1371/journal.pone.0064541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724059	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100028
J	Azzaroli, F; Raspanti, ME; Simoni, P; Montagnani, M; Lisotti, A; Cecinato, P; Arena, R; Simonazzi, G; Farina, A; Rizzo, N; Mazzella, G				Azzaroli, Francesco; Raspanti, Maria Elena; Simoni, Patrizia; Montagnani, Marco; Lisotti, Andrea; Cecinato, Paolo; Arena, Rosario; Simonazzi, Giuliana; Farina, Antonio; Rizzo, Nicola; Mazzella, Giuseppe			High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							PRIMARY BILE-ACIDS; TRANSPORT; ABCG2; LIVER; SERUM	Background: Ursodeoxycholic acid (UDCA) administration in intrahepatic cholestasis of pregnancy (ICP) induces bile acids (BA) efflux from the foetal compartment, but the molecular basis of this transplacental transport is only partially defined. Aim: To determine if placental breast cancer resistance protein (BCRP), able to transport BA, is regulated by UDCA in ICP. Methods: 32 pregnant women with ICP (14 untreated, 34.9 +/- 5.17 years; 18 treated with UDCA - 25 mg/Kg/day, 32.7 +/- 4.62 years,) and 12 healthy controls (33.4 +/- 3.32 years) agreed to participate in the study. Placentas were obtained at delivery and processed for membrane extraction. BCRP protein expression was evaluated by immunoblotting techniques and chemiluminescence quantified with a luminograph measuring emitted photons; mRNA expression with real time PCR. Statistical differences between groups were evaluated by ANOVA with Dunn's Multiple Comparison test. Results: BCRP was expressed only on the apical membrane of the syncytiotrophoblast. A significant difference was observed among the three groups both for mRNA (ANOVA, p = 0.0074) and protein (ANOVA, p<0.0001) expression. BCRP expression was similar in controls and in the untreated ICP group. UDCA induced a significant increase in placental BCRP mRNA and protein expression compared to controls (350.7 +/- 106.3 vs 100 +/- 18.68% of controls, p<0.05 and 397.8 +/- 56.02 vs 100 +/- 11.44% of controls, p<0.001, respectively) and untreated ICP (90.29 +/- 17.59% of controls, p<0.05 and 155.0 +/- 13.87%, p<0.01). Conclusion: Our results confirm that BCRP is expressed only on the apical membrane of the syncytiotrophoblast and show that ICP treatment with high dose UDCA significantly upregulates placental BCRP expression favouring BA efflux from the foetal compartment.	[Azzaroli, Francesco; Raspanti, Maria Elena; Simoni, Patrizia; Montagnani, Marco; Lisotti, Andrea; Cecinato, Paolo; Arena, Rosario; Simonazzi, Giuliana; Farina, Antonio; Rizzo, Nicola; Mazzella, Giuseppe] Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, I-40126 Bologna, Italy; [Azzaroli, Francesco; Raspanti, Maria Elena; Montagnani, Marco; Mazzella, Giuseppe] St Orsola Marcello Malpighi Hosp, Ctr Appl Biomed Res, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Azzaroli, F (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, I-40126 Bologna, Italy.	francesco.azzaroli@unibo.it	Cecinato, Paolo/AAB-1079-2021; mazzella, giuseppe/A-1865-2016; Lisotti, Andrea/L-6762-2019	Cecinato, Paolo/0000-0002-1870-5952; Lisotti, Andrea/0000-0002-7724-7402; Mazzella, Giuseppe/0000-0001-8656-8112; Farina, Antonio/0000-0002-6862-1810; simoni, patrizia/0000-0001-8581-3585; MONTAGNANI, MARCO/0000-0003-0103-0327	University of Bologna (RFO)	University of Bologna (RFO)	The study received funding from the University of Bologna (RFO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2001, BBA-BIOMEMBRANES, V1511, P7, DOI 10.1016/S0005-2736(00)00355-2; ALTSHULER G, 1992, OBSTET GYNECOL, V79, P760; Azzaroli F, 2007, ALIMENT PHARM THERAP, V26, P1139, DOI 10.1111/j.1365-2036.2007.03462.x; Blazquez AG, 2012, MOL PHARMACOL, V81, P273, DOI 10.1124/mol.111.075143; Blazquez AM, 2011, MOL PHARM; BOWERS GN, 1966, CLIN CHEM, V12, P70; Geenes VL, 2011, PLACENTA, V32, P535, DOI 10.1016/j.placenta.2011.04.014; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Germain AM, 2003, AM J OBSTET GYNECOL, V189, P577, DOI 10.1067/S0002-9378(03)00545-3; Grube M, 2005, DRUG METAB DISPOS, V33, P31, DOI 10.1124/dmd.104.001560; Hahnova-Cygalova L, 2011, DRUG METAB REV, V43, P53, DOI 10.3109/03602532.2010.512293; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Janvilisri T, 2005, BIOCHEM J, V385, P419, DOI 10.1042/BJ20040791; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kumkate S, 2008, MOL CELL BIOCHEM, V317, P77, DOI 10.1007/s11010-008-9833-2; Lammert F, 2000, J HEPATOL, V33, P1012, DOI 10.1016/S0168-8278(00)80139-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Marin JJG, 2003, PLACENTA, V24, P431, DOI 10.1053/plac.2002.0951; Mazzella G, 2001, HEPATOLOGY, V33, P504, DOI 10.1053/jhep.2001.22647; Meng LJ, 1997, J HEPATOL, V27, P346, DOI 10.1016/S0168-8278(97)80181-X; Mennone A, 2010, DRUG METAB DISPOS, V38, P1673, DOI 10.1124/dmd.110.034512; Monte MJ, 1996, HEPATOLOGY, V23, P1208; Ropponen A, 2006, HEPATOLOGY, V43, P723, DOI 10.1002/hep.21111; SEPULVEDA WH, 1991, EUR J OBSTET GYN R B, V42, P211, DOI 10.1016/0028-2243(91)90222-7; Serrano MA, 1998, J HEPATOL, V28, P829, DOI 10.1016/S0168-8278(98)80234-1; Vaidya SS, 2006, MOL PHARMACEUT, V3, P303, DOI 10.1021/mp0600079	27	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64101	10.1371/journal.pone.0064101	http://dx.doi.org/10.1371/journal.pone.0064101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717540	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300027
J	Koido, S; Homma, S; Okamoto, M; Namiki, Y; Takakura, K; Takahara, A; Odahara, S; Tsukinaga, S; Yukawa, T; Mitobe, J; Matsudaira, H; Nagatsuma, K; Kajihara, M; Uchiyama, K; Arihiro, S; Imazu, H; Arakawa, H; Kan, S; Hayashi, K; Komita, H; Kamata, Y; Ito, M; Hara, E; Ohkusa, T; Gong, JL; Tajiri, H				Koido, Shigeo; Homma, Sadamu; Okamoto, Masato; Namiki, Yoshihisa; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Kajihara, Mikio; Uchiyama, Kan; Arihiro, Seiji; Imazu, Hiroo; Arakawa, Hiroshi; Kan, Shin; Hayashi, Kazumi; Komita, Hideo; Kamata, Yuko; Ito, Masaki; Hara, Eiichi; Ohkusa, Toshifumi; Gong, Jianlin; Tajiri, Hisao			Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-beta 1 Blockade and IL-12p70 Production	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEAT-SHOCK PROTEINS; STREPTOCOCCAL PREPARATION; TRANSFORMING GROWTH-FACTOR-BETA-1; MONOCLONAL-ANTIBODY; VACCINE EFFICACY; GASTRIC-CANCER; ANTIGEN; INDUCTION; EXPRESSION	The therapeutic efficacy of fusion cell (FC)-based cancer vaccine generated with whole tumor cells and dendritic cells (DCs) requires the improved immunogenicity of both cells. Treatment of whole tumor cells with ethanol resulted in blockade of immune-suppressive soluble factors such as transforming growth factor (TGF)-beta 1, vascular endothelial growth factor, and IL-10 without decreased expression of major histocompatibility complex (MHC) class I and the MUC1 tumor-associated antigen. Moreover, the ethanol-treated tumor cells expressed "eat-me'' signals such as calreticulin (CRT) on the cell surface and released immunostimulatory factors such as heat shock protein (HSP)90 alpha and high-mobility group box 1 (HMGB1). A dual stimulation of protein-bound polysaccharides isolated from Coriolus versicolor (TLR2 agonist) and penicillin-inactivated Streptococcus pyogenes (TLR4 agonist) led human monocyte-derived DCs to produce HSP90 alpha and multiple cytokines such as IL-12p70 and IL-10. Interestingly, incorporating ethanol-treated tumor cells and TLRs-stimulated DCs during the fusion process promoted fusion efficiency and up-regulated MHC class II molecules on a per fusion basis. Moreover, fusions of ethanol-treated tumor cells and dual TLRs-stimulated DCs (E-tumor/FCs) inhibited the production of multiple immune-suppressive soluble factors including TGF-beta 1 and up-regulated the production of IL-12p70 and HSP90 alpha. Most importantly, E-tumor/FCs activated T cells capable of producing high levels of IFN-gamma, resulting in augmented MUC1-specific CTL induction. Collectively, our results illustrate the synergy between ethanol-treated whole tumor cells and dual TLRs-stimulated DCs in inducing augmented CTL responses in vitro by FC preparations. The alternative system is simple and may provide a platform for adoptive immunotherapy.	[Koido, Shigeo; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Kajihara, Mikio; Uchiyama, Kan; Arihiro, Seiji; Arakawa, Hiroshi; Komita, Hideo; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Koido, Shigeo; Namiki, Yoshihisa] Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba, Japan; [Koido, Shigeo; Homma, Sadamu; Kan, Shin; Hayashi, Kazumi; Komita, Hideo; Kamata, Yuko; Ito, Masaki] Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Okamoto, Masato] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Imazu, Hiroo; Arakawa, Hiroshi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Hara, Eiichi] Saitama Canc Ctr Res, Inst Clin Oncol, Saitama, Japan; [Gong, Jianlin] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Jikei University; Jikei University; Jikei University; Keio University; Jikei University; Boston University	Koido, S (corresponding author), Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	shigeo_koido@jikei.ac.jp	大草, 敏史/HGD-2376-2022	Gong, Jianlin/0000-0003-0910-014X	Ministry of Education, Cultures, Sports, Science and Technology of Japan; Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research [25463119] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan, the Foundation for Promotion of Cancer Research, Mitsui Life Social Welfare Foundation, Grant-in-Aid of the Japan Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Buschard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017931; Calderwood SK, 2005, INT J HYPERTHER, V21, P713, DOI 10.1080/02656730500340794; Conroy H, 2012, CANCER IMMUNOL IMMUN, V61, P425, DOI 10.1007/s00262-011-1188-y; Delmas F, 1998, CELL BIOL TOXICOL, V14, P39, DOI 10.1023/A:1007464421018; DELMAS F, 1995, INT J BIOCHEM CELL B, V27, P385, DOI 10.1016/1357-2725(94)00069-N; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Huang A, 2003, CLIN EXP IMMUNOL, V134, P270, DOI 10.1046/j.1365-2249.2003.02295.x; INGE TH, 1992, CANCER RES, V52, P1386; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Koido S, 2000, J IMMUNOL, V165, P5713, DOI 10.4049/jimmunol.165.10.5713; Koido S, 2007, J IMMUNOL, V178, P613, DOI 10.4049/jimmunol.178.1.613; Koido S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059280; Koido S, 2013, ANTICANCER RES, V33, P347; Koido S, 2010, CLIN IMMUNOL, V135, P384, DOI 10.1016/j.clim.2010.02.003; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Lu HL, 2011, CLIN CANCER RES, V17, P6742, DOI 10.1158/1078-0432.CCR-11-1142; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; NAKAZATO H, 1994, LANCET, V343, P1122, DOI 10.1016/S0140-6736(94)90233-X; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Perlmutter MA, 2004, J MOL DIAGN, V6, P371, DOI 10.1016/S1525-1578(10)60534-X; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Somersan S, 2001, J IMMUNOL, V167, P4844, DOI 10.4049/jimmunol.167.9.4844; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; TANAKA N, 1994, CANCER, V74, P3097, DOI 10.1002/1097-0142(19941215)74:12<3097::AID-CNCR2820741206>3.0.CO;2-P; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; Terabe M, 2009, CLIN CANCER RES, V15, P6560, DOI 10.1158/1078-0432.CCR-09-1066; Ueda R, 2009, CLIN CANCER RES, V15, P6551, DOI 10.1158/1078-0432.CCR-09-1067; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Zhang M, 2008, J IMMUNOL, V181, P3690, DOI 10.4049/jimmunol.181.5.3690; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669	43	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63498	10.1371/journal.pone.0063498	http://dx.doi.org/10.1371/journal.pone.0063498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717436	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300036
J	Wirtz, S; Seeger, M; Zell, A; Wagner, C; Wagner, JF; Ries, JB				Wirtz, Stefan; Seeger, Manuel; Zell, Andreas; Wagner, Christian; Wagner, Jean-Frank; Ries, Johannes B.			Applicability of Different Hydraulic Parameters to Describe Soil Detachment in Eroding Rills	PLOS ONE			English	Article							SEDIMENT TRANSPORT CAPACITY; CONCENTRATED FLOW; BEDLOAD TRANSPORT; BED-LOAD; AGGREGATE TRANSPORT; SIZE DISTRIBUTION; EROSION PROCESS; WATER EROSION; GRAVEL; ENTRAINMENT	This study presents the comparison of experimental results with assumptions used in numerical models. The aim of the field experiments is to test the linear relationship between different hydraulic parameters and soil detachment. For example correlations between shear stress, unit length shear force, stream power, unit stream power and effective stream power and the detachment rate does not reveal a single parameter which consistently displays the best correlation. More importantly, the best fit does not only vary from one experiment to another, but even between distinct measurement points. Different processes in rill erosion are responsible for the changing correlations. However, not all these procedures are considered in soil erosion models. Hence, hydraulic parameters alone are not sufficient to predict detachment rates. They predict the fluvial incising in the rill's bottom, but the main sediment sources are not considered sufficiently in its equations. The results of this study show that there is still a lack of understanding of the physical processes underlying soil erosion. Exerted forces, soil stability and its expression, the abstraction of the detachment and transport processes in shallow flowing water remain still subject of unclear description and dependence.	[Wirtz, Stefan; Seeger, Manuel; Ries, Johannes B.] Univ Trier, Dept Phys Geog, Trier, Germany; [Seeger, Manuel] Wageningen Univ, Dept Land Degradat & Dev, NL-6700 AP Wageningen, Netherlands; [Zell, Andreas; Wagner, Christian] Univ Saarland, Dept Tech Phys 7 3, D-66123 Saarbrucken, Germany; [Wagner, Jean-Frank] Univ Trier, Dept Geol, Trier, Germany	Universitat Trier; Wageningen University & Research; Saarland University; Universitat Trier	Wirtz, S (corresponding author), Univ Trier, Dept Phys Geog, Trier, Germany.	wirtz@uni-trier.de	Wagner, Christian/A-1307-2009; Seeger, Manuel/V-9675-2017	Wagner, Christian/0000-0001-7788-4594; Seeger, Manuel/0000-0002-9195-156X; Wagner, Jean-Frank/0000-0003-4467-3437	"Internationale Graduiertenzentrum" of Trier University; Freundeskreis Trierer Universitat e.V.	"Internationale Graduiertenzentrum" of Trier University; Freundeskreis Trierer Universitat e.V.	The research was supported by the "Internationale Graduiertenzentrum" of Trier University and the "Freundeskreis Trierer Universitat e.V.". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams AD, 2000, EARTH SURF PROC LAND, V25, P497, DOI 10.1002/(SICI)1096-9837(200005)25:5&lt;497::AID-ESP77&gt;3.0.CO;2-P; Ad-hoc-Arbeitsgruppe Boden, 2005, BOD KART; Ajayi A.E., 2007, AN 13 S BRAS SENS RE, P3243; Allen JRL., 1994, SEDIMENT TRANSPORT D, P25; ANDREWS ED, 1986, WATER RESOUR RES, V22, P191, DOI 10.1029/WR022i002p00191; ANDREWS ED, 1984, GEOL SOC AM BULL, V95, P371, DOI 10.1130/0016-7606(1984)95<371:BEAHGO>2.0.CO;2; ANDREWS ED, 1983, GEOL SOC AM BULL, V94, P1225, DOI 10.1130/0016-7606(1983)94<1225:EOGFNS>2.0.CO;2; ASHWORTH PJ, 1989, WATER RESOUR RES, V25, P627, DOI 10.1029/WR025i004p00627; ASHWORTH PJ, 1989, J SEDIMENT PETROL, V59, P623, DOI 10.1306/212F901B-2B24-11D7-8648000102C1865D; BAGNOLD RA, 1977, WATER RESOUR RES, V13, P303, DOI 10.1029/WR013i002p00303; BAGNOLD RA, 1980, P ROY SOC LOND A MAT, V372, P453, DOI 10.1098/rspa.1980.0122; BRYAN RB, 1989, CATENA, V16, P393, DOI 10.1016/0341-8162(89)90023-4; BRYAN RB, 1990, CATENA SUPP, V17, P111; Chisci G., 1985, Soil erosion and conservation, P558; DEPLOEY J, 1990, CATENA SUPP, V17, P147; Deutsches Institut fur Normung, 1997, 18124 DIN; DIPLAS P, 1987, J HYDRAUL ENG-ASCE, V113, P277, DOI 10.1061/(ASCE)0733-9429(1987)113:3(277); Dunkerley D, 2008, HYDROL PROCESS, V22, P4415, DOI 10.1002/hyp.7045; Einstein A, 1911, ANN PHYS-BERLIN, V34, P591, DOI 10.1002/andp.19113390313; Einstein A, 1906, ANN PHYS-BERLIN, V19, P289, DOI 10.1002/andp.19063240204; Einstein HA, 1936, GESCHIEBETRIEB ALS W; ELLIOT WJ, 1993, T ASAE, V36, P65; EPA-homepage, 2009, CHANN PROC BEDL TRAN; FAO, 2006, GUID SOIL DESCR; Flanagan D.C., 1995, 11 NSERL; Foster G.R., 1982, ASAE MONOGRAPH, V5; Foster G.R., 1995, USDA WATER EROSION P, P12; GHEBREIYESSUS YT, 1994, T ASAE, V37, P1791, DOI 10.13031/2013.28268; Gimenez R, 2002, SOIL SCI SOC AM J, V66, P1475, DOI 10.2136/sssaj2002.1475; GOVERS G, 1987, CATENA, P17; GOVERS G, 1991, CATENA, V18, P133, DOI 10.1016/0341-8162(91)90013-N; Govers G., 1992, Overland flow: hydraulics and erosion mechanics., P243; Govers G, 2007, EARTH-SCI REV, V84, P87, DOI 10.1016/j.earscirev.2007.06.001; Graf W. H., 1971, HYDRAULICS SEDIMENT; HAIRSINE PB, 1992, WATER RESOUR RES, V28, P245, DOI 10.1029/91WR02381; Hessel R, 2007, ENG GEOL, V91, P56, DOI 10.1016/j.enggeo.2006.12.013; Kleinhans MG, 2010, HYDROL EARTH SYST SC, V14, P369, DOI 10.5194/hess-14-369-2010; Knapen A, 2007, EARTH-SCI REV, V80, P75, DOI 10.1016/j.earscirev.2006.08.001; Kohl K. D., 1988, THESIS IOWA STATE U; KOMAR PD, 1987, SEDIMENTOLOGY, V34, P1165, DOI 10.1111/j.1365-3091.1987.tb00599.x; KOMAR PD, 1991, SEDIMENTOLOGY, V38, P489, DOI 10.1111/j.1365-3091.1991.tb00363.x; KOMAR PD, 1987, J SEDIMENT PETROL, V57, P203; Landau L., 1971, MECANIQUES FLUIDS; Liu BY, 1997, T ASAE, V40, P945, DOI 10.13031/2013.21345; LOW HS, 1989, J HYDRAUL ENG-ASCE, V115, P124; Lyle WM., 1965, T ASAE, V8, P419, DOI DOI 10.13031/2013.40536; Macosko C. W., 1994, RHEOLOGY PRINCIPLES; MILLER MC, 1977, SEDIMENTOLOGY, V24, P507, DOI 10.1111/j.1365-3091.1977.tb00136.x; MOORE ID, 1986, WATER RESOUR RES, V22, P1350, DOI 10.1029/WR022i008p01350; Nearing MA, 1998, CATENA, V32, P15, DOI 10.1016/S0341-8162(97)00052-0; NEARING MA, 1991, SOIL SCI SOC AM J, V55, P339, DOI 10.2136/sssaj1991.03615995005500020006x; NEARING MA, 1994, SOIL SCI SOC AM J, V58, P1612, DOI 10.2136/sssaj1994.03615995005800060004x; NEARING MA, 1991, T ASAE, V34, P81, DOI 10.13031/2013.31627; Nearing MA, 1997, WATER RESOUR RES, V33, P865, DOI 10.1029/97WR00013; Ott W.P., 1936, HYDRODYNAMICS LAB CA, V167; OWOPUTI LO, 1995, T ASAE, V38, P1099, DOI 10.13031/2013.27927; PARKER G, 1990, J HYDRAUL RES, V28, P417, DOI 10.1080/00221689009499058; PARKER G, 1979, J HYDR ENG DIV-ASCE, V105, P1185; PARKER G, 1982, J HYDR ENG DIV-ASCE, V108, P544; Partheniades E., 1970, J HYDRAULICS DIVISIO, V96, P755; Rapp I., 1998, THESIS U PRETORIA S; Reid D.M., 1996, RAPID EVALUATION SED; RICKENMANN D, 1991, J HYDRAUL ENG-ASCE, V117, P1419, DOI 10.1061/(ASCE)0733-9429(1991)117:11(1419); RISSE LM, 1993, SOIL SCI SOC AM J, V57, P825, DOI 10.2136/sssaj1993.03615995005700030032x; RUTTIMANN M, 1995, CATENA, V25, P127, DOI 10.1016/0341-8162(95)00005-D; Scherer U., 2008, DISS; Seeger M, 2007, CATENA, V71, P56, DOI 10.1016/j.catena.2006.10.005; SHIELDS A., 1936, THESIS TU BERLIN; Sidorchuk A, 2008, HYDROL PROCESS, V22, P4035, DOI 10.1002/hyp.7006; Sidorchuk A, 2005, HYDROL PROCESS, V19, P1399, DOI 10.1002/hyp.5568; Sidorchuk A, 2005, CATENA, V63, P299, DOI 10.1016/j.catena.2005.06.007; Sidorchuk A, 2004, IAHS-AISH P, P345; Sidorchuk A, 2002, 12 ISCO C BEIJ 2002; Sidorchuk AY, 2009, EURASIAN SOIL SCI+, V42, P543, DOI 10.1134/S106422930905010X; Sidorchuk A, 2009, GEOMORPHOLOGY, V110, P2, DOI 10.1016/j.geomorph.2008.12.019; Sidorchuk AY, 2001, EURASIAN SOIL SCI+, V34, P893; Stefanovic JR, 2009, EARTH SURF PROC LAND, V34, P133, DOI 10.1002/esp.1707; TORRI D, 1987, CATENA, P97; Vandekerckhove L, 1998, CATENA, V33, P271, DOI 10.1016/S0341-8162(98)00068-X; WENDT RC, 1986, SOIL SCI SOC AM J, V50, P730, DOI 10.2136/sssaj1986.03615995005000030035x; WILSON BN, 1993, T ASAE, V36, P1105; Wirtz S, 2010, Z GEOMORPHOL, V54, P47, DOI 10.1127/0372-8854/2010/0054-0004; Yalin M.S., 1963, J HYDRAUL DIV, V89, P221, DOI [10.1061/JYCEAJ.0000874, DOI 10.1061/JYCEAJ.0000874]; Yang CT, 1973, PROC ASCE JNL HYDR D, V99, P1679, DOI 10.1061/JYCEAJ.0003766; Yang CT., 1972, ASCE J HYDRAUL DIV, V98, P1805, DOI [10.1061/JYCEAJ.0003439, DOI 10.1061/JYCEAJ.0003439]; Zhang GH, 2003, SOIL SCI SOC AM J, V67, P713, DOI 10.2136/sssaj2003.0713; Zhang XC, 1996, T ASAE, V39, P855, DOI 10.13031/2013.27570; ZHU JC, 1995, SOIL SCI SOC AM J, V59, P211, DOI 10.2136/sssaj1995.03615995005900010032x	88	18	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64861	10.1371/journal.pone.0064861	http://dx.doi.org/10.1371/journal.pone.0064861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717669	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300009
J	Sellathurai, J; Cheedipudi, S; Dhawan, J; Schroder, HD				Sellathurai, Jeeva; Cheedipudi, Sirisha; Dhawan, Jyotsna; Schroder, Henrik Daa			A Novel In Vitro Model for Studying Quiescence and Activation of Primary Isolated Human Myoblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE DEVELOPMENT; GROWTH-FACTOR-I; GENE-EXPRESSION; SATELLITE CELLS; STEM-CELLS; MOLECULAR REGULATION; PRECURSOR CELLS; MYOD FAMILY; CYCLIN D1; PROLIFERATION	Skeletal muscle stem cells, satellite cells, are normally quiescent but become activated upon muscle injury. Recruitment of resident satellite cells may be a useful strategy for treatment of muscle disorders, but little is known about gene expression in quiescent human satellite cells or the mechanisms involved in their early activation. We have developed a method to induce quiescence in purified primary human myoblasts isolated from healthy individuals. Analysis of the resting state showed absence of BrdU incorporation and lack of KI67 expression, as well as the extended kinetics during synchronous reactivation into the cell cycle, confirming arrest in the G(0) phase. Reactivation studies showed that the majority (>95%) of the G(0) arrested cells were able to re-enter the cell cycle, confirming reversibility of arrest. Furthermore, a panel of important myogenic factors showed expression patterns similar to those reported for mouse satellite cells in G(0), reactivated and differentiated cultures, supporting the applicability of the human model. In addition, gene expression profiling showed that a large number of genes (4598) were differentially expressed in cells activated from G0 compared to long term exponentially proliferating cultures normally used for in vitro studies. Human myoblasts cultured through many passages inevitably consist of a mixture of proliferating and non-proliferating cells, while cells activated from G(0) are in a synchronously proliferating phase, and therefore may be a better model for in vivo proliferating satellite cells. Furthermore, the temporal propagation of proliferation in these synchronized cultures resembles the pattern seen in vivo during regeneration. We therefore present this culture model as a useful and novel condition for molecular analysis of quiescence and reactivation of human myoblasts.	[Sellathurai, Jeeva; Schroder, Henrik Daa] Univ So Denmark, SDU Muscle Res Cluster, Inst Clin Res, Odense, Denmark; [Cheedipudi, Sirisha] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Dhawan, Jyotsna] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Schroder, Henrik Daa] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark	University of Southern Denmark; Max Planck Society; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Southern Denmark; Odense University Hospital	Schroder, HD (corresponding author), Univ So Denmark, SDU Muscle Res Cluster, Inst Clin Res, Odense, Denmark.	henrik.daa.schroeder@ouh.regionsyddanmark.dk	Schrøder, Henrik Daa/E-2077-2013; Sampaolesi, Maurilio/H-6509-2013	Schrøder, Henrik Daa/0000-0001-7588-235X; Sampaolesi, Maurilio/0000-0002-2422-3757; cheedipudi, sirisha/0000-0002-3202-3229	Lundbeck Foundation; Institute of Clinical Research, University of Southern Denmark; Institute for Clinical Pathology, Odense University Hospital, Denmark; Govt of India, Dept of Biotechnology; collaborative Indo-Denmark grant from the Govt of India, Dept of Biotechnology; Danish Council for Strategic Research; Council of Scientific and Industrial Research	Lundbeck Foundation(Lundbeckfonden); Institute of Clinical Research, University of Southern Denmark; Institute for Clinical Pathology, Odense University Hospital, Denmark; Govt of India, Dept of Biotechnology; collaborative Indo-Denmark grant from the Govt of India, Dept of Biotechnology; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Lundbeck Foundation (HDS), grant from Institute of Clinical Research, University of Southern Denmark (JS, HDS), grant from Institute for Clinical Pathology, Odense University Hospital, Denmark (JS, HDS), grant from the Govt of India, Dept of Biotechnology (JD) and a collaborative Indo-Denmark grant from the Govt of India, Dept of Biotechnology and the Danish Council for Strategic Research (HDS, JD). SC was supported by a doctoral fellowship from the Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Ansved T, 2003, CURR OPIN CLIN NUTR, V6, P435, DOI 10.1097/00075197-200307000-00013; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bonavaud S, 2002, IN VITRO CELL DEV-AN, V38, P66; Brower RG., 2009, CRIT CARE MED, V37, pS422, DOI [DOI 10.1097/CCM.0b013e3181b6e30a, 10.1097/ccm.0b013e3181b6e30a, 10.1097/CCM.0b013e3181b6e30a]; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Carroll JS, 2003, CANCER RES, V63, P4322; Cassano M, 2011, DEVELOPMENT, V138, P4523, DOI 10.1242/dev.070706; Chambers Melissa A, 2009, Crit Care Med, V37, pS337, DOI 10.1097/CCM.0b013e3181b6e974; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dhawan J, 2004, J CELL SCI, V117, P3735, DOI 10.1242/jcs.01197; DHAWAN J, 1990, J BIOL CHEM, V265, P9015; DIKE LE, 1988, P NATL ACAD SCI USA, V85, P6792, DOI 10.1073/pnas.85.18.6792; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Evdokiou A, 1998, EXP CELL RES, V240, P359, DOI 10.1006/excr.1998.4011; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Georgia S, 2006, DIABETES, V55, P2950, DOI 10.2337/db06-0249; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; HARPER JW, 1993, CELL, V75, P805; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heissig B, 2009, J CELL PHYSIOL, V221, P521, DOI 10.1002/jcp.21897; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hitomi M, 1999, MOL CELL BIOL, V19, P4623; Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Jones TE, 2009, J GERIATR PHYS THER, V32, P39, DOI 10.1519/00139143-200932020-00008; Jump SS, 2009, EXP PHYSIOL, V94, P739, DOI 10.1113/expphysiol.2008.046136; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x; Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Montarras D, 2005, DIRECT ISOLATION SAT; Murton AJ, 2009, CURR OPIN NEUROL, V22, P500, DOI 10.1097/WCO.0b013e32832f15e1; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sachidanandan C, 2002, J CELL SCI, V115, P2701; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Sveen ML, 2007, NEUROLOGY, V68, P59, DOI 10.1212/01.wnl.0000250358.32199.24; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; van Bree C, 2008, RADIAT RES, V170, P184, DOI 10.1667/RR0845.1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Yoshida N, 1998, J CELL SCI, V111, P769	78	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64067	10.1371/journal.pone.0064067	http://dx.doi.org/10.1371/journal.pone.0064067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717533	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600042
J	Seo, HS; Xiong, YQ; Sullam, PM				Seo, Ho Seong; Xiong, Yan Q.; Sullam, Paul M.			Role of the Serine-Rich Surface Glycoprotein Srr1 of Streptococcus agalactiae in the Pathogenesis of Infective Endocarditis	PLOS ONE			English	Article							FIBRINOGEN-BINDING-PROTEIN; STAPHYLOCOCCUS-AUREUS; CLUMPING FACTOR; PLATELET-AGGREGATION; REPEAT PROTEINS; IN-VITRO; ACTIVATION; MECHANISMS; GLYCOSYLATION; COMPLEMENT	The binding of bacteria to fibrinogen and platelets are important events in the pathogenesis of infective endocarditis. Srr1 is a serine-rich repeat glycoprotein of Streptococcus agalactiae that binds directly to the A alpha chain of human fibrinogen. To assess the impact of Srr1 on the pathogenesis of endocarditis due to S. agalactiae, we first examined the binding of this organism to immobilized human platelets. Strains expressing Srr1 had significantly higher levels of binding to human platelets in vitro, as compared with isogenic Delta srr1 mutants. In addition, platelet binding was inhibited by pretreatment with anti-fibrinogen IgG or purified Srr1 binding region. To assess the contribution of Srr1 to pathogenicity, we compared the relative virulence of S. agalactiae NCTC 10/84 strain and its Delta srr1 mutant in a rat model of endocarditis, where animals were co-infected with the WT and the mutant strains at a 1: 1 ratio. At 72 h post-infection, bacterial densities (CFU/g) of the WT strain within vegetations, kidneys, and spleens were significantly higher, as compared with the Delta srr1 mutant. These results indicate that Srr1 contributes to the pathogenesis of endocarditis due to S. agalactiae, at least in part through its role in fibrinogen-mediated platelet binding.	[Seo, Ho Seong; Sullam, Paul M.] Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Seo, Ho Seong; Sullam, Paul M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Xiong, Yan Q.] Harbor UCLA Med Ctr, Dept Med, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Xiong, Yan Q.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sullam, PM (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu	Xiong, Yan Q/AAC-6362-2021; Seo, Ho Seong/V-1806-2019	Xiong, Yan Q/0000-0002-8732-6948; Seo, Ho Seong/0000-0002-7103-1344	Department of Veterans Affairs; Northern California Institute for Research and Education, NIH [R01-AI41513, R01-AI057433]; American Heart Association, Western Affiliate; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513, R01AI057433] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001653] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Northern California Institute for Research and Education, NIH; American Heart Association, Western Affiliate(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Department of Veterans Affairs and the VA Merit Review program, the Northern California Institute for Research and Education, NIH grants R01-AI41513 (P. M. S.), R01-AI057433 (P. M. S.), and a Fellowship Award from the American Heart Association, Western Affiliate (H. S. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Devi AS, 2010, PROTEIN EXPRES PURIF, V74, P148, DOI 10.1016/j.pep.2010.07.004; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Georgieva RI, 2010, J INFECTION, V61, P54, DOI 10.1016/j.jinf.2010.04.005; Kannan R, 2001, J Assoc Physicians India, V49, P1125; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Miajlovic H, 2007, INFECT IMMUN, V75, P3335, DOI 10.1128/IAI.01993-06; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Munoz P, 1997, ARCH INTERN MED, V157, P213, DOI 10.1001/archinte.157.2.213; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Pietrocola G, 2006, BIOCHEMISTRY-US, V45, P12840, DOI 10.1021/bi060696u; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Rollan MJ, 2003, AM HEART J, V146, P1095, DOI 10.1016/S0002-8703(03)00444-7; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; SANTORO J, 1978, INFECT IMMUN, V19, P915, DOI 10.1128/IAI.19.3.915-918.1978; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Seo HS, 2011, INFECT IMMUN, V79, P3518, DOI 10.1128/IAI.05088-11; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Siciliano RF, 2010, HEART LUNG, V39, P331, DOI 10.1016/j.hrtlng.2009.06.018; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Sullam PM, 1996, INFECT IMMUN, V64, P4915, DOI 10.1128/IAI.64.12.4915-4921.1996; SULLAM PM, 1987, INFECT IMMUN, V55, P1743, DOI 10.1128/IAI.55.8.1743-1750.1987; Sunkara B, 2012, INT J INFECT DIS, V16, pE182, DOI 10.1016/j.ijid.2011.11.008; Tazi A, 2012, CURR OPIN MICROBIOL, V15, P44, DOI 10.1016/j.mib.2011.12.002; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Veloso TR, 2013, INFECT IMMUN, V81, P697, DOI 10.1128/IAI.01030-12; WESSELS MR, 1992, INFECT IMMUN, V60, P392, DOI 10.1128/IAI.60.2.392-400.1992; Widmer Eleonora, 2006, Curr Infect Dis Rep, V8, P271, DOI 10.1007/s11908-006-0071-z; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Xiang H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002751; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Xiong YQ, 2009, J INFECT DIS, V199, P201, DOI 10.1086/595738; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	52	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64204	10.1371/journal.pone.0064204	http://dx.doi.org/10.1371/journal.pone.0064204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717569	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600051
J	Bath, C; Muttuvelu, D; Emmersen, J; Vorum, H; Hjortdal, J; Zachar, V				Bath, Chris; Muttuvelu, Danson; Emmersen, Jeppe; Vorum, Henrik; Hjortdal, Jesper; Zachar, Vladimir			Transcriptional Dissection of Human Limbal Niche Compartments by Massive Parallel Sequencing	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; EX-VIVO EXPANSION; IN-VITRO; AMPLIFYING CELLS; GENE-EXPRESSION; EPIDERMAL STEM; CULTURE; POPULATION; LRIG1; PREECLAMPSIA	Corneal epithelium is maintained throughout life by well-orchestrated proliferation of limbal epithelial stem cells (LESCs), followed by migration and maturation centripetally towards the ocular surface. Disturbance of LESCs can potentially lead to a blinding condition, which can be reversed by reconstitution of a functional LESC pool. The current clinical procedures are effective to some degree, however, deeper knowledge of the molecular interplay within the limbal niche is necessary to achieve a fully satisfactory patient outcome. The present study was thus undertaken to carry out a comprehensive transcriptome analysis of four distinct human limbal compartments, including basal limbal crypts (BLCs), superficial limbal crypts (SLCs), cornea, and the supporting stroma, with the aid of laser capture microdissection and deep RNA sequencing. The tissue harvest pipeline was rigorously optimized so that the exposure to cold ischemia would be less than five minutes. The global gene ontology analysis confirmed existence of primitive cells in BLCs, migratory and activated cells in SLCs, and differentiated cells in cornea. Interestingly, many significantly upregulated genes in SLCs mapped to processes involved in regulation of vasculature, such as sFLT1. In contrast, BLCs exhibited many genes mapping to neurogenic processes and processes related to cell development. The primitive nature of BLCs was, furthermore, confirmed by the KEGG pathway analysis, and some potential regulators of LESCs were revealed, such as Lrig1 and SOX9. The analysis also yielded comprehensive lists of uniquely expressed genes in both BLCs and cornea, which may be useful to identify possible biomarkers. In conclusion, the current investigation provides new insight into the relationship between distinct cell populations within the limbal niche, identifies candidates to be verified for novel biological functions, and yields a wealth of information for prospective data mining.	[Bath, Chris; Muttuvelu, Danson; Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Bath, Chris; Emmersen, Jeppe; Zachar, Vladimir] Aalborg Univ, Lab Stem Cell Res, Aalborg, Denmark; [Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aarhus University	Zachar, V (corresponding author), Aalborg Univ, Lab Stem Cell Res, Aalborg, Denmark.	vlaz@hst.aau.dk		Muttuvelu, Danson V./0000-0003-4304-9704; Zachar, Vladimir/0000-0002-5279-2690	Danish Eye Foundation; Aalborg University Hospital; John and Birthe Meyer; Jochum Jensen & hustru Mette Marie Jensen f. Poulsen; Marie Jensen; Heinrich Kopps foundations	Danish Eye Foundation; Aalborg University Hospital; John and Birthe Meyer; Jochum Jensen & hustru Mette Marie Jensen f. Poulsen; Marie Jensen; Heinrich Kopps foundations	This study was supported by grants from The Danish Eye Foundation, Aalborg University Hospital, the John and Birthe Meyer, Jochum Jensen & hustru Mette Marie Jensen f. Poulsen, Marie Jensen, and Heinrich Kopps foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Akinci MAM, 2009, INVEST OPHTH VIS SCI, V50, P5630, DOI 10.1167/iovs.09-3791; Akinci MAM, 2009, INVEST OPHTH VIS SCI, V50, P4162, DOI 10.1167/iovs.08-2861; Albert R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047187; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Bath C, 2013, STEM CELL RES, V10, P349, DOI 10.1016/j.scr.2013.01.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Bian F, 2010, INT J BIOCHEM CELL B, V42, P1142, DOI 10.1016/j.biocel.2010.03.022; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Deng SX, 2012, ARCH OPHTHALMOL-CHIC, V130, P440, DOI 10.1001/archophthalmol.2011.378; Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Donisi PM, 2003, CORNEA, V22, P533, DOI 10.1097/00003226-200308000-00009; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Elder MJ, 1997, HUM PATHOL, V28, P1348, DOI 10.1016/S0046-8177(97)90222-7; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; Futterer A, 2012, CELL DEATH DIFFER, V19, P132, DOI 10.1038/cdd.2011.62; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; KASPER M, 1988, HISTOCHEMISTRY, V89, P369, DOI 10.1007/BF00500639; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kulkarni BB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-526; Larouche D, 2008, FASEB J, V22, P1404, DOI 10.1096/fj.07-8109com; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1983; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lehrer MS, 1998, J CELL SCI, V111, P2867; Lekhanont K, 2009, MOL VIS, V15, P1294; Mann I., 1944, BRIT JOUR OPHTHALMOL, V28, P26, DOI 10.1136/bjo.28.1.26; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Michel M, 1996, J CELL SCI, V109, P1017; Mikkola ML, 2011, ADV EXP MED BIOL, V691, P23, DOI 10.1007/978-1-4419-6612-4_3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Notara M, 2007, REGEN MED, V2, P919, DOI 10.2217/17460751.2.6.919; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Selver OB, 2011, INVEST OPHTH VIS SCI, V52, P4330, DOI 10.1167/iovs.10-5897; Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma SM, 2012, STEM CELL REV REP, V8, P696, DOI 10.1007/s12015-011-9319-6; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Ueno H, 2012, INVEST OPHTH VIS SCI, V53, P867, DOI 10.1167/iovs.11-8438; van Abel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029769; van Dijk M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/521826; van Dijk M, 2010, HUM MOL GENET, V19, P2658, DOI 10.1093/hmg/ddq152; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wolosin JM, 2006, OCUL SURF, V4, P10, DOI 10.1016/S1542-0124(12)70261-6; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Zachar V, 2011, EXPERT OPIN BIOL TH, V11, P775, DOI 10.1517/14712598.2011.570258; Zachar V, 2010, IN VITRO CELL DEV-AN, V46, P276, DOI 10.1007/s11626-010-9305-3; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	76	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64244	10.1371/journal.pone.0064244	http://dx.doi.org/10.1371/journal.pone.0064244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717577	Green Submitted, gold, Green Published			2022-12-25	WOS:000320362700123
J	Hu, C; Dillon, J; Kearn, J; Murray, C; O'Connor, V; Holden-Dye, L; Morgan, H				Hu, Chunxiao; Dillon, James; Kearn, James; Murray, Caitriona; O'Connor, Vincent; Holden-Dye, Lindy; Morgan, Hywel			NeuroChip: A Microfluidic Electrophysiological Device for Genetic and Chemical Biology Screening of Caenorhabditis elegans Adult and Larvae	PLOS ONE			English	Article							HIGH-THROUGHPUT; C. ELEGANS; GLUTAMATERGIC NEUROTRANSMISSION; SYNAPTIC-TRANSMISSION; ELECTRICAL-ACTIVITY; PHARYNX; SEROTONIN; SYSTEM; BEHAVIOR; IMMOBILIZATION	Genetic and chemical biology screens of C. elegans have been of enormous benefit in providing fundamental insight into neural function and neuroactive drugs. Recently the exploitation of microfluidic devices has added greater power to this experimental approach providing more discrete and higher throughput phenotypic analysis of neural systems. Here we make a significant addition to this repertoire through the design of a semi-automated microfluidic device, NeuroChip, which has been optimised for selecting worms based on the electrophysiological features of the pharyngeal neural network. We demonstrate this device has the capability to sort mutant from wild-type worms based on high definition extracellular electrophysiological recordings. NeuroChip resolves discrete differences in excitatory, inhibitory and neuromodulatory components of the neural network from individual animals. Worms may be fed into the device consecutively from a reservoir and recovered unharmed. It combines microfluidics with integrated electrode recording for sequential trapping, restraining, recording, releasing and recovering of C. elegans. Thus mutant worms may be selected, recovered and propagated enabling mutagenesis screens based on an electrophysiological phenotype. Drugs may be rapidly applied during the recording thus permitting compound screening. For toxicology, this analysis can provide a precise description of sub-lethal effects on neural function. The chamber has been modified to accommodate L2 larval stages showing applicability for small size nematodes including parasitic species which otherwise are not tractable to this experimental approach. We also combine NeuroChip with optogenetics for targeted interrogation of the function of the neural circuit. NeuroChip thus adds a new tool for exploitation of C. elegans and has applications in neurogenetics, drug discovery and neurotoxicology.	[Hu, Chunxiao; Morgan, Hywel] Univ Southampton, Hybrid Biodevices Grp, Southampton, Hants, England; [Dillon, James; Kearn, James; Murray, Caitriona; O'Connor, Vincent; Holden-Dye, Lindy] Univ Southampton, Inst Life Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; University of Southampton	Holden-Dye, L (corresponding author), Univ Southampton, Inst Life Sci, Ctr Biol Sci, Southampton, Hants, England.	lmhd@soton.ac.uk		Holden-Dye, Lindy/0000-0002-9704-1217; Morgan, Hywel/0000-0003-4850-5676; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483; Hu, Chunxiao/0000-0003-4031-1340	Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/E022251/1, BB/F009208/1]; NIH Office of Research Infrastructure Programs [P40 OD010440]; BBSRC [BB/F009208/1, BB/E022251/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022251/1, BB/F009208/1] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	James Dillon and Caitriona Murray were funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK Grant numbers BB/E022251/1 and BB/F009208/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; eat-4 strains were provided by the C. elegans Genetics Center (CGC) which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). Gareth Jones (University of Southampton) provided expertise for the fabrication of micro-valves. Alexander Gottschalk (Johann Wolfgang Goethe-University Frankfurt) provided pmyo-3::ChR2(gf)::yfp. Elodie Siney (University of Southampton) conducted C. elegans outcrossing. Ben Mulcahy and Hans Schuppe (University of Southampton) assisted with confocal imaging. Christopher James, Institute of Digital Healthcare, University of Warwick, UK provided the AutoEPG software for analysis.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; BRENNER S, 1974, GENETICS, V77, P71; Solvas XCI, 2011, CHEM COMMUN, V47, P9801, DOI 10.1039/c1cc14076k; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; Chokshi TV, 2009, LAB CHIP, V9, P151, DOI 10.1039/b807345g; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cook Alan, 2006, WormBook, P1; Crane MM, 2012, NAT METHODS, V9, P977, DOI [10.1038/NMETH.2141, 10.1038/nmeth.2141]; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Crisford A, 2011, MOL PHARMACOL, V79, P1031, DOI 10.1124/mol.111.071043; Cui XQ, 2008, P NATL ACAD SCI USA, V105, P10670, DOI 10.1073/pnas.0804612105; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dillon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008482; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; Hall DH., 2008, C ELEGANS ATLAS; HEINZEL HG, 1993, J NEUROSCI, V13, P1793; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hu C, 2012, 16 INT C MIN SYST CH, P1441; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Johari S, 2012, MATER SCI FORUM, V700, P182, DOI 10.4028/www.scientific.net/MSF.700.182; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LEES GM, 1974, BRIT J PHARMACOL, V50, P79, DOI 10.1111/j.1476-5381.1974.tb09595.x; Li HY, 1997, P NATL ACAD SCI USA, V94, P5912, DOI 10.1073/pnas.94.11.5912; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Lockery SR, 2012, LAB CHIP, V12, P2211, DOI 10.1039/c2lc00001f; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; O'Connor V, 2012, BRIT SOC PAR SPRING, P79; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; Pilon M, 2005, ACTA PHARMACOL SIN, V26, P396, DOI 10.1111/j.1745-7254.2005.00070.x; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rezai P, 2010, LAB CHIP, V10, P220, DOI 10.1039/b917486a; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shi WW, 2008, LAB CHIP, V8, P1432, DOI 10.1039/b808753a; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; STEWARD O, 1976, EXP BRAIN RES, V26, P423; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Studer V, 2004, J APPL PHYS, V95, P393, DOI 10.1063/1.1629781; Sznitman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011631; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vidal-Gadea Andres G, 2012, Worm, V1, P5; WILLIAMS BD, 1992, GENETICS, V131, P609; Willson J, 2004, CURR BIOL, V14, P1374, DOI 10.1016/j.cub.2004.07.056; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	69	27	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64297	10.1371/journal.pone.0064297	http://dx.doi.org/10.1371/journal.pone.0064297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717588	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700132
J	Huang, XE; Liu, XY; Chen, XH; Snyder, A; Song, WY				Huang, Xiaoen; Liu, Xueying; Chen, Xiuhua; Snyder, Anita; Song, Wen-Yuan			Members of the XB3 Family from Diverse Plant Species Induce Programmed Cell Death in Nicotiana benthamiana	PLOS ONE			English	Article							XA21-MEDIATED INNATE IMMUNITY; DISEASE RESISTANCE; POSITIVE REGULATOR; REPEAT PROTEIN; KINASE; MAPKKK; GENE; TOMATO; EXPRESSION; XA21	Programmed cell death has been associated with plant immunity and senescence. The receptor kinase XA21 confers resistance to bacterial blight disease of rice (Oryza sativa) caused by Xanthomonas oryzae pv. oryzae (Xoo). Here we show that the XA21 binding protein 3 (XB3) is capable of inducing cell death when overexpressed in Nicotiana benthamiana. XB3 is a RING finger-containing E3 ubiquitin ligase that has been positively implicated in XA21-mediated resistance. Mutation abolishing the XB3 E3 activity also eliminates its ability to induce cell death. Phylogenetic analysis of XB3-related sequences suggests a family of proteins (XB3 family) with members from diverse plant species. We further demonstrate that members of the XB3 family from rice, Arabidopsis and citrus all trigger a similar cell death response in Nicotiana benthamiana, suggesting an evolutionarily conserved role for these proteins in regulating programmed cell death in the plant kingdom.	[Huang, Xiaoen; Chen, Xiuhua; Song, Wen-Yuan] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Snyder, Anita; Song, Wen-Yuan] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA; [Liu, Xueying] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Song, WY (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	wsong@ifas.ufl.edu	Huang, Xiaoen/ABD-5778-2021	Huang, Xiaoen/0000-0002-7514-1663	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This research was supported by the Citrus Research and Development Foundation (http://citrusrdf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Gmitter FG, 2011, SAN DIEG CA PLANT AN; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Goodman R. N., 1994, HYPERSENSITIVE REACT; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jiang YN, 2013, PLANT J, V73, P814, DOI 10.1111/tpj.12076; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Park CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009262; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Rogers HJ, 2006, ANN BOT-LONDON, V97, P309, DOI 10.1093/aob/mcj051; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu XJ, 2007, J EXP BOT, V58, P3623, DOI 10.1093/jxb/erm212; Xu XJ, 2007, J EXP BOT, V58, P2193, DOI 10.1093/jxb/erm058; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	39	11	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63868	10.1371/journal.pone.0063868	http://dx.doi.org/10.1371/journal.pone.0063868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717500	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700072
J	Rhie, SK; Coetzee, SG; Noushmehr, H; Yan, CL; Kim, JM; Haiman, CA; Coetzee, GA				Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Kim, Jae Mun; Haiman, Christopher A.; Coetzee, Gerhard A.			Comprehensive Functional Annotation of Seventy-One Breast Cancer Risk Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; REGULATORY ELEMENTS; ANDROGEN-RECEPTOR; DIFFERENTIAL EXPRESSION; SUSCEPTIBILITY LOCUS; COMMON VARIANTS; DATA SETS; DATABASE; PROTEIN	Breast Cancer (BCa) genome-wide association studies revealed allelic frequency differences between cases and controls at index single nucleotide polymorphisms (SNPs). To date, 71 loci have thus been identified and replicated. More than 320,000 SNPs at these loci define BCa risk due to linkage disequilibrium (LD). We propose that BCa risk resides in a subgroup of SNPs that functionally affects breast biology. Such a shortlist will aid in framing hypotheses to prioritize a manageable number of likely disease-causing SNPs. We extracted all the SNPs, residing in 1 Mb windows around breast cancer risk index SNP from the 1000 genomes project to find correlated SNPs. We used FunciSNP, an R/Bioconductor package developed in-house, to identify potentially functional SNPs at 71 risk loci by coinciding them with chromatin biofeatures. We identified 1,005 SNPs in LD with the index SNPs (r(2) >= 0.5) in three categories; 21 in exons of 18 genes, 76 in transcription start site (TSS) regions of 25 genes, and 921 in enhancers. Thirteen SNPs were found in more than one category. We found two correlated and predicted non-benign coding variants (rs8100241 in exon 2 and rs8108174 in exon 3) of the gene, ANKLE1. Most putative functional LD SNPs, however, were found in either epigenetically defined enhancers or in gene TSS regions. Fifty-five percent of these non-coding SNPs are likely functional, since they affect response element (RE) sequences of transcription factors. Functionality of these SNPs was assessed by expression quantitative trait loci (eQTL) analysis and allele-specific enhancer assays. Unbiased analyses of SNPs at BCa risk loci revealed new and overlooked mechanisms that may affect risk of the disease, thereby providing a valuable resource for follow-up studies.	[Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Haiman, Christopher A.; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Rhie, Suhn Kyong; Coetzee, Simon G.; Noushmehr, Houtan; Yan, Chunli; Haiman, Christopher A.; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA; [Kim, Jae Mun] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Coetzee, GA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	coetzee@usc.edu	N, Houtan/C-9692-2013; coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019; Coetzee, Simon/C-1218-2014	N, Houtan/0000-0003-4051-8114; Coetzee, Simon/0000-0003-4267-5930; Coetzee, Gerhard/0000-0001-8820-8364; Rhie, Suhn/0000-0002-5522-5296; Kim, Hugo/0000-0002-8610-9677	National Institutes of Health [R01 CA136924, T32CA009320]; Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE [R01CA136924, T32CA009320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [R01 CA136924 to GAC and T32CA009320 to HN). The scientific development and funding of this project were in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Adiseshaiah P, 2003, J BIOL CHEM, V278, P47423, DOI 10.1074/jbc.M303505200; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brachner A, 2012, J CELL SCI, V125, P1048, DOI 10.1242/jcs.098392; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; D'Amato NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045684; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; GHOUSSAINI M, 2013, NAT GENET, V44, P312; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hansson A, 2003, BIOCHEM BIOPH RES CO, V312, P1073, DOI 10.1016/j.bbrc.2003.11.030; Hardison RC, 2012, J BIOL CHEM, V287, P30932, DOI 10.1074/jbc.R112.352427; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu Y, 2000, J BIOL CHEM, V275, P12231, DOI 10.1074/jbc.275.16.12231; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MONDA KL, 2013, NAT GENET, DOI DOI 10.1038/NG.2608.[; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Qi W, 2007, EMBO J, V26, P65, DOI 10.1038/sj.emboj.7601483; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Seelan RS, 2004, ARCH BIOCHEM BIOPHYS, V431, P95, DOI 10.1016/j.abb.2004.08.002; Shin S, 2003, P NATL ACAD SCI USA, V100, P7201, DOI 10.1073/pnas.1132020100; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Smith AJP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002908; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Ting MC, 2012, DIS MODEL MECH, V5, P366, DOI 10.1242/dmm.008458; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; VISVADER J, 1991, ONCOGENE, V6, P187; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	95	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63925	10.1371/journal.pone.0063925	http://dx.doi.org/10.1371/journal.pone.0063925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717510	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700080
J	Tan, CY; Hagen, T				Tan, Chia Yee; Hagen, Thilo			mTORC1 Dependent Regulation of REDD1 Protein Stability	PLOS ONE			English	Article							HYPOXIA; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; INHIBITOR; RTP801; CELLS; GENE	REDD1 is known to be transcriptionally upregulated in hypoxia. During hypoxic stress, REDD1 plays an important role as a mediator of mTORC1 inhibition. REDD1 is also subject to highly dynamic transcriptional regulation in response to a variety of other stress signals. In addition, the REDD1 protein is highly unstable. However, it is currently not well understood how REDD1 protein stability is regulated. In this study, we discovered that mTORC1 regulates REDD1 protein stability in a 26S proteasome dependent manner. Inhibition of mTORC1 resulted in reduced REDD1 protein stability and a consequent decrease in REDD1 expression. Conversely, activation of the mTORC1 pathway increases REDD1 protein levels. We show that REDD1 degradation is not regulated by HUWE1, Cul4a or other Cullin E3 ubiquitin ligases. Our study shows that mTORC1 increases REDD1 protein stability and reveals a novel mTORC1-REDD1 feedback loop. This feedback mechanism may limit the inhibitory action of REDD1 on mTORC1.	[Tan, Chia Yee; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Biomedical Research Council, A*STAR [10/1/21/19/647]	Biomedical Research Council, A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council, A*STAR, grant number 10/1/21/19/647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Lee MH, 2004, PHARM RES-DORDR, V21, P736, DOI 10.1023/B:PHAM.0000026421.09367.b3; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	17	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63970	10.1371/journal.pone.0063970	http://dx.doi.org/10.1371/journal.pone.0063970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717519	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700086
J	Keown, JR; Griffin, MDW; Mertens, HDT; Pearce, FG				Keown, Jeremy R.; Griffin, Michael D. W.; Mertens, Haydyn D. T.; Pearce, F. Grant			Small Oligomers of Ribulose-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase Are Required for Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-BINDING INHIBITOR; SEDIMENTATION COEFFICIENT DISTRIBUTIONS; SIZE-DISTRIBUTION ANALYSIS; SCATTERING DATA-ANALYSIS; RIBULOSEBISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE; SLOW INACTIVATION; INTRINSIC FLUORESCENCE; CATALYTIC SITE	Ribulose-bisphosphate carboxylase/oxygenase (Rubisco) activase uses the energy from ATP hydrolysis to remove tight binding inhibitors from Rubisco, thus playing a key role in regulating photosynthesis in plants. Although several structures have recently added much needed structural information for different Rubisco activase enzymes, the arrangement of these subunits in solution remains unclear. In this study, we use a variety of techniques to show that Rubisco activase forms a wide range of structures in solution, ranging from monomers to much higher order species, and that the distribution of these species is highly dependent on protein concentration. The data support a model in which Rubisco activase forms an open spiraling structure rather than a closed hexameric structure. At protein concentrations of 1 mu M, corresponding to the maximal activity of the enzyme, Rubisco activase has an oligomeric state of 2-4 subunits. We propose a model in which Rubisco activase requires at least 1 neighboring subunit for hydrolysis of ATP.	[Keown, Jeremy R.; Pearce, F. Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Keown, Jeremy R.; Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Mertens, Haydyn D. T.] Australian Synchrotron, Clayton, Vic 3168, Australia	University of Canterbury; University of Canterbury; University of Melbourne	Pearce, FG (corresponding author), Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8140, New Zealand.	grant.pearce@canterbury.ac.nz	Keown, Jeremy/AAH-4361-2021	Keown, Jeremy/0000-0003-0159-9257; Griffin, Michael/0000-0001-9845-7735; Mertens, Haydyn/0000-0002-5664-744X; Pearce, Frederick/0000-0002-2683-0331	Australian Research Council [DP110103528]; Marsden Fund [UOC0902]	Australian Research Council(Australian Research Council); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Recipient of an Australian Research Council Postdoctoral Fellowship, Project DP110103528.; Supported by the Marsden Fund Grant UOC0902. To whom correspondence should be addressed. Tel.: 64-3-364-2987 (ext. 45722); Fax: 64-3-364-2590; E-mail: grant.pearce@canterbury.ac.nz.	Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; BERRY JA, 1987, P NATL ACAD SCI USA, V84, P734, DOI 10.1073/pnas.84.3.734; Blayney MJ, 2011, J AM SOC MASS SPECTR, V22, P1588, DOI 10.1007/s13361-011-0187-8; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2004, METHOD ENZYMOL, V384, P185; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1383, DOI 10.1104/pp.93.4.1383; EDMONDSON DL, 1990, FEBS LETT, V260, P62, DOI 10.1016/0014-5793(90)80066-R; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1390, DOI 10.1104/pp.93.4.1390; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; GUREVITZ M, 1985, P NATL ACAD SCI USA, V82, P6546, DOI 10.1073/pnas.82.19.6546; GUTTERIDGE S, 1986, NATURE, V324, P274, DOI 10.1038/324274a0; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KEYS AJ, 1995, J EXP BOT, V46, P1245, DOI 10.1093/jxb/46.special_issue.1245; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Lilley RM, 1997, PLANT PHYSIOL, V114, P605, DOI 10.1104/pp.114.2.605; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Paul MJ, 1996, J EXP BOT, V47, P1963, DOI 10.1093/jxb/47.12.1963; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PON NG, 1963, BIOCHEM Z, V338, P7; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2002, PHOTOSYNTH RES, V73, P257, DOI 10.1023/A:1020423802875; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; ROBINSON SP, 1988, PLANT PHYSIOL, V88, P1008, DOI 10.1104/pp.88.4.1008; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; Salvucci ME, 1996, PHOTOSYNTH RES, V47, P1, DOI 10.1007/BF00017748; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; WANG ZY, 1993, BIOCHIM BIOPHYS ACTA, V1202, P47, DOI 10.1016/0167-4838(93)90061-U; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Zhu GH, 1998, PHOTOSYNTH RES, V55, P67, DOI 10.1023/A:1005989012003; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354; ZHU GH, 1991, PLANT PHYSIOL, V97, P1348, DOI 10.1104/pp.97.4.1348	59	25	25	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20607	20615		10.1074/jbc.M113.466383	http://dx.doi.org/10.1074/jbc.M113.466383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720775	Green Published, hybrid			2022-12-25	WOS:000321715100046
J	Minogue, PJ; Beyer, EC; Berthoud, VM				Minogue, Peter J.; Beyer, Eric C.; Berthoud, Viviana M.			A Connexin50 Mutant, CX50fs, That Causes Cataracts Is Unstable, but Is Rescued by a Proteasomal Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONS; CONGENITAL CATARACTS; ATRIAL-FIBRILLATION; LIFE-CYCLE; WILD-TYPE; DEGRADATION; LENS; MUTATIONS; CHANNELS; PATHWAY	The mechanisms by which mutant connexins lead to disease are diverse, including those of connexin50 (CX50) encoded by the GJA8 gene. We investigated the cellular and functional behavior of CX50fs, a mutant CX50 that has a frameshift after amino acid 255 and causes recessive congenital cataracts. Cellular levels of CX50fs were much lower than those of wild type CX50 in stably transfected HeLa cells. Whereas CX50 localized at distinct gap junction plaques and supported extensive intercellular transfer of Neurobiotin, CX50fs gap junctions were rare, and their support of Neurobiotin transfer was reduced by >90%. After inhibition of new protein synthesis with cycloheximide, CX50fs disappeared much more rapidly than CX50, suggesting increased degradation of the mutant. Treatment of cells with epoxomicin (a proteasomal inhibitor) led to a dramatic increase in CX50fs levels and in the abundance of gap junctions. Epoxomicin treatment also rescued intercellular transfer of Neurobiotin to levels similar to those in cells expressing the wild type protein. Treatment with eeyarestatin I (an inhibitor of p97-dependent protein degradation) resulted in many abundant slowly migrating CX50 and CX50fs bands consistent with polyubiquitination of the proteins. These results demonstrate that the CX50fs mutant is rapidly degraded by endoplasmic reticulum-associated degradation in mammalian cells. This accelerated degradation reduces the abundance of gap junctions and the extent of intercellular communication, potentially explaining the pathogenesis of cataracts linked to this mutant. The efficacy of epoxomicin in restoring function suggests that protease inhibition might have therapeutic value for this and other diseases caused by mutants with similar defects.	[Minogue, Peter J.; Beyer, Eric C.; Berthoud, Viviana M.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, 900 E 57th St,KCBD 5, Chicago, IL 60637 USA.	vberthou@peds.bsd.uchicago.edu		Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [R01EY08368]; NATIONAL EYE INSTITUTE [R01EY008368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant R01EY08368.	Abrams CK, 2012, BBA-BIOMEMBRANES, V1818, P2030, DOI 10.1016/j.bbamem.2011.08.015; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Berthoud VM, 2003, EUR J CELL BIOL, V82, P209, DOI 10.1078/0171-9335-00316; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; DeRosa AM, 2007, J CELL SCI, V120, P4107, DOI 10.1242/jcs.012237; DeRosa AM, 2006, INVEST OPHTH VIS SCI, V47, P4474, DOI 10.1167/iovs.05-1582; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Dunn CA, 2012, J BIOL CHEM, V287, P2600, DOI 10.1074/jbc.M111.276261; Eckert R, 2002, PFLUG ARCH EUR J PHY, V443, P843, DOI 10.1007/s00424-001-0760-2; Girao H, 2003, MOL VIS, V9, P24; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Kaffy J, 2013, CURR PHARM DESIGN, V19, P4115, DOI 10.2174/1381612811319220016; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Lichtenstein A, 2009, EXP EYE RES, V88, P600, DOI 10.1016/j.exer.2008.11.024; Lin JS, 1998, EUR J CELL BIOL, V76, P246; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Pal JD, 1999, AM J PHYSIOL-CELL PH, V276, pC1443, DOI 10.1152/ajpcell.1999.276.6.C1443; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Pereira P, 2003, EXP EYE RES, V76, P623, DOI 10.1016/S0014-4835(03)00020-4; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Rong P, 2002, DEVELOPMENT, V129, P167; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schmidt W, 2008, MOL VIS, V14, P851; Scott CA, 2011, BIOCHEM J, V438, P245, DOI 10.1042/BJ20110278; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Thibodeau IL, 2010, CIRCULATION, V122, P236, DOI 10.1161/CIRCULATIONAHA.110.961227; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Wilke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052070; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2008, CELL COMMUN ADHES, V15, P1, DOI 10.1080/15419060802253663	51	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20427	20434		10.1074/jbc.M113.452847	http://dx.doi.org/10.1074/jbc.M113.452847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720739	Green Published, hybrid			2022-12-25	WOS:000321715100030
J	White, EA; Raghuraman, H; Perozo, E; Glotzer, M				White, Erin A.; Raghuraman, Hariharasundaram; Perozo, Eduardo; Glotzer, Michael			Binding of the CYK-4 Subunit of the Centralspindlin Complex Induces a Large Scale Conformational Change in the Kinesin Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; CULTURED EPITHELIAL-CELLS; CENTRAL SPINDLE; CRYSTAL-STRUCTURE; CLEAVAGE FURROW; DISTANCE MEASUREMENTS; CONTRACTILE RING; CYTOKINESIS; PROTEIN; MICROTUBULES	Centralspindlin is a critical regulator of cytokinesis in animal cells. It is a tetramer consisting of ZEN-4/MKLP1, a kinesin-6 motor, and CYK-4/MgcRacGAP, a Rho GTPase-activating protein. At anaphase, centralspindlin localizes to a narrow region of antiparallel microtubule overlap and initiates central spindle assembly. Central spindle assembly requires complex formation between ZEN-4 and CYK-4. However, the structural consequences of CYK-4 binding to ZEN-4 are unclear as are the mechanisms of microtubule bundling. Here we investigate whether CYK-4 binding induces a conformational change in ZEN-4. Characterization of the structure and conformational dynamics of the minimal interacting regions between ZEN-4 and CYK-4 by continuous wave EPR and double electron-electron resonance (DEER) spectroscopy reveals that CYK-4 binding dramatically stabilizes the relative positions of the neck linker regions of ZEN-4. Additionally, our data indicate that each neck linker is similarly structured in the bound and unbound states. CYK-4 binding decreases the rate of ZEN-4-mediated microtubule gliding. These results constrain models for the molecular organization of centralspindlin.	[White, Erin A.; Perozo, Eduardo] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Raghuraman, Hariharasundaram; Glotzer, Michael] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Glotzer, M (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	mglotzer@uchicago.edu		Glotzer, Michael/0000-0002-8723-7232; Raghuraman, H./0000-0001-9106-8278	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074743, R01GM085087, T32GM007183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074743, R01 GM085087, T32 GM007183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Alsop GB, 2003, J CELL BIOL, V162, P383, DOI 10.1083/jcb.200301073; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; FAIRMAN R, 1995, PROTEIN SCI, V4, P1457, DOI 10.1002/pro.5560040803; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2006, J MAGN RESON, V180, P137, DOI 10.1016/j.jmr.2006.02.002; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simossis VA, 2003, COMPUT BIOL CHEM, V27, P511, DOI 10.1016/j.compbiolchem.2003.09.002; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Wade RH, 2000, NAT STRUCT BIOL, V7, P456, DOI 10.1038/75850; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	43	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19785	19795		10.1074/jbc.M113.463695	http://dx.doi.org/10.1074/jbc.M113.463695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720745	Green Published, hybrid			2022-12-25	WOS:000321515800047
J	Adler, WT; Platt, MP; Mehlhorn, AJ; Haight, JL; Currier, TA; Etchegaray, MA; Galaburda, AM; Rosen, GD				Adler, William T.; Platt, Maryann P.; Mehlhorn, Alison J.; Haight, Joshua L.; Currier, Timothy A.; Etchegaray, Mikel A.; Galaburda, Albert M.; Rosen, Glenn D.			Position of Neocortical Neurons Transfected at Different Gestational Ages with shRNA Targeted against Candidate Dyslexia Susceptibility Genes	PLOS ONE			English	Article							DOUBLECORTIN-LIKE-KINASE; IN-UTERO RNAI; DEVELOPMENTAL DYSLEXIA; KIAA0319; DCDC2; MIGRATION; DYX1C1; ASSOCIATION; EXPRESSION; ENCODES	Developmental dyslexia is a language learning disorder that affects approximately 4-10% of the population. A number of candidate dyslexia susceptibility genes have been identified, including DCDC2 and KIAA0319 on Chromosome (Chr) 6p22.2 and DYX1C1 on Chr 15q21. Embryonic knockdown of the function of homologs of these genes in rat neocortical projection cell progenitors by in utero electroporation of plasmids encoding small hairpin RNA (shRNA) revealed that all three genes disrupted neuronal migration to the neocortex. Specifically, this disruption would result in heterotopia formation (Dyx1c1 and Kiaa0319) and/or overmigration past their expected laminar location (Dyx1c1 and Dcdc2). In these experiments, neurons normally destined for the upper neocortical lamin were transfected on embryonic day (E) 15.5, and we designed experiments to test whether these migration phenotypes were the result of targeting a specific type of projection neuron. We transfected litters with Dcdc2 shRNA, Dyx1c1 shRNA, Kiaa0319 shRNA, or fluorescent protein (as a control) at each of three gestational ages (E14.5, E15.5, or E16.5). Pups were allowed to come to term, and their brains were examined at 3 weeks of age for the position of transfected cells. We found that age of transfection did not affect the percentage of unmigrated neurons-transfection with Kiaa0319 shRNA resulted in heterotopia formation at all three ages. Overmigration of neurons transfected with Dcdc2 shRNA, while present following transfections at the later ages, did not occur following E14.5 transfections. These results are considered in light of the known functions of each of these candidate dyslexia susceptibility genes.	[Adler, William T.; Platt, Maryann P.; Mehlhorn, Alison J.; Haight, Joshua L.; Currier, Timothy A.; Etchegaray, Mikel A.; Galaburda, Albert M.; Rosen, Glenn D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Rosen, GD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	grosen@bidmc.harvard.edu	Adler, William/AAC-9146-2022	Platt, Maryann/0000-0001-8900-1226; Rosen, Glenn/0000-0001-8281-5446; Haight, Joshua/0000-0003-1508-4123; Adler, William/0000-0003-4720-7861	NIH [P01 HD057853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported by NIH grant P01 HD057853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthoni H, 2012, BEHAV GENET, V42, P509, DOI 10.1007/s10519-012-9532-3; Bates T. C., 2009, MOL PSYCHIAT; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Chang BS, 2007, NEUROLOGY, V69, P2146, DOI 10.1212/01.wnl.0000286365.41070.54; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Currier TA, 2011, NEUROSCIENCE, V172, P535, DOI 10.1016/j.neuroscience.2010.11.002; Dahdouh F, 2009, PSYCHIAT GENET; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Galaburda AM, 1978, T AM NEUROL ASSOC, V103, P1; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Kirsten H, 2012, PSYCHIAT GENET, V22, P216, DOI 10.1097/YPG.0b013e32834c0c97; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Lind PA, 2010, EUR J HUM GENET; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Luciano M, 2007, BIOL PSYCHIAT, V62, P811, DOI 10.1016/j.biopsych.2007.03.007; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Marino C, 2012, PSYCHIAT GENET, V22, P25, DOI 10.1097/YPG.0b013e32834acdb2; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Massinen S, 2009, HUM MOL GENET, V18, P2802, DOI 10.1093/hmg/ddp215; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Szalkowski CE, 2011, GENES BRAIN BEHAV, V10, P244, DOI 10.1111/j.1601-183X.2010.00662.x; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2012, BIOL PSYCHIAT; Tammimies K, 2012, MOL ENDOCRINOL, V26, P619, DOI 10.1210/me.2011-1376; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Velayos-Baeza A, 2008, HUM MOL GENET, V17, P859, DOI 10.1093/hmg/ddm358; Velayos-Baeza A, 2007, MAMM GENOME, V18, P627, DOI 10.1007/s00335-007-9051-3; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Wilcke A, 2009, ANN DYSLEXIA, V59, P1, DOI 10.1007/s11881-008-0020-7; Zhang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042969; Zuo PX, 2012, CHINESE MED J-PEKING, V125, P622, DOI 10.3760/cma.j.issn.0366-6999.2012.04.012	49	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65179	10.1371/journal.pone.0065179	http://dx.doi.org/10.1371/journal.pone.0065179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724130	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000123
J	Chaiyachati, KH; Loveday, M; Lorenz, S; Lesh, N; Larkan, LM; Cinti, S; Friedland, GH; Haberer, JE				Chaiyachati, Krisda H.; Loveday, Marian; Lorenz, Stephen; Lesh, Neal; Larkan, Lee-Megan; Cinti, Sandro; Friedland, Gerald H.; Haberer, Jessica E.			A Pilot Study of an mHealth Application for Healthcare Workers: Poor Uptake Despite High Reported Acceptability at a Rural South African Community-Based MDR-TB Treatment Program	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CLUSTER-RANDOMIZED-TRIAL; XDR-TB; ADHERENCE; HIV; INTERVENTION; SYMPTOMS; MODEL	Introduction: As the South African province of KwaZulu-Natal addresses a growing multidrug-resistant tuberculosis (MDR-TB) epidemic by shifting care and treatment from trained specialty centers to community hospitals, delivering and monitoring MDR-TB therapy has presented new challenges. In particular, tracking and reporting adverse clinical events have been difficult for mobile healthcare workers (HCWs), trained health professionals who travel daily to patient homes to administer and monitor therapy. We designed and piloted a mobile phone application (Mobilize) for mobile HCWs that electronically standardized the recording and tracking of MDR-TB patients on low-cost, functional phones. Objective: We assess the acceptability and feasibility of using Mobilize to record and submit adverse events forms weekly during the intensive phase of MDR-TB therapy and evaluate mobile HCW perceptions throughout the pilot period. Methods: All five mobile HCWs at one site were trained and provided with phones. Utilizing a mixed-methods evaluation, mobile HCWs' usage patterns were tracked electronically for seven months and analyzed. Qualitative focus groups and questionnaires were designed to understand the impact of mobile phone technology on the work environment. Results: Mobile HCWs submitted nine of 33 (27%) expected adverse events forms, conflicting with qualitative results in which mobile HCWs stated that Mobilize improved adverse events communication, helped their daily workflow, and could be successfully expanded to other health interventions. When presented with the conflict between their expressed views and actual practice, mobile HCWs cited forgetfulness and believed patients should take more responsibility for their own care. Discussion: This pilot experience demonstrated poor uptake by HCWs despite positive responses to using mHealth. Though our results should be interpreted cautiously because of the small number of mobile HCWs and MDR-TB patients in this study, we recommend carefully exploring the motivations of HCWs and technologic enhancements prior to scaling new mHealth initiatives in resource poor settings.	[Chaiyachati, Krisda H.; Friedland, Gerald H.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Chaiyachati, Krisda H.; Friedland, Gerald H.] Tugela Ferry Care & Res Collaborat TF CARES, Tugela Ferry, South Africa; [Loveday, Marian] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Loveday, Marian] Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa; [Lorenz, Stephen] Massachusetts Gen Hosp, Comp Sci Lab, Boston, MA 02114 USA; [Lesh, Neal] Dimagi Inc, Charlestown, MA USA; [Larkan, Lee-Megan] KwaZulu Natal Dept Hlth, Greytown, South Africa; [Cinti, Sandro] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Cinti, Sandro] Vet Affairs Ann Arbor Hlth Syst, Ann Arbor, MI USA; [Haberer, Jessica E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Yale University; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chaiyachati, KH (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	Krisda.Chaiyachati@yale.edu	Haberer, Jessica/AAH-7976-2019; Loveday, Marian/M-8016-2013	Haberer, Jessica/0000-0001-5845-3190; Loveday, Marian/0000-0001-9205-9314; Chaiyachati, Krisda/0000-0003-3326-6641	Infectious Disease Society of America through the Medical Scholars Program; International Institute at the University of Michigan; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	Infectious Disease Society of America through the Medical Scholars Program; International Institute at the University of Michigan; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We received financial support from the Infectious Disease Society of America through the Medical Scholars Program and the International Institute at the University of Michigan through the Individual Fellowship Award. Neither the Infectious Disease Society of American nor the International Institute at the University of Michigan had any role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review or approval of the manuscript.	Al-Dakkak I, 2012, AIDS CARE; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Creswell JW, 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; DeRenzi B, 2011, MT SINAI J MED, V78, P406, DOI 10.1002/msj.20256; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Grameen Foundation, 2011, MOB TECHN COMM HLTH; Haberer JE, 2010, AIDS BEHAV, V14, P1294, DOI 10.1007/s10461-010-9720-1; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Jansen YJFM, 2010, EUR J PUBLIC HEALTH, V20, P220, DOI 10.1093/eurpub/ckp085; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Loveday M, 2011, TROP MED INT HLTH; Loveday M, 2012, TREATMENT OUTCOMES D; Padayatchi N, 2008, INT J TUBERC LUNG D, V12, P978; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; South African Department of Health, 2009, GUID MAN DRUG RES TB, P109; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Statistics South Africa, 2011, MID YEAR POP EST 201; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zwarenstein M, 2009, J CLIN EPIDEMIOL, V62, P461, DOI 10.1016/j.jclinepi.2009.01.011	33	65	65	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64662	10.1371/journal.pone.0064662	http://dx.doi.org/10.1371/journal.pone.0064662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155FM	23724075	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000076
J	Garg, A; Manidhar, DM; Gokara, M; Malleda, C; Reddy, CS; Subramanyam, R				Garg, Archit; Manidhar, Darla Mark; Gokara, Mahesh; Malleda, Chandramouli; Reddy, Cirandur Suresh; Subramanyam, Rajagopal			Elucidation of the Binding Mechanism of Coumarin Derivatives with Human Serum Albumin	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; GENETIC ALGORITHM; FATTY-ACIDS; CRYSTALLOGRAPHIC ANALYSIS; CRYSTAL-STRUCTURE; LIGAND-BINDING; BETULINIC ACID; RETINOIC ACID; PROTEIN; SITES	Coumarin is a benzopyrone which is widely used as an anti-coagulant, anti-oxidant, anti-cancer and also to cure arthritis, herpes, asthma and inflammation. Here, we studied the binding of synthesized coumarin derivatives with human serum albumin (HSA) at physiological pH 7.2 by using fluorescence spectroscopy, circular dichroism spectroscopy, molecular docking and molecular dynamics simulation studies. By addition of coumarin derivatives to HSA the maximum fluorescence intensity was reduced due to quenching of intrinsic fluorescence upon binding of coumarin derivatives to HSA. The binding constant and free energy were found to be 1.957 +/- 0.01x10(5) M-1, -7.175 Kcal M-1 for coumarin derivative (CD) enamide; 0.837 +/- 0.01x10(5) M-1, -6.685 Kcal M-1 for coumarin derivative (CD) enoate, and 0.606 +/- 0.01x10(5) M-1, -6.49 Kcal M-1 for coumarin derivative methylprop (CDM) enamide. The CD spectroscopy showed that the protein secondary structure was partially unfolded upon binding of coumarin derivatives. Further, the molecular docking studies showed that coumarin derivatives were binding to HSA at sub-domain IB with the hydrophobic interactions and also with hydrogen bond interactions. Additionally, the molecular dynamics simulations studies contributed in understanding the stability of protein-drug complex system in the aqueous solution and the conformational changes in HSA upon binding of coumarin derivatives. This study will provide insights into designing of the new inspired coumarin derivatives as therapeutic agents against many life threatening diseases.	[Garg, Archit; Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India; [Manidhar, Darla Mark; Reddy, Cirandur Suresh] Sri Venkateswara Univ, Dept Chem, Tirupati, Andhrapradesh, India; [Gokara, Mahesh; Malleda, Chandramouli] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; Sri Venkateswara University; University of Hyderabad	Subramanyam, R (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	srgsl@uohyd.ernet.in	Gokara, Mahesh/G-1061-2011; Garg, Archit/H-6179-2013	Gokara, Mahesh/0000-0001-7095-887X; Garg, Archit/0000-0002-5931-2522	Department of Science and Technology [SR/SO/BB-0123/2010]; University of Hyderabad (UPE-II), India	Department of Science and Technology(Department of Science & Technology (India)); University of Hyderabad (UPE-II), India	RS thanks the Department of Science and Technology (No. SR/SO/BB-0123/2010) and University of Hyderabad (UPE-II), India, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Allouche AR, 2011, J COMPUT CHEM, V32, P174, DOI 10.1002/jcc.21600; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; BOURINBAIAR AS, 1993, ACTA VIROL, V37, P21; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1985, P NATL ACAD SCI USA, V82, P8458, DOI 10.1073/pnas.82.24.8458; BYE A, 1970, BIOCHEM J, V117, P237, DOI 10.1042/bj1170237; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CASE DA, 1979, J MOL BIOL, V132, P343, DOI 10.1016/0022-2836(79)90265-1; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Cheng ZJ, 2012, MOL BIOL REP, V39, P9493, DOI 10.1007/s11033-012-1814-6; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; de Julian-Ortiz JV, 1999, J MED CHEM, V42, P3308, DOI 10.1021/jm981132u; Farinola Nicholas, 2005, Lymphatic Research and Biology, V3, P81, DOI 10.1089/lrb.2005.3.81; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HOULT JRS, 1994, AGENTS ACTIONS, V42, P44, DOI 10.1007/BF02014299; Il'ichev YV, 2002, CHEM-BIOL INTERACT, V141, P275, DOI 10.1016/S0009-2797(02)00078-9; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kandagal PB, 2008, J PHARMACEUT BIOMED, V47, P260, DOI 10.1016/j.jpba.2008.01.027; Karnaukhova E, 2007, BIOCHEM PHARMACOL, V73, P901, DOI 10.1016/j.bcp.2006.11.023; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kiselev MA, 2001, BIOFIZIKA+, V46, P423; Krishnakumar SS, 2002, BIOCHEMISTRY-US, V41, P7443, DOI 10.1021/bi025699v; Kubarych CJ, 2010, ORG LETT, V12, P4780, DOI 10.1021/ol101906g; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Malleda C, 2012, J MOL MODEL, V18, P2589, DOI 10.1007/s00894-011-1287-x; Manidhar DM, 2012, J KOREAN CHEM SOC, V56, P459, DOI 10.5012/jkcs.2012.56.4.459; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLER WE, 1979, PHARMACOLOGY, V19, P59, DOI 10.1159/000137289; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; Neelam S, 2010, J PHYS CHEM B, V114, P3005, DOI 10.1021/jp910156k; NILSSON L, 1986, J MOL BIOL, V188, P455, DOI 10.1016/0022-2836(86)90168-3; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Pils B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-210; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shobini J, 2001, SPECTROCHIM ACTA A, V57, P1133, DOI 10.1016/S1386-1425(00)00492-3; Singh R, 2010, FOOD CHEM, V120, P825, DOI 10.1016/j.foodchem.2009.11.022; Sinha SS, 2008, J PHYS CHEM B, V112, P4884, DOI 10.1021/jp709809b; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V95, P81, DOI 10.1016/j.jphotobiol.2009.01.002; Sudhamalla B, 2010, J PHYS CHEM B, V114, P9054, DOI 10.1021/jp102730p; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Yue YY, 2009, J PHARMACEUT BIOMED, V49, P753, DOI 10.1016/j.jpba.2008.12.017; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	63	49	50	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63805	10.1371/journal.pone.0063805	http://dx.doi.org/10.1371/journal.pone.0063805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724004	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000027
J	Haseneder, R; Starker, L; Berkmann, J; Kellermann, K; Jungwirth, B; Blobner, M; Eder, M; Kochs, E; Rammes, G				Haseneder, Rainer; Starker, Laura; Berkmann, Jasmin; Kellermann, Kristine; Jungwirth, Bettina; Blobner, Manfred; Eder, Matthias; Kochs, Eberhard; Rammes, Gerhard			Sevoflurane Anesthesia Improves Cognitive Performance in Mice, but Does Not Influence In Vitro Long-Term Potentation in Hippocampus CA1 Stratum Radiatum	PLOS ONE			English	Article							MODIFIED HOLE BOARD; NITROUS OXIDE ANESTHESIA; PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; SPATIAL MEMORY; VOLATILE ANESTHETICS; GENERAL-ANESTHESIA; RAT HIPPOCAMPUS; AGED RATS; DDN MICE	Background: Whether the occurrence of postoperative cognitive dysfunction is a result of the effects of surgery or anesthesia is under debate. In this study, we investigated the impact of sevoflurane anesthesia on cognitive performance and cellular mechanisms involved in learning and memory. Methods: Male C57Bl6/J mice (4-5 months) were exposed to one minimum alveolar concentration sevoflurane for two hours. After 24 h, cognitive performance of mice was assessed using the modified hole board test. Additionally, we evaluated hippocampal long-term potentiation and expression levels of different receptor subunits by recording excitatory postsynaptic field potentials and using the western blot technique, respectively. Non-anesthetized mice served as controls. Results: In anesthetized mice, neither cognitive performance nor long-term potentiation was impaired 24 h after anesthesia. Interestingly, sevoflurane anesthesia induced even an improvement of cognitive performance and an elevation of the expression levels of N-methyl-D-aspartate (NMDA) receptor type 1 and 2B subunits in the hippocampus. Conclusions: Since NMDA receptor type 1 and 2B subunits play a crucial role in processes related to learning and memory, we hypothesize that sevoflurane-induced changes in NMDA receptor subunit composition might cause hippocampus-dependent cognitive improvement. The data of the present study are in favor of a minor role of anesthesia in mediating postoperative cognitive dysfunction.	[Haseneder, Rainer; Starker, Laura; Berkmann, Jasmin; Kellermann, Kristine; Jungwirth, Bettina; Blobner, Manfred; Kochs, Eberhard; Rammes, Gerhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-80290 Munich, Germany; [Eder, Matthias] Max Planck Inst Psychiat, Res Grp Neuronal Network Dynam, D-80804 Munich, Germany	Technical University of Munich; Max Planck Society	Haseneder, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-80290 Munich, Germany.	r.haseneder@lrz.tum.de	Blobner, Manfred/R-4411-2017	Blobner, Manfred/0000-0002-0370-5247; Jungwirth, Bettina/0000-0001-9749-7460; Eder, Matthias/0000-0002-2579-2628				Alkire MT, 2005, ANESTHESIOLOGY, V103, P1167, DOI 10.1097/00000542-200512010-00010; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cain DP, 1997, CURR OPIN NEUROBIOL, V7, P235, DOI 10.1016/S0959-4388(97)80012-8; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Clayton DA, 2002, J NEUROSCI, V22, P3628; Criswell HE, 2004, BRAIN RES, V1015, P107, DOI 10.1016/j.brainres.2004.04.050; Crosby C, 2005, ANESTH ANALG, V101, P1389, DOI 10.1213/01.ANE.0000180835.72669.AD; Culley DJ, 2006, EUR J PHARMACOL, V549, P71, DOI 10.1016/j.ejphar.2006.08.028; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Futterer CD, 2004, ANESTHESIOLOGY, V100, P302; Gordan ML, 2012, BEHAV BRAIN RES, V235, P7, DOI 10.1016/j.bbr.2012.07.027; Hirota K, 1998, TOXICOL LETT, V101, P203, DOI 10.1016/S0378-4274(98)00186-6; Holscher C, 1999, J NEUROSCI RES, V58, P62; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Ishizeki J, 2008, ANESTHESIOLOGY, V108, P447, DOI 10.1097/ALN.0b013e318164cfba; Jungwirth Bettina, 2008, Central Nervous System Agents in Medicinal Chemistry, V8, P37; Komatsu H, 1997, CLIN EXP PHARMACOL P, V24, P706, DOI 10.1111/j.1440-1681.1997.tb02116.x; KOMATSU H, 1993, ANESTH ANALG, V76, P609; KOMATSU H, 1991, ANESTH ANALG, V73, P295; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; MACIVER MB, 1989, BRIT J ANAESTH, V62, P301, DOI 10.1093/bja/62.3.301; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; Moe MC, 2003, J NEUROSURG ANESTH, V15, P209, DOI 10.1097/00008506-200307000-00008; Nagashima K, 2005, ANESTHESIOLOGY, V103, P318, DOI 10.1097/00000542-200508000-00015; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Nishikawa K, 2005, BRAIN RES, V1039, P153, DOI 10.1016/j.brainres.2005.01.060; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; Ohl F, 2003, EUR J PHARMACOL, V480, P219, DOI 10.1016/j.ejphar.2003.08.108; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Ramakers GMJ, 1997, PROG NEURO-PSYCHOPH, V21, P455, DOI 10.1016/S0278-5846(97)00013-4; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Rampil IJ, 2006, ANESTH ANALG, V102, P1431, DOI 10.1213/01.ane.0000202384.96269.51; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Sasaki R, 2002, ANESTHESIOLOGY, V96, P681, DOI 10.1097/00000542-200203000-00026; Scheller M, 1997, ANESTHESIOLOGY, V86, P118, DOI 10.1097/00000542-199701000-00016; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Shin WJ, 2003, ANESTH ANALG, V96, P1340, DOI 10.1213/01.ANE.0000055365.31940.0A; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vinje ML, 2002, ACTA ANAESTH SCAND, V46, P103, DOI 10.1046/j.0001-5172.2001.00412.x; White TL, 2004, BRAIN RES, V1021, P1, DOI 10.1016/j.brainres.2004.05.114; Zhao X, 2009, NEUROSCIENCE, V162, P933, DOI 10.1016/j.neuroscience.2009.05.018	51	24	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64732	10.1371/journal.pone.0064732	http://dx.doi.org/10.1371/journal.pone.0064732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724087	Green Published, gold			2022-12-25	WOS:000319733000088
J	Lamprou, DA; Venkatpurwar, V; Kumar, MNVR				Lamprou, Dimitrios A.; Venkatpurwar, Vinod; Kumar, M. N. V. Ravi			Atomic Force Microscopy Images Label-Free, Drug Encapsulated Nanoparticles In Vivo and Detects Difference in Tissue Mechanical Properties of Treated and Untreated: A Tip for Nanotoxicology	PLOS ONE			English	Article							DIABETES-MELLITUS; ORAL DELIVERY; NANOMEDICINE; STIFFNESS; DESIGN; SYSTEM; CANCER; CELLS	Overcoming the intractable challenge of imaging of label-free, drug encapsulated nanoparticles in tissues in vivo would directly address associated regulatory concerns over 'nanotoxicology'. Here we demonstrate the utility of Atomic Force Microscopy (AFM) for visualising label-free, drug encapsulated polyester particles of similar to 280 nm distributed within tissues following their intravenous or peroral administration to rodents. A surprising phenomenon, in which the tissues' mechanical stiffness was directly measured (also by AFM) and related to the number of embedded nanoparticles, was utilised to generate quantitative data sets for nanoparticles localisation. By coupling the normal determination of a drug's pharmacokinetics/pharmacodynamics with post-sacrifice measurement of nanoparticle localisation and number, we present for the first time an experimental design in which a single in vivo study relates the PK/PD of a nanomedicine to its toxicokinetics.	[Lamprou, Dimitrios A.; Venkatpurwar, Vinod; Kumar, M. N. V. Ravi] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde	Lamprou, DA (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	dimitrios.lamprou@strath.ac.uk; mnvrkumar@strath.ac.uk	Lamprou, Dimitrios/ABB-6826-2020; Lamprou, Dimitrios A./C-4546-2014	Lamprou, Dimitrios A./0000-0002-8740-1661	Cunningham Trust [ACC/KWF/CT10/01]; Engineering and Physical Sciences Research Council [EP/E036244/1]; EPSRC [EP/E036244/1] Funding Source: UKRI	Cunningham Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The partial financial support by the Cunningham Trust (ACC/KWF/CT10/01) to MNVRK is acknowledged. The authors acknowledge the instrument support from the Engineering and Physical Sciences Research Council (grant EP/E036244/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Forsyth AM, 2010, MICROVASC RES, V80, P37, DOI 10.1016/j.mvr.2010.03.008; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Kalaria DR, 2009, PHARM RES-DORDR, V26, P492, DOI 10.1007/s11095-008-9763-4; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; Maugis D., 2000, CONTACT ADHESION RUP; Merchante N, 2012, HEPATOLOGY, V56, P228, DOI 10.1002/hep.25616; Moghimi SM, 2012, ADV DRUG DELIVER REV, V64, P1385, DOI 10.1016/j.addr.2012.05.010; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Ratnam DV, 2013, CHEM REV, V113, P1686; Rosen H, 2005, NAT REV DRUG DISCOV, V4, P381, DOI 10.1038/nrd1721; Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117, DOI 10.1681/ASN.V12102117; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Tong L, 2007, J PHYS CHEM B, V111, P9980, DOI 10.1021/jp073478z; Tsukada K, 2001, MICROVASC RES, V61, P231, DOI 10.1006/mvre.2001.2307; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866	26	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64490	10.1371/journal.pone.0064490	http://dx.doi.org/10.1371/journal.pone.0064490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724054	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319733000061
J	Sarkar, S; Germeraad, WTV; Rouschop, KMA; Steeghs, EMP; van Gelder, M; Bos, GMJ; Wieten, L				Sarkar, Subhashis; Germeraad, Wilfred T. V.; Rouschop, Kasper M. A.; Steeghs, Elisabeth M. P.; van Gelder, Michel; Bos, Gerard M. J.; Wieten, Lotte			Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELL; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; CLASS-I; INDUCIBLE FACTOR-1-ALPHA; OXYGEN-TENSION; NKG2D LIGANDS; CANCER-CELLS; IMMUNOTHERAPY; EXPRESSION	Background: Multiple Myeloma (MM) is an incurable plasma cell malignancy residing within the bone marrow (BM). We aim to develop allogeneic Natural Killer (NK) cell immunotherapy for MM. As the BM contains hypoxic regions and the tumor environment can be immunosuppressive, we hypothesized that hypoxia inhibits NK cell anti-MM responses. Methods: NK cells were isolated from healthy donors by negative selection and NK cell function and phenotype were examined at oxygen levels representative of hypoxic BM using flowcytometry. Additionally, NK cells were activated with IL-2 to enhance NK cell cytotoxicity under hypoxia. Results: Hypoxia reduced NK cell killing of MM cell lines in an oxygen dependent manner. Under hypoxia, NK cells maintained their ability to degranulate in response to target cells, though, the percentage of degranulating NK cells was slightly reduced. Adaptation of NK- or MM cells to hypoxia was not required, hence, the oxygen level during the killing process was critical. Hypoxia did not alter surface expression of NK cell ligands (HLA-ABC, -E, MICA/B and ULBP1-2) and receptors (KIR, NKG2A/C, DNAM-1, NCRs and 2B4). It did, however, decrease expression of the activating NKG2D receptor and of intracellular perforin and granzyme B. Pre-activation of NK cells by IL-2 abrogated the detrimental effects of hypoxia and increased NKG2D expression. This emphasized that activated NK cells can mediate anti-MM effects, even under hypoxic conditions. Conclusions: Hypoxia abolishes the killing potential of NK cells against multiple myeloma, which can be restored by IL-2 activation. Our study shows that for the design of NK cell-based immunotherapy it is necessary to study biological interactions between NK- and tumor cells also under hypoxic conditions.	[Sarkar, Subhashis; Germeraad, Wilfred T. V.; Steeghs, Elisabeth M. P.; van Gelder, Michel; Bos, Gerard M. J.] Maastricht Univ Med Ctr, Div Hematol, Dept Internal Med, Maastricht, Netherlands; [Rouschop, Kasper M. A.] Maastricht Univ Med Ctr, Dept Radiat Oncol, Maastro Lab, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Wieten, Lotte] Maastricht Univ Med Ctr, Dept Transplantat Immunol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Wieten, L (corresponding author), Maastricht Univ Med Ctr, Dept Transplantat Immunol, Maastricht, Netherlands.	lotte.wieten@maastrichtuniversity.nl	Steeghs, Elisabeth M.P./E-2498-2018	Steeghs, Elisabeth M.P./0000-0002-4164-5652; Rouschop, Kasper/0000-0002-4208-5415	GROW, School of Oncology and Developmental Biology, Maastricht University Medical Center+; STFC [ST/I001719/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001719/1] Funding Source: researchfish	GROW, School of Oncology and Developmental Biology, Maastricht University Medical Center+; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This study was supported by a PhD student grant to SS by GROW, School of Oncology and Developmental Biology, Maastricht University Medical Center+. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici E, 2008, BLOOD, V111, P3155, DOI 10.1182/blood-2007-09-110312; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Azab AK, 2012, BLOOD, V119, P5782, DOI 10.1182/blood-2011-09-380410; Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Benson DM, 2012, BLOOD, V120, P4324, DOI 10.1182/blood-2012-06-438028; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Chavez-Blanco A, 2011, INT J ONCOL, V39, P1491, DOI 10.3892/ijo.2011.1144; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Delorme S, 2009, EUR J RADIOL, V70, P401, DOI 10.1016/j.ejrad.2009.02.005; Fink T, 2003, SCAND J IMMUNOL, V58, P607, DOI 10.1111/j.1365-3083.2003.01347.x; Frings PWH, 2011, BREAST CANCER RES TR, V130, P773, DOI 10.1007/s10549-011-1355-z; Garg TK, 2012, HAEMATOL-HEMATOL J, V97, P1348, DOI 10.3324/haematol.2011.056747; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; Katodritou E, 2011, AM J HEMATOL, V86, P967, DOI 10.1002/ajh.22163; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; LOEFFLER DA, 1991, INT J CANCER, V48, P895, DOI 10.1002/ijc.2910480617; Mamessier E, 2011, CANCER RES, V71, P6621, DOI 10.1158/0008-5472.CAN-11-0792; Martin SK, 2011, LEUKEMIA, V25, P1533, DOI 10.1038/leu.2011.122; Martin SK, 2010, HAEMATOL-HEMATOL J, V95, P776, DOI 10.3324/haematol.2009.015628; Matsunaga T, 2012, LEUKEMIA RES, V36, pE122, DOI 10.1016/j.leukres.2012.02.028; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Rehn M, 2011, BLOOD, V118, P1534, DOI 10.1182/blood-2011-01-332890; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Shi J, 2008, BRIT J HAEMATOL, V143, P641, DOI 10.1111/j.1365-2141.2008.07340.x; Siemens DR, 2008, CANCER RES, V68, P4746, DOI 10.1158/0008-5472.CAN-08-0054; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Watanabe Y, 2007, J ORTHOP TRAUMA, V21, P456, DOI 10.1097/BOT.0b013e318126bb56; Xu S, 2012, STEM CELLS, V30, P266, DOI 10.1002/stem.787	39	101	106	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64835	10.1371/journal.pone.0064835	http://dx.doi.org/10.1371/journal.pone.0064835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724099	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000099
J	Sun, J; Sun, GB; Meng, XB; Wang, HW; Luo, Y; Qin, M; Ma, B; Wang, M; Cai, DY; Guo, P; Sun, XB				Sun, Jing; Sun, Guibo; Meng, Xiangbao; Wang, Hongwei; Luo, Yun; Qin, Meng; Ma, Bo; Wang, Min; Cai, Dayong; Guo, Peng; Sun, Xiaobo			Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro	PLOS ONE			English	Article							INDUCED APOPTOSIS; PATHWAY; ACTIVATION; INHIBITION; MODULATION; MECHANISMS; CELLS; ERK; CARDIOMYOPATHY; VINBLASTINE	Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced cardiotoxicity and its underlying mechanisms. In an in vivo investigation, rats were intraperitoneally (i.p.) administered with Dox to duplicate the model of Dox-induced chronic cardiotoxicity. Daily pretreatment with isorhamnetin (5 mg/kg, i.p.) for 7 days was found to reduce Dox-induced myocardial damage significantly, including the decline of cardiac index, decrease in the release of serum cardiac enzymes and amelioration of heart vacuolation. In vitro studies on H9c2 cardiomyocytes, isorhamnetin was effective to reduce Dox-induced cell toxicity. A further mechanism study indicated that isorhamnetin pretreatment can counteract Dox-induced oxidative stress and suppress the activation of mitochondrion apoptotic pathway and mitogen-activated protein kinase pathway. Isorhamnetin also potentiated the anti-cancer activity of Dox in MCF-7, HepG2 and Hep2 cells. These findings indicated that isorhamnetin can be used as an adjuvant therapy for the long-term clinical use of Dox.	[Sun, Jing; Sun, Guibo; Meng, Xiangbao; Luo, Yun; Qin, Meng; Ma, Bo; Wang, Min; Cai, Dayong; Guo, Peng; Sun, Xiaobo] Chinese Acad Med Sci, Inst Med Plant Dev, Minist Educ, Key Lab Bioact Subst & Resources Utilizat Chinese, Beijing 100730, Peoples R China; [Sun, Jing; Sun, Guibo; Meng, Xiangbao; Luo, Yun; Qin, Meng; Ma, Bo; Wang, Min; Cai, Dayong; Guo, Peng; Sun, Xiaobo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Hongwei] Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Hongwei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing University; Nanjing University	Sun, GB (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Minist Educ, Key Lab Bioact Subst & Resources Utilizat Chinese, Beijing 100730, Peoples R China.	sunguibo@126.com; sun_xiaobo163@163.com	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Cai, Dayong/0000-0001-9043-3659	Key Projects of the National Science and Technology Pillar Program [2008BAI51B02]; National 973 Program [2009CB522805]; Major Scientific and Technological Special Project for "Significant New Drugs Formulation" [2012ZX09301002-001, 2012ZX09501001-004]; Natural Science Foundation of Jiangsu Province China [BK2010245]	Key Projects of the National Science and Technology Pillar Program; National 973 Program(National Basic Research Program of China); Major Scientific and Technological Special Project for "Significant New Drugs Formulation"; Natural Science Foundation of Jiangsu Province China(Natural Science Foundation of Jiangsu Province)	The present work was supported by the Key Projects of the National Science and Technology Pillar Program (Grant No. 2008BAI51B02), National 973 Program (no. 2009CB522805), the Major Scientific and Technological Special Project for "Significant New Drugs Formulation'' (Grant Nos. 2012ZX09301002-001, and 2012ZX09501001-004) and Natural Science Foundation of Jiangsu Province China (no. BK2010245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Banu SK, 2011, TOXICOL APPL PHARM, V251, P253, DOI 10.1016/j.taap.2011.01.011; Bao M, 2006, EUR J PHARMACOL, V547, P22, DOI 10.1016/j.ejphar.2006.07.021; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Florentin A, 2012, J CELL BIOL, V196, P513, DOI 10.1083/jcb.201107133; Green PS, 2002, BBA-MOL BASIS DIS, V1588, P94, DOI 10.1016/S0925-4439(02)00144-8; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Ibarra M, 2003, PLANTA MED, V69, P995, DOI 10.1055/s-2003-45144; Jahnukainen K, 2001, CANCER RES, V61, P6423; Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kang YJ, 2000, J BIOL CHEM, V275, P13690, DOI 10.1074/jbc.275.18.13690; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kulich SM, 2003, J BIOSCIENCES, V28, P83, DOI 10.1007/BF02970136; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Li L, 2007, CLIN CANCER RES, V13, P6753, DOI 10.1158/1078-0432.CCR-07-1579; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Liu PF, 2009, PLANT FOOD HUM NUTR, V64, P141, DOI 10.1007/s11130-009-0116-1; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Panda VS, 2009, ALTERN MED REV, V14, P161; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Qin QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009999; Ramachandran L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388702; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774; Stadheim TA, 2001, CANCER RES, V61, P1533; Sun B, 2012, J CELL BIOCHEM, V113, P473, DOI 10.1002/jcb.23371; Swamy AV, 2012, INDIAN J PHARMACOL, V44, P73, DOI 10.4103/0253-7613.91871; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Tikoo K, 2011, TOXICOL APPL PHARM, V251, P191, DOI 10.1016/j.taap.2010.12.012; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Wang HB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/506214; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Xiao J, 2012, TOXICOLOGY, V292, P53, DOI 10.1016/j.tox.2011.11.018; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028335; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhang NJ, 2011, EXP TOXICOL PATHOL, V63, P33, DOI 10.1016/j.etp.2009.09.005; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhao G, 2012, DRUG DEV IND PHARM, V3, P3	48	76	79	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64526	10.1371/journal.pone.0064526	http://dx.doi.org/10.1371/journal.pone.0064526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724057	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000064
J	Untiet, V; Karunakaran, R; Kramer, M; Poole, P; Priefer, U; Prell, J				Untiet, Verena; Karunakaran, Ramakrishnan; Kraemer, Maria; Poole, Philip; Priefer, Ursula; Prell, Juergen			ABC Transport Is Inactivated by the PTSNtr under Potassium Limitation in Rhizobium leguminosarum 3841	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ENZYME I-NTR; PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; SINORHIZOBIUM-MELILOTI; PROTEIN-PHOSPHORYLATION; CATABOLITE REPRESSION; CARBON METABOLISM; IDENTIFICATION; NITROGEN	PTSNtr is a regulatory phosphotransferase system in many bacteria. Mutation of the PTSNtr enzymes causes pleiotropic growth phenotypes, dry colony morphology and a posttranslational inactivation of ABC transporters in Rhizobium leguminosarum 3841. The PTSNtr proteins EINtr and 2 copies of EIIA(Ntr) have been described previously. Here we identify the intermediate phosphocarrier protein NPr and show its phosphorylation by EINtr in vitro. Furthermore we demonstrate that phosphorylation of EINtr and NPr is required for ABC transport activation and that the N-terminal GAF domain of EINtr is not required for autophosphorylation. Previous studies have shown that non-phosphorylated EIIA(Ntr) is able to modulate the transcriptional activation of the high affinity potassium transporter KdpABC. In R. leguminosarum 3841 kdpABC expression strictly depends on EIIA(Ntr). Here we demonstrate that under strong potassium limitation ABC transport is inactivated, presumably by non-phosphorylated EIIA(Ntr). This is to our knowledge the first report where PTSNtr dictates an essential cellular function. This is achieved by the inverse regulation of two important ATP dependent transporter classes.	[Untiet, Verena; Kraemer, Maria; Priefer, Ursula; Prell, Juergen] Rhein Westfal TH Aachen, Soil Ecol, D-52062 Aachen, Germany; [Karunakaran, Ramakrishnan; Poole, Philip] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	RWTH Aachen University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Prell, J (corresponding author), Rhein Westfal TH Aachen, Soil Ecol, D-52062 Aachen, Germany.	jprell@bio1.rwth-aachen.de	Untiet, Verena/AAZ-4783-2020	Untiet, Verena/0000-0002-1888-6378; Ramakrishnan, Karunakaran/0000-0002-6450-1299	Biotechnology and Biological Sciences Research Council [BB/K006134/1] Funding Source: researchfish; BBSRC [BB/K006134/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bahr T, 2011, J BACTERIOL, V193, P2013, DOI 10.1128/JB.01459-10; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cases I, 2007, RES MICROBIOL, V158, P666, DOI 10.1016/j.resmic.2007.08.002; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; King ND, 2001, J BIOL CHEM, V276, P21311, DOI 10.1074/jbc.M101982200; Kumar S, 2005, J BACTERIOL, V187, P5493, DOI 10.1128/JB.187.15.5493-5495.2005; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Luttmann D, 2012, MOL MICROBIOL, V86, P96, DOI 10.1111/j.1365-2958.2012.08176.x; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; Meyer FM, 2011, J BACTERIOL, V193, P6939, DOI 10.1128/JB.06197-11; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Mulley G, 2011, MOL MICROBIOL, V80, P149, DOI 10.1111/j.1365-2958.2011.07565.x; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Pfluger-Grau K, 2011, BBA-GEN SUBJECTS, V1810, P995, DOI 10.1016/j.bbagen.2011.01.002; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Pinedo CA, 2008, J BACTERIOL, V190, P2947, DOI 10.1128/JB.01917-07; Pinedo CA, 2009, J BACTERIOL, V191, P298, DOI 10.1128/JB.01115-08; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2012, MOL MICROBIOL, V84, P117, DOI 10.1111/j.1365-2958.2012.08014.x; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; Reizer J, 1996, GENE, V181, P103, DOI 10.1016/S0378-1119(96)00481-7; ROOSSIEN FF, 1983, BIOCHIM BIOPHYS ACTA, V760, P185, DOI 10.1016/0304-4165(83)90141-1; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	44	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64682	10.1371/journal.pone.0064682	http://dx.doi.org/10.1371/journal.pone.0064682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724079	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000080
J	Musilova, Z; Kalous, L; Petrtyl, M; Chaloupkova, P				Musilova, Zuzana; Kalous, Lukas; Petrtyl, Miloslav; Chaloupkova, Petra			Cichlid Fishes in the Angolan Headwaters Region: Molecular Evidence of the Ichthyofaunal Contact between the Cuanza and Okavango-Zambezi Systems	PLOS ONE			English	Article							CENTRAL-AFRICA; EVOLUTION; SOUTHERN; TELEOSTEI; DRAINAGE; RIVER; COMPLEX; RAPIDS; MODEL; FLOW	The headwaters of five large African river basins flow through the Bie Plateau in Angola and still remain faunistically largely unexplored. We investigated fish fauna from the Cuanza and Okavango-Zambezi river systems from central Angola. We reconstructed molecular phylogenies of the most common cichlid species from the region, Tilapia sparrmanii and Serranochromis macrocephalus, using both mitochondrial and nuclear markers. We found evidence for ichthyofaunal contact and gene flow between the Cuanza and Okavango-Zambezi watersheds in the Bie Plateau in central Angola. Waterfalls and rapids also appeared to restrict genetic exchange among populations within the Cuanza basin. Further, we found that the Angolan Serranochromis cichlid fishes represent a monophyletic lineage with respect to other haplochromines, including the serranochromines from the Congo and Zambezi rivers. This study represents an important initial step in a biodiversity survey of this extremely poorly explored region, as well as giving further understanding to species distributions and gene flow both between and within river basins.	[Musilova, Zuzana] Inst Anim Physiol & Genet AV CR Vvi, Lab Fish Genet, Libechov, Czech Republic; [Musilova, Zuzana; Kalous, Lukas; Petrtyl, Miloslav] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Musilova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Chaloupkova, Petra] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Prague, Czech Republic	Czech Academy of Sciences; Czech University of Life Sciences Prague; Charles University Prague; Czech University of Life Sciences Prague	Musilova, Z (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	zuzmus@gmail.com	Musilova, Zuzana/S-2899-2017; Petrtyl, Miloslav/AAB-9648-2020; Kalous, Lukáš/B-2952-2013	Musilova, Zuzana/0000-0001-8759-8663; Petrtyl, Miloslav/0000-0003-0697-0772; Kalous, Lukáš/0000-0001-5518-1505	Official Development Cooperation Programme of the Czech Republic [MZe/B/2]; Centre for Biodiversity Research [LC06073]; IRP IAPG [AVOZ50450515]; GAUK [129510]; IRP FAPPZ; CZU MSMT [6046070901]	Official Development Cooperation Programme of the Czech Republic; Centre for Biodiversity Research; IRP IAPG; GAUK; IRP FAPPZ; CZU MSMT	The work was supported by the Official Development Cooperation Programme of the Czech Republic specifically by the project "Poradenstvi v oblasti chovu ryb a drubeze, Angola" No. MZe/B/2. Further support was realised within the Centre for Biodiversity Research LC06073 (MSMT), IRP IAPG AVOZ50450515, GAUK 129510 and IRP FAPPZ, CZU MSMT 6046070901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert J.S., 2010, NAT ED KNOWL, V3, P13; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; BALON EK, 1983, ENVIRON BIOL FISH, V9, P225, DOI 10.1007/BF00692373; BALON EK, 1974, COPEIA, P643; Berra TM., 2001, FRESHWATER FISH DIST; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; Chaloupkova P, 2010, WORKSH AN BIOD JEV C, P61; Chow S, 1998, MOL ECOL, V7, P1255; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Decru E, 2012, J NAT HIST, V46, P1, DOI 10.1080/00222933.2011.622055; Farias IP, 2010, MOL PHYLOGENET EVOL, V56, P1129, DOI 10.1016/j.ympev.2010.03.028; FOWLER HENRY W., 1930, PROC ACAD SCI PHILADELPHIA, V82, P27; Genner MJ, 2010, J FISH BIOL, V76, P435, DOI 10.1111/j.1095-8649.2009.02549.x; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goudie AS, 2005, GEOMORPHOLOGY, V67, P437, DOI 10.1016/j.geomorph.2004.11.008; Greenwood P.H., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P187; Haddon IG, 2005, J AFR EARTH SCI, V43, P316, DOI 10.1016/j.jafrearsci.2005.07.008; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES R.H., 1992, DIRECTORY AFRICAN WE; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Kano Y, 2012, ECOL EVOL, V2, P1805, DOI 10.1002/ece3.295; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katongo C, 2005, SCIENCE, V435; Katongo C, 2007, MOL PHYLOGENET EVOL, V45, P326, DOI 10.1016/j.ympev.2007.02.011; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Koblmuller S, 2012, AFR ZOOL, V47, P182, DOI 10.3377/004.047.0115; Koblmuller S, 2008, MOL PHYLOGENET EVOL, V49, P153, DOI 10.1016/j.ympev.2008.05.045; Koblmuller S, 2009, ZOOL SCR, V38, P257, DOI 10.1111/j.1463-6409.2008.00378.x; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kramer B, 2007, J NAT HIST, V41, P647, DOI 10.1080/00222930701250987; Kramer B, 2010, J NAT HIST, V44, P2213, DOI 10.1080/00222931003764089; Ladiges W., 1961, Mitteilungen der Hamburgischen Zoologischen Museum und Institut, V59, P117; Leveque C., 1997, BIODIVERSITY DYNAMIC; Markert JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-149; NICHOLS J. T., 1927, AMER MUS NOVITATES, V264, P1; Penrith M.J., 1982, Journal of the Limnological Society of Southern Africa, V8, P71; Poll M., 1967, DIAMANG PUBLICACOES, V75; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; ROBERTS TR, 1975, ZOOL J LINN SOC-LOND, V57, P249, DOI 10.1111/j.1096-3642.1975.tb01893.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Schwarzer J, 2012, P ROY SOC B-BIOL SCI, V279, P4389, DOI 10.1098/rspb.2012.1667; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Skelton P. H, 2001, COMPLETE GUTIDE FRES; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thieme ML, 2005, FRESHWATER ECOREGION; TREWAVAS E, 1973, Bulletin of the British Museum (Natural History) Zoology, V25, P27; TREWAVAS ETHELWYNN, 1936, NOVITATES ZOOL, V40, P63; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Whiteley AR, 2010, CONSERV GENET, V11, P1929, DOI 10.1007/s10592-010-0083-y; Zengeya TA, 2011, J NAT HIST, V45, P1723, DOI 10.1080/00222933.2011.560724	55	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e65047	10.1371/journal.pone.0065047	http://dx.doi.org/10.1371/journal.pone.0065047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724120	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100038
J	Smith, N; Tierney, R; Wei, WB; Vockerodt, M; Murray, PG; Woodman, CB; Rowe, M				Smith, Nikki; Tierney, Rosemary; Wei, Wenbin; Vockerodt, Martina; Murray, Paul G.; Woodman, Ciaran B.; Rowe, Martin			Induction of Interferon-Stimulated Genes on the IL-4 Response Axis by Epstein-Barr Virus Infected Human B Cells; Relevance to Cellular Transformation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; LATENT MEMBRANE PROTEIN-1; REED-STERNBERG CELLS; GROWTH-IN-VITRO; NF-KAPPA-B; HODGKINS-DISEASE; SIGNALING PATHWAY; PANCREATIC-CANCER; IFN-GAMMA; EXPRESSION	Epstein-Barr virus (EBV) is an oncogenic virus that is associated with the pathogenesis of several human lymphoid malignancies, including Hodgkin's lymphoma. Infection of normal resting B cells with EBV results in activation to lymphoblasts that are phenotypically similar to those generated by physiological stimulation with CD40L plus IL-4. One important difference is that infection leads to the establishment of permanently growing lymphoblastoid cell lines, whereas CD40L/IL-4 blasts have finite proliferation lifespans. To identify early events which might later determine why EBV infected blasts go on to establish transformed cell lines, we performed global transcriptome analyses on resting B cells and on EBV and CD40L/IL-4 blasts after 7 days culture. As anticipated there was considerable overlap in the transcriptomes of the two types of lymphoblasts when compared to the original resting B cells, reflecting common changes associated with lymphocyte activation and proliferation. Of interest to us was a subset of 255 genes that were differentially expressed between EBV and CD40L/IL-4 blasts. Genes which were more highly expressed in EBV blasts were substantially and significantly enriched for a set of interferon-stimulated genes which on further in silico analyses were found to be repressed by IL-4 in other cell contexts and to be up-regulated in micro-dissected malignant cells from Hodgkin's lymphoma biopsies when compared to their normal germinal center cell counterparts. We hypothesized that EBV and IL-4 were targeting and discordantly regulating a common set of genes. This was supported experimentally in our B cell model where IL-4 stimulation partially reversed transcriptional changes which follow EBV infection and it impaired the efficiency of EBV-induced B cell transformation. Taken together, these data suggest that the discordant regulation of interferon and IL-4 pathway genes by EBV that occurs early following infection of B cells has relevance to the development or maintenance of an EBV-associated malignancy.	[Woodman, Ciaran B.] Univ Birmingham, Coll Med & Dent Sci, Birmingham Canc Res UK Ctr, Sch Canc Sci, Birmingham, W Midlands, England; Univ Birmingham, Coll Med & Dent Sci, Birmingham Ctr Human Virol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Woodman, CB (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham Canc Res UK Ctr, Sch Canc Sci, Birmingham, W Midlands, England.	m.rowe@bham.ac.uk; c.b.woodman@bham.ac.uk	Vockerodt, Martina/L-4465-2014; Rowe, Martin/B-2880-2009	Vockerodt, Martina/0000-0001-7761-5829; Rowe, Martin/0000-0003-4139-7326; Wei, Wenbin/0000-0003-1288-6999	University of Birmingham; Cancer Research UK, London; Leukaemia Lymphoma Research, London; Cancer Research UK [15032] Funding Source: researchfish	University of Birmingham; Cancer Research UK, London(Cancer Research UK); Leukaemia Lymphoma Research, London; Cancer Research UK(Cancer Research UK)	Funded by the University of Birmingham; Cancer Research UK, London; and Leukaemia Lymphoma Research, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Degl'Innocenti D, 2013, ENDOCR-RELAT CANCER, V20, P23, DOI 10.1530/ERC-12-0078; Delecluse HJ, 2000, J CLIN PATHOL-MOL PA, V53, P270, DOI 10.1136/mp.53.5.270; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; GERDES J, 1990, Cytokine, V2, P307, DOI 10.1016/1043-4666(90)90033-P; Gooch JL, 1998, CANCER RES, V58, P4199; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; HENLE W, 1967, SCIENCE, V157, P1064, DOI 10.1126/science.157.3792.1064; Herbst H, 1996, BLOOD, V87, P2918, DOI 10.1182/blood.V87.7.2918.bloodjournal8772918; HOLLYOAKE M, 1995, CANCER RES, V55, P4784; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUEN DS, 1995, ONCOGENE, V10, P549; Iskra S, 2010, J VIROL, V84, P3612, DOI 10.1128/JVI.01400-09; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jochum S, 2012, P NATL ACAD SCI USA, V109, pE1396, DOI 10.1073/pnas.1115906109; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kashuba E, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-23; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; LARNER AC, 1993, J IMMUNOL, V150, P1944; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGNECKER R, 1991, J VIROL, V65, P3681, DOI 10.1128/JVI.65.7.3681-3692.1991; Lundin J, 2001, BRIT J HAEMATOL, V112, P155, DOI 10.1046/j.1365-2141.2001.02525.x; LUO HY, 1991, J IMMUNOTHER, V10, P418, DOI 10.1097/00002371-199112000-00005; MAHER DW, 1990, SCAND J IMMUNOL, V32, P631, DOI 10.1111/j.1365-3083.1990.tb03205.x; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; MERZ H, 1991, AM J PATHOL, V139, P1173; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Minamino K, 2012, INT IMMUNOL, V24, P573, DOI 10.1093/intimm/dxs060; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; PANDRAU D, 1992, J CLIN INVEST, V90, P1697, DOI 10.1172/JCI116042; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Rowe M, 2001, SEMIN CANCER BIOL, V11, P403, DOI 10.1006/scbi.2000.0406; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Serrano D, 1997, HAEMATOLOGICA, V82, P542; Shannon-Lowe C, 2005, J GEN VIROL, V86, P3009, DOI 10.1099/vir.0.81153-0; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAYLOR CW, 1990, BLOOD, V75, P1114; TOPP MS, 1995, CANCER RES, V55, P2173; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trieu Y, 2004, CANCER RES, V64, P3271, DOI 10.1158/0008-5472.CAN-03-3764; Umeshita-Suyama R, 2000, INT IMMUNOL, V12, P1499, DOI 10.1093/intimm/12.11.1499; Vockerodt M, 2008, J PATHOL, V216, P83, DOI 10.1002/path.2384; Vockerodt M, 2013, J PATHOL, V230, P399, DOI 10.1002/path.4198; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Xu SH, 2005, J HUM GENET, V50, P159, DOI 10.1007/s10038-005-0235-y; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	75	13	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64868	10.1371/journal.pone.0064868	http://dx.doi.org/10.1371/journal.pone.0064868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724103	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000319738100035
J	Wang, X; Fan, JW; Zhang, M; Sun, ZC; Xu, GZ				Wang, Xin; Fan, Jiawen; Zhang, Meng; Sun, Zhongcui; Xu, Gezhi			Gene Expression Changes under Cyclic Mechanical Stretching in Rat Retinal Glial (Muller) Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN SCLERAL FIBROBLASTS; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; CHOROIDAL NEOVASCULARIZATION; PIGMENT EPITHELIUM; PROLIFERATION; MYOPIA; STRESS; STRAIN	Objective: The retina is subjected to tractional forces in various conditions. As the predominant glial element in the retina, Muller cells are active players in all forms of retinal injury and disease. In this study, we aim to identify patterns of gene expression changes induced by cyclic mechanical stretching in Muller cells. Methods: Rat Muller cells were seeded onto flexible bottom culture plates and subjected to a cyclic stretching regimen of 15% equibiaxial stretching for 1 and 24 h. RNA was extracted and amplified, labeled, and hybridized to rat genome microarrays. The expression profiles were analyzed using GeneSpring software, and gene ontology analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to select, annotate, and visualize genes by function and pathway. The selected genes of interest were further validated by Quantitative Real-time PCR (qPCR). Results: Microarray data analysis showed that at 1 and 24 h, the expression of 532 and 991 genes in the Muller cells significantly (t-test, p<0.05) differed between the mechanically stretched and unstretched groups. Of these genes, 56 genes at 1 h and 62 genes at 24 h showed more than a twofold change in expression. Several genes related to response to stimulus (e.g., Egr2, IL6), cell proliferation (e.g., Areg, Atf3), tissue remodeling (e.g., PVR, Loxl2), and vasculogenesis (e.g., Epha2, Nrn1) were selected and validated by qPCR. KEGG pathway analysis showed significant changes in MAPK signaling at both time points. Conclusions: Cyclic mechanical strain induces extensive changes in the gene expression in Muller cells through multiple molecular pathways. These results indicate the complex mechanoresponsive nature of Muller cells, and they provide novel insights into possible molecular mechanisms that would account for many retinal diseases in which the retina is often subjected to mechanical forces, such as pathological myopia and proliferative vitreoretinopathy.	[Wang, Xin; Fan, Jiawen; Zhang, Meng; Sun, Zhongcui; Xu, Gezhi] Fudan Univ, Eye & ENT Hosp, Shanghai Med Coll, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China; [Wang, Xin; Zhang, Meng; Xu, Gezhi] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, GZ (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai Med Coll, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China.	academicxw@163.com		wu, Ji-Hong/0000-0003-3892-5757	National Natural Science Foundation of China [NSFC 81170857]; National Science and Technology Major Project [2011ZX09302-007-02]; National Key Basic Research Program of China [2013CB967503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; National Key Basic Research Program of China(National Basic Research Program of China)	This work was funded by National Natural Science Foundation of China (Grant No. NSFC 81170857); National Science and Technology Major Project (2011ZX09302-007-02); National Key Basic Research Program of China (2013CB967503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Benelli R, 2013, CANCER LETT, V328, P73, DOI 10.1016/j.canlet.2012.09.008; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Chen J, 2006, EXP EYE RES, V82, P664, DOI 10.1016/j.exer.2005.09.004; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; Enloe BM, 2011, J NEURO-ONCOL, V102, P225, DOI 10.1007/s11060-010-0323-5; Guo Y, 2011, INVEST OPHTH VIS SCI, V52, P1460, DOI 10.1167/iovs.10-5930; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Han DD, 2011, BIOCHEM BIOPH RES CO, V415, P608, DOI 10.1016/j.bbrc.2011.10.118; Kirwan RP, 2004, J GLAUCOMA, V13, P327, DOI 10.1097/00061198-200408000-00011; Kurpinski Kyle, 2006, Molecular & Cellular Biomechanics, V3, P21; Lindqvist N, 2010, INVEST OPHTH VIS SCI, V51, P1683, DOI 10.1167/iovs.09-4159; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Luna C, 2009, MOL VIS, V15, P534; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Munoz-Erazo L, 2012, MOL VIS, V18, P730; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; Sebag J, 2004, GRAEF ARCH CLIN EXP, V242, P690, DOI 10.1007/s00417-004-0980-1; Seko Y, 1999, INVEST OPHTH VIS SCI, V40, P3287; Sethi A, 2012, EXP EYE RES, V104, P97, DOI 10.1016/j.exer.2012.02.002; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Shyu KG, 2009, CLIN SCI, V116, P377, DOI 10.1042/CS20080163; Suzuma I, 2001, DIABETES, V50, P444, DOI 10.2337/diabetes.50.2.444; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Wang JL, 2012, INVEST OPHTH VIS SCI, V53, P7348, DOI 10.1167/iovs.12-9955; Wurm A, 2011, PROG RETIN EYE RES, V30, P324, DOI 10.1016/j.preteyeres.2011.06.001; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Ye XF, 2012, INVEST OPHTH VIS SCI, V53, P3481, DOI 10.1167/iovs.11-9076	37	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63467	10.1371/journal.pone.0063467	http://dx.doi.org/10.1371/journal.pone.0063467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723984	Green Submitted, gold, Green Published			2022-12-25	WOS:000319738100011
J	Laillou, A; Wieringa, F; Tran, TN; Van, PT; Le, BM; Fortin, S; Le, TH; Pfanner, RM; Berger, J				Laillou, Arnaud; Wieringa, Frank; Thuy Nga Tran; Pham Thuy Van; Bach Mai Le; Fortin, Sonia; Thi Hop Le; Pfanner, Regina Moench; Berger, Jacques			Hypovitaminosis D and Mild Hypocalcaemia Are Highly Prevalent among Young Vietnamese Children and Women and Related to Low Dietary Intake	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CALCIUM INTAKE; D INSUFFICIENCY; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; ASSOCIATION; PREVENTION; RICKETS; AGE; BIOAVAILABILITY	Introduction: In many developing countries including Vietnam, data are lacking on vitamin D and calcium deficiencies whereas those deficiencies can play an important role in the development of bone health and possibly non-communicable diseases. The purpose of this study was to determine the overall prevalence of vitamin D and calcium deficiencies in women and young children and their nutritional related risk factors. Methods: A cross-sectional study conducted among 595 women of reproductive age and 532 children,5 years from 19 provinces of Vietnam. For each individual, data concerning daily diet, socioeconomic group, anthropometric status were obtained, and plasma concentrations of calcium and vitamin D were measured. Results: The prevalence of hypovitaminosis D status was very high, with the prevalence of vitamin D deficiency (25(OH) D, 30 nmol/L) and insufficiency (25(OH) D between 30-49.9 nmol/L) being 17% and 40% in women and 21% and 37% in children, respectively. Using more liberal cut-off of 75 nmol/L, approximately 90% of the women and children were classified as having hypovitaminosis D. Overweight/obese women had a 2 times lower risk (OR = 0.46, [0.24-0.90]) for vitamin D deficiency than non-overweight and non-obese women. No participant had severe calcium deficiency but moderate and mild hypocalcaemia (plasma calcium concentrations between 1.15-0.9 mmol/L for mild deficiency and between 0.9-0.8 mmol/L for moderate deficiency) affected respectively 14% and 83% of the women with 97% of the children having mild hypocalcaemia. Women and children consumed about 1% of the Institute of Medicine (IOM) recommended nutrient intake (RNI) for vitamin D and less than 43% of the RNI for calcium. Conclusion: Our study suggests that calcium and vitamin D deficiencies represent a major public health concern in Vietnam. Thus, actions to improve the vitamin D and calcium status of the Vietnamese population should be considered.	[Laillou, Arnaud; Pfanner, Regina Moench] GAIN, Geneva, Switzerland; [Thuy Nga Tran; Pham Thuy Van; Bach Mai Le; Thi Hop Le] Natl Inst Nutr, Hanoi, Vietnam; [Wieringa, Frank; Fortin, Sonia; Berger, Jacques] IRD, UMR Nutripass IRD UM2 UM1, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Laillou, A (corresponding author), GAIN, Geneva, Switzerland.	alaillou@gainhealth.org	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X	Bill and Melinda Gates Foundation (BMGF); Bel Group; Department For International Development (DFID)	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Bel Group; Department For International Development (DFID)	The work was funded by Bill and Melinda Gates Foundation (BMGF), Bel Group and the Department For International Development (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], INTR SURV SAMPL AN P; [Anonymous], DHS WEALTH INDEX APP; Atiq M, 1998, ACTA OBSTET GYN SCAN, V77, P970, DOI 10.1034/j.1600-0412.1998.771004.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Calvo MS, 2004, AM J CLIN NUTR, V80, p1710S, DOI 10.1093/ajcn/80.6.1710S; Cashman KD, 2002, BRIT J NUTR, V87, pS169, DOI 10.1079/BJN/2002534; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dop MC, 2000, VALIDATION 24 HOUR R; Earl S, 2010, P NUTR SOC, V69, P25, DOI 10.1017/S0029665109991765; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Flynn A, 2003, P NUTR SOC, V62, P851, DOI 10.1079/PNS2003301; Foo LH, 2009, OSTEOPOROSIS INT, V20, P417, DOI 10.1007/s00198-008-0667-2; Garcia VC, 2010, NUTRIENTS, V2, P426, DOI 10.3390/nu2040426; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gomez-Alonso C, 2003, KIDNEY INT, V63, pS44, DOI 10.1046/j.1523-1755.63.s85.11.x; Green TJ, 2008, EUR J CLIN NUTR, V62, P373, DOI 10.1038/sj.ejcn.1602696; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Heaney RP, 2008, AM J CLIN NUTR, V88, p541S, DOI 10.1093/ajcn/88.2.541S; Ho-Pham LT, 2011, OSTEOPOROSIS INT, V22, P241, DOI 10.1007/s00198-010-1207-4; Ho-Pham LT, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-182; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F., 1999, P1; Institute Of Medecine, 2010, UPD GUID VIT D CALC; Jain V, 2011, INDIAN J MED RES, V133, P267; Khoi H, 2000, GEN NUTR SURVEY; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Lanham-New SA, 2008, P NUTR SOC, V67, P163, DOI 10.1017/S0029665108007003; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; LAU E, 1988, BRIT MED J, V297, P1441, DOI 10.1136/bmj.297.6661.1441; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; Lee MS, 2008, ASIA PAC J CLIN NUTR, V17, P397; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lyu LC, 2009, BRIT J NUTR, V102, P1828, DOI 10.1017/S0007114509991243; Ministry of Public Health and National Institute of Nutrition, 2000, NUTR COMP TABL VIETN; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nakamura K, 2001, NUTRITION, V17, P921, DOI 10.1016/S0899-9007(01)00662-1; NIN-UNICEF, 2011, REV NUTR SIT VIETN 2; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Pettifor JM, 2004, AM J CLIN NUTR, V80, p1725S, DOI 10.1093/ajcn/80.6.1725S; Pettifor JM, 2008, INDIAN J MED RES, V127, P245; Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784; Rodriguez-Rodriguez E, 2009, OBESITY, V17, P778, DOI 10.1038/oby.2008.649; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rustein SO, 2004, DHS COMPERATIVE REPO; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Strand MA, 2007, PEDIATR INT, V49, P202, DOI 10.1111/j.1442-200X.2007.02343.x; Turpeinen U, 2003, CLIN CHEM, V49, P1521, DOI 10.1373/49.9.1521; Vu TTH, 2012, MATERN CHILD NUTR, V8, P533, DOI 10.1111/j.1740-8709.2011.00327.x; Woo J, 2008, BRIT J NUTR, V99, P1330, DOI 10.1017/S0007114507844382; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	56	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63979	10.1371/journal.pone.0063979	http://dx.doi.org/10.1371/journal.pone.0063979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717521	Green Submitted, gold, Green Published			2022-12-25	WOS:000319385300029
J	Mortaza, N; Abu Osman, NA; Jamshidi, AA; Razjouyan, J				Mortaza, Niyousha; Abu Osman, Noor Azuan; Jamshidi, Ali Ashraf; Razjouyan, Javad			Influence of Functional Knee Bracing on the Isokinetic and Functional Tests of Anterior Cruciate Ligament Deficient Patients	PLOS ONE			English	Article							GROUND REACTION FORCES; ACL DEFICIENT; BRACES; WALKING; PERFORMANCE; NONWEIGHTBEARING; RECOMMENDATIONS; RECONSTRUCTION; WEIGHTBEARING; STRENGTH	Use of functional knee braces has been suggested to provide protection and to improve kinetic performance of the knee in Anterior cruciate ligament(ACL)-injured patients. However, many athletes might refrain from wearing the braces because of the fear of performance hindrance in the playing field. The aim of this study was to examine the effect of three functional knee brace/sleeves upon the isokinetic and functional performance of ACL-deficient and healthy subjects. Six anterior cruciate ligament deficient (29.0 +/- 5.3 yrs., 175.2 +/- 5.4 cm, and 73.0 +/- 10.0 kg) and six healthy male subjects (27.2 +/- 3.7 yrs., 176.4 +/- 6.4 cm, and 70.3 +/- 6.9 kg) were selected. The effect of a custom-made functional knee brace, and two neoprene knee sleeves, one with four metal supports and one without support were examined via the use of isokinetic and functional tests in four sets (non-braced, wearing functional knee brace, and wearing the sleeves). Cross-over hop and single leg vertical jump test were performed and jump height, and hop distance were recorded. Peak torque to body weight ratio and average power in two isokinetic velocities(60 degrees.s(-1),180 degrees.s(-1)) were recorded and the brace/sleeves effect was calculated as the changes in peak torque measured in the brace/sleeves conditions, expressed as a percentage of peak torque measured in non-braced condition. Frequency content of the isokinetic torque-time curves was also analyzed. Wilcoxon signed rank test was used to compare the measured values in four test conditions within each control and ACL-deficient group, and Mann-Whitney U test was used for the comparison between the two groups. No significant differences in peak torque, average power, torque-time curve frequency content, vertical-jump and hop measurements were found within the experimental and the non-braced conditions (p>0.05). Although the examined functional knee brace/sleeves had no significant effect on the knee muscle performance, there have been some enhancement regarding the extension peak torques and power generating capacity of the ACL-deficient subjects that could be helpful in reducing the bilateral asymmetry in these patients.	[Mortaza, Niyousha; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Mortaza, Niyousha] Univ Tehran Med Sci, Fac Rehabil, Dept Orthot & Prosthet, Tehran, Iran; [Jamshidi, Ali Ashraf] Univ Tehran Med Sci, Fac Rehabil, Dept Phys Therapy, Tehran, Iran; [Jamshidi, Ali Ashraf] Univ Tehran Med Sci, Fac Rehabil, Rehabil Res Ctr, Tehran, Iran; [Razjouyan, Javad] Islamic Azad Univ, Garmsar Branch, Dept Elect & Elect Engn, Garmsar, Iran	Universiti Malaya; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Islamic Azad University	Mortaza, N (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	niymor@gmail.com	ABU OSMAN, NOOR AZUAN/B-9265-2010	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Mortaza, Niyousha/0000-0001-9237-4031	Malaysia UM/MOHE/HIR [D000014-16001]	Malaysia UM/MOHE/HIR	This study was partly supported by the Malaysia UM/MOHE/HIR (project no: D000014-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALBRIGHT JP, 1995, SPORTS MED, V20, P281, DOI 10.2165/00007256-199520050-00001; Beynnon BD, 2003, AM J SPORT MED, V31, P99, DOI 10.1177/03635465030310012801; Birmingham TB, 2002, ARCH PHYS MED REHAB, V83, P1472, DOI 10.1053/apmr.2002.35093; CAWLEY PW, 1991, AM J SPORT MED, V19, P226, DOI 10.1177/036354659101900304; Chew KTL, 2007, AM J PHYS MED REHAB, V86, P678, DOI 10.1097/PHM.0b013e318114e416; Devir Z, 2004, ISOKINETICS MUSCLE T, P150; DeVita P, 1998, AM J SPORT MED, V26, P778, DOI 10.1177/03635465980260060701; Fleming BC, 2000, AM J SPORT MED, V28, P815, DOI 10.1177/03635465000280060901; Giakas G, 1997, GAIT POSTURE, V5, P189, DOI 10.1016/S0966-6362(96)01083-1; HOUSTON ME, 1982, ARCH PHYS MED REHAB, V63, P431; Lu TW, 2006, CLIN BIOMECH, V21, P517, DOI 10.1016/j.clinbiomech.2005.12.017; Mortaza N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050110; Myer GD, 2009, CLIN J SPORT MED, V19, P3, DOI 10.1097/JSM.0b013e318190bddb; Paluska SA, 2000, AM FAM PHYSICIAN, V61, P411; Ramsey DK, 2003, CLIN BIOMECH, V18, P28, DOI 10.1016/S0268-0033(02)00138-9; Rishiraj N, 2009, SPORTS MED, V39, P937, DOI 10.2165/11317790-000000000-00000; Seigal S, 1988, NONPARAMETRIC STAT B; SFORZO GA, 1989, MED SCI SPORT EXER, V21, P254; Snyder-Macker L, 2005, JOINT STRUCTURE FUNC, P393; Stergiou N, 2002, CLIN BIOMECH, V17, P615, DOI 10.1016/S0268-0033(02)00072-4; TEGNER Y, 1988, ACTA ORTHOP SCAND, V59, P284, DOI 10.3109/17453678809149364; Theoret D, 2006, KNEE SURG SPORT TR A, V14, P555, DOI 10.1007/s00167-006-0072-3; Tracy BL, 2002, J APPL PHYSIOL, V92, P1004, DOI 10.1152/japplphysiol.00954.2001; Tsepis E, 2004, J BIOMECH, V37, P857, DOI 10.1016/j.jbiomech.2003.11.009; VELDHUIZEN JW, 1991, INT J SPORTS MED, V12, P577, DOI 10.1055/s-2007-1024737; Wojtys EM, 1996, AM J SPORT MED, V24, P539, DOI 10.1177/036354659602400421; Zachazewski JE, 1996, RETURN COMPETITION F, P245	27	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64308	10.1371/journal.pone.0064308	http://dx.doi.org/10.1371/journal.pone.0064308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717593	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600058
J	Dunn, RR; Fierer, N; Henley, JB; Leff, JW; Menninger, HL				Dunn, Robert R.; Fierer, Noah; Henley, Jessica B.; Leff, Jonathan W.; Menninger, Holly L.			Home Life: Factors Structuring the Bacterial Diversity Found within and between Homes	PLOS ONE			English	Article							MICROBIAL-CONTAMINATION; AIRBORNE BACTERIAL; BUILDING-MATERIALS; COMMUNITY; HEALTH; VARIABILITY; EXPOSURE; BIODIVERSITY; IMPACT; AIR	Most of our time is spent indoors where we are exposed to a wide array of different microorganisms living on surfaces and in the air of our homes. Despite their ubiquity and abundance, we have a limited understanding of the microbial diversity found within homes and how the composition and diversity of microbial communities change across different locations within the home. Here we examined the diversity of bacterial communities found in nine distinct locations within each of forty homes in the Raleigh-Durham area of North Carolina, USA, using high-throughput sequencing of the bacterial 16S rRNA gene. We found that each of the sampled locations harbored bacterial communities that were distinct from one another with surfaces that are regularly cleaned typically harboring lower levels of diversity than surfaces that are cleaned infrequently. These location-specific differences in bacterial communities could be directly related to usage patterns and differences in the likely sources of bacteria dispersed onto these locations. Finally, we examined whether the variability across homes in bacterial diversity could be attributed to outdoor environmental factors, indoor habitat structure, or the occupants of the home. We found that the presence of dogs had a significant effect on bacterial community composition in multiple locations within homes as the homes occupied by dogs harbored more diverse communities and higher relative abundances of dog-associated bacterial taxa. Furthermore, we found a significant correlation between the types of bacteria deposited on surfaces outside the home and those found inside the home, highlighting that microbes from outside the home can have a direct effect on the microbial communities living on surfaces within our homes. Together this work provides the first comprehensive analysis of the microbial communities found in the home and the factors that shape the structure of these communities both within and between homes.	[Dunn, Robert R.; Menninger, Holly L.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Dunn, Robert R.; Menninger, Holly L.] N Carolina State Univ, Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Fierer, Noah; Henley, Jessica B.; Leff, Jonathan W.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Dunn, RR (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	Rob_Dunn@ncsu.edu		FIERER, NOAH/0000-0002-6432-4261; Dunn, Robert/0000-0002-6030-4837; Leff, Jonathan/0000-0003-3309-2709	A.P. Sloan Microbiology of the Built Environment Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program [52006933]	A.P. Sloan Microbiology of the Built Environment Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program	Funding for this work was provided by a grant from the A.P. Sloan Microbiology of the Built Environment Program (http://www.sloan.org/major-program-areas/basic-research/microbiology-of-the-built-environment/) to NF and RRD. The public science aspects of this project were supported by grant #52006933 to NC State University from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program (http://www.hhmi.org/grants/office/undergrad/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichbhaumik N, 2008, CLIN EXP ALLERGY, V38, P1787, DOI 10.1111/j.1365-2222.2008.03079.x; [Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; Batterman S.A., 1995, HVACR RES, V1, P61, DOI DOI 10.1080/10789669.1995.10391309; Berglund B., 1992, INDOOR AIR, DOI 10.1111/j.1600-0668.1992.02-21.x.; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; BURGE H, 1990, J ALLERGY CLIN IMMUN, V86, P687, DOI 10.1016/S0091-6749(05)80170-8; BURRELL R, 1991, ENVIRON HEALTH PERSP, V95, P29, DOI 10.2307/3431102; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dickinson J.L., 2012, CITIZEN SCI PUBLIC P; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ellringer PJ, 2000, AIHAJ, V61, P895, DOI 10.1080/15298660008984603; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044563; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Gaylarde C, 2003, MATER STRUCT, V36, P342, DOI 10.1007/BF02480875; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Havstad S, 2011, J ALLERGY CLIN IMMUN, V128, P880, DOI 10.1016/j.jaci.2011.06.039; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hodgson M, 2002, ENVIRON HEALTH PERSP, V110, P663, DOI 10.1289/ehp.02110s4663; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Hulcr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047712; KARLSSON S, 1989, MATER STRUCT, V22, pS163; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kujundzic E, 2006, J OCCUP ENVIRON HYG, V3, P536, DOI 10.1080/15459620600909799; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x; Ojima M, 2002, J APPL MICROBIOL, V93, P800, DOI 10.1046/j.1365-2672.2002.01746.x; Portnoy JM, 2005, ANN ALLERG ASTHMA IM, V94, P313, DOI 10.1016/S1081-1206(10)60982-9; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; R Core Team, 2012, R LANG ENV STAT COMP; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Remold SK, 2011, MICROB ECOL, V62, P505, DOI 10.1007/s00248-011-9844-5; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rusin P, 1998, J APPL MICROBIOL, V85, P819, DOI 10.1046/j.1365-2672.1998.00598.x; Samet JM, 2003, AM J PUBLIC HEALTH, V93, P1489, DOI 10.2105/AJPH.93.9.1489; Sinclair RG, 2011, LETT APPL MICROBIOL, V52, P144, DOI 10.1111/j.1472-765X.2010.02978.x; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sordillo JE, 2011, ENVIRON HEALTH PERSP, V119, P189, DOI 10.1289/ehp.1002004; Tsai FC, 2005, INDOOR AIR, V15, P71, DOI 10.1111/j.1600-0668.2005.00346.x; Wegienka G, 2011, CLIN EXP ALLERGY, V41, P979, DOI 10.1111/j.1365-2222.2011.03747.x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	58	201	202	6	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64133	10.1371/journal.pone.0064133	http://dx.doi.org/10.1371/journal.pone.0064133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717552	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700107
J	Eseberri, I; Lasa, A; Churruca, I; Portillo, MP				Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.			Resveratrol Metabolites Modify Adipokine Expression and Secretion in 3T3-L1 Pre-Adipocytes and Mature Adipocytes	PLOS ONE			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; LEPTIN; APELIN; ADIPONECTIN; INHIBITION; MECHANISMS; APOPTOSIS	Objective: Due to the low bioavailability of resveratrol, determining whether its metabolites exert any beneficial effect is an interesting issue. Methods: 3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 mu M of resveratrol or with its metabolites and 3T3-L1 mature adipocytes were treated for 24 hours with 10 mM resveratrol or its metabolites. The gene expression of adiponectin, leptin, visfatin and apelin was assessed by Real Time RT-PCR and their concentration in the incubation medium was quantified by ELISA. Results: Resveratrol reduced mRNA levels of leptin and increased those of adiponectin. It induced the same changes in leptin secretion. Trans-resveratrol-3-O-glucuronide and trans-resveratrol-4'-O-glucuronide increased apelin and visfatin mRNA levels. Trans-resveratrol-3-O-sulfate reduced leptin mRNA levels and increased those of apelin and visfatin. Conclusions: The present study shows for the first time that resveratrol metabolites have a regulatory effect on adipokine expression and secretion. Since resveratrol has been reported to reduce body-fat accumulation and to improve insulin sensitivity, and considering that these effects are mediated in part by changes in the analyzed adipokines, it may be proposed that resveratrol metabolites play a part in these beneficial effects of resveratrol.	[Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.] Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Nutr & Food Sci, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Churruca, Itziar; Portillo, Maria P.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Portillo, MP (corresponding author), Univ Basque Country UPV EHU, Nutr & Obes Grp, Dept Nutr & Food Sci, Vitoria, Spain.	mariapuy.portillo@ehu.es	Churruca, Itziar/L-7992-2014; Lasa, Arrate/L-7549-2014; Eseberri, Itziar/ABE-7228-2020; Portillo, Maria Puy/ABH-2374-2020; Eseberri, Itziar/AAA-8168-2021	Churruca, Itziar/0000-0003-3771-3963; Lasa, Arrate/0000-0003-2399-4979; Portillo, Maria Puy/0000-0003-0210-6549; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Eseberri, Itziar/0000-0001-5036-963X; LASA ELGUEZUA, ARRATE/0000-0002-8309-8212	Ministerio de Economia y Competitividad [AGL2011-27406-ALI]; Instituto de Salud Carlos III; Government of the Basque Country [IT-512-13]; University of the Basque Country (UPV/EHU) [ELDUNANOTEK UFI11/32]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of the Basque Country; University of the Basque Country (UPV/EHU)	This study was supported by grants from the Ministerio de Economia y Competitividad (AGL2011-27406-ALI), Instituto de Salud Carlos III (RETIC PREDIMED and CiberObn), Government of the Basque Country (IT-512-13) and University of the Basque Country (UPV/EHU) (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Alberdi G, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-29; Andres-Lacueva C., 2009, PLANT PHENOLICS HUMA, P265; Andres-Lacueva C, 2012, J AGR FOOD CHEM, V60, P4833, DOI 10.1021/jf3001108; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Baile CA, 2011, ANN NY ACAD SCI, V1215, P40, DOI 10.1111/j.1749-6632.2010.05845.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bertelli AAE, 1996, INT J TISSUE REACT, V18, P67; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Carpene C, 2007, J PHYSIOL BIOCHEM, V63, P359; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Chen SF, 2012, CAN J PHYSIOL PHARM, V90, P237, DOI [10.1139/Y11-123, 10.1139/y11-123]; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; De Santi C, 2000, XENOBIOTICA, V30, P857, DOI 10.1080/004982500433282; Lobo SMD, 2012, CYTOKINE, V60, P150, DOI 10.1016/j.cyto.2012.04.039; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Derdemezis CS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/285618; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gatz SA, 2008, CARCINOGENESIS, V29, P321, DOI 10.1093/carcin/bgm276; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Hoshino J, 2010, J MED CHEM, V53, P5033, DOI 10.1021/jm100274c; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macarulla MT, 2009, J PHYSIOL BIOCHEM, V65, P369, DOI 10.1007/BF03185932; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Portillo MP, 2012, MOL NUTR FOOD RES, V00, P1; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Szkudelska K, 2009, EUR J CLIN INVEST, V39, P899, DOI 10.1111/j.1365-2362.2009.02188.x; Taylor JM, MOL CELL PROTEOMICS, V1, P304; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang P, 2006, DIABETOLOGIA, V49, P2453, DOI 10.1007/s00125-006-0321-5; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	54	52	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63918	10.1371/journal.pone.0063918	http://dx.doi.org/10.1371/journal.pone.0063918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717508	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700079
J	Geiser, F; Klingenspor, M; McAllan, BM				Geiser, Fritz; Klingenspor, Martin; McAllan, Bronwyn M.			A Functional Nexus between Photoperiod Acclimation, Torpor Expression and Somatic Fatty Acid Composition in a Heterothermic Mammal	PLOS ONE			English	Article							HAMSTER PHODOPUS-SUNGORUS; SATURATED DIETARY LIPIDS; DJUNGARIAN HAMSTER; ADIPOSE-TISSUE; BODY-TEMPERATURE; FOOD-INTAKE; HIBERNATION; MOUSE; METABOLISM; SELECTION	The seasonal changes in thermal physiology and torpor expression of many heterothermic mammals are controlled by photoperiod. As function at low body temperatures during torpor requires changes of tissue lipid composition, we tested for the first time whether and how fatty acids are affected by photoperiod acclimation in hamsters, Phodopus sungorus, a strongly photoperiodic species. We also examined changes in fatty acid composition in relation to those in morphology and thermal biology. Hamsters in short photoperiod had smaller reproductive organs and most had a reduced body mass in comparison to those in long photoperiod. Pelage colour of hamsters under short photoperiod was almost white while that of long photoperiod hamsters was grey-brown and black. Short photoperiod acclimation resulted in regular (28% of days) torpor use, whereas all hamsters in long photoperiod remained normothermic. The composition of total fatty acids differed between acclimation groups for brown adipose tissue (5 of 8 fatty acids), heart muscle (4 of 7 fatty acids) and leg muscle (3 of 11 fatty acids). Importantly, 54% of all fatty acids detected were correlated (r(2) = 0.60 to 0.87) with the minimum surface temperature of individuals, but the responses of tissues differed. While some of the compositional changes of fatty acids were consistent with a 'homeoviscous' response, this was not the case for all, including the sums of saturated and unsaturated fatty acids, which did not differ between acclimation groups. Our data identify a possible nexus between photoperiod acclimation, morphology, reproductive biology, thermal biology and fatty acid composition. They suggest that some of the changes in thermal physiology are linked to the composition of tissue and organ fatty acids.	[Geiser, Fritz; Klingenspor, Martin; McAllan, Bronwyn M.] Univ Marburg, Marburg, Germany	Philipps University Marburg	Geiser, F (corresponding author), Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia.	fgeiser@une.edu.au	Geiser, Fritz/O-4175-2018; Klingenspor, Martin/K-5033-2019; Klingenspor, Martin/D-6930-2011	Geiser, Fritz/0000-0001-7621-5049; Klingenspor, Martin/0000-0002-4502-6664; McAllan, Bronwyn/0000-0002-6075-3405	Australian Research Council; University of New England	Australian Research Council(Australian Research Council); University of New England	This study received financial support from Australian Research Council, University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Arnold W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018641; Barnes Brian M., 1996, P71; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Diedrich Victoria, 2012, P231; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Florant GL, 1998, AM ZOOL, V38, P331; FRANK CL, 1994, ECOLOGY, V75, P458, DOI 10.2307/1939549; GEISER F, 1995, J COMP PHYSIOL B, V165, P406, DOI 10.1007/BF00387311; GEISER F, 1991, J COMP PHYSIOL B, V161, P590, DOI 10.1007/BF00260749; GEISER F, 1990, BIOCHIM BIOPHYS ACTA, V1046, P159, DOI 10.1016/0005-2760(90)90183-X; GEISER F, 1987, AM J PHYSIOL, V252, pR897, DOI 10.1152/ajpregu.1987.252.5.R897; Geiser F, 2007, NATURWISSENSCHAFTEN, V94, P319, DOI 10.1007/s00114-006-0193-z; Geiser Fritz, 2012, P109; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Giroud S, 2009, AM J PHYSIOL-REG I, V297, pR950, DOI 10.1152/ajpregu.00214.2009; HELDMAIER G, 1981, OECOLOGIA, V48, P265, DOI 10.1007/BF00347975; Hickman C.P., 2011, INTEGRATED PRINCIPLE; Hiebert SM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P850, DOI 10.1086/378142; HILL RW, 1975, COMP BIOCHEM PHYS A, V51, P413, DOI 10.1016/0300-9629(75)90389-8; Hoffman RA, 1964, BIOLOGICA, V71, P199; HOFFMANN K, 1978, J REPROD FERTIL, V54, P29, DOI 10.1530/jrf.0.0540029; Hulbert AJ, 2011, AUST J ZOOL, V59, P369, DOI 10.1071/ZO11064; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; KLINGENSPOR M, 1989, AM J PHYSIOL, V257, pR1123, DOI 10.1152/ajpregu.1989.257.5.R1123; Lovegrove Barry G., 2012, P3; LYNCH GR, 1978, J COMP PHYSIOL, V125, P157, DOI 10.1007/BF00686752; McAllan BM, 2012, GEN COMP ENDOCR, V179, P265, DOI 10.1016/j.ygcen.2012.08.024; Morrow G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006070; Mzilikazi N, 2002, J COMP PHYSIOL B, V172, P7, DOI 10.1007/s003600100221; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Price ER, 2013, PHYSIOL BIOCHEM ZOOL, V86, P205, DOI 10.1086/668892; Rojas AD, 2012, BIOL LETTERS, V8, P868, DOI 10.1098/rsbl.2012.0269; RUF T, 1991, J COMP PHYSIOL B, V160, P609, DOI 10.1007/BF00571257; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; Schalk G, 1995, CAN J ZOOL, V73, P1855, DOI 10.1139/z95-218; SCHLATT S, 1993, BIOL REPROD, V49, P243, DOI 10.1095/biolreprod49.2.243; Stamper JL, 1999, PHYSIOL BEHAV, V66, P113, DOI 10.1016/S0031-9384(98)00283-2; Stawski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040278; Steinlechner S., 1986, P301; Swoap SJ, 2009, AM J PHYSIOL-REG I, V297, pR769, DOI 10.1152/ajpregu.00131.2009; TANNENBAUM MG, 1989, AM MIDL NAT, V121, P194, DOI 10.2307/2425671; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63803	10.1371/journal.pone.0063803	http://dx.doi.org/10.1371/journal.pone.0063803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717487	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700062
J	Haidari, LA; Connor, DL; Wateska, AR; Brown, ST; Mueller, LE; Norman, BA; Schmitz, MM; Paul, P; Rajgopal, J; Welling, JS; Leonard, J; Chen, SI; Lee, BY				Haidari, Leila A.; Connor, Diana L.; Wateska, Angela R.; Brown, Shawn T.; Mueller, Leslie E.; Norman, Bryan A.; Schmitz, Michelle M.; Paul, Proma; Rajgopal, Jayant; Welling, Joel S.; Leonard, Jim; Chen, Sheng-I; Lee, Bruce Y.			Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains	PLOS ONE			English	Article							DECISION-MAKING; IMPACT	Background: When addressing the urgent task of improving vaccine supply chains, especially to accommodate the introduction of new vaccines, there is often a heavy emphasis on stationary storage. Currently, donations to vaccine supply chains occur largely in the form of storage equipment. Methods: This study utilized a HERMES-generated detailed, dynamic, discrete event simulation model of the Niger vaccine supply chain to compare the impacts on vaccine availability of adding stationary cold storage versus transport capacity at different levels and to determine whether adding stationary storage capacity alone would be enough to relieve potential bottlenecks when pneumococcal and rotavirus vaccines are introduced by 2015. Results: Relieving regional level storage bottlenecks increased vaccine availability (by 4%) more than relieving storage bottlenecks at the district (1% increase), central (no change), and clinic (no change) levels alone. Increasing transport frequency (or capacity) yielded far greater gains (e.g., 15% increase in vaccine availability when doubling transport frequency to the district level and 18% when tripling). In fact, relieving all stationary storage constraints could only increase vaccine availability by 11%, whereas doubling the transport frequency throughout the system led to a 26% increase and tripling the frequency led to a 30% increase. Increasing transport frequency also reduced the amount of stationary storage space needed in the supply chain. The supply chain required an additional 61,269L of storage to relieve constraints with the current transport frequency, 55,255L with transport frequency doubled, and 51,791L with transport frequency tripled. Conclusions: When evaluating vaccine supply chains, it is important to understand the interplay between stationary storage and transport. The HERMES-generated dynamic simulation model showed how augmenting transport can result in greater gains than only augmenting stationary storage and can reduce stationary storage needs.	[Haidari, Leila A.; Connor, Diana L.; Wateska, Angela R.; Mueller, Leslie E.; Schmitz, Michelle M.; Paul, Proma; Lee, Bruce Y.] Univ Pittsburgh, Sch Med, Publ Hlth Computat & Operat Res PHICOR Grp, Pittsburgh, PA 15213 USA; [Haidari, Leila A.; Connor, Diana L.; Wateska, Angela R.; Mueller, Leslie E.; Schmitz, Michelle M.; Paul, Proma; Lee, Bruce Y.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Brown, Shawn T.; Welling, Joel S.; Leonard, Jim] Pittsburgh Supercomp Ctr, Pittsburgh, PA USA; [Norman, Bryan A.; Rajgopal, Jayant; Chen, Sheng-I] Univ Pittsburgh, Sch Engn, Dept Ind Engn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BY (corresponding author), Univ Pittsburgh, Sch Med, Publ Hlth Computat & Operat Res PHICOR Grp, Pittsburgh, PA 15213 USA.	BYL1@pitt.edu	Schmitz, Michelle M/O-4375-2019	Schmitz, Michelle M/0000-0001-9554-7997; Rajgopal, Jayant/0000-0001-7730-8749; Brown, Shawn/0000-0001-6980-8372; Norman, Bryan/0000-0001-6488-7788	Vaccine Modeling Initiative (VMI); Bill and Melinda Gates Foundation; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) [1U54GM088491-0109]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Vaccine Modeling Initiative (VMI); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Vaccine Modeling Initiative (VMI), funded by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx) and the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) (http://www.nigms.nih.gov/Initiatives/MIDAS/) grant 1U54GM088491-0109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other financial disclosures were reported by the authors of this paper.	Assi TM, 2012, VACCINE, V30, P4517, DOI 10.1016/j.vaccine.2012.04.041; Assi TM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-425; de Oliveira LH, 2008, EXPERT REV VACCINES, V7, P345, DOI 10.1586/14760584.7.3.345; GAVI Alliance, 2012, NIG COUNTR HUB; Humphreys G, 2011, B WORLD HEALTH ORGAN, V89, P324, DOI 10.2471/BLT.11.030511; Isselmou BO, 2011, UNICEF GOVT JAPAN BO; Kaufmann JR, 2011, HEALTH AFFAIR, V30, P1113, DOI 10.1377/hlthaff.2011.0368; Lee BY, 2008, CLIN INFECT DIS, V46, P1139, DOI 10.1086/529441; Lee BY, 2012, AM J PUBLIC HEALTH, V102, P269, DOI 10.2105/AJPH.2011.300218; Lee BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024673; Lee BY, 2011, VACCINE, V29, P3811, DOI 10.1016/j.vaccine.2011.03.013; Lee BY, 2011, HUM VACCINES, V7, P115, DOI 10.4161/hv.7.1.13740; Lee BY, 2006, PLOS MED, V3, P168, DOI 10.1371/journal.pmed.0030099; Maternal and Child Health Integrated Program, 2011, IMP NEW VACC INTR DE; PATH, 2012, CCEM 2; Riders for Health, 2012, WHAT RID HLTH DOES; Rinzin YC, 2012, 16 KEROSENE COOLERS; TransAid, 2012, TRANSAID TRANSP LIF; VillageReach, 2012, VILLAGEREACH LAST MI; Welling J, 2012, VACCINE; WHO, 2010, WHO PREQ VACC; WHO, 2010, EVM ASS TOOL; WHO, 2011, NIG COMPR MULT PLAN; WHO, 2010, IMM PROF NIG; WHO, 2009, VACC VOL CALC	25	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64303	10.1371/journal.pone.0064303	http://dx.doi.org/10.1371/journal.pone.0064303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717590	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700133
J	Hosseini, I; Mac Gabhann, F				Hosseini, Iraj; Mac Gabhann, Feilim			APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; APOBEC3 CYTIDINE DEAMINASES; MESSENGER-RNA LEVELS; VIF PROTEIN; REVERSE TRANSCRIPTION; TYPE-1 VIF; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; VIRAL DYNAMICS; EDITING ENZYME	The interplay between the innate immune system restriction factor APOBEC3G and the HIV protein Vif is a key host-retrovirus interaction. APOBEC3G can counteract HIV infection in at least two ways: by inducing lethal mutations on the viral cDNA; and by blocking steps in reverse transcription and viral integration into the host genome. HIV-Vif blocks these antiviral functions of APOBEC3G by impeding its encapsulation. Nonetheless, it has been shown that overexpression of APOBEC3G, or interfering with APOBEC3G-Vif binding, can efficiently block in vitro HIV replication. Some clinical studies have also suggested that high levels of APOBEC3G expression in HIV patients are correlated with increased CD4+ T cell count and low levels of viral load; however, other studies have reported contradictory results and challenged this observation. Stem cell therapy to replace a patient's immune cells with cells that are more HIV-resistant is a promising approach. Pre-implantation gene transfection of these stem cells can augment the HIV-resistance of progeny CD4+ T cells. As a protein, APOBEC3G has the advantage that it can be genetically encoded, while small molecules cannot. We have developed a mathematical model to quantitatively study the effects on in vivo HIV replication of therapeutic delivery of CD34+ stem cells transfected to overexpress APOBEC3G. Our model suggests that stem cell therapy resulting in a high fraction of APOBEC3G-overexpressing CD4+ T cells can effectively inhibit in vivo HIV replication. We extended our model to simulate the combination of APOBEC3G therapy with other biological activities, to estimate the likelihood of improved outcomes.	[Hosseini, Iraj; Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA	Johns Hopkins University	Hosseini, I (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA.	ihossei1@jhu.edu			Johns Hopkins University; Open Access Promotion Fund; ohns Hopkins University Libraries	Johns Hopkins University(Johns Hopkins University); Open Access Promotion Fund; ohns Hopkins University Libraries	This study was supported by the Ruth H. Aranow fellowship and unrestricted startup funds from the Johns Hopkins University. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Amoedo ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024118; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Bieniasz PD, 2012, HIV RESTRICTION FACT; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Bristol G, 2012, 19 INT AIDS C; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cho SJ, 2006, J VIROL, V80, P2069, DOI 10.1128/JVI.80.4.2069-2072.2006; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Fessel WJ, 2005, MED HYPOTHESES, V64, P261, DOI 10.1016/j.mehy.2004.07.015; Gandhi SK, 2008, J VIROL, V82, P3125, DOI 10.1128/JVI.01533-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho V, 2012, 19 INT AIDS C; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hosseini I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002371; Hutter G, 2011, THESCIENTIFICWORLDJO, V11, P1068, DOI 10.1100/tsw.2011.102; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Koito A, 2012, WIRES RNA, V3, P529, DOI 10.1002/wrna.1117; Kourteva Y, 2012, VIROLOGY, V430, P1, DOI 10.1016/j.virol.2012.03.018; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Miller JH, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-81; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Mous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033934; Nelson PW, 2002, MATH BIOSCI, V179, P73, DOI 10.1016/S0025-5564(02)00099-8; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niu M, 2007, J VIROL JVI, P00162; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Piantadosi A, 2009, J VIROL, V83, P7805, DOI 10.1128/JVI.00280-09; Porteus MH, 2013, MOL THER; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sedaghat AR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-2; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sheehy AM, 2012, MOL BIOL INT, V2012, P11; Siliciano RF, 2012, TRENDS IMMUNOLOGY; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Ulenga NK, 2008, AIDS RES HUM RETROV, V24, P1285, DOI 10.1089/aid.2008.0072; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vandegraaff N, 2007, J VIROL JVI, P00272; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wissing S, 2010, MOL ASPECTS MED, V31, P383, DOI 10.1016/j.mam.2010.06.001; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Yang YL, 2007, VIROLOGY, V365, P92, DOI 10.1016/j.virol.2007.03.022; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	95	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63984	10.1371/journal.pone.0063984	http://dx.doi.org/10.1371/journal.pone.0063984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23724012	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700088
J	House, CM; Lewis, Z; Hodgson, DJ; Wedell, N; Sharma, MD; Hunt, J; Hosken, DJ				House, Clarissa M.; Lewis, Zenobia; Hodgson, Dave J.; Wedell, Nina; Sharma, Manmohan D.; Hunt, John; Hosken, David J.			Sexual and Natural Selection Both Influence Male Genital Evolution	PLOS ONE			English	Article							ONE-SIZE-FITS; GENETIC-VARIATION; DROSOPHILA; MORPHOLOGY; BEETLE; ALLOMETRY; RESPONSES; PATTERNS; SUCCESS; TRAITS	Rapid and divergent evolution of male genital morphology is a conspicuous and general pattern across internally fertilizing animals. Rapid genital evolution is thought to be the result of sexual selection, and the role of natural selection in genital evolution remains controversial. However, natural and sexual selection are believed to act antagonistically on male genital form. We conducted an experimental evolution study to investigate the combined effects of natural and sexual selection on the genital-arch lobes of male Drosophila simulans. Replicate populations were forced to evolve under lifetime monogamy (relaxed sexual selection) or lifetime polyandry (elevated sexual selection) and two temperature regimes, 25 degrees C (relaxed natural selection) or 27 degrees C (elevated natural selection) in a fully factorial design. We found that natural and sexual selection plus their interaction caused genital evolution. Natural selection caused some aspects of genital form to evolve away from their sexually selected shape, whereas natural and sexual selection operated in the same direction for other shape components. Additionally, sexual and natural selection tended to favour larger genitals. Thus we find that the underlying selection driving genital evolution is complex, does not only involve sexual selection, and that natural selection and sexual selection do not always act antagonistically.	[House, Clarissa M.; Lewis, Zenobia; Hodgson, Dave J.; Wedell, Nina; Sharma, Manmohan D.; Hunt, John; Hosken, David J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Hosken, DJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	d.j.hosken@exeter.ac.uk	Sharma, Manmohan/F-8530-2013; Hunt, John/F-1279-2014; Lewis, Zenobia/T-2928-2019	Sharma, Manmohan/0000-0002-9957-3153; Hodgson, Dave/0000-0003-4220-2076; Lewis, Zenobia/0000-0001-9464-7638; Hunt, John/0000-0002-4962-8750	Natural Environment Research Council; Leverhulme Trust; Royal Society; NERC [NE/G005303/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005303/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D. Hoskin, JH, D. Hodgson, and NW were funded by the Natural Environment Research Council to investigate genital evolution, CMH was funded by a Leverhulme Trust fellowship and JH by a Royal Society Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CAC, 2005, J THERM BIOL, V30, P518, DOI 10.1016/j.jtherbio.2005.05.011; [Anonymous], 1984, SPERM COMPETITION EV; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Bernstein S, 2002, EVOLUTION, V56, P1707, DOI 10.1111/j.0014-3820.2002.tb01483.x; Blanckenhorn WU, 1999, EVOL ECOL, V13, P395, DOI 10.1023/A:1006741222586; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Garcia-Gonzalez F, 2011, ENCY LIFE SCI ELE, DOI [10.1002/9780470015902.0022859, DOI 10.1002/9780470015902.0022859]; Ghiselin Michael T., 2010, P9; Higgins SL, 2009, BIOL J LINN SOC, V98, P400, DOI 10.1111/j.1095-8312.2009.01292.x; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; House CM, 2005, J EVOLUTION BIOL, V18, P1281, DOI 10.1111/j.1420-9101.2005.00926.x; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P311, DOI 10.1111/jeb.12045; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Jennions MD, 2002, OIKOS, V97, P79, DOI 10.1034/j.1600-0706.2002.970108.x; Kamimura Y, 2010, ZOOMORPHOLOGY, V129, P163, DOI 10.1007/s00435-010-0109-5; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Langerhans RB, 2005, P NATL ACAD SCI USA, V102, P7618, DOI 10.1073/pnas.0500935102; Preziosi RF, 1998, HEREDITY, V81, P92, DOI 10.1046/j.1365-2540.1998.00380.x; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reinhardt K, 2010, GENETICA, V138, P119, DOI 10.1007/s10709-009-9360-4; ROFF DA, 2001, LIFE HIST EVOLUTION; Rohlf FJ, 2008, TPSRELW RELATIVE WAR; Rohlf FJ, 2009, TPSDIG DIGITIZE LAND; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Sharma MD, 2012, EVOLUTION, V66, P665, DOI 10.1111/j.1558-5646.2011.01468.x; Simmons LW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1379; Simmons LW, 2009, CURR BIOL, V19, P1442, DOI 10.1016/j.cub.2009.06.056; Taylor ML, 2008, ANIM BEHAV, V76, P963, DOI 10.1016/j.anbehav.2008.05.015; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; True JR, 1997, EVOLUTION, V51, P816, DOI [10.2307/2411157, 10.1111/j.1558-5646.1997.tb03664.x]; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zeng ZB, 2000, GENETICS, V154, P299	44	41	41	11	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63807	10.1371/journal.pone.0063807	http://dx.doi.org/10.1371/journal.pone.0063807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717488	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700063
J	Jansen, D; Zerbi, V; Janssen, CIF; Dederen, PJWC; Mutsaers, MPC; Hafkemeijer, A; Janssen, AL; Nobelen, CLM; Veltien, A; Asten, JJ; Heerschap, A; Kiliaan, AJ				Jansen, Diane; Zerbi, Valerio; Janssen, Carola I. F.; Dederen, Pieter J. W. C.; Mutsaers, Martina P. C.; Hafkemeijer, Anne; Janssen, Anna-Lena; Nobelen, Cindy L. M.; Veltien, Andor; Asten, Jack J.; Heerschap, Arend; Kiliaan, Amanda J.			A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and A beta PPswe-PS1dE9 Mice	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; AMYLOID PRECURSOR PROTEIN; APPSWE/PS1DE9 MOUSE MODEL; MORRIS WATER MAZE; AGE-RELATED-CHANGES; ADULT HIPPOCAMPAL NEUROGENESIS; MICROTUBULE-ASSOCIATED PROTEIN; APP/PS1 TRANSGENIC MICE; N-ACETYL ASPARTATE; MULTIPLE T-TESTS	Proton magnetic resonance spectroscopy (H-1 MRS) is a valuable tool in Alzheimer's disease research, investigating the functional integrity of the brain. The present longitudinal study set out to characterize the neurochemical profile of the hippocampus, measured by single voxel H-1 MRS at 7 Tesla, in the brains of A beta PPSswe-PS1dE9 and wild-type mice at 8 and 12 months of age. Furthermore, we wanted to determine whether alterations in hippocampal metabolite levels coincided with behavioral changes, cognitive decline and neuropathological features, to gain a better understanding of the underlying neurodegenerative processes. Moreover, correlation analyses were performed in the 12-month-old A beta PP-PS1 animals with the hippocampal amyloid-beta deposition, TBS-T soluble A beta levels and high-molecular weight A beta aggregate levels to gain a better understanding of the possible involvement of A beta in neurochemical and behavioral changes, cognitive decline and neuropathological features in A beta PP-PS1 transgenic mice. Our results show that at 8 months of age A beta PPswe-PS1dE9 mice display behavioral and cognitive changes compared to age-matched wild-type mice, as determined in the open field and the (reverse) Morris water maze. However, there were no variations in hippocampal metabolite levels at this age. A beta PP-PS1 mice at 12 months of age display more severe behavioral and cognitive impairment, which coincided with alterations in hippocampal metabolite levels that suggest reduced neuronal integrity. Furthermore, correlation analyses suggest a possible role of A beta in inflammatory processes, synaptic dysfunction and impaired neurogenesis.	[Jansen, Diane; Zerbi, Valerio; Janssen, Carola I. F.; Dederen, Pieter J. W. C.; Mutsaers, Martina P. C.; Hafkemeijer, Anne; Janssen, Anna-Lena; Nobelen, Cindy L. M.; Kiliaan, Amanda J.] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Donders Ctr Neurosci, Dept Anat, Nijmegen, Netherlands; [Veltien, Andor; Asten, Jack J.; Heerschap, Arend] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Donders Ctr Neurosci, Dept Anat, Nijmegen, Netherlands.	A.Kiliaan@anat.umcn.nl	Veltien, Andor/E-2834-2016; Dederen, Pieter.J.W.C/E-1899-2016; Zerbi, Valerio/K-3405-2018; Kiliaan, Amanda J/D-8778-2012; Heerschap, Arend/G-5228-2010	Veltien, Andor/0000-0002-8090-5445; Butscher, Anna-Lena/0000-0001-5556-4610; Zerbi, Valerio/0000-0001-7984-9565; Hafkemeijer, Anne/0000-0002-2940-4768	European Community [211696]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283; BROWN JD, 1990, TESOL QUART, V24, P770, DOI 10.2307/3587135; Burgermeister P, 2000, ANN NY ACAD SCI, V903, P307, DOI 10.1111/j.1749-6632.2000.tb06381.x; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chen SQ, 2012, BEHAV BRAIN RES, V235, P1, DOI 10.1016/j.bbr.2012.07.016; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Choi IY, 2003, NEUROCHEM RES, V28, P987, DOI 10.1023/A:1023370104289; Choi JK, 2007, NMR BIOMED, V20, P216, DOI 10.1002/nbm.1145; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Franklin KBJ, 1997, MOUSE BRAIN STEREOTA, Vxxii; Frederick BD, 2002, AM J GERIAT PSYCHIAT, V10, P81, DOI 10.1176/appi.ajgp.10.1.81; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; Grossberg GT, 2003, J CLIN PSYCHIAT, V64, P3; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Hooijmans CR, 2007, BRAIN RES, V1181, P93, DOI 10.1016/j.brainres.2007.08.063; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Jack CR, 2007, NEUROSCIENTIST, V13, P38, DOI 10.1177/1073858406295610; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen D, 2012, J ALZHEIMERS DIS, V31, P813, DOI 10.3233/JAD-2012-120298; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jessen F, 2009, NEUROLOGY, V72, P1735, DOI 10.1212/WNL.0b013e3181a60a20; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Lovasic L, 2005, GENES BRAIN BEHAV, V4, P197, DOI 10.1111/j.1601-183X.2004.00104.x; Machova E, 2010, NEUROBIOL DIS, V38, P27, DOI 10.1016/j.nbd.2009.12.023; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Masliah E, 1996, J NEUROSCI, V16, P5795; MASLIAH E, 1994, NEUROSCI LETT, V174, P67, DOI 10.1016/0304-3940(94)90121-X; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; Meyer JS, 1998, EUR NEUROL, V39, P7, DOI 10.1159/000052064; Mlynarik V, 2012, J ALZHEIMERS DIS, V31, pS87, DOI 10.3233/JAD-2012-112072; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7; Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patterson M B, 1990, J Geriatr Psychiatry Neurol, V3, P21, DOI 10.1177/089198879000300106; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4; Ross AJ, 2005, BRAIN RES BULL, V66, P9, DOI 10.1016/j.brainresbull.2005.01.015; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Rupsingh R, 2011, NEUROBIOL AGING, V32, P802, DOI 10.1016/j.neurobiolaging.2009.05.002; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Rutten BR, 2003, NEUROBIOL DIS, V12, P110, DOI 10.1016/S0969-9961(02)00015-3; Satlin A, 1997, AM J PSYCHIAT, V154, P1459; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Scheff SW, 1996, DEMENTIA, V7, P226, DOI 10.1159/000106884; Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006; Schuff N, 1997, NEUROLOGY, V49, P1513, DOI 10.1212/WNL.49.6.1513; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shukla C, 1999, NEUROREPORT, V10, P3785, DOI 10.1097/00001756-199912160-00012; SIEGEL AF, 1990, TESOL QUART, V24, P773, DOI 10.2307/3587136; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skoog I, 2002, ANN NY ACAD SCI, V977, P29, DOI 10.1111/j.1749-6632.2002.tb04796.x; Stover KR, 2012, BEHAV BRAIN RES, V231, P75, DOI 10.1016/j.bbr.2012.02.044; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; Su DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050172; Szapacs ME, 2004, NEUROBIOL DIS, V16, P572, DOI 10.1016/j.nbd.2004.04.010; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; von Kienlin M, 2005, NEUROBIOL DIS, V18, P32, DOI 10.1016/j.nbd.2004.09.005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watanabe T, 2012, NEUROBIOL LEARN MEM, V97, P289, DOI 10.1016/j.nlm.2012.01.006; Weller RO, 2003, NEUROL RES, V25, P611, DOI 10.1179/016164103101202057; Woo DC, 2010, BEHAV BRAIN RES, V211, P125, DOI 10.1016/j.bbr.2010.03.026; Xu W, 2010, J NEUROSCI RES, V88, P3155, DOI 10.1002/jnr.22479; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048540; Yao PJ, 2005, BIOCHEM BIOPH RES CO, V330, P34, DOI 10.1016/j.bbrc.2005.02.121; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zerbi V, 2013, BRAIN STRUCT FUNCT, V218, P1085, DOI 10.1007/s00429-012-0448-8; Zerbi V, 2013, NEUROBIOL AGING, V34, P1440, DOI 10.1016/j.neurobiolaging.2012.11.017; Zhang B, 2009, J CLIN NEUROSCI, V16, P635, DOI 10.1016/j.jocn.2008.07.080; Zilka N, 2006, Bratisl Lek Listy, V107, P374	125	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63643	10.1371/journal.pone.0063643	http://dx.doi.org/10.1371/journal.pone.0063643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717459	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700045
J	Lee, EJ; Bhat, AR; Kamli, MR; Pokharel, S; Chun, T; Lee, YH; Nahm, SS; Nam, JH; Hong, SK; Yang, B; Chung, KY; Kim, SH; Choi, I				Lee, Eun Ju; Bhat, Abdul R.; Kamli, Majid Rasool; Pokharel, Smritee; Chun, Tahoon; Lee, Yong-Ho; Nahm, Sang-Seop; Nam, Joo Hyun; Hong, Seong Koo; Yang, Bohsuk; Chung, Ki Young; Kim, Sang Hoon; Choi, Inho			Transthyretin Is a Key Regulator of Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; THYROID-HORMONE; CALCIUM-CHANNELS; RESPONSE ELEMENT; GENE-EXPRESSION; CELL-FUSION; CA2+ ENTRY; MYOGENIN; OVEREXPRESSION; IDENTIFICATION	Transthyretin (TTR) is a known carrier protein for thyroxine (T-4) and retinol-binding protein in the blood that is primarily synthesized in the liver and choroid plexus of the brain. Herein, we report that the TTR gene is expressed in skeletal muscle tissue and up-regulated during myotube formation in C2C12 cells. TTR silencing (TTRkd) significantly reduced myogenin expression and myotube formation, whereas myogenin silencing (MYOG(kd)) did not have any effect on TTR gene expression. Both TTRkd and MYOG(kd) led to a decrease in calcium channel related genes including Cav1.1, STIM1 and Orai1. A significant decrease in intracellular T-4 uptake during myogenesis was observed in TTRkd cells. Taken together, the results of this study suggest that TTR initiates myoblast differentiation via affecting expression of the genes involved during early stage of myogenesis and the genes related to calcium channel.	[Lee, Eun Ju; Bhat, Abdul R.; Kamli, Majid Rasool; Pokharel, Smritee; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Chun, Tahoon] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Lee, Yong-Ho] Catholic Univ Daegu, Dept Biomed Sci, Gyongsan, South Korea; [Nahm, Sang-Seop] Konkuk Univ, Coll Vet Med, Seoul, South Korea; [Nam, Joo Hyun] Dongguk Univ, Coll Med, Dept Physiol, Gyeongju, South Korea; [Hong, Seong Koo; Yang, Bohsuk; Chung, Ki Young] Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Pyongchang, South Korea; [Kim, Sang Hoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea	Yeungnam University; Korea University; Catholic University of Daegu; Konkuk University; Dongguk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyung Hee University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Kamli, Majid Rasool/AAN-6151-2020; kamli, majid/AFS-7216-2022; Nam, Joohyun/AAD-4491-2021	Kamli, Majid Rasool/0000-0003-0553-0046; Kim, Sanghoon/0000-0002-4078-6269; Nam, Joo Hyun/0000-0001-8300-6974	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ 907099]	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (project no. PJ 907099), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Barnoy S, 1997, BBA-MOL CELL RES, V1358, P181, DOI 10.1016/S0167-4889(97)00068-2; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARNAC G, 1993, ONCOGENE, V8, P3103; CATTERALL WA, 2011, COLD SPRING HARB PER, V3, P3947; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chemin J, 2002, J NEUROSCI, V22, P6856; COGNARD C, 1993, DEVELOPMENT, V117, P1153; DIANNE RS, 1985, J BIOL CHEM, V260, P11793; DOWNES M, 1993, CELL GROWTH DIFFER, V4, P901; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; KUBO Y, 1991, J PHYSL, V443, P711; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lin HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00029; Liu JH, 1999, BRIT J PHARMACOL, V126, P245, DOI 10.1038/sj.bjp.0702321; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Monk JA, 2013, AM J PHYSIOL-ENDOC M, V304, pE23, DOI 10.1152/ajpendo.00216.2012; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Numaga-Tomita T, 2013, J CELL SCI, V126, P605, DOI 10.1242/jcs.115980; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Pavlath GK, 2003, CELL CYCLE, V2, P420, DOI 10.4161/cc.2.5.497; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Picard B, 1998, BASIC APPL MYOL, V8, P197; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; ROSEN HN, 1993, J CLIN ENDOCR METAB, V77, P370, DOI 10.1210/jc.77.2.370; SAMANTHA JR, 2007, INT REV CYTOL, V258, P137; SLOTKIN TA, 1992, TERATOLOGY, V45, P303, DOI 10.1002/tera.1420450309; Smith KL, 2012, J NEUROSCI METH, V203, P398, DOI 10.1016/j.jneumeth.2011.09.023; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Weick JP, 2003, J NEUROSCI, V23, P3446	51	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63627	10.1371/journal.pone.0063627	http://dx.doi.org/10.1371/journal.pone.0063627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717457	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700043
J	Rahman, A; Languille, S; Lamberty, Y; Babiloni, C; Perret, M; Bordet, R; Blin, OJ; Jacob, T; Auffret, A; Schenker, E; Richardson, J; Pifferi, F; Aujard, F				Rahman, Anisur; Languille, Solene; Lamberty, Yves; Babiloni, Claudio; Perret, Martine; Bordet, Regis; Blin, Olivier J.; Jacob, Tom; Auffret, Alexandra; Schenker, Esther; Richardson, Jill; Pifferi, Fabien; Aujard, Fabienne			Sleep Deprivation Impairs Spatial Retrieval but Not Spatial Learning in the Non-Human Primate Grey Mouse Lemur	PLOS ONE			English	Article							PARADOXICAL SLEEP; REM-SLEEP; MEMORY CONSOLIDATION; RAT HIPPOCAMPUS; WORKING-MEMORY; ACQUISITION; AVOIDANCE; INFORMATION; ALZHEIMERS; STRESS	A bulk of studies in rodents and humans suggest that sleep facilitates different phases of learning and memory process, while sleep deprivation (SD) impairs these processes. Here we tested the hypothesis that SD could alter spatial learning and memory processing in a non-human primate, the grey mouse lemur (Microcebus murinus), which is an interesting model of aging and Alzheimer's disease (AD). Two sets of experiments were performed. In a first set of experiments, we investigated the effects of SD on spatial learning and memory retrieval after one day of training in a circular platform task. Eleven male mouse lemurs aged between 2 to 3 years were tested in three different conditions: without SD as a baseline reference, 8 h of SD before the training and 8 h of SD before the testing. The SD was confirmed by electroencephalographic recordings. Results showed no effect of SD on learning when SD was applied before the training. When the SD was applied before the testing, it induced an increase of the amount of errors and of the latency prior to reach the target. In a second set of experiments, we tested the effect of 8 h of SD on spatial memory retrieval after 3 days of training. Twenty male mouse lemurs aged between 2 to 3 years were tested in this set of experiments. In this condition, the SD did not affect memory retrieval. This is the first study that documents the disruptive effects of the SD on spatial memory retrieval in this primate which may serve as a new validated challenge to investigate the effects of new compounds along physiological and pathological aging.	[Rahman, Anisur; Languille, Solene; Perret, Martine; Pifferi, Fabien; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Lamberty, Yves] UCB Pharma Sa, Neurosci Therapeut Area, Braine Lalleud, Belgium; [Babiloni, Claudio] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Babiloni, Claudio] IRCCS San Raffalele Pisana, Rome, Italy; [Bordet, Regis] Univ Lille Nord France, CHU Lille, UDSL, Fac Med,Dept Pharmacol Med,EA 1046, Lille, France; [Blin, Olivier J.; Auffret, Alexandra] Aix Marseille Univ, CNRS, UMR 7289, INT,AP HM Timone,CPCET CIC, Marseille, France; [Jacob, Tom] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium; [Schenker, Esther] Inst Rech Servier, Croissy Sur Seine, France; [Richardson, Jill] GlaxoSmithKline, R&D China UK Grp, Stevenage, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UCB Pharma SA; University of Foggia; IRCCS San Raffaele Pisana; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Johnson & Johnson; Janssen Pharmaceuticals; Servier; Institut de Recherches Internationales Servier; GlaxoSmithKline	Aujard, F (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	aujard@mnhn.fr	Babiloni, Claudio/AAC-5324-2022	Babiloni, Claudio/0000-0002-5245-9839; Pifferi, Fabien/0000-0001-9316-1935	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative [115009]	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative	This work was financially supported as part of the Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009. For further information please refer to www.pharmacog.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM K, 1977, J ROY COLL PHYS LOND, V11, P376; Alvarenga TA, 2008, NEUROBIOL LEARN MEM, V90, P624, DOI 10.1016/j.nlm.2008.07.013; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Bjorness TE, 2005, LEARN MEMORY, V12, P352, DOI 10.1101/lm.84805; Bons N, 1998, BRAIN RES BULL, V46, P1; Buccafusco JJ, 2008, J ALZHEIMERS DIS, V15, P709; BUENO OFA, 1994, PHYSIOL BEHAV, V56, P775, DOI 10.1016/0031-9384(94)90241-0; Dametto M, 2002, BEHAV BRAIN RES, V129, P171, DOI 10.1016/S0166-4328(01)00345-X; Dang-Vu T T, 2006, Pediatr Rehabil, V9, P98, DOI 10.1080/13638490500138702; DANGUIR J, 1976, PHYSIOL BEHAV, V17, P489, DOI 10.1016/0031-9384(76)90112-8; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Fernandes-Santos L, 2012, PROG NEURO-PSYCHOPH, V38, P216, DOI 10.1016/j.pnpbp.2012.03.014; Ferrara M, 2008, HIPPOCAMPUS, V18, P844, DOI 10.1002/hipo.20444; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; FLOOD JF, 1972, PHYSIOL BEHAV, V9, P589, DOI 10.1016/0031-9384(72)90017-0; FRANKEN P, 1993, PHYSIOL BEHAV, V54, P885, DOI 10.1016/0031-9384(93)90297-S; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; GruartMasso A, 1996, BEHAV BRAIN RES, V72, P181; HARS B, 1985, BEHAV BRAIN RES, V18, P241, DOI 10.1016/0166-4328(85)90032-4; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Kim EY, 2005, NEUROSCI LETT, V388, P163, DOI 10.1016/j.neulet.2005.06.057; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Laurijssens Bart, 2013, Drug Discov Today Technol, V10, pe319, DOI 10.1016/j.ddtec.2012.04.001; LECONTE P, 1974, PHYSIOL BEHAV, V13, P675, DOI 10.1016/0031-9384(74)90239-X; Leenaars CHC, 2012, BEHAV BRAIN RES, V230, P40, DOI 10.1016/j.bbr.2012.01.047; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; PEARLMAN CA, 1979, NEUROSCI BIOBEHAV R, V3, P57, DOI 10.1016/0149-7634(79)90034-4; PERON JE, 1985, BRAZ J MED BIOL RES, V18, P381; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Poirrier JE, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-14; PORKKAHEISKANEN T, 1994, LIFE SCI, V54, P1719, DOI 10.1016/0024-3205(94)00612-1; Rauchs G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002949; Rothman SM, 2012, NEUROMOL MED, V14, P194, DOI 10.1007/s12017-012-8181-2; Ruskin DN, 2006, LIFE SCI, V78, P2833, DOI 10.1016/j.lfs.2005.11.003; Ruskin DN, 2004, EUR J NEUROSCI, V19, P3121, DOI 10.1111/j.0953-816X.2004.03426.x; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Silva RH, 2004, NEUROBIOL LEARN MEM, V82, P90, DOI 10.1016/j.nlm.2004.04.005; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Smith C, 1997, BEHAV NEUROSCI, V111, P1197, DOI 10.1037/0735-7044.111.6.1197; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Smith CT, 1998, NEUROBIOL LEARN MEM, V69, P211, DOI 10.1006/nlme.1997.3809; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Toppila J, 1997, J SLEEP RES, V6, P171, DOI 10.1046/j.1365-2869.1997.00049.x; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; VANHULZEN ZJM, 1982, PHYSIOL BEHAV, V29, P581, DOI 10.1016/0031-9384(82)90223-2; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Ward CP, 2009, BRAIN RES, V1294, P128, DOI 10.1016/j.brainres.2009.07.064; Ward CP, 2009, J SLEEP RES, V18, P238, DOI 10.1111/j.1365-2869.2008.00714.x; Weatherall FRS D, 2006, US NONH PRIM RES WEA; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851; Youngblood BD, 1997, PHYSIOL BEHAV, V61, P249, DOI 10.1016/S0031-9384(96)00363-0; Youngblood BD, 1999, PHYSIOL BEHAV, V67, P643, DOI 10.1016/S0031-9384(99)00120-1	60	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64493	10.1371/journal.pone.0064493	http://dx.doi.org/10.1371/journal.pone.0064493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717620	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700151
J	Roy, P; Kumar, B; Shende, A; Singh, A; Meena, A; Ghosal, R; Ranganathan, M; Bandyopadhyay, A				Roy, Priti; Kumar, Brijesh; Shende, Akhilesh; Singh, Anupama; Meena, Anil; Ghosal, Ritika; Ranganathan, Madhav; Bandyopadhyay, Amitabha			A Genome-Wide Screen Indicates Correlation between Differentiation and Expression of Metabolism Related Genes	PLOS ONE			English	Article							EARLY HEART DEVELOPMENT; MOONLIGHTING PROTEINS; CHICK-EMBRYO; MOUSE; CHONDROGENESIS; ACTIVATION; EPITHELIUM; FATE; KEGG; TUBE	Differentiated tissues may be considered as materials with distinct properties. The differentiation program of a given tissue ensures that it acquires material properties commensurate with its function. It may be hypothesized that some of these properties are acquired through production of tissue-specific metabolites synthesized by metabolic enzymes. To establish correlation between metabolism and organogenesis we have carried out a genome-wide expression study of metabolism related genes by RNA in-situ hybridization. 23% of the metabolism related genes studied are expressed in a tissue-restricted but not tissue-exclusive manner. We have conducted the screen on whole mount chicken (Gallus gallus) embryos from four distinct developmental stages to correlate dynamic changes in expression patterns of metabolic enzymes with spatio-temporally unique developmental events. Our data strongly suggests that unique combinations of metabolism related genes, and not specific metabolic pathways, are upregulated during differentiation. Further, expression of metabolism related genes in well established signaling centers that regulate different aspects of morphogenesis indicates developmental roles of some of the metabolism related genes. The database of tissue-restricted expression patterns of metabolism related genes, generated in this study, should serve as a resource for systematic identification of these genes with tissue-specific functions during development. Finally, comprehensive understanding of differentiation is not possible unless the downstream genes of a differentiation cascade are identified. We propose, metabolic enzymes constitute a significant portion of these downstream target genes. Thus our study should help elucidate different aspects of tissue differentiation.	[Roy, Priti; Kumar, Brijesh; Singh, Anupama; Meena, Anil; Ghosal, Ritika; Bandyopadhyay, Amitabha] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Shende, Akhilesh; Ranganathan, Madhav] Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Bandyopadhyay, A (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	abandopa@iitk.ac.in	Kumar, Prof. Brijesh/A-7485-2012; Bandyopadhyay, Amitabha/B-9735-2008; Kumar, Brijesh/GPP-3392-2022	Kumar, Prof. Brijesh/0000-0003-0271-3445; Kumar, Brijesh/0000-0003-0271-3445; Bandyopadhyay, Amitabha/0000-0002-0429-438X; Kumar, Brijesh/0000-0002-7251-492X	Department of Biotechnology, India; IIT Kanpur [IITK/BSBE/20060277]; Council of Scientific & Industrial Research (CSIR), India; Department of Biotechnology (DBT), India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); IIT Kanpur; Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, India and initiation grant from IIT Kanpur (IITK/BSBE/20060277). P. R. and B. K. are supported by fellowships from Council of Scientific & Industrial Research (CSIR), India. Anupama Singh was supported by fellowship from Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Cankaya M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-232; Choi D, 2006, GENOMICS, V87, P500, DOI 10.1016/j.ygeno.2005.11.015; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Duncan SA, 2000, DEV DYNAM, V219, P131, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1051>3.3.CO;2-E; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hiramatsu H, 2004, INT J DEV BIOL, V48, P1141, DOI 10.1387/ijdb.041886hh; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hubbard SJ, 2005, GENOME RES, V15, P174, DOI 10.1101/gr.3011405; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Li NX, 2005, DEV DYNAM, V233, P907, DOI 10.1002/dvdy.20434; Lopez-Sanchez C, 2010, CARDIOVASC RES, V88, P111, DOI 10.1093/cvr/cvq179; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Montero JA, 2010, APOPTOSIS, V15, P1197, DOI 10.1007/s10495-010-0523-7; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; Ohana E, 2012, J BIOL CHEM, V287, P5122, DOI 10.1074/jbc.M111.297192; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; Ozbudak EM, 2010, P NATL ACAD SCI USA, V107, P4224, DOI 10.1073/pnas.0909375107; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pindyurin AlexeyA Ozgur Z, 2012, MOL CELL, P133; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Wagner M, 2007, EXP BIOL MED, V232, P852; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xie ZH, 2011, P NATL ACAD SCI USA, V108, P12119, DOI 10.1073/pnas.1100160108; Zhang Y, 2011, DEV BIOL, V353, P259, DOI 10.1016/j.ydbio.2011.02.030; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63670	10.1371/journal.pone.0063670	http://dx.doi.org/10.1371/journal.pone.0063670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717462	Green Published, gold			2022-12-25	WOS:000320362700047
J	Shaw, L; Sneddon, SF; Zeef, L; Kimber, SJ; Brison, DR				Shaw, Lisa; Sneddon, Sharon F.; Zeef, Leo; Kimber, Susan J.; Brison, Daniel R.			Global Gene Expression Profiling of Individual Human Oocytes and Embryos Demonstrates Heterogeneity in Early Development	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; AMINO-ACID TURNOVER; PREIMPLANTATION EMBRYO; DNA METHYLATION; NONINVASIVE MEASUREMENT; BASEMENT-MEMBRANES; NUCLEAR MATURATION; CELL-ADHESION; IDENTIFICATION; GLUCOSE	Early development in humans is characterised by low and variable embryonic viability, reflected in low fecundity and high rates of miscarriage, relative to other mammals. Data from assisted reproduction programmes provides additional evidence that this is largely mediated at the level of embryonic competence and is highly heterogeneous among embryos. Understanding the basis of this heterogeneity has important implications in a number of areas including: the regulation of early human development, disorders of pregnancy, assisted reproduction programmes, the long term health of children which may be programmed in early development, and the molecular basis of pluripotency in human stem cell populations. We have therefore investigated global gene expression profiles using polyAPCR amplification and microarray technology applied to individual human oocytes and 4-cell and blastocyst stage embryos. In order to explore the basis of any variability in detail, each developmental stage is replicated in triplicate. Our data show that although transcript profiles are highly stage-specific, within each stage they are relatively variable. We describe expression of a number of gene families and pathways including apoptosis, cell cycle and amino acid metabolism, which are variably expressed and may be reflective of embryonic developmental competence. Overall, our data suggest that heterogeneity in human embryo developmental competence is reflected in global transcript profiles, and that the vast majority of existing human embryo gene expression data based on pooled oocytes and embryos need to be reinterpreted.	[Shaw, Lisa; Sneddon, Sharon F.; Brison, Daniel R.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Shaw, Lisa; Sneddon, Sharon F.; Brison, Daniel R.] Cent Manchester Univ Hosp NHS Fdn Trust, Old St Marys Hosp, Dept Reprod Med, Manchester, Lancs, England; [Shaw, Lisa; Sneddon, Sharon F.; Zeef, Leo; Kimber, Susan J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Brison, DR (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	Daniel.Brison@manchester.ac.uk	Shaw, Lisa/I-5560-2019	Shaw, Lisa/0000-0002-6226-6467; Kimber, Susan/0000-0002-0568-6342; Sneddon, Sharon/0000-0001-9767-4180	Cancer Research UK [C19686/A6233]; Biotechnology and Biological Sciences Research Council [BB/J021636/1] Funding Source: researchfish; Medical Research Council [G0801057, G0300484, G0700092] Funding Source: researchfish; Wellbeing of Women [RG1442] Funding Source: researchfish; BBSRC [BB/J021636/1] Funding Source: UKRI; MRC [G0300484, G0700092, G0801057] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellbeing of Women(Wellbeing of Women (WoW)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Cancer Research UK www.cancerresearchuk.org (grant reference C19686/A6233). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, REPROD FERT DEVELOP, V17, P37, DOI 10.1071/RD04075; Al-Taher A, 2000, YEAST, V17, P201, DOI 10.1002/1097-0061(20000930)17:3<201::AID-YEA30>3.0.CO;2-R; Aplin John D, 2004, Reprod Biol Endocrinol, V2, P48; Arraztoa JA, 2005, HUM REPROD, V20, P476, DOI 10.1093/humrep/deh498; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Bloor DJ, 2002, MOL HUM REPROD, V8, P237, DOI 10.1093/molehr/8.3.237; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booth PJ, 2005, REPRODUCTION, V130, P655, DOI 10.1530/rep.1.00727; Brady G, 2000, YEAST, V17, P211, DOI 10.1002/1097-0061(20000930)17:3<211::AID-YEA26>3.0.CO;2-7; BRADY G, 1993, METHOD ENZYMOL, V225, P611; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Brison DR, 2007, REPROD BIOMED ONLINE, V15, P296, DOI 10.1016/S1472-6483(10)60342-2; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Cailliau K, 2001, CELL SIGNAL, V13, P51, DOI 10.1016/S0898-6568(00)00138-8; Camarasa MV, 2010, IN VITRO CELL DEV-AN, V46, P386, DOI 10.1007/s11626-010-9291-5; Chandrakanthan V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-39; Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Croteau S, 2003, MAMM GENOME, V14, P231, DOI 10.1007/s00335-002-2244-x; De Sousa PA, 2009, STEM CELL RES, V2, P188, DOI 10.1016/j.scr.2009.01.002; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Fragouli E, 2010, MOL HUM REPROD, V16, P570, DOI 10.1093/molehr/gaq033; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Funahashi H, 2008, THERIOGENOLOGY, V70, P1041, DOI 10.1016/j.theriogenology.2008.06.025; Gardner DK, 1999, CURR OPIN OBSTET GYN, V11, P307, DOI 10.1097/00001703-199906000-00013; GARDNER DK, 1986, HUM REPROD, V1, P25, DOI 10.1093/oxfordjournals.humrep.a136336; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Harbig J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni027; HARDY K, 1989, HUM REPROD, V4, P188, DOI 10.1093/oxfordjournals.humrep.a136869; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Huntriss J, 2011, FERTIL STERIL, V95, P2564, DOI 10.1016/j.fertnstert.2011.04.035; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Jones GM, 2007, MOL REPROD DEV, V74, P8, DOI 10.1002/mrd.20621; Kiessling AA, 2010, J ASSIST REPROD GEN, V27, P265, DOI 10.1007/s10815-010-9407-6; Kiessling AA, 2009, J ASSIST REPROD GEN, V26, P187, DOI 10.1007/s10815-009-9306-x; Kim J, 2010, J CELL SCI, V123, P993, DOI 10.1242/jcs.060442; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Li T, 2005, MOL HUM REPROD, V11, P631, DOI 10.1093/molehr/gah230; MARTIN KL, 1993, J REPROD FERTIL, V99, P259; Metcalfe AD, 2004, MOL REPROD DEV, V68, P35, DOI 10.1002/mrd.20055; Mummery CL, 2001, MICROSC RES TECHNIQ, V52, P374, DOI 10.1002/1097-0029(20010215)52:4<374::AID-JEMT1022>3.0.CO;2-8; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Obata Y, 2011, J REPROD DEVELOP, V57, P327, DOI 10.1262/jrd.10-145A; Picton HM, 2010, MOL HUM REPROD, V16, P557, DOI 10.1093/molehr/gaq040; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Roberts SA, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14380; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sato H, 2007, ANIM REPROD SCI, V99, P299, DOI 10.1016/j.anireprosci.2006.05.008; Schultz JF, 1997, DEV GENET, V21, P31, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;31::AID-DVG4&gt;3.0.CO;2-9; Shapiro RS, 2006, DEVELOPMENT, V133, P1467, DOI 10.1242/dev.02318; Shaw L, 2012, REPRODUCTION, V144, P569, DOI 10.1530/REP-12-0047; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sneddon SF, 2011, FERTIL STERIL, V95, P1410, DOI 10.1016/j.fertnstert.2010.08.050; STEER CV, 1992, HUM REPROD, V7, P117, DOI 10.1093/oxfordjournals.humrep.a137542; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sugiura K, 2009, BIOL REPROD, V81, P833, DOI 10.1095/biolreprod.109.078485; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Sutton-McDowall ML, 2005, REPROD FERT DEVELOP, V17, P407, DOI 10.1071/RD04135; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tian X, 2010, GENE EXPR PATTERNS, V10, P105, DOI 10.1016/j.gep.2010.02.003; VandeVoort CA, 2009, BIOL REPROD, V81, P1139, DOI 10.1095/biolreprod.109.077198; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Watkins AJ, 2008, SEMIN REPROD MED, V26, P175, DOI 10.1055/s-2008-1042956; Wells D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.030; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wu XQ, 2006, ACTA PHARMACOL SIN, V27, P1353, DOI 10.1111/j.1745-7254.2006.00407.x; Yamamuro T, 2008, BIOL REPROD, V79, P1202, DOI 10.1095/biolreprod.108.070326; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang P, 2007, FERTIL STERIL, V87, P677, DOI 10.1016/j.fertnstert.2006.07.1509; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	86	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64192	10.1371/journal.pone.0064192	http://dx.doi.org/10.1371/journal.pone.0064192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717564	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000320362700115
J	Tajima, K; Shirakawa, J; Togashi, Y; Inoue, H; Sato, K; Orime, K; Ito, Y; Kaji, M; Sakamoto, E; Nakamura, A; Aoki, K; Goshima, Y; Atsumi, T; Terauchi, Y				Tajima, Kazuki; Shirakawa, Jun; Togashi, Yu; Inoue, Hideaki; Sato, Koichiro; Orime, Kazuki; Ito, Yuzuru; Kaji, Mitsuyo; Sakamoto, Eri; Nakamura, Akinobu; Aoki, Kazutaka; Goshima, Yoshio; Atsumi, Tatsuya; Terauchi, Yasuo			AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; ANTIBODIES; METFORMIN; GLP-1; GENE; SPECIFICITY	The precise role of AMP-activated protein kinase (AMPK), a target of metformin, in pancreatic beta cells remains controversial, even though metformin was recently shown to enhance the expression of incretin receptors (GLP-1 and GIP receptors) in pancreatic beta cells. In this study, we investigated the effect of AMPK in the regulation of incretin receptors expression in pancreatic islets. The phosphorylation of AMPK in the mouse islets was decreased by increasing glucose concentrations. We showed the expression of incretin receptors in bell-shaped response to glucose; Expression of the incretin receptors in the isolated islets showed higher levels under a medium glucose concentration (11.1 mM) than that under a low glucose concentration (2.8 mM), but was suppressed under a high glucose concentration (22.2 mM). Both treatment with an AMPK inhibitor and DN-AMPK expression produced a significant increase of the incretin receptors expression under a low glucose concentration. By contrast, in hyperglycemic db/db islets, the enhancing effect of the AMPK inhibitor on the expression of incretin receptors was diminished under a low glucose concentration. Taken together, AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration.	[Tajima, Kazuki; Shirakawa, Jun; Togashi, Yu; Inoue, Hideaki; Sato, Koichiro; Orime, Kazuki; Ito, Yuzuru; Kaji, Mitsuyo; Sakamoto, Eri; Nakamura, Akinobu; Aoki, Kazutaka; Terauchi, Yasuo] Yokohama City Univ, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan; [Tajima, Kazuki; Atsumi, Tatsuya] Hokkaido Univ, Dept Med 2, Sapporo, Hokkaido, Japan; [Shirakawa, Jun; Goshima, Yoshio] Yokohama City Univ, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Hokkaido University; Yokohama City University	Terauchi, Y (corresponding author), Yokohama City Univ, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan.	terauchi-tky@umin.ac.jp	Terauchi, Yasuo/AAO-4347-2020; Atsumi, Tatsuya/G-1739-2012	Shirakawa, Jun/0000-0002-0822-8750	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19390251, 21390282, 24390235]; Japan Science and Technology Agency; Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; Yokohama General Promotion Foundation; Novo Nordisk Insulin Research Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [25670435] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Yokohama General Promotion Foundation; Novo Nordisk Insulin Research Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) 19390251, (B) 21390282 and (B) 24390235 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant for the Strategic Japanese-Danish Cooperative Program on Molecular Diabetology from the Japan Science and Technology Agency, a Medical Award from the Japan Medical Association, a Grant-in-Aid from the Japan Diabetes Foundation, a Grant-in-Aid from the Suzuken Memorial Foundation, a Grant-in-Aid from the Naito Foundation, a Grant-in-Aid from the Uehara Memorial Foundation (to Y.T.), and a Grant-in-Aid for JSPS Fellows, a Grant-in-Aid from Yokohama General Promotion Foundation, a Grant-in-Aid from the Novo Nordisk Insulin Research Foundation, a Grant-in-Aid from Japan Foundation for Applied Enzymology (to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheong YH, 2011, BIOCHEM BIOPH RES CO, V414, P220, DOI 10.1016/j.bbrc.2011.09.061; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; Cuthbertson J, 2009, DIABETIC MED, V26, P649, DOI 10.1111/j.1464-5491.2009.02748.x; De Marinis YZ, 2010, CELL METAB, V11, P543, DOI 10.1016/j.cmet.2010.04.007; Dichmann DS, 2003, J HISTOCHEM CYTOCHEM, V51, P397, DOI 10.1177/002215540305100314; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lu XY, 2009, N-S ARCH PHARMACOL, V379, P417, DOI 10.1007/s00210-009-0394-z; Lynn FC, 2002, FASEB J, V16, P91, DOI 10.1096/fj.02-0243fje; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Pan QR, 2009, HORM METAB RES, V41, P799, DOI 10.1055/s-0029-1234043; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Rajan S, 2012, AM J PHYSIOL-ENDOC M, V302, pE714, DOI 10.1152/ajpendo.00486.2011; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Shirakawa J, 2011, J BIOL CHEM, V286, P25467, DOI 10.1074/jbc.M110.217216; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Xavier GD, 2003, BIOCHEM J, V371, P761; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Yamamoto M, 2008, ANTIOXID REDOX SIGN, V10, P43, DOI 10.1089/ars.2007.1586; Yasuda N, 2002, BIOCHEM BIOPH RES CO, V298, P779, DOI 10.1016/S0006-291X(02)02565-2	54	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64633	10.1371/journal.pone.0064633	http://dx.doi.org/10.1371/journal.pone.0064633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717642	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700162
J	van Dijk, J				van Dijk, Jan			Towards Risk-Based Test Protocols: Estimating the Contribution of Intensive Testing to the UK Bovine Tuberculosis Problem	PLOS ONE			English	Article							GAMMA-INTERFERON ASSAY; SKIN-TEST; MYCOBACTERIUM-BOVIS; CATTLE HERDS; DIAGNOSTIC-TESTS; IRISH CONDITIONS; FIELD-EVALUATION; INFECTED CATTLE; CAUDAL FOLD; SPECIFICITY	Eradicating disease from livestock populations involves the balancing act of removing sufficient numbers of diseased animals without removing too many healthy individuals in the process. As ever more tests for bovine tuberculosis (BTB) are carried out on the UK cattle herd, and each positive herd test triggers more testing, the question arises whether 'false positive' results contribute significantly to the measured BTB prevalence. Here, this question is explored using simple probabilistic models of test behaviour. When the screening test is applied to the average UK herd, the estimated proportion of test-associated false positive new outbreaks is highly sensitive to small fluctuations in screening test specificity. Estimations of this parameter should be updated as a priority. Once outbreaks have been confirmed in screening-test positive herds, the following rounds of intensive testing with more sensitive, albeit less specific, tests are highly likely to remove large numbers of false positive animals from herds. Despite this, it is unlikely that significantly more truly infected animals are removed. BTB test protocols should become based on quantified risk in order to prevent the needless slaughter of large numbers of healthy animals.	Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Neston, Cheshire, England	University of Liverpool	van Dijk, J (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Neston, Cheshire, England.	jan.van-dijk@liverpool.ac.uk						Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; Ameni G, 2000, TROP ANIM HEALTH PRO, V32, P267, DOI 10.1023/A:1005271421976; [Anonymous], 2006, 20060014 VLA SEB4008; Archetti IL, 2000, VET J, V53, P214; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Booker C, 2008, SUNDAY TELEGRAP 0518; Brown R, 2008, VET TIMES, V38, P35; Buddle BM, 2001, VET MICROBIOL, V80, P37, DOI 10.1016/S0378-1135(00)00375-8; Cagiola M, 2004, CLIN DIAGN LAB IMMUN, V11, P952, DOI 10.1128/CDLI.11.5.952-956.2004; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Corner L, 1990, AUS VET J, V67, P173; Costello E, 1997, VET REC, V141, P222, DOI 10.1136/vr.141.9.222; Daborn CJ, 1998, EMERG INFECT DIS, V4, P59; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Domingo M., 1995, Medicina Veterinaria, V12, P307; FRANCIS J, 1978, VET REC, V103, P420, DOI 10.1136/vr.103.19.420; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Gordon SV, 2008, NATURE, V456, P700, DOI 10.1038/456700b; HARTNACK S., 2012, J MYCOBACTERIAL DIS, V2, P120, DOI DOI 10.4172/2161-1068.1000120; Karolemeas K, 2010, PREV VET MED, V97, P183, DOI 10.1016/j.prevetmed.2010.09.007; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; LESSLIE IW, 1975, VET REC, V96, P332, DOI 10.1136/vr.96.15.332; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lilenbaum W, 1999, J VET MED B, V46, P353, DOI 10.1111/j.1439-0450.1999.tb01240.x; Llamazares ORG, 1999, VET MICROBIOL, V70, P55, DOI 10.1016/S0378-1135(99)00121-2; Monaghan M, 1997, IRISH VET J, V50, P229; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; More SJ, 2009, VET J, V180, P275, DOI 10.1016/j.tvjl.2009.01.027; Neill S. D., 1994, P1; NEILL SD, 1994, VET REC, V135, P134, DOI 10.1136/vr.135.6.134; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; O'Reilly L. M., 1975, Irish Veterinary Journal, V29, P63; O'Reilly L M, 1986, Dev Biol Stand, V58 ( Pt B), P695; Pollock JM, 2000, VET REC, V146, P659, DOI 10.1136/vr.146.23.659; Queiros J, 2012, PREV VET MED, V104, P327, DOI 10.1016/j.prevetmed.2011.11.009; Ryan T., 2000, Surveillance (Wellington), V27, P8; Schiller I, 2010, VET IMMUNOL IMMUNOP, V136, P1, DOI 10.1016/j.vetimm.2010.02.007; Szmaragd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043116; Torgerson PR, 2010, TRENDS MICROBIOL, V18, P67, DOI 10.1016/j.tim.2009.11.002; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Vordermeier M, 2006, SB4021 DEFRA; Vose D, 2000, RISK ANAL QUANTITATI, P349; Waddle H, 2008, VET TIMES, V38, P1; Whelan C, 2010, CLIN VACCINE IMMUNOL, V17, P813, DOI 10.1128/CVI.00489-09; WHIPPLE DL, 1995, AM J VET RES, V56, P415; WILESMITH JW, 1987, EPIDEMIOL INFECT, V99, P173, DOI 10.1017/S0950268800067005; WOOD PR, 1991, AUST VET J, V68, P286, DOI 10.1111/j.1751-0813.1991.tb03254.x; WOOD PR, 1992, VET MICROBIOL, V31, P71, DOI 10.1016/0378-1135(92)90142-G	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63961	10.1371/journal.pone.0063961	http://dx.doi.org/10.1371/journal.pone.0063961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717517	Green Published, gold			2022-12-25	WOS:000320362700085
J	van Haren, H; Compton, TJ				van Haren, Hans; Compton, Tanya J.			Diel Vertical Migration in Deep Sea Plankton Is Finely Tuned to Latitudinal and Seasonal Day Length	PLOS ONE			English	Article							ACOUSTIC DOPPLER CURRENT; CIRCADIAN CLOCKS; NORTH-ATLANTIC; ZOOPLANKTON; MODEL; BACKSCATTER; CARBONATE; PROFILER; PATTERNS; FLUXES	Diel vertical migration (DVM) is a ubiquitous phenomenon in marine and freshwater plankton communities. Most commonly, plankton migrate to surface waters at dusk and return to deeper waters at dawn. Up until recently, it was thought that DVM was triggered by a relative change in visible light intensity. However, evidence has shown that DVM also occurs in the deep sea where no direct and background sunlight penetrates. To identify whether such DVM is associated with latitudinal and seasonal day light variation, one and a half years of recorded acoustic data, a measure of zooplankton abundance and movement, were examined. Acoustic Doppler current profilers, moored at eight different sub-tropical latitudes in the North-Atlantic Ocean, measured in the vertical range of 500-1600 m. DVM was observed to follow day length variation with a change in season and latitude at all depths. DVM followed the rhythm of local sunrise and sunset precisely between 500 and 650 m. It continued below 650 m, where the deepest penetrable irradiance level are <10(-7) times their near-surface values, but plankton shortened their time at depth by up to about 63% at 1600 m. This suggests light was no longer a cue for DVM. This trend stayed consistent both across latitudes and between the different seasons. It is hypothesized that another mechanism, rather than light, viz. a precise biochemical clock could maintain the solar diurnal and seasonal rhythms in deep sea plankton motions. In accordance with this hypothesis, the deepest plankton were consistently the first to migrate upwards.	[van Haren, Hans; Compton, Tanya J.] Royal Netherlands Inst Sea Res NIOZ, Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	van Haren, H (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Den Burg, Netherlands.	hans.van.haren@nioz.nl			Netherlands Organization for the advancement of scientific research (N.W.O.) large investment program Longterm Ocean Current Observations (LOCO)	Netherlands Organization for the advancement of scientific research (N.W.O.) large investment program Longterm Ocean Current Observations (LOCO)	The funding of instrumentation by the Netherlands Organization for the advancement of scientific research (N.W.O.) large investment program Longterm Ocean Current Observations (LOCO) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berge J, 2009, BIOL LETTERS, V5, P69, DOI 10.1098/rsbl.2008.0484; BIJMA J, 1994, DEEP-SEA RES PT I, V41, P511, DOI 10.1016/0967-0637(94)90093-0; Clay C.S., 1977, ACOUSTICAL OCEANOGRA; Dronkers JJ., 1964, TIDAL COMPUTATIONS R; Fielding S, 2004, ICES J MAR SCI, V61, P184, DOI 10.1016/j.icesjms.2003.10.011; FISCHER J, 1993, DEEP-SEA RES PT I, V40, P1547, DOI 10.1016/0967-0637(93)90015-U; FLAGG CN, 1989, DEEP-SEA RES, V36, P455, DOI 10.1016/0198-0149(89)90047-2; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Fortier M, 2001, J PLANKTON RES, V23, P1263, DOI 10.1093/plankt/23.11.1263; HANEY JF, 1988, B MAR SCI, V43, P583; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Jiang SN, 2007, DEEP-SEA RES PT I, V54, P608, DOI 10.1016/j.dsr.2006.12.011; KAMPA EM, 1970, J MAR BIOL ASSOC UK, V50, P397, DOI 10.1017/S0025315400004604; Khripounoff A, 1998, DEEP-SEA RES PT I, V45, P193, DOI 10.1016/S0967-0637(97)00104-0; Krause J, 2002, LIVING GROUPS; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Latreille P.A., 1829, REGNE ANIMAL DISTRIB; Loncaric N, 2005, DEEP-SEA RES PT I, V52, P1178, DOI 10.1016/j.dsr.2005.02.003; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Murray J, 1912, DEPTHS OCEAN; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Piersma T, 2002, NATURWISSENSCHAFTEN, V89, P278, DOI 10.1007/s00114-002-0325-z; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; PLUEDDEMANN AJ, 1989, DEEP-SEA RES, V36, P509, DOI 10.1016/0198-0149(89)90003-4; RDI, 1996, PRACT PRIM; Ringelberg J, 2003, HYDROBIOLOGIA, V491, P85, DOI 10.1023/A:1024407021957; Ringelberg J, 1999, BIOL REV, V74, P397, DOI 10.1017/S0006323199005381; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; SCHOTT F, 1987, J GEOPHYS RES-OCEANS, V92, P5169, DOI 10.1029/JC092iC05p05169; Thomson RE, 2000, CAN J FISH AQUAT SCI, V57, P1919, DOI 10.1139/cjfas-57-9-1919; van Haren H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029947; Vinogradov GM, 2005, MAR BIOL, V146, P325, DOI 10.1007/s00227-004-1436-1; Vinogradov ME, 2000, IZV AKAD NAUK BIOL+, P496; Zmijewska Maria Iwona, 2000, Oceanologia, V42, P89; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	35	32	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64435	10.1371/journal.pone.0064435	http://dx.doi.org/10.1371/journal.pone.0064435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717613	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700147
J	Xiang, Y; Wang, X; Yan, C; Gao, Q; Li, SA; Liu, J; Zhou, KF; Guo, XL; Lee, WH; Zhang, Y				Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun			Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome	PLOS ONE			English	Article							EXTRACELLULAR ATP; NEUTROPHIL RECRUITMENT; NUCLEOTIDES; RESISTANCE; IL-1-BETA; RECEPTORS; IMMUNITY; RELEASE; SEPSIS; P2X(7)	It has been established that Adenosine-5'-triphosphate (ATP) can activate the NLRP3 inflammasome. However, the physiological effect of extracellular ATP on NLRP3 inflammasome activation has not yet been investigated. In the present study, we found that ATP was indeed released during bacterial infection. By using a murine peritonitis model, we also found that ATP promotes the fight against bacterial infection in mice. ATP induced the secretion of IL-1 beta and chemokines by murine bone marrow-derived macrophages in vitro. Furthermore, the intraperitoneal injection of ATP elevated the levels of IL-1b and chemokines in the mouse peritoneal lavage. Neutrophils were rapidly recruited to the peritoneum after ATP injection. In addition, the effects on cytokine and chemokine secretion and neutrophil recruitment were markedly attenuated by the pre-administration of the caspase-1 inhibitor Ac-YVAD-cho. Ac-YVAD-cho also significantly attenuated the protective effect of ATP against bacterial infection. In the present study, we demonstrated a protective role for ATP during bacterial infection and this effect was related to NLRP3 inflammasome activation. Together, these results suggest a role for ATP in initiating the immune response in hosts suffering from infections.	[Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Xiang, Yang; Wang, Xuan; Yan, Chao; Gao, Qian; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Wang, Xuan; Yan, Chao; Li, Sheng-An; Liu, Jie; Zhou, Kaifeng; Guo, Xiaolong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn		Zhang, Yun/0000-0002-8636-183X	National Basic Research Program of China (973 Program) [2010CB529800]; Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding) [U1132601, 31270835]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (973 Program, 2010CB529800), and the Chinese National Natural Science Foundation (NSFC-Yunnan-joint funding U1132601, 31270835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Breitbach K, 2009, INFECT IMMUN, V77, P1589, DOI 10.1128/IAI.01257-08; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Charmoy M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/719361; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Coutinho-Silva R, 2012, MICROBES INFECT, V14, P1271, DOI 10.1016/j.micinf.2012.05.009; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; FRIMODTMOLLER N, 1993, J ANTIMICROB CHEMOTH, V31, P55, DOI 10.1093/jac/31.suppl_D.55; Godaly G, 2001, J LEUKOCYTE BIOL, V69, P899; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martens RJ, 2005, INFECT IMMUN, V73, P7040, DOI 10.1128/IAI.73.10.7040-7042.2005; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; MURPHY K, 2012, JANEWAYS IMMUNOBIOLO, V19; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Ramakers BP, 2011, SHOCK, V36, P208, DOI 10.1097/SHK.0b013e318225aee4; Renckens R, 2006, J IMMUNOL, V177, P1189, DOI 10.4049/jimmunol.177.2.1189; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Save S, 2010, INFECT IMMUN, V78, P3609, DOI 10.1128/IAI.00074-10; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Xiang Y, 2012, CYTOTECHNOLOGY, V64, P95, DOI 10.1007/s10616-011-9399-9	39	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63759	10.1371/journal.pone.0063759	http://dx.doi.org/10.1371/journal.pone.0063759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717478	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700056
J	van der Deen, M; Taipaleenmaki, H; Zhang, Y; Teplyuk, NM; Gupta, A; Cinghu, S; Shogren, K; Maran, A; Yaszemski, MJ; Ling, L; Cool, SM; Leong, DT; Dierkes, C; Zustin, J; Salto-Tellez, M; Ito, Y; Bae, SC; Zielenska, M; Squire, JA; Lian, JB; Stein, JL; Zambetti, GP; Jones, SN; Galindo, M; Hesse, E; Stein, GS; van Wijnen, AJ				van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; Ling, Ling; Cool, Simon M.; Leong, David T.; Dierkes, Christian; Zustin, Jozef; Salto-Tellez, Manuel; Ito, Yoshiaki; Bae, Suk-Chul; Zielenska, Maria; Squire, Jeremy A.; Lian, Jane B.; Stein, Janet L.; Zambetti, Gerard P.; Jones, Stephen N.; Galindo, Mario; Hesse, Eric; Stein, Gary S.; van Wijnen, Andre J.			MicroRNA-34c Inversely Couples the Biological Functions of the Runt-related Transcription Factor RUNX2 and the Tumor Suppressor p53 in Osteosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; TARGETED DISRUPTION; GENE-EXPRESSION; GROWTH; MOUSE; PROLIFERATION; PATHOGENESIS; PROGRESSION; OCCUPANCY; INTERACTS	Osteosarcoma (OS) is a primary bone tumor that is most prevalent during adolescence. RUNX2, which stimulates differentiation and suppresses proliferation of osteoblasts, is deregulated in OS. Here, we define pathological roles of RUNX2 in the etiology of OS and mechanisms by which RUNX2 expression is stimulated. RUNX2 is often highly expressed in human OS biopsies and cell lines. Small interference RNA-mediated depletion of RUNX2 inhibits growth of U2OS OS cells. RUNX2 levels are inversely linked to loss of p53 (which predisposes to OS) in distinct OS cell lines and osteoblasts. RUNX2 protein levels decrease upon stabilization of p53 with the MDM2 inhibitor Nutlin-3. Elevated RUNX2 protein expression is post-transcriptionally regulated and directly linked to diminished expression of several validated RUNX2 targeting microRNAs in human OS cells compared with mesenchymal progenitor cells. The p53-dependent miR-34c is the most significantly down-regulated RUNX2 targeting microRNAs in OS. Exogenous supplementation of miR-34c markedly decreases RUNX2 protein levels, whereas 3'-UTR reporter assays establish RUNX2 as a direct target of miR-34c in OS cells. Importantly, Nutlin-3-mediated stabilization of p53 increases expression of miR-34c and decreases RUNX2. Thus, a novel p53-miR-34c-RUNX2 network controls cell growth of osseous cells and is compromised in OS.	[van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Lian, Jane B.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Lian, Jane B.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Taipaleenmaeki, Hanna; Hesse, Eric] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Heisenberg Grp Mol Skeletal Biol, D-20246 Hamburg, Germany; [Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ling, Ling; Cool, Simon M.; van Wijnen, Andre J.] Agcy Sci Technol & Res, Inst Med Biol, Singapore 138648, Singapore; [Cool, Simon M.; van Wijnen, Andre J.] Natl Univ Singapore Hosp, Dept Orthopaed Surg, Singapore 119228, Singapore; [Leong, David T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore; [Dierkes, Christian] Med Care Unit Histol Cytol & Mol Diagnost, D-54296 Trier, Germany; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Salto-Tellez, Manuel; Ito, Yoshiaki] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Bae, Suk-Chul] Chungbuk Natl Univ, Sch Med, Dept Biochem, Cheongju 361763, South Korea; [Zielenska, Maria] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Squire, Jeremy A.] Queens Univ, Kingston Gen Hosp, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Lian, Jane B.; Stein, Janet L.; Stein, Gary S.] Univ Vermont, Sch Med, Dept Biochem, Vermont Canc Ctr Basic & Translat Res, Burlington, VT 05405 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Galindo, Mario] Univ Chile, Fac Med, Millennium Inst Immunol & Immunotherapy, Santiago 7, Chile; [Galindo, Mario] Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago 7, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Hamburg; University Medical Center Hamburg-Eppendorf; Mayo Clinic; Mayo Clinic; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University Belfast; National University of Singapore; Chungbuk National University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Queens University - Canada; University of Vermont; St Jude Children's Research Hospital; Universidad de Chile; Universidad de Chile	Stein, GS (corresponding author), Univ Vermont, Sch Med, Dept Biochem, Vermont Canc Ctr Basic & Translat Res, HSRF 326, Burlington, VT 05405 USA.	gary.stein@uvm.edu; vanwijnen.andre@mayo.edu	Zambetti, Gerard/N-8093-2018; Taipaleennmäki, Hanna/GRX-7143-2022; van Wijnen, Andre J./AAG-3578-2019; Leong, David/AAE-5620-2019; Squire, Jeremy A/A-9352-2012; Cool, Simon/W-1257-2018; Leong, David/G-1056-2012; Cool, Simon McKenzie/AAG-4346-2021	Zambetti, Gerard/0000-0002-0929-5007; van Wijnen, Andre J./0000-0002-4458-0946; Leong, David/0000-0001-8539-9062; Squire, Jeremy A/0000-0002-9863-468X; Cool, Simon/0000-0001-8543-3056; Leong, David/0000-0001-8539-9062; Taipaleenmaki, Hanna/0000-0002-8254-9333; Salto-Tellez, Manuel/0000-0001-8586-282X	National Institutes of Health [AR49069, CA082834]; Iniciativa Cientifico Milenio [P09/016-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1095234]; Deutsche Forschungsgemeinschaft [HE 5208/2-1]; EMBO postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA077735, P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iniciativa Cientifico Milenio; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49069 (to A. v- W.) and CA082834 (to G. S. S.). This work was also supported by grant sponsors Iniciativa Cientifico Milenio P09/016-F (to M. G.), Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1095234 (to M. G.), and Deutsche Forschungsgemeinschaft Grant HE 5208/2-1 (to E. H.).; Recipient of an EMBO postdoctoral fellowship.	Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Das K, 2008, PATHOLOGY, V40, P441, DOI 10.1080/00313020802198101; Das K, 2009, EUR J CANCER, V45, P2239, DOI 10.1016/j.ejca.2009.06.021; Fuchs B, 2002, CLIN ORTHOP RELAT R, P40; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; HANSEN MF, 1991, CLIN ORTHOP RELAT R, P237; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Martin JW, 2010, CYTOGENET GENOME RES, V128, P199, DOI 10.1159/000308353; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Ong CW, 2010, HISTOPATHOLOGY, V56, P523, DOI 10.1111/j.1365-2559.2010.03496.x; Pereira BP, 2009, J CELL PHYSIOL, V221, P778, DOI 10.1002/jcp.21921; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	45	89	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21307	21319		10.1074/jbc.M112.445890	http://dx.doi.org/10.1074/jbc.M112.445890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720736	Green Published, hybrid			2022-12-25	WOS:000322014400050
J	Zamanian-Daryoush, M; Lindner, D; Tallant, TC; Wang, ZN; Buffa, J; Klipfell, E; Parker, Y; Hatala, D; Parsons-Wingerter, P; Rayman, P; Yusufishaq, MSS; Fisher, EA; Smith, JD; Finke, J; DiDonato, JA; Hazen, SL				Zamanian-Daryoush, Maryam; Lindner, Daniel; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; Parker, Yvonne; Hatala, Denise; Parsons-Wingerter, Patricia; Rayman, Pat; Yusufishaq, Mohamed Sharif S.; Fisher, Edward A.; Smith, Jonathan D.; Finke, Jim; DiDonato, Joseph A.; Hazen, Stanley L.			The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOA-I; MATRIX METALLOPROTEINASES; CORONARY ATHEROSCLEROSIS; OXIDATIVE STRESS; HDL; INFLAMMATION; CANCER; CELLS; CHOLESTEROL	Here, we show that apolipoprotein A1 (apoA1), the major protein component of high density lipoprotein (HDL), through both innate and adaptive immune processes, potently suppresses tumor growth and metastasis in multiple animal tumor models, including the aggressive B16F10L murine malignant melanoma model. Mice expressing the human apoA1 transgene (A1Tg) exhibited increased infiltration of CD11b(+) F4/80(+) macrophages with M1, anti-tumor phenotype, reduced tumor burden and metastasis, and enhanced survival. In contrast, apoA1-deficient (A1KO) mice showed markedly heightened tumor growth and reduced survival. Injection of human apoA1 into A1KO mice inoculated with tumor cells remarkably reduced both tumor growth and metastasis, enhanced survival, and promoted regression of both tumor and metastasis burden when administered following palpable tumor formation and metastasis development. Studies with apolipoprotein A2 revealed the anti-cancer therapeutic effect was specific to apoA1. In vitro studies ruled out substantial direct suppressive effects by apoA1 or HDL on tumor cells. Animal models defective in different aspects of immunity revealed both innate and adaptive arms of immunity contribute to complete apoA1 anti-tumor activity. This study reveals a potent immunomodulatory role for apoA1 in the tumor microenvironment, altering tumor-associated macrophages from a pro-tumor M2 to an anti-tumor M1 phenotype. Use of apoA1 to redirect in vivo elicited tumor-infiltrating macrophages toward tumor rejection may hold benefit as a potential cancer therapeutic.	[Zamanian-Daryoush, Maryam; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; Yusufishaq, Mohamed Sharif S.; Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Zamanian-Daryoush, Maryam; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Lindner, Daniel; Parker, Yvonne] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Hatala, Denise] Cleveland Clin, Imaging Core, Cleveland, OH 44195 USA; [Rayman, Pat; Finke, Jim] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Parsons-Wingerter, Patricia] NASA, John H Glenn Res Ctr, Cleveland, OH 44135 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Fisher, Edward A.; Hazen, Stanley L.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Aeronautics & Space Administration (NASA); New York University; New York University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Lindner, Daniel/ABB-5440-2020; Fisher, Edward/ABE-7469-2020; Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [P01HL098055, P01HL076491, HL094525]; LeDucq Fondation; Abbott; Cleveland Heart Lab; Esperion; Lilly; Liposcience Inc.; Merck Co., Inc.; Pfizer Inc.; NATIONAL CANCER INSTITUTE [R01CA150959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL094525, P01HL076491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Fondation; Abbott(Abbott Laboratories); Cleveland Heart Lab; Esperion; Lilly(Eli Lilly); Liposcience Inc.; Merck Co., Inc.(Merck & Company); Pfizer Inc.(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL098055, P01HL076491, and HL094525. This work was also supported in part by a grant from the LeDucq Fondation. Drs. Zamanian-Daryoush, DiDonato, and Hazen report being listed as co-inventors on pending and issued patents held by the Cleveland Clinic. Dr. Hazen reports having been paid as a consultant for the following companies: Abbott, Cleveland Heart Lab, Esperion, Lilly, Liposcience Inc., Merck & Co., Inc., and Pfizer Inc. and receiving research funds from Abbott, Cleveland Heart Lab, Liposcience Inc., and Pfizer Inc.	Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chen W, 2012, CHINESE MED J-PEKING, V125, P481, DOI 10.3760/cma.j.issn.0366-6999.2012.03.015; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Fuhrman B, 2010, ATHEROSCLEROSIS, V211, P61, DOI 10.1016/j.atherosclerosis.2010.01.025; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao F, 2011, INTEGR BIOL-UK, V3, P479, DOI 10.1039/c0ib00147c; Godar DE, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/858425; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grunfeld C, 1999, J LIPID RES, V40, P245; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Jafri H, 2010, J AM COLL CARDIOL, V55, P2846, DOI 10.1016/j.jacc.2009.12.069; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; Kim S, 2011, ANN NY ACAD SCI, V1217, P191, DOI 10.1111/j.1749-6632.2010.05882.x; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; Murph M, 2007, METHOD ENZYMOL, V433, P1, DOI 10.1016/S0076-6879(07)33001-2; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Navarini-Meury AA, 2009, SEMIN CANCER BIOL, V19, P84, DOI 10.1016/j.semcancer.2008.10.012; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Piras F, 2007, HISTOPATHOLOGY, V50, P835, DOI 10.1111/j.1365-2559.2007.02695.x; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Sarov-Blat L, 2007, ARTERIOSCL THROM VAS, V27, P1115, DOI 10.1161/ATVBAHA.106.138990; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang SH, 2012, ATHEROSCLEROSIS, V225, P105, DOI 10.1016/j.atherosclerosis.2012.07.029; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wilhelm AJ, 2010, J BIOL CHEM, V285, P36158, DOI 10.1074/jbc.M110.134130; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang SO, 2013, P NATL ACAD SCI USA, V110, P2511, DOI 10.1073/pnas.1213657110; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	65	155	162	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21237	21252		10.1074/jbc.M113.468967	http://dx.doi.org/10.1074/jbc.M113.468967			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720750	Green Published, hybrid			2022-12-25	WOS:000322014400045
J	De Zutter, JK; Levine, KB; Deng, D; Carruthers, A				De Zutter, Julie K.; Levine, Kara B.; Deng, Di; Carruthers, Anthony			Sequence Determinants of GLUT1 Oligomerization ANALYSIS BY HOMOLOGY-SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE GLUCOSE-TRANSPORTER; ESCHERICHIA-COLI; SUGAR-TRANSPORT; OUTER HELIX; STRUCTURAL BASIS; LIGAND-BINDING; CYTOCHALASIN-B; AMINO-ACID; PROTEINS; SITES	The human blood-brain barrier glucose transport protein (GLUT1) forms homodimers and homotetramers in detergent micelles and in cell membranes, where the GLUT1 oligomeric state determines GLUT1 transport behavior. GLUT1 and the neuronal glucose transporter GLUT3 do not form heterocomplexes in human embryonic kidney 293 (HEK293) cells as judged by co-immunoprecipitation assays. Using homology-scanning mutagenesis in which GLUT1 domains are substituted with equivalent GLUT3 domains and vice versa, we show that GLUT1 transmembrane helix 9 (TM9) is necessary for optimal association of GLUT1-GLUT3 chimeras with parental GLUT1 in HEK cells. GLUT1 TMs 2, 5, 8, and 11 also contribute to a less abundant heterocomplex. Cell surface GLUT1 and GLUT3 containing GLUT1 TM9 are 4-fold more catalytically active than GLUT3 and GLUT1 containing GLUT3 TM9. GLUT1 and GLUT3 display allosteric transport behavior. Size exclusion chromatography of detergent solubilized, purified GLUT1 resolves GLUT1/lipid/detergent micelles as 6- and 10-nm Stokes radius particles, which correspond to GLUT1 dimers and tetramers, respectively. Studies with GLUTs expressed in and solubilized from HEK cells show that HEK cell GLUT1 resolves as 6- and 10-nm Stokes radius particles, whereas GLUT3 resolves as a 6-nm particle. Substitution of GLUT3 TM9 with GLUT1 TM9 causes chimeric GLUT3 to resolve as 6- and 10-nm Stokes radius particles. Substitution of GLUT1 TM9 with GLUT3 TM9 causes chimeric GLUT1 to resolve as a mixture of 6- and 4-nm particles. We discuss these findings in the context of determinants of GLUT oligomeric structure and transport function.	[De Zutter, Julie K.; Levine, Kara B.; Deng, Di; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ALVAREZ J, 1987, J BIOL CHEM, V262, P3502; APPLEMAN JR, 1985, J BIOL CHEM, V260, P4575; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2008, J BIOL CHEM, V283, P36416, DOI 10.1074/jbc.M804802200; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Carruthers A., 1996, TRANSPORT PROCESSES, P311; CASEY JR, 1991, J BIOL CHEM, V266, P15726; CHIN JJ, 1987, P NATL ACAD SCI USA, V84, P4113, DOI 10.1073/pnas.84.12.4113; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2012, AM J PHYSIOL-CELL PH, V303, pC806, DOI 10.1152/ajpcell.00437.2011; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055408; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; JUNG CY, 1980, J BIOL CHEM, V255, P361; Leeds JA, 2001, J MOL BIOL, V313, P181, DOI 10.1006/jmbi.2001.5007; Levine KB, 2005, BIOCHEMISTRY-US, V44, P5606, DOI 10.1021/bi0477541; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; Lis M, 2006, BIOCHEM BIOPH RES CO, V339, P321, DOI 10.1016/j.bbrc.2005.11.022; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	51	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20734	20744		10.1074/jbc.M113.469023	http://dx.doi.org/10.1074/jbc.M113.469023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720776	Green Published, hybrid			2022-12-25	WOS:000321715100058
J	He, C; Ryan, AJ; Murthy, S; Carter, AB				He, Chao; Ryan, Alan J.; Murthy, Shubha; Carter, A. Brent			Accelerated Development of Pulmonary Fibrosis via Cu, Zn-superoxide Dismutase-induced Alternative Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; ALVEOLAR MACROPHAGES; MITOCHONDRIAL SUPEROXIDE; SCHISTOSOMA-MANSONI; HYDROGEN-PEROXIDE; TH2 CELLS; GENERATION; MECHANISM; PROTEINS	Macrophages not only initiate and accentuate inflammation after tissue injury, but they are also involved in resolution and repair. This difference in macrophage activity is the result of a differentiation process to either M1 or M2 phenotypes. M1 macrophages are pro-inflammatory and have microbicidal and tumoricidal activity, whereas the M2 macrophages are involved in tumor progression and tissue remodeling and can be profibrotic in certain conditions. Because mitochondrial Cu, Zn-superoxide dismutase (Cu, Zn-SOD)-mediated H2O2 is crucial for development of pulmonary fibrosis, we hypothesized that Cu, Zn-SOD modulated the macrophage phenotype. In this study, we demonstrate that Cu, Zn-SOD polarized macrophages to an M2 phenotype, and Cu, Zn-SOD-mediated H2O2 levels modulated M2 gene expression at the transcriptional level by redox regulation of a critical cysteine in STAT6. Furthermore, overexpression of Cu, Zn-SOD in mice resulted in a profibrotic environment and accelerated the development of pulmonary fibrosis, whereas polarization of macrophages to the M1 phenotype attenuated pulmonary fibrosis. Taken together, these observations provide a novel mechanism of Cu, Zn-SOD-mediated and Th2-independent M2 polarization and provide a potential therapeutic target for attenuating the accelerated development of pulmonary fibrosis.	[Ryan, Alan J.; Murthy, Shubha; Carter, A. Brent] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Grad Program Free Rad & Radiat Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Carter, A. Brent] Iowa City Vet Adm Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, C33 GH, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu			National Institutes of Health [2R01ES015981-06, R01ES014871]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant [1BX001135-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES015981, R01ES014871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01ES015981-06 and R01ES014871. This work was also supported by a Merit Review from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant 1BX001135-01.	BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chang SC, 2001, FREE RADICAL BIO MED, V31, P1084, DOI 10.1016/S0891-5849(01)00691-8; Chensue SW, 1997, J IMMUNOL, V159, P3565; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Daniel C, 2000, J BIOL CHEM, V275, P14255, DOI 10.1074/jbc.C000129200; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Mandal D, 2010, CELL SIGNAL, V22, P1485, DOI 10.1016/j.cellsig.2010.05.017; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pearce EJ, 1996, INT IMMUNOL, V8, P435, DOI 10.1093/intimm/8.4.435; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PONNAPPA BC, 1981, AM J PHYSIOL, V240, pG122, DOI 10.1152/ajpgi.1981.240.2.G122; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; REMBISH SJ, 1994, FREE RADICAL BIO MED, V17, P117, DOI 10.1016/0891-5849(94)90109-0; Saito A, 2001, STROKE, V32, P1652, DOI 10.1161/01.STR.32.7.1652; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; TREDE NS, 1995, J IMMUNOL, V155, P902; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634; Wakisaka Y, 2010, STROKE, V41, P790, DOI 10.1161/STROKEAHA.109.569616; Zhang LF, 2009, J PROTEOME RES, V8, P1631, DOI 10.1021/pr800685h	46	78	86	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20745	20757		10.1074/jbc.M112.410720	http://dx.doi.org/10.1074/jbc.M112.410720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720777	hybrid, Green Published			2022-12-25	WOS:000321715100059
J	Wei, Q; Li, JH; Liu, T; Tong, XM; Ye, X				Wei, Qian; Li, Junhui; Liu, Ting; Tong, Xiaomei; Ye, Xin			Phosphorylation of Minichromosome Maintenance Protein 7 (MCM7) by Cyclin/Cyclin-dependent Kinase Affects Its Function in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; HELICASE ACTIVITY; CHECKPOINT; INITIATION; PATHWAY; CDK	MCM7 is one of the subunits of the MCM2-7 complex that plays a critical role in DNA replication initiation and cell proliferation of eukaryotic cells. After forming the pre-replication complex (pre-RC) with other components, the MCM2-7 complex is activated by DDK/cyclin-dependent kinase to initiate DNA replication. Each subunit of the MCM2-7 complex functions differently under regulation of various kinases on the specific site, which needs to be investigated in detail. In this study, we demonstrated that MCM7 is a substrate of cyclin E/Cdk2 and can be phosphorylated on Ser-121. We found that the distribution of MCM7-S121A is different from wild-type MCM7 and that the MCM7-S121A mutant is much less efficient to form a pre-RC complex with MCM3/MCM5/cdc45 compared with wild-type MCM7. By using the Tet-On inducible HeLa cell line, we revealed that overexpression of wild-type MCM7 but not MCM7-S121A can block S phase entry, suggesting that an excess of the pre-RC complex may activate the cell cycle checkpoint. Further analysis indicates that the Chk1 pathway is activated in MCM7-overexpressed cells in a p53-dependent manner. We performed experiments with the human normal cell line HL-7702 and also observed that overexpression of MCM7 can cause S phase block through checkpoint activation. In addition, we found that MCM7 could also be phosphorylated by cyclin B/Cdk1 on Ser-121 both in vitro and in vivo. Furthermore, overexpression of MCM7-S121A causes an obvious M phase exit delay, which suggests that phosphorylation of MCM7 on Ser-121 in M phase is very important for a proper mitotic exit. These data suggest that the phosphorylation of MCM7 on Ser-121 by cyclin/Cdks is involved in preventing DNA rereplication as well as in regulation of the mitotic exit.	[Wei, Qian; Li, Junhui; Liu, Ting; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China; [Wei, Qian; Li, Junhui; Liu, Ting] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003, 2011CB504705]; Chinese Academy of Sciences [KSCX2-EW-J-6]; Innovative Research Group of the National Natural Science Foundation of China [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81272272; by Ministry of Science and Technology of China Grants 2013ZX10004611, 2012CB519003, and 2011CB504705; by Chinese Academy of Sciences Innovation Project Grant KSCX2-EW-J-6; and by Innovative Research Group of the National Natural Science Foundation of China Grant 81021003 (to X. Y.).	Abe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040129; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Lei M, 2001, J CELL SCI, V114, P1447; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu YZ, 2012, LUNG CANCER, V77, P176, DOI 10.1016/j.lungcan.2012.03.001; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Porter ACG, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-3; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shohet JM, 2002, CANCER RES, V62, P1123; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200; Yun HJ, 2012, MOL CELL BIOCHEM, V363, P281, DOI 10.1007/s11010-011-1180-z	27	25	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19715	19725		10.1074/jbc.M112.449652	http://dx.doi.org/10.1074/jbc.M112.449652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720738	hybrid, Green Published			2022-12-25	WOS:000321515800041
J	Liu, Y; Chakravarty, S; Dey, M				Liu, Yi; Chakravarty, Suvobrata; Dey, Moul			Phenethylisothiocyanate Alters Site- and Promoter-Specific Histone Tail Modifications in Cancer Cells	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; CHEMOPREVENTIVE AGENTS; NITRIC-OXIDE; IN-VITRO; ACTIVATION; ISOTHIOCYANATES; METHYLATION; CHROMATIN	Site-specific histone modifications are important epigenetic regulators of gene expression. As deregulation of genes often results in complex disorders, corrective modulation of site-specific histone marks could be a powerful therapeutic or disease-preventive strategy. However, such modulation by dietary compounds and the resulting impact on disease risk remain relatively unexplored. Here we examined phenethylisothiocyanate ( PEITC), a common dietary compound derived from cruciferous vegetables with known chemopreventive properties under experimental conditions, as a possible modulator of histone modifications in human colon cancer cells. The present study reports novel, dynamic, site-specific chemical changes to histone H3 in a gene-promoter-specific manner, associated with PEITC exposure in human colon tumor-derived SW480 epithelial cells. In addition, PEITC attenuated cell proliferation in a concentration- and time-dependent manner, likely mediated by caspase-dependent apoptotic signalling. The effects of PEITC on histone modifications and gene expression changes were achieved at low, non-cytotoxic concentrations, in contrast to the higher concentrations necessary to halt cancer cell proliferation. Increased understanding of specific epigenetic alterations by dietary compounds may provide improved chemopreventive strategies for reducing the healthcare burden of cancer and other human diseases.	[Liu, Yi; Dey, Moul] S Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA; [Chakravarty, Suvobrata] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Dey, M (corresponding author), S Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA.	moul.dey@sdstate.edu		DEY, MOUL/0000-0002-6423-9593	National Institutes of Health [R00AT4245]; South Dakota Agriculture Experiment Station [328100/318000, 3AH386]; Biological Control And Analysis by Applied Photonics: the South Dakota center [3SG163]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT004245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Dakota Agriculture Experiment Station; Biological Control And Analysis by Applied Photonics: the South Dakota center; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Major support for this work came from the National Institutes of Health grant [R00AT4245] (to MD). Additional supports came from South Dakota Agriculture Experiment Station grants 328100/318000 (to MD) and 3AH386 (to SC), Biological Control And Analysis by Applied Photonics: the South Dakota 2010 center grant 3SG163 (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; [Anonymous], 1996, J Cell Biochem Suppl, V26, P149; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chen YH, 2003, PLANTA MED, V69, P696, DOI 10.1055/s-2003-42790; Cheung KL, 2010, CARCINOGENESIS, V31, P880, DOI 10.1093/carcin/bgp285; Davis CD, 2007, NUTR REV, V65, P88, DOI [10.1111/j.1753-4887.2007.tb00285.x, 10.1301/nr.2007.feb.88-94]; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Del Prete A, 2011, BIOCHEM MEDICA, V21, P264; Dey M, 2006, J PHARMACOL EXP THER, V317, P326, DOI 10.1124/jpet.105.096511; Du Ting-Ting, 2007, Yichuan, V29, P387, DOI 10.1360/yc-007-0387; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Gerhauser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hewings DS, 2011, J MED CHEM, V54, P6761, DOI 10.1021/jm200640v; Ho E, 2010, WORLD REV NUTR DIET, V101, P95, DOI 10.1159/000314514; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang J, 2011, CURR DRUG TARGETS, V12, P1925, DOI 10.2174/138945011798184155; Illemann M, 2006, MOL CANCER RES, V4, P293, DOI 10.1158/1541-7786.MCR-06-0003; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Koskensalo S, 2011, TUMOR BIOL, V32, P259, DOI 10.1007/s13277-010-0080-2; Kurdistani SK, 2011, PROG DRUG RES, V67, P91, DOI 10.1007/978-3-7643-8989-5_5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maharshak N, 2010, INFLAMM BOWEL DIS, V16, P1496, DOI 10.1002/ibd.21254; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Nakamura Y, 2009, FORUM NUTR, V61, P170, DOI 10.1159/000212749; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nishikawa A, 2004, CURR CANCER DRUG TAR, V4, P373, DOI 10.2174/1568009043332970; Rahman MA, 2012, KOREAN J PHYSIOL PHA, V16, P321, DOI 10.4196/kjpp.2012.16.5.321; Ramos EAS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029461; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rath T, 2010, SCAND J GASTROENTERO, V45, P1186, DOI 10.3109/00365521.2010.499961; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Ribnicky DM PA, 2001, J NUTRACEUTICALS FUN, V3, P22; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rose P, 2005, NITRIC OXIDE-BIOL CH, V12, P237, DOI 10.1016/j.niox.2005.03.001; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Singh SV, 2012, J NATL CANC I; Statistics USC, 2008, 1999 2008 CANC INC M; Suzuki M, 2003, INFECT IMMUN, V71, P3503, DOI 10.1128/IAI.71.6.3503-3511.2003; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagschal A., 2007, CSH PROTOC, V2007; Wang LG, 2008, INT J ONCOL, V33, P375, DOI 10.3892/ijo_00000018	60	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64535	10.1371/journal.pone.0064535	http://dx.doi.org/10.1371/journal.pone.0064535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724058	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000065
J	Mittal, S; Revell, M; Barone, F; Hardie, DL; Matharu, GS; Davenport, AJ; Martin, RA; Grant, M; Mosselmans, F; Pynsent, P; Sumathi, VP; Addison, O; Revell, PA; Buckley, CD				Mittal, Saloni; Revell, Matthew; Barone, Francesca; Hardie, Debbie L.; Matharu, Gulraj S.; Davenport, Alison J.; Martin, Richard A.; Grant, Melissa; Mosselmans, Frederick; Pynsent, Paul; Sumathi, Vaiyapuri P.; Addison, Owen; Revell, Peter A.; Buckley, Christopher D.			Lymphoid Aggregates That Resemble Tertiary Lymphoid Organs Define a Specific Pathological Subset in Metal-on-Metal Hip Replacements	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; GERMINAL CENTER FORMATION; SJOGRENS-SYNDROME; RHEUMATOID SYNOVITIS; FOLLOW-UP; RESURFACING ARTHROPLASTY; INFLAMMATORY PSEUDOTUMOR; AUTOANTIBODY PRODUCTION; TISSUE-REACTIONS; NEOGENESIS	Aseptic lymphocyte-dominated vasculitis-associated lesion (ALVAL) has been used to describe the histological lesion associated with metal-on-metal (M-M) bearings. We tested the hypothesis that the lymphoid aggregates, associated with ALVAL lesions resemble tertiary lymphoid organs (TLOs). Histopathological changes were examined in the periprosthetic tissue of 62 M-M hip replacements requiring revision surgery, with particular emphasis on the characteristics and pattern of the lymphocytic infiltrate. Immunofluorescence and immunohistochemistry were used to study the classical features of TLOs in cases where large organized lymphoid follicles were present. Synchrotron X-ray fluorescence (XRF) measurements were undertaken to detect localisation of implant derived ions/particles within the samples. Based on type of lymphocytic infiltrates, three different categories were recognised; diffuse aggregates (51%), T cell aggregates (20%), and organised lymphoid aggregates (29%). Further investigation of tissues with organised lymphoid aggregates showed that these tissues recapitulate many of the features of TLOs with T cells and B cells organised into discrete areas, the presence of follicular dendritic cells, acquisition of high endothelial venule like phenotype by blood vessels, expression of lymphoid chemokines and the presence of plasma cells. Co-localisation of implant-derived metals with lymphoid aggregates was observed. These findings suggest that in addition to the well described general foreign body reaction mediated by macrophages and a T cell mediated type IV hypersensitivity response, an under-recognized immunological reaction to metal wear debris involving B cells and the formation of tertiary lymphoid organs occurs in a distinct subset of patients with M-M implants.	[Mittal, Saloni; Barone, Francesca; Hardie, Debbie L.; Buckley, Christopher D.] Univ Birmingham, MRC Ctr Immune Regulat, Inst Biomed Res, Rheumatol Res Grp, Birmingham, W Midlands, England; [Mittal, Saloni; Revell, Matthew; Matharu, Gulraj S.; Pynsent, Paul; Sumathi, Vaiyapuri P.; Revell, Peter A.] Royal Orthoped Hosp, Birmingham, W Midlands, England; [Grant, Melissa; Addison, Owen] Univ Birmingham, Sch Dent, Biomat Unit, Birmingham, W Midlands, England; [Davenport, Alison J.] Univ Birmingham, Sch Met & Mat, Birmingham B15 2TT, W Midlands, England; [Martin, Richard A.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Martin, Richard A.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Mosselmans, Frederick] Diamond Light Source, Didcot, Oxon, England	University of Birmingham; Royal Orthopaedic Hospital; University of Birmingham; University of Birmingham; Aston University; Aston University; Diamond Light Source	Buckley, CD (corresponding author), Univ Birmingham, MRC Ctr Immune Regulat, Inst Biomed Res, Rheumatol Res Grp, Birmingham, W Midlands, England.	c.d.buckley@bham.ac.uk	Martin, Richard/AAG-9489-2020; addison, owen/AAA-4185-2022; mosselmans, j fred w/H-4985-2013; Buckley, Christopher/AAN-6378-2021; Revell, Peter/AAH-2110-2019; addison, owen/AAI-8946-2021; Grant, Melissa/A-5590-2010; Davenport, Alison/J-6089-2013	addison, owen/0000-0002-0981-687X; Buckley, Christopher/0000-0001-6924-6402; Grant, Melissa/0000-0003-1154-7266; Davenport, Alison/0000-0003-0853-515X; mosselmans, julian/0000-0001-6473-2743; Barone, Francesca/0000-0002-5287-9614; Martin, Richard/0000-0002-6013-2334	Smith and Nephew; National Institute for Health Research [NIHR/CS/010/001] Funding Source: researchfish; Versus Arthritis [19791] Funding Source: researchfish	Smith and Nephew; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	Financial support for this study was provided by Smith and Nephew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. Funding by Smith and Nephew does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials and the authors do not have any declarations to make relating to employment, consultancy, patents, products in development that relate to the work described in this manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Barone F, 2005, ARTHRITIS RHEUM-US, V52, P1773, DOI 10.1002/art.21062; Beaule PE, 2004, J ARTHROPLASTY, V19, P17, DOI 10.1016/j.arth.2004.09.004; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; Fang CSJ, 2008, SKELETAL RADIOL, V37, P715, DOI 10.1007/s00256-008-0492-x; Glyn-Jones S, 2009, J BONE JOINT SURG BR, V91B, P1566, DOI 10.1302/0301-620X.91B12.22287; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Gregorio A, 2007, RHEUMATOLOGY, V46, P308, DOI 10.1093/rheumatology/kel225; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; Hart AJ, 2012, ACTA BIOMATER, V8, P3865, DOI 10.1016/j.actbio.2012.05.003; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Kwon YM, 2010, J ORTHOP RES, V28, P444, DOI 10.1002/jor.21015; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Lohmann CH, 2007, ORTHOPEDICS, V30, P760, DOI 10.3928/01477447-20070901-12; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Marsee DK, 2009, APPL IMMUNOHISTO M M, V17, P102, DOI 10.1097/PAI.0b013e318183a8e2; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Murray DW, 2011, HIP INT, V21, P279, DOI 10.5301/HIP.2011.8405; Natu S, 2012, J CLIN PATHOL, V65, P409, DOI 10.1136/jclinpath-2011-200398; Pandit H, 2008, VIRCHOWS ARCH, V453, P529, DOI 10.1007/s00428-008-0659-9; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pollard RPE, 2011, J RHEUMATOL, V38, P2198, DOI 10.3899/jrheum.110077; Revell PA, 2008, WOODHEAD PUBL MATER, P349, DOI 10.1533/9781845694807.3.349; Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tarlinton D, 1998, CURR BIOL, V8, pR753, DOI 10.1016/S0960-9822(07)00478-2; Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp	50	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63470	10.1371/journal.pone.0063470	http://dx.doi.org/10.1371/journal.pone.0063470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723985	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000319733000010
J	Rodriguez-Rubio, L; Martinez, B; Rodriguez, A; Donovan, DM; Gotz, F; Garcia, P				Rodriguez-Rubio, Lorena; Martinez, Beatriz; Rodriguez, Ana; Donovan, David M.; Goetz, Friedrich; Garcia, Pilar			The Phage Lytic Proteins from the Staphylococcus aureus Bacteriophage vB_SauS-phiIPLA88 Display Multiple Active Catalytic Domains and Do Not Trigger Staphylococcal Resistance	PLOS ONE			English	Article							CELL-WALL; STREPTOCOCCUS-PNEUMONIAE; ENDOLYSIN RELIES; HYDROLASE; LYSIS; CYSTEINE; SYNERGY; ENZYMES; HYDH5	The increase in antibiotic resistance world-wide revitalized the interest in the use of phage lysins to combat pathogenic bacteria. In this work, we analyzed the specific cleavage sites on the staphylococcal peptidoglycan produced by three phage lytic proteins. The investigated cell wall lytic enzymes were the endolysin LysH5 derived from the S. aureus bacteriophage vB_SauS-phi-IPLA88 (phi-IPLA88) and two fusion proteins between lysostaphin and the virion-associated peptidoglycan hydrolase HydH5 (HydH5SH3b and HydH5Lyso). We determined that all catalytic domains present in these proteins were active. Additionally, we tested for the emergence of resistant Staphylococcus aureus to any of the three phage lytic proteins constructs. Resistant S. aureus could not be identified after 10 cycles of bacterial exposure to phage lytic proteins either in liquid or plate cultures. However, a quick increase in lysostaphin resistance (up to 1000-fold in liquid culture) was observed. The lack of resistant development supports the use of phage lytic proteins as future therapeutics to treat staphylococcal infections.	[Rodriguez-Rubio, Lorena; Martinez, Beatriz; Rodriguez, Ana; Garcia, Pilar] CSIC, Inst Prod Lacteos Asturias, Dept Technol & Biotechnol Dairy Prod, DairySafe Grp, Villaviciosa, Asturias, Spain; [Donovan, David M.] ARS, Anim Biosci & Biotechnol Lab, Anim & Nat Resources Inst, Beltsville Agr Res Ctr,USDA, Beltsville, MD USA; [Goetz, Friedrich] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); United States Department of Agriculture (USDA); Eberhard Karls University of Tubingen	Garcia, P (corresponding author), CSIC, Inst Prod Lacteos Asturias, Dept Technol & Biotechnol Dairy Prod, DairySafe Grp, Villaviciosa, Asturias, Spain.	pgarcia@ipla.csic.es	Rodriguez, Ana/GLQ-7829-2022; Garcia, Pilar/AAP-3768-2020; Suárez, Pilar García/H-2544-2012; Rodríguez, Ana/GQR-0554-2022; Rodriguez, Ana/H-4846-2012; Martínez, Beatriz/H-2953-2012; Rodriguez-Rubio, Lorena/D-2888-2017	Rodriguez, Ana/0000-0002-1577-9905; Garcia, Pilar/0000-0003-1213-8165; Suárez, Pilar García/0000-0003-1213-8165; Rodriguez, Ana/0000-0002-1577-9905; Martínez, Beatriz/0000-0001-7692-1963; Rodriguez-Rubio, Lorena/0000-0002-7846-4791	Ministry of Science and Innovation, Spain [AGL2009-13144-C02-01]; Science, Technology and Innovation Programme, Principado de Asturias, Spain [IB08-052]; Consejo Superior de Investigaciones Cientificas, Spain [PIE200970I090]; bacteriophage network FAGOMA; National Institutes of Health [1RO1AI075077-01A1]; National Research Initiative [2007-35204-18395]; United States State Department funds; German Research Foundation [SFB766]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075077] Funding Source: NIH RePORTER	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science, Technology and Innovation Programme, Principado de Asturias, Spain; Consejo Superior de Investigaciones Cientificas, Spain; bacteriophage network FAGOMA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Initiative(United States Department of Agriculture (USDA)); United States State Department funds; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research study was supported by grants AGL2009-13144-C02-01 (Ministry of Science and Innovation, Spain), IB08-052 (Science, Technology and Innovation Programme, Principado de Asturias, Spain), PIE200970I090 (Consejo Superior de Investigaciones Cientificas, Spain) and bacteriophage network FAGOMA; National Institutes of Health, grant 1RO1AI075077-01A1 (DMD), National Research Initiative grant 2007-35204-18395 (DMD) and United States State Department funds (DMD); German Research Foundation, SFB766. LR-R is a fellow of the Science, Technology and Innovation Programme (Principado de Asturias, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Donovan DM, 2009, BIOTECH INT, V21, P6; Fenton Mark, 2010, Bioeng Bugs, V1, P9, DOI 10.4161/bbug.1.1.9818; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; GARCIA P, 1983, CURR MICROBIOL, V8, P137, DOI 10.1007/BF01568846; Garcia P, 2010, INT J FOOD MICROBIOL, V141, P151, DOI 10.1016/j.ijfoodmicro.2010.04.029; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; Horgan M, 2009, APPL ENVIRON MICROB, V75, P872, DOI 10.1128/AEM.01831-08; Kusuma C, 2007, ANTIMICROB AGENTS CH, V51, P475, DOI 10.1128/AAC.00786-06; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mo KF, 2012, J AM CHEM SOC, V134, P15556, DOI 10.1021/ja3069962; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138; Rodriguez-Rubio L, 2013, CRIT REV MICROBIOL, V39, P427, DOI 10.3109/1040841X.2012.723675; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P2241, DOI 10.1128/AEM.07621-11; Schmelcher M, 2012, J BIOTECHNOL, V162, P289, DOI 10.1016/j.jbiotec.2012.09.010; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Shen Y, 2012, ADV M C M, P217, DOI 10.1079/9781845939847.0217	29	39	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64671	10.1371/journal.pone.0064671	http://dx.doi.org/10.1371/journal.pone.0064671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724076	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000077
J	Yao, XL; Ye, CH; Liu, Q; Wan, JB; Zhen, J; Xiang, AP; Li, WQ; Wang, YT; Su, HX; Lu, XL				Yao, Xiao-Li; Ye, Cheng-Hui; Liu, Qiang; Wan, Jian-bo; Zhen, Jun; Xiang, Andy Peng; Li, Wei-Qiang; Wang, Yitao; Su, Huangxing; Lu, Xi-Lin			Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice	PLOS ONE			English	Article							DIRECTED DIFFERENTIATION; MOTOR-NEURONS; ALS; FIBROBLASTS; PROGRESSION	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder mainly affecting motor neurons. Mutations in superoxide dismutase-1 (SOD-1) account for about 20% of familial ALS patients. A robust supply of motoneurons carrying the mutated gene would help understand the causes of motoneuron death and develop new therapeutics for the disease. Here, we established induced pluripotent stem (iPS) cell lines from SOD1G93A mice and compared their potency in motoneuron generation with normal iPS cells and mouse embryonic stem cells (E14). Our results showed that iPS cells derived from SOD1G93A mice possessed the similar potency in neuronal differentiation to normal iPS cells and E14 cells and can be efficiently driven to motoneuron-like phenotype. These cells exhibited typical neuronal morphology, expressed key motoneuron markers, including ChAT and HB9, and generated repetitive trains of action potentials. Furthermore, these neurons highly expressed human SOD-1 and exhibited shorter neurites compared to controls. The present study provides evidence that ALS-iPS cells can be used as disease models in high-throughput screening and mechanistic studies due to their ability to efficiently differentiate into specific neuronal subtypes.	[Yao, Xiao-Li; Ye, Cheng-Hui; Liu, Qiang; Lu, Xi-Lin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Cheng-Hui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Geriatr, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Jian-bo; Wang, Yitao; Su, Huangxing] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhen, Jun] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Rehabil Med, Zhuhai, Guangdong, Peoples R China; [Xiang, Andy Peng; Li, Wei-Qiang] Sun Yat Sen Univ, Minist Educ, Ctr Stem Cell Biol & Tissue Engn, Key Lab Stem Cells & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Macau; Sun Yat Sen University; Sun Yat Sen University	Su, HX (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	Huanxingsu@umac.mo; goodxilin@163.com	Su, Huanxing/X-3980-2019; Wang, Yitao/O-5184-2016; Su, Huanxing/X-3954-2019; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Wan, Jian-Bo/0000-0002-6750-2617	National Key Clinical Department, National Key Discipline and Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases; National Natural Science Foundation of China [81041056]; Science and Technology Planning Program of Guangdong Province [2010B050700024, 2012B031800107]; multi-year research grant, university of Macau [MYRG122 (Y1-L3)-ICMS12-SHX]	National Key Clinical Department, National Key Discipline and Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Program of Guangdong Province; multi-year research grant, university of Macau	This study was supported by grants from the National Key Clinical Department, National Key Discipline and Guangdong Key Laboratory For Diagnosis And Treatment of Major Neurological Diseases. This study was supported by National Natural Science Foundation of China (81041056) and Science and Technology Planning Program of Guangdong Province (2010B050700024, 2012B031800107). This study was also supported by multi-year research grant, university of Macau, MYRG122 (Y1-L3)-ICMS12-SHX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; LI W, 2010, FRONT BIOL, V5, P455; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Onorati M, 2010, MOL CELL NEUROSCI, V43, P287, DOI 10.1016/j.mcn.2009.12.002; Orrell RW, 2007, NEW ENGL J MED, V357, P822, DOI 10.1056/NEJMe078146; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64720	10.1371/journal.pone.0064720	http://dx.doi.org/10.1371/journal.pone.0064720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724084	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000085
J	Smid, J; Carranza, S; Kratochvil, L; Gvozdik, V; Nasher, AK; Moravec, J				Smid, Jiri; Carranza, Salvador; Kratochvil, Lukas; Gvozdik, Vaclav; Nasher, Abdul Karim; Moravec, Jiri			Out of Arabia: A Complex Biogeographic History of Multiple Vicariance and Dispersal Events in the Gecko Genus Hemidactylus (Reptilia: Gekkonidae)	PLOS ONE			English	Article							RED-SEA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; SOCOTRA ISLAND; MITOCHONDRIAL; EVOLUTION; SQUAMATA; PHYLOGEOGRAPHY; NUCLEAR	The geological history of the Arabian Peninsula has played a crucial role in shaping current diversity and distribution patterns of many Arabian and African faunal elements. The gecko genus Hemidactylus is not an exception. In this study, we provide an insight into the phylogeny and systematics of 45 recognized species of the so-called Arid clade of the genus Hemidactylus from Arabia, the Horn of Africa, the Levant and Iran. The material comprises 358 specimens sequenced for up to two mitochondrial (12S rRNA, cytochrome b) and four nuclear (mc1r, cmos, rag1, rag2) genes with 4766 bp of the concatenated alignment length. A robust calibrated phylogeny and reconstruction of historical biogeography are inferred. We link the history of this genus with major geological events that occurred in the region within the last 30 million years. Two basal divergences correspond with the break-ups of the Arabian and African landmasses and subsequent separation of Socotra from the Arabian mainland, respectively, segregating the genus by means of vicariance. Formation of the Red Sea led to isolation and subsequent radiation in the Arabian Peninsula, which was followed by multiple independent expansions: 13.1 Ma to Iran; 9.8 Ma to NE Africa; 8.2 to Socotra Archipelago; 7-7.3 Ma two colonizations to the Near East; 5.9 Ma to NE Africa; and 4.1 to Socotra. Moreover, using multiple genetic markers we detected cryptic diversity within the genus, particularly in south-western Arabia and the Ethiopian highlands, and confirmed the existence of at least seven new species in the area. These findings highlight the role of Arabia and the Horn of Africa as an important Hemidactylus diversity hotspot.	[Smid, Jiri; Gvozdik, Vaclav; Moravec, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic; [Smid, Jiri] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Carranza, Salvador] CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain; [Kratochvil, Lukas] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Gvozdik, Vaclav] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Nasher, Abdul Karim] Sanaa Univ, Fac Sci, Sanaa, Yemen	National Museum; Charles University Prague; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Charles University Prague; University of Basel	Smid, J (corresponding author), Natl Museum, Dept Zool, Prague, Czech Republic.	jirismd@gmail.com	Gvozdik, Vaclav/E-4043-2010; Smid, Jiri/N-1616-2013; Kratochvil, Lukas/M-2134-2019; Kratochvíl, Lukáš/A-1997-2008; Carranza, Salvador/A-2126-2012	Smid, Jiri/0000-0002-0309-209X; Kratochvíl, Lukáš/0000-0002-3515-729X; Carranza, Salvador/0000-0002-5378-3008	Ministry of Culture of the Czech Republic [DKRVO 2013/14, 00023272]; Ministerio de Economia y Competitividad, Spain, Fondos FEDER - EU [CGL2009-11663 /BOS]	Ministry of Culture of the Czech Republic; Ministerio de Economia y Competitividad, Spain, Fondos FEDER - EU	This work was financially supported by Ministry of Culture of the Czech Republic (DKRVO 2013/14, National Museum, 00023272); and by grant CGL2009-11663 /BOS from the Ministerio de Economia y Competitividad, Spain, Fondos FEDER - EU, (TO SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer SAM, 2005, BIOL J LINN SOC, V85, P247, DOI 10.1111/j.1095-8312.2005.00485.x; Arnold EN, 2008, ZOOL SCR, V37, P619, DOI 10.1111/j.1463-6409.2008.00351.x; Arnold E.N., 1977, P81; Arnold E. N., 1980, J OMAN STUDIES SPECI, P273; Autin J, 2010, GEOPHYS J INT, V180, P501, DOI 10.1111/j.1365-246X.2009.04424.x; Baha El Din S. M., 2005, ZOOLOGY MIDDLE E, V34, P27, DOI DOI 10.1080/09397140.2005.10638078; Baldo D., 2008, CHECK LIST, V4, P434, DOI [10.15560/4.4.434, DOI 10.15560/4.4.434]; Bansal R, 2010, MOL PHYLOGENET EVOL, V57, P459, DOI 10.1016/j.ympev.2010.06.008; Bauer AM, 2010, MOL PHYLOGENET EVOL, V57, P343, DOI 10.1016/j.ympev.2010.06.014; Bauer Aaron M., 2006, Zoology in the Middle East, V39, P59; Bosworth W, 2005, J AFR EARTH SCI, V43, P334, DOI 10.1016/j.jafrearsci.2005.07.020; Brogard J, 2005, ZOOGEOGRAPHICAL CHEC, V1; Busais S, 2011, ZOOL MIDDLE EAST, V53, P25, DOI 10.1080/09397140.2011.10648859; Busais SM, 2011, VERTEBR ZOOL, V61, P267; Carranza S, 2006, MOL PHYLOGENET EVOL, V38, P531, DOI 10.1016/j.ympev.2005.07.012; Carranza Salvador, 2012, Zootaxa, V3378, P1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chorowicz J, 2005, J AFR EARTH SCI, V43, P379, DOI 10.1016/j.jafrearsci.2005.07.019; DAVISON I, 1994, GEOL SOC AM BULL, V106, P1474, DOI 10.1130/0016-7606(1994)106<1474:GEOTSR>2.3.CO;2; DELANY MJ, 1989, MAMMAL REV, V19, P133, DOI 10.1111/j.1365-2907.1989.tb00408.x; Drummond A. J., 2011, GENEIOUS V5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandes CA, 2006, J BIOGEOGR, V33, P961, DOI 10.1111/j.1365-2699.2006.01478.x; Fernandes CA, 2011, ZOOL MIDDLE EAST, P111, DOI 10.1080/09397140.2011.10648903; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Ghebreab W, 1998, EARTH-SCI REV, V45, P1, DOI 10.1016/S0012-8252(98)00036-1; Gomez-Diaz E, 2012, MOL ECOL, V21, P4074, DOI 10.1111/j.1365-294X.2012.05672.x; Gvozdik V, 2010, MOL PHYLOGENET EVOL, V55, P1146, DOI 10.1016/j.ympev.2010.03.015; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kluge AG, 1969, MISCELLANEOUS PUBLIC, V138, P1; Kornilios P, 2010, MOL PHYLOGENET EVOL, V54, P445, DOI 10.1016/j.ympev.2009.09.015; Lanza Benedetto, 1990, Biogeographia, V14, P407; Largen MJ, 2006, TROP ZOOL, V19, P21; Macey JR, 2008, MOL PHYLOGENET EVOL, V49, P1015, DOI 10.1016/j.ympev.2008.08.024; Mallon DP, 2011, ZOOL MIDDLE EAST, P13, DOI 10.1080/09397140.2011.10648896; Metallinou M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-258; Mittermeier Russell A., 2004, P1; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moravec Jiri, 2011, Zootaxa, V2894, P21; Papenfuss TJ, 2011, ZOOTAXA, V3221, P26; Pook CE, 2009, MOL PHYLOGENET EVOL, V53, P792, DOI 10.1016/j.ympev.2009.08.002; Portik DM, 2012, MOL PHYLOGENET EVOL, V62, P561, DOI 10.1016/j.ympev.2011.09.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Rato C, 2011, MOL PHYLOGENET EVOL, V58, P365, DOI 10.1016/j.ympev.2010.12.004; Razzetti E, 2011, ZOOTAXA, P1; Rocha S, 2005, MOL PHYLOGENET EVOL, V35, P292, DOI 10.1016/j.ympev.2004.11.023; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Scott H, 1942, HIGH YEMEN; Short KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026258; Sindaco Roberto, 2008, P1; Sindaco R, 2009, ACTA HERPETOL, V4, P83; Spawls Stephen, 1999, Journal of East African Natural History, V86, P61, DOI 10.2982/0012-8317(1997)86[61:AACOTL]2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tonione MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026874; Torki Farhang, 2011, Sauria, V33, P47; Uetz P., 2012, REPTILE DATABASE; van der Kooij Jeroen, 2000, Podarcis, V1, pUnpaginated; Vences M, 2004, BIOL J LINN SOC, V83, P115, DOI 10.1111/j.1095-8312.2004.00370.x; Weiss AJ, 2007, MOL PHYLOGENET EVOL, V45, P409, DOI 10.1016/j.ympev.2007.01.006; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Winney BJ, 2004, MOL ECOL, V13, P2819, DOI 10.1111/j.1365-294X.2004.02288.x; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	74	78	81	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64018	10.1371/journal.pone.0064018	http://dx.doi.org/10.1371/journal.pone.0064018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724016	Green Published, gold			2022-12-25	WOS:000319738100017
J	Koh, J; Choi, JR; Han, KH; Kim, EK; Yoon, JH; Moon, HJ; Kwak, JY				Koh, Jieun; Choi, Jong Rak; Han, Kyung Hwa; Kim, Eun-Kyung; Yoon, Jung Hyun; Moon, Hee Jung; Kwak, Jin Young			Proper Indication of BRAF(V600E) Mutation Testing in Fine-Needle Aspirates of Thyroid Nodules	PLOS ONE			English	Article							PREVALENT AREA; BRAF MUTATION; DIAGNOSIS; SAMPLES; CARCINOMA; CYTOLOGY; BENIGN; BIOPSY; PREDICTION; FEATURES	Background: The aim of this study was to evaluate the proper indication of adjunctive BRAF(V600E) mutation analysis at the time of ultrasound-guided fine-needle aspiration in the diagnosis of thyroid nodules. Methods: This study included 518 nodules in 479 patients who underwent ultrasound-guided fine-needle aspiration with BRAF(V600E) mutation. We calculated and compared the diagnostic performances of cytology and cytology with BRAF(V600E) mutation analysis to detect malignancy among thyroid nodules according to ultrasound features and size. Results: Sensitivity, negative predictive value, and accuracy of cytology with BRAF(V600E) mutation analysis were significantly higher than those of cytology alone in thyroid nodules with suspicious ultrasound features, regardless of size. Diagnostic performances did not show significant differences between cytology and cytology with BRAF(V600E) mutation analysis in nodules without any suspicious ultrasound features, regardless of size. Conclusion: The BRAF(V600E) mutation analysis was a useful adjunctive diagnostic tool in the diagnosis of thyroid nodules with suspicious ultrasound features regardless of size.	[Koh, Jieun; Kim, Eun-Kyung; Yoon, Jung Hyun; Moon, Hee Jung; Kwak, Jin Young] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Choi, Jong Rak] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Med Res Ctr, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	docjin@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Koh, Jieun/E-4647-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Koh, Jieun/0000-0002-5290-6248; Han, Kyunghwa/0000-0002-5687-7237; Kwak, Jin Young/0000-0002-6212-1495; Moon, Hee Jung/0000-0002-5643-5885; Yoon, Jung Hyun/0000-0002-2100-3513				Adeniran AJ, 2011, THYROID, V21, P717, DOI 10.1089/thy.2011.0021; Ahn D, 2012, AURIS NASUS LARYNX, V39, P198, DOI 10.1016/j.anl.2011.07.011; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Hamfjord J, 2011, DIAGN MOL PATHOL, V20, P158, DOI 10.1097/PDM.0b013e31820b49e2; Hassell LA, 2012, CANCER CYTOPATHOL, V120, P7, DOI 10.1002/cncy.20186; Hwang J, 2010, AM J ROENTGENOL, V194, pW425, DOI 10.2214/AJR.09.3512; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim SK, 2011, J CLIN ENDOCR METAB, V96, P658, DOI 10.1210/jc.2010-1082; Kim SW, 2010, J CLIN ENDOCR METAB, V95, P3693, DOI 10.1210/jc.2009-2795; Kim SH, 2010, KOREAN J RADIOL, V11, P149, DOI 10.3348/kjr.2010.11.2.149; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; Kwak JY, 2010, HEAD NECK-J SCI SPEC, V32, P490, DOI 10.1002/hed.21210; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; Lee EJ, 2011, CLIN ENDOCRINOL, V75, P844, DOI 10.1111/j.1365-2265.2011.04154.x; Lee MJ, 2011, YONSEI MED J, V52, P838, DOI 10.3349/ymj.2011.52.5.838; Lee ST, 2012, J CLIN ENDOCR METAB, V97, P2299, DOI 10.1210/jc.2011-3135; Moon HJ, 2011, ANN SURG ONCOL, V18, P792, DOI 10.1245/s10434-010-1354-z; Nam SY, 2010, THYROID, V20, P273, DOI 10.1089/thy.2009.0226; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Ohori NP, 2012, CANC CYTOPATHOL; Park SH, 2009, AM J ROENTGENOL, V193, pW416, DOI 10.2214/AJR.09.2541; Tonacchera M, 2012, J ENDOCRINOL INVEST, V35, P754, DOI 10.3275/8012; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Yeo MK, 2011, CLIN ENDOCRINOL, V75, P555, DOI 10.1111/j.1365-2265.2011.04115.x	31	23	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64505	10.1371/journal.pone.0064505	http://dx.doi.org/10.1371/journal.pone.0064505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717622	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300020
J	Wang, K; Li, YY; Dai, CY; Wang, KS; Yu, JH; Tan, YR; Zhang, WY; Yu, XF				Wang, Kang; Li, Yuanyuan; Dai, Chunyan; Wang, Kaishi; Yu, Jinghua; Tan, Yiran; Zhang, Wenyan; Yu, Xiao-Fang			Characterization of the Relationship between APOBEC3B Deletion and ACE Alu Insertion	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CYTIDINE DEAMINASES; GENE POLYMORPHISM; BLOOD-PRESSURE; EVOLUTION; RETROTRANSPOSITION; ASSOCIATION; DNA; POPULATIONS; PROGRESSION	The insertion/deletion (I/D) polymorphism of the angiotensin converting enzyme (ACE), commonly associated with many diseases, is believed to have affected human adaptation to environmental changes during the out-of-Africa expansion. APOBEC3B (A3B), a member of the cytidine deaminase family APOBEC3s, also exhibits a variable gene insertion/deletion polymorphism across world populations. Using data available from published reports, we examined the global geographic distribution of ACE and A3B genotypes. In tracking the modern human dispersal routes of these two genes, we found that the variation trends of the two I/D polymorphisms were directly correlated. We observed that the frequencies of ACE insertion and A3B deletion rose in parallel along the expansion route. To investigate the presence of a correlation between the two polymorphisms and the effect of their interaction on human health, we analyzed 1199 unrelated Chinese adults to determine their genotypes and other important clinical characteristics. We discovered a significant difference between the ACE genotype/allele distribution in the A3B DD and A3B II/ID groups (P = 0.045 and 0.015, respectively), indicating that the ACE Alu I allele frequency in the former group was higher than in the latter group. No specific clinical phenotype could be associated with the interaction between the ACE and A3B I/D polymorphisms. A3B has been identified as a powerful inhibitor of Alu retrotransposition, and primate A3 genes have undergone strong positive selection (and expansion) for restricting the mobility of endogenous retrotransposons during evolution. Based on these findings, we suggest that the ACE Alu insertion was enabled (facilitated) by the A3B deletion and that functional loss of A3B provided an opportunity for enhanced human adaptability and survival in response to the environmental and climate challenges arising during the migration from Africa.	[Wang, Kang; Li, Yuanyuan; Dai, Chunyan; Wang, Kaishi; Yu, Jinghua; Zhang, Wenyan; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China; [Tan, Yiran; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China.	xfyu@jhsph.edu	li, yuanyuan/GZA-4435-2022		Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China	This work was supported in part by funding from the Chinese Ministry of Science and Technology (No. 2012CB911100 and No. 2013ZX0001-005), the Chinese Ministry of Education (No IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Crews DE, 2004, AM J PHYS ANTHROPOL, V124, P364, DOI 10.1002/ajpa.10355; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Di Pasquale P, 2004, EUR J HEART FAIL, V6, P11, DOI 10.1016/j.ejheart.2003.07.009; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; Eisenmann JC, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-14; Feng Y, 2002, DIABETES, V51, P1986, DOI 10.2337/diabetes.51.6.1986; HARDEN PN, 1995, LANCET, V345, P1540, DOI 10.1016/S0140-6736(95)91088-3; Herrmann FH, 2004, AM J HUM BIOL, V16, P82, DOI 10.1002/ajhb.10229; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Ismail M, 2004, J BIOCHEM MOL BIOL, V37, P552; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jha P, 2012, INFECT GENET EVOL, V12, P142, DOI 10.1016/j.meegid.2011.11.001; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Li X, 2011, EUR J HUM GENET, V19, P1002, DOI 10.1038/ejhg.2011.66; LIEBERMAN J, 1983, LAB INVEST, V48, P711; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Medeiros R, 2004, J PATHOL, V202, P330, DOI 10.1002/path.1529; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rupert JL, 2003, ANN HUM GENET, V67, P17, DOI 10.1046/j.1469-1809.2003.00004.x; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Vargas-Alarcon G, 2003, HUM BIOL, V75, P889, DOI 10.1353/hub.2004.0012; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang T, 2012, HUM MOL GENET; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x	40	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64809	10.1371/journal.pone.0064809	http://dx.doi.org/10.1371/journal.pone.0064809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717661	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300010
J	Wang, QG; Jia, PL; Zhao, ZM				Wang, Qingguo; Jia, Peilin; Zhao, Zhongming			VirusFinder: Software for Efficient and Accurate Detection of Viruses and Their Integration Sites in Host Genomes through Next Generation Sequencing Data	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; READ ALIGNMENT; IDENTIFY; TISSUE; IDENTIFICATION; RESOLUTION; TOOL	Next generation sequencing (NGS) technologies allow us to explore virus interactions with host genomes that lead to carcinogenesis or other diseases; however, this effort is largely hindered by the dearth of efficient computational tools. Here, we present a new tool, VirusFinder, for the identification of viruses and their integration sites in host genomes using NGS data, including whole transcriptome sequencing (RNA-Seq), whole genome sequencing (WGS), and targeted sequencing data. VirusFinder's unique features include the characterization of insertion loci of virus of arbitrary type in the host genome and high accuracy and computational efficiency as a result of its well-designed pipeline. The source code as well as additional data of VirusFinder is publicly available at http://bioinfo.mc.vanderbilt.edu/VirusFinder/.	[Wang, Qingguo; Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, ZM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu		Wang, Qingguo/0000-0002-5125-3724	National Institutes of Health [R01LM011177, P30CA68485, P50CA095103]; NATIONAL CANCER INSTITUTE [P30CA068485, P50CA095103] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health grants (R01LM011177, P30CA68485, and P50CA095103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hirahata M, 2007, NUCLEIC ACIDS RES, V35, pD339, DOI 10.1093/nar/gkl1004; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Lace MJ, 2011, J VIROL, V85, P1645, DOI 10.1128/JVI.02093-10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lasithiotaki I, 2013, INT J CANCER, V133, P604, DOI 10.1002/ijc.28062; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JW, 2013, BIOINFORMATICS, V29, P649, DOI 10.1093/bioinformatics/btt011; Naeem R, 2013, BIOINFORMATICS, V29, P391, DOI 10.1093/bioinformatics/bts684; Patowary Ashok, 2012, BMC Res Notes, V5, P11, DOI 10.1186/1756-0500-5-11; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	22	107	110	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64465	10.1371/journal.pone.0064465	http://dx.doi.org/10.1371/journal.pone.0064465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717618	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300022
J	Lin, KR; Li, CL; Yen, JJY; Yang-Yen, HF				Lin, Kou-Ray; Li, Chung-Leung; Yen, Jeffrey Jong-Young; Yang-Yen, Hsin-Fang			Constitutive Phosphorylation of GATA-1 at Serine(26) Attenuates the Colony-Forming Activity of Erythrocyte-Committed Progenitors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; GENE-EXPRESSION; DNA-BINDING; ERYTHROPOIETIN RECEPTOR; IN-VIVO; C-KIT; DIFFERENTIATION; SURVIVAL; PROLIFERATION; HEMATOPOIESIS	We previously reported that IL-3 signaling induces phosphorylation of GATA-1 at the serine(26) position, which contributes to IL-3-mediated anti-apoptotic response. Here, we demonstrate that phosphorylation of GATA-1 at serine(26) is also transiently induced in cells of the erythroid lineage (primary erythroblasts and erythrocyte-committed progenitors [EPs]) by erythropoietin (EPO), the principal cytokine regulating erythropoiesis. To examine whether phosphorylation of GATA-1 at serine(26) would have any impact on erythropoiesis, mutant mice carrying either a glutamic acid (GATA-1(S26E)) or alanine (GATA-1(S26A)) substitution at serine(26) were generated. Neither GATA-1(S26E) nor GATA-1(S26A) mice showed any significant difference from control mice in peripheral blood cell composition under either steady state or stress conditions. The erythroblast differentiation in both mutant mice also appeared to be normal. However, a moderate reduction in the CFU-E progenitor population was consistently observed in the bone marrow of GATA-1(S26E), but not GATA-1(S26A) mice, suggesting that such defect was compensated for within the bone marrow. Surprisingly, reduced CFU-E progenitor population in GATA-1(S26E) mice was mainly due to EPO-induced growth suppression of GATA-1(S26E) EPs, albeit in the absence of EPO these cells manifested a survival advantage. Further analyses revealed that EPO-induced growth suppression of GATA-1(S26E) EPs was largely due to the proliferation block resulted from GATA-1(S26E)-mediated transcriptional activation of the gene encoding the cell cycle inhibitor p21 Waf1/Cip1. Taken together, these results suggest that EPO-induced transient phosphorylation of GATA-1 at serine(26) is dispensable for erythropoiesis. However, failure to dephosphorylate this residue following its transient phosphorylation significantly attenuates the colony-forming activity of EPs.	[Lin, Kou-Ray; Yen, Jeffrey Jong-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Li, Chung-Leung] Acad Sinica, Inst Cell & Organism Biol, Genom Res Ctr, Taipei, Taiwan; [Yang-Yen, Hsin-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yen, JJY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmjyen@ibms.sinica.edu.tw; imbyy@gate.sinica.edu.tw	Lin, Kuo-Ray/V-6333-2019; Yen, Jeffrey Jong-Young/Q-5134-2018; Yang-Yen, Hsin-Fang/ABA-5808-2021	Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Yang-Yen, Hsin-Fang/0000-0001-9048-4800; Lin, Kuo-Ray/0000-0002-6525-1674	Academia Sinica; National Science Council of Taiwan [NSC96-2320-B-001-012-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by an intramural fund from Academia Sinica (http://www.sinica.edu.tw/index.shtml) and by a grant (NSC96-2320-B-001-012-MY3) from the National Science Council of Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fawcett DW, 1997, BLOOM FAWCETT CONCIS, P84; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GREGORY CJ, 1978, BLOOD, V51, P527; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Jegalian AG, 2002, BLOOD, V99, P2603, DOI 10.1182/blood.V99.7.2603; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; Kapur R, 2001, J BIOL CHEM, V276, P1099, DOI 10.1074/jbc.M007442200; LEONARD M, 1993, BLOOD, V82, P1071; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; Papetti M, 2010, CELL CYCLE, V9, P1972, DOI 10.4161/cc.9.10.11602; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Rooke HM, 2006, BLOOD, V107, P3527, DOI 10.1182/blood-2005-10-4309; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stamatoyannopoulos G, 2000, MOL BASIS BLOOD DIS, P80; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64269	10.1371/journal.pone.0064269	http://dx.doi.org/10.1371/journal.pone.0064269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717580	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700125
J	Simkin, JE; Zhang, DC; Rollo, BN; Newgreen, DF				Simkin, Johanna E.; Zhang, Dongcheng; Rollo, Benjamin N.; Newgreen, Donald F.			Retinoic Acid Upregulates Ret and Induces Chain Migration and Population Expansion in Vagal Neural Crest Cells to Colonise the Embryonic Gut	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; VITAMIN-A; NEURONAL DIFFERENTIATION; PHARYNGEAL ARCHES; AVIAN EMBRYO; CHICK HEARTS; EXPRESSION; PATTERN; GDNF; ADHESION	Vagal neural crest cells (VNCCs) arise in the hindbrain, and at (avian) embryonic day (E) 1.5 commence migration through paraxial tissues to reach the foregut as chains of cells 1-2 days later. They then colonise the rest of the gut in a rostrocaudal wave. The chains of migrating cells later resolve into the ganglia of the enteric nervous system. In organ culture, E4.5 VNCCs resident in the gut (termed enteric or ENCC) which have previously encountered vagal paraxial tissues, rapidly colonised aneural gut tissue in large numbers as chains of cells. Within the same timeframe, E1.5 VNCCs not previously exposed to paraxial tissues provided very few cells that entered the gut mesenchyme, and these never formed chains, despite their ability to migrate in paraxial tissue and in conventional cell culture. Exposing VNCCs in vitro to paraxial tissue normally encountered en route to the foregut conferred enteric migratory ability. VNCC after passage through paraxial tissue developed elements of retinoic acid signalling such as Retinoic Acid Binding Protein 1 expression. The paraxial tissue's ability to promote gut colonisation was reproduced by the addition of retinoic acid, or the synthetic retinoid Am80, to VNCCs (but not to trunk NCCs) in organ culture. The retinoic acid receptor antagonist CD 2665 strongly reduced enteric colonisation by E1.5 VNCC and E4.5 ENCCs, at a concentration suggesting RAR alpha signalling. By FACS analysis, retinoic acid application to vagal neural tube and NCCs in vitro upregulated Ret; a Glial-derived-neurotrophic-factor receptor expressed by ENCCs which is necessary for normal enteric colonisation. This shows that early VNCC, although migratory, are incapable of migrating in appropriate chains in gut mesenchyme, but can be primed for this by retinoic acid. This is the first instance of the characteristic form of NCC migration, chain migration, being attributed to the application of a morphogen.	[Simkin, Johanna E.; Zhang, Dongcheng; Rollo, Benjamin N.; Newgreen, Donald F.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Embryol Lab, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Newgreen, DF (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Embryol Lab, Flemington Rd, Parkville, Vic 3052, Australia.	don.newgreen@mcri.edu.au		Rollo, Benjamin/0000-0001-6907-3468; Newgreen, Donald/0000-0002-3467-6389	NHMRC project grant [607379 NEWGREEN]	NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an NHMRC project grant, 607379 NEWGREEN, DF, LANDMAN, KA, "Migratory cells to ganglionated network: self-organization of the enteric nervous system'' (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN IJ, 1980, AM J ANAT, V157, P137, DOI 10.1002/aja.1001570203; Anderson RB, 2006, GASTROENTEROLOGY, V130, P1221, DOI 10.1053/j.gastro.2006.01.002; Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Aquino JB, 2009, NEUROSCIENCE, V162, P1106, DOI 10.1016/j.neuroscience.2009.05.035; Barlow AJ, 2008, DEVELOPMENT, V135, P1681, DOI 10.1242/dev.017418; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Blentic A, 2003, DEV DYNAM, V227, P114, DOI 10.1002/dvdy.10292; Breau MA, 2009, DEVELOPMENT, V136, P2791, DOI 10.1242/dev.031419; Broders-Bondon F, 2012, DEV BIOL, V364, P178, DOI 10.1016/j.ydbio.2012.02.001; Broekhuizen MLA, 1998, ANAT EMBRYOL, V197, P391, DOI 10.1007/s004290050150; Chang CL, 2008, ONCOGENE, V27, P2951, DOI 10.1038/sj.onc.1210969; Connor PJ, 2003, DEV DYNAM, V226, P727, DOI 10.1002/dvdy.10285; Cui J, 2003, DEV BIOL, V260, P496, DOI 10.1016/S0012-1606(03)00257-4; Delalande JM, 2008, DEV BIOL, V313, P279, DOI 10.1016/j.ydbio.2007.10.028; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Diez del Corral R, 2003, NEURON, V40, P65; Diman NYSG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027624; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Dupe V, 1999, DEVELOPMENT, V126, P5051; Flynn B, 2007, DEV DYNAM, V236, P134, DOI 10.1002/dvdy.21013; Fu M, 2010, DEVELOPMENT, V137, P631, DOI 10.1242/dev.040550; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Hackett-Jones EJ, 2011, J THEOR BIOL, V287, P148, DOI 10.1016/j.jtbi.2011.07.013; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Homma S, 2000, DEV BIOL, V217, P121, DOI 10.1006/dbio.1999.9543; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; Kim MJ, 2000, J INVEST DERMATOL, V114, P349, DOI 10.1046/j.1523-1747.2000.00868.x; KIRBY ML, 1985, CIRC RES, V56, P392, DOI 10.1161/01.RES.56.3.392; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Kuo BR, 2011, DEV DYNAM, V240, P2084, DOI 10.1002/dvdy.22715; KURATANI SC, 1991, AM J ANAT, V191, P215, DOI 10.1002/aja.1001910302; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; LEE YM, 1995, DEVELOPMENT, V121, P825; Malpel S, 2000, DEVELOPMENT, V127, P3057; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Nagy N, 2012, DEV DYNAM, V241, P842, DOI 10.1002/dvdy.23767; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P329, DOI 10.1007/s10024-002-0002-4; Newgreen DF, 2000, METH MOL B, V137, P201; Newgreen DF, 1996, ACTA ANAT, V157, P105; NEWGREEN DF, 1980, CELL TISSUE RES, V208, P1; NEWGREEN DF, 1979, CELL TISSUE RES, V203, P115; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; O'Donnell AM, 2004, PEDIATR SURG INT, V20, P229, DOI 10.1007/s00383-003-1116-0; Patrone G, 1997, FEBS LETT, V419, P76, DOI 10.1016/S0014-5793(97)01435-X; PIJNAPPEL WWM, 1993, NATURE, V366, P340, DOI 10.1038/366340a0; Pitera JE, 2001, AM J PATHOL, V159, P2321, DOI 10.1016/S0002-9440(10)63082-9; Reichenbach B, 2008, DEV BIOL, V318, P52, DOI 10.1016/j.ydbio.2008.02.061; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; ROBERTSON K, 1995, MECH DEVELOP, V53, P329, DOI 10.1016/0925-4773(95)00449-1; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Simpson MJ, 2006, J THEOR BIOL, V243, P343, DOI 10.1016/j.jtbi.2006.06.021; Sinning AR, 1998, ANAT RECORD, V253, P147, DOI 10.1002/(SICI)1097-0185(199810)253:5<147::AID-AR8>3.0.CO;2-0; Smith CA, 2005, DEV BIOL, V284, P337, DOI 10.1016/j.ydbio.2005.05.030; SMITH J, 1977, CELL DIFFER DEV, V6, P199, DOI 10.1016/0045-6039(77)90016-1; Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381; TAKAHASHI M, 1991, ONCOGENE, V6, P297; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Testaz S, 2001, DEV DYNAM, V222, P127, DOI 10.1002/dvdy.1181; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; TUCKER GC, 1986, DEV BIOL, V116, P439, DOI 10.1016/0012-1606(86)90145-4; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vermot J, 2003, P NATL ACAD SCI USA, V100, P1763, DOI 10.1073/pnas.0437920100; Walters LC, HUMAN MOL GENETICS, V19, P4353; Wendling O, 2000, DEVELOPMENT, V127, P1553; Yin MZ, 2006, PEDIATR DEVEL PATHOL, V9, P56, DOI 10.2350/06-05-0072.1; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100; Young HM, 2000, SOC NEUR ABSTR; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014	84	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64077	10.1371/journal.pone.0064077	http://dx.doi.org/10.1371/journal.pone.0064077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717535	Green Published, gold			2022-12-25	WOS:000320362700097
J	Walther, S; Czerny, CP; Diesterbeck, US				Walther, Stefanie; Czerny, Claus-Peter; Diesterbeck, Ulrike S.			Exceptionally Long CDR3H Are Not Isotype Restricted in Bovine Immunoglobulins	PLOS ONE			English	Article							H GENE FAMILY; VARIABLE-REGION; V(D)J RECOMBINATION; CHAIN DIVERSITY; CLUSTAL-W; HEAVY; REPERTOIRE; SEQUENCE; CATTLE; LOCUS	Exceptionally long third complementarity determining regions of the heavy chain (CDR3H) were previously described as a specificity of bovine IgG and IgM immunoglobulins. In addition, the genomic organization of the immunoglobulin heavy chain locus remains to be elucidated with a special focus on the number of variable segments (IGHV). By analyzing the variable regions according to the isotype-specific PCR using cDNA-PCR, we were able to prove the existence of exceptional long CDR3H in all bovine isotypes. The corresponding sequences of three distinct amplicons were grouped according to the length of the CDR3H. Sequences of CDR3H possessed 5 to 10, 12 to 31 or at least 48 amino acid residues. Long and mid-length CDR3H were composed of mainly hydrophilic amino acid residues, while short CDR3H also contained hydrophobic amino acid residues. All sequences with long CDR3H were related to the germline variable segment 10. Using the current genome assembly, Bos taurus NCBI build 6.1, the genomic organization of the bovine immunoglobulin heavy-chain locus was analyzed. A main locus was investigated on BTA21. Exons coding for variable, diversity, and joining segments, as well as for the constant regions of different isotypes, were also localized on BTA7, BTA8, and BTA20. Together with the information from unplaced contigs, 36 IGHV were detected of which 13 are putatively functional. Phylogenetic analysis revealed two bovine IGHV families (boVH1, boVH2). Thus, the existence of the two bovine families suggested was demonstrated, where boVH1 comprises all functional segments. This study substantially improves the understanding of the generation of immunoglobulin diversity in cattle.	[Walther, Stefanie; Czerny, Claus-Peter; Diesterbeck, Ulrike S.] Univ Gottingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, D-37073 Gottingen, Germany	University of Gottingen	Diesterbeck, US (corresponding author), Univ Gottingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, D-37073 Gottingen, Germany.	udieste@gwdg.de						AKAMATSU Y, 1994, J IMMUNOL, V153, P4520; Almagro JC, 2006, MOL IMMUNOL, V43, P1836, DOI 10.1016/j.molimm.2005.10.017; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dufour V, 1996, J IMMUNOL, V156, P2163; Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P737, DOI 10.1101/pdb.prot5636; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; Everts-van der Wind A, 2004, GENOME RES, V14, P1424, DOI 10.1101/gr.2554404; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRIEDMAN ML, 1994, J IMMUNOL, V152, P632; GU F, 1992, HEREDITAS, V117, P237, DOI 10.1111/j.1601-5223.1992.tb00020.x; Hayes H, 2000, CYTOGENET CELL GENET, V90, P315, DOI 10.1159/000056795; HAYES HC, 1993, MAMM GENOME, V4, P207, DOI 10.1007/BF00417564; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; HEUERTZ S, 1978, ANN GENET-PARIS, V21, P197; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KABAT EA, 2006, SEQUENCES PROTEINS I; Kaushik AK, 2009, VET IMMUNOL IMMUNOP, V127, P106, DOI 10.1016/j.vetimm.2008.09.024; KNIGHT KL, 1987, VET IMMUNOL IMMUNOP, V17, P17, DOI 10.1016/0165-2427(87)90123-1; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 1998, EXP CLIN IMMUNOGENET, V15, P1, DOI 10.1159/000019049; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Matsuda F, 1996, ADV IMMUNOL, V62, P1, DOI 10.1016/S0065-2776(08)60426-5; MILLER JR, 1992, ANIM GENET, V23, P51, DOI 10.1111/j.1365-2052.1992.tb00017.x; OTA T, 1994, MOL BIOL EVOL, V11, P469; Parng CL, 1996, J IMMUNOL, V157, P5478; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ramsland PA, 2001, EXP CLIN IMMUNOGENET, V18, P176, DOI 10.1159/000049197; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 2002, SCAND J IMMUNOL, V55, P140, DOI 10.1046/j.1365-3083.2002.01028.x; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT WE, 1983, H-S Z PHYSIOL CHEM, V364, P713, DOI 10.1515/bchm2.1983.364.1.713; Shojaei F, 2003, MOL IMMUNOL, V40, P61, DOI 10.1016/S0161-5890(03)00098-1; Sinclair MC, 1995, GENE, V167, P285, DOI 10.1016/0378-1119(95)00627-3; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; SYMONS DBA, 1989, MOL IMMUNOL, V26, P841, DOI 10.1016/0161-5890(89)90140-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBINJANZEN TC, 1992, IMMUNOGENETICS, V36, P157, DOI 10.1007/BF00661092; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TUTTER A, 1989, P NATL ACAD SCI USA, V86, P7460, DOI 10.1073/pnas.86.19.7460; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	64	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64234	10.1371/journal.pone.0064234	http://dx.doi.org/10.1371/journal.pone.0064234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717573	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700121
J	Mujtaba, S; Winer, BY; Jaganathan, A; Patel, J; Sgobba, M; Schuch, R; Gupta, YK; Haider, S; Wang, R; Fischetti, VA				Mujtaba, Shiraz; Winer, Benjamin Y.; Jaganathan, Anbalagan; Patel, Jigneshkumar; Sgobba, Miriam; Schuch, Raymond; Gupta, Yogesh K.; Haider, Shozeb; Wang, Rong; Fischetti, Vincent A.			Anthrax SET Protein A POTENTIAL VIRULENCE DETERMINANT THAT EPIGENETICALLY REPRESSES NF-kappa B ACTIVATION IN INFECTED MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; HISTONE METHYLATION; LYSINE METHYLATION; STRUCTURAL BASIS; KINASE-KINASE; LETHAL FACTOR; TRANSCRIPTION; BACTERIAL; GERMINATION; GENES	Toxins play a major role in the pathogenesis of Bacillus anthracis by subverting the host defenses. However, besides toxins, B. anthracis expresses effector proteins, whose role in pathogenesis are yet to be investigated. Here we present that suppressor-of-variegation, enhancer-of-zeste, trithorax protein from B. anthracis (BaSET) methylates human histone H1, resulting in repression of NF-kappa B functions. Notably, BaSET is secreted and undergoes nuclear translocation to enhance H1 methylation in B. anthracis-infected macrophages. Compared with wild type Sterne, delayed growth kinetics and altered septum formation were observed in the BaSET knock-out (Ba Delta SET) bacilli. Uncontrolled BaSET expression during complementation of the BaSET gene in Ba Delta SET partially restored growth during stationary phase but resulted in substantially shorter bacilli throughout the growth cycle. Importantly, in contrast to Sterne, the Ba Delta SET B. anthracis is avirulent in a lethal murine bacteremia model of infection. Collectively, BaSET is required for repression of host transcription as well as proper B. anthracis growth, making it a potentially unique virulence determinant.	[Mujtaba, Shiraz; Jaganathan, Anbalagan; Patel, Jigneshkumar; Gupta, Yogesh K.] Mt Sinai Sch Med, Dept Struct & Chem, New York, NY 10029 USA; [Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Biol, New York, NY 10029 USA; [Winer, Benjamin Y.; Schuch, Raymond; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10065 USA; [Sgobba, Miriam; Haider, Shozeb] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Queens University Belfast	Mujtaba, S (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem, New York, NY 10029 USA.	shiraz.mujtaba@mssm.edu; vaf@mail.rockefeller.edu	Gupta, Yogesh K/B-6949-2009; Haider, Shozeb M/B-3452-2015; Haider, Shozeb/Q-1599-2019; Gupta, Yogesh/AFH-5204-2022; Wang, Rong/A-8721-2009	Gupta, Yogesh K/0000-0001-6372-5007; Haider, Shozeb M/0000-0003-2650-2925; Haider, Shozeb/0000-0003-2650-2925; Gupta, Yogesh/0000-0001-6372-5007; Winer, Benjamin/0000-0001-7895-2544	National Institutes of Health [5R01AI057472, 5R01CA143662-02]; Centre for Cancer Research and Cell Biology startup funds; NATIONAL CANCER INSTITUTE [R01CA143662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Cancer Research and Cell Biology startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI057472 (USPHS; to V. A. F.) and 5R01CA143662-02 (to S. M.). This work was also supported by Centre for Cancer Research and Cell Biology startup funds (to S. H.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Venegas R, 2007, MOL BIOL EVOL, V24, P482, DOI 10.1093/molbev/msl184; Aravind L, 2003, CELL CYCLE, V2, P369, DOI 10.4161/cc.2.4.419; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Barua S, 2009, INFECT IMMUN, V77, P23, DOI 10.1128/IAI.00801-08; Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dodatko T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006398; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Fazzini MM, 2010, J BACTERIOL, V192, P4012, DOI 10.1128/JB.00197-10; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Giebel JD, 2009, J BACTERIOL, V191, P5569, DOI 10.1128/JB.00408-09; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Goodman RH, 2000, GENE DEV, V14, P1553; Gut IM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-46; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Ling BMT, 2012, MOL BIOL CELL, V23, P4778, DOI 10.1091/mbc.E12-04-0311; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McGillivray SM, 2009, J INNATE IMMUN, V1, P494, DOI 10.1159/000225955; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mogridge J, 2004, LANCET, V364, P393, DOI 10.1016/S0140-6736(04)16779-2; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Mujtaba S, 2011, METHODS, V53, P97, DOI 10.1016/j.ymeth.2010.09.001; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	59	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23458	23472		10.1074/jbc.M113.467696	http://dx.doi.org/10.1074/jbc.M113.467696			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23720780	Green Published, hybrid			2022-12-25	WOS:000330598200052
J	Ahmed, S; Wittenmayer, N; Kremer, T; Hoeber, J; Akula, AK; Urlaub, H; Islinger, M; Kirsch, J; Dean, C; Dresbach, T				Ahmed, Saheeb; Wittenmayer, Nina; Kremer, Thomas; Hoeber, Jan; Akula, Asha Kiran; Urlaub, Henning; Islinger, Markus; Kirsch, Joachim; Dean, Camin; Dresbach, Thomas			Mover Is a Homomeric Phospho-Protein Present on Synaptic Vesicles	PLOS ONE			English	Article							BASSOON; SYNAPSES; BRAIN; PHOSPHORYLATION; ASSOCIATION; EXOCYTOSIS; RELEASE	With remarkably few exceptions, the molecules mediating synaptic vesicle exocytosis at active zones are structurally and functionally conserved between vertebrates and invertebrates. Mover was found in a yeast-2-hybrid assay using the vertebrate-specific active zone scaffolding protein bassoon as a bait. Peptides of Mover have been reported in proteomics screens for self-interacting proteins, phosphorylated proteins, and synaptic vesicle proteins, respectively. Here, we tested the predictions arising from these screens. Using flotation assays, carbonate stripping of peripheral membrane proteins, mass spectrometry, immunogold labelling of purified synaptic vesicles, and immuno-organelle isolation, we found that Mover is indeed a peripheral synaptic vesicle membrane protein. In addition, by generating an antibody against phosphorylated Mover and Western blot analysis of fractionated rat brain, we found that Mover is a bona fide phosphoprotein. The localization of Mover to synaptic vesicles is phosphorylation dependent; treatment with a phosphatase caused Mover to dissociate from synaptic vesicles. A yeast-2-hybrid screen, co-immunoprecipitation and cell-based optical assays of homomerization revealed that Mover undergoes homophilic interaction, and regions within both the N- and C-terminus of the protein are required for this interaction. Deleting a region required for homomeric interaction abolished presynaptic targeting of recombinant Mover in cultured neurons. Together, these data prove that Mover is associated with synaptic vesicles, and implicate phosphorylation and multimerization in targeting of Mover to synaptic vesicles and presynaptic sites.	[Ahmed, Saheeb; Dean, Camin] European Neurosci Inst, Gottingen, Germany; [Wittenmayer, Nina; Hoeber, Jan; Akula, Asha Kiran; Dresbach, Thomas] Univ Goettingen, Med Sch Goettingen, Ctr Anat, Gottingen, Germany; [Kremer, Thomas; Kirsch, Joachim] Heidelberg Univ, Sch Med, Inst Anat & Cell Biol, Heidelberg, Germany; [Islinger, Markus] Heidelberg Univ, Med Fac Mannheim, Dept Neuroanat, Heidelberg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	University of Gottingen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society	Dean, C (corresponding author), European Neurosci Inst, Gottingen, Germany.	c.dean@eni-g.de; thomas.dresbach@med.uni-goettingen.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138; Hoeber, Jan/0000-0001-5602-0850	FRONTIER Innovation Fund from the University of Heidelberg; German Research Foundation/Deutsche Forschungsgemeinschaft (DFG) [DR 373/3-3]; Sofja Kovalevskaja grant from the Alexander von Humboldt Foundation; European Research Council (ERC) [FP7 260916]; DFG [DE 1951/1-1]; DFG via the Collaborative Research Center [889]; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)	FRONTIER Innovation Fund from the University of Heidelberg; German Research Foundation/Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sofja Kovalevskaja grant from the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); DFG via the Collaborative Research Center(German Research Foundation (DFG)); DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)(German Research Foundation (DFG))	This work was supported by a FRONTIER Innovation Fund from the University of Heidelberg, and by a German Research Foundation/Deutsche Forschungsgemeinschaft (DFG) grant (DR 373/3-3) to TD, a Sofja Kovalevskaja grant from the Alexander von Humboldt Foundation, European Research Council (ERC) starting grant (SytActivity FP7 260916), a DFG grant (DE 1951/1-1) to CD, and by the DFG via the Collaborative Research Center 889 and DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) to TD and CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Antonini D, 2008, J INVEST DERMATOL, V128, P1676, DOI 10.1038/jid.2008.12; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Burre J, 2006, ELECTROPHORESIS, V27, P3488, DOI 10.1002/elps.200500864; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Greengard P., 1987, Advances in Experimental Medicine and Biology, V221, P135; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jahn RM, 1988, A BENZON S, V25, P411; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Kremer T, 2007, FEBS LETT, V581, P4727, DOI 10.1016/j.febslet.2007.08.070; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang Thorsten, 2008, V184, P107; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Monaldi I, 2010, BIOCHEM J, V426, P55, DOI 10.1042/BJ20090762; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63474	10.1371/journal.pone.0063474	http://dx.doi.org/10.1371/journal.pone.0063474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723986	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000011
J	Futas, J; Horin, P				Futas, Jan; Horin, Petr			Natural Killer Cell Receptor Genes in the Family Equidae: Not only Ly49	PLOS ONE			English	Article							IG-LIKE RECEPTORS; CATTLE KIR GENES; EVOLUTION; HORSE; IDENTIFICATION; SEQUENCE; INNATE	Natural killer (NK) cells have important functions in immunity. NK recognition in mammals can be mediated through killer cell immunoglobulin-like receptors (KIR) and/or killer cell lectin-like Ly49 receptors. Genes encoding highly variable NK cell receptors (NKR) represent rapidly evolving genomic regions. No single conservative model of NKR genes was observed in mammals. Single-copy low polymorphic NKR genes present in one mammalian species may expand into highly polymorphic multigene families in other species. In contrast to other non-rodent mammals, multiple Ly49-like genes appear to exist in the horse, while no functional KIR genes were observed in this species. In this study, Ly49 and KIR were sought and their evolution was characterized in the entire family Equidae. Genomic sequences retrieved showed the presence of at least five highly conserved polymorphic Ly49 genes in horses, asses and zebras. These findings confirmed that the expansion of Ly49 occurred in the entire family. Several KIR-like sequences were also identified in the genome of Equids. Besides a previously identified non-functional KIR-Immunoglobulin-like transcript fusion gene (KIR-ILTA) and two putative pseudogenes, a KIR3DL-like sequence was analyzed. In contrast to previous observations made in the horse, the KIR3DL sequence, genomic organization and mRNA expression suggest that all Equids might produce a functional KIR receptor protein molecule with a single non-mutated immune tyrosine-based inhibition motif (ITIM) domain. No evidence for positive selection in the KIR3DL gene was found. Phylogenetic analysis including rhinoceros and tapir genomic DNA and deduced amino acid KIR-related sequences showed differences between families and even between species within the order Perissodactyla. The results suggest that the order Perissodactyla and its family Equidae with expanded Ly49 genes and with a potentially functional KIR gene may represent an interesting model for evolutionary biology of NKR genes.	[Futas, Jan; Horin, Petr] Univ Vet & Pharmaceut Sci Brno, Dept Anim Genet, Brno, Czech Republic; [Futas, Jan; Horin, Petr] Univ Vet & Pharmaceut Sci Brno, CEITEC VFU, Brno, Czech Republic	University of Veterinary Sciences Brno; University of Veterinary Sciences Brno	Horin, P (corresponding author), Univ Vet & Pharmaceut Sci Brno, Dept Anim Genet, Brno, Czech Republic.	horin@dior.ics.muni.cz	Horin, Petr/E-3907-2012	Futas, Jan/0000-0002-2847-879X	Czech National Science Foundation GA CR project [523/09/1972]; European Regional Development Fund [CZ.1.05/1.100/02.0068]	Czech National Science Foundation GA CR project; European Regional Development Fund(European Commission)	This work was supported by the Czech National Science Foundation GA CR project 523/09/1972 and by the project "CEITEC-Central European Institute of Technology'' (CZ.1.05/1.100/02.0068) from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Brinkmeyer-Langford CL, 2010, ANIM GENET, V41, P186, DOI 10.1111/j.1365-2052.2010.02137.x; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Dobromylskyj M, 2007, IMMUNOGENETICS, V59, P463, DOI 10.1007/s00251-007-0215-9; Dobromylskyj MJ, 2009, IMMUNOGENETICS, V61, P789, DOI 10.1007/s00251-009-0406-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gagnier L, 2003, IMMUNOGENETICS, V55, P109, DOI 10.1007/s00251-003-0558-9; Guethlein LA, 2002, J IMMUNOL, V169, P220, DOI 10.4049/jimmunol.169.1.220; Guethlein LA, 2007, IMMUNOGENETICS, V59, P517, DOI 10.1007/s00251-007-0214-x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammond JA, 2009, J IMMUNOL, V182, P3618, DOI 10.4049/jimmunol.0803026; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Hao L, 2004, IMMUNOGENETICS, V56, P343, DOI 10.1007/s00251-004-0703-0; Hogan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034291; Janova E, 2009, IMMUNOGENETICS, V61, P513, DOI 10.1007/s00251-009-0380-0; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mager DL, 2001, CURR BIOL, V11, P626, DOI 10.1016/S0960-9822(01)00148-8; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Nei M., 2000, MOL EVOLUTION PHYLOG; Nergadze SG, 2010, ANIM GENET, V41, P176, DOI 10.1111/j.1365-2052.2010.02130.x; Noronha LE, 2012, PLACENTA, V33, P379, DOI 10.1016/j.placenta.2012.01.018; Noronha LE, 2010, AM J REPROD IMMUNOL, V64, P231, DOI 10.1111/j.1600-0897.2010.00895.x; Oakenfull EA, 1998, J MOL EVOL, V47, P772, DOI 10.1007/PL00006436; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Price Samantha A., 2009, Zoosystematics and Evolution, V85, P277, DOI 10.1002/zoos.200900005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook JG, 2006, IMMUNOGENETICS, V58, P481, DOI 10.1007/s00251-006-0110-9; Takahashi T, 2004, EUR J IMMUNOL, V34, P773, DOI 10.1002/eji.200324695; Tallmadge RL, 2010, IMMUNOGENETICS, V62, P159, DOI 10.1007/s00251-009-0420-9; Tallmadge RL, 2005, IMMUNOGENETICS, V57, P763, DOI 10.1007/s00251-005-0034-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trifonov VA, 2012, CYTOGENET GENOME RES, V137, P208, DOI 10.1159/000339900; Vagnoni KE, 1996, AM J REPROD IMMUNOL, V36, P184, DOI 10.1111/j.1600-0897.1996.tb00160.x; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Westgaard IH, 1998, EUR J IMMUNOL, V28, P1839, DOI 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zizzadoro C, 2002, VET IMMUNOL IMMUNOP, V89, P99, DOI 10.1016/S0165-2427(02)00185-X	41	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64736	10.1371/journal.pone.0064736	http://dx.doi.org/10.1371/journal.pone.0064736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724088	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000089
J	Jin, Y; Tymen, SD; Chen, D; Fang, ZJ; Zhao, Y; Dragas, D; Dai, Y; Marucha, PT; Zhou, XF				Jin, Yi; Tymen, Stephanie D.; Chen, Dan; Fang, Zong Juan; Zhao, Yan; Dragas, Dragan; Dai, Yang; Marucha, Phillip T.; Zhou, Xiaofeng			MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; EXPRESSION; MIR-100; PLK1; CANCER; SKIN; PROLIFERATION; PATHOGENESIS; PROGRESSION	Recent studies suggest that microRNAs play important roles in dermal wound healing and microRNA deregulation has been linked with impaired wound repair. Here, using a mouse experimental wound healing model, we identified a panel of 63 differentially expressed microRNAs during dermal wound healing, including members of miR-99 family (miR-99a, miR-99b, miR-100). We further demonstrated that miR-99 family members regulate cell proliferation, cell migration, and AKT/mTOR signaling. Combined experimental and bioinformatics analyses revealed that miR-99 family members regulate AKT/mTOR signaling by targeting multiple genes, including known target genes (e.g., IGF1R, mTOR) and a new target (AKT1). The effects of miR-99 family members on the expression of IGF1R, mTOR and AKT1 were validated at both the mRNA and protein levels. Two adjacent miR-99 family targeting sites were identified in the 39-UTR of the AKT1 mRNA. The direct interaction of miR-100 with these targeting sites was confirmed using luciferase reporter assays. The microRNA-100-directed recruitment of AKT1 mRNA to the RNAi-induced silencing complex (RISC) was confirmed by a ribonucleoprotein-IP assay. In summary, we identified a panel of differentially expressed microRNAs which may play important roles in wound healing. We provide evidence that miR-99 family members contribute to wound healing by regulating the AKT/mTOR signaling.	[Jin, Yi; Chen, Dan; Dragas, Dragan; Zhou, Xiaofeng] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA; [Tymen, Stephanie D.; Fang, Zong Juan; Zhao, Yan; Marucha, Phillip T.; Zhou, Xiaofeng] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA; [Chen, Dan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Guangzhou 510275, Guangdong, Peoples R China; [Dai, Yang] Univ Illinois, Coll Engn, Dept Bioengn, Chicago, IL USA; [Dai, Yang; Zhou, Xiaofeng] Univ Illinois, UIC Canc Ctr, Chicago, IL USA; [Marucha, Phillip T.; Zhou, Xiaofeng] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, XF (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA.	marucha@uic.edu; xfzhou@uic.edu			National Institutes of Health (NIH) [CA139596, DE017686, GM078426]; University of Illinois at Chicago Centre for Clinical and Translational Science (UIC CCTS) [UL1RR029879]; NIH T32 training grant [DE018381]; NIH R25 grant [DE022675]; Research Open Access Publishing (ROAAP) fund of the University of Illinois at Chicago; NATIONAL CANCER INSTITUTE [R01CA139596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017686, T32DE018381, R25DE022675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078426] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago Centre for Clinical and Translational Science (UIC CCTS); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R25 grant; Research Open Access Publishing (ROAAP) fund of the University of Illinois at Chicago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) PHS grants (CA139596, DE017686, and GM078426), and supplementary funding from University of Illinois at Chicago Centre for Clinical and Translational Science (UIC CCTS)(UL1RR029879). Y.J. is supported by a NIH T32 training grant (DE018381). D.D. is supported in part by a NIH R25 grant (DE022675). The open access publication fee is supported by the Research Open Access Publishing (ROAAP) fund of the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertero T, 2011, FASEB J, V25, P3092, DOI 10.1096/fj.10-168401; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cheng J, 2010, TOHOKU J EXP MED, V221, P203, DOI 10.1620/tjem.221.203; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Emmerson E, 2012, J INVEST DERMATOL, V132, P2838, DOI 10.1038/jid.2012.228; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Feng B, 2012, CANCER LETT, V317, P184, DOI 10.1016/j.canlet.2011.11.024; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Jiang L, INT J CANC, V127, P505; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jin Y, 2012, METHOD MOL BIOL, V936, P117; Jin Y, 2011, J BIOL CHEM, V286, P40104, DOI 10.1074/jbc.C111.296707; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Kashiyama K, 2012, J INVEST DERMATOL, V132, P1597, DOI 10.1038/jid.2012.22; Kim YW, 2012, J GASTROEN HEPATOL, V27, P397, DOI 10.1111/j.1440-1746.2011.06873.x; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mihai C, 2012, AM J PHYSIOL-LUNG C, V302, pL287, DOI 10.1152/ajplung.00037.2011; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Petrelli A, 2012, ONCOGENE, V31, P4517, DOI 10.1038/onc.2011.631; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; Tymen SD, 2013, BRAIN BEHAV IMMUN, V28, P207, DOI 10.1016/j.bbi.2012.07.013; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	46	133	141	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64434	10.1371/journal.pone.0064434	http://dx.doi.org/10.1371/journal.pone.0064434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724047	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000056
J	Liao, WI; Sheu, WHH; Chang, WC; Hsu, CW; Chen, YL; Tsai, SH				Liao, Wen-I; Sheu, Wayne Huey-Herng; Chang, Wei-Chou; Hsu, Chin-Wang; Chen, Yu-Long; Tsai, Shih-Hung			An Elevated Gap between Admission and A(1C)-Derived Average Glucose Levels Is Associated with Adverse Outcomes in Diabetic Patients with Pyogenic Liver Abscess	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; GLYCEMIC CONTROL; KLEBSIELLA-PNEUMONIAE; STRESS-HYPERGLYCEMIA; HEAD-INJURY; A1C ASSAY; MELLITUS; SEPSIS; PROGNOSIS; INSULIN	Objectives: To assess whether chronic glycemic control and stress-induced hyperglycemia, determined by the gap between admission glucose levels and A(1C)-derived average glucose (ADAG) levels adversely affects outcomes in diabetic patients with pyogenic liver abscess (PLA). Methods: Clinical, laboratory, and multi-detector computed tomography (MDCT) findings of 329 PLA patients (2004-2010) were retrospectively reviewed. HbA(1C) levels were used to determine long-term glycemic control status, which were then converted to estimated average glucose values. For the gap between admission glucose levels and ADAG levels, we used receiver operating characteristic (ROC) curve to determine the optimal cut-off values predicting adverse outcomes. Univariate and multivariate logistic regressions were used to identify predictors of adverse outcomes. Results: Diabetic PLA patients with poorer glycemic control had significantly higher Klebsiella pneumoniae (KP) infection rates, lower albumin levels, and longer hospital stays than those with suboptimal and good glycemic control. The ROC curve showed that a glycemic gap of 72 mg/dL was the optimal cut-off value for predicting adverse outcomes and showed a 22.3% relative increase in adverse outcomes compared with a glycemic gap, 72 mg/dL. Multivariate analysis revealed that an elevated glycemic gap >= 72 mg/dL was important predictor of adverse outcomes. Conclusions: A glycemic gap >= 72 mg/dL, rather than admission hyperglycemia or chronic glycemic control, was significantly correlated with adverse outcomes in diabetic PLA patients. Poorer chronic glycemic control in diabetic PLA patients is associated with high incidence of KP infection, hypoalbuminemia and longer hospital stay.	[Liao, Wen-I; Chen, Yu-Long; Tsai, Shih-Hung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Sheu, Wayne Huey-Herng] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Chang, Wei-Chou] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Chin-Wang] Taipei Med Univ, Wan Fang Hosp, Dept Emergency & Crit Care Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Tsai, SH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan.	tsaishihung@yahoo.com.tw		Tsai, Shih-Hung/0000-0003-0215-3193	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan [TSGH-C101-063, TSGH-C102-060]; National Science Council, Taipei, Taiwan [NSC 101-2314-B-016-037]	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported in part by research grants from the Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (TSGH-C101-063, and TSGH-C102-060) and the National Science Council, Taipei, Taiwan (NSC 101-2314-B-016-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaif HS, 2011, RADIOLOGY, V260, P129, DOI 10.1148/radiol.11101876; Annuzzi G, 2004, ARTERIOSCL THROM VAS, V24, P2397, DOI 10.1161/01.ATV.0000146267.71816.30; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2011, CRIT CARE MED, V39, P105, DOI 10.1097/CCM.0b013e3181feb5ea; Fiaccadori E, 2001, KIDNEY INT, V59, P1510, DOI 10.1046/j.1523-1755.2001.0590041510.x; Foo NP, 2010, AM J GASTROENTEROL, V105, P328, DOI 10.1038/ajg.2009.586; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; GALLACHER SJ, 1995, DIABETIC MED, V12, P916, DOI 10.1111/j.1464-5491.1995.tb00396.x; Huang CW, 2008, EPILEPSY RES, V79, P71, DOI 10.1016/j.eplepsyres.2007.12.012; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Kavanagh BP, 2010, NEW ENGL J MED, V363, P2540, DOI 10.1056/NEJMcp1001115; Kim SB, 2007, J COMPUT ASSIST TOMO, V31, P59, DOI 10.1097/01.rct.0000224629.48068.69; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lamloum SM, 2009, MED PRIN PRACT, V18, P447, DOI 10.1159/000235893; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Li ZM, 2010, MED PRIN PRACT, V19, P17, DOI 10.1159/000252829; Lin JC, 2006, J CLIN ENDOCR METAB, V91, P3084, DOI 10.1210/jc.2005-2749; Lind M, 2012, DIABETOLOGIA, V55, P2946, DOI 10.1007/s00125-012-2681-3; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; MARGULIES DR, 1994, AM SURGEON, V60, P387; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Menchine MD, 2011, ACAD EMERG MED, V18, P326, DOI 10.1111/j.1553-2712.2011.01014.x; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; Rueda AM, 2010, J INFECTION, V60, P99, DOI 10.1016/j.jinf.2009.12.003; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Sato H, 2010, J CLIN ENDOCR METAB, V95, P4338, DOI 10.1210/jc.2010-0135; Schuetz P, 2012, AM J MED, V125, P670, DOI 10.1016/j.amjmed.2012.03.001; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Takahara M, 2010, DIABETES CARE, V33, P2538, DOI 10.2337/dc10-0939; Thomsen RW, 2007, CLIN INFECT DIS, V44, P1194, DOI 10.1086/513201; Tiruvoipati R, 2012, J CRIT CARE, V27, P153, DOI 10.1016/j.jcrc.2011.06.011; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; YANG CC, 1993, AM J GASTROENTEROL, V88, P1911; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176	43	32	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64476	10.1371/journal.pone.0064476	http://dx.doi.org/10.1371/journal.pone.0064476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724053	Green Submitted, gold, Green Published			2022-12-25	WOS:000319733000060
J	Czamara, D; Tiesler, CMT; Kohlbock, G; Berdel, D; Hoffmann, B; Bauer, CP; Koletzko, S; Schaaf, B; Lehmann, I; Herbarth, O; von Berg, A; Muller-Myhsok, B; Schulte-Korne, G; Heinrich, J				Czamara, Darina; Tiesler, Carla M. T.; Kohlboeck, Gabriele; Berdel, Dietrich; Hoffmann, Barbara; Bauer, Carl-Peter; Koletzko, Sibylle; Schaaf, Beate; Lehmann, Irina; Herbarth, Olf; von Berg, Andrea; Mueller-Myhsok, Bertram; Schulte-Koerne, Gerd; Heinrich, Joachim			Children with ADHD Symptoms Have a Higher Risk for Reading, Spelling and Math Difficulties in the GINIplus and LISAplus Cohort Studies	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; NORMATIVE DATA; DISABILITY; QUESTIONNAIRE; COMORBIDITY; DIAGNOSIS; STRENGTHS; ASSOCIATION; ELEMENTARY	Attention-deficit/hyperactivity disorder (ADHD) and dyslexia belong to the most common neuro-behavioral childhood disorders with prevalences of around 5% in school-aged children. It is estimated that 20-60% of individuals affected with ADHD also present with learning disorders. We investigated the comorbidity between ADHD symptoms and reading/spelling and math difficulties in two on-going population-based birth cohort studies. Children with ADHD symptoms were at significantly higher risk of also showing reading/spelling difficulties or disorder (Odds Ratio (OR) = 2.80, p = 6.59x10(-13)) as compared to children without ADHD symptoms. For math difficulties the association was similar (OR = 2.55, p = 3.63x10(-04)). Our results strengthen the hypothesis that ADHD and learning disorders are comorbid and share, at least partially, the same underlying process. Up to date, it is not clear, on which exact functional processes this comorbidity is based.	[Czamara, Darina; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Czamara, Darina; Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Tiesler, Carla M. T.; Kohlboeck, Gabriele; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Tiesler, Carla M. T.] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Berdel, Dietrich; von Berg, Andrea] Marien Hosp, Dept Pediat, Wesel, Germany; [Hoffmann, Barbara] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, D-40225 Dusseldorf, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Koletzko, Sibylle] Univ Munich, Dr von Hauner Childrens Hosp, Div Paediat Gastroenterol & Hepatol, Munich, Germany; [Lehmann, Irina] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Herbarth, Olf] Univ Leipzig, Fac Med Environm Med & Hyg, D-04109 Leipzig, Germany; [Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	Max Planck Society; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; St. Marien Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Munich	Heinrich, J (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	heinrich@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Schulte-Körne, Gerd/AAI-4828-2021	Heinrich, Joachim/0000-0002-9620-1629; Schulte-Körne, Gerd/0000-0002-9960-1572; Lehmann, Irina/0000-0001-8875-5587	Federal Ministry for Education, Science, Research and Technology [01 EE 9401-4]; Helmholtz Zentrum Munchen; Federal Ministry of Environment (IUF) [FKZ 20462296]; Federal Ministry of Environment (BMU) [FKZ 20462296]; Federal Ministry for Education, Science, Research, and Technology [01 EG 9705/2, 01EG9732]	Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munchen(Helmholtz Association); Federal Ministry of Environment (IUF); Federal Ministry of Environment (BMU); Federal Ministry for Education, Science, Research, and Technology	The GINI Intervention study was funded for 3 years by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EE 9401-4) and Helmholtz Zentrum Munchen, the 6 and 10 years follow-up of the GINIplus study was funded by Helmholtz Zentrum Munchen and, in addition, partly by the Federal Ministry of Environment (IUF, FKZ 20462296). The LISAplus study was funded by Helmholtz Zentrum Munchen, by grants of the Federal Ministry of Environment (BMU) (for IUF, FKZ 20462296), and Federal Ministry for Education, Science, Research, and Technology (No. 01 EG 9705/2 and 01EG9732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Gillberg C, 2004, EUR CHILD ADOLES PSY, V13, P80, DOI 10.1007/s00787-004-1008-4; Goodman R, 2003, INT REV PSYCHIATR, V15, P173, DOI 10.1080/0954026021000046137; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greven CU, 2012, J CHILD PSYCHOL PSYC, V53, P234, DOI 10.1111/j.1469-7610.2011.02445.x; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Kaufmann L, 2008, DEVELOPMENTAL SCI, V11, P692, DOI 10.1111/j.1467-7687.2008.00718.x; Langberg JM, 2010, PEDIATRICS, V126, pE1033, DOI 10.1542/peds.2010-1267; Lingineni RK, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-50; Monuteaux MC, 2005, J LEARN DISABIL-US, V38, P86, DOI 10.1177/00222194050380010701; Pliszka SR, 1998, J CLIN PSYCHIAT, V59, P50; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Romanos M, 2008, NERVENARZT, V79, P782, DOI 10.1007/s00115-008-2511-5; Rommelse NNJ, 2009, J ABNORM CHILD PSYCH, V37, P793, DOI 10.1007/s10802-009-9312-6; Ruckinger S, 2010, ENVIRON HEALTH PERSP, V118, P150, DOI 10.1289/ehp.0901209; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Sagiv SK, 2013, J ATTEN DISORD, V17, P47, DOI 10.1177/1087054711427563; Schneider H, 2006, PEDIATRICS, V117, pE601, DOI 10.1542/peds.2005-1308; SchulteKorne G, 1997, READ WRIT, V9, P55, DOI 10.1023/A:1007941403441; Shalev RS, 2004, J CHILD NEUROL, V19, P765, DOI 10.1177/08830738040190100601; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Tiesler CMT, 2011, ENVIRON RES, V111, P1173, DOI 10.1016/j.envres.2011.06.011; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-2002-6; Woerner W, 2002, Z KINDER JUG-PSYCH, V30, P105, DOI 10.1024//1422-4917.30.2.105; Zutavern A, 2006, PEDIATRICS, V117, P401, DOI 10.1542/peds.2004-2521	32	44	46	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63859	10.1371/journal.pone.0063859	http://dx.doi.org/10.1371/journal.pone.0063859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HH	23724008	Green Submitted, Green Published, gold			2022-12-25	WOS:000319738100014
J	Jaszai, J; Graupner, S; Tanaka, EM; Funk, RHW; Huttner, WB; Brand, M; Corbeil, D				Jaszai, Jozsef; Graupner, Sylvi; Tanaka, Elly M.; Funk, Richard H. W.; Huttner, Wieland B.; Brand, Michael; Corbeil, Denis			Spatial Distribution of Prominin-1 (CD133) - Positive Cells within Germinative Zones of the Vertebrate Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR MEMBRANE-PARTICLES; APICAL PLASMA-MEMBRANE; RNA-BINDING PROTEIN; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; SPINAL-CORD; PROGENITOR CELLS; ADULT NEUROGENESIS	Background: In mammals, embryonic neural progenitors as well as adult neural stem cells can be prospectively isolated based on the cell surface expression of prominin-1 (CD133), a plasma membrane glycoprotein. In contrast, characterization of neural progenitors in non-mammalian vertebrates endowed with significant constitutive neurogenesis and inherent self-repair ability is hampered by the lack of suitable cell surface markers. Here, we have investigated whether prominin-1-orthologues of the major non-mammalian vertebrate model organisms show any degree of conservation as for their association with neurogenic geminative zones within the central nervous system (CNS) as they do in mammals or associated with activated neural progenitors during provoked neurogenesis in the regenerating CNS. Methods: We have recently identified prominin-1 orthologues from zebrafish, axolotl and chicken. The spatial distribution of prominin-1-positive cells - in comparison to those of mice - was mapped in the intact brain in these organisms by non-radioactive in situ hybridization combined with detection of proliferating neural progenitors, marked either by proliferating cell nuclear antigen or 5-bromo-deoxyuridine. Furthermore, distribution of prominin-1 transcripts was investigated in the regenerating spinal cord of injured axolotl. Results: Remarkably, a conserved association of prominin-1 with germinative zones of the CNS was uncovered as manifested in a significant co-localization with cell proliferation markers during normal constitutive neurogenesis in all species investigated. Moreover, an enhanced expression of prominin-1 became evident associated with provoked, compensatory neurogenesis during the epimorphic regeneration of the axolotl spinal cord. Interestingly, significant prominin-1-expressing cell populations were also detected at distinct extraventricular (parenchymal) locations in the CNS of all vertebrate species being suggestive of further, non-neurogenic neural function(s). Conclusion/Interpretation: Collectively, our work provides the first data set describing a comparative analysis of prominin-1-positive progenitor cells across species establishing a framework for further functional characterization in the context of regeneration.	[Jaszai, Jozsef; Graupner, Sylvi; Corbeil, Denis] Tech Univ Dresden, Med Fac Carl Gustav Carus, Tissue Engn Labs BIOTEC, D-01062 Dresden, Germany; [Tanaka, Elly M.; Brand, Michael; Corbeil, Denis] Tech Univ Dresden, DFG Res Ctr, D-01062 Dresden, Germany; [Tanaka, Elly M.; Brand, Michael; Corbeil, Denis] Tech Univ Dresden, Cluster Excellence Regenerat Therapies Dresden CR, D-01062 Dresden, Germany; [Jaszai, Jozsef; Funk, Richard H. W.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Anat, D-01062 Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Jaszai, J (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Tissue Engn Labs BIOTEC, D-01062 Dresden, Germany.	jozsef.jaszai@tu-dresden.de; corbeil@biotec.tu-dresden.de	Tanaka, Elly M/F-8572-2010; Funk, Richard HW/I-1780-2013; Corbeil, Denis/AFL-1008-2022; Brand, Michael/A-5509-2010; Corbeil, Denis/L-2340-2019; Huttner, Wieland B./P-4080-2018	Brand, Michael/0000-0001-5711-6512; Corbeil, Denis/0000-0003-1181-3659; Tanaka, Elly/0000-0003-4240-2158	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG) [MeDDrive38, CO298/5-1, SFB655 A3, SFB655 A4, SFB655 A2, SFB655 B3]	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Intramural funds of the Medical Faculty of Technische Universitat Dresden and Deutsche Forschungsgemeinschaft (DFG) supported JJ (grants MeDDrive38 and CO298/5-1, respectively). The DFG supported MB (SFB655 A3), EMT (SFB655 A4), WBH (SFB655 A2; TRR83 #6) and DC (SFB655 B3; TRR83 # 6 and CO298/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Brand M, 2002, KEEPING RAISING ZEBR; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Enguita-German M, 2010, TUMOR BIOL, V31, P381, DOI 10.1007/s13277-010-0046-4; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Han Z, 2011, MOL VIS, V17, P1381; HOLTZER SYBIL W., 1956, J MORPH, V99, P1, DOI 10.1002/jmor.1050990102; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Huttner HB, 2012, EPILEPSY RES, V99, P101, DOI 10.1016/j.eplepsyres.2011.10.029; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jaszai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017590; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kirsche K., 1964, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V71, P505; Kirsche W, 1965, Ergeb Anat Entwicklungsgesch, V38, P143; Kirsche W., 1967, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V77, P313; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kunz G, 1971, Anat Anz, V129, P289; Ladewig J, 2011, PLOS ONE, V7; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; Lazzari M, 1997, J BRAIN RES, V38, P187; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lv SQ, 2012, MED SCI MONITOR, V18, pCS37, DOI 10.12659/MSM.882720; Marz M, 2010, DEV DYNAM, V239, P3336, DOI 10.1002/dvdy.22455; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; NORDLANDER RH, 1978, J COMP NEUROL, V180, P349, DOI 10.1002/cne.901800211; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; OHARA CM, 1994, TISSUE CELL, V26, P599, DOI 10.1016/0040-8166(94)90012-4; OHARA CM, 1992, DEV DYNAM, V193, P103, DOI 10.1002/aja.1001930202; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; RICHTER W, 1981, Z MIKROSK ANAT FORSC, V95, P883; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Scicolone G, 1995, INT J DEV NEUROSCI, V13, P845, DOI 10.1016/0736-5748(95)00069-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tator CH, 2002, INJURY PREV, V8, pIV33, DOI 10.1136/ip.8.suppl_4.iv33; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Voss SR, 2010, EMERGING MODEL ORGANISMS: LABORATORY MANUAL, VOL 2, P397, DOI 10.1101/pdb.emo128; Walder S, 2003, DEV GENES EVOL, V213, P625, DOI 10.1007/s00427-003-0364-2; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Westerfield M, 1994, ZEBRAFISH BOOK; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang F, 2003, DEV DYNAM, V226, P341, DOI 10.1002/dvdy.10230; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571	104	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63457	10.1371/journal.pone.0063457	http://dx.doi.org/10.1371/journal.pone.0063457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723983	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100010
J	Yassin, MA; Datiko, DG; Tulloch, O; Markos, P; Aschalew, M; Shargie, EB; Dangisso, MH; Komatsu, R; Sahu, S; Blok, L; Cuevas, LE; Theobald, S				Yassin, Mohammed A.; Datiko, Daniel G.; Tulloch, Olivia; Markos, Paulos; Aschalew, Melkamsew; Shargie, Estifanos B.; Dangisso, Mesay H.; Komatsu, Ryuichi; Sahu, Suvanand; Blok, Lucie; Cuevas, Luis E.; Theobald, Sally			Innovative Community-Based Approaches Doubled Tuberculosis Case Notification and Improve Treatment Outcome in Southern Ethiopia	PLOS ONE			English	Article							GENDER; DIAGNOSIS; WOMEN; DETERMINANTS; EXPERIENCES; DELAYS; TB	Background: TB Control Programmes rely on passive case-finding to detect cases. TB notification remains low in Ethiopia despite major expansion of health services. Poor rural communities face many barriers to service access. Methods and Findings: A community-based intervention package was implemented in Sidama zone, Ethiopia. The package included advocacy, training, engaging stakeholders and communities and active case-finding by female Health Extension Workers (HEWs) at village level. HEWs conducted house-to-house visits, identified individuals with a cough for two or more weeks, with or without other symptoms, collected sputum, prepared smears and supervised treatment. Supervisors transported smears for microscopy, started treatment, screened contacts and initiated Isoniazid preventive therapy (IPT) for children. Outcomes were compared with the pre-implementation period and a control zone. Qualitative research was conducted to understand community and provider perceptions and experiences. HEWs screened 49,857 symptomatic individuals (60% women) from October 2010 to December 2011. 2,262 (4.5%) had smear-positive TB (53% women). Case notification increased from 64 to 127/100,000 population/year resulting in 5,090 PTB+ and 7,071 cases of all forms of TB. Of 8,005 contacts visited, 1,949 were symptomatic, 1,290 symptomatic were tested and 69 diagnosed with TB. 1,080 children received IPT. Treatment success for smear-positive TB increased from 77% to 93% and treatment default decreased from 11% to 3%. Service users and providers found the intervention package highly acceptable. Conclusions: Community-based interventions made TB diagnostic and treatment services more accessible to the poor, women, elderly and children, doubling the notification rate and improving treatment outcome. This approach could improve TB diagnosis and treatment in other high burden settings.	[Yassin, Mohammed A.; Shargie, Estifanos B.; Komatsu, Ryuichi] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Yassin, Mohammed A.; Datiko, Daniel G.; Tulloch, Olivia; Cuevas, Luis E.; Theobald, Sally] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Datiko, Daniel G.; Markos, Paulos; Dangisso, Mesay H.] TB REACH Project, Hawassa, Ethiopia; [Aschalew, Melkamsew] Southern Reg Hlth Bur, Hawassa, Ethiopia; [Sahu, Suvanand] Stop TB Partnership, TB REACH, Geneva, Switzerland; [Blok, Lucie] Royal Trop Inst KIT, Amsterdam, Netherlands	Liverpool School of Tropical Medicine; University of Liverpool	Yassin, MA (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	mohammed.yassin@theglobalfund.org	Dangisso, Mesay Hailu/AAU-7743-2020; Datiko, Daniel G./AAE-6856-2020; Datiko, Daniel/AAE-7019-2020; Cuevas, Luis E/I-3697-2015	Datiko, Daniel/0000-0002-8556-3069; Cuevas, Luis E/0000-0002-6581-0587; Theobald, Sally/0000-0002-9053-211X; Yassin, Mohammed Ahmed/0000-0002-9766-2072	TB REACH Initiative of the Stop TB Partnership (through Canadian International Development Agency) [T9-370-114]	TB REACH Initiative of the Stop TB Partnership (through Canadian International Development Agency)	This project was supported by TB REACH Initiative of the Stop TB Partnership (through a grant from the Canadian International Development Agency,) contract number T9-370-114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Cuevas LE, 2011, PLOS ONE, V6, P1; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Federal Ministry of Health Ethiopia, 2007, HLTH EXT PROGR IMPL; Federal Ministry of Health of Ethiopia, 2012, GUID CLIN PROGR MAN; Ganapathy Sudha, 2008, Indian J Tuberc, V55, P9; Global Health Workforce Alliance, 2010, INT COMM HLTH WORK N; Harries AD, 2003, INT J TUBERC LUNG D, V7, P953; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Khan KB, 2012, HEALTH CARE WOMEN IN, V33, P3, DOI 10.1080/07399332.2011.610541; Long NH, 1999, INT J TUBERC LUNG D, V3, P388; Ponticiello A, 2002, Monaldi Arch Chest Dis, V57, P169; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ramsay A, 2010, INT J TUBERC LUNG D, V14, P165; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; VANDIJK JM, 1993, NETH J MED, V42, P12; Wares DF, 2000, INT J TUBERC LUNG D, V4, P920; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; WHO World Health Organization, GLOB TB REP 2010; Yassin MA, 2003, TROP MED INT HEALTH, V8, P927, DOI 10.1046/j.1365-3156.2003.01107.x; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	26	110	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63174	10.1371/journal.pone.0063174	http://dx.doi.org/10.1371/journal.pone.0063174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723975	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100006
J	Kelly, L; Bryan, K; Kim, SY; Janeway, KA; Killian, JK; Schildhaus, HU; Miettinen, M; Helman, L; Meltzer, PS; van de Rijn, M; Debiec-Rychter, M; O'Sullivan, M				Kelly, Lorna; Bryan, Kenneth; Kim, Su Young; Janeway, Katherine A.; Killian, J. Keith; Schildhaus, Hans-Ulrich; Miettinen, Markku; Helman, Lee; Meltzer, Paul S.; van de Rijn, Matt; Debiec-Rychter, Maria; O'Sullivan, Maureen		NIH Pediat Wild-type GIST Clin	Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST]	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILE; GENE-EXPRESSION; DOWN-REGULATION; KIT ACTIVATION; CARNEY TRIAD; WILD-TYPE; MUTATIONS; DISTINCT; ADULT; PROLIFERATION	In contrast to adult mutant gastrointestinal stromal tumors [GISTs], pediatric/wild-type GISTs remain poorly understood overall, given their lack of oncogenic activating tyrosine kinase mutations. These GISTs, with a predilection for gastric origin in female patients, show limited response to therapy with tyrosine kinase inhibitors and generally pursue a more indolent course, but still may prove fatal. Defective cellular respiration appears to underpin tumor development in these wild-type cases, which as a group lack expression of succinate dehydrogenase [SDH] B, a surrogate marker for respiratory chain metabolism. Yet, only a small subset of the wild-type tumors show mutations in the genes coding for the SDH subunits [SDHx]. To explore additional pathogenetic mechanisms in these wild-type GISTs, we elected to investigate post-transcriptional regulation of these tumors by conducting microRNA (miRNA) profiling of a mixed cohort of 73 cases including 18 gastric pediatric wild-type, 25 (20 gastric, 4 small bowel and 1 retroperitoneal) adult wild-type GISTs and 30 gastric adult mutant GISTs. By this approach we have identified distinct signatures for GIST subtypes which correlate tightly with clinico-pathological parameters. A cluster of miRNAs on 14q32 show strikingly different expression patterns amongst GISTs, a finding which appears to be explained at least in part by differential allelic methylation of this imprinted region. Small bowel and retroperitoneal wild-type GISTs segregate with adult mutant GISTs and express SDHB, while adult wildtype gastric GISTs are dispersed amongst adult mutant and pediatric wild-type cases, clustering in this situation on the basis of SDHB expression. Interestingly, global methylation analysis has recently similarly demonstrated that these wild-type, SDHB-immunonegative tumors show a distinct pattern compared with KIT and PDGFRA mutant tumors, which as a rule do express SDHB. All cases with Carney triad within our cohort cluster together tightly.	[Kelly, Lorna; O'Sullivan, Maureen] Trinity Coll Dublin, Sch Med, Dept Histopathol, Dublin, Ireland; [Kelly, Lorna; O'Sullivan, Maureen] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Bryan, Kenneth] TEAGASC, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Kim, Su Young; Killian, J. Keith; Miettinen, Markku; Helman, Lee; Meltzer, Paul S.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Janeway, Katherine A.] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Janeway, Katherine A.] Childrens Hosp, Boston, MA 02115 USA; [Schildhaus, Hans-Ulrich] Univ Cologne, Inst Pathol, Med Ctr, Cologne, Germany; [van de Rijn, Matt] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Debiec-Rychter, Maria] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Debiec-Rychter, Maria] Univ Hosp, Louvain, Belgium	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Teagasc; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; University of Cologne; Stanford University; Universite Catholique Louvain	O'Sullivan, M (corresponding author), Trinity Coll Dublin, Sch Med, Dept Histopathol, Dublin, Ireland.	maureen.osullivan@tcd.ie		van de Rijn, Matt/0000-0002-1909-9739; Bryan, Kenneth/0000-0002-9550-8354; Lodish, Maya/0000-0002-7701-9290; O'Sullivan, Maureen/0000-0001-5838-1609	Medical Research Charities Group; Health Research Board of Ireland; Children's Medical and Research Foundation; GIST Cancer Awareness Foundation [GCAF]; Life Raft Group; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0286.05 MD-R]; NATIONAL CANCER INSTITUTE [R01CA112270, ZIABC010759] Funding Source: NIH RePORTER	Medical Research Charities Group; Health Research Board of Ireland; Children's Medical and Research Foundation; GIST Cancer Awareness Foundation [GCAF]; Life Raft Group; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was obtained from the Medical Research Charities Group (http://www.mrcg.ie/) and Health Research Board of Ireland (http://www.hrb.ie) (MO'S), The Children's Medical and Research Foundation (http://www.cmrf.org) (MO'S), the GIST Cancer Awareness Foundation [GCAF] (http://www.gistawareness.org/)(MO'S), and research grants from the Life Raft Group (http://www.liferaftgroup.org/)(MD-R) and from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (http://www.fwo.be/)(grant # G.0286.05 MD-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez JA, 2011, BIOCHEM BIOPH RES CO, V409, P513, DOI 10.1016/j.bbrc.2011.05.036; Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; Allander SV, 2001, CANCER RES, V61, P8624; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Antonescu CR, 2004, CLIN CANCER RES, V10, P3282, DOI 10.1158/1078-0432.CCR-03-0715; Bao BL, 2010, J NUTR, V140, P1546, DOI 10.3945/jn.110.126359; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carney JA, 2002, AM J MED GENET, V108, P132, DOI 10.1002/ajmg.10235; CARNEY JA, 1977, NEW ENGL J MED, V296, P1517, DOI 10.1056/NEJM197706302962609; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Chen CF, 2011, MOL PHARMACOL, V79, P735, DOI 10.1124/mol.110.069633; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Choi HJ, 2010, INT J CANCER, V126, P1640, DOI 10.1002/ijc.24897; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Debiec-Rychter M, 2004, J PATHOL, V202, P430, DOI 10.1002/path.1546; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Dietz LG, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e46; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaal J, 2011, MODERN PATHOL, V24, P147, DOI 10.1038/modpathol.2010.185; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janeway KA, 2007, CANCER RES, V67, P9084, DOI 10.1158/0008-5472.CAN-07-1938; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2010, INT J CANCER, V127, P2718, DOI 10.1002/ijc.25247; Jia HY, 2012, INT J MOL SCI, V13, P8762, DOI 10.3390/ijms13078762; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kang HJ, 2005, ONCOGENE, V24, P1066, DOI 10.1038/sj.onc.1208358; Killian JK, 2013, CANC DISCOVERY; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Matyakhina L, 2007, J CLIN ENDOCR METAB, V92, P2938, DOI 10.1210/jc.2007-0797; McWhinney SR, 2007, NEW ENGL J MED, V357, P1054, DOI 10.1056/NEJMc071191; Miettinen M, 2013, AM J SURG PATHOL, V37, P234, DOI 10.1097/PAS.0b013e3182671178; Miettinen M, 2011, AM J SURG PATHOL, V35, P1712, DOI 10.1097/PAS.0b013e3182260752; Murphy SK, 2003, HUM MUTAT, V22, P92, DOI 10.1002/humu.10237; O'Sullivan MJ, 2009, PEDIATR SURG INT, V25, P841, DOI 10.1007/s00383-009-2477-9; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Oudijk L, 2013, MODERN PATHOL, V26, P456, DOI 10.1038/modpathol.2012.186; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Prakash S, 2005, J PEDIAT HEMATOL ONC, V27, P179, DOI 10.1097/01.mph.0000157790.81329.47; Rink L, 2009, CURR ONCOL REP, V11, P314, DOI 10.1007/s11912-009-0044-0; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Subramanian S, 2004, ONCOGENE, V23, P7780, DOI 10.1038/sj.onc.1208056; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	59	30	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64102	10.1371/journal.pone.0064102	http://dx.doi.org/10.1371/journal.pone.0064102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717541	gold, Green Published, Green Submitted			2022-12-25	WOS:000319385300026
J	Kim, SY; Park, MS; Kim, YS; Kim, SK; Chang, J; Yong, D; Kim, HS; Lee, K; Kang, YA				Kim, Song Yee; Park, Moo Suk; Kim, Young Sam; Kim, Se Kyu; Chang, Joon; Yong, Dongeun; Kim, Hyun Sook; Lee, Kyungwon; Kang, Young Ae			Tuberculin Skin Test and Boosted Reactions among Newly Employed Healthcare Workers: An Observational Study	PLOS ONE			English	Article							HIGH PREVALENCE; INFECTION; REACTIVITY; DIALYSIS; ADULTS; KOREA; ASSAY; RISK; BCG	Objective: To evaluate the prevalence of and factors associated with latent tuberculosis infection (LTBI) based on the tuberculin skin test (TST) and to estimate the boosted reaction rate among newly employed healthcare workers (HCWs). Design: Newly employed HCWs between January 2010 and July 2012 at Severance Hospital in South Korea were enrolled in this study. A one-step TST was conducted before October 2011, and a two-step TST after October 2011. Results: Of 2132 participants, 778 (36.5%) had positive TST results. Being older (odds ratio [OR] 1.10, 95% confidence interval [CI] 1.06-1.13, P<0.001), male (OR 1.78, 95% CI 1.21-2.62, P = 0.003), rejoining the hospital workforce (OR 1.58, 95% CI 1.04-2.40, P = 0.032), and having a previous history of tuberculosis (TB) (OR 18.21, 95% CI 2.15-154.10, P = 0.008) during the one-step period, and being older (OR 1.15, 95% CI 1.10-1.21, P<0.001) during the two-step period were significantly associated with a positive TST. A two-step TST was performed in 556 HCWs, and a boosted reaction was observed in 79 (14.2%). The induration size on the first TST (5-9-mm group) was the only factor associated with a boosted reaction on the second TST. Conclusions: The prevalence of LTBI based on the TST among newly employed HCWs was high. The boosted reaction rate on two-step TST was not low; therefore, the use of two-step TST may be necessary for regular monitoring in countries with an intermediate TB burden and a high rate of Bacillus Calmette-Guerin vaccination.	[Kim, Song Yee; Park, Moo Suk; Kim, Young Sam; Kim, Se Kyu; Chang, Joon; Kang, Young Ae] Yonsei Univ, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea; [Yong, Dongeun; Kim, Hyun Sook; Lee, Kyungwon] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, YA (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea.	mdkang@yuhs.ac	Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Chang, Joon/0000-0003-4542-6841; Lee, Kyungwon/0000-0003-3788-2134; Kim, Young Sam/0000-0001-9656-8482; Kim, Song Yee/0000-0001-8627-486X; dongeun, yong/0000-0002-1225-8477; Kang, Young Ae/0000-0002-7783-5271; Park, Moo Suk/0000-0003-0820-7615				Al Mazrou AM, 2004, INFECT CONT HOSP EP, V25, P1117, DOI 10.1086/502355; Altunoren O, 2012, RENAL FAILURE, V34, P304, DOI 10.3109/0886022X.2011.647299; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; [Anonymous], 1995, Wkly Epidemiol Rec, V70, P229; CAUTHEN CM, 1994, AM J RESP CRIT CARE, V149, P1597, DOI 10.1164/ajrccm.149.6.8004319; Christopoulos AI, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-36; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Frenzel EC, 2006, INFECT CONT HOSP EP, V27, P512, DOI 10.1086/503640; Hizel K, 2004, CLIN MICROBIOL INFEC, V10, P980, DOI 10.1111/j.1469-0691.2004.00970.x; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Jeon K, 2008, J KOREAN MED SCI, V23, P402, DOI 10.3346/jkms.2008.23.3.402; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Joint Committee for the Development of Korean Guidelines for Tuberculosis. Korea Centers for Disease Control and Prevention, 2011, KOR GUID TUB, V1st; Joos TJ, 2006, INT J TUBERC LUNG D, V10, P883; Kim SY, 2013, INFECTION, V41, P103, DOI 10.1007/s15010-012-0291-0; Lee K, 2009, INFECT CONT HOSP EP, V30, P1218, DOI 10.1086/648082; Lee KJ, 2010, SCAND J INFECT DIS, V42, P672, DOI 10.3109/00365548.2010.485575; Manuel O, 2007, AM J TRANSPLANT, V7, P2797, DOI 10.1111/j.1600-6143.2007.02011.x; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; MENZIES R, 1994, ANN INTERN MED, V120, P190, DOI 10.7326/0003-4819-120-3-199402010-00003; Park HY, 2010, SCAND J INFECT DIS, V42, P943, DOI 10.3109/00365548.2010.524658; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Salles CG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-38; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; WHO, 2011, WHO GLOBAL TUBERCULO	28	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64563	10.1371/journal.pone.0064563	http://dx.doi.org/10.1371/journal.pone.0064563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717631	Green Submitted, gold, Green Published			2022-12-25	WOS:000319385300015
J	Neal, RE; Rossmeisl, JH; Robertson, JL; Arena, CB; Davis, EM; Singh, RN; Stallings, J; Davalos, RV				Neal, Robert E., II; Rossmeisl, John H., Jr.; Robertson, John L.; Arena, Christopher B.; Davis, Erica M.; Singh, Ravi N.; Stallings, Jonathan; Davalos, Rafael V.			Improved Local and Systemic Anti-Tumor Efficacy for Irreversible Electroporation in Immunocompetent versus Immunodeficient Mice	PLOS ONE			English	Article							CD8 T-CELLS; DENDRITIC CELLS; IN-VIVO; IMMUNE-RESPONSE; GENE-THERAPY; PANCREATIC ADENOCARCINOMA; RADIOFREQUENCY ABLATION; APOPTOTIC CELLS; TUMOR ABLATION; BREAST-CANCER	Irreversible electroporation (IRE) is a non-thermal focal ablation technique that uses a series of brief but intense electric pulses delivered into a targeted region of tissue, killing the cells by irrecoverably disrupting cellular membrane integrity. This study investigates if there is an improved local anti-tumor response in immunocompetent (IC) BALB/c versus immunodeficient (ID) nude mice, including the potential for a systemic protective effect against rechallenge. Subcutaneous murine renal carcinoma tumors were treated with an IRE pulsing protocol that used 60% of the predicted voltage required to invoke complete regressions in the ID mice. Tumors were followed for 34 days following treatment for 11 treated mice from each strain, and 7 controls from each strain. Mouse survival based on tumor burden and the progression-free disease period was substantially longer in the treated IC mice relative to the treated ID mice and sham controls for both strains. Treated IC mice were rechallenged with the same cell line 18 days after treatment, where growth of the second tumors was shown to be significantly reduced or prevented entirely. There was robust CD3(+) cell infiltration in some treated BALB/C mice, with immunocytes focused at the transition between viable and dead tumor. There was no difference in the low immunocyte presence for untreated tumors, nude mice, and matrigel-only injections in both strains. These findings suggest IRE therapy may have greater therapeutic efficacy in immunocompetent patients than what has been suggested by immunodeficient models, and that IRE may invoke a systemic response beyond the targeted ablation region.	[Neal, Robert E., II] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Neal, Robert E., II; Arena, Christopher B.; Davalos, Rafael V.] Virginia Tech, Bioelectromech Syst Lab, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA USA; [Rossmeisl, John H., Jr.] Virginia Tech, Dept Small Anim Clin Sci, VA MD Reg Coll Vet Med, Blacksburg, VA USA; [Robertson, John L.; Davis, Erica M.] Virginia Tech, Ctr Comparat Oncol, VA MD Reg Coll Vet Med, Blacksburg, VA USA; [Singh, Ravi N.] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA; [Stallings, Jonathan] Virginia Tech, Dept Stat, Blacksburg, VA USA	Florey Institute of Neuroscience & Mental Health; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University	Neal, RE (corresponding author), Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia.	Robert.Neal@alfred.org.au	Rossmeisl, John H/Q-7119-2016; Singh, Ravi N/A-5740-2011	Rossmeisl, John H/0000-0003-1655-7076; Singh, Ravi N/0000-0003-0750-1804; Neal II, Robert/0000-0001-5828-6564; Stallrich, Jonathan/0000-0002-0180-9309	Coulter Foundation; Whitaker International Programs; Virginia Tech's Laboratory for Interdisciplinary Statistical Analysis; NSF CAREER Award [CBET-1055913]; NIH/NCI career development grant [K99CA154006]; NATIONAL CANCER INSTITUTE [R00CA154006, K99CA154006] Funding Source: NIH RePORTER	Coulter Foundation; Whitaker International Programs; Virginia Tech's Laboratory for Interdisciplinary Statistical Analysis; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH/NCI career development grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Coulter Foundation, Whitaker International Programs, Virginia Tech's Laboratory for Interdisciplinary Statistical Analysis, NSF CAREER Award CBET-1055913, and NIH/NCI career development grant K99CA154006. The Whitaker International Programs, Virginia Tech's Laboratory for Interdisciplinary Statistical Analysis, and K99CA154006 solely provided student and researcher support, while the other grants provided support for researchers and the expenses of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, TECHNOL CANCER RES T, V6, P301, DOI 10.1177/153303460700600406; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Andersen MH, 2003, SEMIN CANCER BIOL, V13, P449, DOI 10.1016/j.semcancer.2003.09.009; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Garcia PA, 2011, TECHNOL CANCER RES T, V10, P73, DOI 10.7785/tcrt.2012.500181; Gravante G, 2009, LIVER INT, V29, P18, DOI 10.1111/j.1478-3231.2008.01915.x; Heller L, 2000, MELANOMA RES, V10, P577, DOI 10.1097/00008390-200012000-00010; Henry F, 1999, CANCER RES, V59, P3329; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048749; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Martin RCG, 2012, J AM COLL SURGEONS, V215, P361, DOI 10.1016/j.jamcollsurg.2012.05.021; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Mir LM, 1999, ADV DRUG DELIVER REV, V35, P107, DOI 10.1016/S0169-409X(98)00066-0; MIR LM, 1995, J IMMUNOTHER, V17, P30, DOI 10.1097/00002371-199501000-00004; Mirza AN, 2001, CANCER J, V7, P95; Miyazaki S, 2003, SURG TODAY, V33, P39, DOI 10.1007/s005950300006; Narayanan G, 2012, J VASC INTERV RADIOL, V23, P1613, DOI 10.1016/j.jvir.2012.09.012; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; Neal RE, 2010, BREAST CANCER RES TR, V123, P295, DOI 10.1007/s10549-010-0803-5; Niu GL, 1999, CANCER RES, V59, P5059; Nuccitelli R, 2012, PIGM CELL MELANOMA R, V25, P618, DOI 10.1111/j.1755-148X.2012.01027.x; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Roux S, 2008, CANCER IMMUNOL IMMUN, V57, P1291, DOI 10.1007/s00262-008-0462-0; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sabel MS, 2009, CRYOBIOLOGY, V58, P1, DOI 10.1016/j.cryobiol.2008.10.126; Sabel MS, 2004, ANN SURG ONCOL, V11, P542, DOI 10.1245/ASO.2004.08.003; Saito K, 2011, HEAD NECK-J SCI SPEC, V33, P359, DOI 10.1002/hed.21456; SALUP RR, 1985, J UROLOGY, V134, P1236, DOI 10.1016/S0022-5347(17)47702-0; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Skinner MG, 1998, PHYS MED BIOL, V43, P3535, DOI 10.1088/0031-9155/43/12/011; Skoberne M, 2004, TRENDS MOL MED, V10, P251, DOI 10.1016/j.molmed.2004.04.001; SOANES WA, 1970, J UROLOGY, V104, P154, DOI 10.1016/S0022-5347(17)61690-2; TANAKA S, 1982, CRYOBIOLOGY, V19, P247, DOI 10.1016/0011-2240(82)90151-1; Thakur A, 2011, J IMMUNOTHER, V34, P457, DOI 10.1097/CJI.0b013e31821dcba5; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Yamashita Y, 2001, CANCER RES, V61, P1005; Zhou W, 2012, J CANCER RES THER, V8, P80, DOI 10.4103/0973-1482.95179	52	55	75	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64559	10.1371/journal.pone.0064559	http://dx.doi.org/10.1371/journal.pone.0064559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717630	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300016
J	Adams, MJ; Miller, DAW; Muths, E; Corn, PS; Grant, EHC; Bailey, LL; Fellers, GM; Fisher, RN; Sadinski, WJ; Waddle, H; Walls, SC				Adams, Michael J.; Miller, David A. W.; Muths, Erin; Corn, Paul Stephen; Grant, Evan H. Campbell; Bailey, Larissa L.; Fellers, Gary M.; Fisher, Robert N.; Sadinski, Walter J.; Waddle, Hardin; Walls, Susan C.			Trends in Amphibian Occupancy in the United States	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; CHYTRID FUNGUS; EXTINCTION; DECLINE; CALIFORNIA; PATHOGEN; ECOLOGY	Though a third of amphibian species worldwide are thought to be imperiled, existing assessments simply categorize extinction risk, providing little information on the rate of population losses. We conducted the first analysis of the rate of change in the probability that amphibians occupy ponds and other comparable habitat features across the United States. We found that overall occupancy by amphibians declined 3.7% annually from 2002 to 2011. Species that are Red-listed by the International Union for Conservation of Nature (IUCN) declined an average of 11.6% annually. All subsets of data examined had a declining trend including species in the IUCN Least Concern category. This analysis suggests that amphibian declines may be more widespread and severe than previously realized.	[Adams, Michael J.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Miller, David A. W.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Miller, David A. W.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Muths, Erin] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Corn, Paul Stephen] US Geol Survey, Northern Rocky Mt Sci Ctr, Missoula, MT USA; [Grant, Evan H. Campbell] US Geol Survey, Patuxent Wildlife Res Ctr, Turners Falls, MA USA; [Bailey, Larissa L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Fellers, Gary M.] US Geol Survey, Western Ecol Res Ctr, Point Reyes Stn, CA USA; [Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Sadinski, Walter J.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA; [Waddle, Hardin] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA USA; [Walls, Susan C.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Adams, MJ (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA.	mjadams@usgs.gov	Bailey, Larissa/ABH-3513-2020; Fisher, Robert/AAA-7301-2022; Bailey, Larissa/A-2565-2009; Grant, Evan/N-5160-2014; Waddle, Hardin/D-3845-2009; Miller, David AW/E-4492-2012	Fisher, Robert/0000-0002-2956-3240; Grant, Evan/0000-0003-4401-6496; Waddle, Hardin/0000-0003-1940-2133; Miller, David AW/0000-0002-3011-3677; Walls, Susan/0000-0001-7391-9155				Adams MJ, 2011, J WILDLIFE MANAGE, V75, P30, DOI 10.1002/jwmg.29; Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Alford RA, 2001, NATURE, V412, P499, DOI 10.1038/35087658; Bates D., 2010, LME4 LINEAR MIXED EF; Bradford DF, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P915; Collins J.P., 2009, EXTINCTION OUR TIMES; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; Corn P.S., 1989, ACID PRECIPITATION S; Corn Paul Stephen, 2005, Alytes (Paris), V22, P65; FELLERS GM, 1993, BIOL CONSERV, V65, P177, DOI 10.1016/0006-3207(93)90447-9; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Gould WR, 2012, WETLANDS, V32, P379, DOI 10.1007/s13157-012-0273-0; Green David M., 1997, Herpetological Conservation, V1, P291; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Hines, 2017, OCCUPANCY ESTIMATION; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; Miller DAW, 2012, J ANIMAL ECOLOGY; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; R Development Core Team, 2008, R LANG ENV STAT COMP; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thompson W.L., 1998, MONITORING VERTEBRAT; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Walls SC, 2011, J WILDLIFE MANAGE, V75, P751, DOI 10.1002/jwmg.97	32	149	158	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64347	10.1371/journal.pone.0064347	http://dx.doi.org/10.1371/journal.pone.0064347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717602	Green Submitted, gold, Green Published			2022-12-25	WOS:000320362700142
J	Clancy, KBH; Baerwald, AR; Pierson, RA				Clancy, Kathryn B. H.; Baerwald, Angela R.; Pierson, Roger A.			Systemic Inflammation Is Associated with Ovarian Follicular Dynamics during the Human Menstrual Cycle	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ORAL-CONTRACEPTIVE USE; ESTROUS-CYCLE; WEIGHT-LOSS; WAVES; HORMONE; INTERLEUKIN-6; OVULATION; ADULTS; PREDICTORS	Background: Ovarian processes and the timing pathology. Multiple waves of antral follicular development have been documented during the menstrual cycle in women. However, the mechanisms underlying the development of follicular waves and their clinical significance are not fully understood. The objective of this study was to examine the relationship between C-reactive protein (CRP) and follicular waves in healthy women. We wanted to determine whether follicular wave dynamics influence systemic inflammation, as ovarian activity increases local inflammatory processes and blood flow. We tested the hypothesis that women with 3 follicular waves would have higher CRP concentrations than those with 2 waves. We further hypothesized that a greater number of major waves (those with a dominant follicle) would be positively associated with CRP. Methods/Principal Findings: Thirty-nine healthy women underwent daily transvaginal ultrasound examinations for one interovulatory interval, as part of an earlier study. Serum was collected every 3 days during the interovulatory interval (IOI). Enzyme-linked immunosorbent assays were conducted to quantify serum CRP concentrations. Women with 3 waves had higher average log CRP concentrations (n=14, -0.43 +/- 0.35) over the IOI than those with 2 waves (n=25, -0.82 +/- 0.47, p=02). Average log CRP concentrations were greater in women with 3 (0.30 +/- 0.31) versus 1 (-0.71 +/- 0.55) or 2 (-0.91 +/- 0.47) major waves (p=0.03). Greater average CRP over the IOI was attributed to greater CRP in the follicular, but not the luteal phase, of the IOI. Conclusions/Significance: A greater number of total antral follicular waves, in particular major waves, corresponded to greater serum concentrations of CRP. These findings suggest that women with a greater number of follicular waves exhibit greater tissue remodeling and therefore greater local and systemic inflammation.	[Clancy, Kathryn B. H.] Univ Illinois, Dept Anthropol, Lab Evolutionary Endocrinol, Urbana, IL 61801 USA; [Baerwald, Angela R.; Pierson, Roger A.] Univ Saskatchewan, Dept Obstet Gynecol & Reprod Sci, Saskatoon, SK, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of Saskatchewan	Clancy, KBH (corresponding author), Univ Illinois, Dept Anthropol, Lab Evolutionary Endocrinol, Urbana, IL 61801 USA.	kclancy@illinois.edu	; Stefanadis, Christodoulos/ABH-2232-2020	Pierson, Roger/0000-0003-4435-0515; Stefanadis, Christodoulos/0000-0001-5974-6454	Canadian Institutes for Health Research; University of Illinois Campus Research Board	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Illinois Campus Research Board	The original research from which this study developed was completed with the support of an operating grant from the Canadian Institutes for Health Research (RAP). The secondary research was supported with a grant from the University of Illinois Campus Research Board (KBHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G, 2006, ULTRASONOGRAPHIC CHA; ADAMS GP, 1990, J REPROD FERTIL, V90, P535, DOI 10.1530/jrf.0.0900535; Adams GP, 2011, RANGIFER, V17, P119; Almagor M, 2004, HUM REPROD, V19, P104, DOI 10.1093/humrep/deh036; ALPIZAR E, 1994, BIOL REPROD, V50, P38, DOI 10.1095/biolreprod50.1.38; Asher GW, 1997, J REPROD FERTIL, V111, P91, DOI 10.1530/jrf.0.1110091; Baerwald AR, 2004, CONTRACEPTION, V70, P371, DOI 10.1016/j.contraception.2004.05.006; Baerwald AR, 2003, FERTIL STERIL, V80, P116, DOI 10.1016/S0015-0282(03)00544-2; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; Bentov Y, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2009.12.033; Bishop CV, 2009, AM J PRIMATOL, V71, P384, DOI 10.1002/ajp.20664; BLOCK E, 1951, ACTA ENDOCRINOL-COP, V8, P33, DOI 10.1530/acta.0.0080033; Boggess KA, 2005, AM J PERINAT, V22, P299, DOI 10.1055/s-2005-872045; Bole Jr G, 2005, ARTHRITIS RHEUMATISM, V14, P239; Burger H, 2012, MAJOR FOLLICLE WAVE; Chenillot O, 2000, CLIN CHEM LAB MED, V38, P1003, DOI 10.1515/CCLM.2000.149; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Clancy KBH, 2012, BUILDING BABIES PRIM; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Dervain I, 1980, ETUDE ECHOGRAPHIQUE; Doring A, 2004, ATHEROSCLEROSIS, V172, P281, DOI 10.1016/j.atherosclerosis.2003.10.005; Dreon DM, 2003, LIFE SCI, V73, P1245, DOI 10.1016/S0024-3205(03)00425-9; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; ESPEY LL, 1980, BIOL REPROD, V22, P73, DOI 10.1095/biolreprod22.1.73; Evans ACO, 2000, THERIOGENOLOGY, V53, P699, DOI 10.1016/S0093-691X(99)00268-X; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Frohlich M, 1999, FIBRINOLYSIS PROTEOL, V13, P239, DOI 10.1054/fipr.1999.0037; Gaskins AJ, 2012, AM J EPIDEMIOL, V175, P423, DOI 10.1093/aje/kwr343; GINTHER OJ, 1995, THERIOGENOLOGY, V43, P689, DOI 10.1016/0093-691X(94)00074-5; GINTHER OJ, 1993, J EQUINE VET SCI, V13, P18, DOI 10.1016/S0737-0806(07)80012-8; GINTHER OJ, 1989, ANIM REPROD SCI, V20, P187, DOI 10.1016/0378-4320(89)90084-5; Guzelmeric K, 2007, GYNECOL ENDOCRINOL, V23, P505, DOI 10.1080/09513590701554306; HACKELOER BJ, 1979, AM J OBSTET GYNECOL, V135, P122; Heilbronn LK, 2001, ARTERIOSCL THROM VAS, V21, P968, DOI 10.1161/01.ATV.21.6.968; Hutchinson WL, 2000, CLIN CHEM, V46, P934; Jilma B, 1997, J LAB CLIN MED, V130, P69, DOI 10.1016/S0022-2143(97)90060-3; Kluft C, 2002, VASC PHARMACOL, V39, P149, DOI 10.1016/S1537-1891(02)00304-X; Kuzawa CW, 2009, P ROYAL SOC B; Lipson SF, 1996, HUM REPROD, V11, P2090; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; McCorkell R, 2006, THERIOGENOLOGY, V65, P540, DOI 10.1016/j.theriogenology.2005.05.049; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; McDade TW, 2009, AM J CLIN NUTR, V89, P1237, DOI 10.3945/ajcn.2008.27080; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Noyes N, 2001, FERTIL STERIL, V76, P92, DOI 10.1016/S0015-0282(01)01823-4; Or Y, 2013, FERTIL STER IN PRESS; Orvieto R, 2004, HUM REPROD, V19, P357, DOI 10.1093/humrep/deh089; PIERSON RA, 1987, ANIM REPROD SCI, V14, P219, DOI 10.1016/0378-4320(87)90085-6; PIERSON RA, 1988, THERIOGENOLOGY, V29, P21, DOI 10.1016/0093-691X(88)90029-5; PIERSON RA, 1987, ANIM REPROD SCI, V14, P165, DOI 10.1016/0378-4320(87)90080-7; Rezaei E, 2009, ULTRASONOGRAPHIC IMA; Rutherford JN, 2010, AM J HUM BIOL, V22, P310, DOI 10.1002/ajhb.20986; Sacks GP, 2004, HUM REPROD, V19, P1025, DOI 10.1093/humrep/deh179; Salmassi A, 2001, J ENDOCRINOL, V170, P471, DOI 10.1677/joe.0.1700471; SIROIS J, 1988, BIOL REPROD, V39, P308, DOI 10.1095/biolreprod39.2.308; Sirois J., 2010, EQUINE VET J S, V21, P43, DOI [10.1111/j.2042-3306.1989.tb04672.x, DOI 10.1111/J.2042-3306.1989.TB04672.X)]; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Taneja M, 1996, THERIOGENOLOGY, V46, P121, DOI 10.1016/0093-691X(96)00147-1; Thorand B, 2006, ATHEROSCLEROSIS, V184, P216, DOI 10.1016/j.atherosclerosis.2005.04.011; Van der Hoek KH, 1998, BIOL REPROD, V58, P1266, DOI 10.1095/biolreprod58.5.1266; van Rooijen M, 2006, J THROMB HAEMOST, V4, P77, DOI 10.1111/j.1538-7836.2005.01690.x; Vanden Brink H, 2011, MENOPAUSE, V18, P1377; Vanden Brink H, 2013, MENOPAUSE IN PRESS; Vaughan JL, 2004, ANIM REPROD SCI, V80, P353, DOI 10.1016/j.anireprosci.2003.08.002; Vinatier D, 1995, EUR J OBSTET GYN R B, V63, P155, DOI 10.1016/0301-2115(95)02227-9; Wander K, 2008, AM J PHYS ANTHROPOL, V136, P138, DOI 10.1002/ajpa.20785; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Williams MJA, 2004, INT J OBESITY, V28, P998, DOI 10.1038/sj.ijo.0802713; Wunder DM, 2006, EUR J ENDOCRINOL, V155, P137, DOI 10.1530/eje.1.02178; Ziomkiewicz A, AM J HUMAN BIOL	72	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64807	10.1371/journal.pone.0064807	http://dx.doi.org/10.1371/journal.pone.0064807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717660	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700172
J	Cutler, PJ; Malik, MD; Liu, S; Byars, JM; Lidke, DS; Lidke, KA				Cutler, Patrick J.; Malik, Michael D.; Liu, Sheng; Byars, Jason M.; Lidke, Diane S.; Lidke, Keith A.			Multi-Color Quantum Dot Tracking Using a High-Speed Hyperspectral Line-Scanning Microscope	PLOS ONE			English	Article							FC-EPSILON-RI; SINGLE-PARTICLE TRACKING; SUPERRESOLUTION MICROSCOPY; IGE RECEPTOR; LOCALIZATION; BLINKING; PROTEIN; SCMOS; SHIFT; FRET	Many cellular signaling processes are initiated by dimerization or oligomerization of membrane proteins. However, since the spatial scale of these interactions is below the diffraction limit of the light microscope, the dynamics of these interactions have been difficult to study on living cells. We have developed a novel high-speed hyperspectral microscope (HSM) to perform single particle tracking of up to 8 spectrally distinct species of quantum dots (QDs) at 27 frames per second. The distinct emission spectra of the QDs allows localization with similar to 10 nm precision even when the probes are clustered at spatial scales below the diffraction limit. The capabilities of the HSM are demonstrated here by application of multi-color single particle tracking to observe membrane protein behavior, including: 1) dynamic formation and dissociation of Epidermal Growth Factor Receptor dimers; 2) resolving antigen induced aggregation of the high affinity IgE receptor, Fc epsilon R1; 3) four color QD tracking while simultaneously visualizing GFP-actin; and 4) high-density tracking for fast diffusion mapping.	[Malik, Michael D.; Liu, Sheng; Byars, Jason M.; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Cutler, Patrick J.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Cutler, Patrick J.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	klidke@unm.edu			NIH [R21RR024438]; INCBN IGERT Fellowships [DGE-0549500]; New Mexico Spatiotemporal Modeling Center NIH [P50GM085273, R01GM100114]; NSF CAREER [MCB-0845062]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, R01GM100114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INCBN IGERT Fellowships(National Science Foundation (NSF)); New Mexico Spatiotemporal Modeling Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The development of the instrument was funded by NIH R21RR024438 (K.A.L). M.D.M and P.J.C were additionally supported by INCBN IGERT Fellowships (DGE-0549500). Additional support provided by the New Mexico Spatiotemporal Modeling Center NIH P50GM085273 (P.J.C., S.L., J.M.B., K.A.L., D.S.L.), R01GM100114 (D.S.L) and NSF CAREER MCB-0845062 (D.S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Arnspang EC, PLOS ONE; Balkay L, 1997, CYTOMETRY, V28, P42, DOI 10.1002/(SICI)1097-0320(19970501)28:1<42::AID-CYTO5>3.0.CO;2-J; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; Elliott AD, 2012, J CELL SCI; Esposito A, 2011, OPT EXPRESS, V19, P1020, DOI [10.1002/cphc.201000833.16, DOI 10.1002/CPHC.201000833.16]; Haaland DM, 2009, APPL SPECTROSC, V63, P271, DOI 10.1366/000370209787598843; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hoyer P, 2011, NANO LETT, V11, P245, DOI 10.1021/nl103639f; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Huang ZL, 2011, OPT EXPRESS, V19, P19156, DOI 10.1364/OE.19.019156; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jones HDT, 2012, CHEMOMETRICS INTELLI, P1; Jones M, 2003, J PHYS CHEM B, V107, P11346, DOI 10.1021/jp035598m; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lee SF, 2009, CHEMPHYSCHEM, V10, P2174, DOI 10.1002/cphc.200900200; Lerner JM, 2006, CYTOM PART A, V69A, P712, DOI 10.1002/cyto.a.20242; Lidke DS, 2012, J CELL SCI, V125, P2571, DOI 10.1242/jcs.090027; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; LIU FT, 1980, J IMMUNOL, V124, P2728; Long F, 2012, OPT EXPRESS, V20, P17741, DOI 10.1364/OE.20.017741; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marchuk K, 2012, J AM CHEM SOC, V134, P6108, DOI 10.1021/ja301332t; Milles S, 2012, MOL BIOSYST, V8, P2531, DOI 10.1039/c2mb25135c; Mittal R, 2011, BIOCONJUGATE CHEM, V22, P362, DOI 10.1021/bc100321c; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Ow H, 2005, NANO LETT, V5, P113, DOI [10.1021/nl0482478, 10.1012/nl0482478]; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; SEAGRAVE J, 1991, J CELL PHYSIOL, V148, P139, DOI 10.1002/jcp.1041480117; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Sinclair MB, 2004, APPL OPTICS, V43, P2079, DOI 10.1364/AO.43.002079; Sinclair MB, 2006, APPL OPTICS, V45, P6283, DOI 10.1364/AO.45.006283; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; STUMP RF, 1989, AM J ANAT, V185, P128, DOI 10.1002/aja.1001850206; van Vliet LJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P109; Veatch SL, 2012, J PHYS CHEM B, V116, P6923, DOI 10.1021/jp300197p; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Warren DW, 1997, OPT ENG, V36, P1174, DOI 10.1117/1.601237; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yao J, 2005, P NATL ACAD SCI USA, V102, P14284, DOI 10.1073/pnas.0506523102; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819	55	76	80	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64320	10.1371/journal.pone.0064320	http://dx.doi.org/10.1371/journal.pone.0064320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717596	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700137
J	Dowd, JB; Palermo, T; Brite, J; McDade, TW; Aiello, A				Dowd, Jennifer Beam; Palermo, Tia; Brite, Jennifer; McDade, Thomas W.; Aiello, Allison			Seroprevalence of Epstein-Barr Virus Infection in US Children Ages 6-19, 2003-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNITED-STATES; SOCIAL-STATUS; SUSCEPTIBILITY; PREVALENCE; RISK; MONONUCLEOSIS; INFLAMMATION; ANTIBODIES; PATTERNS	Background: Epstein-Barr virus (EBV) is a common herpesvirus linked to infectious mononucleosis and multiple cancers. There are no national estimates of EBV seroprevalence in the United States. Our objective was to estimate the overall prevalence and sociodemographic predictors of EBV among U.S. children and adolescents aged 6-19. Methods: We calculated prevalence estimates and prevalence ratios for EBV seroprevalence using data from the 2003-2010 U.S. National Health and Nutrition Examination Survey (NHANES) for children aged 6-19 (n = 8417). Poisson regression was used to calculate multivariable-adjusted prevalence ratios across subgroup categories (sex, race/ethnicity, parental education, household income, household size, foreign-born, BMI, and household smoking). Findings: Overall EBV seroprevalence was 66.5% (95% CI 64.3%-68.7%.). Seroprevalence increased with age, ranging from 54.1% (95% CI 50.2%-57.9%) for 6-8 year olds to 82.9% (95% CI 80.0%-85.9%) for 18-19 year olds. Females had slightly higher seroprevalence (68.9%, 95% CI 66.3%-71.6%) compared to males (64.2%, 95% CI 61.7%-66.8%). Seroprevalence was substantially higher for Mexican-Americans (85.4%, 95% CI 83.1%-87.8%) and Non-Hispanic Blacks (83.1%, 95% CI 81.1%-85.1%) than Non-Hispanic Whites (56.9%, 95% CI 54.1%-59.8%). Large differences were also seen by family income, with children in the lowest income quartile having 81.0% (95% CI 77.6%-84.5%) seroprevalence compared to 53.9% (95% CI 50.5%-57.3%) in the highest income quartile, with similar results for parental education level. These results were not explained by household size, BMI, or parental smoking. Among those who were seropositive, EBV antibody titers were significantly higher for females, Non-Hispanic Blacks and Mexican-Americans, with no association found for socioeconomic factors. Conclusions: In the first nationally representative U.S. estimates, we found substantial socioeconomic and race/ethnic differences in the seroprevalence of EBV across all ages for U.S. children and adolescents. These estimates can help researchers and clinicians identify groups most at risk, inform research on EBV-cancer etiology, and motivate potential vaccine development.	[Dowd, Jennifer Beam] CUNY Sch Publ Hlth, CUNY Hunter Coll, New York, NY USA; [Dowd, Jennifer Beam; Brite, Jennifer] CIDR, New York, NY 10021 USA; [Palermo, Tia] SUNY Stony Brook, Dept Prevent Med, Grad Program Publ Hlth, Stony Brook, NY 11794 USA; [Brite, Jennifer] CUNY Grad Ctr, New York, NY USA; [McDade, Thomas W.] Northwestern Univ, Inst Policy Res, Ctr Social Dispar & Hlth, Cells Soc C2S, Evanston, IL USA; [McDade, Thomas W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Aiello, Allison] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	City University of New York (CUNY) System; Hunter College (CUNY); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Northwestern University; Northwestern University; University of Michigan System; University of Michigan	Dowd, JB (corresponding author), CUNY Sch Publ Hlth, CUNY Hunter Coll, New York, NY USA.	jdowd@hunter.cuny.edu	Palermo, Tia/ABI-8328-2020; Dowd, Jennifer B/C-1127-2012	Dowd, Jennifer B/0000-0003-2006-5656				Bagni R, 2012, J INFECT DIS, V205, P873, DOI 10.1093/infdis/jir871; Binkley PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054008; Centers for Disease Control and Prevention (CDC), 2002, NAT CTR HLTH STAT NH; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Cohen S, 2005, INT J BEHAV MED, V12, P123, DOI 10.1207/s15327558ijbm1203_1; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cohen S, 2008, HEALTH PSYCHOL, V27, P268, DOI 10.1037/0278-6133.27.2.268; de-The G, 1975, IARC Sci Publ, P3; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Evans P, 2000, BRAIN BEHAV IMMUN, V14, P41, DOI 10.1006/brbi.1999.0571; Evens AM, 2012, ANN ONCOL, V23, P2128, DOI 10.1093/annonc/mdr578; Haeri S, 2010, AM J PERINAT, V27, P715, DOI 10.1055/s-0030-1253098; HALLEE TJ, 1974, YALE J BIOL MED, V47, P182; HENLE G, 1968, P NATL ACAD SCI USA, V59, P94, DOI 10.1073/pnas.59.1.94; HENLE W, 1970, J NATL CANCER I, V44, P225; Henle W, 1976, Adv Pathobiol, P5; Hildesheim A, 2012, AM J EPIDEMIOLOGY; Hjalgrim H, 2007, CANCER RES, V67, P2382, DOI 10.1158/0008-5472.CAN-06-3566; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; Jennings E, 1973, PREVALENCE EB VIRUS; Kaslow RA, 1997, VIRAL INFECT HUMANS; Kuczmarski R J, 2000, Adv Data, P1; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Martro E, 2004, J MED VIROL, V72, P126, DOI 10.1002/jmv.10548; McDade TW, 2000, PSYCHOSOM MED, V62, P560, DOI 10.1097/00006842-200007000-00015; Morris MC, 2002, J MED VIROL, V67, P522, DOI 10.1002/jmv.10132; NIEDERMAN JC, 1970, NEW ENGL J MED, V282, P361, DOI 10.1056/NEJM197002122820704; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Preciado MV, 2012, INT J CANC; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Verghese P, 2013, J INFECT DIS; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	40	125	130	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64921	10.1371/journal.pone.0064921	http://dx.doi.org/10.1371/journal.pone.0064921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717674	Green Published, gold			2022-12-25	WOS:000320362700181
J	Kuc, S; Koster, MPH; Franx, A; Schielen, PCJI; Visser, GHA				Kuc, Sylwia; Koster, Maria P. H.; Franx, Arie; Schielen, Peter C. J. I.; Visser, Gerard H. A.			Maternal Characteristics, Mean Arterial Pressure and Serum Markers in Early Prediction of Preeclampsia	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; BIOCHEMICAL MARKERS; PULSATILITY INDEX; BLOOD-PRESSURE; 1ST TRIMESTER; RESTRICTION; GESTATION; PREGNANCY; DOPPLER; PREVENTION	Objectives: In a previous study, we have described the predictive value of first-trimester Pregnancy-Associated Plasma Protein-A (PAPP-A), free beta-subunit of human Chorionic Gonadotropin (f beta-hCG), Placental Growth Factor (PlGF) and A Disintegrin And Metalloprotease 12 (ADAM12) for early onset preeclampsia (EO-PE; delivery <34 weeks). The objective of the current study was to obtain the predictive value of these serum makers combined with maternal characteristics and first-trimester maternal mean arterial blood pressure (MAP) in a large series of patients, for both EO-PE and late onset PE (LO-PE; delivery >= 34 weeks). Methods: This was a nested case-control study, using stored first-trimester maternal serum from women who developed EO-PE (n = 68) or LO-PE (n = 99), and 500 uncomplicated singleton pregnancies. Maternal characteristics, MAP, and pregnancy outcome were collected for each individual woman and used to calculate prior risks for PE in a multiple logistic regression model. Models containing prior PE risks, serum markers, and MAP were developed for the prediction of EO-PE and LO-PE. The model-predicted detection rates (DR) for fixed 10% false-positive rates were calculated for EO-PE and LO-PE with or without the presence of a small-for-gestational age infant (SGA, birth weight <10th centile). Results: The best prediction model included maternal characteristics, MAP, PAPP-A, ADAM12, and PlGF, with DR of 72% for EO-PE and 49% for LO-PE. Prediction for PE with concomitant SGA was better than for PE alone (92% for EO-PE and 57% for LO-PE). Conclusion: First-trimester MAP, PAPP-A, ADAM12, and PlGF combined with maternal characteristics and MAP are promising markers in the risk assessment of PE, especially for EO-PE complicated by SGA.	[Kuc, Sylwia; Koster, Maria P. H.; Franx, Arie; Visser, Gerard H. A.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands; [Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment	Kuc, S (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands.	S.Kuc@umcutrecht.nl	Franx, Arie/AAA-1739-2021; Schielen, Peter/AAP-4539-2020		University Medical Centre Alexandre Suerman MD-PhD scholarship	University Medical Centre Alexandre Suerman MD-PhD scholarship	Funding provided by a University Medical Centre Alexandre Suerman MD-PhD scholarship: http://www.umcutrecht.nl/subsite/opleiding-geneeskunde/Overige/MDPhD-traject/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2008, ULTRASOUND OBST GYN, V32, P732, DOI 10.1002/uog.6244; Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; Akolekar R, 2010, PRENATAL DIAG, V30, P191, DOI 10.1002/pd.2433; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Bujold E, 2009, J OBSTET GYNAECOL CA, V31, P818, DOI 10.1016/S1701-2163(16)34300-6; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Dieber-Rotheneder M, 2012, LIFE SCI, V91, P710, DOI 10.1016/j.lfs.2012.04.040; Foidart JM, 2010, ULTRASOUND OBST GYN, V35, P680, DOI 10.1002/uog.7621; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kahn SR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-91; Kuc S, 2011, OBSTET GYNECOL SURV, V66, P225, DOI 10.1097/OGX.0b013e3182227027; Lindqvist PG, 1999, ACTA OBSTET GYN SCAN, V78, P693, DOI 10.1034/j.1600-0412.1999.780806.x; Llurba E, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/275613; North RA, 2000, AM J OBSTET GYNECOL, V183, P136, DOI 10.1016/S0002-9378(00)96405-6; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberge S, 2012, AM J PERINAT, V29, P551, DOI 10.1055/s-0032-1310527; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Vandenberghe G, 2011, PRENATAL DIAG, V31, P955, DOI 10.1002/pd.2807; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Wortelboer EJ, 2011, ULTRASOUND OBST GYN, V38, P383, DOI 10.1002/uog.9029; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; Yu J, 2011, ULTRASOUND OBST GYN, V37, P528, DOI 10.1002/uog.8800	33	50	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63546	10.1371/journal.pone.0063546	http://dx.doi.org/10.1371/journal.pone.0063546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717445	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700033
J	Luan, JW; Liu, SR; Wang, JX; Zhu, XL				Luan, Junwei; Liu, Shirong; Wang, Jingxin; Zhu, Xueling			Factors Affecting Spatial Variation of Annual Apparent Q(10) of Soil Respiration in Two Warm Temperate Forests	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; CLIMATE-CHANGE; TERRESTRIAL ECOSYSTEMS; SEASONAL-VARIATIONS; TEMPORAL VARIATION; GLOBAL PATTERNS; ROOT TURNOVER; WATER-CONTENT; BEECH FOREST; RAIN-FOREST	A range of factors has been identified that affect the temperature sensitivity (Q(10) values) of the soil-to-atmosphere CO2 flux. However, the factors influencing the spatial distribution of Q(10) values within warm temperate forests are poorly understood. In this study, we examined the spatial variation of Q(10) values and its controlling factors in both a naturally regenerated oak forest (OF) and a pine plantation (PP). Q(10) values were determined based on monthly soil respiration (R-S) measurements at 35 subplots for each stand from Oct. 2008 to Oct. 2009. Large spatial variation of Q(10) values was found in both OF and PP, with their respective ranges from 1.7 to 5.12 and from 2.3 to 6.21. In PP, fine root biomass (FR) (R = 0.50, P = 0.002), non-capillary porosity (NCP) (R = 0.37, P = 0.03), and the coefficients of variation of soil temperature at 5 cm depth (CV of T-5) (R = -0.43, P = 0.01) well explained the spatial variance of Q(10). In OF, carbon pool lability reflected by light fractionation method (L-LFOC) well explained the spatial variance of Q(10) (R = -0.35, P = 0.04). Regardless of forest type, L-LFOC and FR correlation with the Q(10) values were significant and marginally significant, respectively; suggesting a positive relationship between substrate availability and apparent Q(10) values. Parameters related to gas diffusion, such as average soil water content (SWC) and NCP, negatively or positively explained the spatial variance of Q(10) values. Additionally, we observed significantly higher apparent Q(10) values in PP compared to OF, which might be partly attributed to the difference in soil moisture condition and diffusion ability, rather than different substrate availabilities between forests. Our results suggested that both soil chemical and physical characters contributed to the observed large Q(10) value variation.	[Luan, Junwei; Liu, Shirong] Chinese Acad Forestry, Chinas State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wang, Jingxin] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Zhu, Xueling] Baotianman Nat Reserve Adm, Chengguan Town, Henan Province, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; West Virginia University	Liu, SR (corresponding author), Chinese Acad Forestry, Chinas State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	liusr@caf.ac.cn	Junwei, Luan/E-2706-2017	Junwei, Luan/0000-0002-3848-4747	Ministry of Finance [200804001, 201104006]; China's National Natural Science Foundation [30590383, 31200370]; Ministry of Science and Technology [2011CB403205, 2008DFA32070, 2006BAD03A04]; CFERN & GENE Award Funds on Ecological Paper	Ministry of Finance; China's National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); CFERN & GENE Award Funds on Ecological Paper	This study was jointly funded by the Ministry of Finance (numbers 200804001 and 201104006), China's National Natural Science Foundation (30590383; 31200370), the Ministry of Science and Technology (2011CB403205, 2008DFA32070, 2006BAD03A04), and CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren G.I, 1998, THEORETICAL ECOSYSTE; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Hammond R, 1978, QUANTITATIVE TECHNIQ; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Hashimoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041962; Henry HAL, 2005, GLOBAL CHANGE BIOL, V11, P1808, DOI 10.1111/j.1365-2486.2005.001007.x; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2010, NEW PHYTOL, V188, P10, DOI 10.1111/j.1469-8137.2010.03366.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; JANZEN HH, 1992, SOIL SCI SOC AM J, V56, P1799, DOI 10.2136/sssaj1992.03615995005600060025x; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Katterer T, 2005, BIOGEOSCIENCES DISCU, V2, P737; Khomik M, 2006, AGR FOREST METEOROL, V140, P244, DOI 10.1016/j.agrformet.2006.08.006; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Knohl A, 2008, PLANT SOIL, V302, P189, DOI 10.1007/s11104-007-9467-2; Kosugi Y, 2007, AGR FOREST METEOROL, V147, P35, DOI 10.1016/j.agrformet.2007.06.005; Laik R, 2009, APPL SOIL ECOL, V42, P71, DOI 10.1016/j.apsoil.2009.02.004; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Lu RK, 2000, SOIL AGR CHEM ANAL M; Luan JW, 2012, SOIL BIOL BIOCHEM, V44, P143, DOI 10.1016/j.soilbio.2011.08.012; Luan JW, 2011, PLANT SOIL, V347, P243, DOI 10.1007/s11104-011-0842-7; Luan JW, 2010, GEODERMA, V156, P228, DOI 10.1016/j.geoderma.2010.02.021; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Metcalfe D, 2008, FOREST ECOL MANAG, V255, P558, DOI 10.1016/j.foreco.2007.09.026; Ohashi M, 2007, SOIL BIOL BIOCHEM, V39, P1130, DOI 10.1016/j.soilbio.2006.12.021; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Powlson D, 2005, NATURE, V433, P204, DOI 10.1038/433204a; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Savage K, 2008, FUNCT ECOL, V22, P1000, DOI 10.1111/j.1365-2435.2008.01414.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Shi Z, 1998, OVERVIEW BAOTIANMAN, P45; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Soe ARB, 2005, TREE PHYSIOL, V25, P1427, DOI 10.1093/treephys/25.11.1427; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365	59	17	18	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64167	10.1371/journal.pone.0064167	http://dx.doi.org/10.1371/journal.pone.0064167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717560	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700112
J	Niemiller, ML; Zigler, KS				Niemiller, Matthew L.; Zigler, Kirk S.			Patterns of Cave Biodiversity and Endemism in the Appalachians and Interior Plateau of Tennessee, USA	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; CUMBERLAND PLATEAU; DIVERSITY PATTERNS; CRYPTIC DIVERSITY; FRANKLIN COUNTY; GENE FLOW; FAUNA; PHYLOGEOGRAPHY; POPULATION; CRAYFISHES	Using species distribution data, we developed a georeferenced database of troglobionts (cave-obligate species) in Tennessee to examine spatial patterns of species richness and endemism, including >2000 records for 200 described species. Forty aquatic troglobionts (stygobionts) and 160 terrestrial troglobionts are known from caves in Tennessee, the latter having the greatest diversity of any state in the United States. Endemism was high, with 25% of terrestrial troglobionts (40 species) and 20% of stygobionts (eight species) known from just a single cave and nearly two-thirds of all troglobionts (130 species) known from five or fewer caves. Species richness and endemism were greatest in the Interior Plateau (IP) and Southwestern Appalachians (SWA) ecoregions, which were twice as diverse as the Ridge and Valley (RV). Troglobiont species assemblages were most similar between the IP and SWA, which shared 59 species, whereas the RV cave fauna was largely distinct. We identified a hotspot of cave biodiversity with a center along the escarpment of the Cumberland Plateau in south-central Tennessee defined by both species richness and endemism that is contiguous with a previously defined hotspot in northeastern Alabama. Nearly half (91 species) of Tennessee's troglobiont diversity occurs in this region where several cave systems contain ten or more troglobionts, including one with 23 species. In addition, we identified distinct troglobiont communities across the state. These communities corresponded to hydrological boundaries and likely reflect past or current connectivity between subterranean habitats within and barriers between hydrological basins. Although diverse, Tennessee's subterranean fauna remains poorly studied and many additional species await discovery and description. We identified several undersampled regions and outlined conservation and management priorities to improve our knowledge and aid in protection of the subterranean biodiversity in Tennessee.	[Niemiller, Matthew L.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Zigler, Kirk S.] Univ South, Dept Biol, Sewanee, TN USA	Yale University; Sewanee: University of the South	Zigler, KS (corresponding author), Univ South, Dept Biol, Sewanee, TN USA.	kzigler@sewanee.edu	Niemiller, Matthew L./B-2454-2012; Zigler, Kirk S./GZM-2049-2022	Niemiller, Matthew L./0000-0001-6353-8797; 	Tennessee Wildlife Resources Agency [ED-06-02149-99, ED-08-023417-00]; American Museum of Natural History; Cave Research Foundation; National Speleological Society; Yale Institute for Biospheric Studies; University of the South	Tennessee Wildlife Resources Agency; American Museum of Natural History; Cave Research Foundation; National Speleological Society; Yale Institute for Biospheric Studies; University of the South	This work was supported by the Tennessee Wildlife Resources Agency (contract nos. ED-06-02149-99 and ED-08-023417-00 to MLN), American Museum of Natural History (MLN), Cave Research Foundation (MLN), National Speleological Society (MLN), the Yale Institute for Biospheric Studies (MLN), and the University of the South (KSZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DM, 2004, J CAVE KARST STUD, V66, P46; Barr TC, 1961, BULLETIN, V64; Barr Thomas C. Jr, 2004, Virginia Museum of Natural History Special Publication, V11, P1; BISBY FA, 2011, SPECIES 2000 ITIS CA; Brahana J.V., 1986, PRELIMINARY DELINEAT; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2008, J CRUSTACEAN BIOL, V28, P57, DOI 10.1651/07-2827R.1; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Cardoso P, 2012, INT J SPELEOL, V41, P83, DOI 10.5038/1827-806X.41.1.9; Castellarini F, 2007, DIVERS DISTRIB, V13, P213, DOI 10.1111/j.1472-4642.2006.00317.x; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Christman MC, 2001, J BIOGEOGR, V28, P367, DOI 10.1046/j.1365-2699.2001.00549.x; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Cope E.D., 1881, AM NAT, V15, P877, DOI DOI 10.1086/272948; Crawford NC, 1984, GROUNDWATER GEOMORPH, P294; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Culver David C., 1999, Journal of the Alabama Academy of Science, V70, P97; Culver David C., 1999, Journal of Caves and Karst Studies, V61, P139; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Culver DC, 2003, BIODIVERS CONSERV, V12, P441, DOI 10.1023/A:1022425908017; Decu V, 1995, ENCY BIOSPEOLOGICA, P403; Deharveng L, 2009, FRESHWATER BIOL, V54, P709, DOI 10.1111/j.1365-2427.2008.01972.x; Deharvening Louis, 2005, P166; Dixon GB, 2011, SOUTHEAST NAT, V10, P251; Elliott WR, 2007, J CAVE KARST STUD, V69, P135; Ferreira D, 2007, BIODIVERS CONSERV, V16, P567, DOI 10.1007/s10531-005-0305-7; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graening G. O., 2011, CAVE LIFE OKLAHOMA A; HAY WP, 1902, P US NATL MUS, V25, P417, DOI DOI 10.5479/SI.00963801.25-1292.417; Hedin M, 2005, ZOOTAXA, P1; Herak M, 1972, KARST IMPORTANT KARS, P467; Hobbs III HH, 2012, ENCY CAVES, P251, DOI DOI 10.1016/B978-0-12-383832-2.00033-5; HOLSINGER J R, 1971, Bulletin of the National Speleological Society, V33, P23; HOLSINGER JR, 1988, BRIMLEYANA, P1; Juan Carlos, 2010, Journal of Biology (London), V9, P17, DOI 10.1186/jbiol227; Kovach WL., 2007, MVSP A MULTIVARIATE; LEWIS J J, 1982, Brimleyana, P65; Lewis J. J., 2005, BIOINVENTORY CAVES C; Lewis JJ, 2005, ZOOTAXA, P17, DOI 10.11646/zootaxa.1080.1.2; Lewis JJ, 2004, TECHNICAL REPORT; Lewis Julian J., 2010, Journal of the Tennessee Academy of Science, V85, P53; Lewis JJ, 2009, P BIOL SOC WASH, V122, P215, DOI 10.2988/08-47.1; Loria Stephanie F., 2011, International Journal of Myriapodology, V5, P35, DOI 10.3897/ijm.5.1891; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Mays JD, 2002, THESIS W CAROLINA U; Michel G, 2009, FRESHWATER BIOL, V54, P861, DOI 10.1111/j.1365-2427.2009.02192.x; Miller BT, 2008, HERPETOL CONSERV BIO, V3, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nicholas G., 1960, American Midland Naturalist, V64, P123, DOI 10.2307/2422897; Niemiller M. L., 2009, P 15 INT C SPEL KERR, V1, P242; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Packard A.S., 1888, MEMOIRS NATL ACAD SC, V4, P1, DOI [10.5962/bhl.title.51841, DOI 10.5962/BHL.TITLE.51841]; Peck S.B., 1990, Bulletin of the National Speleological Society, V51, P11; Peck S.B, 1995, NSS B, V57, P1; PECK SB, 1984, CAN J ZOOL, V62, P730, DOI 10.1139/z84-103; Peck Stewart B., 1998, Journal of Caves and Karst Studies, V60, P18; Pipan T, 2007, BULLETIN, V16; R Development Core Team, 2012, R LANG ENV STAT COMP; Reeves Will K., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P334; Shear William A., 2010, Zootaxa, V2385, P1; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Snowman CV, 2010, J ARACHNOL, V38, P49, DOI 10.1636/A09-057.1; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Wakefield Katherine R., 2012, Speleobiology Notes, V4, P24; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wicks CM, 2002, SPECIAL PUBLICATION, V7, P60; Zhang J., 2003, VIRGINIA MUSEUM NATU, V6, P1, DOI [DOI 10.25777/S8TW-2Q09, 10.1163/156854008X354894]	78	54	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64177	10.1371/journal.pone.0064177	http://dx.doi.org/10.1371/journal.pone.0064177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717562	gold, Green Published			2022-12-25	WOS:000320362700114
J	Wang, GS; Hu, N; Yang, HH; Wang, LM; Su, H; Wang, CY; Clifford, R; Dawsey, EM; Li, JM; Ding, T; Han, XY; Giffen, C; Goldstein, AM; Taylor, PR; Lee, MP				Wang, Gangshi; Hu, Nan; Yang, Howard H.; Wang, Lemin; Su, Hua; Wang, Chaoyu; Clifford, Robert; Dawsey, Erica M.; Li, Jian-Min; Ding, Ti; Han, Xiao-You; Giffen, Carol; Goldstein, Alisa M.; Taylor, Philip R.; Lee, Maxwell P.			Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China	PLOS ONE			English	Article							NUTRITION INTERVENTION TRIALS; DISEASE-SPECIFIC MORTALITY; DISTINCTIVE PATTERNS; HELICOBACTER-PYLORI; SOMATIC MUTATIONS; FAMILY-HISTORY; ESOPHAGEAL; LINXIAN; SUPPLEMENTATION; ADENOCARCINOMA	Objective: To profile RNA expression in gastric cancer by anatomic subsites as an initial step in identifying molecular subtypes and providing targets for early detection and therapy. Methods: We performed transcriptome analysis using the Affymetrix GeneChip U133A in gastric cardia adenocarcinomas (n = 62) and gastric noncardia adenocarcinomas (n = 72) and their matched normal tissues from patients in Shanxi Province, and validated selected dysregulated genes with additional RNA studies. Expression of dysregulated genes was also related to survival of cases. Results: Principal Component Analysis showed that samples clustered by tumor vs. normal, anatomic location, and histopathologic features. Paired t-tests of tumor/normal tissues identified 511 genes whose expression was dysregulated (P<4.7E-07 and at least two-fold difference in magnitude) in cardia or noncardia gastric cancers, including nearly one-half (n = 239, 47%) dysregulated in both cardia and noncardia, one-fourth dysregulated in cardia only (n = 128, 25%), and about one-fourth in noncardia only (n = 144, 28%). Additional RNA studies confirmed profiling results. Expression was associated with case survival for 20 genes in cardia and 36 genes in noncardia gastric cancers. Conclusions: The dysregulated genes identified here represent a comprehensive starting point for future efforts to understand etiologic heterogeneity, develop diagnostic biomarkers for early detection, and test molecularly-targeted therapies for gastric cancer.	[Wang, Gangshi; Hu, Nan; Wang, Lemin; Su, Hua; Wang, Chaoyu; Dawsey, Erica M.; Goldstein, Alisa M.; Taylor, Philip R.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Yang, Howard H.; Lee, Maxwell P.] NCI, Off Director, Ctr Canc Res, Bethesda, MD 20892 USA; [Clifford, Robert] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA; [Li, Jian-Min; Ding, Ti; Han, Xiao-You] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Giffen, Carol] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Information Management Services, Inc.	Taylor, PR (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	ptaylor@mail.nih.gov; leemax@mail.nih.gov			National Institutes of Health; Center for Cancer Research; National Cancer Institute, the Division of Cancer Epidemiology and Genetics	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, the Division of Cancer Epidemiology and Genetics	This research is funded by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, the Division of Cancer Epidemiology and Genetics, and the Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Baumgartner JM, 2009, J SURG RES, V154, P13, DOI 10.1016/j.jss.2008.04.043; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boussioutas A, 2003, CANCER RES, V63, P2569; *CANC I CAOMS, 2011, CHIN CANC DAT; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chong IW, 2006, ONCOL REP, V16, P981; Corley DA, 2004, J NATL CANCER I, V96, P1383, DOI 10.1093/jnci/djh265; Fujimura T, 2010, CANCER SCI, V101, P646, DOI 10.1111/j.1349-7006.2009.01451.x; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao Y, 2011, CANCER EPIDEMIOL, V35, pE91, DOI 10.1016/j.canep.2011.06.006; Gao Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-269; Gleeson CM, 1998, BRIT J CANCER, V77, P277, DOI 10.1038/bjc.1998.44; Hasegawa S, 2002, CANCER RES, V62, P7012; Hippo Y, 2002, CANCER RES, V62, P233; Hu N, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-33; Huch M, 2011, NAT GENET, V43, P9, DOI 10.1038/ng0111-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; *JOHN WIL SONS LTD, 2009, TNM CLASSIFICATION M; Kamangar F, 2007, BRIT J CANCER, V96, P172, DOI 10.1038/sj.bjc.6603517; Kim B, 2003, CANCER RES, V63, P8248; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; LIU SF, 1994, INT J CANCER, V57, P775, DOI 10.1002/ijc.2910570603; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Park WS, 1999, CANCER RES, V59, P4257; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng CW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-101; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; RIO FT, 2010, NEW ENGL J MED, V363, P2628, DOI DOI 10.1056/NEJM0A1006565; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; SIPPONEN P, 1995, AM J SURG PATHOL, V19, pS30; Su H, 2003, CANCER RES, V63, P3872; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Sun Xiudi, 2002, Zhonghua Zhongliu Zazhi, V24, P4; Tajima Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055345; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Tytgat GNJ, 2004, DIS ESOPHAGUS, V17, P10, DOI 10.1111/j.1442-2050.2004.00371.x; VAN DH, 2009, CANCER GENET CYTOGEN, V189, P37, DOI DOI 10.1016/J.CANCERGENCYT0.2008.08.018; Wei WQ, 2004, AM J CLIN NUTR, V79, P80; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350	49	76	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63826	10.1371/journal.pone.0063826	http://dx.doi.org/10.1371/journal.pone.0063826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717493	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700068
J	Millon-Fremillon, A; Brunner, M; Abed, N; Collomb, E; Ribba, AS; Block, MR; Albiges-Rizo, C; Bouvard, D				Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel			Calcium and Calmodulin-dependent Serine/Threonine Protein Kinase Type II (CaMKII)-mediated Intramolecular Opening of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP-1 alpha) Negatively Regulates beta 1 Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-LIKE DOMAIN; SMOOTH-MUSCLE; ALPHA(5)BETA(1) INTEGRIN; BETA(1) INTEGRIN; CELL-MIGRATION; TAIL DOMAINS; ADHESION; TALIN; ACTIVATION; ALPHA(V)BETA(3)	Focal adhesion turnover during cell migration is an integrated cyclic process requiring tight regulation of integrin function. Interaction of integrin with its ligand depends on its activation state, which is regulated by the direct recruitment of proteins onto the beta integrin chain cytoplasmic domain. We previously reported that ICAP-1 alpha, a specific cytoplasmic partner of beta 1A integrins, limits both talin and kindlin interaction with beta 1 integrin, thereby restraining focal adhesion assembly. Here we provide evidence that the calcium and calmodulin-dependent serine/threonine protein kinase type II (CaMKII) is an important regulator of ICAP-1 alpha for controlling focal adhesion dynamics. CaMKII directly phosphorylates ICAP-1 alpha and disrupts an intramolecular interaction between the N- and the C-terminal domains of ICAP-1 alpha, unmasking the PTB domain, thereby permitting ICAP-1 alpha binding onto the beta 1 integrin tail. ICAP-1 alpha direct interaction with the beta 1 integrin tail and the modulation of beta 1 integrin affinity state are required for down-regulating focal adhesion assembly. Our results point to a molecular mechanism for the phosphorylation-dependent control of ICAP-1 alpha function by CaMKII, allowing the dynamic control of beta 1 integrin activation and cell adhesion.	[Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] INSERM, Inst Albert Bonniot U823, F-38042 Grenoble, France; [Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] CNRS, Inst Albert Bonniot ERL5224, F-38042 Grenoble, France; [Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] Univ Grenoble Alpes, Inst Albert Bonniot U823, F-38042 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Albiges-Rizo, C (corresponding author), Univ Grenoble 1, ERL CNRS 5284, INSERM U823, Inst Albert Bonniot, Site Sante,BP170 La Tronche, F-38042 Grenoble 9, France.	Corinne.albiges-rizo@ujf-grenoble.fr; daniel.bouvard@ujf-grenoble.fr	ribba, anne-sophie/N-3109-2013; Bouvard, Daniel/M-2727-2013; Block, Marc R/M-2740-2013; Bouvard, Daniel/B-1260-2017; Albiges-Rizo, Corinne/M-2568-2013	Block, Marc R/0000-0003-2214-9706; Bouvard, Daniel/0000-0002-0845-6681; ALBIGES-RIZO, Corinne/0000-0002-6333-4150; Ribba, Anne-Sophie/0000-0001-5342-8455	Pro-INSERM grant, Ligue contre le Cancer, and INCa; Ligue contre le Cancer; ARC fellowship; Ministere de la Recherche	Pro-INSERM grant, Ligue contre le Cancer, and INCa; Ligue contre le Cancer(Ligue nationale contre le cancer); ARC fellowship(Australian Research Council); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by a Pro-INSERM grant, Ligue contre le Cancer, and INCa (to D.B.) and Ligue contre le Cancer (equipe labelise 2010) (to C.A.-R.).; 1 Supported by an ARC fellowship. Present address: Wellcome Trust Centre for Cell-Matrix Research, Manchester University, Oxford Road, M13 9PT, United Kingdom.; 2 Supported by a fellowship from the Ministere de la Recherche.	Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bejar R, 2002, J NEUROSCI, V22, P5719; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouvard D, 2006, EUR J CELL BIOL, V85, P275, DOI 10.1016/j.ejcb.2005.10.005; Bouvard D, 1998, J CELL SCI, V111, P657; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Bouvard D, 1998, BIOCHEM BIOPH RES CO, V252, P46, DOI 10.1006/bbrc.1998.9592; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Bretscher A, 1995, BIOCHEMISTRY-US, V34, P16830, DOI 10.1021/bi00051a034; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Chang DD, 2002, J BIOL CHEM, V277, P8140, DOI 10.1074/jbc.M109031200; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Degani S, 2002, J CELL BIOL, V156, P377, DOI 10.1083/jcb.200108030; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Lundberg MS, 1998, J MOL CELL CARDIOL, V30, P2377, DOI 10.1006/jmcc.1998.0795; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11	50	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20248	20260		10.1074/jbc.M113.455956	http://dx.doi.org/10.1074/jbc.M113.455956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720740	hybrid, Green Published			2022-12-25	WOS:000321715100014
J	Poulsen, N; Scheffel, A; Sheppard, VC; Chesley, PM; Kroger, N				Poulsen, Nicole; Scheffel, Andre; Sheppard, Vonda C.; Chesley, Patrick M.; Kroeger, Nils			Pentalysine Clusters Mediate Silica Targeting of Silaffins in Thalassiosira pseudonana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; VALVE MORPHOGENESIS; MATRIX VESICLES; DIATOM; BIOMINERALIZATION; BACILLARIOPHYCEAE; BIOGENESIS; BIOSILICA; PROTEINS; IDENTIFICATION	The biological formation of inorganic materials (biomineralization) often occurs in specialized intracellular vesicles. Prominent examples are diatoms, a group of single-celled eukaryotic microalgae that produce their SiO2 (silica)-based cell walls within intracellular silica deposition vesicles (SDVs). SDVs contain protein-based organic matrices that control silica formation, resulting in species specifically nanopatterned biosilica, an organic-inorganic composite material. So far no information is available regarding the molecular mechanisms of SDV biogenesis. Here we have investigated by fluorescence microscopy and subcellular membrane fractionation the intracellular transport of silaffin Sil3. Silaffins are a group of phosphoproteins constituting the main components of the organic matrix of diatom biosilica. We demonstrate that the N-terminal signal peptide of Sil3 mediates import into a specific subregion of the endoplasmic reticulum. Additional segments from the mature part of Sil3 are required to reach post-endoplasmic reticulum compartments. Further transport of Sil3 and incorporation into the biosilica (silica targeting) require protein segments that contain a high density of modified lysine residues and phosphoserines. Silica targeting of Sil3 is not dependent on a particular peptide sequence, yet a lysine-rich 12-14-amino acid peptide motif (pentalysine cluster), which is conserved in all silaffins, strongly promotes silica targeting. The results of the present work provide the first insight into the molecular mechanisms for biogenesis of mineral-forming vesicles from an eukaryotic organism.	[Poulsen, Nicole; Kroeger, Nils] Tech Univ Dresden, B CUBE, D-01307 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Poulsen, Nicole; Scheffel, Andre; Sheppard, Vonda C.; Chesley, Patrick M.; Kroeger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroeger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	Technische Universitat Dresden; Technische Universitat Dresden; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE, Arnoldstr. 18, D-01307 Dresden, Germany.	kroeger@bcube-dresden.de			Deutsche Forschungsgemeinschaft (DFG) [KR1853/3-1]; United States Department of Energy (DOE) Office of Basic Energy Sciences [SCHE1637/1-1, DE-SC0002245]; National Science Foundation (NSF) [DMR-0845939]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); United States Department of Energy (DOE) Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through Grant KR1853/3-1 (to N.K.) and Postdoctoral Fellowship SCHE1637/1-1 (to A.S.), by the United States Department of Energy (DOE) Office of Basic Energy Sciences through Grant DE-SC0002245 (to N.K.), and by the National Science Foundation (NSF) through Grant DMR-0845939 (to N.K.).	ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Felsner G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-223; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; Graham T. R., 2002, PROTEIN TARGETING TR, P322; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hildebrand M, 2003, PROG MOLEC, V33, P11; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Poulsen N, 2007, ANGEW CHEM INT EDIT, V46, P1843, DOI 10.1002/anie.200603928; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; SCHMID AMM, 1994, PROTOPLASMA, V181, P43, DOI 10.1007/BF01666388; Sheppard V, 2010, J BIOL CHEM, V285, P1166, DOI 10.1074/jbc.M109.039529; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2007, ANGEW CHEM INT EDIT, V46, P8405, DOI 10.1002/anie.200702413; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; van de Meene AML, 2002, J PHYCOL, V38, P351, DOI 10.1046/j.1529-8817.2002.01124.x; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Vrieling EG, 1999, J PHYCOL, V35, P548, DOI 10.1046/j.1529-8817.1999.3530548.x; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020523; Ward DM, 2005, MOL B INT U, P111; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Wilt FH, 2008, EXP CELL RES, V314, P1744, DOI 10.1016/j.yexcr.2008.01.036	43	45	45	3	76	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20100	20109		10.1074/jbc.M113.469379	http://dx.doi.org/10.1074/jbc.M113.469379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720751	hybrid, Green Published			2022-12-25	WOS:000321715100001
J	Mendes-Pinto, MM; Galzerano, D; Telfer, A; Pascal, AA; Robert, B; Ilioaia, C				Mendes-Pinto, Maria M.; Galzerano, Denise; Telfer, Alison; Pascal, Andrew A.; Robert, Bruno; Ilioaia, Cristian			Mechanisms Underlying Carotenoid Absorption in Oxygenic Photosynthetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; BETA-CAROTENE; ELECTRONIC ABSORPTION; CRYSTAL-STRUCTURE; TRIPLET-STATES; SPECTRA; XANTHOPHYLLS; IDENTIFICATION; INSIGHTS	The electronic properties of carotenoid molecules underlie their multiple functions throughout biology, and tuning of these properties by their in vivo locus is of vital importance in a number of cases. This is exemplified by photosynthetic carotenoids, which perform both light-harvesting and photoprotective roles essential to the photosynthetic process. However, despite a large number of scientific studies performed in this field, the mechanism( s) used to modulate the electronic properties of carotenoids remain elusive. We have chosen two specific cases, the two beta-carotene molecules in photosystem II reaction centers and the two luteins in the major photosystem II light-harvesting complex, to investigate how such a tuning of their electronic structure may occur. Indeed, in each case, identical molecular species in the same protein are seen to exhibit different electronic properties (most notably, shifted absorption peaks). We assess which molecular parameters are responsible for this in vivo tuning process and attempt to assign it to specific molecular events imposed by their binding pockets.	[Mendes-Pinto, Maria M.; Galzerano, Denise; Pascal, Andrew A.; Robert, Bruno; Ilioaia, Cristian] Univ Paris 11, Inst Biol & Technol Saclay, CNRS, UMR 8221, F-91191 Gif Sur Yvette, France; [Telfer, Alison] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Robert, B (corresponding author), Univ Paris 11, Inst Biol & Technol Saclay, CNRS, UMR 8221, F-91191 Gif Sur Yvette, France.	bruno.robert@cea.fr	pascal, andrew a/B-6186-2014; Robert, Bruno/D-1264-2012; Pinto, Maria Manuela Mendes/M-2804-2013	pascal, andrew a/0000-0002-1844-6065; Robert, Bruno/0000-0001-5999-4538; Mendes Pinto, Maria Manuela/0000-0001-7541-7335; ILIOAIA, Cristian/0000-0001-7505-1900	European Union program Marie Curie FP7 Initial Training Network HARVEST; European Research Council project PHOTPROT; French National Research Agency project Cyanoprotect; Commissariat a l'Energie Atomique-EUROTALENS program [PCOFUND-GA-2008-228664]	European Union program Marie Curie FP7 Initial Training Network HARVEST; European Research Council project PHOTPROT; French National Research Agency project Cyanoprotect(French National Research Agency (ANR)); Commissariat a l'Energie Atomique-EUROTALENS program	This work was supported by European Union program Marie Curie FP7 Initial Training Network HARVEST, by the European Research Council project PHOTPROT, and by the French National Research Agency project Cyanoprotect.; Supported by a Commissariat a l'Energie Atomique-EUROTALENS program under European Contract PCOFUND-GA-2008-228664.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; ANDERSSON PO, 1991, PHOTOCHEM PHOTOBIOL, V54, P353, DOI 10.1111/j.1751-1097.1991.tb02027.x; Andreeva A, 2011, SPECTROCHIM ACTA A, V78, P1261, DOI 10.1016/j.saa.2010.12.071; ARAKI G, 1952, PROG THEOR PHYS, V8, P639, DOI 10.1143/PTP.8.639; Britton G., 2008, CAROTENOIDS; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Cerezo J, 2012, J PHYS CHEM A, V116, P3498, DOI 10.1021/jp301485k; Chen ZG, 2006, J PHYS CHEM A, V110, P11291, DOI 10.1021/jp0643247; Christensen RL, 2004, ARCH BIOCHEM BIOPHYS, V430, P30, DOI 10.1016/j.abb.2004.02.026; COGDELL RJ, 1994, PURE APPL CHEM, V66, P1041; DALE J, 1954, ACTA CHEM SCAND, V8, P1235, DOI 10.3891/acta.chem.scand.08-1235; DURRANT JR, 1990, BIOCHIM BIOPHYS ACTA, V1017, P167, DOI 10.1016/0005-2728(90)90148-W; Foote C.S, 1976, FREE RADICALS BIOL, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X; Gall A, 1999, BIOCHEMISTRY-US, V38, P5185, DOI 10.1021/bi982486q; Golibrzuch K, 2011, PHYS CHEM CHEM PHYS, V13, P6340, DOI 10.1039/c0cp02525a; HEMLEY R, 1977, BIOPHYS J, V20, P377, DOI 10.1016/S0006-3495(77)85556-2; HIRAYAMA K, 1955, J AM CHEM SOC, V77, P379, DOI 10.1021/ja01607a042; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; KUKI M, 1994, PHOTOCHEM PHOTOBIOL, V59, P116; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1099, P193; LEROSEN AL, 1952, J CHEM PHYS, V20, P233, DOI 10.1063/1.1700384; Liu WL, 2012, CHINESE J CHEM, V30, P2573, DOI 10.1002/cjoc.201200661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; MIMURO M, 1995, BBA-BIOENERGETICS, V1232, P81, DOI 10.1016/0005-2728(95)00116-2; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Papagiannakis E, 2002, P NATL ACAD SCI USA, V99, P6017, DOI 10.1073/pnas.092626599; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m; Renge I, 2011, J PHOTOCH PHOTOBIO A, V218, P156, DOI 10.1016/j.jphotochem.2010.12.015; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUZUKI H, 1964, J PHYS SOC JPN, V19, P724, DOI 10.1143/JPSJ.19.724; TAKAHASHI Y, 1987, BIOCHIM BIOPHYS ACTA, V893, P49, DOI 10.1016/0005-2728(87)90147-2; Tomo T, 1997, BBA-BIOENERGETICS, V1321, P21, DOI 10.1016/S0005-2728(97)00037-6; TRUSCOTT TG, 1973, PHOTOCHEM PHOTOBIOL, V17, P43, DOI 10.1111/j.1751-1097.1973.tb06329.x; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; Wang P, 2005, CHEM PHYS LETT, V410, P108, DOI 10.1016/j.cplett.2005.05.037; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wirtz AC, 2007, BIOPHYS J, V93, P981, DOI 10.1529/biophysj.106.103473; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	48	33	33	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18758	18765		10.1074/jbc.M112.423681	http://dx.doi.org/10.1074/jbc.M112.423681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720734	Green Published, hybrid			2022-12-25	WOS:000321335800011
J	Huber, M; Kupferberg, A; Lenz, C; Knoll, A; Brandt, T; Glasauer, S				Huber, Markus; Kupferberg, Aleksandra; Lenz, Claus; Knoll, Alois; Brandt, Thomas; Glasauer, Stefan			Spatiotemporal Movement Planning and Rapid Adaptation for Manual Interaction	PLOS ONE			English	Article							JOINT-ACTION; ACTION COORDINATION; INTERFERENCE; PERCEPTION; MODELS; ROBOTS; PRIORS	Many everyday tasks require the ability of two or more individuals to coordinate their actions with others to increase efficiency. Such an increase in efficiency can often be observed even after only very few trials. Previous work suggests that such behavioral adaptation can be explained within a probabilistic framework that integrates sensory input and prior experience. Even though higher cognitive abilities such as intention recognition have been described as probabilistic estimation depending on an internal model of the other agent, it is not clear whether much simpler daily interaction is consistent with a probabilistic framework. Here, we investigate whether the mechanisms underlying efficient coordination during manual interactions can be understood as probabilistic optimization. For this purpose we studied in several experiments a simple manual handover task concentrating on the action of the receiver. We found that the duration until the receiver reacts to the handover decreases over trials, but strongly depends on the position of the handover. We then replaced the human deliverer by different types of robots to further investigate the influence of the delivering movement on the reaction of the receiver. Durations were found to depend on movement kinematics and the robot's joint configuration. Modeling the task was based on the assumption that the receiver's decision to act is based on the accumulated evidence for a specific handover position. The evidence for this handover position is collected from observing the hand movement of the deliverer over time and, if appropriate, by integrating this sensory likelihood with prior expectation that is updated over trials. The close match of model simulations and experimental results shows that the efficiency of handover coordination can be explained by an adaptive probabilistic fusion of a-priori expectation and online estimation.	[Huber, Markus; Kupferberg, Aleksandra; Glasauer, Stefan] Univ Munich, Inst Clin Neurosci, Ctr Sensorimotor Res, Munich, Germany; [Kupferberg, Aleksandra; Brandt, Thomas; Glasauer, Stefan] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Lenz, Claus; Knoll, Alois] Tech Univ Munich, Dept Informat, D-80290 Munich, Germany; [Brandt, Thomas] Univ Munich, Chair Clin Neurosci, Munich, Germany	University of Munich; University of Munich; Technical University of Munich; University of Munich	Huber, M (corresponding author), Univ Munich, Inst Clin Neurosci, Ctr Sensorimotor Res, Munich, Germany.	markus.huber@lrz.uni-muenchen.de	Glasauer, Stefan/A-5898-2008; Knoll, Alois/AAN-8417-2021	Glasauer, Stefan/0000-0002-4313-6210; Knoll, Alois/0000-0003-4840-076X	DFG Cluster of Excellence CoTeSys; German Center for Vertigo and Balance Disorders [BMBF IFB 01EO0901]; Graduiertenforderung nach dem Bay. Eliteforderungsgesetz	DFG Cluster of Excellence CoTeSys(German Research Foundation (DFG)); German Center for Vertigo and Balance Disorders; Graduiertenforderung nach dem Bay. Eliteforderungsgesetz	This research was supported by the DFG Cluster of Excellence CoTeSys (http://www.cotesys.de/), the German Center for Vertigo and Balance Disorders (BMBF IFB 01EO0901), and a grant to AK by Graduiertenforderung nach dem Bay. Eliteforderungsgesetz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Basili P, 2009, COGN SYST MONOGR, V6, P151; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bishop C.M., 2006, PATTERN RECOGNITION; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bouquet CA, 2007, J SPORT SCI, V25, P519, DOI 10.1080/02640410600946803; Chaminade T, 2005, INT C DEVEL LEARN, P96; Chapman CS, 2010, J VISION, V10, DOI 10.1167/10.11.17; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Craig J.J., 2005, INTRO ROBOTICS MECH; Cuijpers RH, 2006, NEURAL NETWORKS, V19, P311, DOI 10.1016/j.neunet.2006.02.004; Ernst M. O., 2011, SENSORY CUE INTEGRAT, P224, DOI 10.1093/acprof:oso/9780195387247.003.0012; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Galantucci B, 2009, TOP COGN SCI, V1, P255, DOI 10.1111/j.1756-8765.2009.01017.x; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; GEORGOPOULOS AP, 1986, ANNU REV NEUROSCI, V9, P147, DOI 10.1146/annurev.ne.09.030186.001051; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gordon R., 1986, MIND LAN GUAGE, V1, P158, DOI [10.1111/j.1468-0017.1986.tb00324.x, DOI 10.1111/J.1468-0017.1986.TB00324.X]; Herbort O, 2012, ACTA PSYCHOL, V139, P404, DOI 10.1016/j.actpsy.2012.01.001; Huber M, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P107, DOI 10.1109/ROMAN.2008.4600651; Huber M, 2009, ANN NY ACAD SCI, V1164, P380, DOI 10.1111/j.1749-6632.2008.03743.x; KAJIKAWA S, 1995, IROS '95 - 1995 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS: HUMAN ROBOT INTERACTION AND COOPERATIVE ROBOTS, PROCEEDINGS, VOL 1, P193, DOI 10.1109/IROS.1995.525796; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KIM I, 1992, IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN COMMUNICATION : PROCEEDINGS, P199, DOI 10.1109/ROMAN.1992.253888; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Knoblich G, 2003, J EXP PSYCHOL LEARN, V29, P1006, DOI 10.1037/0278-7393.29.5.1006; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kupferberg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039637; Lenz C, 2011, THESIS TU MUNCHEN MU; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meulenbroek RGJ, 2007, EXP BRAIN RES, V180, P333, DOI 10.1007/s00221-007-0861-z; Oztop E., 2005, P 4 IEEE RAS INT C H, V2, P537, DOI [10.1142/S0219843605000582, DOI 10.1142/S0219843605000582]; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Ray M, 2011, J MOTOR BEHAV, V43, P329, DOI 10.1080/00222895.2011.592871; Rickert M, 2007, LECT NOTES COMPUT SC, V4555, P987; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Van Wanrooij MM, 2010, EUR J NEUROSCI, V31, P1763, DOI 10.1111/j.1460-9568.2010.07198.x; Verstynen T, 2011, J NEUROSCI, V31, P10050, DOI 10.1523/JNEUROSCI.6525-10.2011; Vesper C, 2008, 2008 ECSIS SYMPOSIUM ON LEARNING AND ADAPTIVE BEHAVIORS FOR ROBOTIC SYSTEMS - LAB-RS 2008, PROCEEDINGS, P17, DOI 10.1109/LAB-RS.2008.21; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64982	10.1371/journal.pone.0064982	http://dx.doi.org/10.1371/journal.pone.0064982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724112	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000109
J	Marcy, AE; Fendorf, S; Patton, JL; Hadly, EA				Marcy, Ariel E.; Fendorf, Scott; Patton, James L.; Hadly, Elizabeth A.			Morphological Adaptations for Digging and Climate-Impacted Soil Properties Define Pocket Gopher (Thomomys spp.) Distributions	PLOS ONE			English	Article							BEHAVIOR; BOTTAE; TALPOIDES; GEOMYIDAE; PATTERNS; MAMMALS; RODENT; VALLEY; COSTS	Species ranges are mediated by physiology, environmental factors, and competition with other organisms. The allopatric distribution of five species of northern Californian pocket gophers (Thomomys spp.) is hypothesized to result from competitive exclusion. The five species in this environmentally heterogeneous region separate into two subgenera, Thomomys or Megascapheus, which have divergent digging styles. While all pocket gophers dig with their claws, the tooth-digging adaptations of subgenus Megascapheus allow access to harder soils and climate-protected depths. In a Northern Californian locality, replacement of subgenus Thomomys with subgenus Megascapheus occurred gradually during the Pleistocene-Holocene transition. Concurrent climate change over this transition suggests that environmental factors - in addition to soil - define pocket gopher distributional limits. Here we show 1) that all pocket gophers occupy the subset of less energetically costly soils and 2) that subgenera sort by percent soil clay, bulk density, and shrink-swell capacity (a mineralogical attribute). While clay and bulk density (without major perturbations) stay constant over decades to millennia, low precipitation and high temperatures can cause shrink-swell clays to crack and harden within days. The strong yet underappreciated interaction between soil and moisture on the distribution of vertebrates is rarely considered when projecting species responses to climatic change. Furthermore, increased precipitation alters the weathering processes that create shrink-swell minerals. Two projected outcomes of ongoing climate change-higher temperatures and precipitation-will dramatically impact hardness of soil with shrink-swell minerals. Current climate models do not include factors controlling soil hardness, despite its impact on all organisms that depend on a stable soil structure.	[Marcy, Ariel E.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fendorf, Scott] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Patton, James L.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of California System; University of California Berkeley	Marcy, AE (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	aemarcy@gmail.com		Marcy, Ariel/0000-0001-8034-1048; Fendorf, Scott/0000-0002-9177-1809	Stanford University [4297];  [4517]	Stanford University(Stanford University); 	Undergraduate Advising and Research and the Vice Provost for Undergraduate Education at Stanford University provided a Major Grant to proposal #4297 to support this work. The same funders also provided a Conference Grant to proposal #4517 that supported travel to present preliminary data and receive feedback at the 9th International Congress of Vertebrate Morphology in Punta Del Este, Uruguay (Funder's website: http://www.stanford.edu/dept/undergrad/cgi-bin/drupal_ual/OO_research_opps_Grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1988, MYCOLOGIA, V80, P754, DOI 10.2307/3807733; ANDERSEN DC, 1981, ECOL MONOGR, V51, P179, DOI 10.2307/2937262; Bailey V., 1915, U S Department of Agriculture Bureau of Biological Survey North American Fauna, VNo. 39; BAKER AEM, 1974, ECOLOGY, V55, P671, DOI 10.2307/1935160; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Brady N, 2010, NATURE PROPERTIES SO, P114; Brown K. W., 1977, Minerals in Soil Environments (Dixon, J.B.; Weed, S.B., Editors)., P689; Buffenstein R, 2000, LIFE UNDERGROUND, P62; Buol S, 2011, SOIL GENESIS CLASSIF, P268; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; BURTON DH, 1978, J WILDLIFE MANAGE, V42, P383, DOI 10.2307/3800274; Busch C, 2000, LIFE UNDERGROUND, P183; Chillo V, 2010, ACTA OECOL, V36, P611, DOI 10.1016/j.actao.2010.09.006; Connior MB, 2010, AM MIDL NAT, V164, P217, DOI 10.1674/0003-0031-164.2.217; COX GW, 1992, J MAMMAL, V73, P123, DOI 10.2307/1381873; COX GW, 1989, NORTHWEST SCI, V63, P77; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Eviner VT, 2003, ECOLOGY, V84, P120, DOI 10.1890/0012-9658(2003)084[0120:GPFIAE]2.0.CO;2; Gobetz K, 2007, J VERTEBR PALEONTOL, V27, p82A; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; Hillel D, 1998, ENV SOIL PHYS, V771, P16; Hoffman JD, 2007, SOUTHWEST NAT, V52, P296, DOI 10.1894/0038-4909(2007)52[296:EOLUAS]2.0.CO;2; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; HUNTLY N, 1988, BIOSCIENCE, V38, P786, DOI 10.2307/1310788; JENKINS SH, 1989, J MAMMAL, V70, P406, DOI 10.2307/1381529; Jones Cheri A., 2004, Mammalian Species, P1, DOI 10.1644/742; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; LESSA EP, 1989, J MAMMAL, V70, P689, DOI 10.2307/1381704; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; MILLER MA, 1948, J MAMMAL, V29, P38, DOI 10.2307/1375279; MILLER MILTON A., 1957, HILGARDIA, V26, P431; MILLER RS, 1964, ECOLOGY, V45, P256, DOI 10.2307/1933839; MOULTON MP, 1983, SOUTHWEST NAT, V28, P53, DOI 10.2307/3670592; PATTON JL, 1990, U CALIFORNIA PUBLICA, V123, P1; Reed S, 2012, GEOL SOC AM SPEC PAP, V490, P21, DOI 10.1130/2012.2490(01); Reichman OJ, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P271, DOI 10.1007/978-3-540-69276-8_20; REICHMAN OJ, 1972, J MAMMAL, V53, P21, DOI 10.2307/1378824; Reid-Soukup Deborah A., 2002, P467; Romanach SS, 2007, ECOLOGY, V88, P2047, DOI 10.1890/06-1461.1; Schmeisser RL, 2009, PALAIOS, V24, P809, DOI 10.2110/palo.2009.p09-037r; Sedlacek F, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P35, DOI 10.1007/978-3-540-69276-8_4; Stein BR, 2000, LIFE UNDERGROUND, P19; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; STUEBE MM, 1985, CAN J ZOOL, V63, P1101, DOI 10.1139/z85-165; Taylor DS, 2009, NORTHWEST SCI, V83, P367, DOI 10.3955/046.083.0408; Thaeler C, 1968, ANAL DISTRIBUTION PO; Vassallo AI, 1998, J ZOOL, V244, P415, DOI 10.1111/j.1469-7998.1998.tb00046.x; VAUGHAN TERRY A., 1964, AMER MIDLAND NATUR, V72, P444, DOI 10.2307/2423517; Verts B. J., 2000, Mammalian Species, P1; Verts B.J., 2003, Mammalian Species, V719, P1, DOI 10.1644/719; VERTS BJ, 1999, MAMMALIAN SPECIES, V618, P1; VLECK D, 1981, OECOLOGIA, V49, P391, DOI 10.1007/BF00347605; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; White CR, 2005, J ZOOL, V265, P395, DOI 10.1017/S0952836905006473; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; YASSOGLOU N, 1994, GEODERMA, V63, P289, DOI 10.1016/0016-7061(94)90070-1; Yoo K, 2005, GEOLOGY, V33, P917, DOI 10.1130/G21831.1; Zaitlin B, 2007, APPL SOIL ECOL, V37, P88, DOI 10.1016/j.apsoil.2007.04.003	61	24	24	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64935	10.1371/journal.pone.0064935	http://dx.doi.org/10.1371/journal.pone.0064935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717675	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300008
J	Zang, XB; Zhang, SL; Xia, YL; Li, SS; Fu, FF; Li, XC; Wang, F; Zhang, RF; Tian, XC; Gao, LJ; Zhang, JY; Yang, YZ; Tu, X; Wang, Q				Zang, Xiaobiao; Zhang, Shulong; Xia, Yunlong; Li, Sisi; Fu, Fenfen; Li, Xiuchun; Wang, Fan; Zhang, Rongfeng; Tian, Xiaochen; Gao, Lianjun; Zhang, Jiaying; Yang, Yanzong; Tu, Xin; Wang, Qing			SNP rs3825214 in TBX5 Is Associated with Lone Atrial Fibrillation in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; HOLT-ORAM-SYNDROME; PR INTERVAL; VENTRICULAR-ARRHYTHMIAS; ISCHEMIC-STROKE; RISK-FACTORS; MANAGEMENT; MUTATIONS; DURATION	Background: A prolonged PR interval is a sign of increased risk of cardiac arrhythmia. Recent genome-wide association studies found that the single-nucleotide polymorphism (SNP) rs3825214 in T-box 5 (TBX5) was positively associated with PR interval, QRS duration, QT interval, and common arrhythmia disorders such as atrial fibrillation (AF) and advanced atrioventricular block. However, other independent replication studies are required to validate the result. This study assessed associations between rs3825214 and ECG parameters, AF, and ventricular tachycardia (VT) in a Chinese Han population. Methodology/Principal Findings: To assess the association between rs3825214 and AF and VT, we carried out case-control association studies with 692 AF patients (including 275 lone AF patients), 235 VT patients, and 856 controls. Genotyping was performed using a Rotor-Gene TM 6000 High Resolution Melt system. Statistical analyses of associations were adjusted for potential confounding factors. A moderate association was detected between rs3825214 and AF (P-adj = 0.036, OR = 0.79) and a highly significant association was detected between the G allele of rs3825214 and lone AF (P-adj = 0.001, OR = 0.65; genotypic P = 3.75 x 10(-4) with a dominant model). We also found that rs3825214 showed a significant association with atrial-ventricular block (AVB; P = 0.028; P-adj = 0.035, OR = 0.494). Conclusions: Our results indicate that rs3825214 conferred a significant risk of lone AF in this Chinese Han population.	[Zang, Xiaobiao; Zhang, Shulong; Xia, Yunlong; Zhang, Rongfeng; Tian, Xiaochen; Gao, Lianjun; Yang, Yanzong] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Sisi; Fu, Fenfen; Li, Xiuchun; Wang, Fan; Tu, Xin; Wang, Qing] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Coll Life Sci & Technol, Minist Educ, Wuhan 430074, Peoples R China; [Li, Sisi; Fu, Fenfen; Li, Xiuchun; Wang, Fan; Tu, Xin; Wang, Qing] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Cardio X Inst, Wuhan 430074, Peoples R China; [Zang, Xiaobiao; Zhang, Jiaying] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China	Dalian Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Zhengzhou University	Yang, YZ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China.	yyzheart@126.com; xtu@mail.hust.edu.cn		WANG, FAN/0000-0001-9806-5037	National Basic Research Program of China (973 Program) [2013CB531100]; National Natural Science Foundation of China [81070106]; Program for New Century Excellent Talents in University of China [NCET-11-0181]; Fundamental Research Funds for the Central Universities [2010MS015, 2011TS082]; Hubei Province Natural Science Key Program [2008CDA047]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Province Natural Science Key Program	This work was supported by the National Basic Research Program of China (973 Program No. 2013CB531100), the National Natural Science Foundation of China (No. 81070106), Program for New Century Excellent Talents in University of China (NCET-11-0181), Fundamental Research Funds for the Central Universities (2010MS015, 2011TS082), and a Hubei Province Natural Science Key Program (2008CDA047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098; BUXTON AE, 1981, CHEST, V80, P68, DOI 10.1378/chest.80.1.68; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Cheng XA, 2011, DIABETES, V60, P680, DOI 10.2337/db10-0185; Chopra N, 2011, CURR OPIN CARDIOL, V26, P196, DOI 10.1097/HCO.0b013e3283459893; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Frost L, 2007, CIRCULATION, V115, P3040, DOI 10.1161/CIRCULATIONAHA.107.709287; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOLDSTEIN M, 1989, Stroke, V20, P1407; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Goodloe AH, 2011, AM J CARDIOL, V107, P1802, DOI 10.1016/j.amjcard.2011.02.326; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; Kozlowski D, 2010, HEART, V96, P498, DOI 10.1136/hrt.2009.176321; Li QY, 1997, NAT GENET, V15, P21; Macfarlane PW, 2011, EUROPACE, V13, P634, DOI 10.1093/europace/eur016; Marcus GM, 2008, HEART RHYTHM, V5, P826, DOI 10.1016/j.hrthm.2008.02.016; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Prystowsky EN, 2012, J AM COLL CARDIOL, V59, P1733, DOI 10.1016/j.jacc.2012.01.036; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Xu CQ, 2010, STROKE, V41, P1587, DOI 10.1161/STROKEAHA.110.583096	31	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64966	10.1371/journal.pone.0064966	http://dx.doi.org/10.1371/journal.pone.0064966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717681	gold, Green Published, Green Submitted			2022-12-25	WOS:000319385300007
J	Milojevic, T; Grishkovskaya, I; Sonnleitner, E; Djinovic-Carugo, K; Blasi, U				Milojevic, Tetyana; Grishkovskaya, Irina; Sonnleitner, Elisabeth; Djinovic-Carugo, Kristina; Blaesi, Udo			The Pseudomonas aeruginosa Catabolite Repression Control Protein Crc Is Devoid of RNA Binding Activity	PLOS ONE			English	Article							GLOBAL REGULATOR; INHIBITS TRANSLATION; DNA-REPAIR; PUTIDA; HFQ; METABOLISM; PHOSPHOENOLPYRUVATE; PURIFICATION; SEQUENCE; MUTANTS	The Crc protein has been shown to mediate catabolite repression control in Pseudomonas, leading to a preferential assimilation of carbon sources. It has been suggested that Crc acts as a translational repressor of mRNAs, encoding functions involved in uptake and breakdown of different carbon sources. Moreover, the regulatory RNA CrcZ, the level of which is increased in the presence of less preferred carbon sources, was suggested to bind to and sequester Crc, resulting in a relief of catabolite repression. Here, we determined the crystal structure of Pseudomonas aeruginosa Crc, a member of apurinic/apyrimidinic (AP) endonuclease family, at 1.8 angstrom. Although Crc displays high sequence similarity with its orthologs, there are amino acid alterations in the area corresponding to the active site in AP proteins. Unlike typical AP endonuclease family proteins, Crc has a reduced overall positive charge and the conserved positively charged amino-acid residues of the DNA-binding surface of AP proteins are partially substituted by negatively charged, polar and hydrophobic residues. Crc protein purified to homogeneity from P. aeruginosa did neither display DNase activity, nor did it bind to previously identified RNA substrates. Rather, the RNA chaperone Hfq was identified as a contaminant in His-tagged Crc preparations purified by one step Ni-affinity chromatography from Escherichia coli, and was shown to account for the RNA binding activity observed with the His-Crc preparations. Taken together, these data challenge a role of Crc as a direct translational repressor in carbon catabolite repression in P. aeruginosa.	[Milojevic, Tetyana; Sonnleitner, Elisabeth; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria; [Grishkovskaya, Irina; Djinovic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria; [Djinovic-Carugo, Kristina] Univ Ljubljana, Dept Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Ljubljana	Djinovic-Carugo, K (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria.	Kristina.Djinovic-Carugo@univie.ac.at; Udo.Blaesi@univie.ac.at	Milojevic, Tetyana/AFW-4158-2022; Djinovic-Carugo, Kristina/AAW-1167-2021	Milojevic, Tetyana/0000-0001-8415-1890; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Grishkovskaya, Irina/0000-0003-0164-9373; Sonnleitner, Elisabeth/0000-0002-6961-9536	Austrian Science Fund [T448-B20, F1722, F43, AF04311]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by grants T448-B20 (E. S.), F1722 (K.Dj.C.) and F43 "Regulation of the Transcriptome'', sub-project AF04311 (U. B.) by the Austrian Science Fund. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DURHAM DR, 1982, J BACTERIOL, V149, P534, DOI 10.1128/JB.149.2.534-541.1982; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hernandez-Arranz S, 2013, ENVIRON MICROBIOL, V15, P227, DOI 10.1111/j.1462-2920.2012.02863.x; Huang JF, 2012, APPL ENVIRON MICROB, V78, P5016, DOI 10.1128/AEM.00026-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Linares JF, 2010, ENVIRON MICROBIOL, V12, P3196, DOI 10.1111/j.1462-2920.2010.02292.x; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; MacGregor CH, 1996, J BACTERIOL, V178, P5627, DOI 10.1128/jb.178.19.5627-5635.1996; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Moreno R, 2007, MOL MICROBIOL, V64, P665, DOI 10.1111/j.1365-2958.2007.05685.x; Moreno R, 2012, MOL MICROBIOL, V83, P24, DOI 10.1111/j.1365-2958.2011.07912.x; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; PHILLIPS AT, 1981, J BACTERIOL, V145, P1286, DOI 10.1128/JB.145.3.1286-1292.1981; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; SIEGEL LS, 1977, J BACTERIOL, V129, P87, DOI 10.1128/JB.129.1.87-96.1977; SMYTH PF, 1975, J GEN MICROBIOL, V90, P81, DOI 10.1099/00221287-90-1-81; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wei Y, 2013, IUBMB LIFE, V65, P50, DOI 10.1002/iub.1103; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991	38	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64609	10.1371/journal.pone.0064609	http://dx.doi.org/10.1371/journal.pone.0064609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717639	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600070
J	Wang, H; Liu, B; Wang, Q; Wang, L				Wang, Hui; Liu, Bin; Wang, Quan; Wang, Lei			Genome-Wide Analysis of the Salmonella Fis Regulon and Its Regulatory Mechanism on Pathogenicity Islands	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NUCLEOID-ASSOCIATED PROTEIN; ARAC/XYLS FAMILY-MEMBERS; ESCHERICHIA-COLI; GENE-EXPRESSION; H-NS; RNA-SEQ; DIFFERENTIAL REGULATION; BIOSYNTHETIC GENES; SECRETION SYSTEM	Fis, one of the most important nucleoid-associated proteins, functions as a global regulator of transcription in bacteria that has been comprehensively studied in Escherichia coli K12. Fis also influences the virulence of Salmonella enterica and pathogenic E. coli by regulating their virulence genes, however, the relevant mechanism is unclear. In this report, using combined RNA-seq and chromatin immunoprecipitation (ChIP)-seq technologies, we first identified 1646 Fis-regulated genes and 885 Fis-binding targets in the S. enterica serovar Typhimurium, and found a Fis regulon different from that in E. coli. Fis has been reported to contribute to the invasion ability of S. enterica. By using cell infection assays, we found it also enhances the intracellular replication ability of S. enterica within macrophage cell, which is of central importance for the pathogenesis of infections. Salmonella pathogenicity islands (SPI)-1 and SPI-2 are crucial for the invasion and survival of S. enterica in host cells. Using mutation and overexpression experiments, real-time PCR analysis, and electrophoretic mobility shift assays, we demonstrated that Fis regulates 63 of the 94 Salmonella pathogenicity island (SPI)-1 and SPI-2 genes, by three regulatory modes: i) binds to SPI regulators in the gene body or in upstream regions; ii) binds to SPI genes directly to mediate transcriptional activation of themselves and downstream genes; iii) binds to gene encoding OmpR which affects SPI gene expression by controlling SPI regulators SsrA and HilD. Our results provide new insights into the impact of Fis on SPI genes and the pathogenicity of S. enterica.	[Wang, Hui; Liu, Bin; Wang, Quan; Wang, Lei] Nankai Univ, TEDA, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Wang, Hui; Liu, Bin; Wang, Quan; Wang, Lei] Tianjin Key Lab Microbial Funct Genom, Tianjin, Peoples R China; [Wang, Lei] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin, Peoples R China	Nankai University	Wang, L (corresponding author), Nankai Univ, TEDA, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Wang, Lei/C-5176-2009	Wang, Lei/0000-0003-4427-0881	National Key Programs for Infectious Diseases of China [2013ZX10004-216-001]; National 973 Program of China Grant [2012CB721001]; National Natural Science Foundation of China (NSFC) [31030002]; NSFC General Program Grant [81171524, 31270003]	National Key Programs for Infectious Diseases of China; National 973 Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC General Program Grant	This work was supported by the National Key Programs for Infectious Diseases of China (2013ZX10004-216-001); the National 973 Program of China Grant (2012CB721001); the National Natural Science Foundation of China (NSFC) Key Program Grant 31030002; the NSFC General Program Grant (81171524, 31270003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 2003, MOL MICROBIOL, V47, P715, DOI 10.1046/j.1365-2958.2003.03322.x; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; BARACCHINI E, 1991, J BIOL CHEM, V266, P11753; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bokal AJ, 1997, EMBO J, V16, P154, DOI 10.1093/emboj/16.1.154; Bowden SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013871; Browning DF, 2004, MOL MICROBIOL, V51, P241, DOI 10.1046/j.1365-2958.2003.03824.x; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; CHEN YM, 1987, MOL GEN GENET, V210, P331, DOI 10.1007/BF00325702; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Gerlach RG, 2008, CELL MICROBIOL, V10, P2364, DOI 10.1111/j.1462-5822.2008.01218.x; Goldberg MD, 2001, MOL MICROBIOL, V41, P549, DOI 10.1046/j.1365-2958.2001.02526.x; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Hengen PN, 1997, NUCLEIC ACIDS RES, V25, P4994, DOI 10.1093/nar/25.24.4994; Husnain SI, 2008, MICROBIOL-SGM, V154, P1729, DOI 10.1099/mic.0.2008/016774-0; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Karambelkar S, 2012, NUCLEIC ACIDS RES, V40, P4358, DOI 10.1093/nar/gks037; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Morett E, 1998, FEBS LETT, V433, P108, DOI 10.1016/S0014-5793(98)00888-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagarajavel V, 2007, J BIOL CHEM, V282, P23622, DOI 10.1074/jbc.M702753200; Nasser W, 2002, EMBO J, V21, P715, DOI 10.1093/emboj/21.4.715; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Schechter LM, 2001, MOL MICROBIOL, V40, P1289, DOI 10.1046/j.1365-2958.2001.02462.x; Schneider R, 1997, MOL MICROBIOL, V26, P519, DOI 10.1046/j.1365-2958.1997.5951971.x; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P5275, DOI 10.1093/nar/gkm471; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ussery D, 2001, BIOCHIMIE, V83, P201, DOI 10.1016/S0300-9084(00)01225-6; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Weinstein-Fischer D, 2000, MOL MICROBIOL, V35, P1413, DOI 10.1046/j.1365-2958.2000.01805.x; Weinstein-Fischer D, 2007, MOL MICROBIOL, V63, P1131, DOI 10.1111/j.1365-2958.2006.05569.x; Wilson RL, 2001, MOL MICROBIOL, V39, P79, DOI 10.1046/j.1365-2958.2001.02192.x; YAMADA M, 1988, J MOL BIOL, V203, P569, DOI 10.1016/0022-2836(88)90193-3; Zhi HJ, 2003, J BIOL CHEM, V278, P47340, DOI 10.1074/jbc.M305430200	81	22	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64688	10.1371/journal.pone.0064688	http://dx.doi.org/10.1371/journal.pone.0064688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717649	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600074
J	Allais-Bonnet, A; Grohs, C; Medugorac, I; Krebs, S; Djari, A; Graf, A; Fritz, S; Seichter, D; Baur, A; Russ, I; Bouet, S; Rothammer, S; Wahlberg, P; Esquerre, D; Hoze, C; Boussaha, M; Weiss, B; Thepot, D; Fouilloux, MN; Rossignol, MN; van Marle-Koster, E; Hreidarsdottir, GE; Barbey, S; Dozias, D; Cobo, E; Reverse, P; Catros, O; Marchand, JL; Soulas, P; Roy, P; Marquant-Leguienne, B; Le Bourhis, D; Clement, L; Salas-Cortes, L; Venot, E; Pannetier, M; Phocas, F; Klopp, C; Rocha, D; Fouchet, M; Journaux, L; Bernard-Capel, C; Ponsart, C; Eggen, A; Blum, H; Gallard, Y; Boichard, D; Pailhoux, E; Capitan, A				Allais-Bonnet, Aurelie; Grohs, Cecile; Medugorac, Ivica; Krebs, Stefan; Djari, Anis; Graf, Alexander; Fritz, Sebastien; Seichter, Doris; Baur, Aurelia; Russ, Ingolf; Bouet, Stephan; Rothammer, Sophie; Wahlberg, Per; Esquerre, Diane; Hoze, Chris; Boussaha, Mekki; Weiss, Bernard; Thepot, Dominique; Fouilloux, Marie-Noelle; Rossignol, Marie-Noelle; van Marle-Koster, Este; Hreidarsdottir, Gunnfridur Elin; Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Reverse, Patrick; Catros, Olivier; Marchand, Jean-Luc; Soulas, Pascal; Roy, Pierre; Marquant-Leguienne, Brigitte; Le Bourhis, Daniel; Clement, Laetitia; Salas-Cortes, Laura; Venot, Eric; Pannetier, Maelle; Phocas, Florence; Klopp, Christophe; Rocha, Dominique; Fouchet, Michel; Journaux, Laurent; Bernard-Capel, Carine; Ponsart, Claire; Eggen, Andre; Blum, Helmut; Gallard, Yves; Boichard, Didier; Pailhoux, Eric; Capitan, Aurelien			Novel Insights into the Bovine Polled Phenotype and Horn Ontogenesis in Bovidae	PLOS ONE			English	Article							INSULIN-LIKE FACTOR-3; DECREASES COLLAGEN-SYNTHESIS; WNT/BETA-CATENIN; GENE; RELAXIN; MUTATIONS; ASSOCIATION; EXPRESSION; RECEPTORS; CATTLE	Despite massive research efforts, the molecular etiology of bovine polledness and the developmental pathways involved in horn ontogenesis are still poorly understood. In a recent article, we provided evidence for the existence of at least two different alleles at the Polled locus and identified candidate mutations for each of them. None of these mutations was located in known coding or regulatory regions, thus adding to the complexity of understanding the molecular basis of polledness. We confirm previous results here and exhaustively identify the causative mutation for the Celtic allele (P-C) and four candidate mutations for the Friesian allele (P-F). We describe a previously unreported eyelash-and-eyelid phenotype associated with regular polledness, and present unique histological and gene expression data on bovine horn bud differentiation in fetuses affected by three different horn defect syndromes, as well as in wild-type controls. We propose the ectopic expression of a lincRNA in P-C/p horn buds as a probable cause of horn bud agenesis. In addition, we provide evidence for an involvement of OLIG2, FOXL2 and RXFP2 in horn bud differentiation, and draw a first link between bovine, ovine and caprine Polled loci. Our results represent a first and important step in understanding the genetic pathways and key process involved in horn bud differentiation in Bovidae.	[Allais-Bonnet, Aurelie; Thepot, Dominique; Le Bourhis, Daniel; Pannetier, Maelle; Pailhoux, Eric] INRA, Biol Dev & Reprod UMR 1198, Jouy En Josas, France; [Grohs, Cecile; Fritz, Sebastien; Baur, Aurelia; Bouet, Stephan; Wahlberg, Per; Hoze, Chris; Boussaha, Mekki; Weiss, Bernard; Venot, Eric; Phocas, Florence; Rocha, Dominique; Eggen, Andre; Boichard, Didier; Capitan, Aurelien] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Medugorac, Ivica; Rothammer, Sophie] Univ Munich, Chair Anim Genet & Husb, Munich, Germany; [Krebs, Stefan; Graf, Alexander; Blum, Helmut] Univ Munich, Lab Funct Genome Anal, Gene Ctr, Munich, Germany; [Djari, Anis; Klopp, Christophe] INRA, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Fritz, Sebastien; Baur, Aurelia; Hoze, Chris; Marquant-Leguienne, Brigitte; Le Bourhis, Daniel; Clement, Laetitia; Salas-Cortes, Laura; Journaux, Laurent; Ponsart, Claire; Capitan, Aurelien] Natl Assoc Livestock & Artificial Inseminat Coope, Paris, France; [Seichter, Doris; Russ, Ingolf] Tierzuchtforsch eV Munchen, Grub, Germany; [Esquerre, Diane] Genotoul, GeT PlaGe, Castanet Tolosan, France; [Esquerre, Diane] INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Fouilloux, Marie-Noelle; Bernard-Capel, Carine] Inst Elevage, Paris, France; [Rossignol, Marie-Noelle] Genet Anal Lab Anim Species, Jouy En Josas, France; [van Marle-Koster, Este] Univ Pretoria, Dept Anim & Wildlife Sci, ZA-0002 Pretoria, South Africa; [Hreidarsdottir, Gunnfridur Elin] Farmers Assoc Iceland, Reykjavik, Iceland; [Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Gallard, Yves] INRA, Domaine Expt Pin au Haras UE0326, Exmes, France; [Reverse, Patrick; Fouchet, Michel] Genes Diffus, Douai, France; [Catros, Olivier; Marchand, Jean-Luc] Evolution, Rennes, France; [Soulas, Pascal] UCATRC, Lempdes, France; [Roy, Pierre] UALC, Naves, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Munich; University of Munich; INRAE; INRAE; University of Pretoria; INRAE	Capitan, A (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	aurelien.capitan@jouy.inra.fr	Van Marle-Köster, Este/S-2197-2016; Rocha, Dominique/R-5546-2019; Boichard, Didier/AAD-8675-2020; Klopp, Christophe/J-3164-2019; Emilie, Cobo/AAM-9178-2021; Pannetier, Maëlle/AAQ-1626-2020; Capitan, Aurélien/M-3732-2015; Phocas, Florence/V-9579-2019	Van Marle-Köster, Este/0000-0002-3672-6976; Rocha, Dominique/0000-0003-4998-9641; Boichard, Didier/0000-0003-0361-2961; Klopp, Christophe/0000-0001-7126-5477; Emilie, Cobo/0000-0003-2902-5730; Ponsart, Claire/0000-0002-9633-4464; ROSSIGNOL, Marie-Noelle/0000-0003-1673-5258; boussaha, mekki/0000-0002-5432-4604; FRITZ, Sebastien/0000-0002-3378-1048; Pannetier, Maelle/0000-0002-5826-619X; Medugorac, Ivica/0000-0002-6891-3039; Seichter, Doris/0000-0002-0325-1134; Rothammer, Sophie/0000-0001-5704-5814; Phocas, Florence/0000-0003-1161-3665	Apis Gene "Hornout"; Institut National de la Recherche Agronomique-DGA "Interpolled" grant; Institut National de la Recherche Agronomique-DGA "Hornaseq" grant	Apis Gene "Hornout"; Institut National de la Recherche Agronomique-DGA "Interpolled" grant; Institut National de la Recherche Agronomique-DGA "Hornaseq" grant	This project was funded by Apis Gene "Hornout" and Institut National de la Recherche Agronomique-DGA "Interpolled" and "Hornaseq" grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; BILDSOE H, 2012, DEV BIOL, DOI DOI 10.1016/J.YDBI0.2012.12.004; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bruchle NO, 2008, J INVEST DERMATOL, V128, P791, DOI 10.1038/sj.jid.5701088; CAPITAN A, 2010, THESIS I SCI IND VIV; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cargill Edward J, 2008, BMC Res Notes, V1, P128, DOI 10.1186/1756-0500-1-128; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cervantes-Barragan DE, 2011, J MED GENET, V48, P716, DOI 10.1136/jmedgenet-2011-100251; COLE LJ, 1924, P WORLDS DAIRY C, V2, P1383; Cooney TE, 2009, ANN NY ACAD SCI, V1160, P329, DOI 10.1111/j.1749-6632.2008.03801.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Delalande JM, 2008, DEV DYNAM, V237, P1060, DOI 10.1002/dvdy.21485; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Drogemuller C, 2005, COMP FUNCT GENOM, V6, P194, DOI 10.1002/cfg.476; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI [10.1359/jbmr.080204, 10.1359/JBMR.080204]; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Ferlin A, 2009, ANN NY ACAD SCI, V1160, P215, DOI 10.1111/j.1749-6632.2008.03787.x; Fu P, 2006, J ENDOCRINOL, V189, P397, DOI 10.1677/joe.1.06697; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; HERODOTUS, HISTORY; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Lee WJ, 2012, PLAST RECONSTR SURG, V130, p407E, DOI 10.1097/PRS.0b013e31825dbf56; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LLOYDJONES O, 1916, IOWA AGR EXP STA AME, V30, P67; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; LONG SE, 1970, VET REC, V86, P161, DOI 10.1136/vr.86.6.161; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; MANSOUR S, 1993, GENEREVIEWS; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; MARQUANTLEGUIEN.B, 2011, REPROD FERT DEVELOP, V24, P198; Maruhashi M, 2005, DEV DYNAM, V234, P332, DOI 10.1002/dvdy.20546; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Misch LJ, 2007, CAN VET J, V48, P1249; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pepe A, 2009, ANN NY ACAD SCI, V1160, P219, DOI 10.1111/j.1749-6632.2008.03785.x; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; ROMAN A, 2004, B SOC FR HIST MED SC, V3, P35; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2003, ARCH BIOCHEM BIOPHYS, V411, P47, DOI 10.1016/S0003-9861(02)00710-5; SCHMULIAN A, 2006, THESIS U PRETORIA PR; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; SPECHT LW, 2008, POLLED HOLSTEIN HIST; SPILLMAN WJ, 1906, P AM BREEDERS ASS, V1, P171; TACITUS, OXFORD TRANSLATION R; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; UNEMORI EN, 1992, J INVEST DERMATOL, V99, P337, DOI 10.1111/1523-1747.ep12616665; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	86	70	76	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63512	10.1371/journal.pone.0063512	http://dx.doi.org/10.1371/journal.pone.0063512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717440	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700030
J	Chang, Y; Sung, E; Yun, KE; Jung, HS; Kim, CW; Kwon, MJ; Cho, SI; Ryu, S				Chang, Yoosoo; Sung, Eunju; Yun, Kyung Eun; Jung, Hyun-Suk; Kim, Chan-Won; Kwon, Min-Jung; Cho, Sung-Il; Ryu, Seungho			Weight Change as a Predictor of Incidence and Remission of Insulin Resistance	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; BARIATRIC SURGERY; ADIPOSE-TISSUE; OBESITY; ADIPONECTIN; ADIPOKINES; LEPTIN; GAIN; HYPERINSULINEMIA	Objective: The objective of this study was to assess the longitudinal relationship of weight change on incidence and remission of insulin resistance (IR). Methods: We performed a cohort study in apparently healthy Korean men, 30 to 59 years of age, who underwent a health checkup and were followed annually or biennially between 2002 and 2009. The computer model of homeostasis model assessment, HOMA2-IR, was obtained at each visit, and IR was defined as HOMA2-IR >= 75th percentile. Results: For IR development, 1,755 of the 6,612 IR-free participants at baseline developed IR (rate 5.1 per 100 person-years) during 34,294.8 person-years of follow-up. The hazard ratios (95% confidence intervals) for incident IR with weight changes of <-0.9 kg, 0.6-2.1 kg and >= 2.2 kg from visit 1 to visit 2 (average 1.8 years) compared to weight change of -0.9-0.5 kg (reference) were 0.78 (0.68-0.90), 1.19 (1.04-1.35) and 1.26 (1.11-1.44), respectively. This association persisted in normal-weight individuals or those without any metabolic syndrome traits and remained significant after introducing weight categories and confounders as time-dependent exposures (P-trend <0.001). For IR remission, 903 of 1,696 IR participants had no IR (remission rate 10.3 per 100 person-years) during 8,777.4 person-years of follow-up. IR remission decreased with increasing quartiles of weight change (P-trend <0.001) and this association persisted in normal-weight individuals. Conclusions: Weight gain was associated with increased IR development and decreased IR remission regardless of baseline BMI status. Preventing weight gain, even in healthy and normal-weight individuals, is an important strategy for reducing IR and its associated consequences.	[Chang, Yoosoo; Yun, Kyung Eun; Jung, Hyun-Suk; Kim, Chan-Won; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr,Ctr Cohort Studies, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Sung, Eunju] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea; [Kwon, Min-Jung] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Cho, Sung-Il] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Cho, Sung-Il] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU)	Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr,Ctr Cohort Studies, Seoul, South Korea.	sh703.yoo@gmail.com	; Cho, Sung-il/D-5703-2012	Ryu, Seungho/0000-0002-3927-8646; Kim, Chan-Won/0000-0001-5836-1974; Cho, Sung-il/0000-0003-4085-1494; Chang, Yoosoo/0000-0002-6945-9050; SUNG, EUNJU/0000-0002-6045-3154				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson JW, 2003, J AM COLL NUTR, V22, P331, DOI 10.1080/07315724.2003.10719316; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bonora E, 2007, DIABETES CARE, V30, P318, DOI 10.2337/dc06-0919; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Chang Y, 2012, INT J OBESITY, V36, P1187, DOI 10.1038/ijo.2011.247; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Erdmann J, 2008, AM J PHYSIOL-ENDOC M, V294, pE568, DOI 10.1152/ajpendo.00560.2007; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Everson SA, 1998, DIABETES CARE, V21, P1637, DOI 10.2337/diacare.21.10.1637; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Iniguez G, 2004, J CLIN ENDOCR METAB, V89, P5500, DOI 10.1210/jc.2004-0792; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Klimcakova E, 2010, OBES REV, V11, P446, DOI 10.1111/j.1467-789X.2009.00704.x; Kumar AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032395; Lakka HM, 2002, HORM METAB RES, V34, P492, DOI 10.1055/s-2002-34788; Lang HF, 2011, NUTR RES, V31, P378, DOI 10.1016/j.nutres.2011.04.004; Lankinen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022646; Lee YH, 2011, METABOLISM, V60, P1664, DOI 10.1016/j.metabol.2011.04.008; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maison P, 2001, DIABETES CARE, V24, P1758, DOI 10.2337/diacare.24.10.1758; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Padwal Raj S, 2009, Evid Based Med, V14, P138, DOI 10.1136/ebm.14.5.138; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Petridou ET, 2011, METABOLISM, V60, P1100, DOI 10.1016/j.metabol.2010.12.002; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2012, AM J EPIDEMIOL, V175, P133, DOI 10.1093/aje/kwr291; Samocha-Bonet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036320; Sesti G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017737; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Verhagen SN, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-100; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; *WHO, WHO W PAC REG IAI AS	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63690	10.1371/journal.pone.0063690	http://dx.doi.org/10.1371/journal.pone.0063690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717466	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700049
J	Graham, JM; Ayati, BP; Holstein, SA; Martin, JA				Graham, Jason M.; Ayati, Bruce P.; Holstein, Sarah A.; Martin, James A.			The Role of Osteocytes in Targeted Bone Remodeling: A Mathematical Model	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; RANK LIGAND; SCLEROSTIN; OSTEOPROTEGERIN; RESORPTION; BIOLOGY; LAW; OSTEOPOROSIS; SIMULATION; OSTEOBLAST	Until recently many studies of bone remodeling at the cellular level have focused on the behavior of mature osteoblasts and osteoclasts, and their respective precursor cells, with the role of osteocytes and bone lining cells left largely unexplored. This is particularly true with respect to the mathematical modeling of bone remodeling. However, there is increasing evidence that osteocytes play important roles in the cycle of targeted bone remodeling, in serving as a significant source of RANKL to support osteoclastogenesis, and in secreting the bone formation inhibitor sclerostin. Moreover, there is also increasing interest in sclerostin, an osteocyte-secreted bone formation inhibitor, and its role in regulating local response to changes in the bone microenvironment. Here we develop a cell population model of bone remodeling that includes the role of osteocytes, sclerostin, and allows for the possibility of RANKL expression by osteocyte cell populations. We have aimed to give a simple, yet still tractable, model that remains faithful to the underlying system based on the known literature. This model extends and complements many of the existing mathematical models for bone remodeling, but can be used to explore aspects of the process of bone remodeling that were previously beyond the scope of prior modeling work. Through numerical simulations we demonstrate that our model can be used to explore theoretically many of the qualitative features of the role of osteocytes in bone biology as presented in recent literature.	[Graham, Jason M.] Univ Scranton, Dept Math, Scranton, PA 18510 USA; [Ayati, Bruce P.] Univ Iowa, Dept Math, Iowa City, IA 52242 USA; [Ayati, Bruce P.] Univ Iowa, Program Appl Math & Computat Sci, Iowa City, IA USA; [Holstein, Sarah A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Ayati, Bruce P.; Martin, James A.] Univ Iowa, Dept Orthopaed & Rehabil, Iowa City, IA USA	University of Scranton; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Graham, JM (corresponding author), Univ Scranton, Dept Math, Scranton, PA 18510 USA.		Ayati, Bruce P/J-6427-2012	Ayati, Bruce P/0000-0002-4472-6271; Martin, James/0000-0001-5085-0108; Graham, James/0000-0003-4778-2161	National Science Foundation (NSF) [DMS-0914514]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1 P50 AR055533]; PhRMA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055533] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PhRMA Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	BPA was partially supported by the National Science Foundation (NSF) under award DMS-0914514. JAM and BPA were partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant #1 P50 AR055533. SAH was partially supported by the PhRMA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardawi MSM, 2012, J BONE MINER RES, V27, P2592, DOI 10.1002/jbmr.1718; Ayati B, 2012, P 6 EUR C COMP METH; Ayati BP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-28; Bell NH, 2003, J CLIN INVEST, V111, P1120, DOI 10.1172/JCI200318358; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunetti G, 2011, ANN NY ACAD SCI, V1237, P19, DOI 10.1111/j.1749-6632.2011.06196.x; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; Buenzli PR, 2012, J THEOR BIOL, V307, P42, DOI 10.1016/j.jtbi.2012.04.019; Buenzli PR, 2012, BONE, V50, P378, DOI 10.1016/j.bone.2011.10.021; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cohen MM, 1997, J BONE MINER RES, V12, P322, DOI 10.1359/jbmr.1997.12.3.322; Defranoux NA, 2005, J BONE MINER RES, V20, P1079, DOI 10.1359/JBMR.050401; Geris L, 2010, BIOMECH MODEL MECHAN, V9, P713, DOI 10.1007/s10237-010-0208-8; Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008; Geris L, 2006, MED BIOL ENG COMPUT, V44, P280, DOI 10.1007/s11517-006-0040-6; Geris L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000915; Geris L, 2010, ACTA BIOTHEOR, V58, P355, DOI 10.1007/s10441-010-9112-y; Giuliani N, 2012, LEUKEMIA, V26, P1391, DOI 10.1038/leu.2011.381; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Graham JM, 2012, MATH BIOSCI ENG, V9, P281, DOI 10.3934/mbe.2012.9.281; Heino Terhi J, 2009, Technol Health Care, V17, P49, DOI 10.3233/THC-2009-0534; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642; Komarova SV, 2003, BONE, V33, P206, DOI 10.1016/S8756-3282(03)00157-1; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Lewiecki EM, 2011, DISCOV MED, V12, P263; Lim V, 2012, MATURITAS, V73, P269, DOI 10.1016/j.maturitas.2012.08.002; Lio P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S12; Martin MJ, 2005, CALCIFIED TISSUE INT, V77, P250, DOI 10.1007/s00223-005-0101-0; Martin MJ, 2004, BONE, V35, P918, DOI 10.1016/j.bone.2004.06.010; Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243; Neve A, 2012, ACTA PHYSIOL, V204, P317, DOI 10.1111/j.1748-1716.2011.02385.x; Parfitt A, 2012, BONE; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Pivonka P, 2010, BONE, V47, P181, DOI 10.1016/j.bone.2010.04.601; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Rossi J, 2012, COMPUT METH IN PRESS; Ryser MD, 2010, SIAM J APPL MATH, V70, P1899, DOI 10.1137/090746094; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shampine LF, 2003, SOLVING ODES MATLAB, DOI [10.1017/CBO9780511615542, DOI 10.1017/CB09780511615542.AVAILABLE:H]; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Udagawa N., 2002, PRINCIPLES BONE BIOL, V2nd ed.; Voit E. O., 2000, COMPUTATIONAL ANAL B; Xiong J, 2002, NAT MED, V17, P1235; Xu J, 2012, CLIN BIOCH IN PRESS; Yavropoulou MP, 2012, BONE, V51, P153, DOI 10.1016/j.bone.2012.04.016; Zumsande M, 2011, BONE, V48, P910, DOI 10.1016/j.bone.2010.12.010	59	60	61	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63884	10.1371/journal.pone.0063884	http://dx.doi.org/10.1371/journal.pone.0063884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717504	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700076
J	Hermes, M; Albrecht, C; Schrod, A; Brameier, M; Walter, L				Hermes, Meike; Albrecht, Christina; Schrod, Annette; Brameier, Markus; Walter, Lutz			Expression Patterns of Killer Cell Immunoglobulin-Like Receptors (KIR) of NK-Cell and T-Cell Subsets in Old World Monkeys	PLOS ONE			English	Article							IG-LIKE RECEPTOR; RHESUS MACAQUES; FUNCTIONAL-CHARACTERIZATION; CYNOMOLGUS MACAQUES; HLA-C; HAPLOTYPES; NKG2A; IDENTIFICATION; REPERTOIRES; RECOGNITION	The expression of killer cell immunoglobulin-like receptors (KIR) on lymphocytes of rhesus macaques and other Old World monkeys was unknown so far. We used our recently established monoclonal anti-rhesus macaque KIR antibodies in multicolour flow cytometry for phenotypic characterization of KIR protein expression on natural killer (NK) cells and T cell subsets of rhesus macaques, cynomolgus macaques, hamadryas baboons, and African green monkeys. Similar to human KIR, we found clonal expression patterns of KIR on NK and T cell subsets in rhesus macaques and differences between individuals using pan-KIR3D antibody 1C7 and antibodies specific for single KIR. Similar results were obtained with lymphocytes from the other studied species. Notably, African green monkeys show only a low frequency of KIR3D expressed on CD8(+) alpha beta T cells. Contrasting human NK cells are KIR-positive CD56bright NK cells and frequencies of KIR-expressing NK cells that are independent of the presence of their cognate MHC class I ligands in rhesus macaques. Interestingly, the frequency of KIR-expressing cells and the expression strength of KIR3D are correlated in gamma delta T cells of rhesus macaques and CD8(+) alpha beta T cells of baboons.	[Hermes, Meike; Albrecht, Christina; Brameier, Markus; Walter, Lutz] Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Schrod, Annette] Leibniz Inst Primate Res, German Primate Ctr, Pathol Unit, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Walter, L (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Primate Genet Lab, Gottingen, Germany.	lwalter@gwdg.de	Walter, Lutz/I-2606-2017	Walter, Lutz/0000-0001-9408-3131				Abi-Rached L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001192; Anfossi N, 2001, IMMUNOL REV, V181, P269, DOI 10.1034/j.1600-065X.2001.1810123.x; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Biassoni R, 2005, J IMMUNOL, V174, P5695, DOI 10.4049/jimmunol.174.9.5695; Bimber BN, 2008, J IMMUNOL, V181, P6301, DOI 10.4049/jimmunol.181.9.6301; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Blokhuis JH, 2011, EUR J IMMUNOL, V41, P2719, DOI 10.1002/eji.201141621; Blokhuis JH, 2010, IMMUNOGENETICS, V62, P295, DOI 10.1007/s00251-010-0434-3; Blokhuis JH, 2009, IMMUNOGENETICS, V61, P503, DOI 10.1007/s00251-009-0379-6; Blokhuis JH, 2009, MOL IMMUNOL, V46, P640, DOI 10.1016/j.molimm.2008.08.270; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Brown KN, 2009, J MED PRIMATOL, V38, P272, DOI 10.1111/j.1600-0684.2009.00353.x; Carter DL, 1999, CYTOMETRY, V37, P41, DOI 10.1002/(SICI)1097-0320(19990901)37:1<41::AID-CYTO5>3.0.CO;2-4; Chaichompoo P, 2010, CELL IMMUNOL, V263, P176, DOI 10.1016/j.cellimm.2010.03.014; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Colantonio AD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001316; Harris LD, 2010, BLOOD, V116, P4148, DOI 10.1182/blood-2010-05-283549; Hellmann I, 2013, J VIROL, V87, P5305, DOI 10.1128/JVI.02949-12; Hellmann I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002436; Hermes M, 2012, IMMUNOGENETICS, V64, P845, DOI 10.1007/s00251-012-0640-2; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; Hong HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00032; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Johansson S, 2006, CURR TOP MICROBIOL, V298, P259; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Korbel DS, 2009, J IMMUNOL, V182, P6426, DOI 10.4049/jimmunol.0804224; Kruse PH, 2010, IMMUNOGENETICS, V62, P281, DOI 10.1007/s00251-010-0433-4; Maloveste SM, 2012, J IMMUNOL, V189, P4338, DOI 10.4049/jimmunol.1201360; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Moreland AJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-295; O'Leary CE, 2009, IMMUNOGENETICS, V61, P689, DOI 10.1007/s00251-009-0397-4; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Otting N, 2008, IMMUNOGENETICS, V60, P507, DOI 10.1007/s00251-008-0311-5; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Rosner C, 2011, J IMMUNOL, V186, P2156, DOI 10.4049/jimmunol.1002634; Rosner C, 2010, IMMUNOGENETICS, V62, P149, DOI 10.1007/s00251-010-0424-5; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; Schonberg K, 2011, BLOOD, V117, P5152, DOI 10.1182/blood-2011-02-334441; Schonberg K, 2011, BLOOD, V117, P98, DOI 10.1182/blood-2010-03-273656; Sivori S, 2010, BLOOD, V116, P1637, DOI 10.1182/blood-2009-12-256586; Uhrberg M, 2001, J IMMUNOL, V166, P3923, DOI 10.4049/jimmunol.166.6.3923; van Bergen J, 2004, J IMMUNOL, V173, P6719, DOI 10.4049/jimmunol.173.11.6719; van Bergen J, 2010, IMMUNOLOGY, V131, P301, DOI 10.1111/j.1365-2567.2010.03337.x; Warren HS, 2006, J LEUKOCYTE BIOL, V79, P1252, DOI 10.1189/jlb.0905536; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x	50	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64936	10.1371/journal.pone.0064936	http://dx.doi.org/10.1371/journal.pone.0064936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717676	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700182
J	Iwashita, H; Shiraki, N; Sakano, D; Ikegami, T; Shiga, M; Kume, K; Kume, S				Iwashita, Hidefumi; Shiraki, Nobuaki; Sakano, Daisuke; Ikegami, Takashi; Shiga, Masanobu; Kume, Kazuhiko; Kume, Shoen			Secreted Cerberus1 as a Marker for Quantification of Definitive Endoderm Differentiation of the Pluripotent Stem Cells	PLOS ONE			English	Article							MOUSE; INDUCTION; EXPRESSION; GENE	To date, CXCR4 and E-cadherin double-positive cells detected by flow cytometry have been used to identify the differentiation of embryonic stem (ES) cells or induced pluripotent stem (iPS) cells into definitive endoderm (DE) lineages. Quantification of DE differentiation from ES/iPS cells by using flow cytometry is a multi-step procedure including dissociation of the cells, antibody reaction, and flow cytometry analysis. To establish a quick assay method for quantification of ES/iPS cell differentiation into the DE without dissociating the cells, we examined whether secreted Cerberus1 (Cer1) protein could be used as a marker. Cer1 is a secreted protein expressed first in the anterior visceral endoderm and then in the DE. The amount of Cer1 secreted correlated with the proportion of CXCR4+/E-Cadherin+ cells that differentiated from mouse ES cells. In addition, we found that human IPS cell-derived DE also expressed the secreted CER1 and that the expression level correlated with the proportion of SOX17+/FOXA2+ cells present. Taken together, these results show that Cer1 (or CER1) serves as a good marker for quantification of DE differentiation of mouse and human ES/IPS cells.	[Shiraki, Nobuaki; Sakano, Daisuke; Kume, Kazuhiko; Kume, Shoen] Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan; [Kume, Shoen] Kumamoto Univ, Global COE, Kumamoto, Japan; [Iwashita, Hidefumi; Ikegami, Takashi; Shiga, Masanobu] Dojindo Labs, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kume, S (corresponding author), Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan.	skume@kumamoto-u.ac.jp	Kume, Shoen/M-4356-2016	Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657; shiraki, nobuaki/0000-0001-6708-9976; Sakano, Daisuke/0000-0001-5305-5556	JST [21390280]; National Institute of Biomedical Innovation; Global COE grant (Cell Fate Regulation Research and Education Unit); Dojindo Laboratories	JST(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Global COE grant (Cell Fate Regulation Research and Education Unit); Dojindo Laboratories(Randox Laboratories)	This work was supported by a Grant-in-Aid (#21390280 to SK and NEXT program from JST to SK), National Institute of Biomedical Innovation (to NS), and, in part, by a Global COE grant (Cell Fate Regulation Research and Education Unit). SK received funding from the Dojindo Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.3.CO;2-W; Belo JA, 2009, INT J DEV BIOL, V53, P1399, DOI 10.1387/ijdb.072297jb; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Lah M, 1999, GENOMICS, V55, P364, DOI 10.1006/geno.1998.5671; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Ogaki S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-13; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shawlot W, 1998, P NATL ACAD SCI USA, V95, P6198, DOI 10.1073/pnas.95.11.6198; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Shiraki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024228; Shiraki N, 2010, CELL STRUCT FUNCT, V35, P73, DOI 10.1247/csf.10004; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Silva AC, 2003, DEVELOPMENT, V130, P4943, DOI 10.1242/dev.00705; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Umeda K, 2013, STEM CELL RES, V10, P179, DOI 10.1016/j.scr.2012.11.003; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	24	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64291	10.1371/journal.pone.0064291	http://dx.doi.org/10.1371/journal.pone.0064291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717584	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700129
J	Ondrovics, M; Silbermayr, K; Mitreva, M; Young, ND; Razzazi-Fazeli, E; Gasser, RB; Joachim, A				Ondrovics, Martina; Silbermayr, Katja; Mitreva, Makedonka; Young, Neil D.; Razzazi-Fazeli, Ebrahim; Gasser, Robin B.; Joachim, Anja			Proteomic Analysis of Oesophagostomum dentatum (Nematoda) during Larval Transition, and the Effects of Hydrolase Inhibitors on Development	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; IN-VITRO DEVELOPMENT; CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; ASCARIS-SUUM; STRONGYLID NEMATODES; ROUNDWORM ASCARIS; 4TH-STAGE LARVAE; DRUG-RESISTANCE; BRUGIA-MALAYI	In this study, in vitro drug testing was combined with proteomic and bioinformatic analyses to identify and characterize proteins involved in larval development of Oesophagostomum dentatum, an economically important parasitic nematode. Four hydrolase inhibitors o-phenanthroline, sodium fluoride, iodoacetamide and 1,2-epoxy-3-(pnitrophenoxy)-propane (EPNP) significantly inhibited (>= 90%) larval development. Comparison of the proteomic profiles of the development-inhibited larvae with those of uninhibited control larvae using two-dimensional gel electrophoresis, and subsequent MALDI-TOF mass spectrometric analysis identified a down-regulation of 12 proteins inferred to be involved in various larval developmental processes, including post-embryonic development and growth. Furthermore, three proteins (i.e. intermediate filament protein B, tropomyosin and peptidyl-prolyl cis-trans isomerase) inferred to be involved in the moulting process were down-regulated in moulting-and development-inhibited O. dentatum larvae. This first proteomic map of O. dentatum larvae provides insights in the protein profile of larval development in this parasitic nematode, and significantly improves our understanding of the fundamental biology of its development. The results and the approach used might assist in developing new interventions against parasitic nematodes by blocking or disrupting their key biological pathways.	[Ondrovics, Martina; Silbermayr, Katja; Joachim, Anja] Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Young, Neil D.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Razzazi-Fazeli, Ebrahim] Univ Vet Med Vienna, VetCore Facil Res, Vienna, Austria	University of Veterinary Medicine Vienna; Washington University (WUSTL); Washington University (WUSTL); University of Melbourne; University of Veterinary Medicine Vienna	Ondrovics, M (corresponding author), Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria.	Martina.Ondrovics@vetmeduni.ac.at	Gasser, Robin/ABH-6185-2020; Young, Neil David/AAU-4572-2020	Gasser, Robin/0000-0002-4423-1690; Young, Neil David/0000-0001-8756-229X; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301; Joachim, Anja/0000-0003-3082-6885; Mitreva, Makedonka/0000-0001-9572-3436	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Alexander von Humboldt Foundation; National Institutes of Health [AI081803]; DOC-fFORTE-fellowship of the Austrian Academy of Sciences	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOC-fFORTE-fellowship of the Austrian Academy of Sciences	MO is recipient of a DOC-fFORTE-fellowship of the Austrian Academy of Sciences. Funding support to RBG from the Australian Research Council (ARC), the National Health and Medical Research Council (NHMRC) and the Alexander von Humboldt Foundation is gratefully acknowledged. Work at Washington University is supported by National Institutes of Health grant AI081803 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Anyanful A, 2001, J MOL BIOL, V313, P525, DOI 10.1006/jmbi.2001.5052; Artis D, 2006, INT J PARASITOL, V36, P723, DOI 10.1016/j.ijpara.2006.02.011; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Cantacessi C, 2012, PARASITE IMMUNOL, V34, P265, DOI 10.1111/j.1365-3024.2011.01304.x; Cantacessi C, 2012, BIOTECHNOL ADV, V30, P469, DOI 10.1016/j.biotechadv.2011.08.016; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Coles GC, 2001, VET PARASITOL, V98, P31, DOI 10.1016/S0304-4017(01)00421-6; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Daugschies A, 1999, PARASITOL RES, V85, P158, DOI 10.1007/s004360050527; Daugschies A, 1995, EXP PARASITOL, V81, P574, DOI 10.1006/expr.1995.1151; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ford L, 2005, J BIOL CHEM, V280, P40845, DOI 10.1074/jbc.M504434200; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gasser RB, 2007, BIOTECHNOL ADV, V25, P281, DOI 10.1016/j.biotechadv.2007.01.008; GEMS D, 1995, J BIOL CHEM, V270, P18517, DOI 10.1074/jbc.270.31.18517; Guiliano DB, 2004, MOL BIOCHEM PARASIT, V136, P227, DOI 10.1016/j.molbiopara.2004.03.015; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; Harhay MO, 2010, EXPERT REV ANTI-INFE, V8, P219, DOI [10.1586/eri.09.119, 10.1586/ERI.09.119]; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; HOTEZ P, 1990, INFECT IMMUN, V58, P3883, DOI 10.1128/IAI.58.12.3883-3892.1990; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Huang YJ, 1998, ARCH BIOCHEM BIOPHYS, V352, P263, DOI 10.1006/abbi.1998.0596; Inoue T, 1997, ARCH BIOCHEM BIOPHYS, V339, P226, DOI 10.1006/abbi.1996.9813; Islam MK, 2003, EUR J BIOCHEM, V270, P2814, DOI 10.1046/j.1432-1033.2003.03658.x; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Jeong Pan-Young, 2009, V519, P145, DOI 10.1007/978-1-59745-281-6_10; Joachim A, 2008, PARASITOLOGY, V135, P1215, DOI 10.1017/S0031182008004769; Joachim A, 2001, PARASITOL RES, V87, P37, DOI 10.1007/s004360000305; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; KLEIN RD, 1992, MOL BIOCHEM PARASIT, V50, P285, DOI 10.1016/0166-6851(92)90226-A; KOTLAN A., 1948, ACTA VET HUNGARICA, V1, P14; KRAUSE M, 1989, J MOL BIOL, V208, P381, DOI 10.1016/0022-2836(89)90503-2; LOBOS E, 1990, MOL BIOCHEM PARASIT, V39, P135, DOI 10.1016/0166-6851(90)90016-F; Lustigman S, 1996, J BIOL CHEM, V271, P30181, DOI 10.1074/jbc.271.47.30181; MCCRACKEN RM, 1970, J COMP PATHOL, V80, P619, DOI 10.1016/0021-9975(70)90061-7; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; MCLEOD RS, 1995, INT J PARASITOL, V25, P1363, DOI 10.1016/0020-7519(95)00071-9; Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008; Mitreva Makedonka, 2009, V533, P153, DOI 10.1007/978-1-60327-136-3_8; Myers CD, 1996, J CELL BIOL, V132, P1061, DOI 10.1083/jcb.132.6.1061; Newton SE, 1999, PARASITOL TODAY, V15, P116, DOI 10.1016/S0169-4758(99)01399-X; Nikolaou S, 2006, INT J PARASITOL, V36, P859, DOI 10.1016/j.ijpara.2006.04.007; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OHTSUKI I, 1986, ADV PROTEIN CHEM, V38, P1, DOI 10.1016/S0065-3233(08)60525-2; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; Page AP, 1996, BIOCHEM J, V317, P179, DOI 10.1042/bj3170179; Page AP, 1998, MOL BIOCHEM PARASIT, V95, P215, DOI 10.1016/S0166-6851(98)00096-6; Page AP, 2007, BIOLOGY, P1; Rhoads ML, 1998, J PARASITOL, V84, P686, DOI 10.2307/3284570; Rhoads ML, 2001, J PARASITOL, V87, P1144, DOI 10.1645/0022-3395(2001)087[1144:CCSBAS]2.0.CO;2; Rhoads ML, 1997, J PARASITOL, V83, P780, DOI 10.2307/3284267; Rogalski TM, 2003, GENETICS, V163, P905; Roos MH, 1997, PARASITOLOGY, V114, pS137, DOI 10.1017/S0031182097008986; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith G, 1997, VET PARASITOL, V72, P437, DOI 10.1016/S0304-4017(97)00109-X; Sologub L, 2011, CELL MICROBIOL, V13, P897, DOI 10.1111/j.1462-5822.2011.01588.x; Stepek G, 2011, PARASITOLOGY, V138, P237, DOI 10.1017/S0031182010001113; STOCKDALE PH, 1970, BRIT VET J, V126, P526, DOI 10.1016/S0007-1935(17)48138-3; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Talvik H, 1997, PARASITOL RES, V83, P563, DOI 10.1007/s004360050298; TANG J, 1971, J BIOL CHEM, V246, P4510; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yatsuda AP, 2003, J BIOL CHEM, V278, P16941, DOI 10.1074/jbc.M212453200; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001	81	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63955	10.1371/journal.pone.0063955	http://dx.doi.org/10.1371/journal.pone.0063955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717515	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700084
J	Zhang, YL; Luan, B; Wang, XF; Qiao, JY; Song, L; Lei, RR; Gao, WX; Liu, Y				Zhang, Yan-Li; Luan, Bin; Wang, Xiu-Fang; Qiao, Jun-Ying; Song, Li; Lei, Rui-Rui; Gao, Wei-Xia; Liu, Ying			Peripheral Blood MDSCs, IL-10 and IL-12 in Children with Asthma and Their Importance in Asthma Development	PLOS ONE			English	Article							INFLAMMATION; CELLS; INTERLEUKIN-10; POLYMORPHISMS; ASSOCIATION; RECEPTORS; ANTIGEN; SYSTEM; GROWTH	Objective: To investigate myeloid-derived suppressor cell (MDSC) accumulation and interleukin 10 (IL-10) and interleukin 12 (IL-12) levels during the onset of asthma in both pediatric patients and mouse models, as well as their possible roles in the development of asthma. Methods: Peripheral blood samples were gathered from children with asthma attacks (attack group) and alleviated asthma (alleviated group), as well as two control groups, children with pneumonia and healthy children. The pathological characteristics of asthma in asthmatic mice, budesonide-treated asthmatic mice, and normal control mice were also evaluated by immunohistochemistry (IHC) and hematoxylin and eosin (H&E) staining. Results: MDSC accumulation and serum IL-10 levels were significantly elevated in the children with asthma compared with the budesonide-treated alleviated group, normal healthy controls, and pneumonia controls (p<0.05), whereas those in the latter three groups showed no statistical differences (p>0.05). The level of serum IL-12 in the asthmatic children was drastically reduced compared to the budesonide-treated alleviated group, healthy controls, and pneumonia controls (p<0.05), whereas the latter three groups showed no significant differences in their serum IL-12 levels. The percentage of MDSCs in children with asthma was positively correlated with the level of serum IL-10 and negatively correlated with the level of serum IL-12. The levels of MDSCs and IL-10 in asthmatic mice were significantly higher than those in the normal control mice (both p<0.05) and were reduced after budesonide treatment (both p<0.05). IL-12 expression in the asthmatic mice was significantly lower than the control and was increased upon budesonide treatment (both p<0.05). Conclusion: During the onset of asthma, the accumulation of MDSCs and the level of serum IL-10 increase, while the level of IL-12 decreases. These fluctuations may play an important role in the development of asthma.	[Zhang, Yan-Li; Luan, Bin; Wang, Xiu-Fang; Qiao, Jun-Ying; Song, Li; Lei, Rui-Rui; Gao, Wei-Xia; Liu, Ying] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhang, YL (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Henan, Peoples R China.	yanlizhang2012@gmail.com			Scientific and technological project of Henan Province Health Department [201003063]	Scientific and technological project of Henan Province Health Department	This work was supported by Scientific and technological project of Henan Province Health Department (201003063) to Yan-Li Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae S, 2002, J IMMUNOL, V168, P3874, DOI 10.4049/jimmunol.168.8.3874; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen TY, 2011, HUM IMMUNOL, V72, P603, DOI 10.1016/j.humimm.2011.03.018; Deshane J, 2011, MUCOSAL IMMUNOL, V4, P503, DOI 10.1038/mi.2011.16; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Du Q, 2008, CAN J PHYSIOL PHARM, V86, P449, DOI [10.1139/Y08-053, 10.1139/y08-053]; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hakimizadeh E, 2012, CLIN LAB, V58, P267; Heffler E, 2006, RESP MED, V100, P1981, DOI 10.1016/j.rmed.2006.02.019; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Kao J, 2011, CRIT REV ONCOL HEMAT, V77, P13, DOI 10.1016/j.critrevonc.2010.02.004; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li RB, 2010, PHARMACOLOGY, V85, P319, DOI 10.1159/000302725; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Ohbayashi Hiroyuki, 2005, Current Drug Targets - Inflammation and Allergy, V4, P177, DOI 10.2174/1568010053586246; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Pukelsheim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014299; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Tsai TC, 2009, J ASTHMA, V46, P21, DOI 10.1080/02770900802460548; Ugel S, 2009, CURR OPIN PHARMACOL, V9, P470, DOI 10.1016/j.coph.2009.06.014; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Zheng XQ, 2010, HUM IMMUNOL, V71, P982, DOI 10.1016/j.humimm.2010.06.018	28	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63775	10.1371/journal.pone.0063775	http://dx.doi.org/10.1371/journal.pone.0063775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717481	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700059
J	Zhou, L; Situ, SJ; Huang, T; Hu, SX; Wang, XJ; Zhu, XP; Gao, LD; Li, Z; Feng, A; Jin, H; Wang, SY; Su, QR; Xu, Z; Feng, ZJ				Zhou, Lei; Situ, Sujian; Huang, Ting; Hu, Shixiong; Wang, Xianjun; Zhu, Xiaoping; Gao, Lidong; Li, Zhong; Feng, Ao; Jin, Hui; Wang, Shiyuan; Su, Qiru; Xu, Zhen; Feng, Zijian			Direct Medical Cost of Influenza-Related Hospitalizations among Severe Acute Respiratory Infections Cases in Three Provinces in China	PLOS ONE			English	Article							CHILDREN; IMPACT	Background: Influenza-related hospitalizations impose a considerable economic and social burden. This study aimed to better understand the economic burden of influenza-related hospitalizations among patients in China in different age and risk categories. Methods: Laboratory-confirmed influenza-related hospitalizations between December 2009 and June 2011 from three hospitals participating in the Chinese Severe Acute Respiratory Infections (SARI) sentinel surveillance system were included in this study. Hospital billing data were collected from each hospital's Hospital Information System (HIS) and divided into five cost categories. Demographic and clinical information was collected from medical records. Mean (range) and median (interquartile range [IQR]) costs were calculated and compared among children (<= 15 years), adults (16-64 years) and elderly (>= 65 years) groups. Factors influencing cost were analyzed. Results: A total of 106 laboratory-confirmed influenza-related hospitalizations were identified, 60% of which were children. The mean (range) direct medical cost was $1,797 ($80-$27,545) for all hospitalizations, and the median (IQR) direct medical cost was $231 ($164), $854 ($890), and $2,263 ($7,803) for children, adults, and elderly, respectively. Therapeutics and diagnostics were the two largest components of direct medical cost, comprising 57% and 23%, respectively. Cost of physician services was the lowest at less than 1%. Conclusion: Direct medical cost of influenza-related hospitalizations imposes a heavy burden on patients and their families in China. Further study is needed to provide more comprehensive evidence on the economic burden of influenza. Our study highlights the need to increase vaccination rate and develop targeted national preventive strategies.	[Zhou, Lei; Feng, Ao; Su, Qiru; Feng, Zijian] Chinese Ctr Dis Control & Prevent China CDC, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Situ, Sujian] US Ctr Dis Control & Prevent, Beijing, Peoples R China; [Huang, Ting; Zhu, Xiaoping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Hu, Shixiong; Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Xianjun; Li, Zhong] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Jin, Hui; Wang, Shiyuan] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Xu, Zhen] Chinese Ctr Dis Control & Prevent China CDC, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Southeast University - China; Chinese Center for Disease Control & Prevention	Zhou, L (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Publ Hlth Emergency Ctr, Beijing, Peoples R China.	zhoulei@chinacdc.cn; xuzhen@chinacdc.cn	JIN, HUI/AAA-8732-2019; Jin, Hui/GXG-2296-2022		China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases	This study was supported by the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], FACT SHEET INFL SEAS; Census and statistics department Hong Kong SAR P.R. China, 2009, 2009 10 HOUS EXP SUR; Chinese Center for Disease Control and Prevention, 2011, SARI SURV PROT 2011; Chinese Center for Disease Control and Prevention, GUID SEAS INFL VACC; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Financial management service, 2010, TREAS REP RAT EXCH D; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Hassan F, 2009, AM J PREV MED, V36, P292, DOI 10.1016/j.amepre.2008.11.016; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Ministry of Health of the People's Republic of China, GUID MIN HLTH 12 5 Y; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; World Bank, GDP PER CAP CURR US; World Health Organization Regional Office for Europe, 2011, WHO REG OFF EUR GUID; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044391	19	22	35	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63788	10.1371/journal.pone.0063788	http://dx.doi.org/10.1371/journal.pone.0063788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717485	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700061
J	Kim, GW; Li, L; Gorbani, M; You, LY; Yang, XJ				Kim, Go-Woon; Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao			Mice Lacking alpha-Tubulin Acetyltransferase 1 Are Viable but Display alpha-Tubulin Acetylation Deficiency and Dentate Gyrus Distortion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; LONG-TERM POTENTIATION; LYSINE ACETYLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE DEACETYLASES; STABILIZATION; DOUBLECORTIN; SENSITIVITY; INDUCTION; MEC-17	alpha-Tubulin acetylation at Lys-40, located on the luminal side of microtubules, has been widely studied and used as a marker for stable microtubules in the cilia and other subcellular structures, but the functional consequences remain perplexing. Recent studies have shown that Mec-17 and its paralog are responsible for alpha-tubulin acetylation in Caenorhabditis elegans. There is one such protein known as Atat1 (alpha-tubulin acetyltransferase 1) per higher organism. Zebrafish Atat1 appears to govern embryo development, raising the intriguing possibility that Atat1 is also critical for development in mammals. In addition to Atat1, three other mammalian acetyltransferases, ARD1-NAT1, ELP3, and GCN5, have been shown to acetylate alpha-tubulin in vitro, so an important question is how these four enzymes contribute to the acetylation in vivo. We demonstrate here that Atat1 is a major alpha-tubulin acetyltransferase in mice. It is widely expressed in mouse embryos and tissues. Although Atat1-null animals display no overt phenotypes, alpha-tubulin acetylation is lost in sperm flagella and the dentate gyrus is slightly deformed. Furthermore, human ATAT1 colocalizes on bundled microtubules with doublecortin. These results thus suggest that mouse Atat1 may regulate advanced functions such as learning and memory, thereby shedding novel light on the physiological roles of alpha-tubulin acetylation in mammals.	[Kim, Go-Woon; Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Canadian Cancer Society; Canada Foundation for Innovation; Ministere du Developpement Economique, Innovation, et Exportation du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ministere du Developpement Economique, Innovation, et Exportation du Quebec	This work was supported by research grants from the Canadian Institutes of Health Research, the Canadian Cancer Society, the Canada Foundation for Innovation, and the Ministere du Developpement Economique, Innovation, et Exportation du Quebec (to X.J.Y.).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; des Portes V, 1998, CELL, V92, P51; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dong H.W., 2008, ALLEN REFERENCE ATLA; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Fukada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030924; Fukushige T, 1999, J CELL SCI, V112, P395; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nagy A., 2003, MANIPULATING MOUSE E; Nam HJ, 2010, J BIOL CHEM, V285, P32888, DOI 10.1074/jbc.M110.162743; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Paxinos G., 2008, MOUSE BRAIN STEREOTA; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; SMITH CL, 1994, J CELL BIOL, V127, P1407, DOI 10.1083/jcb.127.5.1407; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tahmasebi S, 2013, J BIOL CHEM, V288, P12791, DOI 10.1074/jbc.M113.465443; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Xiong X, 2013, J INTEGR PLANT BIOL, V55, P209, DOI 10.1111/jipb.12003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	87	84	85	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20334	20350		10.1074/jbc.M113.464792	http://dx.doi.org/10.1074/jbc.M113.464792			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720746	Green Published, hybrid			2022-12-25	WOS:000321715100022
J	Qin, HM; Miyakawa, T; Jia, MZ; Nakamura, A; Ohtsuka, J; Xue, YL; Kawashima, T; Kasahara, T; Hibi, M; Ogawa, J; Tanokura, M				Qin, Hui-Min; Miyakawa, Takuya; Jia, Min Ze; Nakamura, Akira; Ohtsuka, Jun; Xue, You-Lin; Kawashima, Takashi; Kasahara, Takuya; Hibi, Makoto; Ogawa, Jun; Tanokura, Masaru			Crystal Structure of a Novel N-Substituted L-Amino Acid Dioxygenase from Burkholderia ambifaria AMMD	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ESCHERICHIA-COLI; MECHANISM; HYDROXYLASES; SOFTWARE; IRON	A novel dioxygenase from Burkholderia ambifaria AMMD (SadA) stereoselectively catalyzes the C3-hydroxylation of Nsubstituted branched-chain or aromatic L-amino acids, especially N-succinyl-L-leucine, coupled with the conversion of alpha-ketoglutarate to succinate and CO2. To elucidate the structural basis of the substrate specificity and stereoselective hydroxylation, we determined the crystal structures of the SadA. Zn(II) and SadA. Zn(II). alpha-KG complexes at 1.77 angstrom and 1.98 angstrom resolutions, respectively. SadA adopted a double-stranded beta-helix fold at the core of the structure. In addition, an HXD/EXnH motif in the active site coordinated a Zn(II) as a substitute for Fe(II). The alpha-KG molecule also coordinated Zn(II) in a bidentate manner via its 1-carboxylate and 2-oxo groups. Based on the SadA. Zn(II). alpha-KG structure and mutation analyses, we constructed substrate-binding models with N-succinyl-L-leucine and N-succinyl-L-phenylalanine, which provided new insight into the substrate specificity. The results will be useful for the rational design of SadA variants aimed at the recognition of various N-succinyl L-amino acids.	[Qin, Hui-Min; Miyakawa, Takuya; Jia, Min Ze; Nakamura, Akira; Ohtsuka, Jun; Xue, You-Lin; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Jia, Min Ze] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Kawashima, Takashi; Kasahara, Takuya; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Hibi, Makoto] Kyoto Univ, Grad Sch Agr, Lab Ind Microbiol, Kyoto, Japan	University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS; Kyoto University; Kyoto University	Tanokura, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Hibi, Makoto/L-6422-2017; Nakamura, Akira/C-1658-2016; Nakamura, Akira/K-2982-2019	Hibi, Makoto/0000-0002-6714-9008; Nakamura, Akira/0000-0001-7733-4007; Nakamura, Akira/0000-0001-7733-4007; Xue, You-lin/0000-0002-4241-7942; Nakamura, Akira/0000-0001-7250-7175; Tanokura, Masaru/0000-0001-5072-2480	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Targeted Proteins Research Program (TPRP) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hara R, 2009, BIOCHEM BIOPH RES CO, V379, P882, DOI 10.1016/j.bbrc.2008.12.158; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmetag V, 2009, FEBS J, V276, P3669, DOI 10.1111/j.1742-4658.2009.07085.x; Hibi M, LETT APPL MICROBIOL, V55, P414; Hibi M, 2011, APPL ENVIRON MICROB, V77, P6926, DOI 10.1128/AEM.05035-11; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Horton JR, 2011, J MOL BIOL, V406, P1, DOI 10.1016/j.jmb.2010.12.013; Kodera T, 2009, BIOCHEM BIOPH RES CO, V390, P506, DOI 10.1016/j.bbrc.2009.09.126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Qin HM, 2012, ACTA CRYSTALLOGR F, V68, P1067, DOI 10.1107/S1744309112031508; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Taniguchi M, 2003, TETRAHEDRON, V59, P4533, DOI 10.1016/S0040-4020(03)00680-X; TYMIAK AA, 1989, J ORG CHEM, V54, P1149, DOI 10.1021/jo00266a029; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	31	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63996	10.1371/journal.pone.0063996	http://dx.doi.org/10.1371/journal.pone.0063996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724013	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000032
J	Sanchez-Alvarez, R; Gayen, S; Vadigepalli, R; Anni, H				Sanchez-Alvarez, Rosa; Gayen, Saurabh; Vadigepalli, Rajanikanth; Anni, Helen			Ethanol Diverts Early Neuronal Differentiation Trajectory of Embryonic Stem Cells by Disrupting the Balance of Lineage Specifiers	PLOS ONE			English	Article							GENOME-WIDE; TRANSCRIPTIONAL NETWORK; NEURAL DIFFERENTIATION; PLURIPOTENCY FACTORS; EXPRESSION; ALCOHOL; GENES; FIBROBLASTS; PROTEIN; OCT4	Background: Ethanol is a toxin responsible for the neurodevelopmental deficits of Fetal Alcohol Spectrum Disorders (FASD). Recent evidence suggests that ethanol modulates the protein expression of lineage specifier transcription factors Oct4 (Pou5f1) and Sox2 in early stages of mouse embryonic stem (ES) cell differentiation. We hypothesized that ethanol induced an imbalance in the expression of Oct4 and Sox2 in early differentiation, that dysregulated the expression of associated and target genes and signaling molecules and diverted cells from neuroectodermal (NE) formation. Methodology/Principal Findings: We showed modulation by ethanol of 33 genes during ES cell differentiation, using high throughput microfluidic dynamic array chips measuring 2,304 real time quantitative PCR assays. Based on the overall gene expression dynamics, ethanol drove cells along a differentiation trajectory away from NE fate. These ethanol-induced gene expression changes were observed as early as within 2 days of differentiation, and were independent of cell proliferation or apoptosis. Gene expression changes were correlated with fewer beta III-tubulin positive cells of an immature neural progenitor phenotype, as well as a disrupted actin cytoskeleton were observed. Moreover, Tuba1a and Gapdh housekeeping genes were modulated by ethanol during differentiation and were replaced by a set of ribosomal genes with stable expression. Conclusions/Significance: These findings provided an ethanol-response gene signature and pointed to the transcriptional dynamics underlying lineage imbalance that may be relevant to FASD phenotype.	[Sanchez-Alvarez, Rosa; Gayen, Saurabh; Vadigepalli, Rajanikanth; Anni, Helen] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Vadigepalli, Rajanikanth] Thomas Jefferson Univ, Daniel Baugh Inst Funct Genom & Computat Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Vadigepalli, R (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	Rajanikanth.Vadigepalli@jefferson.edu; Eleni.Anni@jefferson.edu		Vadigepalli, Rajanikanth/0000-0002-8405-1037	ABMRF; Thomas Jefferson University Pilot Award; Graham Fund;  [K05 AA017261]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017261, T32AA007463] Funding Source: NIH RePORTER	ABMRF; Thomas Jefferson University Pilot Award; Graham Fund; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by ABMRF (HA) (http://www.abmrf.org/), Thomas Jefferson University Pilot Award (HA, RV), the Graham Fund (HA), and mentoring grant K05 AA017261 (HA, RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Ali RG, 2012, INT J BIOCHEM CELL B, V44, P2065, DOI 10.1016/j.biocel.2012.08.012; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aruga J, 2011, NEUROCHEM RES, V36, P1286, DOI 10.1007/s11064-011-0422-5; Arzumanyan A, 2009, ALCOHOL CLIN EXP RES, V33, P2172, DOI 10.1111/j.1530-0277.2009.01057.x; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Boucas Jorge, 2012, Frontiers in Genetics, V3, P159, DOI 10.3389/fgene.2012.00159; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chae HD, 2011, STEM CELLS DEV, V20, P1277, DOI 10.1089/scd.2010.0465; Chen W, 2012, BIOCHEM BIOPH RES CO, V418, P571, DOI 10.1016/j.bbrc.2012.01.078; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Duval D, 2006, CELL DEATH DIFFER, V13, P564, DOI 10.1038/sj.cdd.4401789; Duval D, 2004, CELL DEATH DIFFER, V11, P331, DOI 10.1038/sj.cdd.4401337; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Franco D, 2009, ANAT REC, V292, P891, DOI 10.1002/ar.20899; Freeman K, 2012, ALCOHOL CLIN EXP RES, V36, P1688, DOI 10.1111/j.1530-0277.2012.01791.x; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Green ML, 2007, DEV DYNAM, V236, P613, DOI 10.1002/dvdy.21048; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; HASSLER JA, 1986, EXPERIENTIA, V42, P575, DOI 10.1007/BF01946710; Hong F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000607; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Jones KL, 2011, BIRTH DEFECTS RES C, V93, P3, DOI 10.1002/bdrc.20200; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lombard Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-389; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Ogony JW, 2013, STEM CELLS DEV, V22, P2196, DOI 10.1089/scd.2012.0513; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Romero AM, 2010, TOXICOL SCI, V118, P602, DOI 10.1093/toxsci/kfq260; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sandie Reatha, 2009, BMC Res Notes, V2, P39, DOI 10.1186/1756-0500-2-39; SAUNDERS DE, 1995, ALCOHOL, V12, P475, DOI 10.1016/0741-8329(95)00034-O; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; SULIK KK, 1984, CIBA F SYMP, V105, P124; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talens-Visconti R, 2011, STEM CELLS DEV, V20, P327, DOI 10.1089/scd.2010.0037; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14	67	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63794	10.1371/journal.pone.0063794	http://dx.doi.org/10.1371/journal.pone.0063794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724002	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000025
J	Wang, XH; Marcinkiewicz, M; Gatain, Y; Bouchard, M; Mao, JN; Tremblay, M; Uetani, N; Hanissian, S; Qi, SJ; Wu, JP; Luo, HY				Wang, Xuehai; Marcinkiewicz, Martin; Gatain, Yaned; Bouchard, Maxime; Mao, Jianning; Tremblay, Michel; Uetani, Noriko; Hanissian, Silva; Qi, Shijie; Wu, Jiangping; Luo, Hongyu			Investigation of Tissue-Specific Expression and Functions of MLF1-IP during Development and in the Immune System	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIATION; KINETOCHORES; COMPLEX; MICE	Myeloid leukemia factor 1-interacting protein (MLF1-IP) has been found to exert functions in mitosis, although studies have been conducted only in cell lines up to now. To understand its roles during ontogeny and immunity, we analyzed its mRNA expression pattern by in situ hybridization and generated MLF1-IP gene knockout (KO) mice. MLF1-IP was expressed at elevated levels in most rudimentary tissues during the mid-gestation stage, between embryonic day 9.5 (e9.5) and e15.5. It declined afterwards in these tissues, but was very high in the testes and ovaries in adulthood. At post-natal day 10 (p10), the retina and cerebellum still expressed moderate MLF1-IP levels, although these tissues do not contain fast-proliferating cells at this stage. MLF1-IP expression in lymphoid organs, such as the thymus, lymph nodes, spleen and bone marrow, was high between e15.5 and p10, and decreased in adulthood. MLF1-IP KO embryos failed to develop beyond e6.5. On the other hand, MLF1-IP+/- mice were alive and fertile, with no obvious anomalies. Lymphoid organ size, weight, cellularity and cell sub-populations in MLF1-IP+/- mice were in the normal range. The functions of MLF1-IP+/- T cells and naive CD4 cells, in terms of TCR-stimulated proliferation and Th1, Th17 and Treg cell differentiation in vitro, were comparable to those of wild type T cells. Our study demonstrates that MLF1-IP performs unique functions during mouse embryonic development, particularly around e6.5, when there was degeneration of epiblasts. However, the cells could proliferate dozens of rounds without MLF1-IP. MLF1-IP expression at about 50% of its normal level is sufficient to sustain mice life and the development of their immune system without apparent abnormalities. Our results also raise an intriguing question that MLF1-IP might have additional functions unrelated to cell proliferation.	[Wang, Xuehai; Mao, Jianning; Qi, Shijie; Wu, Jiangping; Luo, Hongyu] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Immunol Lab, Montreal, PQ H2L 4K8, Canada; [Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Serv Nephrol, Montreal, PQ H2L 4K8, Canada; [Marcinkiewicz, Martin] Cytochem Inc, Montreal, PQ, Canada; [Gatain, Yaned; Bouchard, Maxime; Tremblay, Michel; Uetani, Noriko] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr GCRC, Montreal, PQ, Canada; [Hanissian, Silva] Univ Tennessee, Dept Neurosurg, Memphis, TN USA	Universite de Montreal; Universite de Montreal; McGill University; University of Tennessee System; University of Tennessee Health Science Center	Luo, HY (corresponding author), Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Immunol Lab, Montreal, PQ H2L 4K8, Canada.	hongyu.luo@umontreal.ca		Bouchard, Maxime/0000-0002-7619-9680	Canadian Institutes of Health Research [IMH79565, MOP79565, MOP57697, MOP123389]; Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council [2039062012]; Jean-Louis Levesque Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jean-Louis Levesque Foundation	This work was supported by grants from the Canadian Institutes of Health Research to HL (IMH79565, and MOP79565) and JW (MOP57697 and MOP123389). It was also funded by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council (2039062012) and the Jean-Louis Levesque Foundation to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Han B, 2007, ARTHRITIS RHEUM-US, V56, P3748, DOI 10.1002/art.22978; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Pan HY, 2003, J VIROL, V77, P9758, DOI 10.1128/JVI.77.18.9758-9768.2003; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	17	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63783	10.1371/journal.pone.0063783	http://dx.doi.org/10.1371/journal.pone.0063783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724000	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000023
J	Clancey, LF; Beirl, AJ; Linbo, TH; Cooper, CD				Clancey, Lauren F.; Beirl, Alisha J.; Linbo, Tor H.; Cooper, Cynthia D.			Maintenance of Melanophore Morphology and Survival Is Cathepsin and vps11 Dependent in Zebrafish	PLOS ONE			English	Article							CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; EMBRYONIC-DEVELOPMENT; H+-ATPASE; IN-VITRO; AUTOPHAGY; APOPTOSIS; NECROSIS; LYSOSOMES; CLEAVAGE	Here, we characterize a Danio rerio zebrafish pigment cell mutant (melanophore integrity mutant), which displays a defect in maintenance of melanophore and iridophore number. Mapping and candidate gene analysis links the melanophore integrity mutant mutation to the vacuolar protein sorting 11 (vps11(w66)) gene. Quantification of vps11(w66) chromatophores during larval stages suggests a decrease in number as compared to wildtype siblings. TUNEL analysis and treatment with the caspase inhibitor, zVAD-fmk, indicate that vps11(w66) chromatophore death is caspase independent. Western blot analysis of PARP-1 cleavage patterns in mutant lysates suggests that increases in pH dependent cathepsin activity is involved in the premature chromatophore death observed in vps11(w66) mutants. Consistently, treatment with ALLM and Bafilomycin A1 (cathepsin/calpain and vacuolar-type H+-ATPase inhibitors, respectively), restore normal melanophore morphology and number in vps11(w66) mutants. Last, LC3B western blot analysis indicates an increase in autophagosome marker, LC3B II in vps11(w66) mutants as compared to wildtype control, but not in ALLM or Bafilomycin A1 treated mutants. Taken together, these data suggest that vps11 promotes normal melanophore morphology and survival by inhibiting cathepsin release and/or activity.	[Clancey, Lauren F.; Beirl, Alisha J.; Cooper, Cynthia D.] Washington State Univ Vancouver, Sch Mol Biosci, Vancouver, WA USA; [Linbo, Tor H.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Washington State University; University of Washington; University of Washington Seattle	Cooper, CD (corresponding author), Washington State Univ Vancouver, Sch Mol Biosci, Vancouver, WA USA.	cdcooper@vancouver.wsu.edu			Melanoma Research Foundation; Cosmopolitan Magazine (Career Development Award); American Cancer Society Institutional Research Grant Program (School of Molecular Biosciences, Washington State University)	Melanoma Research Foundation; Cosmopolitan Magazine (Career Development Award); American Cancer Society Institutional Research Grant Program (School of Molecular Biosciences, Washington State University)	This project received funding from the Melanoma Research Foundation in partnership with Cosmopolitan Magazine (Career Development Award) http://www.melanoma.org/research/research-grant-program and an American Cancer Society Institutional Research Grant Program (School of Molecular Biosciences, Washington State University) http://informer.ogrd.wsu.edu/Opportunity.aspx?ID = 3451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissy RE, 2012, J DERMATOL; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cooper CD, 2009, DEV DYNAM, V238, P875, DOI 10.1002/dvdy.21910; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Kanamori A, 2006, PIGMENT CELL RES, V19, P628; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rawls JF, 2003, DEV BIOL, V262, P152, DOI 10.1016/S0012-1606(03)00386-5; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Thomas JL, 2011, INVEST OPHTH VIS SCI, V52, P3119, DOI 10.1167/iovs.10-5957; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; White E, 2008, AUTOPHAGY, V4, P399, DOI 10.4161/auto.5907; Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	35	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e65096	10.1371/journal.pone.0065096	http://dx.doi.org/10.1371/journal.pone.0065096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724125	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100040
J	Gras, L; Geskus, RB; Jurriaans, S; Bakker, M; van Sighem, A; Bezemer, D; Fraser, C; Prins, JM; Berkhout, B; de Wolf, F				Gras, Luuk; Geskus, Ronald B.; Jurriaans, Suzanne; Bakker, Margreet; van Sighem, Ard; Bezemer, Daniela; Fraser, Christophe; Prins, Jan M.; Berkhout, Ben; de Wolf, Frank		ATHENA Natl Observational Cohort	Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?	PLOS ONE			English	Article							PLASMA VIRAL LOAD; SET-POINT; PROGNOSTIC MARKERS; TRANSMISSION; AMSTERDAM; INFECTION; VIRULENCE; AIDS; SEROCONVERSION; PROGRESSION	Introduction: Studies suggest that the HIV-1 epidemic in the Netherlands may have become more virulent, leading to faster disease progression if untreated. Analysis of CD4 cell count decline before antiretroviral therapy (ART) initiation, a surrogate marker for disease progression, may be hampered by informative censoring as ART initiation is more likely with a steeper CD4 cell count decline. Methods: Development of CD4 cell count from 9 to 48 months after seroconversion was analyzed using a mixed-effects model and 2 models that jointly modeled CD4 cell counts and time to censoring event (start ART, <100 CD4 cells/mm(3), or AIDS) among therapy-naive MSM HIV-1 seroconverters in the Netherlands. These models make different assumptions about the censoring process. Results: All 3 models estimated lower median CD4 cell counts 9 months after seroconversion in later calendar years (623, 582, and 541 cells/mm(3) for 1984-1995 [n = 111], 1996-2002 [n = 139], and 2003-2007 seroconverters [n = 356], respectively, shared-parameter model). Only the 2 joint-models found a trend for a steeper decline of CD4 cell counts with seroconversion in later calendar years (overall p-values 0.002 and 0.06 for the pattern-mixture and the shared-parameter model, respectively). In the shared-parameter model the median decline from 9 to 48 months was 276 cellsmm(3) for 1984-1995 seroconverters and 308 cells/mm(3) for 2003-2007 seroconverters (difference in slope, p = 0.045). Conclusion: Mixed-effects models underestimate the CD4 cell decline prior to starting ART. Joint-models suggest that CD4 cell count declines more rapidly in patients infected between 2003 and 2007 compared to patients infected before 1996.	[Gras, Luuk; van Sighem, Ard; Bezemer, Daniela; de Wolf, Frank] Stichting HIV Monitoring, Amsterdam, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Jurriaans, Suzanne; Bakker, Margreet; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Fraser, Christophe; de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald B.] Publ Hlth Serv Amsterdam, Dept Res, Cluster Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Gras, L (corresponding author), Stichting HIV Monitoring, Amsterdam, Netherlands.	l.a.gras@amc.uva.nl	Geskus, Ronald B/H-3684-2019; Fraser, Christophe/A-8109-2008; Prins, Jan M./AAF-4945-2020	Geskus, Ronald B/0000-0002-2740-3155; Fraser, Christophe/0000-0003-2399-9657; van der Valk, Marc/0000-0002-8290-6425; Oosterheert, Jan Jelrik/0000-0001-6146-3808; van der Hilst, Jeroen/0000-0003-4527-6310; Prins, Jan/0000-0002-5415-8933; Rijnders, Bart/0000-0003-3343-9610	Netherlands Ministry of Health, Welfare and Sport; Netherlands National Institute for Public Health and the Environment; MRC [G0800596, MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, G0800596, G0600719B, MR/K010174/1] Funding Source: researchfish	Netherlands Ministry of Health, Welfare and Sport; Netherlands National Institute for Public Health and the Environment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The ATHENA observational clinical cohort is part of Stichting HIV Monitoring, Amsterdam, the Netherlands and is supported by a grant of the Netherlands Ministry of Health, Welfare and Sport. The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Centre of the University of Amsterdam, Sanquin Blood Supply Foundation and the University Medical Centre Utrecht, are part of Stichting HIV Monitoring and are financially supported by the Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bekele Yonas, 2011, Ethiop Med J, V49, P187; Cornelissen M, 2007, AIDS, V21, P807, DOI 10.1097/QAD.0b013e3280f3c08a; Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Fife K, 2011, INFECTED PARTNERS PL; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; Geskus RB, 2005, JAIDS-J ACQ IMM DEF, V39, P321, DOI 10.1097/01.qai.0000142017.25897.06; Geskus RB, 2014, STAT METHODS MED RES, V23, P91, DOI 10.1177/0962280212445840; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Gras L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007365; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Levering WHBM, 2008, CYTOM PART B-CLIN CY, V74B, P79, DOI 10.1002/cyto.b.20370; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Rachinger A, 2011, J INFECT DIS, V203, P1621, DOI 10.1093/infdis/jir164; Rizopoulos D, 2010, J STAT SOFTWARE, V35; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Santagostino A, 1999, HAEMATOLOGICA, V84, P499; SCHELLEKENS PTA, 1992, AIDS, V6, P665, DOI 10.1097/00002030-199207000-00008; Schellens IMM, 2011, AIDS, V25, P1691, DOI 10.1097/QAD.0b013e32834981b3; Stolte I, 2011, MONITORING HUMAN IMM; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Thijs H, 2002, BIOSTATISTICS, V3, P245, DOI 10.1093/biostatistics/3.2.245; van der Helm JJ, 2009, OVERVIEW AMSTERDAM C; van der Kuyl AC, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-60; van der Kuyl AC, 2010, AIDS, V24, P1607, DOI 10.1097/QAD.0b013e32833b318f; van der Kuyl AC, 2009, CLIN INFECT DIS, V48, P973, DOI 10.1086/597356; van Manen D, 2011, AIDS, V25, P2217, DOI 10.1097/QAD.0b013e32834bec9c; Veugelers PJ, 1997, J INFECT DIS, V176, P112, DOI 10.1086/514012; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0	43	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64437	10.1371/journal.pone.0064437	http://dx.doi.org/10.1371/journal.pone.0064437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724048	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100026
J	Zheng, XF; Hong, YX; Feng, GJ; Zhang, GF; Rogers, H; Lewis, MAO; Williams, DW; Xia, ZF; Song, B; Wei, XQ				Zheng, Xing-Feng; Hong, Yu-Xiao; Feng, Gui-Jie; Zhang, Gao-Feng; Rogers, Helen; Lewis, Michael A. O.; Williams, David W.; Xia, Zhao-Fan; Song, Bing; Wei, Xiao-Qing			Lipopolysaccharide-Induced M2 to M1 Macrophage Transformation for IL-12p70 Production Is Blocked by Candida albicans Mediated Up-Regulation of EBI3 Expression	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; POLARIZATION; CELLS; INFECTION; RESPONSES; IL-35	Macrophages are heterogeneous cell populations that are present in all tissues. Macrophages can be divided into classically activated inflammatory macrophages (M1) and alternatively activated anti-inflammatory macrophages (M2). It has been generally accepted that M1 macrophages are polarised in an inflammatory environment to produce pro-inflammatory cytokines, whilst M2 macrophages are involved in anti-inflammation and aid tissue repair in wound healing. Bacterial endotoxin (lipopolysaccharide; LPS) is a potent factor in infection, which induces M1 macrophages resulting in higher levels of iNOS, TNF alpha and IL-12p70 which dictate inflammatory T cell responses. M2 macrophages can be transformed into M1 macrophages following LPS stimulation to promote inflammation. Candida albicans is a commensal fungal microorganism, which has been suggested to induce immune tolerance; however, the mechanism of C. albicans-induced immune tolerance has not been investigated in detail. IL-35 is a recently identified anti-inflammatory cytokine which is a heterodimeric protein consisting of the Epstein-Barr virus-induced gene 3 (EBI3) and IL-12p35. IL-35 shares the protein subunit p35, with IL-12p70. IL-12p70 is the most potent cytokine to induce Th1 responses during inflammation. In this study, we demonstrate that heat-killed C. albicans (HKC) strongly suppressed LPS-induced IL-12p70 production in M2 macrophages. Candida albicans induced a high level of EBI3 expression in M2 macrophages, which served as a mechanism for IL-12p70 suppression by competitive binding of the common protein subunit (p35) of IL-35 and IL-12p70. To demonstrate that EBI3 expression had the ability to block IL-12p70 production intracellularly, a Chinese Hamster Ovary (CHO) cell line with biscistronic expression of IL-12p40 and p35 was constructed, followed by ectopic over-expression of EBI3. The over-expression of EBI3 in the IL-12p70 producing cell line effectively suppressed IL-12p70 production. IL-35 secretion was also detected in the cell line, with suppressed IL-12p70 production by immune-precipitation Western blotting. However, this secretion was not evident in M2 macrophages following stimulation by HKC. This can be explained by the constitutive expression of IL-35 receptors (gp130 and IL-12R beta 2) in M2 macrophages for cytokine consumption. Our results have indicated that C. albicans can suppress host inflammatory responses in mucosal skin by suppressing LPS-induced IL-12p70 production. Lower IL-12p70 production may avoid an unnecessary Th1 response in order to retain immune tolerance, which may be one of the mechanisms by which C. albicans achieves a successful commensal lifestyle without having a detrimental effect on the host's health.	[Zheng, Xing-Feng; Hong, Yu-Xiao; Zhang, Gao-Feng; Rogers, Helen; Lewis, Michael A. O.; Williams, David W.; Song, Bing; Wei, Xiao-Qing] Cardiff Univ, Sch Dent, Cardiff CF10 3AX, S Glam, Wales; [Zheng, Xing-Feng; Xia, Zhao-Fan] Second Mil Med Univ, Changhai Hosp, Burn Unit, Shanghai, Peoples R China; [Hong, Yu-Xiao] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Peoples R China; [Feng, Gui-Jie] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Naval Medical University; China Medical University; Cardiff University	Wei, XQ (corresponding author), Cardiff Univ, Sch Dent, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	weix1@cf.ac.uk	Williams, David/E-5506-2012; Song, Bing/AAB-4755-2021	Williams, David/0000-0002-7351-5131; Song, Bing/0000-0001-9356-2333	Cardiff University; China Scholarship Council	Cardiff University; China Scholarship Council(China Scholarship Council)	This work was supported by Cardiff University research funding and funding for XFZ from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee J, 2012, RECENT PATENTS INFLA, V6, P222, DOI 10.2174/187221312802652820; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056; Malic S, 2007, ORAL MICROBIOL IMMUN, V22, P188, DOI 10.1111/j.1399-302X.2007.00344.x; Morales O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032197; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Natarajan K, 2011, TUBERCULOSIS, V91, P427, DOI 10.1016/j.tube.2011.04.003; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rahat MA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00045; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Schmieder A, 2012, SEMIN CANCER BIOL, V22, P289, DOI 10.1016/j.semcancer.2012.02.002; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Wei XQ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/697340; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651	32	87	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63967	10.1371/journal.pone.0063967	http://dx.doi.org/10.1371/journal.pone.0063967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724011	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100016
J	Ehrhardt, C; Dudek, SE; Holzberg, M; Urban, S; Hrincius, ER; Haasbach, E; Seyer, R; Lapuse, J; Planz, O; Ludwig, S				Ehrhardt, Christina; Dudek, Sabine Eva; Holzberg, Magdalena; Urban, Sabine; Hrincius, Eike Roman; Haasbach, Emanuel; Seyer, Roman; Lapuse, Julia; Planz, Oliver; Ludwig, Stephan			A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells	PLOS ONE			English	Article							INFLUENZA-A VIRUS; ACTIVATED RECEPTOR-2; BLACK-CURRANTS; H5N1 VIRUS; PROTEIN; PROANTHOCYANIDINS; RESISTANCE; HEALTH; LEAVES; MICE	Infections with influenza A viruses (IAV) are still amongst the major causes of highly contagious severe respiratory diseases not only bearing a devastating effect to human health, but also significantly impact the economy. Besides vaccination that represents the best option to protect from IAV infections, only two classes of anti-influenza drugs, inhibitors of the M2 ion channel and the neuraminidase, often causing resistant IAV variants have been approved. That is why the need for effective and amply available antivirals against IAV is of high priority. Here we introduce LADANIA067 from the leaves of the wild black currant (Ribes nigrum folium) as a potent compound against IAV infections in vitro and in vivo. LADANIA067 treatment resulted in a reduction of progeny virus titers in cell cultures infected with prototype avian and human influenza virus strains of different subtypes. At the effective dose of 100 mu g/ml the extract did not exhibit apparent harming effects on cell viability, metabolism or proliferation. Further, viruses showed no tendency to develop resistance to LADANIA067 when compared to amantadine that resulted in the generation of resistant variants after only a few passages. On a molecular basis the protective effect of LADANIA067 appears to be mainly due to interference with virus internalisation. In the mouse infection model LADANIA067 treatment reduces progeny virus titers in the lung upon intranasal application. In conclusion, an extract from the leaves of the wild black currant might be a promising source for the development of new antiviral compounds to fight IAV infections.	[Ehrhardt, Christina; Dudek, Sabine Eva; Holzberg, Magdalena; Urban, Sabine; Hrincius, Eike Roman; Seyer, Roman; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Haasbach, Emanuel; Planz, Oliver] Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, Tubingen, Germany; [Lapuse, Julia] Dr Pandalis NatUrprod GmbH, Glandorf, Germany	University of Munster; Eberhard Karls University of Tubingen	Ludwig, S (corresponding author), Univ Munster, Inst Mol Virol, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany.	ludwigs@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft [EH 235/1-2]; DFG Graduate School [GRK 1409]; University of Muenster Medical School; German ministry of education and research (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Graduate School(German Research Foundation (DFG)); University of Muenster Medical School; German ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (EH 235/1-2), the DFG Graduate School GRK 1409 and the fund "Innovative Medical Research" (IMF) of the University of Muenster Medical School. It is part of the activities of the German FluResearchNet, a nationwide research network on zoonotic influenza, funded by the German ministry of education and research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bearman Gonzalo M L, 2010, Recent Pat Antiinfect Drug Discov, V5, P152; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Eierhoff T, 2009, BIOL CHEM, V390, P509, DOI 10.1515/BC.2009.053; Feld M, 2008, J IMMUNOL, V180, P6903, DOI 10.4049/jimmunol.180.10.6903; Garbacki Nancy, 2004, BMC Pharmacology, V4, P25, DOI 10.1186/1471-2210-4-25; Gopalan A, 2012, FOOD FUNCT, V3, P795, DOI 10.1039/c2fo30058c; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Ikuta K, 2012, MICROBIOL IMMUNOL, V56, P805, DOI 10.1111/j.1348-0421.2012.00510.x; Kalus U, 2009, ANTIVIR RES, V84, P267, DOI 10.1016/j.antiviral.2009.10.001; Karoline D, 2007, ANTIVIR RES, V76, P1, DOI 10.1016/j.antiviral.2007.04.001; Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Knox YM, 2003, PHYTOTHER RES, V17, P120, DOI 10.1002/ptr.1053; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Tabart J, 2006, J AGR FOOD CHEM, V54, P6271, DOI 10.1021/jf061112y; Tabart J, 2011, J AGR FOOD CHEM, V59, P4763, DOI 10.1021/jf104445c; TITS M, 1992, J PHARMACEUT BIOMED, V10, P1097, DOI 10.1016/0731-7085(91)80128-V; Tosh C, 2011, VIRUS GENES, V42, P10, DOI 10.1007/s11262-010-0534-z; van der Vries E, 2011, CURR OPIN INFECT DIS, V24, P599, DOI 10.1097/QCO.0b013e32834cfb43; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	28	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63657	10.1371/journal.pone.0063657	http://dx.doi.org/10.1371/journal.pone.0063657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717460	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600026
J	Hu, Y; McIntosh, GH; Le Leu, RK; Nyskohus, LS; Woodman, RJ; Young, GP				Hu, Ying; McIntosh, Graeme H.; Le Leu, Richard K.; Nyskohus, Laura S.; Woodman, Richard J.; Young, Graeme P.			Combination of Selenium and Green Tea Improves the Efficacy of Chemoprevention in a Rat Colorectal Cancer Model by Modulating Genetic and Epigenetic Biomarkers	PLOS ONE			English	Article							INDUCED COLON TUMORS; HISTONE DEACETYLASE; NATURAL COMPOUNDS; BETA-CATENIN; IN-VIVO; AZOXYMETHANE; PREVENTION; CARCINOGENESIS; CELLS; MICE	Dietary supplementation of selenium and green tea holds promise in cancer prevention. In this study, we evaluated the efficacies of selenium and green tea administered individually and in combination against colorectal cancer in an azoxymethane (AOM)-induced rat colonic carcinogenesis model and determined the underlying mechanisms of the protection. Four-week old Sprague-Dawley male rats were fed with diets containing 0.5% green tea extract, 1ppm selenium as selenium-enriched milk protein, or combination of 1ppm selenium and 0.5% green tea extract. Animals received 2 AOM (15 mg/kg) treatments to induce colonic oncogenesis. Rats were killed 8 or 30 wk later after the last AOM to examine the effect of dietary intervention on aberrant crypt foci (ACF) formation or tumor development. On sacrifice, colons were examined for ACF and tumors, the mRNA levels of SFRP5 and Cyclin D1, and the proteins levels of beta-catenin, COX-2, Ki-67, DNMT1 and acetyl histone H3. The combination of selenium and green tea resulted in a significant additive inhibition of large ACF formation, this effect was greater than either selenium or green tea alone, P<0.01; the combination also had a significant additive inhibition effect on all tumor endpoints, the effect of the combination diet on tumor incidence, multiplicity and size was greater than selenium or green tea alone, P<0.01. Rats fed the combination diet showed marked reduction of DNMT1 expression and induction of histone H3 acetylation, which were accompanied by restoration of SFRP5 mRNA in normal-appearing colonic crypts. The combination diet also significantly reduced beta-catenin nuclear translocation, Cyclin D1 expression and cell proliferation. These data show, for the first time, that combination of selenium and green tea is more effective in suppressing colorectal oncogenesis than either agent alone. The preventive effect is associated with regulation of genetic and epigenetic biomarkers implicated in colonic carcinogenesis.	[Hu, Ying; McIntosh, Graeme H.; Le Leu, Richard K.; Nyskohus, Laura S.; Young, Graeme P.] Flinders Univ South Australia, Flinders Ctr Innovat Canc, Adelaide, SA, Australia; [Woodman, Richard J.] Flinders Univ South Australia, Flinders Prevent Promot & Primary Hlth Care, Adelaide, SA, Australia	Flinders University South Australia; Flinders University South Australia	Hu, Y (corresponding author), Flinders Univ South Australia, Flinders Ctr Innovat Canc, Adelaide, SA, Australia.	ying.hu@flinders.edu.au	Le Leu, Richard K/H-4555-2013	Le Leu, Richard K/0000-0003-4704-4943; Woodman, Richard/0000-0002-4094-1222; Young, Graeme/0000-0001-9458-8383	National Health and Medical Research Council; Cancer Council of South Australia [1007501, 525925]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of South Australia(Cancer Council South Australia)	Financial support was provided by National Health and Medical Research Council grant and Cancer Council of South Australia (project number 1007501 and 525925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; Burdge GC, 2010, GENOME MED, V2, DOI 10.1186/gm201; Chung FL, 2003, J NUTR, V133, p3268S, DOI 10.1093/jn/133.10.3268S; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Davis CD, 2007, EXP BIOL MED, V232, P176; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dennert G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005195.pub2; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; Fang MZ, 2003, CANCER RES, V63, P7563; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Group CW, 1999, CANCER RES, V59, P4743; Half E, 2009, EXPERT OPIN PHARMACO, V10, P211, DOI [10.1517/14656560802560153 , 10.1517/14656560802560153]; Hamdy SM, 2011, TOXICOL IND HLTH; Hao XP, 2007, NUTR CANCER, V59, P62, DOI 10.1080/01635580701365050; Hu Y, 2005, INT J CANCER, V115, P561, DOI 10.1002/ijc.20876; Hu Y, 2011, BR J NUTR, P1; Hu Y, 2008, CANCER RES, V68, P4936, DOI 10.1158/0008-5472.CAN-07-6042; Inoue M, 2009, GUT, V58, P1323, DOI 10.1136/gut.2008.166710; Lee JI, 2009, CANCER PREV RES, V2, P683, DOI 10.1158/1940-6207.CAPR-09-0047; McCarty Mark F, 2004, Integr Cancer Ther, V3, P349, DOI 10.1177/1534735404270757; McIntosh GH, 2006, NUTR CANCER, V54, P209, DOI 10.1207/s15327914nc5402_7; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Novotny L, 2010, NEOPLASMA, V57, P383, DOI 10.4149/neo_2010_05_383; Ohishi T, 2002, CANCER LETT, V177, P49, DOI 10.1016/S0304-3835(01)00767-4; Polakis P, 2000, GENE DEV, V14, P1837; Rao CV, 2009, CANCER RES, V69, P8175, DOI 10.1158/0008-5472.CAN-09-1377; Reddy Bandaru S, 2007, Subcell Biochem, V42, P213; Reddy BS, 2004, ENVIRON MOL MUTAGEN, V44, P26, DOI 10.1002/em.20026; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sporn MB, 2008, CANCER PREV RES, V1, P9, DOI 10.1158/1940-6207.CAPR-08-0049; Suh N, 2007, CLIN CANCER RES, V13, P350, DOI 10.1158/1078-0432.CCR-06-1528; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takahashi M, 2000, CARCINOGENESIS, V21, P1117, DOI 10.1093/carcin/21.6.1117; Takahashi M, 2000, CARCINOGENESIS, V21, P1319, DOI 10.1093/carcin/21.7.1319; Telang N, 2007, ONCOL REP, V17, P909; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Tulp M, 2006, DRUG DISCOV TODAY, V11, P1115, DOI 10.1016/j.drudis.2006.10.010; Volate SR, 2009, MOL CARCINOGEN, V48, P920, DOI 10.1002/mc.20542; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1316; Wang LS, 2013, NUTR CANCER, V65, P118, DOI 10.1080/01635581.2013.741759; Wang LS, 2011, CLIN CANCER RES, V17, P598, DOI 10.1158/1078-0432.CCR-10-1260; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Xiao H, 2008, CARCINOGENESIS, V29, P113, DOI 10.1093/carcin/bgm204; Xu G, 2010, FOOD CHEM TOXICOL, V48, P390, DOI 10.1016/j.fct.2009.10.027; Xu J, 2008, J AGR FOOD CHEM, V56, P3869, DOI 10.1021/jf073063a; Xu J, 2007, J AGR FOOD CHEM, V55, P5349, DOI 10.1021/jf070568s; Yang CS, 1997, NATURE, V389, P134, DOI 10.1038/38154; Yang H, 2011, CARCINOGENESIS, V32, P381, DOI 10.1093/carcin/bgq279; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347; Zhou JR, 2007, AM J CLIN NUTR, V86, p882S, DOI 10.1093/ajcn/86.3.882S	58	35	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64362	10.1371/journal.pone.0064362	http://dx.doi.org/10.1371/journal.pone.0064362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717604	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600061
J	Purcell, SW; Agudo, NS				Purcell, Steven W.; Agudo, Natacha S.			Optimisation of Mesh Enclosures for Nursery Rearing of Juvenile Sea Cucumbers	PLOS ONE			English	Article							HOLOTHURIA-SCABRA; GROWTH; PONDS; SEED	Mariculture of tropical sea cucumbers is promising, but the nursery rearing of juveniles is a bottleneck for farming and sea ranching. We conducted four medium-scale experiments lasting 3-6 weeks, using thousands of cultured juvenile sandfish Holothuria scabra, to optimise nursery rearing in mesh enclosures in earthen seawater ponds and to test rearing in enclosures in the sea. In one experiment, survival in fine-mesh enclosures (1 m(3); 660-mu m mesh) related nonlinearly to juvenile size, revealing a threshold body length of 5-8 mm for initial transfer from hatchery tanks. Survival in enclosures within ponds in the other experiments ranged from 78-97%, and differences in growth rates among experiments were explained largely by seasonal differences in seawater temperatures in ponds. Stripped shadecloth units within fine-mesh enclosures increased feeding surfaces and improved growth rates by >15%. On the other hand, shading over the enclosures may lower growth rates. Following the rearing in fine-mesh enclosures, small juveniles (0.5 to 1 g) were grown to stocking size (3-10 g) in coarse-mesh enclosures of 1-mm mesh. Sand or mud added to coarse-mesh enclosures did not significantly improve growth compared to controls without sediment. Survival of sandfish juveniles in coarse-mesh enclosures set on the benthos within seagrass beds differed between two sheltered bays and growth was slow compared to groups within the same type of enclosures in an earthen pond. Our findings should lead to significant improvement in the cost-effectiveness of rearing sandfish juveniles to a stocking size compared to established methods and highlight the need for further research into nursery systems in the sea.	[Purcell, Steven W.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Purcell, Steven W.; Agudo, Natacha S.] WorldFish Ctr, George Town, Malaysia	Southern Cross University; CGIAR; Worldfish	Purcell, SW (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steven.w.purcell@gmail.com	Purcell, Steven/I-2554-2013; Purcell, Steven/AAQ-1326-2021	Purcell, Steven/0000-0002-6227-6454; Purcell, Steven/0000-0002-6227-6454	Australian Centre for International Agricultural Research (ACIAR) [FIS/1999/025]	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res)	This study was funded by the Australian Centre for International Agricultural Research (ACIAR), through project FIS/1999/025, and the three Provinces of New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo N, 2006, SANDFISH HATCHERY TE; Ahlgren MO, 1998, J WORLD AQUACULT SOC, V29, P133, DOI 10.1111/j.1749-7345.1998.tb00972.x; Barman BK, 2011, AQUACULTURE, V317, P214, DOI 10.1016/j.aquaculture.2011.04.005; Battaglene S.C., 1999, Naga, V22, P4; Battaglene SC, 1999, AQUACULTURE, V178, P293, DOI 10.1016/S0044-8486(99)00130-1; Bell JD, 2007, AQUACULTURE, V273, P509, DOI 10.1016/j.aquaculture.2007.07.015; Bhujel RC, 2000, AQUACULTURE, V181, P37, DOI 10.1016/S0044-8486(99)00217-3; Burnham K. P., 1998, MODEL SELECTION INFE; Conand C., 1989, THESIS U BRETAGNE OC; Gamboa R.U., 2012, ASIA PACIFIC TROPICA, P63; Juinio-Men~ez M.A., 2012, ASIA PACIFIC TROPICA, P57; Massin C, 2009, ZOOL J LINN SOC-LOND, V155, P40, DOI 10.1111/j.1096-3642.2008.00430.x; Mercier A, 1999, J EXP MAR BIOL ECOL, V239, P125, DOI 10.1016/S0022-0981(99)00034-9; Mercier A, 2000, HYDROBIOLOGIA, V440, P81, DOI 10.1023/A:1004121818691; Mercier A, 2000, J EXP MAR BIOL ECOL, V249, P89, DOI 10.1016/S0022-0981(00)00187-8; Mercier A., 2012, AUST CTR INT AGR RES, V106, P79; Mills, 2012, ACIAR P, V136, P34; Mills D.J., 2012, ACIAR P, V136, P22; Paltzat DL, 2008, AQUACULTURE, V275, P124, DOI 10.1016/j.aquaculture.2007.12.014; Pitt R, 2001, SPC BECHE DE MER INF, V14, P14; Pitt R., 2004, ADV SEA CUCUMBER AQU, P333; Pitt R, 2003, SPC BECHE DE MER INF, V18, P15; Purcell S, 2006, SPC BECHE DE MER INF, V23, P29; Purcell S.W., 2004, P AUSTRALASIAN AQUAC, P244; Purcell SW, 2008, REV FISH SCI, V16, P204, DOI 10.1080/10641260701686895; Purcell SW, 2012, AQUACULTURE, V368, P68, DOI 10.1016/j.aquaculture.2012.08.053; Purcell SW, 2010, MAR BIOL, V157, P663, DOI 10.1007/s00227-009-1351-6; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raison C. M., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, P1, DOI 10.1079/PAVSNNR20083082; Robinson G., 2012, ACIAR P, P142; RODRIGUEZ EM, 1993, AQUACULTURE, V112, P107, DOI 10.1016/0044-8486(93)90162-R; Skewes T., 2000, SURVEY HOLOTHURIA SC; Slater MJ, 2009, AQUACULTURE, V292, P219, DOI 10.1016/j.aquaculture.2009.04.027; So JJ, 2010, FISHERIES MANAG ECOL, V17, P473, DOI 10.1111/j.1365-2400.2010.00747.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Xiyin L, 2004, ADV SEA CUCUMBER AQU, P287; Yanagisawa T, 1998, TROPICAL MARICULTURE, P291, DOI 10.1016/B978-012210845-7/50009-X	37	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64103	10.1371/journal.pone.0064103	http://dx.doi.org/10.1371/journal.pone.0064103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717542	gold, Green Submitted, Green Published			2022-12-25	WOS:000319435600044
J	Liu, BY; Escalera, J; Balakrishna, S; Fan, L; Caceres, AI; Robinson, E; Sui, AW; McKay, MC; McAlexander, MA; Herrick, CA; Jordt, SE				Liu, Boyi; Escalera, Jasmine; Balakrishna, Shrilatha; Fan, Lu; Caceres, Ana I.; Robinson, Eve; Sui, Aiwei; McKay, M. Craig; McAlexander, M. Allen; Herrick, Christina A.; Jordt, Sven E.			TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis	FASEB JOURNAL			English	Article						pruritis; sensory neurons; TRP channels	ITCH-ASSOCIATED RESPONSE; POTENTIAL ANKYRIN 1; P-INDUCED ITCH; SUBSTANCE-P; ATOPIC-DERMATITIS; NEUROKININ-1 RECEPTOR; TRPV1 ANTAGONIST; NERVE-FIBERS; MURINE MODEL; CRUCIAL ROLE	Allergic contact dermatitis is a common skin disease associated with inflammation and persistent pruritus. Transient receptor potential (TRP) ion channels in skin-innervating sensory neurons mediate acute inflammatory and pruritic responses following exogenous stimulation and may contribute to allergic responses. Genetic ablation or pharmacological inhibition of TRPA1, but not TRPV1, inhibited skin edema, keratinocyte hyperplasia, nerve growth, leukocyte infiltration, and antihistamine-resistant scratching behavior in mice exposed to the haptens, oxazolone and urushiol, the contact allergen of poison ivy. Hapten-challenged skin of TRPA1-deficient mice contained diminished levels of inflammatory cytokines, nerve growth factor, and endogenous pruritogens, such as substance P (SP) and serotonin. TRPA1-deficient sensory neurons were defective in SP signaling, and SP-induced scratching behavior was abolished in Trpa1(-/-) mice. SP receptor antagonists, such as aprepitant inhibited both hapten-induced cutaneous inflammation and scratching behavior. These findings support a central role for TRPA1 and SP in the integration of immune and neuronal mechanisms leading to chronic inflammatory responses and pruritus associated with contact dermatitis.Liu, B., Escalera, J., Balakrishna, S., Fan, L., Caceres, A. I., Robinson, E., Sui, A., McKay, M. C., McAlexander, M. A., Herrick, C. A., Jordt, S. E. TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis.	[Liu, Boyi; Escalera, Jasmine; Balakrishna, Shrilatha; Fan, Lu; Caceres, Ana I.; Sui, Aiwei; Jordt, Sven E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Robinson, Eve; Herrick, Christina A.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [McKay, M. Craig] GlaxoSmithKline, Biol Reagents & Assay Dev, Res Triangle Pk, NC USA; [McAlexander, M. Allen] GlaxoSmithKline, Resp Therapy Area, King Of Prussia, PA USA	Yale University; Yale University; GlaxoSmithKline; GlaxoSmithKline	Jordt, SE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06510 USA.	sven.jordt@yale.edu	Liu, Boyi/J-5396-2014; Jordt, Sven-Eric/ABE-6517-2020; Caceres, Ana I/E-5542-2012	Jordt, Sven-Eric/0000-0001-6171-5622; Caceres, Ana I/0000-0001-7219-8851	U.S. National Institute of Environmental Health Sciences [R01 ES015056, U01 ES015674, F31 ES015932]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES015932, U01ES015674, R01ES015056] Funding Source: NIH RePORTER	U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors are grateful to David Julius (University of California, San Francisco, CA, USA) for Trpa1<SUP>-/-</SUP> mice, and to Jaime Garcia-Anoveros (Northwestern University, Chicago, IL, USA) for mouse TRPA1 cDNA. This work was funded by grants from the U.S. National Institute of Environmental Health Sciences (awards R01 ES015056 and U01 ES015674 to S.E.J. and predoctoral fellowship F31 ES015932 to J.E.). S.E.J. is serving on the scientific advisory board of, and has equity interest in, Hydra Biosciences (Cambridge, MA, USA), a biotechnology company developing TRP channel inhibitors. Authors affiliated with GlaxoSmithKline may have equity interest in GlaxoSmithKline.	Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Andoh T, 2007, J INVEST DERMATOL, V127, P2042, DOI 10.1038/sj.jid.5700810; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Banvolgyi A, 2005, J NEUROIMMUNOL, V169, P86, DOI 10.1016/j.jneuroim.2005.08.012; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Beresford L, 2004, IMMUNOLOGY, V111, P118, DOI 10.1111/j.1365-2567.2004.01786.x; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Buddenkotte J, 2010, ALLERGY, V65, P805, DOI 10.1111/j.1398-9995.2010.01995.x; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Carlton SM, 1996, BRAIN RES, V734, P103, DOI 10.1016/S0006-8993(96)00619-1; DUNN IS, 1982, CELL IMMUNOL, V68, P377, DOI 10.1016/0008-8749(82)90122-8; Duval A, 2009, NEW ENGL J MED, V361, P1415, DOI 10.1056/NEJMc0906670; Dux M, 1996, INFLAMM RES, V45, P10, DOI 10.1007/BF02263498; EKBLOM A, 1993, SKIN PHARMACOL, V6, P215; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; El-Nour H, 2007, ACTA DERM-VENEREOL, V87, P390, DOI 10.2340/00015555-0288; Fernandes ES, 2013, FASEB J, V27, P1664, DOI 10.1096/fj.12-221218; FJELLNER B, 1981, ACTA DERM-VENEREOL, V61, P245; Gladman AC, 2006, WILD ENVIRON MED, V17, P120, DOI 10.1580/PR31-05.1; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Hox V, 2013, AM J RESP CRIT CARE, V187, P486, DOI 10.1164/rccm.201208-1358OC; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Johnson KR, 2003, GENOMICS, V81, P6, DOI 10.1016/S0888-7543(02)00013-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kinkelin I, 2000, CELL TISSUE RES, V302, P31, DOI 10.1007/s004410000202; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; Li HS, 1998, EUR J NEUROSCI, V10, P1292, DOI 10.1046/j.1460-9568.1998.00140.x; Liang JX, 2011, NEUROSCI LETT, V492, P175, DOI 10.1016/j.neulet.2011.02.009; Liu T, 2012, NEUROSCI BULL, V28, P145, DOI 10.1007/s12264-012-1207-9; Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Mir O, 2011, NEW ENGL J MED, V364, P487, DOI 10.1056/NEJMc1013027; Neisius U, 2002, J AM ACAD DERMATOL, V47, P28, DOI 10.1067/mjd.2002.120462; Niwa Y, 2003, BRIT J DERMATOL, V149, P248, DOI 10.1046/j.1365-2133.2003.05417.x; Nojima H, 2003, J PHARMACOL EXP THER, V306, P245, DOI 10.1124/jpet.103.049239; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; RATZLAFF RE, 1992, J NEUROIMMUNOL, V41, P89, DOI 10.1016/0165-5728(92)90199-U; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Rukwied R, 1999, EXP DERMATOL, V8, P39, DOI 10.1111/j.1600-0625.1999.tb00346.x; Scholzen TE, 2001, J IMMUNOL, V166, P1285, DOI 10.4049/jimmunol.166.2.1285; Shiba T, 2012, TOXICOL APPL PHARM, V264, P370, DOI 10.1016/j.taap.2012.08.012; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Stander S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010968; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUNDELIN JB, 1992, EUR J BIOCHEM, V203, P625, DOI 10.1111/j.1432-1033.1992.tb16592.x; Tang HB, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-42; Tang HB, 2008, NEUROPHARMACOLOGY, V55, P1405, DOI 10.1016/j.neuropharm.2008.08.037; Togashi Y, 2002, EUR J PHARMACOL, V435, P259, DOI 10.1016/S0014-2999(01)01588-6; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Tsukumo Y, 2010, J PHARMACOL SCI, V113, P255, DOI 10.1254/jphs.10050FP; Vincenzi B, 2010, NEW ENGL J MED, V363, P397, DOI 10.1056/NEJMc1003937; von Banchet GS, 1999, NEUROSCI LETT, V274, P175, DOI 10.1016/S0304-3940(99)00719-3; Wakabayashi T, 2005, IMMUNOL CELL BIOL, V83, P18, DOI 10.1111/j.1440-1711.2005.01310.x; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yun JW, 2011, J INVEST DERMATOL, V131, P1576, DOI 10.1038/jid.2011.87; Yun JW, 2011, J DERMATOL SCI, V62, P8, DOI 10.1016/j.jdermsci.2010.10.014	68	150	156	0	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3549	3563		10.1096/fj.13-229948	http://dx.doi.org/10.1096/fj.13-229948			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23722916	Green Published			2022-12-25	WOS:000328840500015
J	Feldman-Salit, A; Hering, S; Messiha, HL; Veith, N; Cojocaru, V; Sieg, A; Westerhoff, HV; Kreikemeyer, B; Wade, RC; Fiedler, T				Feldman-Salit, Anna; Hering, Silvio; Messiha, Hanan L.; Veith, Nadine; Cojocaru, Vlad; Sieg, Antje; Westerhoff, Hans V.; Kreikemeyer, Bernd; Wade, Rebecca C.; Fiedler, Tomas			Regulation of the Activity of Lactate Dehydrogenases from Four Lactic Acid Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS; LACTOBACILLUS-PLANTARUM; KINETIC-PARAMETERS; GENOME SEQUENCE; BINDING; SUBSTITUTION; PATHOGENESIS; METABOLISM; MECHANISM; EVOLUTION	Despite high similarity in sequence and catalytic properties, the L-lactate dehydrogenases (LDHs) in lactic acid bacteria (LAB) display differences in their regulation that may arise from their adaptation to different habitats. We combined experimental and computational approaches to investigate the effects of fructose 1,6-bisphosphate (FBP), phosphate (P-i), and ionic strength (NaCl concentration) on six LDHs from four LABs studied at pH 6 and pH 7. We found that 1) the extent of activation by FBP (K-act) differs. Lactobacillus plantarum LDH is not regulated by FBP, but the other LDHs are activated with increasing sensitivity in the following order: Enterococcus faecalis LDH2 <= Lactococcus lactis LDH2 < E. faecalis LDH1 < L. lactis LDH1 <= Streptococcus pyogenes LDH. This trend reflects the electrostatic properties in the allosteric binding site of the LDH enzymes. 2) For L. plantarum, S. pyogenes, and E. faecalis, the effects of Pi are distinguishable from the effect of changing ionic strength by adding NaCl. 3) Addition of Pi inhibits E. faecalis LDH2, whereas in the absence of FBP, Pi is an activator of S. pyogenes LDH, E. faecalis LDH1, and L. lactis LDH1 and LDH2 at pH 6. These effects can be interpreted by considering the computed binding affinities of Pi to the catalytic and allosteric binding sites of the enzymes modeled in protonation states corresponding to pH 6 and pH 7. Overall, the results show a subtle interplay among the effects of P-i, FBP, and pH that results in different regulatory effects on the LDHs of different LABs.	[Feldman-Salit, Anna; Veith, Nadine; Cojocaru, Vlad; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany; [Feldman-Salit, Anna; Veith, Nadine] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany; [Wade, Rebecca C.] Heidelberg Univ, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Hering, Silvio; Sieg, Antje; Kreikemeyer, Bernd; Fiedler, Tomas] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Messiha, Hanan L.; Westerhoff, Hans V.] Univ Manchester, MIB, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England; [Westerhoff, Hans V.] Univ Amsterdam, SILS, NL-1018 HV Amsterdam, Netherlands; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, FALW, NL-1018 HV Amsterdam, Netherlands	Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Rostock; University of Manchester; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Wade, RC (corresponding author), Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany.	rebecca.wade@h-its.org; tomas.fiedler@med.uni-rostock.de	Cojocaru, Vlad/GZA-7475-2022; Wade, Rebecca/L-1489-2019; Westerhoff, Hans V/I-5762-2012	Cojocaru, Vlad/0000-0003-0886-3401; Wade, Rebecca/0000-0001-5951-8670; Westerhoff, Hans V/0000-0002-0443-6114; Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098	Systems Biology of Microorganisms Network (SysMO) SysMO-LAB project; Systems Biology of Microorganisms Network (SysMO) SysMO-LAB2 project; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung); Klaus Tschira Foundation; BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Manchester Centre for Integrative Systems Biology [BB/C008219/1, G530225/1, I017186/1, I004696/1, F003552/1]; EU-FP7; NWO; BBSRC [BB/I004696/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C008219/1, BB/I004696/1] Funding Source: researchfish	Systems Biology of Microorganisms Network (SysMO) SysMO-LAB project; Systems Biology of Microorganisms Network (SysMO) SysMO-LAB2 project; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation; BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Manchester Centre for Integrative Systems Biology; EU-FP7(European Commission); NWO(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Systems Biology of Microorganisms Network (SysMO) SysMO-LAB and SysMO-LAB2 projects with funding from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung), the Klaus Tschira Foundation (to A. F.-S., V. C., and R. C. W.), the BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg (to A. F.-S.), and Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council funding also of the Manchester Centre for Integrative Systems Biology (to H. M. and H. W.; Grants BB/C008219/1, G530225/1, I017186/1, I004696/1, F003552/1), EU-FP7, and NWO.	CAMERON AD, 1994, J MOL BIOL, V238, P615, DOI 10.1006/jmbi.1994.1318; CLARKE AR, 1987, BIOCHIM BIOPHYS ACTA, V913, P72, DOI 10.1016/0167-4838(87)90234-2; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V829, P387, DOI 10.1016/0167-4838(85)90249-3; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Enderton H., 2001, MATH INTRO LOGIC; Fiedler T, 2011, APPL ENVIRON MICROB, V77, P612, DOI 10.1128/AEM.01838-10; Fiedler T, 2010, FUTURE MICROBIOL, V5, P1675, DOI [10.2217/fmb.10.128, 10.2217/FMB.10.128]; Fisher K, 2009, BRIT J BIOMED SCI, V66, P180, DOI 10.1080/09674845.2009.11730270; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; IWATA S, 1994, NAT STRUCT BIOL, V1, P176, DOI 10.1038/nsb0394-176; Jonsson M, 2009, APPL ENVIRON MICROB, V75, P4901, DOI 10.1128/AEM.00344-09; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Levering J, 2012, FEBS J, V279, P1274, DOI 10.1111/j.1742-4658.2012.08523.x; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Messiha HL, 2011, METHOD ENZYMOL, V500, P215, DOI 10.1016/B978-0-12-385118-5.00012-8; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Sanchez R, 2000, METH MOL B, V143, P97; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Swainston N, 2010, FEBS J, V277, P3769, DOI 10.1111/j.1742-4658.2010.07778.x; TAGUCHI H, 1992, EUR J BIOCHEM, V209, P993, DOI 10.1111/j.1432-1033.1992.tb17373.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; WIGLEY DB, 1992, J MOL BIOL, V223, P317, DOI 10.1016/0022-2836(92)90733-Z	32	34	34	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21295	21306		10.1074/jbc.M113.458265	http://dx.doi.org/10.1074/jbc.M113.458265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720742	Green Published, hybrid			2022-12-25	WOS:000322014400049
J	Ogunwobi, OO; Puszyk, W; Dong, HJ; Liu, C				Ogunwobi, Olorunseun O.; Puszyk, William; Dong, Hui-Jia; Liu, Chen			Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ADVANCED PROSTATE; CANCER; EXPRESSION; GROWTH; PROGNOSIS; DIAGNOSIS; PROMOTER; SURVIVAL	Hepatocyte growth factor (HGF) and its receptor, c-Met, are important regulators of growth and differentiation of healthy hepatocytes. However, upregulation of HGF and c-Met have been associated with tumor progression and metastasis in hepatocellular carcinoma (HCC). Hematogenous dissemination is the most common route for cancer metastasis, but the role of HGF and c-Met in circulating tumor cells (CTCs) is unknown. We have isolated and established a circulating tumor cell line from the peripheral blood of a mouse HCC model. Our studies show that these CTCs have increased expression of HGF and c-Met in comparison to the primary tumor cells. The CTCs display phenotypic evidence of epithelial-mesenchymal transition (EMT) and the EMT appears to be inducible by HGF. Epigenetic analysis of the c-Met promoter identified significant loss of DNA methylation in CTCs which correlated with overexpression of c-Met and increased expression of HGF. Six specific CpG sites of c-Met promoter demethylation were identified. CTCs show significantly increased tumorigenicity and metastatic potential in a novel orthotopic syngeneic model of metastatic HCC. We conclude that during hematogenous dissemination in HCC, CTCs undergo EMT under the influence of increased HGF. This process also involves up regulation of c-Met via promoter demethylation at 6 CpG sites. Consequently, targeting HGF and c-Met expression by CTCs may be a novel non-invasive approach with potential clinical applications in HCC management.	[Ogunwobi, Olorunseun O.; Puszyk, William; Dong, Hui-Jia; Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Ogunwobi, Olorunseun O.; Liu, Chen] Univ Florida, Shands Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, C (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	liu@pathology.ufl.edu		Ogunwobi, Olorunseun/0000-0003-3388-2137	National Institutes of Health [5T32CA009126-35, R01CA133086, R01AA019976, K26RR023976]; NATIONAL CANCER INSTITUTE [R01CA133086, T32CA009126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR023976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Olorunseun O. Ogunwobi is supported by the National Institutes of Health T32 grant (5T32CA009126-35). Chen Liu is supported by National Institutes of Health grants R01CA133086, R01AA019976 and K26RR023976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Cao MD, 2011, LAB INVEST, V91, P598, DOI 10.1038/labinvest.2010.205; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; FALCHOOK GS, 2011, EJC SUPPL, V47, pS158; Fan ZC, 2012, CANCER RES, V72, P2683, DOI 10.1158/0008-5472.CAN-11-3733; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gumustekin M, 2012, PATHOL ONCOL RES, V18, P209, DOI 10.1007/s12253-011-9430-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Inagaki Y, 2011, BIOSCI TRENDS, V5, P52, DOI 10.5582/bst.2011.v5.2.52; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Konishi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027889; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Mego M, 2011, INT J CANCER, V129, P417, DOI 10.1002/ijc.25690; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Ogunwobi OO, 2012, J GASTROEN HEPATOL, V27, P566, DOI 10.1111/j.1440-1746.2011.06980.x; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Pinkas J, 2002, CANCER RES, V62, P4781; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Previdi S, 2012, MOL CANCER THER, V11, P214, DOI 10.1158/1535-7163.MCT-11-0277; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rink M, 2012, EUR UROL, V61, P810, DOI 10.1016/j.eururo.2012.01.017; Saad F, 2012, FUTURE ONCOL, V8, P321, DOI [10.2217/FON.12.3, 10.2217/fon.12.3]; Seol DW, 1999, J BIOL CHEM, V274, P3565, DOI 10.1074/jbc.274.6.3565; Son G, 2006, J HEPATOL, V45, P688, DOI 10.1016/j.jhep.2006.04.011; Steube KG, 2008, CYTOTECHNOLOGY, V56, P49, DOI 10.1007/s10616-007-9106-z; Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392; Sun YF, 2011, J CANCER RES CLIN, V137, P1151, DOI 10.1007/s00432-011-0988-y; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Xie Q, 2001, WORLD J GASTROENTERO, V7, P816, DOI 10.3748/wjg.v7.i6.816; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Yu M, 2012, NATURE	45	69	77	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63765	10.1371/journal.pone.0063765	http://dx.doi.org/10.1371/journal.pone.0063765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723997	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000021
J	Yan, J; Wong, N; Hung, C; Chen, WXY; Tang, DM				Yan, Judy; Wong, Nicholas; Hung, Claudia; Chen, Wendy Xin-Yi; Tang, Damu			Contactin-1 Reduces E-Cadherin Expression Via Activating AKT in Lung Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; PROSTATE-CANCER; PTEN EXPRESSION; GENE-EXPRESSION; CELLS; ADHESION; PROTEIN; INVASION; PROMOTES; ANGIOGENESIS	Contactin-1 has been shown to promote cancer metastasis. However, the underlying mechanisms remain unclear. We report here that knockdown of contactin-1 in A549 lung cancer cells reduced A549 cell invasion and the cell's ability to grow in soft agar without affecting cell proliferation. Reduction of contactin-1 resulted in upregulation of E-cadherin, consistent with E-cadherin being inhibitive of cancer cell invasion. In an effort to investigate the mechanisms whereby contactin-1 reduces E-cadherin expression, we observed that contactin-1 plays a role in AKT activation, as knockdown of contactin-1 attenuated AKT activation. Additionally, inhibition of AKT activation significantly enhanced E-cadherin expression, an observation that mimics the situation observed in contactin-1 knockdown, suggesting that activation of AKT plays a role in contactin-1-mediated downregulation of E-cadherin. In addition, we were able to show that knockdown of contactin-1 did not further reduce A549 cell's invasion ability, when AKT activation was inhibited by an AKT inhibitor. To further support our findings, we overexpressed CNTN-1 in two CNTN-1 null breast cancer cell lines expressing E-cadherin. Upon overexpression, CNTN-1 reduced E-cadherin levels in one cell line and increased AKT activation in the other. Furthermore, in our study of 63 primary lung cancers, we observed 65% of primary lung cancers being contactin-1 positive and in these carcinomas, 61% were E-cadherin negative. Collectively, we provide evidence that contactin-1 plays a role in the downregulation of E-cadherin in lung cancer and that AKT activation contributes to this process. In a study of mechanisms responsible for contactin-1 to activate AKT, we demonstrated that knockdown of CNTN-1 in A549 cells did not enhance PTEN expression but upregulated PHLPP2, a phosphatase that dephosphorylates AKT. These observations thus suggest that contactin-1 enhances AKT activation in part by preventing PHLPP2-mediated AKT dephosphrorylation.	[Yan, Judy; Wong, Nicholas; Hung, Claudia; Chen, Wendy Xin-Yi; Tang, Damu] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Yan, Judy; Wong, Nicholas; Hung, Claudia; Chen, Wendy Xin-Yi; Tang, Damu] McMaster Univ, Dept Surg, Div Urol, Hamilton, ON L8S 4L8, Canada; [Yan, Judy; Wong, Nicholas; Hung, Claudia; Chen, Wendy Xin-Yi; Tang, Damu] St Josephs Hosp, Father Sean OSullivan Res Inst, Hamilton, ON, Canada; [Yan, Judy; Wong, Nicholas; Hung, Claudia; Chen, Wendy Xin-Yi; Tang, Damu] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON, Canada	McMaster University; McMaster University; McGill University; McMaster University; McGill University; McMaster University	Tang, DM (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	damut@mcmaster.ca	Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521; Hung, Claudia Lin-Kar/0000-0003-4811-5280	Prostate Cancer Canada; St. Joseph's HealthCare at Hamilton, Ontario, Canada	Prostate Cancer Canada; St. Joseph's HealthCare at Hamilton, Ontario, Canada	This research was supported by Prostate Cancer Canada to D. Tang. The authors also like to acknowledge the financial support from St. Joseph's HealthCare at Hamilton, Ontario, Canada to the Hamilton Centre for Kidney Research (HCKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; Davisson MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029538; Deeb G, 2004, MODERN PATHOL, V17, P430, DOI 10.1038/modpathol.3800041; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Fetissov SO, 2005, EUR J NEUROSCI, V22, P3217, DOI 10.1111/j.1460-9568.2005.04513.x; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita N, 2007, DEV GENES EVOL, V217, P709, DOI 10.1007/s00427-007-0183-y; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Hao L, 2012, BRIT J DERMATOL, V166, P1184, DOI 10.1111/j.1365-2133.2012.10824.x; He LZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1309; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Hung YH, 2009, CHEM-BIOL INTERACT, V179, P154, DOI 10.1016/j.cbi.2008.10.042; Kase S, 2000, CLIN CANCER RES, V6, P4789; Kisslov L, 2012, BBA-MOL CELL BIOL L, V1821, P1224, DOI 10.1016/j.bbalip.2012.06.005; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Lim SC, 2000, J KOREAN MED SCI, V15, P501, DOI 10.3346/jkms.2000.15.5.501; Liu PF, 2012, JPN J CLIN ONCOL, V42, P612, DOI 10.1093/jjco/hys066; Liu PF, 2011, CYTOKINE, V55, P8, DOI 10.1016/j.cyto.2011.03.008; Mauerer A, 2011, EXP DERMATOL, V20, P502, DOI 10.1111/j.1600-0625.2011.01254.x; Mehta R, 2001, CLIN CANCER RES, V7, P81; Myong Na-Hye, 2004, Cancer Res Treat, V36, P56, DOI 10.4143/crt.2004.36.1.56; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qin XJ, 2011, INT J MOL MED, V28, P761, DOI 10.3892/ijmm.2011.758; Randall LM, 2009, GYNECOL ONCOL, V112, P583, DOI 10.1016/j.ygyno.2008.11.013; REID RA, 1994, MOL BRAIN RES, V21, P1, DOI 10.1016/0169-328X(94)90372-7; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Wu HM, 2012, MOL MED REP, V6, P265, DOI 10.3892/mmr.2012.910; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xie YY, 2012, BBA-MOL BASIS DIS, V1822, P875, DOI 10.1016/j.bbadis.2012.02.019	50	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65463	10.1371/journal.pone.0065463	http://dx.doi.org/10.1371/journal.pone.0065463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724143	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000132
J	Young, RC; Goloman, G				Young, Roger C.; Goloman, Gabriela			Phasic Oscillations of Extracellular Potassium (K-o) in Pregnant Rat Myometrium	PLOS ONE			English	Article							SMOOTH-MUSCLE; HYPERPOLARIZING FACTOR; SKELETAL-MUSCLE; ACCUMULATION; CONTRACTIONS	K-sensitive microelectrodes were used to measure K+ within the extracellular space (Ko) of pregnant rat myometrium. Contractile activity was monitored by measuring either force or bioelectrical signals. Single and double-barreled electrodes were used. Double-barreled electrodes allowed monitoring of electrical activity 15 microns from the site of K-o measurement. From double-barreled electrode experiments, the bioelectrical burst started first, and then K-o began to rise 0.6 +/- 0.1 seconds later. This delay indicates that K+ leaves the cells in response to local electrical activity rather than vice versa. Four control experiments were performed to assess the influence of electrical artifacts caused by tissue motion on K-o values. When observed, artifacts were negative and transient, and hence would result in an underestimation of K-o rises. Artifacts were minimized when tissue motion was minimized by fixing the tissue at both ends. At 37 degrees C, 7 single barreled experiments and 45 contractions were analyzed. Resting K-o was within 1 mM of bath K+ (5 mM) at the beginning and end of the experiments. K-o rose during the contraction, fell after the completion of the contraction, and normalized before the next contraction began. Peak K-o values observed during force production were 18.8 +/- 5.9 mM, a value high enough to modulate tissue-level electrical activity. K-o required 15.7 +/- 2.8 seconds to normalize halfway (t(50)). Six experiments expressing 38 contractions were performed at 24 degrees C. The contraction period was longer at 24 degrees C. Values for peak Ko (26.2 +/- 9.9 mM) and t50 (29.8 +/- 16.2 sec) were both larger than at 37 degrees C (p<0.0003 for both). The direct relationships between peak K-o, t(50) and the contraction period, suggest elevations in K-o may modulate contraction frequency. The myometrial interstitial space appears to be functionally important, and K-o metabolism may participate in cell-cell interactions.	[Young, Roger C.; Goloman, Gabriela] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA	University of Vermont	Young, RC (corresponding author), Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA.	youngschwarzenberger@gmail.com			Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT, USA	Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT, USA	This work was supported by funds from the Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NC, 1969, J GEN PHYSIOL, V54, P145, DOI 10.1085/jgp.54.2.145; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P183, DOI 10.1016/j.pbiomolbio.2011.07.004; Burns WR, 2004, MICROCIRCULATION, V11, P279, DOI 10.1080/10739680490425985; Bursztyn L, 2007, ANN NY ACAD SCI, V1101, P110, DOI 10.1196/annals.1389.025; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Coats P, 2001, CIRCULATION, V103, P1702, DOI 10.1161/01.CIR.103.12.1702; Daub B, 2000, CELL CALCIUM, V27, P3, DOI 10.1054/ceca.1999.0084; Davis MJ, 2012, MICROCIRCULATION, V19, P99, DOI 10.1111/j.1549-8719.2011.00131.x; Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR400, DOI 10.1152/ajpregu.2000.278.2.R400; KLINE RP, 1982, J PHYSIOL-LONDON, V324, P507, DOI 10.1113/jphysiol.1982.sp014127; KLINE RP, 1978, J PHYSIOL-LONDON, V280, P537, DOI 10.1113/jphysiol.1978.sp012400; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; LAW RO, 1982, EXPERIENTIA, V38, P411, DOI 10.1007/BF01952615; Noble K, 2010, CELL CALCIUM, V47, P47, DOI 10.1016/j.ceca.2009.11.004; Obrocea GV, 1998, CAN J PHYSIOL PHARM, V76, P148; Sanborn BM, 2000, J SOC GYNECOL INVEST, V7, P4, DOI 10.1016/S1071-5576(99)00051-9; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; SINGER W, 1973, BRAIN RES, V64, P17, DOI 10.1016/0006-8993(73)90168-6; Smith RD, 2005, AM J PHYSIOL-CELL PH, V288, pC982, DOI 10.1152/ajpcell.00120.2004; Smith RC, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-41; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Taggart MJ, 1998, J PHYSIOL-LONDON, V509, P315, DOI 10.1111/j.1469-7793.1998.315bn.x; Young RC, 1999, OBSTET GYNECOL, V93, P94, DOI 10.1016/S0029-7844(98)00345-7; Young RC, 2011, REPROD SCI, V18, P64, DOI 10.1177/1933719110379637; Young RC, 2009, REPROD SCI, V16, P734, DOI 10.1177/1933719109334965; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65110	10.1371/journal.pone.0065110	http://dx.doi.org/10.1371/journal.pone.0065110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724127	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000120
J	Yang, L; Liu, DX; Liang, S; Guo, RH; Zhang, ZH; Xu, H; Yang, C; Zhu, Y				Yang, Li; Liu, Dongxiao; Liang, Song; Guo, Renhua; Zhang, Zhihong; Xu, Hao; Yang, Chao; Zhu, Yi			Janus Kinase 2 Polymorphisms Are Associated with Risk in Patients with Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ACTIVATION; STAT3; INFLAMMATION; RECEPTOR; CARCINOGENESIS; EPIDEMIOLOGY; INHIBITOR; HEAD	Aim: To evaluate the impact of the Janus kinase 2 single nucleotide polymorphisms (SNPs) on gastric cancer risk. Methods: In this hospital-based, case-control study, the genotypes were identified by polymerase chain reaction-restriction fragment length polymorphism protocols in 661 individuals (359 gastric cancer patients and 302 age and sex matched cancer-free controls). Results: Both the frequency of A allele in rs2230724 and G allele in rs1887427 were more frequent in patients with gastric cancer (P = 0.013 and 0.001, respectively). Compared with the common genotype, subjects with the (AG+AA) genotypes of rs2230724 and the (AG+GG) genotypes of rs1887427 had a 59% and 98% increased risk of developing gastric cancer, respectively (P = 0.010, adjusted OR = 1.59, 95% CI = 1.12-2.27; P<0.001, adjusted OR = 1.98, 95% CI = 1.39-2.81, respectively). Further stratified analysis showed that the association between the risk of gastric cancer and the rare genotypes of rs2230724 were more profound in the subgroups of elder individuals (>56 years), males, nonsmokers and urban subjects, while the association between the risk and the rare genotypes of rs1887427 persisted in subgroups of younger individuals (<= 56 years), males, nonsmokers and both of rural and urban subjects. Conclusion: The JAK2 gene rs2230724 and rs1887427 polymorphisms are associated with an increased risk of gastric cancer in a Chinese Han population.	[Yang, Li; Liang, Song; Xu, Hao; Yang, Chao; Zhu, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Liu, Dongxiao] Southeast Univ, Affiliated Hosp 2, Hosp Nanjing 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Guo, Renhua] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Pathol, Nanjing, Jiangsu, Peoples R China; [Zhu, Yi] Jiangsu Prov Acad Clin Med, Inst Tumor Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Nanjing Medical University	Yang, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	pwkyangli@yahoo.com.cn	Zhu, Yifan/GXH-6179-2022		"Medical ZhongDianRenCai Project" of Jiangsu Province [RC2011059]; 333 Project; Six RenCai Gaofeng; Jiangsu Province	"Medical ZhongDianRenCai Project" of Jiangsu Province; 333 Project(Natural Science Foundation of Jiangsu Province); Six RenCai Gaofeng; Jiangsu Province	This study was supported by the following grants: "Medical ZhongDianRenCai Project" of Jiangsu Province (RC2011059), "333 Project," and "Six RenCai Gaofeng." Funding was also received from the Young Academic Leader of Jiangsu Province to Yang L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cong YH, 2009, MOL VIS, V15, P1412; Constantinescu SN, 2008, TRENDS BIOCHEM SCI, V33, P122, DOI 10.1016/j.tibs.2007.12.002; CORREA P, 1992, CANCER RES, V52, P6735; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Gu HJ, 2008, EUR J CANCER, V44, P1253, DOI 10.1016/j.ejca.2007.09.013; Gu HJ, 2008, CLIN CANCER RES, V14, P3627, DOI 10.1158/1078-0432.CCR-07-4808; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Lee JJ, 2011, CANCER PREV RES, V4, P185, DOI 10.1158/1940-6207.CAPR-10-0125; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Pham TM, 2006, INT J CANCER, V119, P2408, DOI 10.1002/ijc.22122; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Prager M, 2012, INT J COLORECTAL DIS, V27, P565, DOI 10.1007/s00384-011-1345-y; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Sriuranpong V, 2003, CANCER RES, V63, P2948; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Traer E, 2012, LEUKEMIA, V26, P1140, DOI 10.1038/leu.2011.325; Vera J, 2011, PROG BIOPHYS MOL BIO, V106, P426, DOI 10.1016/j.pbiomolbio.2011.06.013; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yang L, 2008, EJSO-EUR J SURG ONC, V34, P636, DOI 10.1016/j.ejso.2007.09.003; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong Y, 2012, INT J LAB HEMATOL, V34, P248, DOI 10.1111/j.1751-553X.2011.01386.x; Zhou JJ, 2011, GASTRIC CANCER, V14, P322, DOI 10.1007/s10120-011-0044-2; Zhu HJ, 2006, CARCINOGENESIS, V27, P2491, DOI 10.1093/carcin/bgl121	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64628	10.1371/journal.pone.0064628	http://dx.doi.org/10.1371/journal.pone.0064628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717640	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300014
J	Ferrer-Paris, JR; Sanchez-Mercado, A; Viloria, AL; Donaldson, J				Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Viloria, Angel L.; Donaldson, John			Congruence and Diversity of Butterfly-Host Plant Associations at Higher Taxonomic Levels	PLOS ONE			English	Article							NEOTROPICAL MISTLETOE BUTTERFLIES; LARVAL FOOD PLANTS; LYCAENID BUTTERFLIES; HUBNER LEPIDOPTERA; ANT ASSOCIATION; IMMATURE STAGES; DIET BREADTH; DIVERSIFICATION; EVOLUTION; CLASSIFICATION	We aggregated data on butterfly-host plant associations from existing sources in order to address the following questions: (1) is there a general correlation between host diversity and butterfly species richness?, (2) has the evolution of host plant use followed consistent patterns across butterfly lineages?, (3) what is the common ancestral host plant for all butterfly lineages? The compilation included 44,148 records from 5,152 butterfly species (28.6% of worldwide species of Papilionoidea) and 1,193 genera (66.3%). The overwhelming majority of butterflies use angiosperms as host plants. Fabales is used by most species (1,007 spp.) from all seven butterfly families and most subfamilies, Poales is the second most frequently used order, but is mostly restricted to two species-rich subfamilies: Hesperiinae (56.5% of all Hesperiidae), and Satyrinae (42.6% of all Nymphalidae). We found a significant and strong correlation between host plant diversity and butterfly species richness. A global test for congruence (Parafit test) was sensitive to uncertainty in the butterfly cladogram, and suggests a mixed system with congruent associations between Papilionidae and magnoliids, Hesperiidae and monocots, and the remaining subfamilies with the eudicots (fabids and malvids), but also numerous random associations. The congruent associations are also recovered as the most probable ancestral states in each node using maximum likelihood methods. The shift from basal groups to eudicots appears to be more likely than the other way around, with the only exception being a Satyrine-clade within the Nymphalidae that feed on monocots. Our analysis contributes to the visualization of the complex pattern of interactions at superfamily level and provides a context to discuss the timing of changes in host plant utilization that might have promoted diversification in some butterfly lineages.	[Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Donaldson, John] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, Western Cape, South Africa; [Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada; Donaldson, John] Univ Cape Town, Dept Bot, ZA-7925 Cape Town, Western Cape, South Africa; [Ferrer-Paris, Jose R.; Sanchez-Mercado, Ada] Inst Venezolano Invest Cient, Ctr Estudios Bot & Agroforestales, Maracaibo, Estado Zulia, Venezuela; [Viloria, Angel L.] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Distrito Capita, Venezuela	South African National Biodiversity Institute; University of Cape Town; Venezuelan Institute Science Research; Venezuelan Institute Science Research	Sanchez-Mercado, A (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, Western Cape, South Africa.	asanchez@ivic.gob.ve	Yakovlev, Roman/J-7243-2013; Ferrer-Paris, José/M-3785-2015; Sánchez-Mercado, Ada/AAL-4235-2021; Donaldson, John/F-6833-2011	Ferrer-Paris, José/0000-0002-9554-3395; Sánchez-Mercado, Ada/0000-0001-5030-2128; Donaldson, John/0000-0002-7930-1695	Instituto Venezolano de Investigaciones Cientificas (IVIC); South African National Biodiversity Institute (SANBI); University of Cape Town (UCT)	Instituto Venezolano de Investigaciones Cientificas (IVIC); South African National Biodiversity Institute (SANBI); University of Cape Town (UCT)	This work was supported by Instituto Venezolano de Investigaciones Cientificas (IVIC), and by a postdoctoral fellowship "Threatened species program" from South African National Biodiversity Institute (SANBI) and University of Cape Town (UCT) to ASM and JRFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERY PR, 1988, BIOL J LINN SOC, V33, P95, DOI 10.1111/j.1095-8312.1988.tb00446.x; ACKERY PR, 1991, BIOL J LINN SOC, V44, P335, DOI 10.1111/j.1095-8312.1991.tb00624.x; Anderson D.R., 2008, MODEL BASED INFERENC; Beccaloni GW, 2000, OIKOS, V90, P50, DOI 10.1034/j.1600-0706.2000.900106.x; Beccaloni GW, 2008, CATALOGO PLANTAS HUE; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Braby MF, 2005, INVERTEBR SYST, V19, P113, DOI 10.1071/IS04020; Braby MF, 2005, J NAT HIST, V39, P499, DOI 10.1080/00222930410001708687; Braby Michael F., 2007, Journal of the Lepidopterists' Society, V61, P181; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Braby MF, 2006, ENTOMOL SCI, V9, P383, DOI 10.1111/j.1479-8298.2006.00185.x; Braby MF, 2010, J NAT HIST, V44, P1831, DOI 10.1080/00222931003633227; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; de Jong R, 2003, INVERTEBR SYST, V17, P143, DOI 10.1071/IS02021; Eastwood R, 2006, EVOLUTION, V60, P315; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Farrell BD, 1998, BIOL J LINN SOC, V63, P553, DOI 10.1006/bijl.1997.0207; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fiedler K, 1996, ENTOMOL EXP APPL, V80, P259, DOI 10.1007/BF00194770; FIEDLER K, 1994, ECOL ENTOMOL, V19, P79, DOI 10.1111/j.1365-2311.1994.tb00393.x; FIEDLER K, 1995, ETHOL ECOL EVOL, V7, P107, DOI 10.1080/08927014.1995.9522960; Fiedler K, 1998, ECOL ENTOMOL, V23, P285, DOI 10.1046/j.1365-2311.1998.00132.x; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HERNANDEZ L. M., 2002, HOSTPLANTS MOTH BUTT; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; KROON D.M., 1999, LEPIDOPTERA SO AFRIC; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Lamas G, 2008, SISTEMATICA MARIPOSA; Lamas G, 2004, ATLAS EOTROPICAL LEP; Lamas G., 2008, CONTRIBUCIONES TAXON, P57; Larsen TB, 2005, BUTTERFLIES W AFRICA; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Megens HJ, 2005, BIOL J LINN SOC, V84, P225, DOI 10.1111/j.1095-8312.2005.00426.x; Megens HJ, 2004, MOL PHYLOGENET EVOL, V31, P1181, DOI 10.1016/j.ympev.2003.10.002; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; MILLER J S, 1987, Cladistics, V3, P105, DOI 10.1111/j.1096-0031.1987.tb00501.x; Miller Jacqueline Y., 2001, P127; MILLER JS, 1992, BIOSCIENCE, V42, P50, DOI 10.2307/1311628; Mulder C, 2011, AMBIO, V40, P335, DOI 10.1007/s13280-010-0069-5; Nylin S, 2008, BIOL J LINN SOC, V94, P115, DOI 10.1111/j.1095-8312.2008.00964.x; Nylin S, 2009, EVOL ECOL, V23, P807, DOI 10.1007/s10682-008-9274-0; Oksanen J, 2010, R PACKAGE VERSION 1; Pagel MD, 1994, PHYLOGENETICS ECOLOG, P29; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Robbins CS, 1997, BREEDING BIRD SURVEY; Robinson G. S., 2001, Hostplants of the moth and butterfly caterpillars of the Oriental Region; SCOBLE MJ, 1990, ENTOMOL SCAND, V21, P113; Scriber JM, 2002, EUR J ENTOMOL, V99, P225, DOI 10.14411/eje.2002.032; Slove J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016057; Symons FB, 1999, OECOLOGIA, V119, P427, DOI 10.1007/s004420050804; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; Viloria A.L., 2003, PERSPECTIVA LATINOAM, P247; Viloria Angel L., 2010, Zootaxa, V2622, P1; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Woodhall S., 2005, FIELD GUIDE BUTTERFL; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	78	26	32	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63570	10.1371/journal.pone.0063570	http://dx.doi.org/10.1371/journal.pone.0063570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717448	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600023
J	Arora, H; Qureshi, R; Park, WY				Arora, Himanshu; Qureshi, Rehana; Park, Woong-Yang			miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; KINASE ACTIVATION; TETRASPANIN CD151; PROSTATE-CANCER; STEM-CELLS; PROGRESSION; GROWTH; PROLIFERATION; EXPRESSION; MIGRATION	Epithelial-mesenchymal transition (EMT) is an important parameter related to breast cancer survival. Among several microRNAs predicted to target EMT-related genes, miR-506 is a novel miRNA found to be significantly related to breast cancer patient survival in a meta-analysis. miR-506 suppressed the expression of mesenchymal genes such as Vimentin, Snai2, and CD151 in MDA-MB-231 human breast cancer cell line. Moreover, NF-kappa B bound to the upstream promoter region of miR-506 to suppress transcription. Overexpression of miR-506 inhibited TGF beta-induced EMT and suppressed adhesion, invasion, and migration of MDA-MB-231 cells. From these results, we concluded that miR-506 plays a key role in the process of EMT through posttranslational control of EMT-related genes.	[Arora, Himanshu; Qureshi, Rehana] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea.	woongyang@skku.edu	Arora, Himanshu/I-5230-2019	Arora, Himanshu/0000-0003-3143-6387; Park, Woong-Yang/0000-0003-4234-0380	National Research Foundation of Korea; Ministry of Education, Science and Technology [2012M2B2A9A02029603, 2012M3A9B2029132]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2012M2B2A9A02029603 and 2012M3A9B2029132 to W.-Y.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chometon G, 2006, EXP CELL RES, V312, P983, DOI 10.1016/j.yexcr.2005.12.034; Connelly L, 2007, J BIOL CHEM, V282, P10028, DOI 10.1074/jbc.M611300200; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dubois-Marshall S, 2011, CLIN EXP METASTAS, V28, P811, DOI 10.1007/s10585-011-9412-x; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P94, DOI 10.1016/j.mrgentox.2010.05.006; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Lynam-Lennon N, 2010, RAD RES; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Ridolfi E, 2008, BRIT J CANCER, V99, P1623, DOI 10.1038/sj.bjc.6604726; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Sadej R, 2010, CANCER RES, V70, P6059, DOI 10.1158/0008-5472.CAN-09-3497; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Surmacz E, 2004, J EXP CLIN CANC RES, V23, P385; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wu W, 2010, DRUGS R&D, V10, P1, DOI 10.2165/11537800-000000000-00000; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319	38	90	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64273	10.1371/journal.pone.0064273	http://dx.doi.org/10.1371/journal.pone.0064273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717581	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700126
J	Banerjee, N; Fonge, H; Mikhail, A; Reilly, RM; Bendayan, R; Allen, C				Banerjee, Nilasha; Fonge, Humphrey; Mikhail, Andrew; Reilly, Raymond M.; Bendayan, Reina; Allen, Christine			Estrone-3-Sulphate, a Potential Novel Ligand for Targeting Breast Cancers	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; ESTRONE SULFATE; ENDOCRINE RESISTANCE; AROMATASE ACTIVITIES; STEROID SULFATASE; RAT; EXPRESSION; ESTRADIOL; ESTROGENS; RECEPTOR	The current study investigates the potential of estrone-3-sulphate (E3S) as a ligand for targeting Organic Anion Transporting Polypeptides (OATP), a family of membrane associated uptake transporters, for detection and diagnosis of hormone dependent breast cancers. E3S, an OATP substrate, is a predominant source of tumour estradiol in post-menopausal patients. To assess the potential of E3S as a ligand, distribution of exogenous E3S was determined at the whole body, tumour and cellular levels in murine models of hormone-dependent (MCF-7) and independent (MDA-MB-231) breast cancers. The highest levels of tumour uptake were observed at 6 h post injection (p.i) with significant difference (p = 0.04) between the level in MCF-7 (13.9 +/- 3.1%ID/g) and MDA-MB-231 (10.4 +/- 1.1%ID/g) (%ID/g: percentage of the total injected dose per gram tissue). The highest tumour-to-blood ratios (MCF-7:7.4 +/- 1.2; MDA-MB-231:9.1 +/- 2.1) were observed at 48 p.i., and highest tumour-to-muscle ratios (MCF-7:10.7 +/- 1.5; MDA-MB-231:3.8 +/- 0.7) were observed at 6 h p.i. Analogous to total tumour uptake, ex vivo tumour cell uptake at 2 h p.i. was 6 fold higher in MCF-7 in comparison to MDA-MB-231 tumour cells. Blocking studies, conducted by pre-administration of 100-fold excess E3S, resulted in significantly lower (MCF-7: p = 0.01; MDA-MB-231: p = 0.02) tumour uptake in both xenograft models, suggesting the involvement of an active carrier-mediated process. The expression of OATP1A2 was detected in tumour sections from both xenografts, with significantly higher expression (p = 0.002) in the MCF-7 xenografts. Overall, the higher tumour uptake and tumour-to-muscle ratio, alongside the higher expression of OATP1A2, in the MCF-7 xenograft model suggests the potential of E3S to serve as a novel ligand for targeting hormone dependent breast cancers.	[Banerjee, Nilasha; Fonge, Humphrey; Mikhail, Andrew; Reilly, Raymond M.; Bendayan, Reina; Allen, Christine] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada	University of Toronto	Allen, C (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.	cj.allen@utoronto.ca	Mikhail, Andrew S./AAE-7439-2019	Mikhail, Andrew S./0000-0001-9206-5765; Allen, Christine/0000-0002-4916-3965	Canadian Breast Cancer Foundation-Ontario region; Canadian Institutes of Health Research - Strategic Training in Biological Therapeutics Program	Canadian Breast Cancer Foundation-Ontario region; Canadian Institutes of Health Research - Strategic Training in Biological Therapeutics Program(Canadian Institutes of Health Research (CIHR))	This research is supported by internal start-up funds allocated to Drs. Christine Allen and Reina Bendayan. Ms. Nilasha Banerjee is a recipient of doctoral fellowships from Canadian Breast Cancer Foundation-Ontario region (http://www.cbcf.org/ontario/YourDollarAtWork/Grants/Pages/2012-Approvals-by-Focus.aspx) and from Canadian Institutes of Health Research - Strategic Training in Biological Therapeutics Program (http://www.utoronto.ca/biotherapeutics_training/Assets/CurrentGrads.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2009, STEROIDS, V74, P42, DOI 10.1016/j.steroids.2008.09.006; BACK DJ, 1981, J STEROID BIOCHEM, V14, P1045, DOI 10.1016/0022-4731(81)90214-4; Banerjee N, 2012, J PHARMACOL EXP THER, V342, P510, DOI 10.1124/jpet.112.192344; Benard F, 2008, EUR J NUCL MED MOL I, V35, P1473, DOI 10.1007/s00259-008-0745-x; Blom MJ, 2001, DRUG METAB DISPOS, V29, P76; Chetrite GS, 2007, J STEROID BIOCHEM, V104, P289, DOI 10.1016/j.jsbmb.2007.03.030; Chetrite GS, 2000, J STEROID BIOCHEM, V72, P23, DOI 10.1016/S0960-0760(00)00040-6; Fung AS, 2012, NEOPLASIA, V14, P324, DOI 10.1593/neo.12346; Geisler H, 2003, J STEROID BIOCHEM, V86, P245, DOI 10.1016/S0960-0760(03)00364-9; Hagenbuch B, 2010, CLIN PHARMACOL THER, V87, P39, DOI 10.1038/clpt.2009.235; Hayes E, 2011, FRONT BIOSCI-LANDMRK, V16, P838, DOI 10.2741/3723; Howell A, 2008, ADV EXP MED BIOL, V617, P201, DOI 10.1007/978-0-387-69080-3_19; Ismair MG, 2001, GASTROENTEROLOGY, V121, P1185, DOI 10.1053/gast.2001.28704; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kis O, 2010, J PHARMACOL EXP THER, V334, P1009, DOI 10.1124/jpet.110.166314; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lonning PE, 2011, STEROIDS, V76, P786, DOI 10.1016/j.steroids.2011.02.040; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; Miki Y, 2006, CANCER RES, V66, P535, DOI 10.1158/0008-5472.CAN-05-1070; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Nozawa T, 2005, PHARM RES-DORDR, V22, P1634, DOI 10.1007/s11095-005-7096-0; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Osborne JR, 2010, J NUCL MED, V51, P543, DOI 10.2967/jnumed.108.060459; Pasqualini JR, 1996, J ENDOCRINOL, V150, pS99; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; Pasqualini JR, 2004, BBA-REV CANCER, V1654, P123, DOI 10.1016/j.bbcan.2004.03.001; PASQUALINI JR, 1995, J STEROID BIOCHEM, V53, P407, DOI 10.1016/0960-0760(95)00116-H; Pizzagalli F, 2003, J CLIN ENDOCR METAB, V88, P3902, DOI 10.1210/jc.2003-030174; Purohit A, 2011, MOL CELL ENDOCRINOL, V340, P154, DOI 10.1016/j.mce.2011.06.012; Roop RP, 2012, FUTURE ONCOL, V8, P273, DOI [10.2217/fon.12.8, 10.2217/FON.12.8]; Sacco SM, 2007, EXP BIOL MED, V232, P754; SANTNER SJ, 1986, BREAST CANCER RES TR, V7, P35, DOI 10.1007/BF01886734; SCHARL A, 1991, AM J OBSTET GYNECOL, V165, P1847, DOI 10.1016/0002-9378(91)90044-R; Scherr FF, 2011, J ENVIRON SCI HEAL B, V46, P763, DOI 10.1080/03601234.2012.597702; Schwabedissen HEMZ, 2008, CANCER RES, V68, P9338, DOI 10.1158/0008-5472.CAN-08-0265; Subramanian A, 2008, BREAST CANCER RES TR, V111, P191, DOI 10.1007/s10549-007-9788-0; Tan E, 2001, J PHARMACOL EXP THER, V297, P423; Tan E, 2001, DRUG METAB DISPOS, V29, P335; Tan E, 1999, DRUG METAB DISPOS, V27, P336; Utsumi T, 2000, J STEROID BIOCHEM, V73, P141, DOI 10.1016/S0960-0760(00)00060-1; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; VERHEUGEN C, 1984, J CLIN ENDOCR METAB, V59, P1128, DOI 10.1210/jcem-59-6-1128; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Zahedi P, 2011, J PHARM PHARM SCI, V14, P90, DOI 10.18433/J3QW26	46	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64069	10.1371/journal.pone.0064069	http://dx.doi.org/10.1371/journal.pone.0064069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717534	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700096
J	Sharma, P; Wollenberg, K; Sellers, M; Zainabadi, K; Galinsky, K; Moss, E; Nguitragool, W; Neafsey, D; Desai, SA				Sharma, Paresh; Wollenberg, Kurt; Sellers, Morgan; Zainabadi, Kayvan; Galinsky, Kevin; Moss, Eli; Nguitragool, Wang; Neafsey, Daniel; Desai, Sanjay A.			An Epigenetic Antimalarial Resistance Mechanism Involving Parasite Genes Linked to Nutrient Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; RHOPTRY PROTEIN; CHLOROQUINE RESISTANCE; ANTIGENIC VARIATION; FUNCTIONAL-ANALYSIS; MULTIGENE FAMILY; PFMDR1 GENE; ERYTHROCYTE	Acquired antimalarial drug resistance produces treatment failures and has led to periods of global disease resurgence. In Plasmodium falciparum, resistance is known to arise through genome-level changes such as mutations and gene duplications. We now report an epigenetic resistance mechanism involving genes responsible for the plasmodial surface anion channel, a nutrient channel that also transports ions and antimalarial compounds at the host erythrocyte membrane. Two blasticidin S-resistant lines exhibited markedly reduced expression of clag genes linked to channel activity, but had no genome-level changes. Silencing aborted production of the channel protein and was directly responsible for reduced uptake. Silencing affected clag paralogs on two chromosomes and was mediated by specific histone modifications, allowing a rapidly reversible drug resistance phenotype advantageous to the parasite. These findings implicate a novel epigenetic resistance mechanism that involves reduced host cell uptake and is a worrisome liability for water-soluble antimalarial drugs.	[Sharma, Paresh; Sellers, Morgan; Zainabadi, Kayvan; Nguitragool, Wang; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA; [Wollenberg, Kurt] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA; [Galinsky, Kevin; Moss, Eli; Neafsey, Daniel] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA.	sdesai@niaid.nih.gov		Sellers, Morgan/0000-0003-2539-9903; Nguitragool, Wang/0000-0002-5484-7130; Desai, Sanjay/0000-0003-2150-2483; Galinsky, Kevin/0000-0003-0311-4938	National Institutes of Health Intramural Research Program; Bill and Melinda Gates Foundation; NIAID; NATIONAL CANCER INSTITUTE [T32CA009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIAID, and by a Global Health Program grant from the Bill and Melinda Gates Foundation.	Alexandre Jean S.F., 2011, Tropical Medicine and Health, V39, P77, DOI 10.2149/tmh.2011-12; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bhat PJ, 2009, J BIOSCIENCES, V34, P513, DOI 10.1007/s12038-009-0070-y; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kyes S, 2002, MOL BIOCHEM PARASIT, V123, P79, DOI 10.1016/S0166-6851(02)00135-4; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Lisk G, 2007, MOL PHARMACOL, V71, P1241, DOI 10.1124/mol.106.030734; Lisk G, 2010, BBA-BIOMEMBRANES, V1798, P1679, DOI 10.1016/j.bbamem.2010.04.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Lyko B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-124; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; Martinez A, 2009, J BIOL INORG CHEM, V14, P863, DOI 10.1007/s00775-009-0498-4; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pillai AD, 2013, MOL MICROBIOL, V88, P20, DOI 10.1111/mmi.12159; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P164, DOI 10.1016/j.drudis.2010.11.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; Wanamaker CP, 2003, ANN NY ACAD SCI, V998, P66, DOI 10.1196/annals.1254.009; Wickham ME, 2003, MOL BIOCHEM PARASIT, V129, P147, DOI 10.1016/S0166-6851(03)00118-X; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	58	57	57	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19429	19440		10.1074/jbc.M113.468371	http://dx.doi.org/10.1074/jbc.M113.468371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720749	hybrid, Green Published			2022-12-25	WOS:000321515800011
J	Hua, Z				Hua, Zhu			The Floras of Southern and Tropical Southeastern Yunnan Have Been Shaped by Divergent Geological Histories	PLOS ONE			English	Article							RAIN-FOREST; CHINA; BIOGEOGRAPHY; AFFINITIES	The southern and tropical southeastern regions of the Yunnan Province in southwestern China have similar monsoonal climates and lowland tropical rain forest vegetations. The floras of both regions are dominated by tropical floristic elements (78.3% in southern Yunnan and 68.83% in southeastern Yunnan), and both belong to the Indo-Malaysian flora at the northern margin of tropical Asia. However, some temperate East Asian characteristic families are well represented in the flora of tropical southeastern Yunnan, while families characteristic of tropical Asia are well represented in the flora of southern Yunnan. Additionally, there are 14 mainly east Asian families in tropical southeastern Yunnan that are not found in southern Yunnan. Although the two regions share 80% of their genera, 237 genera are restricted to southern Yunnan, and 349 genera to tropical southeastern Yunnan. Furthermore, 57 genera with an East Asian distribution, 53 genera with a North temperate distribution, 22 genera endemic to China, and 17 genera with an East Asia and North America disjunct distribution are found only in tropical southeastern Yunnan. The flora of tropical southeastern Yunnan is more closely related to Eastern Asian flora, while the flora of southern Yunnan is more closely related to Indo-Malaysian flora. The divergence of the flora is well supported by the geological history of the region; the flora of tropical southeastern Yunnan was mainly derived from the South China Geoblock, while the southern Yunnan flora derived from the Shan-Thai Geoblock.	Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Hua, Z (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	zhuh@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022		The National Natural Science Foundation of China [41071040, 31170195]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by The National Natural Science Foundation of China (41071040, 31170195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audley-Charles MG, 1987, BIOGEOGRAPHICAL EVOL; FEDOROV A A., 1957, KOMAROV CHTEN, V10, P20; FEDOROV An. A., 1958, BOT ZHUR, V43, P1385; Feng QL, 2005, J ASIAN EARTH SCI, V24, P777, DOI 10.1016/j.jseaes.2004.11.008; Fortey R.A., 1998, BIOGEOGRAPHY GEOLOGI, P43; Hill KD, 2008, TELOPEA, V12, P71; Hill KD, 2004, BOT REV, V70, P134, DOI 10.1663/0006-8101(2004)070[0134:TGCCIV]2.0.CO;2; Hirsch F, 2006, GEOSCI J, V10, P195, DOI 10.1007/BF02910364; Hua Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045601; Hua Z, 2008, TROP CONSERV SCI, V1, P34, DOI 10.1177/194008290800100103; Jin XC, 2002, J ASIAN EARTH SCI, V20, P633, DOI 10.1016/S1367-9120(01)00084-0; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Lepvrier C, 2008, CR GEOSCI, V340, P94, DOI 10.1016/j.crte.2007.10.005; Metcalfe I, 2006, GONDWANA RES, V9, P24, DOI 10.1016/j.gr.2005.04.002; Pan Q. H., 2007, FIELD GUIDE MAMMALS, P1; Takhtajian Y., 1978, FLORISTIC REGION WOR; Whitmore T.C., 1984, TROPICAL RAM FORESTS; WHITMORE TC, 1982, COMMONW FOREST REV, V61, P51; Whitmore TC, 1990, INTRO TROPICAL RAIN; Wu CY., 1996, P 1 INT S FLOR CHAR, P3, DOI DOI 10.1111/JSE.12037; Wu Z., 1991, ACTA BOT YUNNANICA, P1; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Yunnan Geology and Mineral Bureau, 1995, ATLAS GEOLOGY PALAEO, P1; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhu H., 2006, Gardens' Bulletin (Singapore), V58, P81; Zhu H., 2004, Telopea, V10, P639; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x; Zhu H, 2003, ANN MO BOT GARD, V90, P444, DOI 10.2307/3298536; Zhu H, 1997, J BIOGEOGR, V24, P647, DOI 10.1111/j.1365-2699.1997.tb00075.x; Zhu H., 2012, NATIVE SEED PLANTS X, P1; Zhu H., 1994, CHINESE GEOGR SCI, V4, P174, DOI [10.1007/BF02664300, DOI 10.1007/BF02664300]; Zhu H., 2001, GUIHAIA, V21, P127; Zhu H, 1998, CHINESE BIODIVERSITY, V6, P241, DOI 10.3321/j.issn:1005-0094.1998.04.001; Zhu H, 2005, ADV EARTH SCI S, V20, P1; Zhu H., 2019, CHINESE GEOGR SCI, V2, P64, DOI [10.1007/BF02664547, DOI 10.1007/BF02664547]; Zhu Hua, 1993, Acta Botanica Yunnanica, V15, P34; [朱华 Zhu Hua], 2011, [地球科学进展, Advance in Earth Sciences], V26, P916; Zhu Hua, 1998, Gardens' Bulletin (Singapore), V50, P5; Zhu H, 2009, BOT STUD, V50, P467; Zhu H, 2008, ANN MO BOT GARD, V95, P661, DOI 10.3417/2006081; Zhu Hua, 1993, Acta Botanica Yunnanica, V15, P233; Zhu Hua, 1994, Acta Botanica Yunnanica, V16, P97	43	24	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64213	10.1371/journal.pone.0064213	http://dx.doi.org/10.1371/journal.pone.0064213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724036	Green Published, gold			2022-12-25	WOS:000319733000049
J	Iftikar, FI; Hickey, AJR				Iftikar, Fathima I.; Hickey, Anthony J. R.			Do Mitochondria Limit Hot Fish Hearts? Understanding the Role of Mitochondrial Function with Heat Stress in Notolabrus celidotus	PLOS ONE			English	Article							ACUTE TEMPERATURE INCREASE; OXIDATIVE-PHOSPHORYLATION; OXYGEN LIMITATION; THERMAL TOLERANCE; CLIMATE-CHANGE; CYTOPATHIC HYPOXIA; ENERGY-METABOLISM; RED MUSCLE; RESPIRATION; PHYSIOLOGY	Hearts are the first organs to fail in animals exposed to heat stress. Predictions of climate change mediated increases in ocean temperatures suggest that the ectothermic heart may place tight constraints on the diversity and distribution of marine species with cardiovascular systems. For many such species, their upper temperature limits (T-max) and respective heart failure (HF) temperature (T-HF) are only a few degrees from current environmental temperatures. While the ectothermic cardiovascular system acts as an "ecological thermometer," the exact mechanism that mediates HF remains unresolved. We propose that heat-stressed cardiac mitochondria drive HF. Using a common New Zealand fish, Notolabrus celidotus, we determined the T-HF (27.5 degrees C). Haemoglobin oxygen saturation appeared to be unaltered in the blood surrounding and within heat stressed hearts. Using high resolution respirometry coupled to fluorimeters, we explored temperature-mediated changes in respiration, ROS and ATP production, and overlaid these changes with T-HF. Even at saturating oxygen levels several mitochondrial components were compromised before T-HF. Importantly, the capacity to efficiently produce ATP in the heart is limited at 25 degrees C, and this is prior to the acute THF for N. celidotus. Membrane leakiness increased significantly at 25 degrees C, as did cytochrome c release and permeability to NADH. Maximal flux rates and the capacity for the electron transport system to uncouple were also altered at 25 degrees C. These data indicate that mitochondrial membrane integrity is lost, depressing ATP synthesis capacity and promoting cytochrome c release, prior to T-HF. Mitochondria can mediate HF in heat stressed hearts in fish and play a significant role in thermal stress tolerance, and perhaps limit species distributions by contributing to HF.	[Iftikar, Fathima I.; Hickey, Anthony J. R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Hickey, AJR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	a.hickey@auckland.ac.nz			Royal Society of New Zealand Marsden grant	Royal Society of New Zealand Marsden grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a Royal Society of New Zealand Marsden grant (to AJRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio R, 2011, BIOINFORMATICS, V27, P2316, DOI 10.1093/bioinformatics/btr379; Ansaldo M, 2000, POLAR BIOL, V23, P160, DOI 10.1007/s003000050022; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Birkedal R, 2004, J COMP PHYSIOL B, V174, P255, DOI 10.1007/s00360-003-0410-4; Birkedal R, 2003, J COMP PHYSIOL B, V173, P493, DOI 10.1007/s00360-003-0357-5; BLIER PU, 1993, PHYSIOL ZOOL, V66, P474, DOI 10.1086/physzool.66.4.30163804; Blier PU, 2001, J COMP PHYSIOL B, V171, P247, DOI 10.1007/s003600000169; Borutaite V, 2003, FEBS LETT, V541, P1, DOI 10.1016/S0014-5793(03)00278-3; Boveris A, 2000, ANN NY ACAD SCI, V899, P121; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Clark TD, 2008, AM J PHYSIOL-REG I, V295, pR1631, DOI 10.1152/ajpregu.90461.2008; Domenis R, 2011, J BIOENERG BIOMEMBR, V43, P493, DOI 10.1007/s10863-011-9380-5; Farrell A.P., 1997, Society for Experimental Biology Seminar Series, V61, P135; Farrell AP, 2009, CAN J ZOOL, V87, P835, DOI 10.1139/Z09-092; Farrell Anthony P., 1992, P1; Feidantsis K, 2009, MAR BIOL, V156, P797, DOI 10.1007/s00227-009-1135-z; Fink MP, 2002, CRIT CARE CLIN, V18, P165, DOI 10.1016/S0749-0704(03)00071-X; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Francis MP, 2005, ESTUAR COAST SHELF S, V64, P419, DOI 10.1016/j.ecss.2005.03.007; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Galli GLJ, 2012, J THERM BIOL, V37, P195, DOI 10.1016/j.jtherbio.2011.12.012; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; Gnaiger E, 2000, LIFE IN THE COLD, P431; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Gollock MJ, 2005, DIS AQUAT ORGAN, V64, P223, DOI 10.3354/dao064223; GRIESHABER MK, 1994, REV PHYSL BIOCH PHAR, V125, P44; Guderley H, 2002, J EXP BIOL, V205, P2237; GUDERLEY HE, 1995, MAR BIOL, V122, P409, DOI 10.1007/BF00350873; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; HARPER AA, 1995, J EXP BIOL, V198, P137; Hickey A., 2011, J COMP PHYSIOL B, P1; Hickey AJR, 2003, J COMP PHYSIOL B, V173, P113, DOI 10.1007/s00360-002-0313-9; Hickey AJR, 2009, AM J PHYSIOL-CELL PH, V297, pC766, DOI 10.1152/ajpcell.00111.2009; Hilton Z, 2010, COMP BIOCH PHY UNPUB; Hilton Z, 2010, J COMP PHYSIOL B, V180, P979, DOI 10.1007/s00360-010-0477-7; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; HOCHACHKA PW, 1968, COMP BIOCHEM PHYSIOL, V27, P659, DOI 10.1016/0010-406X(68)90605-1; Hochachka PW., 1994, MUSCLES MOL METABOLI; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Iftikar FI, 2010, J EXP MAR BIOL ECOL, V395, P232, DOI 10.1016/j.jembe.2010.09.005; JOHNSTON IA, 1994, J EXP BIOL, V195, P293; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lane N., 2005, POWER SEX SUICIDE MI; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lemieux H, 2008, COMP BIOCHEM PHYS A, V149, P20, DOI 10.1016/j.cbpa.2007.09.015; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lemieux H, 2010, J EXP MAR BIOL ECOL, V384, P113, DOI 10.1016/j.jembe.2009.12.007; Lemieux H, 2010, J THERM BIOL, V35, P105, DOI 10.1016/j.jtherbio.2009.12.003; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MAILER K, 1990, BIOCHEM BIOPH RES CO, V170, P59, DOI 10.1016/0006-291X(90)91240-S; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; MOURIK J, 1983, COMP BIOCHEM PHYS B, V76, P851, DOI 10.1016/0305-0491(83)90403-0; MOYES CD, 1992, CAN J ZOOL, V70, P1246, DOI 10.1139/z92-172; Moyes CD, 1996, COMP BIOCHEM PHYS A, V113, P69, DOI 10.1016/0300-9629(95)02057-8; MOYES CD, 1992, AM J PHYSIOL, V262, pR295, DOI 10.1152/ajpregu.1992.262.2.R295; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NEWSHOLME EA, 1986, J EXP ZOOL, V239, P159, DOI 10.1002/jez.1402390203; Oellermann M, 2012, J EXP BIOL, V215, P2992, DOI 10.1242/jeb.068163; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Podrabsky JE, 2007, J EXP BIOL, V210, P2253, DOI 10.1242/jeb.005116; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Qian LJ, 2004, CELL STRESS CHAPERON, V9, P281, DOI 10.1379/CSC-20R.1; Seebacher F, 2010, PHYSIOL BIOCHEM ZOOL, V83, P721, DOI 10.1086/649964; Shiels HA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P816, DOI 10.1086/378918; Somero GN, 2011, AM J PHYSIOL-REG I, V301, pR1, DOI 10.1152/ajpregu.00719.2010; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Somero GN, 1996, ANIMALS TEMPERATURE; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179; SteinlechnerMaran R, 1997, TRANSPLANTATION, V63, P136, DOI 10.1097/00007890-199701150-00025; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; TARBA C, 1990, BIOCHIM BIOPHYS ACTA, V1019, P19, DOI 10.1016/0005-2728(90)90120-S; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van Dijk PLM, 1999, J EXP BIOL, V202, P3611; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Villas-Boas SG, 2003, ANAL BIOCHEM, V322, P134, DOI 10.1016/j.ab.2003.07.018; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wells RMG, 2005, MAR FRESHW BEHAV PHY, V38, P71, DOI 10.1080/10236240400029341; Willmer P, 2005, ENV PHYSL ANIMALS; Zakhartsev MV, 2003, J COMP PHYSIOL B, V173, P365, DOI 10.1007/s00360-003-0342-z; Zielinski S, 2000, COMP BIOCHEM PHYS B, V125, P147, DOI 10.1016/S0305-0491(99)00162-5; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Zukiene R, 2010, INT J HYPERTHER, V26, P56, DOI 10.3109/02656730903262140	102	99	99	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64120	10.1371/journal.pone.0064120	http://dx.doi.org/10.1371/journal.pone.0064120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724026	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000042
J	Sun, JM; Hwang, DW; Ahn, JS; Ahn, MJ; Park, K				Sun, Jong-Mu; Hwang, Deok Won; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil			Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; K-RAS MUTATIONS; 1ST-LINE TREATMENT; CLINICAL-TRIALS; OPEN-LABEL; EGFR; CHEMOTHERAPY; ERLOTINIB; ADENOCARCINOMA; GEFITINIB	Clinical implications of KRAS mutations in advanced non-small cell lung cancer remain unclear. We retrospectively evaluated the prognostic and predictive value of KRAS mutations in patients with advanced NSCLC. Among 484 patients with available results for both KRAS and EGFR mutations, 39 (8%) had KRAS and 182 (38%) EGFR mutations, with two cases having both mutations. The median overall survivals for patients with KRAS mutations, EGFR mutations, or both wild types were 7.7, 38.0, and 15.0 months, respectively (P<0.001). The KRAS mutation was an independent poor prognostic factor in the multivariate analysis (hazard ratio = 2.6, 95% CI: 1.8-3.7). Response rates and progression-free survival (PFS) for the pemetrexed-based regimen in the KRAS mutation group were 14% and 2.1 months, inferior to those (28% and 3.9 months) in the KRAS wild type group. KRAS mutation tended to be associated with inferior treatment outcomes after gemcitabine-based chemotherapy, while there was no difference regarding taxane-based regimen. Although the clinical outcomes to EGFR tyrosine kinase inhibitors (TKIs) seemed to be better in patients with KRAS wild type than those with KRAS mutations, there was no statistical difference in response rates and PFS according to KRAS mutation status when EGFR mutation status was considered. Two patients with both KRAS and EGFR mutations showed partial response to EGFR TKIs. Although G12D mutation appeared more frequently in never smokers, there was no difference in clinical outcomes according to KRAS genotypes. These results suggested KRAS mutations have an independent prognostic value but a limited predictive role for EGFR TKIs or cytotoxic chemotherapy in advanced NSCLC.	[Sun, Jong-Mu; Hwang, Deok Won; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.	kpark@skku.edu	Park, Keunchil/ABD-7072-2021; Park, Keunchil/ABD-5852-2021; sun, jm/O-5938-2014	Park, Keunchil/0000-0002-4846-7449; 	Korean Health 21 R&D Project, Ministry of Health Welfare, Korea [A040041]	Korean Health 21 R&D Project, Ministry of Health Welfare, Korea	This work was supported by Korean Health 21 R&D Project, Ministry of Health & Welfare, Korea, grant A040041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Keohavong P, 1996, CLIN CANCER RES, V2, P411; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moran DM, 2012, CANCER RES, V72, pLB; O'Byrne KJ, 2011, LANCET ONCOL, V12, P795, DOI 10.1016/S1470-2045(11)70189-9; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Querings S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019601; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Riely GJ, 2011, J THORAC ONCOL, V6, P1435, DOI 10.1097/JTO.0b013e318223c099; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; Schiller JH, 2001, J CLIN ONCOL, V19, P448, DOI 10.1200/JCO.2001.19.2.448; Shepherd FA, 2012, ASCO M S, V30, P7007; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Tsao MS, 2007, J CLIN ONCOL, V25, P5240, DOI 10.1200/JCO.2007.12.6953; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	32	57	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64816	10.1371/journal.pone.0064816	http://dx.doi.org/10.1371/journal.pone.0064816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724098	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000098
J	Wamsteeker Cusulin, JI; Fuzesi, T; Watts, AG; Bains, JS				Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Watts, Alan G.; Bains, Jaideep S.			Characterization of Corticotropin-Releasing Hormone neurons in the Paraventricular Nucleus of the Hypothalamus of Crh-IRES-Cre Mutant Mice	PLOS ONE			English	Article							PARVOCELLULAR NEUROSECRETORY NEURONS; SHORT-TERM PLASTICITY; IMMUNOREACTIVE NEURONS; GLUTAMATE SYNAPSES; RAT HYPOTHALAMUS; NEURAL CIRCUITS; CO-EXPRESSION; STRESS; MOUSE; NEUROENDOCRINE	Corticotropin-releasing hormone (CRH)-containing neurons in the paraventricular nucleus of the hypothalamus (PVN) initiate and control neuroendocrine responses to psychogenic and physical stress. Investigations into the physiology of CRH neurons, however, have been hampered by the lack of tools for adequately targeting or visualizing this cell population. Here we characterize CRH neurons in the PVN of mice that express tdTomato fluorophore, generated by crosses of recently developed Crh-IRES-Cre driver and Ai14 Cre-reporter mouse strains. tdTomato containing PVN neurons in Crh-IRES-Cre;Ai14 mice are readily visualized without secondary-detection methods. These neurons are predominantly neuroendocrine and abundantly express CRH protein, but not other PVN phenotypic neuropeptides. After an acute stress, a large majority of tdTomato cells express neuronal activation marker c-Fos. Finally, tdTomato PVN neurons exhibit homogenous intrinsic biophysical and synaptic properties, and can be optogenetically manipulated by viral Cre-driven expression of channelrhodopsin. These observations highlight basic cell-type characteristics of CRH neurons in a mutant mouse, providing validation for its future use in probing neurophysiology of endocrine stress responses.	[Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Watts, Alan G.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Calgary; University of Calgary; University of Southern California	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca		Bains, Jaideep/0000-0002-3634-6463	Canadian Institutes of Health Research [MOP 86501]; National Institutes of Health [NS029728]; Alberta Innovates - Health Solutions (AI-HS); Hotchkiss Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029728] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Innovates - Health Solutions (AI-HS); Hotchkiss Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported through grants from the Canadian Institutes of Health Research (MOP 86501 to JSB) and National Institutes of Health (NS029728 to AGW). JIWC and TF receive scholarship/fellowship support from Alberta Innovates - Health Solutions (AI-HS). JIWC also received scholarship support from the Hotchkiss Brain Institute. The funders were not involved in any of the following: study design, data collection, analysis, decision to publish, or preparation of the manuscript.; We thank present and past members of the Bains lab for thoughtful discussions: in particular, Dr. Karl J. Iremonger for providing critical comments on this manuscript. We are grateful to Cheryl Sank and Rob Cantrup for their technical assistance. We also acknowledge the Hotchkiss Brain Institute (HBI) for their support of the optogenetics core.	Alon T, 2009, ENDOCRINOLOGY, V150, P5626, DOI 10.1210/en.2009-0881; ARMSTRONG WE, 1980, NEUROSCIENCE, V5, P1931, DOI 10.1016/0306-4522(80)90040-8; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BARTANUSZ V, 1993, ENDOCRINOLOGY, V132, P895, DOI 10.1210/en.132.2.895; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; BLOOM FE, 1982, REGUL PEPTIDES, V4, P43, DOI 10.1016/0167-0115(82)90107-0; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; DE GOEIJ DCE, 1991, NEUROENDOCRINOLOGY, V53, P150, DOI 10.1159/000125712; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; DOHANICS J, 1990, NEUROENDOCRINOLOGY, V51, P515, DOI 10.1159/000125385; Gafford GM, 2012, P NATL ACAD SCI USA, V109, P16330, DOI 10.1073/pnas.1119261109; Grissom N., 2008, NEUROBIOL LEARN MEM, V92, P1; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; HENNESSY MB, 1977, PHYSIOL BEHAV, V18, P799, DOI 10.1016/0031-9384(77)90186-X; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; HOFFMAN NW, 1991, J COMP NEUROL, V307, P405, DOI 10.1002/cne.903070306; Hoyda TD, 2009, ENDOCRINOLOGY, V150, P832, DOI 10.1210/en.2008-1179; Jo YH, 2009, AM J PHYSIOL-ENDOC M, V297, pE563, DOI 10.1152/ajpendo.00064.2009; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Kadar A, 2010, J COMP NEUROL, V518, P3948, DOI 10.1002/cne.22432; Korosi A, 2010, J NEUROSCI, V30, P703, DOI 10.1523/JNEUROSCI.4214-09.2010; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin EI, 2010, BIOL PSYCHIAT, V67, P1212, DOI 10.1016/j.biopsych.2010.01.026; Marty V, 2011, J PHYSIOL-LONDON, V589, P4259, DOI 10.1113/jphysiol.2011.208082; Melnick I, 2007, NEURON, V56, P1103, DOI 10.1016/j.neuron.2007.10.034; Morrison CD, 2012, ENDOCRINOLOGY, V153, P1005, DOI 10.1210/en.2011-2169; Nyuyki KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052371; Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665; Price CJ, 2008, J NEUROENDOCRINOL, V20, P245, DOI 10.1111/j.1365-2826.2007.01641.x; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; RHO JH, 1989, J NEUROSCI, V9, P1375; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; SAWCHENKO PE, 1984, P NATL ACAD SCI-BIOL, V81, P1883, DOI 10.1073/pnas.81.6.1883; SAWCHENKO PE, 1984, J NEUROSCI, V4, P1118; Silberman Y, 2013, J NEUROSCI, V33, P950, DOI 10.1523/JNEUROSCI.2949-12.2013; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; SWANSON LW, 1986, PROG BRAIN RES, V68, P169, DOI 10.1016/S0079-6123(08)60238-1; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; Wamsteeker JI, 2010, EUR J NEUROSCI, V32, P2011, DOI 10.1111/j.1460-9568.2010.07513.x; WATTS AG, 1995, J COMP NEUROL, V352, P501, DOI 10.1002/cne.903520403; Watts AG, 1996, FRONT NEUROENDOCRIN, V17, P281, DOI 10.1006/frne.1996.0008; WHITNALL MH, 1985, NATURE, V317, P248, DOI 10.1038/317248a0; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	56	93	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64943	10.1371/journal.pone.0064943	http://dx.doi.org/10.1371/journal.pone.0064943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724107	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000106
J	Deng, B; Zhu, JM; Wang, Y; Liu, TT; Ding, YB; Xiao, WM; Lu, GT; Bo, P; Shen, XZ				Deng, Bin; Zhu, Ji-Min; Wang, Yi; Liu, Tao-Tao; Ding, Yan-Bing; Xiao, Wei-Ming; Lu, Guo-Tao; Bo, Ping; Shen, Xi-Zhong			Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-beta 1 in Gastric Cancer	PLOS ONE			English	Article							TUMOR-IMMUNITY; TGF-BETA; PROGRESSION; PROTECTION; PATHWAYS; GROWTH	Regulatory T cell (Treg)-mediated immunosuppression represents one of the crucial tumor immune evasion mechanisms and is a main obstacle for successful tumor immunotherapy. Hypoxia, a common feature of solid tumors, has been associated with potentiated immunosuppression, decreased therapeutic response, malignant progression and local invasion. Unfortunately, the link between hypoxia and Treg-mediated immune tolerance in gastric cancer remains poorly understood. In our study, Tregs and hypoxia inducible factor-1 alpha were found to be positively correlated with each other and were increased with the tumor progression. A subsequent in vitro study indicated that supernatants derived from gastric cancer cells under hypoxic condition, could induce the expression of Foxp3 via TGF-beta 1. These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.	[Deng, Bin; Ding, Yan-Bing; Xiao, Wei-Ming; Lu, Guo-Tao] Yangzhou Univ, Clin Sch 2, Dept Gastroenterol, Yangzhou, Jiangsu, Peoples R China; [Deng, Bin; Zhu, Ji-Min; Wang, Yi; Liu, Tao-Tao; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Bo, Ping] Yangzhou Univ, Coll Med, Inst Integrated Chinese Tradit & Western Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Fudan University; Yangzhou University	Bo, P (corresponding author), Yangzhou Univ, Coll Med, Inst Integrated Chinese Tradit & Western Med, Yangzhou, Jiangsu, Peoples R China.	chinadbin@yahoo.com.cn; shen.xizhong@zs-hospital.sh.cn	liu, taotao/GSI-7460-2022; zhu, jimin/HDN-1451-2022; Lu, Guotao/AAM-6969-2021	Zhu, Ji-Min/0000-0002-2150-473X	Shanghai Science and Technology Commission [10410709400, 10411950100]; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273]; National Clinical Key Special Subject of China	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China	This study was supported by the Shanghai Science and Technology Commission (10410709400, 10411950100), National Nature Science Foundation of China (81000968, 81101540, 81101637 and 81172273) and the National Clinical Key Special Subject of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Isobe T, 2012, INT J CLIN ONCOL; Kim HI, 2011, J SURG ONCOL, V104, P728, DOI 10.1002/jso.22038; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lukashev D, 2007, CANCER METAST REV, V26, P273, DOI 10.1007/s10555-007-9054-2; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Noda S, 2010, EUR J CANCER, V46, P995, DOI 10.1016/j.ejca.2010.01.007; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Raghavan S, 2011, EXPERT REV GASTROENT, V5, P489, DOI [10.1586/egh.11.44, 10.1586/EGH.11.44]; Raja KRM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047077; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shen LS, 2009, CLIN IMMUNOL, V131, P109, DOI 10.1016/j.clim.2008.11.010; Shen X, 2013, DIG DIS SCI; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang YX, 2010, CANCER BIOL THER, V10, P376, DOI 10.4161/cbt.10.4.12441; Wang Y, 2012, J CELL MOL MED, V16, P425, DOI 10.1111/j.1582-4934.2011.01437.x; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	32	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e63777	10.1371/journal.pone.0063777	http://dx.doi.org/10.1371/journal.pone.0063777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723999	Green Published, Green Submitted, gold			2022-12-25	WOS:000319738100013
J	Jeyabalaratnam, J; Bharmauria, V; Bachatene, L; Cattan, S; Angers, A; Molotchnikoff, S				Jeyabalaratnam, Jeyadarshan; Bharmauria, Vishal; Bachatene, Lyes; Cattan, Sarah; Angers, Annie; Molotchnikoff, Stephane			Adaptation Shifts Preferred Orientation of Tuning Curve in the Mouse Visual Cortex	PLOS ONE			English	Article							INDUCED PLASTICITY; MOTION; SPECIFICITY; DIRECTION; NEURONS; CELLS; SELECTIVITY; MECHANISMS; EXPERIENCE; BRAIN	In frontalized mammals it has been demonstrated that adaptation produces shift of the peak of the orientation tuning curve of neuron following frequent or lengthier presentation of a non-preferred stimulus. Depending on the duration of adaptation the shift is attractive (toward the adapter) or repulsive (away from the adapter). Mouse exhibits a salt-and-pepper cortical organization of orientation maps, hence this species may respond differently to adaptation. To examine this question, we determined the effect of twelve minutes of adaptation to one particular orientation on neuronal orientation tuning curves in V1 of anesthetized mice. Multi-unit activity of neurons in V1 was recorded in a conventional fashion. Cells were stimulated with sine-wave drifting gratings whose orientation tilted in steps. Results revealed that similarly to cats and monkeys, majority of cells shifted their optimal orientation in the direction of the adapter while a small proportion exhibited a repulsive shift. Moreover, initially untuned cells showing poor tuning curves reacted to adaptation by displaying sharp orientation selectivity. It seems that modification of the cellular property following adaptation is a general phenomenon observed in all mammals in spite of the different organization pattern of the visual cortex. This study is of pertinence to comprehend the mechanistic pathways of brain plasticity.	[Jeyabalaratnam, Jeyadarshan; Bharmauria, Vishal; Bachatene, Lyes; Cattan, Sarah; Angers, Annie; Molotchnikoff, Stephane] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Molotchnikoff, S (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	stephane.molotchnikoff@umontreal.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X	Natural Sciences and Engineering Research Council [8290]; Fonds de Recherche du Quebec - Nature et Technolgies [137773]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Nature et Technolgies	Natural Sciences and Engineering Research Council 8290 AND Fonds de Recherche du Quebec - Nature et Technolgies - 137773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bachatene L, 2012, NEUROREPORT, V23, P88, DOI 10.1097/WNR.0b013e32834e7e71; Bouchard M, 2008, EXP BRAIN RES, V188, P289, DOI 10.1007/s00221-008-1362-4; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fregnac Y., 2010, FRONT COMPUT NEUROSC, V2, P1; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Ghisovan N, 2009, NEUROSCIENCE, V164, P1274, DOI 10.1016/j.neuroscience.2009.09.003; Ghisovan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003689; Hietanen MA, 2007, J PHYSIOL-LONDON, V584, P451, DOI 10.1113/jphysiol.2007.131631; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Marshansky S, 2011, NEUROSCIENCE, V172, P355, DOI 10.1016/j.neuroscience.2010.10.017; Mccoy PA, 2009, CURR OPIN NEUROBIOL, V19, P298, DOI 10.1016/j.conb.2009.05.010; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Molotchnikoff S, 2012, FRONT BIOSCI-LANDMRK, V17, P583, DOI 10.2741/3946; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nemri A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-147; O'Hasi K, 2007, NEUROSCI RES, V58, P86, DOI 10.1016/j.neures.2007.01.005; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Patterson CA, 2013, J NEUROSCI, V33, P532, DOI 10.1523/JNEUROSCI.3345-12.2013; Pienkowski M, 2009, NEUROREPORT, V20, P1198, DOI 10.1097/WNR.0b013e32832f812c; Priebe NJ, 2010, J NEUROPHYSIOL, V104, P2615, DOI 10.1152/jn.00241.2010; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; SAUL AB, 1989, VISUAL NEUROSCI, V2, P609, DOI 10.1017/S0952523800003539; Schlack A, 2007, NEURON, V53, P881, DOI 10.1016/j.neuron.2007.02.028; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; Sur M, 2002, CURR BIOL, V12, pR168, DOI 10.1016/S0960-9822(02)00733-9; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Vetencourt JFM, 2008, SCIENCE, V320, P1588; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850	45	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64294	10.1371/journal.pone.0064294	http://dx.doi.org/10.1371/journal.pone.0064294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717586	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600056
J	Arndt, T; Jorns, A; Weiss, H; Tiedge, M; Hedrich, HJ; Lenzen, S; Wedekind, D				Arndt, Tanja; Joerns, Anne; Weiss, Heike; Tiedge, Markus; Hedrich, Hans-Juergen; Lenzen, Sigurd; Wedekind, Dirk			A Variable CD3(+) T-Cell Frequency in Peripheral Blood Lymphocytes Associated with Type 1 Diabetes Mellitus Development in the LEW.1AR1-iddm Rat	PLOS ONE			English	Article							ADOPTIVE TRANSFER; GENETIC-CONTROL; BB RATS; SUBSETS; SUBPOPULATIONS; LOCUS; ONSET; SUSCEPTIBILITY; LYMPHOPENIA; DEFICIENCY	Purpose: The LEW. 1AR1-iddm rat is an animal model of human type 1 diabetes mellitus (T1DM), which arose through a spontaneous mutation within the MHC-congenic inbred strain LEW. 1AR1 (RT1(r2)). In contrast to the diabetes-resistant LEW. 1AR1 background strain in LEW. 1AR1-iddm rats a highly variable T-cell frequency could be observed in peripheral blood lymphocytes (PBLs). Methods: In this study we therefore characterised the T-cell repertoire within the PBLs of the two strains by flow cytometry analysis and identified the CD3(+) T-cell phenotype and its possible linkage to diabetes susceptibility. To map loci conferring susceptibility to variable CD3(+) T-cell frequency, backcross strains (N2) were generated with the genetically divergent BN and PAR rats for microsatellite analysis. Results: The LEW. 1AR1-iddm rat strain was characterised by a higher variability of CD3(+) T-cells in PBLs along with a slightly decreased mean value compared to the LEW. 1AR1 background strain. The reason for this reduction was a decrease in the CD4(+) T-cell count while the CD8(+) T-cell proportion remained unchanged. However, both T-cell subpopulations showed a high variability. This resulted in a lower CD4(+)/CD8(+) T-cell ratio than in LEW. 1AR1 rats. Like LEW. 1AR1-iddm rats all animals of the backcross populations, N2 BN and N2 PAR rats, also showed large variations of the CD3(+) T-cell frequency. The phenotype of variable CD3(+) T-cell frequency mapped to the telomeric region of chromosome 1 (RNO1), which is identical with the already known Iddm8 diabetes susceptibility region. The data indicate that a variable CD3(+) T-cell frequency in PBLs is genetically linked to diabetes susceptibility in the LEW. 1AR1-iddm rat. Conclusion: The T-cell variability in PBLs could be related to the previously reported imbalance between regulatory and effector T-cell populations which results in beta-cell autoimmunity. Since similar T-cell phenotypes have also been described in human T1DM the identification of the functional role of the observed variable CD3(+) T-cell frequency may help to understand the mechanisms of autoimmunity in T1DM.	[Arndt, Tanja; Joerns, Anne; Weiss, Heike; Tiedge, Markus; Lenzen, Sigurd] Hannover Med Sch, Inst Clin Biochem, Hannover, Germany; [Arndt, Tanja; Hedrich, Hans-Juergen; Wedekind, Dirk] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Joerns, Anne] Hannover Med Sch, Ctr Anat, Hannover, Germany; [Weiss, Heike; Tiedge, Markus] Univ Rostock, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Rostock	Wedekind, D (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.	wedekind.dirk@mh-hannover.de			Deutsche Forschungsgemeinschaft; European Union [241447]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work has been supported by grants from the Deutsche Forschungsgemeinschaft to AJ and the European Union (Collaborative Project NAIMIT in the 7th Framework Programme, Contract No. 241447) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSAKKAF L, 1992, ACTA DIABETOL, V28, P189, DOI 10.1007/BF00778996; ALSAKKAF L, 1989, DIABETOLOGIA, V32, P322, DOI 10.1007/BF00265550; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Arndt T, 2009, DIABETOLOGIA, V52, P1381, DOI 10.1007/s00125-009-1348-1; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BELLGRAU D, 1982, DIABETOLOGIA, V23, P359; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BUSCHARD K, 1983, DIABETOLOGIA, V25, P247, DOI 10.1007/BF00279938; CHURCHILL GA, 1994, GENETICS, V138, P963; Chwalisz WT, 2003, MAMM GENOME, V14, P620, DOI 10.1007/s00335-003-3009-x; ELDER ME, 1983, J IMMUNOL, V130, P1723; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; FAUSTMAN D, 1989, DIABETES, V38, P1462, DOI 10.2337/diabetes.38.11.1462; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; GALLUZZO A, 1984, DIABETOLOGIA, V26, P426; GUPTA S, 1982, IMMUNOL LETT, V4, P289, DOI 10.1016/0165-2478(82)90054-2; GUTTMANN RD, 1983, J IMMUNOL, V130, P1732; Held N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015669; HEROLD KC, 1984, DIABETOLOGIA, V27, P102, DOI 10.1007/BF00275660; ILONEN J, 1984, DIABETOLOGIA, V27, P106, DOI 10.1007/BF00275661; JACKSON RA, 1984, J EXP MED, V159, P1629, DOI 10.1084/jem.159.6.1629; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; KAABA SA, 1995, IMMUNOL LETT, V47, P209, DOI 10.1016/0165-2478(95)00088-5; Kloting I, 1997, BIOCHEM BIOPH RES CO, V239, P106, DOI 10.1006/bbrc.1997.7436; Kloting I, 1995, DIABETES METAB, V21, P338; KRAAL G, 1983, IMMUNOGENETICS, V18, P585, DOI 10.1007/BF00345966; Kunstyr I, 1992, DIAGNOSTIC MICROBIOL; Lapolla A, 2005, CYTOKINE, V31, P280, DOI 10.1016/j.cyto.2005.05.004; LEGENDRE CM, 1988, DIABETES, V37, P792, DOI 10.2337/diabetes.37.6.792; Lenzen S, 2001, DIABETOLOGIA, V44, P1189, DOI 10.1007/s001250100625; Mori A, 2008, J VET MED SCI, V70, P185, DOI 10.1292/jvms.70.185; Northrup E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038001; PEAKMAN M, 1994, DIABETOLOGIA, V37, P155, DOI 10.1007/s001250050087; Petersen LD, 1996, J AUTOIMMUN, V9, P731; Pickup JC, 2003, TXB DIABETES, V1; Pickup JC, 2003, TXB DIABETES; PONTESILLI O, 1986, CLIN EXP IMMUNOL, V63, P68; RICHENS ER, 1985, ACTA DIABETOL LAT, V22, P229, DOI 10.1007/BF02590774; RODIER M, 1984, DIABETOLOGIA, V27, P136, DOI 10.1007/BF00275671; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; SPOOREN PFMJ, 1993, NETH J MED, V42, P163; Wedekind D, 2005, AUTOIMMUNITY, V38, P265, DOI 10.1080/08916930500114321; Weiss H, 2005, MAMM GENOME, V16, P432, DOI 10.1007/s00335-004-3022-8; Weiss H, 2008, MAMM GENOME, V19, P292, DOI 10.1007/s00335-008-9102-4; WHALEN BJ, 1994, J AUTOIMMUN, V7, P819, DOI 10.1006/jaut.1994.1065; Yokoi N, 1997, J CLIN INVEST, V100, P2015, DOI 10.1172/JCI119733; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64305	10.1371/journal.pone.0064305	http://dx.doi.org/10.1371/journal.pone.0064305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717591	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700134
J	Ashkenazi, E; Baranovski, BM; Shahaf, G; Lewis, EC				Ashkenazi, Efrat; Baranovski, Boris M.; Shahaf, Galit; Lewis, Eli C.			Pancreatic Islet Xenograft Survival in Mice Is Extended by a Combination of Alpha-1-Antitrypsin and Single-Dose Anti-CD4/CD8 Therapy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; DIABETIC NOD MICE; RECEPTOR ANTAGONIST; BETA-CELLS; TRANSPLANTATION; TOLERANCE; REJECTION; BLOCKADE; INTERLEUKIN-1; MONOTHERAPY	Clinical pancreatic islet transplantation is under evaluation for the treatment of autoimmune diabetes, yet several limitations preclude widespread use. For example, there is a critical shortage of human pancreas donors. Xenotransplantation may solve this problem, yet it evokes a rigorous immune response which can lead to graft rejection. Alpha-1-antitrypsin (AAT), a clinically available and safe circulating anti-inflammatory and tissue protective glycoprotein, facilitates islet alloimmune-tolerance and protects from inflammation in several models. Here, we examine whether human AAT (hAAT), alone or in combination with clinically relevant approaches, achieves long-term islet xenograft survival. Rat-to-mouse islet transplantation was examined in the following groups: untreated (n = 6), hAAT (n = 6, 60-240 mg/kg every 3 days from day -10), low-dose co-stimulation blockade (anti-CD154/LFA-1) and single-dose anti-CD4/CD8 (n = 5-7), either as mono-or combination therapies. Islet grafting was accompanied by blood glucose follow-up. In addition, skin xenografting was performed in order to depict responses that occur in draining lymph nodes. According to our results hAAT monotherapy and hAAT/anti-CD154/LFA-1 combined therapy, did not delay rejection day (11-24 days untreated vs. 10-22 day treated). However, host and donor intragraft inflammatory gene expression was diminished by hAAT therapy in both setups. Single dose T-cell depletion using anti-CD4/CD8 depleting antibodies, which provided 14-15 days of reduced circulating T-cells, significantly delayed rejection day (28-52 days) but did not achieve graft acceptance. In contrast, in combination with hAAT, the group displayed significantly extended rejection days and a high rate of graft acceptance (59, 61, >90, >90, >90). In examination of graft explants, marginal mononuclear-cell infiltration containing regulatory T-cells predominated surviving xenografts. We suggest that temporal T-cell depletion, as in the clinically practiced anti-thymocyte-globulin therapy, combined with hAAT, may promote islet xenograft acceptance. Further studies are required to elucidate the mechanism behind the observed synergy, as well as the applicability of the approach for pig-to-human islet xenotransplantation.	[Ashkenazi, Efrat; Baranovski, Boris M.; Shahaf, Galit; Lewis, Eli C.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Lewis, EC (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.	lewis@bgu.ac.il	LEWIS, ELI C/F-1552-2012	LEWIS, ELI C/0000-0002-4189-2207	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The study was funded by the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis A, 2011, MOL MED; Arefanian H, 2007, CELL TRANSPLANT, V16, P787, DOI 10.3727/000000007783465244; Arefanian H, 2010, DIABETES, V59, P958, DOI 10.2337/db09-0413; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bellacen K, 2012, CELL TRANSPLANTATION; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Broady R, 2009, BLOOD, V114, P5003, DOI 10.1182/blood-2009-04-214437; Chen X, 2010, J SURG RES, V164, P336, DOI 10.1016/j.jss.2009.08.016; de Kort H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d217; Deng S, 1997, TRANSPLANT P, V29, P2062, DOI 10.1016/S0041-1345(97)00232-7; Dhami R, 1999, J MOL MED-JMM, V77, P377, DOI 10.1007/s001090050364; Gaber AO, 2010, DRUGS, V70, P691, DOI 10.2165/11315940-000000000-00000; Guo L, 2003, TRANSPL IMMUNOL, V12, P41, DOI 10.1016/S0966-3274(03)00016-9; Hadzic R, 2006, IMMUNOL LETT, V102, P141, DOI 10.1016/j.imlet.2005.08.006; Hsu BR, 2009, TRANSPL P, V41, P1781, DOI 10.1016/j.transproceed.2008.10.099; Jeannin P, 1998, EUR J IMMUNOL, V28, P1815, DOI 10.1002/(SICI)1521-4141(199806)28:06<1815::AID-IMMU1815>3.0.CO;2-5; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Jones PM, 2008, DRUG DISCOV TODAY, V13, P888, DOI 10.1016/j.drudis.2008.06.014; Kahraman S, 2011, DIABETES-METAB RES, V27, P575, DOI 10.1002/dmrr.1216; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; KarlssonParra A, 1996, TRANSPLANTATION, V61, P1313, DOI 10.1097/00007890-199605150-00005; Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x; Korsgren O, 2009, CURR OPIN ORGAN TRAN, V14, P683, DOI 10.1097/MOT.0b013e328332c44c; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Loganathan G, 2010, TRANSPL P, V42, P2055, DOI 10.1016/j.transproceed.2010.05.119; MANDRUPPOULSEN T, 1993, CYTOKINE, V5, P185, DOI 10.1016/1043-4666(93)90003-N; Mordwinkin NM, 2007, EXPERT OPIN PHARMACO, V8, P2609, DOI 10.1517/14656566.8.15.2609; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Niclauss N, 2011, TRANSPLANTATION, V91, P714, DOI 10.1097/TP.0b013e31820c10c8; Pan H, 2007, TRANSPL P, V39, P3452, DOI 10.1016/j.transproceed.2007.06.091; Rayat GR, 2003, DIABETES, V52, P1433, DOI 10.2337/diabetes.52.6.1433; Salehi A, 2011, MOL CELL ENDOCRINOL; Schroppel B, 2005, J AM SOC NEPHROL, V16, P444, DOI 10.1681/ASN.2004090743; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Snanoudj R, 2010, DRUGS, V70, P2121, DOI 10.2165/11538140-000000000-00000; Song S, 2004, GENE THER, V11, P181, DOI 10.1038/sj.gt.3302156; Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135; Strom TB, 2005, P NATL ACAD SCI USA, V102, P12651, DOI 10.1073/pnas.0506079102; Subramanian S, 2011, METAB BRAIN DIS, V2011, P25; Tchorsh-Yutsis D, 2011, TRANSPLANTATION, V91, P398, DOI 10.1097/TP.0b013e318204be15; Tchorsh-Yutsis D, 2009, DIABETES, V58, P1585, DOI 10.2337/db09-0112; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Tredget EB, 2008, CELL TRANSPLANT, V17, P599, DOI 10.3727/096368908786092757; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854	50	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63625	10.1371/journal.pone.0063625	http://dx.doi.org/10.1371/journal.pone.0063625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717456	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700042
J	Egbert, MD				Egbert, Matthew D.			Bacterial Chemotaxis: Introverted or Extroverted? A Comparison of the Advantages and Disadvantages of Basic Forms of Metabolism-Based and Metabolism-Independent Behavior Using a Computational Model	PLOS ONE			English	Article							PROTON MOTIVE FORCE; ENERGY TAXIS; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; AZOSPIRILLUM-BRASILENSE; RHODOBACTER-SPHAEROIDES; CHEMORECEPTORS; RECEPTORS; AER; PATHWAYS	Using a minimal model of metabolism, we examine the limitations of behavior that is (a) solely in response to environmental phenomena or (b) solely in response to metabolic dynamics, showing that basic forms of each of these kinds of behavior are incapable of driving survival-prolonging behavior in certain situations. Inspired by experimental evidence of concurrent metabolism-based and metabolism-independent chemotactic mechanisms in Escherichia coli and Rhodobacter sphaeroides, we then investigate how metabolism-independent and metabolism-based sensitivities can be integrated into a single behavioral response, demonstrating that a simple switching mechanism can be sufficient to effectively integrate metabolism-based and metabolism-independent behaviors. Finally, we use a spatial simulation of bacteria to show that the investigated forms of behavior produce different spatio-temporal patterns that are influenced by the metabolic-history of the bacteria. We suggest that these patterns could be a way to experimentally derive insight into the relationship between metabolism and chemotaxis in real bacteria.	[Egbert, Matthew D.] Univ Jena, Biosyst Anal Grp, Jena, Germany; [Egbert, Matthew D.] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England	Friedrich Schiller University of Jena; University of Sussex	Egbert, MD (corresponding author), Univ Jena, Biosyst Anal Grp, Jena, Germany.	mde@matthewegbert.com						ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; Alexandre G, 2000, J BACTERIOL, V182, P6042, DOI 10.1128/JB.182.21.6042-6048.2000; Alexandre G, 2004, FEMS MICROBIOL REV, V28, P113, DOI 10.1016/j.femsre.2003.10.003; Alexandre G, 2010, MICROBIOL-SGM, V156, P2283, DOI 10.1099/mic.0.039214-0; Barak R, 1999, MOL MICROBIOL, V31, P1125, DOI 10.1046/j.1365-2958.1999.01251.x; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry RM, 2000, BIOPHYS J, V78, P1207, DOI 10.1016/S0006-3495(00)76678-1; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; CLAYTON RK, 1953, ARCH MIKROBIOL, V19, P125, DOI 10.1007/BF00446396; Costa RS, 2010, BIOSYSTEMS, V100, P150, DOI 10.1016/j.biosystems.2010.03.001; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Egbert MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001004; Egbert MD, 2012, ARTIFICIAL LIFE, V18; Egbert MD, 2013, ARTIFICIAL LIFE; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Ganti T., 2003, PRINCIPLES LIFE; GOLDBETER A, 1982, J MOL BIOL, V161, P395, DOI 10.1016/0022-2836(82)90246-7; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; Hamadeh A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001130; Harvey I, 2011, P 10 EUR C ADV ART L, P126; Jeziore-Sassoon Y, 1998, MICROBIOL-SGM, V144, P229, DOI 10.1099/00221287-144-1-229; Jiang ZY, 2001, J BACTERIOL, V183, P171, DOI 10.1128/JB.183.1.171-177.2001; Maturana H.R., 1980, AUTOPOIESIS COGNITIO; Peach ML, 2002, PROTEIN SCI, V11, P912, DOI 10.1110/ps.4640102; Piedrafita G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000872; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Sarand I, 2008, ENVIRON MICROBIOL, V10, P1320, DOI 10.1111/j.1462-2920.2007.01546.x; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Schweinitzer T, 2010, ARCH MICROBIOL, V192, P507, DOI 10.1007/s00203-010-0575-7; SEGEL LA, 1976, J THEOR BIOL, V57, P23, DOI 10.1016/S0022-5193(76)80004-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock J, 2000, CURR BIOL, V10, pR11, DOI 10.1016/S0960-9822(99)00248-1; STOCK J, 1985, CELL, V42, P683, DOI 10.1016/0092-8674(85)90125-4; Taylor BL, 1998, MOL MICROBIOL, V28, P683, DOI 10.1046/j.1365-2958.1998.00835.x; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Tindall MJ, 2012, WIRES SYST BIOL MED, V4, P247, DOI 10.1002/wsbm.1168; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; Zhang JJ, 2008, J ENVIRON SCI-CHINA, V20, P1238, DOI 10.1016/S1001-0742(08)62215-9; Zhulin IB, 1996, J BACTERIOL, V178, P5199, DOI 10.1128/jb.178.17.5199-5204.1996; Zhulin IB, 1997, J BACTERIOL, V179, P3196, DOI 10.1128/jb.179.10.3196-3201.1997	43	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63617	10.1371/journal.pone.0063617	http://dx.doi.org/10.1371/journal.pone.0063617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717454	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700040
J	Lewis, DE; Pearson, J; Khuu, SK				Lewis, David E.; Pearson, Joel; Khuu, Sieu K.			The Color "Fruit'': Object Memories Defined by Color	PLOS ONE			English	Article							SURFACE DETAIL; RECOGNITION; KNOWLEDGE; VISION; CATEGORIZATION; INFORMATION; EVOLUTION; CHROMATICITY; PERCEPTION; RETRIEVAL	Most fruits and other highly color-diagnostic objects have color as a central aspect of their identity, which can facilitate detection and visual recognition. It has been theorized that there may be a large amount of overlap between the neural representations of these objects and processing involved in color perception. In accordance with this theory we sought to determine if the recognition of highly color diagnostic fruit objects could be facilitated by the visual presentation of their known color associates. In two experiments we show that color associate priming is possible, but contingent upon multiple factors. Color priming was found to be maximally effective for the most highly color diagnostic fruits, when low spatial-frequency information was present in the image, and when determination of the object's specific identity, not merely its category, was required. These data illustrate the importance of color for determining the identity of certain objects, and support the theory that object knowledge involves sensory specific systems.	[Lewis, David E.; Pearson, Joel] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Lewis, David E.; Khuu, Sieu K.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Lewis, DE (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	dave37@gmail.com	Khuu, Sieu/N-7957-2019	Khuu, Sieu/0000-0003-1850-0225; Pearson, Joel/0000-0003-3704-5037	Australian Research Council [DP110104713]; NHMRC [APP1024800]; University International Postgraduate Award (UIPA) from the University of New South Wales	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University International Postgraduate Award (UIPA) from the University of New South Wales	This work was supported by an Australian Research Council Discovery grant DP110104713 to S. Khuu, an NHMRC project grant APP1024800 to J. Pearson, and a University International Postgraduate Award (UIPA) from the University of New South Wales to D. Lewis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Grant, 1879, COLOUR SENSE ITS ORI; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Bowmaker JK, 1998, EYE, V12, P541, DOI 10.1038/eye.1998.143; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bramao I, 2012, BRAIN COGNITION, V78, P28, DOI 10.1016/j.bandc.2011.10.004; Bramao I, 2011, ACTA PSYCHOL, V138, P244, DOI 10.1016/j.actpsy.2011.06.010; Bramao I, 2010, AM J PSYCHOL, V123, P437; Bramao Ines, 2010, Open Neuroimag J, V4, P164, DOI 10.2174/1874440001004010164; Bramao I, 2011, J GEN PSYCHOL, V138, P49, DOI 10.1080/00221309.2010.533718; Chao LL, 1999, J COGNITIVE NEUROSCI, V11, P25, DOI 10.1162/089892999563229; DEVREESE LP, 1991, NEUROPSYCHOLOGIA, V29, P1, DOI 10.1016/0028-3932(91)90090-U; DZMURA M, 1986, J OPT SOC AM A, V3, P1662, DOI 10.1364/JOSAA.3.001662; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hansen T, 2006, NAT NEUROSCI, V9, P1367, DOI 10.1038/nn1794; Hering E., 1920, GRUNDZUGE LEHRE LICH; Hsu NS, 2012, NEUROPSYCHOLOGIA, V50, P327, DOI 10.1016/j.neuropsychologia.2011.12.003; Hsu NNS, 2011, J COGNITIVE NEUROSCI, V23, P2544, DOI 10.1162/jocn.2011.21619; Hurlbert AC., 2005, J VISION, V5, P787, DOI DOI 10.1167/5.8.787; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Joseph JE, 1996, J EXP PSYCHOL LEARN, V22, P407, DOI 10.1037/0278-7393.22.2.407; Joseph JE, 1997, ACTA PSYCHOL, V97, P95, DOI 10.1016/S0001-6918(97)00026-7; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Laws KR, 2006, BRAIN COGNITION, V62, P89, DOI 10.1016/j.bandc.2006.03.002; Lu AT, 2010, NEUROSCI LETT, V469, P405, DOI 10.1016/j.neulet.2009.12.039; LUZZATTI C, 1994, NEUROPSYCHOLOGIA, V32, P933, DOI 10.1016/0028-3932(94)90044-2; Mapelli D, 1997, NEUROCASE, V3, P237; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; Naor-Raz G, 2003, PERCEPTION, V32, P667, DOI 10.1068/p5050; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Olkkonen M, 2008, J VISION, V8, DOI [10.1167/8.5.13, 10.1167/8.8.8]; PARKER DM, 1992, PERCEPTION, V21, P147, DOI 10.1068/p210147; Perez-Carpinell J, 1998, COLOR RES APPL, V23, P416, DOI 10.1002/(SICI)1520-6378(199812)23:6<416::AID-COL10>3.0.CO;2-N; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Rogers TT, 2007, J EXP PSYCHOL GEN, V136, P451, DOI 10.1037/0096-3445.136.3.451; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Shuren JE, 1996, NEUROPSYCHOLOGIA, V34, P485, DOI 10.1016/0028-3932(95)00153-0; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Tanaka JW, 1999, PERCEPT PSYCHOPHYS, V61, P1140, DOI 10.3758/BF03207619; Therriault DJ, 2009, COGN PROCESS, V10, P335, DOI 10.1007/s10339-009-0260-4; Uttl B, 2006, SCAND J PSYCHOL, V47, P313, DOI 10.1111/j.1467-9450.2006.00532.x; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Witzel C, 2011, I-PERCEPTION, V2, P13, DOI 10.1068/i0396; WURM LH, 1993, J EXP PSYCHOL HUMAN, V19, P899, DOI 10.1037/0096-1523.19.4.899; Yee E, 2012, PSYCHOL SCI, V23, P364, DOI 10.1177/0956797611430691	51	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64960	10.1371/journal.pone.0064960	http://dx.doi.org/10.1371/journal.pone.0064960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717677	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700183
J	Razzauti, M; Plyusnina, A; Henttonen, H; Plyusnin, A				Razzauti, Maria; Plyusnina, Angelina; Henttonen, Heikki; Plyusnin, Alexander			Microevolution of Puumala hantavirus during a Complete Population Cycle of Its Host, the Bank Vole (Myodes glareolus)	PLOS ONE			English	Article							CLETHRIONOMYS-GLAREOLUS; INDIRECT TRANSMISSION; HEMORRHAGIC-FEVER; ETIOLOGIC AGENT; CO-CIRCULATION; VIRUS; INFECTION; REASSORTMENT; DYNAMICS; ACCUMULATION	Microevolution of Puumala hantavirus (PUUV) was studied throughout a population cycle of its host, the bank vole (Myodes glareolus). We monitored PUUV variants circulating in the host population in Central Finland over a five-year period that included two peak-phases and two population declines. Of 1369 bank voles examined, 360 (26.3%) were found infected with PUUV. Partial sequences of each of the three genome segments were recovered (approx. 12% of PUUV genome) from 356 bank voles. Analyses of these sequences disclosed the following features of PUUV evolution: 1) nucleotide substitutions are mostly silent and deduced amino acid changes are mainly conservative, suggesting stabilizing selection at the protein level; 2) the three genome segments accumulate mutations at a different rate; 3) some of the circulating PUUV variants are frequently observed while others are transient; 4) frequently occurring PUUV variants are composed of the most abundant segment genotypes (copious) and new transient variants are continually generated; 5) reassortment of PUUV genome segments occurs regularly and follows a specific pattern of segments association; 6) prevalence of reassortant variants oscillates with season and is higher in the autumn than in the spring; and 7) reassortants are transient, i.e., they are not competitively superior to their parental variants. Collectively, these observations support a quasi-neutral mode of PUUV microevolution with a steady generation of transient variants, including reassortants, and preservation of a few preferred genotypes.	[Razzauti, Maria; Plyusnina, Angelina; Plyusnin, Alexander] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Razzauti, Maria; Henttonen, Heikki] Finnish Forest Res Inst, Vantaa, Finland	University of Helsinki; Natural Resources Institute Finland (Luke)	Razzauti, M (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	maria.razzauti@helsinki.fi			Academy of Finland; EU [GOCE-2003-010284 EDEN, FP7-261504 EDENext]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); EU(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by grants from the Academy of Finland, Sigrid Juselius Foundation, and was partially funded by EU-FP6 grant GOCE-2003-010284 EDEN (http://www.eden-fp6project.net) and the EU grant FP7-261504 EDENext (http://www.edenext.eu) and is catalogued by the EDENext Steering Committee as EDENext021. The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST THREAT; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bernshtein AD, 1999, ARCH VIROL, V144, P2415, DOI 10.1007/s007050050654; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; BRUMMERKORVENKONTIO M, 1982, SCAND J INFECT DIS, P88; Chao L, 1997, GENETICS, V147, P953; CHAO L, 1992, EVOLUTION, V46, P289, DOI 10.1111/j.1558-5646.1992.tb02038.x; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GAVRILOVSKAYA IN, 1990, ARCH VIROL         S, V1, P57; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Jaaskelainen KM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-3; Kallio ER, 2006, P ROY SOC B-BIOL SCI, V273, P2771, DOI 10.1098/rspb.2006.3645; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; Kallio ER, 2010, P ROY SOC B-BIOL SCI, V277, P3783, DOI 10.1098/rspb.2010.1022; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; King AMQ, 2011, VIRUS TAXONOMY CLASS, P731; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; LEE HW, 1981, AM J TROP MED HYG, V30, P477, DOI 10.4269/ajtmh.1981.30.477; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lundkvist A, 1997, J VIROL, V71, P9515, DOI 10.1128/JVI.71.12.9515-9523.1997; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Meyer BJ, 2000, TRENDS MICROBIOL, V8, P61, DOI 10.1016/S0966-842X(99)01658-3; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; PLYUSNIN A, 1995, VIRUS RES, V38, P25, DOI 10.1016/0168-1702(95)00038-R; Plyusnina A, 2006, SCAND J INFECT DIS, V38, P512, DOI 10.1080/00365540600585040; Plyusnina A, 2012, EMERG INFECT DIS, V18, P2070, DOI 10.3201/eid1811.120747; Plyusnina A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-12; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRINGLE CR, 1984, VIROLOGY, V135, P244, DOI 10.1016/0042-6822(84)90134-X; Provine WB, 2004, GENETICS, V167, P1041; Razzauti M, 2008, J GEN VIROL, V89, P1649, DOI 10.1099/vir.0.2008/001248-0; Razzauti M, 2012, J MED VIROL, V84, P314, DOI 10.1002/jmv.22263; Razzauti M, 2009, J GEN VIROL, V90, P1923, DOI 10.1099/vir.0.011304-0; Razzauti-Sanfeliu M, 2012, MICROEVOLUTION PUUMA; Rodriguez LL, 1998, VIROLOGY, V242, P99, DOI 10.1006/viro.1997.8990; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Sibold C, 1999, J VIROL, V73, P667, DOI 10.1128/JVI.73.1.667-675.1999; Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001; Tersago K, 2011, EPIDEMIOL INFECT, V139, P381, DOI 10.1017/S0950268810000956; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6	49	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64447	10.1371/journal.pone.0064447	http://dx.doi.org/10.1371/journal.pone.0064447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717616	Green Published, gold			2022-12-25	WOS:000320362700149
J	Roegholt, E; van Vonderen, JJ; Walther, FJ; Roehr, CC; te Pas, AB				Roegholt, Evelien; van Vonderen, Jeroen J.; Walther, Frans J.; Roehr, Charles C.; te Pas, Arjan B.			Do We Deliver the Pressures We Intend to When Using a T-Piece Resuscitator?	PLOS ONE			English	Article							2010 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; NEONATAL RESUSCITATION; CARDIOPULMONARY-RESUSCITATION; TREATMENT RECOMMENDATIONS; FACE MASKS; VENTILATION; INFANTS; PEEP	Background: A T-piece resuscitator (TPR) uses a built-in manometer to set the inflation pressures, but we are not informed what pressures are actually delivered distally. Aim of this study was to measure the proximal and distal pressures under different gas conditions when using a TPR. Methodology/Findings: A test lung was ventilated using a TPR (PIP 25 cmH(2)O, PEEP 5 cmH(2)O) with a gas flow rate of 8 L/min. A) Pressure delivered by six different TPRs was tested. To test variability 20 participants were asked to set PEEP and PIP pressures to 25/5 cmH(2)O. B) PIP and PEEP were measured proximal and distal of the TPR when using standard tubing or heated tubing with or without a humidifier. In experiment A mean (SD) proximal PIP and PEEP of the TPRs were respectively 20.3 (0.3) cmH(2)O (19.9-20.6 cmH(2)O) and 4.9 (0.1) cmH(2)O. When 20 participants set pressures; PIP 26.7 (0.5) cmH(2)O and PEEP 5.9 (0.44) cmH(2)O were measured. Experiment B showed that the decrease of PIP between proximal and distal pressures was not clinically significant. However there was a significant decrease of PEEP using the standard tubing (5.1 (0.1) cmH(2)O proximally versus 4.8 (0.2) cmH(2)O distally; p < 0.001) compared to, when using a humidifier with associated tubing and the humidifier turned on, 5.1 (0.1) proximally versus 3.9 (0.2) cmH2O distally; (p < 0.001). Conclusion/Significance: The accuracy of the built-in manometer of a TPR is acceptable. Most pressures set proximally are comparable to the actual pressures delivered distally. However, when using tubing associated with the humidifier PEEP decreases distally by 1.1-1.2 cmH(2)O and users should anticipate on this.	[Roegholt, Evelien; van Vonderen, Jeroen J.; Walther, Frans J.; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Roehr, Charles C.] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	van Vonderen, JJ (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	j.j.van_vonderen@lumc.nl	van Vonderen, Jeroen J./L-4067-2019; pas, arjan te/AAA-9019-2020	van Vonderen, Jeroen J./0000-0002-1258-5224; pas, arjan te/0000-0001-7831-8797; Roehr, Charles Christoph/0000-0001-7965-4637; Walther, Frans/0000-0003-1931-159X	Veni-grant; Innovational Research Incentives Scheme Veni-Vidi-Vici [91612027]; Willem-Alexander Children's Foundation scholarship	Veni-grant; Innovational Research Incentives Scheme Veni-Vidi-Vici; Willem-Alexander Children's Foundation scholarship	A.B. te Pas is recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici, project number 91612027. J.J. van Vonderen is recipient of Willem-Alexander Children's Foundation scholarship. www.willemalexanderkinderfonds.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dawson JA, 2011, J PAEDIATR CHILD H, V47, P698, DOI 10.1111/j.1440-1754.2011.02036.x; Fox R.W., 2004, INTRO FLUID MECH; Fuchs H, 2012, NEOREVIEWS, V13, P353; Hawkes CP, 2011, ACTA PAEDIATR, V100, P360, DOI 10.1111/j.1651-2227.2010.02086.x; Kelm M, 2009, KLIN PADIATR, V221, P415, DOI 10.1055/s-0029-1233493; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF392, DOI 10.1136/adc.2004.064691; O'Donnell CPF, 2004, ACTA PAEDIATR, V93, P583, DOI 10.1111/j.1651-2227.2004.tb02981.x; PALME C, 1985, LANCET, V1, P207; Perlman JM, 2010, PEDIATRICS, V126, pE1319, DOI 10.1542/peds.2010-2972B; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Schmolzer GM, 2012, J PEDIATR-US, V160, P377, DOI 10.1016/j.jpeds.2011.09.017; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Te Pas AB, 2008, J PEDIATR-US, V152, P607, DOI 10.1016/j.jpeds.2007.10.041	13	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64706	10.1371/journal.pone.0064706	http://dx.doi.org/10.1371/journal.pone.0064706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717652	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700168
J	Wen, XY; Wu, X; Liu, JT; Li, K; Yao, L				Wen, Xuyun; Wu, Xia; Liu, Jiangtao; Li, Ke; Yao, Li			Abnormal Baseline Brain Activity in Non-Depressed Parkinson's Disease and Depressed Parkinson's Disease: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBRAL BLOOD-FLOW; TREATMENT-RESPONSE; PREFRONTAL CORTEX; MAJOR DEPRESSION; GRAY-MATTER; HEAD MOTION; CONNECTIVITY; STIMULATION; CEREBELLUM	Depression is the most common psychiatric disorder observed in Parkinson's disease (PD) patients, however the neural contribution to the high rate of depression in the PD group is still unclear. In this study, we used resting-state functional magnetic resonance imaging (fMRI) to investigate the underlying neural mechanisms of depression in PD patients. Twenty-one healthy individuals and thirty-three patients with idiopathic PD, seventeen of whom were diagnosed with major depressive disorder, were recruited. An analysis of amplitude of low-frequency fluctuations (ALFF) was performed on the whole brain of all subjects. Our results showed that depressed PD patients had significantly decreased ALFF in the dorsolateral prefrontal cortex (DLPFC), the ventromedial prefrontal cortex (vMPFC) and the rostral anterior cingulated cortex (rACC) compared with non-depressed PD patients. A significant positive correlation was found between Hamilton Depression Rating Scale (HDRS) and ALFF in the DLPFC. The findings of changed ALFF in these brain regions implied depression in PD patients may be associated with abnormal activities of prefrontal-limbic network.	[Wen, Xuyun; Wu, Xia; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wu, Xia; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Liu, Jiangtao] Beijing Xuan Wu Hosp, Beijing, Peoples R China; [Li, Ke] Beijing 306 Hosp, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Wu, X (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	wuxia@bnu.edu.cn			Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program) [2012CB720704]; National Natural Science Foundation of China [6121001, 61222113]; Program for New Century Excellent Talents in University [NCET-12-0056]; State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB1216]	Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by the Fundamental Research Funds for the Central Universities National Key Basic Research Program of China (973 Program) (2012CB720704), the Key Program of National Natural Science Foundation of China (6121001), General Program of National Natural Science Foundation of China (61222113), Program for New Century Excellent Talents in University (NCET-12-0056) and program of State Key Laboratory of Cognitive Neuroscience and Learning (CNLYB1216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardoso EF, 2008, INT J NEUROPSYCHOPH, V11, P173, DOI 10.1017/S1461145707007961; Cardoso EF, 2009, NEUROIMAGE, V47, P467, DOI 10.1016/j.neuroimage.2009.04.059; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dragasevic N, 2002, MOVEMENT DISORD, V17, P528, DOI 10.1002/mds.10109; Edwards E, 2002, DEPRESS ANXIETY, V16, P39, DOI 10.1002/da.10057; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Feldmann A, 2008, MOVEMENT DISORD, V23, P42, DOI 10.1002/mds.21765; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, NEUROLOGY, V66, P1629, DOI 10.1212/01.wnl.0000218194.12054.60; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuhn W, 1996, J NEURAL TRANSM, V103, P349, DOI 10.1007/BF01271246; Kwak Y, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00052; Lang A. E. T., 1989, QUANTIFICATION NEURO, P285; Liotti M, 2002, AM J PSYCHIAT, V159, P1830, DOI 10.1176/appi.ajp.159.11.1830; Liu CH, 2012, PSYCHIAT RES-NEUROIM, V203, P175, DOI 10.1016/j.pscychresns.2012.02.007; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Long D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047714; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P695, DOI 10.1001/archneur.1995.00540310069018; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mottaghy FM, 2002, PSYCHIAT RES-NEUROIM, V115, P1, DOI 10.1016/S0925-4927(02)00032-X; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Philip DZ, 2002, BLACKWELL HDB CHILD; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Preziosi TJ, 1990, J NEUROL NEUROSURG P, V53; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; RING HA, 1994, BRIT J PSYCHIAT, V165, P333, DOI 10.1192/bjp.165.3.333; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Skidmore FM, 2011, NEUROIMAGE; Skidmore FM, 2011, NEUROIMAGE; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; STERN Y, 1993, NEUROLOGY, V43, P1690, DOI 10.1212/WNL.43.9.1690; Surguladze S, 2003, ADV PSYCHIAT TREAT, V9, P446, DOI DOI 10.1192/APT.9.6.446; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vu TC, 2012, BR J CLIN PHARM; Wagner G, 2008, J PSYCHIATR NEUROSCI, V33, P199; Wu X, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21269, DOI 10.1002/HBM.21269]; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang Zhi-Qiang, 2008, Zhonghua Yi Xue Za Zhi, V88, P1594	66	57	59	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63691	10.1371/journal.pone.0063691	http://dx.doi.org/10.1371/journal.pone.0063691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717467	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700050
J	Zhong, LX; Pon, V; Srinivas, S; Nguyen, N; Frear, M; Kwon, S; Gong, C; Malmstrom, R; Wilson, L				Zhong, Lixian; Pon, Vickie; Srinivas, Sandy; Nguyen, Nicole; Frear, Meghan; Kwon, Sherry; Gong, Cynthia; Malmstrom, Robert; Wilson, Leslie			Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							MITOXANTRONE; HEALTH; PREDNISONE; UTILITIES; SURVIVAL	Background: Docetaxel is an established first-line therapy to treat metastatic castration-resistant prostate cancer (mCRPC). Recently, abiraterone and cabazitaxel were approved for use after docetaxel failure, with improved survival. National Institute for Health and Clinical Excellence (NICE) preliminary recommendations were negative for both abiraterone (now positive in final recommendation) and cabazitaxel (negative in final recommendation). Objective: To evaluate the cost-effectiveness of abiraterone, cabazitaxel, mitoxantrone and prednisone for mCRPC treatment in US. Methods: A decision-tree model was constructed to compare the two mCRPC treatments versus two placebos over 18 months from a societal perspective. Chance nodes include baseline pain as a severity indicator, grade III/IV side-effects, and survival at 18 months. Probabilities, survival and health utilities were from published studies. Model cost inputs included drug treatment, side-effect management and prevention, radiation for pain, and death associated costs in 2010 US dollars. Results: Abiraterone is a cost-effective choice at $94K/QALY (quality adjusted life years) compared to placebo in our base-case analysis. Cabazitaxel and abiraterone are the most effective, yet also most expensive agents. The incremental cost-effectiveness ratios (ICER) at base-case are $101K/QALY (extended dominated) for mitoxantrone vs. placebo, $91K/QALY for abiraterone vs. mitoxantrone, $956K/QALY for cabazitaxel vs. abiraterone. Abiraterone becomes less cost-effective as its AWP increases, or if the cost of mitoxantrone side-effect management decreases. Increases in the percentage of patients with baseline pain leads to an increased ICER for both mitoxantrone and abiraterone, but mitoxantrone does relatively better. Cabazitaxel remains not cost-effective. Conclusion: Our base case model suggests that abiraterone is a cost-effective option in docetaxel-refractory mCRPC patients. Newer treatments will also need a CEA assessment compared to abiraterone.	[Zhong, Lixian; Pon, Vickie; Nguyen, Nicole; Frear, Meghan; Kwon, Sherry; Wilson, Leslie] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Srinivas, Sandy; Gong, Cynthia; Malmstrom, Robert] VA Northern Calif, Martinez, CA USA; [Srinivas, Sandy] Stanford Univ, Med Ctr, Palo Alto, CA USA	University of California System; University of California San Francisco; Stanford University	Wilson, L (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	WilsonL@pharmacy.ucsf.edu		Zhong, Lixian/0000-0003-2048-122X; Nguyen, Nicole/0000-0002-2856-4065				ADAMS E, 2010, TREATMENTS METASTATI; *AG HEALTHC RES QU, 2007, HEALTHC COST UT PROJ; BECK JR, 1982, AM J MED, V73; Berthold DR, 2008, ANN ONCOL, V19, P1749, DOI 10.1093/annonc/mdn288; CONNOCK M, 2011, WARWICK EVIDENCE DEC; DAVIS JB, 2010, MED FEES US 2010; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; GOLD MR, 1996, COST EFFECTIVENESS H, P456; *HCUP, 2011, COST TO CHARG RAT FI; Hwang SS, 2004, CANCER INVEST, V22, P849, DOI 10.1081/CNV-200039643; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JILANI A, 2012, LANCET ONCOLOGY; KONSKI A, 2009, AM J CLIN ONCOL-CANC, V32, P6; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Krahn M, 2003, MED CARE, V41, P153, DOI 10.1097/00005650-200301000-00017; Loriot Y, 2012, ANN ONCOL, V23, P1085, DOI 10.1093/annonc/mdr573; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; *NAT I HLTH CLIN E, 2012, CAB HORM REFR MET PR; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; OZER H, 2007, J SUPPORTIVE ONCOLOG, V5; Ozguroglu M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e15131; OZGUROGLU M, 2011, 2011 GEN CANC S; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; RAMSEY S, 2005, VALUE HEALTH, P8; Rosenberg JE, 2007, CANCER-AM CANCER SOC, V110, P556, DOI 10.1002/cncr.22811; SCHILLING MB, 2011, EXPT THERAPEUTIC MED, V2, P8; SHENOUDA N, RED BOOK DRUG REFERE; SHENOUDA N, 2010, RED BOOK DRUG REFERE; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Ward JF, 2005, NAT CLIN PRACT UROL, V2, P174, DOI 10.1038/ncpuro0145; 2012, PROSTATE CANC METAST	37	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64275	10.1371/journal.pone.0064275	http://dx.doi.org/10.1371/journal.pone.0064275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717582	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700127
J	Hallacoglu, B; Sassaroli, A; Fantini, S				Hallacoglu, Bertan; Sassaroli, Angelo; Fantini, Sergio			Optical Characterization of Two-Layered Turbid Media for Non-Invasive, Absolute Oximetry in Cerebral and Extracerebral Tissue	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; STRONGLY SCATTERING MEDIA; LIQUID DIFFUSIVE MEDIUM; FREQUENCY-DOMAIN; OXYGEN-SATURATION; ABSORPTION PROPERTIES; NIR WAVELENGTHS; CONTINUOUS-WAVE; BRAIN; LIGHT	We introduce a multi-distance, frequency-domain, near-infrared spectroscopy (NIRS) method to measure the optical coefficients of two-layered media and the thickness of the top layer from diffuse reflectance measurements. This method features a direct solution based on diffusion theory and an inversion procedure based on the Levenberg-Marquardt algorithm. We have validated our method through Monte Carlo simulations, experiments on tissue-like phantoms, and measurements on the forehead of three human subjects. The Monte Carlo simulations and phantom measurements have shown that, in ideal two-layered samples, our method accurately recovers the top layer thickness (L), the absorption coefficient (mu(alpha)) and the reduced scattering coefficient (mu'(s)) of both layers with deviations that are typically less than 10% for all parameters. Our method is aimed at absolute measurements of hemoglobin concentration and saturation in cerebral and extracerebral tissue of adult human subjects, where the top layer (layer 1) represents extracerebral tissue (scalp, skull, dura mater, subarachnoid space, etc.) and the bottom layer (layer 2) represents cerebral tissue. Human subject measurements have shown a significantly greater total hemoglobin concentration in cerebral tissue (82 +/- 14 mu M) with respect to extracerebral tissue (30 +/- 7 mu M). By contrast, there was no significant difference between the hemoglobin saturation measured in cerebral tissue (56% +/- 10%) and extracerebral tissue (62% +/- 6%). To our knowledge, this is the first time that an inversion procedure in the frequency domain with six unknown parameters with no other prior knowledge is used for the retrieval of the optical coefficients and top layer thickness with high accuracy on two-layered media. Our absolute measurements of cerebral hemoglobin concentration and saturation are based on the discrimination of extracerebral and cerebral tissue layers, and they can enhance the impact of NIRS for cerebral hemodynamics and oxygenation assessment both in the research arena and clinical practice.	[Hallacoglu, Bertan; Sassaroli, Angelo; Fantini, Sergio] Tufts Univ, Dept Biomed Engn, Medford, MA USA	Tufts University	Hallacoglu, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA USA.	bertan.hallacoglu@tufts.edu			Unilever USA; Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts; US Department of Agriculture, Agricultural Research Service [58-1950-7-707]; National Institutes of Health [R03-MH093846]; National Science Foundation [IIS-1065154]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093846] Funding Source: NIH RePORTER	Unilever USA(Unilever); Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts; US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a strategic research agreement between Unilever USA and the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts, and by the US Department of Agriculture, Agricultural Research Service, under agreement No. 58-1950-7-707. The authors also acknowledge support from the National Institutes of Health through Grants R03-MH093846 and the National Science Foundation through Award IIS-1065154. The funders in this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Although the authors have received commercial funding from Unilever USA, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexandrakis G, 2001, APPL OPTICS, V40, P3810, DOI 10.1364/AO.40.003810; [Anonymous], [No title captured]; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; Beauchamp MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024981; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Bluestone AY, 2001, OPT EXPRESS, V9, P272, DOI 10.1364/OE.9.000272; Boden S, 2007, NEUROIMAGE, V36, P100, DOI 10.1016/j.neuroimage.2007.01.045; Choe R, 2003, P NATL ACAD SCI USA, V100, P12950, DOI 10.1073/pnas.1735462100; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Comelli D, 2007, APPL OPTICS, V46, P1717, DOI 10.1364/AO.46.001717; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; DAYAN I, 1992, J MOD OPTIC, V39, P1567, DOI 10.1080/09500349214551581; Dehaes M, 2011, BIOMED OPT EXPRESS, V2, P552, DOI 10.1364/BOE.2.000552; Dehghani H, 2009, COMMUN NUMER METH EN, V25, P711, DOI 10.1002/cnm.1162; Del Bianco S, 2004, OPT EXPRESS, V12, P2102, DOI 10.1364/OPEX.12.002102; Di Ninni P, 2012, APPL OPTICS, V51, P7176, DOI 10.1364/AO.51.007176; Di Ninni P, 2011, PHYS MED BIOL, V56, pN21, DOI 10.1088/0031-9155/56/2/N01; Drayna PC, 2011, PEDIATR EMERG CARE, V27, P432, DOI 10.1097/PEC.0b013e3182188442; Fantini S, 1999, PHYS MED BIOL, V44, P1543, DOI 10.1088/0031-9155/44/6/308; FANTINI S, 1994, APPL OPTICS, V33, P5204, DOI 10.1364/AO.33.005204; FANTINI S, 1994, J OPT SOC AM B, V11, P2128, DOI 10.1364/JOSAB.11.002128; Fantini S., 2002, HDB OPTICAL BIOMEDIC; Fantini S, 2012, ANN BIOMED ENG, V40, P398, DOI 10.1007/s10439-011-0404-4; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FISHKIN JB, 1993, J OPT SOC AM A, V10, P127, DOI 10.1364/JOSAA.10.000127; FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Gagnon L, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982524; Gibson A, 2009, PHILOS T R SOC A, V367, P3055, DOI 10.1098/rsta.2009.0080; Grabtchak S, 2012, BIOMED OPT EXPRESS, V3, P2371, DOI 10.1364/BOE.3.002371; Grant PE, 2009, J CEREBR BLOOD F MET, V29, P1704, DOI 10.1038/jcbfm.2009.90; Habermehl C, 2012, NEUROIMAGE, V59, P3201, DOI 10.1016/j.neuroimage.2011.11.062; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hallacoglu B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081406; Hallacoglu B, 2011, J CEREBR BLOOD F MET, V31, P1482, DOI 10.1038/jcbfm.2011.13; HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727; Heringlake M, 2011, ANESTHESIOLOGY, V114, P58, DOI 10.1097/ALN.0b013e3181fef34e; Hintz SR, 1999, PEDIATR RES, V45, P54, DOI 10.1203/00006450-199901000-00009; Hirsch Jennifer C, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P51, DOI 10.1053/j.pcsu.2010.01.005; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; Kellert L, 2011, STROKE, V42, P2832, DOI 10.1161/STROKEAHA.110.606665; Kienle A, 1997, J OPT SOC AM A, V14, P246, DOI 10.1364/JOSAA.14.000246; Kienle A, 1998, APPL OPTICS, V37, P779, DOI 10.1364/AO.37.000779; Koch Stefan P, 2010, Front Neuroenergetics, V2, P12, DOI 10.3389/fnene.2010.00012; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Lemmers PMA, 2006, EXP BRAIN RES, V173, P458, DOI 10.1007/s00221-006-0388-8; Li A, 2007, APPL OPTICS, V46, P4828, DOI 10.1364/AO.46.004828; Liemert A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368685; Liemert A, 2010, OPT EXPRESS, V18, P9266, DOI 10.1364/OE.18.009266; Markham J, 2009, HUM BRAIN MAPP, V30, P2382, DOI 10.1002/hbm.20678; Martelli F, 2004, OPT LETT, V29, P2037, DOI 10.1364/OL.29.002037; Martelli F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056623; Martelli F, 2007, OPT EXPRESS, V15, P486, DOI 10.1364/OE.15.000486; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Parnia S, 2012, RESUSCITATION, V83, P982, DOI 10.1016/j.resuscitation.2012.01.039; Pham TH, 2000, APPL OPTICS, V39, P4733, DOI 10.1364/AO.39.004733; Press W. H., 1992, NUMERICAL RECIPES FO, V77; Pucci O, 2010, APPL OPTICS, V49, P6324, DOI 10.1364/AO.49.006324; Ripoll J, 2001, J OPT SOC AM A, V18, P821, DOI 10.1364/JOSAA.18.000821; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Saager R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940587; Saager RB, 2011, NEUROIMAGE, V55, P1679, DOI 10.1016/j.neuroimage.2011.01.043; Sassaroli A, 2010, J OPT SOC AM A, V27, P1723, DOI 10.1364/JOSAA.27.001723; Saxena V, 2007, PHYS MED BIOL, V52, P5295, DOI 10.1088/0031-9155/52/17/013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Spinelli L, 2007, OPT EXPRESS, V15, P6589, DOI 10.1364/OE.15.006589; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Tina LG, 2009, CURR NEUROVASC RES, V6, P148, DOI 10.2174/156720209788970090; Tingleff O., 2008, METHODS NONLINEAR LE, V2nd ed.; TORRICELLI A, 2011, ADV OPTICAL IMAGING, P287; Tualle JM, 2000, J OPT SOC AM A, V17, P2046, DOI 10.1364/JOSAA.17.002046; Tweddell James S, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P44, DOI 10.1053/j.pcsu.2010.02.008; VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Wolf M, 2008, OPTO-ELECTRON REV, V16, P413, DOI 10.2478/sll772-008-0042-z; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wong FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043165; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050271; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Yeganeh HZ, 2012, BIOMED OPT EXPRESS, V3, P2761, DOI 10.1364/BOE.3.002761; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2754714; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	91	47	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64095	10.1371/journal.pone.0064095	http://dx.doi.org/10.1371/journal.pone.0064095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23724023	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200115
J	Kao, CJ; Martiniez, A; Shi, XB; Yang, J; Evans, CP; Dobi, A; White, RWD; Kung, HJ				Kao, C-J; Martiniez, A.; Shi, X-B; Yang, J.; Evans, C. P.; Dobi, A.; White, R. W. deVere; Kung, H-J			miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT	ONCOGENE			English	Article						prostate cancer; EGF; Src; miRNA; ERG and EMT	PROSTATE-CANCER CELLS; TO-MESENCHYMAL TRANSITION; FAMILY KINASE INHIBITOR; FOCAL ADHESION KINASE; ANDROGEN RECEPTOR; TYROSINE PHOSPHORYLATION; GENE FUSIONS; SRC; EXPRESSION; PATHWAY	Src tyrosine kinase (Src) is implicated in the development of bone metastasis and castration resistance of prostate cancer. Src inhibitors are currently being tested in clinical trials for such diseases. Understanding the molecular and cellular actions of Src inhibitors holds the key to future improvement of this line of therapy. Here we describe the microRNA expression profiles modulated by two Src inhibitors and demonstrate that the miR-30 family members are the most prominently induced species. Consistent with its tumor suppressor role, miR-30 is downmodulated by oncogenic signals such as epidermal growth factor (EGF) and hepatocyte growth factor, and is generally underexpressed in prostate cancer specimens. A number of epithelial-to-mesenchymal transition (EMT)-associated genes are predicted targets of miR-30. Among these genes the Ets-related gene (ERG) is the most frequently overexpressed oncogene in prostate cancer activated by genomic fusion events between promoter upstream sequences of the TMPRSS2 and coding sequences of ERG. We showed by ERG 3' untranslated region reporter and mutagenesis assays that ERG is a direct target of miR-30. Overexpression of miR-30 in prostate cancer cells suppresses EMT phenotypes and inhibits cell migration and invasion. It also inhibits the in vitro and in vivo growth of VCaP cells, which depends on TMPRSS2-ERG for proliferation. TMPRSS2-ERG is generally regulated by androgen at the transcriptional level. Our finding reveals a new post-transcriptional mechanism of TMPRSS2-ERG regulation by Src and growth signals via miR-30 providing a rationale for targeting ERG-positive castration-resistant tumors with Src inhibitors.	[Kao, C-J; Martiniez, A.; Kung, H-J] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Shi, X-B; Yang, J.; Evans, C. P.; White, R. W. deVere] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Dobi, A.] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Dept Surg, Rockville, MD USA; [Kung, H-J] Natl Hlth Res Inst, Inst Mol & Genom Med, Maioli, Taiwan; [Kung, H-J] Taipei Med Univ, Translat Med & Integrated Lab, Taipei, Taiwan	University of California System; University of California Davis; University of California System; University of California Davis; Uniformed Services University of the Health Sciences - USA; National Health Research Institutes - Taiwan; Taipei Medical University	Kung, HJ (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, UCDMC Res 3,Room 2400,4645 2nd Ave, Sacramento, CA 95817 USA.	hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013		NIH [CA150197, CA165263]; DOD [PC093350]; DOD postdoctoral fellowship [PC110744]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA165263, R01CA150197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); DOD postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants (CA150197 and CA165263) and DOD grant (PC093350) to HJK. CJK acknowledges the support of DOD postdoctoral fellowship (PC110744). We are grateful to M Bradnam for excellent editorial assistance of this manuscript.	Araujo J, 2009, INT J CANCER, V124, P1, DOI 10.1002/ijc.23998; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hebbard L, 2011, ONCOGENE, V30, P301, DOI 10.1038/onc.2010.412; Hollenhorst Peter C, 2011, Genes Cancer, V1, P1044; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Kung Hsing-Jien, 2011, Hormones & Cancer, V2, P38, DOI 10.1007/s12672-010-0053-3; Lee LF, 2004, ONCOGENE, V23, P2197, DOI 10.1038/sj.onc.1207344; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Quintavalle C, 2013, ONCOGENE, V32, P4001, DOI 10.1038/onc.2012.410; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yang JC, 2010, MOL CANCER THER, V9, P1629, DOI 10.1158/1535-7163.MCT-09-1058; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhou J, 2005, CANCER RES, V65, P9906, DOI 10.1158/0008-5472.CAN-05-1481; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	52	119	127	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2495	2503		10.1038/onc.2013.200	http://dx.doi.org/10.1038/onc.2013.200			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23728339	Green Accepted			2022-12-25	WOS:000336033600009
J	Salin-Cantegrel, A; Shekarabi, M; Rasheed, S; Charron, FM; Laganiere, J; Gaudet, R; Dion, PA; Lapointe, JY; Rouleau, GA				Salin-Cantegrel, Adele; Shekarabi, Masoud; Rasheed, Sarah; Charron, Francois M.; Laganiere, Janet; Gaudet, Rebecca; Dion, Patrick A.; Lapointe, Jean-Yves; Rouleau, Guy A.			Potassium-Chloride Cotransporter 3 Interacts with Vav2 to Synchronize the Cell Volume Decrease Response with Cell Protrusion Dynamics	PLOS ONE			English	Article							K-CL COTRANSPORT; GTP-BINDING PROTEINS; CORPUS-CALLOSUM; SENSORY NEUROPATHY; HEREDITARY MOTOR; RAC1; KCC3; ACTIVATION; AGENESIS; GROWTH	Loss-of-function of the potassium-chloride cotransporter 3 (KCC3) causes hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), a severe neurodegenerative disease associated with defective midline crossing of commissural axons in the brain. Conversely, KCC3 over-expression in breast, ovarian and cervical cancer is associated with enhanced tumor cell malignancy and invasiveness. We identified a highly conserved proline-rich sequence within the C-terminus of the cotransporter which when mutated leads to loss of the KCC3-dependent regulatory volume decrease (RVD) response in Xenopus Laevis oocytes. Using SH3 domain arrays, we found that this poly-proline motif is a binding site for SH3-domain containing proteins in vitro. This approach identified the guanine nucleotide exchange factor (GEF) Vav2 as a candidate partner for KCC3. KCC3/Vav2 physical interaction was confirmed using GST-pull down assays and immuno-based experiments. In cultured cervical cancer cells, KCC3 co-localized with the active form of Vav2 in swelling-induced actin-rich protruding sites and within lamellipodia of spreading and migrating cells. These data provide evidence of a molecular and functional link between the potassium-chloride co-transporters and the Rho GTPase-dependent actin remodeling machinery in RVD, cell spreading and cell protrusion dynamics, thus providing new insights into KCC3' s involvement in cancer cell malignancy and in corpus callosum agenesis in HMSN/ACC.	[Salin-Cantegrel, Adele; Shekarabi, Masoud; Rasheed, Sarah; Laganiere, Janet; Gaudet, Rebecca; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ, Canada; [Salin-Cantegrel, Adele; Shekarabi, Masoud; Rasheed, Sarah; Laganiere, Janet; Gaudet, Rebecca; Dion, Patrick A.; Rouleau, Guy A.] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Charron, Francois M.; Lapointe, Jean-Yves] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca			Canadian Institutes of Health Research grant [172248]; Fondation des Jumelles Coude	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Fondation des Jumelles Coude	This work was supported by a Canadian Institutes of Health Research grant (172248 to G.A.R.) and the Fondation des Jumelles Coude. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Barfod ET, 2005, J BIOL CHEM, V280, P25548, DOI 10.1074/jbc.M411717200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Dupre N, 2003, ANN NEUROL, V54, P9, DOI 10.1002/ana.77777; Gagnon KB, 2012, CELL PHYSIOL BIOCHEM, V30, P466, DOI 10.1159/000339040; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Howard HC, 2003, M S-MED SCI, V19, P414, DOI 10.1051/medsci/2003194414; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Hsu YM, 2007, CANCER RES, V67, P11064, DOI 10.1158/0008-5472.CAN-07-2443; Hsu YM, 2007, J CELL PHYSIOL, V210, P626, DOI 10.1002/jcp.20859; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Lai SY, 2008, ORAL ONCOL, V44, P683, DOI 10.1016/j.oraloncology.2007.08.017; LAUF PK, 1984, J MEMBRANE BIOL, V82, P167, DOI 10.1007/BF01868941; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lauf PK, 2001, CELL PHYSIOL BIOCHEM, V11, P143, DOI 10.1159/000047802; LAUF PK, 1984, J MEMBRANE BIOL, V77, P57, DOI 10.1007/BF01871100; Malartre M, 2010, J NEUROSCI, V30, P2257, DOI 10.1523/JNEUROSCI.1820-09.2010; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; Moon MS, 2010, MOL CELL NEUROSCI, V44, P118, DOI 10.1016/j.mcn.2010.03.001; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Pedersen SF, 2002, J PHYSIOL-LONDON, V541, P779, DOI 10.1113/jphysiol.2002.018887; Pedersen SF, 1999, EXP CELL RES, V252, P63, DOI 10.1006/excr.1999.4615; Ringel F, 2008, NEUROSCI LETT, V442, P219, DOI 10.1016/j.neulet.2008.07.017; Salin-Cantegrel A, 2007, NEUROLOGY, V69, P1350, DOI 10.1212/01.wnl.0000291779.35643.15; Salin-Cantegrel A, 2008, HUM MOL GENET, V17, P2703, DOI 10.1093/hmg/ddn172; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Schmid RS, 2004, NEUROREPORT, V15, P2791; Shen MR, 1999, ACTA PHYSIOL SCAND, V167, P215; Shen MR, 2000, PFLUG ARCH EUR J PHY, V440, P751, DOI 10.1007/s004240000338; Shen MR, 2001, P NATL ACAD SCI USA, V98, P14714, DOI 10.1073/pnas.251388798	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65294	10.1371/journal.pone.0065294	http://dx.doi.org/10.1371/journal.pone.0065294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724134	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000126
J	Shiou, SR; Yu, YY; Guo, YE; He, SM; Mziray-Andrew, CH; Hoenig, J; Sun, J; Petrof, EO; Claud, EC				Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; He, Shu-Mei; Mziray-Andrew, C. Haikaeli; Hoenig, Jeanette; Sun, Jun; Petrof, Elaine O.; Claud, Erika C.			Synergistic Protection of Combined Probiotic Conditioned Media against Neonatal Necrotizing Enterocolitis-Like Intestinal Injury	PLOS ONE			English	Article							NF-KAPPA-B; RAT MODEL; TIGHT JUNCTION; BIFIDOBACTERIUM-BIFIDUM; PROTEASOME INHIBITOR; FLUID ABSORPTION; LACTOBACILLUS-GG; TERMINAL ILEUM; DOUBLE-BLIND; TNF-ALPHA	Balance among the complex interactions of the gut microbial community is important for intestinal health. Probiotic bacteria can improve bacterial balance and have been used to treat gastrointestinal diseases. Neonatal necrotizing enterocolitis (NEC) is a life-threatening inflammatory bowel disorder primarily affecting premature infants. NEC is associated with extensive inflammatory NF-kappa B signaling activation as well as intestinal barrier disruption. Clinical studies have shown that probiotic administration may protect against NEC, however there are safety concerns associated with the ingestion of large bacterial loads in preterm infants. Bacteria-free conditioned media (CM) from certain probiotic organisms have been shown to retain bioactivity including anti-inflammatory and cytoprotective properties without the risks of live organisms. We hypothesized that the CM from Lactobacillus acidophilus (La), Bifidobacterium infantis (Bi), and Lactobacillus plantarum (Lp), used separately or together would protect against NEC. A rodent model with intestinal injury similar to NEC was used to study the effect of CM from Lp, La/Bi, and La/Bi/Lp on the pathophysiology of NEC. All the CM suppressed NF-kappa B activation via preserved I kappa B alpha expression and this protected I kappa B alpha was associated with decreased liver activity of the proteasome, which is the degrading machinery for I kappa B alpha. These CM effects also caused decreases in intestinal production of the pro-inflammatory cytokine TNF-alpha, a downstream target of the NF-kappa B pathway. Combined La/Bi and La/Bi/Lp CM in addition protected intestinal barrier function by maintaining tight junction protein ZO-1 levels and localization at the tight junction. Double combined La/Bi CM significantly reduced intestinal injury incidence from 43% to 28% and triple combined La/Bi/Lp CM further reduced intestinal injury incidence to 20%. Thus, this study demonstrates different protective mechanisms and synergistic bioactivity of the CM from different organisms in ameliorating NEC-like intestinal injury in an animal model.	[Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; Claud, Erika C.] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA; [He, Shu-Mei; Petrof, Elaine O.] Queens Univ, Dept Med, Infect Dis Sect, Kingston, ON, Canada; [He, Shu-Mei; Petrof, Elaine O.] Queens Univ, GIDRU, Kingston, ON, Canada; [Mziray-Andrew, C. Haikaeli] So Illinois Univ, Sch Med, Dept Pediat, Sect Pediat Gastroenterol & Nutr, Carbondale, IL 62901 USA; [Hoenig, Jeanette] Edward Hosp, Naperville, IL USA; [Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Claud, Erika C.] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA	University of Chicago; Queens University - Canada; Queens University - Canada; Southern Illinois University System; Southern Illinois University; Rush University; University of Chicago	Claud, EC (corresponding author), Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	Crohn's and Colitis Foundation of Canada; National Institutes of Health (NIH) [F32DK064840, R01HD059123]; Digestive Disease Research Core Center [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064840, P30DK042086] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of Canada; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Crohn's and Colitis Foundation of Canada (http://www.ccfc.ca/site/c.ajIRK4NLLhJ0E/b.6319851/k.BDBF/Home.htm) to E.O.P. and by National Institutes of Health (NIH) grants F32DK064840 to S. S., R01HD059123 to E. C. C. and Digestive Disease Research Core Center grant DK42086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Antony Suresh J., 2000, Journal of the National Medical Association, V92, P83; Apostolou E, 2001, FEMS IMMUNOL MED MIC, V31, P35, DOI 10.1111/j.1574-695X.2001.tb01583.x; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; CAPLAN MS, 1993, PEDIATR PATHOL, V13, P357, DOI 10.3109/15513819309048223; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Chung DH, 2001, ANN SURG, V233, P835, DOI 10.1097/00000658-200106000-00014; Clark JA, 2005, AM J PHYSIOL-GASTR L, V288, pG755, DOI 10.1152/ajpgi.00172.2004; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; D'Souza A, 2012, AM J TRANSL RES, V4, P187; D'Souza A, 2010, PEDIATR RES, V67, P526, DOI 10.1203/PDR.0b013e3181d4ff2b; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; Drago L, 2010, J CHEMOTHERAPY, V22, P373, DOI 10.1179/joc.2010.22.6.373; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; FOULKES EC, 1991, P SOC EXP BIOL MED, V197, P477; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2000, J GASTROEN HEPATOL, V15, P489, DOI 10.1046/j.1440-1746.2000.02162.x; HOLMAN RC, 1989, AM J PUBLIC HEALTH, V79, P987, DOI 10.2105/AJPH.79.8.987; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Katan MB, 2012, BENEF MICROBES, V3, P85, DOI 10.3920/BM2012.0008; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kleessen B, 1995, ACTA PAEDIATR, V84, P1347, DOI 10.1111/j.1651-2227.1995.tb13567.x; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Liu H, 2012, CELL PHYSIOL BIOCHEM, V29, P799, DOI 10.1159/000188076; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; MACKENDRICK W, 1993, PEDIATR CLIN N AM, V40, P1047; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Montalto M, 2004, DIGESTION, V69, P225, DOI 10.1159/000079152; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Naftalin RJ, 1999, J PHYSIOL-LONDON, V514, P211, DOI 10.1111/j.1469-7793.1999.211af.x; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Niedzielin K, 2001, EUR J GASTROEN HEPAT, V13, P1143, DOI 10.1097/00042737-200110000-00004; Noth R, 2012, J CROHNS COLITIS, V6, P464, DOI 10.1016/j.crohns.2011.10.004; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; Puleo F, 2010, METABOLISM, V59, P1680, DOI 10.1016/j.metabol.2010.03.021; Scanlon TC, 2009, EXP CELL RES, V315, P176, DOI 10.1016/j.yexcr.2008.10.027; Schlegel L, 1998, EUR J CLIN MICROBIOL, V17, P887, DOI 10.1007/s100960050216; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Thiagarajah JR, 2000, GUT, V47, P675, DOI 10.1136/gut.47.5.675; Thyoka M, 2012, EUR J PEDIATR SURG, V22, P8, DOI 10.1055/s-0032-1306263; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Underwood MA, 2012, PEDIATR RES, V71, P546, DOI 10.1038/pr.2012.11; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Zamora R, 2005, FREE RADICAL BIO MED, V39, P1428, DOI 10.1016/j.freeradbiomed.2005.07.004; Zamora R, 2005, AM J PHYSIOL-GASTR L, V289, pG643, DOI 10.1152/ajpgi.00067.2005; Zufferey C, 2009, IMMUNOLOGY, V128, P351, DOI 10.1111/j.1365-2567.2009.03110.x	77	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e65108	10.1371/journal.pone.0065108	http://dx.doi.org/10.1371/journal.pone.0065108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717690	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300004
J	Sea, VRF; Cruz, ACR; Gurgel, RQ; Nunes, BTD; Silva, EVP; Dolabella, SS; dos Santos, RL				Faria Sea, Vanessa Ramos; Ribeiro Cruz, Ana Cecilia; Gurgel, Ricardo Q.; Diniz Nunes, Bruno Tardelli; Pinto Silva, Eliana Vieira; Dolabella, Silvio S.; dos Santos, Roseli La Corte			Underreporting of Dengue-4 in Brazil Due to Low Sensitivity of the NS1 Ag Test in Routine Control Programs	PLOS ONE			English	Article							SPECIFICITY; DIAGNOSIS; ANTIGEN; VIRUSES; ASSAYS; STATE; ELISA	We have identified fifty-eight samples that were positive for Dengue-4 among 119 samples with negative diagnoses for dengue via the Platelia (TM) dengue NS1 Ag in Aracaju, State of Sergipe, Brazil. We determined that the low sensitivity of the NS1 Ag test could be related to secondary dengue infections in the studied population. Therefore, we concluded that the sensitivity and specificity of the Platelia (TM) dengue NS1 Ag test as a screening method for monitoring circulating dengue serotypes must be reevaluated. In addition, regional endo-epidemic profiles should also be considered due to the prevalence of secondary responses.	[Faria Sea, Vanessa Ramos; Gurgel, Ricardo Q.; Dolabella, Silvio S.; dos Santos, Roseli La Corte] Univ Fed Sergipe, Aracaju, Sergipe, Brazil; [Ribeiro Cruz, Ana Cecilia; Diniz Nunes, Bruno Tardelli; Pinto Silva, Eliana Vieira] Inst Evandro Chagas, Belem, Para, Brazil; [Ribeiro Cruz, Ana Cecilia] Univ Estado Para, Belem, Para, Brazil	Universidade Federal de Sergipe; Instituto Evandro Chagas; Universidade do Estado do Para (UEPA)	dos Santos, RL (corresponding author), Univ Fed Sergipe, Aracaju, Sergipe, Brazil.	rlacorte@ufs.br	Dolabella, Silvio/X-4351-2019; Gurgel, RQ/N-5105-2018; Ribeiro Cruz, Ana Cecilia/V-9276-2019; Santos, Roseli LC/F-1735-2015	Gurgel, RQ/0000-0001-9651-3713; Ribeiro Cruz, Ana Cecilia/0000-0002-4607-9346; Santana Dolabella, Silvio/0000-0001-5576-3214	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES Edital 32/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Edital 32/2010; www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Ministerio da Saude/Secretaria de Vigilancia em Saude MS/SVS, 2012, INC DENG, VGrandes Regioes e Unidades Federadas; Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004; Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53; Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002; Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681; World Health Organization, 2009, DENG GUID TREATM PRE	14	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64056	10.1371/journal.pone.0064056	http://dx.doi.org/10.1371/journal.pone.0064056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717529	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600041
J	Masia, M; Robledano, C; de la Tabla, VO; Antequera, P; Lopez, N; Gutierrez, F				Masia, Mar; Robledano, Catalina; Ortiz de la Tabla, Victoria; Antequera, Pedro; Lopez, Natividad; Gutierrez, Felix			Increased Carotid Intima-Media Thickness Associated with Antibody Responses to Varicella-Zoster Virus and Cytomegalovirus in HIV-Infected Patients	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CORONARY ATHEROSCLEROSIS; ARTERY-DISEASE; RISK-FACTOR; ACTIVATION; COHORT; WOMEN	Objective: We investigated the relationship of the Herpesviridiae with inflammation and subclinical atherosclerosis in HIV-infected patients. Methods: Prospective study including virologically suppressed HIV-infected patients. IgG antibodies against herpesviruses, carotid intima-media thickness (cIMT), endothelial function through flow-mediated dilatation (FMD) of the brachial artery, and blood atherosclerosis biomarkers (hsCRP, TNF-alpha, IL-6, MCP-1, MDA, sCD14, sCD163, VCAM-1, ICAM-1, D-dimer, and PAI-1) were measured. Results: 136 patients with HIV viral load <200 copies/ml were included. 93.4% patients were infected with herpes simplex virus type-1, 55.9% with herpes simplex virus type-2, 97.1% with varicella-zoster virus, 65.4% with human herpesvirus-6, 91.2% with cytomegalovirus, and 99.3% with Epstein-Barr virus. Previous AIDS diagnosis was associated with higher cytomegalovirus IgG titers (23,000 vs 17,000 AU, P = 0.011) and higher varicella-zoster virus IgG titers (3.19 vs 2.88 AU, P = 0.047), and there was a positive correlation of the Framingham risk score with IgG levels against cytomegalovirus (Spearman's Rho 0.216, P = 0.016) and Herpes simplex virus-2 (Spearman's Rho 0.293, P = 0.001). IgG antibodies against cytomegalovirus correlated in adjusted analysis with the cIMT (P = 0.030). High seropositivity for varicella-zoster virus (OR 2.91, 95% CI 1.05-8.01, P = 0.039), and for cytomegalovirus (OR 3.79, 95% CI 1.20-11.97, P = 0.023) were predictors for the highest quartile of the cIMT in adjusted analyses. PAI-1 levels were independently associated with cytomegalovirus IgG titers (P = 0.041), IL-6 and ICAM-1 levels with varicella-zoster virus IgG (P = 0.046 and P = 0.035 respectively), and hsCRP levels with Herpes simplex virus-2 IgG (P = 0.035). Conclusion: In virologically suppressed HIV-infected patients, antibody responses against herpesviruses are associated with subclinical atherosclerosis, and with increased inflammation and coagulation biomarkers.	[Masia, Mar; Robledano, Catalina; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain; [Ortiz de la Tabla, Victoria; Antequera, Pedro] Hosp Univ San Juan, Microbiol Serv, Alicante, Spain; [Lopez, Natividad] Hosp Gen Univ Elche, Biochem Sect, Alicante, Spain	Universidad Miguel Hernandez de Elche	Masia, M (corresponding author), Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain.	marmasiac@gmail.com	Masiá, Mar/U-7510-2017; Rodero, Félix Gutiérrez/Q-7880-2018; López, Natividad/ABH-1323-2020	Masiá, Mar/0000-0001-9878-2458; Rodero, Félix Gutiérrez/0000-0002-9485-6867; López, Natividad/0000-0003-0423-4616	Red Tematica de Investigacion Cooperativa en VIH/SIDA-Instituto de Salud Carlos III-RETIC [RD06/0027, RD12/0017/0023, FIBELX10/11, FIBELX10/12]; Instituto de Salud Carlos III-FIS [PI081893]	Red Tematica de Investigacion Cooperativa en VIH/SIDA-Instituto de Salud Carlos III-RETIC; Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported in part by Red Tematica de Investigacion Cooperativa en VIH/SIDA-Instituto de Salud Carlos III-RETIC RD06/0027, RD12/0017/0023, FIBELX10/11, FIBELX10/12, and Instituto de Salud Carlos III-FIS (PI081893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Gutierrez F, 2008, AIDS, V22, P1369, DOI 10.1097/QAD.0b013e3282f7cb88; Hechter RC, 2012, ATHEROSCLEROSIS, V223, P433, DOI 10.1016/j.atherosclerosis.2012.03.002; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Ibrahim AI, 2005, J CLIN VIROL, V32, P29, DOI 10.1016/j.jcv.2004.06.010; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Masia M, 2010, ANTIVIR THER, V15, P101, DOI 10.3851/IMP1491; Nicholson AC, 1998, ARTERIOSCL THROM VAS, V18, P339, DOI 10.1161/01.ATV.18.3.339; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392	14	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64327	10.1371/journal.pone.0064327	http://dx.doi.org/10.1371/journal.pone.0064327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717597	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600060
J	Biundo, R; Calabrese, M; Weis, L; Facchini, S; Ricchieri, G; Gallo, P; Antonini, A				Biundo, Roberta; Calabrese, Massimiliano; Weis, Luca; Facchini, Silvia; Ricchieri, Gianluigi; Gallo, Paolo; Antonini, Angelo			Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients	PLOS ONE			English	Article							ITALIAN POPULATION-SAMPLE; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; NORMATIVE VALUES; DIAGNOSTIC-CRITERIA; LEWY BODIES; STROOP TASK; IMPAIRMENT	Background: Cognitive deficits may occur early in Parkinson's disease (PD) but the extent of cortical involvement associated with cognitive dysfunction needs additional investigations. The aim of our study is to identify the anatomical pattern of cortical thickness alterations in patients with early stage PD and its relationship with cognitive disability. Methods: We recruited 29 PD patients and 21 healthy controls. All PD patients performed an extensive neuropsychological examination and 14 were diagnosed with mild cognitive impairment (PD-MCI). Surface-based cortical thickness analysis was applied to investigate the topographical distribution of cortical and subcortical alterations in early PD compared with controls and to assess the relationship between cognition and regional cortical changes in PD-MCI. Results: Overall PD patients showed focal cortical (occipital-parietal areas, orbito-frontal and olfactory areas) and subcortical thinning when compared with controls. PD-MCI showed a wide spectrum of cognitive deficits and related significant regional thickening in the right parietal-frontal as well as in the left temporal-occipital areas. Conclusion: Our results confirm the presence of changes in grey matter thickness at relatively early PD stage and support previous studies showing thinning and atrophy in the neocortex and subcortical regions. Relative cortical thickening in PD-MCI may instead express compensatory neuroplasticity. Brain reserve mechanisms might first modulate cognitive decline during the initial stages of PD.	[Biundo, Roberta; Weis, Luca; Facchini, Silvia; Antonini, Angelo] IRCCS, Fdn Osped San Camillo, Dept Parkinsons Dis, Venice, Italy; [Calabrese, Massimiliano; Ricchieri, Gianluigi] AO Univ, Neurol Clin, Padua, Italy; [Gallo, Paolo] Univ Padua, St Anthony Hosp, Neurol Clin, Dept Neurosci SNPSRR, Padua, Italy	IRCCS Ospedale San Camillo; University of Padua	Biundo, R (corresponding author), IRCCS, Fdn Osped San Camillo, Dept Parkinsons Dis, Venice, Italy.	roberta.biundo@ospedalesancamillo.net	Calabrese, Massimiliano/I-6195-2012; Calabrese, Massimiliano/AAB-7082-2022; Weis, Luca/J-2805-2018; Antonini, Angelo/H-9726-2019	Calabrese, Massimiliano/0000-0002-3362-7403; Weis, Luca/0000-0002-2286-0795; Antonini, Angelo/0000-0003-1040-2807; Biundo, Roberta/0000-0001-5846-755X				Aarsland D, 2011, MOVEMENT DISORD, V26, P334, DOI 10.1002/mds.23416; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Bassett SS, 2006, BRAIN, V129, P1229, DOI 10.1093/brain/awl089; Biundo R, 2013, J NEURAL TRANSM, V120, P627, DOI 10.1007/s00702-013-1004-2; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Caffarra P., 2002, NUOVA RIV NEUROL, V12, P111; Caffarra P, 2011, J CLIN EXP NEUROPSYC, V33, P982, DOI 10.1080/13803395.2011.589373; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geng DY, 2006, NEUROSURGERY, V58, P256, DOI 10.1227/01.NEU.0000194845.19462.7B; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibarretxe-Bilbao N, 2008, J NEUROL, V255, P1324, DOI 10.1007/s00415-008-0885-8; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kaufmann L, 2008, CORTEX, V44, P1248, DOI 10.1016/j.cortex.2007.11.009; Li G, 2012, NEUROIMAGE, V59, P3805, DOI 10.1016/j.neuroimage.2011.11.012; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; Martinez-Horta S, 2011, J NEURAL TRANSM, V118, P1185, DOI 10.1007/s00702-011-0675-9; Meyer JS, 2007, J NEUROL SCI, V257, P97, DOI 10.1016/j.jns.2007.01.016; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Monchi O, 2012, LANCET NEUROL, V11, P653, DOI 10.1016/S1474-4422(12)70162-X; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Nobili F, 2010, MOVEMENT DISORD, V25, P35, DOI 10.1002/mds.22899; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Pellicano C, 2012, EUR J NEUROL, V19, P172, DOI 10.1111/j.1468-1331.2011.03465.x; Pereira JB, 2009, MOVEMENT DISORD, V24, P1193, DOI 10.1002/mds.22560; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poletti M, 2011, PARKINSONISM RELAT D, V17, P579, DOI 10.1016/j.parkreldis.2011.03.013; Protzner AB, 2011, HUM BRAIN MAPP, V32, P1277, DOI 10.1002/hbm.21107; Sollinger AB, 2010, PARKINSONISM RELAT D, V16, P177, DOI 10.1016/j.parkreldis.2009.11.002; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; SPINNLER H, 1987, ITAL J NEUROL SCI S8, V6, P1; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troster AI, 2008, NEUROPSYCHOL REV, V18, P103, DOI 10.1007/s11065-008-9055-0; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008	62	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64222	10.1371/journal.pone.0064222	http://dx.doi.org/10.1371/journal.pone.0064222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717572	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700120
J	Iberkleid, I; Vieira, P; Engler, JD; Firester, K; Spiegel, Y; Horowitz, SB				Iberkleid, Ionit; Vieira, Paulo; Engler, Janice de Almeida; Firester, Kalia; Spiegel, Yitzhak; Horowitz, Sigal Brown			Fatty Acid-and Retinol-Binding Protein, Mj-FAR-1 Induces Tomato Host Susceptibility to Root-Knot Nematodes	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CYST-NEMATODE; EFFECTOR PROTEIN; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; PARASITISM PROTEINS; SIGNALING PATHWAYS; DEFENSE GENES; FAR PROTEINS; PLANT	Plant-parasitic nematodes produce at least one structurally unique class of small helix-rich retinol-and fatty-acid-binding proteins that have no counterparts in their plant hosts. Herein we describe a protein of the plant-parasitic root-knot nematode Meloidogyne javanica, which is a member of the nematode-specific fatty-acid- and retinol-binding (Mj-FAR-1) family of proteins. The mj-far-1 mRNA was detected through M. javanica pre-parasitic J2s, migratory and sedentary parasitic stages by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Immunolocalization assays demonstrate that the FAR protein of Meloidogyne is secreted during sedentary stages, as evidenced by the accumulation of FAR at the nematode cuticle surface and along the adjacent host root tissues. Tomato roots constitutively expressing mj-far-1 demonstrated an increased susceptibility to root-knot nematodes infection as observed by accelerated gall induction and expansion, accompanied by a higher percentage of nematodes developing into mature females compared to control roots. RNA interference assays that expressed double-stranded RNA complementary to mj-far-1 in transgenic tomato lines specifically reduced nematode infection levels. Histological analysis of nematode-infested roots indicated that in roots overexpressing mj-far-1, galls contained larger feeding cells and might support a faster nematode development and maturation. Roots overexpressing mj-far-1 suppressed jasmonic acid responsive genes such as the proteinase inhibitor (Pin2) and c-thionin, illustrating the possible role of Mj-FAR-1 in manipulating the lipid based signaling in planta. This data, suggests that Meloidogyne FAR might have a strategic function during the interaction of the nematode with its plant host. Our study present the first demonstration of an in planta functional characterization and localization of FAR proteins secreted by plant-parasitic nematodes. It provides evidence that Mj-FAR-1 facilitates infection most likely via the manipulation of host lipid-based defenses, as critical components for a successful parasitism by plant-parasitic nematodes.	[Iberkleid, Ionit; Firester, Kalia; Spiegel, Yitzhak; Horowitz, Sigal Brown] Agr Res Org, Volcani Ctr, Dept Entomol, Nematol Unit, IL-50250 Bet Dagan, Israel; [Iberkleid, Ionit; Firester, Kalia; Spiegel, Yitzhak; Horowitz, Sigal Brown] Agr Res Org, Volcani Ctr, Dept Entomol, Chem Unit, IL-50250 Bet Dagan, Israel; [Iberkleid, Ionit] Hebrew Univ Jerusalem, Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Vieira, Paulo; Engler, Janice de Almeida] CNRS, INRA, UNS, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Vieira, Paulo] Univ Evora, ICAAM, NemaLab, Evora, Portugal	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; University of Evora	Horowitz, SB (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, Nematol Unit, IL-50250 Bet Dagan, Israel.	sigalhor@volcani.agri.gov.il	Vieira, Paulo/I-7173-2019	Vieira, Paulo/0000-0001-5627-2628	Israeli Ministry of Agriculture and Rural Development [131-1644-10]; Agriculture Research Organization; Volcani Center, Israel	Israeli Ministry of Agriculture and Rural Development; Agriculture Research Organization; Volcani Center, Israel	This work was supported by The Israeli Ministry of Agriculture and Rural Development (Program No. 131-1644-10) and "Seeds money'' for young scientist from Agriculture Research Organization; Volcani Center, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN I, 1992, PLANT MOL BIOL, V19, P193, DOI 10.1007/BF00027341; Bannenberg G, 2009, PLANT PHYSIOL, V151, P1421, DOI 10.1104/pp.109.145094; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Baum Thomas J, 2007, Genet Eng (N Y), V28, P17, DOI 10.1007/978-0-387-34504-8_2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bird DM, 2004, CURR OPIN PLANT BIOL, V7, P372, DOI 10.1016/j.pbi.2004.05.005; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Bradley JE, 2001, TRENDS PARASITOL, V17, P471, DOI 10.1016/S1471-4922(01)02036-0; BYBD DW, 1983, J NEMATOL, V15, P142; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Conconi A, 1996, PLANT PHYSIOL, V111, P797, DOI 10.1104/pp.111.3.797; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis RF, 2009, J NEMATOL, V41, P140; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; Elling AA, 2007, INT J PARASITOL, V37, P1269, DOI 10.1016/j.ijpara.2007.03.012; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; FARMER EE, 1992, PLANT PHYSIOL, V98, P995, DOI 10.1104/pp.98.3.995; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fujimoto T, 2011, J PLANT PHYSIOL, V168, P1084, DOI 10.1016/j.jplph.2010.12.002; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Goetz M, 2001, P NATL ACAD SCI USA, V98, P6522, DOI 10.1073/pnas.091097998; Goverse A, 2000, PLANT MOL BIOL, V43, P747, DOI 10.1023/A:1006367126077; Grunewald W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000266; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; HUSSEY RS, 1989, J NEMATOL, V21, P686; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Hwang D, 1999, AM J CLIN NUTR, V70, P545; Jalloul A, 2002, PLANT J, V32, P1, DOI 10.1046/j.1365-313X.2002.01393.x; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Karczmarek A, 2004, MOL PLANT PATHOL, V5, P343, DOI 10.1111/j.1364-3703.2004.00230.x; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; Li SS, 2002, BIOCHEM J, V366, P405, DOI 10.1042/BJ20020221; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McPherson MJ, 2001, BIOCHEM SOC SYMP, V68, P125; MELAN MA, 1993, PLANT PHYSIOL, V101, P441, DOI 10.1104/pp.101.2.441; Melo FR, 2002, PROTEINS, V48, P311, DOI 10.1002/prot.10142; Mitchum MG, 2008, CURR OPIN PLANT BIOL, V11, P75, DOI 10.1016/j.pbi.2007.10.010; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NIEBEL A, 1993, PLANT CELL, V5, P1697, DOI 10.1105/tpc.5.12.1697; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Rehman S, 2009, MOL PLANT MICROBE IN, V22, P330, DOI 10.1094/MPMI-22-3-0330; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; ROST B, 1993, PROTEIN ENG, V6, P831, DOI 10.1093/protein/6.8.831; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; SHEN WJ, 1989, NUCLEIC ACIDS RES, V17, P8385, DOI 10.1093/nar/17.20.8385; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; SIJMONS PC, 1993, PLANT MOL BIOL, V23, P917, DOI 10.1007/BF00021809; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Spiegel Y, 1997, PARASITOLOGY, V115, P513, DOI 10.1017/S0031182097001637; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Tytgat T, 2004, MOL PLANT MICROBE IN, V17, P846, DOI 10.1094/MPMI.2004.17.8.846; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; van Vuuren RJ, 2001, EUPHYTICA, V120, P109, DOI 10.1023/A:1017524210671; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanholme B, 2004, GENE, V332, P13, DOI [10.1016/j.gene.2004.02.024, 10.1016/j.gnee.2004.02.024]; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Westerink N, 2004, MOL MICROBIOL, V54, P533, DOI 10.1111/j.1365-2958.2004.04288.x; Wubben MJE, 2001, MOL PLANT MICROBE IN, V14, P1206, DOI 10.1094/MPMI.2001.14.10.1206; WYSS U, 1986, Revue de Nematologie, V9, P153	97	77	83	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64586	10.1371/journal.pone.0064586	http://dx.doi.org/10.1371/journal.pone.0064586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717636	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700159
J	Noonan, SHC; Fabricius, KE; Humphrey, C				Noonan, Sam H. C.; Fabricius, Katharina E.; Humphrey, Craig			Symbiodinium Community Composition in Scleractinian Corals Is Not Affected by Life-Long Exposure to Elevated Carbon Dioxide	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HOST-SYMBIONT SPECIFICITY; OCEAN ACIDIFICATION; ALGAL SYMBIOSIS; ACROPORA CORALS; CLADE-D; DIVERSITY; PHOTOSYNTHESIS; CALCIFICATION; ENDOSYMBIONTS	Ocean acidification (OA) is expected to negatively affect coral reefs, however little is known about how OA will change the coral-algal symbiosis on which reefs ultimately depend. This study investigated whether there would be differences in coral Symbiodinium types in response to OA, potentially improving coral performance. We used denaturing gradient gel electrophoresis (DGGE) of the internal transcribed spacer 2 (ITS2) region of ribosomal DNA to investigate the dominant types of Symbiodinium associating with six species of scleractinian coral that were exposed to elevated partial pressures of carbon dioxide (pCO(2)) in situ from settlement and throughout their lives. The study was conducted at three naturally occurring volcanic CO2 seeps (pCO(2)similar to 500 to 900 ppm, pH(Total) 7.8-7.9) and adjacent control areas (pCO(2) similar to 390 ppm, pH(Total) similar to 8.0-8.05) in Papua New Guinea. The Symbiodinium associated with corals living in an extreme seep site (pCO(2)>1000 ppm) were also examined. Ten clade C types and three clade D types dominated the 443 coral samples. Symbiodinium types strongly contrasted between coral species, however, no differences were observed due to CO2 exposure. Within five species, 85-95% of samples exhibited the same Symbiodinium type across all sites, with remaining rare types having no patterns attributable to CO2 exposure. The sixth species of coral displayed site specific differences in Symbiodinium types, unrelated to CO2 exposure. Symbiodinium types from the coral inhabiting the extreme CO2 seep site were found commonly throughout the moderate seeps and control areas. Our finding that symbiotic associations did not change in response to CO2 exposure suggest that, within the six coral hosts, none of the investigated 13 clade C and D Symbiodinium types had a selective advantage at high pCO(2). Acclimatisation through changing symbiotic association therefore does not seem to be an option for Indo-Pacific corals to deal with future OA.	[Noonan, Sam H. C.; Fabricius, Katharina E.; Humphrey, Craig] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Noonan, SHC (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	s.noonan@aims.gov.au	Fabricius, Katharina E/F-1759-2010	Fabricius, Katharina E/0000-0001-7671-4358; Humphrey, Craig/0000-0002-1303-036X; Noonan, Sam/0000-0002-0392-6197	Australian Institute of Marine Science	Australian Institute of Marine Science	The Australian Institute of Marine Science not only funded the project but is the employer of all three authors (as reflected in the authors affiliations). Therefore the Australian Institute of Marine Science was involved in all stages of the project.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Abrego D, 2009, MOL ECOL, V18, P3518, DOI 10.1111/j.1365-294X.2009.04275.x; Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2011, MAR ECOL PROG SER, V439, P117, DOI 10.3354/meps09315; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Buxton L, 2009, J PHYCOL, V45, P357, DOI 10.1111/j.1529-8817.2009.00659.x; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025536; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; DONE TJ, 1992, MAR BIOL, V114, P479, DOI 10.1007/BF00350040; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Pochon X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029816; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; R Development Core Team, 2012, LANG ENV STAT COMP; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; Thornhill DJ, 2010, CORAL REEFS, V29, P83, DOI 10.1007/s00338-009-0550-4; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Towanda T, 2012, BIOL OPEN, V1, P615, DOI 10.1242/bio.2012521; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; van Oppen Madeleine J.H., 2011, Diversity, V3, P405, DOI 10.3390/d3030405; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; WHITNEY SM, 1995, P ROY SOC B-BIOL SCI, V259, P271, DOI 10.1098/rspb.1995.0040	74	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63985	10.1371/journal.pone.0063985	http://dx.doi.org/10.1371/journal.pone.0063985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717522	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700089
J	Wang, SY; Chopp, M; Nazem-Zadeh, MR; Ding, GL; Nejad-Davarani, SP; Qu, CS; Lu, M; Li, L; Davoodi-Bojd, E; Hu, JN; Li, QJ; Mahmood, A; Jiang, Q				Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Qu, Changsheng; Lu, Mei; Li, Lian; Davoodi-Bojd, Esmaeil; Hu, Jiani; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Comparison of Neurite Density Measured by MRI and Histology after TBI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; NONRIGID REGISTRATION; WATER DIFFUSION; AXON DIAMETER; TRANSPLANTATION; STROKE; MODEL; RATS; QUANTIFICATION	Background: Functional recovery after brain injury in animals is improved by marrow stromal cells (MSC) which stimulate neurite reorganization. However, MRI measurement of neurite density changes after injury has not been performed. In this study, we investigate the feasibility of MRI measurement of neurite density in an animal model of traumatic brain injury (TBI) with and without MSC treatment. Methods: Fifteen male Wistar rats, were treated with saline (n = 6) or MSCs (n = 9) and were sacrificed at 6 weeks after controlled cortical impact (CCI). Healthy non-CCI rats (n = 5), were also employed. Ex-vivo MRI scans were performed two days after the rats were sacrificed. Multiple-shell hybrid diffusion imaging encoding scheme and spherical harmonic expansion of a two-compartment water diffusion displacement model were used to extract neurite related parameters. Bielshowski and Luxol Fast blue was used for staining axons and myelin, respectively. Modified Morris water maze and neurological severity score (mNSS) test were performed for functional evaluation. The treatment effects, the correlations between neurite densities measured by MRI and histology, and the correlations between MRI and functional variables were calculated by repeated measures analysis of variance, the regression correlation analysis tests, and spearman correlation coefficients. Results: Neurite densities exhibited a significant correlation (R-2>0.80, p<1E-20) between MRI and immuno-histochemistry measurements with 95% lower bound of the intra-correlation coefficient (ICC) as 0.86. The conventional fractional anisotropy (FA) correlated moderately with histological neurite density (R-2 = 0.59, P<1E-5) with 95% lower bound of ICC as 0.76. MRI data revealed increased neurite reorganization with MSC treatment compared with saline treatment, confirmed by histological data from the same animals. mNSS were significantly correlated with MRI neurite density in the hippocampus region. Conclusions: The present studies demonstrated that neurite density can be estimated by MRI after TBI and MRI measurement of neurite density is a sensitive marker to MSC treatment response.	[Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Li, Lian; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shiyang; Chopp, Michael; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Nazem-Zadeh, Mohammad-Reza] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Hu, Jiani] Wayne State Univ, Harper Hosp, MR Ctr, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University; University of Michigan System; University of Michigan; Wayne State University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Li, Lian/0000-0003-0097-1184; Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and Stroke [P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506, HL64766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048349, R01NS064134, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research presented herein was supported by National Institute of Neurological Disorders and Stroke, grants P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506 and HL64766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Denton ERE, 1999, J COMPUT ASSIST TOMO, V23, P800, DOI 10.1097/00004728-199909000-00031; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kybic J, 2008, METH APPL MAGEJ US D; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pfeifer JD, 2008, WASHINGTON MANUAL SU; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ueno Y, 2009, NEUROSCIENCE, V162, P317, DOI 10.1016/j.neuroscience.2009.04.065; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63511	10.1371/journal.pone.0063511	http://dx.doi.org/10.1371/journal.pone.0063511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717439	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700029
J	Wang, Y; Sheng, SJ; Zhang, JZ; Dzinic, S; Li, SL; Fang, F; Wu, N; Zheng, QF; Yang, Y				Wang, Yang; Sheng, Shijie; Zhang, Jianzhi; Dzinic, Sijana; Li, Shaolei; Fang, Fang; Wu, Nan; Zheng, Qingfeng; Yang, Yue			Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE MASPIN; INVASIVE BREAST-CANCER; PLASMINOGEN-ACTIVATOR; GENETIC POLYMORPHISMS; CLINICAL-IMPLICATIONS; NUCLEAR-LOCALIZATION; VEGF-A; INHIBITION; METASTASIS; GROWTH	Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I-III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p<0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression.	[Wang, Yang; Zhang, Jianzhi; Li, Shaolei; Fang, Fang; Wu, Nan; Zheng, Qingfeng; Yang, Yue] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China; [Sheng, Shijie; Dzinic, Sijana] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst,Tumor & Microenvir, Detroit, MI 48201 USA	Peking University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sheng, SJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst,Tumor & Microenvir, Detroit, MI 48201 USA.	ssheng@med.wayne.edu; zlyangyue@bjmu.edu.cn			NIH [CA15431, CA084176]; Ruth Sager Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA084176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Sager Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants (CA15431 and CA084176) and the Ruth Sager Memorial Fund (to S. Sheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2005, CANCER BIOL THER, V4, P400; Ashida A, 2006, INT J ONCOL, V28, P1345; Bernardo M Margarida, 2011, Genes Cancer, V2, P1009, DOI 10.1177/1947601912440170; Bieche I, 2003, BRIT J CANCER, V88, P863, DOI 10.1038/sj.bjc.6600812; Biliran H, 2001, CANCER RES, V61, P8676; Bodenstine TM, 2012, CANCER METAST REV, V31, P529, DOI 10.1007/s10555-012-9361-0; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Denk AE, 2007, PIGM CELL RES, V20, P112, DOI 10.1111/j.1600-0749.2007.00363.x; Fitzgerald M, 2003, NEOPLASIA, V5, P427, DOI 10.1016/S1476-5586(03)80045-3; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Frey A, 2009, HISTOPATHOLOGY, V54, P590, DOI 10.1111/j.1365-2559.2009.03260.x; Goulet B, 2012, BIOCHEM CELL BIOL, V90, P109; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Joensuu KM, 2009, HUM PATHOL, V40, P1143, DOI 10.1016/j.humpath.2009.02.006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Koshy M, 2004, ONCOLOGIST, V9, P147, DOI 10.1634/theoncologist.9-2-147; Lezzi G, 2007, J CRANIOFAC SURG, V18, P1039, DOI 10.1097/scs.0b013e31814b2a36; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; MacDougall R, 2012, VOGELSTEIN CONSIDERS; McGowen R, 2000, CANCER RES, V60, P4771; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Nakagawara A, 2011, J BIOMED BIOTECHNOL; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pierson CR, 2002, PROSTATE, V53, P255, DOI 10.1002/pros.10107; Qin L, 2010, J BIOL CHEM, V285, P32360, DOI 10.1074/jbc.M110.131045; Sharma G, 2011, TUMOR BIOL, V32, P23, DOI 10.1007/s13277-010-0087-8; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Sopel M, 2010, FOLIA MORPHOL, V69, P1; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Umekita Y, 2002, INT J CANCER, V100, P452, DOI 10.1002/ijc.10500; Wedel S, 2011, PROSTATE, V71, P722, DOI 10.1002/pros.21288; Woenckhaus M, 2007, J CLIN PATHOL, V60, P483, DOI 10.1136/jcp.2005.033407; Xia WY, 2000, ONCOGENE, V19, P2398, DOI 10.1038/sj.onc.1203535; Xing DY, 2003, ONCOL REP, V10, P1615; Yie SM, 2007, AM J CLIN PATHOL, V128, P1002, DOI 10.1309/JNCW1QLDFB6AM9WE; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x; Younes M, 2002, SCAND J GASTROENTERO, V37, P1359, DOI 10.1080/003655202762671215; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	48	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63581	10.1371/journal.pone.0063581	http://dx.doi.org/10.1371/journal.pone.0063581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717449	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700036
J	Kale, S; Raja, R; Thorat, D; Soundararajan, G; Patil, TV; Kundu, GC				Kale, S.; Raja, R.; Thorat, D.; Soundararajan, G.; Patil, T. V.; Kundu, G. C.			Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha 9 beta 1 integrin	ONCOGENE			English	Article						osteopontin; tumor-associated macrophages; COX-2 and melanoma growth	BREAST-CANCER; ALPHA(V)BETA(3) INTEGRIN; CRUCIAL ROLE; INFILTRATION; METASTASIS; KINASE; PROGRESSION; INHIBITION; PROTEIN; M2	Tumor-associated macrophages (TAMs) have multifaceted roles in tumor development, particularly linked with tumor angiogenesis and invasion, but the molecular mechanism underlying this association remains unclear. In this study, we report that lack of osteopontin (OPN) suppresses melanoma growth in opn -/- mice and macrophages are the crucial component responsible for OPN-regulated melanoma growth. In tumor microenvironment, OPN activates macrophages and influences angiogenesis by enhancing cyclooxygenase-2 (COX-2)-dependent prostaglandin E-2 (PGE(2)) production in an autocrine manner. Furthermore, we identify alpha 9b1 integrin as a functional receptor for OPN that mediates its effect and activates ERK and p38 signaling, which ultimately leads to COX-2 expression in macrophages. The major role played by OPN and PGE(2) in angiogenesis are further amplified by upregulation of MMP-9. OPN-activated macrophages promote the migration of endothelial and cancer cells via PGE(2). These findings provide evidence that TAMs serve as source of key components such as OPN and COX-2-derived PGE(2) and MMP-9 in melanoma microenvironment. Clinical specimens analyses revealed that increased infiltration of OPN-positive TAMs correlate with melanoma growth and angiogenesis. These data provide compelling evidence that OPN and COX-2 expressing macrophages are obligatory factors in melanoma growth. We conclude that OPN signaling is involved in macrophage recruitment into tumor, and our results emphasize the potential role of macrophage in modulation of tumor microenvironment via secretion of OPN, PGE(2) and MMP-9, which trigger angiogenesis and melanoma growth. Thus, blockade of OPN and its regulated signaling network provides unique strategy to eradicate melanoma by manipulating TAMs.	[Kale, S.; Raja, R.; Thorat, D.; Soundararajan, G.; Kundu, G. C.] Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, Pune 411007, Maharashtra, India; [Patil, T. V.] YCM Hosp, Dept Pathol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Kundu, GC (corresponding author), Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, NCCS Complex, Pune 411007, Maharashtra, India.	kundu@nccs.res.in	Kundu, Gopal C./ABA-9897-2020; Raja, Remya/GXM-8598-2022	Raja, Remya/0000-0002-7576-6778	Department of Biotechnology (DBT), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; Indian Council of Medical Research (ICMR), Government of India; Department of Science and Technology (DST), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	We thank Dr B Ramanamurthy, In-charge, Experimental Animal Facility, National Center for Cell Science, Pune, India for breeding and maintaining the Opn<SUP>-/-</SUP> mice. We also thank Dr S Ghaskabdi and Dr K Pai, Department of Zoology, University of Pune, India for providing the facility for CAM assay. Skillful assistance was provided by Dr S Vishwakarma, Department of Pathology, YCM Hospital, Pune, India for preparation of Cryosections. The project was supported by Department of Biotechnology (DBT) (GCK), Council of Scientific and Industrial Research (CSIR) (SK and GS), Indian Council of Medical Research (ICMR) (RR) and Department of Science and Technology (DST) (DT), Government of India.	Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; BAXEVANIS CN, 1993, CANCER-AM CANCER SOC, V72, P491, DOI 10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO;2-1; Behera R, 2010, CARCINOGENESIS, V31, P192, DOI 10.1093/carcin/bgp289; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bianchini F, 2007, PROSTAG OTH LIPID M, V83, P320, DOI 10.1016/j.prostaglandins.2007.03.003; BROWN LF, 1994, AM J PATHOL, V145, P610; Chakraborty G, 2008, MOL MED REP, V1, P641, DOI 10.3892/mmr_00000005; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Cheng JS, 2007, CANCER RES, V67, P5141, DOI 10.1158/0008-5472.CAN-06-4763; Crawford HC, 1998, CANCER RES, V58, P5206; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; FENG B, 1995, CLIN EXP METASTAS, V13, P453, DOI 10.1007/BF00118184; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Fujimoto J, 2000, CANCER RES, V60, P2632; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; GORELIK E, 1982, INT J CANCER, V29, P575, DOI 10.1002/ijc.2910290514; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hsu HP, 2010, CANCER BIOL THER, V10, P144, DOI 10.4161/cbt.10.2.12160; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leek RD, 1996, CANCER RES, V56, P4625; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Liguori Manuela, 2011, Cancers (Basel), V3, P3740, DOI 10.3390/cancers3043740; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; NAYLOR MS, 1994, INT J CANCER, V58, P50, DOI 10.1002/ijc.2910580110; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nesbit M, 2001, J IMMUNOL, V166, P6483, DOI 10.4049/jimmunol.166.11.6483; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Salvesen HB, 1999, INT J CANCER, V84, P539; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Shin Hun Sub, 2004, Korean Journal of Internal Medicine, V19, P48; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	52	79	81	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2295	2306		10.1038/onc.2013.184	http://dx.doi.org/10.1038/onc.2013.184			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23728342				2022-12-25	WOS:000335451800003
J	Gonzalez-Montalban, N; Lee, YJ; Makarava, N; Savtchenko, R; Baskakov, IV				Gonzalez-Montalban, Nuria; Lee, Young Jin; Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.			Changes in prion replication environment cause prion strain mutation	FASEB JOURNAL			English	Article						protein misfolding cyclic amplification; neurodegenerative diseases; protein misfolding; amyloid; conformational stability; proteinase K digestion	SCRAPIE AGENT; MOUSE SCRAPIE; PROTEIN; TRANSMISSION; SELECTION; CONFORMATION; COFACTOR; HAMSTERS	Interspecies prion transmission often leads to stable changes in physical and biological features of prion strains, a phenomenon referred to as a strain mutation. It remains unknown whether changes in the replication environment in the absence of changes in PrP primary structure can be a source of strain mutations. To approach this question, RNA content was altered in the course of amplification of hamster strains in serial protein misfolding cyclic amplification (sPMCAb). On adaptation to an RNA-depleted environment and then readaptation to an environment containing RNA, strain 263K gave rise to a novel PrPSc conformation referred to as 263K(R+), which is characterized by very low conformational stability, high sensitivity to proteolytic digestion, and a replication rate of 10(6)-fold/PMCAb round, which exceeded that of 263K by almost 10(4)-fold. A series of PMCAb experiments revealed that 263K(R+) was lacking in brain-derived 263K material, but emerged de novo as a result of changes in RNA content. A similar transformation was also observed for strain Hyper, suggesting that this phenomenon was not limited to 263K. The current work demonstrates that dramatic PrPSc transformations can be induced by changes in the prion replication environment and without changes in PrP primary structure.Gonzalez-Montalban, N., Jin Lee, Y., Makarava, N., Savtchenko, R., Baskakov, I. V. Changes in prion replication environment cause prion strain mutation.	[Gonzalez-Montalban, Nuria; Lee, Young Jin; Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Gonzalez-Montalban, Nuria; Lee, Young Jin; Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, 725 W Lombard St, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Lee, Young Jin/K-9635-2019; Lee, Young Jin/AAF-6189-2019	Lee, Young Jin/0000-0002-2325-5271; 	U.S. National Institutes of Health [NS045585, NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585, R56NS074998, R01NS074998] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Robert Rohwer for assistance in conducting bioassays and Pamela Wright for editing the manuscript. This work was supported by U.S. National Institutes of Health grants NS045585 and NS074998 to I.V.B.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Ghaemmaghami S, 2013, AM J PATHOL, V182, P866, DOI 10.1016/j.ajpath.2012.11.038; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Giles K, 2010, ANN NEUROL, V68, P151, DOI 10.1002/ana.22104; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2011, PLOS PATHOG, V7; Makarava N, 2013, J BIOL CHEM, V288, P33, DOI 10.1074/jbc.M112.419531; Makarava N, 2012, J BIOL CHEM, V287, P30205, DOI 10.1074/jbc.M112.392985; Makarava N, 2012, PRION, V6, P252, DOI 10.4161/pri.19930; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Piro JR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002001; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	43	32	33	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3702	3710		10.1096/fj.13-230466	http://dx.doi.org/10.1096/fj.13-230466			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23729586	Green Published			2022-12-25	WOS:000328840500028
J	Hong, SB; Lee, M; Kim, DH; Varga, J; Frisvad, JC; Perrone, G; Gomi, K; Yamada, O; Machida, M; Houbraken, J; Samson, RA				Hong, Seung-Beom; Lee, Mina; Kim, Dae-Ho; Varga, Janos; Frisvad, Jens C.; Perrone, Giancarlo; Gomi, Katsuya; Yamada, Osamu; Machida, Masayuki; Houbraken, Jos; Samson, Robert A.			Aspergillus luchuensis, an Industrially Important Black Aspergillus in East Asia	PLOS ONE			English	Article							NIGER VAR. PHOENICIS; WELWITSCHIA-MIRABILIS; POPULATIONS; INFECTION	Aspergilli known as black- and white-koji molds which are used for awamori, shochu, makgeolli and other food and beverage fermentations, are reported in the literature as A. luchuensis, A. awamori, A. kawachii, or A. acidus. In order to elucidate the taxonomic position of these species, available ex-type cultures were compared based on morphology and molecular characters. A. luchuensis, A. kawachii and A. acidus showed the same banding patterns in RAPD, and the three species had the same rDNA-ITS, beta-tubulin and calmodulin sequences and these differed from those of the closely related A. niger and A. tubingensis. Morphologically, the three species are not significantly different from each other or from A. niger and A. tubingensis. It is concluded that A. luchuensis, A. kawachii and A. acidus are the same species, and A. luchuensis is selected as the correct name based on priority. Strains of A. awamori which are stored in National Research Institute of Brewing in Japan, represent A. niger (n = 14) and A. luchuensis (n = 6). The neotype of A. awamori (CBS 557.65 = NRRL 4948) does not originate from awamori fermentation and it is shown to be identical with the unknown taxon Aspergillus welwitschiae. Extrolite analysis of strains of A. luchuensis showed that they do not produce mycotoxins and therefore can be considered safe for food and beverage fermentations. A. luchuensis is also frequently isolated from meju and nuruk in Korea and Puerh tea in China and the species is probably common in the fermentation environment of East Asia. A re-description of A. luchuensis is provided because the incomplete data in the original literature.	[Hong, Seung-Beom; Lee, Mina; Kim, Dae-Ho] RDA, Natl Acad Agr Sci, Agr Microbiol Div, Suwon, South Korea; [Varga, Janos] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Perrone, Giancarlo] CNR, Inst Sci Food Prod, I-70126 Bari, Italy; [Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, Sendai, Miyagi 980, Japan; [Yamada, Osamu] Dept Natl Res Inst Brewing, Higashihiroshima, Japan; [Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Ibaraki, Japan; [Machida, Masayuki] Kanazawa Inst Technol, Genome Biotechnol Lab, Haku San, Ishikawa, Japan; [Houbraken, Jos; Samson, Robert A.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Rural Development Administration (RDA); Szeged University; Technical University of Denmark; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); Kanazawa Institute of Technology; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Samson, RA (corresponding author), CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.	r.samson@cbs.knaw.nl	Frisvad, Jens C/K-2818-2017; Perrone, Giancarlo/O-7475-2014; Samson, Robert/ABE-6704-2020; Houbraken, Jos/AAE-7955-2019	Frisvad, Jens C/0000-0002-0573-4340; Perrone, Giancarlo/0000-0002-3841-6066; Houbraken, Jos/0000-0003-4893-4438; Gomi, Katsuya/0000-0003-3463-8072; Samson, Robert A./0000-0002-2979-3097	National Academy of Agricultural Science (NAAS), Rural Development Administration, Republic of Korea [PJ00866601]	National Academy of Agricultural Science (NAAS), Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was partly supported by the National Academy of Agricultural Science (NAAS), Rural Development Administration, Republic of Korea (Project no. PJ00866601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMUSALLAM A, 1980, THESIS UTRECHT; Cooper-Driver GA, 2000, J ARID ENVIRON, V46, P181, DOI 10.1006/jare.2000.0660; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; FUJIMOTO Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1222, DOI 10.1271/bbb.57.1222; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2011, STUD MYCOL, P53, DOI 10.3114/sim.2011.70.02; Inui T, 1901, J TOKYO CHEM SOC, V22, P669; Inui T, 1901, J COLL SCI IMP U TOK, V15, P465; Kitahara K., 1949, J FERMENT TECHNOL, V27, P162; Kitahara K., 1949, J FERMENT TECHNOL, V27, P182; Kozakiewicz Z, 1989, MYCOLOGICAL PAPERS, V161, P1; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Mogensen JM, 2009, INT J FOOD MICROBIOL, V132, P141, DOI 10.1016/j.ijfoodmicro.2009.04.011; Murakami H., 1976, Journal of the Society of Brewing, Japan [Nihon Jozo Kyokai Zasshi], V71, P956; Murakami H., 1979, Journal of the Society of Brewing, Japan [Nihon Jozo Kyokai Zasshi], V74, P849; Nakazawa R, 1936, J AGR CHEM SOC JPN, V12, P931; Nakazawa R, 1911, 2 GOV RES I, P93; Nakazawa R, 1915, 4 GOV RES I, P215; Nehira T, 1945, J FERMENT TECHNOL, V23, P18; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Pekarek E, 2006, J HERED, V97, P270, DOI 10.1093/jhered/esj031; Perrone G, 2011, FUNGAL BIOL-UK, V115, P1138, DOI 10.1016/j.funbio.2011.07.008; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Raper K.B., 1965, GENUS ASPERGILLUS, P293; Sakaguchi K, 1950, J AGR CHEM SOC JPN, V24, P138; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Samson RA, 2004, STUD MYCOL, P45; Szigeti G, 2012, MYCOPATHOLOGIA, V174, P143, DOI 10.1007/s11046-012-9529-8; Szigeti G, 2012, MYCOSES, V55, P333, DOI 10.1111/j.1439-0507.2011.02103.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Brewing Society of Japan, 2011, KOJ MOLDS AR NAT FUN; Thom C., 1945, MANUAL ASPERGILLI; Varga J, 2012, ACTA ALIMENT HUNG, V41, P414, DOI 10.1556/AAlim.41.2012.4.3; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Wehmer C., 1907, CENTR BAKTERIOL PARA, V18, P385; Whitaker C, 2008, S AFR J BOT, V74, P41, DOI 10.1016/j.sajb.2007.08.008; Yamada O, 2011, J BIOSCI BIOENG, V112, P233, DOI 10.1016/j.jbiosc.2011.05.005; Yu TS, 2004, J MICROBIOL BIOTECHN, V14, P182	39	107	110	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63769	10.1371/journal.pone.0063769	http://dx.doi.org/10.1371/journal.pone.0063769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723998	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000022
J	Sun, D; Bu, L; Liu, CX; Yin, ZC; Zhou, XD; Li, XJ; Xiao, AG				Sun, Dong; Bu, Lin; Liu, Caixia; Yin, Zhongcheng; Zhou, Xudong; Li, Xiaoju; Xiao, Aiguo			Therapeutic Effects of Human Amniotic Fluid-Derived Stem Cells on Renal Interstitial Fibrosis in a Murine Model of Unilateral Ureteral Obstruction	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHRONIC KIDNEY-DISEASE; ACUTE TUBULAR INJURY; PERITUBULAR CAPILLARY LOSS; TUBULOINTERSTITIAL FIBROSIS; EPITHELIAL-CELLS; IMPAIRED ANGIOGENESIS; POSTISCHEMIC KIDNEY; MOUSE MODEL; IN-VIVO	Interstitial fibrosis is regarded as the main pathway for the progression of chronic kidney disease (CKD) and is often associated with severe renal dysfunction. Stem cell-based therapies may provide alternative approaches for the treatment of CKD. Human amniotic fluid-derived stem cells (hAFSCs) are a novel stem cell population, which exhibit both embryonic and mesenchymal stem cell characteristics. Herein, the present study investigated whether the transplantation of hAFSCs into renal tissues could improve renal interstitial fibrosis in a murine model of unilateral ureteral obstruction (UUO). We showed that hAFSCs provided a protective effect and alleviated interstitial fibrosis as reflected by an increase in microvascular density; additionally, hAFSCs treatment beneficially modulated protein levels of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1 alpha (HIF-1 alpha) and transforming growth factor-beta 1 (TGF-beta 1). Therefore, we hypothesize that hAFSCs could represent an alternative, readily available source of stem cells that can be applied for the treatment of renal interstitial fibrosis.	[Sun, Dong; Bu, Lin; Liu, Caixia; Yin, Zhongcheng] Xuzhou Med Coll, Affiliated Hosp, Dept Nephrol, Xuzhou, Peoples R China; [Sun, Dong; Zhou, Xudong; Li, Xiaoju; Xiao, Aiguo] Kuitun Hosp Ili Kazakh Autonomous Prefecture, Dept Nephrol, Kuitun, Peoples R China; [Sun, Dong] Xuzhou Med Coll, Dept Internal Med & Diagnost, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Sun, D (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Dept Nephrol, Xuzhou, Peoples R China.	sundong126@yahoo.com			Science Foundation of Affiliated Hospital of Xuzhou Medical College, Qinglan Lan Project [53051106]; Special Talents Fund of Dean of Xuzhou Medical College [2010KJZ23]; Project of Technology Development Foundation of Xuzhou City [XF10C76]; Project of 7th "Liu Da Ren Cai Gao Feng" of Jiangsu Province, China [2010-WS043]; Project of Technology Development Foundation of Kuitun City [201134]; National Natural Science Foundation of China [81270769]	Science Foundation of Affiliated Hospital of Xuzhou Medical College, Qinglan Lan Project; Special Talents Fund of Dean of Xuzhou Medical College; Project of Technology Development Foundation of Xuzhou City; Project of 7th "Liu Da Ren Cai Gao Feng" of Jiangsu Province, China; Project of Technology Development Foundation of Kuitun City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of the Science Foundation of Affiliated Hospital of Xuzhou Medical College, Qinglan Lan Project (53051106), Special Talents Fund of Dean of Xuzhou Medical College (2010KJZ23), the Project of Technology Development Foundation of Xuzhou City (XF10C76), the Project of 7th "Liu Da Ren Cai Gao Feng" of Jiangsu Province, China (2010-WS043) and the Project of Technology Development Foundation of Kuitun City (201134), and also supported by the Project of National Natural Science Foundation of China (81270769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Brodie JC, 2005, PHARMACOL REV, V57, P299, DOI 10.1124/pr.57.3.3; Broekema M, 2005, KIDNEY INT, V68, P2572, DOI 10.1111/j.1523-1755.2005.00728.x; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Chiurchiu C, 2005, J AM SOC NEPHROL, V16, pS58, DOI 10.1681/ASN.2004110968; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Djudjaj S, 2012, J PATHOL, V228, P286, DOI 10.1002/path.4076; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Fang TC, 2008, CELL PROLIFERAT, V41, P575, DOI 10.1111/j.1365-2184.2008.00545.x; Flaquer M, 2010, NEFROLOGIA, V30, P385, DOI 10.3265/Nefrologia.pre2010.Jun.10463; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hopkins C, 2009, J PATHOL, V217, P265, DOI 10.1002/path.2477; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Ma YY, 2010, LIFE SCI, V86, P798, DOI 10.1016/j.lfs.2010.03.013; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Moriyama T, 1998, KIDNEY INT, V54, P110, DOI 10.1046/j.1523-1755.1998.00964.x; Nigam SK, 2000, AM J PHYSIOL-RENAL, V279, pF3, DOI 10.1152/ajprenal.2000.279.1.F3; Orphanides C, 1997, KIDNEY INT, V52, P637, DOI 10.1038/ki.1997.377; Peister A, 2009, TISSUE ENG PT A, V15, P3129, DOI 10.1089/ten.TEA.2008.0536; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Phermthai T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-79; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stravodimos KG, 2009, UROL INT, V82, P38, DOI 10.1159/000176023; Sun D, 2006, AM J NEPHROL, V26, P363, DOI 10.1159/000094778; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Wang MG, 2010, INT J MOL MED, V26, P795, DOI 10.3892/ijmm_00000527; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Zhang B, 2005, NEPHROLOGY, V10, P351, DOI 10.1111/j.1440-1797.2005.00412.x; ZHANG GH, 1993, J BIOL CHEM, V268, P11542; 1989, IMMUNODEFICIENT RODE	50	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65042	10.1371/journal.pone.0065042	http://dx.doi.org/10.1371/journal.pone.0065042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724119	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000116
J	Teshiba, R; Tajiri, T; Sumitomo, K; Masumoto, K; Taguchi, T; Yamamoto, K				Teshiba, Risa; Tajiri, Tatsuro; Sumitomo, Kenzo; Masumoto, Kouji; Taguchi, Tomoaki; Yamamoto, Ken			Identification of a KEAP1 Germline Mutation in a Family with Multinodular Goitre	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; THYROID CARCINOMAS; EUTHYROID GOITER; LINKAGE ANALYSES; CELL TUMORS; NRF2; CANCER; PREDISPOSITION; PERSPECTIVES; POPULATION	Background: The familial clustering of multinodular goitres (MNGs) with a dominant mode of inheritance has been repeatedly reported. Linkage studies have revealed several genetic loci responsible for familial MNG; however, most of the causative variants remain unknown. Methods and Results: Through linkage analysis using single-nucleotide polymorphism markers, we identified a new MNG locus on 19p13.2-q12 in a five-generation Japanese MNG family. Subsequent mutation searches focusing on the candidate 25-Mb region of chromosome 19 identified a heterozygous mutation, c. 879_880delinsA, p. Asp294Thr, fs*23, in exon 3 of the KEAP1, which plays a central role in the cytoprotection pathway against oxidative stress. Reverse transcriptase-PCR analysis showed low expression of wild type KEAP1 accompanied by no transcription product of mutant allele in the normal and goitre region of thyroid tissues obtained from the proband. In agreement with previous studies showing that KEAP1 negatively regulates NFE2L2, the NFE2L2 target genes GSTA4 and GCLC were up-regulated in the thyroid tissues of the patient. Conclusions: This study identified the first KEAP1 mutation in MNG. The results provide insights into the pathogenesis of goitre which develops in the organ continuously exposed to oxidative stress during hormone synthesis.	[Teshiba, Risa; Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan; [Tajiri, Tatsuro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Surg, Kyoto, Japan; [Sumitomo, Kenzo] Shimonoseki City Hosp, Dept Pediat Surg, Shimonoseki, Yamaguchi, Japan; [Masumoto, Kouji] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan; [Teshiba, Risa; Taguchi, Tomoaki] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg Reprod & Dev Med, Fukuoka, Japan	Kyushu University; Kyoto Prefectural University of Medicine; University of Tsukuba; Kyushu University	Yamamoto, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan.	kyama@bioreg.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22133003]; Grants-in-Aid for Scientific Research [22133003, 23256006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant (No. 22133003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arora N, 2008, WORLD J SURG, V32, P1237, DOI 10.1007/s00268-008-9484-1; Bayer Y, 2004, J CLIN ENDOCR METAB, V89, P4044, DOI 10.1210/jc.2003-032096; BAYOUMI RA, 1988, HUM HERED, V38, P8, DOI 10.1159/000153746; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Brix TH, 2000, ANN MED, V32, P153, DOI 10.3109/07853890008998821; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Capon F, 2000, AM J HUM GENET, V67, P1004, DOI 10.1086/303095; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; GREIG WR, 1967, Q J MED, V36, P175; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hegedus L, 2003, ENDOCR REV, V24, P102, DOI 10.1210/er.2002-0016; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Knudsen N, 2000, EUR J ENDOCRINOL, V142, P224, DOI 10.1530/eje.0.1420224; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krohn K, 2005, ENDOCR REV, V26, P504, DOI 10.1210/er.2004-0005; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P219, DOI 10.1530/eje.1.02210; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Neumann S, 1999, J CLIN ENDOCR METAB, V84, P3750, DOI 10.1210/jc.84.10.3750; Neumann S, 2003, J MOL MED, V81, P736, DOI 10.1007/s00109-003-0463-6; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Takahashi T, 2001, BIOCHEM BIOPH RES CO, V284, P648, DOI 10.1006/bbrc.2001.4998; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65141	10.1371/journal.pone.0065141	http://dx.doi.org/10.1371/journal.pone.0065141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724128	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000121
J	Rankin, JS; Zalcman, SS; Zhu, YH; Siegel, A				Rankin, James S.; Zalcman, Steven S.; Zhu, Youhua; Siegel, Allan			Short- and Long-Term Effects of Interleukin-2 Treatment on the Sensitivity of Periadolescent Female Mice to Interleukin-2 and Dopamine Uptake Inhibitor	PLOS ONE			English	Article							DEFENSIVE RAGE BEHAVIOR; PERIAQUEDUCTAL GRAY PAG; PSYCHIATRIC-DISORDERS; GENE-EXPRESSION; IMMUNE-SYSTEM; ANIMAL-MODELS; SCHIZOPHRENIA; BRAIN; LYMPHOCYTES; ACTIVATION	Interleukin (IL)-2, a T-helper 1 (Th1) cell-derived cytokine, which potently modulates dopamine activity and neuronal excitability in mesolimbic structures, is linked with pathological outcomes (e. g., schizophrenia, depression, etc.) that at least partly reflect alterations in central dopaminergic processes. It has been suggested that dopamine neurons undergo pruning during adolescence and abnormalities in pruning predispose individuals to behavioral disorders. Since IL-2 is known as a neurodevelopmental factor affecting associated behavioral processes, the present study tested whether IL-2 can modulate stereotypic behaviors in both the periadolescent and adult periods. This study determined whether IL-2 treatment would produce long-lasting changes in sensitivity to a later challenge with IL-2 or GBR 12909, a highly selective dopamine uptake inhibitor. Four experiments were conducted. Firstly, a decrease in novelty-induced stereotypic behavior was observed in BALB/c periadolescent mice (38 days of age) following IL-2 administration (0.4 mu g/2 ml) relative to vehicle control. In the second experiment, an initial dose of IL-2 was given in the periadolescent period, but did not affect rearing responses. A second dose of IL-2 given to the animals 30 days later as adults, resulted in a significant increase in rearing behaviors relative to control animals. In the third experiment, separate groups of experimental and control mice were administered GBR 12909, a highly selective dopamine reuptake inhibitor, 30 days following treatment with either IL-2 or vehicle. It was noted that this experimental group, which initially received IL-2, exhibited stereotypy, as evidenced by increased sniffing behavior. A fourth experiment revealed that IL-2 administered in periadolesecence and adulthood had no effect on other motor responses, indicating that IL-2 selectively modulates selective stereotypic behaviors. The results provide evidence, for the first time, that long-term changes in stereotypy in periadolescent mice are linked to an IL-2 mechanism, possibly utilizing dopamine.	[Rankin, James S.; Zalcman, Steven S.; Zhu, Youhua; Siegel, Allan] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; [Siegel, Allan] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rankin, JS (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA.	Rankinjs@gmail.com			Society for Woman's Health Research	Society for Woman's Health Research	S.S. Zalcman received funds provided by the 'Society for Woman's Health Research' to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Angelidou A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-89; Banks WA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-231; Bhatt S, 2006, BEHAV BRAIN RES, V167, P251, DOI 10.1016/j.bbr.2005.09.011; Bhatt S, 2005, NEUROSCIENCE, V133, P17, DOI 10.1016/j.neuroscience.2005.01.065; Bhatt S, 2008, BRAIN BEHAV IMMUN, V22, P224, DOI 10.1016/j.bbi.2007.07.011; Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006; Brown KA, 2001, INT IMMUNOPHARMACOL, V1, P2043; Camacho-Arroyo I, 2009, NEUROIMMUNOMODULAT, V16, P1, DOI 10.1159/000179661; de Araujo EG, 2009, ANN NY ACAD SCI, V1153, P57, DOI 10.1111/j.1749-6632.2008.03974.x; Duchesne A, 2009, PROG NEURO-PSYCHOPH, V33, P251, DOI 10.1016/j.pnpbp.2008.11.012; Elamin I, 2013, BEHAV NEUROL, V27, P23, DOI [10.3233/BEN-120295, 10.1155/2013/329375]; Gabor F, 2011, INT J DEV NEUROSCI, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Gadek-Michalska A, 2010, PHARMACOL REP, V62, P969, DOI 10.1016/s1734-1140(10)70359-5; Hanisch UK, 1995, BRAIN RES REV, V21, P246, DOI 10.1016/0165-0173(95)00015-1; Igue R, 2011, PROG NEURO-PSYCHOPH, V35, P1695, DOI 10.1016/j.pnpbp.2011.05.011; Ikemoto S, 2002, NEUROSCIENCE, V113, P939, DOI 10.1016/S0306-4522(02)00247-6; Karrenbauer BD, 2009, J NEUROIMMUNOL, V208, P10, DOI 10.1016/j.jneuroim.2008.12.003; Karson A, 2013, BASIC CLIN PHARMACOL, V112, P335, DOI 10.1111/bcpt.12037; Kazakova TB, 2005, B EXP BIOL MED+, V139, P718, DOI 10.1007/s10517-005-0388-x; Kerr D, 2006, INT REV PSYCHIATR, V17, P443, DOI 10.1080/0264830500381435; Korneva EA, 2000, ANN NY ACAD SCI, V917, P197; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Marra C, 2011, J NEUROIMMUNOL, V233, P120, DOI 10.1016/j.jneuroim.2010.12.008; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Rawdin BJ, 2013, BRAIN BEHAV IMMUN, V31, P143, DOI 10.1016/j.bbi.2012.11.011; Rolls ET, 2011, NEUROSCI BIOBEHAV R, V35, P1644, DOI 10.1016/j.neubiorev.2010.09.001; Rook GAW, 2008, TRENDS IMMUNOL, V29, P150, DOI 10.1016/j.it.2008.01.002; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Sanders VM, 2002, BRAIN BEHAV IMMUN, V16, P290, DOI 10.1006/brbi.2001.0639; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Shen Y, 2010, ANAT REC, V293, P1017, DOI 10.1002/ar.21118; Smith RF, 2003, NEUROTOXICOL TERATOL, V25, P291, DOI 10.1016/S0892-0362(02)00349-5; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; STEWART J, 1988, BEHAV NEURAL BIOL, V49, P344, DOI 10.1016/S0163-1047(88)90354-8; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4; ZALCMAN S, 1994, J PHARMACOL EXP THER, V271, P977; Zalcman SS, 2001, BRAIN RES, V899, P1, DOI 10.1016/S0006-8993(01)02090-X; Zalcman SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036316; Zhang DH, 2012, BRAIN BEHAV IMMUN, V26, P521, DOI 10.1016/j.bbi.2012.01.005	46	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64473	10.1371/journal.pone.0064473	http://dx.doi.org/10.1371/journal.pone.0064473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717619	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300021
J	Adolph, MB; Webb, J; Chelico, L				Adolph, Madison B.; Webb, Jonathon; Chelico, Linda			Retroviral Restriction Factor APOBEC3G Delays the Initiation of DNA Synthesis by HIV-1 Reverse Transcriptase	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; ANTIVIRAL PROTEIN APOBEC3G; CYTIDINE DEAMINASE; VIF PROTEIN; PRIMED INITIATION; VIRAL REPLICATION; ENZYME APOBEC3G; TYPE-1; INHIBITION	It is well established that the cytosine deaminase APOBEC3G can restrict HIV-1 virions in the absence of the virion infectivity factor (Vif) by inducing genome mutagenesis through deamination of cytosine to uracil in single-stranded HIV-1 (-)DNA. However, whether APOBEC3G is able to restrict HIV-1 using a deamination-independent mode remains an open question. In this report we use in vitro primer extension assays on primer/templates that model (-)DNA synthesis by reverse transcriptase from the primer binding site (PBS) and within the protease gene of HIV-1. We find that APOBEC3G is able to decrease the initiation of DNA synthesis by reverse transcriptase approximately 2-fold under conditions where reverse transcriptase is in excess to APOBEC3G, as found in HIV-1 virions. However, the delay in the initiation of DNA synthesis on RNA templates up to 120 nt did not decrease the total amount of primer extended after extended incubation unless the concentration of reverse transcriptase was equal to or less than that of APOBEC3G. By determining apparent K-d values of reverse transcriptase and APOBEC3G for the primer/templates and of reverse transcriptase binding to APOBEC3G we conclude that APOBEC3G is able to decrease the efficiency of reverse transcriptase-mediated DNA synthesis by binding to the RNA template, rather than by physically interacting with reverse transcriptase. All together the data support a model in which this deamination-independent mode of APOBEC3G would play a minor role in restricting HIV-1. We propose that the deamination-independent inhibition of reverse transcriptase we observed can be a mechanism used by APOBEC3G to slow down proviral DNA formation and increase the time in which single-stranded (-)DNA is available for deamination by APOBEC3G, rather than a direct mechanism used by APOBEC3G for HIV-1 restriction.	[Adolph, Madison B.; Webb, Jonathon; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	linda.chelico@usask.ca		Chelico, Linda/0000-0003-4673-8978	Canadian Institutes of Health Operating Grant [HOP-111407]; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation	Canadian Institutes of Health Operating Grant(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by a Canadian Institutes of Health Operating Grant (HOP-111407) (http://www.cihr-irsc.gc.ca/e/193.html), a new investigator establishment grant from the Saskatchewan Health Research Foundation (no grant number) (http://shrf.ca/) and the Canadian Foundation for Innovation (no grant number) (http://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Coffin J, 1997, RETROVIRUSES; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Feng Y., 2011, J BIOL CHEM; Fygenson DK, 1997, J BIOL CHEM, V272, P27931, DOI 10.1074/jbc.272.44.27931; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Liu SX, 2010, NAT STRUCT MOL BIOL, V17, P1453, DOI 10.1038/nsmb.1937; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Thrall SH, 1998, BIOCHEMISTRY-US, V37, P13349; Vaccaro JA, 1999, BIOCHEMISTRY-US, V38, P15978, DOI 10.1021/bi990945x; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wurtzer S, 2006, J VIROL, V80, P3679, DOI 10.1128/JVI.80.7.3679-3683.2006; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	53	33	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64196	10.1371/journal.pone.0064196	http://dx.doi.org/10.1371/journal.pone.0064196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717565	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600050
J	Mani, S; Tripathi, L; Raut, R; Tyagi, P; Arora, U; Barman, T; Sood, R; Galav, A; Wahala, W; de Silva, A; Swaminathan, S; Khanna, N				Mani, Shailendra; Tripathi, Lav; Raut, Rajendra; Tyagi, Poornima; Arora, Upasana; Barman, Tarani; Sood, Ruchi; Galav, Alka; Wahala, Wahala; de Silva, Aravinda; Swaminathan, Sathyamangalam; Khanna, Navin			Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies	PLOS ONE			English	Article							DOMAIN-III; SUBVIRAL PARTICLES; RECOMBINANT; VACCINE; SURFACE; TYPE-2; MATURATION; GENERATION; INDUCTION; SEROTYPES	Dengue is a mosquito-borne viral disease with a global prevalence. It is caused by four closely-related dengue viruses (DENVs 1-4). A dengue vaccine that can protect against all four viruses is an unmet public health need. Live attenuated vaccine development efforts have encountered unexpected interactions between the vaccine viruses, raising safety concerns. This has emphasized the need to explore non-replicating dengue vaccine options. Virus-like particles (VLPs) which can elicit robust immunity in the absence of infection offer potential promise for the development of non-replicating dengue vaccine alternatives. We have used the methylotrophic yeast Pichia pastoris to develop DENV envelope (E) protein-based VLPs. We designed a synthetic codon-optimized gene, encoding the N-terminal 395 amino acid residues of the DENV-2 E protein. It also included 5' pre-membrane-derived signal peptide-encoding sequences to ensure proper translational processing, and 3' 66 His tag-encoding sequences to facilitate purification of the expressed protein. This gene was integrated into the genome of P. pastoris host and expressed under the alcohol oxidase 1 promoter by methanol induction. Recombinant DENV-2 protein, which was present in the insoluble membrane fraction, was extracted and purified using Ni2+-affinity chromatography under denaturing conditions. Amino terminal sequencing and detection of glycosylation indicated that DENV-2 E had undergone proper post-translational processing. Electron microscopy revealed the presence of discrete VLPs in the purified protein preparation after dialysis. The E protein present in these VLPs was recognized by two different conformation-sensitive monoclonal antibodies. Low doses of DENV-2 E VLPs formulated in alum were immunogenic in inbred and outbred mice eliciting virus neutralizing titers >1:1200 in flow cytometry based assays and protected AG129 mice against lethal challenge (p<0.05). The formation of immunogenic DENV-2 E VLPs in the absence of pre-membrane protein highlights the potential of P. pastoris in developing non-replicating, safe, efficacious and affordable dengue vaccine.	[Mani, Shailendra; Tripathi, Lav; Raut, Rajendra; Tyagi, Poornima; Arora, Upasana; Galav, Alka; Swaminathan, Sathyamangalam; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India; [Barman, Tarani; Sood, Ruchi] Ranbaxy Res Labs, Dept Infect Dis, Gurgaon, Haryana, India; [Wahala, Wahala; de Silva, Aravinda] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Swaminathan, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India.	swami@icgeb.res.in; navin@icgeb.res.in	desilva, Aravinda/ABE-6260-2020; Tripathi, Lav/AAG-5708-2021; Barman, Tarani Kanta/AAG-9774-2019	desilva, Aravinda/0000-0003-3317-5950; Barman, Tarani Kanta/0000-0003-4121-4526; Swaminathan, Sathyamangalam/0000-0002-4388-2248; Mani, Shailendra/0000-0001-8541-8315; RAUT, RAJENDRA/0000-0003-0719-930X; Khanna, Navin/0000-0003-1208-614X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by funding to SS and NK from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D., 1998, Cellular and Molecular Biology Letters, V3, P21; Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Batra G, 2010, J BIOSCI BIOENG, V110, P408, DOI 10.1016/j.jbiosc.2010.05.001; Batra G, 2010, J VIROL METHODS, V167, P10, DOI 10.1016/j.jviromet.2010.03.002; Bisht H, 2002, J BIOTECHNOL, V99, P97, DOI 10.1016/S0168-1656(02)00181-5; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Edelman R, 2011, EXPERT REV VACCINES, V10, P133, DOI 10.1586/ERV.10.159; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Gurramkonda C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-13; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Hermida L, 2002, J BIOTECHNOL, V94, P213, DOI 10.1016/S0168-1656(01)00406-0; Innis Bruce L., 1997, P221; Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3; Korrapati AB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001735; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuwahara M, 2010, CLIN VACCINE IMMUNOL, V17, P1560, DOI 10.1128/CVI.00087-10; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu WQ, 2010, VIRUS GENES, V40, P53, DOI 10.1007/s11262-009-0418-2; Lunsdorf H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-48; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Sugrue RJ, 1997, J GEN VIROL, V78, P1861, DOI 10.1099/0022-1317-78-8-1861; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476; Swaminathan S, 2009, CURR MOL MED, V9, P152, DOI 10.2174/156652409787581592; Tang YX, 2012, CHINESE MED J-PEKING, V125, P1986, DOI 10.3760/cma.j.issn.0366-6999.2012.11.027; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Thomas SJ, 2011, J INFECT DIS, V203, P299, DOI 10.1093/infdis/jiq060; Valdes I, 2007, MOL BIOTECHNOL, V35, P23, DOI 10.1385/MB:35:1:23; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; WHO, 2012, DENG DENG HAEM FEV; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Zhao QJ, 2006, HUM VACCINES, V2, P174, DOI 10.4161/hv.2.4.3015	46	45	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64595	10.1371/journal.pone.0064595	http://dx.doi.org/10.1371/journal.pone.0064595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717637	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600069
J	Pencovich, N; Jaschek, R; Dicken, J; Amit, A; Lotem, J; Tanay, A; Groner, Y				Pencovich, Niv; Jaschek, Ram; Dicken, Joseph; Amit, Ayelet; Lotem, Joseph; Tanay, Amos; Groner, Yoram			Cell-Autonomous Function of Runx1 Transcriptionally Regulates Mouse Megakaryocytic Maturation	PLOS ONE			English	Article							CORE-BINDING FACTORS; PLATELET FACTOR-IV; IN-VIVO; ADULT HEMATOPOIESIS; TGF-BETA; DIFFERENTIATION; MICE; THROMBOCYTOPENIA; EXPRESSION; ENHANCERS	RUNX1 transcription factor (TF) is a key regulator of megakaryocytic development and when mutated is associated with familial platelet disorder and predisposition to acute myeloid leukemia (FPD-AML). We used mice lacking Runx1 specifically in megakaryocytes (MK) to characterized Runx1-mediated transcriptional program during advanced stages of MK differentiation. Gene expression and chromatin-immunoprecipitation-sequencing (ChIP-seq) of Runx1 and p300 identified functional Runx1 bound MK enhancers. Runx1/p300 co-bound regions showed significant enrichment in genes important for MK and platelet homeostasis. Runx1 occupied genomic regions were highly enriched in RUNX and ETS motifs and to a lesser extent in GATA motif. Megakaryocytic specificity of Runx1/P300 bound enhancers was validated by transfection mutagenesis and Runx1/P300 co-bound regions of two key megakaryocytic genes Nfe2 and Selp were tested by in vivo transgenesis. The data provides the first example of genome wide Runx1/p300 occupancy in maturating primary FL-MK, unravel the Runx1-regulated program controlling MK maturation in vivo and identify a subset of its bona fide regulated genes. It advances our understanding of the molecular events that upon RUNX1mutations in human lead to the predisposition to familial platelet disorders and FPD-AML.	[Pencovich, Niv; Dicken, Joseph; Amit, Ayelet; Lotem, Joseph; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Jaschek, Ram; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Groner, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yoram.groner@weizmann.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This study was supported by grants from Israel Science Foundation individual grants to YG and AT. URL: http://isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Asou N, 2003, CRIT REV ONCOL HEMAT, V45, P129, DOI 10.1016/S1040-8428(02)00003-3; Bee T, 2009, BLOOD, V113, P5121, DOI 10.1182/blood-2008-12-193003; Ben Aziz-Aloya R, 1998, CELL DEATH DIFFER, V5, P765, DOI 10.1038/sj.cdd.4400415; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Eckly A, 2010, J THROMB HAEMOST, V8, P2243, DOI 10.1111/j.1538-7836.2010.04009.x; EISMAN R, 1990, BLOOD, V76, P336; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Fock EF, 2008, EXP HEMATOL, V36, P78, DOI 10.1016/j.exphem.2007.08.015; Goldfarb AN, 2007, ONCOGENE, V26, P6795, DOI 10.1038/sj.onc.1210762; Goldfarb AN, 2009, J CELL BIOCHEM, V107, P377, DOI 10.1002/jcb.22142; Greif PA, 2012, HAEMATOLOGICA; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Halene S, 2010, BLOOD, V116, P1942, DOI 10.1182/blood-2010-01-261743; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; Kim JA, 2002, STEM CELLS, V20, P402, DOI 10.1634/stemcells.20-5-402; Lange B, 2000, BRIT J HAEMATOL, V110, P512, DOI 10.1046/j.1365-2141.2000.02027.x; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, NAT BIOTECHNOL, V28, P495; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; Pencovich N, 2011, BLOOD; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; Shivdasani R A, 1996, Stem Cells, V14 Suppl 1, P112; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Shivdasani RA, 2005, CURR PROTOC IMMUNOL; Smith EC, 2012, BLOOD; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang YH, 2011, BLOOD, V118, P6183, DOI 10.1182/blood-2011-06-363580; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522; Zingariello M, 2009, BIOTECH HISTOCHEM, P1	40	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64248	10.1371/journal.pone.0064248	http://dx.doi.org/10.1371/journal.pone.0064248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717578	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600055
J	Subenthiran, S; Abdullah, NR; Joseph, JP; Muniandy, PK; Mok, BT; Kee, CC; Ismail, Z; Mohamed, Z				Subenthiran, Soobitha; Abdullah, Noor Rain; Joseph, Joyce Pauline; Muniandy, Prem Kumar; Mok, Boon Teck; Kee, Chee Cheong; Ismail, Zakiah; Mohamed, Zahurin			Linkage Disequilibrium between Polymorphisms of ABCB1 and ABCC2 to Predict the Treatment Outcome of Malaysians with Complex Partial Seizures on Treatment with Carbamazepine Mono-Therapy at the Kuala Lumpur Hospital	PLOS ONE			English	Article							P-GLYCOPROTEIN; RESISTANCE; EXPRESSION; HAPLOTYPE; GENE; ASSOCIATION; GENOTYPE; EPILEPSY; C3435T; SHESIS	Purpose: Carbamazepine (CBZ) is used as the first line of treatment of Complex Partial Seizures (CPS) in the Epilepsy Clinic, Neurology Department of Kuala Lumpur Hospital (KLH). More than 30% of the patients remain drug resistant to CBZ monotherapy. CBZ is transported by the P-glycoprotein (P-gp). The P-gp encoded by the ABCB1 and ABCC2 genes are expressed in drug resistant patients with epilepsy. A few studies have shown significant association between CBZ resistant epilepsy and Linkage Disequilibrium (LD) with adjacent polymorphisms of these genes. Our study is aimed at determining the correlation between patients' response to CBZ mono-therapy to Single Nucleotide Polymorphisms G2677T and C3435T of the ABCB1 gene as well as G1249A and -24C>T of the ABCC2 gene. Method: 314 patients with CPS were recruited from the Neurology Department of the KLH based on stringent inclusion and exclusion criteria, of whom 152 were responders and the other 162 were non-responders. DNA was extracted from their blood samples and Taqman technology for allelic discrimination was performed. Results were described as genotype frequencies. The SHEsis analysis platform was used to calculate linkage disequilibrium index and infer haplotype frequencies. Haploview was used to do permutation test to obtain a corrected p-value. Results: Resistance to treatment with CBZ mono-therapy was significantly associated with the 2677TT and the 3435TT genotypes while it was not significantly associated with the G1249A and -24C>T polymorphisms. The GCGC haplotype combination of the 2677G>T, 3435C>T, 1249G>A and -24C>T respectively was found to be extremely significant (p = 1.10e-20) with good drug response to CBZ mono-therapy. Conclusion: Linkage disequilibrium between the 2677G>T, 3435C>T, 1249G>A and -24C>T SNPs may be used as a reliable screening marker to determine the treatment outcome of CBZ mono-therapy with CPS irrespective of race or gender.	[Subenthiran, Soobitha; Abdullah, Noor Rain; Muniandy, Prem Kumar; Mok, Boon Teck; Ismail, Zakiah] Inst Med Res, Bioassay Unit, Herbal Med Res Ctr, Kuala Lumpur 50588, Malaysia; [Joseph, Joyce Pauline] Kuala Lumpur Gen Hosp, Dept Neurol, Kuala Lumpur, Malaysia; [Kee, Chee Cheong] Inst Med Res, Med Res Ctr, Kuala Lumpur 50588, Malaysia; [Mohamed, Zahurin] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Malaya	Subenthiran, S (corresponding author), Inst Med Res, Bioassay Unit, Herbal Med Res Ctr, Kuala Lumpur 50588, Malaysia.	soobitha@imr.gov.my	Kee, Chee Cheong/AAB-2971-2019; Mohamed, Zahurin/C-1112-2010; Mat Nor, Mohd Basri/O-7334-2018	Kee, Chee Cheong/0000-0003-1372-9549; Mohamed, Zahurin/0000-0002-4396-0517; Mat Nor, Mohd Basri/0000-0002-5433-6357	National Institute of Health, Ministry of Health, Malaysia;  [JPP-IMR 09-003]	National Institute of Health, Ministry of Health, Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This research was funded by the National Institute of Health, Ministry of Health, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grant number is JPP-IMR 09-003.	[Anonymous], 2010, MICROMEDEX HEALTHCAR; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; CHAUDHARY PM, 1992, BLOOD, V80, P2735; Eichelbaum M, 2004, THER DRUG MONIT, V26, P180, DOI 10.1097/00007691-200404000-00017; Elizabeth C., 2011, COMPLEX PARTIAL SEIZ; Engelborghs S, 2000, ACTA NEUROL BELG, V100, P201; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Grover S, 2010, BIOCHIMIE, V92, P1207, DOI 10.1016/j.biochi.2010.04.008; Haerian BS, 2011, SEIZURE-EUR J EPILEP, V20, P387, DOI 10.1016/j.seizure.2011.01.008; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Kim DW, 2009, EPILEPSY RES, V84, P86, DOI 10.1016/j.eplepsyres.2008.12.001; Kim WJ, 2010, PHARMACOGENET GENOM, V20, P249, DOI 10.1097/FPC.0b013e328338073a; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Meissner K, 2004, PHARMACOGENETICS, V14, P381, DOI 10.1097/00008571-200406000-00007; Miller John W, 2007, Epilepsy Curr, V7, P98, DOI 10.1111/j.1535-7511.2007.00186.x; Mosyagin I, 2008, EPILEPSIA, V49, P1555, DOI 10.1111/j.1528-1167.2008.01661.x; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Nakano T, 2009, DRUG METAB DISPOS, V37, P1521, DOI 10.1124/dmd.108.024836; Ozgon GO, 2008, EUR NEUROL, V59, P67, DOI 10.1159/000109264; PRATAP RC, 1989, ACTA NEUROL SCAND, V79, P123, DOI 10.1111/j.1600-0404.1989.tb03723.x; Qiang L. U., 2007, NEUROL ASIA, V12, P94; Qu J, 2012, CNS NEUROSCI THER, V18, P647, DOI 10.1111/j.1755-5949.2012.00336.x; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Saito T, 2001, ACTA OTO-LARYNGOL, V121, P735, DOI 10.1080/00016480152583683; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Seo T, 2006, PHARMACOGENOMICS, V7, P551, DOI 10.2217/14622416.7.4.551; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Ufer M, 2009, PHARMACOGENET GENOM, V19, P353, DOI 10.1097/FPC.0b013e328329940b; Vahab SA, 2009, DRUG METAB PHARMACOK, V24, P255, DOI 10.2133/dmpk.24.255; Yin ZH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-153; Zakaria AK, 1998, MALAYSIAN J MED SCI, V5, P11	32	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64827	10.1371/journal.pone.0064827	http://dx.doi.org/10.1371/journal.pone.0064827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717663	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600078
J	Turner, K; Reynolds-May, MF; Zitek, EM; Tisdale, RL; Carlisle, AB; Westphal, LM				Turner, Kathy; Reynolds-May, Margaret F.; Zitek, Emily M.; Tisdale, Rebecca L.; Carlisle, Allison B.; Westphal, Lynn M.			Stress and Anxiety Scores in First and Repeat IVF Cycles: A Pilot Study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; SELF-EFFICACY; GROUP INTERVENTION; INFERTILE WOMEN; PREGNANCY RATES; ADJUSTMENT; ACUPUNCTURE	Background: The role of stress in reproduction, particularly during treatment for infertility, has been of considerable interest; however, few studies have objectively measured stress and anxiety over the course of the IVF cycle or compared the experience of first-time and repeat patients. Methods: This prospective cohort pilot study enrolled 44 women undergoing IVF at a university-based clinic to complete the State-Trait Anxiety Inventory (STAI), Perceived Stress Scale (PSS) and Infertility Self-Efficacy Scale (ISES) at three time points prior to ovarian stimulation (T1), one day prior to oocyte retrieval (T2), and 5-7 days post embryo transfer (T3). Results: Mean STAI State scores were significantly elevated at all three time points (p<0.01). STAI State and PSS mean values did not change over time and did not differ in first-time vs. repeat patients. Self-efficacy (ISES) scores declined over time, with a greater decline for repeat patients. Of the 36 women who completed a cycle, 15 achieved clinical pregnancy. Using logistic regression modeling, all scores at T2 were correlated with pregnancy outcome with lower scores on the STAI State and PSS and higher scores on the ISES associated with higher pregnancy rates. Conclusions: Stress and anxiety levels remained elevated across all cycles. Women with lower stress and anxiety levels on the day prior to oocyte retrieval had a higher pregnancy rate. These results emphasize the need to investigate stress reduction modalities throughout the IVF cycle.	[Turner, Kathy; Tisdale, Rebecca L.; Carlisle, Allison B.; Westphal, Lynn M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Reynolds-May, Margaret F.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Zitek, Emily M.] Stanford Univ, Sch Med, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Westphal, LM (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	lynnw@stanford.edu		Tisdale, Rebecca/0000-0003-2749-6889				Ardenti R, 1999, HUM REPROD, V14, P3126, DOI 10.1093/humrep/14.12.3126; Arnetz BB, 2006, STRESS HLTH DIS; Balk Judith, 2010, Complement Ther Clin Pract, V16, P154, DOI 10.1016/j.ctcp.2009.11.004; Beerendonk C, 1999, J PSYCHOSOM OBST GYN, V20, P97, DOI 10.3109/01674829909075582; Bloch M, 2011, FERTIL STERIL, V95, P307, DOI 10.1016/j.fertnstert.2010.07.1073; BOIVIN J, 1995, FERTIL STERIL, V64, P802, DOI 10.1016/S0015-0282(16)57858-3; Boivin J, 2003, SOC SCI MED, V57, P2325, DOI 10.1016/S0277-9536(03)00138-2; Bringhenti F, 1997, ACTA OBSTET GYN SCAN, V76, P431, DOI 10.3109/00016349709047824; Campagne DM, 2006, HUM REPROD, V21, P1651, DOI 10.1093/humrep/del078; Chan CHY, 2006, FERTIL STERIL, V85, P339, DOI 10.1016/j.fertnstert.2005.07.1310; COHEN S, 1988, CLAR SYMP, P31; Cousineau TM, 2006, FERTIL STERIL, V85, P1684, DOI 10.1016/j.fertnstert.2005.10.077; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; de Klerk C, 2008, HUM REPROD, V23, P112, DOI 10.1093/humrep/dem357; DEMYTTENAERE K, 1994, GYNECOL ENDOCRINOL, V8, P233, DOI 10.3109/09513599409023626; Domar AD, 2000, FERTIL STERIL, V73, P805, DOI 10.1016/S0015-0282(99)00493-8; Eugster A, 1999, SOC SCI MED, V48, P575, DOI 10.1016/S0277-9536(98)00386-4; Galhardo A, 2013, RES NURS HEALTH, V36, P65, DOI 10.1002/nur.21516; Gallinelli A, 2001, FERTIL STERIL, V76, P85, DOI 10.1016/S0015-0282(01)01826-X; Harlow CR, 1996, HUM REPROD, V11, P274, DOI 10.1093/HUMREP/11.2.274; Hosaka T, 2002, GEN HOSP PSYCHIAT, V24, P353, DOI 10.1016/S0163-8343(02)00194-9; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Kovarova P, 2010, EXPLORE-NY, V6, P330, DOI 10.1016/j.explore.2010.06.002; Lee TY, 2000, ARCH ANDROLOGY, V45, P149; Li W, 2012, REPROD BIOMED ONLINE, V25, P180, DOI 10.1016/j.rbmo.2012.03.012; Lintsen AME, 2009, HUM REPROD, V24, P1092, DOI 10.1093/humrep/den491; Lovely LP, 2003, SOUTH MED J, V96, P548, DOI 10.1097/01.SMJ.0000054567.79881.E9; Mahajan NN, 2010, FERTIL STERIL, V93, P517, DOI 10.1016/j.fertnstert.2008.12.054; MERARI D, 1992, J ASSIST REPROD GEN, V9, P161, DOI 10.1007/BF01203757; Milad MP, 1998, HUM REPROD, V13, P2296, DOI 10.1093/humrep/13.8.2296; Pinto-Gouveia J, 2012, HUM FERTIL, V15, P27, DOI 10.3109/14647273.2011.654310; Sanders KA, 1999, HUM REPROD, V14, P1656, DOI 10.1093/humrep/14.6.1656; Schetter Christine Dunkel, 1991, INFERTILITY PERSPECT, P29, DOI DOI 10.1007/978-1-4899-0753-0_3; Serafini P, 2009, INT J GYNECOL OBSTET, V105, P136, DOI 10.1016/j.ijgo.2008.12.013; Smith CA, 2011, J ALTERN COMPLEM MED, V17, P923, DOI 10.1089/acm.2010.0380; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stoleru S, 1997, J PSYCHOSOM OBST GYN, V18, P189, DOI 10.3109/01674829709080688; Terzioglu F, 2001, J PSYCHOSOM OBST GYN, V22, P133, DOI 10.3109/01674820109049965; Tiplady S, 2013, HUM REPROD, V28, P138, DOI 10.1093/humrep/des372; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Wichman CL, 2011, FERTIL STERIL, V95, P717, DOI 10.1016/j.fertnstert.2010.09.043; Yong P, 2000, J ASSIST REPROD GEN, V17, P553, DOI 10.1023/A:1026429712794	43	84	88	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63743	10.1371/journal.pone.0063743	http://dx.doi.org/10.1371/journal.pone.0063743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717472	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600030
J	Arnaud, L; Sato, M; Menard, L; Gracco, VL				Arnaud, Laureline; Sato, Marc; Menard, Lucie; Gracco, Vincent L.			Repetition Suppression for Speech Processing in the Associative Occipital and Parietal Cortex of Congenitally Blind Adults	PLOS ONE			English	Article							VISUAL-CORTEX; PERCEPTION; ACTIVATION; BRAIN; LOCALIZATION; REVEALS; GYRUS	In the congenitally blind (CB), sensory deprivation results in cross-modal plasticity, with visual cortical activity observed for various auditory tasks. This reorganization has been associated with enhanced auditory abilities and the recruitment of visual brain areas during sound and language processing. The questions we addressed are whether visual cortical activity might also be observed in CB during passive listening to auditory speech and whether cross-modal plasticity is associated with adaptive differences in neuronal populations compared to sighted individuals (SI). We focused on the neural substrate of vowel processing in CB and SI adults using a repetition suppression (RS) paradigm. RS has been associated with enhanced or accelerated neural processing efficiency and synchronous activity between interacting brain regions. We evaluated whether cortical areas in CB were sensitive to RS during repeated vowel processing and whether there were differences across the two groups. In accordance with previous studies, both groups displayed a RS effect in the posterior temporal cortex. In the blind, however, additional occipital, temporal and parietal cortical regions were associated with predictive processing of repeated vowel sounds. The findings suggest a more expanded role for cross-modal compensatory effects in blind persons during sound and speech processing and a functional transfer of specific adaptive properties across neural regions as a consequence of sensory deprivation at birth.	[Arnaud, Laureline; Menard, Lucie; Gracco, Vincent L.] McGill Univ, Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Sato, Marc] CNRS, Ctr Res Brain Language & Mus, Grenoble, France; [Sato, Marc] CNRS, GIPSA lab, Grenoble, France; [Sato, Marc] Grenoble Univ, Grenoble, France; [Menard, Lucie] Univ Quebec, Dept Linguist, Montreal, PQ H3C 3P8, Canada; [Gracco, Vincent L.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Gracco, Vincent L.] Haskins Labs Inc, New Haven, CT 06511 USA	McGill University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Quebec; University of Quebec Montreal; McGill University; Yale University; Haskins Laboratories	Gracco, VL (corresponding author), McGill Univ, Ctr Res Brain Language & Mus, Montreal, PQ, Canada.	vincent.gracco@mcgill.ca			Natural Sciences and Engineering Research Council of Canada; Centre for Research on Brain, Language and Music	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Centre for Research on Brain, Language and Music	The authors declare no competing financial interests. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Centre for Research on Brain, Language and Music. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bhattacharjee A, 2010, J NEUROSCI, V30, P14288, DOI 10.1523/JNEUROSCI.1447-10.2010; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Friston KJ, 2012, COGN NEUROSCI-UK, V3, P238, DOI 10.1080/17588928.2012.691277; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gordon-Salant S, 2011, J SPEECH LANG HEAR R, V54, P622, DOI 10.1044/1092-4388(2010/10-0052); Gotts SJ, 2012, COGN NEUROSCI-UK, V3, P227, DOI 10.1080/17588928.2012.670617; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Grabski K, 2013, J NEUROLINGUIST, V26, P384, DOI 10.1016/j.jneuroling.2012.11.003; Gracco VL, 2005, NEUROIMAGE, V26, P294, DOI 10.1016/j.neuroimage.2005.01.033; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Henson RN, 2012, COGN NEUROSCI-UK, V3, P240, DOI 10.1080/17588928.2012.689962; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hertrich I, 2013, BRAIN LANG, V124, P9, DOI 10.1016/j.bandl.2012.10.006; Hertrich I, 2009, NEUROCASE, V15, P163, DOI 10.1080/13554790802709054; Hugdahl K, 2004, COGNITIVE BRAIN RES, V19, P28, DOI 10.1016/j.cogbrainres.2003.10.015; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Menard L, 2009, J ACOUST SOC AM, V126, P1406, DOI 10.1121/1.3158930; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Trouvain J., 2007, SAARLAND WORKING PAP, V1, P5; Vaden KI, 2010, NEUROIMAGE, V49, P1018, DOI 10.1016/j.neuroimage.2009.07.063; Weeks R, 2000, J NEUROSCI, V20, P2664	41	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64553	10.1371/journal.pone.0064553	http://dx.doi.org/10.1371/journal.pone.0064553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717628	Green Published, gold			2022-12-25	WOS:000320362700153
J	Auvinen, HE; Wang, YA; Princen, H; Romijn, JA; Havekes, LM; Smit, JWA; Meijer, OC; Biermasz, NR; Rensen, PCN; Pereira, AM				Auvinen, Hanna E.; Wang, Yanan; Princen, Hans; Romijn, Johannes A.; Havekes, Louis M.; Smit, Johannes W. A.; Meijer, Onno C.; Biermasz, Nienke R.; Rensen, Patrick C. N.; Pereira, Alberto M.			Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; INCREASES HDL-CHOLESTEROL; CUSHINGS-DISEASE; CARDIOVASCULAR RISK; BODY-COMPOSITION; TRANSGENIC MICE; ACTIVE DISEASE; DEXAMETHASONE; EXPRESSION; OBESITY	Introduction: The role of glucocorticoids in atherosclerosis development is not clearly established. Human studies show a clear association between glucocorticoid excess and cardiovascular disease, whereas most animal models indicate an inhibitory effect of glucocorticoids on atherosclerosis development. These animal models, however, neither reflect long-term glucocorticoid overexposure nor display human-like lipoprotein metabolism. Aim: To investigate the effects of transient and continuous glucocorticoid excess on atherosclerosis development in a mouse model with human-like lipoprotein metabolism upon feeding a Western-type diet. Methods: Pair-housed female APOE*3-Leiden.CETP (E3L.CETP) mice fed a Western-type containing 0.1% cholesterol for 20 weeks were given corticosterone (50 mu g/ml) for either 5 (transient group) or 17 weeks (continuous group), or vehicle (control group) in the drinking water. At the end of the study, atherosclerosis severity, lesion area in the aortic root, the number of monocytes adhering to the endothelial wall and macrophage content of the plaque were measured. Results: Corticosterone treatment increased body weight and food intake for the duration of the treatment and increased gonadal and subcutaneous white adipose tissue weight in transient group by +35% and +31%, and in the continuous group by +140% and 110%. Strikingly, both transient and continuous corticosterone treatment decreased total atherosclerotic lesion area by -39% without lowering plasma cholesterol levels. In addition, there was a decrease of -56% in macrophage content of the plaque with continuous corticosterone treatment, and a similar trend was present with the transient treatment. Conclusion: Increased corticosterone exposure in mice with human-like lipoprotein metabolism has beneficial, long-lasting effects on atherosclerosis, but negatively affects body fat distribution by promoting fat accumulation in the long-term. This indicates that the increased atherosclerosis observed in humans in states of glucocorticoid excess may not be related to cortisol per se, but might be the result of complex indirect effects of cortisol.	[Auvinen, Hanna E.; Wang, Yanan; Romijn, Johannes A.; Havekes, Louis M.; Smit, Johannes W. A.; Meijer, Onno C.; Biermasz, Nienke R.; Rensen, Patrick C. N.; Pereira, Alberto M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Princen, Hans; Havekes, Louis M.] TNO Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands; [Auvinen, Hanna E.; Wang, Yanan; Havekes, Louis M.; Meijer, Onno C.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Auvinen, HE (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	h.e.auvinen@lumc.nl	Princen, Hans MG/AID-9392-2022; meijer, onno c/D-8070-2018; Wang, Yanan/C-4143-2019; Pereira, Alberto M./Q-7175-2017; Biermasz, Nienke/ABE-9436-2021; Smit, J.W.A./H-8091-2014; Rensen, Patrick C.N./D-7176-2018	Princen, Hans MG/0000-0002-7206-1596; meijer, onno c/0000-0002-8394-6859; Wang, Yanan/0000-0002-0327-0458; Pereira, Alberto M./0000-0002-1194-9866; Biermasz, Nienke/0000-0001-5817-3594; Smit, J.W.A./0000-0003-1052-9314; Rensen, Patrick C.N./0000-0002-8455-4988				Albiger N, 2006, HORM METAB RES, V38, P405, DOI 10.1055/s-2006-944545; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; ASAI K, 1993, ARTERIOSCLER THROMB, V13, P892, DOI 10.1161/01.ATV.13.6.892; BAILEY JM, 1985, ATHEROSCLEROSIS, V54, P205; Barahona MJ, 2009, J CLIN ENDOCR METAB, V94, P3365, DOI 10.1210/jc.2009-0766; Bell ME, 2000, J NEUROENDOCRINOL, V12, P461; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bernberg E, 2008, STRESS, V11, P381, DOI 10.1080/10253890701824051; Bernberg E, 2009, ATHEROSCLEROSIS, V204, P90, DOI 10.1016/j.atherosclerosis.2008.08.013; Bhatnagar S, 2000, J NEUROENDOCRINOL, V12, P453; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Colao A, 1999, J CLIN ENDOCR METAB, V84, P2664, DOI 10.1210/jc.84.8.2664; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dekkers OM, 2007, J CLIN ENDOCR METAB, V92, P976, DOI 10.1210/jc.2006-2112; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2527, DOI 10.1210/jc.2002-021558; Feelders RA, 2012, EUR J ENDOCRINOL, V167, P311, DOI 10.1530/EJE-11-1095; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Garcia RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053192; Geer EB, 2012, J CLIN ENDOCR METAB, V97, P1702, DOI 10.1210/jc.2011-3123; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Giordano R, 2011, CLIN ENDOCRINOL, V75, P354, DOI 10.1111/j.1365-2265.2011.04055.x; GORDON D, 1954, J EXP MED, V99, P371, DOI 10.1084/jem.99.4.371; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kuhnast S, 2012, J HYPERTENS, V30, P107, DOI 10.1097/HJH.0b013e32834ddd8e; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; la Fleur SE, 2004, ENDOCRINOLOGY, V145, P2174, DOI 10.1210/en.2003-1359; Laskowitz DT, 2000, J LIPID RES, V41, P613; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; NAITO M, 1992, J NUTR SCI VITAMINOL, V38, P255, DOI 10.3177/jnsv.38.255; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; OPPENHEIM E, 1952, AMA ARCH PATHOL, V53, P520; Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009; Popova A, 2011, IMMUNOBIOLOGY, V216, P164, DOI 10.1016/j.imbio.2010.06.003; Resmini E, 2010, HORM METAB RES, V42, P613, DOI 10.1055/s-0030-1255032; Roelfsema F, 1998, J CLIN ENDOCR METAB, V83, P688, DOI 10.1210/jc.83.2.688; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakai M, 1999, ARTERIOSCL THROM VAS, V19, P1726, DOI 10.1161/01.ATV.19.7.1726; Strecker EP, 1998, CARDIOVASC INTER RAD, V21, P487, DOI 10.1007/s002709900309; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Pas R, 2012, J CLIN ENDOCR METAB, V97, P1303, DOI 10.1210/jc.2011-2753; van der Sluis RJ, 2012, ATHEROSCLEROSIS, V221, P76, DOI 10.1016/j.atherosclerosis.2011.12.022; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Volger OL, 2001, ATHEROSCLEROSIS, V157, P375, DOI 10.1016/S0021-9150(00)00750-4; Warne JP, 2009, AM J PHYSIOL-REG I, V296, pR1366, DOI 10.1152/ajpregu.91016.2008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wheller SK, 1997, EUR J PHARMACOL, V331, P65, DOI 10.1016/S0014-2999(97)01015-7; YAMADA K, 1993, ARTERY, V20, P253; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	62	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63882	10.1371/journal.pone.0063882	http://dx.doi.org/10.1371/journal.pone.0063882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717502	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700074
J	Lattenist, L; Kers, J; Claessen, N; ten Berge, IJM; Bemelman, FJ; Florquin, S; Roelofs, JJTH				Lattenist, Lionel; Kers, Jesper; Claessen, Nike; ten Berge, Ineke J. M.; Bemelman, Frederike J.; Florquin, Sandrine; Roelofs, Joris J. T. H.			Renal and Urinary Levels of Endothelial Protein C Receptor Correlate with Acute Renal Allograft Rejection	PLOS ONE			English	Article							FACTOR-KAPPA-B; ACTIVATED RECEPTOR-1; EPITHELIAL-CELLS; ALPHA PRODUCTION; HUMAN MONOCYTES; IN-VIVO; EXPRESSION; MECHANISMS; SEPSIS; CLASSIFICATION	The Endothelial Protein C Receptor (EPCR) is expressed on leukocytes, on endothelium of large blood vessels and to a lesser extent on capillaries. Membrane bound EPCR plays an important role in the activation of protein C which has anticoagulant, anti-inflammatory and cytoprotective effects. After cleavage by a protease EPCR is also found as a soluble protein. Acute rejection of kidney allografts can be divided in T-cell-mediated rejection (TCMR) and antibody-mediated (ABMR) rejection. The latter is characterized by strong activation of coagulation. Currently no reliable non-invasive biomarkers are available to monitor rejection. Renal biopsies were available from 81 renal transplant patients (33 without rejection, 26 TCMR and 22 ABMR), we had access to mRNA material, matched plasma and urine samples for a portion of this cohort. Renal EPCR expression was assessed by RT-PCR and immunostaining. Plasma and urine sEPCR levels were measured by ELISA. ABMR patients showed higher levels of EPCR mRNA than TCMR patients. EPCR expression on glomeruli was significantly elevated in ABMR patients than in TCMR or control patients. In the peritubular capillaries EPCR expression was higher in ABMR patients than in control patients. EPCR expression was higher in tubules and arteries of rejection patients than in control patients. Plasma sEPCR levels did not differ. Urine sEPCR levels were more elevated in the ABMR group than in patients with TCMR or without rejection. ROC analysis demonstrated that urinary sEPCR is appropriate to discriminate between ABMR patients and TCMR or control patients. We conclude that urinary sEPCR could be a novel non-invasive biomarker of antibody mediated rejection in renal transplantation.	[Lattenist, Lionel; Kers, Jesper; Claessen, Nike; Florquin, Sandrine; Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [ten Berge, Ineke J. M.; Bemelman, Frederike J.] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, Renal Transplant Unit, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Lattenist, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	l.c.lattenist@amc.uva.nl	Kers, Jesper/F-1995-2010	Florquin, Sandrine/0000-0002-9676-1722; Roelofs, Joris/0000-0001-9595-6571	Dutch Kidney Foundation [C09.2287]; RISET EU FP6 consortium; ERA-EDTA [ALTF 69-2010]	Dutch Kidney Foundation; RISET EU FP6 consortium; ERA-EDTA	This work was financially supported by a research grant of the Dutch Kidney Foundation (http://www.nierstichting.nl/, grant C09.2287 awarded to J.J.T.H. Roelofs), the RISET EU FP6 consortium (http://www.nds.ox.ac.uk/riset/) and the ERA-EDTA (http://www.era-edta.org, ALTF 69-2010 long-term fellowship awarded to J. Kers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2010, J CELL PHYSIOL, V225, P233, DOI 10.1002/jcp.22249; Brueckmann M, 2004, CYTOKINE, V26, P106, DOI 10.1016/j.cyto.2004.01.004; Chen P, 2010, DIGEST DIS SCI, V55, P1599, DOI 10.1007/s10620-009-0909-y; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Egin Y, 2009, INT UROL NEPHROL; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Feistritzer C, 2003, J ALLERGY CLIN IMMUN, V112, P375, DOI 10.1067/mai.2003.1609; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Galligan L, 2001, BRIT J HAEMATOL, V115, P408, DOI 10.1046/j.1365-2141.2001.03187.x; Gao XH, 2009, J NAT MED-TOKYO, V63, P421, DOI 10.1007/s11418-009-0348-2; GREY ST, 1994, J IMMUNOL, V153, P3664; Gupta A, 2007, J AM SOC NEPHROL, V18, P860, DOI 10.1681/ASN.2006101167; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Keller SA, 2011, J SURG RES, V168, pE103, DOI 10.1016/j.jss.2011.01.008; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Laszik Z, 1997, CIRCULATION, V96, P3633; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liaw PCY, 2000, J BIOL CHEM, V275, P5447, DOI 10.1074/jbc.275.8.5447; Lu Zhong-qiu, 2009, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V27, P453; Menschikowski M, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-4; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Nakamura M, 2005, J THROMB HAEMOST, V3, P2721, DOI 10.1111/j.1538-7836.2005.01635.x; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rowshani AT, 2006, J AM SOC NEPHROL, V17, P305, DOI 10.1681/ASN.2005030249; Scheepstra C, 2008, TRANSPLANTATION, V86, P772, DOI 10.1097/TP.0b013e3181860a74; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; Sesin CA, 2005, KIDNEY INT, V68, P110, DOI 10.1111/j.1523-1755.2005.00385.x; Sis B, 2012, AM J TRANSPLANT, V12, P1168, DOI 10.1111/j.1600-6143.2011.03931.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; US Renal Data System, 2010, USRDS 2010 ANN DAT R; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038; Yuksel M, 2002, THROMB HAEMOSTASIS, V88, P267	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64994	10.1371/journal.pone.0064994	http://dx.doi.org/10.1371/journal.pone.0064994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717683	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700188
J	Nguyen, AM; Noymer, A				Nguyen, Ann M.; Noymer, Andrew			Influenza Mortality in the United States, 2009 Pandemic: Burden, Timing and Age Distribution	PLOS ONE			English	Article							A H1N1 VIRUS; ORIGINAL ANTIGENIC SIN; HONG-KONG; ANTIBODY-RESPONSES; GLOBAL MORTALITY; VACCINATION; DEATHS; IMMUNITY; PROGRESS; HEALTH	Background: In April 2009, the most recent pandemic of influenza A began. We present the first estimates of pandemic mortality based on the newly-released final data on deaths in 2009 and 2010 in the United States. Methods: We obtained data on influenza and pneumonia deaths from the National Center for Health Statistics (NCHS). Age- and sex-specific death rates, and age-standardized death rates, were calculated. Using negative binomial Serfling-type methods, excess mortality was calculated separately by sex and age groups. Results: In many age groups, observed pneumonia and influenza cause-specific mortality rates in October and November 2009 broke month-specific records since 1959 when the current series of detailed US mortality data began. Compared to the typical pattern of seasonal flu deaths, the 2009 pandemic age-specific mortality, as well as influenza-attributable (excess) mortality, skewed much younger. We estimate 2,634 excess pneumonia and influenza deaths in 2009-10; the excess death rate in 2009 was 0.79 per 100,000. Conclusions: Pandemic influenza mortality skews younger than seasonal influenza. This can be explained by a protective effect due to antigenic cycling. When older cohorts have been previously exposed to a similar antigen, immune memory results in lower death rates at older ages. Age-targeted vaccination of younger people should be considered in future pandemics.	[Nguyen, Ann M.] Palomar Hlth, Escondido, CA USA; [Noymer, Andrew] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA	University of California System; University of California Irvine	Noymer, A (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA.	noymer@uci.edu	Nguyen, Ann M/N-7042-2014	Nguyen, Ann M/0000-0002-7903-0223				ANDERSON RN, 2001, NATL VITAL STAT REPO; Avitsur R, 2011, HORM BEHAV, V59, P257, DOI 10.1016/j.yhbeh.2010.12.002; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brammer L., 2010, Morbidity and Mortality Weekly Report, V59, P38; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P1156; Chan M., 2009, WORLD NOW START 2009; Chan M, 2010, H1N1 POSTPANDEMIC PE; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; COCKBURN WC, 1969, B WORLD HEALTH ORGAN, V41, P345; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; EICKHOFF TC, 1961, JAMA-J AM MED ASSOC, V176, P776, DOI 10.1001/jama.1961.03040220024005; EICKHOFF TC, 1960, EPIDEMIOLOGY ASIAN I; Eshima N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019409; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Garenne M, 1998, PERSPECT BIOL MED, V41, P176; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gilca R, 2009, AM J EPIDEMIOL, V170, P925, DOI 10.1093/aje/kwp195; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hsu JP, 2012, INT J INFECT DIS, V16, pE621, DOI 10.1016/j.ijid.2012.04.010; *HUM MORT DAT, US COMPL DAT SER EXP; Iorio AM, 2012, VACCINE, V30, P1617, DOI 10.1016/j.vaccine.2011.12.107; Jacobs JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042328; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; KLEBBA AJ, 1975, VITAL HLTH STAT, V2; Klebba AJ, 1980, ESTIMATES SELECTED C; Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427; Kochanek KD, 2011, NATL VITAL STAT REPO; Laver WG, 2000, PERSPECT BIOL MED, V43, P173; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Lorenzo ME, 2011, VACCINE, V29, P9246, DOI 10.1016/j.vaccine.2011.09.110; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; Murphy SL, 2012, NATL VITAL STAT REPO; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; *NAT CTR HLTH STAT, MORT MULT CAUS OF DE; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Nicoll A, 2012, EUROSURVEILLANCE, V17, P18; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; O'Donnell CD, 2012, J VIROL, V86, P8625, DOI 10.1128/JVI.00147-12; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Pan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023910; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Robertson JS, 2011, VIRUS RES, V162, P39, DOI 10.1016/j.virusres.2011.09.024; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simonsen L, 2004, INT CONGR SER, V1263, P791, DOI 10.1016/j.ics.2004.01.029; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2005, J INFECT DIS, V192, P1860, DOI 10.1086/497155; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Viboud C, 2013, J INFECT DIS, V207, P721, DOI 10.1093/infdis/jis745; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882	74	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64198	10.1371/journal.pone.0064198	http://dx.doi.org/10.1371/journal.pone.0064198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717567	Green Published, gold			2022-12-25	WOS:000320362700117
J	Tong, YA; Peng, H; Zhan, C; Fan, LH; Ai, TB; Wang, SH				Tong, Yong-ao; Peng, Hua; Zhan, Cheng; Fan, LinHong; Ai, Taobo; Wang, Shenghua			Genome-Wide Analysis Reveals Diversity of Rice Intronic miRNAs in Sequence Structure, Biogenesis and Function	PLOS ONE			English	Article							INTRAGENIC DNA METHYLATION; SMALL RNAS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; HOST GENES; MICRORNA; ARABIDOPSIS; IDENTIFICATION; PROTEIN; ANNOTATION	Intronic microRNAs (in-miRNAs) as a class of miRNA family that regulates gene expression are still poorly understood in plants. In this study, we systematically identified rice in-miRNAs by re-mining eight published small RNA-sequencing datasets of rice. Furthermore, based on the collected expression, annotation, and putative target data, we investigated the structures, potential functions, and expression features of these in-miRNAs and the expression patterns of their host genes. A total of 153 in-miRNAs, which account for over 1/4 of the total rice miRNAs, were identified. In silico expression analysis showed that most of them (similar to 63%) are tissue or stage-specific. However, a majority of their host genes, especially those containing clustered in-miRNAs, exhibit stable high-level expressions among 513 microarray datasets. Although in-miRNAs show diversity in function and mechanism, the DNA methylation directed by 24 nt in-miRNAs may be the main pathway that controls the expressions of target genes, host genes, and even themselves. These findings may enhance our understanding on special functions of in-miRNAs, especially in mediating DNA methylation that was concluded to affect the stability of expression and structure of host and target genes.	[Tong, Yong-ao; Peng, Hua; Zhan, Cheng; Fan, LinHong; Ai, Taobo; Wang, Shenghua] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, SH (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Sichuan, Peoples R China.	shwang200@yahoo.com.cn			National Natural Science Foundation of China [31270360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31270360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Cui X, 2009, GENE, V431, P61, DOI 10.1016/j.gene.2008.11.016; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Isik Meltem, 2010, Silence, V1, P5, DOI 10.1186/1758-907X-1-5; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim VN, 2005, MOL CELLS, V19, P1; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peng H., 2012, P ALAFAR C CANC 2012, P1; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sanan-Mishra N, 2009, MOL GENET GENOMICS, V282, P463, DOI 10.1007/s00438-009-0478-y; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soukas A, 2000, GENE DEV, V14, P963; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Teixeira FK, 2009, EMBO J, V28, P997, DOI 10.1038/emboj.2009.87; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XS, 2010, INT J MOL SCI, V11, P3138, DOI 10.3390/ijms11093138; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	56	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63938	10.1371/journal.pone.0063938	http://dx.doi.org/10.1371/journal.pone.0063938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717514	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700083
J	Yang, W; Dietz, T; Kramer, DB; Chen, XD; Liu, JG				Yang, Wu; Dietz, Thomas; Kramer, Daniel Boyd; Chen, Xiaodong; Liu, Jianguo			Going Beyond the Millennium Ecosystem Assessment: An Index System of Human Well-Being	PLOS ONE			English	Article							SERVICES; CONSERVATION; TRADEOFFS; SUSTAINABILITY; SCIENCE; LEVEL	Understanding the linkages between ecosystem services (ES) and human well-being (HWB) is crucial to sustain the flow of ES for HWB. The Millennium Ecosystem Assessment (MA) provided a state-of-the-art synthesis of such knowledge. However, due to the complexity of the linkages between ES and HWB, there are still many knowledge gaps, and in particular a lack of quantitative indicators and integrated models based on the MA framework. To fill some of these research needs, we developed a quantitative index system to measure HWB, and assessed the impacts of an external driver - the 2008 Wenchuan Earthquake - on HWB. Our results suggest that our proposed index system of HWB is well-designed, valid and could be useful for better understanding the linkages between ES and HWB. The earthquake significantly affected households' well-being in our demonstration sites. Such impacts differed across space and across the five dimensions of the sub-index (i.e., the basic material for good life, security, health, good social relations, and freedom of choice and action). Since the conceptual framework is based on the generalizable MA framework, our methods should also be applicable to other study areas.	[Yang, Wu; Dietz, Thomas; Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Dietz, Thomas] Michigan State Univ, Dept Sociol, Environm Sci & Policy Program, E Lansing, MI 48824 USA; [Dietz, Thomas] Michigan State Univ, Anim Studies Program, E Lansing, MI 48824 USA; [Kramer, Daniel Boyd] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA; [Kramer, Daniel Boyd] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Chen, Xiaodong] Univ N Carolina, Dept Geog, Chapel Hill, NC USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill	Yang, W (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	yangwu1201@gmail.com	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Dietz, Thomas/0000-0001-9399-0784; Yang, Wu/0000-0002-1682-3349	National Science Foundation (NSF) [0709717, OISE-0729709]; National Aeronautics and Space Administration (NASA) [NNX08AL04G]; Michigan State University AgBioResearch; Michigan State University's Environmental Science and Policy Program; Graduate Office	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Michigan State University AgBioResearch; Michigan State University's Environmental Science and Policy Program; Graduate Office	The authors gratefully acknowledge financial support from the National Science Foundation (NSF Award Numbers 0709717 and OISE-0729709), the National Aeronautics and Space Administration (NASA Award Number NNX08AL04G), Michigan State University AgBioResearch (http://agbioresearch.msu.edu/), and fellowships from Michigan State University's Environmental Science and Policy Program (http://www.espp.msu.edu/) and Graduate Office (http://grad.msu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah S, 2008, ECOL ECON, V65, P35, DOI 10.1016/j.ecolecon.2007.11.009; An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2010, EC EC BIOD MAINSTR E; Axinn WG, 1999, SOC SCI RES, V28, P243, DOI 10.1006/ssre.1998.0641; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Butler CD, 2006, ECOL SOC, V11; Camfield L, 2008, J HEALTH PSYCHOL, V13, P764, DOI 10.1177/1359105308093860; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chang J, 2011, ECOL ECON, V70, P740, DOI 10.1016/j.ecolecon.2010.11.011; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; Diener E, 2009, SCI WELL BEING COLLE; Diener E, 2009, S AFR J PSYCHOL, V39, P391, DOI 10.1177/008124630903900402; Dietz T, 2009, HUM ECOL REV, V16, P114; Dietz T, 2012, APPL GEOGR, V32, P21, DOI 10.1016/j.apgeog.2010.10.011; Eagly A.H., 1997, ENV ETHICS BEHAV, P122; Elliott JR, 2006, SOC SCI RES, V35, P295, DOI 10.1016/j.ssresearch.2006.02.003; Freedman D, 1988, Sociol Methodol, V18, P37, DOI 10.2307/271044; Gefen D., 2020, COMMUN ASSOC INF SYS, V4, P7, DOI [10.17705/1CAIS.00407, DOI 10.17705/1CAIS.00407, 10.17705/1cais.00407]; Gunderson L, 2010, ECOL SOC, V15; Jordan SJ, 2010, ENVIRON SCI TECHNOL, V44, P1530, DOI 10.1021/es902597u; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Li Y, 2013, LAND USE POLICY, V33, P42, DOI 10.1016/j.landusepol.2012.12.003; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Maginnis S., 2004, GETTING BIODIVERSITY, P321, DOI [DOI 10.7312/MCSH12764-003, 10.7312/mcsh12764-016, DOI 10.7312/MCSH12764-016]; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Muthen LK., 1998, MPLUS USERS GUIDE, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; [欧阳志云 OUYANG ZhiYun], 2008, [生态学报, Acta Ecologica Sinica], V28, P5801; Pereira E., 2005, Ecology and Society, V10, P14; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Rosa EA., 2010, HUMAN FOOTPRINTS GLO; Rowe K., 2006, MEASUREMENT COMPOSIT; Rowe KS, 1997, J ABNORM CHILD PSYCH, V25, P425, DOI 10.1023/A:1022678013979; SANDOVAL J, 1981, J ABNORM CHILD PSYCH, V9, P203, DOI 10.1007/BF00919115; State Planning Group of Post-Wenchuan Earthquake Restoration and Reconstruction, 2008, STAT OV PLANN POSTW; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; Swallow BM, 2009, ENVIRON SCI POLICY, V12, P504, DOI 10.1016/j.envsci.2008.11.003; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Vemuri AW, 2006, ECOL ECON, V58, P119, DOI 10.1016/j.ecolecon.2005.02.008; World Wildlife Fund, 2007, TERR EC; Xinhua News Agency, 2008, XINHUA NEWS AGENCY; Yang W, 2013, J ENV MANAG IN PRESS, DOI [10.1016/j.jenvman.2013.1004.1019, DOI 10.1016/J.JENVMAN.2013.1004.1019]; Yang W, 2008, ECOL ECON, V68, P116, DOI 10.1016/j.ecolecon.2008.02.008; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064581	53	19	28	7	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64582	10.1371/journal.pone.0064582	http://dx.doi.org/10.1371/journal.pone.0064582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717635	Green Submitted, gold, Green Published			2022-12-25	WOS:000320362700158
J	Motizuki, M; Isogaya, K; Miyake, K; Ikushima, H; Kubota, T; Miyazono, K; Saitoh, M; Miyazawa, K				Motizuki, Mitsuyoshi; Isogaya, Kazunobu; Miyake, Kunio; Ikushima, Hiroaki; Kubota, Takeo; Miyazono, Kohei; Saitoh, Masao; Miyazawa, Keiji			Oligodendrocyte Transcription Factor 1 (Olig1) Is a Smad Cofactor Involved in Cell Motility Induced by Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; SIGNAL-TRANSDUCTION; SYNEXPRESSION GROUP; INITIATING CELLS; I RECEPTORS; C-SKI; CANCER; PROTEINS; PIN1	Transforming growth factor (TGF)-beta plays crucial roles in embryonic development and adult tissue homeostasis by eliciting various cellular responses in target cells. TGF-beta signaling is principally mediated through receptor-activated Smad proteins, which regulate expression of target genes in cooperation with other DNA-binding transcription factors (Smad cofactors). In this study, we found that the basic helix-loop-helix transcription factor Olig1 is a Smad cofactor involved in TGF-beta-induced cell motility. Knockdown of Olig1 attenuated TGF-beta-induced cell motility in chamber migration and wound healing assays. In contrast, Olig1 knockdown had no effect on bone morphogenetic protein-induced cell motility, TGF-beta-induced cytostasis, or epithelial-mesenchymal transition. Furthermore, we observed that cooperation of Smad2/3 with Olig1 is regulated by a peptidyl-prolyl cis/trans-isomerase, Pin1. TGF-beta-induced cell motility, induction of Olig1-regulated genes, and physical interaction between Smad2/3 and Olig1 were all inhibited after knockdown of Pin1, indicating a novel mode of regulation of Smad signaling. We also found that Olig1 interacts with the L3 loop of Smad3. Using a synthetic peptide corresponding to the L3 loop of Smad3, we succeeded in selectively inhibiting TGF-beta-induced cell motility. These findings may lead to a new strategy for selective regulation of TGF-beta-induced cellular responses.	[Motizuki, Mitsuyoshi; Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan; [Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Dept Epigenet Med, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan; [Isogaya, Kazunobu; Ikushima, Hiroaki; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan	University of Yamanashi; University of Yamanashi; University of Tokyo	Miyazawa, K (corresponding author), Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan.	keiji-miyazawa@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014		Japan Society for the Promotion of Science (JSPS) KAKENHI [40209896]; JSPS; Fugaku Memorial Foundation; Grants-in-Aid for Scientific Research [22112002] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fugaku Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 40209896, JSPS Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling" and the Fugaku Memorial Foundation.	Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ekman M, 2012, MOL BIOL CELL, V23, P2109, DOI 10.1091/mbc.E10-12-1000; Germain S, 2000, GENE DEV, V14, P435; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Ishii R, 2012, EMBO J, V31, P2541, DOI 10.1038/emboj.2012.77; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	40	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18911	18922		10.1074/jbc.M113.480996	http://dx.doi.org/10.1074/jbc.M113.480996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720758	Green Published, hybrid			2022-12-25	WOS:000321335800029
J	Chen, ZC; Lee, KS; Chen, LJ; Wang, LY; Niu, HS; Cheng, JT				Chen, Zhih-Cherng; Lee, Kung Shing; Chen, Li-Jen; Wang, Lin-Yu; Niu, Ho-Shan; Cheng, Juei-Tang			Cardiac Peroxisome Proliferator-Activated Receptor delta (PPAR delta) as a New Target for Increased Contractility without Altering Heart Rate	PLOS ONE			English	Article							TROPONIN-I PHOSPHORYLATION; FATTY-ACID OXIDATION; CARDIOTONIC ACTIVITY; REGULATORY FUNCTION; SKELETAL-MUSCLE; SALIVARY-GLANDS; DIABETIC-RATS; SEPTIC SHOCK; DOBUTAMINE; BETA/DELTA	Background and Aims: Agents having a positive inotropic effect on the heart are widely used for the treatment of heart failure. However, these agents have the side effect of altering heart rate. It has been established that peroxisome proliferator-activated receptor delta (PPAR delta) is mediated in cardiac contraction, however the effect on heart rate is unknown. Thus, we used an agonist of PPAR delta, GW0742, to investigate this issue in the present study. Methods and Results: We used isolated hearts in Langendorff apparatus and hemodynamic analysis in catheterized rats to measure the actions of GW0742 extra-vivo and in vivo. In diabetic rats with heart failure, GW0742 at a dose sufficient to activate PPAR delta reversed cardiac contraction without changes in heart rate. In normal rats, PPAR delta enhanced cardiac contractility and hemodynamic dP/dt(max) significantly more than dobutamine. Both actions were diminished by GSK0660 at a dose enough to block PPAR delta. However, GW0742 at the same dose failed to modify heart rate, although it did produce a mild increase in blood pressure. Detection of intracellular calcium level and Western blotting analysis showed that the intracellular calcium concentration and troponin I phosphorylation were both enhanced by GW0742. Conclusion: Activation of PPAR delta by GW0742 increases cardiac contractility but not heart rate. Thus, PPAR delta may be a suitable target for the development of inotropic agents to treat heart failure without changing heart rate.	[Chen, Zhih-Cherng] Chi Mei Med Ctr, Dept Cardiol, Tainan, Taiwan; [Chen, Zhih-Cherng; Cheng, Juei-Tang] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lee, Kung Shing] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung, Taiwan; [Lee, Kung Shing] Kaohsiung Med Univ, Dept Surg, Kaohsiung, Taiwan; [Chen, Li-Jen; Cheng, Juei-Tang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wang, Lin-Yu] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Niu, Ho-Shan] Tzu Chi Coll Technol, Dept Nursing, Hualien, Taiwan; [Chen, Zhih-Cherng] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; National Cheng Kung University; Chi Mei Hospital; Tzu Chi University of Science & Technology; Chia Nan University of Pharmacy & Science	Cheng, JT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	m980103@mail.chimei.org.tw	wang, lin/HHM-2225-2022		Chi-Mei Medical Center of the Taiwan, Republic of China [CMFHR10158]	Chi-Mei Medical Center of the Taiwan, Republic of China	The present study was supported in part by a grant from the Chi-Mei Medical Center (CMFHR10158) of the Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmed I, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-24; ALOUSI AA, 1979, CIRC RES, V45, P666, DOI 10.1161/01.RES.45.5.666; ANGELAKOS ET, 1969, ANN NY ACAD SCI, V156, P219, DOI 10.1111/j.1749-6632.1969.tb16730.x; Antman E M, 1989, Adv Intern Med, V34, P425; Bao YG, 2012, EUR J PHARMACOL, V690, P142, DOI 10.1016/j.ejphar.2012.06.039; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; BEISER GD, 1970, CIRCULATION, V42, P805, DOI 10.1161/01.CIR.42.5.805; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; BORTHNE K, 1995, J MOL CELL CARDIOL, V27, P693, DOI 10.1016/S0022-2828(08)80060-0; Chen ZC, 2012, HORM METAB RES; Chen ZC, 2011, BRIT J PHARMACOL, V163, P390, DOI 10.1111/j.1476-5381.2011.01212.x; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Cheng LH, 2004, BIOCHEM BIOPH RES CO, V313, P277, DOI 10.1016/j.bbrc.2003.11.127; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chou MT, 2012, SCI WORLD J, DOI 10.1100/2012/248320; Cohen G, 2011, DIABETES, V60, P2830, DOI 10.2337/db11-0347; Coletta C, 1998, G Ital Cardiol, V28, P349; Collino M, 2011, FREE RADICAL BIO MED, V50, P345, DOI 10.1016/j.freeradbiomed.2010.10.710; Dani C, 2007, J MATERN-FETAL NEO M, V20, P325, DOI 10.1080/14767050701227992; Editor, 2011, MED LETT DRUGS THER, V53, P90; Gao S, 2012, PEPTIDES, V36, P199, DOI 10.1016/j.peptides.2012.05.004; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; HALLAQ HA, 1989, P NATL ACAD SCI USA, V86, P10080, DOI 10.1073/pnas.86.24.10080; HJEMDAHL P, 1993, BAILLIERE CLIN ENDOC, V7, P307, DOI 10.1016/S0950-351X(05)80179-X; Iino Kenji, 2007, Nihon Rinsho, V65 Suppl 5, P30; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Zarzuelo MJ, 2011, HYPERTENSION, V58, P733, DOI 10.1161/HYPERTENSIONAHA.111.174490; Kagaya Yutaka, 2007, Nihon Rinsho, V65 Suppl 5, P25; Kapoor A, 2010, AM J RESP CRIT CARE, V182, P1506, DOI 10.1164/rccm.201002-0240OC; KATZ AM, 1980, CIRC RES, V46, P887, DOI 10.1161/01.RES.46.6.887; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Leone M, 2008, CURR OPIN ANESTHESIO, V21, P141, DOI 10.1097/ACO.0b013e3282f46d20; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Liu XL, 1996, BBA-MOL BASIS DIS, V1316, P78, DOI 10.1016/0925-4439(96)00007-5; Quintela AM, 2012, FREE RADICAL BIO MED, V53, P730, DOI 10.1016/j.freeradbiomed.2012.05.045; MARQUARDT R, 1979, MED WELT, V30, P707; McEntee K, 1998, RES VET SCI, V64, P45, DOI 10.1016/S0034-5288(98)90114-X; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Oh YJ, 2005, J INT MED RES, V33, P329, DOI 10.1177/147323000503300308; Ohtsuki I, 2008, BIOCHEM BIOPH RES CO, V369, P62, DOI 10.1016/j.bbrc.2007.11.187; Paterniti I, 2010, J PHARMACOL EXP THER, V333, P465, DOI 10.1124/jpet.110.165605; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Sarazan RD, 2012, J PHARMACOL TOX MET, V66, P71, DOI 10.1016/j.vascn.2012.05.009; SCHNEYER CA, 1986, J ORAL PATHOL MED, V15, P66, DOI 10.1111/j.1600-0714.1986.tb00579.x; SCHNEYER CA, 1985, J AUTONOM NERV SYST, V13, P275, DOI 10.1016/0165-1838(85)90017-7; SCRIVEN AJI, 1983, CLIN PHARMACOL THER, V33, P710, DOI 10.1038/clpt.1983.97; Seldinger Sven Ivar, 2008, Acta Radiol Suppl (Stockholm), V434, P47, DOI 10.1080/02841850802133386; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025618; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; TATE CA, 1991, SPORTS MED, V12, P208, DOI 10.2165/00007256-199112030-00005; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wu JY, 2002, CHINESE J PHYSIOL, V45, P155; Yang QF, 2007, J MOL MED-JMM, V85, P697, DOI 10.1007/s00109-007-0170-9; Zaugg Christian E, 2004, Indian Pacing Electrophysiol J, V4, P85; Zivkovic V, 2012, MOL CELL BIOCHEM, V370, P59, DOI 10.1007/s11010-012-1398-4	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64229	10.1371/journal.pone.0064229	http://dx.doi.org/10.1371/journal.pone.0064229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724037	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000050
J	Hertlein, T; Sturm, V; Jakob, P; Ohlsen, K				Hertlein, Tobias; Sturm, Volker; Jakob, Peter; Ohlsen, Knut			F-19 Magnetic Resonance Imaging of Perfluorocarbons for the Evaluation of Response to Antibiotic Therapy in a Staphylococcus aureus Infection Model	PLOS ONE			English	Article							UNITED-STATES; INFLAMMATION; THIGH; MRI	Background: The emergence of antibiotic resistant bacteria in recent decades has highlighted the importance of developing new drugs to treat infections. However, in addition to the design of new drugs, the development of accurate preclinical testing methods is essential. In vivo imaging technologies such as bioluminescence imaging (BLI) or magnetic resonance imaging (MRI) are promising approaches. In a previous study, we showed the effectiveness of F-19 MRI using perfluorocarbon (PFC) emulsions for detecting the site of Staphylococcus aureus infection. In the present follow-up study, we investigated the use of this method for in vivo visualization of the effects of antibiotic therapy. Methods/Principal findings: Mice were infected with S. aureus Xen29 and treated with 0.9% NaCl solution, vancomycin or linezolid. Mock treatment led to the highest bioluminescence values during infection followed by vancomycin treatment. Counting the number of colony-forming units (cfu) at 7 days post-infection (p.i.) showed the highest bacterial burden for the mock group and the lowest for the linezolid group. Administration of PFCs at day 2 p.i. led to the accumulation of F-19 at the rim of the abscess in all mice (in the shape of a hollow sphere), and antibiotic treatment decreased the F-19 signal intensity and volume. Linezolid showed the strongest effect. The BLI, cfu, and MRI results were comparable. Conclusions: F-19-MRI with PFCs is an effective non-invasive method for assessing the effects of antibiotic therapy in vivo. This method does not depend on pathogen specific markers and can therefore be used to estimate the efficacy of antibacterial therapy against a broad range of clinically relevant pathogens, and to localize sites of infection.	[Hertlein, Tobias; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Sturm, Volker; Jakob, Peter] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Jakob, P (corresponding author), Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany.	peja@physik.uni-wuerzburg.de; knut.ohlsen@mail.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft [SFB630 B5, TR-34 Z3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by grants of the Deutsche Forschungsgemeinschaft SFB630 B5 and TR-34 Z3. SFB630 B5 and TR-34 Z3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Beckmann N, 2007, NMR BIOMED, V20, P154, DOI 10.1002/nbm.1153; CRAIG WA, 1991, J ANTIMICROB CHEMOTH, V27, P29, DOI 10.1093/jac/27.suppl_C.29; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Marzola P, 1999, MAGN RESON MATER PHY, V9, P21; Mera RM, 2011, MICROB DRUG RESIST, V17, P321, DOI 10.1089/mdr.2010.0193; Pohmann R, 2001, MAGN RESON MED, V45, P817, DOI 10.1002/mrm.1110; Sandanaraj BS, 2010, FUTURE MED CHEM, V2, P317, DOI 10.4155/FMC.09.175; Speck O, 2002, MAGNET RESON MED, V48, P633, DOI 10.1002/mrm.10279; Stoll G, 2012, WIRES NANOMED NANOBI, V4, P438, DOI 10.1002/wnan.1168; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Wang JL, 2005, CURR TOP MED CHEM, V5, P1053, DOI 10.2174/156802605774297056	21	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64440	10.1371/journal.pone.0064440	http://dx.doi.org/10.1371/journal.pone.0064440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724049	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000057
J	Lefeuvre, P; Cellier, G; Remenant, B; Chiroleu, F; Prior, P				Lefeuvre, Pierre; Cellier, Gilles; Remenant, Benoit; Chiroleu, Frederic; Prior, Philippe			Constraints on Genome Dynamics Revealed from Gene Distribution among the Ralstonia solanacearum Species	PLOS ONE			English	Article							NATURAL TRANSFORMATION; POPULATION-STRUCTURE; BURKHOLDERIA; STRAINS; COMPLEX; DIVERSITY; HOST; IDENTIFICATION; PHYLOGENY; EVOLUTION	Because it is suspected that gene content may partly explain host adaptation and ecology of pathogenic bacteria, it is important to study factors affecting genome composition and its evolution. While recent genomic advances have revealed extremely large pan-genomes for some bacterial species, it remains difficult to predict to what extent gene pool is accessible within or transferable between populations. As genomes bear imprints of the history of the organisms, gene distribution pattern analyses should provide insights into the forces and factors at play in the shaping and maintaining of bacterial genomes. In this study, we revisited the data obtained from a previous CGH microarrays analysis in order to assess the genomic plasticity of the R. solanacearum species complex. Gene distribution analyses demonstrated the remarkably dispersed genome of R. solanacearum with more than half of the genes being accessory. From the reconstruction of the ancestral genomes compositions, we were able to infer the number of gene gain and loss events along the phylogeny. Analyses of gene movement patterns reveal that factors associated with gene function, genomic localization and ecology delineate gene flow patterns. While the chromosome displayed lower rates of movement, the megaplasmid was clearly associated with hot-spots of gene gain and loss. Gene function was also confirmed to be an essential factor in gene gain and loss dynamics with significant differences in movement patterns between different COG categories. Finally, analyses of gene distribution highlighted possible highways of horizontal gene transfer. Due to sampling and design bias, we can only speculate on factors at play in this gene movement dynamic. Further studies examining precise conditions that favor gene transfer would provide invaluable insights in the fate of bacteria, species delineation and the emergence of successful pathogens.	[Lefeuvre, Pierre; Cellier, Gilles; Remenant, Benoit; Chiroleu, Frederic; Prior, Philippe] Univ Reunion, CIRAD, CIRAD UMR Peuplements Vegetaux & Bioagresseurs Mi, St Pierre, Reunion, France; [Cellier, Gilles] Anses, Lab Sante Vegetaux, Unite Ravageurs & Agents Pathogenes Tropicaux, St Pierre, Reunion, France; [Remenant, Benoit; Prior, Philippe] INRA, Dept Sante Plantes & Environm, Paris, France	CIRAD; University of La Reunion; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; INRAE	Lefeuvre, P (corresponding author), Univ Reunion, CIRAD, CIRAD UMR Peuplements Vegetaux & Bioagresseurs Mi, St Pierre, Reunion, France.	pierre.lefeuvre@cirad.fr	Cellier, Gilles/B-5891-2015	Cellier, Gilles/0000-0003-2587-3169; CHIROLEU, Frederic/0000-0002-4874-5357; Lefeuvre, Pierre/0000-0003-2645-8098	Federation Nationale des Producteurs de Plants de Pommes de Terre (Mission-DAR of the French Ministry of Food, Agriculture, and Fisheries) [7124]; European Regional Development Fund (ERDF) of the European Union; Conseil Regional de La Reunion; INRA (PARASOL project)	Federation Nationale des Producteurs de Plants de Pommes de Terre (Mission-DAR of the French Ministry of Food, Agriculture, and Fisheries); European Regional Development Fund (ERDF) of the European Union; Conseil Regional de La Reunion; INRA (PARASOL project)	This work was funded by the Federation Nationale des Producteurs de Plants de Pommes de Terre (Mission-DAR, Grant-7124 of the French Ministry of Food, Agriculture, and Fisheries) and the European Regional Development Fund (ERDF) of the European Union, the Conseil Regional de La Reunion and INRA (PARASOL project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Aris-Brosou S, 2005, MOL BIOL EVOL, V22, P200, DOI 10.1093/molbev/msi006; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; Bertolla F, 1999, MOL PLANT MICROBE IN, V12, P467, DOI 10.1094/MPMI.1999.12.5.467; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Canonne J, 2012, PLANT SIGNAL BEHAV, V7, P217, DOI 10.4161/psb.18885; Castillo-Ramirez S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-300; Cellier G, 2012, APPL ENVIRON MICROB, V78, P2367, DOI 10.1128/AEM.06123-11; Cellier G, 2010, PHYTOPATHOLOGY, V100, P1250, DOI 10.1094/PHYTO-02-10-0059; Coenye T, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-10; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; COOK D, 1989, Molecular Plant-Microbe Interactions, V2, P113, DOI 10.1094/MPMI-2-113; Coupat B, 2008, FEMS MICROBIOL ECOL, V66, P14, DOI 10.1111/j.1574-6941.2008.00552.x; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Genin S, 2004, ANNU REV PHYTOPATHOL, V42, P107, DOI 10.1146/annurev.phyto.42.011204.104301; GILLINGS MR, 1994, BACTERIAL WILT, P95; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Guidot A, 2009, ISME J, V3, P549, DOI 10.1038/ismej.2009.14; Haegeman B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-196; Hao WL, 2011, GENOME BIOL EVOL, V3, P1406, DOI 10.1093/gbe/evr119; HAYWARD AC, 1964, J APPL BACTERIOL, V27, P265, DOI 10.1111/j.1365-2672.1964.tb04912.x; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Keymer DP, 2011, APPL ENVIRON MICROB, V77, P537, DOI 10.1128/AEM.02062-10; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marteyn BS, 2012, GUT MICROBES, V3, P104, DOI 10.4161/gmic.19325; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remenant B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-379; RODLEY PD, 1995, MOL MICROBIOL, V17, P57, DOI 10.1111/j.1365-2958.1995.mmi_17010057.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Shen K, 2006, INFECT IMMUN, V74, P5272, DOI 10.1128/IAI.00546-06; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STOUTHAMER AH, 1993, ANTON LEEUW INT J G, V63, P39, DOI 10.1007/BF00871730; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vial, 2007, J MICROBIOL BIOTECHN, V17, P1407; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Villa Joselito E., 2005, Journal of General Plant Pathology, V71, P39, DOI 10.1007/s10327-004-0156-1; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	63	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63155	10.1371/journal.pone.0063155	http://dx.doi.org/10.1371/journal.pone.0063155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723974	Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000006
J	Yuan, J; Liu, Y; Huang, WL; Zhou, SY; Ling, SQ; Chen, JQ				Yuan, Jin; Liu, Yi; Huang, Weilan; Zhou, Shiyou; Ling, Shiqi; Chen, Jiaqi			The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) Gene	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ALLOGRAFT SURVIVAL; TGF-BETA; CELLS; TRANSPLANTATION; RANTES; RAT; INDUCTION	Purpose: To investigate the protective effects of interleukin-1 receptor antagonist (IL-1ra) gene transfer in a rat model of corneal graft rejection. Methods: We constructed a recombinant plasmid (pcDNA3.1-hIL-1ra) with high IL-1ra expression in eukaryotic cells. Using a Wistar-SD rat model of corneal graft rejection, we examined the effects of IL-1ra in vivo after cationic polymer jetPEI-mediated nonviral gene delivery. Four groups were included: negative controls (group I, n = 20), pcDNA3.1-hIL-1ra corneal stromal injection (group II, n = 34), pcDNA3.1-hIL-1ra anterior chamber injection (group III, n = 34), and 500 mg/ml IL-1ra protein subconjunctiva injection (group IV, n = 20). IL-1ra expression after transfection was evaluated by real-time polymerase chain reaction (RT-PCR) and western blotting. The rejection indices of corneal grafts were analysed in the different groups. The expression levels of transforming growth factor beta 1 (TGF-beta 1), inflammatory chemokines including RANTES, interleukin-1 (IL-1) and the numbers of CD4+ and CD8+ T cells in the grafts were determined by biochemical assays at different time points after corneal transplantation. Results: Various degrees of inflammatory cell infiltration and graft neovascularisation were observed by histopathology. After injecting the pcDNA3.1-hIL-1ra plasmid into the cornea, IL-1ra mRNA and protein expression was detected in the corneal stroma and reached a peak on day 3. The graft survival curves indicated that the corneal transparency rates of grafts in the IL-1ra gene-treated group and the IL-1ra protein-treated group were higher compared with the untreated group (P<0.05). During the period of acute rejection, TGF-beta 1, RANTES, IL-1 alpha and IL-1 beta levels in the grafts in the IL-1ra treatment groups were lower than the control group (P<0.05). CD4+ and CD8+ T cell counts were reduced significantly in the corneal grafts of groups II, III and IV compared with group I (P<0.05). Conclusion: Interleukin-1 receptor antagonist (IL-1ra) gene transfer treatment inhibits graft rejection after corneal transplantation through the downregulation of immune mediators.	[Yuan, Jin; Huang, Weilan; Zhou, Shiyou; Chen, Jiaqi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yi] Nanjing Hosp Tradit Chinese Med, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Ling, Shiqi] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ling, SQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	104014121@qq.com; liuyiphd@yahoo.com.cn			Natural Science Foundation of China [30801263]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (30801263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEZRA D, 1990, ARCH OPHTHALMOL-CHIC, V108, P573, DOI 10.1001/archopht.1990.01070060121061; Comer RM, 2002, INVEST OPHTH VIS SCI, V43, P1095; Dana MR, 1997, TRANSPLANTATION, V63, P1501, DOI 10.1097/00007890-199705270-00022; Dana Reza, 2007, Trans Am Ophthalmol Soc, V105, P330; Dekaris I, 1999, CURR EYE RES, V19, P456, DOI 10.1076/ceyr.19.5.456.5292; Inoue K, 2001, ACTA OPHTHALMOL SCAN, V79, P251, DOI 10.1034/j.1600-0420.2001.790308.x; IWAMOTO TAKEO, 1965, INVEST OPHTHALMOL, V4, P815; Jie Y, 2004, TRANSPL P, V36, P3267, DOI 10.1016/j.transproceed.2004.10.075; Jin Y, 2012, CURR EYE RES, V37, P997; Khanna AK, 1999, TRANSPLANTATION, V67, P882, DOI 10.1097/00007890-199903270-00016; Klebe S, 2001, TRANSPLANTATION, V71, P1214, DOI 10.1097/00007890-200105150-00006; Larkin DFP, 1997, CLIN EXP IMMUNOL, V107, P381, DOI 10.1111/j.1365-2249.1997.279-ce1171.x; Masle R, 1994, CORNEA, V13, P324; NIEDERKORN JY, 1995, EYE, V9, P215, DOI 10.1038/eye.1995.42; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; Rayner SA, 2001, INVEST OPHTH VIS SCI, V42, P1568; Sano Y, 1995, INVEST OPHTH VIS SCI, V36, P211; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Tran MT, 1996, INVEST OPHTH VIS SCI, V37, P987; WALLICK SC, 1990, J EXP MED, V172, P1777, DOI 10.1084/jem.172.6.1777; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILLIAMS KA, 1985, INVEST OPHTH VIS SCI, V26, P23; Yamada J, 2000, INVEST OPHTH VIS SCI, V41, P4203; Yamagami S, 1999, INVEST OPHTH VIS SCI, V40, P2892	24	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e60714	10.1371/journal.pone.0060714	http://dx.doi.org/10.1371/journal.pone.0060714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723965	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000002
J	Roullier, C; Duputie, A; Wennekes, P; Benoit, L; Bringas, VMF; Rossel, G; Tay, D; McKey, D; Lebot, V				Roullier, Caroline; Duputie, Anne; Wennekes, Paul; Benoit, Laure; Fernandez Bringas, Victor Manuel; Rossel, Genoveva; Tay, David; McKey, Doyle; Lebot, Vincent			Disentangling the Origins of Cultivated Sweet Potato (Ipomoea batatas (L.) Lam.)	PLOS ONE			English	Article							ASSESSING GENETIC DIVERSITY; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY CONSEQUENCES; CHLOROPLAST GENOME; WILD RELATIVES; MICROSATELLITES; CONVOLVULACEAE; DOMESTICATION; SPECIATION; INFERENCE	Sweet potato (Ipomoea batatas (L.) Lam., Convolvulaceae) counts among the most widely cultivated staple crops worldwide, yet the origins of its domestication remain unclear. This hexaploid species could have had either an autopolyploid origin, from the diploid I. trifida, or an allopolyploid origin, involving genomes of I. trifida and I. triloba. We generated molecular genetic data for a broad sample of cultivated sweet potatoes and its diploid and polyploid wild relatives, for noncoding chloroplast and nuclear ITS sequences, and nuclear SSRs. Our data did not support an allopolyploid origin for I. batatas, nor any contribution of I. triloba in the genome of domesticated sweet potato. I. trifida and I. batatas are closely related although they do not share haplotypes. Our data support an autopolyploid origin of sweet potato from the ancestor it shares with I. trifida, which might be similar to currently observed tetraploid wild Ipomoea accessions. Two I. batatas chloroplast lineages were identified. They show more divergence with each other than either does with I. trifida. We thus propose that cultivated I. batatas have multiple origins, and evolved from at least two distinct autopolyploidization events in polymorphic wild populations of a single progenitor species. Secondary contact between sweet potatoes domesticated in Central America and in South America, from differentiated wild I. batatas populations, would have led to the introgression of chloroplast haplotypes of each lineage into nuclear backgrounds of the other, and to a reduced divergence between nuclear gene pools as compared with chloroplast haplotypes.	[Roullier, Caroline; Benoit, Laure; Lebot, Vincent] CIRAD, Unite Mixte Rech Ameliorat & Adaptat Plantes UMR, Montpellier, France; [Roullier, Caroline; Duputie, Anne; Wennekes, Paul; Benoit, Laure; McKey, Doyle] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Roullier, Caroline; McKey, Doyle] Univ Montpellier 2, Montpellier, France; [Fernandez Bringas, Victor Manuel; Rossel, Genoveva; Tay, David] Int Potato Ctr CIP, Lima, Peru; [McKey, Doyle] Inst Univ France, Paris, France	CIRAD; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Montpellier; CGIAR; International Potato Center (CIP); Institut Universitaire de France	Roullier, C (corresponding author), CIRAD, Unite Mixte Rech Ameliorat & Adaptat Plantes UMR, Montpellier, France.	carolineroullier@hotmail.com		Duputie, Anne/0000-0003-2213-7940; Rossel, Genoveva/0000-0003-2796-9674	Pacific funds; French Ministry of Higher Education and Research; IOF grant within the European Commission's 7th Framework Programme [TRECC-2009-237228]	Pacific funds; French Ministry of Higher Education and Research; IOF grant within the European Commission's 7th Framework Programme	This study was funded by grants from the "Pacific funds'' distributed by the French Ministry of European and Foreign Affairs. C. Roullier was supported by a doctoral grant from the French Ministry of Higher Education and Research. A. Duputie was supported by an IOF grant within the European Commission's 7th Framework Programme (TRECC-2009-237228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; [Anonymous], 2009, TROPICAL ROOT TUBER; Austin D.F., 1988, EXPLORATION MAINTENA, P27; AUSTIN DF, 1991, ECON BOT, V45, P251, DOI 10.1007/BF02862052; Bardy KE, 2010, MOL PHYLOGENET EVOL, V57, P771, DOI 10.1016/j.ympev.2010.06.025; BOHAC JR, 1993, ECON BOT, V47, P193, DOI 10.1007/BF02862022; Buteler MI, 1999, THEOR APPL GENET, V99, P123, DOI 10.1007/s001220051216; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Emshwiller E, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P153; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fortune PM, 2007, MOL PHYLOGENET EVOL, V43, P1040, DOI 10.1016/j.ympev.2006.11.018; Gao M, 2011, EUPHYTICA, V177, P111, DOI 10.1007/s10681-010-0275-z; Grant V., 1981, PLANT SPECIATION, Vsecond; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HILU KW, 1993, AM J BOT, V80, P1494, DOI 10.2307/2445679; Huang JC, 2000, THEOR APPL GENET, V100, P1050, DOI 10.1007/s001220051386; Huang JC, 2002, GENET RESOUR CROP EV, V49, P541, DOI 10.1023/A:1021290927362; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CE, 2007, P NATL ACAD SCI USA, V104, P14389, DOI 10.1073/pnas.0702193104; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Jarret R. L., 1994, Genetic Resources and Crop Evolution, V41, P165, DOI 10.1007/BF00051633; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Kobayashi M., 1984, Proceedings: sixth symposium of the International Society for Tropical Root Crops, Lima, Peru, 21-26 February, 1983, P561; Komaki K, 1998, BREEDING SCI, V48, P281; MAGOON ML, 1970, THEOR APPL GENET, V40, P360, DOI 10.1007/BF00285415; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; MCDONALD JA, 1990, BRITTONIA, V42, P116, DOI 10.2307/2807625; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Motta-Aldana JR, 2010, CROP SCI, V50, P1773, DOI 10.2135/cropsci2009.12.0706; ORJEDA G, 1991, THEOR APPL GENET, V83, P159, DOI 10.1007/BF00226245; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Parisod C, 2007, MOL ECOL, V16, P2755, DOI 10.1111/j.1365-294X.2007.03315.x; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rajapakse S, 2004, MOL PHYLOGENET EVOL, V30, P623, DOI 10.1016/S1055-7903(03)00249-5; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Ravi V., 2009, J ROOT CROPS, V35, P1; Robertson A, 2010, MOL ECOL, V19, P1675, DOI 10.1111/j.1365-294X.2010.04585.x; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SHIOTANI I, 1990, JPN J BREED, V40, P159; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Ugent D, 1988, 16 CIP, V16, P1; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhang DP, 2000, GENET RESOUR CROP EV, V47, P659, DOI 10.1023/A:1026520507223; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2	58	81	92	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e62707	10.1371/journal.pone.0062707	http://dx.doi.org/10.1371/journal.pone.0062707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23723970	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100003
J	Ahn, SG; Lee, HM; Cho, SH; Bae, SJ; Lee, SA; Hwang, SH; Jeong, J; Lee, HD				Ahn, Sung Gwe; Lee, Hak Min; Cho, Sang-Hoon; Bae, Suk Jin; Lee, Seung Ah; Hwang, Seung Hyun; Jeong, Joon; Lee, Hy-De			The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; TUMOR DORMANCY; RISK; HAZARD; TIME; SURVIVAL; CELLS	Background: Probability of recurrence in patients with estrogen receptor (ER)-positive breast cancer remains constant for long periods. We compared tumor burden impact on late versus early recurrence in our cohort with long-term follow-up. Methods: Five hundred and ninety five patients diagnosed with ER-positive breast cancer between 1989 and 2001 were classified into three groups: early recurrence within 5 years, late recurrence after 5 years, and no recurrence. We identified prognostic factors among the groups using logistic regression analysis. Results: At median follow-up of 11.7 years, among 595 ER-positive women, 98 (16.4%) had early recurrence and 58 (9.7%) had late recurrence. On multivariate analysis, higher nodal stage (N0 vs. N2, odds ratio [OR] 3.189; N0 vs. N3, OR 9.948), higher histologic grade (grade 1 vs. grade 2, OR 3.896; grade 1 vs. grade 3, OR 5.945), age >35 years (OR 0.295), and receiving endocrine therapy (OR 0.293) affected early recurrence. Compared to no recurrence, receiving endocrine therapy (OR 0.285) was solely related to decreased risk of late recurrence. Increased risk of early recurrence was noted with the higher nodal stage when early and no recurrences were compared. This phenomenon was not found in late recurrence. In the last comparison between the early and late recurrence, higher nodal stage (N0 vs. N3, OR 16.779) and higher histologic grade (grade 1 vs. grade 3, OR 18.111) repeatedly weighted for early recurrence. Conclusions: Nodal burden had an attenuated influence on late recurrence, which suggests that, unlike early recurrence, tumor biology might have a more important role than tumor load for late recurrence in ER-positive disease.	[Ahn, Sung Gwe; Lee, Hak Min; Lee, Seung Ah; Hwang, Seung Hyun; Jeong, Joon; Lee, Hy-De] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Cho, Sang-Hoon; Bae, Suk Jin] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Soongsil University	Jeong, J (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.	gsjjoon@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Ahn, Sung Gwe/0000-0002-8778-9686				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BIANCHINI G, 2011, CANC RES S3, V71; Bosco JLF, 2009, CANCER EPIDEM BIOMAR, V18, P2979, DOI 10.1158/1055-9965.EPI-09-0607; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke M, 1998, LANCET, V351, P1451; Cufer T, 2007, ANN ONCOL, V18, P18, DOI 10.1093/annonc/mdm262; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Dignam JJ, 2009, BREAST CANCER RES TR, V116, P595, DOI 10.1007/s10549-008-0200-5; Goss P, 2008, APMIS, V116, P552, DOI 10.1111/j.1600-0463.2008.001059.x; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hilsenbeck SG, 1998, BREAST CANCER RES TR, V52, P227, DOI 10.1023/A:1006133418245; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Joensuu K, 2011, VIRCHOWS ARCH, V459, P31, DOI 10.1007/s00428-011-1096-8; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke HF, 2007, ANN ONCOL, V18, P45, DOI 10.1093/annonc/mdl334; Kennecke H, 2008, CANCER-AM CANCER SOC, V112, P1437, DOI 10.1002/cncr.23320; Liu MC, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-S1-8; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Mansell J, 2009, BREAST CANCER RES TR, V117, P91, DOI 10.1007/s10549-008-0291-z; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Saghatchian M, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-S1-6; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	27	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63510	10.1371/journal.pone.0063510	http://dx.doi.org/10.1371/journal.pone.0063510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717438	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700028
J	Ale, SB; Brown, JS; Sullivan, AT				Ale, Som B.; Brown, Joel S.; Sullivan, Amy T.			Evolution of Cooperation: Combining Kin Selection and Reciprocal Altruism into Matrix Games with Social Dilemmas	PLOS ONE			English	Article							MUTUALISM; BEHAVIOR; ECOLOGY	Darwinian selection should preclude cooperation from evolving; yet cooperation is widespread among organisms. We show how kin selection and reciprocal altruism can promote cooperation in diverse 262 matrix games (prisoner's dilemma, snowdrift, and hawk-dove). We visualize kin selection as non-random interactions with like-strategies interacting more than by chance. Reciprocal altruism emerges from iterated games where players have some likelihood of knowing the identity of other players. This perspective allows us to combine kin selection and reciprocal altruism into a general matrix game model. Both mechanisms operating together should influence the evolution of cooperation. In the absence of kin selection, reciprocal altruism may be an evolutionarily stable strategy but is unable to invade a population of non-co-operators. Similarly, it may take a high degree of relatedness to permit cooperation to supplant non-cooperation. Together, a little bit of reciprocal altruism can, however, greatly reduce the threshold at which kin selection promotes cooperation, and vice-versa. To properly frame applications and tests of cooperation, empiricists should consider kin selection and reciprocal altruism together rather than as alternatives, and they should be applied to a broader class of social dilemmas than just the prisoner's dilemma.	[Ale, Som B.; Brown, Joel S.; Sullivan, Amy T.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ale, SB (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sale1@uic.edu						Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Brown JS, 2001, OIKOS, V94, P6, DOI 10.1034/j.1600-0706.2001.11309.x; BROWN JS, 1982, J THEOR BIOL, V99, P319, DOI 10.1016/0022-5193(82)90008-X; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Darwin G., 1871, P423; Darwin C., 1859, ORIGIN SPECIES MEANS; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1991, AM NAT, V138, P687, DOI 10.1086/285243; GRAFEN A, 1979, ANIM BEHAV, V27, P905, DOI 10.1016/0003-3472(79)90028-9; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Michor F, 2002, NATURE, V419, P677, DOI 10.1038/419677a; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Waibel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000615; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Williams G. C., 1966, P307; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; WILSON DS, 1991, EVOL ECOL, V5, P291, DOI 10.1007/BF02214233	38	15	15	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63761	10.1371/journal.pone.0063761	http://dx.doi.org/10.1371/journal.pone.0063761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717479	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700057
J	Degenkolbe, T; Do, PT; Kopka, J; Zuther, E; Hincha, DK; Kohl, KI				Degenkolbe, Thomas; Do, Phuc T.; Kopka, Joachim; Zuther, Ellen; Hincha, Dirk K.; Koehl, Karin I.			Identification of Drought Tolerance Markers in a Diverse Population of Rice Cultivars by Expression and Metabolite Profiling	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHOTOSYNTHETIC SUCROSE SYNTHESIS; WATER-USE EFFICIENCY; GRAIN-YIELD; CYTOSOLIC FRUCTOSE-1,6-BISPHOSPHATASE; FRUCTOSE 2,6-BISPHOSPHATE; PHYSIOLOGICAL TRAITS; GAS-CHROMATOGRAPHY; PHOSPHATE SYNTHASE; FREEZING TOLERANCE	Rice provides about half of the calories consumed in Asian countries, but its productivity is often reduced by drought, especially when grown under rain-fed conditions. Cultivars with increased drought tolerance have been bred over centuries. Slow selection for drought tolerance on the basis of phenotypic traits may be accelerated by using molecular markers identified through expression and metabolic profiling. Previously, we identified 46 candidate genes with significant genotype x environment interaction in an expression profiling study on four cultivars with contrasting drought tolerance. These potential markers and in addition GC-MS quantified metabolites were tested in 21 cultivars from both indica and japonica background that varied in drought tolerance. Leaf blades were sampled from this population of cultivars grown under control or long-term drought condition and subjected to expression analysis by qRT-PCR and metabolite profiling. Under drought stress, metabolite levels correlated mainly negatively with performance parameters, but eight metabolites correlated positively. For 28 genes, a significant correlation between expression level and performance under drought was confirmed. Negative correlations were predominant. Among those with significant positive correlation was the gene coding for a cytosolic fructose-1,6-bisphosphatase. This enzyme catalyzes a highly regulated step in C-metabolism. The metabolic and transcript marker candidates for drought tolerance were identified in a highly diverse population of cultivars. Thus, these markers may be used to select for tolerance in a wide range of rice germplasms.	[Degenkolbe, Thomas; Do, Phuc T.; Kopka, Joachim; Zuther, Ellen; Hincha, Dirk K.; Koehl, Karin I.] Max Planck Inst Mol Plant Physiol, Potsdam, Brandenburg, Germany	Max Planck Society	Kohl, KI (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Brandenburg, Germany.	koehl@mpimp-golm.mpg.de	Zuther, Ellen/H-9814-2019; Do, Phuc Thi/A-2318-2014	Zuther, Ellen/0000-0002-7446-0515; Kopka, Joachim/0000-0001-9675-4883; Do, Phuc Thi/0000-0002-2893-8223	German Ministry for Education and Research (BMBF) [BMBF 0312854]; Max Planck Society; Vietnamese government (MOET); German Academic Exchange Council (DAAD)	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Vietnamese government (MOET); German Academic Exchange Council (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the German Ministry for Education and Research (BMBF) (grant BMBF 0312854) and the Max Planck Society. Phuc Thi Do was supported by fellowships from the Vietnamese government (MOET), the German Academic Exchange Council (DAAD) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Chin JoongHyoun, 2007, Journal of Crop Science and Biotechnology, V10, P175; Cho MH, 2012, PHOTOSYNTH RES, V111, P261, DOI 10.1007/s11120-012-9720-2; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; DAIE J, 1993, PHOTOSYNTH RES, V38, P5, DOI 10.1007/BF00015056; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; DINGKUHN M, 1989, AUST J AGR RES, V40, P1171, DOI 10.1071/AR9891171; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Gonzalez A, 2010, J AGR SCI-CAMBRIDGE, V148, P319, DOI 10.1017/S0021859610000031; Gouda PK, 2012, CROP SCI, V52, P644, DOI 10.2135/cropsci2011.04.0206; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; HANSON AD, 1990, NATURE, V345, P26, DOI 10.1038/345026b0; HAVAUX M, 1985, Z PFLANZENZUCHT, V95, P1; Hedrich R, 1984, PLANT PHYSIOL, V75, P130; HERZOG B, 1984, PLANT PHYSIOL, V75, P561, DOI 10.1104/pp.75.3.561; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Jongdee B., 1998, Agronomy - growing a greener future. Proceedings of the 9th  Australian Agronomy Conference, Wagga Wagga, New South Wales, Australia, 20-23 July 1998; Jongdee S, 1997, ACIAR PROC, P65; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Kiani SP, 2007, THEOR APPL GENET, V114, P193, DOI 10.1007/s00122-006-0419-7; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; KS Fischer, 2003, BREEDING RICE DROUGH, P98; Kumar R, 2007, FIELD CROP RES, V103, P42, DOI 10.1016/j.fcr.2007.04.013; Kumar S, 2012, EUPHYTICA, V186, P265, DOI 10.1007/s10681-012-0675-3; Laza MR, 2006, CROP SCI, V46, P763, DOI 10.2135/cropsci2005.05.0084; Liu HY, 2005, CHINESE SCI BULL, V50, P317, DOI 10.1360/982004-619; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Manickavelu A, 2006, PLANT GROWTH REGUL, V50, P121, DOI 10.1007/s10725-006-9109-3; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mohammadi M, 2007, PLANT CELL ENVIRON, V30, P630, DOI 10.1111/j.1365-3040.2007.01645.x; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Nie YuanYuan, 2012, Acta Agronomica Sinica, V38, P988; Oikawa A, 2008, RICE, V1, P63, DOI 10.1007/s12284-008-9009-4; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Price AH, 1997, THEOR APPL GENET, V95, P132, DOI 10.1007/s001220050541; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland G, 2000, PLANT PHYSIOL, V154, P357; ROYMACAULEY H, 1992, PHYSIOL PLANTARUM, V85, P90, DOI 10.1111/j.1399-3054.1992.tb05268.x; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Sanchez DH, 2012, PLANT CELL ENVIRON, V35, P136, DOI 10.1111/j.1365-3040.2011.02423.x; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Siahpoosh MR, 2011, CROP SCI, V51, P1198, DOI 10.2135/cropsci2010.05.0243; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stich B, 2010, THEOR APPL GENET, V120, P553, DOI 10.1007/s00122-009-1175-2; STITT M, 1983, PLANT PHYSIOL, V72, P767, DOI 10.1104/pp.72.3.767; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Strand A, 2000, PLANT J, V23, P759, DOI 10.1046/j.1365-313x.2000.00847.x; Strehmel N, 2008, J CHROMATOGR B, V871, P182, DOI 10.1016/j.jchromb.2008.04.042; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tripathy JN, 2000, THEOR APPL GENET, V100, P1197, DOI 10.1007/s001220051424; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Warren CR, 2012, METABOLOMICS, V8, P186, DOI 10.1007/s11306-011-0299-y; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zrenner R, 1996, PLANT J, V9, P671, DOI 10.1046/j.1365-313X.1996.9050671.x; Zuther E, 2007, ADV MOL BREEDING DRO, P285, DOI DOI 10.1007/978-1-4020-5578-2_12; Zuther E, 2012, PLANT CELL ENVIRON, V35, P1860, DOI 10.1111/j.1365-3040.2012.02522.x	85	81	85	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63637	10.1371/journal.pone.0063637	http://dx.doi.org/10.1371/journal.pone.0063637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717458	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700044
J	Diaz-Bello, B; Rangel-Garcia, CI; Salvador, C; Carrisoza-Gaytan, R; Escobar, LI				Diaz-Bello, Beatriz; Rangel-Garcia, Claudia I.; Salvador, Carolina; Carrisoza-Gaytan, Rolando; Escobar, Laura I.			The Polarization of the G-Protein Activated Potassium Channel GIRK5 to the Vegetal Pole of Xenopus laevis Oocytes Is Driven by a Di-Leucine Motif	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; EPITHELIAL-CELLS; DILEUCINE MOTIF; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CORTICAL ROTATION; RNA LOCALIZATION; CYTOPLASMIC TAIL; SEQUENCE MOTIFS; SORTING SIGNAL	The G protein-coupled inwardly-rectifying potassium channels (known as GIRK or Kir3) form functional heterotetramers gated by G-beta gamma subunits. GIRK channels participate in heart rate modulation and neuronal postsynaptic inhibition in mammals. In Xenopus laevis oocytes, GIRK5 is a functional homomultimer. Previously, we found that phosphorylation of a tyrosine (Y16) at its N-terminus downregulates the surface expression of GIRK5. In this work, we elucidated the subcellular localization and trafficking of GIRK5 in oocytes. Several EGFP-GIRK5 chimeras were produced and an ECFP construct was used to identify the endoplasmic reticulum (ER). Whereas GIRK5-WT was retained in the ER at the animal pole, the phospho-null GIRK5-Y16A was localized to the vegetal pole. Interestingly, a construct with an N-terminal Delta 25 deletion produced an even distribution of the channel in the whole oocyte. Through an alanine-scan, we identified an acidic cluster/di-leucine sorting-signal recognition motif between E17 and I22. We quantified the effect of each amino acid residue within this di-leucine motif in determining the distribution of GIRK5 to the animal and vegetal poles. We found that Y16 and I22 contributed to functional expression and were dominant in the polarization of GIRK5. We thus conclude that the N-terminal acidic di-leucine motif of GIRK5 determines its retention and polarized trafficking within Xl oocytes.	[Diaz-Bello, Beatriz; Rangel-Garcia, Claudia I.; Salvador, Carolina; Carrisoza-Gaytan, Rolando; Escobar, Laura I.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Escobar, LI (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico.	laurae@unam.mx			Direccion General de Estudios de Posgrado (DGAPA) at the Universidad Nacional Autonoma de Mexico [IN224406, IN202110]; CONACYT [166913]	Direccion General de Estudios de Posgrado (DGAPA) at the Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Direccion General de Estudios de Posgrado (DGAPA) Grants IN224406 and IN202110 at the Universidad Nacional Autonoma de Mexico. CONACYT Grant 166913. Beatriz Diaz-Bello (PhD) and Claudia Rangel (MSc) were supported by a fellowship from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison R, 2004, RNA, V10, P1751, DOI 10.1261/rna.7450204; BARNARD EA, 1982, PROC R SOC SER B-BIO, V215, P241, DOI 10.1098/rspb.1982.0040; Bauer CK, 1996, PFLUG ARCH EUR J PHY, V432, P812, DOI 10.1007/s004240050203; Bello V, 2001, MOL BIOL CELL, V12, P3004, DOI 10.1091/mbc.12.10.3004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chan AP, 2007, MECH DEVELOP, V124, P350, DOI 10.1016/j.mod.2007.02.001; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Dhar Madhu S, 2006, BMC Physiol, V6, P8, DOI 10.1186/1472-6793-6-8; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; King ML, 2005, BIOL CELL, V97, P19; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Kloc M, 2001, DIFFERENTIATION, V67, P80, DOI 10.1046/j.1432-0436.2001.067003080.x; Kloc M, 2007, INT J DEV BIOL, V51, P701, DOI 10.1387/ijdb.072293mk; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Machaca K, 1998, BIOPHYS J, V74, P1286, DOI 10.1016/S0006-3495(98)77842-7; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MERRIAM RW, 1983, DEV BIOL, V95, P439, DOI 10.1016/0012-1606(83)90045-3; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mohanty BK, 2012, MOL REPROD DEV, V79, P138, DOI 10.1002/mrd.22012; Mora SI, 2005, FEBS LETT, V579, P3019, DOI 10.1016/j.febslet.2005.04.056; Newton EE, 2005, J CELL SCI, V118, P2461, DOI 10.1242/jcs.02367; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; PETER AB, 1991, J CELL BIOL, V114, P455, DOI 10.1083/jcb.114.3.455; Plummer HK, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-104; Rai T, 2006, AM J PHYSIOL-CELL PH, V290, pC298, DOI 10.1152/ajpcell.00356.2005; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Salvador C, 2001, BBA-BIOMEMBRANES, V1512, P135, DOI 10.1016/S0005-2736(01)00314-5; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Seabold GK, 2012, J BIOL CHEM, V287, P4470, DOI 10.1074/jbc.M111.279661; Shankar H, 2004, BLOOD, V104, P1335, DOI 10.1182/blood-2004-01-0069; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; SOKOL SY, 1995, DEVELOPMENT, V121, P3487; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yamada M, 1998, PHARMACOL REV, V50, P723	44	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64096	10.1371/journal.pone.0064096	http://dx.doi.org/10.1371/journal.pone.0064096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717539	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700100
J	Heitland, I; Groenink, L; Bijlsma, EY; Oosting, RS; Baas, JMP				Heitland, Ivo; Groenink, Lucianne; Bijlsma, Elisabeth Y.; Oosting, Ronald S.; Baas, Johanna M. P.			Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter	PLOS ONE			English	Article							POLYMORPHISM 5-HTTLPR; BASOLATERAL AMYGDALA; POTENTIATED STARTLE; ANXIETY; EXTINCTION; METAANALYSIS; ASSOCIATION; MODULATION; RESPONSES; ETIOLOGY	The ability to identify predictors of aversive events allows organisms to appropriately respond to these events, and failure to acquire these fear contingencies can lead to maladaptive contextual anxiety. Recently, preclinical studies demonstrated that the corticotropin-releasing factor and serotonin systems are interactively involved in adaptive fear acquisition. Here, 150 healthy medication-free human subjects completed a cue and context fear conditioning procedure in a virtual reality environment. Fear potentiation of the eyeblink startle reflex (FPS) was measured to assess both uninstructed fear acquisition and instructed fear expression. All participants were genotyped for polymorphisms located within regulatory regions of the corticotropin releasing hormone receptor 1 (CRHR1 - rs878886) and the serotonin transporter (5HTTLPR). These polymorphisms have previously been linked to panic disorder and anxious symptomology and personality, respectively. G-allele carriers of CRHR1 (rs878886) showed no acquisition of fear conditioned responses (FPS) to the threat cue in the uninstructed phase, whereas fear acquisition was present in C/C homozygotes. Moreover, carrying the risk alleles of both rs878886 (G-allele) and 5HTTLPR (short allele) was associated with increased FPS to the threat context during this phase. After explicit instructions regarding the threat contingency were given, the cue FPS and context FPS normalized in all genotype groups. The present results indicate that genetic variability in the corticotropin-releasing hormone receptor 1, especially in interaction with the 5HTTLPR, is involved in the acquisition of fear in humans. This translates prior animal findings to the human realm.	[Heitland, Ivo; Baas, Johanna M. P.] Univ Utrecht, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands; [Heitland, Ivo; Baas, Johanna M. P.] Helmholtz Res Inst, Utrecht, Netherlands; [Groenink, Lucianne; Bijlsma, Elisabeth Y.; Oosting, Ronald S.] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	Baas, JMP (corresponding author), Univ Utrecht, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands.	j.m.p.baas@uu.nl	Heitland, Ivo/AAU-5671-2020; Groenink, Lucianne/O-6588-2016	Heitland, Ivo/0000-0002-6672-7857; Groenink, Lucianne/0000-0002-4971-7796; Baas, Johanna/0000-0001-6267-8712	Linschoten Institute for Psychological Research; Brain Foundation of the Netherlands	Linschoten Institute for Psychological Research; Brain Foundation of the Netherlands	This research was supported by grants from the Linschoten Institute for Psychological Research (http://www.uu.nl/faculty/socialsciences/EN/organisation/Departments/Psychology/research/Pages/linschoteninstitute.aspx) and the Brain Foundation of the Netherlands (Hersenstichting Nederland; https://www.hersenstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster D, 2009, INT J NEUROPSYCHOPH, V12, P393, DOI 10.1017/S1461145708009565; Baas JMP, 2008, ACTA PSYCHOL, V127, P581, DOI 10.1016/j.actpsy.2007.09.009; Baas JM, 2004, BIOL PSYCHIAT, V55, P1056, DOI 10.1016/j.biopsych.2004.02.024; Baas JMP, 2013, BIOL PSYCHOL, V92, P17, DOI 10.1016/j.biopsycho.2012.02.001; Bijlsma EY, 2011, NEUROSCIENCE, V173, P82, DOI 10.1016/j.neuroscience.2010.11.026; BIJLSMA EY, 2012, NEUR M PLANN NEW ORL, P20109; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bocker KBE, 2004, BIOL PSYCHOL, V67, P343, DOI 10.1016/j.biopsycho.2004.01.001; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Brocke B, 2006, MOL PSYCHIATR, V11, P1106, DOI 10.1038/sj.mp.4001908; Cicchetti D, 2011, DEV PSYCHOPATHOL, V23, P1125, DOI 10.1017/S0954579411000599; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Grillon C, 2006, BIOL PSYCHIAT, V60, P760, DOI 10.1016/j.biopsych.2005.11.027; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Heils A, 1996, J NEUROCHEM, V66, P2621; Heitland I, 2012, COGN AFFECT BEHAV NE, V12, P678, DOI 10.3758/s13415-012-0108-8; Heitland I, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.90; Hermann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044352; Hettema JM, 2003, ARCH GEN PSYCHIAT, V60, P702, DOI 10.1001/archpsyc.60.7.702; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Holloway JL, 2011, BEHAV BRAIN RES, V216, P301, DOI 10.1016/j.bbr.2010.08.008; Holsboer F, 2008, EUR J PHARMACOL, V583, P350, DOI 10.1016/j.ejphar.2007.12.032; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Keck ME, 2008, AM J MED GENET B, V147B, P1196, DOI 10.1002/ajmg.b.30750; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Klucken T, 2013, SOC COGN AFFECT NEUR, V8, P318, DOI 10.1093/scan/nss005; Klumpers F, 2010, J PSYCHOPHARMACOL, V24, P657, DOI 10.1177/0269881109103115; Klumpers F, 2012, BIOL PSYCHOL, V89, P277, DOI 10.1016/j.biopsycho.2011.10.018; Klumpers F, 2010, BIOL PSYCHIAT, V68, P1031, DOI 10.1016/j.biopsych.2010.09.006; Kraft JB, 2005, BIOL PSYCHIAT, V58, P374, DOI 10.1016/j.biopsych.2005.04.048; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Larson CL, 2010, PSYCHOPHYSIOLOGY, V47, P857, DOI 10.1111/j.1469-8986.2010.01005.x; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LIANG KC, 1988, PSYCHOPHARMACOLOGY, V96, P232; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lonsdorf TB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.36; Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Lukkes J, 2009, J NEUROSCI, V29, P9955, DOI 10.1523/JNEUROSCI.0854-09.2009; Meyer-Lindenberg A, 2012, NEUROIMAGE, V62, P1286, DOI 10.1016/j.neuroimage.2011.10.063; Milad MR, 2006, BEHAV NEUROSCI, V120, P1196, DOI 10.1037/0735-7044.120.5.1196; Mineka S, 1996, Nebr Symp Motiv, V43, P135; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Pauli P, 2010, PSYCHOPHYSIOLOGY, V47, P25, DOI 10.1111/j.1469-8986.2009.00923.x; Ressler KJ, 2010, AM J MED GENET B, V153B, P812, DOI 10.1002/ajmg.b.31052; Risbrough VB, 2009, NEUROPSYCHOPHARMACOL, V34, P1494, DOI 10.1038/npp.2008.205; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Roozendaal B, 2008, J NEUROSCI, V28, P6642, DOI 10.1523/JNEUROSCI.1336-08.2008; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Smoller JW, 2008, AM J MED GENET C, V148C, P118, DOI 10.1002/ajmg.c.30174; Steckler Thomas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P147, DOI 10.2174/187152706776359619; Valentino RJ, 2010, BRAIN RES, V1314, P29, DOI 10.1016/j.brainres.2009.09.100; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6	64	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63772	10.1371/journal.pone.0063772	http://dx.doi.org/10.1371/journal.pone.0063772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717480	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700058
J	Kawakami, E; Kawai, N; Kinouchi, N; Mori, H; Ohsawa, Y; Ishimaru, N; Sunada, Y; Noji, S; Tanaka, E				Kawakami, Emi; Kawai, Nobuhiko; Kinouchi, Nao; Mori, Hiroyo; Ohsawa, Yutaka; Ishimaru, Naozumi; Sunada, Yoshihide; Noji, Sumihare; Tanaka, Eiji			Local Applications of Myostatin-siRNA with Atelocollagen Increase Skeletal Muscle Mass and Recovery of Muscle Function	PLOS ONE			English	Article							FIBER-TYPE COMPOSITION; MUSCULAR-DYSTROPHY; RNA INTERFERENCE; JAW MUSCLES; PPAR-GAMMA; HYPERTROPHY; DUCHENNE; MICE; HYPERPLASIA; DELIVERY	Background: Growing evidence suggests that small-interfering RNA (siRNA) can promote gene silencing in mammalian cells without induction of interferon synthesis or nonspecific gene suppression. Recently, a number of highly specific siRNAs targeted against disease-causing or disease-promoting genes have been developed. In this study, we evaluate the effectiveness of atelocollagen (ATCOL)-mediated application of siRNA targeting myostatin (Mst), a negative regulator of skeletal muscle growth, into skeletal muscles of muscular dystrophy model mice. Methods and Findings: We injected a nanoparticle complex containing myostatin-siRNA and ATCOL (Mst-siRNA/ATCOL) into the masseter muscles of mutant caveolin-3 transgenic (mCAV-3Tg) mice, an animal model for muscular dystrophy. Scrambled (scr) -siRNA/ATCOL complex was injected into the contralateral muscles as a control. Two weeks after injection, the masseter muscles were dissected for histometric analyses. To investigate changes in masseter muscle activity by local administration of Mst-siRNA/ATCOL complex, mouse masseter electromyography (EMG) was measured throughout the experimental period via telemetry. After local application of the Mst-siRNA/ATCOL complex, masseter muscles were enlarged, while no significant change was observed on the contralateral side. Histological analysis showed that myofibrils of masseter muscles treated with the Mst-siRNA/ATCOL complex were significantly larger than those of the control side. Real-time PCR analysis revealed a significant downregulation of Mst expression in the treated masseters of mCAV-3Tg mice. In addition, expression of myogenic transcription factors was upregulated in the Mst-siRNA-treated masseter muscle, while expression of adipogenic transcription factors was significantly downregulated. EMG results indicate that masseter muscle activity in mCAV-3Tg mice was increased by local administration of the Mst-siRNA/ATCOL complex. Conclusion: These data suggest local administration of Mst-siRNA/ATCOL complex could lead to skeletal muscle hypertrophy and recovery of motor disability in mCAV-3Tg mice. Therefore, ATCOL-mediated application of siRNA is a potential tool for therapeutic use in muscular atrophy diseases.	[Kawakami, Emi; Kawai, Nobuhiko; Kinouchi, Nao; Mori, Hiroyo; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan; [Ohsawa, Yutaka; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Okayama, Japan; [Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Noji, Sumihare] Univ Tokushima, Inst Technol & Sci, Dept Life Syst, Tokushima 770, Japan	Tokushima University; Kawasaki Medical School; Tokushima University; Tokushima University	Tanaka, E (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan.	etanaka@tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015	Tanaka, Eiji/0000-0002-2707-1613	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [23-5]; Ministry of Education, Science and Culture, Japan [23659966]	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported partially by an Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP and a Grant (No. 23659966) for Science Research from the Ministry of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; COOPER BJ, 1989, BRIT MED BULL, V45, P703, DOI 10.1093/oxfordjournals.bmb.a072353; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EMORY AEH, 1988, DUCHENNE MUSCULAR DY; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Kawai N, 2008, J OROFAC PAIN, V22, P153; Kawai N, 2007, EUR J ORAL SCI, V115, P15, DOI 10.1111/j.1600-0722.2007.00424.x; Kawai N, 2010, J ANAT, V216, P717, DOI 10.1111/j.1469-7580.2010.01235.x; Kawakami E, 2011, DEV GROWTH DIFFER, V53, P48, DOI 10.1111/j.1440-169X.2010.01221.x; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Korfage JAM, 2005, J DENT RES, V84, P774, DOI 10.1177/154405910508400901; Langenbach GEJ, 2002, J NEUROSCI METH, V114, P197, DOI 10.1016/S0165-0270(01)00528-3; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; O'Brien KF, 2001, MOL GENET METAB, V74, P75, DOI 10.1006/mgme.2001.3220; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Paul AC, 2002, J CELL BIOL, V156, P751, DOI 10.1083/jcb.200105147; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sano R, 2007, J ANAT, V211, P464, DOI 10.1111/j.1469-7580.2007.00783.x; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Tagami T, 2012, INT J PHARMACEUT, V422, P280, DOI 10.1016/j.ijpharm.2011.10.059; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; TINSLEY JM, 1993, NEUROMUSCULAR DISORD, V3, P537, DOI 10.1016/0960-8966(93)90111-V; van Wessel T, 2005, EUR J NEUROSCI, V22, P2783, DOI 10.1111/j.1460-9568.2005.04466.x; Yoshida Y, 2012, MUSCLE NERVE, V46, P813, DOI 10.1002/mus.23506; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	39	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64719	10.1371/journal.pone.0064719	http://dx.doi.org/10.1371/journal.pone.0064719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717655	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700170
J	Borgdorff, V; Rix, U; Winter, GE; Gridling, M; Muller, AC; Breitwieser, FP; Wagner, C; Colinge, J; Bennett, KL; Superti-Furga, G; Wagner, SN				Borgdorff, V.; Rix, U.; Winter, G. E.; Gridling, M.; Mueller, A. C.; Breitwieser, F. P.; Wagner, C.; Colinge, J.; Bennett, K. L.; Superti-Furga, G.; Wagner, S. N.			A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF	ONCOGENE			English	Article						MITF; melanoma; AMPK; compound C; midostaurin; sunitinib	ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; GLUCOSE DEPRIVATION; SIGNALING PATHWAYS; LINEAGE SURVIVAL; ENERGY SENSOR; CELL-GROWTH; MICROPHTHALMIA; CANCER; PROLIFERATION	The microphthalmia-associated transcription factor (MITF) is indispensable for the viability of melanocytic cells, is an oncogene in melanoma and has a cell type-specific expression pattern. As the modulation of MITF activity by direct chemical targeting remains a challenge, we assessed a panel of drugs for their ability to downregulate MITF expression or activity by targeting its upstream modulators. We found that the multi-kinase inhibitors midostaurin and sunitinib downregulate MITF protein levels. To identify the target molecules shared by both the drugs in melanocytic cells, a chemical proteomic approach was applied and AMP-activated kinase (AMPK) was identified as the relevant target for the observed phenotype. RNA interference and chemical inhibition of AMPK led to a decrease in MITF protein levels. Reduction of MITF protein levels was the result of proteasomal degradation, which was preceded by enhanced phosphorylation of MITF mediated by ERK. As expected, downregulation of MITF protein levels by AMPK inhibition was associated with decreased viability. Together, these results identify AMPK as an important regulator for the maintenance of MITF protein levels in melanocytic cells.	[Borgdorff, V.; Wagner, C.; Wagner, S. N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; [Borgdorff, V.; Rix, U.; Winter, G. E.; Gridling, M.; Mueller, A. C.; Breitwieser, F. P.; Colinge, J.; Bennett, K. L.; Superti-Furga, G.; Wagner, S. N.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Wagner, SN (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	vborgdorff@gmail.com; stephan.wagner@meduniwien.ac.at	Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Colinge, Jacques/D-1578-2017	Superti-Furga, Giulio/0000-0002-0570-1768; Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Winter, Georg/0000-0001-6606-1437; Wagner, Stephan/0000-0003-4941-7029; Mueller, Andre/0000-0002-0608-8176; Bennett, Keiryn L./0000-0001-9356-7708; Breitwieser, Florian P/0000-0001-6192-0853	FWF-Austrian Science Fund [L590-B12]; Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research (PLACEBO GZ) [BMWF-70.081/0018-II/1a/2008, APP-III 820965]; Austrian Science Fund (FWF) [P 24321, L 590] Funding Source: researchfish	FWF-Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research (PLACEBO GZ); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Hans Widlund (Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, MA, USA) for providing us with human immortalised melanocytes with and without ectopic expression of BRAF<SUP>V600E</SUP> and HA-MITF as described in Garraway et al.<SUP>1</SUP> We thank Gaurav Pathria for helpful discussions and critical reading of the manuscript. This study was funded by FWF-Austrian Science Fund (L590-B12) to SNW. The team at CeMM is supported by the Austrian Academy of Sciences, and the GEN-AU initiative of the Austrian Federal Ministry for Science and Research (PLACEBO GZ BMWF-70.081/0018-II/1a/2008 and APP-III 820965).	Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166; Fernbach NV, 2009, J PROTEOME RES, V8, P4753, DOI 10.1021/pr900455x; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641; HA J, 1994, J BIOL CHEM, V269, P22162; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kim MJ, 2010, J BIOL CHEM, V285, P14617, DOI 10.1074/jbc.M109.085456; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laderoute KR, 2010, CANCER BIOL THER, V10, P68, DOI 10.4161/cbt.10.1.12162; Lee KH, 2011, J BIOL CHEM, V286, P39247, DOI 10.1074/jbc.M111.264598; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu M, 2000, GENE DEV, V14, P301; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	55	21	22	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2531	2539		10.1038/onc.2013.185	http://dx.doi.org/10.1038/onc.2013.185			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23728343				2022-12-25	WOS:000336033600013
J	Zhang, J; Nakatsu, Y; Shinjo, T; Guo, Y; Sakoda, H; Yamamotoya, T; Otani, Y; Okubo, H; Kushiyama, A; Fujishiro, M; Fukushima, T; Tsuchiya, Y; Kamata, H; Iwashita, M; Nishimura, F; Katagiri, H; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Zhang, Jun; Nakatsu, Yusuke; Shinjo, Takanori; Guo, Ying; Sakoda, Hideyuki; Yamamotoya, Takeshi; Otani, Yuichiro; Okubo, Hirofumi; Kushiyama, Akifumi; Fujishiro, Midori; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Kamata, Hideaki; Iwashita, Misaki; Nishimura, Fusanori; Katagiri, Hideki; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Par14 Protein Associates with Insulin Receptor Substrate 1 (IRS-1), Thereby Enhancing Insulin-induced IRS-1 Phosphorylation and Metabolic Actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; PRERIBOSOMAL RIBONUCLEOPROTEIN COMPLEXES; IMMUNOSUPPRESSANT FK506; CIS/TRANS ISOMERASE; BINDING-PROTEIN; PIN1; RESISTANCE; KINASE; IDENTIFICATION; CYCLOPHILIN	Pin1 and Par14 are parvulin-type peptidyl-prolyl cis/trans isomerases. Although numerous proteins have been identified as Pin1 substrates, the target proteins of Par14 remain largely unknown. Par14 expression levels are increased in the livers and embryonic fibroblasts of Pin1KO mice, suggesting a compensatory relationship between the functions of Pin1 and Par14. In this study, the association of Par14 with insulin receptor substrate 1 (IRS-1) was demonstrated in HepG2 cells overexpressing both as well as endogenously in the mouse liver. The analysis using deletion-mutated Par14 and IRS-1 constructs revealed the N-terminal portion containing the basic domain of Par14 and the two relatively C-terminal portions of IRS-1 to be involved in these associations, in contrast to the WW domain of Pin1 and the SAIN domain of IRS-1. Par14 overexpression in HepG2 markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events, PI3K binding with IRS-1 and Akt phosphorylation. In contrast, treating HepG2 cells with Par14 siRNA suppressed these events. In addition, overexpression of Par14 in the insulin-resistant ob/ob mouse liver by adenoviral transfer significantly improved hyperglycemia with normalization of hepatic PEPCK and G6Pase mRNA levels, and gene suppression of Par14 using shRNA adenovirus significantly exacerbated the glucose intolerance in Pin1 KO mice. Therefore, although Pin1 and Par14 associate with different portions of IRS-1, the prolyl cis/trans isomerization in multiple sites of IRS-1 by these isomerases appears to be critical for efficient insulin receptor-induced IRS-1 phosphorylation. This process is likely to be one of the major mechanisms regulating insulin sensitivity and also constitutes a potential therapeutic target for novel insulin-sensitizing agents.	[Zhang, Jun; Nakatsu, Yusuke; Guo, Ying; Otani, Yuichiro; Okubo, Hirofumi; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Shinjo, Takanori; Iwashita, Misaki; Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Yamamotoya, Takeshi; Fujishiro, Midori] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo 1000006, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 7348553, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; Hiroshima University; University of Tokyo; Asahi Life Foundation; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; 祐介, 中津/AAP-8396-2020; Kushiyama, Akifumi/W-5988-2019; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Okubo, Hirofumi/0000-0002-9220-9084; Nakatsu, Yusuke/0000-0003-3279-1276; Kurihara, Hiroki/0000-0002-6476-5593; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Shinjo, Takanori/0000-0002-8269-2826; Uchida, Takafumi/0000-0003-3665-4906; Iwashita, Misaki/0000-0002-8557-346X				Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujiyama S, 2002, J BIOL CHEM, V277, P23773, DOI 10.1074/jbc.M201181200; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Luo ML, 2007, ENDOCRINOLOGY, V148, P4895, DOI 10.1210/en.2007-0049; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Rulten S, 1999, BIOCHEM BIOPH RES CO, V259, P557, DOI 10.1006/bbrc.1999.0828; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Surmacz TA, 2002, J MOL BIOL, V321, P235, DOI 10.1016/S0022-2836(02)00615-0; Takahashi N, 2003, MASS SPECTROM REV, V22, P287, DOI 10.1002/mas.10057; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wang XDJ, 2006, BIOPOLYMERS, V84, P125, DOI 10.1002/bip.20240; WHITE MF, 1994, J BIOL CHEM, V269, P1; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	36	17	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20692	20701		10.1074/jbc.M113.485730	http://dx.doi.org/10.1074/jbc.M113.485730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720771	Green Published, hybrid			2022-12-25	WOS:000321715100054
J	Huang, YT; Liu, TH; Lin, SM; Chen, YW; Pan, YJ; Lee, CH; Sun, YJ; Tseng, FG; Pan, RL				Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Tseng, Fan-Gang; Pan, Rong-Long			Squeezing at Entrance of Proton Transport Pathway in Proton-translocating Pyrophosphatase upon Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-PYROPHOSPHATASE; RESIDUES; PROTEIN; MEMBRANE; DOMAINS	Homodimeric proton-translocating pyrophosphatase (H+- PPase; EC 3.6.1.1) is indispensable for many organisms in maintaining organellar pH homeostasis. This unique proton pump couples the hydrolysis of PPi to proton translocation across the membrane. H+-PPase consists of 14-16 relatively hydrophobic transmembrane domains presumably for proton translocation and hydrophilic loops primarily embedding a catalytic site. Several highly conserved polar residues located at or near the entrance of the transport pathway in H+-PPase are essential for proton pumping activity. In this investigation single molecule FRET was employed to dissect the action at the pathway entrance in homodimeric Clostridium tetani H+-PPase upon ligand binding. The presence of the substrate analog, imidodiphosphate mediated two sites at the pathway entrance moving toward each other. Moreover, single molecule FRET analyses after the mutation at the first proton-carrying residue (Arg-169) demonstrated that conformational changes at the entrance are conceivably essential for the initial step of H+-PPase proton translocation. Aworking model is accordingly proposed to illustrate the squeeze at the entrance of the transport pathway in H+-PPase upon substrate binding.	[Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw		Tseng, Fan-Gang/0000-0001-7654-6905	National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 100-2627-M-007-012, 100-2311-B-007-001-MY3, NSC 101-2627-M-007-003, NSC 1002120-M-007-006, NSC 099-2811-B-007-012]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grants NSC 101-2627-M-007-008, NSC 100-2627-M-007-012, and 100-2311-B-007-001-MY3 (to R.-L. P.), NSC 101-2627-M-007-003 and NSC 1002120-M-007-006 (to F.-G. T.), and NSC 099-2811-B-007-012 (to Y.-T. H.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Ishii Y, 1999, CHEM PHYS, V247, P163, DOI 10.1016/S0301-0104(99)00174-3; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; SATO MH, 1994, J BIOL CHEM, V269, P6725; Schultz A, 2003, BBA-BIOENERGETICS, V1607, P141, DOI 10.1016/j.bbabio.2003.09.003; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	32	8	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19312	19320		10.1074/jbc.M113.469353	http://dx.doi.org/10.1074/jbc.M113.469353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720778	Green Published, hybrid			2022-12-25	WOS:000321515800002
J	Yu, N; Huangyang, PW; Yang, XH; Han, X; Yan, RR; Jia, HT; Shang, YF; Sun, LY				Yu, Na; Huangyang, Peiwei; Yang, Xiaohan; Han, Xiao; Yan, Ruorong; Jia, Hongti; Shang, Yongfeng; Sun, Luyang			microRNA-7 Suppresses the Invasive Potential of Breast Cancer Cells and Sensitizes Cells to DNA Damages by Targeting Histone Methyltransferase SET8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH; METHYLATION; REPAIR; MONOMETHYLATION; RECOGNITION; PR-SET7; GENE; OVEREXPRESSION; REPRESSION; 53BP1	SET8 (SET domain containing 8) is a histone H4 lysine 20 (H4K20)-specific monomethyltransferase in higher eukaryotes that exerts diverse functions in transcription regulation, DNA repair, tumor metastasis, and genome integrity. The activity of SET8 is tightly controlled during cell cycle through post-translational modifications, including ubiquitination, phosphorylation, and sumoylation. However, how the expression of SET8 is regulated is not fully understood. Here, we report that microRNA-7 is a negative regulator of SET8. We demonstrated that microRNA-7 inhibits H4K20 monomethylation and suppresses epithelial-mesenchymal transition and the invasive potential of breast cancer cells. We showed that microRNA-7 promotes spontaneous DNA damages and sensitizes cells to induced DNA damages. Our experiments provide a molecular mechanism for the regulation of SET8 and extend the biological function of microRNA-7 to DNA damage response, supporting the pursuit of microRNA-7 as a potential target for breast cancer intervention.	[Yu, Na; Huangyang, Peiwei; Yang, Xiaohan; Han, Xiao; Yan, Ruorong; Jia, Hongti; Shang, Yongfeng; Sun, Luyang] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Sun, LY (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	Luyang_sun@hsc.pku.edu.cn	Han, Xiao/A-1109-2017; HUANG, YANGPEIWEI/AAS-7683-2021; Huangyang, Peiwei/AAS-8905-2021	Han, Xiao/0000-0002-5395-4022; HUANG, YANGPEIWEI/0000-0002-9131-3891; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [81071673, 91219201, 81130048]; Beijing Natural Science Foundation [5112017, 5132020]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 81071673 (to L. S.) and 91219201 and 81130048 (to Y. S.) from the National Natural Science Foundation of China, Grants 5112017 and 5132020 (to L. S.) from Beijing Natural Science Foundation, and Grant 973 Program 2011CB504204 (to Y. S.) from the Ministry of Science and Technology of China.	Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Fedoriw A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008136; Giovannetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049145; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kalinowski FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047067; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Kredo-Russo S, 2012, EXP DIABETES RES, DOI 10.1155/2012/695214; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mansour WY, 2013, RADIOTHER ONCOL, V106, P147, DOI 10.1016/j.radonc.2012.10.020; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Munoz MC, 2012, J BIOL CHEM, V287, P40618, DOI 10.1074/jbc.M112.410951; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Park JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-82; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Zhang N, 2013, ONCOGENE, V32, P5078, DOI 10.1038/onc.2012.526; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	51	38	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19633	19642		10.1074/jbc.M113.475657	http://dx.doi.org/10.1074/jbc.M113.475657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720754	Green Published, hybrid			2022-12-25	WOS:000321515800029
J	Cuff, AR; Rayfield, EJ				Cuff, Andrew R.; Rayfield, Emily J.			Feeding Mechanics in Spinosaurid Theropods and Extant Crocodilians	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; ALLIGATOR; EVOLUTION; BITE; PERFORMANCE; DINOSAUR; BEHAVIOR; GROWTH; SKULLS; SIZE	A number of extant and extinct archosaurs evolved an elongate, narrow rostrum. This longirostrine condition has been associated with a diet comprising a higher proportion of fish and smaller prey items compared to taxa with broader, more robust snouts. The evolution of longirostrine morphology and a bulbous anterior rosette of premaxillary teeth also occurs in the spinosaurid theropod dinosaurs, leading to suggestions that at least some members of this clade also had a diet comprising a notable proportion of fish or other small vertebrates. Here we compare the rostral biomechanics of the spinosaurs Baryonyx walkeri and Spinosaurus c.f. S. aegyptiacus to three extant crocodilians: two longistrine taxa, the African slender-snouted crocodile Mecistops cataphractus and the Indian gharial Gavialis gangeticus; and the American alligator Alligator mississippiensis. Using computed tomography (CT) data, the second moments of area and moments of inertia at successive transverse slices along the rostrum were calculated for each of the species. Size-independent results tested the biomechanical benefits of material distribution within the rostra. The two spinosaur rostra were both digitally reconstructed from CT data and compared against all three crocodilians. Results show that African slender-snouted crocodile skulls are more resistant to bending than an equivalent sized gharial. The alligator has the highest resistances to bending and torsion of the crocodiles for its size and greater than that of the spinosaurs. The spinosaur rostra possess similar resistance to bending and torsion despite their different morphologies. When size is accounted for, B. walkeri performs mechanically differently from the gharial, contradicting previous studies whereas Spinosaurus does not. Biomechanical data support known feeding ecology for both African slender-snouted crocodile and alligator, and suggest that the spinosaurs were not obligate piscivores with diet being determined by individual animal size.	[Cuff, Andrew R.; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of Bristol	Cuff, AR (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	Andrew.Cuff@bristol.ac.uk	Rayfield, Emily/F-5038-2010; Cuff, Andrew R/H-7197-2019	Rayfield, Emily/0000-0002-2618-750X; Cuff, Andrew R/0000-0001-9509-4297				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; Buffetaut E., 1986, Revue de Paleobiologie, V5, P217; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; BUSBEY AB, 1989, J MORPHOL, V202, P99, DOI 10.1002/jmor.1052020108; Busbey AB, 1977, THESIS U TEXAS AUSTI; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; CLEUREN J, 1995, BELG J ZOOL, V125, P79; DAEGLING DJ, 1992, AM J PHYS ANTHROPOL, V89, P59, DOI 10.1002/ajpa.1330890106; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Daniel WJT, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P135; DODSON P, 1975, J ZOOL, V175, P315; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Gatesy J, 2008, MOL PHYLOGENET EVOL, V48, P1232, DOI 10.1016/j.ympev.2008.02.009; Holtz TR, 1998, SCIENCE, V282, P1276, DOI 10.1126/science.282.5392.1276; KITCHENER A, 1987, NATURE, V325, P114, DOI 10.1038/325114a0; Langston W. Jr., 1973, P263; Martill DM, 1996, J GEOL SOC LONDON, V153, P5, DOI 10.1144/gsjgs.153.1.0005; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; McAliley LR, 2006, MOL PHYLOGENET EVOL, V39, P16, DOI 10.1016/j.ympev.2006.01.012; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; MCLLHENNY EA, 1935, ALLIGATORS LIFE HIST; Metzger KA, 2005, ANAT REC PART A, V283A, P331, DOI 10.1002/ar.a.20167; Milner AC., 2003, ACT 2 JORN INT PAL D, V2, P129; Pauwels Olivier S.G., 2003, Hamadryad, V27, P200; Pierce SE, 2009, J ANAT, V215, P555, DOI 10.1111/j.1469-7580.2009.01137.x; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Piras P, 2010, EVOL DEV, V12, P568, DOI 10.1111/j.1525-142X.2010.00442.x; Pooley A.C., 1989, P76; Preuschoft H., 1986, P249; Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rowe T, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011200; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; TAYLOR MA, 1993, PHILOS T ROY SOC B, V341, P399, DOI 10.1098/rstb.1993.0124; TAYLOR MA, 1987, ZOOL J LINN SOC-LOND, V91, P171, DOI 10.1111/j.1096-3642.1987.tb01727.x; Therrien F, 2005, LIFE O PAST, P179; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; THOMASON JJ, 1986, J MORPHOL, V189, P199, DOI 10.1002/jmor.1051890210; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Warfel M, 2005, MOMENTMACROJ VERSION; Weishampel DB, 1993, VERTEBRATE SKULL, P303; WHITAKER R, 1982, Journal of the Bombay Natural History Society, V79, P531; WOLFE J L, 1987, Northeast Gulf Science, V9, P1; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Young MT, 2011, ZOOL J LINN SOC-LOND, V163, P1199, DOI 10.1111/j.1096-3642.2011.00734.x; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zapata U, 2010, BONE, V46, P860, DOI 10.1016/j.bone.2009.11.010	58	43	44	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65295	10.1371/journal.pone.0065295	http://dx.doi.org/10.1371/journal.pone.0065295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724135	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000127
J	Ferir, G; Petrova, MI; Andrei, G; Huskens, D; Hoorelbeke, B; Snoeck, R; Vanderleyden, J; Balzarini, J; Bartoschek, S; Bronstrup, M; Sussmuth, RD; Schols, D				Ferir, Geoffrey; Petrova, Mariya I.; Andrei, Graciela; Huskens, Dana; Hoorelbeke, Bart; Snoeck, Robert; Vanderleyden, Jos; Balzarini, Jan; Bartoschek, Stefan; Broenstrup, Mark; Suessmuth, Roderich D.; Schols, Dominique			The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SYNERGISTIC ACTIVITY; SEXUAL TRANSMISSION; IN-VITRO; ENTRY; GEL; GRIFFITHSIN; INFECTION; TENOFOVIR; TARGET	Lantibiotics are peptides, produced by bacteria, that contain the noncanonicalamino acid lanthionine and many of them exhibit antibacterial activities. The labyrinthopeptin A1 (LabyA1) is a prototype peptide of a novel class of carbacyclic lantibiotics. Here, we extensively evaluated its broad-spectrum activity against HIV and HSV in vitro, studied its mechanism of action and evaluated potential microbicidal applications. LabyA1 exhibited a consistent and broad anti-HIV activity (EC(50)s:0.70-3.3 mu M) and anti-HSV activity (EC(50)s:0.29-2.8 mu M) in cell cultures. LabyA1 also inhibited viral cell-cell transmission between persistently HIV-infected T cells and uninfected CD4(+) T cells (EC50:2.5 mu M) and inhibited the transmission of HIV captured by DC-SIGN(+)-cells to uninfected CD4(+) T cells (EC50:4.1 mu M). Time-of-drug addition studies revealed that LabyA1 acts as an entry inhibitor against HIV and HSV. Cellular and virus binding studies combined with SPR/FLIPR technology showed that LabyA1 interacted with the HIV envelope protein gp120, but not with the HIV cellular receptors. LabyA1 also demonstrated additive to synergistic effects in its anti-HIV-1 and anti-HSV-2 activity with anti(retro) viral drugs in dual combinations such as tenofovir, acyclovir, saquinavir, raltegravir and enfuvirtide. LabyA1 can be considered as a novel lead peptide as it had profound antiviral activity against HIV and HSV. Pretreatment of PBMCs with LabyA1 neither increased the expression of the activation markers CD69 and CD25, nor enhanced HIV replication, nor significantly induced various inflammatory cytokines/chemokines. LabyA1 also did not affect the growth of vaginal Lactobacilli populations. Based on the lack of toxicity on the vaginal Lactobacillus strains and its synergistic/additive profile in combination with clinically approved anti(retro) virals, it deserves further attention as a potential microbicide candidate in the prevention of sexual transmitted diseases.	[Ferir, Geoffrey; Andrei, Graciela; Huskens, Dana; Hoorelbeke, Bart; Snoeck, Robert; Balzarini, Jan; Schols, Dominique] Univ Louvain, Rega Inst Med Res, Louvain, Belgium; [Petrova, Mariya I.; Vanderleyden, Jos] Univ Louvain, Ctr Microbial & Plant Genet, Louvain, Belgium; [Petrova, Mariya I.] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium; [Bartoschek, Stefan; Broenstrup, Mark] Sanofi R&D, Frankfurt, Germany; [Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Fak 2, Berlin, Germany	KU Leuven; University of Antwerp; Sanofi-Aventis; Technical University of Berlin	Schols, D (corresponding author), Univ Louvain, Rega Inst Med Res, Louvain, Belgium.	dominique.schols@rega.kuleuven.be	Andrei, Graciela/V-7721-2017; Petrova, Mariya/U-8087-2019; Schols, Dominique/AAC-1309-2021; Brönstrup, Mark/AAP-7598-2020; Snoeck, Robert/V-3867-2017; Schols, Dominique/S-9057-2017	Andrei, Graciela/0000-0003-2609-4896; Schols, Dominique/0000-0003-3256-5850; Brönstrup, Mark/0000-0002-8971-7045; Snoeck, Robert/0000-0002-7586-5434; Schols, Dominique/0000-0003-3256-5850; Sussmuth, Roderich/0000-0001-7027-2069	KU Leuven (GOA) [10/014, PF/10/018]; "Fonds voor Wetenschappelijk Onderzoek'' (FWO) [G. 485.08]; European Commission [242135]; COST action [CM0804]; Dormeur Services Inc.; Deutsche Forschungsgemeinschaft (DFG) [SU 239/9-2]; Cluster of Excellence "Unifying Concepts in Catalysis''	KU Leuven (GOA)(KU Leuven); "Fonds voor Wetenschappelijk Onderzoek'' (FWO)(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); COST action(European Cooperation in Science and Technology (COST)); Dormeur Services Inc.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Unifying Concepts in Catalysis''(German Research Foundation (DFG))	This work was supported by the KU Leuven (GOA number 10/014 and PF/10/018), the "Fonds voor Wetenschappelijk Onderzoek'' (FWO number G. 485.08) and the European Commission (FP7/2007-2013) (CHAARM number 242135), COST action CM0804, the Dormeur Services Inc., the Deutsche Forschungsgemeinschaft (DFG grant SU 239/9-2, the Cluster of Excellence "Unifying Concepts in Catalysis'' coordinated by the Technische Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Aranha CC, 2008, CYTOKINE, V43, P63, DOI 10.1016/j.cyto.2008.04.005; Arien KK, 2011, REV MED VIROL, V21, P110, DOI 10.1002/rmv.684; BALZARINI J, 1993, ANTIMICROB AGENTS CH, V37, P332, DOI 10.1128/AAC.37.2.332; Blower S, 2004, CLIN INFECT DIS, V39, pS240, DOI 10.1086/422361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Celum Connie L, 2011, Top Antivir Med, V19, P181; Choi MH, 2000, LETT APPL MICROBIOL, V30, P173, DOI 10.1046/j.1472-765X.2000.00719.x; Chono K, 2013, ANTIVIR RES, V97, P154, DOI 10.1016/j.antiviral.2012.12.006; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chung W, 2000, INT J FOOD MICROBIOL, V60, P25, DOI 10.1016/S0168-1605(00)00330-5; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Ferir G, 2012, J ANTIVIR ANTIRETROV, V4, P103, DOI DOI 10.4172/JAA.1000054; Ferir G, 2012, VIROLOGY, V433, P308, DOI 10.1016/j.virol.2012.08.007; Ferir G, 2011, VIROLOGY, V417, P253, DOI 10.1016/j.virol.2011.07.004; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Goethals O, 2010, VIROLOGY, V402, P338, DOI 10.1016/j.virol.2010.03.034; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Huskens D, 2007, VIROLOGY, V360, P294, DOI 10.1016/j.virol.2006.10.027; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Krawczyk B, 2012, J AM CHEM SOC, V134, P9922, DOI 10.1021/ja3040224; Krawczyk JM, 2013, CHEM BIOL IN PRESS; Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30; Meindl K, 2010, ANGEW CHEM INT EDIT, V49, P1151, DOI 10.1002/anie.200905773; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Muller WM, 2011, BIOCHEMISTRY-US, V50, P8362, DOI 10.1021/bi200526q; Muller WM, 2010, ANGEW CHEM INT EDIT, V49, P2436, DOI 10.1002/anie.200905909; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; Princen K, 2004, CYTOM PART A, V51, P35; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romano J, 2009, AIDS RES HUM RETROV, V25, P483, DOI 10.1089/aid.2008.0184; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Seibert G., 2008, WIPO Patent WO, Patent No. [2008/040469, 2008040469, WO2008/040469]; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shattock RJ, 2012, COLD SPRING HARB PER, V4; SKINNER MA, 1988, AIDS RES HUM RETROV, V4, P187, DOI 10.1089/aid.1988.4.187; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Thurman AR, 2012, INT J STD AIDS, V23, P613, DOI 10.1258/ijsa.2012.011356; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vermeire K, 2004, AIDS, V18, P2115, DOI 10.1097/00002030-200411050-00003; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Wink J, 2003, INT J SYST EVOL MICR, V53, P721, DOI 10.1099/ijs.0.02286-0; Ying C, 2000, J VIRAL HEPATITIS, V7, P79	56	88	96	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64010	10.1371/journal.pone.0064010	http://dx.doi.org/10.1371/journal.pone.0064010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724015	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000034
J	Picazio, S; Oliveri, M; Koch, G; Caltagirone, C; Petrosini, L				Picazio, Silvia; Oliveri, Massimiliano; Koch, Giacomo; Caltagirone, Carlo; Petrosini, Laura			Continuous Theta Burst Stimulation (cTBS) on Left Cerebellar Hemisphere Affects Mental Rotation Tasks during Music Listening	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; FUNCTIONAL TOPOGRAPHY; NEURAL MECHANISMS; STATE-DEPENDENCY; DECISION-MAKING; SEX-DIFFERENCES; FMRI; BRAIN; PERCEPTION	Converging evidence suggests an association between spatial and music domains. A cerebellar role in music-related information processing as well as in spatial-temporal tasks has been documented. Here, we investigated the cerebellar role in the association between spatial and musical domains, by testing performances in embodied (EMR) or abstract (AMR) mental rotation tasks of subjects listening Mozart Sonata K. 448, which is reported to improve spatial-temporal reasoning, in the presence or in the absence of continuous theta burst stimulation (cTBS) of the left cerebellar hemisphere. In the absence of cerebellar cTBS, music listening did not influence either MR task, thus not revealing a "Mozart Effect". Cerebellar cTBS applied before musical listening made subjects faster (P = 0.005) and less accurate (P = 0.005) in performing the EMR but not the AMR task. Thus, cerebellar inhibition by TBS unmasked the effect of musical listening on motor imagery. These data support a coupling between music listening and sensory-motor integration in cerebellar networks for embodied representations.	[Picazio, Silvia; Oliveri, Massimiliano; Koch, Giacomo; Caltagirone, Carlo; Petrosini, Laura] IRCCS Santa Lucia Fdn, Rome, Italy; [Picazio, Silvia; Petrosini, Laura] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Oliveri, Massimiliano] Univ Palermo, Dept Psychol, Palermo, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata; University of Palermo	Picazio, S (corresponding author), IRCCS Santa Lucia Fdn, Rome, Italy.	s.picazio@hsantalucia.it	Picazio, Silvia/K-5764-2016; Koch, Giacomo/G-3155-2012; Oliveri, Massimiliano/HDO-5602-2022	Picazio, Silvia/0000-0002-4403-2261; KOch, Giacomo/0000-0001-6155-9439; Picazio, Silvia/0000-0002-1784-7537	grant of Italian Ministero of Health [RF09255]	grant of Italian Ministero of Health	This work was supported by a grant of Italian Ministero of Health to MO (RF09255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Beste C., 2011, PLOS CURRENTS, V3; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Bodner M, 2001, NEUROL RES, V23, P683, DOI 10.1179/016164101101199108; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chen JL, 2005, ANN NY ACAD SCI, V1060, P400, DOI 10.1196/annals.1360.044; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Garcia-Casares N, 2011, NEUROLOGIA; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Ionta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034382; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Janczyk M, 2012, J EXP PSYCHOL GEN, V141, P489, DOI 10.1037/a0026997; Jansen-Osmann P, 2007, BRAIN COGNITION, V64, P217, DOI 10.1016/j.bandc.2007.03.002; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Lahav A, 2005, ANN NY ACAD SCI, V1060, P189, DOI 10.1196/annals.1360.042; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; Marshall JAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043443; Mohr C, 2006, BEHAV NEUROSCI, V120, P528, DOI 10.1037/0735-7044.120.3.528; Molinari M, 2004, J NEUROL NEUROSUR PS, V75, P235; Molinari M, 2007, CEREBELLUM, V6, P214, DOI 10.1080/14734220701230870; Molinari M, 2007, CEREBELLUM, V6, P18, DOI 10.1080/14734220601142886; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; RATCLIFF G, 1979, NEUROPSYCHOLOGIA, V17, P49, DOI 10.1016/0028-3932(79)90021-6; RAUSCHER FH, 1995, NEUROSCI LETT, V185, P44, DOI 10.1016/0304-3940(94)11221-4; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Seurinck R, 2004, NEUROIMAGE, V23, P1440, DOI 10.1016/j.neuroimage.2004.08.010; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, BEHAV NEUROL, V23, P65, DOI [10.3233/BEN-2010-0268, 10.1155/2010/840942]; Thurstone LL, 1937, SCIENCE, V85, P227, DOI 10.1126/science.85.2201.227; Tomasino B, 2005, COGN NEUROPSYCHOL, V22, P348, DOI 10.1080/02643290442000185; Tomasino B, 2011, J COGNITIVE NEUROSCI, V23, P2068, DOI 10.1162/jocn.2010.21577; Torriero S, 2004, J COGNITIVE NEUROSCI, V16, P1605, DOI 10.1162/0898929042568488; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Vallesi A, 2012, HUM BRAIN MAPP, V33, P1677, DOI 10.1002/hbm.21312; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weiss MM, 2009, NEUROIMAGE, V44, P1063, DOI 10.1016/j.neuroimage.2008.09.042; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Williamson VJ, 2011, BRAIN COGNITION, V76, P70, DOI 10.1016/j.bandc.2011.02.016; Wohlschlager A, 1998, J EXP PSYCHOL HUMAN, V24, P397, DOI 10.1037/0096-1523.24.2.397; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	73	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64640	10.1371/journal.pone.0064640	http://dx.doi.org/10.1371/journal.pone.0064640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724071	gold, Green Published, Green Submitted			2022-12-25	WOS:000319733000071
J	Zou, FG; Belbin, O; Carrasquillo, MM; Culley, OJ; Hunter, TA; Ma, L; Bisceglio, GD; Allen, M; Dickson, DW; Graff-Radford, NR; Petersen, RC; Morgan, K; Younkin, SG				Zou, Fanggeng; Belbin, Olivia; Carrasquillo, Minerva M.; Culley, Oliver J.; Hunter, Talisha A.; Ma, Li; Bisceglio, Gina D.; Allen, Mariet; Dickson, Dennis W.; Graff-Radford, Neill R.; Petersen, Ronald C.; Morgan, Kevin; Younkin, Steven G.		Genetic Environm Risk Alzheimer's	Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer's Disease Pathology	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; GENE-EXPRESSION; COMMON VARIANTS; RISK; CLU; CARRIERS; MODIFY; CD2AP; EPHA1	GRB-associated binding protein 2 (GAB2) represents a compelling genome-wide association signal for late-onset Alzheimer's disease (LOAD) with reported odds ratios (ORs) ranging from 0.75-0.85. We tested eight GAB2 variants in four North American Caucasian case-control series (2,316 LOAD, 2,538 controls) for association with LOAD. Meta-analyses revealed ORs ranging from (0.61-1.20) with no significant association (all p>0.32). Four variants were hetergeneous across the populations (all p<0.02) due to a potentially inflated effect size (OR = 0.61-0.66) only observed in the smallest series (702 LOAD, 209 controls). Despite the lack of association in our series, the previously reported protective association for GAB2 remained after meta-analyses of our data with all available previously published series (11,952-22,253 samples; OR = 0.82-0.88; all p<0.04). Using a freely available database of lymphoblastoid cell lines we found that protective GAB2 variants were associated with increased GAB2 expression (p = 9.5x10(-7) -9.3x10(-6)). We next measured GAB2 mRNA levels in 249 brains and found that decreased neurofibrillary tangle (r = -0.34, p = 0.0006) and senile plaque counts (r = -0.32, p = 0.001) were both good predictors of increased GAB2 mRNA levels albeit that sex (r = -0.28, p = 0.005) may have been a contributing factor. In summary, we hypothesise that GAB2 variants that are protective against LOAD in some populations may act functionally to increase GAB2 mRNA levels (in lymphoblastoid cells) and that increased GAB2 mRNA levels are associated with significantly decreased LOAD pathology. These findings support the hypothesis that Gab2 may protect neurons against LOAD but due to significant population heterogeneity, it is still unclear whether this protection is detectable at the genetic level.	[Zou, Fanggeng; Belbin, Olivia; Carrasquillo, Minerva M.; Culley, Oliver J.; Hunter, Talisha A.; Ma, Li; Bisceglio, Gina D.; Allen, Mariet; Dickson, Dennis W.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Belbin, Olivia; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Graff-Radford, Neill R.] Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Mayo Alzheimer Dis Res Ctr, Rochester, MN USA	Mayo Clinic; University of Nottingham; Mayo Clinic; Mayo Clinic; Mayo Clinic	Younkin, SG (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	younkin.steven@mayo.edu	McQuillin, Andrew/C-1623-2008; Kornhuber, Johannes/B-9613-2014; Ramirez, Alfredo/S-5126-2019; Kehoe, Patrick/P-8760-2018; Hardy, John/C-2451-2009	McQuillin, Andrew/0000-0003-1567-2240; Kornhuber, Johannes/0000-0002-8096-3987; Ramirez, Alfredo/0000-0003-4991-763X; Belbin, Olivia/0000-0002-6109-6371; Hampel, Harald/0000-0003-0894-8982; Rossor, Martin/0000-0001-8215-3120; Guerreiro, Rita/0000-0001-5879-3486; Brayne, Carol/0000-0001-5307-663X; Belbin, Olivia/0000-0002-9805-8408; Dickson, Dennis W/0000-0001-7189-7917; Drichel, Dmitriy/0000-0001-5978-3458; Denning, Nicola/0000-0001-8467-7382; Lovestone, Simon/0000-0003-0473-4565; Goate, Alison/0000-0002-0576-2472; Mead, Simon/0000-0002-4326-1468; Lacour, Andre/0000-0003-2692-2583; Morgan, Kevin/0000-0002-8217-2396; McGuinness, Bernadette/0000-0002-7028-5633; Harold, Denise/0000-0001-5195-0143; Wiltfang, Jens/0000-0003-1492-5330; Dichgans, Martin/0000-0002-0654-387X; Nothen, Markus/0000-0002-8770-2464; Williams, Julie/0000-0002-4069-0259; Kehoe, Patrick/0000-0002-7542-1139; Lupton, Michelle/0000-0002-7274-7299; Hardy, John/0000-0002-3122-0423; Culley, Oliver/0000-0002-6765-9390	National Institutes of Health grant: National Institute on Aging [R01 AG018023, AG025711, AG017216, AG003949]; National Institutes of Health grant: Mayo Alzheimer's Disease Research Center [P50 AG016574]; National Institutes of Health grant: Mayo Alzheimer's Disease Patient Registry [U01AG006576]; Wellcome Trust; Medical Research Council (MRC); Alzheimer's Research United Kingdom (ARUK); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; N. Ireland Research & Development Office; Royal College of Physicians/Dunhill Medical Trust; Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; OPTIMA group; UCLH/UCL Biomedical Centre; Lundbeck SA; German Federal Ministry of Education and Research Competence Network Dementia and Competence Network Degenerative Dementia; Alfried Krupp von Bohlen und Halbach-Stiftung; NATIONAL INSTITUTE ON AGING [P01AG017216, P01AG003949, R01AG018023, P50AG016574, P50AG025711] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-PG2014-1, ART-RF2007-3] Funding Source: researchfish; Medical Research Council [G0902227, G0801418B, MC_PC_14095, MC_U123192748, MR/K013041/1, MC_U123160651] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [MC_PC_14095, G0902227, MC_U123160651, MC_U123192748, MR/K013041/1] Funding Source: UKRI	National Institutes of Health grant: National Institute on Aging; National Institutes of Health grant: Mayo Alzheimer's Disease Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health grant: Mayo Alzheimer's Disease Patient Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research United Kingdom (ARUK); Welsh Assembly Government; Alzheimer's Society; Ulster Garden Villages; N. Ireland Research & Development Office; Royal College of Physicians/Dunhill Medical Trust(Dunhill Medical Trust); Trinity College group; Bristol Research into Alzheimer's and Care of the Elderly; OPTIMA group; UCLH/UCL Biomedical Centre; Lundbeck SA(Lundbeck Corporation); German Federal Ministry of Education and Research Competence Network Dementia and Competence Network Degenerative Dementia(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support for this research was provided by the National Institutes of Health grants: National Institute on Aging (R01 AG018023 to NRG-R and SGY); Mayo Alzheimer's Disease Research Center:(P50 AG016574 to RP, DWD, NRG-R, SGY, and NET); Mayo Alzheimer's Disease Patient Registry: (U01AG006576 to RP); National Institute on Aging (AG025711, AG017216, AG003949 to DWD). This project was also generously supported by the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (to RP, DWD, NRG-R, and SGY), and by the Palumbo Professorship in Alzheimer's Disease Research (to SGY). GERAD fincancial disclosures: Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC), Alzheimer's Research United Kingdom (ARUK) and the Welsh Assembly Government. ARUK supported sample collections at the Kings College London, the South West Dementia Bank, Universities of Cambridge, Nottingham, Manchester and Belfast. The Belfast group acknowledges support from the Alzheimer's Society, Ulster Garden Villages, N. Ireland Research & Development Office and the Royal College of Physicians/Dunhill Medical Trust. The MRC and Mercer's Institute for Research on Ageing supported the Trinity College group. The South West Dementia Brain Bank acknowledges support from Bristol Research into Alzheimer's and Care of the Elderly. The Charles Wolfson Charitable Trust supported the OPTIMA group. Patient recruitment for the MRC Prion Unit/UCL Department of Neurodegenerative Disease collection was supported by the UCLH/UCL Biomedical Centre. LASER-AD was funded by Lundbeck SA. The Bonn group was supported by the German Federal Ministry of Education and Research Competence Network Dementia and Competence Network Degenerative Dementia, and by the Alfried Krupp von Bohlen und Halbach-Stiftung. The GERAD1 Consortium also used samples ascertained by the National Institute of Mental Health AD Genetics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Belbin O, 2011, HUM GENET, V129, P273, DOI 10.1007/s00439-010-0924-2; BERTRAM L, 2006, ALZGENE DATABASE; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Carrasquillo MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008764; CARRASQUILLO MM, 2011, J ALZHEIMERS DIS; Chapuis J, 2008, NEUROBIOL DIS, V30, P103, DOI 10.1016/j.nbd.2007.12.006; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Feulner TM, 2009, MOL PSYCHIAT; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Ikram MA, 2009, BIOL PSYCHIAT, V65, P995, DOI 10.1016/j.biopsych.2008.11.014; Jun G, 2010, ARCH NEUROL; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2010, ARCH NEUROL; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Lin KG, 2010, NEUROL SCI, V31, P277, DOI 10.1007/s10072-009-0178-8; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyashita A, 2009, EUR J HUM GENET, V17, P682, DOI 10.1038/ejhg.2008.181; Nacmias B, 2009, J ALZHEIMERS DIS, V16, P513, DOI 10.3233/JAD-2009-1005; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez-Lorca R, 2009, J NUTR HEALTH AGING, V13, P214, DOI 10.1007/s12603-009-0061-6; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schjeide BMM, 2009, ARCH NEUROL-CHICAGO, V66, P250, DOI 10.1001/archneurol.2008.552; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sleegers K, 2009, HUM MUTAT, V30, pE338, DOI 10.1002/humu.20909; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654	34	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64802	10.1371/journal.pone.0064802	http://dx.doi.org/10.1371/journal.pone.0064802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724096	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319733000097
J	Hirai, T; Uchida, K; Nakajima, H; Guerrero, AR; Takeura, N; Watanabe, S; Sugita, D; Yoshida, A; Johnson, WEB; Baba, H				Hirai, Takayuki; Uchida, Kenzo; Nakajima, Hideaki; Guerrero, Alexander Rodriguez; Takeura, Naoto; Watanabe, Shuji; Sugita, Daisuke; Yoshida, Ai; Johnson, William E. B.; Baba, Hisatoshi			The Prevalence and Phenotype of Activated Microglia/Macrophages within the Spinal Cord of the Hyperostotic Mouse (twy/twy) Changes in Response to Chronic Progressive Spinal Cord Compression: Implications for Human Cervical Compressive Myelopathy	PLOS ONE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; ALTERNATIVE ACTIVATION; SPONDYLOTIC MYELOPATHY; MACROPHAGE ACTIVATION; CELL-DEATH; INFLAMMATORY RESPONSE; INTERFERON-GAMMA; INJURY; MICROGLIA; OSSIFICATION	Background: Cervical compressive myelopathy, e. g. due to spondylosis or ossification of the posterior longitudinal ligament is a common cause of spinal cord dysfunction. Although human pathological studies have reported neuronal loss and demyelination in the chronically compressed spinal cord, little is known about the mechanisms involved. In particular, the neuroinflammatory processes that are thought to underlie the condition are poorly understood. The present study assessed the localized prevalence of activated M1 and M2 microglia/macrophages in twy/twy mice that develop spontaneous cervical spinal cord compression, as a model of human disease. Methods: Inflammatory cells and cytokines were assessed in compressed lesions of the spinal cords in 12-, 18- and 24-weeks old twy/twy mice by immunohistochemical, immunoblot and flow cytometric analysis. Computed tomography and standard histology confirmed a progressive spinal cord compression through the spontaneously development of an impinging calcified mass. Results: The prevalence of CD11b-positive cells, in the compressed spinal cord increased over time with a concurrent decrease in neurons. The CD11b-positive cell population was initially formed of arginase-1- and CD206-positive M2 microglia/macrophages, which later shifted towards iNOS- and CD16/32-positive M1 microglia/macrophages. There was a transient increase in levels of T helper 2 (Th2) cytokines at 18 weeks, whereas levels of Th1 cytokines as well as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and macrophage antigen (Mac) -2 progressively increased. Conclusions: Spinal cord compression was associated with a temporal M2 microglia/macrophage response, which may act as a possible repair or neuroprotective mechanism. However, the persistence of the neural insult also associated with persistent expression of Th1 cytokines and increased prevalence of activated M1 microglia/macrophages, which may lead to neuronal loss and demyelination despite the presence of neurotrophic factors. This understanding of the aetiopathology of chronic spinal cord compression is of importance in the development of new treatment targets in human disease.	[Hirai, Takayuki; Uchida, Kenzo; Nakajima, Hideaki; Guerrero, Alexander Rodriguez; Takeura, Naoto; Watanabe, Shuji; Sugita, Daisuke; Yoshida, Ai; Baba, Hisatoshi] Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Fukui 910, Japan; [Johnson, William E. B.] Aston Univ, Birmingham B4 7ET, W Midlands, England	University of Fukui; Aston University	Uchida, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Fukui 910, Japan.	kuchida@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [B-22390287, B-24390351]; Investigation Committee on Ossification of the Spinal ligaments, Public Health Bureau of the Japanese Ministry of Health and Welfare	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Investigation Committee on Ossification of the Spinal ligaments, Public Health Bureau of the Japanese Ministry of Health and Welfare	This study was supported by Grants-in-Aid to HB and KU for General Scientific Research of the Ministry of Education, Science and Culture of Japan (#B-22390287 and #B-24390351) and also by grants to HB and KU from the Investigation Committee on Ossification of the Spinal ligaments, Public Health Bureau of the Japanese Ministry of Health and Welfare (2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba H, 1996, J NEUROL, V243, P109, DOI 10.1007/BF02443999; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BOHLMAN HH, 1988, SPINE, V13, P843, DOI 10.1097/00007632-198807000-00025; Bomstein Y, 2003, J NEUROIMMUNOL, V142, P10, DOI 10.1016/S0165-5728(03)00260-1; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Fehlings MG, 1998, SPINE, V23, P2730, DOI 10.1097/00007632-199812150-00012; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Inukai T, 2009, SPINE, V34, P2848, DOI 10.1097/BRS.0b013e3181b0d078; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; KAMEYAMA T, 1995, BRAIN, V118, P263, DOI 10.1093/brain/118.1.263; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsunaga S, 2008, SPINE, V33, P2648, DOI 10.1097/BRS.0b013e31817f988c; McCormack BM, 1996, WESTERN J MED, V165, P43; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Mizuno J, 2005, SPINAL CORD, V43, P503, DOI 10.1038/sj.sc.3101727; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shin WH, 2004, GLIA, V46, P142, DOI 10.1002/glia.10357; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Suzuki Y, 2005, INT J PARASITOL, V35, P83, DOI 10.1016/j.ijpara.2004.10.020; Uchida K, 1998, J NEUROL, V245, P781, DOI 10.1007/s004150050287; Uchida K, 2003, ACTA NEUROPATHOL, V106, P29, DOI 10.1007/s00401-003-0691-4; Uchida K, 2012, EUR SPINE J, V21, P490, DOI 10.1007/s00586-011-2025-x; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Yu WR, 2011, BRAIN, V134, P1277, DOI 10.1093/brain/awr054; Yu WR, 2009, NEUROBIOL DIS, V33, P149, DOI 10.1016/j.nbd.2008.09.024	48	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64528	10.1371/journal.pone.0064528	http://dx.doi.org/10.1371/journal.pone.0064528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717624	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300018
J	Jaekel, J; Baumann, N; Wolke, D				Jaekel, Julia; Baumann, Nicole; Wolke, Dieter			Effects of Gestational Age at Birth on Cognitive Performance: A Function of Cognitive Workload Demands	PLOS ONE			English	Article							KAUFMAN ASSESSMENT BATTERY; EXTREMELY PRETERM CHILDREN; WORKING-MEMORY CAPACITY; ACADEMIC ATTAINMENT; EXECUTIVE FUNCTIONS; BRAIN-DEVELOPMENT; K-ABC; DISTURBANCES; ORGANIZATION; PREDICTORS	Objective: Cognitive deficits have been inconsistently described for late or moderately preterm children but are consistently found in very preterm children. This study investigates the association between cognitive workload demands of tasks and cognitive performance in relation to gestational age at birth. Methods: Data were collected as part of a prospective geographically defined whole-population study of neonatal at-risk children in Southern Bavaria. At 8; 5 years, n = 1326 children (gestation range: 23-41 weeks) were assessed with the K-ABC and a Mathematics Test. Results: Cognitive scores of preterm children decreased as cognitive workload demands of tasks increased. The relationship between gestation and task workload was curvilinear and more pronounced the higher the cognitive workload: GA(2) (quadratic term) on low cognitive workload: R-2 = .02, p<0.001; moderate cognitive workload: R-2 = .09, p<0.001; and high cognitive workload tasks: R-2 = .14, p<0.001. Specifically, disproportionally lower scores were found for very (<32 weeks gestation) and moderately (32-33 weeks gestation) preterm children the higher the cognitive workload of the tasks. Early biological factors such as gestation and neonatal complications explained more of the variance in high (12.5%) compared with moderate (8.1%) and low cognitive workload tasks (1.7%). Conclusions: The cognitive workload model may help to explain variations of findings on the relationship of gestational age with cognitive performance in the literature. The findings have implications for routine cognitive follow-up, educational intervention, and basic research into neuro-plasticity and brain reorganization after preterm birth.	[Jaekel, Julia] Ruhr Univ Bochum, Dept Dev Psychol, Bochum, Germany; [Jaekel, Julia; Baumann, Nicole; Wolke, Dieter] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Wolke, Dieter] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Ruhr University Bochum; University of Warwick; University of Warwick	Wolke, D (corresponding author), Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England.	D.Wolke@warwick.ac.uk	Wolke, Dieter/C-5372-2008; Jaekel, Julia/P-1548-2014; Jaekel, Julia/AAB-5795-2021; Jaekel, Julia/AAC-4459-2021; Jaekel, Julia/B-7193-2009	Wolke, Dieter/0000-0003-0304-268X; Jaekel, Julia/0000-0001-6123-3375; Jaekel, Julia/0000-0001-6123-3375; Jaekel, Julia/0000-0001-6123-3375; Jaekel, Julia/0000-0001-6123-3375	German Federal Ministry of Education and Science (BMBF) [PKE24, JUG14, 01EP9504, 01ER0801]; German Research Foundation (DFG) [JA 1913]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by grants PKE24, JUG14, 01EP9504 and 01ER0801 from the German Federal Ministry of Education and Science (BMBF) and by grant JA 1913 from the German Research Foundation (DFG). The contents are solely the responsibility of the authors and do not necessarily represent the official view of the BMBF or the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Bauer A., 1988, VERFAHREN MESSUNG BI; Bornstein MH, 2013, CHILD DEV, V84, P154, DOI 10.1111/j.1467-8624.2012.01849.x; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Breslau N, 2006, INTELLIGENCE, V34, P351, DOI 10.1016/j.intell.2005.10.003; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Clark CAC, 2010, DEV NEUROPSYCHOL, V35, P622, DOI 10.1080/87565641.2010.508669; Davis EP, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00001; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Dudink J, 2008, EARLY HUM DEV, V84, P777, DOI 10.1016/j.earlhumdev.2008.09.004; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gutbrod T, 2000, ARCH DIS CHILD-FETAL, V82, pF208, DOI 10.1136/fn.82.3.F208; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Jaekel J, 2012, DEV MED CHILD NEUROL, V54, P716, DOI 10.1111/j.1469-8749.2012.04323.x; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; KAUFMAN AS, 1984, J EDUC PSYCHOL, V76, P623, DOI 10.1037/0022-0663.76.4.623; KLINE RB, 1992, J PSYCHOEDUC ASSESS, V10, P141, DOI 10.1177/073428299201000207; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Leon-Villagra J, 1993, MATHEMATIKTEST GRUND; Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Melchers P., 1991, K ABC KAUFMAN BATTER; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Mulder H, 2010, ARCH DIS CHILD-FETAL, V95, pF267, DOI 10.1136/adc.2009.167965; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nosarti C, 2010, NEURODEVELOPMENTAL O; Nutley SB, 2010, DEV NEUROPSYCHOL, V35, P81, DOI 10.1080/87565640903325741; Oberauer K, 2000, PERS INDIV DIFFER, V29, P1017, DOI 10.1016/S0191-8869(99)00251-2; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Panigrahy A, 2012, PEDIATR RADIOL, V42, P33, DOI 10.1007/s00247-011-2239-4; Peterson BS, 2003, ANN NY ACAD SCI, V1008, P219, DOI 10.1196/annals.1301.023; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Rees S, 2005, EARLY HUM DEV, V81, P753, DOI 10.1016/j.earlhumdev.2005.07.004; Sameroff A, 1975, REV CHILD DEV RES, P187; Schermann L, 2004, ACTA PAEDIATR, V93, P1619, DOI 10.1080/08035250410023386; Schmid G, 2011, CHILD CARE HLTH DEV, V37, P493, DOI 10.1111/j.1365-2214.2010.01201.x; Schneider W, 2004, EUR J PSYCHOL EDUC, V19, P385, DOI 10.1007/BF03173217; Simms V, 2013, PEDIATR RES, V73, P236, DOI 10.1038/pr.2012.157; STIGLER JW, 1990, MATH KNOWLEDGE JAPAN; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; TOFT PB, 1995, EARLY HUM DEV, V43, P15, DOI 10.1016/0378-3782(95)01657-O; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201; Wolke D, 2011, SAGE HDB DEV DISORDE, P497, DOI DOI 10.4135/9781446201107.N26; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	62	56	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e65219	10.1371/journal.pone.0065219	http://dx.doi.org/10.1371/journal.pone.0065219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717694	Green Submitted, Green Published, gold			2022-12-25	WOS:000319385300002
J	Munder, M; Engelhardt, M; Knies, D; Medenhoff, S; Wabnitz, G; Luckner-Minden, C; Feldmeyer, N; Voss, RH; Kropf, P; Muller, I; Conradi, R; Samstag, Y; Theobald, M; Ho, AD; Goldschmidt, H; Hundemer, M				Munder, Markus; Engelhardt, Melanie; Knies, Diana; Medenhoff, Sergej; Wabnitz, Guido; Luckner-Minden, Claudia; Feldmeyer, Nadja; Voss, Ralf-Holger; Kropf, Pascale; Mueller, Ingrid; Conradi, Roland; Samstag, Yvonne; Theobald, Matthias; Ho, Anthony D.; Goldschmidt, Hartmut; Hundemer, Michael			Cytotoxicity of Tumor Antigen Specific Human T Cells Is Unimpaired by Arginine Depletion	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; DENDRITIC CELLS; MULTIPLE-MYELOMA; INFILTRATING LYMPHOCYTES; IN-VITRO; CANCER; ARGINASE; EXPRESSION; CARCINOMA; COFILIN	Tumor-growth is often associated with the expansion of myeloid derived suppressor cells that lead to local or systemic arginine depletion via the enzyme arginase. It is generally assumed that this arginine deficiency induces a global shut-down of T cell activation with ensuing tumor immune escape. While the impact of arginine depletion on polyclonal T cell proliferation and cytokine secretion is well documented, its influence on chemotaxis, cytotoxicity and antigen specific activation of human T cells has not been demonstrated so far. We show here that chemotaxis and early calcium signaling of human T cells are unimpaired in the absence of arginine. We then analyzed CD8(+) T cell activation in a tumor peptide as well as a viral peptide antigen specific system: (i) CD8(+) T cells with specificity against the MART-1(aa26-35*A27L) tumor antigen expanded with in vitro generated dendritic cells, and (ii) clonal CMV pp65(aa495-503) specific T cells and T cells retrovirally transduced with a CMV pp65(aa495-503) specific T cell receptor were analyzed. Our data demonstrate that human CD8(+) T cell antigen specific cytotoxicity and perforin secretion are completely preserved in the absence of arginine, while antigen specific proliferation as well as IFN-gamma and granzyme B secretion are severely compromised. These novel results highlight the complexity of antigen specific T cell activation and demonstrate that human T cells can preserve important activation-induced effector functions in the context of arginine deficiency.	[Munder, Markus; Knies, Diana; Luckner-Minden, Claudia; Voss, Ralf-Holger; Theobald, Matthias] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Engelhardt, Melanie; Medenhoff, Sergej; Feldmeyer, Nadja; Ho, Anthony D.; Goldschmidt, Hartmut; Hundemer, Michael] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Wabnitz, Guido; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Kropf, Pascale] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Mueller, Ingrid] Univ London Imperial Coll Sci Technol & Med, Dept Med, Immunol Sect, London, England; [Conradi, Roland] Univ Med Ctr Mainz, Transfus Ctr, Mainz, Germany; [Goldschmidt, Hartmut] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany	Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Hundemer, M (corresponding author), Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany.	michael.hundemer@med.uni-heidelberg.de	Munder, Markus/K-6737-2013; Goldschmidt, Hartmut/AAL-8069-2021	Conradi, Roland/0000-0003-4645-3569; Ho, Anthony D./0000-0002-1656-0833; Wabnitz, Guido/0000-0001-5101-9885	Deutsche Forschungsgemeinschaft; Dietmar Hopp-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar Hopp-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de) and the Dietmar Hopp-Stiftung (http://www.dietmar-hoppstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Correale P, 2001, BRIT J CANCER, V85, P1722, DOI 10.1054/bjoc.2001.2136; Curti A, 2007, BRIT J HAEMATOL, V139, P415, DOI 10.1111/j.1365-2141.2007.06832.x; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Feldmeyer N, 2012, INT IMMUNOL, V24, P303, DOI 10.1093/intimm/dxs004; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hunderner M, 2006, EXP HEMATOL, V34, P486, DOI 10.1016/j.exphem.2006.01.008; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Singer K, 2011, CANCER IMMUNOL IMMUN, V60, P425, DOI 10.1007/s00262-010-0967-1; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Tadmor T, 2011, BRIT J HAEMATOL, V153, P557, DOI 10.1111/j.1365-2141.2011.08678.x; Titzer S, 2000, BRIT J HAEMATOL, V108, P805, DOI 10.1046/j.1365-2141.2000.01958.x; Valmori D, 1998, J IMMUNOL, V160, P1750; Voss RH, 2005, METH MOLEC MED, V109, P229; Wang W, 2009, LUNG CANCER, V63, P23, DOI 10.1016/j.lungcan.2008.04.009; Willemsen RA, 2000, GENE THER, V7, P1369, DOI 10.1038/sj.gt.3301253; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	42	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63521	10.1371/journal.pone.0063521	http://dx.doi.org/10.1371/journal.pone.0063521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717444	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319435600022
J	Li, XL; Qi, YC; Ma, XR; Huang, FJ; Guo, H; Jiang, XH; Hong, J; Lin, DP; Cui, B; Ning, G; Xu, LY; Wang, S				Li, Xiaoli; Qi, Yicheng; Ma, Xinran; Huang, Fengjiao; Guo, Hua; Jiang, Xiaohua; Hong, Jie; Lin, Dongping; Cui, Bin; Ning, Guang; Xu, Lingyan; Wang, Shu			Chemokine (C-C Motif) Ligand 20, a Potential Biomarker for Graves' Disease, Is Regulated by Osteopontin	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CCR6-EXPRESSING TH17 CELLS; INTERFERON-GAMMA; T-CELLS; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; SERUM-LEVELS; EXPRESSION; ALPHA; POLYMORPHISMS	Context: Graves' disease (GD) is a common autoimmune disease involving the thyroid gland. The altered balance of pro- and anti-inflammatory cytokines plays an important role in the pathogenesis of GD. Chemokine (C-C motif) ligand 20 (CCL20) is important for interleukin-17 (IL-17) signal activation and a potent chemoattractant for Th17 cells. Meanwhile, Osteopontin (OPN), a broadly expressed pleiotropic cytokine, has been implicated in GD through inducing Th1-involved response to enhance the production of proinflammatory cytokines and chemokines, but little is known about the role of OPN in regulating CCL20 and IL-17 signaling. Objective: This study sought to explore the possibility of CCL20 level as a biomarker for GD, as well as investigate the role of OPN in regulating CCL20 production. Methods: Fifty untreated GD patients, fifteen euthyroid GD patients, twelve TRAb-negative GD patients and thirty-five healthy control donors were recruited. OPN, CCL20 and other clinical GD diagnosis parameters were measured. CD4+T cells were isolated from peripheral blood mononuclear cells (PBMCs) using antibody-coated magnetic beads. Enzyme-linked immune-sorbent assay and quantitative polymerase chain reaction were used to determine CCL20 expression level. Results: We found that the plasma CCL20 level was enhanced in GD patients and decreased in euthyroid and TRAb-negative GD patients. In addition, CCL20 level correlated with GD clinical diagnostic parameters and plasma OPN level. Moreover, we demonstrated that recombinant OPN and plasma from untreated GD patients increased the expression of CCL20 in CD4+T cells, which could be blocked by OPN antibody. Furthermore, we found that the effect of OPN on CCL20 expression was mediated by beta 3 integrin receptor, IL-17, NF-kappa B and MAPK pathways. Conclusions: These results demonstrated that CCL20 might serve as a biomarker for GD and suggested the possible role of OPN in induction of CCL20 expression.	[Li, Xiaoli; Qi, Yicheng; Huang, Fengjiao; Guo, Hua; Jiang, Xiaohua; Hong, Jie; Cui, Bin; Ning, Guang; Wang, Shu] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol & Metab, Ruijin Hosp,Shanghai Clin Ctr Endocrine & Metab D, Shanghai, Peoples R China; [Li, Xiaoli; Qi, Yicheng; Ma, Xinran; Cui, Bin; Ning, Guang; Xu, Lingyan; Wang, Shu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China; [Li, Xiaoli; Qi, Yicheng; Ma, Xinran; Cui, Bin; Ning, Guang; Xu, Lingyan; Wang, Shu] Shanghai Jiao Tong Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China; [Ma, Xinran; Xu, Lingyan] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Lin, Dongping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Shanghai Jiao Tong University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol & Metab, Ruijin Hosp,Shanghai Clin Ctr Endocrine & Metab D, Shanghai, Peoples R China.	guangning@medmail.com.cn; xul7@mail.nih.gov; shuw@sibs.ac.cn	Li, Xiaoli/GYQ-7384-2022		National Natural Science Foundation of China [81270872]; Shanghai Municipal Natural Science Foundation [11495803400]; Sector Funds of Ministry of Health [201002002, 201202008]; The National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Sector Funds of Ministry of Health; The National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology	This study was supported by the grants from the National Natural Science Foundation of China (No.81270872), Shanghai Municipal Natural Science Foundation (No. 11495803400), the Sector Funds of Ministry of Health (No. 201002002, No. 201202008) and The National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (No. 2012ZX09303006-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2006, BRIT J SURG, V93, P1226, DOI 10.1002/bjs.5401; Antonelli A, 2007, J CLIN ENDOCR METAB, V92, P1485, DOI 10.1210/jc.2006-1571; Antonelli A, 2010, J CLIN ENDOCR METAB, V95, pE413, DOI 10.1210/jc.2010-0923; Chen G, 2012, ARTHRITIS RHEUM, V62, P2900; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Guo T, 2013, GENE, V512, P300, DOI 10.1016/j.gene.2012.10.021; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Iizuka J, 1998, LAB INVEST, V78, P1523; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; LAMPE MA, 1991, J IMMUNOL, V147, P2902; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lichiardopol Corina, 2009, Rom J Intern Med, V47, P207; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Niino M, 2003, J NEUROIMMUNOL, V136, P125, DOI 10.1016/S0165-5728(03)00004-3; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Rossi DL, 1997, J IMMUNOL, V158, P1033; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Sakata M, 2001, J RHEUMATOL, V28, P1492; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Standal T, 2004, EXP ONCOL, V26, P179; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Xu GW, 2005, J CLIN INVEST, V115, P1060; Xu LY, 2011, J CLIN ENDOCR METAB, V96, pE1866, DOI 10.1210/jc.2011-1339; Zheng WX, 2009, ARTHRITIS RHEUM-US, V60, P1957, DOI 10.1002/art.24625	41	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64277	10.1371/journal.pone.0064277	http://dx.doi.org/10.1371/journal.pone.0064277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717583	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700128
J	Mouawad, CA; Mrad, MF; Al-Hariri, M; Soussi, H; Hamade, E; Alam, J; Habib, A				Mouawad, Charbel A.; Mrad, May F.; Al-Hariri, Moustafa; Soussi, Hiba; Hamade, Eva; Alam, Jawed; Habib, Aida			Role of Nitric Oxide and CCAAT/Enhancer-Binding Protein Transcription Factor in Statin-Dependent Induction of Heme Oxygenase-1 in Mouse Macrophages	PLOS ONE			English	Article							RAW264.7 MACROPHAGES; P38 MAPK; EXPRESSION; SIMVASTATIN; SYNTHASE; ANTIGEN-1; MONOXIDE; INHIBIT; INJURY; CELLS	The effect of statins on heme oxygenase-1 (HO-1) was compared in 2 murine cell lines, RAW 264.7 and J774A.1 cell lines, and in primary peritoneal macrophages of BALB/c or C57BL/6 mice. The role of endogenous nitric oxide and the type of transcription factors involved were explored. Simvastatin and fluvastatin induced HO-1. Pretreatment of cells with l-NMMA or 1400 W, two different nitric oxide synthase inhibitors, partially blocked statin-dependent induction of HO-1 in RAW 264.7 and J774A.1 but not in primary peritoneal macrophages. Induction of HO-1 by statins was dependent on p-38 MAP kinase activation in all types of macrophages. In RAW 264.7 cells, both statins increased the activity of reporter genes linked to the proximal 1.3 kbp promoter of HO-1 (EC50 of 1.4 +/- 0.3 mu M for simvastatin and 0.6 +/- 0.03 mu M for fluvastatin). This effect was significantly blocked by 1400 W (80 +/- 5.2% inhibition, p<0.02) and mevalonate, the direct metabolite of HMGCoA reductase. Gel retardation experiments implicated C/EBP beta, AP-1 but not USF, for both RAW 264.7 and primary peritoneal macrophages of C57BL/6 mice. Collectively we showed a differential role of endogenous nitric oxide between macrophage cell lines and primary macrophages and an effect of statins in the protection against inflammation by increasing HO-1 expression.	[Mouawad, Charbel A.; Mrad, May F.; Al-Hariri, Moustafa; Soussi, Hiba; Habib, Aida] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon; [Hamade, Eva] Lebanese Univ, Hadath, Lebanon; [Alam, Jawed] Ochsner Clin Fdn, Dept Mol Genet, New Orleans, LA USA; [Alam, Jawed] Univ Queensland, Sch Med, Ochsner Clin Sch, Brisbane, Qld, Australia	American University of Beirut; Lebanese University; Ochsner Health System; University of Queensland	Habib, A (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon.	ah31@aub.edu.lb	Habib, Aida/H-8647-2019; Alam, Jawed/F-2596-2010	Habib, Aida/0000-0001-6027-0043; Alam, Jawed/0000-0001-6520-482X; Mrad, May/0000-0003-4379-5862; Hamade, Eva/0000-0001-5152-913X	American University of Beirut; Lebanese National Council for Scientific Research (LNCSR) [02-09-12]	American University of Beirut; Lebanese National Council for Scientific Research (LNCSR)	This work was supported by grants from the American University of Beirut (MPP and URB) and the Lebanese National Council for Scientific Research (LNCSR grant number 02-09-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM J, 1994, J BIOL CHEM, V269, P1001; ALAM J, 1994, J BIOL CHEM, V269, P25049; ALAM J, 1992, J BIOL CHEM, V267, P21894; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Alcaraz MJ, 2003, CURR PHARM DESIGN, V9, P2541, DOI 10.2174/1381612033453749; Alcaraz MJ, 2001, BBA-GEN SUBJECTS, V1526, P13, DOI 10.1016/S0304-4165(01)00112-X; Ali F, 2007, J THROMB HAEMOST, V5, P2537, DOI 10.1111/j.1538-7836.2007.02787.x; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chen JC, 2006, CELL SIGNAL, V18, P32, DOI 10.1016/j.cellsig.2005.03.016; Chen YC, 2002, J CELL BIOCHEM, V86, P331, DOI 10.1002/jcb.10230; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; de Bont N, 1998, ATHEROSCLEROSIS, V139, P147, DOI 10.1016/S0021-9150(98)00074-4; Dunoyer-Geindre S, 2005, THROMB HAEMOSTASIS, V93, P339, DOI 10.1160/TH04-05-0297; Forrester JS, 2007, AM J CARDIOL, V99, P732, DOI 10.1016/j.amjcard.2006.09.125; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Gueler F, 2007, AM J PATHOL, V170, P1192, DOI 10.2353/ajpath.2007.060782; Habib A, 1997, J IMMUNOL, V158, P3845; Habib A, 2007, FASEB J, V21, P1665, DOI 10.1096/fj.06-6766com; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Leung PO, 2011, TOXICOL LETT, V207, P159, DOI 10.1016/j.toxlet.2011.09.004; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LUTTON JD, 1992, J CELL BIOCHEM, V49, P259, DOI 10.1002/jcb.240490308; MacLeod RAF, 1999, INT J CANCER, V83, P555; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; MITANI K, 1993, BIOCHEM J, V290, P819, DOI 10.1042/bj2900819; Mrad MF, 2012, J CELL BIOCHEM, V113, P3466, DOI 10.1002/jcb.24223; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Polte T, 2000, ARTERIOSCL THROM VAS, V20, P1209, DOI 10.1161/01.ATV.20.5.1209; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Tanimoto A, 2008, J BIOL CHEM, V283, P4643, DOI 10.1074/jbc.M708853200; Tuomisto TT, 2008, CARDIOVASC RES, V78, P175, DOI 10.1093/cvr/cvn007; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Weitz-Schmidt G, 2003, ENDOTHELIUM-J ENDOTH, V10, P43, DOI 10.1080/10623320303360; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219; Zhou Q, 2009, CURR PHARM DESIGN, V15, P467, DOI 10.2174/138161209787315684	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64092	10.1371/journal.pone.0064092	http://dx.doi.org/10.1371/journal.pone.0064092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717538	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700099
J	Munzbergova, Z; Skuhrovec, J				Munzbergova, Zuzana; Skuhrovec, Jiri			Effect of Habitat Conditions and Plant Traits on Leaf Damage in the Carduoideae Subfamily	PLOS ONE			English	Article							CIRSIUM-ARVENSE; INSECT HERBIVORES; NATURAL ENEMIES; GROWTH; NITROGEN; LEAVES; DRIVE; PERFORMANCE; RESISTANCE; EVOLUTION	Plant traits are the key factors that determine herbivore foraging selection. The traits serving as defense traits against herbivores represent a wide range of traits, such as chemical, physiological, morphological and life-history traits. While many studies considered plant defense traits at the within-species scale, much less is known from comparisons of a wide range of closely related species. The aim of this study was to identify factors responsible for the intensity of leaf damage in the Carduoideae subfamily of Asteraceae, which hosts many invasive species and thus is potential candidate plant species that could be controlled by biological control. Specifically, we wanted to see the relative importance of habitat characteristics, plant size and plants traits in determining the degree of folivory. The study identified several defense traits able to explain differences in herbivory between species after accounting for differences in the habitats in which the species occur and the plant size. Specifically, the most important traits were traits related to the quality of the leaf tissue expressed as the content of phosphorus, water and specific leaf area, which suggests that the leaf quality had a more important effect on the degree of herbivory than the presence of specific defense mechanisms such as spines and hair. Leaf quality is thus a candidate factor that drives herbivore choice when selecting which plant to feed on and should be considered when assessing the danger that a herbivore will switch hosts when introduced to a new range.	[Munzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Munzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Skuhrovec, Jiri] Res Inst Crop Prod, Dept Plant Ecol & Weed Sci, CR-16106 Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Crop Research Institute (CRI)	Munzbergova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Skuhrovec, Jiri/E-9699-2016	Münzbergová, Zuzana/0000-0002-4026-6220; Skuhrovec, Jiri/0000-0002-7691-5990	MSMT;  [ME10037];  [RVO 67985939];  [CZ0002700604]	MSMT(Ministry of Education, Youth & Sports - Czech Republic); ; ; 	The study was supported by project ME10037 (www.msmt.cz) and partly also by institutional research projects RVO 67985939, MSMT and CZ0002700604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Hofbauerova I, 2011, WEED RES, V51, P394, DOI 10.1111/j.1365-3180.2011.00851.x; Abela-Hofbauerova I, 2011, FLORA, V206, P1012, DOI 10.1016/j.flora.2011.07.007; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; ARNONE JA, 1995, OECOLOGIA, V104, P72, DOI 10.1007/BF00365564; ARSUFFI TL, 1984, OIKOS, V42, P144, DOI 10.2307/3544786; BAZELY DR, 1991, OIKOS, V61, P327, DOI 10.2307/3545240; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Cejka T, 2009, POL J ECOL, V57, P741; CLANCY KM, 1992, ECOL ENTOMOL, V17, P189, DOI 10.1111/j.1365-2311.1992.tb01047.x; Cobb NS, 1997, OECOLOGIA, V109, P389, DOI 10.1007/s004420050098; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Coombs E.M., 2004, BIOL CONTROL INVASIV; Cuevas-Reyes P, 2011, J TROP ECOL, V27, P631, DOI 10.1017/S0266467411000368; Diekmann M, 1997, J VEG SCI, V8, P855, DOI 10.2307/3237030; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Eber S, 2003, J VEG SCI, V14, P259, DOI 10.1111/j.1654-1103.2003.tb02151.x; Ehrenberger F., 1973, METHODEN ORGANISCHEN; Eichhorn MP, 2010, ECOLOGY, V91, P1092, DOI 10.1890/09-0300.1; Ellenberg H., 1992, ZEIGERWERTE GEFASSPL; FREESE G, 1994, ENTOMOL GEN, V19, P191; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Gomez JM, 2000, AM NAT, V155, P657, DOI 10.1086/303353; Gowda JH, 1996, OIKOS, V77, P279, DOI 10.2307/3546066; Graca Manuel A. S., 2005, P121; Hare JD, 2012, SCIENCE, V338, P50, DOI 10.1126/science.1228893; Hemrova L, 2012, ANN BOT-LONDON, V110, P1411, DOI 10.1093/aob/mcs064; Johnson MTJ, 2009, P NATL ACAD SCI USA, V106, P18079, DOI 10.1073/pnas.0904695106; Johnson SN, 2010, APPL SOIL ECOL, V44, P75, DOI 10.1016/j.apsoil.2009.10.002; Kluth S, 2001, J APPL ECOL, V38, P548, DOI 10.1046/j.1365-2664.2001.00612.x; Knepp RG, 2005, NEW PHYTOL, V167, P207, DOI 10.1111/j.1469-8137.2005.01399.x; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Lamarre GPA, 2012, ECOLOGY, V93, pS195, DOI 10.1890/11-0397.1; Loaiza V, 2011, INSECT SCI, V18, P533, DOI 10.1111/j.1744-7917.2010.01376.x; Louda SM, 2002, CONSERV BIOL, V16, P717, DOI 10.1046/j.1523-1739.2002.00541.x; LOWMAN MD, 1983, AUST J ECOL, V8, P17, DOI 10.1111/j.1442-9993.1983.tb01515.x; Massey FP, 2006, J ECOL, V94, P646, DOI 10.1111/j.1365-2745.2006.01127.x; Moles AT, 2000, OIKOS, V90, P517, DOI 10.1034/j.1600-0706.2000.900310.x; Obeso JR, 1997, PLANT ECOL, V129, P149, DOI 10.1023/A:1009767931817; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Olsen R., 1954, US DEP AGR CIRCULAR, V939, P1; Patocka J., 2009, LEPIDOPTERA SLOVAKIA; Pearson TRH, 2003, OECOLOGIA, V137, P456, DOI 10.1007/s00442-003-1361-x; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rahman A., 1982, Biology and ecology of weeds [Holzner, W. and Numata, M. (Editors)], P299; Rauschert ESJ, 2012, BIOL INVASIONS, V14, P151, DOI 10.1007/s10530-011-9992-z; Redfern M, 1995, NATURALISTS HDB, V4; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Ricklefs RE, 2008, OECOLOGIA, V157, P53, DOI 10.1007/s00442-008-1050-x; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; Stenberg JA, 2008, ECOLOGY, V89, P126, DOI 10.1890/07-0252.1; Stenberg JA, 2006, OECOLOGIA, V148, P414, DOI 10.1007/s00442-006-0390-7; Tajek P, 2011, ACTA OECOL, V37, P495, DOI 10.1016/j.actao.2011.06.009; Tanentzap AJ, 2011, ECOLOGY, V92, P994, DOI 10.1890/10-0861.1; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Trotter RT, 2008, ECOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-2311.2007.00941.x; Willis JC, 2008, ANN APPL BIOL, V153, P105, DOI 10.1111/j.1744-7348.2008.00242.x; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; Young TP, 2003, OIKOS, V101, P171, DOI 10.1034/j.1600-0706.2003.12067.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	69	23	23	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64639	10.1371/journal.pone.0064639	http://dx.doi.org/10.1371/journal.pone.0064639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717643	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700163
J	Sharma, V; Harafuji, N; Belayew, A; Chen, YW				Sharma, Vishakha; Harafuji, Naoe; Belayew, Alexandra; Chen, Yi-Wen			DUX4 Differentially Regulates Transcriptomes of Human Rhabdomyosarcoma and Mouse C2C12 Cells	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; HUMAN UROTENSIN-II; PREMATURE MYOGENIC DIFFERENTIATION; FSHD CANDIDATE GENE; PHARMACOLOGICAL CHARACTERIZATION; PROGENITOR CELLS; IN-VITRO; MUSCLE; EXPRESSION; D4Z4	Facioscapulohumeral muscular dystrophy (FSHD) is linked to the deletion of the D4Z4 arrays at chromosome 4q35. Recent studies suggested that aberrant expression of double homeobox 4 (DUX4) from the last D4Z4 repeat causes FSHD. The aim of this study is to determine transcriptomic responses to ectopically expressed DUX4 in human and mouse cells of muscle lineage. We expression profiled human rhabdomyosarcoma (RD) cells and mouse C2C12 cells transfected with expression vectors of DUX4 using the Affymetrix Human Genome U133 Plus 2.0 Arrays and Mouse Genome 430 2.0 Arrays, respectively. A total of 2267 and 150 transcripts were identified to be differentially expressed in the RD and C2C12 cells, respectively. Amongst the transcripts differentially expressed in the RD cells, MYOD and MYOG (2 fold, p < 0.05), and six MYOD downstream targets were up-regulated in RD but not C2C12 cells. Furthermore, 13 transcripts involved in germline function were dramatically induced only in the RD cells expressing DUX4. The top 3 IPA canonical pathways affected by DUX4 were different between the RD (inflammation, BMP signaling and NRF-2 mediated oxidative stress) and the C2C12 cells (p53 signaling, cell cycle regulation and cellular energy metabolism). Amongst the 40 transcripts shared by the RD and C2C12 cells, UTS2 was significantly induced by 76 fold and 224 fold in the RD and C2C12 cells, respectively. The differential expression of MYOD, MYOG and UTS2 were validated using real-time quantitative RT-PCR. We further validated the differentially expressed genes in immortalized FSHD myoblasts and showed up-regulation of MYOD, MYOG, ZSCAN4 and UTS2. The results suggest that DUX4 regulates overlapped and distinct groups of genes and pathways in human and mouse cells as evident by the selective up-regulation of genes involved in myogenesis and gametogenesis in human RD and immortalized cells as well as the different molecular pathways identified in the cells.	[Sharma, Vishakha] George Washington Univ, Dept Mol Med, Washington, DC USA; [Harafuji, Naoe; Chen, Yi-Wen] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium; [Chen, Yi-Wen] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA	George Washington University; Children's National Health System; University of Mons; George Washington University	Chen, YW (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	ychen@cnmcresearch.org	BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424	NIH/NIAMS [1R01AR052027]; DOD [DOD W81XWH-10-1-0659];  [NIH/NIAMS1R01AR052027];  [NIH/NICHD1R24HD050846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052027] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DOD(United States Department of Defense); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the NIH/NIAMS under Award Number 1R01AR052027. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. V. S and N. H. are supported by NIH/NIAMS1R01AR052027. Y-W. C. is supported by NIH/NIAMS1R01AR052027, NIH/NICHD1R24HD050846 and DOD DOD W81XWH-10-1-0659. A.B. acknowledges the Global FSHD Foundation (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Batuwangala MS, 2009, N-S ARCH PHARMACOL, V380, P451, DOI 10.1007/s00210-009-0441-9; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Birker-Robaczewska M, 2003, J RECEPT SIG TRANSD, V23, P289, DOI 10.1081/RRS-120026972; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Douglas SA, 2005, BRIT J PHARMACOL, V145, P620, DOI 10.1038/sj.bjp.0706229; Douglas SA, 2004, BRIT J PHARMACOL, V142, P921, DOI 10.1038/sj.bjp.0705743; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; FELIX CA, 1992, CANCER RES, V52, P2243; FITZSIMONS RB, 1987, BRAIN, V110, P631, DOI 10.1093/brain/110.3.631; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gendron G, 2004, CAN J PHYSIOL PHARM, V82, P16, DOI 10.1139/Y03-122; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Ghosh MC, 2009, BLOOD, V114, P1366, DOI 10.1182/blood-2008-08-175869; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Homma S, 2012, EUR J HUM GENET, V20, P404, DOI 10.1038/ejhg.2011.213; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Krom YD, 2012, AM J PATHOL, V181, P1387, DOI 10.1016/j.ajpath.2012.07.007; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Matsusaka S, 2006, N-S ARCH PHARMACOL, V373, P381, DOI 10.1007/s00210-006-0086-x; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; PADBERG GW, 1995, MUSCLE NERVE, pS73; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Shi LB, 2006, ATHEROSCLEROSIS, V188, P260, DOI 10.1016/j.atherosclerosis.2005.10.044; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Spinazzi R, 2006, INT J MOL MED, V18, P1107; Stadler G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-12; Suguro T, 2008, CLIN SCI, V115, P327, DOI 10.1042/CS20080014; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu SK, 2012, MOL MED REP, V6, P197, DOI 10.3892/mmr.2012.899; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	66	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64691	10.1371/journal.pone.0064691	http://dx.doi.org/10.1371/journal.pone.0064691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717650	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700166
J	Verhulst, EC; Lynch, JA; Bopp, D; Beukeboom, LW; van de Zande, L				Verhulst, Eveline C.; Lynch, Jeremy A.; Bopp, Daniel; Beukeboom, Leo W.; van de Zande, Louis			A New Component of the Nasonia Sex Determining Cascade Is Maternally Silenced and Regulates Transformer Expression	PLOS ONE			English	Article							WASP NASONIA; DETERMINING MECHANISMS; DETERMINATION PATHWAY; MUSCA-DOMESTICA; GENE; VITRIPENNIS; DROSOPHILA; EVOLUTION; CHROMOSOME; INSECTS	Although sex determination is a universal process in sexually reproducing organisms, sex determination pathways are among the most highly variable genetic systems found in nature. Nevertheless, general principles can be identified among the diversity, like the central role of transformer (tra) in insects. When a functional TRA protein is produced in early embryogenesis, the female sex determining route is activated, while prevention of TRA production leads to male development. In dipterans, male development is achieved by prevention of female-specific splicing of tra mRNA, either mediated by X-chromosome dose or masculinizing factors. In Hymenoptera, which have haplodiploid sex determination, complementary sex determination and maternal imprinting have been identified to regulate timely TRA production. In the parasitoid Nasonia, zygotic transformer (Nvtra) expression and splicing is regulated by a combination of maternal provision of Nvtra mRNA and silencing of Nvtra expression in unfertilized eggs. It is unclear, however, if this silencing is directly on the tra locus or whether it is mediated through maternal silencing of a trans-acting factor. Here we show that in Nasonia, female sex determination is dependent on zygotic activation of Nvtra expression by an as yet unknown factor. This factor, which we propose to term womanizer (wom), is maternally silenced during oogenesis to ensure male development in unfertilized eggs. This finding implicates the upstream recruitment of a novel gene in the Nasonia sex determining cascade and supports the notion that sex determining cascades can rapidly change by adding new components on top of existing regulators.	[Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Lynch, Jeremy A.] Univ Cologne, Inst Entwicklungsbiol, D-50931 Cologne, Germany; [Lynch, Jeremy A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Bopp, Daniel] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Groningen; University of Cologne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Zurich	Verhulst, EC (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	e.c.verhulst@rug.nl	Bopp, Daniel/L-3517-2018; Verhulst, Eveline/J-2641-2013	Bopp, Daniel/0000-0002-0740-9672; Verhulst, Eveline/0000-0002-4781-535X; van de Zande, Louis/0000-0001-5687-3220	NWO ALW TOP [854.10.001];  [SFB 680]	NWO ALW TOP; 	Eveline C. Verhulst was supported by NWO ALW TOP grant no.similar to 854.10.001 granted to Leo W. Beukeboom and Louis van de Zande (http://www.nwo.nl/). Jeremy A. Lynch was funded by the SFB 680 "Molecular Basis of Evolutionary Innovations". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; CLINE TW, 1984, GENETICS, V107, P231; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Kamping A, 2007, GENETICS, V175, P1321, DOI 10.1534/genetics.106.067082; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Martin I, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-19; McAllister BF, 2004, HEREDITY, V92, P5, DOI 10.1038/sj.hdy.6800355; Mullon C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-5; Nissen I, 2012, GENETICS, V192, P1015, DOI 10.1534/genetics.112.143925; Niu BL, 2005, ACTA BIOCH BIOPH SIN, V37, P728, DOI 10.1111/j.1745-7270.2005.00106.x; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; Pane A, 2002, DEVELOPMENT, V129, P3715; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sarno F, 2011, INT J DEV BIOL, V55, P975, DOI 10.1387/ijdb.103279fs; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Trent C, 2006, HEREDITY, V96, P368, DOI 10.1038/sj.hdy.6800810; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; WERREN JH, 1991, AM NAT, V137, P392, DOI 10.1086/285172; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whiting PW, 1943, GENETICS, V28, P365; Zwier MV, 2012, INSECT MOL BIOL, V21, P129, DOI 10.1111/j.1365-2583.2011.01121.x	40	24	26	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63618	10.1371/journal.pone.0063618	http://dx.doi.org/10.1371/journal.pone.0063618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717455	Green Published, gold, Green Accepted			2022-12-25	WOS:000320362700041
J	Zaika, E; Bhardwaj, V; Wei, JX; Washington, MK; Souza, R; El-Rifai, W; Zaika, A				Zaika, Elena; Bhardwaj, Vikas; Wei, Jinxiong; Washington, Mary Kay; Souza, Rhonda; El-Rifai, Wael; Zaika, Alexander			Proinflammatory Cytokines and Bile Acids Upregulate Delta Np73 Protein, an Inhibitor of p53 and p73 Tumor Suppressors	PLOS ONE			English	Article							NF-KAPPA-B; GASTROESOPHAGEAL-REFLUX DISEASE; DNA-DAMAGE; CELL-SURVIVAL; KINASE; EXPOSURE; P38; P63; PATHOGENESIS; ACTIVATION	Gastroesophageal reflux disease (GERD) is the main etiological factor behind the recent rapid increase in the incidence of esophageal adenocarcinoma. During reflux, esophageal cells are exposed to bile at low pH resulting in cellular damage and inflammation, which are known to facilitate cancer development. In this study, we investigated the regulation of p73 isoform, Delta Np73 alpha, in the reflux condition. Previous studies have reported that Delta Np73 exhibits anti-apoptotic and oncogenic properties through inhibition of p53 and p73 proteins. We found that direct exposure of esophageal cells to bile acids in an acidic environment alters the phosphorylation of Delta Np73, its subcellular localization and increases Delta Np73 protein levels. Upregulation of Delta Np73 was also observed in esophageal tissues collected from patients with GERD and Barrett's metaplasia, a precancerous lesion in the esophagus associated with gastric reflux. c-Abl, p38 MAPK, and IKK protein kinases were identified to interact in the regulation of Delta Np73. Their inhibition with chemotherapeutic agents and siRNA suppresses Delta Np73. We also found that pro-inflammatory cytokines, IL-1 beta and TNF alpha, are potent inducers of Delta Np73 alpha, which further enhance the bile acids/acid effect. Combined, our studies provide evidence that gastroesophageal reflux alters the regulation of oncogenic Delta Np73 isoform that may facilitate tumorigenic transformation of esophageal metaplastic epithelium.	[Zaika, Elena; Bhardwaj, Vikas; Wei, Jinxiong; El-Rifai, Wael; Zaika, Alexander] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37212 USA; [Zaika, Elena; Bhardwaj, Vikas; Wei, Jinxiong; El-Rifai, Wael; Zaika, Alexander] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Washington, Mary Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [El-Rifai, Wael; Zaika, Alexander] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Souza, Rhonda] VA N Texas Hlth Care Syst, Dept Med, Dallas, TX USA; [Souza, Rhonda] Univ Texas Southwestern Med Sch, Dallas, TX USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Zaika, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37212 USA.	alex.zaika@vanderbilt.edu	Bhardwaj, Vikas/O-7795-2019	Bhardwaj, Vikas/0000-0003-3364-8711	National Cancer Institute [NIH CA138833]; Vanderbilt-Ingram Cancer Center [P30 CA68485]; National Center for Advancing Translational Sciences [UL1TR000445]; Vanderbilt Digestive Disease Research Center [P30 DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA138833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute grants NIH CA138833, Vanderbilt-Ingram Cancer Center (P30 CA68485), CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences and the Vanderbilt Digestive Disease Research Center (P30 DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2011, MOL CELL BIOL, V31, P2210, DOI 10.1128/MCB.00964-10; ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Huo XF, 2011, AM J PHYSIOL-GASTR L, V301, pG278, DOI 10.1152/ajpgi.00092.2011; Jaiswal K, 2006, AM J PHYSIOL-GASTR L, V290, pG335, DOI 10.1152/ajpgi.00167.2005; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katayama H, 2012, CANCER CELL, V21, P196, DOI 10.1016/j.ccr.2011.12.025; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Roman S, 2007, AM J PHYSIOL-GASTR L, V293, pG45, DOI 10.1152/ajpgi.00583.2006; Ryan S, 2007, BIOCHEM BIOPH RES CO, V355, P728, DOI 10.1016/j.bbrc.2007.02.015; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Stiewe T, 2002, CANCER RES, V62, P3598; Stiewe T, 2003, J BIOL CHEM, V278, P14230, DOI 10.1074/jbc.M300357200; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Vilgelm AE, 2010, MOL CANCER THER, V9, P693, DOI 10.1158/1535-7163.MCT-09-0912; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yen CJ, 2008, CANCER RES, V68, P2632, DOI 10.1158/0008-5472.CAN-07-5460; Zaika E, 2011, FASEB J, V25, P4406, DOI 10.1096/fj.11-192815; Zhang HY, 2009, CANCER LETT, V275, P170, DOI 10.1016/j.canlet.2008.07.006	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64306	10.1371/journal.pone.0064306	http://dx.doi.org/10.1371/journal.pone.0064306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717592	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700135
J	Zhou, WR; Zhu, H; Zhao, JZ; Li, HJ; Wan, Y; Cao, JJ; Zhao, HX; Yu, J; Zhou, RJ; Yao, YY; Zhang, LL; Wang, LF; He, L; Ma, G; Yao, ZJ; Guo, XZ				Zhou, Wenrong; Zhu, Huang; Zhao, Jianzhi; Li, Hanjun; Wan, Yong; Cao, Jingjing; Zhao, Haixia; Yu, Jian; Zhou, Rujiang; Yao, Yiyun; Zhang, Lingling; Wang, Lifang; He, Lin; Ma, Gang; Yao, Zhengju; Guo, Xizhi			Misexpression of Pknox2 in Mouse Limb Bud Mesenchyme Perturbs Zeugopod Development and Deltoid Crest Formation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MULTIPLE ROLES; EXPRESSION; GENE; PROTEINS; SKELETON; PREP1; MICE; FORELIMB; GROWTH	The TALE (Three Amino acid Loop Extension) family consisting of Meis, Pbx and Pknox proteins is a group of transcriptional co-factors with atypical homeodomains that play pivotal roles in limb development. Compared to the in-depth investigations of Meis and Pbx protein functions, the role of Pknox2 in limb development remains unclear. Here, we showed that Pknox2 was mainly expressed in the zeugopod domain of the murine limb at E10.5 and E11.5. Misexpression of Pknox2 in the limb bud mesenchyme of transgenic mice led to deformities in the zeugopod and forelimb stylopod deltoid crest, but left the autopod and other stylopod skeletons largely intact. These malformations in zeugopod skeletons were recapitulated in mice overexpressing Pknox2 in osteochondroprogenitor cells. Molecular and cellular analyses indicated that the misexpression of Pknox2 in limb bud mesenchyme perturbed the Hox10-11 gene expression profiles, decreased Col2 expression and Bmp/Smad signaling activity in the limb. These results indicated that Pknox2 misexpression affected mesenchymal condensation and early chondrogenic differentiation in the zeugopod skeletons of transgenic embryos, suggesting Pknox2 as a potential regulator of zeugopod and deltoid crest formation.	[Zhou, Wenrong; Zhu, Huang; Zhao, Jianzhi; Li, Hanjun; Wan, Yong; Cao, Jingjing; Zhao, Haixia; Yu, Jian; Zhou, Rujiang; Yao, Yiyun; Zhang, Lingling; Wang, Lifang; He, Lin; Ma, Gang; Yao, Zhengju; Guo, Xizhi] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China.	xzguo2005@sjtu.edu.cn	zhang, lingling/HDM-2189-2022; zhu, Huang/Q-2196-2017	zhu, Huang/0000-0002-5700-8068; Zhang, Lingling/0000-0002-9390-8880; Guo, Xizhi/0000-0001-8047-6049; Li, Hanjun/0000-0002-7017-8782	National Major Fundamental Research 973 program of China [2007CB947301, 2012CB966903]; National Natural Science Foundation of China [31171396, 81121001, 31100624]	National Major Fundamental Research 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Fundamental Research 973 program of China under grants 2007CB947301 and 2012CB966903 and by grants from the National Natural Science Foundation of China [31171396, 81121001 and 31100624]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Capellini TD, 2011, DEV DYNAM, V240, P1063, DOI 10.1002/dvdy.22605; Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Coy SE, 2010, DEV DYNAM, V239, P1234, DOI 10.1002/dvdy.22264; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Fognani C, 2002, NUCLEIC ACIDS RES, V30, P2043, DOI 10.1093/nar/30.9.2043; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goff DJ, 1997, DEVELOPMENT, V124, P627; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Haller K, 2002, DEV DYNAM, V225, P358, DOI 10.1002/dvdy.10167; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2001, DEVELOPMENT, V128, P5099; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Mercader N, 2009, INT J DEV BIOL, V53, P1483, DOI 10.1387/ijdb.072430nm; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yi SE, 2000, DEVELOPMENT, V127, P621; Zha LB, 2008, J GENET GENOMICS, V35, P525, DOI 10.1016/S1673-8527(08)60072-7; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	36	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64237	10.1371/journal.pone.0064237	http://dx.doi.org/10.1371/journal.pone.0064237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717575	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700122
J	Pinakoulaki, E; Daskalakis, V; Ohta, T; Richter, OMH; Budiman, K; Kitagawa, T; Ludwig, B; Varotsis, C				Pinakoulaki, Eftychia; Daskalakis, Vangelis; Ohta, Takehiro; Richter, Oliver-Matthias H.; Budiman, Kerstin; Kitagawa, Teizo; Ludwig, Bernd; Varotsis, Constantinos			The Protein Effect in the Structure of Two Ferryl-Oxo Intermediates at the Same Oxidation Level in the Heme Copper Binuclear Center of Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRETCHING RAMAN BAND; OXYGEN ACTIVATION; ELECTRON-TRANSFER; DIOXYGEN ACTIVATION; BOND-CLEAVAGE; REDUCTION; RESOLUTION; MECHANISM; SPECTRA; ENERGY	Identification of the intermediates and determination of their structures in the reduction of dioxygen to water by cytochrome c oxidase (CcO) are particularly important to understanding both O-2 activation and proton pumping by the enzyme. In this work, we report the products of the rapid reaction of O-2 with the mixed valence form (Cu-A(2+), heme a(3+), heme a(3)(2+)-Cu-B(1+)) of the enzyme. The resonance Raman results show the formation of two ferryl-oxo species with characteristic Fe(IV)=O stretching modes at 790 and 804 cm(-1) at the peroxy oxidation level (P-M). Density functional theory calculations show that the protein environment of the proximal H-bonded His-411 determines the strength of the distal Fe(IV)=O bond. In contrast to previous proposals, the P-M intermediate is also formed in the reaction of Y167F with O-2. These results suggest that in the fully reduced enzyme, the proton pumping nu(Fe(IV)=O) = 804 cm(-1) to nu(Fe(IV)=O) = 790 cm(-1) transition (P -> F, where P is peroxy and F is ferryl) is triggered not only by electron transfer from heme a to heme a(3) but also by the formation of the H-bonded form of the His-411-Fe(IV)=O conformer in the proximal site of heme a(3). The implications of these results with respect to the role of an O=Fe(IV)His-411-H-bonded form to the ring A propionate of heme a(3)-Asp-399-H2O site and, thus, to the exit/output proton channel (H2O) pool during the proton pumping P -> F transition are discussed. We propose that the environment proximal to the heme a(3) controls the spectroscopic properties of the ferryl intermediates in cytochrome oxidases.	[Pinakoulaki, Eftychia] Univ Cyprus, Dept Chem, CY-1678 Nicosia, Cyprus; [Daskalakis, Vangelis; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Ohta, Takehiro] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8128581, Japan; [Ohta, Takehiro] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8128581, Japan; [Richter, Oliver-Matthias H.; Ludwig, Bernd] Goethe Univ Frankfurt, Biozentrum, Inst Biochem, D-60439 Frankfurt, Germany; [Budiman, Kerstin] Max Planck Inst Biophys, D-60439 Frankfurt, Germany; [Kitagawa, Teizo] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Hyogo 6781297, Japan	University of Cyprus; Cyprus University of Technology; Kyushu University; Kyushu University; Goethe University Frankfurt; Max Planck Society; University of Hyogo	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, POB 50329, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy	Daskalakis, Vangelis/G-9890-2018	Daskalakis, Vangelis/0000-0001-8870-0850; Pinakoulaki, Eftychia/0000-0003-3320-6112; Varotsis, Constantinos/0000-0003-2771-8891	Cyprus Research Promotion Foundation [TEXNOLOGIA/THEPIS/0609(BE)/05]; Minister of Science, Sports and Culture, Japan [14001004]; Deutsche Forschungsgemeinschaft (DFG) [SFB472]; Japan Society for the Promotion of Science (JSPS)	Cyprus Research Promotion Foundation; Minister of Science, Sports and Culture, Japan; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funds from the Cyprus Research Promotion Foundation (to C.V.) (TEXNOLOGIA/THEPIS/0609(BE)/05), the Minister of Science, Sports and Culture, Japan (Grant 14001004) (to T.K.), and Deutsche Forschungsgemeinschaft (DFG) (Grant SFB472) (to B.L.).; 1 Recipient of a research fellowship from the Japan Society for the Promotion of Science (JSPS).	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; Blomberg MRA, 2003, INORG CHEM, V42, P5231, DOI 10.1021/ic034060s; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Daskalakis V, 2008, J AM CHEM SOC, V130, P12385, DOI 10.1021/ja801840y; Daskalakis V, 2010, J PHYS CHEM B, V114, P1136, DOI 10.1021/jp910006k; Dey A, 2002, J AM CHEM SOC, V124, P3206, DOI 10.1021/ja012402s; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; OGURA T, 1990, J AM CHEM SOC, V112, P5630, DOI 10.1021/ja00170a032; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OGURA T, 1990, J BIOL CHEM, V265, P14721; Pinakoulaki E, 2003, J BIOL CHEM, V278, P18761, DOI 10.1074/jbc.M211925200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P13563, DOI 10.1074/jbc.M112200200; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P76, DOI 10.1021/bi9511705; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Takahashi T, 2005, J AM CHEM SOC, V127, P9970, DOI 10.1021/ja051761a; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TURBOMOLE GMbH, 2005, TURBOMOLE VERS 5 8 0; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; VAROTSIS C, 1990, BIOCHEMISTRY-US, V29, P7357, DOI 10.1021/bi00484a001; VAROTSIS C, 1989, J AM CHEM SOC, V111, P6439, DOI 10.1021/ja00198a075; VAROTSIS C, 1990, J BIOL CHEM, V265, P11131; VAROTSIS CA, 1995, J AM CHEM SOC, V117, P11260, DOI 10.1021/ja00150a025; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	39	19	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20261	20266		10.1074/jbc.M113.468488	http://dx.doi.org/10.1074/jbc.M113.468488			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723073	hybrid, Green Published			2022-12-25	WOS:000321715100015
J	Burdett, HL; Donohue, PJC; Hatton, AD; Alwany, MA; Kamenos, NA				Burdett, Heidi L.; Donohue, Penelope J. C.; Hatton, Angela D.; Alwany, Magdy A.; Kamenos, Nicholas A.			Spatiotemporal Variability of Dimethylsulphoniopropionate on a Fringing Coral Reef: The Role of Reefal Carbonate Chemistry and Environmental Variability	PLOS ONE			English	Article							OCEAN ACIDIFICATION; MARINE MACROALGAE; DMSP; SEAWATER; ALGAE; CALCIFICATION; DIMETHYLSULFIDE; CO2; DIMETHYLSULFONIOPROPIONATE; DISSOCIATION	Oceanic pH is projected to decrease by up to 0.5 units by 2100 (a process known as ocean acidification, OA), reducing the calcium carbonate saturation state of the oceans. The coastal ocean is expected to experience periods of even lower carbonate saturation state because of the inherent natural variability of coastal habitats. Thus, in order to accurately project the impact of OA on the coastal ocean, we must first understand its natural variability. The production of dimethylsulphoniopropionate (DMSP) by marine algae and the release of DMSP's breakdown product dimethylsulphide (DMS) are often related to environmental stress. This study investigated the spatiotemporal response of tropical macroalgae (Padina sp., Amphiroa sp. and Turbinaria sp.) and the overlying water column to natural changes in reefal carbonate chemistry. We compared macroalgal intracellular DMSP and water column DMSP+DMS concentrations between the environmentally stable reef crest and environmentally variable reef flat of the fringing Suleman Reef, Egypt, over 45-hour sampling periods. Similar diel patterns were observed throughout: maximum intracellular DMSP and water column DMS/P concentrations were observed at night, coinciding with the time of lowest carbonate saturation state. Spatially, water column DMS/P concentrations were highest over areas dominated by seagrass and macroalgae (dissolved DMS/P) and phytoplankton (particulate DMS/P) rather than corals. This research suggests that macroalgae may use DMSP to maintain metabolic function during periods of low carbonate saturation state. In the reef system, seagrass and macroalgae may be more important benthic producers of dissolved DMS/P than corals. An increase in DMS/P concentrations during periods of low carbonate saturation state may become ecologically important in the future under an OA regime, impacting larval settlement and increasing atmospheric emissions of DMS.	[Burdett, Heidi L.; Donohue, Penelope J. C.; Kamenos, Nicholas A.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland; [Hatton, Angela D.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Alwany, Magdy A.] Suez Canal Univ, Dept Marine Sci, Ismailia, Egypt	University of Glasgow; UHI Millennium Institute; Egyptian Knowledge Bank (EKB); Suez Canal University	Burdett, HL (corresponding author), Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland.	h.burdett.1@research.gla.ac.uk	Kamenos, Nick/F-2421-2010; Burdett, Heidi L./B-8910-2013	Kamenos, Nick/0000-0003-3434-0807; Burdett, Heidi L./0000-0002-3909-2235	NERC studentship [NE/H525303/1]; University of Glasgow Mobility Scholarship; Royal Society of Edinburgh/Scottish Government Fellowship [RSE 48701/1]; Carnegie Trust for the Universities of Scotland	NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Glasgow Mobility Scholarship; Royal Society of Edinburgh/Scottish Government Fellowship; Carnegie Trust for the Universities of Scotland	This research was financially supported by a NERC studentship (NE/H525303/1) to HB, a University of Glasgow Mobility Scholarship to HB and PD and a Royal Society of Edinburgh/Scottish Government Fellowship (RSE 48701/1) and Carnegie Trust for the Universities of Scotland grant to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, RAPP COMMUN INT MER; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Arnold HE, 2012, GLOBAL CHANGE BIOL; Ayers GP, 2007, ENVIRON CHEM, V4, P366, DOI 10.1071/EN07080; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Broadbent AD, 2002, ESTUAR COAST SHELF S, V55, P547, DOI 10.1006/ecss.2002.1021; Budenbender J, 2011, MAR ECOL PROG SER, V441, P79, DOI 10.3354/meps09405; Burdett HL, 2012, MAR BIOL RES, V8, P756, DOI 10.1080/17451000.2012.676189; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chiffings A, 2003, MARINE REGION 11 ARA; DACEY JWH, 1994, MAR ECOL PROG SER, V112, P67, DOI 10.3354/meps112067; Dethier M, 2001, SPATIAL PATTERNS MAC, P301; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gray SEC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004114; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Johnson VR, 2012, GLOBAL CHANGE BIOL; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Karsten U, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P143; Kerrison P, 2012, BIOGEOCHEMISTRY, V110, P5, DOI 10.1007/s10533-012-9707-2; Kirst G.O., 1989, ANNU REV PLANT PHYS, V40, P21, DOI [10.1146/annurev.pp.41.060190.000321, DOI 10.1146/ANNUREV.PP.41.060190.000321]; Kirst GO, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P121; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; NOAA, TRENDS ATM CARB DIOX; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Pierrot D., 2006, ORNLCDIAC105 US DEP; Ragazzola F, 2012, GLOBAL CHANGE BIOL, V18, P2804, DOI 10.1111/j.1365-2486.2012.02756.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Spielmeyer A, 2012, MAR ENVIRON RES, V73, P62, DOI 10.1016/j.marenvres.2011.11.002; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Steller DL, 2009, MAR ECOL PROG SER, V396, P49, DOI 10.3354/meps08261; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.3402/tellusb.v55i2.16761; TURNER SM, 1990, MAR CHEM, V29, P47, DOI 10.1016/0304-4203(90)90005-W; Van Alstyne KL, 2007, AQUAT SCI, V69, P394, DOI 10.1007/s00027-007-0888-z; Van Alstyne KL, 2009, J EXP MAR BIOL ECOL, V379, P85, DOI 10.1016/j.jembe.2009.08.002; Van Alstyne KL, 2003, MAR ECOL PROG SER, V250, P175, DOI 10.3354/meps250175; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhang ZL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007603	63	18	18	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64651	10.1371/journal.pone.0064651	http://dx.doi.org/10.1371/journal.pone.0064651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724073	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000319733000073
J	Hemmingsen, M; Vedel, S; Skafte-Pedersen, P; Sabourin, D; Collas, P; Bruus, H; Dufva, M				Hemmingsen, Mette; Vedel, Soren; Skafte-Pedersen, Peder; Sabourin, David; Collas, Philippe; Bruus, Henrik; Dufva, Martin			The Role of Paracrine and Autocrine Signaling in the Early Phase of Adipogenic Differentiation of Adiposederived Stem Cells	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; TISSUE; BINDING; BONE; OSTEOBLASTOGENESIS; COMMITMENT; INCREASE; RECEPTOR; PATHWAY	Introduction: High cell density is known to enhance adipogenic differentiation of mesenchymal stem cells, suggesting secretion of signaling factors or cell-contact-mediated signaling. By employing microfluidic biochip technology, we have been able to separate these two processes and study the secretion pathways. Methods and results: Adipogenic differentiation of human adipose-derived stem cells (ASCs) cultured in a microfluidic system was investigated under perfusion conditions with an adipogenic medium or an adipogenic medium supplemented with supernatant from differentiating ASCs (conditioned medium). Conditioned medium increased adipogenic differentiation compared to adipogenic medium with respect to accumulation of lipid-filled vacuoles and gene expression of key adipogenic markers (C/EBP alpha, C/EBP beta, C/EBP delta, PPAR gamma, LPL and adiponectin). The positive effects of conditioned medium were observed early in the differentiation process. Conclusions: Using different cell densities and microfluidic perfusion cell cultures to suppress the effects of cell-released factors, we have demonstrated the significant role played by auto-or paracrine signaling in adipocyte differentiation. The cell-released factor(s) were shown to act in the recruitment phase of the differentiation process.	[Hemmingsen, Mette; Vedel, Soren; Skafte-Pedersen, Peder; Sabourin, David; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Fac Med, Stem Cell Epigenet Lab, Oslo, Norway; [Bruus, Henrik] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Oslo; Technical University of Denmark	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Bruus, Henrik/C-4475-2008; Dufva, Martin/V-9469-2019; Hemmingsen, Mette/H-8143-2012; Dufva, Martin/D-1873-2012	Bruus, Henrik/0000-0001-5827-2939; Dufva, Martin/0000-0001-5449-0189	Programme Commission on Strategic Growth Technologies [2106-08-0018, 09-067112]; Danish Agency for Science, Technology and Innovation	Programme Commission on Strategic Growth Technologies; Danish Agency for Science, Technology and Innovation	This work was supported by Grant No. 2106-08-0018 "ProCell" and grant no. 09-067112, under the Programme Commission on Strategic Growth Technologies, the Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Bruus H., 2008, THEORETICAL MICROFLU, V18; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Choi J, 2011, BIOMATERIALS, V32, P7013, DOI 10.1016/j.biomaterials.2011.05.090; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fujimori K, 2012, PPAR RES, V2012, DOI 10.1155/2012/527607; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Inazumi T, 2011, J LIPID RES, V52, P1500, DOI 10.1194/jlr.M013615; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; LEE SC, 1993, J IMMUNOL, V150, P2659; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Margoni A, 2012, INT J BIOCHEM CELL B, V44, P475, DOI 10.1016/j.biocel.2011.12.014; Maxson S, 2008, J TISSUE ENG REGEN M, V2, P147, DOI 10.1002/term.76; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Noer A, 2006, MOL BIOL CELL, V17, P3543, DOI 10.1091/mbc.E06-04-0322; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabourin D, 2012, J LAB AUTOMATION; SAVINELL JM, 1989, BIOPROCESS ENG, V4, P231, DOI 10.1007/BF00369177; Skafte-Pedersen P, 2012, BIOMED MICRODEVICES, V14, P385, DOI 10.1007/s10544-011-9615-6; Styner M, 2010, J CELL BIOCHEM, V111, P1042, DOI 10.1002/jcb.22793; Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Vedel S, 2012, SOLUTES CELLS ASPECT; Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wu L, 2012, CELL PROLIFERAT, V45, P311, DOI 10.1111/j.1365-2184.2012.00823.x; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	49	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63638	10.1371/journal.pone.0063638	http://dx.doi.org/10.1371/journal.pone.0063638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723991	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000016
J	Queipo-Ortuno, MI; Seoane, LM; Murri, M; Pardo, M; Gomez-Zumaquero, JM; Cardona, F; Casanueva, F; Tinahones, FJ				Isabel Queipo-Ortuno, Maria; Maria Seoane, Luisa; Murri, Mora; Pardo, Maria; Miguel Gomez-Zumaquero, Juan; Cardona, Fernando; Casanueva, Felipe; Tinahones, Francisco J.			Gut Microbiota Composition in Male Rat Models under Different Nutritional Status and Physical Activity and Its Association with Serum Leptin and Ghrelin Levels	PLOS ONE			English	Article							ANOREXIA-NERVOSA; RIBOSOMAL-RNA; SELF-STARVATION; GROWTH-HORMONE; BACTERIA; OBESE; SECRETION; PRIMERS; POPULATION; METABOLISM	Backgrount: Several evidences indicate that gut microbiota is involved in the control of host energy metabolism. Objective: To evaluate the differences in the composition of gut microbiota in rat models under different nutritional status and physical activity and to identify their associations with serum leptin and ghrelin levels. Methods: In a case control study, forty male rats were randomly assigned to one of these four experimental groups: ABA group with food restriction and free access to exercise; control ABA group with food restriction and no access to exercise; exercise group with free access to exercise and feed ad libitum and ad libitum group without access to exercise and feed ad libitum. The fecal bacteria composition was investigated by PCR-denaturing gradient gel electrophoresis and real-time qPCR. Results: In restricted eaters, we have found a significant increase in the number of Proteobacteria, Bacteroides, Clostridium, Enterococcus, Prevotella and M. smithii and a significant decrease in the quantities of Actinobacteria, Firmicutes, Bacteroidetes, B. coccoides-E. rectale group, Lactobacillus and Bifidobacterium with respect to unrestricted eaters. Moreover, a significant increase in the number of Lactobacillus, Bifidobacterium and B. coccoides-E. rectale group was observed in exercise group with respect to the rest of groups. We also found a significant positive correlation between the quantity of Bifidobacterium and Lactobacillus and serum leptin levels, and a significant and negative correlation among the number of Clostridium, Bacteroides and Prevotella and serum leptin levels in all experimental groups. Furthermore, serum ghrelin levels were negatively correlated with the quantity of Bifidobacterium, Lactobacillus and B. coccoides-Eubacterium rectale group and positively correlated with the number of Bacteroides and Prevotella. Conclusions: Nutritional status and physical activity alter gut microbiota composition affecting the diversity and similarity. This study highlights the associations between gut microbiota and appetite-regulating hormones that may be important in terms of satiety and host metabolism.	[Isabel Queipo-Ortuno, Maria; Murri, Mora; Cardona, Fernando] Virgen de la Victoria Hosp FIMABIS, Biomed Res Lab, Malaga, Spain; [Isabel Queipo-Ortuno, Maria; Maria Seoane, Luisa; Pardo, Maria; Cardona, Fernando; Casanueva, Felipe; Tinahones, Francisco J.] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Maria Seoane, Luisa; Pardo, Maria] Santiago de Compostela CHUS SERGAS, Hlth Res Inst Santiago de Compostela IDIS, Univ Hosp Complex Santiago de Compostela, Santiago De Compostela, Spain; [Miguel Gomez-Zumaquero, Juan] Civil Hosp FIMABIS, Mol Biol Lab, Malaga, Spain; [Casanueva, Felipe] Clin Hosp Santiago de Compostela, Endocrinol & Nutr Serv, Santiago De Compostela, Spain; [Tinahones, Francisco J.] Virgen de la Victoria Hospital, Endocrinol & Nutr Serv, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Queipo-Ortuno, MI (corresponding author), Virgen de la Victoria Hosp FIMABIS, Biomed Res Lab, Malaga, Spain.	maribelqo@gmail.com	Cardona, Fernando/H-6022-2015; Ortuño, María Isabel Queipo/AAC-1238-2021; Cardona, Fernando/AAG-7835-2019; Tinahones, Francisco José/AAB-2882-2020; Pardo, María/C-5124-2012	Cardona, Fernando/0000-0003-4460-6824; Cardona, Fernando/0000-0003-4460-6824; Pardo, María/0000-0002-9967-1650; QUEIPO ORTUNO, MARIA ISABEL/0000-0002-2867-0845; Murri, Mora/0000-0002-6482-192X; Tinahones, Francisco J/0000-0001-6871-4403	CIBER (Centro de Investigacion en Red) of the "Instituto de Salud Carlos III (ISCIII)" [CB06/03/0018]; Instituto de Salud Carlos III Madrid (Spain) [CP07/0095]; Servicio Andaluz de Salud [PI0696/2010]; Fondo de Investigacion Sanitaria (FIS) from the Instituto de Salud Carlos III (ISCIII), Madrid (Spain) [PI12/02355]; Spanish Ministry of Economy and Competitiveness [CD11/0030]	CIBER (Centro de Investigacion en Red) of the "Instituto de Salud Carlos III (ISCIII)"; Instituto de Salud Carlos III Madrid (Spain)(Instituto de Salud Carlos III); Servicio Andaluz de Salud; Fondo de Investigacion Sanitaria (FIS) from the Instituto de Salud Carlos III (ISCIII), Madrid (Spain); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported in part by a grant from CIBER (Centro de Investigacion en Red) CB06/03/0018 of the "Instituto de Salud Carlos III (ISCIII)", the Instituto de Salud Carlos III CP07/0095 Madrid (Spain), the Servicio Andaluz de Salud (PI0696/2010) and Fondo de Investigacion Sanitaria (FIS) PI12/02355 from the Instituto de Salud Carlos III (ISCIII), Madrid (Spain). The post-doctoral grant "Sara Borrell'' (CD11/0030) from the Spanish Ministry of Economy and Competitiveness (MM) and the Miguel Servet Fellow from the Instituto de Salud Carlos III/SERGAS (MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenito SG, 2002, J PEDIATR-US, V141, P701, DOI 10.1067/mpd.2002.129840; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Boakes RA, 2001, BEHAV NEUROSCI, V115, P718, DOI 10.1037/0735-7044.115.3.718; Boakes RA, 2007, SPAN J PSYCHOL, V10, P251, DOI 10.1017/S113874160000651X; Broglio F, 2006, FRONT HORM RES, V35, P102, DOI 10.1159/000094313; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; De Vriese C, 2008, INT J BIOCHEM CELL B, V40, P1420, DOI 10.1016/j.biocel.2007.04.020; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Deplancke B, 2002, AM J CLIN NUTR, V76, P1117, DOI 10.1093/ajcn/76.5.1117; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; El Homsi M, 2007, AM J PHYSIOL-GASTR L, V293, pG365, DOI 10.1152/ajpgi.00091.2007; Fetissov SO, 2008, NUTRITION, V24, P854, DOI 10.1016/j.nut.2008.06.021; Fetissov SO, 2008, NUTRITION, V24, P348, DOI 10.1016/j.nut.2007.12.006; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hooda S., 2012, BR NUTR, P1; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Kinzig KP, 2010, PHYSIOL BEHAV, V101, P269, DOI 10.1016/j.physbeh.2010.05.010; Kowalska I, 2011, CLIN CHIM ACTA, V412, P1702, DOI 10.1016/j.cca.2011.06.007; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; MILLER RS, 1981, GASTROENTEROLOGY, V81, P759; Nedvidkova J, 2003, J CLIN ENDOCR METAB, V88, P1678, DOI 10.1210/jc.2002-021669; Pardo M, 2010, PEPTIDES, V31, P1912, DOI 10.1016/j.peptides.2010.06.022; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Plaisancie P, 2006, AM J PHYSIOL-GASTR L, V290, pG805, DOI 10.1152/ajpgi.00433.2005; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Seoane LM, 2007, J ENDOCRINOL INVEST, V30, pRC22, DOI 10.1007/BF03350806; Seoane LM, 2007, ENDOCRINOLOGY, V148, P3998, DOI 10.1210/en.2007-0226; Sonoyama K, 2009, APPL ENVIRON MICROB, V75, P6451, DOI 10.1128/AEM.00692-09; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yager J, 2005, NEW ENGL J MED, V353, P1481, DOI 10.1056/NEJMcp050187	51	290	307	9	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65465	10.1371/journal.pone.0065465	http://dx.doi.org/10.1371/journal.pone.0065465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724144	Green Published, gold			2022-12-25	WOS:000319733000133
J	Jancek, S; Bezier, A; Gayral, P; Paillusson, C; Kaiser, L; Dupas, S; Le Ru, BP; Barbe, V; Periquet, G; Drezen, JM; Herniou, EA				Jancek, Severine; Bezier, Annie; Gayral, Philippe; Paillusson, Corentin; Kaiser, Laure; Dupas, Stephane; Le Ru, Bruno Pierre; Barbe, Valerie; Periquet, Georges; Drezen, Jean-Michel; Herniou, Elisabeth A.			Adaptive Selection on Bracovirus Genomes Drives the Specialization of Cotesia Parasitoid Wasps	PLOS ONE			English	Article							VIRAL HISTONE H4; MULTIPLE SEQUENCE ALIGNMENT; PLUTELLAE BRACOVIRUS; POLYDNAVIRUS GENE; TRANSIENT EXPRESSION; STATISTICAL-METHODS; POSITIVE SELECTION; DIAMONDBACK MOTH; CLUSTAL-W; PROTEIN	The geographic mosaic of coevolution predicts parasite virulence should be locally adapted to the host community. Cotesia parasitoid wasps adapt to local lepidopteran species possibly through their symbiotic bracovirus. The virus, essential for the parasitism success, is at the heart of the complex coevolutionary relationship linking the wasps and their hosts. The large segmented genome contained in the virus particles encodes virulence genes involved in host immune and developmental suppression. Coevolutionary arms race should result in the positive selection of particular beneficial alleles. To understand the global role of bracoviruses in the local adaptation or specialization of parasitoid wasps to their hosts, we studied the molecular evolution of four bracoviruses associated with wasps of the genus Cotesia, including C congregata, C vestalis and new data and annotation on two ecologically differentiated populations of C sesamie, Kitale and Mombasa. Paired orthologs analyses revealed more genes under positive selection when comparing the two C sesamiae bracoviruses belonging to the same species, and more genes under strong evolutionary constraint between species. Furthermore branch-site evolutionary models showed that 17 genes, out of the 54 currently available shared by the four bracoviruses, harboured sites under positive selection including: the histone H4-like, a C-type lectin, two ep1-like, ep2, a viral ankyrin, CrV1, a ben-domain, a Serine-rich, and eight unknown genes. Lastly the phylogenetic analyses of the histone, ep2 and CrV1 genes in different African C sesamiae populations showed that each gene described differently the individual relationships. In particular we found recombination had happened between the ep2 and CrV1 genes, which are localized 37.5 kb apart on the wasp chromosomes. Involved in multidirectional coevolutionary interactions, C sesamiae wasps rely on different bracovirus mediated molecular pathways to overcome local host resistance.	[Jancek, Severine; Bezier, Annie; Gayral, Philippe; Paillusson, Corentin; Periquet, Georges; Drezen, Jean-Michel; Herniou, Elisabeth A.] Univ Tours, UFR Sci & Tech, CNRS, Inst Rech Biol Insecte,UMR 7261, Tours, France; [Kaiser, Laure; Dupas, Stephane; Le Ru, Bruno Pierre] CNRS, Lab Evolut Genomes & Speciat, IRD UR 072, UPR9034, Gif Sur Yvette, France; [Kaiser, Laure; Dupas, Stephane; Le Ru, Bruno Pierre] Univ Paris Sud, Gif Sur Yvette, France; [Kaiser, Laure] INRA, Unite Rech, UMR 1272, F-78026 Versailles, France; [Le Ru, Bruno Pierre] ICIPE, IRD UR 072, Nairobi, Kenya; [Barbe, Valerie] Univ Evry, CNRS, Genoscope CEA, UMR 8030, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; International Centre of Insect Physiology & Ecology (ICIPE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Herniou, EA (corresponding author), Univ Tours, UFR Sci & Tech, CNRS, Inst Rech Biol Insecte,UMR 7261, Parc Grandmont, Tours, France.	elisabeth.herniou@univ-tours.fr	LE RU, BRUNO/C-5862-2011; Le Ru, bruno/K-3480-2016; BEZIER, Annie/B-4429-2016; Gayral, Philippe/E-9726-2010; Herniou, Elisabeth/B-3786-2016	Le Ru, bruno/0000-0002-4208-3727; BEZIER, Annie/0000-0002-2528-4260; Gayral, Philippe/0000-0002-2276-5202; Herniou, Elisabeth/0000-0001-5362-6056; Drezen, Jean-Michel/0000-0001-7578-635X	ERC [205206]; CEA-Genoscop [AP09/10 25]	ERC(European Research Council (ERC)European Commission); CEA-Genoscop	Funding for this study was provided by the ERC project 205206 'GENOVIR' and the CEA-Genoscope project AP09/10#25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Beckage NE, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P163, DOI 10.1016/B978-0-12-384858-1.00013-8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BEZIER A, 2013, PHILOS T R IN PRESS; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Branca A, 2011, MOL ECOL, V20, P959, DOI 10.1111/j.1365-294X.2010.04977.x; Branca A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-185; Cameron PJ, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P236; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; DREZEN JM, 1999, VIROLOGIE, V3, P11; Drummond A., 2011, GENEIOUS V5 5; Dupas S, 2009, ADV PARASIT, V70, P281, DOI 10.1016/S0065-308X(09)70011-9; Dupas S, 2008, J HERED, V99, P491, DOI 10.1093/jhered/esn047; Dupuy C, 2006, VIRUS RES, V117, P81, DOI 10.1016/j.virusres.2006.01.001; Dupuy C, 2011, GENETICA, V139, P489, DOI 10.1007/s10709-011-9569-x; Dupuy C, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P47, DOI 10.1016/B978-0-12-384858-1.00004-7; DUSHAY MS, 1993, J INSECT PHYSIOL, V39, P1029, DOI 10.1016/0022-1910(93)90127-D; EDSON KM, 1981, SCIENCE, V211, P582, DOI 10.1126/science.7455695; Eisenhaber F, 1998, TRENDS CELL BIOL, V8, P169, DOI 10.1016/S0962-8924(98)01226-4; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; FLEMING JAGW, 1992, ANNU REV ENTOMOL, V37, P401, DOI 10.1146/annurev.en.37.010192.002153; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; FULTON B. B., 1940, ANN ENT SOC AMERICA, V33, P231, DOI 10.1093/aesa/33.2.231; Gad W, 2009, INSECT MOL BIOL, V18, P111, DOI 10.1111/j.1365-2583.2009.00860.x; Gad W, 2008, J GEN VIROL, V89, P931, DOI 10.1099/vir.0.83585-0; Gilmore JU, 1938, J ECON ENTOMOL, V31, P712, DOI 10.1093/jee/31.6.712; Gitau CW, 2007, J INSECT PHYSIOL, V53, P676, DOI 10.1016/j.jinsphys.2007.04.008; Glatz R, 2003, J BIOL CHEM, V278, P19743, DOI 10.1074/jbc.M301396200; Glatz RV, 2004, TRENDS MICROBIOL, V12, P545, DOI 10.1016/j.tim.2004.10.004; GOJOBORI T, 1983, GENETICS, V105, P1011; Gruber A, 1996, J GEN VIROL, V77, P2873, DOI 10.1099/0022-1317-77-11-2873; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harwood SH, 1998, J INVERTEBR PATHOL, V71, P271, DOI 10.1006/jipa.1997.4745; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hepat R, 2011, BIOCHEM BIOPH RES CO, V415, P279, DOI 10.1016/j.bbrc.2011.10.040; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Huguet E, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P63, DOI 10.1016/B978-0-12-384858-1.00005-9; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Lapointe R, 2007, J VIROL, V81, P6491, DOI 10.1128/JVI.02702-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le NT, 2003, J INSECT PHYSIOL, V49, P533, DOI 10.1016/S0022-1910(03)00052-0; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Lynch M, 2000, GENETICS, V154, P459; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moreau Sebastien, 2009, P137; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; RABB RL, 1969, B N CAROLINA AGR EXP, V394; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; *RTEAM, 2010, R LANG ENV STAT COMP; Savary S, 1997, J GEN VIROL, V78, P3125, DOI 10.1099/0022-1317-78-12-3125; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; Serbielle C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-253; Shenefelt RD, 1972, HYMENOPTERORUM CATAL, V7, P429; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Strand MR, 2012, VIRUS TAXONOMY CLASS, P267; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tennessen JA, 2008, BIOINFORMATICS, V24, P1421, DOI 10.1093/bioinformatics/btn205; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	91	38	39	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64432	10.1371/journal.pone.0064432	http://dx.doi.org/10.1371/journal.pone.0064432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724046	gold, Green Submitted, Green Published			2022-12-25	WOS:000319733000055
J	Kyhn, LA; Tougaard, J; Beedholm, K; Jensen, FH; Ashe, E; Williams, R; Madsen, PT				Kyhn, Line A.; Tougaard, Jakob; Beedholm, Kristian; Jensen, Frants H.; Ashe, Erin; Williams, Rob; Madsen, Peter T.			Clicking in a Killer Whale Habitat: Narrow-Band, High-Frequency Biosonar Clicks of Harbour Porpoise (Phocoena phocoena) and Dall's Porpoise (Phocoenoides dalli)	PLOS ONE			English	Article							TRANSMISSION BEAM PATTERN; ECHOLOCATION SIGNALS; NEOPHOCAENA-PHOCAENOIDES; ORCINUS-ORCA; TONAL SIGNALS; DOLPHINS; SONAR; KHZ; EVOLUTION; BEHAVIOR	Odontocetes produce a range of different echolocation clicks but four groups in different families have converged on producing the same stereotyped narrow band high frequency (NBHF) click. In microchiropteran bats, sympatric species have evolved the use of different acoustic niches and subtly different echolocation signals to avoid competition among species. In this study, we examined whether similar adaptations are at play among sympatric porpoise species that use NBHF echolocation clicks. We used a six-element hydrophone array to record harbour and Dall's porpoises in British Columbia (BC), Canada, and harbour porpoises in Denmark. The click source properties of all porpoise groups were remarkably similar and had an average directivity index of 25 dB. Yet there was a small, but consistent and significant 4 kHz difference in centroid frequency between sympatric Dall's (137 +/- 3 kHz) and Canadian harbour porpoises (141 +/- 2 kHz). Danish harbour porpoise clicks (136 +/- 3 kHz) were more similar to Dall's porpoise than to their conspecifics in Canada. We suggest that the spectral differences in echolocation clicks between the sympatric porpoises are consistent with evolution of a prezygotic isolating barrier (i.e., character displacement) to avoid hybridization of sympatric species. In practical terms, these spectral differences have immediate application to passive acoustic monitoring.	[Kyhn, Line A.; Tougaard, Jakob; Beedholm, Kristian; Jensen, Frants H.; Madsen, Peter T.] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Ashe, Erin; Williams, Rob] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland	Aarhus University; University of St Andrews	Kyhn, LA (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	lky@dmu.dk	Madsen, Peter T/K-5832-2013; Jensen, Frants H/G-3438-2013; Tougaard, Jakob/G-4948-2011; Kyhn, Line Anker/AAY-9923-2021; Williams, Rob/C-5882-2011	Madsen, Peter T/0000-0002-5208-5259; Jensen, Frants H/0000-0001-8776-3606; Tougaard, Jakob/0000-0002-4422-7800; Ashe, Erin/0000-0001-9918-1419; Williams, Rob/0000-0001-7496-453X; Kyhn, Line/0000-0002-0926-6812	Aarhus University Research Foundation; Danish Ministry of Environment (Jagttegnsmidlerne); National Danish Science Research Council; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme; Danish Council for Independent Research \ Natural Sciences	Aarhus University Research Foundation; Danish Ministry of Environment (Jagttegnsmidlerne); National Danish Science Research Council; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	This study was funded by the Aarhus University Research Foundation, the Danish Ministry of Environment (Jagttegnsmidlerne) and by frame grants to PTM from the National Danish Science Research Council. RW was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme, and FHJ by a postdoctoral fellowship from the Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S.H., 1976, Aquatic Mamm, V4, P56; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 1986, J ACOUST SOC AM, V80, P688, DOI 10.1121/1.394012; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Baird RW, 1998, CAN J ZOOL, V76, P198, DOI 10.1139/z97-175a; Bassett H. R, 2009, J ACOUST SOC AM, V125, P2677, DOI [10.1121/1.4784219, DOI 10.1121/1.4784219]; Beedholm K, 2010, C EUR CET SOC ECS ST; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Deecke VB, 2005, ANIM BEHAV, V69, P395, DOI 10.1016/j.anbehav.2004.04.014; Denzinger A., 2004, ECHOLOCATION BATS DO, P311; DeRuiter SL, 2010, J ACOUST SOC AM, V127, P560, DOI 10.1121/1.3257203; Eskesen IG, 2011, J ACOUST SOC AM, V130, P9, DOI 10.1121/1.3583499; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; Fontaine PM, 1997, MAMMALIA, V61, P65, DOI 10.1515/mamm.1997.61.1.65; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Gotz T, 2010, J ACOUST SOC AM, V128, P563, DOI 10.1121/1.3353078; Hatakeyama Y, 1994, SC090G9 INT WHAL COM, P549; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Kastelein RA, 2002, J ACOUST SOC AM, V112, P334, DOI 10.1121/1.1480835; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Kastelein RA, 2009, J ACOUST SOC AM, V126, P1588, DOI 10.1121/1.3177274; Kinze C, 2007, DANSK PATTEDYRATLAS, P392; Koblitz JC, 2012, J ACOUST SOC AM, V131, P2315, DOI 10.1121/1.3683254; Kyhn L, 2010, PASSIVE ACOUSTOC MON; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Kyhn LA, 2009, J ACOUST SOC AM, V125, P1783, DOI 10.1121/1.3075600; Li SH, 2007, J ACOUST SOC AM, V121, P3938, DOI 10.1121/1.2721658; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Madsen PT, 2010, J EXP BIOL, V213, P3105, DOI 10.1242/jeb.044420; Madsen PT, 2005, BIOACOUSTICS, V15, P195, DOI 10.1080/09524622.2005.9753547; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Melcon ML, 2012, J ACOUST SOC AM, V131, pEL448, DOI 10.1121/1.4710837; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Morisaka T, 2007, J EVOLUTION BIOL, V20, P1439, DOI 10.1111/j.1420-9101.2007.01336.x; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Neuweiler G., 2000, BIOL BATS; Popov VV, 2006, J ACOUST SOC AM, V119, P3173, DOI 10.1121/1.2184290; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Scharf B., 1970, FDN MODERN AUDITORY; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; SILBER G K, 1991, Aquatic Mammals, V17, P130; SPIESBERGER JL, 1990, AM NAT, V135, P107, DOI 10.1086/285035; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; THOMPSON RKR, 1975, J ACOUST SOC AM, V57, P943, DOI 10.1121/1.380513; Tyack PL, 2000, SPR HDB AUD, V12, P156; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wahlberg M, 2001, J ACOUST SOC AM, V109, P397, DOI 10.1121/1.1329619; Williams Rob, 2007, Journal of Cetacean Research and Management, V9, P15; Williams R, 2008, CAN J FISH AQUAT SCI, V65, P1867, DOI 10.1139/F08-098; Willis PM, 2007, ETHOLOGY, V113, P587, DOI 10.1111/j.1439-0310.2007.01347.x; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059; Wisniewska DM, 2012, J EXP BIOL, V215, P4358, DOI 10.1242/jeb.074013	57	50	50	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63763	10.1371/journal.pone.0063763	http://dx.doi.org/10.1371/journal.pone.0063763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723996	Green Published, gold			2022-12-25	WOS:000319733000020
J	Rendeiro, C; Vauzour, D; Rattray, M; Waffo-Teguo, P; Merillon, JM; Butler, LT; Williams, CM; Spencer, JPE				Rendeiro, Catarina; Vauzour, David; Rattray, Marcus; Waffo-Teguo, Pierre; Merillon, Jean Michel; Butler, Laurie T.; Williams, Claire M.; Spencer, Jeremy P. E.			Dietary Levels of Pure Flavonoids Improve Spatial Memory Performance and Increase Hippocampal Brain-Derived Neurotrophic Factor	PLOS ONE			English	Article							BDNF MESSENGER-RNA; GINKGO-BILOBA EXTRACT; ELEMENT-BINDING PROTEIN; AGE-RELATED DECLINES; FLAVANOL-RICH COCOA; GREEN TEA; BLUEBERRY SUPPLEMENTATION; DENTATE GYRUS; AGING BRAIN; SYNAPTIC PLASTICITY	Evidence suggests that flavonoid-rich foods are capable of inducing improvements in memory and cognition in animals and humans. However, there is a lack of clarity concerning whether flavonoids are the causal agents in inducing such behavioral responses. Here we show that supplementation with pure anthocyanins or pure flavanols for 6 weeks, at levels similar to that found in blueberry (2% w/w), results in an enhancement of spatial memory in 18 month old rats. Pure flavanols and pure anthocyanins were observed to induce significant improvements in spatial working memory (p = 0.002 and p = 0.006 respectively), to a similar extent to that following blueberry supplementation (p = 0.002). These behavioral changes were paralleled by increases in hippocampal brain-derived neurotrophic factor (R = 0.46, p < 0.01), suggesting a common mechanism for the enhancement of memory. However, unlike protein levels of BDNF, the regional enhancement of BDNF mRNA expression in the hippocampus appeared to be predominantly enhanced by anthocyanins. Our data support the claim that flavonoids are likely causal agents in mediating the cognitive effects of flavonoid-rich foods.	[Rendeiro, Catarina; Vauzour, David; Spencer, Jeremy P. E.] Univ Reading, Sch Chem Food & Pharm, Mol Nutr Grp, Reading, Berks, England; [Rendeiro, Catarina; Butler, Laurie T.; Williams, Claire M.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Rattray, Marcus] Univ Reading, Reading Sch Pharm, Reading, Berks, England; [Waffo-Teguo, Pierre; Merillon, Jean Michel] Univ Bordeaux, ISVV, Grp Etud Subst Vegetales Act Biol, Villenave Dornon, France	University of Reading; University of Reading; University of Reading; UDICE-French Research Universities; Universite de Bordeaux	Spencer, JPE (corresponding author), Univ Reading, Sch Chem Food & Pharm, Mol Nutr Grp, Reading, Berks, England.	j.p.e.spencer@reading.ac.uk	Rattray, Marcus/C-4088-2009; Spencer, Jeremy P. E./F-4757-2010; Vauzour, Dr David/C-2245-2008	Rattray, Marcus/0000-0002-6620-9830; Spencer, Jeremy P. E./0000-0003-2931-7274; Vauzour, Dr David/0000-0001-5952-8756; Williams, Claire/0000-0003-4452-671X; Rendeiro, Catarina/0000-0003-1225-7105	Biotechnology and Biological Sciences Research Council [BB/F008953/1]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/69711/2010]; BBSRC [BB/F008953/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Biotechnology and Biological Sciences Research Council (grant BB/F008953/1) and the Fundacao para a Ciencia e a Tecnologia (FCT) (grant SFRH/BD/69711/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1; Aggleton JP, 1996, BEHAV BRAIN RES, V81, P189, DOI 10.1016/S0166-4328(96)89080-2; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Augustin S, 2009, J CLIN BIOCHEM NUTR, V45, P315, DOI 10.3164/jcbn.08-248; Banerjee S, 2003, BIOTECHNIQUES, V35, P450, DOI 10.2144/03353bm02; Beking K, 2010, PUBLIC HEALTH NUTR, V13, P1403, DOI 10.1017/S1368980009992990; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Carey AN, 2012, NUTR AGING, V1, P55, DOI DOI 10.3233/nua-2012-0007; Casadesus G, 2004, NUTR NEUROSCI, V7, P309, DOI 10.1080/10284150400020482; Chan YC, 2006, J NUTR SCI VITAMINOL, V52, P266, DOI 10.3177/jnsv.52.266; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cohen-Salmon C, 1997, J PHYSIOL-PARIS, V91, P291, DOI 10.1016/S0928-4257(97)82409-6; Conner JM, 1997, J NEUROSCI, V17, P2295; Coultrap SJ, 2008, AGE, V30, P263, DOI 10.1007/s11357-008-9067-y; Dinges DF, 2006, J CARDIOVASC PHARM, V47, pS221; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fisher NDL, 2006, J CARDIOVASC PHARM, V47, pS210, DOI 10.1097/00005344-200606001-00017; Francis ST, 2006, J CARDIOVASC PHARM, V47, pS215, DOI 10.1097/00005344-200606001-00018; Gallagher M, 2003, ALZ DIS ASSOC DIS, V17, pS45, DOI 10.1097/00002093-200304002-00004; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gooney M, 2004, NEUROBIOL AGING, V25, P1323, DOI 10.1016/j.neurobiolaging.2004.01.003; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hayashi M, 2001, BRAIN RES, V918, P191, DOI 10.1016/S0006-8993(01)03002-5; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Hwang K, 2006, EXP NEUROL, V201, P75, DOI 10.1016/j.expneurol.2006.02.129; Igaz LM, 2004, NEUROTOX RES, V6, P189, DOI 10.1007/BF03033221; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Jin CH, 2009, J NEUROSCI RES, V87, P3658, DOI 10.1002/jnr.22159; Joseph JA, 1999, J NEUROSCI, V19, P8114; Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l; Kaur T, 2008, BRAIN COGNITION, V67, P25, DOI 10.1016/j.bandc.2007.10.003; Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941; Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Lai HC, 2004, CANCER LETT, V213, P181, DOI 10.1016/j.canlet.2004.04.031; Lamport D.J., 2012, NUTR AGING, V1, P5, DOI DOI 10.3233/NUA-2012-0002; Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Li Q, 2009, NEUROSCIENCE, V163, P741, DOI 10.1016/j.neuroscience.2009.07.014; Li Q, 2009, NEUROSCIENCE, V159, P1208, DOI 10.1016/j.neuroscience.2009.02.008; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milbury PE, 2010, J AGR FOOD CHEM, V58, P3950, DOI 10.1021/jf903529m; Oliveira DR, 2009, BRAIN RES, V1269, P68, DOI 10.1016/j.brainres.2008.11.105; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patel AK, 2008, INT J CLIN EXP MED, V1, P181; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rattray M, 1999, NEUROSCIENCE, V88, P169, DOI 10.1016/S0306-4522(98)00231-0; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rendeiro C, 2012, PSYCHOPHARMACOLOGY, V223, P319, DOI 10.1007/s00213-012-2719-8; Robbins RJ, 2009, J CHROMATOGR A, V1216, P4831, DOI 10.1016/j.chroma.2009.04.006; Rodriguez-Mateos A., 2012, J AGR FOOD CHEM; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Saunders C, 2012, NUTR AGING, V1, P69; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Schroeter H, 2007, J NEUROCHEM, V101, P1596, DOI 10.1111/j.1471-4159.2006.04434.x; Shif O, 2006, PHARMACOL BIOCHEM BE, V84, P17, DOI 10.1016/j.pbb.2006.04.003; Shukitt-Hale B, 2008, J AGR FOOD CHEM, V56, P636, DOI 10.1021/jf072505f; Silhol M, 2007, NEUROSCIENCE, V146, P962, DOI 10.1016/j.neuroscience.2007.02.013; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Spencer JPE, 2008, P NUTR SOC, V67, P238, DOI 10.1017/S0029665108007088; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Unno K, 2007, BIOGERONTOLOGY, V8, P89, DOI 10.1007/s10522-006-9036-8; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Vauzour D, 2007, J NEUROCHEM, V103, P1355, DOI 10.1111/j.1471-4159.2007.04841.x; Wang YF, 2006, BRIT J PHARMACOL, V148, P147, DOI 10.1038/sj.bjp.0706720; Williams B, 2004, NEUROBIOL AGING, V25, P955, DOI 10.1016/j.neurobiolaging.2003.10.008; Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001	84	109	112	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63535	10.1371/journal.pone.0063535	http://dx.doi.org/10.1371/journal.pone.0063535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23723987	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000319733000012
J	McConnachie, LA; Botta, D; White, CC; Weldy, CS; Wilkerson, HW; Yu, JB; Dills, R; Yu, XZ; Griffith, WC; Faustman, EM; Farin, FM; Gill, SE; Parks, WC; Hu, XG; Gao, XH; Eaton, DL; Kavanagh, TJ				McConnachie, Lisa A.; Botta, Dianne; White, Collin C.; Weldy, Chad S.; Wilkerson, Hui-Wen; Yu, Jianbo; Dills, Russell; Yu, Xiaozhong; Griffith, William C.; Faustman, Elaine M.; Farin, Federico M.; Gill, Sean E.; Parks, William C.; Hu, Xiaoge; Gao, Xiaohu; Eaton, David L.; Kavanagh, Terrance J.			The Glutathione Synthesis Gene Gclm Modulates Amphiphilic Polymer-Coated CdSe/ZnS Quantum Dot-Induced Lung Inflammation in Mice	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; CUTTING EDGE; TOXICITY; MOUSE; CELLS; ACTIVATION; REDUCTION; IMMUNITY; SUBUNIT; SHELL	Quantum dots (QDs) are unique semi-conductor fluorescent nanoparticles with potential uses in a variety of biomedical applications. However, concerns exist regarding their potential toxicity, specifically their capacity to induce oxidative stress and inflammation. In this study we synthesized CdSe/ZnS core/shell QDs with a tri-n-octylphosphine oxide, poly(maleic anhydride-alt-1-tetradecene) (TOPO-PMAT) coating and assessed their effects on lung inflammation in mice. Previously published in vitro data demonstrated these TOPO-PMAT QDs cause oxidative stress resulting in increased expression of antioxidant proteins, including heme oxygenase, and the glutathione (GSH) synthesis enzyme glutamate cysteine ligase (GCL). We therefore investigated the effects of these QDs in vivo in mice deficient in GSH synthesis (Gclm +/- and Gclm -/- mice). When mice were exposed via nasal instillation to a TOPO-PMAT QD dose of 6 mg cadmium (Cd) equivalents/kg body weight, neutrophil counts in bronchoalveolar lavage fluid (BALF) increased in both Gclm wild-type (+/+) and Gclm heterozygous (+/-) mice, whereas Gclm null (-/-) mice exhibited no such increase. Levels of the pro-inflammatory cytokines KC and TNF alpha increased in BALF from Gclm+/+ and +/- mice, but not from Gclm (-/-) mice. Analysis of lung Cd levels suggested that QDs were cleared more readily from the lungs of Gclm -/- mice. There was no change in matrix metalloproteinase (MMP) activity in any of the mice. However, there was a decrease in whole lung myeloperoxidase (MPO) content in Gclm -/- mice, regardless of treatment, relative to untreated Gclm +/+ mice. We conclude that in mice TOPO-PMAT QDs have in vivo pro-inflammatory properties, and the inflammatory response is dependent on GSH synthesis status. Because there is a common polymorphism in humans that influences GCLM expression, these findings imply that humans with reduced GSH synthesis capabilities may be more susceptible to the pro-inflammatory effects of QDs.	[McConnachie, Lisa A.; Botta, Dianne; White, Collin C.; Weldy, Chad S.; Wilkerson, Hui-Wen; Yu, Jianbo; Dills, Russell; Yu, Xiaozhong; Griffith, William C.; Faustman, Elaine M.; Farin, Federico M.; Eaton, David L.; Kavanagh, Terrance J.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Gill, Sean E.; Parks, William C.] Univ Washington, Dept Med, Seattle, WA USA; [Hu, Xiaoge; Gao, Xiaohu] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kavanagh, TJ (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	tjkav@uw.edu	Eaton, David/AAO-1832-2020; Gao, Xiaohu/C-8869-2009; Parks, William C./AAH-6786-2021; Gill, Sean E/G-4057-2012	yu, xiaozhong/0000-0002-5523-9583; Weldy, Chad/0000-0003-4652-6422; Faustman, Elaine/0000-0002-3085-6403	National Institutes of Health [R01ES016189, U19ES019545, P01HL098067, P30ES007033, T32ES007032]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, U19ES019545, R01ES016189, T32ES007032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01ES016189, U19ES019545, P01HL098067, P30ES007033 and T32ES007032 (www.NIH.gov), and by a grant from the Parker B. Francis Foundation (www.francisfellowships.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161; Bagalkot V, 2011, ACS NANO, V5, P8131, DOI 10.1021/nn202772p; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Bottrill M, 2011, CHEM COMMUN, V47, P7039, DOI 10.1039/c1cc10692a; Bretz F., 2010, MULTIPLE COMP USING, P205; Coppo L, 2011, BIOCHEM SOC T, V39, P1268, DOI 10.1042/BST0391268; Cox DP, 2012, NANOTOXICOLOGY; Edwards JR, 2012, J PHARM EXP THER; Finn NA, 2012, MOL BIOSYST, V8, P650, DOI 10.1039/c1mb05315a; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gill SE, 2010, AM J PATHOL, V176, P64, DOI 10.2353/ajpath.2010.090158; Gopee NV, 2007, TOXICOL SCI, V98, P249, DOI 10.1093/toxsci/kfm074; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Ho C. C., 2011, NANOTOXICOLOGY; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hsiang-Yu Lu, 2006, Journal of Medical and Biological Engineering, V26, P89; HU J, 1995, CHEM-BIOL INTERACT, V95, P291, DOI 10.1016/0009-2797(94)03568-S; Johansson E, 2010, BIOCHEM BIOPH RES CO, V396, P407, DOI 10.1016/j.bbrc.2010.04.105; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Ma-Hock L, 2012, TOXICOL LETT, V208, P115, DOI 10.1016/j.toxlet.2011.10.011; MacKinnon Y, 2010, BIRTH DEFECTS RES A, V88, P707, DOI 10.1002/bdra.20703; Madl AK, 2009, CRIT REV TOXICOL, V39, P629, DOI 10.1080/10408440903133788; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j; Pelley JL, 2009, TOXICOL SCI, V112, P276, DOI 10.1093/toxsci/kfp188; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Rikans LE, 2000, J BIOCHEM MOL TOXIC, V14, P110, DOI 10.1002/(SICI)1099-0461(2000)14:2<110::AID-JBT7>3.0.CO;2-J; SANDERSON MJ, 1988, AM J PHYSIOL, V254, pC63, DOI 10.1152/ajpcell.1988.254.1.C63; Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC; Smith WE, 2012, ACS NANO, V6, P9475, DOI 10.1021/nn302288r; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Weldy CS, 2011, INHAL TOXICOL, V23, P724, DOI 10.3109/08958378.2011.608095; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	42	27	28	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2013	8	5							e64165	10.1371/journal.pone.0064165	http://dx.doi.org/10.1371/journal.pone.0064165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HH	23724032	Green Published, gold, Green Submitted			2022-12-25	WOS:000319738100020
J	Yokota, S; Ooto, S; Hangai, M; Takayama, K; Ueda-Arakawa, N; Yoshihara, Y; Hanebuchi, M; Yoshimura, N				Yokota, Satoshi; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Ueda-Arakawa, Naoko; Yoshihara, Yuki; Hanebuchi, Masaaki; Yoshimura, Nagahisa			Objective Assessment of Foveal Cone Loss Ratio in Surgically Closed Macular Holes Using Adaptive Optics Scanning Laser Ophthalmoscopy	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; LIVING HUMAN EYE; COHERENCE TOMOGRAPHY; PHOTORECEPTOR LAYER; ULTRAHIGH-RESOLUTION; SEGMENT JUNCTION; VISUAL RECOVERY; OUTER SEGMENT; SURGERY; PATHOLOGY	Purpose: To use adaptive optics scanning laser ophthalmoscopy (AO-SLO) to quantify cone loss ratio in the foveola in order to assess foveal cone status and to investigate relationships between foveal structural abnormalities and visual function in patients with macular hole (MH) after surgery. Methods: We evaluated 10 normal eyes of 10 healthy volunteers and 19 eyes of 18 patients in whom anatomically successful MH closure had been performed. All subjects underwent a comprehensive ophthalmologic examination that included measurements of spectral-domain optical coherence tomography and AO-SLO. Results: On AO-SLO regular cone mosaic was seen in all normal eyes whereas dark regions suggesting cone loss were seen in all eyes after MH repair. Visual acuity was better in eyes without dark regions at the center of the fovea than in eyes with them (P = 0.001). Cone loss ratio in the foveola correlated with postoperative visual acuity (P<0.001), mean foveal sensitivity (P = 0.029), thinner inner and outer segments at the center of the fovea (P = 0.002), larger size of the disrupted inner and outer segment junction line (P = 0.018), and cone outer segment tip line (P<0.001). Cone loss ratio in the foveola was significantly greater in eyes that had moderately reflective foveal lesions after surgery (P = 0.006). Conclusions: AO-SLO is a useful means of assessing foveal cone damage objectively and quantitatively. The location and extent of cone damage, especially if it involves the foveola, is an important factor determining visual function after MH surgery.	[Yokota, Satoshi; Ooto, Sotaro; Hangai, Masanori; Takayama, Kohei; Ueda-Arakawa, Naoko; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Yoshihara, Yuki; Hanebuchi, Masaaki] NIDEK Co Ltd, Gamagori, Japan	Kyoto University; Nidek Co., Ltd	Ooto, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp	Yokota, Satoshi/A-5961-2019	Yokota, Satoshi/0000-0002-3727-7279	New Energy and Industrial Technology Development Organization (NEDO), Kawasaki, Japan [P05002]	New Energy and Industrial Technology Development Organization (NEDO), Kawasaki, Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by the New Energy and Industrial Technology Development Organization (NEDO; P05002), Kawasaki, Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, RETINA-J RET VIT DIS, V28, P453, DOI 10.1097/IAE.0b013e3181571398; Bainbridge J, 2008, EYE, V22, P1301, DOI 10.1038/eye.2008.23; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bottoni F, 2011, INVEST OPHTH VIS SCI, V52, P4439, DOI 10.1167/iovs.10-6732; Brooks HL, 2000, OPHTHALMOLOGY, V107, P1939, DOI 10.1016/S0161-6420(00)00331-6; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; Choi SS, 2008, J NEURO-OPHTHALMOL, V28, P120, DOI 10.1097/WNO.0b013e318175c6f5; Choi SS, 2008, INVEST OPHTH VIS SCI, V49, P2103, DOI 10.1167/iovs.07-0980; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Christensen UC, 2009, OPHTHALMOLOGY, V116, P2430, DOI 10.1016/j.ophtha.2009.06.001; Chung H, 2011, AM J OPHTHALMOL, V151, P128, DOI 10.1016/j.ajo.2010.06.040; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Ferguson RD, 2010, J OPT SOC AM A, V27, pA265, DOI 10.1364/JOSAA.27.00A265; GASS JDM, 1995, AM J OPHTHALMOL, V119, P752, DOI 10.1016/S0002-9394(14)72781-3; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P618, DOI 10.1097/00006982-200607000-00005; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Ip MS, 2002, ARCH OPHTHALMOL-CHIC, V120, P29; Kang SW, 2010, AM J OPHTHALMOL, V150, P551, DOI 10.1016/j.ajo.2010.04.030; Kawano H, 2011, AM J OPHTHALMOL, V151, P318, DOI 10.1016/j.ajo.2010.08.034; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031; Kitaguchi Y, 2008, OPHTHALMOLOGY, V115, P1771, DOI 10.1016/j.ophtha.2008.03.026; Kitaya N, 2004, AM J OPHTHALMOL, V138, P308, DOI 10.1016/j.ajo.2004.03.004; Ko TH, 2005, OPHTHALMOLOGY, V112, P1922, DOI 10.1016/j.ophtha.2005.05.027; Kusuhara S, 2004, AM J OPHTHALMOL, V138, P709, DOI 10.1016/j.ajo.2004.04.063; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; Meng QL, 2011, AM J OPHTHALMOL, V151, P896, DOI 10.1016/j.ajo.2010.11.006; Moshfeghi AA, 2005, AM J OPHTHALMOL, V139, P183, DOI 10.1016/j.ajo.2004.06.082; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2012, AM J OPHTHALMOL, V154, P174, DOI 10.1016/j.ajo.2012.01.031; Ooto S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1633, DOI 10.1001/archophthalmol.2011.345; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P5541, DOI 10.1167/iovs.11-7251; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Pircher M, 2006, OPT LETT, V31, P1821, DOI 10.1364/OL.31.001821; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4; Ruiz-Moreno JM, 2008, BRIT J OPHTHALMOL, V92, P640, DOI 10.1136/bjo.2007.136176; Sano M, 2009, AM J OPHTHALMOL, V147, P313, DOI 10.1016/j.ajo.2008.08.002; Smiddy WE, 2001, OPHTHALMOLOGY, V108, P1471, DOI 10.1016/S0161-6420(00)00645-X; Takahashi A, 2010, OPHTHALMOLOGY, V117, P806, DOI 10.1016/j.ophtha.2009.09.022; Takayama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033158; Tranos PG, 2004, AM J OPHTHALMOL, V138, P995, DOI 10.1016/j.ajo.2004.07.049; Villate N, 2005, AM J OPHTHALMOL, V139, P280, DOI 10.1016/j.ajo.2004.09.029; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056; Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63786	10.1371/journal.pone.0063786	http://dx.doi.org/10.1371/journal.pone.0063786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717484	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300033
J	Ghysels, B; Godaux, D; Matagne, RF; Cardol, P; Franck, F				Ghysels, Bart; Godaux, Damien; Matagne, Rene F.; Cardol, Pierre; Franck, Fabrice			Function of the Chloroplast Hydrogenase in the Microalga Chlamydomonas: The Role of Hydrogenase and State Transitions during Photosynthetic Activation in Anaerobiosis	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHLOROPHYLL FLUORESCENCE; GENE-EXPRESSION; CO2 FIXATION; REINHARDTII; INDUCTION; PHOSPHORYLATION; RESPIRATION; METABOLISM; TRANSPORT	Like a majority of photosynthetic microorganisms, the green unicellular alga Chlamydomonas reinhardtii may encounter O-2 deprived conditions on a regular basis. In response to anaerobiosis or in a respiration defective context, the photosynthetic electron transport chain of Chlamydomonas is remodeled by a state transition process to a conformation that favours the photoproduction of ATP at the expense of reductant synthesis. In some unicellular green algae including Chlamydomonas, anoxia also triggers the induction of a chloroplast-located, oxygen sensitive hydrogenase, which accepts electrons from reduced ferredoxin to convert protons into molecular hydrogen. Although microalgal hydrogen evolution has received much interest for its biotechnological potential, its physiological role remains unclear. By using specific Chlamydomonas mutants, we demonstrate that the state transition ability and the hydrogenase function are both critical for induction of photosynthesis in anoxia. These two processes are thus important for survival of the cells when they are transiently placed in an anaerobic environment.	[Ghysels, Bart; Franck, Fabrice] Univ Liege, Inst Plant Biol B22, Lab Bioenerget, Liege, Belgium; [Godaux, Damien; Matagne, Rene F.; Cardol, Pierre] Univ Liege, Inst Plant Biol B22, Lab Genet Microorganisms, Liege, Belgium	University of Liege; University of Liege	Franck, F (corresponding author), Univ Liege, Inst Plant Biol B22, Lab Bioenerget, Liege, Belgium.	f.franck@ulg.ac.be	Cardol, Pierre/AAA-3090-2019	Cardol, Pierre/0000-0001-9799-0546	FRS-FNRS- Fonds de la Recherche Scientifique (fund for scientific research); FP7 [GA 245070]	FRS-FNRS- Fonds de la Recherche Scientifique (fund for scientific research)(Fonds de la Recherche Scientifique - FNRS); FP7	This study was supported by FRS-FNRS- Fonds de la Recherche Scientifique (fund for scientific research) and the FP7-funded Sunbiopath project (GA 245070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1992, TRENDS BIOCHEM SCI, V17, P12, DOI 10.1016/0968-0004(92)90418-9; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Forti G, 2005, PLANT PHYSIOL, V137, P492, DOI 10.1104/pp.104.048256; Forti G, 2008, BBA-BIOENERGETICS, V1777, P1449, DOI 10.1016/j.bbabio.2008.08.011; Franck F., 2008, PHOTOSYNTHESIS ENERG, P581; Ghysels B, 2010, PHOTOSYNTH RES, V106, P145, DOI 10.1007/s11120-010-9582-4; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; KESSLER E, 1973, ARCH MIKROBIOL, V93, P91, DOI 10.1007/BF00424940; Kobayashi Y, 1995, PLANT CELL PHYSIOL, V36, P1629; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; LIEN S, 1979, ARCH BIOCHEM BIOPHYS, V197, P178, DOI 10.1016/0003-9861(79)90234-0; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; MOTT KA, 1986, PLANT PHYSIOL, V82, P77, DOI 10.1104/pp.82.1.77; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; PORTIS AR, 1976, BIOCHIM BIOPHYS ACTA, V449, P434, DOI 10.1016/0005-2728(76)90154-7; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; SCHREIBER U, 1974, BIOCHIM BIOPHYS ACTA, V368, P97, DOI 10.1016/0005-2728(74)90100-5; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	35	33	35	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64161	10.1371/journal.pone.0064161	http://dx.doi.org/10.1371/journal.pone.0064161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717558	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600048
J	Hwang, CC; Chang, YH; Lee, HJ; Wang, TP; Su, YM; Chen, HW; Liang, PH				Hwang, Chi-Ching; Chang, Yi-Hsun; Lee, Hwei-Jen; Wang, Tzu-Pin; Su, Yu-Mei; Chen, Hsin-Wei; Liang, Po-Huang			The Catalytic Roles of P185 and T188 and Substrate-Binding Loop Flexibility in 3 alpha-Hydroxysteroid Dehydrogenase/Carbonyl Reductase from Comamonas testosteroni	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; ALPHA-HYDROXYSTEROID DEHYDROGENASE; X-RAY CRYSTALLOGRAPHY; ALCOHOL-DEHYDROGENASE; CONFORMATIONAL-CHANGE; ENZYME SPECIFICITY; INDUCED FIT; MECHANISM; DYNAMICS; SDR	3 alpha-Hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni reversibly catalyzes the oxidation of androsterone with NAD(+) to form androstanedione and NADH. Structurally the substrate-binding loop of the residues, T188-K208, is unresolved, while binding with NAD(+) causes the appearance of T188-P191 in the binary complex. This study determines the functional roles of the flexible substrate-binding loop in conformational changes and enzyme catalysis. A stopped-flow study reveals that the rate-limiting step in the reaction is the release of the NADH. The mutation at P185 in the hinge region and T188 in the loop causes a significant increase in the K-d value for NADH by fluorescence titration. A kinetic study of the mutants of P185A, P185G, T188A and T188S shows an increase in k(cat), K-androsterone and K-iNAD and equal primary isotope effects of V-D and (D)(V/K). Therefore, these mutants increase the dissociation of the nucleotide cofactor, thereby increasing the rate of release of the product and producing the rate-limiting step in the hydride transfer. Simulated molecular modeling gives results that are consistent with the conformational change in the substrate-binding loop after NAD(+) binding. These results indicate that P185, T188 and the flexible substrate-binding loop are involved in binding with the nucleotide cofactor and with androsterone and are also involved in catalysis.	[Hwang, Chi-Ching; Chang, Yi-Hsun; Su, Yu-Mei; Chen, Hsin-Wei] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan; [Lee, Hwei-Jen] Natl Def Med Ctr, Dept & Grad Inst Biochem, Taipei, Taiwan; [Wang, Tzu-Pin] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Liang, Po-Huang] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Kaohsiung Medical University; National Defense Medical Center; Kaohsiung Medical University; Academia Sinica - Taiwan	Hwang, CC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan.	cchwang@kmu.edu.tw	Liang, Po-Huang/H-6610-2015; Hwang, Chi-Ching/K-7933-2012; Wang, Tzu-Pin/D-4442-2009	Liang, Po-Huang/0000-0003-1207-5256; Hwang, Chi-Ching/0000-0002-8328-674X; Wang, Tzu-Pin/0000-0003-3668-7329	National Science Council, Taiwan [NSC 100-2320-B-037-014, NSC 101-2320-B-037-037]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2320-B-037-014 and NSC 101-2320-B-037-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benach J, 1999, J MOL BIOL, V289, P335, DOI 10.1006/jmbi.1999.2765; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang YH, 2007, J BIOL CHEM, V282, P34306, DOI 10.1074/jbc.M706336200; Chang YH, 2010, BBA-PROTEINS PROTEOM, V1804, P235, DOI 10.1016/j.bbapap.2009.10.012; Chang YH, 2009, BBA-PROTEINS PROTEOM, V1794, P1459, DOI 10.1016/j.bbapap.2009.06.006; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook PF, 2007, ENZYME KINETICS MECH, Vxxii; Cook PF, 1991, ENZYME MECH ISOTOPE; Dhindwal S, 2011, J BIOL CHEM, V286, P37011, DOI 10.1074/jbc.M111.291013; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ghanem M, 2009, BIOCHEMISTRY-US, V48, P3658, DOI 10.1021/bi802339c; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hwang CC, 2005, J BIOL CHEM, V280, P3522, DOI 10.1074/jbc.M411751200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Ladenstein R, 2008, CELL MOL LIFE SCI, V65, P3918, DOI 10.1007/s00018-008-8590-4; Li B, 1996, EUR J BIOCHEM, V235, P180, DOI 10.1111/j.1432-1033.1996.00180.x; Maser E, 2001, CHEM-BIOL INTERACT, V130, P707, DOI 10.1016/S0009-2797(00)00302-1; Mobus E, 1998, J BIOL CHEM, V273, P30888, DOI 10.1074/jbc.273.47.30888; Mobus E, 1997, J BACTERIOL, V179, P5951; Negri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012026; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Paithankar KS, 2007, FEBS J, V274, P5767, DOI 10.1111/j.1742-4658.2007.06102.x; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Petschacher B, 2005, BIOCHEM J, V385, P75, DOI 10.1042/BJ20040363; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; SKALHEGG BA, 1975, EUR J BIOCHEM, V50, P603, DOI 10.1111/j.1432-1033.1975.tb09901.x; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Uversky VN, 2007, METHODS PROTEIN STRU; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024	41	7	7	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63594	10.1371/journal.pone.0063594	http://dx.doi.org/10.1371/journal.pone.0063594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717450	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600024
J	Xu, YN; Zhang, Z; Li, DL; Liu, YJ; Pan, SW; Qi, X; Wang, B; Luo, FJ; Xiao, D; Shao, YM; Ruan, YH				Xu, Yunan; Zhang, Zheng; Li, Dongliang; Liu, Yingjie; Pan, Stephen W.; Qi, Xiao; Wang, Bo; Luo, Fengji; Xiao, Dong; Shao, Yiming; Ruan, Yuhua			Willingness to Use the Oral Fluid HIV Rapid Test among Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							RURAL INDIA; RISK; TRANSMISSION; PREVALENCE; MUNICIPALITY; METAANALYSIS; CLIENTS	Background: Early detection of HIV infection enables timely care and treatment. However, many men who have sex with men (MSM) remain unaware of their HIV status because they do not or are unable to access HIV testing services. Oral fluid HIV rapid tests have the potential to increase HIV testing. This study is the first to evaluate willingness to use the oral fluid test among MSM in China. Methods: A cross-sectional study was conducted in Beijing from July to October, 2012. Data were collected by self-administered questionnaires. Results: Of 262 who participated in the survey, 223(85.1%) reported that they were willing to use the oral fluid HIV rapid test. Willingness to use the oral fluid test was associated with higher education (adjusted odds ratio (AOR): 2.40, 95% confidence interval (CI): 1.13-5.10), lack of unprotected anal intercourse (UAI) with male partners in the past one month (AOR: 2.38; 95% 95% CI: 1.15-4.95), having taken more than 4 HIV tests (AOR: 3.54; 95% CI: 1.52-8.28), and having ever heard of the oral fluid HIV rapid test from gay friends or gay organizations (AOR: 3.24, 95% CI: 1.40-7.51). Among those who expressed willingness to use the oral fluid HIV rapid test, the median amount of money they were willing to pay was 8 dollars. Among the 39 participants who were unwilling to use the oral fluid test, 79.5% (31/39) expressed concerns about the accuracy of the oral fluid HIV rapid test results and 17.9%(7/39) reported that they were not familiar with the oral fluid test and did not know how to use such a test. Conclusions: A high proportion of MSM in Beijing appear to be willing to use the oral fluid HIV rapid test. Appropriate cost and education measures could help improve acceptance of the oral fluid test.	[Xu, Yunan; Shao, Yiming; Ruan, Yuhua] Chinese Ctr Dis Control & Prevent China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Yunan; Shao, Yiming; Ruan, Yuhua] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Zhang, Zheng; Li, Dongliang; Liu, Yingjie; Qi, Xiao; Wang, Bo; Luo, Fengji] Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China; [Pan, Stephen W.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Xiao, Dong] Chaoyang Chinese AIDS Volunteer Grp, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of British Columbia	Ruan, YH (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	ruanyuhua92@gmail.com	Xu, Yunan/AGX-9883-2022	Xu, Yunan/0000-0001-6484-6118	National Natural Science Foundation of China [81273188]; Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory for Infectious Disease Development Grant [2012SKLID103]; U.S. National Institute of Health [R01AI094562]; U.S. government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Development Grant; U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Natural Science Foundation of China (81273188), the Ministry of Science and Technology of China (2012ZX10001-002), Chinese State Key Laboratory for Infectious Disease Development Grant (2012SKLID103) and the U.S. National Institute of Health grants (R01AI094562). SWP was supported by a Fulbright student grant from the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron-Limon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-433; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Branson Bernard M, 2004, AIDS Clin Care, V16, P39; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Ellen JM, 2004, INT J STD AIDS, V15, P728, DOI 10.1258/0956462042395258; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Fernandez MI, 2002, AIDS CARE, V14, P375, DOI 10.1080/09540120220123757; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gottfried TD, 2006, EXPERT REV MOL DIAGN, V6, P139, DOI 10.1586/14737159.6.2.139; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Liang TS, 2005, AIDS PATIENT CARE ST, V19, P253, DOI 10.1089/apc.2005.19.253; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mash R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000638; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Morin SF, 2008, JAIDS-J ACQ IMM DEF, V49, P544, DOI 10.1097/QAI.0b013e31818d5def; Pai NP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000367; Pai NP, 2008, PLOS MED, V5, P768, DOI 10.1371/journal.pmed.0050092; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Seipone K., 2004, Morbidity and Mortality Weekly Report, V53, P1083; Sharma Akshay, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P357, DOI 10.1177/1545109711404946; Snyder H, 2012, AIDS EDUC PREV, V24, P309, DOI 10.1521/aeap.2012.24.4.309; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; Ti LP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-189; Vergidis PI, 2009, INFECT DIS CLIN N AM, V23, P309, DOI 10.1016/j.idc.2009.02.001; Vermund SH, 2007, TUBERCULOSIS, V87, pS18, DOI 10.1016/j.tube.2007.05.008; Tam VV, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-53; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Zyaambo C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-389	37	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64652	10.1371/journal.pone.0064652	http://dx.doi.org/10.1371/journal.pone.0064652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717645	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600072
J	Chakraborty, S; Christoforou, N; Fattahi, A; Herzog, RW; Leong, KW				Chakraborty, Syandan; Christoforou, Nicolas; Fattahi, Ali; Herzog, Roland W.; Leong, Kam W.			A Robust Strategy for Negative Selection of Cre-LoxP Recombination-Based Excision of Transgenes in Induced Pluripotent Stem Cells	PLOS ONE			English	Article							ENHANCES EXPRESSION; DIFFERENTIATION; GENERATION; MURINE; MODEL; GENE	Viral vectors remain the most efficient and popular in deriving induced pluripotent stem cells (iPSCs). For translation, it is important to silence or remove the reprogramming factors after induction of pluripotency. In this study, we design an excisable loxP-flanked lentiviral construct that a) includes all the reprogramming elements in a single lentiviral vector expressed by a strong EF-1 alpha promoter; b) enables easy determination of lentiviral titer; c) enables transgene removal and cell enrichment using LoxP-site-specific Cre-recombinase excision and Herpes Simplex Virus-thymidine kinase/ganciclovir (HSV-tk/gan) negative selection; and d) allows for transgene excision in a colony format. A reprogramming efficiency comparable to that reported in the literature without boosting molecules can be consistently obtained. To further demonstrate the utility of this Cre-loxP/HSV-tk/gan strategy, we incorporate a non-viral therapeutic transgene (human blood coagulation Factor IX) in the iPSCs, whose expression can be controlled by a temporal pulse of Cre recombinase. The robustness of this platform enables the implementation of an efficacious and cost-effective protocol for iPSC generation and their subsequent transgenesis for downstream studies.	[Chakraborty, Syandan; Christoforou, Nicolas; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Fattahi, Ali] Kermanshah Univ Med Sci, Fac Pharm, Dept Pharmaceut, Kermanshah, Iran; [Herzog, Roland W.] Univ Florida, Dept Pediat, Gainesville, FL USA	Duke University; Kermanshah University of Medical Sciences; State University System of Florida; University of Florida	Leong, KW (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	kam.leong@duke.edu	Leong, Kam W/A-7270-2009; Fattahi, Ali/R-9274-2017; Fattahi, Ali/S-3169-2017; Leong, Kam/O-9302-2019	Leong, Kam W/0000-0002-8133-4955; Leong, Kam/0000-0002-8133-4955; Fattahi, Ali/0000-0003-3304-5232	Flight Attendant Medical Research Institute (Young Clinical Scientist Award); NIH [HL089764, HL109442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089764, R01HL109442] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (Young Clinical Scientist Award); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Flight Attendant Medical Research Institute (Young Clinical Scientist Award to NC) and NIH (HL089764, HL109442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, BLOOD COAGUL FIBRIN, V21, P502, DOI 10.1097/MBC.0b013e32833580e9; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Davis RP, 2008, NAT PROTOC, V3, P1550, DOI 10.1038/nprot.2008.146; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eggenschwiler Reto, 2009, Hepatology, V49, P1048, DOI 10.1002/hep.22827; FREEMAN SM, 1993, CANCER RES, V53, P5274; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim SY, 2002, J BIOTECHNOL, V93, P183, DOI 10.1016/S0168-1656(01)00388-1; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lee GS, 2008, MOL CELLS, V25, P487; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lohle M, 2012, STEM CELLS, V30, P570, DOI 10.1002/stem.1016; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Schnutgen F, 2006, METHOD ENZYMOL, V420, P100, DOI 10.1016/S0076-6879(06)20007-7; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt26; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	42	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64342	10.1371/journal.pone.0064342	http://dx.doi.org/10.1371/journal.pone.0064342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717601	Green Submitted, gold, Green Published			2022-12-25	WOS:000320362700141
J	Smyth, CM; Akasheh, N; Woods, S; Kay, E; Morgan, RK; Thornton, MA; O'Grady, A; Cummins, R; Sheils, O; Smyth, P; Gleich, GJ; Murray, FM; Costello, RW				Smyth, Claire M.; Akasheh, Nadim; Woods, Sara; Kay, Elaine; Morgan, Ross K.; Thornton, Margaret A.; O'Grady, Anthony; Cummins, Robert; Sheils, Orla; Smyth, Peter; Gleich, Gerald J.; Murray, Frank M.; Costello, Richard W.			Activated Eosinophils in Association with Enteric Nerves in Inflammatory Bowel Disease	PLOS ONE			English	Article							MAJOR BASIC-PROTEIN; M-2 MUSCARINIC RECEPTORS; OXIDE SYNTHASE ACTIVITY; NITRIC-OXIDE; ULCERATIVE-COLITIS; CATIONIC PROTEIN; GRANULE PROTEINS; AIRWAY HYPERRESPONSIVENESS; ADHESION MOLECULES; NERVOUS-SYSTEM	Enteric neural dysfunction leads to increased mucous production and dysmotility in inflammatory bowel disease (IBD). Prior studies have shown that tissue eosinophilia is related to disease activity. We hypothesized that interactions between eosinophils and nerves contribute to neural dysfunction in IBD. Tissue from patients with intractable IBD, endoscopic biopsies from patients with steroid responsive IBD, both when active and quiescent, and control tissue were studied. Immunohistochemical studies showed that eosinophils localize to nerves in the mucosal layer of patients with Crohn's disease (CD) (p<0.001) and ulcerative colitis (UC), (p<0.01). Eosinophils localized to substance P and choline acetyltransferase (ChAT) immunostained nerves. Real time PCR of laser capture micro-dissected enteric ganglia demonstrated Intercellular Adhesion Molecule 1 (ICAM-1) mRNA was increased 7-fold in UC (n = 4), (p = 0.03), and 10-fold in CD (n = 3), (p = 0.05). Compared with controls, eotaxin-3 (CCL-26) mRNA was increased 9-fold in UC (p = 0.04) and 15-fold in CD (p = 0.06). Eosinophil numbers correlated with disease activity, while deposition of major basic protein (MBP) and eosinophil Transforming Growth Factor beta-1 (TGF beta-1) expression were seen in therapeutically responsive disease. These data indicate a significant localization of eosinophils to nerves in IBD, mediated through neurally expressed ICAM-1 and eotaxin-3. This cell/neural interaction may influence the function of nerves and contribute to symptoms in IBD.	[Smyth, Claire M.; Akasheh, Nadim; Woods, Sara; Morgan, Ross K.; Thornton, Margaret A.; O'Grady, Anthony; Cummins, Robert; Murray, Frank M.; Costello, Richard W.] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Dublin 2, Ireland; [Kay, Elaine; Sheils, Orla; Smyth, Peter] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Pathol, Dublin 2, Ireland; [Gleich, Gerald J.] Sch Med, Dept Dermatol, Salt Lake City, UT USA	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Akasheh, N (corresponding author), Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Dublin 2, Ireland.	nadimakasheh@physicians.ie	Sheils, Orla Sheils M/B-8461-2015	Sheils, Orla Sheils M/0000-0002-4493-9496; Costello, Richard/0000-0003-1179-6692	Health Research Board of Ireland [HRA_POR/2011/59]; Wellcome Trust [WT/081276]	Health Research Board of Ireland; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding for this project was from: (1) The Health Research Board of Ireland, Grant number: HRA_POR/2011/59, http://www.hrb.ie. (2) The Wellcome Trust, Grant number: WT/081276, http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Ardizzone S, 1999, EUR J GASTROEN HEPAT, V11, P27, DOI 10.1097/00042737-199901000-00006; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Chou DL, 2003, AM J RESP CRIT CARE, V167, pA483; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; Costello RW, 2000, HISTOL HISTOPATHOL, V15, P861, DOI 10.14670/HH-15.861; Coulson FR, 2003, J PHARM EXP THER; Dainese R, 2012, EUR J GASTROEN HEPAT, V24, P393, DOI 10.1097/MEG.0b013e328350f91f; Dakhama A, 2002, AM J RESP CRIT CARE, V165, P1137, DOI 10.1164/ajrccm.165.8.2109058; DVORAK AM, 1980, J IMMUNOL, V125, P460; Eglen RM, 2001, LIFE SCI, V68, P2573, DOI 10.1016/S0024-3205(01)01054-2; Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Erjefalt JS, 2001, THORAX, V56, P341, DOI 10.1136/thorax.56.5.341; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Evans CM, 2000, AM J PHYSIOL-LUNG C, V279, pL477, DOI 10.1152/ajplung.2000.279.3.L477; Evans S, 1999, PRACTITIONER, V243, P307; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; FILLEY WV, 1982, LANCET, V2, P11; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; Fryer AD, 1997, J CLIN INVEST, V99, P2036, DOI 10.1172/JCI119372; Furuta GT, 2005, AM J PHYSIOL-GASTR L, V289, pG890, DOI 10.1152/ajpgi.00015.2005; Garland A, 1997, AM J PHYSIOL-LUNG C, V273, pL1096, DOI 10.1152/ajplung.1997.273.5.L1096; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P219, DOI 10.1016/S0163-7258(96)00196-9; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P173, DOI 10.1016/S0163-7258(96)00195-7; Jacoby DB, 1999, CLIN EXP ALLERGY, V29, P59; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Jacoby DB, 2001, J ALLERGY CLIN IMMUN, V107, P211, DOI 10.1067/mai.2001.112940; JONES SC, 1995, GUT, V36, P724, DOI 10.1136/gut.36.5.724; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kobayashi T, 2003, J IMMUNOL, V170, P5756, DOI 10.4049/jimmunol.170.11.5756; Lampinen M, 2001, DIGEST DIS SCI, V46, P2004, DOI 10.1023/A:1010659803912; LEHRER RI, 1989, J IMMUNOL, V142, P4428; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Levy AM, 1997, MAYO CLIN PROC, V72, P117, DOI 10.4065/72.2.117; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; Masterson JC, 2011, AM J PATHOL, V179, P2302, DOI 10.1016/j.ajpath.2011.07.039; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Mourad FH, 2006, AM J PHYSIOL-GASTR L, V290, pG262, DOI 10.1152/ajpgi.00271.2005; Nassenstein C, 2003, J EXP MED, V198, P455, DOI 10.1084/jem.20010897; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Patel RT, 1995, EUR J GASTROEN HEPAT, V7, P1037, DOI 10.1097/00042737-199511000-00005; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Pronk-Admiraal CJ, 2000, CLIN CHEM LAB MED, V38, P619, DOI 10.1515/CCLM.2000.090; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; RACHMILEWITZ D, 1995, GUT, V37, P247, DOI 10.1136/gut.37.2.247; Renzi D, 2000, AM J PATHOL, V157, P1511, DOI 10.1016/S0002-9440(10)64789-X; Rothenberg ME, 2001, ALLERGY, V56, P21, DOI 10.1034/j.1398-9995.2001.00905.x; Saitoh O, 1999, AM J GASTROENTEROL, V94, P3513, DOI 10.1111/j.1572-0241.1999.01640.x; Sangfelt P, 2001, AM J GASTROENTEROL, V96, P1085; Shichijo K, 2005, WORLD J GASTROENTERO, V11, P4505, DOI 10.3748/wjg.v11.i29.4505; Smith AS, 2005, J GASTROEN HEPATOL, V20, P697, DOI 10.1111/j.1440-1746.2005.03759.x; Spiller RC, 2002, GUT, V51, P759, DOI 10.1136/gut.51.6.759; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152; Trocme SD, 1997, INVEST OPHTH VIS SCI, V38, P593; TRUELOVE SC, 1974, LANCET, V1, P1067; TRUELOVE SC, 1954, BRIT MED J, V2, P375, DOI 10.1136/bmj.2.4884.375; VANSTAPEL MJ, 1986, AM J CLIN PATHOL, V85, P160, DOI 10.1093/ajcp/85.2.160; Wallon C, 2011, GASTROENTEROLOGY, V140, P1597, DOI 10.1053/j.gastro.2011.01.042; Winterkamp S, 2000, J CLIN GASTROENTEROL, V30, P170, DOI 10.1097/00004836-200003000-00009; Woodruff SA, 2011, J PEDIATR GASTR NUTR, V52, P650, DOI 10.1097/MPG.0b013e3182128512; Yu RZ, 2003, ANTISENSE NUCLEIC A, V13, P57, DOI 10.1089/108729003764097340	69	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64216	10.1371/journal.pone.0064216	http://dx.doi.org/10.1371/journal.pone.0064216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717571	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700119
J	Sudo, Y; Okazaki, A; Ono, H; Yagasaki, J; Sugo, S; Kamiya, M; Reissig, L; Inoue, K; Ihara, K; Kandori, H; Takagi, S; Hayashi, S				Sudo, Yuki; Okazaki, Ayako; Ono, Hikaru; Yagasaki, Jin; Sugo, Seiya; Kamiya, Motoshi; Reissig, Louisa; Inoue, Keiichi; Ihara, Kunio; Kandori, Hideki; Takagi, Shin; Hayashi, Shigehiko			A Blue-shifted Light-driven Proton Pump for Neural Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN-II; PHARAONIS PHOBORHODOPSIN; RETINAL PROTEINS; NATRONOBACTERIUM-PHARAONIS; WAVELENGTH REGULATION; VISUAL PIGMENTS; OPSIN SHIFT; BACTERIORHODOPSIN; BINDING; CHROMOPHORE	Ion-transporting rhodopsins are widely utilized as optogenetic tools both for light-induced neural activation and silencing. The most studied representative is Bacteriorhodopsin (BR), which absorbs green/red light (similar to 570 nm) and functions as a proton pump. Upon photoexcitation, BR induces a hyperpolarization across the membrane, which, if incorporated into a nerve cell, results in its neural silencing. In this study, we show that several residues around the retinal chromophore, which are completely conserved among BR homologs from the archaea, are involved in the spectral tuning in a BR homolog (HwBR) and that the combination mutation causes a large spectral blue shift (lambda(max) = 498 nm) while preserving the robust pumping activity. Quantum mechanics/molecular mechanics calculations revealed that, compared with the wild type, the beta-ionone ring of the chromophore in the mutant is rotated similar to 130 degrees because of the lack of steric hindrance between the methyl groups of the retinal and the mutated residues, resulting in the breakage of the pi conjugation system on the polyene chain of the retinal. By the same mutations, similar spectral blue shifts are also observed in another BR homolog, archearhodopsin-3 (also called Arch). The color variant of archearhodopsin-3 could be successfully expressed in the neural cells of Caenorhabditis elegans, and illumination with blue light (500 nm) led to the effective locomotory paralysis of the worms. Thus, we successfully produced a blue-shifted proton pump for neural silencing.	[Sudo, Yuki; Okazaki, Ayako; Yagasaki, Jin; Reissig, Louisa; Takagi, Shin] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki; Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sudo, Yuki] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Ono, Hikaru; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Sugo, Seiya; Kamiya, Motoshi; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Nagoya Institute of Technology; Kyoto University	Sudo, Y (corresponding author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022; Inoue, Keiichi/AEO-3337-2022; IHARA, Kunio/D-1952-2011	Sudo, Yuki/0000-0001-8155-9356; Inoue, Keiichi/0000-0002-6898-4347; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22018010, 23687019, 23657100, 24115508, 24655009, 23107717, 23700580]; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [22300126, 23657100] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grants 22018010, 23687019, and 23657100 (to Y. S.), 24115508 and 24655009 (to K. I.), and 23107717 and 23700580 (to S. H.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and by funds from the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S. H.).	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cembran A, 2005, J PHYS CHEM A, V109, P6597, DOI 10.1021/jp052068c; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Fujimoto K, 2007, J CHEM THEORY COMPUT, V3, P605, DOI 10.1021/ct6002687; GREENHALGH DA, 1993, J BIOL CHEM, V268, P20305; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; HU JG, 1994, P NATL ACAD SCI USA, V91, P8880, DOI 10.1073/pnas.91.19.8880; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Kosugi T, 2012, J CHEM THEORY COMPUT, V8, P322, DOI 10.1021/ct2005837; Kouyama T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1458, DOI 10.1039/c0pp00236d; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Nielsen MB, 2009, CHEM SOC REV, V38, P913, DOI 10.1039/b802068j; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pastrana E, 2011, NAT METHODS, V8, P447, DOI 10.1038/nmeth0611-447; Rajamani R, 2002, J COMPUT CHEM, V23, P96, DOI 10.1002/jcc.1159; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Sudo Y, 2002, BIOPHYS J, V83, P427, DOI 10.1016/S0006-3495(02)75180-1; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y., 2012, CRC HDB ORGANIC PHOT, P1173; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2011, J BIOL CHEM, V286, P11328, DOI 10.1074/jbc.M110.187948; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Wanko M, 2005, J PHYS CHEM B, V109, P3606, DOI 10.1021/jp0463060; YAN B, 1995, J BIOL CHEM, V270, P29668; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	39	53	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20624	20632		10.1074/jbc.M113.475533	http://dx.doi.org/10.1074/jbc.M113.475533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720753	Green Published, hybrid			2022-12-25	WOS:000321715100048
J	Itkonen, HM; Mills, IG				Itkonen, Harri M.; Mills, Ian G.			N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; I RECEPTOR; ER STRESS; PROGRESSION; EXPRESSION; THERAPY; ANTIGEN; PROLIFERATION; BIOSYNTHESIS; METABOLISM	Prostate cancer is the second most common cause of cancer-associated deaths in men and signalling via a transcription factor called androgen receptor (AR) is an important driver of the disease. Androgen treatment is known to affect the expression and activity of other oncogenes including receptor tyrosine kinases (RTKs). In this study we report that ARpositive prostate cancer cell-lines express 50% higher levels of enzymes in the hexosamine biosynthesis pathway (HBP) than AR-negative prostate cell-lines. HBP produces hexosamines that are used by endoplasmic reticulum and golgi enzymes to glycosylate proteins targeted to plasma-membrane and secretion. Inhibition of O-linked glycosylation by ST045849 or N-linked glycosylation with tunicamycin decreased cell viability by 20%. In addition, tunicamycin inhibited the androgen-induced expression of AR target genes KLK3 and CaMKK2 by 50%. RTKs have been shown to enhance AR activity and we used an antibody array to identify changes in the phosphorylation status of RTKs in response to androgen stimulation. Hormone treatment increased the activity of Insulin like Growth Factor 1-Receptor (IGF-1R) ten-fold and this was associated with a concomitant increase in the N-linked glycosylation of the receptor, analyzed by lectin enrichment experiments. Glycosylation is known to be important for the processing and stability of RTKs. Inhibition of N-linked glycosylation resulted in accumulation of IGF-1R pro-receptor with altered mobility as shown by immunoprecipitation. Confocal imaging revealed that androgen induced plasma-membrane localization of IGF-1R was blocked by tunicamycin. In conclusion we have established that the glycosylation of IGF-1R is necessary for the full activation of the receptor in response to androgen treatment and that perturbing this process can break the feedback loop between AR and IGF-1R activation in prostate cells. Achieving similar results selectively in a clinical setting will be an important challenge in the future.	[Itkonen, Harri M.; Mills, Ian G.] Univ Oslo, Prostate Canc Res Grp, Ctr Mol Med Norway, Nord European Mol Biol Lab EMBL Partnership, Oslo, Norway; [Itkonen, Harri M.; Mills, Ian G.] Oslo Univ Hosp, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Dept Canc Prevent, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Dept Urol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Mills, IG (corresponding author), Univ Oslo, Prostate Canc Res Grp, Ctr Mol Med Norway, Nord European Mol Biol Lab EMBL Partnership, Oslo, Norway.	ian.mills@ncmm.uio.no	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Itkonen, Harri/0000-0002-5194-7064	PRO-NEST (Prostate Research Organizations - Network Early Stage Training); Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network; Norwegian Research Council; Helse Sor-Ost; University of Oslo through the Centre for Molecular Medicine (Norway); Norwegian Cancer Society; EU FP7	PRO-NEST (Prostate Research Organizations - Network Early Stage Training); Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network; Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse Sor-Ost; University of Oslo through the Centre for Molecular Medicine (Norway); Norwegian Cancer Society(Norwegian Cancer Society); EU FP7(European Commission)	HMI is funded by an Early Stage Researcher fellowship as part of the EU FP7 Marie Curie Integrated Training Network, PRO-NEST (Prostate Research Organizations - Network Early Stage Training). IGM is supported by funding from the Norwegian Research Council, Helse Sor-Ost and the University of Oslo through the Centre for Molecular Medicine (Norway), which is part of the Nordic EMBL (European Molecular Biology Laboratory) partnership. IGM is also supported by the Norwegian Cancer Society and by EU FP7 funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BELANGER A, 1995, PROSTATE, V27, P187, DOI 10.1002/pros.2990270403; Bluemn EG, 2012, CURR OPIN ONCOL, V24, P251, DOI 10.1097/CCO.0b013e32835105b3; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cardillo MR, 2003, ANTICANCER RES, V23, P3825; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen LQ, 2011, CLIN CANCER RES, V17, P6218, DOI 10.1158/1078-0432.CCR-11-1548; Chen R, 2012, J CELL BIOCH; Chi KN, 2012, CLIN CANCER RES, V18, P3407, DOI 10.1158/1078-0432.CCR-12-0482; CHU TM, 1994, J CLIN LAB ANAL, V8, P323, DOI 10.1002/jcla.1860080511; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Filhoulaud G, 2009, J BIOL CHEM, V284, P24583, DOI 10.1074/jbc.M109.025288; Fiorini M, 2001, FEBS LETT, V490, P132, DOI 10.1016/S0014-5793(01)02116-0; Hammerer Peter, 2012, BJU Int, V110 Suppl 1, P23, DOI 10.1111/j.1464-410X.2012.11431.x; Itkonen H, 2012, MOL CELL ENDOCRINOL, V360, P44, DOI 10.1016/j.mce.2011.09.037; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; Kim JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033322; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lynch TP, 2012, J BIOL CHEM; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Pagliarulo V, 2012, EUR UROL, V61, P11, DOI 10.1016/j.eururo.2011.08.026; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Peracaula R, 2003, GLYCOBIOLOGY, V13, P457, DOI 10.1093/glycob/cwg041; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Plymate SR, 2004, PROSTATE, V61, P276, DOI 10.1002/pros.20099; Radtke C, 2005, NEUROSCI LETT, V387, P85, DOI 10.1016/j.neulet.2005.06.073; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Turney BW, 2011, BJU INT, V107, P1488, DOI 10.1111/j.1464-410X.2010.09556.x; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032	49	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e65016	10.1371/journal.pone.0065016	http://dx.doi.org/10.1371/journal.pone.0065016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724116	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000113
J	Turan, A; Grady, M; You, J; Mascha, EJ; Keeyapaj, W; Komatsu, R; Bashour, CA; Sessler, DI; Saager, L; Kurz, A				Turan, Alparslan; Grady, Martin; You, Jing; Mascha, Edward J.; Keeyapaj, Worasak; Komatsu, Ryu; Bashour, C. Allen; Sessler, Daniel I.; Saager, Leif; Kurz, Andrea			Low Vitamin D Concentration Is Not Associated with Increased Mortality and Morbidity after Cardiac Surgery	PLOS ONE			English	Article							NEGATIVE ENDOCRINE REGULATOR; LENGTH-OF-STAY; D DEFICIENCY; CLINICAL-OUTCOMES; MYOCARDIAL-INFARCTION; D METABOLISM; DISEASE; RISK; 25-HYDROXYVITAMIN-D; PREVALENCE	Objective: To determine the effect of vitamin D on postoperative outcomes in cardiac surgical patients. Design: Retrospective study. Setting: Single institution-teaching hospital. Participants: Adult cardiac surgical patients with perioperative 25-hydroxyvitamin D measurements. Interventions: None. We gathered information from the Cardiac Anesthesiology Registry that was obtained at the time of the patients' visit/hospitalization. Measurements and Main Results: We used data of 18,064 patients from the Cardiac Anesthesiology Registry; 426 patients with 25-hydroxyvitamin D measurements met our inclusion criteria. Association with Vitamin D concentration and composite of 11 cardiac morbidities was done by multivariate (i.e., multiple outcomes per subject) analysis. For other outcomes separate multivariable logistic regressions and adjusting for the potential confounders was used. The observed median vitamin D concentration was 19 [Q1-Q3:12, 30] ng/mL. Vitamin D concentration was not associated with our primary composite of serious cardiac morbidities (odds ratio [OR], 0.96; 95% CI, 0.86-1.07). Vitamin D concentration was also not associated with any of the secondary outcomes: neurologic morbidity (P = 0.27), surgical (P = 0.26) or systemic infections (P = 0.58), 30-day mortality (P = 0.55), or length of initial intensive care unit (ICU) stay (P = 0.04). Conclusions: Our analysis suggests that perioperative vitamin D concentration is not associated with clinically important outcomes, likely because the outcomes are overwhelmingly determined by other baseline and surgical factors.	[Turan, Alparslan; Grady, Martin; You, Jing; Mascha, Edward J.; Sessler, Daniel I.; Saager, Leif; Kurz, Andrea] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [Grady, Martin] Cleveland Clin, Dept Reg Anesthesiol, Cleveland, OH 44106 USA; [You, Jing; Mascha, Edward J.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Keeyapaj, Worasak; Bashour, C. Allen] Cleveland Clin, Dept Cardiothorac Anesthesiol, Cleveland, OH 44106 USA; [Komatsu, Ryu] Cleveland Clin, Inst Anesthesiol, Cleveland, OH 44106 USA; [Sessler, Daniel I.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; McMaster University; Population Health Research Institute	Turan, A (corresponding author), Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA.	turana@ccf.org	Saager, Leif/AHB-6208-2022; Sessler, Daniel/D-3504-2011; Saager, Leif/M-4623-2013	Saager, Leif/0000-0003-3416-4727; Sessler, Daniel/0000-0001-9932-3077; Saager, Leif/0000-0003-3416-4727; Kurz, Andrea/0000-0001-5887-3099; Komatsu, Ryu/0000-0002-3824-8680				Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Balden R, 2012, ENDOCRINOLOGY, V153, P2420, DOI 10.1210/en.2011-1783; Bartley J, 2010, EXPERT REV ANTI-INFE, V8, P1359, DOI 10.1586/eri.10.102; Bull SB, 1998, STAT MED, V17, P2179, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2179::AID-SIM921>3.0.CO;2-L; Cecchi A, 2011, MINERVA ANESTESIOL, V77, P1184; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gouni-Berthold I, 2009, CURR VASC PHARMACOL, V7, P414, DOI 10.3390/nu5083005; Graham EM, 2013, J PEDIATR-US, V162, P823, DOI 10.1016/j.jpeds.2012.10.013; Hassan A, 2012, ANN THORAC SURG, V93, P565, DOI 10.1016/j.athoracsur.2011.10.024; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Inamo Y, 2011, PEDIATR INT, V53, P199, DOI 10.1111/j.1442-200X.2010.03224.x; Judd SE, 2011, CURR HYPERTENS REP, V13, P187, DOI 10.1007/s11906-011-0190-2; Khanh VQL, 2011, AM J MED SCI, V341, P493, DOI 10.1097/MAJ.0b013e3182070f47; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Lagishetty V, 2011, MOL CELL ENDOCRINOL, V347, P97, DOI 10.1016/j.mce.2011.04.015; Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; LEGLER JM, 1995, J AM STAT ASSOC, V90, P680; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Lym YL, 2009, ASIA PAC J CLIN NUTR, V18, P372; Mascha EJ, 2011, ANESTH ANALG, V112, P1461, DOI 10.1213/ANE.0b013e31821796d3; Mascha EJ, 2010, STAT MED, V29, P2890, DOI 10.1002/sim.4066; MASCHA EJ, 2011, POWER CALCULATIONS T; Matthews LR, 2012, AM J SURG, V204, P37, DOI 10.1016/j.amjsurg.2011.07.021; McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; Moller Soren, 2007, Int J Med Sci, V4, P190; *NAT HEART LUNG BL, 2011, WHAT IS HEART SURG; Ouzounian M, 2012, ANN THORAC SURG, V93, P559, DOI 10.1016/j.athoracsur.2011.10.058; Pilz S, 2011, CURR DRUG TARGETS, V12, P88, DOI 10.2174/138945011793591563; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Youssef DA, 2011, DERM-ENDOCRINOL, V3, P220, DOI 10.4161/derm.3.4.15027; Zamvar VY, 2002, HEART SURG FORUM, V5, P109; ZITTERMANN A, 2013, EUR HEART J	42	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63831	10.1371/journal.pone.0063831	http://dx.doi.org/10.1371/journal.pone.0063831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724006	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000029
J	Zwart, MP; Tromas, N; Elena, SF				Zwart, Mark P.; Tromas, Nicolas; Elena, Santiago F.			Model-Selection-Based Approach for Calculating Cellular Multiplicity of Infection during Virus Colonization of Multi-Cellular Hosts	PLOS ONE			English	Article							PRISONERS-DILEMMA; MOSAIC-VIRUS; NUCLEOPOLYHEDROVIRUS; POPULATIONS; MOVEMENT	The cellular multiplicity of infection (MOI) is a key parameter for describing the interactions between virions and cells, predicting the dynamics of mixed-genotype infections, and understanding virus evolution. Two recent studies have reported in vivo MOI estimates for Tobacco mosaic virus (TMV) and Cauliflower mosaic virus (CaMV), using sophisticated approaches to measure the distribution of two virus variants over host cells. Although the experimental approaches were similar, the studies employed different definitions of MOI and estimation methods. Here, new model-selection-based methods for calculating MOI were developed. Seven alternative models for predicting MOI were formulated that incorporate an increasing number of parameters. For both datasets the best-supported model included spatial segregation of virus variants over time, and to a lesser extent aggregation of virus-infected cells was also implicated. Three methods for MOI estimation were then compared: the two previously reported methods and the best-supported model. For CaMV data, all three methods gave comparable results. For TMV data, the previously reported methods both predicted low MOI values (range: 1.04-1.23) over time, whereas the best-supported model predicted a wider range of MOI values (range: 1.01-2.10) and an increase in MOI over time. Model selection can therefore identify suitable alternative MOI models and suggest key mechanisms affecting the frequency of coinfected cells. For the TMV data, this leads to appreciable differences in estimated MOI values.	[Zwart, Mark P.; Tromas, Nicolas; Elena, Santiago F.] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Zwart, MP (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	marzwa@upvnet.upv.es	Zwart, Mark P/B-3408-2018; Elena, Santiago F./A-4191-2011	Zwart, Mark P/0000-0003-4361-7636; Elena, Santiago F./0000-0001-8249-5593; Tromas, Nicolas/0000-0003-4332-8463	'Juan de la Cierva' postdoctoral contract from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion [JCI-2011-10379];  [BFU2012-30805]	'Juan de la Cierva' postdoctoral contract from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion; 	This work was supported by grant BFU2012-30805 (SFE) and by 'Juan de la Cierva' postdoctoral contract JCI-2011-10379 (MPZ) from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW ND, 1991, J APPL ECOL, V28, P777, DOI 10.2307/2404207; Barlow ND, 2000, J ANIM ECOL, V69, P703, DOI 10.1046/j.1365-2656.2000.00428.x; Bull JC, 2001, APPL ENVIRON MICROB, V67, P5204, DOI 10.1128/AEM.67.11.5204-5209.2001; Dietrich C, 2003, J GEN VIROL, V84, P2871, DOI 10.1099/vir.0.19245-0; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Froissart R, 2004, GENETICS, V168, P9, DOI 10.1534/genetics.104.030205; Godfray HCJ, 1997, P ROY SOC B-BIOL SCI, V264, P315, DOI 10.1098/rspb.1997.0045; Gonzalez-Jara P, 2013, J VIROL, V87, P2374, DOI 10.1128/JVI.03255-12; Gonzalez-Jara P, 2009, J VIROL, V83, P7487, DOI 10.1128/JVI.00636-09; Gutierrez S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001113; Lafforgue G, 2012, J VIROL, V86, P12912, DOI 10.1128/JVI.02207-12; Miyashita S, 2010, J VIROL, V84, P1828, DOI 10.1128/JVI.01890-09; Morra MR, 2000, PLANT CELL, V12, P2259, DOI 10.1105/tpc.12.11.2259; Olkin I, 1994, PROBABILITY MODELS A; R Core Team, 2012, R LANG ENV STAT COMP; Silva MS, 2002, J GEN VIROL, V83, P1493, DOI 10.1099/0022-1317-83-6-1493; Sokal RR, 1995, BIOMETRY; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; van der Werf W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002097; Zwart MP, 2008, J GEN VIROL, V89, P1220, DOI 10.1099/vir.0.83645-0; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122; Zwart MP, 2009, P ROY SOC B-BIOL SCI, V276, P2233, DOI 10.1098/rspb.2009.0064	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64657	10.1371/journal.pone.0064657	http://dx.doi.org/10.1371/journal.pone.0064657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724074	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000075
J	Bambini, S; Piet, J; Muzzi, A; Keijzers, W; Comandi, S; De Tora, L; Pizza, M; Rappuoli, R; van de Beek, D; van der Ende, A; Comanducci, M				Bambini, Stefania; Piet, Jurgen; Muzzi, Alessandro; Keijzers, Wendy; Comandi, Sara; De Tora, Lisa; Pizza, Mariagrazia; Rappuoli, Rino; van de Beek, Diederik; van der Ende, Arie; Comanducci, Maurizio			An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands	PLOS ONE			English	Article							H-BINDING-PROTEIN; NEISSERIA-MENINGITIDIS; VACCINE CANDIDATE; SEROGROUP; DIVERSITY; STRAIN; POPULATIONS; EVOLUTION; DISEASE; SERUM	Studies of meningococcal evolution and genetic population structure, including the long-term stability of non-random associations between variants of surface proteins, are essential for vaccine development. We analyzed the sequence variability of factor H-binding protein (fHbp), Neisserial Heparin-Binding Antigen (NHBA) and Neisseria adhesin A (NadA), three major antigens in the multicomponent meningococcal serogroup B vaccine 4CMenB. A panel of invasive isolates collected in the Netherlands over a period of 50 years was used. To our knowledge, this strain collection covers the longest time period of any collection available worldwide. Long-term persistence of several antigen sub/variants and of non-overlapping antigen sub/variant combinations was observed. Our data suggest that certain antigen sub/variants including those used in 4CMenB are conserved over time and promoted by selection.	[Bambini, Stefania; Muzzi, Alessandro; Comandi, Sara; De Tora, Lisa; Pizza, Mariagrazia; Rappuoli, Rino; Comanducci, Maurizio] Novartis Vaccines & Diagnost, Siena, Italy; [Piet, Jurgen; Keijzers, Wendy; van der Ende, Arie] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Keijzers, Wendy; van der Ende, Arie] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands; [van de Beek, Diederik] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands	Novartis; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van der Ende, A (corresponding author), Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands.	a.vanderende@amc.uva.nl; maurizio.comanducci@novartis.com	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; van der Ende, Arie/0000-0003-1298-3086	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by Novartis Vaccines and Diagnostics. Authors affiliated to the funder were involved in study design, data collection and analysis and preparation of the manuscript.	Achtman M, 1995, MENINGOCOCCAL DIS, P159; Anne Whitney LM, 2006, 15 INT PATH C 2006 C; Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Bart A, 2000, FEMS MICROBIOL LETT, V188, P111, DOI 10.1111/j.1574-6968.2000.tb09179.x; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brunelli B, 2011, VACCINE, V29, P1072, DOI 10.1016/j.vaccine.2010.11.064; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Callaghan MJ, 2006, INFECT IMMUN, V74, P5085, DOI 10.1128/IAI.00293-06; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; CRAMER H., 1946, Mathematical methods of statistics.; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kimura A, 2011, CLIN VACCINE IMMUNOL, V18, P483, DOI 10.1128/CVI.00304-10; Law DKS, 2006, J CLIN MICROBIOL, V44, P2743, DOI 10.1128/JCM.00601-06; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marsh JW, 2011, VACCINE, V29, P6049, DOI 10.1016/j.vaccine.2011.06.025; Martin DR, 1998, J INFECT DIS, V177, P497, DOI 10.1086/517385; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Peeters CCAM, 1996, VACCINE, V14, P1009, DOI 10.1016/0264-410X(96)00001-1; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Plested JS, 2009, CLIN VACCINE IMMUNOL, V16, P785, DOI 10.1128/CVI.00007-09; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Sexton K, 2004, NZ MED J; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Van Looveren M, 1998, J CLIN MICROBIOL, V36, P2828, DOI 10.1128/JCM.36.10.2828-2834.1998; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welsch JA, 2003, J INFECT DIS, V188, P1730, DOI 10.1086/379375; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	63	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e65043	10.1371/journal.pone.0065043	http://dx.doi.org/10.1371/journal.pone.0065043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717687	gold, Green Submitted, Green Published			2022-12-25	WOS:000319385300005
J	Zander, KK; Parkes, R; Straton, A; Garnett, ST				Zander, Kerstin K.; Parkes, Rowena; Straton, Anna; Garnett, Stephen T.			Water Ecosystem Services in Northern Australia-How Much Are They Worth and Who Should Pay for Their Provision?	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CHOICE EXPERIMENTS; ENVIRONMENTAL SERVICES; DISTANCE-DECAY; VALUATION; BENEFITS; CONSERVATION; HEALTH; VALUES; HETEROGENEITY	There is ongoing pressure to develop the largely unaltered Daly River catchment in northern Australia for agriculture. However, a choice experiment among people in the region and in Australia's largest city, Sydney, shows that people are prepared to pay substantial amounts to maintain the quality of its ecosystem services. The total stated willingness-to-pay (WTP) for a Daly River conservation programme was about $300, of which people would be willing to pay over half ($161) if the programme retained waterholes for Aboriginal people in good condition. The WTP for high quality recreational fishing and biodiversity values was $120 and $91 respectively. Using the average cost of a recreational fishing license in Australia ($35) as a basis for grounding the stated preferences in empirical values, as well as the cost of park entry fees and the amount of support society provides to agriculture in Australia, the total amount that the 110,000 people in the region are likely to be willing to pay for the retention of the values in the Daly River catchment is about $6 million, while the 4.5 million people in Sydney would be willing to pay about $81 million. A significant finding in this research is that, while fishing, biodiversity and agricultural values all have equivalents in the market economy, the value for which people were willing to pay most, the cultural value, has no equivalent at all and is thus receives almost no investment.	[Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia; [Parkes, Rowena] Batchelor Inst Indigenous Tertiary Educ, Sch Hlth Business & Sci, Katherine, NT, Australia; [Straton, Anna] Victorian Dept Primary Ind, Melbourne, Vic, Australia; [Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia	Charles Darwin University; Batchelor Institute of Indigenous Tertiary Education; Victorian Department of Environment & Primary Industries; Charles Darwin University	Zander, KK (corresponding author), Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia.	Kerstin.zander@cdu.edu.au	Zander, Kerstin/M-2888-2013; Garnett, Stephen/M-3877-2013	Zander, Kerstin/0000-0002-2237-1801; Garnett, Stephen/0000-0002-0724-7060	Tropical Rivers and Coastal Knowledge (TRaCK) research program; Australian Research Council [DP09875528]	Tropical Rivers and Coastal Knowledge (TRaCK) research program; Australian Research Council(Australian Research Council)	The project was financed by the Tropical Rivers and Coastal Knowledge (TRaCK) research program. The lead author received funding from the Australian Research Council (grant DP09875528). Other than that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attorney-General for Australia, 2010, JOINT PRESS C NO TER; Australian Bureau of Statistics, 2009, AUSTR DEM STAT; Australian Taxation Office, 2002, DIES FUEL REB SCHEM; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Barkmann J, 2008, ECOL ECON, V65, P48, DOI 10.1016/j.ecolecon.2007.12.002; Bateman IJ, 2006, ECOL ECON, V60, P450, DOI 10.1016/j.ecolecon.2006.04.003; Bayliss P., 2008, ECOLOGICAL RISK ASSE, P271; Beharry-Borg N, 2010, ECOL ECON, V69, P1124, DOI 10.1016/j.ecolecon.2009.12.007; Birol E, 2006, ECOL ECON, V60, P145, DOI 10.1016/j.ecolecon.2006.06.002; Blamey R, 2000, AUST J AGR RESOUR EC, V44, P439, DOI 10.1111/1467-8489.00119; Blamey R, 1999, AUST J AGR RESOUR EC, V43, P337, DOI 10.1111/1467-8489.00083; Blanch S., 2008, Ecological Management & Restoration, V9, P110, DOI 10.1111/j.1442-8903.2008.00401.x; Bliemer MCJ, 2009, TRANSPORT RES B-METH, V43, P19, DOI 10.1016/j.trb.2008.05.008; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Campbell D, 2008, ENVIRON RESOUR ECON, V41, P401, DOI 10.1007/s10640-008-9198-8; Campbell D, 2011, HEALTH POLICY, V99, P83, DOI 10.1016/j.healthpol.2010.07.009; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carson RT, 1996, LAND ECON, V72, P80, DOI 10.2307/3147159; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daly River Management Advisory Committee, 2009, NO AUSTR LAND WAT SC, P60; Department of Finance and Deregulation, 2010, BEST PRACT REG HDB J; Department of Primary Industry Fisheries and Mines, 2006, FUT MON RES OPT RECR; Department of Sustainability Environment Water Population and Communities, 2012, KAK NAT PARK PASS; Dutton A, 2010, CONSERV BIOL, V24, P1479, DOI 10.1111/j.1523-1739.2010.01536.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Garnett ST, 2009, AUST J PUBL ADMIN, V68, P53, DOI 10.1111/j.1467-8500.2008.00609.x; Greene WH, 2006, TRANSPORT RES B-METH, V40, P75, DOI 10.1016/j.trb.2005.01.005; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Hamilton SK, 2005, MAR FRESHWATER RES, V56, P243, DOI 10.1071/MF05063; Hanley N, 2003, J ENVIRON MANAGE, V68, P297, DOI 10.1016/S0301-4797(03)00084-7; Hanley N, 2001, J ECON SURV, V15, P435, DOI 10.1111/1467-6419.00145; Hensher DA, 2005, TRANSPORTATION, V32, P203, DOI 10.1007/s11116-004-7613-8; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Jackson Sue, 2005, Ecological Management & Restoration, V6, P105, DOI 10.1111/j.1442-8903.2005.00226.x; Kragt ME, 2011, AUST J AGR RESOUR EC, V55, P159, DOI 10.1111/j.1467-8489.2011.00533.x; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; MA, 2005, ECOSYSTEMS HUMAN WEL; MacDonald DH, 2011, AUST J AGR RESOUR EC, V55, P374, DOI 10.1111/j.1467-8489.2011.00551.x; May K, 2010, 65 CAEPR AUSTR NAT U; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; McGregor S, 2010, HUM ECOL, V38, P721, DOI 10.1007/s10745-010-9362-y; Meyerhoff J, 2009, J FOREST ECON, V15, P37, DOI 10.1016/j.jfe.2008.03.003; Morrison M., 2000, AUST ECON PAP, V39, P215, DOI [10.1111/1467-8454.00087, DOI 10.1111/1467-8454.00087]; Muller S, 2008, AUST GEOGR, V39, P149, DOI 10.1080/00049180802056831; Northern Territory Government, 2011, INPEX COMM AGR SIGN; Northern Territory Treasury, 2010, LAB FORC NOV 2010; Organisation for Economic Co-operation and Development (OECD), 2002, HDB BIOD EV A GUID P; Organisation for Economic Co-operation and Development (OECD), 2011, AGR STAT PROD CONS S; Rea N, 2008, RANGELAND J, V30, P85, DOI 10.1071/RJ07044; Rolfe J, 2005, AUST J AGR RESOUR EC, V49, P91, DOI 10.1111/j.1467-8489.2005.00265.x; Rolfe JC, 1997, 3 U NEW S WAL; Rolfe J, 2007, AUST J AGR RESOUR EC, V51, P157, DOI 10.1111/j.1467-8489.2007.00369.x; Russell-Smith J., 2009, CULTURE ECOLOGY EC F; Sandor Z, 2001, J MARKETING RES, V38, P430, DOI 10.1509/jmkr.38.4.430.18904; Scarpa R, 2009, EUR REV AGRIC ECON, V36, P151, DOI 10.1093/erae/jbp012; Stoeckl N, 2013, BIOL CONSERV, V159, P214, DOI 10.1016/j.biocon.2012.12.007; Tarfasa S, 2013, APPL ECON, V45, P1099, DOI 10.1080/00036846.2011.613793; TEEB, 2010, EC EC BIOD MAINSTR E; Tourism B.C., 2009, FISHING PRODUCT OVER; Train K. E., 2003, DISCRETE CHOICE METH; WHITEHEAD PJ, 1990, BIOL CONSERV, V52, P85, DOI 10.1016/0006-3207(90)90119-A; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Zander KK, 2013, ECOL ECON, V87, P145, DOI 10.1016/j.ecolecon.2012.12.029; Zander KK, 2010, ECOL ECON, V69, P2417, DOI 10.1016/j.ecolecon.2010.07.010; Zander KK, 2010, J ENVIRON MANAGE, V91, P2519, DOI 10.1016/j.jenvman.2010.07.012; Zheng W, 2009, ECOL ECON, V68, P1626, DOI 10.1016/j.ecolecon.2007.12.005	70	15	16	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64411	10.1371/journal.pone.0064411	http://dx.doi.org/10.1371/journal.pone.0064411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	150JB	23717611	gold, Green Published, Green Submitted			2022-12-25	WOS:000319385300023
J	Domingo, L; Koch, PL; Fernandez, MH; Fox, DL; Domingo, MS; Alberdi, MT				Domingo, Laura; Koch, Paul L.; Hernandez Fernandez, Manuel; Fox, David L.; Domingo, M. Soledad; Teresa Alberdi, Maria			Late Neogene and Early Quaternary Paleoenvironmental and Paleoclimatic Conditions in Southwestern Europe: Isotopic Analyses on Mammalian Taxa	PLOS ONE			English	Article							MESSINIAN SALINITY CRISIS; LATE MIOCENE; DENTAL MICROWEAR; CLIMATIC CHANGES; CARBON; OXYGEN; RECONSTRUCTION; PHOSPHATE; PLEISTOCENE; EVOLUTION	Climatic and environmental shifts have had profound impacts on faunal and floral assemblages globally since the end of the Miocene. We explore the regional expression of these fluctuations in southwestern Europe by constructing long-term records (from similar to 11.1 to 0.8 Ma, late Miocene-middle Pleistocene) of carbon and oxygen isotope variations in tooth enamel of different large herbivorous mammals from Spain. Isotopic differences among taxa illuminate differences in ecological niches. The delta C-13 values (relative to VPDB, mean -10.3 +/- 1.1 parts per thousand; range -13.0 to -7.4 parts per thousand) are consistent with consumption of C-3 vegetation; C-4 plants did not contribute significantly to the diets of the selected taxa. When averaged by time interval to examine secular trends, delta C-13 values increase at similar to 9.5 Ma (MN9-MN10), probably related to the Middle Vallesian Crisis when there was a replacement of vegetation adapted to more humid conditions by vegetation adapted to drier and more seasonal conditions, and resulting in the disappearance of forested mammalian fauna. The mean delta C-13 value drops significantly at similar to 4.2-3.7 Ma (MN14-MN15) during the Pliocene Warm Period, which brought more humid conditions to Europe, and returns to higher delta C-13 values from similar to 2.6 Ma onwards (MN16), most likely reflecting more arid conditions as a consequence of the onset of the Northern Hemisphere glaciation. The most notable feature in oxygen isotope records (and mean annual temperature reconstructed from these records) is a gradual drop between MN13 and the middle Pleistocene (similar to 6.3-0.8 Ma) most likely due to cooling associated with Northern Hemisphere glaciation.	[Domingo, Laura; Koch, Paul L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Hernandez Fernandez, Manuel] Univ Complutense Madrid, Dept Paleontol, Madrid, Spain; [Hernandez Fernandez, Manuel] CSIC, UCM, Inst Geociencias, Dept Cambio Medioambiental, Madrid, Spain; [Fox, David L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN USA; [Domingo, M. Soledad] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Teresa Alberdi, Maria] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	University of California System; University of California Santa Cruz; Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Domingo, L (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	laudomingo@gmail.com	Alberdi, Maria Teresa/ABG-8623-2020; Domingo, Laura/J-6549-2012; Fernández, Manuel Hernández/I-5012-2013; Domingo, M. Soledad/I-1614-2014	Alberdi, Maria Teresa/0000-0002-7071-360X; Domingo, Laura/0000-0002-9062-0881; Fernández, Manuel Hernández/0000-0001-5640-9647; Domingo, M. Soledad/0000-0002-4755-8867; Fox, David L/0000-0002-2291-6146	UCM, Spanish Ministerio de Economia y Competitividad [CGL2009-09000/BTE, CGL2010-19116/BOS]; Personal Investigador de Apoyo contract (Comunidad de Madrid); Fundacion Espanola para la Ciencia y la Tecnologia-FECYT; Spanish Ministerio de Educacion; UCSC; FOCONTUR Project	UCM, Spanish Ministerio de Economia y Competitividad; Personal Investigador de Apoyo contract (Comunidad de Madrid)(Comunidad de Madrid); Fundacion Espanola para la Ciencia y la Tecnologia-FECYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Educacion(Spanish Government); UCSC; FOCONTUR Project	This study was supported by the UCM, Spanish Ministerio de Economia y Competitividad (Plan Nacional I+D project CGL2009-09000/BTE and Plan Nacional I+D and MNCN-CSIC project CGL2010-19116/BOS) and by a Personal Investigador de Apoyo contract (Comunidad de Madrid) to LD, postdoctoral fellowships (Fundacion Espanola para la Ciencia y la Tecnologia-FECYT and Spanish Ministerio de Educacion) to LD and MSD and a UCSC postdoctoral fellowship to LD. This work is a contribution from the research groups UCM-CAM 910161 "Geologic Record of Critical Periods: Paleoclimatic and Paleoenvironmental Factors" and UCM-CAM 910607 "Evolution of Cenozoic Mammals and Continental Palaeoenvironments". Some sampled teeth were found in excavations conducted by L. Alcala with the authorization of the Direccion General de Patrimonio Cultural del Gobierno de Aragon and supported by the FOCONTUR Project (Research Group E-62, Gobierno de Aragon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Agusti J., 1990, Lecture Notes in Earth Sciences, V30, P425; Agusti J, 2001, QUATERNARY RES, V56, P411, DOI 10.1006/qres.2001.2269; Agustui J., 2002, MAMMOTHS SABERTOOTHS; Andeweg B., 2002, THESIS VRIJE U AMSTE; AXELROD DI, 1975, ANN MO BOT GARD, V62, P280, DOI 10.2307/2395199; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Bibi F, 2008, J VERTEBR PALEONTOL, V28, P501, DOI 10.1671/0272-4634(2008)28[501:BMAFTL]2.0.CO;2; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Brugal JP, 2007, QUATERNAIRE, V18, P129; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Capozza M., 2001, WORLD ELEPHANTS, P529; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Croiter Roman, 2011, Acta Palaeontologica Romaniae, V7, P113; DEBRUIJN H, 1992, NEWSL STRATIGR, V26, P65; Domingo L, 2012, PALAEOGEOGR PALAEOCL, V339, P98, DOI 10.1016/j.palaeo.2012.04.026; Domingo L, 2009, NATURWISSENSCHAFTEN, V96, P503, DOI 10.1007/s00114-008-0500-y; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V272, P53, DOI 10.1016/j.palaeo.2008.11.006; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Fakhar-i-Abbas F, 2008, ZOO BIOL, V27, P371, DOI 10.1002/zoo.20202; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fauquette S, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P481; Fauquette S, 1999, PALAEOGEOGR PALAEOCL, V152, P15, DOI 10.1016/S0031-0182(99)00031-0; Fauquette S, 2006, PALAEOGEOGR PALAEOCL, V238, P281, DOI 10.1016/j.palaeo.2006.03.029; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Filippi M. L., 2001, WORLD ELEPHANTS, P534; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Guerin C, 1965, DOCUMENTS LAB GEOLOG, V1; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Haywood AM, 2000, GEOLOGY, V28, P1063; Fernandez MH, 2006, J ARID ENVIRON, V66, P585, DOI 10.1016/j.jaridenv.2006.01.013; Fernandez MH, 2007, PALAEOGEOGR PALAEOCL, V251, P500, DOI 10.1016/j.palaeo.2007.04.015; Hernandez Fernandez Manuel, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P253; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Jimenez-Moreno G, 2007, PALAEOGEOGR PALAEOCL, V253, P208, DOI 10.1016/j.palaeo.2007.03.040; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Koch PL, 2004, PALAEOGEOGR PALAEOCL, V207, P331, DOI 10.1016/j.palaeo.2003.09.034; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lee-Thorp JA, 1987, S AFR J SCI, V83, P71; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; Matson SD, 2012, J HUM EVOL, V63, P127, DOI 10.1016/j.jhevol.2012.04.004; Matson SD, 2010, PALAEOGEOGR PALAEOCL, V287, P28, DOI 10.1016/j.palaeo.2009.12.010; MEIN P, 1979, ANN GEOL PAYS HELL, V3, P1367; MEIN P, 1990, EUROPEAN NEOGENE MAM, P73, DOI DOI 10.1007/978-1-4899-2513-8_6; Mein P., 1975, P 6 C REG COMM MED N, P77; Mein Pierre, 1999, P25; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2005, PALAEOGEOGR PALAEOCL, V217, P173, DOI 10.1016/j.palaeo.2004.11.019; Merceron G, 2006, PALAEOGEOGR PALAEOCL, V241, P637, DOI 10.1016/j.palaeo.2006.05.005; Micheels A, 2011, PALAEOGEOGR PALAEOCL, V304, P337, DOI 10.1016/j.palaeo.2010.09.021; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; O'Neil J.R., 1994, ISR J EARTH SCI, V43, P203; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palmqvist P, 2008, PALAIOS, V23, P724, DOI 10.2110/palo.2007.p07-073r; Palombo MR, 2005, QUATERN INT, V126, P153, DOI 10.1016/j.quaint.2004.04.020; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rivals F, 2008, PALAEOGEOGR PALAEOCL, V265, P134, DOI 10.1016/j.palaeo.2008.05.001; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Sanz de Galdeano C.M., 1996, TERTIARY BASINS SPAI, P9, DOI [10.1017/CBO9780511524851.006, DOI 10.1017/CBO9780511524851.006]; Domingo MS, 2007, PALAEOGEOGR PALAEOCL, V255, P361, DOI 10.1016/j.palaeo.2007.08.004; Solounias N, 1995, J VERTEBR PALEONTOL, V15, P795, DOI 10.1080/02724634.1995.10011262; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Suc Jean-Pierre, 1995, Acta Zoologica Cracoviensia, V38, P3; Tassy P., 1994, GEOLOGY PALAEOBIOLOG, VII, P217; Tipple BJ, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001851; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Urban MA, 2010, GEOLOGY, V38, P1091, DOI 10.1130/G31117.1; van Dam JA, 2009, PALAEOGEOGR PALAEOCL, V274, P64, DOI 10.1016/j.palaeo.2008.12.022; Van Dam JA, 2001, J VERTEBR PALEONTOL, V21, P367, DOI 10.1671/0272-4634(2001)021[0367:TUMMRF]2.0.CO;2; van Dam JA, 2006, PALAEOGEOGR PALAEOCL, V238, P190, DOI 10.1016/j.palaeo.2006.03.025; Van der Meulen AJ, 2012, GEOL ACTA, V10, P159, DOI 10.1344/105.000001710; Vislobokova Inessa, 2005, Annales de Paleontologie, V91, P241, DOI 10.1016/j.annpal.2005.04.001; Vizcaino M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001733; Westerhold T, 2005, PALAEOGEOGR PALAEOCL, V217, P205, DOI 10.1016/j.palaeo.2004.12.001; WHITE F, 1983, VEGETATION AFRICA NA, V20; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009	101	59	59	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63739	10.1371/journal.pone.0063739	http://dx.doi.org/10.1371/journal.pone.0063739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717470	Green Published, gold, Green Accepted			2022-12-25	WOS:000319435600029
J	Zou, YM; Wang, YN; Wang, LX; Yang, L; Wang, R; Li, X				Zou, Yanmin; Wang, Youning; Wang, Lixiang; Yang, Lei; Wang, Rui; Li, Xia			miR172b Controls the Transition to Autotrophic Development Inhibited by ABA in Arabidopsis	PLOS ONE			English	Article							2C PROTEIN PHOSPHATASES; CIS-REGULATORY ELEMENTS; ABSCISIC-ACID; TRANSCRIPTION FACTORS; SEED-GERMINATION; OSMOTIC-STRESS; RESPONSE LOCI; GROWTH; PHASE; EXPRESSION	Seedling establishment is a critical phase in the life of plants when they are the most vulnerable to environment. Growth arrest at post-germinative stage under stress is the major adaptive strategy to help germinating seedlings to survive a spectrum of stressful conditions. ABA signaling is the key pathway to control stress-induced developmental arrest. However, mechanisms controlling the phase transition under abiotic stress are not fully understood. Here, we described miR172b as a new key regulator controlling transition of germinating seedlings from heterotrophic to autotrophic growth under osmotic stress in Arabidopsis. We showed that miR172b and its target SNZ were co-expressed during early seedling development. Expression of miR172b and SNZ was low after radicle emergence and sharply increased at the checkpoint to autotrophic development under normal conditions. Interestingly, activation of miR172b and SNZ was completely abolished by ABA and osmotic stress. miR172b overexpression and snz-1 exhibited increased sensitivity to ABA and osmotic stress during specific post-germinative stage, and resulted in higher expression of ABI3, ABI5 and downstream genes, such as Em6 and RAB18, than wild type under ABA treatment. Our results revealed that miR172b is a critical regulator specifically controlling cotyledon greening during post-germinative growth by directly targeting SNZ under ABA treatment and osmotic stress.	[Zou, Yanmin; Wang, Youning; Wang, Lixiang; Yang, Lei; Wang, Rui; Li, Xia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key State Lab Plant Cell & Chromosome Engn, Shijiazhuang, Hebei, Peoples R China; [Wang, Lixiang; Yang, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, X (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key State Lab Plant Cell & Chromosome Engn, Shijiazhuang, Hebei, Peoples R China.	xli@genetics.ac.cn	邹, 艳敏/HHZ-2831-2022; li, xia/HHZ-7468-2022	Yang, Lei/0000-0001-7969-5981	National Program on Key Basic Research Project [2009CB118305]; NSFC [31230050]; Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KSCX2-EW-J-5]; National Transgenic Key Project of the Ministry of Agriculture of China [2011ZX08009-003-002]; Youth Innovation Promotion Association, CAS	National Program on Key Basic Research Project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences); National Transgenic Key Project of the Ministry of Agriculture of China; Youth Innovation Promotion Association, CAS	This work was supported by grants from the National Program on Key Basic Research Project (2009CB118305), NSFC (31230050), Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (KSCX2-EW-J-5), and National Transgenic Key Project of the Ministry of Agriculture of China (2011ZX08009-003-002). This work was also supported by Youth Innovation Promotion Association, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bies-Etheve N, 1999, PLANT MOL BIOL, V40, P1045, DOI 10.1023/A:1006252512202; Carles C, 2002, PLANT J, V30, P373, DOI 10.1046/j.1365-313X.2002.01295.x; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu CF, 2002, PLANT PHYSIOL, V129, P1352, DOI 10.1104/pp.006122; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nakamura S, 2001, PLANT J, V26, P627, DOI 10.1046/j.1365-313x.2001.01069.x; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P12822, DOI 10.1073/pnas.1202630109; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	43	20	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64770	10.1371/journal.pone.0064770	http://dx.doi.org/10.1371/journal.pone.0064770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717657	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600075
J	Enoch, MA; Baghal, B; Yuan, QP; Goldman, D				Enoch, Mary-Anne; Baghal, Basel; Yuan, Qiaoping; Goldman, David			A Factor Analysis of Global GABAergic Gene Expression in Human Brain Identifies Specificity in Response to Chronic Alcohol and Cocaine Exposure	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; SUBUNIT MESSENGER-RNAS; GABA(A) RECEPTORS; RAT-BRAIN; EVOLUTION; SUBTYPES; DEFINES; CLUSTER; PROFILE; TRANSCRIPTION	Although expression patterns of GABAergic genes in rodent brain have largely been elucidated, no comprehensive studies have been performed in human brain. The purpose of this study was to identify global patterns of GABAergic gene expression in healthy adults, including trans and cis effects in the GABA(A) gene clusters, before determining the effects of chronic alcohol and cocaine exposure on gene expression in the hippocampus. RNA-Seq data from 'BrainSpan' was obtained across 16 brain regions from postmortem samples from nine adults. A factor analysis was performed on global expression of 21 GABAergic pathway genes. Factor specificity for response to chronic alcohol/cocaine exposure was subsequently determined from the analysis of RNA-Seq data from postmortem hippocampus of eight alcoholics, eight cocaine addicts and eight controls. Six gene expression factors were identified. Most genes loaded (>= 0.5) onto one factor; six genes loaded onto two. The largest factor (0.30 variance) included the chromosome 5 gene cluster that encodes the most common GABA(A) receptor, alpha(1)beta(2)gamma(2), and genes encoding the alpha(3)beta(3)gamma(2) receptor. Genes within this factor were largely unresponsive to chronic alcohol/cocaine exposure. In contrast, the chromosome 4 gene cluster factor (0.14 variance) encoding the alpha(2)beta(1)gamma(1) receptor was influenced by chronic alcohol/cocaine exposure. Two other factors (0.17 and 0.06 variance) showed expression changes in alcoholics/cocaine addicts; these factors included genes involved in GABA synthesis and synaptic transport. Finally there were two factors that included genes with exceptionally low (0.10 variance) and high (0.09 variance) expression in the cerebellum; the former factor was unaffected by alcohol/cocaine exposure. This study has shown that there appears to be specificity of GABAergic gene groups, defined by covariation in expression, for response to chronic alcohol/cocaine exposure. These findings might have implications for combating stress-related craving and relapse.	[Enoch, Mary-Anne; Baghal, Basel; Yuan, Qiaoping; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Enoch, MA (corresponding author), NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA.	maenoch@niaaa.nih.gov	; Goldman, David/F-9772-2010	Yuan, Qiaoping/0000-0002-5880-8702; Goldman, David/0000-0002-1724-5405	Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health [AA000305-09 LNG]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, ZIAAA000306] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, program number AA000305-09 LNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Barnard EA, 1998, PHARMACOL REV, V50, P291; BENKE D, 1994, J BIOL CHEM, V269, P27100; Enoch MA, 2008, PHARMACOL BIOCHEM BE, V90, P95, DOI 10.1016/j.pbb.2008.03.007; Enoch MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029369; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; GREGER V, 1995, GENOMICS, V26, P258, DOI 10.1016/0888-7543(95)80209-5; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jin P, 2004, GENOMICS, V83, P566, DOI 10.1016/j.ygeno.2003.09.023; Koomoa DLT, 2008, NEUROSCI LETT, V436, P171, DOI 10.1016/j.neulet.2008.03.030; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Martyniuk CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000894; MCLEAN PJ, 1995, GENOMICS, V26, P580, DOI 10.1016/0888-7543(95)80178-O; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Okada H, 2004, J NEUROCHEM, V89, P7, DOI 10.1111/j.1471-4159.2004.02271.x; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Russek SJ, 1999, GENE, V227, P213, DOI 10.1016/S0378-1119(98)00594-0; RUSSEK SJ, 1994, GENOMICS, V23, P528, DOI 10.1006/geno.1994.1539; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; SINNETT D, 1993, AM J HUM GENET, V52, P1216; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Tian HJ, 2005, MOL BRAIN RES, V137, P174, DOI 10.1016/j.molbrainres.2005.03.001; Tsang SY, 2007, MOL BIOL EVOL, V24, P599, DOI 10.1093/molbev/msl188; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Wilke K, 1997, GENOMICS, V45, P1, DOI 10.1006/geno.1997.4885; WISDEN W, 1992, J NEUROSCI, V12, P1040; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108; 2011, BRAINSPAN TECHNICAL	31	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64014	10.1371/journal.pone.0064014	http://dx.doi.org/10.1371/journal.pone.0064014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717525	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700090
J	Lawton, RJ; de Nys, R; Paul, NA				Lawton, Rebecca J.; de Nys, Rocky; Paul, Nicholas A.			Selecting Reliable and Robust Freshwater Macroalgae for Biomass Applications	PLOS ONE			English	Article							RATE ALGAL PONDS; WASTE-WATER; INORGANIC CARBON; STOCKING DENSITY; BIOFUEL; GROWTH; CHALLENGES; PHYSIOLOGY; SEAWEEDS; LIQUID	Intensive cultivation of freshwater macroalgae is likely to increase with the development of an algal biofuels industry and algal bioremediation. However, target freshwater macroalgae species suitable for large-scale intensive cultivation have not yet been identified. Therefore, as a first step to identifying target species, we compared the productivity, growth and biochemical composition of three species representative of key freshwater macroalgae genera across a range of cultivation conditions. We then selected a primary target species and assessed its competitive ability against other species over a range of stocking densities. Oedogonium had the highest productivity (8.0 g ash free dry weight m(-2) day(-1)), lowest ash content (3-8%), lowest water content (fresh weigh: dry weight ratio of 3.4), highest carbon content (45%) and highest bioenergy potential (higher heating value 20 MJ/kg) compared to Cladophora and Spirogyra. The higher productivity of Oedogonium relative to Cladophora and Spirogyra was consistent when algae were cultured with and without the addition of CO2 across three aeration treatments. Therefore, Oedogonium was selected as our primary target species. The competitive ability of Oedogonium was assessed by growing it in bi-cultures and polycultures with Cladophora and Spirogyra over a range of stocking densities. Cultures were initially stocked with equal proportions of each species, but after three weeks of growth the proportion of Oedogonium had increased to at least 96% (+/- 7 S.E.) in Oedogonium-Spirogyra bi-cultures, 86% (+/- 16 S.E.) in Oedogonium-Cladophora bi-cultures and 82% (+/- 18 S.E.) in polycultures. The high productivity, bioenergy potential and competitive dominance of Oedogonium make this species an ideal freshwater macroalgal target for large-scale production and a valuable biomass source for bioenergy applications. These results demonstrate that freshwater macroalgae are thus far an under-utilised feedstock with much potential for biomass applications.	[Lawton, Rebecca J.; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Lawton, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	rebecca.lawton@jcu.edu.au	Lawton, Rebecca/A-6149-2012; de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014	de Nys, Rocky/0000-0003-3869-4928; Lawton, Rebecca/0000-0001-6296-6415; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MH, 2011, AQUACULTURE, V312, P77, DOI 10.1016/j.aquaculture.2010.12.036; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BIDWELL RGS, 1985, BOT MAR, V28, P87, DOI 10.1515/botm.1985.28.3.87; Bird MI, 2012, GCB BIOENERGY, V4, P61, DOI 10.1111/j.1757-1707.2011.01109.x; BOROWITZKA MA, 1992, J APPL PHYCOL, V4, P267, DOI 10.1007/BF02161212; Cantrell KB, 2010, BIOMASS BIOENERG, V34, P1961, DOI 10.1016/j.biombioe.2010.08.005; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Channiwala SA, 2002, FUEL, V81, P1051, DOI 10.1016/S0016-2361(01)00131-4; Chopin T., 2009, ENCY OCEAN SCI, P317, DOI DOI 10.1016/B978-012374473-9.00757-8; Craggs R, 2012, J APPL PHYCOL, V24, P329, DOI 10.1007/s10811-012-9810-8; De Nys R, GCB BIOENER IN PRESS; EBELING JM, 1985, T ASAE, V28, P898; FRANCKE JA, 1983, AQUAT BOT, V15, P375, DOI 10.1016/0304-3770(83)90005-0; GOLDMAN JC, 1975, NATURE, V254, P594, DOI 10.1038/254594a0; GONEN Y, 1993, HYDROBIOLOGIA, V261, P493; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Grobbelaar JU, 2010, PHOTOSYNTH RES, V106, P135, DOI 10.1007/s11120-010-9573-5; GROBBELAAR JU, 1994, J APPL PHYCOL, V6, P331, DOI 10.1007/BF02181947; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Harrison PJ, 2001, CAH BIOL MAR, V42, P71; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; LAPOINTE BE, 1978, AQUACULTURE, V15, P185, DOI 10.1016/0044-8486(78)90030-3; Lewis SH, 2007, ALGAE AUSTR BATRACHO; Mata L, 2007, J PHYCOL, V43, P1252, DOI 10.1111/j.1529-8817.2007.00421.x; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; Mei H, 2007, PLANT SYST EVOL, V265, P179, DOI 10.1007/s00606-007-0523-4; Menendez M, 2001, J EXP MAR BIOL ECOL, V256, P123, DOI 10.1016/S0022-0981(00)00313-0; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Nagler PL, 2003, AQUACULTURE, V219, P379, DOI 10.1016/S0044-8486(02)00529-X; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; Park JBK, 2011, WATER SCI TECHNOL, V63, P2403, DOI 10.2166/wst.2011.200; Pate R, 2011, APPL ENERG, V88, P3377, DOI 10.1016/j.apenergy.2011.04.023; Pereira R, 2006, AQUACULTURE, V252, P66, DOI 10.1016/j.aquaculture.2005.11.050; Richard TL, 2010, SCIENCE, V329, P793, DOI 10.1126/science.1189139; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; Rowbotham JS, 2012, BIOFUELS-UK, V3, P441, DOI [10.4155/BFS.12.29, 10.4155/bfs.12.29]; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; SIMONS J, 1994, NETH J AQUAT ECOL, V28, P25, DOI DOI 10.1007/BF02334242; Vergara JJ, 1998, MAR ECOL PROG SER, V165, P283, DOI 10.3354/meps165283; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wigmosta MS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009966; Yee N, 2013, ALGKEY WEBSITE INTER	47	51	51	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64168	10.1371/journal.pone.0064168	http://dx.doi.org/10.1371/journal.pone.0064168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717561	gold, Green Published, Green Accepted			2022-12-25	WOS:000320362700113
J	Liccardo, A; Fierro, A				Liccardo, Antonella; Fierro, Annalisa			A Lattice Model for Influenza Spreading	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SOCIAL CONTACTS; EPIDEMICS; PERCOLATION; NETWORK; STRATEGIES; DYNAMICS; PATTERNS	We construct a stochastic SIR model for influenza spreading on a D-dimensional lattice, which represents the dynamic contact network of individuals. An age distributed population is placed on the lattice and moves on it. The displacement from a site to a nearest neighbor empty site, allows individuals to change the number and identities of their contacts. The dynamics on the lattice is governed by an attractive interaction between individuals belonging to the same age-class. The parameters, which regulate the pattern dynamics, are fixed fitting the data on the age-dependent daily contact numbers, furnished by the Polymod survey. A simple SIR transmission model with a nearest neighbors interaction and some very basic adaptive mobility restrictions complete the model. The model is validated against the age-distributed Italian epidemiological data for the influenza A(H1N1) during the 2009/2010 season, with sensible predictions for the epidemiological parameters. For an appropriate topology of the lattice, we find that, whenever the accordance between the contact patterns of the model and the Polymod data is satisfactory, there is a good agreement between the numerical and the experimental epidemiological data. This result shows how rich is the information encoded in the average contact patterns of individuals, with respect to the analysis of the epidemic spreading of an infectious disease.	[Liccardo, Antonella; Fierro, Annalisa] Univ Naples Federico II, Dept Phys, Naples, Italy; [Liccardo, Antonella] INFN, Sez Napoli, Naples, Italy; [Fierro, Annalisa] CNR, Inst Superconductors Oxides & Other Innovat Mat &, I-80125 Naples, Italy	University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR)	Liccardo, A (corresponding author), Univ Naples Federico II, Dept Phys, Naples, Italy.	liccardo@na.infn.it	Fierro, Annalisa/G-8479-2013	Fierro, Annalisa/0000-0001-8431-942X	University of Naples - Physics Department, CNR-SPIN; MIUR; Italian Super Computing Resource Allocation - ISCRA	University of Naples - Physics Department, CNR-SPIN; MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Super Computing Resource Allocation - ISCRA	This work was supported by the University of Naples - Physics Department, CNR-SPIN. This work is partially supported by MIUR-PRIN-2009 and Italian Super Computing Resource Allocation - ISCRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; BERG BA, 1992, PHYS REV LETT, V68, P9, DOI 10.1103/PhysRevLett.68.9; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cugliandolo LF, 2010, PHYSICA A, V389, P4360, DOI 10.1016/j.physa.2009.12.036; de Souza DR, 2010, PHYSICA A, V389, P1142, DOI 10.1016/j.physa.2009.10.039; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fierro A, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11011-2; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Masuda N, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031917; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; MERLER S, 2009, P ROYAL SOC B; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Ochab JK, 2011, EUR PHYS J B, V81, P373, DOI 10.1140/epjb/e2011-10975-6; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Saramaki J, 2005, J THEOR BIOL, V234, P413, DOI 10.1016/j.jtbi.2004.12.003; SWENDSEN RH, 1987, PHYS REV LETT, V58, P86, DOI 10.1103/PhysRevLett.58.86; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; Zhu CP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218702	47	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63935	10.1371/journal.pone.0063935	http://dx.doi.org/10.1371/journal.pone.0063935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717512	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700081
J	Minneci, F; Piovesan, D; Cozzetto, D; Jones, DT				Minneci, Federico; Piovesan, Damiano; Cozzetto, Domenico; Jones, David T.			FFPred 2.0: Improved Homology-Independent Prediction of Gene Ontology Terms for Eukaryotic Protein Sequences	PLOS ONE			English	Article							ANNOTATION; GLYCOSYLATION; DATABASE	To understand fully cell behaviour, biologists are making progress towards cataloguing the functional elements in the human genome and characterising their roles across a variety of tissues and conditions. Yet, functional information -either experimentally validated or computationally inferred by similarity -remains completely missing for approximately 30% of human proteins. FFPred was initially developed to bridge this gap by targeting sequences with distant or no homologues of known function and by exploiting clear patterns of intrinsic disorder associated with particular molecular activities and biological processes. Here, we present an updated and improved version, which builds on larger datasets of protein sequences and annotations, and uses updated component feature predictors as well as revised training procedures. FFPred 2.0 includes support vector regression models for the prediction of 442 Gene Ontology (GO) terms, which largely expand the coverage of the ontology and of the biological process category in particular. The GO term list mainly revolves around macromolecular interactions and their role in regulatory, signalling, developmental and metabolic processes. Benchmarking experiments on newly annotated proteins show that FFPred 2.0 provides more accurate functional assignments than its predecessor and the ProtFun server do; also, its assignments can complement information obtained using BLAST-based transfer of annotations, improving especially prediction in the biological process category. Furthermore, FFPred 2.0 can be used to annotate proteins belonging to several eukaryotic organisms with a limited decrease in prediction quality. We illustrate all these points through the use of both precision-recall plots and of the COGIC scores, which we recently proposed as an alternative numerical evaluation measure of function prediction accuracy.	[Minneci, Federico; Cozzetto, Domenico; Jones, David T.] UCL, Dept Comp Sci, Bioinformat Grp, London, England; [Piovesan, Damiano] Univ Bologna, Dept Biol, Biocomp Grp, I-40126 Bologna, Italy	University of London; University College London; University of Bologna	Jones, DT (corresponding author), UCL, Dept Comp Sci, Bioinformat Grp, London, England.	d.t.jones@ucl.ac.uk	Piovesan, Damiano/H-4675-2016; Cozzetto, Domenico/Y-6345-2019; Piovesan, Damiano/K-7647-2019	Piovesan, Damiano/0000-0001-8210-2390; Piovesan, Damiano/0000-0001-8210-2390; Cozzetto, Domenico/0000-0001-6752-5432	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I023992/1, BB/J002925/1]; Ministry of the Italian University and Research; Marie Curie Intra European Fellowship [PIEF-GA-2009-237292]; Biotechnology and Biological Sciences Research Council [BB/J002925/1, BB/I023992/1] Funding Source: researchfish; BBSRC [BB/I023992/1, BB/J002925/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of the Italian University and Research; Marie Curie Intra European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	FM & DTJ would like to acknowledge support from the United Kingdom Biotechnology and Biological Sciences Research Council (Reference BB/I023992/1). DP is a recipient of a PHD fellowship from the Ministry of the Italian University and Research. DC would like to acknowledge partial support from the United Kingdom Biotechnology and Biological Sciences Research Council (Reference BB/J002925/1) and from a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (Grant Agreement Number: PIEF-GA-2009-237292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cozzetto D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; JOACHIMS T, 1999, MAKING LARGE SCALE S; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Juncker AS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-206; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platt JC, 2000, ADV NEUR IN, P61; RADIVOJAC P, 2013, NAT METH; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Theodoridis S, 2008, PATTERN RECOGN, P119; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wilkins AD, 2012, CURR OPIN STRUC BIOL, V22, P316, DOI 10.1016/j.sbi.2012.05.001	34	37	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63754	10.1371/journal.pone.0063754	http://dx.doi.org/10.1371/journal.pone.0063754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717476	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700054
J	Pauli, BP; McCann, NP; Zollner, PA; Cummings, R; Gilbert, JH; Gustafson, EJ				Pauli, Benjamin P.; McCann, Nicholas P.; Zollner, Patrick A.; Cummings, Robert; Gilbert, Jonathan H.; Gustafson, Eric J.			SEARCH: Spatially Explicit Animal Response to Composition of Habitat	PLOS ONE			English	Article							LEVEL PERCEPTUAL ABILITIES; ELK CERVUS-ELAPHUS; WHITE-FOOTED MICE; PREDATION RISK; POPULATION-DYNAMICS; LANDSCAPE HETEROGENEITY; DISPERSAL MOVEMENTS; TEMPORAL VARIATION; EASTERN CHIPMUNK; BEHAVIOR	Complex decisions dramatically affect animal dispersal and space use. Dispersing individuals respond to a combination of fine-scale environmental stimuli and internal attributes. Individual-based modeling offers a valuable approach for the investigation of such interactions because it combines the heterogeneity of animal behaviors with spatial detail. Most individual-based models (IBMs), however, vastly oversimplify animal behavior and such behavioral minimalism diminishes the value of these models. We present program SEARCH (Spatially Explicit Animal Response to Composition of Habitat), a spatially explicit, individual-based, population model of animal dispersal through realistic landscapes. SEARCH uses values in Geographic Information System (GIS) maps to apply rules that animals follow during dispersal, thus allowing virtual animals to respond to fine-scale features of the landscape and maintain a detailed memory of areas sensed during movement. SEARCH also incorporates temporally dynamic landscapes so that the environment to which virtual animals respond can change during the course of a simulation. Animals in SEARCH are behaviorally dynamic and able to respond to stimuli based upon their individual experiences. Therefore, SEARCH is able to model behavioral traits of dispersing animals at fine scales and with many dynamic aspects. Such added complexity allows investigation of unique ecological questions. To illustrate SEARCH's capabilities, we simulated case studies using three mammals. We examined the impact of seasonally variable food resources on the weight distribution of dispersing raccoons (Procyon lotor), the effect of temporally dynamic mortality pressure in combination with various levels of behavioral responsiveness in eastern chipmunks (Tamias striatus), and the impact of behavioral plasticity and home range selection on disperser mortality and weight change in virtual American martens (Martes americana). These simulations highlight the relevance of SEARCH for a variety of applications and illustrate benefits it can provide for conservation planning.	[Pauli, Benjamin P.; McCann, Nicholas P.; Zollner, Patrick A.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [McCann, Nicholas P.] Minnesota Zoo, Apple Valley, MN USA; [Cummings, Robert] Rancho Deluxe Consulting, Stevens Point, WI USA; [Gilbert, Jonathan H.] Great Lakes Indian Fish & Wildlife Commiss, Odanah, WI USA; [Gustafson, Eric J.] US Forest Serv, USDA, No Res Stn, Rhinelander, WI USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service	Pauli, BP (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	bpauli@purdue.edu	Zollner, Patrick A/A-8727-2010	Zollner, Patrick A/0000-0001-8263-7029	Purdue University; USFS Chief's Award [USFS RJVA 06-JV-11231300-0361]	Purdue University; USFS Chief's Award	Funding was provided by Purdue University and a USFS Chief's Award given to Pat Zollner via USFS RJVA 06-JV-11231300-0361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN E. G., 1938, NEW YORK STATE MUS BULL, V314, P1; Altendorf KB, 2001, J MAMMAL, V82, P430, DOI 10.1644/1545-1542(2001)082&lt;0430:AEOPRO&gt;2.0.CO;2; Aune Keith E., 1997, P61; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Batschelet E, 1965, STAT METHODS ANAL PR; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley James C., 2008, Human-Wildlife Conflicts, V2, P248; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; BELTHOFF JR, 1990, CONDOR, V92, P803, DOI 10.2307/1368710; BIDER J R, 1968, Mammalia, V32, P137, DOI 10.1515/mamm.1968.32.2.137; BOLLINGER EK, 1993, ECOLOGY, V74, P1153, DOI 10.2307/1940485; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Bull Evelyn L., 2001, Northwestern Naturalist, V82, P7, DOI 10.2307/3536641; CLARK WR, 1989, J WILDLIFE MANAGE, V53, P982, DOI 10.2307/3809599; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Csada RD, 1996, OIKOS, V76, P591, DOI 10.2307/3546355; DeCoursey PJ, 2000, J COMP PHYSIOL A, V186, P169, DOI 10.1007/s003590050017; Delgado MD, 2008, AM NAT, V172, P475, DOI 10.1086/590964; Devillers J., 2009, ECOTOXICOLOGY MODELI, P205; DOBSON FS, 1985, AM NAT, V126, P855, DOI 10.1086/284457; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Douglas C. W., 1987, WILD FURBEARER MANAG; Dumyahn JB, 2007, AM MIDL NAT, V158, P382, DOI 10.1674/0003-0031(2007)158[382:WHCOAM]2.0.CO;2; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Fritzell E.K., 1984, Prairie Naturalist, V16, P1; FRITZELL EK, 1985, J WILDLIFE MANAGE, V49, P901, DOI 10.2307/3801366; Gardner RH, 2004, ECOL MODEL, V171, P339, DOI 10.1016/j.ecolmodel.2003.08.008; Gehrt SD, 1999, J WILDLIFE MANAGE, V63, P889, DOI 10.2307/3802802; Gilbert JH, 2009, AM MIDL NAT, V162, P327, DOI 10.1674/0003-0031-162.2.327; GLUECK TF, 1988, WILDLIFE SOC B, V16, P6; Gosling LM, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P13; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; HAEFNER JW, 1994, J THEOR BIOL, V166, P299, DOI 10.1006/jtbi.1994.1027; HASBROUCK JJ, 1992, J WILDLIFE MANAGE, V56, P693, DOI 10.2307/3809462; Hasbrouck JJ, 1991, THESIS IOWA STATE U; Heinz SK, 2006, LANDSCAPE ECOL, V21, P77, DOI 10.1007/s10980-005-0148-3; Hernandez L, 2005, WILDLIFE BIOL, V11, P215, DOI 10.2981/0909-6396(2005)11[215:FITLOF]2.0.CO;2; HOLBROOK SJ, 1988, ECOLOGY, V69, P125, DOI 10.2307/1943167; Holland EP, 2007, PLOS COMPUT BIOL, V3, P1979, DOI 10.1371/journal.pcbi.0030200; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; HOWARD WALTER E., 1960, AMER MIDLAND NAT, V63, P152, DOI 10.2307/2422936; Hudgens BR, 2012, ECOL APPL, V22, P1701; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jepsen JU, 2005, ECOL MODEL, V181, P445, DOI 10.1016/j.ecolmodel.2003.11.019; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima Steven L., 1996, P201; Loew SS, 1999, EVOL ECOL, V13, P557, DOI 10.1023/A:1006701909737; LOMNICKI A, 1992, INDIVIDUAL-BASED MODELS AND APPROACHES IN ECOLOGY, P3; Lotze J.-H., 1979, Mammalian Species, P1, DOI 10.2307/3503959; McAdam AG, 1998, ANIM BEHAV, V55, P109, DOI 10.1006/anbe.1997.0592; McCann NP, 2010, J WILDLIFE MANAGE, V74, P1502, DOI 10.2193/2009-297; McCann NP, 2011, THESIS PURDUE U W LA; McLane AJ, 2011, ECOL MODEL, V222, P1544, DOI 10.1016/j.ecolmodel.2011.01.020; MECH LD, 1968, J MAMMAL, V49, P63, DOI 10.2307/1377728; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Mooij WM, 2003, ECOL APPL, V13, P794, DOI 10.1890/1051-0761(2003)013[0794:UISEAD]2.0.CO;2; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2002, ECOLOGY, V83, P2240; Mosillo M, 1999, J WILDLIFE MANAGE, V63, P278, DOI 10.2307/3802510; Nupp TE, 1998, J MAMMAL, V79, P1234, DOI 10.2307/1383014; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Powell R.A., 2012, BIOL CONSERVATION MA, P93, DOI DOI 10.7591/9780801466076-009; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Railsback SF, 2001, ECOL MODEL, V139, P47, DOI 10.1016/S0304-3800(01)00228-9; Rees EE, 2008, ECOL INFORM, V3, P87, DOI 10.1016/j.ecoinf.2008.01.002; Reese HM, 2002, REMOTE SENS ENVIRON, V82, P224, DOI 10.1016/S0034-4257(02)00039-1; Retamosa Monica I., 2008, Human-Wildlife Conflicts, V2, P225; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; RITKE ME, 1990, AM MIDL NAT, V123, P390, DOI 10.2307/2426567; RIVEST P, 1981, CAN J ZOOL, V59, P1755, DOI 10.1139/z81-241; Sagar RG, 1956, THESIS OHIO STATE U; Sanderson G.C., 1981, Proceedings of the Worldwide Furbearer Conference, V1, P487; SAS Institute Inc, 2011, SAS STAT 9 3 USERS G; Schumaker NH, 2011, HEXSIM VERSION 2 3; Selonen V, 2010, LANDSCAPE ECOL, V25, P331, DOI 10.1007/s10980-009-9432-y; SHARP WARD M., 1956, JOUR MAMMAL, V37, P170, DOI 10.2307/1376674; Sih A, 2000, TRENDS ECOL EVOL, V15, P3, DOI 10.1016/S0169-5347(99)01766-8; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; SNYDER D P, 1982, Mammalian Species, P1, DOI 10.2307/3503819; South A, 1999, CONSERV BIOL, V13, P1039, DOI 10.1046/j.1523-1739.1999.98236.x; Stamps JA, 2005, ECOLOGY, V86, P510, DOI 10.1890/04-0516; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Stuewer F. W., 1943, ECOL MONOGR, V13, P203, DOI 10.2307/1943528; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; TRYON CA, 1973, J MAMMAL, V54, P145, DOI 10.2307/1378877; van der Merwe M, 2008, J MAMMAL, V89, P1162, DOI 10.1644/08-MAMM-A-035.1; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; Williams BW, 2007, HIST PERSPECTIVE REI; Woodford J.E., 2011, CONSERVATION MANAGEM; Woodroffe R, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P33; Wright J.L., 1999, THESIS U WISCONSIN S; YAHNER RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P397, DOI 10.1007/BF00303202; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; Zollner PA, 1999, ANIM BEHAV, V58, P489, DOI 10.1006/anbe.1999.1186; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	117	18	18	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64656	10.1371/journal.pone.0064656	http://dx.doi.org/10.1371/journal.pone.0064656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717647	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700165
J	Penacchio, O; Otazu, X; Dempere-Marco, L				Penacchio, Olivier; Otazu, Xavier; Dempere-Marco, Laura			A Neurodynamical Model of Brightness Induction in V1	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL-FREQUENCY CHANNELS; CORTICAL NETWORK MODEL; UP SALIENCY MAP; CONTEXTUAL INFLUENCES; GRATING-INDUCTION; WORKING-MEMORY; INTRACORTICAL INTERACTIONS; NEURAL DYNAMICS; CONTRAST	Brightness induction is the modulation of the perceived intensity of an area by the luminance of surrounding areas. Recent neurophysiological evidence suggests that brightness information might be explicitly represented in V1, in contrast to the more common assumption that the striate cortex is an area mostly responsive to sensory information. Here we investigate possible neural mechanisms that offer a plausible explanation for such phenomenon. To this end, a neurodynamical model which is based on neurophysiological evidence and focuses on the part of V1 responsible for contextual influences is presented. The proposed computational model successfully accounts for well known psychophysical effects for static contexts and also for brightness induction in dynamic contexts defined by modulating the luminance of surrounding areas. This work suggests that intra-cortical interactions in V1 could, at least partially, explain brightness induction effects and reveals how a common general architecture may account for several different fundamental processes, such as visual saliency and brightness induction, which emerge early in the visual processing pathway.	[Penacchio, Olivier; Otazu, Xavier] Univ Autonoma Barcelona, Comp Vis Ctr, Dept Comp Sci, E-08193 Barcelona, Spain; [Dempere-Marco, Laura] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain	Autonomous University of Barcelona; Centre de Visio per Computador (CVC); Pompeu Fabra University; University of Barcelona	Penacchio, O (corresponding author), Univ Autonoma Barcelona, Comp Vis Ctr, Dept Comp Sci, E-08193 Barcelona, Spain.	penacchio@cvc.uab.cat	Penacchio, Olivier/AAX-5470-2020; Otazu, Xavier/P-6940-2019; Dempere-Marco, Laura/ABH-5264-2020; Otazu, Xavier/A-1208-2009	Penacchio, Olivier/0000-0002-1544-2405; Otazu, Xavier/0000-0002-4982-791X; Otazu, Xavier/0000-0002-4982-791X; Dempere-Marco, Laura/0000-0003-2602-1902	Spanish Ministry of Science and Innovation [TIN2010-21771-C02-01, TIN2010-21771-C02-02]; Spanish Ministry of Science and Innovation through the research project Consolider Ingenio [CSD 2007-00018]; Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation through the research project Consolider Ingenio; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research has been partially supported by the Spanish Ministry of Science and Innovation through the research projects TIN2010-21771-C02-01 and TIN2010-21771-C02-02. OP is supported by the Spanish Ministry of Science and Innovation through the research project Consolider Ingenio (CSD 2007-00018). LDM is a Ramon y Cajal Fellow and acknowledges funding from the Ministry of Science and Innovation through this program. No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Blakeslee B, 2004, VISION RES, V44, P2483, DOI 10.1016/j.visres.2004.05.015; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; Blakeslee B, 1997, VISION RES, V37, P2849, DOI 10.1016/S0042-6989(97)00086-2; Blakeslee B, 2013, VISION RES, V78, P39, DOI 10.1016/j.visres.2012.12.007; Blakeslee B, 2012, VISION RES, V60, P40, DOI 10.1016/j.visres.2012.03.006; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Coen-Cagli R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002405; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cornelissen FW, 2006, J NEUROSCI, V26, P3634, DOI 10.1523/JNEUROSCI.4382-05.2006; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; D'Zmura M, 1999, COLOR VISION GENES P, P369; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; Dempere-Marco L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042719; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; GROSSBERG S, 1987, COMPUT VISION GRAPH, V37, P116, DOI 10.1016/S0734-189X(87)80015-4; HEINEMANN EG, 1955, J EXP PSYCHOL, V50, P89, DOI 10.1037/h0040919; HELSON H, 1963, J OPT SOC AM, V53, P179, DOI 10.1364/JOSA.53.000179; Holschneider M., 1990, ONDELETTES 1989; KINGDOM F, 1992, VISION RES, V32, P1565, DOI 10.1016/0042-6989(92)90212-2; Kingdom F, 1997, PERCEPTION, V26, P673, DOI 10.1068/p260673; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Koene AR, 2007, J VISION, V7, DOI 10.1167/7.7.6; Li Z, 2003, J PHYSIOL-PARIS, V4-6, P503; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; MCCOURT ME, 1982, VISION RES, V22, P119, DOI 10.1016/0042-6989(82)90173-0; McCourt ME, 2004, NEUROREPORT, V15, P49, DOI 10.1097/00001756-200401190-00011; Otazu X, 2008, VISION RES, V48, P733, DOI 10.1016/j.visres.2007.12.008; Pereverzeva M, 2008, J VISION, V8, DOI 10.1167/8.15.8; PESSOA L, 1995, VISION RES, V35, P2201, DOI 10.1016/0042-6989(94)00313-0; Reynaud A, 2012, J NEUROSCI, V32, P12558, DOI 10.1523/JNEUROSCI.1618-12.2012; Robinson AE, 2007, VISION RES, V47, P1631, DOI 10.1016/j.visres.2007.02.017; Rolls ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061078; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SAGI D, 1985, PERCEPT PSYCHOPHYS, V37, P315, DOI 10.3758/BF03211354; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Singer B, 1998, COLOR VISION PERSPEC, P251; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Teichert T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-38; TOLHURST DJ, 1978, VISION RES, V18, P951, DOI 10.1016/0042-6989(78)90023-8; van de Ven V, 2012, J COGNITIVE NEUROSCI, V24, P367, DOI 10.1162/jocn_a_00126; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062	54	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64086	10.1371/journal.pone.0064086	http://dx.doi.org/10.1371/journal.pone.0064086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717536	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700098
J	Song, ZC; Yang, Z; Yang, JJ; Liu, ZN; Peng, ZY; Tang, R; Gu, Y				Song, Zhicheng; Yang, Zhi; Yang, Jianjun; Liu, Zhengni; Peng, Zhiyou; Tang, Rui; Gu, Yan			Repair of Abdominal Wall Defects In Vitro and In Vivo Using VEGF Sustained-Release Multi-Walled Carbon Nanotubes (MWNT) Composite Scaffolds	PLOS ONE			English	Article							ACELLULAR DERMAL MATRIX; INTESTINE SUBMUCOSA; POLYPROPYLENE MESH; RECEPTOR; NANOPARTICLES; MECHANISMS; IMPLANT; GRAFTS; STENT; PLGA	Objective: Porcine acellular dermal matrices (ADM) have been widely used in experimental and clinical research for abdominal wall repair. Compared to porcine small intestinal submucosa (SIS), the effect of these matrices on the regenerative capacity of blood vessels is still not ideal. Multi-walled carbon nanotubes (MWNTs) can more effectively transport VEGF to cells or tissues because of their large specific surface area and interior cavity. In this study, we explored the safety and efficacy of implanted VEGF-loaded MWNT composite scaffolds in vitro and vivo to repair abdominal wall defects. Materials and Methods: VEGF-loaded MWNTs were prepared by a modified plasma polymerization treatment. Four composite scaffolds were evaluated for cytotoxicity, proliferation, and release dynamics. We created 3 cm x 4 cm abdominal wall defects in 43 Sprague-Dawley rats. After implantation times of 2, 4, 8, and 12 weeks, the scaffolds and the surrounding tissues were collected and examined by gross inspection, biomechanical testing, and histological examination. Results: A 5-10 nm poly(lactic-co-glycolic acid) (PLGA) film was evenly distributed on MWNTs. The 3% MWNT composite group showed lower cytotoxicity and appropriate release performance, and it was thus tested in vivo. In rats with the 3% composite implanted, host cells were prevented from migrating to the ADM at 2 weeks, vascularization was established more rapidly at 12 weeks, and the values for both the maximum load and the elastic modulus were significantly lower than in the ADM-alone group (p<0.01). Histological staining revealed that the MWNT was still not completely eliminated 12 weeks after implantation. Conclusion: MWNTs were able to carry VEGF to cells or tissues, and the 3% MWNT composite material showed lower cytotoxicity and had an appropriate release performance, which prompted faster vascularization of the ADM than other scaffolds. Nevertheless, the MWNTs induced harmful effects that should be carefully considered in biomedical studies.	[Song, Zhicheng; Yang, Zhi; Yang, Jianjun; Liu, Zhengni; Peng, Zhiyou; Tang, Rui; Gu, Yan] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Hernia & Abdominal Wall Surg Ctr, Dept Gen Surg,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Gu, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Hernia & Abdominal Wall Surg Ctr, Dept Gen Surg,Sch Med, Shanghai 200030, Peoples R China.	yangu@sjtu.edu.cn	Gu, Yan/AFQ-1163-2022; yang, jian/HIK-0188-2022	liu, zhengni/0000-0002-7262-2568	National Natural Science Foundation of China [81270444]; Shanghai Hospital Development Center [SHDC12010204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Hospital Development Center	This work was supported by a grant from the National Natural Science Foundation of China (Grant No: 81270444) and Shanghai Hospital Development Center (Grant No: SHDC12010204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvang E, 2005, BRIT J ANAESTH, V95, P69, DOI 10.1093/bja/aei019; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Antoniadou EV, 2010, IEEE ENG MED BIO, P815, DOI 10.1109/IEMBS.2010.5626760; Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chen BD, 2010, J MATER CHEM, V20, P9895, DOI 10.1039/c0jm00594k; Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018; Cobb GA, 2005, INT SURG, V90, pS24; Colognato R, 2008, MUTAGENESIS, V23, P377, DOI 10.1093/mutage/gen024; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130; Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028; Espinosa-De-Los-Monteros A, 2007, ANN PLAS SURG, V58, P264, DOI 10.1097/01.sap.0000254410.91132.a8; FELIXLANAO R, 2013, TISSUE ENG B; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Guo DG, 2007, J BIOMED MATER RES B, V82B, P533, DOI 10.1002/jbm.b.30759; Hu XF, 2012, BIOMATERIALS, V33, P8082, DOI 10.1016/j.biomaterials.2012.07.057; Jacob BP, 2007, SURG ENDOSC, V21, P629, DOI 10.1007/s00464-006-9157-9; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Kim H, 2006, AM J SURG, V192, P705, DOI 10.1016/j.amjsurg.2006.09.003; Kolosnjaj J, 2007, ADV EXP MED BIOL, V620, P181; Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378; Lee Y, 2010, ADV MATER, V22, P4076, DOI 10.1002/adma.201000746; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li XJ, 2008, METHOD ENZYMOL, V443, P261, DOI 10.1016/S0076-6879(08)02013-2; Liu H, 2006, J BIOMED MATER RES A, V78A, P798, DOI 10.1002/jbm.a.30734; Liu ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020520; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021; Perlstein I, 2003, GENE THER, V10, P1420, DOI 10.1038/sj.gt.3302043; Rao KDM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/7/075301; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Shi DL, 2003, APPL PHYS LETT, V83, P5301, DOI 10.1063/1.1636521; Shi DL, 2007, ADV MATER, V19, P4033, DOI 10.1002/adma.200700035; Shi XT, 2009, ACTA BIOMATER, V5, P1697, DOI 10.1016/j.actbio.2009.01.010; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Silverman RP, 2011, AESTHET SURG J, V31, p24S, DOI 10.1177/1090820X11418090; Soiderer EE, 2004, J SURG RES, V118, P161, DOI 10.1016/S0022-4804(03)00352-4; SONG Z, 2013, TISSUE ENG A; Stacey Michael, 2011, Biomed Mater, V6, P011002, DOI 10.1088/1748-6041/6/1/011002; Tan MY, 2009, BIOMATERIALS, V30, P3234, DOI 10.1016/j.biomaterials.2009.02.013; Thapa PB, 2009, J NEPAL MED ASSOC, V48, P168, DOI 10.31729/jnma.238; WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036; Wang XT, 2006, BIOMATERIALS, V27, P5588, DOI 10.1016/j.biomaterials.2006.07.016; Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e; Zhang J, 2011, BIOMATERIALS, V32, P7086, DOI 10.1016/j.biomaterials.2011.06.016; Zhong T, 2011, J PLAST RECONSTR AES, V64, P1562, DOI 10.1016/j.bjps.2011.04.035	52	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64358	10.1371/journal.pone.0064358	http://dx.doi.org/10.1371/journal.pone.0064358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717603	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700143
J	de Souza, CRT; Leal, MF; Calcagno, DQ; Sozinho, EKC; Borges, BD; Montenegro, RC; dos Santos, AKCR; dos Santos, SEB; Ribeiro, HF; Assumpcao, PP; Smith, MDC; Burbano, RR				Teixeira de Souza, Carolina Rosal; Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Costa Sozinho, Eliana Kelly; Borges, Barbara do Nascimento; Montenegro, Raquel Carvalho; Campos Ribeiro dos Santos, Andrea Kely; Batista dos Santos, Sidney Emanuel; Ribeiro, Helem Ferreira; Assumpcao, Paulo Pimentel; Cardoso Smith, Marilia de Arruda; Burbano, Rommel Rodriguez			MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; EPSTEIN-BARR-VIRUS; C-MYC; DNA METHYLATION; NORTHERN BRAZIL; COLORECTAL-CANCER; CELL-LINE; CYTOGENETIC CHARACTERIZATION; NUMERICAL ABERRATIONS; GENE AMPLIFICATION	Our study investigated the relationship between MYC alterations and clinicopathological features in gastric cancers. We evaluated the effect of MYC mRNA expression and its protein immunoreactivity, as well as copy number variation, promoter DNA methylation, and point mutations, in 125 gastric adenocarcinoma and 67 paried non-neoplastic tissues. We observed that 77% of the tumors presented MYC immunoreactivity which was significantly associated with increased mRNA expression (p < 0.05). These observations were associated with deeper tumor extension and the presence of metastasis (p < 0.05). MYC protein expression was also more frequently observed in intestinal-type than in diffuse-type tumors (p < 0.001). Additionally, MYC mRNA and protein expression were significantly associated with its copy number (p < 0.05). The gain of MYC copies was associated with late-onset, intestinal-type, advanced tumor stage, and the presence of distant metastasis (p < 0.05). A hypomethylated MYC promoter was detected in 86.4% of tumor samples. MYC hypomethylation was associated with diffuse-type, advanced tumor stage, deeper tumor extension, and the presence of lymph node metastasis (p < 0.05). Moreover, eighteen tumor samples presented at least one known mutation. The presence of MYC mutations was associated with diffuse-type tumor (p < 0.001). Our results showed that MYC deregulation was mainly associated with poor prognostic features and also reinforced the presence of different pathways involved in intestinal-type and diffuse-type gastric carcinogenesis. Thus, our findings suggest that MYC may be a useful marker for clinical stratification and prognosis.	[Teixeira de Souza, Carolina Rosal; Costa Sozinho, Eliana Kelly; Borges, Barbara do Nascimento; Montenegro, Raquel Carvalho; Ribeiro, Helem Ferreira; Burbano, Rommel Rodriguez] Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil; [Leal, Mariana Ferreira] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, Brazil; [Calcagno, Danielle Queiroz; Cardoso Smith, Marilia de Arruda] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, Brazil; [Campos Ribeiro dos Santos, Andrea Kely; Batista dos Santos, Sidney Emanuel] Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Assumpcao, Paulo Pimentel] Fed Univ Para, Nucleo Pesquisa Oncol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Universidade Federal do Para	de Souza, CRT (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil.	carolrosalts@gmail.com	Leal, Mariana/C-4010-2012; Burbano, Rommel R/C-4149-2012; Souza, Carolina Rosal Teixeira/ABF-8886-2021; Montenegro, Raquel/I-1260-2013; Borges, Barbara N/G-1355-2012; Santos, Ândrea Ribeiro dos/B-6061-2013; de A. C. Smith, Marilia/C-4397-2012; Ribeiro, Helem F/A-1692-2015; Ribeiro, Helem/AAC-1391-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019	Leal, Mariana/0000-0003-4375-2563; Burbano, Rommel R/0000-0002-4872-234X; Souza, Carolina Rosal Teixeira/0000-0002-5123-9025; Montenegro, Raquel/0000-0002-3861-293X; Borges, Barbara N/0000-0002-5989-8287; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; de A. C. Smith, Marilia/0000-0002-1441-1033; Ribeiro, Helem F/0000-0002-4798-6183; Ribeiro, Helem/0000-0002-4798-6183; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are thankful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; CRTdS, AKCRdS, SEBdS, RRB and MdACS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; DQC and MFL) that support this study as grants and fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2011, AM J CANCER RES, V1, P413; Assumpcao PP, 2006, CANCER GENET CYTOGEN, V169, P45, DOI 10.1016/j.cancergencyto.2006.03.019; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borges BD, 2010, ANTICANCER RES, V30, P2225; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2010, CANCER GENET CYTOGEN, V202, P63, DOI 10.1016/j.cancergencyto.2010.05.020; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Calcagno DQ, 2005, ANTICANCER RES, V25, P4069; Chang MS, 2006, CLIN CANCER RES, V12, P2995, DOI 10.1158/1078-0432.CCR-05-1601; CORREA P, 1992, CANCER RES, V52, P6735; DALLAFAVERA R, 1982, NATURE, V299, P61; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; De Smet C, 2013, ADV EXP MED BIOL, V754, P149, DOI 10.1007/978-1-4419-9967-2_7; Du YP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-261; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Fang JY, 2004, WORLD J GASTROENTERO, V10, P3394; Fang JY, 1997, J GASTROENTEROL, V32, P171, DOI 10.1007/BF02936363; Fang JY, 1996, J GASTROEN HEPATOL, V11, P1079, DOI 10.1111/j.1440-1746.1996.tb00040.x; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; da Costa JDFB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021988; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Guimaraes AC, 2006, CLIN EXP MED, V6, P129, DOI 10.1007/s10238-006-0108-5; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/631268; Leal MF, 2009, CANCER GENET CYTOGEN, V195, P85, DOI 10.1016/j.cancergencyto.2009.04.020; Li F, 2012, ASIAN PAC J CANCER P, V13, P2593, DOI 10.7314/APJCP.2012.13.6.2593; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Liu XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029670; Liu Y, 2013, DIAGN CYTOPATHOL, V41, P515, DOI 10.1002/dc.22879; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Mehndiratta M, 2011, MOL PHARMACEUT, V8, P2302, DOI 10.1021/mp200177z; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nardone G, 2003, ALIMENT PHARM THER, V17, P75, DOI 10.1046/j.1365-2036.17.s2.10.x; Papaggeli P C, 2003, J BUON, V8, P341; Park KU, 2009, CLIN CHEM LAB MED, V47, P530, DOI 10.1515/CCLM.2009.126; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raiol LCC, 2008, CANCER GENET CYTOGEN, V181, P31, DOI 10.1016/j.cancergencyto.2007.10.011; Ribeiro HF, 2010, BRAZ J MED BIOL RES, V43, P717, DOI 10.1590/S0100-879X2010007500068; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; SHARRARD RM, 1992, BRIT J CANCER, V65, P667, DOI 10.1038/bjc.1992.142; Shen L, 1997, Zhonghua Zhong Liu Za Zhi, V19, P173; SHIBATA D, 1993, CANCER EPIDEM BIOMAR, V2, P213; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Sobin, 2009, UICC TNM CLASSIFICAT; Stamouli MI, 2002, CANCER GENET CYTOGEN, V135, P23, DOI 10.1016/S0165-4608(01)00635-5; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Tahara Eiichi, 2004, IARC Sci Publ, P327; Tsai KW, 2011, EPIGENETICS-US, V6, P1189, DOI 10.4161/epi.6.10.16535; Tuupanen S, 2012, CANCER GENET-NY, V205, P25, DOI 10.1016/j.cancergen.2012.01.005; Weng YR, 2006, WORLD J GASTROENTERO, V12, P7591, DOI 10.3748/wjg.v12.i47.7591; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhang D, 2011, J SURG ONCOL, V103, P124, DOI 10.1002/jso.21792; Zhao Ye, 2010, Chin J Cancer, V29, P752	68	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64420	10.1371/journal.pone.0064420	http://dx.doi.org/10.1371/journal.pone.0064420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717612	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700146
J	Yadav, S; Sehrawat, A; Eroglu, Z; Somlo, G; Hickey, R; Yadav, S; Liu, XL; Awasthi, YC; Awasthi, S				Yadav, Sushma; Sehrawat, Archana; Eroglu, Zeynep; Somlo, George; Hickey, Robert; Yadav, Sailee; Liu, Xueli; Awasthi, Yogesh C.; Awasthi, Sanjay			Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN RLIP76; RAD21 GENE; COHESIN; EXPRESSION; PROTEIN; IDENTIFICATION; CHROMOSOME; PROGNOSIS; TRANSPORT	Triple-negative breast cancer (TNBC) is one of the hardest subtypes of breast cancer to treat due to the heterogeneity of the disease and absence of well-defined molecular targets. Emerging evidence has shown the role of cohesin in the formation and progression of various cancers including colon and lung cancer but the role of cohesin in breast cancer remains elusive. Our data showed that structural maintenance of chromosome 1 (SMC1), a subunit of the cohesin protein complex, is differentially overexpressed both at RNA and protein level in a panel of TNBC cell lines as compared to normal epithelial or luminal breast cancer cells, suggesting that the amplified product of this normal gene may play role in tumorigenesis in TNBC. In addition, our results show that induced overexpression of SMC1 through transient transfection enhanced cell migration and anchorage independent growth while its suppression with targeted small interfering RNA (siRNA) reduced the migration ability of TNBC cells. Increased expression of SMC1 also lead to increase in the mesenchymal marker vimentin and decrease in the normal epithelial marker, E-cadherin. Immunocytochemical studies along with flow cytometry and cell fractionation showed the localization of SMC1 in the nucleus, cytoplasm and also in the plasma membrane. The knockdown of SMC1 by siRNA sensitized the TNBC cells towards a PARP inhibitor (ABT-888) and IC50 was approximately three fold less than ABT-888 alone. The cytotoxic effect of combination of SMC1 suppression and ABT-888 was also confirmed by the colony propagation assay. Taken together, these studies report for the first time that SMC1 is overexpressed in TNBC cells where it plays a role in cell migration and drug sensitivity, and thus provides a potential therapeutic target for this highly invasive breast cancer subtype.	[Yadav, Sushma; Yadav, Sailee; Awasthi, Sanjay] City Hope Comprehens Canc Ctr, Dept Diabet Endocrinol & Metab Dis, Duarte, CA USA; [Sehrawat, Archana; Awasthi, Yogesh C.] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA; [Eroglu, Zeynep; Somlo, George; Awasthi, Sanjay] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA; [Hickey, Robert] City Hope Natl Med Ctr, Beckman Res Inst, Div Radiat Biol, Duarte, CA 91010 USA; [Liu, Xueli] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA	City of Hope; University of North Texas System; University of North Texas Health Science Center; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Yadav, S (corresponding author), City Hope Comprehens Canc Ctr, Dept Diabet Endocrinol & Metab Dis, Duarte, CA USA.	syadav@coh.org	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717	Cancer Research Foundation of North Texas; National Cancer Institute of the National Institutes of Health [P30CA033572, R01CA077495]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA077495] Funding Source: NIH RePORTER	Cancer Research Foundation of North Texas; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Cancer Research Foundation of North Texas (SY). Research reported in this publication was also supported by the National Cancer Institute of the National Institutes of Health under grant numbers P30CA033572 and R01CA077495. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Atienza JM, 2005, MOL CANCER THER, V4, P361; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Brouckaert O, 2012, INT J WOMENS HEALTH, V4, P511, DOI 10.2147/IJWH.S18541; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; CHU QD, 2012, INT J BREAST CANC, V12, P671; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Couchman JR, 1996, J BIOL CHEM, V271, P9595, DOI 10.1074/jbc.271.16.9595; Ghiselli G, 2003, J BIOL CHEM, V278, P20259, DOI 10.1074/jbc.M209511200; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Hagemann C, 2011, INT J MOL MED, V27, P39, DOI 10.3892/ijmm.2010.551; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hopfner KP, 2003, CURR BIOL, V13, pR866, DOI 10.1016/j.cub.2003.10.045; Isakoff SJ, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.1019; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu HY, 2012, ANTICANCER RES, V32, P1627; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; McLellan JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002574; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; O'Shaughnessy J, 2009, J CLIN ONCOL, V27; Ossovskaya Valeria, 2011, Genes Cancer, V2, P870, DOI 10.1177/1947601911432496; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sehrawat A, 2013, BIOCHEM PHARMACOL, V85, P1203, DOI 10.1016/j.bcp.2013.02.012; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Singhal SS, 2008, J BIOL CHEM, V283, P19714, DOI 10.1074/jbc.M708703200; Singhal SS, 2011, MOL CANCER THER, V10, P16, DOI 10.1158/1535-7163.MCT-10-0699; Singhal SS, 2009, CANCER RES, V69, P4244, DOI 10.1158/0008-5472.CAN-08-3521; SOMLO G, 2012, J CLIN ONCOL S, V30; Stebbing Justin, 2012, Br J Nurs, V21, pS18; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; Tentori L, 2005, PHARMACOL RES, V52, P25, DOI 10.1016/j.phrs.2005.02.010; Thompson AM, 2012, CELL CYCLE, V11, P1487, DOI 10.4161/cc.20049; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Walsh SB, 2011, MOL CARCINOGEN, V50, P516, DOI 10.1002/mc.20744; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wu RR, 1997, J CELL BIOL, V136, P433, DOI 10.1083/jcb.136.2.433; Xu HL, 2011, NAT REV CANCER, V11, P199, DOI 10.1038/nrc3018; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Yadav S, 2004, BIOCHEMISTRY-US, V43, P16243, DOI 10.1021/bi0482811; Yadav S, 2009, BIOCHEM PHARMACOL, V77, P1635, DOI 10.1016/j.bcp.2009.02.019; Yamamoto G, 2006, VIRCHOWS ARCH, V448, P435, DOI 10.1007/s00428-005-0132-y; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	51	19	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e64338	10.1371/journal.pone.0064338	http://dx.doi.org/10.1371/journal.pone.0064338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717600	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700140
J	Miyasaki, Y; Rabenstein, JD; Rhea, J; Crouch, ML; Mocek, UM; Kittell, PE; Morgan, MA; Nichols, WS; Van Benschoten, MM; Hardy, WD; Liu, GY				Miyasaki, Yoko; Rabenstein, John D.; Rhea, Joshua; Crouch, Marie-Laure; Mocek, Ulla M.; Kittell, Patricia Emmett; Morgan, Margie A.; Nichols, Wesley Stephen; Van Benschoten, M. M.; Hardy, William David; Liu, George Y.			Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							INFECTIONS; PLATE	The number of fully active antibiotic options that treat nosocomial infections due to multidrug-resistant Acinetobacter baumannii (A. baumannii) is extremely limited. Magnolia officinalis, Mahonia bealei, Rabdosia rubescens, Rosa rugosa, Rubus chingii, Scutellaria baicalensis, and Terminalia chebula plant extracts were previously shown to have growth inhibitory activity against a multidrug-resistant clinical strain of A. baumannii. In this study, the compounds responsible for their antimicrobial activity were identified by fractionating each plant extract using high performance liquid chromatography, and determining the antimicrobial activity of each fraction against A. baumannii. The chemical structures of the fractions inhibiting >40% of the bacterial growth were elucidated by liquid chromatography/mass spectrometry analysis and nuclear magnetic resonance spectroscopy. The six most active compounds were identified as: ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula. The most potent compound was identified as norwogonin with a minimum inhibitory concentration of 128 mg/mL, and minimum bactericidal concentration of 256 mg/mL against clinically relevant strains of A. baumannii. Combination studies of norwogonin with ten anti-Gram negative bacterial agents demonstrated that norwogonin did not enhance the antimicrobial activity of the synthetic antibiotics chosen for this study. In conclusion, of all identified antimicrobial compounds, norwogonin was the most potent against multidrug-resistant A. baumannii strains. Further studies are warranted to ascertain the prophylactic and therapeutic potential of norwogonin for infections due to multidrug-resistant A. baumannii.	[Miyasaki, Yoko; Hardy, William David] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Rabenstein, John D.; Rhea, Joshua; Crouch, Marie-Laure; Mocek, Ulla M.] Albany Mol Res Inc, Bothell Res Ctr, Bothell, WA USA; [Kittell, Patricia Emmett] Cedars Sinai Med Ctr, Dept Patient Financial Serv, Los Angeles, CA 90048 USA; [Morgan, Margie A.; Nichols, Wesley Stephen] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Van Benschoten, M. M.] MM Van Benschoten OMD MA CA & Associates, Canoga Pk, CA USA; [Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Miyasaki, Y (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	yoko.miyasaki@cshs.org	Hardy, W. David/AHD-8960-2022	Rabenstein, John/0000-0002-9702-6586	Cedars-Sinai Medical Center in Los Angeles, California, USA; Cedars-Sinai Medical Center	Cedars-Sinai Medical Center in Los Angeles, California, USA; Cedars-Sinai Medical Center	This research study was funded by Cedars-Sinai Medical Center in Los Angeles, California, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr. M.M. Van Benschoten is a self-employed community-based, private practitioner of oriental medicine. The title of his practice is M. M. Van Benschoten, O.M.D., M.A., C.A. and Associates. As an experienced oriental medicine practitioner, Dr. Van Benschoten helped conceive the experiments conducted in this study and assisted with obtaining the original plant extracts used in the study. For these services, he received consultation fee of $ 3,500 from Cedars-Sinai Medical Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chan BCL, 2011, J ETHNOPHARMACOL, V137, P767, DOI 10.1016/j.jep.2011.06.039; Chusri S, 2009, J ANTIMICROB CHEMOTH, V64, P1203, DOI 10.1093/jac/dkp381; *CLIN LAB STAND I, 2006, METH ANT DIL DISK SU, P16; Clinical and Laboratory Standards Institute, 2009, PERF STAND ANT SUSC, p[46, 100]; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang H, 2010, PLANTA MED, V76, P76, DOI 10.1055/s-0029-1185943; Huang H, 2009, FITOTERAPIA, V80, P448, DOI 10.1016/j.fitote.2009.06.004; Jones WP, 2010, NATURAL PRODUCT ISOL, P323; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Krueger WA, 2002, AM J RESP CRIT CARE, V166, P1029, DOI 10.1164/rccm.2105141; Lu YJ, 2011, J AGR FOOD CHEM, V59, P10934, DOI 10.1021/jf202741x; Mann CM, 1998, J APPL MICROBIOL, V84, P538, DOI 10.1046/j.1365-2672.1998.00379.x; Miyasaki Y, 2012, FEMS MICROBIOL LETT, V328, P26, DOI 10.1111/j.1574-6968.2011.02480.x; Miyasaki Y, 2010, PHYTOTHER RES, V24, P1202, DOI 10.1002/ptr.3113; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Osterburg A, 2009, CLIN MICROBIOL INFEC, V15, P341, DOI 10.1111/j.1469-0691.2009.02710.x; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Smith CF, 1999, J FOOD PROTECT, V62, P1404, DOI 10.4315/0362-028X-62.12.1404; Sukumaran S, 2011, ASIAN PAC J TROP MED, V4, P735, DOI 10.1016/S1995-7645(11)60183-1; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Wu Jing, 2008, Zhong Yao Cai, V31, P707	25	71	78	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e61594	10.1371/journal.pone.0061594	http://dx.doi.org/10.1371/journal.pone.0061594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23724093	Green Published, gold, Green Submitted			2022-12-25	WOS:000317911500050
J	Ghosh, AK; Murphy, SB; Kishore, R; Vaughan, DE				Ghosh, Asish K.; Murphy, Sheila B.; Kishore, Raj; Vaughan, Douglas E.			Global Gene Expression Profiling in PAI-1 Knockout Murine Heart and Kidney: Molecular Basis of Cardiac-Selective Fibrosis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR-BETA; ANKYRIN REPEAT PROTEIN; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; DEFICIENT MICE; TGF-BETA; COMMON; EGR-1; FIBROBLASTS	Fibrosis is defined as an abnormal matrix remodeling due to excessive synthesis and accumulation of extracellular matrix proteins in tissues during wound healing or in response to chemical, mechanical and immunological stresses. At present, there is no effective therapy for organ fibrosis. Previous studies demonstrated that aged plasminogen activator inhibitor-1(PAI-1) knockout mice develop spontaneously cardiac-selective fibrosis without affecting any other organs. We hypothesized that differential expressions of profibrotic and antifibrotic genes in PAI-1 knockout hearts and unaffected organs lead to cardiac selective fibrosis. In order to address this prediction, we have used a genome-wide gene expression profiling of transcripts derived from aged PAI-1 knockout hearts and kidneys. The variations of global gene expression profiling were compared within four groups: wildtype heart vs. knockout heart; wildtype kidney vs. knockout kidney; knockout heart vs. knockout kidney and wildtype heart vs. wildtype kidney. Analysis of illumina-based microarray data revealed that several genes involved in different biological processes such as immune system processing, response to stress, cytokine signaling, cell proliferation, adhesion, migration, matrix organization and transcriptional regulation were affected in hearts and kidneys by the absence of PAI-1, a potent inhibitor of urokinase and tissue-type plasminogen activator. Importantly, the expressions of a number of genes, involved in profibrotic pathways including Ankrd1, Pi16, Egr1, Scx, Timp1, Timp2, Klf6, Loxl1 and Klotho, were deregulated in PAI-1 knockout hearts compared to wildtype hearts and PAI-1 knockout kidneys. While the levels of Ankrd1, Pi16 and Timp1 proteins were elevated during EndMT, the level of Timp4 protein was decreased. To our knowledge, this is the first comprehensive report on the influence of PAI-1 on global gene expression profiling in the heart and kidney and its implication in fibrogenesis and several other biological processes. The significance of these observations in the light of heart-specific profibrotic signaling and fibrogenesis are discussed.	[Ghosh, Asish K.; Murphy, Sheila B.; Kishore, Raj; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ghosh, AK (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	a-ghosh2@northwestern.edu; d-vaughan@northwestern.edu	KUMAR, SUSHIL/T-8493-2017; Bhalla, Kuhulika/A-4297-2014	KUMAR, SUSHIL/0000-0001-8481-9221; Bhalla, Kuhulika/0000-0002-6608-2120; Khanna, Navin/0000-0003-1208-614X; SAMUCHIWAL, SACHIN/0000-0001-6232-5650; Tousif, Sultan/0000-0001-6174-6541	National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI) [1P01HL108795, HL051387, HL091983, HL105597, HL095874, HL053354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051387, R01HL105597, R01HL091983, R01HL053354, P01HL108795, R01HL095874, R37HL053354] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI) (1P01HL108795, HL051387, HL091983, HL105597, HL095874 and HL053354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Du P, 2013, USING LUMI PACKAGE P; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Ellmers LJ, 2010, CURR ENZYME INHIB, V6, P78; Frost RJA, 2007, CIRCULATION, V116, P1768, DOI 10.1161/CIRCULATIONAHA.107.696468; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Ghosh AK, 2010, CURRENT ENZYME INHIB, V6, P54; Ghosh AK, 2012, CELL SIGNAL, V24, P1031, DOI 10.1016/j.cellsig.2011.12.024; Ghosh Asish K, 2012, Front Biosci (Elite Ed), V4, P1556; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Ghosh AK, 2010, CIRCULATION, V122, P1200, DOI 10.1161/CIRCULATIONAHA.110.955245; Heymans S, 2005, AM J PATHOL, V166, P15, DOI 10.1016/S0002-9440(10)62228-6; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; Kardasinski M, 2009, J MOL CELL CARDIOL, V47, P174, DOI 10.1016/j.yjmcc.2009.05.006; Kishore P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000292; Leask A, 2010, CURR ENZYME INHIB, V6, P97; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mastuzaki K, 2010, CURR ENZYME INHIB, V6, P57; Mgbemena V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-409; Micutkova L, 2011, MECH AGEING DEV, V132, P468, DOI 10.1016/j.mad.2011.07.005; Miele L, 2008, GASTROENTEROLOGY, V135, P282, DOI 10.1053/j.gastro.2008.04.004; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Oie E, 2010, SCAND CARDIOVASC J, V44, P359, DOI 10.3109/14017431.2010.511256; Pardo A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S9; PHAN SH, 1987, J LEUKOCYTE BIOL, V42, P106, DOI 10.1002/jlb.42.2.106; Phua YL, 2012, J PATHOL, DOI [10.1002/path.4155, DOI 10.1002/PATH.4155.[]; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Samaras SE, 2012, BIOCHEM BIOPH RES CO, V425, P830, DOI 10.1016/j.bbrc.2012.07.162; SethuNarayanan SR, 2011, INT J HUM GENET, V11, P135, DOI 10.1080/09723757.2011.11886136; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Singh M, 2010, HEART FAIL REV, V15, P487, DOI 10.1007/s10741-010-9158-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK., 2013, LIMMA LINEAR MODELS; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Stoker AW, 1990, CURR OPIN CELL BIOL, V2, P864, DOI 10.1016/0955-0674(90)90085-S; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Yang H.-C., 2010, CURR ENZYM INHIB, V6, P87; Yue X., 2010, CURR ENZYM INHIB, V6, P67, DOI [10.2174/157340810791233033, DOI 10.2174/157340810791233033]; Zhang ZZ, 2007, THESIS; Zirlik A, 2009, THROMB HAEMOSTASIS, V101, P1060, DOI 10.1160/TH08-03-0164	66	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63825	10.1371/journal.pone.0063825	http://dx.doi.org/10.1371/journal.pone.0063825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724005	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000028
J	Chang, CN; Feng, MJ; Chen, YL; Yuan, RH; Jeng, YM				Chang, Chih-Ning; Feng, Mow-Jung; Chen, Yu-Ling; Yuan, Ray-Hwang; Jeng, Yung-Ming			p15(PAF) Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression	PLOS ONE			English	Article							PCNA-ASSOCIATED FACTOR; NUCLEAR ANTIGEN; POOR-PROGNOSIS; OVEREXPRESSION; REPLICATION; EXPRESSION; CARCINOMA; PROMOTER; TARGETS; CANCER	The p15(PAF)/KIAA0101 protein is a proliferating cell nuclear antigen (PCNA)-associated protein overexpressed in multiple types of cancer. Attenuation of p15(PAF) expression leads to modifications in the DNA repair process, rendering cells more sensitive to ultraviolet-induced cell death. In this study, we identified that p15(PAF) expression peaks during the S phase of the cell cycle. We observed that p15(PAF) knockdown markedly inhibited cell proliferation, S-phase progression, and DNA synthesis. Depletion of p15(PAF) resulted in p21 upregulation, especially chromatin-bound p21. We further identified that the p15(PAF) promoter contains 3 E2F-binding motifs. Loss of Rb-mediated transcriptional repression resulted in upregulated p15(PAF) expression. Binding of E2F4 and E2F6 to the p15(PAF) promoter caused transcriptional repression. Overall, these results indicate that p15(PAF) is tightly regulated by the Rb/E2F complex. Loss of Rb/E2F-mediated repression during the G1/S transition phase leads to p15(PAF) upregulation, which facilitates DNA synthesis and S-phase progression.	[Chang, Chih-Ning; Feng, Mow-Jung; Chen, Yu-Ling; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan.	mrna0912@yahoo.com.tw		Yuan, Ray-Hwang/0000-0002-2767-633X; Chiang, Ming-Hui/0000-0002-2106-7963; JENG, YUNG-MING/0000-0002-3878-4491	National Taiwan University Hospital [NTUH-101-S1788]	National Taiwan University Hospital(National Taiwan University)	The work is supported by a grant (NTUH-101-S1788) from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Cheung KJ, 2001, CANCER RES, V61, P4974; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Egelkrout EM, 2002, PLANT CELL, V14, P3225, DOI 10.1105/tpc.006403; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hosokawa M, 2007, CANCER RES, V67, P2568, DOI 10.1158/0008-5472.CAN-06-4356; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026866; Kais Z, 2011, MOL CANCER RES, V9, P1091, DOI 10.1158/1541-7786.MCR-10-0503; Kato T, 2012, LUNG CANCER, V75, P110, DOI 10.1016/j.lungcan.2011.05.024; Liao CC, 2010, J BIOL CHEM, V285, P33134, DOI 10.1074/jbc.M110.143461; Mizutani K, 2005, CANCER-AM CANCER SOC, V103, P1785, DOI 10.1002/cncr.20988; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Simpson F, 2006, EXP CELL RES, V312, P73, DOI 10.1016/j.yexcr.2005.09.020; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113	22	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2013	8	4							e61196	10.1371/journal.pone.0061196	http://dx.doi.org/10.1371/journal.pone.0061196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RK	23593430	Green Submitted, gold, Green Published			2022-12-25	WOS:000319108100080
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600036
